Citrus Sinensis ID: 012518
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 461 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FIM9 | 594 | CDPK-related kinase 4 OS= | yes | no | 0.984 | 0.764 | 0.677 | 1e-178 | |
| Q9SG12 | 594 | CDPK-related kinase 6 OS= | no | no | 0.978 | 0.759 | 0.665 | 1e-167 | |
| Q9ZUZ2 | 595 | CDPK-related kinase 3 OS= | no | no | 0.872 | 0.675 | 0.737 | 1e-165 | |
| Q9SCS2 | 601 | CDPK-related kinase 5 OS= | no | no | 0.861 | 0.660 | 0.671 | 1e-158 | |
| P53681 | 602 | CDPK-related protein kina | N/A | no | 0.965 | 0.739 | 0.610 | 1e-158 | |
| O80673 | 576 | CDPK-related kinase 1 OS= | no | no | 0.956 | 0.765 | 0.590 | 1e-153 | |
| Q9FX86 | 606 | CDPK-related kinase 8 OS= | no | no | 0.978 | 0.744 | 0.556 | 1e-150 | |
| Q9LET1 | 577 | CDPK-related kinase 7 OS= | no | no | 0.839 | 0.670 | 0.643 | 1e-150 | |
| Q9LJL9 | 599 | CDPK-related kinase 2 OS= | no | no | 0.984 | 0.757 | 0.563 | 1e-148 | |
| Q10KY3 | 600 | Calcium/calmodulin-depend | no | no | 0.882 | 0.678 | 0.622 | 1e-148 |
| >sp|Q9FIM9|CAMK4_ARATH CDPK-related kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 626 bits (1614), Expect = e-178, Method: Compositional matrix adjust.
Identities = 321/474 (67%), Positives = 379/474 (79%), Gaps = 20/474 (4%)
Query: 1 MGHCCSKGVN--NDSITPIDH---PKQPTSQPHPASTPRHP----PPDSSSFTCSPFQSP 51
MGHC S+ ++ D P + QP+ AS P+ P P+ +S+ SPFQSP
Sbjct: 1 MGHCYSRNISAVEDDEIPTGNGEVSNQPSQNHRHASIPQSPVASGTPEVNSYNISPFQSP 60
Query: 52 LPAGVAPSP--SPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGD------ 103
LPAGVAPSP +PGRKF+WP PPPSPAKPIM+A++RR G+ Q P++ P D
Sbjct: 61 LPAGVAPSPARTPGRKFKWPFPPPSPAKPIMAALRRRRGAPPQ--PRDEPIPEDSEDVVD 118
Query: 104 -GGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIIS 162
GG +LDKNFG+GKNF K+ELGKEVGRGHFGHTC AK KKG +K + VAVKIIS
Sbjct: 119 HGGDSGGGERLDKNFGFGKNFEGKYELGKEVGRGHFGHTCWAKAKKGKMKNQTVAVKIIS 178
Query: 163 KAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILS 222
KAKMTS L+IEDVRREVK+LKALSGH+HM+KF+D +EDA++V++VME CEGGELLDRIL+
Sbjct: 179 KAKMTSTLSIEDVRREVKLLKALSGHRHMVKFYDVYEDADNVFVVMELCEGGELLDRILA 238
Query: 223 RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282
RGGRY E DAK I+ +IL+ AF HLQGVVHRDLKPENFLFT+R EDA LKVIDFGLSDF
Sbjct: 239 RGGRYPEVDAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSRNEDAILKVIDFGLSDF 298
Query: 283 VRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 342
+R DQRLND+VGSAYYVAPEVLHRSY+ E DMWSIGVI+YILLCGSRPF+ RTES IFR
Sbjct: 299 IRYDQRLNDVVGSAYYVAPEVLHRSYSTEADMWSIGVISYILLCGSRPFYGRTESAIFRC 358
Query: 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
VLRA+PNF D PWPS+SP AKDFV+RLLNKDHRKRMTAAQAL HPWL DEN + LD +
Sbjct: 359 VLRANPNFEDMPWPSISPTAKDFVKRLLNKDHRKRMTAAQALAHPWLRDENPGLLLDFSV 418
Query: 403 YKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPKDGCVSLNNFKV 456
YKLVKSY+RA+P +R+ALKALSKA+ +EELV+L+AQFMLL+PKDG +SLN F +
Sbjct: 419 YKLVKSYIRASPFRRSALKALSKAIPDEELVFLKAQFMLLDPKDGGLSLNCFTM 472
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SG12|CAMK6_ARATH CDPK-related kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 589 bits (1518), Expect = e-167, Method: Compositional matrix adjust.
Identities = 314/472 (66%), Positives = 375/472 (79%), Gaps = 21/472 (4%)
Query: 1 MGHCCSKG---VNNDSITPIDHPKQP--TSQPHPASTPRHPPPDSSS------FTCSPFQ 49
MGHC S+ V++D P + P + Q H ++ P S + + SPFQ
Sbjct: 1 MGHCYSRNISTVDDDDEIPSATAQLPHRSHQNHHQTSSSSSIPQSPATSEVNPYNISPFQ 60
Query: 50 SPLPAGVAPSP--SPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAP-PKEGPTSGDGGV 106
SPLPAGVAPSP +PGRKF+WP PPPSPAKPIM+A++RR G+ AP P++GP D
Sbjct: 61 SPLPAGVAPSPARTPGRKFKWPFPPPSPAKPIMAALRRRRGT---APHPRDGPIPEDSEA 117
Query: 107 KATE----RQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIIS 162
+ +LDKNFG+ KNF K+ELG+EVGRGHFGHTC AK KKG +KG+ VAVKIIS
Sbjct: 118 GGSGGGIGERLDKNFGFAKNFEGKYELGREVGRGHFGHTCWAKAKKGKIKGQTVAVKIIS 177
Query: 163 KAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILS 222
K+KMTSAL+IEDVRREVK+LKALSGH HM+KF+D FED+++V++VME CEGGELLD IL+
Sbjct: 178 KSKMTSALSIEDVRREVKLLKALSGHSHMVKFYDVFEDSDNVFVVMELCEGGELLDSILA 237
Query: 223 RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282
RGGRY E +AK I+ +IL+ AF HLQGVVHRDLKPENFLFT++ EDA LKVIDFGLSD+
Sbjct: 238 RGGRYPEAEAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSKNEDAVLKVIDFGLSDY 297
Query: 283 VRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 342
R DQRLND+VGSAYYVAPEVLHRSY+ E D+WSIGVI+YILLCGSRPF+ RTES IFR
Sbjct: 298 ARFDQRLNDVVGSAYYVAPEVLHRSYSTEADIWSIGVISYILLCGSRPFYGRTESAIFRC 357
Query: 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
VLRA+PNF D PWPS+SP AKDFV+RLLNKDHRKRMTAAQAL HPWL DEN + LD I
Sbjct: 358 VLRANPNFDDLPWPSISPIAKDFVKRLLNKDHRKRMTAAQALAHPWLRDENPGLLLDFSI 417
Query: 403 YKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPKDGCVSLNNF 454
YKLVKSY+RA+P +RAALK+LSKA+ EEELV+L+AQFMLLEP+DG + L+NF
Sbjct: 418 YKLVKSYIRASPFRRAALKSLSKAIPEEELVFLKAQFMLLEPEDGGLHLHNF 469
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUZ2|CAMK3_ARATH CDPK-related kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 582 bits (1499), Expect = e-165, Method: Compositional matrix adjust.
Identities = 304/412 (73%), Positives = 355/412 (86%), Gaps = 10/412 (2%)
Query: 50 SPLPAGVAPSP----SPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGG 105
SPLP+GV+PSP +P R FR P PPPSPAK I +++ +RLG PKEGP + G
Sbjct: 67 SPLPSGVSPSPARTSTPRRFFRRPFPPPSPAKHIKASLIKRLG----VKPKEGPIPEERG 122
Query: 106 VKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAK 165
+ E+ LDK+FGYGKNFGAK+ELGKEVGRGHFGHTC +GKKG +K +AVKIISKAK
Sbjct: 123 TEP-EQSLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSGRGKKGDIKDHPIAVKIISKAK 181
Query: 166 MTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGG 225
MT+A+AIEDVRREVK+LK+LSGHK++IK++DA EDAN+VYIVME C+GGELLDRIL+RGG
Sbjct: 182 MTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACEDANNVYIVMELCDGGELLDRILARGG 241
Query: 226 RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285
+Y E+DAK IV +IL +V+FCHLQGVVHRDLKPENFLFT+ ED+ LK+IDFGLSDF+RP
Sbjct: 242 KYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPENFLFTSSREDSDLKLIDFGLSDFIRP 301
Query: 286 DQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 345
D+RLNDIVGSAYYVAPEVLHRSY++E D+WSIGVITYILLCGSRPFWARTESGIFR+VLR
Sbjct: 302 DERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILLCGSRPFWARTESGIFRTVLR 361
Query: 346 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKL 405
+PN+ D PWPS S E KDFV+RLLNKD+RKRM+A QALTHPWL D++R +PLDILIYKL
Sbjct: 362 TEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMSAVQALTHPWLRDDSRVIPLDILIYKL 421
Query: 406 VKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKV 456
VK+YL ATPL+RAALKAL+KALTE ELVYLRAQFMLL P KDG VSL NFK
Sbjct: 422 VKAYLHATPLRRAALKALAKALTENELVYLRAQFMLLGPNKDGSVSLENFKT 473
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3 an GLN1-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SCS2|CAMK5_ARATH CDPK-related kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 560 bits (1442), Expect = e-158, Method: Compositional matrix adjust.
Identities = 274/408 (67%), Positives = 335/408 (82%), Gaps = 11/408 (2%)
Query: 53 PAGVAPSPSPGRKFRWPLPPPSPAKPIMSAIKRRLGS---GMQAPPKEGPTSGDGGVKAT 109
PA + + +P R F+ P PPPSPAK I + + RR GS A P EG + GGV
Sbjct: 77 PATNSTNSTPKRFFKRPFPPPSPAKHIRAVLARRHGSVKPNSSAIP-EGSEAEGGGVG-- 133
Query: 110 ERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA 169
LDK+FG+ K+F +K+ELG EVGRGHFG+TC AK KKG KG+ VAVK+I KAKMT+A
Sbjct: 134 ---LDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKFKKGDNKGQQVAVKVIPKAKMTTA 190
Query: 170 LAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLE 229
+AIEDVRREVKIL+ALSGH ++ F+DA+ED ++VYIVME CEGGELLDRILSRGG+Y E
Sbjct: 191 IAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYIVMELCEGGELLDRILSRGGKYTE 250
Query: 230 EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL 289
EDAKT++ +ILN+VAFCHLQGVVHRDLKPENFLFT++E+ + LK IDFGLSD+VRPD+RL
Sbjct: 251 EDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSKEDTSQLKAIDFGLSDYVRPDERL 310
Query: 290 NDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN 349
NDIVGSAYYVAPEVLHRSY+ E D+WS+GVI YILLCGSRPFWARTESGIFR+VL+ADP+
Sbjct: 311 NDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLCGSRPFWARTESGIFRAVLKADPS 370
Query: 350 FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP-VPLDILIYKLVKS 408
F D PWP +S EA+DFV+RLLNKD RKR+TAAQAL+HPW+ D N VP+DIL++KL+++
Sbjct: 371 FDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKDSNDAKVPMDILVFKLMRA 430
Query: 409 YLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFK 455
YLR++ L++AAL+ALSK LT +EL YLR QF LLEP K+G +SL N K
Sbjct: 431 YLRSSSLRKAALRALSKTLTVDELFYLREQFALLEPSKNGTISLENIK 478
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53681|CRK_DAUCA CDPK-related protein kinase OS=Daucus carota GN=CRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 560 bits (1442), Expect = e-158, Method: Compositional matrix adjust.
Identities = 288/472 (61%), Positives = 352/472 (74%), Gaps = 27/472 (5%)
Query: 2 GHCCSKGVNNDSITPIDHPKQPTSQPHPASTPRHPPPDSSSFTCSPFQSPLPAG------ 55
H S VN+ S+ P D+ P PA PP S F PF SP PA
Sbjct: 16 NHHTSIPVNDTSLPPQDNSIPPKDIAIPAQDNNKPPGKKSPFL--PFYSPSPAHFLFSKK 73
Query: 56 --VAPSPSPGR-----KFRWPLPPPSPAKPIMSAIKRRLGS---GMQAPPKEGPTSGDGG 105
SP+ G K +P PPPSPAK I +A RR GS A P+ G G
Sbjct: 74 SPAVGSPAAGSSNSTPKRLFPFPPPSPAKHIKAAWARRHGSVKPNEAAIPENNEVDGGAG 133
Query: 106 VKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAK 165
LDK+FG+ K FG+KFE+G+EVGRGHFG+TC AK KKG KG+ VAVK+I KAK
Sbjct: 134 -------LDKSFGFSKKFGSKFEVGEEVGRGHFGYTCRAKFKKGEFKGQDVAVKVIPKAK 186
Query: 166 MTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGG 225
MT+A+AIEDVRREVKIL+AL+GH ++++F+DAFED +VY+VME CEGGELLDRILSRGG
Sbjct: 187 MTTAIAIEDVRREVKILRALTGHNNLVQFYDAFEDHTNVYVVMELCEGGELLDRILSRGG 246
Query: 226 RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285
+Y E+DAK ++ +ILN+VAFCHLQGVVHRDLKPENFLF +++ED+ LK IDFGLSD+V+P
Sbjct: 247 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFKSKDEDSQLKAIDFGLSDYVKP 306
Query: 286 DQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 345
D+RLNDIVGSAYYVAPEVLHRSY+ E D+WSIGVI+YILLCGSRPFWARTESGIFR+VL+
Sbjct: 307 DERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVISYILLCGSRPFWARTESGIFRAVLK 366
Query: 346 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR-PVPLDILIYK 404
A+ +F + PWPSVS EAKDFV+RLLNKD RKRMTAAQAL H W+ + N PLDIL++K
Sbjct: 367 ANLSFDEPPWPSVSSEAKDFVKRLLNKDPRKRMTAAQALCHSWIKNSNDIKFPLDILVFK 426
Query: 405 LVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFK 455
L+K Y+R++PL++AAL+ALSK LT +EL YL+ QF+LLEP K+G +SL N K
Sbjct: 427 LMKVYMRSSPLRKAALRALSKTLTVDELFYLKEQFVLLEPTKNGTISLENIK 478
|
Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80673|CAMK1_ARATH CDPK-related kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 542 bits (1397), Expect = e-153, Method: Compositional matrix adjust.
Identities = 277/469 (59%), Positives = 350/469 (74%), Gaps = 28/469 (5%)
Query: 1 MGHCCSKGVNNDSIT-PIDHPKQPTSQPHPASTPRHPPPDSSSFTCSPFQSPLPA----- 54
MG C K V S + P+ + + + A T PP SS F PF SP P
Sbjct: 1 MGICHGKPVEQQSKSLPV------SGETNEAPTNSQPPAKSSGF---PFYSPSPVPSLFK 51
Query: 55 -----GVAPSPSPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKAT 109
+ S +P R F+ P PPPSPAK I + + RR GS P E S G K
Sbjct: 52 SSPSVSSSVSSTPLRIFKRPFPPPSPAKHIRAFLARRYGS---VKPNE--VSIPEG-KEC 105
Query: 110 ERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA 169
E LDK+FG+ K F + +E+ EVGRGHFG+TC AKGKKG+LKG+ VAVK+I K+KMT+A
Sbjct: 106 EIGLDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQEVAVKVIPKSKMTTA 165
Query: 170 LAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLE 229
+AIEDV REVK+L+AL+GHK++++F+DAFED +VYIVME C+GGELLD+IL RGG+Y E
Sbjct: 166 IAIEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCKGGELLDKILQRGGKYSE 225
Query: 230 EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL 289
+DAK ++ +IL++VA+CHLQGVVHRDLKPENFLF+T++E +PLK IDFGLSD+V+PD+RL
Sbjct: 226 DDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPLKAIDFGLSDYVKPDERL 285
Query: 290 NDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN 349
NDIVGSAYYVAPEVLHR+Y E DMWSIGVI YILLCGSRPFWARTESGIFR+VL+A+PN
Sbjct: 286 NDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKAEPN 345
Query: 350 FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR-PVPLDILIYKLVKS 408
F ++PWPS+SPEA DFV+RLLNKD+RKR+TAAQAL HPWL + +P D++IYKLVK
Sbjct: 346 FEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLVGSHELKIPSDMIIYKLVKV 405
Query: 409 YLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKV 456
Y+ +T L+++AL AL+K LT +L YLR QF LL P K+G +S+ N+K
Sbjct: 406 YIMSTSLRKSALAALAKTLTVPQLAYLREQFTLLGPSKNGYISMQNYKT 454
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3. Confers thermotolerance; involved in the heat-shock-mediated calmodulin-dependent signal transduction leading to the activation of heat-shock transcription factors (HSFs); phosphorylates HSFA1A. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FX86|CAMK8_ARATH CDPK-related kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 531 bits (1368), Expect = e-150, Method: Compositional matrix adjust.
Identities = 272/489 (55%), Positives = 351/489 (71%), Gaps = 38/489 (7%)
Query: 1 MGHCCSK-----GVNNDSITPIDHPKQPTSQP-HPASTPRHPPPDSSSFTCSPFQSPLPA 54
MG C SK G N D+P+ P HP +P P + + PF +P PA
Sbjct: 1 MGGCTSKPSTSSGRPNPFAPGNDYPQIDDFAPDHPGKSPIPTPSAAKASPFFPFYTPSPA 60
Query: 55 ---------------GVAPSPSPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGP 99
+ + +P R+ R PPSPAK I +A++RR G KE
Sbjct: 61 RHRRNKSRDVGGGGESKSLTSTPLRQLRRAFHPPSPAKHIRAALRRRKGK------KEAA 114
Query: 100 TSGDGGVKATERQ--------LDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTL 151
SG + Q LDK FG+ K F ++ ELG+E+GRGHFG+TC AK KKG L
Sbjct: 115 LSGVTQLTTEVPQREEEEEVGLDKRFGFSKEFHSRVELGEEIGRGHFGYTCSAKFKKGEL 174
Query: 152 KGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFC 211
KG+VVAVKII K+KMT+A+AIEDVRREVKIL+ALSGHK++++F+DAFED +VYI ME C
Sbjct: 175 KGQVVAVKIIPKSKMTTAIAIEDVRREVKILQALSGHKNLVQFYDAFEDNANVYIAMELC 234
Query: 212 EGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP 271
EGGELLDRIL+RGG+Y E DAK ++ +ILN+VAFCH QGVVHRDLKPENFL+T++EE++
Sbjct: 235 EGGELLDRILARGGKYSENDAKPVIIQILNVVAFCHFQGVVHRDLKPENFLYTSKEENSQ 294
Query: 272 LKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPF 331
LK IDFGLSDFVRPD+RLNDIVGSAYYVAPEVLHRSY E D+WSIGVI YILLCGSRPF
Sbjct: 295 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADVWSIGVIAYILLCGSRPF 354
Query: 332 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL-- 389
WARTESGIFR+VL+ADP+F + PWP +S +AKDFV+RLL KD R+RM+A+QAL HPW+
Sbjct: 355 WARTESGIFRAVLKADPSFDEPPWPFLSSDAKDFVKRLLFKDPRRRMSASQALMHPWIRA 414
Query: 390 HDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGC 448
++ + +P DILI++ +K+YLR++ L++AAL+ALSK L ++E++YL+ QF LL P KDG
Sbjct: 415 YNTDMNIPFDILIFRQMKAYLRSSSLRKAALRALSKTLIKDEILYLKTQFSLLAPNKDGL 474
Query: 449 VSLNNFKVV 457
++++ ++
Sbjct: 475 ITMDTIRMA 483
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LET1|CAMK7_ARATH CDPK-related kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 530 bits (1365), Expect = e-150, Method: Compositional matrix adjust.
Identities = 254/395 (64%), Positives = 320/395 (81%), Gaps = 8/395 (2%)
Query: 64 RKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNF 123
R F+ P PPPSPAK I + + RR GS P E +G E LDK FG+ K F
Sbjct: 67 RIFKRPFPPPSPAKHIRALLARRHGS---VKPNEASIP-EGS--ECEVGLDKKFGFSKQF 120
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ +E+ EVGRGHFG+TC AKGKKG+LKG+ VAVK+I K+KMT+A+AIEDVRREVKIL+
Sbjct: 121 ASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQDVAVKVIPKSKMTTAIAIEDVRREVKILR 180
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
AL+GHK++++F+DAFED +VYIVME C+GGELLD+IL RGG+Y E DAK ++ +IL++V
Sbjct: 181 ALTGHKNLVQFYDAFEDDENVYIVMELCQGGELLDKILQRGGKYSEVDAKKVMIQILSVV 240
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV 303
A+CHLQGVVHRDLKPENFLFTT++E +PLK IDFGLSD+VRPD+RLNDIVGSAYYVAPEV
Sbjct: 241 AYCHLQGVVHRDLKPENFLFTTKDESSPLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEV 300
Query: 304 LHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363
LHR+Y E DMWSIGVI YILLCGSRPFWAR+ESGIFR+VL+A+PNF ++PWPS+SP+A
Sbjct: 301 LHRTYGTEADMWSIGVIAYILLCGSRPFWARSESGIFRAVLKAEPNFEEAPWPSLSPDAV 360
Query: 364 DFVRRLLNKDHRKRMTAAQALTHPWLHDENR-PVPLDILIYKLVKSYLRATPLKRAALKA 422
DFV+RLLNKD+RKR+TAAQAL HPWL + +P D++IYKLVK Y+ ++ L+++AL A
Sbjct: 361 DFVKRLLNKDYRKRLTAAQALCHPWLVGSHELKIPSDMIIYKLVKVYIMSSSLRKSALAA 420
Query: 423 LSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKV 456
L+K LT +L YL+ QF LL P K+G +S+ N+K
Sbjct: 421 LAKTLTVPQLTYLQEQFNLLGPSKNGYISMQNYKT 455
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJL9|CAMK2_ARATH CDPK-related kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 525 bits (1351), Expect = e-148, Method: Compositional matrix adjust.
Identities = 269/477 (56%), Positives = 343/477 (71%), Gaps = 23/477 (4%)
Query: 1 MGHCCSK---GVNNDSITPIDHPKQ--PTSQPHPASTPRHPPPDSSSFTCSPFQSPLPA- 54
MG C SK V + P D Q ++ HP +P P + PF +P PA
Sbjct: 1 MGGCTSKPSSSVKPNPYAPKDAVLQNDDSTPAHPGKSPVRSSPAVKASPFFPFYTPSPAR 60
Query: 55 -------------GVAPSPSPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTS 101
+ + +P R+ PPSPA+ I ++RR A P
Sbjct: 61 HRRNKSRDGGGGESKSVTSTPLRQLARAFHPPSPARHIRDVLRRRKEKKEAALP--AARQ 118
Query: 102 GDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII 161
+ E LDK FG+ K ++ ELG+E+GRGHFG+TC AK KKG LK + VAVK+I
Sbjct: 119 QKEEEEREEVGLDKRFGFSKELQSRIELGEEIGRGHFGYTCSAKFKKGELKDQEVAVKVI 178
Query: 162 SKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRIL 221
K+KMTSA++IEDVRREVKIL+ALSGH+++++F+DAFED +VYIVME C GGELLDRIL
Sbjct: 179 PKSKMTSAISIEDVRREVKILRALSGHQNLVQFYDAFEDNANVYIVMELCGGGELLDRIL 238
Query: 222 SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281
+RGG+Y E+DAK ++ +ILN+VAFCHLQGVVHRDLKPENFL+T++EE++ LKVIDFGLSD
Sbjct: 239 ARGGKYSEDDAKAVLIQILNVVAFCHLQGVVHRDLKPENFLYTSKEENSMLKVIDFGLSD 298
Query: 282 FVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 341
FVRPD+RLNDIVGSAYYVAPEVLHRSY E D+WSIGVI YILLCGSRPFWARTESGIFR
Sbjct: 299 FVRPDERLNDIVGSAYYVAPEVLHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFR 358
Query: 342 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR-PVPLDI 400
+VL+ADP+F + PWPS+S EAKDFV+RLL KD RKRMTA+QAL HPW+ + +P DI
Sbjct: 359 AVLKADPSFDEPPWPSLSFEAKDFVKRLLYKDPRKRMTASQALMHPWIAGYKKIDIPFDI 418
Query: 401 LIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKV 456
LI+K +K+YLR++ L++AAL ALSK LT +EL+YL+AQF L P K+G ++L++ ++
Sbjct: 419 LIFKQIKAYLRSSSLRKAALMALSKTLTTDELLYLKAQFAHLAPNKNGLITLDSIRL 475
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10KY3|CAMK1_ORYSJ Calcium/calmodulin-dependent serine/threonine-protein kinase 1 OS=Oryza sativa subsp. japonica GN=CAMK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 524 bits (1349), Expect = e-148, Method: Compositional matrix adjust.
Identities = 264/424 (62%), Positives = 337/424 (79%), Gaps = 17/424 (4%)
Query: 37 PPDSSSFTCSPFQSPLPAGVAPSPSPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPK 96
P +SS+ SP S VA +P+ G F+ P PPPSPAK I + + RR GS P
Sbjct: 68 PLPASSYKGSPANS----SVASTPARG-GFKRPFPPPSPAKHIRALLARRHGS---VKPN 119
Query: 97 EG--PTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGK 154
E P SG+ GV LDK FG+ ++F AK+ELG+EVGRGHFG+TC A KKG LKG
Sbjct: 120 EASIPESGEPGV-----ALDKGFGFSRHFAAKYELGREVGRGHFGYTCAATCKKGELKGD 174
Query: 155 VVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGG 214
VAVK+I KAKMT+A+AIEDVRREV+IL +L+GH ++++F+DA+ED +VYIVME C+GG
Sbjct: 175 DVAVKVIPKAKMTTAIAIEDVRREVRILSSLAGHSNLVQFYDAYEDEENVYIVMELCKGG 234
Query: 215 ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274
ELLDRIL+RGG+Y EEDAK ++ +IL++ +FCHLQGVVHRDLKPENFLF++++E++ +KV
Sbjct: 235 ELLDRILARGGKYSEEDAKVVMRQILSVASFCHLQGVVHRDLKPENFLFSSKDENSAMKV 294
Query: 275 IDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWAR 334
IDFGLSDFV+PD+RLNDIVGSAYYVAPEVLHRSY E DMWSIGVI YILLCGSRPFWAR
Sbjct: 295 IDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIVYILLCGSRPFWAR 354
Query: 335 TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH-DEN 393
TESGIFR+VL+ADP+F ++PWP++S EAKDFVRRLLNKD+RKRMTAAQAL HPW+ E
Sbjct: 355 TESGIFRAVLKADPSFEEAPWPTLSAEAKDFVRRLLNKDYRKRMTAAQALCHPWIRGTEE 414
Query: 394 RPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLN 452
+PLD++IY+L+++Y+ ++ L+RAAL+AL+K LT +++ YLR QF L+ P K ++L
Sbjct: 415 VKLPLDMIIYRLMRAYISSSSLRRAALRALAKTLTTDQIYYLREQFELIGPNKSDLITLQ 474
Query: 453 NFKV 456
N K
Sbjct: 475 NLKT 478
|
Possesses kinase activity in vitro. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 461 | ||||||
| 255549160 | 589 | calcium-dependent protein kinase, putati | 0.971 | 0.760 | 0.780 | 0.0 | |
| 356516120 | 599 | PREDICTED: CDPK-related protein kinase-l | 0.971 | 0.747 | 0.744 | 0.0 | |
| 16904222 | 599 | calcium/calmodulin-dependent protein kin | 0.984 | 0.757 | 0.740 | 0.0 | |
| 350534546 | 598 | serine/threonine protein kinase pk23 [So | 0.971 | 0.749 | 0.724 | 0.0 | |
| 357464093 | 588 | Calcium dependent protein kinase-like pr | 0.969 | 0.760 | 0.726 | 0.0 | |
| 356507562 | 597 | PREDICTED: CDPK-related protein kinase-l | 0.978 | 0.755 | 0.758 | 0.0 | |
| 399920247 | 661 | serine/threonine protein kinase [Rosa ru | 0.980 | 0.683 | 0.699 | 0.0 | |
| 225455252 | 592 | PREDICTED: CDPK-related protein kinase i | 0.980 | 0.763 | 0.735 | 0.0 | |
| 449519762 | 609 | PREDICTED: LOW QUALITY PROTEIN: CDPK-rel | 0.874 | 0.661 | 0.769 | 0.0 | |
| 449445491 | 609 | PREDICTED: CDPK-related protein kinase-l | 0.874 | 0.661 | 0.769 | 0.0 |
| >gi|255549160|ref|XP_002515635.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223545273|gb|EEF46780.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1813), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/473 (78%), Positives = 397/473 (83%), Gaps = 25/473 (5%)
Query: 1 MGHCCSK---GVNND--SITPIDH--------PKQPTSQPHPASTPRHPPPDSSSFTCSP 47
MGHCCSK V ND S ++H P + H A TP D SSF SP
Sbjct: 1 MGHCCSKDVTAVRNDGSSAVVVNHNMPPSPPPSPPPPTSVHAAETP-PSVNDDSSFAASP 59
Query: 48 FQSPLPAGVAPSPSP----GRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGD 103
FQSPLPAGV PSPSP GRKFRWPLPPPSPAKPIM+ ++RR PKE P D
Sbjct: 60 FQSPLPAGVRPSPSPARTPGRKFRWPLPPPSPAKPIMAIMRRR------GQPKEVPIPED 113
Query: 104 GGVK-ATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIIS 162
GG +RQLDK+FGY KNF AKFELGKEVGRGHFGHTC AKGKKG LKG+ VAVKIIS
Sbjct: 114 GGDGPEGDRQLDKSFGYPKNFQAKFELGKEVGRGHFGHTCWAKGKKGELKGQSVAVKIIS 173
Query: 163 KAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILS 222
KAKMT+A++IEDVRREVKILKALSGH+HMIKFHDAFEDAN+VYIVME CEGGELLDRILS
Sbjct: 174 KAKMTTAISIEDVRREVKILKALSGHRHMIKFHDAFEDANNVYIVMELCEGGELLDRILS 233
Query: 223 RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282
RGGRY EEDAKTI+ +IL++VAFCHLQGVVHRDLKPENFLFTTR+EDAPLK+IDFGLSDF
Sbjct: 234 RGGRYPEEDAKTIIVQILSVVAFCHLQGVVHRDLKPENFLFTTRDEDAPLKIIDFGLSDF 293
Query: 283 VRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 342
+RPDQRLNDIVGSAYYVAPEVLHRSY VE DMWSIGVITYILLCGSRPFWARTESGIFRS
Sbjct: 294 IRPDQRLNDIVGSAYYVAPEVLHRSYTVEADMWSIGVITYILLCGSRPFWARTESGIFRS 353
Query: 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
VLRADPNF DSPWP+VSPEAKDFV+RLLNKDHRKRMTAAQALTHPWL DE RPVPLDILI
Sbjct: 354 VLRADPNFADSPWPAVSPEAKDFVKRLLNKDHRKRMTAAQALTHPWLRDEKRPVPLDILI 413
Query: 403 YKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPKDGCVSLNNFK 455
YKLVK Y+RATP KRAALKALSKA+ E++L YL+AQF LLEPKDG VSLNNFK
Sbjct: 414 YKLVKLYVRATPFKRAALKALSKAIPEDQLFYLKAQFKLLEPKDGFVSLNNFK 466
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516120|ref|XP_003526744.1| PREDICTED: CDPK-related protein kinase-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1779), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/482 (74%), Positives = 404/482 (83%), Gaps = 34/482 (7%)
Query: 1 MGHCCSK--GVNNDSITPIDHPKQPTSQPH------------------PASTPRHPPPDS 40
MGHCCSK VNN+++ P DH +P PH A+TP P +
Sbjct: 1 MGHCCSKNIAVNNETL-PSDHAPKP---PHYAAATVAVASPPPSGSSISAATPGRNTP-A 55
Query: 41 SSFTCSPFQSPLPAGVAPSP--SPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEG 98
SF+ SPF SPLPAGVAPSP +PGRKFRWPLPPPSPAKPIM+A+ RR G +A PKEG
Sbjct: 56 QSFSMSPFPSPLPAGVAPSPAKTPGRKFRWPLPPPSPAKPIMAALLRRQG---KAKPKEG 112
Query: 99 PT----SGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGK 154
P GG ER LDK+FGYGKNFGAKFELGKEVGRGHFGHTC AKGKKG LKG+
Sbjct: 113 PIPEEQGEGGGGGEGERSLDKSFGYGKNFGAKFELGKEVGRGHFGHTCWAKGKKGDLKGQ 172
Query: 155 VVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGG 214
VAVKIISKAKMTSA+AIEDVRREVK+LKALSGHK+++KF+DAFED N+VYIVME CEGG
Sbjct: 173 SVAVKIISKAKMTSAIAIEDVRREVKMLKALSGHKNLVKFYDAFEDVNNVYIVMELCEGG 232
Query: 215 ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274
ELLDRIL RGGRY E+DAK I+ +IL++VAFCHLQGVVHRDLKPENFLF ++EEDA +KV
Sbjct: 233 ELLDRILDRGGRYPEDDAKAILVQILDVVAFCHLQGVVHRDLKPENFLFVSKEEDAVMKV 292
Query: 275 IDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWAR 334
IDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSY+VEGD+WSIGVI+YILLCGSRPFWAR
Sbjct: 293 IDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYSVEGDLWSIGVISYILLCGSRPFWAR 352
Query: 335 TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394
TESGIFRSVLRA+PNF DSPWPS+SPEAKDFV+RLLNKDHRKRMTAAQAL HPWL +E
Sbjct: 353 TESGIFRSVLRANPNFDDSPWPSISPEAKDFVKRLLNKDHRKRMTAAQALAHPWLRNEKN 412
Query: 395 PVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPKDGCVSLNNF 454
+PLDILIYKLVKSY+RA+PL+RAALK+L+KAL E+EL+YLRAQF LLEPKDGC+SL NF
Sbjct: 413 AIPLDILIYKLVKSYVRASPLRRAALKSLAKALNEDELIYLRAQFNLLEPKDGCISLENF 472
Query: 455 KV 456
+V
Sbjct: 473 RV 474
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|16904222|gb|AAL30818.1|AF435450_1 calcium/calmodulin-dependent protein kinase CaMK1 [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1772), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/478 (74%), Positives = 395/478 (82%), Gaps = 24/478 (5%)
Query: 1 MGHCCSKGVNNDS----ITPIDHPKQPTSQPHPASTPRHPPPDS--------------SS 42
MGHCCSKGV D+ ++ +D ++ P +P P S S
Sbjct: 1 MGHCCSKGVTADNDGHVVSVVDGNSSVSTNNRPKPSPSPARPQSVGNGTSYTNNNTPAHS 60
Query: 43 FTCSPFQSPLPAGVAPSPSP----GRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEG 98
FT SPFQSP PAG+ PSPSP RKF+WP PPPSPAKPI+SAI +R G+ A PKEG
Sbjct: 61 FTTSPFQSPYPAGIPPSPSPVGTARRKFKWPFPPPSPAKPILSAILKRQGT-TSAKPKEG 119
Query: 99 PTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAV 158
P D G + ERQLDK+FGY KN AK ELGKEVGRGHFGHTC AKGKKG LK + VAV
Sbjct: 120 PIPEDEGGEG-ERQLDKSFGYPKNLTAKIELGKEVGRGHFGHTCWAKGKKGELKNQPVAV 178
Query: 159 KIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLD 218
KIISKAKMT+A++IEDVRREVKILKALSGH++++KF+DAFEDAN+VYIVME CEGG LLD
Sbjct: 179 KIISKAKMTTAISIEDVRREVKILKALSGHQNLVKFYDAFEDANNVYIVMELCEGGVLLD 238
Query: 219 RILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278
RILSRGGRY EEDAK+I+ +ILN+VAFCHLQGVVHRDLKPENFLFT +EEDAP+KVIDFG
Sbjct: 239 RILSRGGRYTEEDAKSILVQILNVVAFCHLQGVVHRDLKPENFLFTKKEEDAPMKVIDFG 298
Query: 279 LSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESG 338
LSDF+RPDQRLNDIVGSAYYVAPEVLHRSY++E DMWSIGVITYILLCGSRPFWARTESG
Sbjct: 299 LSDFIRPDQRLNDIVGSAYYVAPEVLHRSYSIEADMWSIGVITYILLCGSRPFWARTESG 358
Query: 339 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPL 398
IFRSVLRADPNF DSPWPSVS EA+DFV+RLLNKDHRKRMTA+QAL HPWL EN +PL
Sbjct: 359 IFRSVLRADPNFEDSPWPSVSAEARDFVKRLLNKDHRKRMTASQALAHPWLRTENPVLPL 418
Query: 399 DILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPKDGCVSLNNFKV 456
DILI+KLVKSY RA+PLKRAALKALSKALTEEEL+YLRAQF LLEPKDG VSLNNFK+
Sbjct: 419 DILIFKLVKSYTRASPLKRAALKALSKALTEEELIYLRAQFNLLEPKDGRVSLNNFKM 476
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350534546|ref|NP_001234146.1| serine/threonine protein kinase pk23 [Solanum lycopersicum] gi|19547871|gb|AAL87457.1| serine/threonine protein kinase pk23 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 678 bits (1749), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/483 (72%), Positives = 397/483 (82%), Gaps = 35/483 (7%)
Query: 1 MGHCCSKGVN-------------NDSITPIDHPKQPTSQPHPA----------STPRHPP 37
MG CCSKGV+ N +++ + PK P S + STP H
Sbjct: 1 MGQCCSKGVSGENGGSVVAIGDGNSAVSTNNRPKPPPSPVRQSVGNGMSYTNNSTPAH-- 58
Query: 38 PDSSSFTCSPFQSPLPAGVAPSPSP----GRKFRWPLPPPSPAKPIMSAIKRRLGSGMQA 93
SFT SPFQSP PAG+APSPSP RKF+WP PPPSPAKPI+SAI +R G G
Sbjct: 59 ----SFTASPFQSPYPAGIAPSPSPVGTPRRKFKWPFPPPSPAKPILSAIFKRQG-GTSV 113
Query: 94 PPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKG 153
PKEGP D G + ERQLDK+FGY KN +K+ELGKEVGRGHFGHTC AKGKKG LK
Sbjct: 114 KPKEGPIPEDEGGEG-ERQLDKSFGYPKNLTSKYELGKEVGRGHFGHTCWAKGKKGELKN 172
Query: 154 KVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEG 213
+ VAVKIISKAKMT+A++IEDVRREVKILKALSGH++++KF+DAFEDAN+VYIVME CEG
Sbjct: 173 QPVAVKIISKAKMTTAISIEDVRREVKILKALSGHQNLVKFYDAFEDANNVYIVMELCEG 232
Query: 214 GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 273
GELLDRILSRGGRY EEDAK+IV +ILN+VAFCHLQGVVHRDLKPENFLF ++ED+P+K
Sbjct: 233 GELLDRILSRGGRYTEEDAKSIVVQILNVVAFCHLQGVVHRDLKPENFLFAKKDEDSPMK 292
Query: 274 VIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWA 333
VIDFGLSDF++PDQRLNDIVGSAYYVAPEVLHRSY++E DMWSIGVITYILLCGSRPFWA
Sbjct: 293 VIDFGLSDFIKPDQRLNDIVGSAYYVAPEVLHRSYSIEADMWSIGVITYILLCGSRPFWA 352
Query: 334 RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393
RTESGIFRSVLRADPNF DSPWP+VS EA+DFV+RLLNKDHRKRMTA+QALTHPWL EN
Sbjct: 353 RTESGIFRSVLRADPNFEDSPWPAVSAEARDFVKRLLNKDHRKRMTASQALTHPWLRTEN 412
Query: 394 RPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPKDGCVSLNN 453
VPLDILI+KLVKSY+R +PLKRAALKALSKALTEEEL+YL+AQF LLEPK G VSL+N
Sbjct: 413 PFVPLDILIFKLVKSYIRTSPLKRAALKALSKALTEEELIYLKAQFNLLEPKAGFVSLDN 472
Query: 454 FKV 456
F++
Sbjct: 473 FRM 475
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357464093|ref|XP_003602328.1| Calcium dependent protein kinase-like protein [Medicago truncatula] gi|355491376|gb|AES72579.1| Calcium dependent protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1726), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/476 (72%), Positives = 387/476 (81%), Gaps = 29/476 (6%)
Query: 1 MGHCCSKGVNNDSITPIDHP---------------KQPTSQPHPASTPRHPPPDSSSFTC 45
MGHCCSK + D+ T QP S A+ R P ++SF+
Sbjct: 1 MGHCCSKSIAVDNETVATDHHHKPPPHHTPSPLSVSQPVSGVSDATPGRQTP--ATSFST 58
Query: 46 SPFQSPLPAGVAPSP---SPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPT-- 100
SPF SPLPAGV PSP +PGRKFRWPLPPPSPAKPIM ++ PK+GP
Sbjct: 59 SPFNSPLPAGVMPSPATKTPGRKFRWPLPPPSPAKPIMDLYRK-------MKPKDGPIPE 111
Query: 101 SGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKI 160
G ER LDK+FGYGKNFGAKFELGKEVGRGHFGHTC AKGKKG LKG VAVKI
Sbjct: 112 EHGEGGGGGERTLDKSFGYGKNFGAKFELGKEVGRGHFGHTCWAKGKKGELKGISVAVKI 171
Query: 161 ISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRI 220
I+KAKMTSA+AIEDVRREVK+LKALSGH++++KF+DAFED N+VYIVME CEGGELLDRI
Sbjct: 172 ITKAKMTSAIAIEDVRREVKMLKALSGHRNLVKFYDAFEDVNNVYIVMELCEGGELLDRI 231
Query: 221 LSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280
L RGGRY EEDAK I+ +ILN+VAFCHLQGVVHRDLKPENFLF +++EDA LKVIDFGLS
Sbjct: 232 LDRGGRYTEEDAKVILLQILNVVAFCHLQGVVHRDLKPENFLFVSKDEDAVLKVIDFGLS 291
Query: 281 DFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 340
DFVRP+QRLNDIVGSAYYVAPEVLHRSY+VE D+WS+GVI+YILLCGSRPFWARTESGIF
Sbjct: 292 DFVRPEQRLNDIVGSAYYVAPEVLHRSYSVEADLWSVGVISYILLCGSRPFWARTESGIF 351
Query: 341 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDI 400
RSVLRA+PNF DSPWPS+SPEAKDFV+RLLNKDHRKRMTAAQAL+HPWL DE VPLDI
Sbjct: 352 RSVLRANPNFDDSPWPSISPEAKDFVKRLLNKDHRKRMTAAQALSHPWLRDEKNVVPLDI 411
Query: 401 LIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPKDGCVSLNNFKV 456
LIYKLVKSY+RA+PLKRAALKALSKAL +E+ YLRAQF LLEPKDGC+SL NF+V
Sbjct: 412 LIYKLVKSYVRASPLKRAALKALSKALPVDEVTYLRAQFSLLEPKDGCISLENFRV 467
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507562|ref|XP_003522533.1| PREDICTED: CDPK-related protein kinase-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1720), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/477 (75%), Positives = 407/477 (85%), Gaps = 26/477 (5%)
Query: 1 MGHCCSK--GVNNDSITPIDH-PKQPTSQPHPASTPRHPPPDSS-------------SFT 44
MGHCCSK VNN+++ P DH PK P A++P PP SS SF+
Sbjct: 1 MGHCCSKNIAVNNETL-PADHAPKPPHYAAAVAASPL-PPSGSSVSAATPGRNTPAQSFS 58
Query: 45 CSPFQSPLPAGVAPSP--SPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPT-- 100
SPF SPLPAG+APSP +PGRKFRWPLPPPSPAKPIM+A+ RR G +A PKEGP
Sbjct: 59 MSPFPSPLPAGMAPSPARTPGRKFRWPLPPPSPAKPIMAALLRRQG---KAKPKEGPIPE 115
Query: 101 -SGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVK 159
G+GG ER LDK+FGYGKNFGAKFELGKEVGRGHFGHTC AKGKKG LKG+ VAVK
Sbjct: 116 EQGEGGGGEGERSLDKSFGYGKNFGAKFELGKEVGRGHFGHTCWAKGKKGDLKGQSVAVK 175
Query: 160 IISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDR 219
IISKAKMTSA+AIEDVRREVK+LKALSGHK+++KF+DAFED N+VYIVME CEGGELLDR
Sbjct: 176 IISKAKMTSAIAIEDVRREVKMLKALSGHKNLVKFYDAFEDVNNVYIVMELCEGGELLDR 235
Query: 220 ILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279
IL RGGRY E+DAK I+ +IL++VAFCHLQGVVHRDLKPENFLF ++EEDA +KVIDFGL
Sbjct: 236 ILDRGGRYPEDDAKAILVQILDVVAFCHLQGVVHRDLKPENFLFVSKEEDAVMKVIDFGL 295
Query: 280 SDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGI 339
SDFVRPDQRLNDIVGSAYYVAPEVLHRSY+VEGD+WSIGVI+YILLCGSRPFWARTESGI
Sbjct: 296 SDFVRPDQRLNDIVGSAYYVAPEVLHRSYSVEGDLWSIGVISYILLCGSRPFWARTESGI 355
Query: 340 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLD 399
FRSVLRA+PNF DSPWPS+SPEAKDFV+RLLNKDHRKRMTAAQAL HPWL +E +PLD
Sbjct: 356 FRSVLRANPNFDDSPWPSISPEAKDFVKRLLNKDHRKRMTAAQALAHPWLRNEKNAIPLD 415
Query: 400 ILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPKDGCVSLNNFKV 456
ILIYKLVKSY+RA+PL+RAALKAL+KALTE+EL+YLRAQF LLEPKDGC+ L NF+V
Sbjct: 416 ILIYKLVKSYVRASPLRRAALKALAKALTEDELIYLRAQFNLLEPKDGCILLENFRV 472
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|399920247|gb|AFP55594.1| serine/threonine protein kinase [Rosa rugosa] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1718), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/505 (69%), Positives = 394/505 (78%), Gaps = 53/505 (10%)
Query: 1 MGHCCSKGV-------NNDSITPIDHPKQPTSQPHPASTPRHPPPD-----SSSFTCSPF 48
MGHCCSK N+D TP S+ P D S SFT SPF
Sbjct: 1 MGHCCSKSAAVSVANNNHDHPTPAAAVSVQQSKHPPVPPSPVAAGDVKNTPSHSFTASPF 60
Query: 49 QSPLPAGVAPSP--SPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGG- 105
SPLPAGVAPSP +PGRKFRWPLPPPSPAKPIM+A +RR +A PK+GP +
Sbjct: 61 PSPLPAGVAPSPARTPGRKFRWPLPPPSPAKPIMAAFRRR----REAKPKDGPIPEENNH 116
Query: 106 ---VKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIIS 162
+ ER LDK+FGYGKNFGAKFELGKEVGRGHFGHTC AKGKKG LKG+ VAVKIIS
Sbjct: 117 QGGEEEGERGLDKSFGYGKNFGAKFELGKEVGRGHFGHTCSAKGKKGELKGQPVAVKIIS 176
Query: 163 KAK-------------------------------MTSALAIEDVRREVKILKALSGHKHM 191
KAK MT+A+AIEDVRREVKILKALSGHK++
Sbjct: 177 KAKYIIKYAFSAAKRERLNVALWVMEHISSVMLHMTTAIAIEDVRREVKILKALSGHKNL 236
Query: 192 IKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 251
+KF+DAFEDAN+VYIVME CEGGELLD+ILSRGGRY EEDAK IV +IL++VA+CHLQGV
Sbjct: 237 VKFYDAFEDANNVYIVMELCEGGELLDKILSRGGRYTEEDAKVIVVQILSVVAYCHLQGV 296
Query: 252 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVE 311
VHRDLKPENFLF TREEDA ++VIDFGLSDF+RPDQRLNDIVGSAYYVAPEVLHRSY+VE
Sbjct: 297 VHRDLKPENFLFATREEDASMRVIDFGLSDFIRPDQRLNDIVGSAYYVAPEVLHRSYSVE 356
Query: 312 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 371
DMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF+D+PWP+VSPEAKDFV+RLLN
Sbjct: 357 ADMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFNDTPWPTVSPEAKDFVKRLLN 416
Query: 372 KDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEE 431
KDHRKRMTAAQALTHPWL DE R VPLD++IYK V+SY+RATP +RAA+KALSKA+TE+E
Sbjct: 417 KDHRKRMTAAQALTHPWLRDERRAVPLDLVIYKSVRSYVRATPFRRAAMKALSKAITEDE 476
Query: 432 LVYLRAQFMLLEPKDGCVSLNNFKV 456
L YLRAQF LLEPK G VSL+NF+
Sbjct: 477 LYYLRAQFTLLEPKHGYVSLDNFRT 501
|
Source: Rosa rugosa Species: Rosa rugosa Genus: Rosa Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455252|ref|XP_002273024.1| PREDICTED: CDPK-related protein kinase isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1709), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/472 (73%), Positives = 392/472 (83%), Gaps = 20/472 (4%)
Query: 1 MGHCCSKG---VNNDSI---TPIDHPKQPTS----QPHPASTPRHPPPDSSSFTC-SPF- 48
MGHCCSK V +D++ + +PT+ + A + P S + C SP+
Sbjct: 1 MGHCCSKDISVVKDDTVAGESAAGIGGKPTAPLRLVGNGAVDVKRTPAHSFNSPCPSPYP 60
Query: 49 --QSPLPAGVAPSP--SPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDG 104
SPLP G+APSP +P + RWP PPPSPAKPIMS+I +R GS A PKEGP +G
Sbjct: 61 QGSSPLPPGIAPSPARTPRSRVRWPFPPPSPAKPIMSSILKRRGS---AKPKEGPIPEEG 117
Query: 105 GVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA 164
+ E QLDK+FGY KNF +KFELGKEVGRGHFGHTC A+GKKG LKG+ VAVKIISKA
Sbjct: 118 AGEG-ETQLDKSFGYAKNFSSKFELGKEVGRGHFGHTCWARGKKGELKGQTVAVKIISKA 176
Query: 165 KMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG 224
KMT+A+AIEDVRREVKILKALS HK+++KFHDA EDA++VYI+ME CEGGELLDRILSRG
Sbjct: 177 KMTTAIAIEDVRREVKILKALSVHKNLVKFHDACEDASNVYIIMELCEGGELLDRILSRG 236
Query: 225 GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284
GRY EEDAK IV +ILN+VAFCHLQGVVHRDLKPENFLFTTR+EDAP+KVIDFGLSDF+R
Sbjct: 237 GRYREEDAKAIVVQILNVVAFCHLQGVVHRDLKPENFLFTTRDEDAPMKVIDFGLSDFIR 296
Query: 285 PDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 344
DQRLNDIVGSAYYVAPEVLHRSYN+E D+WSIGVITYILLCGSRPFWARTESGIFRSVL
Sbjct: 297 TDQRLNDIVGSAYYVAPEVLHRSYNLEADVWSIGVITYILLCGSRPFWARTESGIFRSVL 356
Query: 345 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYK 404
RADPNF D PWP+VSPEAKDFV+RLLNKD+RKRMTAAQALTHPWL DEN VPLDIL+YK
Sbjct: 357 RADPNFDDLPWPAVSPEAKDFVKRLLNKDYRKRMTAAQALTHPWLRDENHAVPLDILVYK 416
Query: 405 LVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPKDGCVSLNNFKV 456
LVKSY+R +P KRAALKALSKALTE+ELVYLRAQF LLEPK+G VSL NFK+
Sbjct: 417 LVKSYVRVSPFKRAALKALSKALTEDELVYLRAQFRLLEPKNGRVSLENFKM 468
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449519762|ref|XP_004166903.1| PREDICTED: LOW QUALITY PROTEIN: CDPK-related protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 646 bits (1666), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/412 (76%), Positives = 358/412 (86%), Gaps = 9/412 (2%)
Query: 50 SPLPAGVAPSP----SPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGG 105
SPLP GV+PSP +PGR F+ PPSPAK I +++ +R G PKEGP + G
Sbjct: 81 SPLPVGVSPSPARASTPGRXFKRRFAPPSPAKHIKASLAKRFG---YTKPKEGPIPEERG 137
Query: 106 VKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAK 165
+ E+ LDK+FGYGKNFGAK+ELGKEVGRGHFGHTC AKGKKG L+ + VAVKIISKAK
Sbjct: 138 AEP-EQLLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSAKGKKGELRDQPVAVKIISKAK 196
Query: 166 MTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGG 225
MT+A++IEDVRREVKILK+LSGHKH++KFHDA EDAN+VYIVME CEGGELLDRILSRGG
Sbjct: 197 MTTAISIEDVRREVKILKSLSGHKHLVKFHDACEDANNVYIVMELCEGGELLDRILSRGG 256
Query: 226 RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285
RY EEDAK IV +IL++VAFCHLQGVVHRDLKPENFLFT+R EDA +K+IDFGLSDFVRP
Sbjct: 257 RYTEEDAKNIVVQILSVVAFCHLQGVVHRDLKPENFLFTSRSEDADMKLIDFGLSDFVRP 316
Query: 286 DQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 345
D+RLNDIVGSAYYVAPEVLHRSY +E D+WSIGVITYILLCGSRPFWARTESGIFR+VLR
Sbjct: 317 DERLNDIVGSAYYVAPEVLHRSYTLEADIWSIGVITYILLCGSRPFWARTESGIFRAVLR 376
Query: 346 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKL 405
ADPNF D PWPSVSPEAKDFV+RLLNKD+RKRMTA QALTHPWL D++R +PLDILIYKL
Sbjct: 377 ADPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLQDDSRRIPLDILIYKL 436
Query: 406 VKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPK-DGCVSLNNFKV 456
VKSYL+ATP KRAA+KALSKAL+E EL YLRAQF LLEP DG V L+NFK+
Sbjct: 437 VKSYLQATPFKRAAMKALSKALSETELFYLRAQFALLEPNHDGRVGLDNFKM 488
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449445491|ref|XP_004140506.1| PREDICTED: CDPK-related protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/412 (76%), Positives = 358/412 (86%), Gaps = 9/412 (2%)
Query: 50 SPLPAGVAPSP----SPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGG 105
SPLP GV+PSP +PGR F+ PPSPAK I +++ +R G PKEGP + G
Sbjct: 81 SPLPVGVSPSPARASTPGRFFKRRFAPPSPAKHIKASLAKRFG---YTKPKEGPIPEERG 137
Query: 106 VKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAK 165
+ E+ LDK+FGYGKNFGAK+ELGKEVGRGHFGHTC AKGKKG L+ + VAVKIISKAK
Sbjct: 138 AEP-EQLLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSAKGKKGELRDQPVAVKIISKAK 196
Query: 166 MTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGG 225
MT+A++IEDVRREVKILK+LSGHKH++KFHDA EDAN+VYIVME CEGGELLDRILSRGG
Sbjct: 197 MTTAISIEDVRREVKILKSLSGHKHLVKFHDACEDANNVYIVMELCEGGELLDRILSRGG 256
Query: 226 RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285
RY EEDAK IV +IL++VAFCHLQGVVHRDLKPENFLFT+R EDA +K+IDFGLSDFVRP
Sbjct: 257 RYTEEDAKNIVVQILSVVAFCHLQGVVHRDLKPENFLFTSRSEDADMKLIDFGLSDFVRP 316
Query: 286 DQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 345
D+RLNDIVGSAYYVAPEVLHRSY +E D+WSIGVITYILLCGSRPFWARTESGIFR+VLR
Sbjct: 317 DERLNDIVGSAYYVAPEVLHRSYTLEADIWSIGVITYILLCGSRPFWARTESGIFRAVLR 376
Query: 346 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKL 405
ADPNF D PWPSVSPEAKDFV+RLLNKD+RKRMTA QALTHPWL D++R +PLDILIYKL
Sbjct: 377 ADPNFDDLPWPSVSPEAKDFVKRLLNKDYRKRMTAVQALTHPWLQDDSRRIPLDILIYKL 436
Query: 406 VKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPK-DGCVSLNNFKV 456
VKSYL+ATP KRAA+KALSKAL+E EL YLRAQF LLEP DG V L+NFK+
Sbjct: 437 VKSYLQATPFKRAAMKALSKALSETELFYLRAQFALLEPNHDGRVGLDNFKM 488
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 461 | ||||||
| TAIR|locus:2152876 | 594 | AT5G24430 [Arabidopsis thalian | 0.980 | 0.760 | 0.612 | 3e-149 | |
| TAIR|locus:2062764 | 595 | CRK3 "AT2G46700" [Arabidopsis | 0.878 | 0.680 | 0.663 | 5.7e-146 | |
| TAIR|locus:2082931 | 594 | AT3G49370 [Arabidopsis thalian | 0.976 | 0.757 | 0.602 | 9.3e-146 | |
| TAIR|locus:2063197 | 576 | CRK1 "AT2G41140" [Arabidopsis | 0.971 | 0.777 | 0.536 | 1.3e-123 | |
| TAIR|locus:2103655 | 577 | AT3G56760 [Arabidopsis thalian | 0.973 | 0.778 | 0.534 | 3.5e-123 | |
| TAIR|locus:2012232 | 606 | AT1G49580 [Arabidopsis thalian | 0.854 | 0.650 | 0.565 | 4e-121 | |
| TAIR|locus:2094053 | 599 | AT3G19100 [Arabidopsis thalian | 0.854 | 0.657 | 0.567 | 1.2e-119 | |
| TAIR|locus:2827826 | 571 | CPK16 "AT2G17890" [Arabidopsis | 0.731 | 0.590 | 0.488 | 1.8e-87 | |
| TAIR|locus:2156947 | 523 | CPK28 "calcium-dependent prote | 0.731 | 0.644 | 0.485 | 9.1e-84 | |
| TAIR|locus:2177023 | 528 | CPK17 "calcium-dependent prote | 0.661 | 0.577 | 0.448 | 2e-73 |
| TAIR|locus:2152876 AT5G24430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1457 (517.9 bits), Expect = 3.0e-149, P = 3.0e-149
Identities = 289/472 (61%), Positives = 340/472 (72%)
Query: 1 MGHCCSKGVN--NDSITPIDHPK---QPTSQXXXXXX----XXXXXXDSSSFTCSPFQSP 51
MGHC S+ ++ D P + + QP+ + +S+ SPFQSP
Sbjct: 1 MGHCYSRNISAVEDDEIPTGNGEVSNQPSQNHRHASIPQSPVASGTPEVNSYNISPFQSP 60
Query: 52 LPAGVAPSPS--PGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGD------ 103
LPAGVAPSP+ PGRKF+WP PPPSPAKPIM+A++RR G+ Q P++ P D
Sbjct: 61 LPAGVAPSPARTPGRKFKWPFPPPSPAKPIMAALRRRRGAPPQ--PRDEPIPEDSEDVVD 118
Query: 104 -GGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAXXXXXXXXXXXXXXXXXX 162
GG +LDKNFG+GKNF K+ELGKEVGRGHFGHTC A
Sbjct: 119 HGGDSGGGERLDKNFGFGKNFEGKYELGKEVGRGHFGHTCWAKAKKGKMKNQTVAVKIIS 178
Query: 163 XXXMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILS 222
MTS L+IEDVRREVK+LKALSGH+HM+KF+D +EDA++V++VME CEGGELLDRIL+
Sbjct: 179 KAKMTSTLSIEDVRREVKLLKALSGHRHMVKFYDVYEDADNVFVVMELCEGGELLDRILA 238
Query: 223 RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282
RGGRY E DAK I+ +IL+ AF HLQGVVHRDLKPENFLFT+R EDA LKVIDFGLSDF
Sbjct: 239 RGGRYPEVDAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSRNEDAILKVIDFGLSDF 298
Query: 283 VRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 342
+R DQRLND+VGSAYYVAPEVLHRSY+ E DMWSIGVI+YILLCGSRPF+ RTES IFR
Sbjct: 299 IRYDQRLNDVVGSAYYVAPEVLHRSYSTEADMWSIGVISYILLCGSRPFYGRTESAIFRC 358
Query: 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
VLRA+PNF D PWPS+SP AKDFV+RLLNKDHRKRMTAAQAL HPWL DEN + LD +
Sbjct: 359 VLRANPNFEDMPWPSISPTAKDFVKRLLNKDHRKRMTAAQALAHPWLRDENPGLLLDFSV 418
Query: 403 YKLVKSYLRATPXXXXXXXXXXXXXXXXXXVYLRAQFMLLEPKDGCVSLNNF 454
YKLVKSY+RA+P V+L+AQFMLL+PKDG +SLN F
Sbjct: 419 YKLVKSYIRASPFRRSALKALSKAIPDEELVFLKAQFMLLDPKDGGLSLNCF 470
|
|
| TAIR|locus:2062764 CRK3 "AT2G46700" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1426 (507.0 bits), Expect = 5.7e-146, P = 5.7e-146
Identities = 278/419 (66%), Positives = 324/419 (77%)
Query: 46 SPFQ----SPLPAGVAPSPS----PGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKE 97
SPF SPLP+GV+PSP+ P R FR P PPPSPAK I +++ +RLG PKE
Sbjct: 59 SPFPHGSASPLPSGVSPSPARTSTPRRFFRRPFPPPSPAKHIKASLIKRLG----VKPKE 114
Query: 98 GPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAXXXXXXXXXXXXX 157
GP + G + E+ LDK+FGYGKNFGAK+ELGKEVGRGHFGHTC
Sbjct: 115 GPIPEERGTEP-EQSLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSGRGKKGDIKDHPIA 173
Query: 158 XXXXXXXXMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELL 217
MT+A+AIEDVRREVK+LK+LSGHK++IK++DA EDAN+VYIVME C+GGELL
Sbjct: 174 VKIISKAKMTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACEDANNVYIVMELCDGGELL 233
Query: 218 DRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277
DRIL+RGG+Y E+DAK IV +IL +V+FCHLQGVVHRDLKPENFLFT+ ED+ LK+IDF
Sbjct: 234 DRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPENFLFTSSREDSDLKLIDF 293
Query: 278 GLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTES 337
GLSDF+RPD+RLNDIVGSAYYVAPEVLHRSY++E D+WSIGVITYILLCGSRPFWARTES
Sbjct: 294 GLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILLCGSRPFWARTES 353
Query: 338 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397
GIFR+VLR +PN+ D PWPS S E KDFV+RLLNKD+RKRM+A QALTHPWL D++R +P
Sbjct: 354 GIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMSAVQALTHPWLRDDSRVIP 413
Query: 398 LDILIYKLVKSYLRATPXXXXXXXXXXXXXXXXXXVYLRAQFMLLEP-KDGCVSLNNFK 455
LDILIYKLVK+YL ATP VYLRAQFMLL P KDG VSL NFK
Sbjct: 414 LDILIYKLVKAYLHATPLRRAALKALAKALTENELVYLRAQFMLLGPNKDGSVSLENFK 472
|
|
| TAIR|locus:2082931 AT3G49370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1424 (506.3 bits), Expect = 9.3e-146, P = 9.3e-146
Identities = 285/473 (60%), Positives = 337/473 (71%)
Query: 1 MGHCCSKG---VNNDSITPI--------DHPKQPTSQXXXXXXXXXXXXDSSSFTCSPFQ 49
MGHC S+ V++D P H + + + + SPFQ
Sbjct: 1 MGHCYSRNISTVDDDDEIPSATAQLPHRSHQNHHQTSSSSSIPQSPATSEVNPYNISPFQ 60
Query: 50 SPLPAGVAPSPS--PGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAP-PKEGPT-----S 101
SPLPAGVAPSP+ PGRKF+WP PPPSPAKPIM+A++RR G+ AP P++GP +
Sbjct: 61 SPLPAGVAPSPARTPGRKFKWPFPPPSPAKPIMAALRRRRGT---APHPRDGPIPEDSEA 117
Query: 102 GDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAXXXXXXXXXXXXXXXXX 161
G G ER LDKNFG+ KNF K+ELG+EVGRGHFGHTC A
Sbjct: 118 GGSGGGIGER-LDKNFGFAKNFEGKYELGREVGRGHFGHTCWAKAKKGKIKGQTVAVKII 176
Query: 162 XXXXMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRIL 221
MTSAL+IEDVRREVK+LKALSGH HM+KF+D FED+++V++VME CEGGELLD IL
Sbjct: 177 SKSKMTSALSIEDVRREVKLLKALSGHSHMVKFYDVFEDSDNVFVVMELCEGGELLDSIL 236
Query: 222 SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281
+RGGRY E +AK I+ +IL+ AF HLQGVVHRDLKPENFLFT++ EDA LKVIDFGLSD
Sbjct: 237 ARGGRYPEAEAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSKNEDAVLKVIDFGLSD 296
Query: 282 FVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 341
+ R DQRLND+VGSAYYVAPEVLHRSY+ E D+WSIGVI+YILLCGSRPF+ RTES IFR
Sbjct: 297 YARFDQRLNDVVGSAYYVAPEVLHRSYSTEADIWSIGVISYILLCGSRPFYGRTESAIFR 356
Query: 342 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDIL 401
VLRA+PNF D PWPS+SP AKDFV+RLLNKDHRKRMTAAQAL HPWL DEN + LD
Sbjct: 357 CVLRANPNFDDLPWPSISPIAKDFVKRLLNKDHRKRMTAAQALAHPWLRDENPGLLLDFS 416
Query: 402 IYKLVKSYLRATPXXXXXXXXXXXXXXXXXXVYLRAQFMLLEPKDGCVSLNNF 454
IYKLVKSY+RA+P V+L+AQFMLLEP+DG + L+NF
Sbjct: 417 IYKLVKSYIRASPFRRAALKSLSKAIPEEELVFLKAQFMLLEPEDGGLHLHNF 469
|
|
| TAIR|locus:2063197 CRK1 "AT2G41140" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1215 (432.8 bits), Expect = 1.3e-123, P = 1.3e-123
Identities = 247/460 (53%), Positives = 312/460 (67%)
Query: 1 MGHCCSKGVNNDSIT-PI--DHPKQPTSQXXXXXXXXXXXXDSSSFTCSPFQSPLPAGVA 57
MG C K V S + P+ + + PT+ S S F+S +
Sbjct: 1 MGICHGKPVEQQSKSLPVSGETNEAPTNSQPPAKSSGFPFYSPSPVP-SLFKSSPSVSSS 59
Query: 58 PSPSPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNF 117
S +P R F+ P PPPSPAK I + + RR GS P E S G K E LDK+F
Sbjct: 60 VSSTPLRIFKRPFPPPSPAKHIRAFLARRYGS---VKPNE--VSIPEG-KECEIGLDKSF 113
Query: 118 GYGKNFGAKFELGKEVGRGHFGHTCCAXXXXXXXXXXXXXXXXXXXXXMTSALAIEDVRR 177
G+ K F + +E+ EVGRGHFG+TC A MT+A+AIEDV R
Sbjct: 114 GFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQEVAVKVIPKSKMTTAIAIEDVSR 173
Query: 178 EVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE 237
EVK+L+AL+GHK++++F+DAFED +VYIVME C+GGELLD+IL RGG+Y E+DAK ++
Sbjct: 174 EVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCKGGELLDKILQRGGKYSEDDAKKVMV 233
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY 297
+IL++VA+CHLQGVVHRDLKPENFLF+T++E +PLK IDFGLSD+V+PD+RLNDIVGSAY
Sbjct: 234 QILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPLKAIDFGLSDYVKPDERLNDIVGSAY 293
Query: 298 YVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357
YVAPEVLHR+Y E DMWSIGVI YILLCGSRPFWARTESGIFR+VL+A+PNF ++PWPS
Sbjct: 294 YVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKAEPNFEEAPWPS 353
Query: 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR-PVPLDILIYKLVKSYLRATPXX 416
+SPEA DFV+RLLNKD+RKR+TAAQAL HPWL + +P D++IYKLVK Y+ +T
Sbjct: 354 LSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLVGSHELKIPSDMIIYKLVKVYIMSTSLR 413
Query: 417 XXXXXXXXXXXXXXXXVYLRAQFMLLEP-KDGCVSLNNFK 455
YLR QF LL P K+G +S+ N+K
Sbjct: 414 KSALAALAKTLTVPQLAYLREQFTLLGPSKNGYISMQNYK 453
|
|
| TAIR|locus:2103655 AT3G56760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1211 (431.4 bits), Expect = 3.5e-123, P = 3.5e-123
Identities = 246/460 (53%), Positives = 311/460 (67%)
Query: 1 MGHCCSKGVNNDSIT-PIDHPKQPTSQXXXXXXXXXXX-XDSSSFTCSPFQ-SPLPAGVA 57
MG C K + S PI + + T + S S S F+ SP + +
Sbjct: 1 MGLCHGKPIEQQSKNLPISNEIEETPKNSSQKAKSSGFPFYSPSPLPSLFKTSPAVSSSS 60
Query: 58 PSPSPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNF 117
S +P R F+ P PPPSPAK I + + RR GS P E +G E LDK F
Sbjct: 61 VSSTPLRIFKRPFPPPSPAKHIRALLARRHGS---VKPNEASIP-EGS--ECEVGLDKKF 114
Query: 118 GYGKNFGAKFELGKEVGRGHFGHTCCAXXXXXXXXXXXXXXXXXXXXXMTSALAIEDVRR 177
G+ K F + +E+ EVGRGHFG+TC A MT+A+AIEDVRR
Sbjct: 115 GFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQDVAVKVIPKSKMTTAIAIEDVRR 174
Query: 178 EVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE 237
EVKIL+AL+GHK++++F+DAFED +VYIVME C+GGELLD+IL RGG+Y E DAK ++
Sbjct: 175 EVKILRALTGHKNLVQFYDAFEDDENVYIVMELCQGGELLDKILQRGGKYSEVDAKKVMI 234
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY 297
+IL++VA+CHLQGVVHRDLKPENFLFTT++E +PLK IDFGLSD+VRPD+RLNDIVGSAY
Sbjct: 235 QILSVVAYCHLQGVVHRDLKPENFLFTTKDESSPLKAIDFGLSDYVRPDERLNDIVGSAY 294
Query: 298 YVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357
YVAPEVLHR+Y E DMWSIGVI YILLCGSRPFWAR+ESGIFR+VL+A+PNF ++PWPS
Sbjct: 295 YVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARSESGIFRAVLKAEPNFEEAPWPS 354
Query: 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR-PVPLDILIYKLVKSYLRATPXX 416
+SP+A DFV+RLLNKD+RKR+TAAQAL HPWL + +P D++IYKLVK Y+ ++
Sbjct: 355 LSPDAVDFVKRLLNKDYRKRLTAAQALCHPWLVGSHELKIPSDMIIYKLVKVYIMSSSLR 414
Query: 417 XXXXXXXXXXXXXXXXVYLRAQFMLLEP-KDGCVSLNNFK 455
YL+ QF LL P K+G +S+ N+K
Sbjct: 415 KSALAALAKTLTVPQLTYLQEQFNLLGPSKNGYISMQNYK 454
|
|
| TAIR|locus:2012232 AT1G49580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1165 (415.2 bits), Expect = 4.0e-121, Sum P(2) = 4.0e-121
Identities = 228/403 (56%), Positives = 288/403 (71%)
Query: 61 SPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQ----LDKN 116
+P R+ R PPSPAK I +A++RR G A G T V E + LDK
Sbjct: 82 TPLRQLRRAFHPPSPAKHIRAALRRRKGKKEAA--LSGVTQLTTEVPQREEEEEVGLDKR 139
Query: 117 FGYGKNFGAKFELGKEVGRGHFGHTCCAXXXXXXXXXXXXXXXXXXXXXMTSALAIEDVR 176
FG+ K F ++ ELG+E+GRGHFG+TC A MT+A+AIEDVR
Sbjct: 140 FGFSKEFHSRVELGEEIGRGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIAIEDVR 199
Query: 177 REVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIV 236
REVKIL+ALSGHK++++F+DAFED +VYI ME CEGGELLDRIL+RGG+Y E DAK ++
Sbjct: 200 REVKILQALSGHKNLVQFYDAFEDNANVYIAMELCEGGELLDRILARGGKYSENDAKPVI 259
Query: 237 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA 296
+ILN+VAFCH QGVVHRDLKPENFL+T++EE++ LK IDFGLSDFVRPD+RLNDIVGSA
Sbjct: 260 IQILNVVAFCHFQGVVHRDLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSA 319
Query: 297 YYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356
YYVAPEVLHRSY E D+WSIGVI YILLCGSRPFWARTESGIFR+VL+ADP+F + PWP
Sbjct: 320 YYVAPEVLHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWP 379
Query: 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP--VPLDILIYKLVKSYLRATP 414
+S +AKDFV+RLL KD R+RM+A+QAL HPW+ N +P DILI++ +K+YLR++
Sbjct: 380 FLSSDAKDFVKRLLFKDPRRRMSASQALMHPWIRAYNTDMNIPFDILIFRQMKAYLRSSS 439
Query: 415 XXXXXXXXXXXXXXXXXXVYLRAQFMLLEP-KDGCVSLNNFKV 456
+YL+ QF LL P KDG ++++ ++
Sbjct: 440 LRKAALRALSKTLIKDEILYLKTQFSLLAPNKDGLITMDTIRM 482
|
|
| TAIR|locus:2094053 AT3G19100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1158 (412.7 bits), Expect = 1.2e-119, Sum P(2) = 1.2e-119
Identities = 226/398 (56%), Positives = 287/398 (72%)
Query: 61 SPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGYG 120
+P R+ PPSPA+ I ++RR A P + + E LDK FG+
Sbjct: 80 TPLRQLARAFHPPSPARHIRDVLRRRKEKKEAALPAARQQKEEE--EREEVGLDKRFGFS 137
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAXXXXXXXXXXXXXXXXXXXXXMTSALAIEDVRREVK 180
K ++ ELG+E+GRGHFG+TC A MTSA++IEDVRREVK
Sbjct: 138 KELQSRIELGEEIGRGHFGYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVRREVK 197
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
IL+ALSGH+++++F+DAFED +VYIVME C GGELLDRIL+RGG+Y E+DAK ++ +IL
Sbjct: 198 ILRALSGHQNLVQFYDAFEDNANVYIVMELCGGGELLDRILARGGKYSEDDAKAVLIQIL 257
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVA 300
N+VAFCHLQGVVHRDLKPENFL+T++EE++ LKVIDFGLSDFVRPD+RLNDIVGSAYYVA
Sbjct: 258 NVVAFCHLQGVVHRDLKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSAYYVA 317
Query: 301 PEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360
PEVLHRSY E D+WSIGVI YILLCGSRPFWARTESGIFR+VL+ADP+F + PWPS+S
Sbjct: 318 PEVLHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPSLSF 377
Query: 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR-PVPLDILIYKLVKSYLRATPXXXXX 419
EAKDFV+RLL KD RKRMTA+QAL HPW+ + +P DILI+K +K+YLR++
Sbjct: 378 EAKDFVKRLLYKDPRKRMTASQALMHPWIAGYKKIDIPFDILIFKQIKAYLRSSSLRKAA 437
Query: 420 XXXXXXXXXXXXXVYLRAQFMLLEP-KDGCVSLNNFKV 456
+YL+AQF L P K+G ++L++ ++
Sbjct: 438 LMALSKTLTTDELLYLKAQFAHLAPNKNGLITLDSIRL 475
|
|
| TAIR|locus:2827826 CPK16 "AT2G17890" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 874 (312.7 bits), Expect = 1.8e-87, P = 1.8e-87
Identities = 168/344 (48%), Positives = 231/344 (67%)
Query: 116 NFGYGKNFGAKFELGKEVGRGHFGHTCCAXXXXXXXXXXXXXXXXXXXXXMTSALAIEDV 175
+FGY K+F ++ +GK +G G FG+T A MT +A+EDV
Sbjct: 97 DFGYAKDFDHRYTIGKLLGHGQFGYTYVATDKKTGDRVAVKKIDKAK---MTIPIAVEDV 153
Query: 176 RREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSR-GGRYLEEDAKT 234
+REVKIL+AL+GH+++++F++AFED NSVYIVME CEGGELLDRIL+R RY E DA
Sbjct: 154 KREVKILQALTGHENVVRFYNAFEDKNSVYIVMELCEGGELLDRILARKDSRYSERDAAV 213
Query: 235 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVG 294
+V ++L + A CHL+G+VHRD+KPENFLF + EED+PLK DFGLSDF++P ++ +DIVG
Sbjct: 214 VVRQMLKVAAECHLRGLVHRDMKPENFLFKSTEEDSPLKATDFGLSDFIKPGKKFHDIVG 273
Query: 295 SAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP 354
SAYYVAPEVL R E D+WSIGVI+YILLCG RPFW +TE GIF+ VL+ P+F P
Sbjct: 274 SAYYVAPEVLKRRSGPESDVWSIGVISYILLCGRRPFWDKTEDGIFKEVLKNKPDFRRKP 333
Query: 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD--ENRPVPLDILIYKLVKSYLRA 412
WP++S AKDFV++LL KD R R+TAAQAL+HPW+ + + +P+DI + ++ +++
Sbjct: 334 WPTISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKF 393
Query: 413 TPXXXXXXXXXXXXXXXXXXVYLRAQFMLLE-PKDGCVSLNNFK 455
+ LR QF ++ K+G +SL +
Sbjct: 394 SRLKQFALRALATTLDEEELADLRDQFDAIDVDKNGVISLEEMR 437
|
|
| TAIR|locus:2156947 CPK28 "calcium-dependent protein kinase 28" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 839 (300.4 bits), Expect = 9.1e-84, P = 9.1e-84
Identities = 167/344 (48%), Positives = 223/344 (64%)
Query: 116 NFGYGKNFGAKFELGKEVGRGHFGHTCCAXXXXXXXXXXXXXXXXXXXXXMTSALAIEDV 175
+FGY K+F + +GK +G G FG+T A M +A+EDV
Sbjct: 51 DFGYSKDFHDHYTIGKLLGHGQFGYTYVAIHRPNGDRVAVKRLDKSK---MVLPIAVEDV 107
Query: 176 RREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSR-GGRYLEEDAKT 234
+REV+IL ALSGH+++++FH+AFED + VYIVME CEGGELLDRILS+ G RY E+DA
Sbjct: 108 KREVQILIALSGHENVVQFHNAFEDDDYVYIVMELCEGGELLDRILSKKGNRYSEKDAAV 167
Query: 235 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVG 294
+V ++L + CHL G+VHRD+KPENFLF + + D+PLK DFGLSDF++P +R +DIVG
Sbjct: 168 VVRQMLKVAGECHLHGLVHRDMKPENFLFKSAQLDSPLKATDFGLSDFIKPGKRFHDIVG 227
Query: 295 SAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP 354
SAYYVAPEVL R E D+WSIGVITYILLCG RPFW RTE GIF+ VLR P+F P
Sbjct: 228 SAYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPFWDRTEDGIFKEVLRNKPDFSRKP 287
Query: 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP--VPLDILIYKLVKSYLRA 412
W ++S AKDFV++LL KD R R+TAAQAL+H W+ + +P+DI + ++ ++R
Sbjct: 288 WATISDSAKDFVKKLLVKDPRARLTAAQALSHAWVREGGNATDIPVDISVLNNLRQFVRY 347
Query: 413 TPXXXXXXXXXXXXXXXXXXVYLRAQFMLLE-PKDGCVSLNNFK 455
+ LR QF ++ K+G +SL +
Sbjct: 348 SRLKQFALRALASTLDEAEISDLRDQFDAIDVDKNGVISLEEMR 391
|
|
| TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 721 (258.9 bits), Expect = 2.0e-73, Sum P(2) = 2.0e-73
Identities = 144/321 (44%), Positives = 200/321 (62%)
Query: 93 APPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFG--HTCCAXXXXXX 150
APP P + G + L + ++ A + LGKE+GRG FG H C
Sbjct: 45 APPSPPPATKQGPIGPV---LGRPM---EDVKASYSLGKELGRGQFGVTHLC-----TQK 93
Query: 151 XXXXXXXXXXXXXXXMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210
+ + IEDVRREV+I+ L+G ++++ A+ED +SV++VME
Sbjct: 94 ATGHQFACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMEL 153
Query: 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 270
C GGEL DRI+++G Y E A +++ I+ IV CH GV+HRDLKPENFL ++E++
Sbjct: 154 CAGGELFDRIIAKG-HYSERAAASLLRTIVQIVHTCHSMGVIHRDLKPENFLLLNKDENS 212
Query: 271 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRP 330
PLK DFGLS F +P + DIVGSAYY+APEVL R Y E D+WSIGV+ YILLCG P
Sbjct: 213 PLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEVLKRKYGPEADIWSIGVMLYILLCGVPP 272
Query: 331 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390
FWA +E+GIF ++LR +F PWPS+SP+AKD V+++LN D ++R+TAAQ L HPW+
Sbjct: 273 FWAESENGIFNAILRGHVDFSSDPWPSISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIK 332
Query: 391 DENR-P-VPLDILIYKLVKSY 409
++ P VPLD + +K +
Sbjct: 333 EDGEAPDVPLDNAVMSRLKQF 353
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FIM9 | CAMK4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6772 | 0.9848 | 0.7643 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 461 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-97 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-81 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-62 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-57 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-57 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-55 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-53 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-52 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-51 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-49 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-48 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-47 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-44 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-43 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-43 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-42 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-40 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-39 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-38 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-37 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-36 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-36 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-36 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-36 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-35 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-35 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-35 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-34 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-34 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-34 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-34 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-33 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-33 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-33 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-33 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-32 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-32 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-32 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-32 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-32 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-32 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-32 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-31 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-31 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-30 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-30 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-30 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-30 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-30 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-29 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-29 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-29 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-28 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-28 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-28 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-28 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-28 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-28 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-27 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-27 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-27 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-27 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-27 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-27 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-27 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-27 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-27 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-27 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-26 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-26 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-26 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-26 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-26 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-26 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-26 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-26 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-25 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-25 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-25 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-25 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-25 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-25 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-25 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-25 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-24 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-24 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-24 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-24 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-24 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-24 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-24 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-23 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-23 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-23 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-23 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-23 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-22 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-22 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-22 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-22 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-22 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-22 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-22 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-22 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-22 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-21 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-21 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-21 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-21 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-20 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-19 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-18 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-18 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-18 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-15 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-07 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 4e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-06 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 5e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 4e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-05 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 6e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-05 | |
| pfam06293 | 206 | pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/Waa | 9e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 3e-04 | |
| PLN03188 | 1320 | PLN03188, PLN03188, kinesin-12 family protein; Pro | 4e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.002 | |
| cd05151 | 170 | cd05151, ChoK, Choline Kinase (ChoK) | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 293 bits (753), Expect = 1e-97
Identities = 111/265 (41%), Positives = 166/265 (62%), Gaps = 13/265 (4%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+E+ +++G G FG A+ KK GK+VA+K+I K K+ E + RE+KILK L
Sbjct: 1 YEILEKLGEGSFGKVYLARDKK---TGKLVAIKVIKKKKIKKD--RERILREIKILKKL- 54
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H ++++ +D FED + +Y+VME+CEGG+L D + RG R E++A+ + +IL+ + +
Sbjct: 55 KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYL 113
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-H 305
H +G+VHRDLKPEN L ED +K+ DFGL+ + P ++L VG+ Y+APEVL
Sbjct: 114 HSKGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG 170
Query: 306 RSYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLRADPNFHDSPWPSVSPEAKD 364
+ Y D+WS+GVI Y LL G PF + +F+ + + P F P +SPEAKD
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-PPPEWDISPEAKD 229
Query: 365 FVRRLLNKDHRKRMTAAQALTHPWL 389
+R+LL KD KR+TA +AL HP+
Sbjct: 230 LIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 251 bits (644), Expect = 3e-81
Identities = 114/269 (42%), Positives = 157/269 (58%), Gaps = 15/269 (5%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+EL +++G G FG AK KGT GK+VAVKI+ K S RRE++IL+ LS
Sbjct: 1 YELLRKLGSGSFGTVYKAK-HKGT--GKIVAVKILKKRSEKSKKDQTA-RREIRILRRLS 56
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H ++++ DAFED + +Y+VME+CEGG+L D LSRGG E++AK I +IL + +
Sbjct: 57 -HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFD-YLSRGGPLSEDEAKKIALQILRGLEYL 114
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL- 304
H G++HRDLKPEN L +K+ DFGL+ ++ L VG+ +Y+APEVL
Sbjct: 115 HSNGIIHRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171
Query: 305 -HRSYNVEGDMWSIGVITYILLCGSRPFWARTESG---IFRSVLRADPNFHDSPWPSVSP 360
Y + D+WS+GVI Y LL G PF + R +L F + W S S
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
EAKD +++ LNKD KR TA + L HPW
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 201 bits (515), Expect = 3e-62
Identities = 92/261 (35%), Positives = 139/261 (53%), Gaps = 17/261 (6%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+G+G FG + KK T GK+ A+K++ K K+ +E E IL ++ H ++
Sbjct: 1 LGKGSFGKVLLVR-KKDT--GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIV 56
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 252
K H AF+ +Y+V+E+ GGEL LS+ GR+ EE A+ +I+ + + H G++
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSH-LSKEGRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 253 HRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHRS-YNV 310
+RDLKPEN L D +K+ DFGL+ + R N G+ Y+APEVL Y
Sbjct: 116 YRDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 311 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 370
D WS+GV+ Y +L G PF+A I+ +L+ F P +SPEA+D + LL
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF---P-EFLSPEARDLISGLL 228
Query: 371 NKDHRKRMTAAQALT---HPW 388
KD KR+ + A HP+
Sbjct: 229 QKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-57
Identities = 95/258 (36%), Positives = 136/258 (52%), Gaps = 46/258 (17%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+G G FG A+ KK GK VA+KII K +S L E++ RE++ILK L+ H +++
Sbjct: 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSSLL--EELLREIEILKKLN-HPNIV 54
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 252
K + FED N +Y+VME+CEGG L D + G+ E++ I+ +IL + + H G++
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 253 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH--RSYN 309
HRDLKPEN L + +K+ DFGLS + D L IVG+ Y+APEVL Y+
Sbjct: 115 HRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 310 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 369
+ D+WS+GVI Y L PE KD +R++
Sbjct: 173 EKSDIWSLGVILYEL-----------------------------------PELKDLIRKM 197
Query: 370 LNKDHRKRMTAAQALTHP 387
L KD KR +A + L H
Sbjct: 198 LQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 7e-57
Identities = 86/275 (31%), Positives = 144/275 (52%), Gaps = 32/275 (11%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
K+E+ K++G+G FG + K GK+ +K I + M+ ED EVKILK L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSNMSEK-EREDALNEVKILKKL 56
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNI- 242
+ H ++IK++++FE+ + IVME+ +GG+L +I + G+ E+ +IL+
Sbjct: 57 N-HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE------QILDWF 109
Query: 243 ------VAFCHLQGVVHRDLKPEN-FLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVG 294
+ + H + ++HRD+KP+N FL + +K+ DFG+S + L +VG
Sbjct: 110 VQLCLALKYLHSRKILHRDIKPQNIFLTSNGL----VKLGDFGISKVLSSTVDLAKTVVG 165
Query: 295 SAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 353
+ YY++PE+ ++ YN + D+WS+G + Y L PF + +L+
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----P 221
Query: 354 PWPS-VSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387
P PS S E ++ V LL KD +R + AQ L P
Sbjct: 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 188 bits (477), Expect = 3e-55
Identities = 88/331 (26%), Positives = 155/331 (46%), Gaps = 30/331 (9%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ + +++G G FG A+ +K +VA+K+++K + + +E RE++IL +L
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK------LVALKVLAKKLESKSKEVERFLREIQILASL 54
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRI--LSRGGRYLEEDAKTIVEKILNIV 243
+ +++K +D F+D S+Y+VME+ +GG L D + + R G E +A I+ +IL+ +
Sbjct: 55 NHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-------PDQRLNDIVGSA 296
+ H +G++HRD+KPEN L + +K+IDFGL+ + + VG+
Sbjct: 115 EYLHSKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 297 YYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR------- 345
Y+APEVL + D+WS+G+ Y LL G PF S L+
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 346 --ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIY 403
S +S A D +++LL KD + R++++ L+H L +
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
Query: 404 KLVKSYLRATPLKRAALKALSKALTEEELVY 434
K S L + +S +
Sbjct: 293 KPDDSAPLRLSLPPSLEALISSLNSLAISGS 323
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 1e-53
Identities = 87/288 (30%), Positives = 142/288 (49%), Gaps = 37/288 (12%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F+ GK +G G F AK K+ K A+KI+ K ++ ++ V+ E ++L L+
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKET---NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN 59
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
GH +IK + F+D ++Y V+E+ GELL I G E+ + +IL + +
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-EKCTRFYAAEILLALEYL 118
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ------------------- 287
H +G++HRDLKPEN L +D +K+ DFG + + P+
Sbjct: 119 HSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 288 --RLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 344
R VG+A YV+PE+L + D+W++G I Y +L G PF E F+ +L
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
Query: 345 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA----AQALTHPW 388
+ + +F P P+ P+AKD + +LL D + R+ + HP+
Sbjct: 236 KLEYSF---P-PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-52
Identities = 93/273 (34%), Positives = 148/273 (54%), Gaps = 28/273 (10%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
++LG +GRG FG KG G VA+K IS K+ A++ + +E+ +LK L
Sbjct: 1 NYQLGDLIGRGAFG--VVYKGLN-LETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNL 56
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H +++K+ + E ++S+YI++E+ E G L +I+ + G + E V ++L +A+
Sbjct: 57 K-HPNIVKYIGSIETSDSLYIILEYAENGSLR-QIIKKFGPFPESLVAVYVYQVLQGLAY 114
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL 304
H QGV+HRD+K N L T +D +K+ DFG++ + +VG+ Y++APEV+
Sbjct: 115 LHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 305 HRSYNVEG-----DMWSIGVITYI-LLCGSRPFWARTE-SGIFRSVLRADPNFHDSPWPS 357
+ G D+WS+G T I LL G+ P++ + +FR V P P P
Sbjct: 172 ----EMSGASTASDIWSLG-CTVIELLTGNPPYYDLNPMAALFRIVQDDHP-----PLPE 221
Query: 358 -VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
+SPE KDF+ + KD R TA Q L HPW+
Sbjct: 222 GISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 9e-51
Identities = 90/267 (33%), Positives = 149/267 (55%), Gaps = 18/267 (6%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
FE+ +++G+G FG A+ K+ GK VA+K+I K+ S E + E++ILK
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVI---KLESKEKKEKIINEIQILKKC 54
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H +++K++ ++ + ++IVMEFC GG L D + S E + +++L + +
Sbjct: 55 K-HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH 305
H G++HRD+K N L T+ D +K+IDFGLS + + N +VG+ Y++APEV++
Sbjct: 114 LHSNGIIHRDIKAANILLTS---DGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN 170
Query: 306 R-SYNVEGDMWSIGVITYI-LLCGSRPFWARTESGIFRSVLR-ADPNFHDSPWPS-VSPE 361
Y+ + D+WS+G IT I L G P+ +E +++ + A P S E
Sbjct: 171 GKPYDYKADIWSLG-ITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDE 226
Query: 362 AKDFVRRLLNKDHRKRMTAAQALTHPW 388
KDF+++ L K+ KR TA Q L HP+
Sbjct: 227 FKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 7e-49
Identities = 87/275 (31%), Positives = 137/275 (49%), Gaps = 25/275 (9%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+ +G +G AK KK T G + A+K+I KA M ++ V E IL +++
Sbjct: 1 ISKGAYGRVFLAK-KKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVV 56
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGV 251
K + +F+ ++Y+VME+ GG+L +L G L+ED A+ + +I+ + + H G+
Sbjct: 57 KLYYSFQGKKNLYLVMEYLPGGDLA-SLLENVG-SLDEDVARIYIAEIVLALEYLHSNGI 114
Query: 252 VHRDLKPENFLFTTREEDAPLKVIDFGLSDF---------VRPDQRLNDIVGSAYYVAPE 302
+HRDLKP+N L + LK+ DFGLS ++ IVG+ Y+APE
Sbjct: 115 IHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 303 V-LHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361
V L + ++ D WS+G I Y L G PF T IF+++L + + VS E
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDE 229
Query: 362 AKDFVRRLLNKDHRKRMTAAQA---LTHPWLHDEN 393
A D + +LL D KR+ A HP+ +
Sbjct: 230 AIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 2e-48
Identities = 81/270 (30%), Positives = 139/270 (51%), Gaps = 20/270 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FEL + +G+G FG C + + K+ A+K ++K K ++ +V E +IL+ L+
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRI-LSRGGRYLEEDAKTIVEKILNIVAF 245
H ++ +F+D ++Y+V++ GG+L R LS+ ++ EE K + +I+ + +
Sbjct: 59 -HPFLVNLWYSFQDEENMYLVVDLLLGGDL--RYHLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL- 304
H +G++HRD+KP+N L +E + + DF ++ V PD G+ Y+APEVL
Sbjct: 116 LHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC 172
Query: 305 HRSYNVEGDMWSIGVITYILLCGSRPFWART---ESGIFRSVLRADPNFHDSPWPSVSPE 361
+ Y+V D WS+GV Y L G RP+ + I AD + + S E
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY----PATWSTE 228
Query: 362 AKDFVRRLLNKDHRKRM--TAAQALTHPWL 389
A D + +LL +D +KR+ HP+
Sbjct: 229 AIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-47
Identities = 87/271 (32%), Positives = 138/271 (50%), Gaps = 20/271 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FE K +G G FG + K GK A+KI+SKAK+ +E V E +IL+++
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H ++ + +F+D +++Y+VME+ GGEL L + GR+ E A+ +++ + +
Sbjct: 60 -HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV-LH 305
H +V+RDLKPEN L + D +K+ DFG + V+ R + G+ Y+APE+ L
Sbjct: 118 HSLDIVYRDLKPENLLLDS---DGYIKITDFGFAKRVKG--RTYTLCGTPEYLAPEIILS 172
Query: 306 RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 365
+ Y D W++G++ Y +L G PF+ I+ +L F SP+AKD
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDL 228
Query: 366 VRRLLNKDHRKRM-----TAAQALTHPWLHD 391
+R LL D KR+ HPW
Sbjct: 229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 5e-45
Identities = 95/302 (31%), Positives = 146/302 (48%), Gaps = 58/302 (19%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALA-IEDVR--REVKILK 183
+++ K++G G FG A+ K+ G++VA+K KM E+ REVK L+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKE---TGELVAIK-----KMKKKFYSWEECMNLREVKSLR 52
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYL-EEDAKTIVEKILNI 242
L+ H +++K + F + + +Y V E+ EG L + R G+ E ++I+ +IL
Sbjct: 53 KLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPE 302
+A H G HRDLKPEN L + E +K+ DFGL+ +R D V + +Y APE
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEV---VKIADFGLAREIRSRPPYTDYVSTRWYRAPE 168
Query: 303 VL--HRSYNVEGDMWSIGVIT---YILLCGSRP-FWARTESG-IFR--SVLRADPNFHDS 353
+L SY+ D+W++G I Y L RP F +E +++ SVL P
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTL----RPLFPGSSEIDQLYKICSVL-GTPT--KQ 221
Query: 354 PW--------------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387
W P+ SPEA D ++ +L D +KR TA+QAL HP
Sbjct: 222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
Query: 388 WL 389
+
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 4e-44
Identities = 81/272 (29%), Positives = 141/272 (51%), Gaps = 20/272 (7%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
++ G+ +GRG FG A K G+++AVK + + + +E + RE++IL +L
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKD---TGELMAVKSVELSGDSEEE-LEALEREIRILSSL 56
Query: 186 SGHKHMIKFHDAF--EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
H ++++++ + E+ N++ I +E+ GG L +L + G+ E + +IL +
Sbjct: 57 Q-HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQILEGL 114
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS---DFVRPDQRLNDIVGSAYYVA 300
A+ H G+VHRD+K N L D +K+ DFG + + + + G+ Y++A
Sbjct: 115 AYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 301 PEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW-PS- 357
PEV+ Y D+WS+G + G P+ E G + L + + P P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS---ELGNPMAALYKIGSSGEPPEIPEH 228
Query: 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
+S EAKDF+R+ L +D +KR TA + L HP+L
Sbjct: 229 LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 95/315 (30%), Positives = 145/315 (46%), Gaps = 51/315 (16%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FE+ K +GRG FG + K G+V A+K++ K+ M I VR E IL A +
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDIL-ADA 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAK-TIVEKILNIVAF 245
++K + +F+D +Y+VME+ GG+L+ +L R + EE A+ I E +L + +
Sbjct: 59 DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS--------DFVRPDQRLND------ 291
H G +HRD+KP+N L D +K+ DFGL + N
Sbjct: 118 -HKLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 292 ----------------IVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWAR 334
VG+ Y+APEVL Y +E D WS+GVI Y +L G PF++
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 335 TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA-QALTHP------ 387
T + ++ + P P VSPEA D + RLL D R+ + + +HP
Sbjct: 234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPFFKGID 292
Query: 388 --WLHDENRPVPLDI 400
L + P ++
Sbjct: 293 WENLRETKPPFVPEL 307
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-43
Identities = 84/268 (31%), Positives = 138/268 (51%), Gaps = 16/268 (5%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K + +G FG AK K+ T G A+K++ K+ M + + +V+ E I+ +
Sbjct: 2 KPISKGAFGSVYLAK-KRST--GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQ 249
+ K + +F+ + +Y+VME+ GG+ I + GG L ED AK + +++ V H +
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQR 116
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSY 308
G++HRD+KPEN L ++ LK+ DFGLS +++ VG+ Y+APE +
Sbjct: 117 GIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLENKK---FVGTPDYLAPETILGVGD 170
Query: 309 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368
+ D WS+G + + L G PF A T +F ++L N+ + SPEA D + R
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR 230
Query: 369 LLNKDHRKRMTA---AQALTHPWLHDEN 393
LL D KR+ A + +HP+ N
Sbjct: 231 LLCMDPAKRLGANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 3e-42
Identities = 75/269 (27%), Positives = 133/269 (49%), Gaps = 22/269 (8%)
Query: 133 VGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
+G G FG K K + A+K + K + E + E +IL+ + H
Sbjct: 1 LGVGGFGRVELVKVKSK-----NRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPF 54
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
++K + F+D +Y++ME+C GGEL IL G + E A+ + ++ + H +G
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWT-ILRDRGLFDEYTARFYIACVVLAFEYLHNRG 113
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV-LHRSYN 309
+++RDLKPEN L + +K++DFG + ++ Q+ G+ YVAPE+ L++ Y+
Sbjct: 114 IIYRDLKPENLLLDSN---GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD 170
Query: 310 VEGDMWSIGVITYILLCGSRPFWARTES--GIFRSVLRADPNFHDSPWPSVSPEAKDFVR 367
D WS+G++ Y LL G PF E I+ +L+ + + P + AKD ++
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN-GKLEFP-NYIDKAAKDLIK 228
Query: 368 RLLNKDHRKRMTAAQA-----LTHPWLHD 391
+LL ++ +R+ + H W +
Sbjct: 229 QLLRRNPEERLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 83/301 (27%), Positives = 142/301 (47%), Gaps = 57/301 (18%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM--------TSALAIEDVRRE 178
+E +++G G +G A+ KK G++VA+K I ++ ++AL RE
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKI---RLDNEEEGIPSTAL------RE 48
Query: 179 VKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVE 237
+ +LK L H +++K D +Y+V E+C+ L + L + L + K+I+
Sbjct: 49 ISLLKELK-HPNIVKLLDVIHTERKLYLVFEYCD--MDLKKYLDKRPGPLSPNLIKSIMY 105
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSA 296
++L +A+CH ++HRDLKP+N L LK+ DFGL+ F P + V +
Sbjct: 106 QLLRGLAYCHSHRILHRDLKPQNILINRDGV---LKLADFGLARAFGIPLRTYTHEVVTL 162
Query: 297 YYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESG----IFRSVL-----R 345
+Y APE+L + Y+ D+WS+G I ++ G F +E IF+ +L
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILGTPTEE 221
Query: 346 ADPNFHDSPW-----------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388
+ P P P + PE D + ++L + KR++A +AL HP+
Sbjct: 222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
Query: 389 L 389
Sbjct: 282 F 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 7e-40
Identities = 79/273 (28%), Positives = 133/273 (48%), Gaps = 26/273 (9%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLK--GKVVAVKII---SKAKMTSALAIEDVRREVKI 181
E K +G+G G K K GK+ A+K I + L RE+K
Sbjct: 3 LERVKVLGQGSSG-----VVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL-----RELKT 52
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN 241
L++ +++K + AF + IV+E+ +GG L +L + G+ E I +IL
Sbjct: 53 LRS-CESPYVVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILK 110
Query: 242 IVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYV 299
+ + H + ++HRD+KP N L ++ E +K+ DFG+S + + N VG+ Y+
Sbjct: 111 GLDYLHTKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYM 167
Query: 300 APEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS- 357
+PE + SY+ D+WS+G+ G PF + F +++A + P+
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF-ELMQAICDGPPPSLPAE 226
Query: 358 -VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
SPE +DF+ L KD +KR +AA+ L HP++
Sbjct: 227 EFSPEFRDFISACLQKDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 6e-39
Identities = 85/297 (28%), Positives = 140/297 (47%), Gaps = 51/297 (17%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII-SKAKMTSALAIEDVRREV 179
+ FEL + +G G +G A+ KK G++VA+KI+ E+++ E
Sbjct: 2 PDPTGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMDIIEDE-----EEEIKEEY 53
Query: 180 KILKALSGHKHMIKFHDAFEDANS------VYIVMEFCEGG---ELLDRILSRGGRYLEE 230
IL+ S H ++ F+ AF N +++VME C GG +L+ + +G R EE
Sbjct: 54 NILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEE 113
Query: 231 DAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRL 289
I+ + L +A+ H V+HRD+K +N L T ++A +K++DFG+S R
Sbjct: 114 WIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLGRR 170
Query: 290 NDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWA-----RTESG 338
N +G+ Y++APEV+ SY+ D+WS+G IT I L +P R
Sbjct: 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG-ITAIELADGKPPLCDMHPMRALFK 229
Query: 339 IFRSVLRADPNFHDSPWPSVSPEAK------DFVRRLLNKDHRKRMTAAQALTHPWL 389
I R +P P++ DF+ L K++ +R + L HP++
Sbjct: 230 IPR-----------NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 7e-38
Identities = 93/290 (32%), Positives = 140/290 (48%), Gaps = 42/290 (14%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
++G G +G A+ K L G++VA+K I + + +R E+K+LK L+ H +
Sbjct: 5 GKIGEGTYGVVYKARDK---LTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELN-HPN 59
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQ 249
+IK D F +Y+V EF + L +++ R L E K+ + ++L +AFCH
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLHRS- 307
G++HRDLKPEN L T + LK+ DFGL+ R V + +Y APE+L
Sbjct: 118 GILHRDLKPENLLINT---EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 308 -YNVEGDMWSIGVITYILLCGSRPFWARTE-----SGIFR--------------SVLRAD 347
Y+ D+WS+G I LL RP + IFR S+ R
Sbjct: 175 GYSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233
Query: 348 ----PNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
P P P+ SP+A D + ++L+ D KR+TA QAL HP+
Sbjct: 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 9e-38
Identities = 82/285 (28%), Positives = 146/285 (51%), Gaps = 27/285 (9%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
F L + +G+G FG A K+ +VVA+K+I + + IED+++E++ L
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQC 56
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
++ K++ +F + ++I+ME+C GG LD L + G+ E I+ ++L + +
Sbjct: 57 RS-PYITKYYGSFLKGSKLWIIMEYCGGGSCLD--LLKPGKLDETYIAFILREVLLGLEY 113
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVL 304
H +G +HRD+K N L + E+ +K+ DFG+S + + N VG+ +++APEV+
Sbjct: 114 LHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 305 HRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGI------FRSVLRADPNFHDSPWPS 357
+S Y+ + D+WS+G+ L G P S + F P+ + +
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPPL-----SDLHPMRVLFLIPKNNPPSLEGNKF-- 223
Query: 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
S KDFV LNKD ++R +A + L H ++ + L +LI
Sbjct: 224 -SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLLI 267
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 4e-37
Identities = 88/282 (31%), Positives = 141/282 (50%), Gaps = 23/282 (8%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F++ +VG+G +G AK KK T G++VA+K + K+ + + V E IL +
Sbjct: 3 FQILTQVGQGGYGQVFLAK-KKDT--GEIVALKRMKKSLLFKLNEVRHVLTERDIL-TTT 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
+ ++K AF+D +Y+ ME+ GG+ +L+ G E+ A+ + ++ V
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDAL 117
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH 305
H G +HRDLKPENFL + +K+ DFGLS V N +VGS Y+APEVL
Sbjct: 118 HELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIV---TYANSVVGSPDYMAPEVLR 171
Query: 306 -RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR-----ADPNFHDSPWPSVS 359
+ Y+ D WS+G + Y LCG PF T + + ++ P + D P ++S
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY-DDPRFNLS 230
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDIL 401
EA D + +L+N R+ + HP+ + V + L
Sbjct: 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFF----KEVDWNEL 268
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 92/301 (30%), Positives = 144/301 (47%), Gaps = 51/301 (16%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F+ K +G+G G + KGT GK+ A+K++ K +M ++ V E +IL A
Sbjct: 3 FKKIKLLGKGDVGRVFLVR-LKGT--GKLFALKVLDKKEMIKRNKVKRVLTEQEIL-ATL 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYL-EEDAKTIVEKILNIVAF 245
H + + +F+ + +VM++C GGEL + + G+ L EE A+ ++L + +
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS------------------------- 280
HL G+V+RDLKPEN L E + + DF LS
Sbjct: 119 LHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 281 ---DFVR--PDQRLNDIVGSAYYVAPEVL----HRSYNVEGDMWSIGVITYILLCGSRPF 331
+ P R N VG+ Y+APEV+ H S V D W++G++ Y +L G+ PF
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS-AV--DWWTLGILLYEMLYGTTPF 232
Query: 332 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM----TAAQALTHP 387
F ++L+ + F S P VS A+D +R+LL KD KR+ AA+ HP
Sbjct: 233 KGSNRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290
Query: 388 W 388
+
Sbjct: 291 F 291
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 96/316 (30%), Positives = 146/316 (46%), Gaps = 65/316 (20%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDV----R--REV 179
++EL K +G G +G C A K+ G+ VA+K IS +D+ R RE+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISNV-------FDDLIDAKRILREI 50
Query: 180 KILKALSGHKHMIKFHDAF-----EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKT 234
K+L+ L H+++I D ED N VYIV E E L +++ ++ +
Sbjct: 51 KLLRHL-RHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQPLTDDHIQY 107
Query: 235 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR----LN 290
+ +IL + + H V+HRDLKP N + D LK+ DFGL+ V PD+ L
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSN-ILVNSNCD--LKICDFGLARGVDPDEDEKGFLT 164
Query: 291 DIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWA--------------- 333
+ V + +Y APE+L Y D+WS+G I LL +P +
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPLFPGRDYIDQLNLIVEVL 223
Query: 334 --RTESGI-------FRSVLRADPNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTA 380
+E + R+ L++ P P P SPEA D + ++L D +KR+TA
Sbjct: 224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA 283
Query: 381 AQALTHPWL---HDEN 393
+AL HP+L HD
Sbjct: 284 DEALAHPYLAQLHDPE 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 90/304 (29%), Positives = 143/304 (47%), Gaps = 57/304 (18%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVR----REVKI 181
K+E+ VG G +G + K G++VA+K K + EDV+ REVK+
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKA---TGEIVAIK-----KFKESEDDEDVKKTALREVKV 53
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGG--ELLDRILSRGGRYLEEDA-KTIVEK 238
L+ L H++++ +AF +Y+V E+ E ELL+ S GG L DA ++ + +
Sbjct: 54 LRQLR-HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGG--LPPDAVRSYIWQ 108
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV--RPDQRLNDIVGSA 296
+L +A+CH ++HRD+KPEN L + E LK+ DFG + + RP L D V +
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPASPLTDYVATR 165
Query: 297 YYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTES-----GIFR-------- 341
+Y APE+L +Y D+W+IG I LL G P + I +
Sbjct: 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPPS 224
Query: 342 --SVLRADPNFHDSPWPSVSPE--------------AKDFVRRLLNKDHRKRMTAAQALT 385
+ ++P F +P S A DF++ L D ++R+T + L
Sbjct: 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284
Query: 386 HPWL 389
HP+
Sbjct: 285 HPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 82/269 (30%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM-TSALAIEDVRREVKILKAL 185
FEL + +G G +G + G GK+ A+K++ KA + A E R E ++L+A+
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
++ H AF+ +++++++ GGEL + R + E + + + +I ++A
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEI--VLAL 118
Query: 246 CHLQ--GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAP 301
HL G+++RD+K EN L + + + + DFGLS ++ R G+ Y+AP
Sbjct: 119 DHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 302 EVLHR---SYNVEGDMWSIGVITYILLCGSRPFWA----RTESGIFRSVLRADPNFHDSP 354
EV+ ++ D WS+GV+T+ LL G+ PF ++S I R +L++ P F P
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF---P 232
Query: 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQA 383
++S EA+DF+++LL KD +KR+ A A
Sbjct: 233 -KTMSAEARDFIQKLLEKDPKKRLGANGA 260
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 86/296 (29%), Positives = 141/296 (47%), Gaps = 43/296 (14%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
++++ +G G G AK ++ G+ VA+K ++ ++ + RE+K L+A
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLEGGIP-NQALREIKALQAC 56
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H +++K D F + +VME+ +L + + E K+ + +L VA+
Sbjct: 57 Q-HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD-FVRPDQRL-NDIVGSAYYVAPEV 303
H G++HRDLKP N L + D LK+ DFGL+ F + RL + V + +Y APE+
Sbjct: 115 MHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171
Query: 304 LH--RSYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIFRSVLRADPNFHD----- 352
L+ R Y+ D+W++G I LL GS F + + +FR++ PN
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTL--GTPNEETWPGLT 229
Query: 353 ---------------SPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
P P SPEA D ++ LL D KR++AA+AL HP+
Sbjct: 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 92/309 (29%), Positives = 146/309 (47%), Gaps = 55/309 (17%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSAL------AIEDVRREV 179
++E GK++G G + A+ K+ G++VA+K I + A A+ RE+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTAL----REI 53
Query: 180 KILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGG-ELL--DRILSRGGRYLEEDAKTIV 236
K+L+ L H ++I D F +++ +V EF E E + D+ + D K+ +
Sbjct: 54 KLLQELK-HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI----VLTPADIKSYM 108
Query: 237 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGS 295
L + + H ++HRDLKP N L D LK+ DFGL+ F P++++ V +
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSFGSPNRKMTHQVVT 165
Query: 296 AYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTE-----SGIFRS------ 342
+Y APE+L R Y V DMWS+G I LL PF IF +
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQLGKIFEALGTPTE 224
Query: 343 ----VLRADPNFHD------SPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388
+ + P++ + +P P+ S +A D ++RLL + KR+TA QAL HP+
Sbjct: 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
Query: 389 LHDENRPVP 397
N P P
Sbjct: 285 FS--NDPAP 291
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 74/267 (27%), Positives = 133/267 (49%), Gaps = 16/267 (5%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FE+ ++G+G FG K +V A+K I +KM + E+ E ++L L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD 57
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDA--KTIVEKILNIVA 244
++I+++++F D + IVME+ E G+L + + GR L ED + ++ +L + A
Sbjct: 58 -SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL-A 115
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYYVAPEV 303
H + ++HRD+K N + +K+ D G++ + + N IVG+ YY++PE+
Sbjct: 116 HLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172
Query: 304 LH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362
+ YN + D+W++GV+ Y G PF A + + ++R F S +
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG--VFPPVSQM-YSQQL 229
Query: 363 KDFVRRLLNKDHRKRMTAAQALTHPWL 389
+ + L KD+R+R Q L +P L
Sbjct: 230 AQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-35
Identities = 89/284 (31%), Positives = 141/284 (49%), Gaps = 43/284 (15%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+E+ + +G+G FG + K GK++ K I MT + V EV IL+ L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNMTEKEKQQLVS-EVNILREL 56
Query: 186 SGHKHMIKFHDAFED--ANSVYIVMEFCEGGEL--LDRILSRGGRYLEEDAK-TIVEKIL 240
H ++++++D D ++YIVME+CEGG+L L + + +Y+EE+ I+ ++L
Sbjct: 57 K-HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 241 NIVAFCHLQG-----VVHRDLKPEN-FLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIV 293
+ CH + V+HRDLKP N FL + + +K+ DFGL+ + D V
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFL----DANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 294 GSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWART--------ESGIFRSVL 344
G+ YY++PE L H SY+ + D+WS+G + Y L S PF AR + G FR
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR--- 228
Query: 345 RADPNFHDSPWPSV-SPEAKDFVRRLLNKDHRKRMTAAQALTHP 387
P S E + ++ +LN D KR + + L P
Sbjct: 229 ---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 77/274 (28%), Positives = 137/274 (50%), Gaps = 33/274 (12%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F++ +++G G +G A K+ G+VVA+K++ + ++++ +E+ ILK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKET---GQVVAIKVVP---VEED--LQEIIKEISILKQ-C 55
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
+++K++ ++ ++IVME+C G + D + EE+ I+ + L + +
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND-------IVGSAYYV 299
H +HRD+K N L E+ K+ DFG+S +L D ++G+ +++
Sbjct: 116 HSNKKIHRDIKAGNILLN---EEGQAKLADFGVS------GQLTDTMAKRNTVIGTPFWM 166
Query: 300 APEVLHRS-YNVEGDMWSIGVITYILLCGSRP--FWARTESGIFRSVLRADPNFHD-SPW 355
APEV+ YN + D+WS+G IT I + +P IF + P D W
Sbjct: 167 APEVIQEIGYNNKADIWSLG-ITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKW 225
Query: 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
SPE DFV++ L KD +R +A Q L HP++
Sbjct: 226 ---SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 76/277 (27%), Positives = 134/277 (48%), Gaps = 36/277 (12%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVK--IISKAKMTSALAIEDVRREVKILK 183
++ +++G G G A + GK VA+K + K + E+ I+K
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQNKELII------NEILIMK 70
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
H +++ ++D++ + +++VME+ +GG L D I R E + ++L +
Sbjct: 71 DCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPE 302
+ H Q V+HRD+K +N L + +D +K+ DFG + + + N +VG+ Y++APE
Sbjct: 130 EYLHSQNVIHRDIKSDNILLS---KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186
Query: 303 VLHRS-YNVEGDMWSIGVITYILLCGSRPF---------WARTESGIFRSVLRADPNFHD 352
V+ R Y + D+WS+G++ + G P+ + T GI P +
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI--------PPLKN 238
Query: 353 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
SPE KDF+ + L KD KR +A + L HP+L
Sbjct: 239 P--EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 71/250 (28%), Positives = 125/250 (50%), Gaps = 23/250 (9%)
Query: 152 KGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFC 211
+ VA+K I K ++ ++++R+EV+ + + H +++K++ +F + +++VM +
Sbjct: 25 NNEKVAIKRIDLEKCQTS--VDELRKEVQAM-SQCNHPNVVKYYTSFVVGDELWLVMPYL 81
Query: 212 EGGELLD---RILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 267
GG LLD RGG L+E T+++++L + + H G +HRD+K N L
Sbjct: 82 SGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---G 136
Query: 268 EDAPLKVIDFGLSDFV-----RPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVI 320
ED +K+ DFG+S + R + VG+ ++APEV+ Y+ + D+WS G I
Sbjct: 137 EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFG-I 195
Query: 321 TYI-LLCGSRPFWARTESGIFRSVLRADPNF--HDSPWPSVSPEAKDFVRRLLNKDHRKR 377
T I L G+ P+ + L+ DP + + S + + L KD KR
Sbjct: 196 TAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKR 255
Query: 378 MTAAQALTHP 387
TA + L H
Sbjct: 256 PTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 82/280 (29%), Positives = 138/280 (49%), Gaps = 32/280 (11%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+++ G ++G G FG +T G+++AVK I I+++ E+K+L+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDT-----GELMAVKEIRIQDNDPK-TIKEIADEMKVLE 54
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDA-KTIVEKILNI 242
L H +++K++ VYI ME+C GG L + L GR L+E + ++L
Sbjct: 55 LLK-HPNLVKYYGVEVHREKVYIFMEYCSGGTLEE--LLEHGRILDEHVIRVYTLQLLEG 111
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV-----RPDQRLNDIVGSAY 297
+A+ H G+VHRD+KP N +K+ DFG + + + + + G+
Sbjct: 112 LAYLHSHGIVHRDIKPANIFLDHN---GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168
Query: 298 YVAPEVLHRSYNVEG-----DMWSIGVITYILLCGSRPFWARTESG---IFRSVLRADPN 349
Y+APEV+ +G D+WS+G + + G RP W+ ++ +F P
Sbjct: 169 YMAPEVITGG-KGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGHKPP 226
Query: 350 FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
DS +SPE KDF+ R L D +KR TA++ L HP++
Sbjct: 227 IPDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 7e-34
Identities = 78/278 (28%), Positives = 149/278 (53%), Gaps = 26/278 (9%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL--SGHKH 190
+GRG +G +GK G+VVA+KII+ T + D++REV +L L S +
Sbjct: 9 IGRGAYG--AVYRGKH-VPTGRVVALKIINLD--TPDDDVSDIQREVALLSQLRQSQPPN 63
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+ K++ ++ ++I+ME+ EGG + R L + G E+ I+ ++L + + H G
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHKVG 121
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH--RS 307
V+HRD+K N L T +K+ DFG++ + + + VG+ Y++APEV+ +
Sbjct: 122 VIHRDIKAANILVTN---TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 308 YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL----RADPNFHDSPWPSVSPEAK 363
Y+ + D+WS+G+ Y + G+ P+ ++ FR+++ P D+ + S +
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDNGY---SKLLR 232
Query: 364 DFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDIL 401
+FV L+++ ++R++A + L W+ ++ P+ IL
Sbjct: 233 EFVAACLDEEPKERLSAEELLKSKWIKAHSK-TPVSIL 269
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 80/275 (29%), Positives = 133/275 (48%), Gaps = 30/275 (10%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+EL + +G G +G A+ G++VA+K+I K+ E +++E+ +LK
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIA---TGELVAIKVI---KLEPGDDFEIIQQEISMLKEC 57
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIV-EKILNIVA 244
H +++ + ++ + ++IVME+C GG L D I L E V + L +A
Sbjct: 58 R-HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLA 115
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEV 303
+ H G +HRD+K N L T ED +K+ DFG+S + +G+ Y++APEV
Sbjct: 116 YLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 304 L----HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP----- 354
Y+ + D+W++G IT I L +P + R++ + P
Sbjct: 173 AAVERKGGYDGKCDIWALG-ITAIELAELQP--PMFDLHPMRALFLISKSNFPPPKLKDK 229
Query: 355 --WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387
W SP DF+++ L KD +KR TA + L HP
Sbjct: 230 EKW---SPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 75/267 (28%), Positives = 133/267 (49%), Gaps = 20/267 (7%)
Query: 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAK--MTSALAIEDVRREVKILKALSG 187
G+ +G G FG G AVK +S A T A++ + +E+ +L L
Sbjct: 5 GELLGSGSFGSVYEGLNLD---DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ- 60
Query: 188 HKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH 247
H +++++ + +++YI +E GG L ++L + G + E + +IL + + H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 248 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR- 306
+ VHRD+K N L + + +K+ DFG++ V GS Y++APEV+ +
Sbjct: 120 DRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 307 -SYNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVLRAD-PNFHDSPWPSVSPEA 362
Y + D+WS+G T + + +P W++ E + +F+ + P D +S EA
Sbjct: 177 GGYGLAADIWSLGC-TVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDH----LSDEA 231
Query: 363 KDFVRRLLNKDHRKRMTAAQALTHPWL 389
KDF+ + L +D R TAA+ L HP++
Sbjct: 232 KDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 81/271 (29%), Positives = 136/271 (50%), Gaps = 26/271 (9%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMT--SALAIEDVRREVKI 181
K+E + VGRG FG H C K + K+V +K I +MT LA ++ E ++
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQ-----KLVIIKQIPVEQMTKDERLAAQN---ECQV 52
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE---K 238
LK LS H ++I++++ F + ++ IVME+ GG L + I R L+ED TI+ +
Sbjct: 53 LKLLS-HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED--TILHFFVQ 109
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 298
IL + H + ++HRDLK +N L + +K+ DFG+S + + +VG+ Y
Sbjct: 110 ILLALHHVHTKLILHRDLKTQNILLDKHK--MVVKIGDFGISKILSSKSKAYTVVGTPCY 167
Query: 299 VAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN-FHDSPWP 356
++PE+ + YN + D+W++G + Y L R F A + ++ D
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---- 223
Query: 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387
SP+ + + +LN D KR +Q + P
Sbjct: 224 RYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 76/262 (29%), Positives = 136/262 (51%), Gaps = 18/262 (6%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+G+G FG A + T +V K ++ +++ D E+ IL L H ++I
Sbjct: 8 LGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEK-ERRDALNEIVILSLLQ-HPNII 62
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIV---EKILNIVAFCHLQ 249
+++ F D N++ I ME+ GG L D+I+ + G+ EE + ++ +I++ V++ H
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE--EMVLWYLFQIVSAVSYIHKA 120
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND-IVGSAYYVAPEVLH-RS 307
G++HRD+K N +F T+ +K+ DFG+S + + + + +VG+ YY++PE+
Sbjct: 121 GILHRDIKTLN-IFLTK--AGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 308 YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 367
YN + D+W++G + Y LL R F A + +++ + S + S E V
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELISLVH 234
Query: 368 RLLNKDHRKRMTAAQALTHPWL 389
LL +D KR TA + L P L
Sbjct: 235 SLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 1e-32
Identities = 82/300 (27%), Positives = 127/300 (42%), Gaps = 52/300 (17%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+E ++G G +G A+ K T G++VA+K I I +R E+K+L+ L
Sbjct: 1 YEKIAQIGEGTYGQVYKAR-NKKT--GELVALKKIRMENEKEGFPITAIR-EIKLLQKLR 56
Query: 187 GHKHMIKFHDAF--EDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIV 243
H ++++ + + S+Y+V E+ + L +L E K ++++L +
Sbjct: 57 -HPNIVRLKEIVTSKGKGSIYMVFEYMDHD--LTGLLDSPEVKFTESQIKCYMKQLLEGL 113
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV--RPDQRLNDIVGSAYYVAP 301
+ H G++HRD+K N L LK+ DFGL+ R + V + +Y P
Sbjct: 114 QYLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVITLWYRPP 170
Query: 302 EVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESG----IFRSVLRADPNFHDSPW 355
E+L Y E DMWS+G I L G F TE IF L P D W
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE--LCGSPT--DENW 226
Query: 356 PSV---------------------------SPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388
P V P A D + +LL D +KR++A QAL H +
Sbjct: 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 1e-32
Identities = 86/278 (30%), Positives = 150/278 (53%), Gaps = 30/278 (10%)
Query: 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHM 191
++G G G C A+ K G+ VAVK++ K E + EV I++ H+++
Sbjct: 28 KIGEGSTGIVCIAREKH---SGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQ-HQNV 80
Query: 192 IKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 251
++ + ++ ++++MEF +GG L D I+S+ R EE T+ E +L + + H QGV
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQT-RLNEEQIATVCESVLQALCYLHSQGV 138
Query: 252 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHRS-YN 309
+HRD+K ++ L T D +K+ DFG + D + +VG+ Y++APEV+ R+ Y
Sbjct: 139 IHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 310 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS------VSPEAK 363
E D+WS+G++ ++ G P+++ + ++A DSP P +SP +
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRLRDSPPPKLKNAHKISPVLR 248
Query: 364 DFVRRLLNKDHRKRMTAAQALTHPWLHDENRP---VPL 398
DF+ R+L ++ ++R TA + L HP+L P VPL
Sbjct: 249 DFLERMLTREPQERATAQELLDHPFLLQTGLPECLVPL 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 76/265 (28%), Positives = 134/265 (50%), Gaps = 20/265 (7%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G+G FG A+ K ++ AVK++ K + +E E ++L H
Sbjct: 1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+ + H F+ + ++ VME+ GG+L+ I R GR+ E A+ +I+ + F H +G
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHERG 116
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL-HRSY 308
+++RDLK +N L + + +K+ DFG+ + + + G+ Y+APE+L ++ Y
Sbjct: 117 IIYRDLKLDNVLLDS---EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY 173
Query: 309 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP-SVSPEAKDFVR 367
D W++GV+ Y +L G PF E +F+S+L + + P +S EAK ++
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY-----PRWLSKEAKSILK 228
Query: 368 RLLNKDHRKRM----TAAQALT-HP 387
L K+ KR+ T Q + HP
Sbjct: 229 SFLTKNPEKRLGCLPTGEQDIKGHP 253
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 81/283 (28%), Positives = 147/283 (51%), Gaps = 25/283 (8%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS-ALAIEDVRREVKILKAL 185
FEL K +G G +G + G GK+ A+K++ KA + A E R E ++L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
++ H AF+ +++++++ GGEL + R R+ E++ + +I+ +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEH 120
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPD-QRLNDIVGSAYYVAPEV 303
H G+++RD+K EN L + + + + DFGLS +F + +R G+ Y+AP++
Sbjct: 121 LHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 304 LH---RSYNVEGDMWSIGVITYILLCGSRPFWA----RTESGIFRSVLRADPNFHDSPWP 356
+ ++ D WS+GV+ Y LL G+ PF +++ I R +L+++P P+P
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-----PYP 232
Query: 357 S-VSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393
+S AKD ++RLL KD +KR+ A + HP+ N
Sbjct: 233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 85/267 (31%), Positives = 139/267 (52%), Gaps = 27/267 (10%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
++G G G C A K G+ VAVK K + E + EV I++ H +
Sbjct: 25 VKIGEGSTGIVCIATDKS---TGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQ-HPN 77
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+++ + ++ + +++VMEF EGG L D I++ R EE T+ +L ++F H QG
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIATVCLAVLKALSFLHAQG 135
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHRS-Y 308
V+HRD+K ++ L T+ D +K+ DFG V + R +VG+ Y++APEV+ R Y
Sbjct: 136 VIHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192
Query: 309 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP------SVSPEA 362
E D+WS+G++ ++ G P++ L+A D+ P VSP
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFN-------EPPLQAMKRIRDNLPPKLKNLHKVSPRL 245
Query: 363 KDFVRRLLNKDHRKRMTAAQALTHPWL 389
+ F+ R+L +D +R TAA+ L HP+L
Sbjct: 246 RSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 88/275 (32%), Positives = 138/275 (50%), Gaps = 20/275 (7%)
Query: 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKA 184
+ FE+G+ +G G FG AK KGT G+ A+K + K ++ ++ V +E IL
Sbjct: 18 SDFEMGETLGTGSFGRVRIAK-HKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA 244
LS H ++ +F+D N VY ++EF GGEL L + GR+ + AK +++
Sbjct: 75 LS-HPFIVNMMCSFQDENRVYFLLEFVVGGELFTH-LRKAGRFPNDVAKFYHAELVLAFE 132
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL 304
+ H + +++RDLKPEN L + +KV DFG + V R + G+ Y+APEV+
Sbjct: 133 YLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI 187
Query: 305 H-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363
+ + D W++GV+ Y + G PF+ T I+ +L F + W A+
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRAR 243
Query: 364 DFVRRLLNKDHRKRMTA-----AQALTHPWLHDEN 393
D V+ LL DH KR+ A HP+ H N
Sbjct: 244 DLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278
|
Length = 329 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 102/313 (32%), Positives = 149/313 (47%), Gaps = 62/313 (19%)
Query: 123 FGAKFELG------KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVR 176
FG FE+ + VG G FG C A+ L G+ VA+K I K T LA +
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARD---QLTGQNVAIKKIMKPFSTPVLA-KRTY 57
Query: 177 REVKILKALSGHKHMIKFHDAF----EDANSVYIVMEFCEGGELLDRILSRGGRYLEED- 231
RE+K+LK L H+++I D F ED +Y V E G L R+L+ R LE+
Sbjct: 58 RELKLLKHLR-HENIISLSDIFISPLED---IYFVTELL--GTDLHRLLT--SRPLEKQF 109
Query: 232 AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRLN 290
+ + +IL + + H GVVHRDLKP N L E+ LK+ DFGL+ R D ++
Sbjct: 110 IQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLA---RIQDPQMT 163
Query: 291 DIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF-------- 340
V + YY APE++ + Y+VE D+WS G I +L G F + F
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG 223
Query: 341 -------------------RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 381
+S+ + +P + + P A D + ++L D +KR++AA
Sbjct: 224 TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAA 283
Query: 382 QALTHPWL---HD 391
+AL HP+L HD
Sbjct: 284 EALAHPYLAPYHD 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 79/266 (29%), Positives = 137/266 (51%), Gaps = 17/266 (6%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM-TSALAIEDVRREVKILKALSGHK 189
K +G+G +G + G GK+ A+K++ KA + + + E IL+A+ H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HP 60
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ 249
++ AF+ +Y+++E+ GGEL L R G ++E+ A + +I + H Q
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMH-LEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHRS- 307
G+++RDLKPEN L + +K+ DFGL + + + G+ Y+APE+L RS
Sbjct: 120 GIIYRDLKPENILLDAQ---GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG 176
Query: 308 YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 367
+ D WS+G + Y +L G+ PF A +L+ N P P ++PEA+D ++
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL---P-PYLTPEARDLLK 232
Query: 368 RLLNKDHRKRM-----TAAQALTHPW 388
+LL ++ R+ AA+ +HP+
Sbjct: 233 KLLKRNPSSRLGAGPGDAAEVQSHPF 258
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 82/260 (31%), Positives = 136/260 (52%), Gaps = 30/260 (11%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F++ VGRGHFG + K G + A+K++ K+ + + + E IL ++S
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDIL-SIS 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAF 245
+ + AF+D +++Y+VME+ GG+LL +L+R +ED A+ + +++ +
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI--VGSAYYVAPEV 303
H G VHRD+KPEN L + +K+ DFG + + ++ +N VG+ Y+APEV
Sbjct: 118 VHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 304 LHR-------SYNVEGDMWSIGVITYILLCGSRPFW----ARTESGI--FRSVLRADPNF 350
L +Y VE D WS+GVI Y ++ G PF A+T + I F+ L+ F
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK----F 230
Query: 351 HDSPWPSVSPEAKDFVRRLL 370
+ P VS + D ++ LL
Sbjct: 231 PED--PKVSSDFLDLIQSLL 248
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 6e-31
Identities = 84/280 (30%), Positives = 140/280 (50%), Gaps = 23/280 (8%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+E+ E+G G FG A+ K+ G + A K+I S +ED E+ IL A
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVIDT---KSEEELEDYMVEIDIL-ASC 59
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H +++K DAF N+++I++EFC GG + +L E + + ++ L + +
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL- 304
H ++HRDLK N LFT D +K+ DFG+S R QR + +G+ Y++APEV+
Sbjct: 120 HENKIIHRDLKAGNILFTL---DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 305 -----HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP--WPS 357
R Y+ + D+WS+G+ + P + + +++P P W
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW-- 234
Query: 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH-DENRPV 396
S E KDF+++ L K+ R T Q L HP++ + N+P+
Sbjct: 235 -SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 89/287 (31%), Positives = 144/287 (50%), Gaps = 26/287 (9%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+E+ E+G G FG A+ K+ L A KII ++ S +ED E+ IL
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFA---AAKII---QIESEEELEDFMVEIDILSECK 60
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDA-KTIVEKILNIVAF 245
H +++ ++A+ N ++I++EFC+GG L D I+ R L E + + ++L + F
Sbjct: 61 -HPNIVGLYEAYFYENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL 304
H V+HRDLK N L T D +K+ DFG+S Q+ + +G+ Y++APEV+
Sbjct: 119 LHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV 175
Query: 305 ------HRSYNVEGDMWSIGVITYILLCGSRPFWARTES-GIFRSVLRADPNFHDSP--W 355
Y+ + D+WS+G IT I L P + +L+++P D P W
Sbjct: 176 ACETFKDNPYDYKADIWSLG-ITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW 234
Query: 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
S DF++ L KD R TAA+ L HP++ D++ + L+
Sbjct: 235 ---SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLL 278
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 87/283 (30%), Positives = 140/283 (49%), Gaps = 45/283 (15%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
E E+G G+ G + GK++AVK I + ++ A+ + + RE+ IL
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRP---TGKIMAVKTI-RLEINEAI-QKQILRELDILHK-C 56
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
+++ F+ AF + + I ME+ +GG L D+IL I E+IL +A
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEV-------QGRIPERILGKIAVA 108
Query: 247 HLQG---------VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI----V 293
L+G ++HRD+KP N L +R + +K+ DFG+S Q +N + V
Sbjct: 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSG-----QLVNSLAKTFV 160
Query: 294 GSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSR---PFWARTESGIFRSVLRADPN 349
G++ Y+APE + Y+V+ D+WS+G ++ I L R P GIF +L+ N
Sbjct: 161 GTSSYMAPERIQGNDYSVKSDIWSLG-LSLIELATGRFPYPPENDPPDGIF-ELLQYIVN 218
Query: 350 FHDSP-WPS--VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
P PS SP+ +DFV L KD R+R + + L HP++
Sbjct: 219 -EPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 72/276 (26%), Positives = 128/276 (46%), Gaps = 22/276 (7%)
Query: 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKA 184
E K VG G FG + + A+K+++ ++ + V E ++LK
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRIS---EHYYALKVMAIPEVIRLKQEQHVHNEKRVLKE 57
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA 244
+S H +I+ D +Y++ME+ GGEL + + G R+ +I+ +
Sbjct: 58 VS-HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALE 115
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL 304
+ H + +V+RDLKPEN L +++ +K+ DFG + +R R + G+ Y+APEV+
Sbjct: 116 YLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVI 170
Query: 305 HRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP-SVSPEA 362
+N D W++G++ Y +L G PF+ GI+ +L +P + A
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA-----GKLEFPRHLDLYA 225
Query: 363 KDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393
KD +++LL D +R+ A H W +
Sbjct: 226 KDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-30
Identities = 83/284 (29%), Positives = 145/284 (51%), Gaps = 28/284 (9%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS-ALAIEDVRREVKILKAL 185
FEL K +G G +G + G GK+ A+K++ KA + A +E R E +L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDA-KTIVEKILNIVA 244
++ H AF+ +++++++ GGE+ + R ED + +I+ +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALE 119
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPD-QRLNDIVGSAYYVAPE 302
H G+V+RD+K EN L + + + + DFGLS +F+ + +R G+ Y+APE
Sbjct: 120 HLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 303 VLHRSYNVEG---DMWSIGVITYILLCGSRPFWAR----TESGIFRSVLRADPNFHDSPW 355
++ R G D WS+G++ + LL G+ PF T+S + R +L+ DP P+
Sbjct: 177 II-RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP-----PF 230
Query: 356 PS-VSPEAKDFVRRLLNKDHRKRMTAA-----QALTHPWLHDEN 393
PS + PEA+D + +LL KD +KR+ A + HP+ +
Sbjct: 231 PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 92/289 (31%), Positives = 145/289 (50%), Gaps = 30/289 (10%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+E+ E+G G FG AK K+ G + A K+I + S +ED E++IL A
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKE---TGALAAAKVI---ETKSEEELEDYMVEIEIL-ATC 66
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEE-DAKTIVEKILNIVAF 245
H +++K AF ++I++EFC GG + D I+ R L E + I ++L + +
Sbjct: 67 NHPYIVKLLGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQY 125
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL 304
H ++HRDLK N L T D +K+ DFG+S V+ QR + +G+ Y++APEV+
Sbjct: 126 LHSMKIIHRDLKAGNVLLT---LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 305 ------HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR---ADPNFHDSP- 354
Y+ + D+WS+G IT I + P E R +L+ ++P P
Sbjct: 183 MCETMKDTPYDYKADIWSLG-ITLIEMAQIEP--PHHELNPMRVLLKIAKSEPPTLSQPS 239
Query: 355 -WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
W S E +DF++ L+K R +AAQ L HP++ PL L+
Sbjct: 240 KW---SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELV 285
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 81/259 (31%), Positives = 134/259 (51%), Gaps = 24/259 (9%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRR---EVKILKALSG 187
K +G+G FG + G G++ A+K++ KA L + D R E IL A
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA----TLKVRDRVRTKMERDIL-AEVN 56
Query: 188 HKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH 247
H ++K H AF+ +Y++++F GG+L R LS+ + EED K + ++ + H
Sbjct: 57 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 248 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR 306
G+++RDLKPEN L +E+ +K+ DFGLS + + +++ G+ Y+APEV++R
Sbjct: 116 SLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 307 -SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD---PNFHDSPWPSVSPEA 362
+ D WS GV+ + +L GS PF + +L+A P F +SPEA
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF-------LSPEA 225
Query: 363 KDFVRRLLNKDHRKRMTAA 381
+ +R L ++ R+ A
Sbjct: 226 QSLLRALFKRNPANRLGAG 244
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 88/301 (29%), Positives = 140/301 (46%), Gaps = 55/301 (18%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
VG G +G C A K K VA+K +S+ SA+ + RE+++LK + H+++I
Sbjct: 23 VGSGAYGQVCSAFDTKTGRK---VAIKKLSRP-FQSAIHAKRTYRELRLLKHMD-HENVI 77
Query: 193 KFHDAF------EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
D F ED VY+V G L+ I+ + + ++ + +V +IL + +
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIV-KCQKLSDDHIQFLVYQILRGLKYI 134
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH 305
H G++HRDLKP N ED LK++DFGL+ R D + V + +Y APE++
Sbjct: 135 HSAGIIHRDLKPSNIAVN---EDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIML 188
Query: 306 --RSYNVEGDMWSIGVITYILLCG-----------------------SRPFWARTESGIF 340
YN D+WS+G I LL G + S
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248
Query: 341 RSVLRADP-----NFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL---HDE 392
R+ +++ P +F + + +P A D + ++L D KR+TAA+AL HP+L HD
Sbjct: 249 RNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307
Query: 393 N 393
Sbjct: 308 E 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 92/279 (32%), Positives = 140/279 (50%), Gaps = 24/279 (8%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FE+ K +GRG FG K K G+V A+KI++K +M R E +L ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVL--VN 57
Query: 187 GHKHMI-KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AK-TIVEKILNIV 243
G + I H AF+D N++Y+VM++ GG+LL +LS+ L ED A+ + E +L I
Sbjct: 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVLAID 116
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAP 301
+ H G VHRD+KP+N L +++ DFG + D + N VG+ Y++P
Sbjct: 117 SV-HQLGYVHRDIKPDNVLLDKN---GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
Query: 302 EVLHR------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355
E+L Y E D WS+GV Y +L G PF+A + + ++ +F P
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD 232
Query: 356 -PSVSPEAKDFVRRLL-NKDHRKRMTAAQAL-THPWLHD 391
VS EAKD +RRL+ + + R Q HP+
Sbjct: 233 VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 5e-29
Identities = 87/276 (31%), Positives = 140/276 (50%), Gaps = 26/276 (9%)
Query: 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHM 191
++G G G C A K GK+VAVK K + E + EV I++ H+++
Sbjct: 27 KIGEGSTGIVCIATVKS---SGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQ-HENV 79
Query: 192 IKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 251
++ ++++ + +++VMEF EGG L D + R EE + +L ++ H QGV
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGV 137
Query: 252 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYN 309
+HRD+K ++ L T D +K+ DFG V + R +VG+ Y++APE++ R Y
Sbjct: 138 IHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 310 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP----NFHDSPWPSVSPEAKDF 365
E D+WS+G++ ++ G P++ + + P N H VSP K F
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLH-----KVSPSLKGF 249
Query: 366 VRRLLNKDHRKRMTAAQALTHPWLHDENRP---VPL 398
+ RLL +D +R TAA+ L HP+L P VPL
Sbjct: 250 LDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 79/300 (26%), Positives = 133/300 (44%), Gaps = 50/300 (16%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL- 185
+E E+G G +G A+ G+ VA+K + + + +R E+ +LK L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLE 56
Query: 186 -SGHKHMIKFHDAF-----EDANSVYIVMEFCEG--GELLDRILSRGGRYLEED-AKTIV 236
H ++++ D + + +V E + L + G L + K ++
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG---LPPETIKDLM 113
Query: 237 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA 296
++L V F H +VHRDLKP+N L T+ + +K+ DFGL+ + L +V +
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMALTSVVVTL 170
Query: 297 YYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRP-FWARTESG----IFR--------- 341
+Y APEVL +S Y DMWS+G I L RP F +E+ IF
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 342 -----SVLRADPNFHDSP-------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
S+ R+ +F P + E D ++++L + KR++A +AL HP+
Sbjct: 230 WPRNVSLPRS--SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 92/319 (28%), Positives = 151/319 (47%), Gaps = 63/319 (19%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA---KMTSALAIEDVRREVKILK 183
+EL KE+G+G +G C A+ T + + VA+K I+ K+ + A+ RE+K+L+
Sbjct: 2 YELIKELGQGAYGIVCSAR-NAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLR 56
Query: 184 ALSGHKHM-------IKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIV 236
GHK++ I F F N +Y+ E E L +I+ G + ++ +
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNF---NELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFI 111
Query: 237 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-----DFVRPDQRLND 291
+IL + + H V+HRDLKP N L D LK+ DFGL+ + + +
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGFSENPGENAGFMTE 168
Query: 292 IVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFW----------------- 332
V + +Y APE++ +SY D+WS+G I LL G +P +
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQVLG 227
Query: 333 -------ARTESGIFRSVLRADPNFHDSPWPSV----SPEAKDFVRRLLNKDHRKRMTAA 381
+R S ++ +R+ PN P+ S+ +P A D + +LL D KR++
Sbjct: 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVE 287
Query: 382 QALTHPWL---HD-ENRPV 396
+AL HP+L HD ++ PV
Sbjct: 288 EALEHPYLAIWHDPDDEPV 306
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 77/264 (29%), Positives = 137/264 (51%), Gaps = 26/264 (9%)
Query: 153 GKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF--EDANSVYIVMEF 210
G + A+K I+ + + + RE++I K+ +++K++ AF E ++S+ I ME+
Sbjct: 26 GMIFALKTITT--DPNPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGIAMEY 82
Query: 211 CEGGEL---LDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 267
CEGG L ++ RGGR E+ I E +L +++ H + ++HRD+KP N L T +
Sbjct: 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG 142
Query: 268 EDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPE-VLHRSYNVEGDMWSIGVITYILL 325
+ +K+ DFG+S + V + G+++Y+APE + + Y++ D+WS+G +T + +
Sbjct: 143 Q---VKLCDFGVSGELV--NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLG-LTLLEV 196
Query: 326 CGSR-PFWARTESG-----IFRSVLRAD-PNFHDSPWPSV--SPEAKDFVRRLLNKDHRK 376
+R PF E + ++ P D P + S E KDF+++ L KD +
Sbjct: 197 AQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTR 256
Query: 377 RMTAAQALTHPW-LHDENRPVPLD 399
R T L HPW + V +
Sbjct: 257 RPTPWDMLEHPWIKAQMKKKVNMA 280
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 84/285 (29%), Positives = 138/285 (48%), Gaps = 47/285 (16%)
Query: 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIIS-----------KAKMTSALAIEDVRRE 178
G +G G FG G+++AVK + K M ALA RE
Sbjct: 5 GALIGSGSFGSVYLGMN---ASSGELMAVKQVELPSVSASSKDRKRSMLDALA-----RE 56
Query: 179 VKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEK 238
+ +LK L H++++++ + DA+ + I +E+ GG + +L+ G + E + V +
Sbjct: 57 IALLKELQ-HENIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQ 114
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV------------RPD 286
IL + + H +G++HRD+K N L + +K+ DFG+S + RP
Sbjct: 115 ILKGLNYLHNRGIIHRDIKGANILVDNK---GGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 287 QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVL 344
+ GS +++APEV+ + SY + D+WS+G + +L G PF T+ IF+
Sbjct: 172 -----LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226
Query: 345 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
A P + +S EA DF+ + DH KR TAA+ L HP+L
Sbjct: 227 NASPEIPSN----ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 76/270 (28%), Positives = 129/270 (47%), Gaps = 23/270 (8%)
Query: 134 GRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH--M 191
GRGHFG A+ KK G++ A+K + K + + +E + E +I + + +H +
Sbjct: 8 GRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 192 IKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 251
+ F+ + V VME+ GG+L+ I + + E A ++ + + H +
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKI 122
Query: 252 VHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVL-HRSYN 309
V+RDLK +N L T + +K+ DFGL + + R + G+ ++APEVL SY
Sbjct: 123 VYRDLKLDNLLLDT---EGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 310 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP-SVSPEAKDFVRR 368
D W +GV+ Y +L G PF E +F S++ + +P +S EA +RR
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-----RYPRFLSREAISIMRR 234
Query: 369 LLNKDHRKRM-----TAAQALTHPWLHDEN 393
LL ++ +R+ A P+ D N
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 80/283 (28%), Positives = 141/283 (49%), Gaps = 23/283 (8%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKIL--KALSGHKH 190
+G+G FG + KK T ++ A+K++SK ++ + + E IL L
Sbjct: 1 IGKGTFGQVYQVR-KKDT--RRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPF 57
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
++ +F+ + +Y+V ++ GGEL L + GR+ E+ AK + +++ + H
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWH-LQKEGRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDF-VRPDQRLNDIVGSAYYVAPEVL--HRS 307
+V+RDLKPEN L + + + DFGLS + ++ N G+ Y+APEVL +
Sbjct: 117 IVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 308 YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 367
Y D WS+GV+ + + CG PF+A ++R++ F P +S E + FV+
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVK 230
Query: 368 RLLNKDHRKRMTAAQALT----HPWLHDENRPVPLDILIYKLV 406
LLN++ + R+ A + HP+ D + D+L K +
Sbjct: 231 GLLNRNPQHRLGAHRDAVELKEHPFFADID----WDLLSKKQI 269
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 96/320 (30%), Positives = 149/320 (46%), Gaps = 58/320 (18%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FE K +GRG FG + KK T G + A+K + K++M + VR E IL A +
Sbjct: 3 FESIKVIGRGAFGEVRLVQ-KKDT--GHIYAMKKLRKSEMLEKEQVAHVRAERDIL-AEA 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAK-TIVEKILNIVAF 245
+ ++K + +F+D N +Y++ME+ GG+++ +L + + EE+ + I E IL I +
Sbjct: 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMT-LLMKKDTFTEEETRFYIAETILAIDSI 117
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL---------SDFVR------PDQRLN 290
H G +HRD+KP+N L + +K+ DFGL ++F R P L+
Sbjct: 118 -HKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 291 DI------------------------VGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILL 325
I VG+ Y+APEV ++ YN E D WS+GVI Y +L
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 326 CGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL-NKDHR-KRMTAAQA 383
G PF + +R ++ +SPEAKD ++RL + R +
Sbjct: 234 VGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEI 293
Query: 384 LTHP------WLHDENRPVP 397
+HP W H RP P
Sbjct: 294 KSHPFFKGVDWEHIRERPAP 313
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 75/265 (28%), Positives = 133/265 (50%), Gaps = 30/265 (11%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F++ K++G+G F A L G+VVA+K + +M A A +D +E+ +LK L
Sbjct: 4 FKIEKKIGKGQFSVVYKAICL---LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEK-------- 238
H ++IK+ +F + N + IV+E + G+ LSR ++ ++ + I E+
Sbjct: 61 -HPNVIKYLASFIENNELNIVLELADAGD-----LSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAY 297
+ + + H + ++HRD+KP N T +K+ D GL F + +VG+ Y
Sbjct: 115 LCSALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 298 YVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTES--GIFRSVLRADPNFHDSP 354
Y++PE +H + YN + D+WS+G + Y + PF+ + + + + + D P
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY----PP 227
Query: 355 WPS--VSPEAKDFVRRLLNKDHRKR 377
P+ S E +D V R +N D KR
Sbjct: 228 LPADHYSEELRDLVSRCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 76/277 (27%), Positives = 143/277 (51%), Gaps = 34/277 (12%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
K+ K++G G FG K K+ GK +K I+ +KM+ E+ R+EV +L +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMSPK-EREESRKEVAVLSNM 56
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN-IVA 244
H +++++ ++FE+ ++YIVM++CEGG+L +I ++ G ED +IL+ V
Sbjct: 57 K-HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED------QILDWFVQ 109
Query: 245 FC------HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAY 297
C H + ++HRD+K +N +F T+ D +K+ DFG++ + L +G+ Y
Sbjct: 110 ICLALKHVHDRKILHRDIKSQN-IFLTK--DGTIKLGDFGIARVLNSTVELARTCIGTPY 166
Query: 298 YVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356
Y++PE+ +R YN + D+W++G + Y + F A + ++R +P
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-------YP 219
Query: 357 SV----SPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
V S + ++ V +L ++ R R + L ++
Sbjct: 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 96/322 (29%), Positives = 146/322 (45%), Gaps = 57/322 (17%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FE K +GRG FG + KK T G + A+KI+ KA M + +R E IL
Sbjct: 3 FESLKVIGRGAFGEVRLVQ-KKDT--GHIYAMKILRKADMLEKEQVAHIRAERDILVEAD 59
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
G ++K +F+D ++Y++MEF GG+++ ++ + E I E +L I A
Sbjct: 60 G-AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI- 117
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL---------SDFVR------PD----Q 287
H G +HRD+KP+N L + +K+ DFGL ++F R P Q
Sbjct: 118 HQLGFIHRDIKPDNLLLDAK---GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 288 RLN-----------------DIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSR 329
+N VG+ Y+APEV ++ YN D WS+GVI Y +L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 330 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA---QALTH 386
PF + T +R V+ P +S +AKD + R D R+ + + +H
Sbjct: 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293
Query: 387 P------WLHDENRP--VPLDI 400
P W H RP +P++I
Sbjct: 294 PFFEGVDWGHIRERPAAIPIEI 315
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 79/278 (28%), Positives = 139/278 (50%), Gaps = 28/278 (10%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FEL + VG G +G + K G++ A+K++ + E++++E+ +LK S
Sbjct: 8 FELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTGDEEEEIKQEINMLKKYS 60
Query: 187 GHKHMIKFHDAFEDAN------SVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKI 239
H+++ ++ AF N +++VMEFC G + D I + G L+E+ I +I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYY 298
L ++ H V+HRD+K +N L T E+A +K++DFG+S R R N +G+ Y+
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 177
Query: 299 VAPEVL------HRSYNVEGDMWSIGVITYILLCGSRPFW-ARTESGIFRSVLRADPNFH 351
+APEV+ +Y+ + D+WS+G+ + G+ P +F P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237
Query: 352 DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
W S + + F+ L K+H +R T Q + HP++
Sbjct: 238 SKKW---SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 75/251 (29%), Positives = 127/251 (50%), Gaps = 16/251 (6%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G+G FG + K GK A+KI+ K + + + E ++L+ + H
Sbjct: 1 KLLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPF 56
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+ +F+ + + VME+ GGEL LSR + E+ A+ +I++ + + H
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHRS-Y 308
VV+RDLK EN + ++D +K+ DFGL + + + G+ Y+APEVL + Y
Sbjct: 116 VVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 309 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS-VSPEAKDFVR 367
D W +GV+ Y ++CG PF+ + +F +L + F P +SPEAK +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF-----PRTLSPEAKSLLA 227
Query: 368 RLLNKDHRKRM 378
LL KD ++R+
Sbjct: 228 GLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 84/305 (27%), Positives = 142/305 (46%), Gaps = 55/305 (18%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA--KMTSALAIEDVRREVKILK 183
K+E+ +++G+G +G A ++ +VVA+K I A T A + RE+ L+
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAFRNATDA---QRTFREIMFLQ 61
Query: 184 ALSGHKHMIKFHDAFEDANS--VYIVMEFCEGGELLDRILSRGGRYLEEDAKT-IVEKIL 240
L H +++K + + N +Y+V E+ E L ++ LE+ K I+ ++L
Sbjct: 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYMETD--LHAVIRAN--ILEDVHKRYIMYQLL 117
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP------DQRLNDIVG 294
+ + H V+HRDLKP N L + D +K+ DFGL+ + + L D V
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNS---DCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 295 SAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWART----------------- 335
+ +Y APE+L Y DMWS+G I +L G +P + T
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQLEKIIEVIGPPS 233
Query: 336 -------ESGIFRSVLRADPNFHDSP----WPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384
+S ++L + P+ P P S +A D +++LL + KR+TA +AL
Sbjct: 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL 293
Query: 385 THPWL 389
HP++
Sbjct: 294 EHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 79/272 (29%), Positives = 127/272 (46%), Gaps = 25/272 (9%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F + +G G FG A K VA+K K+K+ ++ V E KIL ++
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPP--VAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H + + +F+D + +Y+V+EF GGE L R R+ + +I+ I +
Sbjct: 90 -HPFCVNLYGSFKDESYLYLVLEFVIGGEFFT-FLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV-LH 305
+V+RDLKPEN L ++D +K+ DFG + V D R + G+ Y+APE+ L+
Sbjct: 148 QSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVV--DTRTYTLCGTPEYIAPEILLN 202
Query: 306 RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD---PNFHDSPWPSVSPEA 362
+ D W++G+ Y +L G PF+A I++ +L P F D+
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDN-------NC 255
Query: 363 KDFVRRLLNKDHRKRM-----TAAQALTHPWL 389
K +++LL+ D KR A HPW
Sbjct: 256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 79/268 (29%), Positives = 127/268 (47%), Gaps = 41/268 (15%)
Query: 153 GKVVAVKII--SKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210
G++VA+K I + T + AI RE+ ++K L H+++++ HD N + +V E+
Sbjct: 25 GEIVALKEIHLDAEEGTPSTAI----REISLMKELK-HENIVRLHDVIHTENKLMLVFEY 79
Query: 211 CEGGELLDRILSRGGR-YLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 268
+ +L + + G R L+ + K+ ++L +AFCH V+HRDLKP+N L R E
Sbjct: 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE 138
Query: 269 DAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILL 325
LK+ DFGL+ F P ++ V + +Y AP+VL R+Y+ D+WS+G I ++
Sbjct: 139 ---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195
Query: 326 CGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS-------------------------P 360
G F + R +S WP +S P
Sbjct: 196 TGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADP 255
Query: 361 EAKDFVRRLLNKDHRKRMTAAQALTHPW 388
D + RLL + R++A AL HPW
Sbjct: 256 LGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 81/306 (26%), Positives = 137/306 (44%), Gaps = 21/306 (6%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G+G FG AK K GK AVK++ K + + + E +L H
Sbjct: 1 KVIGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
++ H +F+ A+ +Y V+++ GGEL L R + E A+ +I + + + H
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSLN 116
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHRS-Y 308
+++RDLKPEN L + + + DFGL + + + + G+ Y+APEVL + Y
Sbjct: 117 IIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 309 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368
+ D W +G + Y +L G PF++R + ++ ++L P++S A+ +
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEG 229
Query: 369 LLNKDHRKRMTAAQAL----THPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALS 424
LL KD KR+ A H + + D L+ K + LK
Sbjct: 230 LLQKDRTKRLGAKDDFLEIKNHVFF----SSINWDDLVNKKITPPFNPNVSGPMDLKHFD 285
Query: 425 KALTEE 430
TEE
Sbjct: 286 PEFTEE 291
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 84/311 (27%), Positives = 139/311 (44%), Gaps = 55/311 (17%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F K +G G FG C + K T + A+K + KA + V+ E IL A +
Sbjct: 3 FVKIKTIGIGAFGEVCLVR-KVDT--NALYAMKTLRKADVLMRNQAAHVKAERDIL-AEA 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
++ ++K + +F+D +++Y VM++ GG+++ +L R G + E+ A+ + ++ +
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRLGIFEEDLARFYIAELTCAIESV 117
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL--------------------SDFVRPD 286
H G +HRD+KP+N L + D +K+ DFGL D + P
Sbjct: 118 HKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 287 QRLNDI------------------------VGSAYYVAPEVLHRS-YNVEGDMWSIGVIT 321
+ ++I VG+ Y+APEVL R+ Y D WS+GVI
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234
Query: 322 YILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL-NKDHR-KRMT 379
Y +L G PF A T + V+ + H +S EA D + RL + R +
Sbjct: 235 YEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNG 294
Query: 380 AAQALTHPWLH 390
A + HP+
Sbjct: 295 ADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 78/276 (28%), Positives = 134/276 (48%), Gaps = 13/276 (4%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G+G FG A+ K + K AVK++ K + + + E +L H
Sbjct: 1 KVIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 57
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
++ H +F+ A+ +Y V+++ GGEL L R +LE A+ +I + + + H
Sbjct: 58 LVGLHFSFQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLN 116
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHRS-Y 308
+V+RDLKPEN L ++ + + DFGL + + + + G+ Y+APEVLH+ Y
Sbjct: 117 IVYRDLKPENILLDSQ---GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 309 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368
+ D W +G + Y +L G PF++R + ++ ++L P+++ A+ +
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEG 229
Query: 369 LLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYK 404
LL KD KR+ A H P+ D LI K
Sbjct: 230 LLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINK 265
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 69/248 (27%), Positives = 127/248 (51%), Gaps = 13/248 (5%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+G+G FG A+ K+ G++ AVK++ K + +E E +IL H +
Sbjct: 3 LGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 252
+ + F+ + ++ VMEF GG+L+ I + R+ E A+ +I + + F H +G++
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFLHDKGII 118
Query: 253 HRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNV 310
+RDLK +N L + + K+ DFG+ + + + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 311 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 370
D W++GV+ Y +LCG PF A E +F ++L + + W +S +A D ++ +
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--PTW--LSQDAVDILKAFM 231
Query: 371 NKDHRKRM 378
K+ R+
Sbjct: 232 TKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 83/290 (28%), Positives = 134/290 (46%), Gaps = 50/290 (17%)
Query: 136 GHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFH 195
G +G A+ KK G++VA+K + K I +R E+ IL L H +++
Sbjct: 16 GTYGVVYRARDKK---TGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQ-HPNIVTVK 70
Query: 196 DAF--EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 253
+ + + +Y+VME+ E +L + + +L+ + K ++ ++L+ VA H ++H
Sbjct: 71 EVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILH 129
Query: 254 RDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNV 310
RDLK N L R LK+ DFGL+ ++ P + +V + +Y APE+L + Y+
Sbjct: 130 RDLKTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 311 EGDMWSIGVITYILLCGSRPFWARTE----SGIFRSVLRADPNFHDSPWPSVS--PEAK- 363
DMWS+G I LL F ++E + IF+ L P + WP S P AK
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK--LLGTPT--EKIWPGFSELPGAKK 242
Query: 364 -------------------------DFVRRLLNKDHRKRMTAAQALTHPW 388
D + RLL D KR++A AL HP+
Sbjct: 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 76/276 (27%), Positives = 137/276 (49%), Gaps = 27/276 (9%)
Query: 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVK-------IISKAKMTSALAIEDVRREVKIL 182
G+ +G+G +G A G+++AVK I + ++ +R E++ L
Sbjct: 6 GELIGKGTYGRVYLALN---VTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 183 KALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI 242
K L H +++++ + I +E+ GG + L GR+ E+ + E++L
Sbjct: 63 KDLD-HLNIVQYLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS----DFVRPDQRLNDIVGSAYY 298
+A+ H +G++HRDLK +N L + D K+ DFG+S D DQ ++ + GS ++
Sbjct: 121 LAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMS-MQGSVFW 176
Query: 299 VAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWARTES--GIFR-SVLRADPNFHD 352
+APEV+H + Y+ + D+WS+G + + G RP W+ E+ +F+ R+ P
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPPIPP 235
Query: 353 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388
++SP A DF+ + R TA + L HP+
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 79/260 (30%), Positives = 133/260 (51%), Gaps = 19/260 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FE+ K +GRG FG K K KV A+KI++K +M R E +L ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNAD---KVFAMKILNKWEMLKRAETACFREERDVL--VN 57
Query: 187 G-HKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
G ++ + H AF+D N++Y+VM++ GG+LL + R E+ A+ + +++ +
Sbjct: 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND--IVGSAYYVAPEV 303
H VHRD+KP+N L + + +++ DFG + D + VG+ Y++PE+
Sbjct: 118 VHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 304 LHR------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH-DSPWP 356
L Y E D WS+GV Y +L G PF+A + + ++ F +
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVT 234
Query: 357 SVSPEAKDFVRRLL-NKDHR 375
VS +AKD +RRL+ +++HR
Sbjct: 235 DVSEDAKDLIRRLICSREHR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 82/264 (31%), Positives = 133/264 (50%), Gaps = 26/264 (9%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FE+ K +GRG FG K K ++ A+KI++K +M R E +L ++
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTE---RIYAMKILNKWEMLKRAETACFREERNVL--VN 57
Query: 187 GHKHMIK-FHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVA 244
G I H AF+D N +Y+VM++ GG+LL +LS+ L ED A+ + +++ +
Sbjct: 58 GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYIAEMVLAIH 116
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND--IVGSAYYVAPE 302
H VHRD+KP+N L + + +++ DFG + D + VG+ Y++PE
Sbjct: 117 SIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 303 VLHR------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356
+L Y E D WS+GV Y +L G PF+A + + ++ + F +P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FP 230
Query: 357 S----VSPEAKDFVRRLLNKDHRK 376
S VS EAKD ++RL+ R+
Sbjct: 231 SHITDVSEEAKDLIQRLICSRERR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-26
Identities = 80/286 (27%), Positives = 140/286 (48%), Gaps = 22/286 (7%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G+G FG + K G+ A+KI+ K + + + E ++L+ + H
Sbjct: 1 KLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPF 56
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+ AF+ + + VME+ GGEL LSR + EE A+ +I++ + + H +
Sbjct: 57 LTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLH-RSY 308
VV+RD+K EN + ++D +K+ DFGL + + + G+ Y+APEVL Y
Sbjct: 116 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 309 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368
D W +GV+ Y ++CG PF+ + +F +L + F ++SPEAK +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAG 228
Query: 369 LLNKDHRKRM-----TAAQALTHPWLHDENRPVPLDILIYKLVKSY 409
LL KD ++R+ A + + H + N D++ KL+ +
Sbjct: 229 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ---DVVQKKLLPPF 271
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 72/267 (26%), Positives = 128/267 (47%), Gaps = 20/267 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F++ K++G+G +G K + A+K + M+ ED E++IL +++
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLS---DNQFYALKEVDLGSMSQK-EREDAVNEIRILASVN 57
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG--GRYLEEDA--KTIVEKILNI 242
H ++I + +AF D N + IVME+ G+L I R + + E + ++ + +
Sbjct: 58 -HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPE 302
A H Q ++HRDLK N L + +K+ D G+S V +G+ +Y+APE
Sbjct: 117 QAL-HEQKILHRDLKSANILLVANDL---VKIGDLGISK-VLKKNMAKTQIGTPHYMAPE 171
Query: 303 VLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV-SP 360
V R Y+ + D+WS+G + Y + + PF AR+ + V R P P + S
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG----KYPPIPPIYSQ 227
Query: 361 EAKDFVRRLLNKDHRKRMTAAQALTHP 387
+ ++F+R +L + R + L P
Sbjct: 228 DLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-26
Identities = 93/321 (28%), Positives = 143/321 (44%), Gaps = 53/321 (16%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FE K +GRG FG + KK T G V A+KI+ KA M + +R E IL +
Sbjct: 3 FESLKVIGRGAFGEVRLVQ-KKDT--GHVYAMKILRKADMLEKEQVGHIRAERDIL-VEA 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
++K +F+D ++Y++MEF GG+++ ++ + EE I E +L I +
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI- 117
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL---------SDFVR------PD----Q 287
H G +HRD+KP+N L ++ +K+ DFGL ++F R P Q
Sbjct: 118 HQLGFIHRDIKPDNLLLDSK---GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 288 RLN-----------------DIVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSR 329
+N VG+ Y+APEV + YN D WS+GVI Y +L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 330 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK-DHRKRMTAAQALTH-- 386
PF + T ++ V+ P +S +AKD + R + +HR + +
Sbjct: 235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNP 294
Query: 387 -----PWLHDENRPVPLDILI 402
W H RP + I I
Sbjct: 295 FFEGVDWEHIRERPAAIPIEI 315
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 65/227 (28%), Positives = 97/227 (42%), Gaps = 44/227 (19%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKV------VAVKIISKAKMTSALAIEDVRREVKI 181
LGK++G G FG KGTLKGK VAVK + + IE+ RE +I
Sbjct: 2 TLGKKLGEGAFGEVY-----KGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARI 54
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN 241
++ L H +++K + + IVME+ GG+LLD + + L ++ L
Sbjct: 55 MRKLD-HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL--SLSDLLSFALQ 111
Query: 242 I---VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 298
I + + + +HRDL N L +K+ DFGLS + D YY
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDD---------YY 159
Query: 299 V-----------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFW 332
APE L + + D+WS GV+ + I G P+
Sbjct: 160 KVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYP 206
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-26
Identities = 82/279 (29%), Positives = 134/279 (48%), Gaps = 37/279 (13%)
Query: 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII---SKAKMTSALAIEDVRREVKILKALS 186
G+ +G+G +G C T +G+++AVK + + + + E ++ EV +LK+L
Sbjct: 5 GEVLGKGAYGTVYCGL----TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H +++++ D N++ I MEF GG + IL+R G E ++IL+ VA+
Sbjct: 61 -HVNIVQYLGTCLDDNTISIFMEFVPGGSI-SSILNRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFG-------LSDFVRPDQRLNDIVGSAYYV 299
H VVHRD+K N + + +K+IDFG + L + G+ Y++
Sbjct: 119 HNNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 300 APEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF----HDSP 354
APEV++ S Y + D+WSIG + + G +P A S+ R F H
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATG-KPPLA--------SMDRLAAMFYIGAHRGL 226
Query: 355 WPSV----SPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
P + S A DFV L +D +R +A Q L H +L
Sbjct: 227 MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 70/250 (28%), Positives = 124/250 (49%), Gaps = 13/250 (5%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G+G FG A+ KGT +V A+K++ K + ++ E +IL + H
Sbjct: 1 KVLGKGSFGKVMLAE-LKGT--DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+ H F+ + ++ VME+ GG+L+ +I R ++ E ++ ++ + F H G
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQI-QRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHR-SY 308
V++RDLK +N L + + K+ DFG+ + + G+ Y+APE+L Y
Sbjct: 117 VIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 309 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368
D W++GV+ Y ++ G PF A E +F S+L D + W +S EA ++
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY--PVW--LSKEAVSILKA 229
Query: 369 LLNKDHRKRM 378
+ K+ KR+
Sbjct: 230 FMTKNPNKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 7e-26
Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 128 ELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
LGK++G G FG + KGK G K VAVK + + IE+ RE +I++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGK-KKVEVAVKTLKEDASEQQ--IEEFLREARIMRKL 58
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H +++K + +YIVME+ EGG+LL + + D + +I + +
Sbjct: 59 D-HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------ 299
+ +HRDL N L +K+ DFGLS + D YY
Sbjct: 118 LESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDD---------YYRKRGGKL 165
Query: 300 -----APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFW 332
APE L + + D+WS GV+ + I G +P+
Sbjct: 166 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP 205
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 73/252 (28%), Positives = 124/252 (49%), Gaps = 13/252 (5%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G+G FG AK K G AVK++ K + + E +L H
Sbjct: 1 KVIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPF 57
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
++ H +F+ A +Y V+++ GGEL L R +LE A+ ++ + + + H
Sbjct: 58 LVGLHYSFQTAEKLYFVLDYVNGGELFFH-LQRERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHRS-Y 308
+++RDLKPEN L ++ + + DFGL + V P++ + G+ Y+APEVL + Y
Sbjct: 117 IIYRDLKPENILLDSQ---GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 309 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368
+ D W +G + Y +L G PF++R S ++ ++L + A D +
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVG 229
Query: 369 LLNKDHRKRMTA 380
LL+KD R+R+ A
Sbjct: 230 LLHKDQRRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 80/278 (28%), Positives = 137/278 (49%), Gaps = 28/278 (10%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FEL + VG G +G KG+ G++ A+K++ + E+++ E+ +LK S
Sbjct: 18 FELVEVVGNGTYGQV--YKGRH-VKTGQLAAIKVMDVTEDEE----EEIKLEINMLKKYS 70
Query: 187 GHKHMIKFHDAF------EDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKI 239
H+++ ++ AF + +++VMEFC G + D + + G L+ED I +I
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYY 298
L +A H V+HRD+K +N L T E+A +K++DFG+S R R N +G+ Y+
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 187
Query: 299 VAPEVL------HRSYNVEGDMWSIGVITYILLCGSRPFW-ARTESGIFRSVLRADPNFH 351
+APEV+ +Y+ D+WS+G+ + G+ P +F P
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 247
Query: 352 DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
W S + DF+ L K++ R + Q L HP++
Sbjct: 248 SKKW---SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 82/278 (29%), Positives = 133/278 (47%), Gaps = 24/278 (8%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G+G FG A+ K + A+K + K + +E E ++L H
Sbjct: 1 KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPF 57
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+ F+ ++ VME+ GG+L+ I S G R+ E A+ +I+ + F H +G
Sbjct: 58 LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKG 116
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDF-VRPDQRLNDIVGSAYYVAPEVLH-RSY 308
+++RDLK +N L ++D +K+ DFG+ + + + + G+ Y+APE+L + Y
Sbjct: 117 IIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 309 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW-PS-VSPEAKDFV 366
N D WS GV+ Y +L G PF E +F S+L +D P P +S EAKD +
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL------NDRPHFPRWISKEAKDCL 227
Query: 367 RRLLNKDHRKRM-TAAQALTHP------WLHDENRPVP 397
+L +D KR+ HP W E R +P
Sbjct: 228 SKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIP 265
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 78/266 (29%), Positives = 134/266 (50%), Gaps = 21/266 (7%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
++ + + VG G FG + + A+K I K +SA +ED R+E +L +
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHV---NSDQKYAMKEIRLPKSSSA--VEDSRKEAVLLAKM 55
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI--- 242
H +++ F ++FE +YIVME+C+GG+L+ +I + G+ ED TI++ + +
Sbjct: 56 K-HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPED--TILQWFVQMCLG 112
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAP 301
V H + V+HRD+K +N T ++ +K+ DFG + + P VG+ YYV P
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP 169
Query: 302 EVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS-VS 359
E+ YN + D+WS+G I Y L PF A + + V + P PS S
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----PLPSHYS 225
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQALT 385
E + ++++ ++ R R +A L+
Sbjct: 226 YELRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 75/251 (29%), Positives = 128/251 (50%), Gaps = 15/251 (5%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G+G FG K K G+ A+KI+ K + + + E ++L+ S H
Sbjct: 1 KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPF 56
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ- 249
+ +F+ + + VME+ GGEL LSR + E+ A+ +I++ + + H +
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLH-RS 307
VV+RDLK EN + ++D +K+ DFGL + ++ + G+ Y+APEVL
Sbjct: 116 NVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 308 YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 367
Y D W +GV+ Y ++CG PF+ + +F +L + F ++SPEAK +
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLS 228
Query: 368 RLLNKDHRKRM 378
LL KD ++R+
Sbjct: 229 GLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 88/306 (28%), Positives = 133/306 (43%), Gaps = 50/306 (16%)
Query: 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKIL 182
G++++ + +G G +G C A + GK VA+K I A LA + RE+KIL
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHAFDVPTLA-KRTLRELKIL 58
Query: 183 KALSGHKHMIKFHDAF----EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEK 238
+ H ++I D D VY+VM+ E L I+ EE + + +
Sbjct: 59 RHFK-HDNIIAIRDILRPPGADFKDVYVVMDLMESD--LHHIIHSDQPLTEEHIRYFLYQ 115
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV--RPDQR---LNDIV 293
+L + + H V+HRDLKP N L ED L++ DFG++ + P + + + V
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 294 GSAYYVAPE---VLHRSYNVEGDMWSIG-----------------------VITYILLCG 327
+ +Y APE L Y DMWS+G +I +L
Sbjct: 173 ATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231
Query: 328 SRPFWARTESGIFRSVLRADPNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQA 383
S R S R ++ P PW P SPEA D + ++L D +R+T QA
Sbjct: 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA 291
Query: 384 LTHPWL 389
L HP+L
Sbjct: 292 LQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 83/273 (30%), Positives = 138/273 (50%), Gaps = 20/273 (7%)
Query: 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHM 191
++G G G C A K GK VAVK K + E + EV I++ H+++
Sbjct: 29 KIGEGSTGIVCIATEKH---TGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYH-HENV 81
Query: 192 IKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 251
+ ++++ + +++VMEF EGG L D + R EE T+ +L +++ H QGV
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGV 139
Query: 252 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYN 309
+HRD+K ++ L T+ D +K+ DFG V + + +VG+ Y++APEV+ R Y
Sbjct: 140 IHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 310 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA-DPNFHDSPWPSVSPEAKDFVRR 368
E D+WS+G++ ++ G P++ R + P DS VS + F+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS--HKVSSVLRGFLDL 254
Query: 369 LLNKDHRKRMTAAQALTHPWLHDENRP---VPL 398
+L ++ +R TA + L HP+L P VPL
Sbjct: 255 MLVREPSQRATAQELLQHPFLKLAGPPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 74/256 (28%), Positives = 130/256 (50%), Gaps = 17/256 (6%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F +G+G FG A+ +KGT ++ A+KI+ K + +E E ++L AL
Sbjct: 2 FNFLMVLGKGSFGKVMLAE-RKGT--DELYAIKILKKDVIIQDDDVECTMVEKRVL-ALP 57
Query: 187 GHKH-MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
G + + H F+ + +Y VME+ GG+L+ I + G++ E A +I + F
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGKFKEPHAVFYAAEIAIGLFF 116
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPE-V 303
H +G+++RDLK +N + + + +K+ DFG+ + + + G+ Y+APE +
Sbjct: 117 LHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII 173
Query: 304 LHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP-SVSPEA 362
++ Y D W+ GV+ Y +L G PF E +F+S++ H+ +P S+S EA
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME-----HNVSYPKSLSKEA 228
Query: 363 KDFVRRLLNKDHRKRM 378
+ LL K KR+
Sbjct: 229 VSICKGLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 86/281 (30%), Positives = 136/281 (48%), Gaps = 32/281 (11%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+E+ + +G+G +G KK G AVKI+ E++ E ILKALS
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIHDID----EEIEAEYNILKALS 72
Query: 187 GHKHMIKFHDAF-----EDANSVYIVMEFCEGGELLDRI---LSRGGRYLEEDAKTIVEK 238
H +++KF+ + ++ + +++V+E C GG + D + L RG R E I+ +
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAY 297
L + H+ +HRD+K N L TT + +K++DFG+S R N VG+ +
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189
Query: 298 YVAPEV------LHRSYNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVLRADPN 349
++APEV L +Y+ D+WS+G IT I L P A +F+ P
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLG-ITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248
Query: 350 FHDSP-WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
H W S E DF+R+ L KD+ KR T + L H ++
Sbjct: 249 LHQPELW---SNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 91/312 (29%), Positives = 143/312 (45%), Gaps = 59/312 (18%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K+VG G +G C A K+ G+ VA+K +S+ + A + RE+ +LK + H++
Sbjct: 21 KQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRPFQSEIFA-KRAYRELTLLKHMQ-HEN 75
Query: 191 MIKFHDAFEDANSV------YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA 244
+I D F A S Y+VM + + L +I G E+ + +V ++L +
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI--MGHPLSEDKVQYLVYQMLCGLK 131
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV- 303
+ H G++HRDLKP N ED LK++DFGL+ D + V + +Y APEV
Sbjct: 132 YIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVI 186
Query: 304 ---LHRSYNVEGDMWSIGVI--------------------TYILLCGSRP---FWARTES 337
+H YN D+WS+G I T IL P F + E
Sbjct: 187 LNWMH--YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244
Query: 338 GIFRSVLRADPNFHDSP----WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL---- 389
+S +++ P + +P SP+A D + ++L D KR+TA +AL HP+
Sbjct: 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304
Query: 390 --HDENRPVPLD 399
+E P D
Sbjct: 305 DADEETEQQPYD 316
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 78/280 (27%), Positives = 136/280 (48%), Gaps = 28/280 (10%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
+E+G G FG A+ + +VVA+K +S + S +D+ +EV+ L+ L H +
Sbjct: 21 REIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPN 76
Query: 191 MIKFHDAFEDANSVYIVMEFCEG--GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL 248
I++ + ++ ++VME+C G ++L+ + + + +E A I L +A+ H
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILE-VHKKPLQEVEIAA--ICHGALQGLAYLHS 133
Query: 249 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL---- 304
+HRD+K N L T E +K+ DFG + V P N VG+ Y++APEV+
Sbjct: 134 HERIHRDIKAGNILLT---EPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMD 187
Query: 305 HRSYNVEGDMWSIGVITYILLCGSRP--FWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362
Y+ + D+WS+G IT I L +P F S ++ P + W S
Sbjct: 188 EGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW---SDYF 243
Query: 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
++FV L K + R ++ + L H ++ R P ++I
Sbjct: 244 RNFVDSCLQKIPQDRPSSEELLKHRFV---LRERPPTVII 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 72/252 (28%), Positives = 120/252 (47%), Gaps = 13/252 (5%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G+G FG AK K L GK AVK++ K + + + + E +L H
Sbjct: 1 KVIGKGSFGKVLLAKRK---LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPF 57
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
++ H +F+ +Y V++F GGEL L R + E A+ +I + + + H
Sbjct: 58 LVGLHYSFQTTEKLYFVLDFVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSIN 116
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHRS-Y 308
+V+RDLKPEN L ++ + + DFGL + + G+ Y+APEV+ + Y
Sbjct: 117 IVYRDLKPENILLDSQ---GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 309 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368
+ D W +G + Y +L G PF+ R + ++ ++L P S A +
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEE 229
Query: 369 LLNKDHRKRMTA 380
LL KD ++R+ A
Sbjct: 230 LLEKDRQRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 85/290 (29%), Positives = 134/290 (46%), Gaps = 57/290 (19%)
Query: 153 GKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA----------- 201
K VAVK I +T +++ RE+KI++ L H +++K ++ +
Sbjct: 30 DKRVAVKKIV---LTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSL 85
Query: 202 ---NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKP 258
NSVYIV E+ E L +L +G EE A+ + ++L + + H V+HRDLKP
Sbjct: 86 TELNSVYIVQEYMETD--LANVLEQG-PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKP 142
Query: 259 ENFLFTTREEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVL--HRSYNVEG 312
N T ED LK+ DFGL+ V P L++ + + +Y +P +L +Y
Sbjct: 143 ANVFINT--EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200
Query: 313 DMWSIGVITYILLCGSRPFWARTESG-----IFRSV-----------LRADPNF-HDSPW 355
DMW+ G I +L G +P +A I SV L P+F +
Sbjct: 201 DMWAAGCIFAEMLTG-KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGG 259
Query: 356 ----------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395
P V+PEA DF+ ++L + R+TA +AL HP++ + P
Sbjct: 260 EPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-25
Identities = 72/272 (26%), Positives = 140/272 (51%), Gaps = 20/272 (7%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
++ L + +G+G FG K KK + ++ +K I ++ ++ +E ++L L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ-ANQEAQLLSKL 59
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRI--LSRGGRYLEEDAKTIVE---KIL 240
H ++KFH +F + ++ I+ E+CEG +L ++ L G+ L E+ + E ++L
Sbjct: 60 D-HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSEN--QVCEWFIQLL 116
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYYV 299
V + H + ++HRDLK +N ++ LK+ DFG+S + L G+ YY+
Sbjct: 117 LGVHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYM 172
Query: 300 APEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD-PNFHDSPWPS 357
+PE L H+ Y+ + D+WS+G I Y + C + F + + ++ P+ + +
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPE----T 228
Query: 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
S + ++ +LNKD R +AA+ L +P++
Sbjct: 229 YSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 59/219 (26%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIIS-------KAKMTSALAIEDVRREV 179
+ + + +G G FG C K +K ++A+K I+ K K +I D+ EV
Sbjct: 2 YAVLEHLGSGAFG--CVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59
Query: 180 KILKALSGHKHMIKFHDAFEDANSVYIVMEFCEG---GELLDRILSRGGRYLEEDAKTIV 236
I+K H ++++++ F + + +YIVM+ EG GE + + + R+ EE I
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 237 EKILNIVAFCHLQG-VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295
+++ + + H + +VHRDL P N + ++ + + DFGL+ +P+ +L +VG+
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK---VTITDFGLAKQKQPESKLTSVVGT 176
Query: 296 AYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWA 333
Y PE++ + Y + D+W+ G I Y + PF++
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 88/327 (26%), Positives = 130/327 (39%), Gaps = 94/327 (28%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKV-----VAVKIISKAKMTSALAIEDVRREVKILKAL 185
K++G G FG KG LKGK VAVK + + +D +E +++K L
Sbjct: 1 KKLGEGAFGEVY-----KGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKL 53
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
GH ++++ + +Y+V+E+ EGG+LLD + + + T+ K L ++F
Sbjct: 54 -GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL--LSF 110
Query: 246 C--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295
+L + VHRDL N L ED +K+ DFGLS V D
Sbjct: 111 AIQIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDD-------- 159
Query: 296 AYYV------------APEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 342
YY APE L + + D+WS GV LL W E IF
Sbjct: 160 -YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGV----LL------W---E--IF-- 201
Query: 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP-WLHDENRPVPLDIL 401
+P+P +S E V L K +R L P + DE
Sbjct: 202 ------TLGATPYPGLSNEE---VLEYLRKGYR--------LPKPEYCPDE--------- 235
Query: 402 IYKLVKSYLRATPLKRAALKALSKALT 428
+Y+L+ S + P R L + L
Sbjct: 236 LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-25
Identities = 78/276 (28%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
++E+ K++G G FG AK K + +K I KM E ++EV IL A
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKMPVK-EKEASKKEV-ILLAK 55
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI--- 242
H +++ F +F++ ++IVME+C+GG+L+ RI + G ED I+ + I
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED--QILSWFVQISLG 113
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND-------IVGS 295
+ H + ++HRD+K +N + A K+ DFG++ ++LND VG+
Sbjct: 114 LKHIHDRKILHRDIKSQNIFLSKNGMVA--KLGDFGIA------RQLNDSMELAYTCVGT 165
Query: 296 AYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP 354
YY++PE+ +R YN + D+WS+G + Y L PF E ++ + +P
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF----EGNNLHQLVLKICQGYFAP 221
Query: 355 W-PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
P+ S + + + +L R R + L P+L
Sbjct: 222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 69/229 (30%), Positives = 101/229 (44%), Gaps = 46/229 (20%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKV------VAVKIISKAKMTSALAIEDVRREVK 180
ELGK++G G FG KGTLKG VAVK + K + E+ E
Sbjct: 1 LELGKKLGEGAFGEVY-----KGTLKGDGEGTETKVAVKTL-KEGASEE-EREEFLEEAS 53
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
I+K LS H ++++ +YIV E+ GG+LLD + G + K +++ L
Sbjct: 54 IMKKLS-HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKL---TLKDLLQMAL 109
Query: 241 NI---VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY 297
I + + + VHRDL N L T E+ +K+ DFGLS + D Y
Sbjct: 110 QIAKGMEYLESKNFVHRDLAARNCLVT---ENLVVKISDFGLSRDIYED---------DY 157
Query: 298 YV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFW 332
Y APE L + + D+WS GV+ + I G +P+
Sbjct: 158 YRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206
|
Length = 258 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 74/250 (29%), Positives = 123/250 (49%), Gaps = 13/250 (5%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G+G FG A+ K KG+ AVK + K + +E E ++L +
Sbjct: 1 KVLGKGSFGKVLLAELKG---KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF 57
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+ + F+ ++ VMEF GG+L+ I +G R+ A +I+ + F H +G
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLH-RSY 308
+++RDLK +N + + D +K+ DFG+ + V D R + G+ Y+APE+L Y
Sbjct: 117 IIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 309 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368
D WS GV+ Y +L G PF E +F S+ P H W ++ E+KD + +
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP--HYPRW--ITKESKDILEK 229
Query: 369 LLNKDHRKRM 378
L +D +R+
Sbjct: 230 LFERDPTRRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 86/314 (27%), Positives = 141/314 (44%), Gaps = 59/314 (18%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F K +G G FG C A+ + A+K + K + + V+ E IL A +
Sbjct: 3 FVKIKTLGIGAFGEVCLARK---VDTKALYAMKTLRKKDVLLRNQVAHVKAERDIL-AEA 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
++ +++ + +F+D +++Y VM++ GG+++ +L R G + E+ A+ + ++ V
Sbjct: 59 DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMGIFPEDLARFYIAELTCAVESV 117
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL---------------SDFVRPD----- 286
H G +HRD+KP+N L + D +K+ DFGL D VR D
Sbjct: 118 HKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 287 --------------------------QRL--NDIVGSAYYVAPEVLHRS-YNVEGDMWSI 317
QR + +VG+ Y+APEVL R+ Y D WS+
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 318 GVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN--KDHR 375
GVI Y +L G PF A+T V+ + H P +SPEA D + +L +D
Sbjct: 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRL 294
Query: 376 KRMTAAQALTHPWL 389
+ A + HP+
Sbjct: 295 GKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 92/305 (30%), Positives = 145/305 (47%), Gaps = 47/305 (15%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIIS----KAKMTSALAIE-DVRREVK 180
++E+ K++G G FG K K+ + K IS K + S L IE +V RE+K
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQ---EFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 181 ILKALSGHKHMIKFHDAF-EDANS-VYIVMEFCEGGEL---LDRILSRGGRYLEEDAKTI 235
HK+++++ D F AN +YI+MEFC+ G+L + + G+ E I
Sbjct: 71 -------HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123
Query: 236 VEKILNIVAFCHL-------QGVVHRDLKPENFLFTT-------------REEDAPL-KV 274
++L+ +A+CH + V+HRDLKP+N +T P+ K+
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183
Query: 275 IDFGLSDFVRPDQRLNDIVGSAYYVAPEVL---HRSYNVEGDMWSIGVITYILLCGSRPF 331
DFGLS + + + VG+ YY +PE+L +SY+ + DMW++G I Y L G PF
Sbjct: 184 GDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
Query: 332 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391
S L+ P D P S E ++ LLN ++R +A Q L + + +
Sbjct: 244 HKANNFSQLISELKRGP---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300
Query: 392 ENRPV 396
PV
Sbjct: 301 VGPPV 305
|
Length = 1021 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 89/309 (28%), Positives = 143/309 (46%), Gaps = 56/309 (18%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
VG G +G C A K L+ VAVK +S+ S + + RE+++LK + H+++I
Sbjct: 25 VGSGAYGSVCAAFDTKTGLR---VAVKKLSRP-FQSIIHAKRTYRELRLLKHMK-HENVI 79
Query: 193 KFHDAF------EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
D F E+ N VY+V G L+ I+ + + ++ + ++ +IL + +
Sbjct: 80 GLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV-KCQKLTDDHVQFLIYQILRGLKYI 136
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR 306
H ++HRDLKP N ED LK++DFGL+ D + V + +Y APE++
Sbjct: 137 HSADIIHRDLKPSNLAVN---EDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLN 191
Query: 307 --SYNVEGDMWSIGVITYILLCGSRPF-----------------------WARTESGIFR 341
YN D+WS+G I LL G F + S R
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251
Query: 342 SVLRADP-----NFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL---HD-E 392
+ +++ NF + + +P A D + ++L D KR+TAAQAL H + HD +
Sbjct: 252 NYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310
Query: 393 NRPV--PLD 399
+ PV P D
Sbjct: 311 DEPVADPYD 319
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 73/257 (28%), Positives = 123/257 (47%), Gaps = 27/257 (10%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G+G FG A+ K + A+K + K + +E E ++L H
Sbjct: 1 KMLGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 57
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRI-------LSRGGRYLEEDAKTIVEKILNIV 243
+ + F+ +++ VME+ GG+L+ I L R Y E I+ +
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE--------IICGL 109
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPE 302
F H +G+V+RDLK +N L T D +K+ DFG+ + + D + G+ Y+APE
Sbjct: 110 QFLHSKGIVYRDLKLDNILLDT---DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPE 166
Query: 303 VL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361
+L + YN D WS GV+ Y +L G PF E +F+S+ +P + W ++ E
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCY--PRW--LTRE 222
Query: 362 AKDFVRRLLNKDHRKRM 378
AKD + +L ++ +R+
Sbjct: 223 AKDILVKLFVREPERRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 73/250 (29%), Positives = 123/250 (49%), Gaps = 14/250 (5%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G+G FG + K GK A+KI+ K + + + E ++LK + H
Sbjct: 1 KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPF 56
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+ +F+ + + VME+ GGEL LSR + E+ + +I++ + + H
Sbjct: 57 LTSLKYSFQTKDRLCFVMEYVNGGELFFH-LSRERVFSEDRTRFYGAEIVSALDYLHSGK 115
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLH-RSY 308
+V+RDLK EN + ++D +K+ DFGL + + + G+ Y+APEVL Y
Sbjct: 116 IVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 309 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368
D W +GV+ Y ++CG PF+ + +F +L D F ++S +AK +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSG 228
Query: 369 LLNKDHRKRM 378
LL KD KR+
Sbjct: 229 LLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 87/328 (26%), Positives = 137/328 (41%), Gaps = 78/328 (23%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII--SKAKMT--SALAIEDVRREVKI 181
K+E+ +GRG +G AK K G GK A+K K + T S A RE+ +
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGK-DGKEYAIKKFKGDKEQYTGISQSAC----REIAL 55
Query: 182 LKALSGHKHMIKFHDAF-EDAN-SVYIVMEFCEGGELLDRI---LSRGGRYLEED-AKTI 235
L+ L H++++ + F E A+ SVY++ ++ E +L I + K++
Sbjct: 56 LRELK-HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 236 VEKILNIVAFCHLQGVVHRDLKPENFLFT-TREEDAPLKVIDFGLSDFVRPDQR----LN 290
+ +ILN V + H V+HRDLKP N L E +K+ D GL+ + L+
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 291 DIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP 348
+V + +Y APE+L R Y D+W+IG I + L P + E+ I +S
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCI-FAELLTLEPIFKGREAKIKKSNP---- 228
Query: 349 NFH---------------DSPWPSV---------------------------------SP 360
F + WP +
Sbjct: 229 -FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDS 287
Query: 361 EAKDFVRRLLNKDHRKRMTAAQALTHPW 388
+ D +R+LL D KR+TA +AL HP+
Sbjct: 288 QGFDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 76/277 (27%), Positives = 133/277 (48%), Gaps = 35/277 (12%)
Query: 127 FELGKEVGRGHFGHT-CCAKGKKGTLKGKVVAVKIISKAKMTSALA--IEDVRREVKILK 183
+ GK +G+G FG C G + +AVK + + + + E+++LK
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTG----RELAVKQVPFDPDSPETKKEVNALECEIQLLK 59
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
L H+ +++++ D ++ I ME+ GG + D++ + G E + +IL V
Sbjct: 60 NLQ-HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGV 117
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI----------V 293
+ H +VHRD+K N L R+ +K+ DFG S +RL I
Sbjct: 118 EYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGAS------KRLQTICSSGTGMKSVT 168
Query: 294 GSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVLRADPNF 350
G+ Y+++PEV+ Y + D+WS+G T + + +P WA E + IF+ + P
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGC-TVVEMLTEKPPWAEFEAMAAIFK--IATQPTN 225
Query: 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387
P VSP+A++F+RR ++ +KR +A + L H
Sbjct: 226 PQLP-SHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 8e-24
Identities = 77/259 (29%), Positives = 132/259 (50%), Gaps = 16/259 (6%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+G+G FG KG K +VVA+KII + IED+++E+ +L ++
Sbjct: 12 IGKGSFGEV--YKGIDNRTK-EVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDS-PYIT 65
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 252
+++ ++ ++I+ME+ GG LD L + G E TI+ +IL + + H + +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALD--LLKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 253 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHRS-YNV 310
HRD+K N L + E +K+ DFG++ + Q + N VG+ +++APEV+ +S Y+
Sbjct: 124 HRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 311 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 370
+ D+WS+G+ L G P ++ R + N + S K+FV L
Sbjct: 181 KADIWSLGITAIELAKGEPPN---SDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237
Query: 371 NKDHRKRMTAAQALTHPWL 389
NKD R R TA + L H ++
Sbjct: 238 NKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 90/318 (28%), Positives = 142/318 (44%), Gaps = 63/318 (19%)
Query: 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISK-AKMTSALAIEDVR--RE 178
+ G +++ +G G +G C A K G VA+K IS T R RE
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHK---PTGVKVAIKKISPFEHQTFCQ-----RTLRE 53
Query: 179 VKILKALSGHKHMIKFHD-----AFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-A 232
+KIL+ H+++I D +FE N VYIV E E L +++ ++L D
Sbjct: 54 IKILRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLIKT--QHLSNDHI 108
Query: 233 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD----QR 288
+ + +IL + + H V+HRDLKP N L T + LK+ DFGL+ P+
Sbjct: 109 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFGLARIADPEHDHTGF 165
Query: 289 LNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFW-------------- 332
L + V + +Y APE++ + Y D+WS+G I +L RP +
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGKDYLHQLNLILG 224
Query: 333 ----------ARTESGIFRSVLRADPNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRM 378
S R+ +++ P PW P+ P+A D + ++L + KR+
Sbjct: 225 VLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284
Query: 379 TAAQALTHPWL---HDEN 393
T +AL HP+L HD +
Sbjct: 285 TVEEALAHPYLEQYHDPS 302
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 75/266 (28%), Positives = 127/266 (47%), Gaps = 17/266 (6%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+G+G FG + K+ T + + A+K I KA + S + E +L A ++
Sbjct: 1 IGKGSFGKVMQVR-KRDTQR--IYALKTIRKAHIVSRSEVTHTLAERTVL-AQVNCPFIV 56
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 252
+F+ +Y+V+ F GGEL L R GR+ A+ ++L + H V+
Sbjct: 57 PLKFSFQSPEKLYLVLAFINGGELFHH-LQREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 253 HRDLKPENFLFTTREEDAPLKVIDFGLSDF-VRPDQRLNDIVGSAYYVAPEVLH-RSYNV 310
+RDLKPEN L + + + DFGL ++ D + N G+ Y+APE+L Y
Sbjct: 116 YRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 311 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 370
D W++GV+ Y +L G PF+ + ++R +L+ F D +AKD + LL
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLL 228
Query: 371 NKDHRKRM---TAAQALTHPWLHDEN 393
++D +R+ A + HP+ +
Sbjct: 229 SRDPTRRLGYNGAQEIKNHPFFSQLS 254
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-23
Identities = 78/265 (29%), Positives = 127/265 (47%), Gaps = 26/265 (9%)
Query: 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKA 184
A F + K++GRG F A L G VA+K + + A A D +E+ +LK
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATC---LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 58
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL--NI 242
L+ H ++IK++ +F + N + IV+E + G+ LSR ++ ++ + I EK +
Sbjct: 59 LN-HPNVIKYYASFIEDNELNIVLELADAGD-----LSRMIKHFKKQKRLIPEKTVWKYF 112
Query: 243 VAFC------HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR-LNDIVGS 295
V C H + V+HRD+KP N T +K+ D GL F + +VG+
Sbjct: 113 VQLCSALEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 296 AYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP 354
YY++PE +H + YN + D+WS+G + Y + PF+ + S+ + P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPP 227
Query: 355 WPS--VSPEAKDFVRRLLNKDHRKR 377
PS S E + V +N D KR
Sbjct: 228 LPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 1e-23
Identities = 84/295 (28%), Positives = 142/295 (48%), Gaps = 46/295 (15%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII---SKAKMTSALAIEDVRREVKILK 183
F+ +++G G +G A+ K G+VVA+K I ++ + + AI RE+ +LK
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGVPSTAI----REISLLK 54
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGG--ELLDRILSRGGRYLEEDAKTIVEKILN 241
L+ H +++K D N +Y+V EF + +D G L K+ + ++L
Sbjct: 55 ELN-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD-ASPLSGIPLPL-IKSYLFQLLQ 111
Query: 242 IVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD-FVRPDQRLNDIVGSAYYVA 300
+AFCH V+HRDLKP+N L + +K+ DFGL+ F P + V + +Y A
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 168
Query: 301 PEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESG----IFRSVLRAD------- 347
PE+L + Y+ D+WS+G I ++ F +E IFR++ D
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 228
Query: 348 ---PNFHDS--PW---------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388
P++ S W P + + +D + ++L+ D KR++A AL HP+
Sbjct: 229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 77/263 (29%), Positives = 131/263 (49%), Gaps = 29/263 (11%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT----SALAIEDVRREVKIL 182
F++ K +GRG FG + K +V A+K++SK +M SA E E I+
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSK---QVYAMKLLSKFEMIKRSDSAFFWE----ERDIM 97
Query: 183 KALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI 242
A + + +++ H AF+D +Y+VME+ GG+L++ L E+ A+ +++
Sbjct: 98 -AHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN--LMSNYDIPEKWARFYTAEVVLA 154
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYY 298
+ H G +HRD+KP+N L ++ LK+ DFG ++ D R + VG+ Y
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTC--MKMDANGMVRCDTAVGTPDY 209
Query: 299 VAPEVL-----HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 353
++PEVL Y E D WS+GV Y +L G PF+A + G + ++ +
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP 269
Query: 354 PWPSVSPEAKDFVRRLL-NKDHR 375
+S +AKD + L +++ R
Sbjct: 270 DDIEISKQAKDLICAFLTDREVR 292
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 3e-23
Identities = 77/274 (28%), Positives = 132/274 (48%), Gaps = 28/274 (10%)
Query: 153 GKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCE 212
G+ VA+K I+ K E + E+ ++K L + +++ F D+F + +++VME+
Sbjct: 44 GQEVAIKQINLQKQPKK---ELIINEILVMKELK-NPNIVNFLDSFLVGDELFVVMEYLA 99
Query: 213 GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 272
GG L D + E + + L + F H V+HRD+K +N L D +
Sbjct: 100 GGSLTDVVTETCMD--EAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM---DGSV 154
Query: 273 KVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRP 330
K+ DFG + P+Q + + +VG+ Y++APEV+ R +Y + D+WS+G++ ++ G P
Sbjct: 155 KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
Query: 331 FWARTE-SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
+ ++ P + +SP +DF+ R L D KR +A + L HP+L
Sbjct: 215 YLNENPLRALYLIATNGTPELQNPE--KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
Query: 390 HDENRPVPLDILIYKLVKSYLRATPLKRAALKAL 423
KL K TPL AA +A+
Sbjct: 273 --------------KLAKPLSSLTPLILAAKEAM 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 4e-23
Identities = 79/289 (27%), Positives = 136/289 (47%), Gaps = 50/289 (17%)
Query: 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKII----SKAKMTSALAIEDVRREVKIL-KALS 186
E+G+G++G + G +A+K I ++K + E+ IL KA+S
Sbjct: 8 ELGKGNYGSVYKVLHRP---TGVTMAMKEIRLELDESKFNQII------MELDILHKAVS 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
+++ F+ AF +VY+ ME+ + G L D++ + G + I E +L + +
Sbjct: 59 --PYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGG-----VATEGIPEDVLRRITYA 110
Query: 247 HLQG---------VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSA 296
++G ++HRD+KP N L + +K+ DFG+S + V + N +G
Sbjct: 111 VVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLVASLAKTN--IGCQ 165
Query: 297 YYVAPEVLHR-------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIF---RSVLRA 346
Y+APE + +Y V+ D+WS+G+ + G P+ T + IF +++
Sbjct: 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG 225
Query: 347 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395
DP + S +A+DFV + LNK +R T AQ L HPWL
Sbjct: 226 DP---PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 4e-23
Identities = 69/223 (30%), Positives = 114/223 (51%), Gaps = 30/223 (13%)
Query: 125 AKFELGKEVGRGHFGH----TCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
A F++ K++GRG F TC L K VA+K + +M A A +D +E+
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATC-------LLDRKPVALKKVQIFEMMDAKARQDCVKEID 54
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
+LK L+ H ++IK+ D+F + N + IV+E + G+L I +Y ++ + I E+ +
Sbjct: 55 LLKQLN-HPNVIKYLDSFIEDNELNIVLELADAGDLSQMI-----KYFKKQKRLIPERTV 108
Query: 241 --NIVAFC------HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR-LND 291
V C H + V+HRD+KP N T +K+ D GL F +
Sbjct: 109 WKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHS 165
Query: 292 IVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWA 333
+VG+ YY++PE +H + YN + D+WS+G + Y + PF+
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 5e-23
Identities = 81/305 (26%), Positives = 138/305 (45%), Gaps = 63/305 (20%)
Query: 126 KFE-LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVK---------IISKAKMTSALAIEDV 175
K+E L K +G G +G + ++ G++VA+K +I K +
Sbjct: 2 KYEKLSK-IGEGSYGVVFKCRNRE---TGQIVAIKKFVESEDDPVIKKIAL--------- 48
Query: 176 RREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDA-KT 234
RE+++LK L H +++ + F +++V E+C+ +L+ L + R + E K
Sbjct: 49 -REIRMLKQLK-HPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNE-LEKNPRGVPEHLIKK 104
Query: 235 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV-RPDQRLNDIV 293
I+ + L V FCH +HRD+KPEN L T + + +K+ DFG + + P D V
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ---IKLCDFGFARILTGPGDDYTDYV 161
Query: 294 GSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWA-----------RTESG-- 338
+ +Y APE+L Y D+W+IG + LL G +P W R G
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDL 220
Query: 339 IFR--SVLRADPNFH-------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQA 383
I R + + F +S +P++S A F++ L D +R++ +
Sbjct: 221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280
Query: 384 LTHPW 388
L HP+
Sbjct: 281 LEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 6e-23
Identities = 78/263 (29%), Positives = 137/263 (52%), Gaps = 24/263 (9%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+G+G FG KG + +VVA+KII + IED+++E+ +L ++
Sbjct: 12 IGKGSFGEV--FKGIDNRTQ-QVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDS-PYVT 65
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 252
K++ ++ ++I+ME+ GG LD L R G + E T++++IL + + H + +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALD--LLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 123
Query: 253 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHRS-YNV 310
HRD+K N L + E +K+ DFG++ + Q + N VG+ +++APEV+ +S Y+
Sbjct: 124 HRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180
Query: 311 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE----AKDFV 366
+ D+WS+G+ L G P ++ R VL P P+++ E K+F+
Sbjct: 181 KADIWSLGITAIELAKGEPP---NSDMHPMR-VLFLIPKN---NPPTLTGEFSKPFKEFI 233
Query: 367 RRLLNKDHRKRMTAAQALTHPWL 389
LNKD R TA + L H ++
Sbjct: 234 DACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 93/364 (25%), Positives = 157/364 (43%), Gaps = 56/364 (15%)
Query: 47 PFQSPLPAGVAPSPS----PGRKFRWP-LPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTS 101
P Q P PS + R R P L P P + A+ L PP +S
Sbjct: 3 PIQPPPGV-PLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPL------PPPSSSSS 55
Query: 102 GDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII 161
A+ ++ E +G G G T + T G++ A+K+I
Sbjct: 56 SSSSSSASGSAPSAAKSL-----SELERVNRIGSGA-GGTVYKVIHRPT--GRLYALKVI 107
Query: 162 SKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRIL 221
+ + RE++IL+ ++ H +++K HD F+ + +++EF +GG L +
Sbjct: 108 YGNHEDTVR--RQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI 164
Query: 222 SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281
+ ++L + A+ +IL+ +A+ H + +VHRD+KP N L + + +K+ DFG+S
Sbjct: 165 ADE-QFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSR 216
Query: 282 FVRPDQRL---NDIVGSAYYVAPEVLHRSYN------VEGDMWSIGVITYILLCGSRPF- 331
+ Q + N VG+ Y++PE ++ N GD+WS+GV G PF
Sbjct: 217 IL--AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274
Query: 332 ------WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385
WA I S P + S E + F+ L ++ KR +A Q L
Sbjct: 275 VGRQGDWASLMCAICMS----QP---PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
Query: 386 HPWL 389
HP++
Sbjct: 328 HPFI 331
|
Length = 353 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 75/256 (29%), Positives = 132/256 (51%), Gaps = 17/256 (6%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F +G+G FG A+ +KGT ++ A+KI+ K + +E E ++L ALS
Sbjct: 2 FNFLMVLGKGSFGKVMLAE-RKGT--DELYAIKILKKDVVIQDDDVECTMVEKRVL-ALS 57
Query: 187 GHK-HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
G + + H F+ + +Y VME+ GG+L+ +I + GR+ E A +I + F
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI-QQVGRFKEPHAVFYAAEIAIGLFF 116
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVL 304
H +G+++RDLK +N + + + +K+ DFG+ + + G+ Y+APE++
Sbjct: 117 LHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII 173
Query: 305 -HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP-SVSPEA 362
++ Y D W+ GV+ Y +L G PF E +F+S++ H+ +P S+S EA
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-----HNVAYPKSMSKEA 228
Query: 363 KDFVRRLLNKDHRKRM 378
+ L+ K KR+
Sbjct: 229 VAICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 84/301 (27%), Positives = 144/301 (47%), Gaps = 55/301 (18%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K+VG G +G C A ++ G VA+K + + S L + RE+++LK + H++
Sbjct: 21 KQVGSGAYGTVCSALDRR---TGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMK-HEN 75
Query: 191 MIKFHDAF------EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA 244
+I D F + + Y+VM F G L +++ + + E+ + +V ++L +
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLM-KHEKLSEDRIQFLVYQMLKGLK 132
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV- 303
+ H G++HRDLKP N ED LK++DFGL+ + D + V + +Y APEV
Sbjct: 133 YIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLAR--QTDSEMTGYVVTRWYRAPEVI 187
Query: 304 ---LHRSYNVEGDMWSIGVITYILLCG-----------------------SRPFWARTES 337
+H + V D+WS+G I +L G S+ F + +S
Sbjct: 188 LNWMHYTQTV--DIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245
Query: 338 GIFRSVLRADPNFHD----SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW---LH 390
++ ++ P F S P+ +P A + + ++L D R+TAA+AL HP+ H
Sbjct: 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305
Query: 391 D 391
D
Sbjct: 306 D 306
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-22
Identities = 83/312 (26%), Positives = 138/312 (44%), Gaps = 59/312 (18%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G G FG C A K T + A+K + K + + + V+ E IL A + ++
Sbjct: 7 KTLGIGAFGEVCLAC-KVDT--HALYAMKTLRKKDVLNRNQVAHVKAERDIL-AEADNEW 62
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
++K + +F+D +++Y VM++ GG+++ +L R + E A+ + ++ + H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMEVFPEVLARFYIAELTLAIESVHKMG 121
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGL--------------------SDFVRPDQRLN 290
+HRD+KP+N L + D +K+ DFGL D + P +
Sbjct: 122 FIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 291 DI----------------------------VGSAYYVAPEVLHRS-YNVEGDMWSIGVIT 321
D+ VG+ Y+APEVL R Y D WS+GVI
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 322 YILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL-LNKDHR-KRMT 379
+ +L G PF A T + V+ + H P +SPEA D + +L + + R R
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNG 298
Query: 380 AAQALTHPWLHD 391
A HP+ +
Sbjct: 299 ADDIKAHPFFSE 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 88/304 (28%), Positives = 141/304 (46%), Gaps = 53/304 (17%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVR----REVKI 181
+E +++G G +G A+ K GK+VA+K K + E + RE+ +
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKN---TGKLVALK-----KTRLEMDEEGIPPTALREISL 53
Query: 182 LKALSGHKHMIKFHDA--FEDAN---SVYIVMEFCEGG--ELLDRILSRGGRYLEED-AK 233
L+ LS ++++ D E+ N S+Y+V E+ + + +D GR L K
Sbjct: 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 234 TIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDI 292
+ + ++L VA CH GV+HRDLKP+N L ++ LK+ D GL F P +
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSYTHE 171
Query: 293 VGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTES----GIFRSVLRA 346
+ + +Y APEVL Y+ D+WS+G I + F +E IF+ L
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK--LLG 229
Query: 347 DPN------------FHDSP-W---------PSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384
P +H+ P W P +SPE D ++++L D KR++A AL
Sbjct: 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289
Query: 385 THPW 388
THP+
Sbjct: 290 THPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 81/312 (25%), Positives = 133/312 (42%), Gaps = 73/312 (23%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIED-VRREVKILKAL 185
FE E+G G+ G + G ++A K+I + AI + + RE+K+L
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRP---SGLIMARKLI---HLEIKPAIRNQIIRELKVL--- 53
Query: 186 SGHK----HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN 241
H+ +++ F+ AF + I ME +GG L D++L + GR I E IL
Sbjct: 54 --HECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGR--------IPENILG 102
Query: 242 IVAFCHLQG---------VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI 292
++ L+G ++HRD+KP N L +R E +K+ DFG+S + D N
Sbjct: 103 KISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSF 158
Query: 293 VGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGI------------ 339
VG+ Y++PE L + Y V+ D+WS+G+ + G P +
Sbjct: 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGE 218
Query: 340 -FRSVLRADPNFHDSPWP---------------------SVSPEAKDFVRRLLNKDHRKR 377
S + DSP P + S E +DFV + L K+ ++R
Sbjct: 219 AKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKER 278
Query: 378 MTAAQALTHPWL 389
+ HP++
Sbjct: 279 ADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+E+ + +G+G +G KK G + AVKI+ E++ E IL++L
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPISDVD----EEIEAEYNILQSLP 76
Query: 187 GHKHMIKFHDAFEDAN-----SVYIVMEFCEGG---ELLDRILSRGGRYLEEDAKTIVEK 238
H +++KF+ F A+ +++V+E C GG EL+ +L G R E I+
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAY 297
L + H ++HRD+K N L TT + +K++DFG+S R N VG+ +
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 193
Query: 298 YVAPEVL------HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN-- 349
++APEV+ SY+ D+WS+G+ L G P + + R P
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253
Query: 350 FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
H W F+ + L KD R + L HP++
Sbjct: 254 LHPEKW---CRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 3e-22
Identities = 64/257 (24%), Positives = 126/257 (49%), Gaps = 22/257 (8%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+GRG + + KK ++ A+K++ K + I+ V+ E + + S H ++
Sbjct: 3 IGRGSYAKVLLVRLKK---TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 252
H F+ + ++ V+E+ GG+L+ + R + EE A+ +I + + H +G++
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 118
Query: 253 HRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNV 310
+RDLK +N L + + +K+ D+G+ + +RP + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 311 EGDMWSIGVITYILLCGSRPF---------WARTESGIFRSVLRADPNFHDSPWPSVSPE 361
D W++GV+ + ++ G PF TE +F+ +L S+S +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 231
Query: 362 AKDFVRRLLNKDHRKRM 378
A ++ LNKD ++R+
Sbjct: 232 AASVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 82/297 (27%), Positives = 140/297 (47%), Gaps = 48/297 (16%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIIS-----KAKMTSALAIEDVRREVK 180
K+E +++G G +G AK ++ ++VA+K + + +SAL RE+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDEGVPSSAL------REIC 51
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
+LK L HK++++ +D + +V E+C+ +L S G E K+ + ++L
Sbjct: 52 LLKELK-HKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL 109
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYV 299
+AFCH V+HRDLKP+N L E LK+ DFGL+ F P + + V + +Y
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYR 166
Query: 300 APEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTE-----SGIFRSV--------- 343
P+VL + Y+ DMWS G I L RP + + IFR +
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226
Query: 344 -LRADPNFHDSP-------W----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388
+ P++ P P ++ +D ++ LL + +R++A +AL HP+
Sbjct: 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-22
Identities = 75/261 (28%), Positives = 133/261 (50%), Gaps = 16/261 (6%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
+++G+G FG KG + KVVA+KII + IED+++E+ +L +
Sbjct: 10 EKIGKGSFGEV--FKGIDNRTQ-KVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDS-PY 63
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+ K++ ++ ++I+ME+ GG LD L G E TI+ +IL + + H +
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHRS-Y 308
+HRD+K N L + E +K+ DFG++ + Q + N VG+ +++APEV+ +S Y
Sbjct: 122 KIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 309 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368
+ + D+WS+G+ L G P + + + +P + + S K+FV
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKPLKEFVEA 235
Query: 369 LLNKDHRKRMTAAQALTHPWL 389
LNK+ R TA + L H ++
Sbjct: 236 CLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-22
Identities = 69/253 (27%), Positives = 126/253 (49%), Gaps = 15/253 (5%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+G+G FG A+ +KGT ++ A+KI+ K + +E E ++L +
Sbjct: 8 LGKGSFGKVMLAE-RKGT--DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 252
+ H F+ + +Y VME+ GG+L+ I + G++ E A +I + F H +G++
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRRGII 123
Query: 253 HRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNV 310
+RDLK +N + + + +K+ DFG+ + + G+ Y+APE++ ++ Y
Sbjct: 124 YRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGK 180
Query: 311 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP-SVSPEAKDFVRRL 369
D W+ GV+ Y +L G PF E +F+S++ H+ +P S+S EA + L
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME-----HNVSYPKSLSKEAVSICKGL 235
Query: 370 LNKDHRKRMTAAQ 382
+ K KR+
Sbjct: 236 MTKHPSKRLGCGP 248
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-22
Identities = 65/258 (25%), Positives = 127/258 (49%), Gaps = 26/258 (10%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+GRG + + KK ++ A+K++ K + I+ V+ E + + S + ++
Sbjct: 3 IGRGSYAKVLLVRLKKND---QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 252
H F+ + +++V+E+ GG+L+ + R + EE A+ +I + F H +G++
Sbjct: 60 GLHSCFQTTSRLFLVIEYVNGGDLMFH-MQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 253 HRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNV 310
+RDLK +N L + D +K+ D+G+ + + P + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 311 EGDMWSIGVITYILLCGSRPF-------WARTESGIFRSVLRAD---PNFHDSPWPSVSP 360
D W++GV+ + ++ G PF TE +F+ +L P F +S
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF-------LSV 228
Query: 361 EAKDFVRRLLNKDHRKRM 378
+A ++ LNKD ++R+
Sbjct: 229 KASHVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 70/249 (28%), Positives = 115/249 (46%), Gaps = 31/249 (12%)
Query: 157 AVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGEL 216
A+K I+K + I+ V E IL + + ++ +FE + +VME+ EGG+
Sbjct: 30 AMKKINKQNLILRNQIQQVFVERDIL-TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDC 88
Query: 217 LDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276
+ + G ++ E +L + + H G+VHRDLKP+N L T+ +K+ D
Sbjct: 89 ATLLKNIGALPVDMARMYFAETVLAL-EYLHNYGIVHRDLKPDNLLITSM---GHIKLTD 144
Query: 277 FGLSD-------------FVRPDQRL---NDIVGSAYYVAPEV-LHRSYNVEGDMWSIGV 319
FGLS + D R + G+ Y+APEV L + Y D W++G+
Sbjct: 145 FGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGI 204
Query: 320 ITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP----SVSPEAKDFVRRLLNKDHR 375
I Y L G PF+ T +F V+ D WP ++ +A+D + RLL ++
Sbjct: 205 ILYEFLVGCVPFFGDTPEELFGQVISD-----DIEWPEGDEALPADAQDLISRLLRQNPL 259
Query: 376 KRMTAAQAL 384
+R+ A
Sbjct: 260 ERLGTGGAF 268
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 6e-22
Identities = 86/314 (27%), Positives = 131/314 (41%), Gaps = 68/314 (21%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
K+E ++G+G FG A+ KK ++VA+K + I +R E+KIL+ L
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKEGFPITALR-EIKILQLL 68
Query: 186 SGHKHMIKFHD--------AFEDANSVYIVMEFCEGGELLDRILSRGG-RYLEEDAKTIV 236
H++++ + S Y+V EFCE L +LS ++ + K ++
Sbjct: 69 K-HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD--LAGLLSNKNVKFTLSEIKKVM 125
Query: 237 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPD----QRLND 291
+ +LN + + H ++HRD+K N L T +D LK+ DFGL+ F R +
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 292 IVGSAYYVAPEVL--HRSYNVEGDMWSIGVI--------------------TYIL-LCGS 328
V + +Y PE+L R Y DMW G I T I LCGS
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242
Query: 329 -----------RPFWARTE--SGIFRSVLRADPNFHDSPWPSVS-PEAKDFVRRLLNKDH 374
+ + E G R V + P V P A D + +LL D
Sbjct: 243 ITPEVWPGVDKLELFKKMELPQGQKRKV-------KERLKPYVKDPHALDLIDKLLVLDP 295
Query: 375 RKRMTAAQALTHPW 388
KR+ A AL H +
Sbjct: 296 AKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 7e-22
Identities = 73/274 (26%), Positives = 128/274 (46%), Gaps = 14/274 (5%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F + +G+G FG C + + GK+ A K + K ++ E +IL+ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAF 245
+ ++ A+E +++ +V+ GG+L I + G EE+ A +IL +
Sbjct: 59 S-QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLED 117
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL- 304
H + V+RDLKPEN L ++ +++ D GL+ + + + VG+ Y+APEVL
Sbjct: 118 LHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN 174
Query: 305 HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
++ Y + D W +G + Y ++ G PF R E V R + S EAK
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS 234
Query: 365 FVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393
+ LL KD ++R+ A + HP+ + N
Sbjct: 235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 81/310 (26%), Positives = 138/310 (44%), Gaps = 50/310 (16%)
Query: 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKA 184
+FE +G G +G A+ G++VA+K + + I +R E+ +L
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTT---SGEIVALKKVRMDNERDGIPISSLR-EITLLLN 62
Query: 185 LSGHKHMIKFHDAF--EDANSVYIVMEFCEG--GELLDRILSRGGRYLEEDAKTIVEKIL 240
L H ++++ + + +S+++VME+CE LLD + + + E K ++ ++L
Sbjct: 63 LR-HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLL 118
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYV 299
+ + H ++HRDLK N L T + LK+ DFGL+ + P + + V + +Y
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYR 175
Query: 300 APEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV--LRADPNFHDSPW 355
APE+L +Y DMW++G I LL ++E + L PN +S W
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN--ESIW 233
Query: 356 PSVS--PEAKDFV--------------------RRLLNK----DHRKRMTAAQALTHPWL 389
P S P F RLLN D +KR TA +AL +
Sbjct: 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
Query: 390 HDENRPVPLD 399
+ +P+P +
Sbjct: 294 KE--KPLPCE 301
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 1e-21
Identities = 71/253 (28%), Positives = 119/253 (47%), Gaps = 31/253 (12%)
Query: 175 VRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKT 234
V RE K H +++ + D++ + +++VME+ GG L D + E
Sbjct: 69 VMRENK-------HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAA 119
Query: 235 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR-LNDIV 293
+ + L + F H V+HRD+K +N L D +K+ DFG + P+Q + +V
Sbjct: 120 VCRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMV 176
Query: 294 GSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD 352
G+ Y++APEV+ R +Y + D+WS+G++ ++ G P+ E+ + L A +
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPE 234
Query: 353 SPWP-SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLR 411
P +S +DF+ R L D KR +A + L HP+L K+ K
Sbjct: 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL--------------KIAKPLSS 280
Query: 412 ATPLKRAALKALS 424
TPL AA +A
Sbjct: 281 LTPLIAAAKEATK 293
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 90/327 (27%), Positives = 140/327 (42%), Gaps = 72/327 (22%)
Query: 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA--KMTSALAIEDVRREVKIL 182
K+ K +GRG +G C AK + + VA+K I+ A A RE+K+L
Sbjct: 5 TKYVPIKPIGRGAYGIVCSAKN---SETNEKVAIKKIANAFDNRIDAKR---TLREIKLL 58
Query: 183 KALSGHKHMIKFHD--------AFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AK 233
+ L H+++I D AF D VYIV E + L +I+ R + L +D +
Sbjct: 59 RHLD-HENVIAIKDIMPPPHREAFND---VYIVYELMDTD--LHQII-RSSQTLSDDHCQ 111
Query: 234 TIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP----DQRL 289
+ ++L + + H V+HRDLKP N L + LK+ DFGL+ R +
Sbjct: 112 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICDFGLA---RTTSEKGDFM 165
Query: 290 NDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTE--------SGI 339
+ V + +Y APE+L Y D+WS+G I LL G +P + + + +
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLITEL 224
Query: 340 FRSVLRADPNFHDSP--------------------WPSVSPEAKDFVRRLLNKDHRKRMT 379
S D F + +P +P A D + ++L D KR+T
Sbjct: 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT 284
Query: 380 AAQALTHPW---LHDENR----PVPLD 399
+AL HP+ LHD + P
Sbjct: 285 VEEALAHPYLASLHDPSDEPVCQTPFS 311
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 79/274 (28%), Positives = 127/274 (46%), Gaps = 22/274 (8%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+G+G FG C + K T GK+ A K + K ++ + E KIL+ +S + ++
Sbjct: 1 LGKGGFGEVCACQ-VKAT--GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIV 56
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEE-DAKTIVEKILNIVAFCHLQGV 251
AFE + + +VM GG+L I + G E A +I+ + H + +
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116
Query: 252 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNV 310
V+RDLKPEN L ++ +++ D GL+ ++ +++ G+ Y+APEVL Y+
Sbjct: 117 VYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 311 EGDMWSIGVITYILLCGSRPFWARTES----GIFRSVLRADPNFHDSPWPSVSPEAKDFV 366
D +++G Y ++ G PF R E + R L + D SPEAKD
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD----KFSPEAKDLC 229
Query: 367 RRLLNKDHRKRM-----TAAQALTHPWLHDENRP 395
LL KD KR+ +A + HP D N
Sbjct: 230 EALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 68/230 (29%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKAL 185
F L +++G G+FG +G K +V VA+KI+ L +D ++EV+ LK L
Sbjct: 8 FTLERKLGSGYFGEVW-----EGLWKNRVRVAIKILKSD---DLLKQQDFQKEVQALKRL 59
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI--- 242
HKH+I VYI+ E E G LL + S G+ L V ++++
Sbjct: 60 R-HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLP------VASLIDMACQ 112
Query: 243 VA--FCHL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY- 297
VA +L Q +HRDL N L ED KV DFGL+ ++ D L+ Y
Sbjct: 113 VAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYK 169
Query: 298 YVAPEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 345
+ APE H +++ + D+WS G++ Y + G P+ ++ +
Sbjct: 170 WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 83/302 (27%), Positives = 139/302 (46%), Gaps = 52/302 (17%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
VG G +G C A + K VAVK +S+ S + RE+++LK + H+++I
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK---VAVKKLSRP-FQSLIHARRTYRELRLLKHMK-HENVI 77
Query: 193 KFHDAF------EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
D F E+ N VY+V G L+ I+ + + +E + ++ ++L + +
Sbjct: 78 GLLDVFTPATSIENFNEVYLVTNLM--GADLNNIV-KCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR 306
H G++HRDLKP N ED L+++DFGL+ + D + V + +Y APE++
Sbjct: 135 HSAGIIHRDLKPSNVAVN---EDCELRILDFGLAR--QADDEMTGYVATRWYRAPEIMLN 189
Query: 307 --SYNVEGDMWSIGVITYILLCG-----------------------SRPFWARTESGIFR 341
YN D+WS+G I LL G S + S R
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249
Query: 342 SVLRADPNFHDSPWPSV----SPEAKDFVRRLLNKDHRKRMTAAQALTHPWL---HD-EN 393
+++ P+ + +P A D + ++L D KR++A++AL HP+ HD E+
Sbjct: 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPED 309
Query: 394 RP 395
P
Sbjct: 310 EP 311
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 72/251 (28%), Positives = 123/251 (49%), Gaps = 24/251 (9%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT----SALAIEDVRREVKIL 182
+E+ K +GRG FG + K KV A+K++SK +M SA E+ + +
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWEE-----RDI 96
Query: 183 KALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI 242
A + +++ AF+D +Y+VME+ GG+L++ L E+ A+ +++
Sbjct: 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN--LMSNYDVPEKWARFYTAEVVLA 154
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVA 300
+ H G +HRD+KP+N L ++ LK+ DFG + + R + VG+ Y++
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 211
Query: 301 PEVLHRS-----YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355
PEVL Y E D WS+GV Y +L G PF+A + G + ++ +
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 271
Query: 356 PSVSPEAKDFV 366
+S EAK+ +
Sbjct: 272 NDISKEAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 24/288 (8%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
+E+G G FG A+ + +VVA+K +S + S +D+ +EVK L+ + H +
Sbjct: 31 REIGHGSFGAVYFARDVRTN---EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPN 86
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEE-DAKTIVEKILNIVAFCHLQ 249
I++ + ++ ++VME+C G +L + L+E + I L +A+ H
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL----H 305
++HRD+K N L T E +K+ DFG + P N VG+ Y++APEV+
Sbjct: 145 NMIHRDIKAGNILLT---EPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDE 198
Query: 306 RSYNVEGDMWSIGVITYILLCGSRP--FWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363
Y+ + D+WS+G IT I L +P F S ++ P + W S +
Sbjct: 199 GQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFR 254
Query: 364 DFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLR 411
+FV L K + R T+ + L H ++ E RP + I + + K +R
Sbjct: 255 NFVDSCLQKIPQDRPTSEELLKHMFVLRE-RPETVLIDLIQRTKDAVR 301
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 78/288 (27%), Positives = 138/288 (47%), Gaps = 24/288 (8%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
+E+G G FG A+ + + +VVA+K +S + S +D+ +EV+ L+ L H +
Sbjct: 21 REIGHGSFGAVYFARDVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPN 76
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEE-DAKTIVEKILNIVAFCHLQ 249
I++ + ++ ++VME+C G +L + L+E + + L +A+ H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL----H 305
++HRD+K N L + E +K+ DFG + + P N VG+ Y++APEV+
Sbjct: 135 NMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDE 188
Query: 306 RSYNVEGDMWSIGVITYILLCGSRP--FWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363
Y+ + D+WS+G IT I L +P F S ++ P W S +
Sbjct: 189 GQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFR 244
Query: 364 DFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLR 411
+FV L K + R T+ L H ++ E RP + + + + K +R
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRE-RPPTVIMDLIQRTKDAVR 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 68/260 (26%), Positives = 127/260 (48%), Gaps = 28/260 (10%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+GRG + + KK ++ A+K+I K + I+ V+ E + + S H ++
Sbjct: 3 IGRGSYAKVLLVELKKTR---RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 252
H F+ + ++ V+EF GG+L+ + R + EE A+ +I + F H +G++
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDLMFH-MQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 253 HRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNV 310
+RDLK +N L + + +K+ D+G+ + +RP + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 311 EGDMWSIGVITYILLCGSRPF---------WARTESGIFRSVLRAD---PNFHDSPWPSV 358
D W++GV+ + ++ G PF TE +F+ +L P S+
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR-------SL 228
Query: 359 SPEAKDFVRRLLNKDHRKRM 378
S +A ++ LNKD ++R+
Sbjct: 229 SVKASSVLKGFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-21
Identities = 86/295 (29%), Positives = 144/295 (48%), Gaps = 51/295 (17%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKII---SKAKMTSALAIEDVRREVKILKALSG 187
+++G G +G + KK G++VA+K I S+ + + AI RE+ +LK L
Sbjct: 6 EKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESEEEGVPSTAI----REISLLKELQ- 57
Query: 188 HKHMIKFHDAFEDANSVYIVMEF--CEGGELLDRILSRGGRYLE-EDAKTIVEKILNIVA 244
H +++ D + +Y++ EF + + LD + G+Y++ E K+ + +IL +
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVKSYLYQILQGIL 115
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEV 303
FCH + V+HRDLKP+N L + +K+ DFGL+ F P + V + +Y APEV
Sbjct: 116 FCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172
Query: 304 LHRS--YNVEGDMWSIGVITYILLCGSRP-FWARTE-SGIFRSVLRADPNFHDSPWPSVS 359
L S Y+ D+WSIG I + + +P F +E +FR + R + WP V+
Sbjct: 173 LLGSPRYSTPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFR-IFRILGTPTEDVWPGVT 230
Query: 360 --PEAK-----------------------DFVRRLLNKDHRKRMTAAQALTHPWL 389
P+ K D + ++L D KR++A +AL HP+
Sbjct: 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 7e-21
Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 26/278 (9%)
Query: 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHM 191
E+G G FG A +VVAVK +S + + +D+ +EVK L+ L H +
Sbjct: 28 EIGHGSFGAVYFATNSH---TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNT 83
Query: 192 IKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEE-DAKTIVEKILNIVAFCHLQG 250
I++ + ++ ++VME+C G +L + L+E + I L +A+ H
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL----HR 306
++HRD+K N L T E +K+ DFG + P N VG+ Y++APEV+
Sbjct: 142 MIHRDIKAGNILLT---EPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEG 195
Query: 307 SYNVEGDMWSIGVITYILLCGSRP--FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
Y+ + D+WS+G IT I L +P F S ++ P + W + +
Sbjct: 196 QYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSFRG 251
Query: 365 FVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
FV L K ++R +A+ L H ++ R P +LI
Sbjct: 252 FVDYCLQKIPQERPASAELLRHDFVR---RDRPARVLI 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 71/253 (28%), Positives = 126/253 (49%), Gaps = 28/253 (11%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT----SALAIEDVRREVKIL 182
+++ K +GRG FG + K KV A+K++SK +M SA E+ + +
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQ---KVYAMKLLSKFEMIKRSDSAFFWEE-----RDI 96
Query: 183 KALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI 242
A + +++ AF+D +Y+VME+ GG+L++ L E+ AK +++
Sbjct: 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN--LMSNYDVPEKWAKFYTAEVVLA 154
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYY 298
+ H G++HRD+KP+N L ++ LK+ DFG ++ D+ R + VG+ Y
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDY 209
Query: 299 VAPEVLHRS-----YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 353
++PEVL Y E D WS+GV + +L G PF+A + G + ++ + +
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP 269
Query: 354 PWPSVSPEAKDFV 366
+S AK+ +
Sbjct: 270 EDVEISKHAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 70/267 (26%), Positives = 136/267 (50%), Gaps = 23/267 (8%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
+ VG+G +G + + GK +K ++ + S + +E ++L L H +
Sbjct: 6 RVVGKGSYGEVSLVRHRT---DGKQYVIKKLN-LRNASRRERKAAEQEAQLLSQLK-HPN 60
Query: 191 MIKFHDAFEDANS-VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VAFC 246
++ + +++E + +YIVM FCEGG+L ++ + G+ L E +VE + I + +
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE--NQVVEWFVQIAMALQYL 118
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYYVAPEVL- 304
H + ++HRDLK +N +F TR +KV D G++ + + + ++G+ YY++PE+
Sbjct: 119 HEKHILHRDLKTQN-VFLTRTN--IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175
Query: 305 HRSYNVEGDMWSIGVITYILLCGSRPFWAR-TESGIFRSVLRADPNFHDSPWPS-VSPEA 362
++ YN + D+W++G Y + F A+ S ++R + P P P SPE
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-----PMPKDYSPEL 230
Query: 363 KDFVRRLLNKDHRKRMTAAQALTHPWL 389
+ + +L+K KR + L P++
Sbjct: 231 GELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 84/298 (28%), Positives = 136/298 (45%), Gaps = 62/298 (20%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKII---SKAKMTSALAIEDVRREVKILKALSGHK 189
+G G +G A+ K G++VA+K I ++ + + AI RE+ +LK L+ H
Sbjct: 7 IGEGTYGVVYKARDKLT---GEIVALKKIRLETEDEGVPSTAI----REISLLKELN-HP 58
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDA------KTIVEKILNIV 243
++++ D N +Y+V EF LD L + K+ + ++L +
Sbjct: 59 NIVRLLDVVHSENKLYLVFEF------LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD-FVRPDQRLNDIVGSAYYVAPE 302
A+CH V+HRDLKP+N L + LK+ DFGL+ F P + V + +Y APE
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDR---EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 169
Query: 303 VL--HRSYNVEGDMWSIGVITYILLCGSRP-FWARTE-SGIFRSVLRA--DPNFHDSPWP 356
+L R Y+ D+WSIG I + + RP F +E +FR + R P+ + WP
Sbjct: 170 ILLGSRQYSTPVDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFR-IFRTLGTPD--EDVWP 225
Query: 357 SVS-------------------------PEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
V+ + D + ++L D KR++A AL HP+
Sbjct: 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 81/328 (24%), Positives = 134/328 (40%), Gaps = 71/328 (21%)
Query: 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKI-----ISKAKMTSALAIEDV------RR 177
G +G G +G A TL GK+VA+K IS + R
Sbjct: 13 KGAHLGEGTYGKVEKAYD---TLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 178 EVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE 237
E+KI+ + H++++ D + + + + +VM+ L +++ R R E K I+
Sbjct: 70 ELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILL 126
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS---------------DF 282
+ILN + H +HRDL P N ++ K+ DFGL+ +
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYSDTLSKDET 183
Query: 283 VRPDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTE---- 336
++ + + V + +Y APE+L + Y+ DMWS+G I LL G F E
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243
Query: 337 SGIFRSVLRADPNFHDSPWPSV------------------------SPEAKDFVRRLLNK 372
IF L PN + WP S +A D ++ LL
Sbjct: 244 GRIFE--LLGTPN--EDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299
Query: 373 DHRKRMTAAQALTHPWLHDENRPVPLDI 400
+ +R++A +AL H + ++ P+P D
Sbjct: 300 NPLERISAKEALKHEYF--KSDPLPCDP 325
|
Length = 335 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 7e-20
Identities = 73/296 (24%), Positives = 132/296 (44%), Gaps = 45/296 (15%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA---KMTSALAIEDVRREVKIL 182
K+E VG G +G K K+ G++VA+K ++ KM +A+ RE+++L
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDKMVKKIAM----REIRML 54
Query: 183 KALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI 242
K L H++++ + F +Y+V EF + +LD + E + + +IL
Sbjct: 55 KQLR-HENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRG 112
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAP 301
+ FCH ++HRD+KPEN L + + +K+ DFG + + P + D V + +Y AP
Sbjct: 113 IEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAP 169
Query: 302 EVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN--------FH 351
E+L Y D+W++G + +L G F ++ +++ N F
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229
Query: 352 DSP-------------------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388
+P +P +S D ++ L D R +++Q L H +
Sbjct: 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 1e-19
Identities = 63/240 (26%), Positives = 114/240 (47%), Gaps = 24/240 (10%)
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ 249
+++ + D++ + +++VME+ GG L D + E + + L + F H
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALDFLHSN 134
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-S 307
V+HRD+K +N L D +K+ DFG + P+Q + + +VG+ Y++APEV+ R +
Sbjct: 135 QVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 308 YNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLRADPNFHDSPWPSVSPEAKDFV 366
Y + D+WS+G++ ++ G P+ ++ P + +S +DF+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE--RLSAVFRDFL 249
Query: 367 RRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKA 426
R L D +R +A + L HP+L KL K TPL AA +A+ +
Sbjct: 250 NRCLEMDVDRRGSAKELLQHPFL--------------KLAKPLSSLTPLIIAAKEAIKNS 295
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 72/268 (26%), Positives = 121/268 (45%), Gaps = 43/268 (16%)
Query: 136 GHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFH 195
G FG K K T K+ KII KAK +A+ E + + + + + IK +
Sbjct: 27 GKFGKVSVLK-HKPT--QKLFVQKII-KAKNFNAI-------EPMVHQLMKDNPNFIKLY 75
Query: 196 DAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDA-KTIVEKILNIVAFCHLQGVVHR 254
+ ++M++ + G+L D L + L E K I+ +++ + H ++H
Sbjct: 76 YSVTTLKGHVLIMDYIKDGDLFD--LLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHN 133
Query: 255 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVG--SAY-----YVAPE-VLHR 306
D+K EN L+ R +D + + D+GL I+G S Y Y +PE +
Sbjct: 134 DIKLENVLYD-RAKDR-IYLCDYGLCK----------IIGTPSCYDGTLDYFSPEKIKGH 181
Query: 307 SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL----RADPNFHDSPWPSVSPEA 362
+Y+V D W++GV+TY LL G PF + + L + F +VS A
Sbjct: 182 NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI----KNVSKNA 237
Query: 363 KDFVRRLLNKDHRKRMTA-AQALTHPWL 389
DFV+ +L + R+T + + HP+L
Sbjct: 238 NDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 62/236 (26%), Positives = 112/236 (47%), Gaps = 24/236 (10%)
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ 249
+++ + D++ + +++VME+ GG L D + E + + L + F H
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSN 135
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-S 307
V+HRD+K +N L D +K+ DFG + P+Q + + +VG+ Y++APEV+ R +
Sbjct: 136 QVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 308 YNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLRADPNFHDSPWPSVSPEAKDFV 366
Y + D+WS+G++ ++ G P+ ++ P + +S +DF+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFL 250
Query: 367 RRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKA 422
R L+ D KR +A + L H +L K+ K TPL AA +A
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFL--------------KIAKPLSSLTPLIAAAKEA 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 64/268 (23%), Positives = 123/268 (45%), Gaps = 17/268 (6%)
Query: 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA---LAIEDVRREVKILKALS 186
G+++G G F +C T G ++AVK ++ + TS+ +E +R+E++++ L+
Sbjct: 5 GQQLGTGAFS-SCYQARDVKT--GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H H+I+ A + + + +E+ GG + +LS+ G + E E++L +++
Sbjct: 62 -HPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSYL 119
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL-----SDFVRPDQRLNDIVGSAYYVAP 301
H ++HRD+K N L + + L++ DFG + + ++G+ ++AP
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 302 EVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS-VS 359
EVL Y D+WS+G + + P+ A S + + P +S
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQALTHP 387
P +D R L R + + L HP
Sbjct: 238 PGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 71/252 (28%), Positives = 117/252 (46%), Gaps = 49/252 (19%)
Query: 177 REVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLD--------RILSRGGRYL 228
RE+ +LK + H ++++ D +Y+V E+ + LD ++ R +
Sbjct: 50 REISLLKEMQ-HGNIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLI 104
Query: 229 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD-FVRPDQ 287
KT + +IL +A+CH V+HRDLKP+N L R LK+ DFGL+ F P +
Sbjct: 105 ----KTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVR 158
Query: 288 RLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRP-FWARTE----SGIF 340
V + +Y APE+L R Y+ D+WS+G I + + +P F +E IF
Sbjct: 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIF 217
Query: 341 RSV----------LRADPNFHDS--PW---------PSVSPEAKDFVRRLLNKDHRKRMT 379
R + + + P++ + W P++ P D + ++L D KR+T
Sbjct: 218 RILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT 277
Query: 380 AAQALTHPWLHD 391
A AL H + D
Sbjct: 278 ARAALEHEYFKD 289
|
Length = 294 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 3e-19
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 129 LGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKALSG 187
KE+G G FG G +GK+ VA+K+I + M+ +D E K++ LS
Sbjct: 8 FLKELGSGQFGVV-----HLGKWRGKIDVAIKMIREGAMSE----DDFIEEAKVMMKLS- 57
Query: 188 HKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH 247
H ++++ + ++IV E+ G LL+ + R G+ E + + + +
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 248 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV---APEVL 304
G +HRDL N L ED +KV DFGL+ +V DQ + G+ + V PEV
Sbjct: 118 SNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVF 173
Query: 305 HRS-YNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 345
S ++ + D+WS GV+ + + G P+ + S + SV
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 4e-19
Identities = 73/271 (26%), Positives = 130/271 (47%), Gaps = 26/271 (9%)
Query: 130 GKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG 187
GK +G+G FG + C L K V S A+E E+++LK L
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALE---CEIQLLKNLQ- 62
Query: 188 HKHMIKFHDAFED--ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H+ +++++ D ++ I ME+ GG + D++ + G E + +IL +++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSY 121
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR----PDQRLNDIVGSAYYVAP 301
H +VHRD+K N L R+ +K+ DFG S ++ + + G+ Y+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 302 EVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVLRADPNFHDSPWPS- 357
EV+ Y + D+WS+G T + + +P WA E + IF+ + P + PS
Sbjct: 179 EVISGEGYGRKADVWSLGC-TVVEMLTEKPPWAEYEAMAAIFK--IATQPT--NPQLPSH 233
Query: 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388
+S A+DF+ + + R R +A + L HP+
Sbjct: 234 ISEHARDFLGCIF-VEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 79/283 (27%), Positives = 133/283 (46%), Gaps = 52/283 (18%)
Query: 145 KGKKGTLKGKVVAVKIISKAKMTSA--LAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202
KG+ L G++VA+K I A AI RE +LK L H +++ HD
Sbjct: 23 KGRS-KLTGQLVALKEIRLEHEEGAPFTAI----REASLLKDLK-HANIVTLHDIIHTKK 76
Query: 203 SVYIVMEFCEGGELLDRILSRGGRYLE-EDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 261
++ +V E+ + L + + G L + + + ++L +A+CH + V+HRDLKP+N
Sbjct: 77 TLTLVFEYLDTD--LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNL 134
Query: 262 LFTTREEDAPLKVIDFGLSDFVR----PDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMW 315
L + R E LK+ DFGL+ R P + ++ V + +Y P+VL S Y+ DMW
Sbjct: 135 LISERGE---LKLADFGLA---RAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMW 188
Query: 316 SIGVITYILLCGSRPFWARTESG-----IFRSV----------LRADP-----NFHDSP- 354
+G I Y + G F T+ IFR + + ++P +F P
Sbjct: 189 GVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPP 248
Query: 355 ------WPSVS--PEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
P + P ++ + L + +KR++AA+A+ HP+
Sbjct: 249 RPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 81/276 (29%), Positives = 125/276 (45%), Gaps = 39/276 (14%)
Query: 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK-ILKALS---- 186
E+G G G + KK G V+AVK + + + E K IL L
Sbjct: 22 EIGSGTCGQVYKMRFKK---TGHVMAVKQMRRT---------GNKEENKRILMDLDVVLK 69
Query: 187 GH--KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKI-LNIV 243
H +++K + F + V+I ME LD++L R + ED I+ K+ + IV
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPED---ILGKMTVAIV 124
Query: 244 AFCHL----QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV 299
H GV+HRD+KP N L + +K+ DFG+S + + G A Y+
Sbjct: 125 KALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM 181
Query: 300 APEVL-----HRSYNVEGDMWSIGVITYILLCGSRPF-WARTESGIFRSVLRADPNFHDS 353
APE + + Y++ D+WS+G+ L G P+ +TE + +L+ +P
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP- 240
Query: 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
P SP+ FV L KDHRKR + L HP++
Sbjct: 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 74/278 (26%), Positives = 129/278 (46%), Gaps = 63/278 (22%)
Query: 163 KAKMTSAL-AIEDVR------------REVKILKALSGHKHMIKFHDAFEDANSVYIVME 209
++K+T L A++++R REV +LK L H +++ HD S+ +V E
Sbjct: 26 RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLVFE 84
Query: 210 FCEGGELLDRILSRGGRYLEE--------DAKTIVEKILNIVAFCHLQGVVHRDLKPENF 261
+ LD+ L + YL++ + K + ++L + +CH + V+HRDLKP+N
Sbjct: 85 Y------LDKDLKQ---YLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNL 135
Query: 262 LFTTREEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWSIG 318
L R E LK+ DFGL+ P + ++ V + +Y P++L S Y+ + DMW +G
Sbjct: 136 LINERGE---LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVG 192
Query: 319 VITYILLCGSRPFWARTESG----IFRSV----------LRADPNFHDSPWPSVSPEA-- 362
I Y + G F T IFR + + ++ F +P +
Sbjct: 193 CIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLH 252
Query: 363 ----------KDFVRRLLNKDHRKRMTAAQALTHPWLH 390
+ + +LL + RKR++A +A+ HP+ H
Sbjct: 253 NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 7e-19
Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 14/274 (5%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F + +G+G FG C + + GK+ A K + K ++ E +IL+ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAF 245
+ ++ A+E +++ +V+ GG+L I + G + EE A +I +
Sbjct: 59 S-RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL- 304
H + +V+RDLKPEN L ++ +++ D GL+ + + + VG+ Y+APEV+
Sbjct: 118 LHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVK 174
Query: 305 HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
+ Y D W +G + Y ++ G PF R E V R + S A+
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARS 234
Query: 365 FVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393
R+LL KD R+ A + HP+ N
Sbjct: 235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 9e-19
Identities = 68/268 (25%), Positives = 121/268 (45%), Gaps = 14/268 (5%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+G+G FG C + + GK+ A K + K ++ E +IL+ ++ + ++
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-RFVV 63
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGR-YLEEDAKTIVEKILNIVAFCHLQGV 251
A+E +++ +V+ GG+L I + G + E+ A ++ + + +
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123
Query: 252 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNV 310
V+RDLKPEN L R +++ D GL+ + + + VG+ Y+APEV+ + Y
Sbjct: 124 VYRDLKPENILLDDR---GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTF 180
Query: 311 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 370
D W +G + Y ++ G PF R E V R + S +AK R LL
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240
Query: 371 NKDHRKRM-----TAAQALTHPWLHDEN 393
K+ ++R+ AA HP + N
Sbjct: 241 TKNPKERLGCRGNGAAGVKQHPIFKNIN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 9e-19
Identities = 79/242 (32%), Positives = 119/242 (49%), Gaps = 22/242 (9%)
Query: 152 KGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFC 211
K KVVA ++ + +A A R E+ L A H ++K D F+ + + ++ME+
Sbjct: 93 KEKVVAKFVMLNDERQAAYA----RSELHCLAACD-HFGIVKHFDDFKSDDKLLLIMEYG 147
Query: 212 EGGELLDRILSRGGRYL---EEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN-FLFTTRE 267
GG+L +I R +L E + + +I+ + H + ++HRDLK N FL T
Sbjct: 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT-- 205
Query: 268 EDAPLKVIDFGLS----DFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITY 322
+K+ DFG S D V D + G+ YY+APE+ R Y+ + DMWS+GVI Y
Sbjct: 206 --GIIKLGDFGFSKQYSDSVSLDVA-SSFCGTPYYLAPELWERKRYSKKADMWSLGVILY 262
Query: 323 ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQ 382
LL RPF ++ I + VL + P P VS K + LL+K+ R T Q
Sbjct: 263 ELLTLHRPFKGPSQREIMQQVLYG--KYDPFPCP-VSSGMKALLDPLLSKNPALRPTTQQ 319
Query: 383 AL 384
L
Sbjct: 320 LL 321
|
Length = 478 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 70/268 (26%), Positives = 123/268 (45%), Gaps = 14/268 (5%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F + +G+G FG C + + GK+ A K + K ++ E +IL+ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAF 245
+ ++ A+E +++ +V+ GG+L I G EE A +I +
Sbjct: 59 S-RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED 117
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL- 304
H + +V+RDLKPEN L ++ +++ D GL+ V Q + VG+ Y+APEV+
Sbjct: 118 LHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 174
Query: 305 HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
+ Y D W++G + Y ++ G PF R + V R + SP+A+
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARS 234
Query: 365 FVRRLLNKDHRKRM-----TAAQALTHP 387
+ LL KD ++R+ A + HP
Sbjct: 235 LCKMLLCKDPKERLGCQGGGAREVKEHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 30/217 (13%)
Query: 131 KEVGRGHFGHT-CCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK 189
K++G GHFG C G G+ VAVK ++ D RE++IL+ L H+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH--SGEEQHRSDFEREIEILRTLD-HE 66
Query: 190 HMIKFHDAFEDA--NSVYIVMEFCEGGELLDRILSRGGRYLEE-----DAKTIV---EKI 239
+++K+ E S+ ++ME+ G L D YL+ + K ++ +I
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRD--------YLQRHRDQINLKRLLLFSSQI 118
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGS- 295
+ + Q +HRDL N L E + +K+ DFGL+ + D+ + + S
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 296 AYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPF 331
++ APE L ++ D+WS GV Y L P
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 67/242 (27%), Positives = 112/242 (46%), Gaps = 31/242 (12%)
Query: 177 REVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIV 236
RE++I+ +++ F+ AF + N++ + MEF + G L DRI +GG E I
Sbjct: 52 RELQIMHECRS-PYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIA 109
Query: 237 EKILNIVAFCH-LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI--- 292
++ + + + + ++HRD+KP N L +R + +K+ DFG+S + +N I
Sbjct: 110 VAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVS-----GELINSIADT 161
Query: 293 -VGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES--------GIF-- 340
VG++ Y++PE + Y V+ D+WS+G+ L G PF GI
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL 221
Query: 341 --RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPL 398
+ V P S +P + +DFV L KD +R T Q P R +
Sbjct: 222 LQQIVQEPPPRLPSSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
Query: 399 DI 400
D+
Sbjct: 279 DL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 80/285 (28%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
+N FEL + +G G +G A+ G++ A+K+I K+ V++E+
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVN---TGELAAIKVI---KLEPGEDFAVVQQEII 58
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
++K H +++ + ++ + ++I MEFC GG L D I G E + + L
Sbjct: 59 MMKDCK-HSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETL 116
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYV 299
+ + H +G +HRD+K N L T ++ +K+ DFG+S + + +G+ Y++
Sbjct: 117 QGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWM 173
Query: 300 APEV--LHRS--YNVEGDMWSIGVITYILLCGSRP--FWARTESGIFRSVLRADPNFHDS 353
APEV + R YN D+W++G IT I L +P F +F L NF
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVG-ITAIELAELQPPMFDLHPMRALF---LMTKSNFQ-- 227
Query: 354 PWPSVSPEAKD----------FVRRLLNKDHRKRMTAAQALTHPW 388
P+ KD FV+ L K+ +KR TA + L HP+
Sbjct: 228 -----PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 84/311 (27%), Positives = 140/311 (45%), Gaps = 68/311 (21%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISK--AKMTSALAIEDVRREVKILKALSGH 188
K +G G G C A T+ G+ VA+K +S+ +T A + RE+ ++K ++ H
Sbjct: 22 KPIGSGAQGIVCAAYD---TVTGQNVAIKKLSRPFQNVTHA---KRAYRELVLMKLVN-H 74
Query: 189 KHMIKFHDAF------EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTI---VEKI 239
K++I + F E+ VY+VME L+D L + + ++ D + + + ++
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVME------LMDANLCQVIQ-MDLDHERMSYLLYQM 127
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV 299
L + H G++HRDLKP N + + D LK++DFGL+ + V + YY
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 184
Query: 300 APEV-LHRSYNVEGDMWSIGVITYILLCGSRPF--------WAR------TESGIF---- 340
APEV L Y D+WS+G I ++ G+ F W + T S F
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244
Query: 341 ----RSVLRADPN---------FHDSPWPSVSPE--------AKDFVRRLLNKDHRKRMT 379
R+ + P F D +P S A+D + ++L D KR++
Sbjct: 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304
Query: 380 AAQALTHPWLH 390
AL HP+++
Sbjct: 305 VDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 75/311 (24%), Positives = 133/311 (42%), Gaps = 49/311 (15%)
Query: 119 YGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRRE 178
+GK KF++ ++G G +G A+ K G++VA+K + I +R E
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDK---DTGELVALKKVRLDNEKEGFPITAIR-E 56
Query: 179 VKILKALSGHKHMIKFHDAF----------EDANSVYIVMEFCEGGELLDRILSRGGRYL 228
+KIL+ L+ H++++ + +D + Y+V E+ + +L+ + S +
Sbjct: 57 IKILRQLN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFS 114
Query: 229 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 288
E+ K+ ++++L + +CH + +HRD+K N L + + +K+ DFGL+ ++
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEES 171
Query: 289 --LNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 344
+ V + +Y PE+L Y D+WS G I L F A E +
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231
Query: 345 RADPNFHDSPWPSV--------------------------SPEAKDFVRRLLNKDHRKRM 378
R + + WP V A D + +L D KR
Sbjct: 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291
Query: 379 TAAQALTHPWL 389
TA +AL PWL
Sbjct: 292 TAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 6e-18
Identities = 77/281 (27%), Positives = 136/281 (48%), Gaps = 36/281 (12%)
Query: 127 FELGKEVGRGHFGHT-CCAKGKKGTLKGKVVAVKIIS-------KAKMTSALAIEDVRRE 178
+ LGK +G+G FG C G + +AVK + +K +AL E
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTG----RELAVKQVQFDPESPETSKEVNALECE----- 54
Query: 179 VKILKALSGHKHMIKFHDAFEDA--NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIV 236
+++LK L H+ +++++ D ++ I ME GG + D++ S G E +
Sbjct: 55 IQLLKNLL-HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYT 112
Query: 237 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR----PDQRLNDI 292
+IL V++ H +VHRD+K N L R+ +K+ DFG S ++ + +
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSV 169
Query: 293 VGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVLRADPN 349
G+ Y+++PEV+ Y + D+WS+G T + + +P WA E + IF+ + P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGC-TVVEMLTEKPPWAEFEAMAAIFK--IATQPT 226
Query: 350 FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390
P P VS +DF++R+ + + R +A + L H ++H
Sbjct: 227 NPVLP-PHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 6e-18
Identities = 78/279 (27%), Positives = 133/279 (47%), Gaps = 31/279 (11%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
+N +EL + VG G +G A+ G++ AVKII K+ +++E+
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLH---TGELAAVKII---KLEPGDDFSLIQQEIF 58
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
++K H +++ + ++ ++I ME+C GG L D I G E + + L
Sbjct: 59 MVKECK-HCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETL 116
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYV 299
+A+ H +G +HRD+K N L T ++ +K+ DFG++ + + +G+ Y++
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFIGTPYWM 173
Query: 300 APEVL----HRSYNVEGDMWSIGVITYILLCGSRP--FWARTESGIFRSVLRADPNFH-- 351
APEV + YN D+W++G IT I L +P F +F L + NF
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVG-ITAIELAELQPPMFDLHPMRALF---LMSKSNFQPP 229
Query: 352 ----DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386
+ W S +FV+ L K+ +KR TA + LTH
Sbjct: 230 KLKDKTKW---SSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 85/312 (27%), Positives = 139/312 (44%), Gaps = 61/312 (19%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+++ K +G G G C A T+ G VAVK +S+ A + RE+ +LK +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFD---TVLGINVAVKKLSRPFQNQTHA-KRAYRELVLLKCV 77
Query: 186 SGHKHMIKFHDAF------EDANSVYIVMEFCEGG--ELLDRILSRGGRYLEEDAKTIVE 237
+ HK++I + F E+ VY+VME + +++ L E ++
Sbjct: 78 N-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELD------HERMSYLLY 130
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY 297
++L + H G++HRDLKP N + + D LK++DFGL+ + + V + Y
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRY 187
Query: 298 YVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPF--------WAR------TESGIF-- 340
Y APEV L Y D+WS+G I L+ GS F W + T S F
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247
Query: 341 ------RSVLRADPNFH---------DSPWPSVS-------PEAKDFVRRLLNKDHRKRM 378
R+ + P + D +PS S +A+D + ++L D KR+
Sbjct: 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI 307
Query: 379 TAAQALTHPWLH 390
+ +AL HP++
Sbjct: 308 SVDEALRHPYIT 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 74/295 (25%), Positives = 135/295 (45%), Gaps = 44/295 (14%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
KFE+ VG G +G + K+ ++VA+K ++ + E RE+K+L+ L
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSEENEEVK-ETTLRELKMLRTL 57
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGG--ELLDRILSRGGRYLEEDAKTIVEKILNIV 243
+++++ +AF +Y+V E+ E ELL+ + G E ++ + +++ +
Sbjct: 58 K-QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE-MPNGV--PPEKVRSYIYQLIKAI 113
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP--DQRLNDIVGSAYYVAP 301
+CH +VHRD+KPEN L + + LK+ DFG + + + + V + +Y +P
Sbjct: 114 HWCHKNDIVHRDIKPENLLISH---NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170
Query: 302 EVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR--------------A 346
E+L + Y DMWS+G I L G F +E ++ + +
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230
Query: 347 DPNFHDSPWPSVS-PEA-------------KDFVRRLLNKDHRKRMTAAQALTHP 387
+P FH +P+V+ P++ D ++ LL + R Q L HP
Sbjct: 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 36/243 (14%)
Query: 177 REVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLE-EDAKTI 235
REV +LK L H +++ HD + +V E+ + L + L G + + K
Sbjct: 52 REVSLLKNLK-HANIVTLHDIIHTERCLTLVFEYLDSD--LKQYLDNCGNLMSMHNVKIF 108
Query: 236 VEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQRLNDIVG 294
+ ++L +++CH + ++HRDLKP+N L + E LK+ DFGL+ P + ++ V
Sbjct: 109 MFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSVPTKTYSNEVV 165
Query: 295 SAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD 352
+ +Y P+VL S Y+ DMW +G I Y + G F T + R +
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE 225
Query: 353 SPWPSVSP--------------------------EAKDFVRRLLNKDHRKRMTAAQALTH 386
WP ++ + D + LL + + R++A AL H
Sbjct: 226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285
Query: 387 PWL 389
+
Sbjct: 286 SYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 86/312 (27%), Positives = 141/312 (45%), Gaps = 36/312 (11%)
Query: 98 GPTSGDGGVKATERQLDKNFGY----GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKG 153
SGD + R F K K+ + + +G G G CAK G
Sbjct: 1 MMASGDAMIGRVCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVS---DG 57
Query: 154 KVVAVKIISKAKMTSALAIEDVRREVKILKALS-GHKHMIKFHDAF--------EDANSV 204
+ AVK++ M+ A + R + ++ L+ ++K H+ F E+ +
Sbjct: 58 EPFAVKVVDMEGMSEA---DKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMI 114
Query: 205 YIVMEFCEGGELLDRILSRG--GR-YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 261
+V+++ G+L I SR R + E +A + ++L V H + ++HRD+K N
Sbjct: 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANI 174
Query: 262 LFTTREEDAPLKVIDFGLSDFVR---PDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSI 317
L + + +K+ DFG S D G+ YYVAPE+ R Y+ + DM+S+
Sbjct: 175 LLCS---NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSL 231
Query: 318 GVITYILLCGSRPFWARTESGIFRSVL--RADPNFHDSPWPSVSPEAKDFVRRLLNKDHR 375
GV+ Y LL RPF + L R DP P PS+SPE ++ V LL+ D +
Sbjct: 232 GVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP----LP-PSISPEMQEIVTALLSSDPK 286
Query: 376 KRMTAAQALTHP 387
+R ++++ L P
Sbjct: 287 RRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 64/243 (26%), Positives = 109/243 (44%), Gaps = 36/243 (14%)
Query: 177 REVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLE-EDAKTI 235
REV +LK L H +++ HD S+ +V E+ + L + + G + + K
Sbjct: 53 REVSLLKDLK-HANIVTLHDIVHTDKSLTLVFEYLDKD--LKQYMDDCGNIMSMHNVKIF 109
Query: 236 VEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQRLNDIVG 294
+ +IL +A+CH + V+HRDLKP+N L R E LK+ DFGL+ P + ++ V
Sbjct: 110 LYQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVV 166
Query: 295 SAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD 352
+ +Y P+VL S Y+ + DMW +G I + + G F T + R +
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE 226
Query: 353 SPWPSVSP--------------------------EAKDFVRRLLNKDHRKRMTAAQALTH 386
WP +S E + + + L + +KR++A +A+ H
Sbjct: 227 ETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286
Query: 387 PWL 389
+
Sbjct: 287 AYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 8e-17
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKALSGHK 189
KE+G G FG K G +G+ VA+K+I + M+ IE E K++ LS H+
Sbjct: 10 KELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLS-HE 59
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ 249
+++ + +YIV E+ G LL+ + G R+ + + + +A+ +
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV---APEVLHR 306
+HRDL N L ++ +KV DFGLS +V D+ + VGS + V PEVL
Sbjct: 120 QFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLY 175
Query: 307 S-YNVEGDMWSIGVITY-ILLCGSRPF 331
S ++ + D+W+ GV+ + + G P+
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 9e-17
Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 14/242 (5%)
Query: 153 GKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS-VYIVMEFC 211
G VA+K++ RRE + L H +++ D+ E ++ V E+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 212 EGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP 271
G L + + + G E + +++ +L+ +A H QG+VHRDLKP+N + +
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQ-VLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 272 LKVIDFG----LSDFVRPDQ----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITY 322
KV+DFG L D R +++G+ Y APE L D+++ G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 323 ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQ 382
L G R + + I L PW + P +R+ LNKD R+R +A
Sbjct: 181 ECLTGQRVVQGASVAEILYQQLSPVD-VSLPPWIAGHPLG-QVLRKALNKDPRQRAASAP 238
Query: 383 AL 384
AL
Sbjct: 239 AL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 9e-17
Identities = 75/273 (27%), Positives = 128/273 (46%), Gaps = 26/273 (9%)
Query: 127 FELGKEVGRGHFGHT-CCAKGKKG-TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKA 184
+ LGK +GRG FG C G L K V S+ A+E E+++LK
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALE---CEIQLLKN 60
Query: 185 LSGHKHMIKFHDAFED--ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI 242
L H +++++ D + I +E+ GG + D++ + G E + +IL
Sbjct: 61 LR-HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQG 118
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR----PDQRLNDIVGSAYY 298
V++ H +VHRD+K N L R+ +K+ DFG S ++ + + G+ Y+
Sbjct: 119 VSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 299 VAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVLR-ADPNFHDSP 354
++PEV+ Y + D+WS+ T + + +P WA E + IF+ + P D
Sbjct: 176 MSPEVISGEGYGRKADVWSVAC-TVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD-- 232
Query: 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387
VS +DF++++ ++ R R TA L HP
Sbjct: 233 --GVSDACRDFLKQIFVEEKR-RPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 79/315 (25%), Positives = 128/315 (40%), Gaps = 67/315 (21%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+E+ ++G G FG A+ K G+VVA+K I I +R E+KILK L
Sbjct: 10 YEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHNEKDGFPITALR-EIKILKKLK 65
Query: 187 GHKHMIKFHDAF--------EDANSVYIVMEFCEGGELLDRILSRGGRYLEE-DAKTIVE 237
H +++ D SVY+V + + L +L L E K +
Sbjct: 66 -HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHD--LSGLLENPSVKLTESQIKCYML 122
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP------------ 285
++L + + H ++HRD+K N L + LK+ DFGL+ RP
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLA---RPYDGPPPNPKGGG 176
Query: 286 ---DQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRP-FWARTE--- 336
++ ++V + +Y PE+L R Y D+W IG + + RP +++
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPILQGKSDIDQ 235
Query: 337 -SGIFR----------SVLRADPNFHDSPWP------------SVSPEAKDFVRRLLNKD 373
IF+ R+ P + PE D + +LL+ D
Sbjct: 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLD 295
Query: 374 HRKRMTAAQALTHPW 388
KR+TA+ AL HP+
Sbjct: 296 PYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 26/224 (11%)
Query: 129 LGKEVGRGHFGHTCCAKGKKGT-LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG 187
L +E+G G FG G L+ + VA+K I + M+ ED E +++ LS
Sbjct: 8 LVQEIGSGQFGLV-----WLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLS- 57
Query: 188 HKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VA 244
H +++ + + + + +V EF E G L D + ++ G++ +T++ L++ +A
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKF---SQETLLGMCLDVCEGMA 114
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV---AP 301
+ V+HRDL N L E+ +KV DFG++ FV DQ + G+ + V +P
Sbjct: 115 YLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQYTSS-TGTKFPVKWSSP 170
Query: 302 EVLHRS-YNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSV 343
EV S Y+ + D+WS GV+ + + G P+ R+ S + ++
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI 214
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 21/197 (10%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG 187
+LG +G+G FG G +G+ VAVK + K T+A A E ++ L
Sbjct: 9 KLGATIGKGEFGDV-----MLGDYRGQKVAVKCL-KDDSTAAQAFLA---EASVMTTLR- 58
Query: 188 HKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLE-EDAKTIVEKILNIVAFC 246
H ++++ N +YIV E+ G L+D + SRG + + + +
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS--AYYVAPEVL 304
+ VHRDL N L + ED KV DFGL+ + G + APE L
Sbjct: 119 EEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEAL 171
Query: 305 -HRSYNVEGDMWSIGVI 320
+ ++ + D+WS G++
Sbjct: 172 REKKFSTKSDVWSFGIL 188
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 79/297 (26%), Positives = 123/297 (41%), Gaps = 42/297 (14%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
++E E+G G +G A+ G VA+K + L + VR EV +LK L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRL 56
Query: 186 SG--HKHMIKFHDAFEDANS-----VYIVMEFCEGG--ELLDRILSRGGRYLEEDAKTIV 236
H ++++ D + + V +V E + LD++ G E K ++
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLM 114
Query: 237 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA 296
+ L + F H +VHRDLKPEN L T+ + +K+ DFGL+ L +V +
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTL 171
Query: 297 YYVAPEVLHRS-YNVEGDMWSIGVI------TYILLCG-----------------SRPFW 332
+Y APEVL +S Y DMWS+G I L CG W
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231
Query: 333 ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
R + + P S P + + +L + KR++A +AL HP+
Sbjct: 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 71/273 (26%), Positives = 128/273 (46%), Gaps = 36/273 (13%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+G+G +G A+ ++ +A+K I + ++ + E+ + L H++++
Sbjct: 16 LGKGTYGIVYAARDLSTQVR---IAIKEIPERDSRY---VQPLHEEIALHSYLK-HRNIV 68
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIV---EKILNIVAFCHLQ 249
++ + + I ME GG L + S+ G L+++ +TI+ ++IL + + H
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI-------VGSAYYVAPE 302
+VHRD+K +N L T +K+ DFG S +RL I G+ Y+APE
Sbjct: 128 QIVHRDIKGDNVLVNTYS--GVVKISDFGTS------KRLAGINPCTETFTGTLQYMAPE 179
Query: 303 VLH---RSYNVEGDMWSIGVITYILLCGSRPFW--ARTESGIFR-SVLRADPNFHDSPWP 356
V+ R Y D+WS+G + G PF ++ +F+ + + P +
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE---- 235
Query: 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
S+S EAK+F+ R D KR +A L P+L
Sbjct: 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-16
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
KE+G G FG K + +K VA+K I++ M+ ED E K++ LS H
Sbjct: 10 KELGSGQFGVVHLGKWR-AQIK---VAIKAINEGAMSE----EDFIEEAKVMMKLS-HPK 60
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+++ + +YIV EF E G LL+ + R G+ ++ ++ + + + +
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV---APEVLHRS 307
+HRDL N L + +KV DFG++ +V D+ + G+ + V PEV + S
Sbjct: 121 FIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNFS 176
Query: 308 -YNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRAD 347
Y+ + D+WS GV+ + + G PF ++ + + R
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 46/234 (19%)
Query: 129 LGKEVGRGHFGHTC---CAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
L +E+G G FG C + K ++VAVK + + S A +D RE ++L
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDK-ELVAVKTLK--ETASNDARKDFEREAELLTNF 65
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG-------------GRYLEEDA 232
H++++KF+ + + +V E+ E G+L + S G G
Sbjct: 66 -QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 233 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI 292
I +I + + + Q VHRDL N L D +K+ DFG+S D+
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVGY---DLVVKIGDFGMS---------RDV 172
Query: 293 VGSAYY------------VAPE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPFW 332
+ YY + PE +++R + E D+WS GV+ + I G +P++
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 69/271 (25%), Positives = 121/271 (44%), Gaps = 17/271 (6%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+G+G FG + + GK+ A K ++K ++ E E +IL + + ++
Sbjct: 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIV 56
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQ 249
AF+ + +VM GG+L I + + E A +I++ + H +
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RS 307
+++RDLKPEN L + D +++ D GL+ ++ Q + G+ ++APE+L
Sbjct: 117 RIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 308 YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 367
Y+ D +++GV Y ++ PF AR E + + + N + SP +K F
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233
Query: 368 RLLNKDHRKRM-----TAAQALTHPWLHDEN 393
LL KD KR+ THP D N
Sbjct: 234 ALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 85/312 (27%), Positives = 132/312 (42%), Gaps = 62/312 (19%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA----LAIEDVRREVKIL 182
E + +G G FG + GK VA+K KM + ++ + V RE+K+L
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPR---DGKRVALK-----KMPNVFQNLVSCKRVFRELKML 53
Query: 183 KALSGHKHMIKFHDAFEDAN-----SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE 237
H +++ D + + +Y+V E + L +I+ + K +
Sbjct: 54 CFFK-HDNVLSALDILQPPHIDPFEEIYVVTELMQSD--LHKIIVSPQPLSSDHVKVFLY 110
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI--VGS 295
+IL + + H G++HRD+KP N L + + LK+ DFGL+ PD+ + V +
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVVT 167
Query: 296 AYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTE----------------- 336
YY APE+L R Y D+WS+G I LL F A++
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227
Query: 337 ------SGIFRSVLRADPNFHDSPWPSV--------SPEAKDFVRRLLNKDHRKRMTAAQ 382
G +LR H P V + EA + R+L D KR++AA
Sbjct: 228 AMRSACEGARAHILRGP---HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD 284
Query: 383 ALTHPWLHDENR 394
AL HP+L DE R
Sbjct: 285 ALAHPYL-DEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 80/303 (26%), Positives = 127/303 (41%), Gaps = 51/303 (16%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
++++ + +G+G +G C A T G+ VA+K I+ + A + RE+K+L+ L
Sbjct: 1 RYKIQEVIGKGSYGVVCSAID---THTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLL 56
Query: 186 SGH------KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKI 239
H KH I + + +Y+V E E L +++ E + + ++
Sbjct: 57 R-HPDIVEIKH-IMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHHQFFLYQL 112
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR----LNDIVGS 295
L + + H V HRDLKP+N L D LK+ DFGL+ D D V +
Sbjct: 113 LRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169
Query: 296 AYYVAPEV---LHRSYNVEGDMWSIGVITYILLCGSRPFWAR------------------ 334
+Y APE+ Y D+WSIG I +L G F +
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229
Query: 335 -TESGI-------FRSVLR-ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385
T S + + S +R P +P+ P A + RLL D + R TA +AL
Sbjct: 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289
Query: 386 HPW 388
P+
Sbjct: 290 DPY 292
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKAL 185
+L +++G G FG GT G VAVK + M+ E +E +I+K L
Sbjct: 8 LKLERKLGAGQFGEVW-----MGTWNGTTKVAVKTLKPGTMSP----EAFLQEAQIMKKL 58
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYL-EEDAKTIVEKILNIVA 244
H +++ + + +YIV E+ G LLD + S G+ L + +I +A
Sbjct: 59 R-HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAP 301
+ + +HRDL N L E+ K+ DFGL+ + D+ G+ + + AP
Sbjct: 118 YLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAP 173
Query: 302 E-VLHRSYNVEGDMWSIGVITY 322
E + + ++ D+WS G++
Sbjct: 174 EAANYGRFTIKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 84/326 (25%), Positives = 133/326 (40%), Gaps = 85/326 (26%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F K +G+G FG + KK T GK+ A+K + K++M + V+ E +L A S
Sbjct: 3 FHTVKVIGKGAFGEVRLVQ-KKDT--GKIYAMKTLLKSEMFKKDQLAHVKAERDVL-AES 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRY--LEEDAKT--IVEKILNI 242
++ + +F+DA +Y++MEF GG+L+ ++ +Y ED + E +L I
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAI 114
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAP 301
A H G +HRD+KP+N L + +K+ DFGLS F + SAYY
Sbjct: 115 EAV-HKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHD-------SAYYQKL 163
Query: 302 ----EVLHRSYNVEGDM----------------W----------SIGVITYI-------- 323
+R N W ++G YI
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223
Query: 324 -----------------LLCGSRPFWARTESGIFRSVL--RADPNFHDSPWPSVSPEAKD 364
L G PF + +R ++ R F D +S EA+D
Sbjct: 224 GYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDD--IHLSVEAED 281
Query: 365 FVRRLL-NKDHR-KRMTAAQALTHPW 388
+RRL+ N ++R R A + +HP+
Sbjct: 282 LIRRLITNAENRLGRGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 72/254 (28%), Positives = 122/254 (48%), Gaps = 21/254 (8%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA--KMTSALAIEDVRREVKILKALSGHKH 190
+GRG FG G + GK+ A+K + K KM + R + L +
Sbjct: 2 IGRGGFGEV---YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
++ AF + + +++ GG+L LS+ G + E++ + +I+ + H +
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDL-HYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR--S 307
VV+RDLKP N L +E +++ D GL+ DF + ++ + VG+ Y+APEVL + +
Sbjct: 118 VVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTA 172
Query: 308 YNVEGDMWSIGVITYILLCGSRPFW---ARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
Y+ D +S+G + + LL G PF + + I R L + D S SPE K
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD----SFSPELKS 228
Query: 365 FVRRLLNKDHRKRM 378
+ LL +D KR+
Sbjct: 229 LLEGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 9e-15
Identities = 53/176 (30%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F + K + RG FG + K K+ AVK++ KA M + + V+ E L ALS
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDAL-ALS 61
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
++ + + + AN+VY+VME+ GG++ +L G + EE A + ++ + +
Sbjct: 62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYL 120
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF-VRPDQRLNDIVGSAYYVAP 301
H G++HRDLKP+N L + +K+ DFGLS + + + DI+ + P
Sbjct: 121 HRHGIIHRDLKPDNMLISNE---GHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 71/255 (27%), Positives = 120/255 (47%), Gaps = 23/255 (9%)
Query: 133 VGRGHFGHTC-CAKGKKGTLKGKVVAVKIISKA--KMTSALAIEDVRREVKILKALSGHK 189
+GRG FG C K G K+ A+K + K KM + R + L +
Sbjct: 2 IGRGGFGEVYGCRKADTG----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ 249
++ AF + + +++ GG+L LS+ G + E + + +I+ + H +
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR-- 306
VV+RDLKP N L +E +++ D GL+ DF + ++ + VG+ Y+APEVL +
Sbjct: 117 FVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGV 171
Query: 307 SYNVEGDMWSIGVITYILLCGSRPF---WARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363
+Y+ D +S+G + + LL G PF + + I R L D S SPE +
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELR 227
Query: 364 DFVRRLLNKDHRKRM 378
+ LL +D +R+
Sbjct: 228 SLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 30/211 (14%)
Query: 131 KEVGRGHFGHT-CCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK 189
+++G GHFG C +G G+ VAVK S + I D+++E++IL+ L H+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLY-HE 66
Query: 190 HMIKFHDAFED--ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH 247
+++K+ + N + ++MEF G L + YL + I K A
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKE--------YLPRNKNKINLKQQLKYAVQI 118
Query: 248 LQGV--------VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL----NDIVGS 295
+G+ VHRDL N L E + +K+ DFGL+ + D+ +D+
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP 175
Query: 296 AYYVAPEVL-HRSYNVEGDMWSIGVITYILL 325
++ APE L + + D+WS GV Y LL
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 69/270 (25%), Positives = 121/270 (44%), Gaps = 26/270 (9%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI 192
+G+G FG C + K GK+ A K + K ++ + E +IL+ ++ ++
Sbjct: 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIV 56
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-----AKTIVEKILNIVAFCH 247
AFE + +VM GG+L I + G R LE + + I IL++ H
Sbjct: 57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL----H 112
Query: 248 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HR 306
+V+RD+KPEN L ++ ++ D GL+ ++ + + G+ Y+APE+L
Sbjct: 113 SMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE 169
Query: 307 SYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIFRSVLRADPNF-HDSPWPSVSPE 361
Y+ D +++G Y ++ G PF E + R L + F H + + E
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ----NFTEE 225
Query: 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391
+KD R L K R+ + + P H+
Sbjct: 226 SKDICRLFLAKKPEDRLGSREKNDDPRKHE 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 72/281 (25%), Positives = 124/281 (44%), Gaps = 51/281 (18%)
Query: 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRR---EVKILKALSGH 188
E+GRG +G + G ++AVK ++ + + ++ +R ++ I
Sbjct: 8 ELGRGAYGVVDKMRHVP---TGTIMAVK-----RIRATVNSQEQKRLLMDLDISMRSVDC 59
Query: 189 KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC-- 246
+ + F+ A V+I ME ++D L + + + + TI E IL +A
Sbjct: 60 PYTVTFYGALFREGDVWICME------VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIV 113
Query: 247 ----HLQ---GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIV-----G 294
+L V+HRD+KP N L + +K+ DFG+S ++ + G
Sbjct: 114 KALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISG-----YLVDSVAKTIDAG 165
Query: 295 SAYYVAPEVL-----HRSYNVEGDMWSIGVITYI-LLCGSRPF--WARTESGIFRSVLRA 346
Y+APE + + Y+V+ D+WS+G IT I L G P+ W + + V
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLG-ITMIELATGRFPYDSWKTPFQQLKQVVEEP 224
Query: 347 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387
P P SPE +DFV + L K++++R + L HP
Sbjct: 225 SPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 42/268 (15%)
Query: 153 GKVVAVKIISKAKMTSALAIEDVR--REVKILKALSGHKHMIKFHDAFED--ANSVYIVM 208
GK A+K + K S +E V RE++ L+ LS H ++++ + D + +V
Sbjct: 24 GKYYAIKCM-KKHFKS---LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79
Query: 209 EFCEGGELLDRILSRGGRYL-EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 267
E + L + I R R L E+ K+ + ++L + H G+ HRD+KPEN L
Sbjct: 80 ELMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---- 133
Query: 268 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILL 325
+D LK+ DFG + + + + +Y APE L Y + D+W++G + + +L
Sbjct: 134 KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193
Query: 326 CGSRPFWARTE----SGI--------------FRSVLRADPNF---HDS--PW--PSVSP 360
F E + I FR + NF + P+ S
Sbjct: 194 SLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASA 253
Query: 361 EAKDFVRRLLNKDHRKRMTAAQALTHPW 388
E D +++LL D +R+TA QAL HP+
Sbjct: 254 EGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 42/237 (17%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKV--VAVKIISKAKMTSALAIEDVRREVKILKALSGH 188
K++G G FG +G+ T GKV VAVK + K++ + +D +E I+ +L H
Sbjct: 1 KKLGDGSFG--VVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM--DDFLKEAAIMHSLD-H 55
Query: 189 KHMIKFHDAFEDANSVYIVMEFCEGGELLDRI-LSRGGRYLEEDAKTIVEKILNIVAFCH 247
+++I+ + + + +V E G LLDR+ G +L +I N + +
Sbjct: 56 ENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 248 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-------- 299
+ +HRDL N L + ++ +K+ DFGL + L +YV
Sbjct: 115 SKRFIHRDLAARNILLASDDK---VKIGDFGLM------RALPQ--NEDHYVMEEHLKVP 163
Query: 300 ----APEVL-HRSYNVEGDMWSIGV-----ITYILLCGSRPFWARTESGIFRSVLRA 346
APE L R+++ D+W GV TY G P+ + S I + + +
Sbjct: 164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMFTY----GEEPWAGLSGSQILKKIDKE 216
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 54/303 (17%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII--SKAKMTSALAIEDVRREVKILKA 184
+E +++G G + K K + GK+VA+K+I + + T AI RE +LK
Sbjct: 7 YEKLEKLGEGSYATVYKGKSK---VNGKLVALKVIRLQEEEGTPFTAI----REASLLKG 59
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA 244
L H +++ HD ++ +V E+ +L + G E+ K + ++L ++
Sbjct: 60 LK-HANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEV 303
+ H + ++HRDLKP+N L + E LK+ DFGL+ P ++ V + +Y P+V
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174
Query: 304 LHRS--YNVEGDMWSIGVITYILLCGSRPFWARTE-----SGIFRSVLRADPNFHDSPWP 356
L S Y+ DMW +G I ++ G F + IF ++ PN + WP
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF--LVLGTPN--EDTWP 230
Query: 357 SV------SPE----------------------AKDFVRRLLNKDHRKRMTAAQALTHPW 388
V PE A+D +LL + R++A AL+H +
Sbjct: 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290
Query: 389 LHD 391
D
Sbjct: 291 FSD 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 70/275 (25%), Positives = 121/275 (44%), Gaps = 47/275 (17%)
Query: 151 LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210
+ G++VA+K+IS K + +R E +LK L H +++ HD ++ V E+
Sbjct: 28 INGQLVALKVIS-MKTEEGVPFTAIR-EASLLKGLK-HANIVLLHDIIHTKETLTFVFEY 84
Query: 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 270
+L ++ G + + + ++L +A+ H Q ++HRDLKP+N L + E
Sbjct: 85 MHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE-- 141
Query: 271 PLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCG 327
LK+ DFGL+ P Q + V + +Y P+VL + Y+ D+W G I +L G
Sbjct: 142 -LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200
Query: 328 SRPFWARTESGIFRSVLR-----ADPNFHDSPWPSVS----------------------- 359
P + S +F + + P + WP VS
Sbjct: 201 Q-PAFPGV-SDVFEQLEKIWTVLGVPT--EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWK 256
Query: 360 -----PEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
P+A+D ++L + R++A AL HP+
Sbjct: 257 RLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 79/287 (27%), Positives = 129/287 (44%), Gaps = 45/287 (15%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG 187
+LG E+GRG FG K G ++AVK I + + ++ ++ S
Sbjct: 8 DLG-EIGRGAFGTVNKMLHKP---SGTIMAVKRIRS--TVDEKEQKRLLMDLDVVMRSSD 61
Query: 188 HKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKT-IVEKILNIVAFC 246
+++KF+ A +I ME L+D L + +Y+ E K+ I E+IL +A
Sbjct: 62 CPYIVKFYGALFREGDCWICME------LMDISLDKFYKYVYEVLKSVIPEEILGKIAVA 115
Query: 247 ------HLQ---GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI----- 292
+L+ ++HRD+KP N L +K+ DFG+S Q ++ I
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRN---GNIKLCDFGISG-----QLVDSIAKTRD 167
Query: 293 VGSAYYVAPEVLHRS----YNVEGDMWSIGVITYILLCGSRPFWARTESGIF---RSVLR 345
G Y+APE + S Y+V D+WS+G+ Y + G P+ + +F V++
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFDQLTQVVK 225
Query: 346 AD-PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391
D P +S SP +F+ L KD KR + L HP++ D
Sbjct: 226 GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 77/307 (25%), Positives = 132/307 (42%), Gaps = 61/307 (19%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G G G C A + + VA+K +S+ A + RE+ ++K ++ HK+
Sbjct: 30 KPIGSGAQGIVCAAYD---AILERNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVN-HKN 84
Query: 191 MIKFHDAF------EDANSVYIVMEFCEGG--ELLDRILSRGGRYLEEDAKTIVEKILNI 242
+I + F E+ VYIVME + +++ L E ++ ++L
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD------HERMSYLLYQMLCG 138
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPE 302
+ H G++HRDLKP N + + D LK++DFGL+ + V + YY APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 303 V-LHRSYNVEGDMWSIGVITYILLCGSRPF--------WARTESGI-------------- 339
V L Y D+WS+G I ++ G F W + +
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 340 FRSVLRADPN---------FHDSPWPSVS-------PEAKDFVRRLLNKDHRKRMTAAQA 383
R+ + P F D +P+ S +A+D + ++L D KR++ +A
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 384 LTHPWLH 390
L HP+++
Sbjct: 316 LQHPYIN 322
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-14
Identities = 66/259 (25%), Positives = 117/259 (45%), Gaps = 46/259 (17%)
Query: 151 LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210
L +++AVK+I +T L + + E++IL ++I F+ AF N + I EF
Sbjct: 24 LTRRILAVKVIP-LDITVELQ-KQIMSELEILYKCDS-PYIIGFYGAFFVENRISICTEF 80
Query: 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG--------VVHRDLKPENFL 262
+GG L + + I E +L +A ++G ++HRD+KP N L
Sbjct: 81 MDGGSL-------------DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNML 127
Query: 263 FTTREEDAPLKVIDFGLSDFVRPDQRLNDI----VGSAYYVAPE-VLHRSYNVEGDMWSI 317
TR + +K+ DFG+S Q +N I VG+ Y+APE + Y + D+WS+
Sbjct: 128 VNTRGQ---VKLCDFGVS-----TQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSL 179
Query: 318 GVITYILLCGSRPFWARTES-------GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 370
G+ L G P+ ++ + + ++ DP P S + F+ + +
Sbjct: 180 GISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV--LPVGQFSEKFVHFITQCM 237
Query: 371 NKDHRKRMTAAQALTHPWL 389
K ++R + HP++
Sbjct: 238 RKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 19/225 (8%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG 187
+L K++G G FG T VAVK + M+ ++ E ++K L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNST----KVAVKTLKPGTMS----VQAFLEEANLMKTLQ- 59
Query: 188 HKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILS-RGGRYLEEDAKTIVEKILNIVAFC 246
H +++ + +YI+ E+ G LLD + S GG+ L +I +A+
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAPEV 303
+ +HRDL+ N L + E K+ DFGL+ + D G+ + + APE
Sbjct: 120 ERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEA 175
Query: 304 LHR-SYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRA 346
++ S+ ++ D+WS G++ Y I+ G P+ + S + ++ R
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 37/231 (16%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G G FG C + K K VA+K + D E I+ H +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFD-HPN 66
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEE-DAKTIVEKILNIVAFCHLQ 249
+I+ + V I+ E+ E G L ++L E D K V +++ + L+
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSL--------DKFLRENDGKFTVGQLVGM-----LR 113
Query: 250 GV------------VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVG--- 294
G+ VHRDL N L + KV DFGLS + + G
Sbjct: 114 GIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLEDSEATYTTKGGKI 170
Query: 295 SAYYVAPEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 343
+ APE + +R + D+WS G++ + ++ G RP+W + + ++V
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 27/191 (14%)
Query: 177 REVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIV 236
RE+++L + +++ F+ AF + I ME +GG L D++L + GR I
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGR--------IP 101
Query: 237 EKILNIVAFCHLQG---------VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ 287
E+IL V+ ++G ++HRD+KP N L +R E +K+ DFG+S + D
Sbjct: 102 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDS 157
Query: 288 RLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFW---ARTESGIFRSV 343
N VG+ Y++PE L + Y+V+ D+WS+G+ + G P A+ +F
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCP 217
Query: 344 LRADPNFHDSP 354
+ DP ++
Sbjct: 218 VEGDPAESETS 228
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 62/234 (26%), Positives = 105/234 (44%), Gaps = 32/234 (13%)
Query: 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKA 184
+L K++G G FG A K T VAVK + M+ +E E ++K
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHT----KVAVKTMKPGSMS----VEAFLAEANVMKT 57
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI-- 242
L H ++K H A +YI+ EF G LLD + S +E +K + K+++
Sbjct: 58 LQ-HDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKS------DEGSKQPLPKLIDFSA 109
Query: 243 -----VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY 297
+AF + +HRDL+ N L + K+ DFGL+ + D G+ +
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIE-DNEYTAREGAKF 165
Query: 298 ---YVAPEVL-HRSYNVEGDMWSIGV-ITYILLCGSRPFWARTESGIFRSVLRA 346
+ APE + S+ ++ D+WS G+ + I+ G P+ + + R++ R
Sbjct: 166 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 75/305 (24%), Positives = 130/305 (42%), Gaps = 57/305 (18%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G G G C A + + VA+K +S+ A + RE+ ++K ++ HK+
Sbjct: 23 KPIGSGAQGIVCAAYD---AVLDRNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVN-HKN 77
Query: 191 MIKFHDAF------EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA 244
+I + F E+ VY+VME + L +++ E ++ ++L +
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLYQMLCGIK 133
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV- 303
H G++HRDLKP N + + D LK++DFGL+ + V + YY APEV
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 304 LHRSYNVEGDMWSIGVIT------YILLCGSR----------------PFWARTESGIFR 341
L Y D+WS+G I IL G P + + R
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 342 SVLRADPNFHDSPWPSVSP----------------EAKDFVRRLLNKDHRKRMTAAQALT 385
+ + P + +P + P +A+D + ++L D KR++ +AL
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310
Query: 386 HPWLH 390
HP+++
Sbjct: 311 HPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 54/164 (32%), Positives = 88/164 (53%), Gaps = 24/164 (14%)
Query: 177 REVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIV 236
RE+++L + +++ F+ AF + I ME +GG L D++L ++AK I
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL--------KEAKRIP 101
Query: 237 EKILNIVAFCHLQG---------VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ 287
E+IL V+ L+G ++HRD+KP N L +R E +K+ DFG+S + D
Sbjct: 102 EEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDS 157
Query: 288 RLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRP 330
N VG+ Y++PE L + Y+V+ D+WS+G+ L G P
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 126 KFELGKEVGRGHFGHT--CCAKGKKGTLKGKVVAVKII-SKAKMTSALAIEDVRREVKIL 182
GK +G G FG A G + VAVK++ A + A+ E+KI+
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREAL---MSELKIM 92
Query: 183 KALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLE-EDAKTIVEKILN 241
L H++++ A + ++ E+C G+LL+ + + +L ED + ++
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 242 IVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIV-GSAY--- 297
+AF + +HRDL N L T +K+ DFGL+ + D N +V G+A
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLT---HGKIVKICDFGLARDIMNDS--NYVVKGNARLPV 207
Query: 298 -YVAPE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPF 331
++APE + + Y E D+WS G++ + I GS P+
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 84/315 (26%), Positives = 137/315 (43%), Gaps = 42/315 (13%)
Query: 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK 189
G +VGRG +GH AK K G K A+K I ++ + RE+ +L+ L H
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGTGISMSAC-----REIALLRELK-HP 58
Query: 190 HMIKFHDAF--EDANSVYIVMEFCEGGELLDRILSRGGRYLEED-------AKTIVEKIL 240
++I F V+++ ++ E R + ++ K+++ +IL
Sbjct: 59 NVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTR-EEDAPLKVIDFGLSDF----VRPDQRLNDIVGS 295
+ + + H V+HRDLKP N L E +K+ D G + ++P L+ +V +
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 296 AYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 353
+Y APE+L R Y D+W+IG I LL F R E + ++P HD
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-----DIKTSNPFHHDQ 233
Query: 354 PWPSVS----PEAKDF--VRRL-----LNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
S P KD+ +R++ L KD R+ A +L + E V D +
Sbjct: 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIK---YMEKHKVKPDSKV 290
Query: 403 YKLVKSYLRATPLKR 417
+ L++ L P KR
Sbjct: 291 FLLLQKLLTMDPTKR 305
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 37/213 (17%)
Query: 131 KEVGRGHFGHT-CCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK 189
+++G+G+FG C G+VVAVK K + ++A + D RE++ILK+L H
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKSLQ-HD 65
Query: 190 HMIKFHDAFEDA--NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIV---EKILNIVA 244
+++K+ A ++ +VME+ G L D + R D + ++ +I +
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQICKGME 122
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV----- 299
+ + VHRDL N L E + +K+ DFGL+ + D+ YY
Sbjct: 123 YLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKVLPQDKE--------YYKVREPG 171
Query: 300 -------APEVLHRS-YNVEGDMWSIGVITYIL 324
APE L S ++V D+WS GV+ Y L
Sbjct: 172 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 63/315 (20%), Positives = 113/315 (35%), Gaps = 70/315 (22%)
Query: 128 ELGKEVGRGHFGHTCC--AKGKKGTLKGKVVAVKIIS--KAKMTSALAIEDVRREVKILK 183
EL +G+ AK K +VAVK I+ ++ E+ +
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP---TNTLVAVKKINLDSCSKEDLKLLQQ---EIITSR 54
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGG---ELLDRILSRGGRYLEEDA-KTIVEKI 239
L H +++ + +F + +Y+V G +LL G L E A I++ +
Sbjct: 55 QLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG---LPELAIAFILKDV 110
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS---DFVRPDQRLNDIVGSA 296
LN + + H +G +HR +K + L KV+ GL ++ +R +
Sbjct: 111 LNALDYIHSKGFIHRSVKASHILL-----SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165
Query: 297 -------YYVAPEVLHRS---YNVEGDMWSIGVITYILLCGSRPFW-------------- 332
+++PEVL ++ YN + D++S+G+ L G PF
Sbjct: 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRG 225
Query: 333 ------------------ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDH 374
+++ S R + + S FV L +D
Sbjct: 226 TVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRD--SVDHPYTRTFSEHFHQFVELCLQRDP 283
Query: 375 RKRMTAAQALTHPWL 389
R +A+Q L H +
Sbjct: 284 ESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 41/235 (17%)
Query: 126 KFELGKEVGRGHFGHTCCA--KGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ LGK +G G FG A G + VAVK++ L+ D+ E++++K
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS--DLVSEMEMMK 70
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAK-----TIVEK 238
+ HK++I +Y+V+E+ G L D + +R R E A E
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR--RPPGEYASPDDPRPPEET 128
Query: 239 ILN--IVAFCHL----------QGVVHRDLKPENFLFTTREEDAPLKVIDFGLS------ 280
+ +V+F + + +HRDL N L T ED +K+ DFGL+
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLARDIHHI 185
Query: 281 DFVRP--DQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPF 331
D+ R + RL ++APE L R Y + D+WS GV+ + I G P+
Sbjct: 186 DYYRKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 34/212 (16%)
Query: 131 KEVGRGHFGHT---CCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG 187
+ +G GHFG C GT G++VAVK + + ++E+ ILK L
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGT--GEMVAVKTLKRE--CGQQNTSGWKKEINILKTLY- 64
Query: 188 HKHMIKFHDAFEDA--NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTI------VEKI 239
H++++K+ + + ++ME+ G L D YL + + ++I
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD--------YLPKHKLNLAQLLLFAQQI 116
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL-----NDIVG 294
+A+ H Q +HRDL N L + D +K+ DFGL+ V P+ D
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDS 172
Query: 295 SAYYVAPEVLHR-SYNVEGDMWSIGVITYILL 325
++ A E L ++ D+WS GV Y LL
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 76/340 (22%), Positives = 143/340 (42%), Gaps = 66/340 (19%)
Query: 100 TSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVV--A 157
+ G + E+ +D + N ++LG +G G FG VV A
Sbjct: 43 NNNAGEDEDEEKMIDNDINRSPN--KSYKLGNIIGNGSFG---------------VVYEA 85
Query: 158 VKIISKAKMTSALAIEDVR---REVKILKALSGHKHMIKFHDAF------EDANSVY--I 206
+ I + K+ ++D + RE+ I+K L+ H ++I D + ++ +++ +
Sbjct: 86 ICIDTSEKVAIKKVLQDPQYKNRELLIMKNLN-HINIIFLKDYYYTECFKKNEKNIFLNV 144
Query: 207 VMEFCEGGELLDRILSRGGRYLEEDAKTIVE----KILNIVAFCHLQGVVHRDLKPENFL 262
VMEF + + + + R +V+ ++ +A+ H + + HRDLKP+N L
Sbjct: 145 VMEFIP--QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLL 202
Query: 263 FTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVI 320
LK+ DFG + + QR + S +Y APE++ +Y D+WS+G I
Sbjct: 203 IDPNTHT--LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCI 260
Query: 321 TYILLCGSRPFWARTESGIFRSVLRA------------DPNFHDSPWPSVSP-------- 360
++ G F ++ +++ +PN+ D +P V P
Sbjct: 261 IAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFP 320
Query: 361 -----EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395
+A +F+ + L + KR+ +AL P+ D P
Sbjct: 321 KGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360
|
Length = 440 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 8e-12
Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 22/250 (8%)
Query: 138 FGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHD 196
G C + GT G VA+K + M ++ E +I+K L H ++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ----EAQIMKKLR-HDKLVPLY- 67
Query: 197 AFEDANSVYIVMEFCEGGELLDRILSRGGRYLE-EDAKTIVEKILNIVAFCHLQGVVHRD 255
A +YIV EF G LLD + G+YL+ + +I + +A+ +HRD
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 256 LKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAPE-VLHRSYNVE 311
L+ N L ++ K+ DFGL+ + D G+ + + APE L+ + ++
Sbjct: 128 LRAANILVG---DNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 312 GDMWSIGVI-TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA-KDFVRRL 369
D+WS G++ T ++ G P+ + V R + P P PE+ + ++
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG----YRMPCPQGCPESLHELMKLC 239
Query: 370 LNKDHRKRMT 379
KD +R T
Sbjct: 240 WKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 29/230 (12%)
Query: 126 KFELGKEVGRGHFGHTCCAKG----KKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI 181
K LGK +G G FG A+ K + VAVK++ L+ D+ E+++
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS--DLVSEMEM 73
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLE------------ 229
+K + HK++I A +Y+++E+ G L + + +R +E
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 230 ---EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRP 285
+D + ++ + + Q +HRDL N L T E+ +K+ DFGL+ D
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNI 190
Query: 286 DQRLNDIVGS--AYYVAPEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPF 331
D G ++APE L R Y + D+WS GV+ + I G P+
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 60/246 (24%), Positives = 111/246 (45%), Gaps = 47/246 (19%)
Query: 129 LGKEVGRGHFGHTCCAK--GKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
L +E+G G FG A+ T +VAVK + + A +D +RE ++L L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELLTNLQ 65
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG--------GRYLEEDAKTIVEK 238
H+H++KF+ D + + +V E+ + G+L + + G G+ + + + +
Sbjct: 66 -HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 239 ILNI-------VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND 291
+L+I + + Q VHRDL N L + +K+ DFG+S D
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMS---------RD 172
Query: 292 IVGSAYY------------VAPE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPFWARTES 337
+ + YY + PE +++R + E D+WS GVI + I G +P++ + +
Sbjct: 173 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
Query: 338 GIFRSV 343
+ +
Sbjct: 233 EVIECI 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
++E E+G G +G A+ K G+ VA+K + + + +R EV +L+ L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHL 58
Query: 186 SG--HKHMIKFHDA-----FEDANSVYIVMEFCEGG--ELLDRILSRGGRYLEEDAKTIV 236
H ++++ D + + +V E + LD++ G E K ++
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMM 116
Query: 237 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA 296
++L + F H VVHRDLKP+N L T+ + +K+ DFGL+ L +V +
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTL 173
Query: 297 YYVAPEV-LHRSYNVEGDMWSIGVI 320
+Y APEV L SY D+WS+G I
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCI 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 80/315 (25%), Positives = 136/315 (43%), Gaps = 42/315 (13%)
Query: 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK 189
G +VGRG +GH AK K G + A+K I ++ + RE+ +L+ L H
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEGTGISMSAC-----REIALLRELK-HP 58
Query: 190 HMIKFHDAF--EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDA-------KTIVEKIL 240
++I F V+++ ++ E R + ++ K+++ +IL
Sbjct: 59 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTR-EEDAPLKVIDFGLSDF----VRPDQRLNDIVGS 295
+ + + H V+HRDLKP N L E +K+ D G + ++P L+ +V +
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 296 AYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 353
+Y APE+L R Y D+W+IG I LL F R E + ++P HD
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-----DIKTSNPYHHDQ 233
Query: 354 PWPSVS----PEAKDF--VRRL-----LNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
+ P KD+ ++++ L KD R+ +L + E V D
Sbjct: 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIK---YMEKHKVKPDSKA 290
Query: 403 YKLVKSYLRATPLKR 417
+ L++ L P+KR
Sbjct: 291 FHLLQKLLTMDPIKR 305
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 23/201 (11%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+L + +G+G FG G +G VAVK I A E ++ L
Sbjct: 8 LKLLQTIGKGEFGDVML-----GDYRGNKVAVKCIKNDATAQAFLAE-----ASVMTQLR 57
Query: 187 GHKHMIKFHDAF-EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI--- 242
H ++++ E+ +YIV E+ G L+D + SRG L D +++ L++
Sbjct: 58 -HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC--LLKFSLDVCEA 114
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPE 302
+ + VHRDL N L + ED KV DFGL+ Q + + APE
Sbjct: 115 MEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPE 169
Query: 303 VL-HRSYNVEGDMWSIGVITY 322
L + ++ + D+WS G++ +
Sbjct: 170 ALREKKFSTKSDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 47/211 (22%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKV--VAVKIISKAKMTSALAIEDVRREVKILKALSGH 188
KE+G G+FG KG GK VAVK + + + + ++ RE ++ L H
Sbjct: 1 KELGHGNFGSV--VKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLD-H 55
Query: 189 KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV----- 243
+++ + + +VME G LL YL++ + V + +
Sbjct: 56 PCIVRLIGVCK-GEPLMLVMELAPLGPLLK--------YLKKRREIPVSDLKELAHQVAM 106
Query: 244 --AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY--- 298
A+ + VHRDL N L R + K+ DFG+S + GS YY
Sbjct: 107 GMAYLESKHFVHRDLAARNVLLVNRHQ---AKISDFGMSRALGA--------GSDYYRAT 155
Query: 299 ---------VAPEVLH-RSYNVEGDMWSIGV 319
APE ++ ++ + D+WS GV
Sbjct: 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGV 186
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 21/232 (9%)
Query: 138 FGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHD 196
G C + GT G VA+K + M+ E +E +++K L H+ +++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLR-HEKLVQLY- 67
Query: 197 AFEDANSVYIVMEFCEGGELLDRILSRGGRYLE-EDAKTIVEKILNIVAFCHLQGVVHRD 255
A +YIV E+ G LLD + G+YL + +I + +A+ VHRD
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 256 LKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAPE-VLHRSYNVE 311
L+ N L E+ KV DFGL+ + D G+ + + APE L+ + ++
Sbjct: 128 LRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 312 GDMWSIGVITYILLCGSR-PFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362
D+WS G++ L R P+ + V R + P P PE+
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----YRMPCPPECPES 231
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 51/278 (18%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKALSGHK 189
+++G+G+FG KG LKG VAVK ++ + L + ++ E +ILK H
Sbjct: 1 EKIGKGNFGDV-----YKGVLKGNTEVAVKT-CRSTLPPDLKRKFLQ-EAEILKQYD-HP 52
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA---FC 246
+++K +YIVME GG LL + + R K +++ L+ A +
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRL---TVKKLLQMSLDAAAGMEYL 109
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY------YVA 300
+ +HRDL N L E+ LK+ DFG+S R ++ V + A
Sbjct: 110 ESKNCIHRDLAARNCLVG---ENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTA 163
Query: 301 PEVLHRS-YNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358
PE L+ Y E D+WS G++ + G P+ + ++ R + + P P +
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRERIESGYR-MPAPQL 219
Query: 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD-ENRP 395
PE + RL+ W +D ENRP
Sbjct: 220 CPEE---IYRLML--------------QCWAYDPENRP 240
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 133 VGRGHFG--HTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKALSGHK 189
+G G FG + A G G + VAVK + K + +E ++ + H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFN-HP 59
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLD-----RILSRGGRYLEEDAKTIVEKILNIVA 244
+++K YI+ME EGG+LL R+ G L K +++ L++
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT--LKELLDICLDVAK 117
Query: 245 FCH-LQGV--VHRDLKPENFLFTTREEDAP--LKVIDFGLSDFVRPDQRLNDIVGSAYY- 298
C L+ + +HRDL N L + + DA +K+ DFGL+ DI S YY
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKSDYYR 168
Query: 299 -----------VAPEVLHRS-YNVEGDMWSIGVITY-ILLCGSRPFWART 335
+APE L + + D+WS GV+ + IL G +P+ A
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 5e-11
Identities = 63/248 (25%), Positives = 112/248 (45%), Gaps = 54/248 (21%)
Query: 129 LGKEVGRGHFG-------HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI 181
L +E+G G FG + C + K +VAVK + A S A +D RE ++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDK-----ILVAVKTLKDA---SDNARKDFHREAEL 60
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGEL--------LDRILSRGGRYLEEDAK 233
L L H+H++KF+ + + + +V E+ + G+L D +L G E +
Sbjct: 61 LTNLQ-HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 234 T----IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL 289
+ I ++I + + Q VHRDL N L E+ +K+ DFG+S
Sbjct: 120 SQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS--------- 167
Query: 290 NDIVGSAYY------------VAPE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPFWART 335
D+ + YY + PE +++R + E D+WS+GV+ + I G +P++ +
Sbjct: 168 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227
Query: 336 ESGIFRSV 343
+ + +
Sbjct: 228 NNEVIECI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 125 AKFELGKEVGRGHFGHTCCAKG----KKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
+ LGK +G G FG A+ K K VAVK++ L+ D+ E++
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS--DLVSEME 69
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSR--GGRYLEEDAKTIVEK 238
++K + HK++I A +Y+++E+ G L + + +R G D + E+
Sbjct: 70 MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE 129
Query: 239 ILNI-------------VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVR 284
L + + Q +HRDL N L T ED +K+ DFGL+ D
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHN 186
Query: 285 PDQRLNDIVGS--AYYVAPEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPF 331
D G ++APE L R Y + D+WS GV+ + I G P+
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKALSGHKHM 191
+G+G+FG KGTLK K VAVK K + L I+ + E +ILK H ++
Sbjct: 3 LGKGNFGEV-----FKGTLKDKTPVAVKT-CKEDLPQELKIKFLS-EARILKQYD-HPNI 54
Query: 192 IKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKT--IVEKILNI---VAFC 246
+K +YIVME GG+ L + R +++ KT +V+ L+ +A+
Sbjct: 55 VKLIGVCTQRQPIYIVMELVPGGDFLSFL-----RKKKDELKTKQLVKFALDAAAGMAYL 109
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS----DFVRPDQRLNDIVGSAYYVAPE 302
+ +HRDL N L E+ LK+ DFG+S D + L I + APE
Sbjct: 110 ESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPE 164
Query: 303 VL-HRSYNVEGDMWSIGVITY 322
L + Y+ E D+WS G++ +
Sbjct: 165 ALNYGRYSSESDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
K LG+ +G G FG +G G+ VAVK I K +T+ +E+ K+
Sbjct: 7 KLTLGEIIGEGEFGAVL-----QGEYTGQKVAVKNI-KCDVTAQAFLEETAVMTKL---- 56
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
HK++++ N +YIVME G L++ + +R GR L + + +
Sbjct: 57 -HHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGM 113
Query: 246 CHLQG--VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV 303
+L+ +VHRDL N L + ED KV DFGL+ +++ + APE
Sbjct: 114 EYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGS--MGVDNSKLPVKWTAPEA 168
Query: 304 L-HRSYNVEGDMWSIGVITY-ILLCGSRPF 331
L H+ ++ + D+WS GV+ + + G P+
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 24/225 (10%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G G FG C + K + VA+K + KA T D E I+ H +
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQR-RDFLSEASIMGQFD-HPN 66
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+I + V IV E+ E G L + G++ ++ I + + + G
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY----------YVA 300
VHRDL N L + + KV DFGLS + D +AY + A
Sbjct: 127 YVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPE------AAYTTRGGKIPIRWTA 177
Query: 301 PEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 343
PE + +R + D+WS G++ + ++ G RP+W + + +++
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 59/247 (23%), Positives = 113/247 (45%), Gaps = 36/247 (14%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG 187
+L K++G G FG G K VA+K + + M+ + E ++K L
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNGHTK---VAIKSLKQGSMSPEAFLA----EANLMKQLQ- 59
Query: 188 HKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI----- 242
H +++ + A +YI+ E+ E G L+D + + E K + K++++
Sbjct: 60 HPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKT------PEGIKLTINKLIDMAAQIA 112
Query: 243 --VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY--- 297
+AF + +HRDL+ N L + E K+ DFGL+ + ++ G+ +
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAR-EGAKFPIK 168
Query: 298 YVAPEVL-HRSYNVEGDMWSIGV-ITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355
+ APE + + ++ ++ D+WS G+ +T I+ G P+ T + +++ R + P
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG----YRMPR 224
Query: 356 PSVSPEA 362
P PE
Sbjct: 225 PDNCPEE 231
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 38/230 (16%)
Query: 126 KFELGKEVGRGHFG--HTCCAKG-KKGTLKGKVVAVKIISK-AKMTSALAIEDVRREVKI 181
K L +E+G+G FG + AKG KG + + VA+K +++ A M + E +
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETR-VAIKTVNENASMRERIEF---LNEASV 62
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTI----VE 237
+K + H H+++ +VME G+L + SR R E+ + ++
Sbjct: 63 MKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR--RPEAENNPGLGPPTLQ 119
Query: 238 KILNIV-------AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL------SDFVR 284
K + + A+ + VHRDL N + ED +K+ DFG+ +D+ R
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETDYYR 176
Query: 285 PD-QRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITY-ILLCGSRPF 331
+ L + ++APE L + + D+WS GV+ + + +P+
Sbjct: 177 KGGKGLLPV----RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKALS 186
+L +++G G FG +G VAVK + M +D E +I+K L
Sbjct: 9 QLLRKLGAGQFGEVW-----EGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR 59
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLE-EDAKTIVEKILNIVAF 245
H +I+ + +YIV E + G LL+ + GR L+ + ++ + +A+
Sbjct: 60 -HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAPE 302
Q +HRDL N L E+ KV DFGL+ ++ D G+ + + APE
Sbjct: 119 LEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPE 174
Query: 303 -VLHRSYNVEGDMWSIGV-ITYILLCGSRPF 331
L+ ++++ D+WS G+ +T I+ G P+
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 147 KKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206
K G + K V VK ++ K RE+ ILK +S H+ +I A+ ++V +
Sbjct: 113 KHGDEQRKKVIVKAVTGGK--------TPGREIDILKTIS-HRAIINLIHAYRWKSTVCM 163
Query: 207 VMEF--CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 264
VM C+ +DR G E A TI ++L +A+ H +G++HRD+K EN +F
Sbjct: 164 VMPKYKCDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTEN-IFL 218
Query: 265 TREEDAPLKVIDFG----LSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGV 319
E+A L DFG L Q G+ +PE+L Y + D+WS G+
Sbjct: 219 DEPENAVLG--DFGAACKLDAHPDTPQCYG-WSGTLETNSPELLALDPYCAKTDIWSAGL 275
Query: 320 ITYILLCGSRPFWAR---TESGIFRSVLRA 346
+ + + + + + + S RS++R
Sbjct: 276 VLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305
|
Length = 392 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 27/261 (10%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKAL 185
+L K++G G FG GT G VAVK + M+ +E E +I+K L
Sbjct: 8 LQLIKKLGNGQFGEVW-----MGTWNGNTKVAVKTLKPGTMSPESFLE----EAQIMKKL 58
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLE-EDAKTIVEKILNIVA 244
H +++ + A +YIV E+ G LLD + GR L+ + + ++ +A
Sbjct: 59 R-HDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAP 301
+ +HRDL+ N L + K+ DFGL+ + D G+ + + AP
Sbjct: 117 YIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAP 172
Query: 302 E-VLHRSYNVEGDMWSIGV-ITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359
E L+ + ++ D+WS G+ +T ++ G P+ + V R + P P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----YRMPCPQDC 228
Query: 360 PEA-KDFVRRLLNKDHRKRMT 379
P + + + + KD +R T
Sbjct: 229 PISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 63/236 (26%), Positives = 105/236 (44%), Gaps = 56/236 (23%)
Query: 132 EVGRGHFGHTCCAKGKKGTLKGK--VVAVKIISKAKMTSALAIEDVRREVKILKALSGHK 189
E+G G FG A+ + +VAVK + +A S A +D +RE ++L L H+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQ-HQ 67
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE------------ 237
H+++F+ + + +V E+ G+L +R L G DAK +
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHG----PDAKILAGGEDVAPGQLTLG 122
Query: 238 KILNIVA-----FCHLQGV--VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN 290
++L I + +L + VHRDL N L + +K+ DFG+S
Sbjct: 123 QMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---QGLVVKIGDFGMS---------R 170
Query: 291 DIVGSAYY------------VAPE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPFW 332
DI + YY + PE +L+R + E D+WS GV+ + I G +P++
Sbjct: 171 DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 129 LGKEVGRGHFGHTCCAKG----KKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKA 184
LGK +G G FG A+ K+ + VAVK++ L+ D+ E++++K
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLS--DLISEMEMMKM 79
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLE--------------- 229
+ HK++I A +Y+++E+ G L + + +R +E
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 230 EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQR 288
+D + ++ + + + +HRDL N L T ED +K+ DFGL+ D D
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 196
Query: 289 LNDIVGS--AYYVAPEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPF 331
G ++APE L R Y + D+WS GV+ + I G P+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 20/211 (9%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG---HK 189
+G G FG C + K + VA+K + K+ T E RR+ ++ G H
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYT-----EKQRRDFLSEASIMGQFDHP 65
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ 249
++I + V I+ EF E G L + G++ ++ I + +
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS------AYYVAPE- 302
VHRDL N L + + KV DFGLS F+ D S + APE
Sbjct: 126 NYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 303 VLHRSYNVEGDMWSIGVITY-ILLCGSRPFW 332
+ +R + D+WS G++ + ++ G RP+W
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYW 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKG-KVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK 189
E+G G+FG KG K K VAVKI+ AL +++ RE +++ L +
Sbjct: 1 GELGSGNFGTV--KKGMYKMKKSEKTVAVKILKNDNNDPALK-DELLREANVMQQLD-NP 56
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ 249
++++ E A S +VME E G L ++ L + E++ +V ++ + +
Sbjct: 57 YIVRMIGICE-AESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKYLEET 114
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA----YYVAPEVL- 304
VHRDL N L T+ K+ DFGLS + D+ + APE +
Sbjct: 115 NFVHRDLAARNVLLVTQHY---AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 305 HRSYNVEGDMWSIGVITY 322
+ ++ + D+WS GV+ +
Sbjct: 172 YYKFSSKSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 62/239 (25%), Positives = 101/239 (42%), Gaps = 42/239 (17%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGK----VVAVKIISKAKMTSALAIEDVRREVKI 181
LGK +G G FG K LKG+ VAVK++ + +S L D+ E +
Sbjct: 1 NLVLGKTLGEGEFGKV--VKATAFRLKGRAGYTTVAVKMLKENASSSEL--RDLLSEFNL 56
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGEL--------------LDRILSRGGRY 227
LK ++ H H+IK + A + +++E+ + G L L +R Y
Sbjct: 57 LKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 228 LEEDAK---------TIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278
L+ + + +I + + +VHRDL N L E +K+ DFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKISDFG 172
Query: 279 LSDFVRPD----QRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPF 331
LS V + +R + ++A E L Y + D+WS GV+ + I+ G P+
Sbjct: 173 LSRDVYEEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 27/216 (12%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG 187
LG+ +G G FG +G + + + +AV + + TS E +E I++
Sbjct: 9 TLGRCIGEGQFGDV--YQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD- 65
Query: 188 HKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEE-----DAKTIVEKILNI 242
H H++K + N V+IVME GEL YL+ D +++ +
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGEL--------RSYLQVNKYSLDLASLILYSYQL 116
Query: 243 -VAFCHLQGV--VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS--AY 297
A +L+ VHRD+ N L ++ + +K+ DFGLS ++ + G
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIK 173
Query: 298 YVAPEVLH-RSYNVEGDMWSIGVITY-ILLCGSRPF 331
++APE ++ R + D+W GV + IL+ G +PF
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
+ +GRG+FG G L+ V + S + +E +ILK S H +
Sbjct: 1 ERIGRGNFGEVF-----SGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPN 54
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+++ +YIVME +GG+ L + + G R ++ +VE + + +
Sbjct: 55 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---------YVAP 301
+HRDL N L T E LK+ DFG+S + D V ++ + AP
Sbjct: 115 CIHRDLAARNCLVT---EKNVLKISDFGMS------REEEDGVYASTGGMKQIPVKWTAP 165
Query: 302 EVL-HRSYNVEGDMWSIGVITY-ILLCGSRPF 331
E L + Y+ E D+WS G++ + G+ P+
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 55/200 (27%), Positives = 83/200 (41%), Gaps = 25/200 (12%)
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ 249
+M+ H +SV++V++ EGG+L I EE K +++ + H +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHRE 104
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYN 309
G+V RDL P N L R +++ F V + V Y APEV S
Sbjct: 105 GIVCRDLNPNNILLDDR---GHIQLTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEE 159
Query: 310 VEG-DMWSIGVITYILLCG-----SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363
E D WS+G I + LL G P SGI P + VS EA+
Sbjct: 160 TEACDWWSLGAILFELLTGKTLVECHP------SGINTHTTLNIPEW-------VSEEAR 206
Query: 364 DFVRRLLNKDHRKRMTAAQA 383
+++LL + +R+ A A
Sbjct: 207 SLLQQLLQFNPTERLGAGVA 226
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 17/215 (7%)
Query: 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKV---VAVKIISKAKMTSALAIEDVRREVKI 181
+ E K +G G FG KG KV VA+K++ + TS A +++ E +
Sbjct: 7 TELEKIKVLGSGAFGTV--YKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAYV 62
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN 241
+ ++ H H+++ ++ V ++ + G LLD + + + +I
Sbjct: 63 MASV-DHPHVVRLL-GICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 242 IVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---Y 298
+++ + +VHRDL N L T + +K+ DFGL+ + D++ G +
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 299 VAPE-VLHRSYNVEGDMWSIGVITYILLC-GSRPF 331
+A E +LHR Y + D+WS GV + L+ G++P+
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRR----EVKILKALSGH 188
+G G+FG A+ KK L+ + + K A +D R E+++L L H
Sbjct: 3 IGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 55
Query: 189 KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED---------AKTIVEKI 239
++I A E +Y+ +E+ G LLD + R R LE D A T+ +
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 240 L--------NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS--DFVRPDQRL 289
L + + + +HRDL N L E+ K+ DFGLS V + +
Sbjct: 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTM 170
Query: 290 NDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 343
+ ++A E L+ S Y D+WS GV+ + I+ G P+ T + ++ +
Sbjct: 171 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 83/354 (23%), Positives = 137/354 (38%), Gaps = 88/354 (24%)
Query: 126 KFELGKEVGRGHFGHTCCAKG----KKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI 181
+ LGK +G G FG A+ K + VAVK++ LA D+ E+++
Sbjct: 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA--DLISEMEL 70
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSR----------GGRYLEE- 230
+K + HK++I +Y+++E+ G L + + +R + EE
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 231 ----DAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS------ 280
D + ++ + + + +HRDL N L T ED +K+ DFGL+
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDI 187
Query: 281 DFVR--PDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTE 336
D+ + + RL ++APE L R Y + D+WS G++ + I G
Sbjct: 188 DYYKKTSNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG-------- 234
Query: 337 SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 396
SP+P + E + +LL + HR M TH
Sbjct: 235 ----------------SPYPGIPVEE---LFKLLREGHR--MDKPSNCTHE--------- 264
Query: 397 PLDILIYKLVKSYLRATPLKRAALKALSKAL------TEEELVYLRAQFMLLEP 444
+Y L++ A P +R K L +AL EE + L F P
Sbjct: 265 -----LYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMPFEQYSP 313
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-09
Identities = 35/135 (25%), Positives = 55/135 (40%), Gaps = 20/135 (14%)
Query: 150 TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMI-KFHDAFEDANSVYIVM 208
K + +KI S D REV IL+ L+ + K + E Y++M
Sbjct: 18 GTKDEDYVLKIN-----PSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72
Query: 209 EFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH---LQGVVHRDLKPENFLFTT 265
E+ EG L EE+ + I E++ ++A H L + H DL P N L
Sbjct: 73 EWIEGETL--------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD- 123
Query: 266 REEDAPLKVIDFGLS 280
+ L +ID+ +
Sbjct: 124 --DGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKG--KVVAVKIISKAKMTSALAIEDVRREVKILKALSGH 188
+GRG FG AK K +G +V VK + K K + + + RRE+ + + LS H
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLS-H 67
Query: 189 KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH- 247
K++++ +A Y+++E+ + G+L + + + + + K VA C
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK--QKVALCTQ 125
Query: 248 -LQGV--------VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 298
G+ VHRDL N L +++ E +KV LS D+ S YY
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLS---------KDVYNSEYY 173
Query: 299 -----------VAPE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPF 331
+APE V ++ + D+WS GV+ + + G PF
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 76/296 (25%), Positives = 123/296 (41%), Gaps = 52/296 (17%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
++++ + +G+G G A + + VA+K I + + L + RE KI L
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRR---VALKKIREDLSENPLLKKRFLREAKIAADL 59
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAK------------ 233
H ++ + D + VY M + EG L +L + E +K
Sbjct: 60 I-HPGIVPVYSICSDGDPVYYTMPYIEG-YTLKSLL-KSVWQKESLSKELAEKTSVGAFL 116
Query: 234 TIVEKILNIVAFCHLQGVVHRDLKPENFL----------------FTTREEDAPLKVIDF 277
+I KI + + H +GV+HRDLKP+N L F EE+ L ID
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD-IDV 175
Query: 278 GL-----SDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEG-DMWSIGVITYILLCGSRPF 331
S P + IVG+ Y+APE L E D++++GVI Y +L S P+
Sbjct: 176 DERNICYSSMTIPGK----IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
Query: 332 WARTESG---IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384
R + G +R V+ P +P+ + P + L D +R ++ Q L
Sbjct: 232 --RRKKGRKISYRDVI-LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 45/231 (19%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRR----EVKILKALSGH 188
+G G+FG A KK LK + + KM A E+ R E+++L L H
Sbjct: 10 IGEGNFGQVIRAMIKKDGLK-------MNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 189 KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED---------AKTIVEKI 239
++I A E+ +YI +E+ G LLD + R R LE D A T+ +
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFL--RKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 240 L--------NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD----FVRPDQ 287
L + + + +HRDL N L E+ K+ DFGLS +V+
Sbjct: 121 LLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLSRGEEVYVKKTM 177
Query: 288 -RLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITY-ILLCGSRPFWART 335
RL ++A E L+ S Y + D+WS GV+ + I+ G P+ T
Sbjct: 178 GRL-----PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHM 191
++G G +G KK VAVK + + M +E+ +E ++K + H ++
Sbjct: 13 KLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNL 64
Query: 192 IKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE---------KILNI 242
++ YI+ EF G LLD YL E + V +I +
Sbjct: 65 VQLLGVCTREPPFYIITEFMTYGNLLD--------YLRECNRQEVNAVVLLYMATQISSA 116
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YV 299
+ + + +HRDL N L E+ +KV DFGLS + D G+ + +
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWT 172
Query: 300 APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPF 331
APE L + ++++ D+W+ GV+ + I G P+
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 12/219 (5%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
K +G G FG K K VA+K + K T +D E I+ S H +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQR-QDFLSEASIMGQFS-HHN 67
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+I+ I+ E+ E G L + G + ++ I + +
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA----YYVAPEVL-H 305
VHRDL N L + E KV DFGLS + D + APE + +
Sbjct: 128 YVHRDLAARNILVNSNLE---CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 306 RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 343
R + D+WS G++ + ++ G RP+W + + +++
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 43/230 (18%)
Query: 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRR---EVKILKALSGHK 189
+G G+FG A+ KK L+ A+K +M + +D R E+++L L H
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDA-AIK-----RMKEYASKDDHRDFAGELEVLCKLGHHP 68
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED---------AKTI-VEKI 239
++I A E +Y+ +E+ G LLD + R R LE D A T+ +++
Sbjct: 69 NIINLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 240 LNIVA-------FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD----FVRPDQ- 287
L+ A + + +HRDL N L E+ K+ DFGLS +V+
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMG 183
Query: 288 RLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITY-ILLCGSRPFWART 335
RL ++A E L+ S Y D+WS GV+ + I+ G P+ T
Sbjct: 184 RL-----PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 4/104 (3%)
Query: 223 RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282
R + A I ++IL + + H Q ++HRD+K EN + + + D G + F
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQF 206
Query: 283 VRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILL 325
+ G+ APEVL R YN + D+WS G++ + +L
Sbjct: 207 PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 54/248 (21%), Positives = 104/248 (41%), Gaps = 33/248 (13%)
Query: 148 KGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIK----FHDAFEDANS 203
KG K V ++ K + I+ E+K L+ + + +++K D +D
Sbjct: 38 KGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSN-NILKIYGFIIDIVDDLPR 96
Query: 204 VYIVMEFCEGGELLDRILSRGGRYLEEDA--KTIVEKILN----IVAFCHLQGVVHRDLK 257
+ +++E+C G L R E+D KT ++ ++ + +++L
Sbjct: 97 LSLILEYCTRGYL------REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150
Query: 258 PENFLFTTREEDAPLKVIDFGLSDF--VRPDQRLNDIVGSAYYVAPEVLH---RSYNVEG 312
+FL T E+ LK+I GL P + +N +V Y + ++L+ Y ++
Sbjct: 151 SVSFLVT---ENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKD 203
Query: 313 DMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP-EAKDFVRRLLN 371
D++S+GV+ + + G PF T I+ ++ + + P P E K V +
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL---KLPLDCPLEIKCIVEACTS 260
Query: 372 KDHRKRMT 379
D KR
Sbjct: 261 HDSIKRPN 268
|
Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 31/221 (14%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
KE+G G FG + G +VV ++ A S E + ++L H +
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQ-HSN 56
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILS-RGGRYLEEDAKTIVEKILNI---VAFC 246
+++ + +VMEFC G+L + S R + D T+ I +
Sbjct: 57 LLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD-------FVRPDQRLNDIVGSAYYV 299
H +H DL N L T D +K+ D+GLS +V PDQ + ++
Sbjct: 117 HKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL----RWI 169
Query: 300 APEVL---HRSYNV-----EGDMWSIGVITYILL-CGSRPF 331
APE++ H + V E ++WS+GV + L GS+P+
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 40/145 (27%), Positives = 60/145 (41%), Gaps = 32/145 (22%)
Query: 151 LKGKVVAVKI-ISKAKMTSALAI----EDVRREVKILKALSGHKHMIKFHDA-------- 197
L K V +K I K L E RRE +I M + A
Sbjct: 18 LGIKAV-IKWRIPKRYRHPELDERIRRERTRREARI---------MSRARKAGVNVPAVY 67
Query: 198 FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 257
F D + IVME+ EG L D +++ G E ++ I +V H G++H DL
Sbjct: 68 FVDPENFIIVMEYIEGEPLKD-LINSNGMEELELSREIGR----LVGKLHSAGIIHGDLT 122
Query: 258 PENFLFTTREEDAPLKVIDFGLSDF 282
N + + + + +IDFGL++F
Sbjct: 123 TSNMILSGGK----IYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 132 EVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
E+G G+FG C KG K ++ VA+K++ S +++ RE +I+ L + +
Sbjct: 2 ELGSGNFG--CVKKGVYKMRKKQIDVAIKVLKNENEKSVR--DEMMREAEIMHQLD-NPY 56
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI-VAFCHLQ 249
+++ E A ++ +VME GG L ++ LS G+ E +VE + + + +L+
Sbjct: 57 IVRMIGVCE-AEALMLVMEMASGGPL-NKFLS--GKKDEITVSNVVELMHQVSMGMKYLE 112
Query: 250 G--VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY--------- 298
G VHRDL N L + K+ DFGLS + D +YY
Sbjct: 113 GKNFVHRDLAARNVLLVNQHY---AKISDFGLSKALGAD--------DSYYKARSAGKWP 161
Query: 299 ---VAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPF 331
APE ++ R ++ D+WS G+ + G +P+
Sbjct: 162 LKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 63/238 (26%), Positives = 106/238 (44%), Gaps = 37/238 (15%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F LG+ +G+G FG A+ K + VAVK++ KA + S+ IE+ RE +K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 187 GHKHMIK-----FHDAFEDANSV-YIVMEFCEGGELLDRIL-SR-GGRYLEEDAKTIVEK 238
H ++IK + + +++ F + G+L +L SR G +T+V
Sbjct: 60 -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 239 ILNIVA---FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS------DFVRPDQRL 289
+++I + + + +HRDL N + E+ + V DFGLS D+ R
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQ---- 171
Query: 290 NDIVGSAY-----YVAPEVLHRS-YNVEGDMWSIGVITY-ILLCGSRPFWARTESGIF 340
G A ++A E L + Y D+W+ GV + I+ G P+ S I+
Sbjct: 172 ----GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 10/105 (9%)
Query: 292 IVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 350
I+G+ Y+APE+L + + D W++GV + L G PF T +F+++L
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN----- 594
Query: 351 HDSPWP----SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391
D PWP +S A++ + LL D KR + HP H
Sbjct: 595 RDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHG 639
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 67/287 (23%), Positives = 111/287 (38%), Gaps = 99/287 (34%)
Query: 126 KFELGKEVGRGHFGHT--CCAKGKKGTLKGKVVAVKIIS--------KAKMTSALAIEDV 175
+ +LGK +GRG FG A G + + + VAVK++ KA MT
Sbjct: 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMT-------- 59
Query: 176 RREVKILKALSGHKHMIKFHDAFEDANS-VYIVMEFCEGGEL------------------ 216
E+KIL + H +++ A + +++E+C+ G L
Sbjct: 60 --ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKS 117
Query: 217 ---------------LDRILSRG----GRYLEEDAKTIVEKILNI--------------- 242
LD + S ++E+ + + VE+
Sbjct: 118 TRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLIS 177
Query: 243 ----VA----FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-------DFVRP-D 286
VA F + +HRDL N L + E+ +K+ DFGL+ D+VR D
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 287 QRLNDIVGSAYYVAPE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPF 331
RL ++APE + + Y + D+WS GV+ + I G+ P+
Sbjct: 235 ARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 39/145 (26%), Positives = 57/145 (39%), Gaps = 20/145 (13%)
Query: 144 AKGKKGTLKGKVVAVKI-ISKAKMTSALAI----EDVRREVKILKALSGHKHMIKFHDAF 198
A G VK I K L E RRE +IL + + +
Sbjct: 10 AIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA--REAGVPVPIVY 67
Query: 199 E-DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 257
+ D ++ IVME+ EG L D LEE ++ ++ +V H G+VH DL
Sbjct: 68 DVDPDNGLIVMEYIEGELLKD--------ALEEARPDLLREVGRLVGKLHKAGIVHGDLT 119
Query: 258 PENFLFTTREEDAPLKVIDFGLSDF 282
N + + + IDFGL +F
Sbjct: 120 TSNIILS----GGRIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 51/185 (27%), Positives = 89/185 (48%), Gaps = 20/185 (10%)
Query: 156 VAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGE 215
VA+K + +A TS A +++ E ++ ++ + H+ + ++V ++ + G
Sbjct: 39 VAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLL-GICLTSTVQLITQLMPFGC 94
Query: 216 LLDRILSR----GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP 271
LLD + G +YL I K +N + L VHRDL N L T +
Sbjct: 95 LLDYVREHKDNIGSQYLLNWCVQIA-KGMNYLEERRL---VHRDLAARNVLVKTPQH--- 147
Query: 272 LKVIDFGLSDFVRPDQRLNDIVGSAY---YVAPE-VLHRSYNVEGDMWSIGVITYILLC- 326
+K+ DFGL+ + D++ G ++A E +LHR Y + D+WS GV + L+
Sbjct: 148 VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 207
Query: 327 GSRPF 331
GS+P+
Sbjct: 208 GSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 53/232 (22%), Positives = 89/232 (38%), Gaps = 38/232 (16%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVV--AVKIISKAKMTSALAIEDVRREVKILKAL 185
L + +G G FG +G G V V + + + S D E I+
Sbjct: 9 TLLRALGHGAFGEV--YEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
+ H+++++ + +I++E GG+L + R R E ++ K L A
Sbjct: 67 N-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFL--RENRPRPERPSSLTMKDLLFCAR 123
Query: 246 -----CHL---QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY 297
C +HRD+ N L T + K+ DFG++ DI ++Y
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASY 174
Query: 298 Y------------VAPEV-LHRSYNVEGDMWSIGVITY-ILLCGSRPFWART 335
Y + PE L + + D+WS GV+ + I G P+ RT
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 49/176 (27%), Positives = 75/176 (42%), Gaps = 32/176 (18%)
Query: 127 FELGKEVGRGHFGHTCCAKG-KKGTLKGKVVAVKIISKAKMTSALAI---EDVRREVKIL 182
F LGK++G G FG A K + K +K KA A+ I E VRR
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK---KATEYGAVEIWMNERVRRACP-- 188
Query: 183 KALSGHKHMIKFHDAFEDANSVYIVMEFCEGGE-LLDRILSRGGRY-------------- 227
+ + + + + + ++V + EG L D + S+ Y
Sbjct: 189 NSCADFVYGFLEPVSSKKEDEYWLVWRY-EGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 228 --LEEDAK---TIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278
LE + K TI+ +IL + H G+VHRD+KP+N +F+ E K+ID G
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 61/287 (21%), Positives = 115/287 (40%), Gaps = 43/287 (14%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGK---VVAVKIISKAKMTSALAIEDVRREVKIL 182
E +++G+G FG A+ G L + +VAVK++ + SA D +RE ++
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAP-GLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALM 62
Query: 183 KALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKT-------- 234
H +++K + ++ E+ G+L + + R R + +
Sbjct: 63 AEFD-HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 235 -------------IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS- 280
I +++ +A+ + VHRDL N L E+ +K+ DFGLS
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSR 178
Query: 281 -----DFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITY-ILLCGSRPFWAR 334
D+ + + ND + + + + Y E D+W+ GV+ + I G +P++
Sbjct: 179 NIYSADYYKASE--NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236
Query: 335 TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 381
+ V D N P + E + +R +K R + A
Sbjct: 237 AHEEVIYYV--RDGNVLSCP-DNCPLELYNLMRLCWSKLPSDRPSFA 280
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 30/134 (22%), Positives = 61/134 (45%), Gaps = 8/134 (5%)
Query: 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 262
S+ +V + G LLD + + +I + + +VHR+L N L
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL 141
Query: 263 FTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIG 318
+ D+ +++ DFG++D + PD + ++ ++A E + Y + D+WS G
Sbjct: 142 LKS---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 319 VITYILLC-GSRPF 331
V + ++ G+ P+
Sbjct: 199 VTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 32/108 (29%), Positives = 47/108 (43%), Gaps = 12/108 (11%)
Query: 170 LAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLE 229
++ RE + L+ L + N +VME+ EG EL R
Sbjct: 151 VSRLAAEREFEALQRLYPEGVKVP---KPIAWNRHAVVMEYIEGVEL------YRLRLDV 201
Query: 230 EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277
E+ I++KIL V + +G+VH DL N L T ED + VID+
Sbjct: 202 ENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---EDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 18/90 (20%)
Query: 252 VHRDLKPENFLFTTREEDAPLKVIDFGLS-------DFVRP-DQRLNDIVGSAYYVAPE- 302
+HRDL N L + E+ +K+ DFGL+ D+VR D RL ++APE
Sbjct: 201 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL-----PLKWMAPET 252
Query: 303 VLHRSYNVEGDMWSIGVITY-ILLCGSRPF 331
+ R Y ++ D+WS GV+ + I G+ P+
Sbjct: 253 IFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 219 RILSRGGRYLEEDAKTIV----------EKILNI-------VAFCHLQGVVHRDLKPENF 261
R R G Y+++D + + E +L+ ++F + +HRDL N
Sbjct: 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNI 245
Query: 262 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIV-GSAY----YVAPE-VLHRSYNVEGDMW 315
L T K+ DFGL+ +R D N +V G+A ++APE + + Y E D+W
Sbjct: 246 LLT---HGRITKICDFGLARDIRNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVW 300
Query: 316 SIGVITY-ILLCGSRPF 331
S G++ + I GS P+
Sbjct: 301 SYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 34/135 (25%), Positives = 61/135 (45%), Gaps = 8/135 (5%)
Query: 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 261
++V +V + G LLD + R +D +I +++ +VHRDL N
Sbjct: 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNV 140
Query: 262 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA----YYVAPEVLHRSYNVEGDMWSI 317
L + +K+ DFGL+ + D+ G + +LHR + + D+WS
Sbjct: 141 LVKSPNH---VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSY 197
Query: 318 GVITYILLC-GSRPF 331
GV + L+ G++P+
Sbjct: 198 GVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 69/286 (24%), Positives = 117/286 (40%), Gaps = 39/286 (13%)
Query: 97 EGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHT-CCA----------- 144
E P G V + +L + F A F + ++ G FG CA
Sbjct: 124 EAPPDAAGPVPLAQAKLKHD----DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEAR 179
Query: 145 KGKKGTLKGKVVAVKIISK-AKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203
+G T +GK ++I+K K S AI+ + E+ L L+ H++++K + +
Sbjct: 180 RGVNSTNQGKPKCERLIAKRVKAGSRAAIQ-LENEILALGRLN-HENILKIEEILRSEAN 237
Query: 204 VYIVM---EFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 260
Y++ +F + D R L + + I++++L V + H + ++HRD+K EN
Sbjct: 238 TYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLEN 297
Query: 261 FLFTTREEDAPLKVIDFG-LSDFVRP-DQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSI 317
D + + DFG F + + VG+ +PE+L Y D+WS
Sbjct: 298 IFLNC---DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354
Query: 318 GVITYILLCGSRPFWARTESG---------IFRSVLRADPNFHDSP 354
G+I +L S F + G I S+ D F D P
Sbjct: 355 GLILLDML--SHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPP 398
|
Length = 501 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 6e-05
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 12/83 (14%)
Query: 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 259
D ++ IVME+ EG L D +EE ++ +I +V H G+VH DL
Sbjct: 68 DPDNKTIVMEYIEGKPLKD--------VIEEGNDELLREIGRLVGKLHKAGIVHGDLTTS 119
Query: 260 NFLFTTREEDAPLKVIDFGLSDF 282
N + + L +IDFGL +
Sbjct: 120 NIIVRDDK----LYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 44/228 (19%), Positives = 91/228 (39%), Gaps = 20/228 (8%)
Query: 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII----SKAKMTSALAIEDVRREVK 180
++ + +G G FG C K + + VA+ + S + LA E
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLA------EAL 58
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKI 239
L H ++++ N++ IV E+ G LD L + G+ + ++ +
Sbjct: 59 TLGQFD-HSNIVRLEGVITRGNTMMIVTEYMSNG-ALDSFLRKHEGQLVAGQLMGMLPGL 116
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS--AY 297
+ + + G VH+ L L + D K+ F + + + G
Sbjct: 117 ASGMKYLSEMGYVHKGLAAHKVLVNS---DLVCKISGFRRLQEDKSEAIYTTMSGKSPVL 173
Query: 298 YVAPEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 343
+ APE + + ++ D+WS G++ + ++ G RP+W + + ++V
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|218977 pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/WaaP) family | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 9e-05
Identities = 21/72 (29%), Positives = 33/72 (45%)
Query: 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 265
++ E EG + L L++ EE + + + ++A H GV H DL N L T
Sbjct: 94 LLTERLEGAQDLVTWLAQWADPAEELRRALWRAVGRLIARMHRAGVNHTDLNAHNILLDT 153
Query: 266 REEDAPLKVIDF 277
E + +IDF
Sbjct: 154 GEGGFKVWLIDF 165
|
These lipopolysaccharide kinases are related to protein kinases pfam00069. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of S. enterica. Length = 206 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 54/239 (22%), Positives = 94/239 (39%), Gaps = 52/239 (21%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGK-----VVAVKIISKAKMTSALAIEDVRREVKIL 182
+E+G G FG K KG L G +V I + + ++ R+E +++
Sbjct: 8 RFLEELGEGAFG-----KVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELM 62
Query: 183 KALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSR------GGRYLEEDAKTIV 236
L H +++ ++ E+ G+L + ++ G +E K+ +
Sbjct: 63 SDLQ-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 237 E--KILNIVA-------FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ 287
+ L+I + VHRDL N L E +K+ DFGLS
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTVKISDFGLS------- 171
Query: 288 RLNDIVGSAYY------------VAPE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPFW 332
DI + YY + PE +L+ + E D+WS GV+ + I G +P++
Sbjct: 172 --RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 7/92 (7%)
Query: 235 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN---D 291
+ ++L+ + + H +G++HRD+K EN L E+ + + DFG + F R
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFARGSWSTPFHYG 321
Query: 292 IVGSAYYVAPEVLH-RSYNVEGDMWSIGVITY 322
I G+ APEVL Y D+WS G++ +
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 47/236 (19%), Positives = 103/236 (43%), Gaps = 33/236 (13%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDV-RREVKILKALSGHK 189
E+G G FG + +G K +VV + + + ++ + + +EV+ + L+ H
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVV----VKELRASATPDEQLLFLQEVQPYRELN-HP 55
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEK-----ILNIVA 244
++++ ++ +V+EFC G+L + + S G + + A+ V + + + +
Sbjct: 56 NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRG-MVAQMAQKDVLQRMACEVASGLL 114
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS------DFVRPDQRLNDIVGSAYY 298
+ H +H DL N T D +K+ D+GL+ D+ +
Sbjct: 115 WLHQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPEDYYITKDCH---AVPLRW 168
Query: 299 VAPEV--------LHRSYNVEGDMWSIGVITYILL-CGSRPFWARTESGIFRSVLR 345
+APE+ L + + ++WS+GV + L +P+ ++ + + V+R
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 29/81 (35%), Positives = 37/81 (45%), Gaps = 13/81 (16%)
Query: 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 259
D IVME+ G +L D + E +V K+ IVA H G+VH DL
Sbjct: 407 DPEEKTIVMEYIGGKDLKDVL---------EGNPELVRKVGEIVAKLHKAGIVHGDLTTS 457
Query: 260 NFLFTTREEDAPLKVIDFGLS 280
NF+ D L +IDFGL
Sbjct: 458 NFIVR----DDRLYLIDFGLG 474
|
Length = 535 |
| >gnl|CDD|215621 PLN03188, PLN03188, kinesin-12 family protein; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 30/104 (28%), Positives = 44/104 (42%), Gaps = 19/104 (18%)
Query: 10 NNDSITPIDHPKQPTSQPHPASTPRHPPPDSSSFTCSPFQSPLPAGVAPSPSPGR-KFRW 68
S P H +P+S+ +S PPPD +S L + + P K +
Sbjct: 19 EEQSPNPSSHKSKPSSRKLKSSKENAPPPDLNS---------LTSDLKPDHRSASAKLKS 69
Query: 69 PLPP-PSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATER 111
PLPP P + P +KR+L + P+ G + D GVK R
Sbjct: 70 PLPPRPPSSNP----LKRKL--SAETAPENGVS--DSGVKVIVR 105
|
Length = 1320 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 56/238 (23%), Positives = 90/238 (37%), Gaps = 55/238 (23%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLK------GKVVAVKIISKAKMTSALAIEDVRREVK 180
+LGK +G G FG +G L K VAVK + K + + IE+ E
Sbjct: 1 LKLGKILGEGEFGSV-----MEGQLSQDDGSQLK-VAVKTM-KLDIHTYSEIEEFLSEAA 53
Query: 181 ILKALSGHKHMIKF------HDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKT 234
+K H +++K + + +++ F + G+L +L R K
Sbjct: 54 CMKDFD-HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY--SRLGGLPEKL 110
Query: 235 IVEKILNIVA-------FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ 287
++ +L + + + +HRDL N + ED + V DFGLS
Sbjct: 111 PLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLS------- 160
Query: 288 RLNDIVGSAYY------------VAPEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPF 331
I YY +A E L R Y + D+W+ GV + I G P+
Sbjct: 161 --KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 33/122 (27%), Positives = 57/122 (46%), Gaps = 18/122 (14%)
Query: 126 KFELGKEVGRGHFGH----TCCAKGKK-GTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
+ GK +G G FG T GK+ L+ VAVK++ + T E + E+K
Sbjct: 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLR---VAVKMLKASAHTDE--REALMSELK 93
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
IL L HK+++ A V ++ E+C G+LL+ +L + A+T + ++
Sbjct: 94 ILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLN--------FLRKKAETFLNFVM 145
Query: 241 NI 242
+
Sbjct: 146 AL 147
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 20/46 (43%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 233 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278
K ++ ++L + H G+VHRD+KPEN L T D +K+IDFG
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 24/93 (25%)
Query: 252 VHRDLKPENFLFTTREEDAPLKVIDFGLS-------DFVRPDQRLNDIVGSAY----YVA 300
+HRDL N L + E+ +K+ DFGL+ D+VR GSA ++A
Sbjct: 196 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRK--------GSARLPLKWMA 244
Query: 301 PE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPF 331
PE + + Y + D+WS GV+ + I G+ P+
Sbjct: 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSA 296
++ N + F + VHRDL N L E +K+ DFGL+ D +R ++ GS
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNYISK--GST 301
Query: 297 Y----YVAPE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPF 331
+ ++APE + + Y D+WS G++ + I G P+
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 36/235 (15%)
Query: 129 LGKEVGRGHFGHTCCAK--GKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
LGK +G G FG + LK VAVK + A T + +ED E +K
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILK---VAVKTMKIAICTRS-EMEDFLSEAVCMKEFD 58
Query: 187 GHKHMIKF------HDAFEDANSVYIVMEFCEGGELLDRIL-SRGG---RYLEEDAKTIV 236
H ++++ E S +++ F + G+L +L SR G +YL + +V
Sbjct: 59 -HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLP--TQMLV 115
Query: 237 EKILNI---VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS------DFVRPDQ 287
+ + +I + + + +HRDL N + E+ + V DFGLS D+ R
Sbjct: 116 KFMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVADFGLSKKIYNGDYYR-QG 171
Query: 288 RLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIF 340
R+ + ++A E L R Y + D+WS GV + I G P+ S I+
Sbjct: 172 RIAKM--PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|240172 cd05151, ChoK, Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.002
Identities = 34/133 (25%), Positives = 47/133 (35%), Gaps = 24/133 (18%)
Query: 150 TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVME 209
+ K V+I T L + E + K + K + F+ V I E
Sbjct: 18 EVANKKYVVRIPGN--GTELL--INRENEAENSKLAAEAGIGPKLYY-FDPETGVLI-TE 71
Query: 210 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV-----HRDLKPENFLFT 264
F EG ELL S +EKI ++ H + H DL P NFL
Sbjct: 72 FIEGSELLTEDFSD---------PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD 122
Query: 265 TREEDAPLKVIDF 277
D L +ID+
Sbjct: 123 ----DGRLWLIDW 131
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate and displays negligible activity towards N-methylated derivatives of Etn. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Length = 170 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 94/355 (26%), Positives = 140/355 (39%), Gaps = 83/355 (23%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA-KMTSALAIEDVRREVKILKA 184
+F++ +G G FG A +K + + AVKI+ K T IE E
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQAD 186
Query: 185 LSGHKHMIKFHDAFE-DANSVYIVMEFCEGGELLDRILSRGG---RYLEEDAKTIVEKIL 240
+ ++K F+ + + IVM G LLD I+ G R+L A+ I + +
Sbjct: 187 PADRFPLMKIQRYFQNETGHMCIVMP-KYGPCLLDWIMKHGPFSHRHL---AQIIFQTGV 242
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLND------ 291
+ F ++H DLKPEN L T + V+D + + PD R+ D
Sbjct: 243 ALDYFHTELHLMHTDLKPENILMETSD-----TVVDPVTNRALPPDPCRVRICDLGGCCD 297
Query: 292 -------IVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPF------------ 331
IV + +Y +PEV L + DMWS+G I Y L G +
Sbjct: 298 ERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357
Query: 332 ----------WAR---TESG--IFRSV--LR--ADPNFHDSPWPSVSPEAKDFVRR---- 368
WA TE ++ S LR DP H + P ++ +R
Sbjct: 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPK-HLARIARARP-VREVIRDDLLC 415
Query: 369 -----LLNKDHRKRMTAAQALTHPWLHD---ENRPVPLDILIYKLVKSYLRATPL 415
LL+ D +KR+ A Q THP++ E R P Y +S LR TP+
Sbjct: 416 DLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHP----NYPDNRSMLRPTPI 466
|
Length = 467 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 26/98 (26%), Positives = 44/98 (44%), Gaps = 10/98 (10%)
Query: 126 KFELGKEVGRGHFGHTCCAKG-----KKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
LG+ +G G FG A + T+K V +K +++ AL E+K
Sbjct: 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALM-----SELK 92
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLD 218
I+ L H +++ A +YI+ E+C G+L+D
Sbjct: 93 IMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVD 130
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 461 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.53 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.43 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.35 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.2 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.13 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.08 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.04 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.01 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.88 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.68 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.67 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.63 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.58 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.54 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.51 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.51 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.46 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.44 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.36 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.31 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.3 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.23 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.01 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.94 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.91 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.89 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.81 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.76 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.73 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.67 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.65 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.63 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.55 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.4 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.36 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.28 | |
| PLN02236 | 344 | choline kinase | 97.27 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.19 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.15 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.13 | |
| PF00036 | 29 | EF-hand_1: EF hand; InterPro: IPR018248 Many calci | 97.02 | |
| KOG1924 | 1102 | consensus RhoA GTPase effector DIA/Diaphanous [Sig | 96.94 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.78 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.74 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.74 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.59 | |
| PF13405 | 31 | EF-hand_6: EF-hand domain; PDB: 2AMI_A 3QRX_A 1W7J | 96.35 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.35 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.32 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.28 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.08 | |
| PF13202 | 25 | EF-hand_5: EF hand; PDB: 3DD4_A 2Q4U_A 2BE4_A 1UHJ | 96.05 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.92 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.81 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.79 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-66 Score=487.91 Aligned_cols=270 Identities=37% Similarity=0.647 Sum_probs=245.5
Q ss_pred CCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH----HHHHHHHHHHHHHHhcCCCCCeeEE
Q 012518 119 YGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA----LAIEDVRREVKILKALSGHKHMIKF 194 (461)
Q Consensus 119 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~----~~~~~~~~Ei~il~~l~~hpniv~l 194 (461)
..+.+.+.|.+.+.||+|+||.|-+|..++ +|+.||||++.+...... .....+.+|++||++|+ |||||++
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~---tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~ 241 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKK---TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRI 241 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcc---cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEE
Confidence 345577889999999999999999999987 999999999988655431 12345789999999997 9999999
Q ss_pred EEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeE
Q 012518 195 HDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 195 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
+++|+..+..||||||++||+|++++..+ +.+.+..-+.+++|++.|+.|||++||+||||||+|||+..+.++..+||
T Consensus 242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 242 KDFFEVPDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred eeeeecCCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEe
Confidence 99999999999999999999999999765 67888889999999999999999999999999999999998778899999
Q ss_pred eecccccccCCCCCccccccCCCcCchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCChhh-HHHHHHhcCCC
Q 012518 275 IDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVITYILLCGSRPFWARTESG-IFRSVLRADPN 349 (461)
Q Consensus 275 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-~~~~i~~~~~~ 349 (461)
+|||+|++.+....+.+.|||+.|.|||++.. .+..++|||||||+||.+++|.+||.+..... ..+.|.++...
T Consensus 321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA 400 (475)
T ss_pred cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence 99999999998888999999999999999852 25568999999999999999999998876655 88999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 350 FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 350 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
|....|..+|+++.+||.+||..||++|+|++|+|+||||+...
T Consensus 401 f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 401 FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 99999999999999999999999999999999999999998753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-60 Score=470.38 Aligned_cols=256 Identities=32% Similarity=0.610 Sum_probs=239.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|+.++.||+|||+.||.+++.. +|+.||+|++.+..+......+.+.+||+|++.|+ |||||++|++|+|.+++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCce
Confidence 479999999999999999999866 89999999999988888888999999999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|||+|+|..++|..++. +.+.++|.+++.+++||+.||.|||+++|+|||||..|+|+ +++.+|||+|||||..+.
T Consensus 94 YivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeec
Confidence 99999999999988765 66789999999999999999999999999999999999999 467889999999999887
Q ss_pred CC-CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.. ++..+.||||.|.|||++. ..++..+||||+|||||.||+|++||...+-.+++..|...+..++. .+|.++
T Consensus 170 ~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A 245 (592)
T KOG0575|consen 170 YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEA 245 (592)
T ss_pred CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHH
Confidence 44 7888999999999999997 46999999999999999999999999999999999999999888776 489999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
++||.+||+.||.+|||++++|.|+||+..
T Consensus 246 ~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 246 KDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 999999999999999999999999999554
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-62 Score=432.35 Aligned_cols=298 Identities=33% Similarity=0.659 Sum_probs=271.0
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+.+.|++.+.||+|.|+.||++.++. +|+.+|+|+|...++... ..+++.+|++|.+.|+ |||||++++.+.+.
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~---tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ-HPNIVRLHDSIQEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhcc---chHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcC-CCcEeehhhhhccc
Confidence 466789999999999999999887765 899999999987766544 6688999999999997 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+..|||+|++.|++|..-|.++ ..++|..+..+++||+.||.|||.+||||||+||+|+|+.+++...-+||+|||+|.
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999999999998888776 568999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
.+..+......+|||.|||||++. ..|+..+|||+.|||||-|+.|.+||++.+...+++.|..+...++...|+.+++
T Consensus 162 ~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 162 EVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred EeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence 998777778899999999999997 4699999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCCc--hHHHHHHHHHHhhcCHHHHHHHHHHHH
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPL--DILIYKLVKSYLRATPLKRAALKALSK 425 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (461)
++++||++||..||.+|+|+.|+|+|||+.+..+.... .....+.+++|....+++-+.+..+..
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~s 308 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVIA 308 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999876432111 224456789999999999999988744
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-60 Score=445.27 Aligned_cols=258 Identities=31% Similarity=0.630 Sum_probs=235.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|+++++||+|+||+||+|+.+. +|+.||+|++++.........+....|..||.+++ ||+||+++..|++.+.+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~d---t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKD---TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKL 100 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcc---cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeE
Confidence 589999999999999999999886 89999999999998888888899999999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|||+||+.||+|+.+|. +.++++|..++.++.+|+.||.|||++|||||||||+|||+ +.+++++|+|||+++..-
T Consensus 101 ylVld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEEEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcc
Confidence 99999999999998875 45799999999999999999999999999999999999999 578999999999998543
Q ss_pred -CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 -PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 -~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.+....++|||+.|||||++. ..|+..+|+|||||++|||++|.+||.+.+...++++|.......... .++.++
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---~ls~~a 253 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---YLSEEA 253 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---cCCHHH
Confidence 445667789999999999986 569999999999999999999999999999999999999887333322 389999
Q ss_pred HHHHHHhcccCcCCCC----CHHHHhcCCCcCCCC
Q 012518 363 KDFVRRLLNKDHRKRM----TAAQALTHPWLHDEN 393 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~----s~~e~L~hp~~~~~~ 393 (461)
++||+++|.+||++|. ++.++-+||||...+
T Consensus 254 rdll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 254 RDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred HHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 9999999999999995 789999999998754
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-58 Score=454.22 Aligned_cols=317 Identities=50% Similarity=0.886 Sum_probs=286.5
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
...+...|++.+.||+|.||.||+++.+. +|+.+|+|++.+.........+.+.+|+.||++|.+|||||.++++|+
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~---tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e 106 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKS---TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE 106 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecC---CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44566789999999999999999999987 799999999998877766677889999999999988999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC-CCCeeEeecc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE-DAPLKVIDFG 278 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~-~~~~kl~DFG 278 (461)
+...+++|||+|.||+|++.+... .++|..+..+++||+.++.|||+.||+||||||+|+|+...+. ++.+|++|||
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999999999887 3999999999999999999999999999999999999987654 4589999999
Q ss_pred cccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 279 LSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 279 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
++............+||++|+|||++. ..|+..+||||+||++|.|++|..||++.+..+....|...+..|....|+.
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence 999988877888999999999999998 6899999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC--CCCCchHHHHHHHHHHhhcCHHHHHHHHHHHHhcCHHHHHHH
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN--RPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYL 435 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~e~~~l 435 (461)
+|..+++||++||..||.+|+|+.++|+|||++... .....+..+...++++...+.+++.++..+...++ +..+
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 341 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLAESLS---ISGL 341 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHhhhhh---HHHH
Confidence 999999999999999999999999999999998753 23344445555667777777777777777777766 7778
Q ss_pred HHHhhhcCC
Q 012518 436 RAQFMLLEP 444 (461)
Q Consensus 436 ~~~f~~~d~ 444 (461)
+.+|..+|.
T Consensus 342 ~~~~~~~~~ 350 (382)
T KOG0032|consen 342 KEMFKLMDT 350 (382)
T ss_pred HHHHHhhcc
Confidence 888988887
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-58 Score=446.42 Aligned_cols=259 Identities=34% Similarity=0.641 Sum_probs=239.0
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
..+|.+++.||+|+|++|++|+++. +++.||||++.+.....+..++.+.+|-.+|.+|.+||.|++||..|+|+..
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~---t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKA---TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred hhhcchhheeccccceeEEEeeecC---CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3589999999999999999999987 8999999999998877777788899999999999889999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+|+||+++|+|+++|.+. +.+++..++.++.||+.||+|||++|||||||||||||| +.++++||+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccC
Confidence 99999999999999998665 789999999999999999999999999999999999999 67899999999999876
Q ss_pred CCCCC--------------ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC
Q 012518 284 RPDQR--------------LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP 348 (461)
Q Consensus 284 ~~~~~--------------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~ 348 (461)
.+... ..+++||..|.+||+|. +..+..+|||+||||||.|+.|.+||.+.++--+++.|+..+.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y 304 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY 304 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence 54321 14589999999999997 5688999999999999999999999999999999999999988
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 349 NFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 349 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.|+. ++++.++|||+++|..||.+|+|+.||.+||||.+.+
T Consensus 305 ~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 305 EFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred cCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 8875 5889999999999999999999999999999998753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-58 Score=429.93 Aligned_cols=255 Identities=29% Similarity=0.488 Sum_probs=224.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-e
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN-S 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~-~ 203 (461)
++.+.++.||+|..|+||+|+++. +++.+|+|+|... .+....+++.+|++|++.+. ||+||++|++|.+++ .
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~---t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKP---TGKIYALKVILLN--IDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGEE 152 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcC---CCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCce
Confidence 467778999999999999999987 8999999999543 45667789999999999995 999999999999999 4
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
++|+||||+||+|.+.+... ++++|.....++.+|++||.|||+ ++||||||||+|||+++ .+.|||||||.++.
T Consensus 153 isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs---kGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS---KGEVKICDFGVSGI 228 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc---CCCEEeccccccHH
Confidence 99999999999998876544 789999999999999999999996 89999999999999964 56699999999998
Q ss_pred cCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC-----ChhhHHHHHHhcCC-CCCCCCC
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWAR-----TESGIFRSVLRADP-NFHDSPW 355 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~-----~~~~~~~~i~~~~~-~~~~~~~ 355 (461)
+... ...+++||..|||||.+.+ .|+.++||||||++++||++|+.||... ...+++..|+...+ .++..
T Consensus 229 lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-- 305 (364)
T KOG0581|consen 229 LVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-- 305 (364)
T ss_pred hhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc--
Confidence 7655 5588999999999999986 6999999999999999999999999774 55667777776533 23322
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.+|+++++||..||++||.+|+++.|+|+|||+++..
T Consensus 306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred -cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 4899999999999999999999999999999998754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-57 Score=430.18 Aligned_cols=261 Identities=34% Similarity=0.653 Sum_probs=235.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|.+.++||+|+||+||+|++++ +|..||||.|.+.++ ....++.+..||.||+.|+ |||||++++++++.+.+
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~---~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKK---SGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccceehhhccCcceEEEEEeEecc---CCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeE
Confidence 589999999999999999999987 789999999988765 4556788999999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCC---CCeeEeeccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED---APLKVIDFGLSD 281 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~---~~~kl~DFG~a~ 281 (461)
|||||||+||||.++|..+ ++++|..++.++.||+.||++||+++||||||||+||||+....+ -.+||+|||+|+
T Consensus 85 ~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999999766 589999999999999999999999999999999999999875233 579999999999
Q ss_pred ccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
......-..+.||++.|||||++. +.|+.|+|+||+|+|||+|++|+.||...+..+++..+.++....+..+ ..++.
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~ 242 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSN 242 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccC
Confidence 999888888999999999999995 7899999999999999999999999999999999987776654443332 34677
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
...+|+..+|..++..|.+..+-+.|+++...
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 88899999999999999999999999999765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-57 Score=412.96 Aligned_cols=254 Identities=32% Similarity=0.633 Sum_probs=237.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||.|+||.|-+++.+. +|..+|+|++++........++...+|..+|+.+. ||+++++++.|.+.+.+
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~---~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKH---SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNL 119 (355)
T ss_pred hhhhheeeeccCccceEEEEEEcc---CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeE
Confidence 589999999999999999999987 79999999999998888888899999999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
||||||+.||.|+.++.+ .+++++..++.++.||+.||+|||+++|++|||||||||+ |.++++||+|||+|+.+.
T Consensus 120 ymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEec
Confidence 999999999999998854 4789999999999999999999999999999999999999 578899999999999875
Q ss_pred CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
.. ..+.||||.|+|||++. ..|+.++|+|||||++|||+.|.+||.+.+...++++|+.++..|+. .++++++
T Consensus 196 ~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~k 269 (355)
T KOG0616|consen 196 GR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAK 269 (355)
T ss_pred Cc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHH
Confidence 43 67899999999999986 67999999999999999999999999999999999999999998875 4899999
Q ss_pred HHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 364 DFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 364 ~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
|||.++|++|-.+|. ...++.+||||+..
T Consensus 270 dLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 270 DLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 999999999999994 67899999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-56 Score=436.30 Aligned_cols=261 Identities=32% Similarity=0.558 Sum_probs=234.2
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
-.++|++++.||+|+||.||+|+.+. +|..+|+|++++..+.....++.++.|-.||... ++++||+||..|++.+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~---Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKD---TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKE 214 (550)
T ss_pred CcccchhheeeccccceeEEEEEEcc---CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCC
Confidence 34689999999999999999999887 9999999999999888888899999999999996 6999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
++||||||++|||+.-+|.. .+.++++.++.++.+++.|++-||+.|+|||||||+|+|| |..|++||+||||+.-
T Consensus 215 ~LYLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTG 290 (550)
T ss_pred eeEEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccch
Confidence 99999999999999887754 4789999999999999999999999999999999999999 6789999999999842
Q ss_pred cCC-----------------------C-C-----C-------------------ccccccCCCcCchhhhh-ccCCCchh
Q 012518 283 VRP-----------------------D-Q-----R-------------------LNDIVGSAYYVAPEVLH-RSYNVEGD 313 (461)
Q Consensus 283 ~~~-----------------------~-~-----~-------------------~~~~~gt~~y~aPE~l~-~~~~~~~D 313 (461)
... + . . ..+.+|||.|||||++. ..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 110 0 0 0 11358999999999987 46999999
Q ss_pred HHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCcC
Q 012518 314 MWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT---AAQALTHPWLH 390 (461)
Q Consensus 314 iwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~L~hp~~~ 390 (461)
+|||||||||||.|.+||.+.+..+.+++|.+....+..+.-..++++++|||.+||+ ||.+|.. ++||.+||||+
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~ 449 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFK 449 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccc
Confidence 9999999999999999999999999999999988666555556789999999999999 9999985 89999999998
Q ss_pred CC
Q 012518 391 DE 392 (461)
Q Consensus 391 ~~ 392 (461)
..
T Consensus 450 ~v 451 (550)
T KOG0605|consen 450 GV 451 (550)
T ss_pred cC
Confidence 75
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-57 Score=434.47 Aligned_cols=262 Identities=33% Similarity=0.521 Sum_probs=232.3
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+.++|.++++||.|+||.||+|+.+. +|..||||.+++.-.. ....-. +||+..|++|..|||||++.+++.+.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~---~~~~VAIK~MK~Kf~s-~ee~~n-LREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKE---TGELVAIKKMKKKFYS-WEECMN-LREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecC---CCceeeHHHHHhhhcc-HHHHHH-HHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 356799999999999999999999887 8999999999765433 322222 57999999997799999999999988
Q ss_pred C-eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 202 N-SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 202 ~-~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
+ .+|+|||||+. +|++.+..++..|++..++.|+.||+.||+|+|.+|+.||||||||||+.. ...|||+|||+|
T Consensus 82 ~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~---~~~iKiaDFGLA 157 (538)
T KOG0661|consen 82 DRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG---NDVIKIADFGLA 157 (538)
T ss_pred CceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc---cceeEecccccc
Confidence 8 99999999975 999999999888999999999999999999999999999999999999963 556999999999
Q ss_pred cccCCCCCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC---
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW--- 355 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--- 355 (461)
+.+......+.++.|.||+|||+|. +.|+.++||||+|||++|+++-++.|.+.++.+.+.+|+..-.......|
T Consensus 158 Rev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 158 REVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 9999888999999999999999975 56999999999999999999999999999999998888765444333322
Q ss_pred -----------------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 356 -----------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 356 -----------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+.++.++.+||.+||.+||.+||||.|+|+||||+..
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 3468999999999999999999999999999999854
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-55 Score=436.51 Aligned_cols=258 Identities=39% Similarity=0.751 Sum_probs=232.8
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA--LAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~--~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
....|++++.||+|+||+|++|++.. +|+.||||++.+...... ...+.+.+|+.+++.+..||||+++++++..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~---t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRL---TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeecc---CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 34589999999999999999999876 789999998877533211 3456777999999999779999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCC-CCeeEeeccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED-APLKVIDFGL 279 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~-~~~kl~DFG~ 279 (461)
...+|+|||||.||+|++++.+ .+++.|..++.+++||+.|++|||++||+||||||+|||++ .+ +++||+|||+
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSDFGL 167 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEecccc
Confidence 9999999999999999999988 68999999999999999999999999999999999999996 34 7899999999
Q ss_pred cccc-CCCCCccccccCCCcCchhhhhc-c-C-CCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 280 SDFV-RPDQRLNDIVGSAYYVAPEVLHR-S-Y-NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 280 a~~~-~~~~~~~~~~gt~~y~aPE~l~~-~-~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
+... ..+....+.+||+.|+|||++.+ . | +.++||||+||+||.|++|..||.+.+...++..|.+....++..
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~-- 245 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY-- 245 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC--
Confidence 9988 56678899999999999999975 3 5 588999999999999999999999999999999988887776653
Q ss_pred CCC-CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 356 PSV-SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 356 ~~~-s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
+ |+++++||.+||..||.+|+++.+++.||||+.
T Consensus 246 --~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 246 --LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 4 999999999999999999999999999999997
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-57 Score=410.00 Aligned_cols=258 Identities=28% Similarity=0.553 Sum_probs=225.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|+.+.++|+|+||+||+++++. +|+.||||.+.... .+....+-.+|||++|++|+ |+|+|.++++|.....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~---TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD---TGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC---cccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhccee
Confidence 478999999999999999999987 99999999986543 33444455789999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
+||+|||+. ++++.+......++++.++.++.|++.|+.|||++++|||||||+||||+ .++.+||||||+|+.+.
T Consensus 77 hLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---QNGVVKLCDFGFARTLS 152 (396)
T ss_pred EEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---cCCcEEeccchhhHhhc
Confidence 999999976 66677776666799999999999999999999999999999999999996 57779999999999887
Q ss_pred -CCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc--------------C
Q 012518 285 -PDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA--------------D 347 (461)
Q Consensus 285 -~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--------------~ 347 (461)
++...+.++.|.||+|||.+-+ +|+..+||||+||++.||++|.+.|.+.++-+++..|... .
T Consensus 153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 6777889999999999998865 6999999999999999999999999999988877666432 2
Q ss_pred CCCCC-------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 348 PNFHD-------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 348 ~~~~~-------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
+.|.. ..+++++..+.||+.+||+.||.+|++.+|+|.|+||.+
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 22221 123568899999999999999999999999999999954
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-56 Score=440.27 Aligned_cols=256 Identities=34% Similarity=0.612 Sum_probs=235.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.-|++++.||+|+-|.|.+|++.. +|+.+|||+|.+...........+.+||-||+.|. ||||+++|++|++..++
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~---TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAE---TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHL 87 (786)
T ss_pred cceeccccccCCCCceehhhhccc---ccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceE
Confidence 469999999999999999999887 99999999998874444445567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+|.||++||.|++++..+ +.+++.+++++++||+.|+.|||..+|+||||||+|+|++ ...+|||+|||+|..-.
T Consensus 88 ylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd---~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD---VKNNIKIADFGMASLEV 163 (786)
T ss_pred EEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh---cccCEeeeccceeeccc
Confidence 9999999999999999876 6899999999999999999999999999999999999995 55559999999999888
Q ss_pred CCCCccccccCCCcCchhhhhcc--CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.+.-+.+.||+++|.|||++.+. -+.++||||+|||||.||||+.||.+++-..++.++.++...++. ++|.++
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs----~Is~ea 239 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS----NISSEA 239 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----cCCHHH
Confidence 88888999999999999999853 478999999999999999999999999999999999998877763 599999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
++||++||+.||.+|+|.+||++|||+...
T Consensus 240 QdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 240 QDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred HHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 999999999999999999999999999864
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-55 Score=435.76 Aligned_cols=258 Identities=28% Similarity=0.521 Sum_probs=238.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|+++++||+|+||+|+++..+. +++.||||++++........++..+.|.+|+.....||.+++++..|+..++
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~---~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKG---TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcC---CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3589999999999999999999987 8899999999999988888999999999999999889999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+.||++..+ .+.+.+++..++.|+..|+.||.|||++||||||||.+|||+ |.++++||+|||+++..
T Consensus 444 l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEeccccccccc
Confidence 9999999999995443 345789999999999999999999999999999999999999 67889999999999865
Q ss_pred C-CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 R-PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~-~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
- .+....++|||+.|||||++. ..|+.++|+|||||+|||||.|+.||.++++.+++..|+..++.|+.. +|.+
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~----ls~e 594 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF----LSKE 594 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCc----ccHH
Confidence 4 456778899999999999997 469999999999999999999999999999999999999998888754 8999
Q ss_pred HHHHHHHhcccCcCCCCCH-----HHHhcCCCcCCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTA-----AQALTHPWLHDEN 393 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~-----~e~L~hp~~~~~~ 393 (461)
+.++++++|.+||.+|..+ .+|.+||||+..+
T Consensus 595 a~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 595 AIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred HHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 9999999999999999864 7899999998753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-55 Score=424.54 Aligned_cols=264 Identities=30% Similarity=0.526 Sum_probs=234.3
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
+....+.|+.+++||+|+||.||+|++.. +|+.||+|.++.+.... ....-..|||.||++|. ||||++|.+...
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~---tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~-HpNIikL~eivt 186 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLE---TGKIVALKKVRFDNEKE-GFPITAIREIKILRRLD-HPNIIKLEEIVT 186 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecc---cCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcC-CCcccceeeEEE
Confidence 34445689999999999999999999877 99999999998776433 33455678999999995 999999999987
Q ss_pred eC--CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 200 DA--NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 200 ~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
+. +.+|||+|||+. ||..++....-+|++.+++.|++||+.||+|||.+||+|||||.+|||| ++++.+||+||
T Consensus 187 ~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDF 262 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADF 262 (560)
T ss_pred ecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccc
Confidence 76 789999999976 8988887767789999999999999999999999999999999999999 57888999999
Q ss_pred ccccccCCCC--CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCC
Q 012518 278 GLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 353 (461)
Q Consensus 278 G~a~~~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 353 (461)
|||+++.... .++..+.|.||+|||+|.| .|+.++|+||+||||.||++|++.|.+.++.+++..|++......+.
T Consensus 263 GLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 263 GLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred cceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 9999876654 5788899999999999875 59999999999999999999999999999999999999887666666
Q ss_pred CCC-------------------------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 354 PWP-------------------------SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 354 ~~~-------------------------~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.|+ .++..+.+|+..||..||.+|.||.++|+|+||...
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 664 257899999999999999999999999999999543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=388.13 Aligned_cols=259 Identities=31% Similarity=0.523 Sum_probs=231.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|...++||+|.||+||+|++.. +|+.||||.|+..+..+... ....|||+.|+.++ |+||+.++++|-..+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~-h~nIi~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---TGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELK-HPNIIELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---CCcEEEEEEeeccccccCcc-HHHHHHHHHHHHcc-CcchhhhhhhccCCCce
Confidence 478899999999999999999877 89999999998876554433 34568999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
.||+||++. +|+..+..+...++..+++.|+.+++.||+|||++.|+||||||+|+|++ .++.+||+|||+|+.+.
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARFFG 152 (318)
T ss_pred EEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhccC
Confidence 999999975 99998888878899999999999999999999999999999999999995 57789999999999887
Q ss_pred CCC-CccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCC----
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS---- 357 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~---- 357 (461)
... ..+..+-|.||+|||.+. +.|+..+||||.|||+.||+-|.+-|.+.++-+++..|++.-.......|++
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 544 334458899999999986 4699999999999999999999999999999999999998877766666654
Q ss_pred --------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 358 --------------------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 358 --------------------~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.+.++.||+.+||..||.+|+++.|+|+|+||...
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 36888999999999999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-54 Score=420.95 Aligned_cols=261 Identities=29% Similarity=0.531 Sum_probs=227.1
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
.......|...++||+|+.|.||.|+... +++.||||.+....... .+-+.+|+.+|+.++ |+|||++++.|.
T Consensus 268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~---~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~-H~NiVnfl~Syl 340 (550)
T KOG0578|consen 268 QGDPRSKYTDFKKIGQGATGGVYVARKIS---TKQEVAIKRMDLRKQPK---KELLLNEILVMRDLH-HPNIVNFLDSYL 340 (550)
T ss_pred CCChhhhhcchhhhccccccceeeeeecc---CCceEEEEEEEeccCCc---hhhhHHHHHHHHhcc-chHHHHHHHHhc
Confidence 34445679999999999999999999876 78999999998765543 366889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
..+.+|+||||++||+|.|.+.. ..++|.+++.|+++++.||+|||.+||+|||||.+|||++ .++.+||+|||+
T Consensus 341 v~deLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~~g~vKltDFGF 415 (550)
T KOG0578|consen 341 VGDELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---MDGSVKLTDFGF 415 (550)
T ss_pred ccceeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---cCCcEEEeeeee
Confidence 89999999999999999998754 3599999999999999999999999999999999999995 566799999999
Q ss_pred ccccCCCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHh-cCCCCCCCCCC
Q 012518 280 SDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR-ADPNFHDSPWP 356 (461)
Q Consensus 280 a~~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~ 356 (461)
+..+.... +-.+.+||++|||||++. ..|++++||||||++++||+-|++||...+....+..|.. +.+.+ ..+.
T Consensus 416 caqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l--k~~~ 493 (550)
T KOG0578|consen 416 CAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL--KNPE 493 (550)
T ss_pred eeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc--CCcc
Confidence 98877655 667899999999999997 5799999999999999999999999987666555555543 33333 3346
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
.+|++++|||.+||+.|+.+|++|.|+|+||||+....
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP 531 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence 79999999999999999999999999999999965543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=395.18 Aligned_cols=261 Identities=35% Similarity=0.642 Sum_probs=239.4
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEeccccc-----CCHHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM-----TSALAIEDVRREVKILKALSGHKHMIKFHDA 197 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~ 197 (461)
+-..|+-.+.||.|..++|.++..+. +|..+|+|+|..... .-...++.-.+|+.||+++.+||+|+++.++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~---t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKE---TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcc---cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 34578888999999999999888877 889999999864321 1233456677899999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 198 FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 198 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
|+.+..+++|+|.|+.|.|+|++.+. -.++|..++.|++|++.|++|||.++||||||||+|||+ +++.++||+||
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDF 167 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDF 167 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEecc
Confidence 99999999999999999999999665 579999999999999999999999999999999999999 57788999999
Q ss_pred ccccccCCCCCccccccCCCcCchhhhh-------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC
Q 012518 278 GLSDFVRPDQRLNDIVGSAYYVAPEVLH-------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 278 G~a~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
|+|+.+..+.++...||||+|.|||.+. ..|+..+|+||+|||||.|+.|.+|||.....-+++.|..++..|
T Consensus 168 GFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF 247 (411)
T KOG0599|consen 168 GFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF 247 (411)
T ss_pred ceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence 9999999999999999999999999884 248999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
..+.|.++|.+.+|||.+||+.||.+|+|++|+|+||||.
T Consensus 248 ~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 248 RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 9999999999999999999999999999999999999994
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-54 Score=396.18 Aligned_cols=261 Identities=28% Similarity=0.467 Sum_probs=229.2
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--eC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE--DA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~--~~ 201 (461)
-++|+.+.+|++|+||.||+|++++ +++.||+|.++.+.......+. ..|||.+|.+++ |||||.+-++.. +-
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~---t~eIVALKr~kmekek~GFPIt-sLREIniLl~~~-H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKK---TDEIVALKRLKMEKEKEGFPIT-SLREINILLKAR-HPNIVEVKEVVVGSNM 149 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCC---cceeEEeeecccccccCCCcch-hHHHHHHHHhcC-CCCeeeeEEEEecccc
Confidence 3579999999999999999999987 8999999999876543333333 358999999997 999999998875 44
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+.+|||||||+. ||...+..-..++...+++.++.|++.||+|||.+.|+|||||++|+|++ +.+.+||+|||+|+
T Consensus 150 d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~---~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 150 DKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS---HKGILKIADFGLAR 225 (419)
T ss_pred ceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec---cCCcEEecccchhh
Confidence 679999999976 88888877777899999999999999999999999999999999999996 57779999999999
Q ss_pred ccCCC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCC-
Q 012518 282 FVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS- 357 (461)
Q Consensus 282 ~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~- 357 (461)
.+... ..++..+-|.||+|||.+-+ .|++++||||+|||+.||+++++.|.+..+.+++..|++......+..|++
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 88654 45788899999999999864 599999999999999999999999999999999999998766666666653
Q ss_pred ---------------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 358 ---------------------------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 358 ---------------------------~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
+++...+|++.+|..||.+|.||.|+|+|.||.+..
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 458889999999999999999999999999998753
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=404.53 Aligned_cols=260 Identities=32% Similarity=0.550 Sum_probs=235.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||.|.-|+||+|+.+. ++..+|+|++.+..+.....+.++..|-+||+.+ +||.++.||..|+.++..
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~---t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRG---TNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYS 152 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecC---CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeecccee
Confidence 589999999999999999999876 6799999999998888788888899999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
|+|||||.||+|....+++ ++.+++..++.++.+++.||+|||..|||+|||||||||| .++++|-|+||.|+...
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccC
Confidence 9999999999998877665 4579999999999999999999999999999999999999 57899999999986321
Q ss_pred C----------------------------------C-C----------------------CCccccccCCCcCchhhhhc
Q 012518 284 R----------------------------------P-D----------------------QRLNDIVGSAYYVAPEVLHR 306 (461)
Q Consensus 284 ~----------------------------------~-~----------------------~~~~~~~gt~~y~aPE~l~~ 306 (461)
. . . .+...++||-.|.|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 0 0 0 11234689999999999986
Q ss_pred -cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC----HH
Q 012518 307 -SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT----AA 381 (461)
Q Consensus 307 -~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~ 381 (461)
..+.++|+|+|||+||||+.|..||.+.+..+.+.+|+.....|+..+ .++..++|||+++|.+||.+|.. |+
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~ 387 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAA 387 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchH
Confidence 599999999999999999999999999999999999999999988764 78999999999999999999998 99
Q ss_pred HHhcCCCcCCCC
Q 012518 382 QALTHPWLHDEN 393 (461)
Q Consensus 382 e~L~hp~~~~~~ 393 (461)
||.+||||+..+
T Consensus 388 eIK~HpFF~gVn 399 (459)
T KOG0610|consen 388 EIKRHPFFEGVN 399 (459)
T ss_pred HhhcCccccCCC
Confidence 999999998864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-54 Score=388.90 Aligned_cols=249 Identities=28% Similarity=0.521 Sum_probs=216.7
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEE-EEEe
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHD-AFED 200 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~-~~~~ 200 (461)
.-..+|+++++||+|+||+||+|.+.. +|+.||.|.|.... .+....+++..|+.+|++|+ |||||++++ .|.+
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~---~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~ 90 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLL---DGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIE 90 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeecc---Ccchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhc
Confidence 344589999999999999999999876 89999999998554 45667788999999999996 999999998 5555
Q ss_pred CCe-EEEEEeccCCCchHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH--cC--ccccCCCCCcEEEecCCCCCCe
Q 012518 201 ANS-VYIVMEFCEGGELLDRIL---SRGGRYLEEDAKTIVEKILNIVAFCHL--QG--VVHRDLKPENFLFTTREEDAPL 272 (461)
Q Consensus 201 ~~~-~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~i~~qil~al~yLH~--~g--ivHrDlkp~NILl~~~~~~~~~ 272 (461)
++. ++||||||.+|+|...+. +....++|..++.++.|++.||..||+ .. |+||||||.||+++ .++.|
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~---~~gvv 167 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT---ANGVV 167 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc---CCCce
Confidence 555 999999999999987664 345679999999999999999999999 44 99999999999995 67789
Q ss_pred eEeecccccccCCCCC-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC
Q 012518 273 KVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 273 kl~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
||+|||+++++..... ..+.+|||+||+||++. ..|+.++||||+||++|||+.-+.||.+.+-.++-++|.+++.
T Consensus 168 KLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~-- 245 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY-- 245 (375)
T ss_pred eeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC--
Confidence 9999999999876554 36789999999999997 5699999999999999999999999999998899999988743
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCH
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 380 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~ 380 (461)
+..+-..+|.++..+|..|+..||.+||+.
T Consensus 246 ~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 246 PPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 222223589999999999999999999986
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-53 Score=406.25 Aligned_cols=262 Identities=32% Similarity=0.644 Sum_probs=225.5
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH-----------HHHHHHHHHHHHHHhcCCC
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA-----------LAIEDVRREVKILKALSGH 188 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~~h 188 (461)
+...-++|++++.||+|.||.|-+|++.. +|+.||||++.+...... ...+.+.+||.||++|. |
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~---~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H 167 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEV---DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-H 167 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecC---CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-C
Confidence 34455799999999999999999999876 899999999976533211 22468999999999996 9
Q ss_pred CCeeEEEEEEEe--CCeEEEEEeccCCCchHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEec
Q 012518 189 KHMIKFHDAFED--ANSVYIVMEFCEGGELLDRILSRGGR-YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 265 (461)
Q Consensus 189 pniv~l~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~-~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~ 265 (461)
||||+|+++..+ .+.+|||+|||..|.+.+ .- .... +++.+++.|+++++.||+|||.+|||||||||+|+||+
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w-~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~- 244 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW-CP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS- 244 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCcccc-CC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc-
Confidence 999999999976 467999999999998853 22 2334 89999999999999999999999999999999999995
Q ss_pred CCCCCCeeEeecccccccC------CCCCccccccCCCcCchhhhhc-----cCCCchhHHHHHHHHHHHhhCCCCCCCC
Q 012518 266 REEDAPLKVIDFGLSDFVR------PDQRLNDIVGSAYYVAPEVLHR-----SYNVEGDMWSIGVITYILLCGSRPFWAR 334 (461)
Q Consensus 266 ~~~~~~~kl~DFG~a~~~~------~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlGvil~elltg~~Pf~~~ 334 (461)
.+++|||+|||.+.... .+..+...+|||.|+|||...+ ..+.+.||||+||+||.|+.|+.||.+.
T Consensus 245 --~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 245 --SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred --CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 56889999999988662 2223455899999999998754 1467899999999999999999999999
Q ss_pred ChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 335 TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 335 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
...+++.+|.+....|+.. +.+.++++|||.+||++||.+|++..++..|||....
T Consensus 323 ~~~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 323 FELELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hHHHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9999999999988887765 4689999999999999999999999999999999755
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=388.68 Aligned_cols=261 Identities=36% Similarity=0.670 Sum_probs=235.4
Q ss_pred cccceeec-eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--
Q 012518 123 FGAKFELG-KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE-- 199 (461)
Q Consensus 123 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~-- 199 (461)
+.++|.+- ++||-|-.|.|..+.++. +|+.+|+|++... ...++|+++....+.|+|||.++++|+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~---T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKR---TQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred chhhheehhhhhccccCCceEEEEecc---chhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 44567765 479999999999998887 8999999998643 345689999988889999999999885
Q ss_pred --eCCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 200 --DANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 200 --~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
...++.+|||.++||+|+.++..++ ..|+|.++..|++||..|+.|||+.+|.||||||+|+|+++...+..+||+|
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence 3567899999999999999998775 3599999999999999999999999999999999999999988999999999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC----hhhHHHHHHhcCCCCC
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART----ESGIFRSVLRADPNFH 351 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~ 351 (461)
||+|+.......+.+.|-|++|.|||++. ..|+..+|+||+||++|.|++|.+||+... ..++...|..+...|+
T Consensus 208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred cccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 99999877777788899999999999997 569999999999999999999999998654 3567888999999999
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 352 DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 352 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
...|..+|++++|+|+++|..+|.+|.|+.++++|||+.....
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 9999999999999999999999999999999999999987643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-54 Score=418.74 Aligned_cols=254 Identities=30% Similarity=0.613 Sum_probs=230.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|.+.+.||+|+||+||+|+.|. +++.||+|.+.+... ....++.+.+|++|++.|+ |||||.++++|+...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~---t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY---TIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc---ceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceE
Confidence 478899999999999999999876 889999999988764 4456788999999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+|+|||.| +|..++ ..++.++|+.++.+..|++.||.|||+++|+|||+||.|||+ +..+.+|+||||+|+.+.
T Consensus 77 ~vVte~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMS 151 (808)
T ss_pred EEEehhhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcc
Confidence 999999987 998766 566899999999999999999999999999999999999999 578889999999999887
Q ss_pred CCCC-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.+.. .+.+.|||.|||||++. +.|+..+|+||||||+|||++|++||....-..+.+.|+......+. ..|.++
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f 227 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSF 227 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHH
Confidence 6653 46678999999999987 56999999999999999999999999999999999999887655443 689999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+.|+..+|.+||.+|.+..+++.|||++..
T Consensus 228 ~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 228 VNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 999999999999999999999999999753
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=402.23 Aligned_cols=257 Identities=33% Similarity=0.633 Sum_probs=238.3
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
.+...+|++.+.||+|+||.|-+|.... .|+.||||.|++++..++..+-.+++||+||..|+ ||||+.+|++|+.
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~---sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFEN 124 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHK---SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFEN 124 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhcc---CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcC
Confidence 3455689999999999999999998866 89999999999999999999999999999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+.+.|||||..+|+|+|++..+ +.++|.+++.+++||+.|+.|||.++++|||||.+|||+ |+++++||+|||++
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLS 200 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLS 200 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchh
Confidence 99999999999999999999665 789999999999999999999999999999999999999 57788999999999
Q ss_pred cccCCCCCccccccCCCcCchhhhhcc--CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
..+....-++++||++-|.+||++++. -++.+|-|||||+||.|+.|..||++.+...+++.|.++.+.-+. -
T Consensus 201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~ 275 (668)
T KOG0611|consen 201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----T 275 (668)
T ss_pred hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----C
Confidence 999888888999999999999999863 478999999999999999999999999999999999887654433 4
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
+.++.-||+.||..||.+|.|+.++..|-|++
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 56899999999999999999999999999985
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=377.81 Aligned_cols=255 Identities=31% Similarity=0.636 Sum_probs=233.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|-||.||+|+.++ ++..||+|++-+........-.++.+|++|...|+ ||||+++|++|.+...+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekk---s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKK---SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRI 97 (281)
T ss_pred hhccccccccCCccccEeEeeecc---CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheecccee
Confidence 589999999999999999999987 88999999998776555555678999999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
||++||..+|+|+..|... ..++++..++.++.|++.||.|||.++||||||||+|+|++. .+.+||+|||.+...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~---~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGS---AGELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCC---CCCeeccCCCceeec
Confidence 9999999999999988643 467999999999999999999999999999999999999964 556999999998765
Q ss_pred CCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
. ..+..+.|||..|.+||+.. ..++..+|+|++||+.||++.|..||...+..+.++.|.+.+..++ ..++.++
T Consensus 175 p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a 249 (281)
T KOG0580|consen 175 P-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGA 249 (281)
T ss_pred C-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhH
Confidence 5 56667899999999999987 4699999999999999999999999999999999999999988777 3589999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
+|||.+||.++|.+|....|++.|||+..
T Consensus 250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 250 ADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999999999865
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=393.14 Aligned_cols=263 Identities=29% Similarity=0.498 Sum_probs=228.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
...+|++...||.|..++||+|++.. +++.||||++..++.... ++.+.+|+..|+.+. ||||+.++..|..+.
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p---~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIP---TNEVVAIKIINLEKCNND--LDALRKEVQTMSLID-HPNIVTYHCSFVVDS 97 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecc---cCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcC-CCCcceEEEEEEecc
Confidence 34689999999999999999999987 789999999988776543 788999999999995 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
.+|+||.||.+|++++.+.... ..+.|..+..|++++++||.|||.+|.||||||+.|||| +.++.|||+|||.+.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSA 174 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeee
Confidence 9999999999999999887652 348899999999999999999999999999999999999 578889999999877
Q ss_pred ccCCCC-----CccccccCCCcCchhhhh---ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC---
Q 012518 282 FVRPDQ-----RLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF--- 350 (461)
Q Consensus 282 ~~~~~~-----~~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~--- 350 (461)
.+.... ++.+++||++|||||++. ..|+.|+||||||++..||.+|..||.......++-.-+++.+..
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT 254 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence 654432 225679999999999965 359999999999999999999999998887777666666665532
Q ss_pred ---CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 351 ---HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 351 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
.......++..++++|..||++||.+|||+.++|+|+||+....
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 22223457889999999999999999999999999999987643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=399.51 Aligned_cols=257 Identities=33% Similarity=0.552 Sum_probs=213.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC--
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN-- 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~-- 202 (461)
.+|..++.||+|+||+||++.+++ +|+.+|||.+.... ... .+.+.+|+.+|++|+ |||||+++|......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~---~g~~~AvK~v~~~~--~~~-~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~ 89 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK---TGELMAVKSVELED--SPT-SESLEREIRILSRLN-HPNIVQYYGSSSSREND 89 (313)
T ss_pred chhhhhccccCccceEEEEEEecC---CCcceeeeeeeccc--chh-HHHHHHHHHHHHhCC-CCCEEeeCCccccccCe
Confidence 468889999999999999999887 68999999987652 121 677899999999997 999999999855444
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.++++|||+.+|+|.+++...++.++|..++.+.+||+.||.|||++|||||||||+|||++.. ++.+||+|||++..
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~--~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS--NGDVKLADFGLAKK 167 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC--CCeEEeccCccccc
Confidence 6999999999999999988776689999999999999999999999999999999999999531 57799999999987
Q ss_pred cCC----CCCccccccCCCcCchhhhhccCC--CchhHHHHHHHHHHHhhCCCCCCCC-ChhhHHHHHHhcCCCCCCCCC
Q 012518 283 VRP----DQRLNDIVGSAYYVAPEVLHRSYN--VEGDMWSIGVITYILLCGSRPFWAR-TESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 283 ~~~----~~~~~~~~gt~~y~aPE~l~~~~~--~~~DiwSlGvil~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~ 355 (461)
... ........||+.|||||++..... .++|||||||++.||+||..||... ...+.+-.+.... ..+ ...
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P-~ip 245 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP-EIP 245 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC-CCC
Confidence 663 122345789999999999974333 4999999999999999999999773 3333333333333 111 222
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..+|+++++||.+||.+||++||||.++|+|||.+..
T Consensus 246 ~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 246 DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 4599999999999999999999999999999999764
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=396.48 Aligned_cols=262 Identities=33% Similarity=0.640 Sum_probs=240.8
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+..=|.+.+.||+|.|.+|-+|++-- +|+.||||+|++.++. ......+.+|++.|+.++ |||||+||++....
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVF---TGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQ 89 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQ 89 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhc---ccceeEEEEecccccc-hhhhhHHHHHHHHHHHhc-CcCeeeeeehhccc
Confidence 345579999999999999999998765 9999999999988764 345567889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
..+|||+|+-++|+|+|+|.++...+.|+.+++|++||+.|+.|||+..+|||||||+||++. ..-+.|||.|||++.
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSN 167 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccc
Confidence 999999999999999999999988999999999999999999999999999999999999997 456789999999999
Q ss_pred ccCCCCCccccccCCCcCchhhhhc-cCC-CchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLHR-SYN-VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
.+.++.++++.||+..|-|||++.+ .|+ +++||||||||||.|++|+.||...++.+.+..|+..++..+. .+|
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS 243 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVS 243 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhh
Confidence 9999999999999999999999875 465 6899999999999999999999999999999999998877664 489
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
.+++|||..||..||++|.+.++|..|+|++....
T Consensus 244 ~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 244 KECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 99999999999999999999999999999997654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=402.88 Aligned_cols=259 Identities=29% Similarity=0.511 Sum_probs=220.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++++...........+.+|+.++..+. |+||+++++.+.+.+.+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~ 76 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---TGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNL 76 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeE
Confidence 379999999999999999999876 78999999998755444455677889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 77 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~---~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLK 152 (363)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCCEEEeeccCccccc
Confidence 9999999999999988654 6799999999999999999999999999999999999994 56789999999987543
Q ss_pred CCC------------------------------------CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhC
Q 012518 285 PDQ------------------------------------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCG 327 (461)
Q Consensus 285 ~~~------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg 327 (461)
... .....+||+.|+|||++. ..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 211 012458999999999986 4699999999999999999999
Q ss_pred CCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcC---CCCCHHHHhcCCCcCCC
Q 012518 328 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHR---KRMTAAQALTHPWLHDE 392 (461)
Q Consensus 328 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~---~R~s~~e~L~hp~~~~~ 392 (461)
..||.+.+..+.+..+..............+++++++||.+|+. +|. .||+++|+++||||++.
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 233 YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 99999988888888887654333333334589999999999876 444 45899999999999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=380.34 Aligned_cols=262 Identities=31% Similarity=0.506 Sum_probs=225.8
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCC-eeEEEEEEEeCC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH-MIKFHDAFEDAN 202 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn-iv~l~~~~~~~~ 202 (461)
...|+.+++||+|+||+||+|+.+. +|+.||+|.++..... +..-....+|+.+|+.|+ |+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~---~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKR---TGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEec---CCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecc
Confidence 3468888999999999999999987 8999999999765322 112234568999999997 999 999999998877
Q ss_pred ------eEEEEEeccCCCchHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCee
Q 012518 203 ------SVYIVMEFCEGGELLDRILSRG---GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 273 (461)
Q Consensus 203 ------~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~k 273 (461)
.++|||||++. +|..++.... ..++...++.+++||+.||.|||++||+||||||+||||+ .++.+|
T Consensus 85 ~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~---~~G~lK 160 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS---SSGVLK 160 (323)
T ss_pred cccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC---CCCcEe
Confidence 89999999975 8988887665 3577789999999999999999999999999999999995 578899
Q ss_pred EeecccccccC-CCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC
Q 012518 274 VIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 274 l~DFG~a~~~~-~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
|+|||+|+... +....+..++|.+|+|||++.+ .|+..+||||+|||++||++++..|.+.++.+++..|++.-...
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 99999999776 3445778899999999999865 59999999999999999999999999999999999998766555
Q ss_pred CCCCCCC--------------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 351 HDSPWPS--------------------------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 351 ~~~~~~~--------------------------~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
....|+. .++++.+++.+||+.+|.+|.|++.+|.||||.....
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 5555543 3468999999999999999999999999999987643
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=382.35 Aligned_cols=260 Identities=33% Similarity=0.578 Sum_probs=220.0
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED-- 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~-- 200 (461)
...+|...+.||+|+||.|+.|.++. +|+.||||.+... +.+....++..||+.+|+.++ |+||+.+++++..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~---t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKR---TGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPS 94 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcC---CCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccccc
Confidence 44567778999999999999999987 8899999998632 344556678889999999997 9999999999864
Q ss_pred ---CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 201 ---ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 201 ---~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
-+.+|+|+|+|+ -+|...+ +.+..++++.++.++.||++||+|+|+.+|+||||||.|+|++ .+..+|||||
T Consensus 95 ~~~f~DvYiV~elMe-tDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n---~~c~lKI~DF 169 (359)
T KOG0660|consen 95 RDKFNDVYLVFELME-TDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN---ADCDLKICDF 169 (359)
T ss_pred ccccceeEEehhHHh-hHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec---cCCCEEeccc
Confidence 456999999994 4776655 4545699999999999999999999999999999999999995 5566999999
Q ss_pred ccccccCC---CCCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC-----
Q 012518 278 GLSDFVRP---DQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD----- 347 (461)
Q Consensus 278 G~a~~~~~---~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~----- 347 (461)
|+|+.... ...++..+.|.||+|||++. ..|+.++||||+||||.||++|++.|.+.+...++..|+..-
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 99998864 45568899999999999874 569999999999999999999999999888777666665332
Q ss_pred ------------------CCCCCCC----CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 348 ------------------PNFHDSP----WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 348 ------------------~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+..+..+ +++.++.+.||+.+||..||.+|+|++|+|+||||...
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 2222222 36789999999999999999999999999999999765
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=399.09 Aligned_cols=254 Identities=32% Similarity=0.603 Sum_probs=223.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRV 93 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEE
Confidence 589999999999999999999876 78999999997654444445677889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD---NKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC---CCCCEEEeeccCceEcC
Confidence 9999999999999988654 5789999999999999999999999999999999999994 56789999999998664
Q ss_pred CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
.. ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+..+......++. .++..++
T Consensus 170 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~ 243 (329)
T PTZ00263 170 DR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRAR 243 (329)
T ss_pred CC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHH
Confidence 32 23468999999999986 45899999999999999999999999988888888888776544432 3789999
Q ss_pred HHHHHhcccCcCCCCC-----HHHHhcCCCcCCC
Q 012518 364 DFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 392 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 392 (461)
+||.+||+.||.+|++ ++++++||||.+.
T Consensus 244 ~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 244 DLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 9999999999999997 7999999999764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=389.45 Aligned_cols=259 Identities=26% Similarity=0.441 Sum_probs=217.1
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
|++.+.||+|+||+||+|.++. +|+.||||.+.+...........+.+|+.+++++. |+||++++++|.+.+.+++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~l 77 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCL 77 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEec---CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEE
Confidence 7889999999999999999876 78999999997655443334456788999999996 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 207 VMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~---~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD---DRGHIRISDLGLAVQIPE 154 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeCCCcEEcCC
Confidence 999999999988775443 4688999999999999999999999999999999999994 567799999999987655
Q ss_pred CCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 012518 286 DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364 (461)
Q Consensus 286 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 364 (461)
........||..|+|||++. ..++.++|||||||++|+|++|+.||...........+..............+++++.+
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 234 (285)
T cd05631 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS 234 (285)
T ss_pred CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHH
Confidence 44555678999999999986 56999999999999999999999999876554333322222111122223468999999
Q ss_pred HHHHhcccCcCCCCC-----HHHHhcCCCcCCC
Q 012518 365 FVRRLLNKDHRKRMT-----AAQALTHPWLHDE 392 (461)
Q Consensus 365 li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 392 (461)
||++||+.||.+|++ ++++++||||.+.
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 999999999999997 8999999999775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=392.20 Aligned_cols=254 Identities=28% Similarity=0.540 Sum_probs=223.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|.++. +|+.||||++...........+.+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 76 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFL 76 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeE
Confidence 378999999999999999999876 78999999997654444445567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~---~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 77 YMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD---KEGHIKLTDFGFAKKLR 152 (291)
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEEecCcchhcc
Confidence 9999999999999988654 5789999999999999999999999999999999999994 56779999999998664
Q ss_pred CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
.. ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+......++. .+++.++
T Consensus 153 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~ 226 (291)
T cd05612 153 DR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAK 226 (291)
T ss_pred CC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHH
Confidence 32 33467999999999986 45899999999999999999999999998888888888877655443 4689999
Q ss_pred HHHHHhcccCcCCCCC-----HHHHhcCCCcCCC
Q 012518 364 DFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 392 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 392 (461)
+||++||+.||.+|++ +.|+++||||...
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 9999999999999995 9999999999754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=397.22 Aligned_cols=250 Identities=29% Similarity=0.553 Sum_probs=218.5
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||.||+|+++. +|+.||||++++...........+.+|+.+++.++ ||||++++++|.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeC
Confidence 469999999999999876 78999999998755444455667889999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC-CCCc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRL 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~-~~~~ 289 (461)
+.||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.... ....
T Consensus 77 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 77 ANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD---KDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEeeCCCCcccccCCCcc
Confidence 999999888764 46789999999999999999999999999999999999995 567799999999875432 2334
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 368 (461)
...+||+.|+|||++. ..++.++|||||||++|||++|..||...+.......+......++ ..+++++.+||.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAG 228 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 5578999999999986 4699999999999999999999999998888777777776655443 3589999999999
Q ss_pred hcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 369 LLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 369 ~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
||++||++|+ ++.++++||||...
T Consensus 229 ~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 229 LLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=396.73 Aligned_cols=255 Identities=26% Similarity=0.438 Sum_probs=207.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|+++++||+|+||+||+|+++. +|+.||||++.... .......+.+|+++++.++ |+||++++++|.+.+.+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRP---TGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEI 147 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECC---CCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeE
Confidence 478889999999999999999876 78999999986542 3344567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+|+|.+. ....+..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 148 ~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 148 QVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN---SAKNVKIADFGVSRILA 219 (353)
T ss_pred EEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEcccccceecc
Confidence 999999999998542 2456788889999999999999999999999999999995 56779999999998764
Q ss_pred CCC-CccccccCCCcCchhhhhc------cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLHR------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
... .....+||..|+|||++.. ..+.++|||||||++|||++|+.||......+....+..............
T Consensus 220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (353)
T PLN00034 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT 299 (353)
T ss_pred cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence 332 2345689999999998742 245689999999999999999999974433322222211111111222246
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
++.++++||.+||..||++||++.|+|+||||....
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 899999999999999999999999999999998753
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=401.82 Aligned_cols=259 Identities=30% Similarity=0.566 Sum_probs=223.1
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||+||+|+++. +|+.||||++.+...........+.+|+.+|+.+. |+||++++++|.+.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~ 76 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYL 76 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeE
Confidence 379999999999999999999876 78999999998654444455667889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+.
T Consensus 77 ~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD---AKGHIKLSDFGLCTGLK 152 (364)
T ss_pred EEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEeecccceecc
Confidence 9999999999999988654 5799999999999999999999999999999999999994 67789999999987543
Q ss_pred CCC---------------------------------------CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHH
Q 012518 285 PDQ---------------------------------------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYIL 324 (461)
Q Consensus 285 ~~~---------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~el 324 (461)
... .....+||+.|+|||++. ..++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 211 011347999999999986 5699999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCcCCC
Q 012518 325 LCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT---AAQALTHPWLHDE 392 (461)
Q Consensus 325 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~L~hp~~~~~ 392 (461)
++|..||...+..+.+..+......+.......+++++++||.+||. +|.+|++ +.|+|+||||+..
T Consensus 233 ~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999888888877777655444443334689999999999997 9999998 9999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=401.19 Aligned_cols=259 Identities=29% Similarity=0.502 Sum_probs=219.3
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
.|++++.||+|+||+||+|+++. +|+.||||++.+...........+.+|+.+++.+. |+||+++++++.+.+.+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~ 77 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD---THALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLY 77 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEE
Confidence 68999999999999999999876 78999999998765555556678899999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 78 lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~---~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID---LDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC---CCCCEEEeeCcCCccccc
Confidence 999999999999887654 5789999999999999999999999999999999999994 567899999999753210
Q ss_pred CC------------------------------------------------CccccccCCCcCchhhhh-ccCCCchhHHH
Q 012518 286 DQ------------------------------------------------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWS 316 (461)
Q Consensus 286 ~~------------------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwS 316 (461)
.. .....+||+.|+|||++. ..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 00 012357999999999986 46899999999
Q ss_pred HHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccc--CcCCCCCHHHHhcCCCcCCC
Q 012518 317 IGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK--DHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 317 lGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dP~~R~s~~e~L~hp~~~~~ 392 (461)
|||++|||++|..||...+..+....+...........+..+++++++||.+||.. ++.+|+++.|+++||||...
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 99999999999999988887776666665443444444456899999999996654 55559999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-51 Score=375.17 Aligned_cols=263 Identities=36% Similarity=0.644 Sum_probs=231.0
Q ss_pred cccceeec-eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 123 FGAKFELG-KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 123 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
|.+-|++. +.||+|+|+.|--+.... +|..||||+|.+. ....+.++.||++++.++++|+||++|+++|+++
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~---t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQ---TGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeec---cchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 34456654 579999999999888766 8999999999886 2345678999999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
..+|||||-+.||.|+.+|.++ ..++|.++..+.++|+.||.|||.+||.||||||+|||-...+.-.-||||||.+..
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence 9999999999999999999876 679999999999999999999999999999999999999876666679999998865
Q ss_pred ccCCC--------CCccccccCCCcCchhhhh---c---cCCCchhHHHHHHHHHHHhhCCCCCCCCCh-----------
Q 012518 282 FVRPD--------QRLNDIVGSAYYVAPEVLH---R---SYNVEGDMWSIGVITYILLCGSRPFWARTE----------- 336 (461)
Q Consensus 282 ~~~~~--------~~~~~~~gt~~y~aPE~l~---~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~----------- 336 (461)
-+... ..+.+.+|+..|||||+.. + .|+.++|.||||||||.||+|.+||.+...
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 43221 2345578999999999863 2 499999999999999999999999965432
Q ss_pred ----hhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 337 ----SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 337 ----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..++..|..+...|++..|..+|.+++|||..+|..|+.+|.++.++++|||++..
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 55788999999999999999999999999999999999999999999999999764
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-50 Score=401.69 Aligned_cols=259 Identities=27% Similarity=0.498 Sum_probs=218.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++.+.........+.+.+|+++++.+. ||||++++++|.+.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~ 76 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYL 76 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCee
Confidence 378999999999999999999876 78999999997654444455677889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 77 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~---~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLSTGFH 152 (377)
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEEeecccccccc
Confidence 9999999999999988654 6789999999999999999999999999999999999994 56789999999986321
Q ss_pred CCC------------------------------------------------CccccccCCCcCchhhhh-ccCCCchhHH
Q 012518 285 PDQ------------------------------------------------RLNDIVGSAYYVAPEVLH-RSYNVEGDMW 315 (461)
Q Consensus 285 ~~~------------------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~Diw 315 (461)
... .....+||+.|+|||++. ..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 100 001257999999999986 4699999999
Q ss_pred HHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCC---CCHHHHhcCCCcCCC
Q 012518 316 SIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKR---MTAAQALTHPWLHDE 392 (461)
Q Consensus 316 SlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---~s~~e~L~hp~~~~~ 392 (461)
||||++|||++|..||......+.+..+......+..+....++.++++||.+||. +|.+| +++.|++.||||.+.
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999999999999888877777777544333333334589999999999998 67665 599999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-52 Score=394.39 Aligned_cols=261 Identities=28% Similarity=0.514 Sum_probs=223.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
..|...+.||+|+||.||+|.+.. +++.||+|++..... ...++++.+|+.+|.++. ++||.++|+.|..+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~---t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK---TKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccchhccccccceeeeeeecc---ccceEEEEEechhhc--chhhHHHHHHHHHHHhcC-cchHHhhhhheeecccH
Confidence 467888999999999999999887 899999999987643 345788999999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|++||||.||++.+.+. .+..+.|..+..++++++.||.|||..+.+|||||+.|||+. .++.+||+|||++....
T Consensus 87 wiiMey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeee
Confidence 99999999999999774 344558899999999999999999999999999999999997 45779999999998876
Q ss_pred CCC-CccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
... +..+++||+.|||||++.+ .|+.++||||||++.|||++|.+|+........+..|-+..+..-. ..+|+.+
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~---~~~S~~~ 239 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD---GDFSPPF 239 (467)
T ss_pred chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc---cccCHHH
Confidence 554 3378999999999999985 7999999999999999999999999777664444444333322222 2589999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCCc
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPL 398 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~ 398 (461)
++||..||++||+.||+|.++|+|.|++...+...+
T Consensus 240 kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L 275 (467)
T KOG0201|consen 240 KEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTSEL 275 (467)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCchHH
Confidence 999999999999999999999999999885443333
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=383.85 Aligned_cols=255 Identities=25% Similarity=0.434 Sum_probs=213.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|+++. +++.||+|+++..... .....+.+|+.+++++. |+||+++++++.+.+..
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEE--GAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCL 78 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECC---CCCEEEEEEecccccC--CcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeE
Confidence 479999999999999999999876 7899999998754322 12345678999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+ +|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN---EKGELKLADFGLARAKS 154 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEECcCcceeecc
Confidence 999999975 89888876666789999999999999999999999999999999999995 56779999999987654
Q ss_pred CC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCC--------
Q 012518 285 PD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS-------- 353 (461)
Q Consensus 285 ~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-------- 353 (461)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+..........
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 32 23345678999999998853 58999999999999999999999998887766665554322111100
Q ss_pred ------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 354 ------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 354 ------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
..+.+++++++||.+||+.||.+|+|++|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 123568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=393.20 Aligned_cols=258 Identities=31% Similarity=0.540 Sum_probs=223.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|+++. +|+.||||++.+...........+.+|+.++..+. ||||+++++++.+.+.+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~ 76 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYL 76 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEE
Confidence 379999999999999999999876 78999999998654444445567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSKGIV 152 (333)
T ss_pred EEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEEEeCcCCcccc
Confidence 999999999999998754 45789999999999999999999999999999999999994 56789999999998654
Q ss_pred CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC----CCCC
Q 012518 285 PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW----PSVS 359 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s 359 (461)
. .....+||+.|+|||++. ..++.++|||||||++|||++|..||...+..+.+..+......+....+ ..++
T Consensus 153 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 153 T--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred c--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence 3 335568999999999986 46899999999999999999999999988887777777654433332222 2579
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+++.+||.+||..+|.+|+++.++++||||.+.
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=400.72 Aligned_cols=258 Identities=30% Similarity=0.533 Sum_probs=221.4
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
.|++++.||+|+||+||+|+++. +++.||||++.+...........+.+|+.+++.+. |+||+++++.|.+.+.+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~ 77 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD---TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLY 77 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEE
Confidence 68999999999999999999876 78999999998755444555678899999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 78 lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~---~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEeECCCCccccc
Confidence 999999999999987654 5789999999999999999999999999999999999994 577899999999753210
Q ss_pred C------------------------------------------------CCccccccCCCcCchhhhh-ccCCCchhHHH
Q 012518 286 D------------------------------------------------QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWS 316 (461)
Q Consensus 286 ~------------------------------------------------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwS 316 (461)
. ......+||+.|+|||++. ..|+.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 0 0012357999999999986 46999999999
Q ss_pred HHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCcCCC
Q 012518 317 IGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT---AAQALTHPWLHDE 392 (461)
Q Consensus 317 lGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~L~hp~~~~~ 392 (461)
|||+||||++|+.||.+.+..+....+...........+..+++++.+||.+|+ .||.+|++ ++++++||||+..
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 999999999999999988877777777765555554555678999999999987 59999997 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=393.21 Aligned_cols=256 Identities=29% Similarity=0.521 Sum_probs=223.0
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||+|+||.||+|.++.. .+..||+|++.+.........+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESY 105 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECC--CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCE
Confidence 35799999999999999999987541 34689999997655444455677889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+.||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEecCCCCeec
Confidence 99999999999999888654 5799999999999999999999999999999999999994 5778999999999876
Q ss_pred CCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.. .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+....+..+......++ ..+++++
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~ 255 (340)
T PTZ00426 182 DT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNC 255 (340)
T ss_pred CC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHH
Confidence 43 2345689999999999864 589999999999999999999999999888888888877655443 3478999
Q ss_pred HHHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
++||++||+.||.+|+ +++++++||||.+.
T Consensus 256 ~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999996 89999999999764
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=398.08 Aligned_cols=260 Identities=28% Similarity=0.506 Sum_probs=224.7
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||+|+||.||+|+++. +|+.||||++.+...........+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKY 117 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCE
Confidence 4589999999999999999999876 78999999997654444444566788999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+|||||.||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc---CCCCEEEEeccceeec
Confidence 9999999999999987754 3588999999999999999999999999999999999994 6778999999999876
Q ss_pred CCCC--CccccccCCCcCchhhhhc-----cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 284 RPDQ--RLNDIVGSAYYVAPEVLHR-----SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 284 ~~~~--~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
.... .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+....+..+.............
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence 4332 2245679999999999853 37899999999999999999999999988888888887765444444445
Q ss_pred CCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCcCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDE 392 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~ 392 (461)
.+|.++++||.+||+.+|.+ |++++|+++||||++.
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 68999999999999999988 9999999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=400.08 Aligned_cols=258 Identities=29% Similarity=0.511 Sum_probs=220.2
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++++.||+|+||+||+|+++. +|+.||||++.+...........+.+|+.+|+.+. |+||+++++.|.+++.+|
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~ 77 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVD---TNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLY 77 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEE
Confidence 79999999999999999999876 78999999997654433444567889999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 78 lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC---CCCCEEEEeCCCCccccc
Confidence 999999999999988654 5789999999999999999999999999999999999994 567899999999753210
Q ss_pred C--------------------------------------------CCccccccCCCcCchhhhh-ccCCCchhHHHHHHH
Q 012518 286 D--------------------------------------------QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVI 320 (461)
Q Consensus 286 ~--------------------------------------------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvi 320 (461)
. ......+||+.|||||++. ..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0 0012357999999999986 458999999999999
Q ss_pred HHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCcCCC
Q 012518 321 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM---TAAQALTHPWLHDE 392 (461)
Q Consensus 321 l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~L~hp~~~~~ 392 (461)
+|||++|+.||.+....+....+......+....+..+++++.+||.+|+ .+|.+|+ ++.++++||||+..
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 99999999999988877777766655544444445678999999999987 5999999 99999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=378.31 Aligned_cols=256 Identities=27% Similarity=0.474 Sum_probs=218.1
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
..-.|+..+++|.|+||.||.|.... +++.||||.+..+.... .+|++||+.+. |||||++..+|...
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e---~~~~vAIKKv~~d~r~k-------nrEl~im~~l~-HpNIV~L~~~f~~~~ 90 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRE---TEEEVAIKKVLQDKRYK-------NRELQIMRKLD-HPNIVRLLYFFSSST 90 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcC---CCceeEEEEecCCCCcC-------cHHHHHHHhcC-CcCeeeEEEEEEecC
Confidence 34478999999999999999999887 68899999986654322 27999999985 99999999888532
Q ss_pred -C---eEEEEEeccCCCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeE
Q 012518 202 -N---SVYIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 202 -~---~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
. ++.+||||++. +|.+.+.. .+.+++.-.++-+..||++||.|||+.||+||||||+|+|++ .+.+.+||
T Consensus 91 ~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKi 167 (364)
T KOG0658|consen 91 ESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKI 167 (364)
T ss_pred CCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEe
Confidence 1 45689999976 88887753 256788899999999999999999999999999999999997 45688999
Q ss_pred eecccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC----
Q 012518 275 IDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP---- 348 (461)
Q Consensus 275 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---- 348 (461)
||||.|+....++...++..|.+|+|||.+.+ .|+.+.||||.||++.||+-|++.|.+.+..+++..|++.-.
T Consensus 168 cDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 168 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred ccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 99999999988888888999999999999864 699999999999999999999999999988888777764321
Q ss_pred --------C--------CCCCCC-----CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 349 --------N--------FHDSPW-----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 349 --------~--------~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+ +....| ...++++.+|+.++|.++|.+|.++.|+|.||||...
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 1 112222 3478999999999999999999999999999999865
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=387.53 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=213.2
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcE-EEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-e
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN-S 203 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~-vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~-~ 203 (461)
...+.+.||.|+||+||++.+ .|+. ||||++......... .+.|.+|+.+|.+|+ |||||+++|++.+.. .
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~-----~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKW-----RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGS 114 (362)
T ss_pred HhhhhhhcccCCceeEEEEEe-----CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCc
Confidence 455667799999999999887 4566 999999876655444 789999999999996 999999999999887 7
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccCCCCCcEEEecCCCCC-CeeEeecccc
Q 012518 204 VYIVMEFCEGGELLDRILS-RGGRYLEEDAKTIVEKILNIVAFCHLQG-VVHRDLKPENFLFTTREEDA-PLKVIDFGLS 280 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~i~~qil~al~yLH~~g-ivHrDlkp~NILl~~~~~~~-~~kl~DFG~a 280 (461)
++|||||+++|+|.+++.. ....++...+..++.||+.||+|||+++ |||||||++|||+. .+. ++||+|||++
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~---~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD---LKGKTLKIADFGLS 191 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc---CCCCEEEECCCccc
Confidence 9999999999999999987 3678999999999999999999999999 99999999999995 554 8999999999
Q ss_pred cccCCC-CCccccccCCCcCchhhhhcc---CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 281 DFVRPD-QRLNDIVGSAYYVAPEVLHRS---YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 281 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~---~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
+..... ...+...||..|||||++.+. |+.++|||||||+||||+||+.||.+.........+.........+ .
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~ 269 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--K 269 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--c
Confidence 887654 445557899999999999853 9999999999999999999999999988766666665443332222 2
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+++.+.+||.+||..||.+||++.+++.
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 38999999999999999999999988764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=387.29 Aligned_cols=248 Identities=28% Similarity=0.546 Sum_probs=216.7
Q ss_pred eccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012518 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCE 212 (461)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~~ 212 (461)
||+|+||+||+|+++. +++.||+|++++...........+.+|+.+++++. ||||++++++|.+.+.+|+||||+.
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCC
Confidence 7999999999999876 78899999997655444555677889999999995 9999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCC-CCccc
Q 012518 213 GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLND 291 (461)
Q Consensus 213 gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~-~~~~~ 291 (461)
+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...... .....
T Consensus 77 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~ 152 (312)
T cd05585 77 GGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD---YQGHIALCDFGLCKLNMKDDDKTNT 152 (312)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC---CCCcEEEEECcccccCccCCCcccc
Confidence 9999998865 46799999999999999999999999999999999999994 5678999999998754322 23345
Q ss_pred cccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhc
Q 012518 292 IVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 370 (461)
Q Consensus 292 ~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 370 (461)
.+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......++ ..+++++++||.+||
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L 228 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLL 228 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHc
Confidence 68999999999986 4589999999999999999999999998888888888877655443 358999999999999
Q ss_pred ccCcCCCC---CHHHHhcCCCcCCC
Q 012518 371 NKDHRKRM---TAAQALTHPWLHDE 392 (461)
Q Consensus 371 ~~dP~~R~---s~~e~L~hp~~~~~ 392 (461)
..||.+|+ ++.|+|.||||...
T Consensus 229 ~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 229 SRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=389.88 Aligned_cols=250 Identities=29% Similarity=0.542 Sum_probs=217.3
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||.||+++++. +|+.||||++.+...........+.+|+++++.+. ||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeC
Confidence 469999999999999876 78999999998765444555677889999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC-CCCc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRL 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~-~~~~ 289 (461)
+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ....
T Consensus 77 ~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 77 VNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD---KDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC---CCCcEEEecCcCCccCCCccccc
Confidence 999999887754 45799999999999999999999999999999999999995 567799999999875432 2233
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 368 (461)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||...+.......+......++ ..+++++.+||.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSG 228 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHH
Confidence 4568999999999986 5689999999999999999999999998887777777766554443 3589999999999
Q ss_pred hcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 369 LLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 369 ~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
||++||.+|+ ++.|+++||||...
T Consensus 229 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 229 LLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=395.59 Aligned_cols=259 Identities=34% Similarity=0.622 Sum_probs=225.2
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||+||+|++.. +|+.||||++++...........+.+|+.++..++ |+||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHL 76 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeE
Confidence 379999999999999999999876 78999999998765444445677889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMN 152 (350)
T ss_pred EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEeecCCCCccCc
Confidence 9999999999999988665 6799999999999999999999999999999999999994 56789999999998655
Q ss_pred CCC------------------------------CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCC
Q 012518 285 PDQ------------------------------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWA 333 (461)
Q Consensus 285 ~~~------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~ 333 (461)
... ......||+.|+|||++. ..++.++|||||||+||+|++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 433 223467999999999986 4699999999999999999999999998
Q ss_pred CChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC-HHHHhcCCCcCCC
Q 012518 334 RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-AAQALTHPWLHDE 392 (461)
Q Consensus 334 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-~~e~L~hp~~~~~ 392 (461)
.........+......+.......+++++.+||.+||. ||.+|++ +.++|+||||++.
T Consensus 233 ~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 233 DTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred CCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 88877777777643333333344589999999999997 9999999 9999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=390.96 Aligned_cols=259 Identities=29% Similarity=0.574 Sum_probs=217.1
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-SALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
+|++++.||+|+||+||+|+...+..+|+.||+|++.+.... .....+.+.+|+++++.+++|+||+++++++.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488999999999999999988765568899999999764322 2233466788999999997799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+|+|.+++..+ ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~---~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD---SEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC---CCCCEEEeeCcCCcccc
Confidence 9999999999999988654 5689999999999999999999999999999999999995 56789999999998653
Q ss_pred CCC--CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCC----hhhHHHHHHhcCCCCCCCCCC
Q 012518 285 PDQ--RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWART----ESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 285 ~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 356 (461)
... .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.... ...+...+....+.+. .
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~ 232 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----S 232 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC----C
Confidence 322 2335689999999999864 47889999999999999999999996432 2334444444443332 3
Q ss_pred CCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
.+++.+++||.+||+.||++|+ +++++++||||++.
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 5899999999999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-49 Score=387.11 Aligned_cols=256 Identities=27% Similarity=0.493 Sum_probs=221.9
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++++.||+|+||.||+|+++. +++.||||++.+.........+.+..|++++..+.+|++|+++++++.+.+.+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence 58899999999999999999876 788999999987554444556778889999999975677999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC-
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR- 284 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~- 284 (461)
+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 78 lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---AEGHIKIADFGMCKENIF 153 (324)
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc---CCCCEEEeecCcceecCC
Confidence 999999999999887544 5789999999999999999999999999999999999995 56779999999987532
Q ss_pred CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
........+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+......++ ..+++++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~ 229 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAV 229 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 222334567999999999986 4589999999999999999999999999888888888877655443 35899999
Q ss_pred HHHHHhcccCcCCCCCH-----HHHhcCCCcCCC
Q 012518 364 DFVRRLLNKDHRKRMTA-----AQALTHPWLHDE 392 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s~-----~e~L~hp~~~~~ 392 (461)
+||.+||.+||.+|++. +++++||||...
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 230 SICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999999999986 899999999764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=371.40 Aligned_cols=259 Identities=29% Similarity=0.570 Sum_probs=237.2
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
-.++|.++++||+|.||.|-+++.+. +|+.||||++++........+..-..|-++|+..+ ||.+..+...|+..+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKa---t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKA---TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQD 241 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecc---cCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCc
Confidence 34689999999999999999999887 89999999999988777777777888999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
++|+||||..||+|+-+|. +...++|..++.+...|+.||.|||+++||+||||.+|.|+ |.++++||+|||+++.
T Consensus 242 rlCFVMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKE 317 (516)
T ss_pred eEEEEEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchh
Confidence 9999999999999987764 45679999999999999999999999999999999999999 6889999999999975
Q ss_pred c-CCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 283 V-RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 283 ~-~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
- ..+.+..++||||.|.|||++. ..|+.++|+|.+||+||||++|+.||+..+...++..|+-.+..|+. .+++
T Consensus 318 ~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~ 393 (516)
T KOG0690|consen 318 EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSP 393 (516)
T ss_pred cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCH
Confidence 3 3455778899999999999997 57999999999999999999999999999999999999999888876 4899
Q ss_pred HHHHHHHHhcccCcCCCC-----CHHHHhcCCCcCCCC
Q 012518 361 EAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~~ 393 (461)
+++.|+..+|.+||.+|. .+.|+.+|+||...+
T Consensus 394 eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 394 EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 999999999999999997 588999999998753
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-49 Score=382.72 Aligned_cols=258 Identities=26% Similarity=0.453 Sum_probs=209.9
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||+||+|+++. +|+.||||++....... ....+.+|+.+++.+. ||||+++++++.+.+..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 78 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKV---NGKLVALKVIRLQEEEG--TPFTAIREASLLKGLK-HANIVLLHDIIHTKETL 78 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECC---CCCEEEEEEeccccccc--cchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeE
Confidence 589999999999999999999876 78999999987543221 2245678999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+. ++|.+++....+.++++.++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKS 154 (303)
T ss_pred EEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECCCCcceecc
Confidence 99999995 588888877667799999999999999999999999999999999999995 56779999999987543
Q ss_pred CC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCh-hhHHHHHHhcCCC-----------
Q 012518 285 PD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLRADPN----------- 349 (461)
Q Consensus 285 ~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~----------- 349 (461)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... .+.+..+......
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 22 23345678999999999853 488999999999999999999999976533 2333332211000
Q ss_pred ---CCCC------------CC--CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 350 ---FHDS------------PW--PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 350 ---~~~~------------~~--~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+... .| ..+++++++||.+||+.||++|+|+.|+|+||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 0000 01 1246789999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=391.62 Aligned_cols=260 Identities=29% Similarity=0.523 Sum_probs=224.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||+||+|+++. +|+.||||++++.........+.+.+|+.+++.+. |+||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~ 76 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNL 76 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeE
Confidence 369999999999999999999876 78999999998765444455677889999999985 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||++||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~---~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID---RTGHIKLADFGSAARLT 153 (330)
T ss_pred EEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC---CCCCEEeccCCCCeECC
Confidence 999999999999998877667899999999999999999999999999999999999994 56789999999998765
Q ss_pred CCCCc--cccccCCCcCchhhhh-------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 285 PDQRL--NDIVGSAYYVAPEVLH-------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 285 ~~~~~--~~~~gt~~y~aPE~l~-------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
..... ....||+.|+|||++. ..++.++|||||||++|+|++|..||...+....+..+............
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED 233 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCC
Confidence 43322 3357999999999985 24788999999999999999999999988887777777765433333333
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+.+++++.+||.+||. ||.+|++++++++||||...
T Consensus 234 ~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 234 PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 4689999999999998 99999999999999999764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=395.10 Aligned_cols=261 Identities=27% Similarity=0.479 Sum_probs=223.1
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||.||+|+++. +++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~ 116 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDK 116 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCC
Confidence 44689999999999999999999876 78999999997654444444566889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+|||||.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~---~~~~~kL~DFG~a~~ 191 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD---KHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEEeccccee
Confidence 99999999999999998754 3589999999999999999999999999999999999994 567899999999987
Q ss_pred cCCCC--CccccccCCCcCchhhhhc-----cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 283 VRPDQ--RLNDIVGSAYYVAPEVLHR-----SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 283 ~~~~~--~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
..... .....+||+.|+|||++.+ .++.++|||||||+||+|++|..||.+.+....+..+......+.....
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 271 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED 271 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc
Confidence 64332 2245689999999999863 2789999999999999999999999998888888888765544443333
Q ss_pred CCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCcCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDE 392 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~ 392 (461)
..++..+++||.+||..++.+ |+++.|+++||||+..
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 468999999999999866544 8999999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=387.97 Aligned_cols=251 Identities=28% Similarity=0.537 Sum_probs=217.7
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||+||+|+++. +|+.||||++.+.........+.+.+|+.++..+.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 469999999999999876 78999999997654434445567788999998876799999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC-CCCc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRL 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~-~~~~ 289 (461)
+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~---~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 78 VNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeeCCCCeecCcCCCcc
Confidence 9999999877544 6799999999999999999999999999999999999994 567799999999875432 2233
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 368 (461)
....||+.|+|||++. ..++.++|||||||++|+|++|+.||...+..+++..+......++ ..+++++++||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~ 229 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKA 229 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHH
Confidence 4567999999999986 4589999999999999999999999999988888888877654443 2479999999999
Q ss_pred hcccCcCCCCCH------HHHhcCCCcCCC
Q 012518 369 LLNKDHRKRMTA------AQALTHPWLHDE 392 (461)
Q Consensus 369 ~L~~dP~~R~s~------~e~L~hp~~~~~ 392 (461)
||++||.+|+++ +++++||||...
T Consensus 230 ~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 999999999998 999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=388.37 Aligned_cols=250 Identities=29% Similarity=0.559 Sum_probs=217.0
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||.||+++++. +|+.||+|++.+...........+.+|+++++.++ ||||++++++|...+.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeC
Confidence 469999999999999876 78999999998654444445667788999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC-CCCc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRL 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~-~~~~ 289 (461)
+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ....
T Consensus 77 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 77 ANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc---CCCCEEecccHHhccccCCCCcc
Confidence 999999887754 45789999999999999999999999999999999999994 567799999999875422 2333
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 368 (461)
....||+.|+|||++. +.++.++|||||||++|+|++|+.||...+.......+......++ ..+++++++||.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAG 228 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHH
Confidence 4567999999999986 5689999999999999999999999998888777777776555443 3589999999999
Q ss_pred hcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 369 LLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 369 ~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
||++||.+|+ ++.++++|+||...
T Consensus 229 ~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 229 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred HccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9999999998 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=385.18 Aligned_cols=256 Identities=27% Similarity=0.484 Sum_probs=222.5
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||+|+||.||+|+++. +++.||||++.+.........+.+..|..++..+.+|++|+++++++.+.+.+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence 58899999999999999999876 788999999987654444455667788999988877999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 78 lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENMW 153 (323)
T ss_pred EEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC---CCCcEEEccCCCceecCC
Confidence 999999999999887544 5789999999999999999999999999999999999994 567899999999875432
Q ss_pred -CCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 286 -DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 286 -~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
.......+||+.|+|||++. +.++.++|||||||++|||++|+.||.+.....++..+......++. .+++++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~ 229 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAV 229 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHHH
Confidence 22344578999999999986 56999999999999999999999999998888888888876555442 4899999
Q ss_pred HHHHHhcccCcCCCCC-----HHHHhcCCCcCCC
Q 012518 364 DFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 392 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 392 (461)
+||.+||++||.+|++ ..++++||||...
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999999998 4899999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=393.34 Aligned_cols=259 Identities=30% Similarity=0.543 Sum_probs=220.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||+||+|+++. +|+.||||++++...........+.+|+.++..+. |+||+++++.|.+.+.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~ 76 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD---TGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNL 76 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEE
Confidence 368999999999999999999876 78999999997654444455677889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+|||||+||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 77 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~---~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD---AKGHVKLSDFGLCTGLK 152 (360)
T ss_pred EEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEeeccCCcccc
Confidence 9999999999999987654 5799999999999999999999999999999999999994 57789999999987542
Q ss_pred CCC------------------------------------CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhC
Q 012518 285 PDQ------------------------------------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCG 327 (461)
Q Consensus 285 ~~~------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg 327 (461)
... .....+||+.|+|||++. ..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 210 012357999999999986 4699999999999999999999
Q ss_pred CCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCcCCC
Q 012518 328 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM---TAAQALTHPWLHDE 392 (461)
Q Consensus 328 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~L~hp~~~~~ 392 (461)
..||.+.+....+..+......+.......+++++++||.+|+ .||.+|+ ++.|+++||||.+.
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 233 YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 9999998888888877764433332333358999999999987 4999998 58999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=395.11 Aligned_cols=262 Identities=31% Similarity=0.480 Sum_probs=220.0
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC-----CCeeEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH-----KHMIKF 194 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-----pniv~l 194 (461)
.+.+.-+|++++.||+|+||+|.+|.+.+ +++.||||+++... ....+...|+.||..|+.| -|||++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~---T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm 253 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHK---TGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRM 253 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecC---CCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence 34555689999999999999999999987 89999999998653 3345667899999999733 489999
Q ss_pred EEEEEeCCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCee
Q 012518 195 HDAFEDANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 273 (461)
Q Consensus 195 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~k 273 (461)
+++|...+++|||+|++. -+|+++|+.+. ..++...++.++.||+.||.+||+.||||+|||||||||...+. ..||
T Consensus 254 ~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r-~~vK 331 (586)
T KOG0667|consen 254 LDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR-SRIK 331 (586)
T ss_pred eeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc-Ccee
Confidence 999999999999999995 59999997764 35889999999999999999999999999999999999987544 4799
Q ss_pred EeecccccccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC-
Q 012518 274 VIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH- 351 (461)
Q Consensus 274 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~- 351 (461)
|+|||+|.+... ...+++.++.|+|||+|.| .|+.+.||||||||++||++|.+.|.+.++.+++..|.......+
T Consensus 332 VIDFGSSc~~~q--~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 332 VIDFGSSCFESQ--RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred EEecccccccCC--cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 999999987643 3447889999999999875 799999999999999999999999999999888877753221100
Q ss_pred -------------CC-C--------------------------------CC------------CCCHHHHHHHHHhcccC
Q 012518 352 -------------DS-P--------------------------------WP------------SVSPEAKDFVRRLLNKD 373 (461)
Q Consensus 352 -------------~~-~--------------------------------~~------------~~s~~~~~li~~~L~~d 373 (461)
.. . .+ .-...+.|||.+||+.|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 00 0 00 01256789999999999
Q ss_pred cCCCCCHHHHhcCCCcCCC
Q 012518 374 HRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 374 P~~R~s~~e~L~hp~~~~~ 392 (461)
|.+|+|+.|+|+||||...
T Consensus 490 P~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 490 PAERITPAQALNHPFLTGT 508 (586)
T ss_pred chhcCCHHHHhcCcccccc
Confidence 9999999999999999843
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=385.24 Aligned_cols=251 Identities=27% Similarity=0.498 Sum_probs=218.0
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||.||+|+++. +|+.||||++.+.........+.+..|++++..+.+||||++++++|.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 469999999999999876 78899999998755444445567778999998876799999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCC-CCc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRL 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~-~~~ 289 (461)
+++|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...... ...
T Consensus 78 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~---~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 78 VNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD---AEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeecccceecccCCccc
Confidence 9999998887544 5789999999999999999999999999999999999994 5678999999998754322 233
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 368 (461)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||...+..+.+..+......++. .++.++.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~ 229 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKA 229 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence 4567999999999986 46999999999999999999999999999988888888876544432 378999999999
Q ss_pred hcccCcCCCC-------CHHHHhcCCCcCCC
Q 012518 369 LLNKDHRKRM-------TAAQALTHPWLHDE 392 (461)
Q Consensus 369 ~L~~dP~~R~-------s~~e~L~hp~~~~~ 392 (461)
||++||++|+ ++.++++||||...
T Consensus 230 ~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred HhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 9999999999 99999999999663
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=385.33 Aligned_cols=250 Identities=27% Similarity=0.537 Sum_probs=211.3
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||.||+|+++. +|+.||||++++.........+.+.+|+.+++.+.+||||++++++|.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 469999999999999876 78999999998765555555677889999999997799999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc-CCCCCc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV-RPDQRL 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~-~~~~~~ 289 (461)
|+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++... ......
T Consensus 78 ~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 78 VSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD---AEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEECcCccccccccCCCcc
Confidence 9999998877544 6799999999999999999999999999999999999995 5677999999998753 223344
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC---------hhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART---------ESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||.... .......+......++ ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~ 229 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCC
Confidence 5678999999999986 468999999999999999999999995321 1223444444433333 3488
Q ss_pred HHHHHHHHHhcccCcCCCCC------HHHHhcCCCcCC
Q 012518 360 PEAKDFVRRLLNKDHRKRMT------AAQALTHPWLHD 391 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s------~~e~L~hp~~~~ 391 (461)
.++.+||.+||+.||.+|++ ++++++||||..
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999999999999987 789999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=383.75 Aligned_cols=254 Identities=29% Similarity=0.515 Sum_probs=218.1
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC--CCCCeeEEEEEEEeCCeE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS--GHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpniv~l~~~~~~~~~~ 204 (461)
|++.+.||+|+||.||+|.++. +|+.||||++++.........+.+.+|++++..++ +||||+++++++.+.+.+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEE
Confidence 7889999999999999999876 78999999998654444445567778877765432 499999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.||+|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 78 ~lv~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~---~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 78 CFVMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD---TEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEEEcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCcEEeCcccCCccCC
Confidence 99999999999987764 35699999999999999999999999999999999999995 56789999999987543
Q ss_pred C-CCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 P-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~-~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
. .......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+......++ ..+++++
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~ 228 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREA 228 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHH
Confidence 2 23345578999999999986 4689999999999999999999999999888888888877655543 3489999
Q ss_pred HHHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
.+||.+||+.||.+|| ++.++++||||.+.
T Consensus 229 ~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 229 ISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999999999999999 79999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-49 Score=386.52 Aligned_cols=250 Identities=29% Similarity=0.555 Sum_probs=216.5
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||.||+|+++. +|+.||+|++.+...........+.+|+++++.+. ||||++++++|.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeC
Confidence 469999999999999876 78999999998765444455667788999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecCCCCCCeeEeecccccccCC-CCC
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQR 288 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~-~~~ 288 (461)
+.||+|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++..... ...
T Consensus 77 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 77 ANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC---CCCCEEEecCCCCeecCCCCcc
Confidence 999999887754 4578999999999999999999997 7999999999999994 567799999999875432 233
Q ss_pred ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012518 289 LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 367 (461)
Q Consensus 289 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 367 (461)
....+||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+.......+......++ ..+++++.+||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 228 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLS 228 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHH
Confidence 44567999999999986 5689999999999999999999999998888777777766555443 248999999999
Q ss_pred HhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 368 RLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 368 ~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
+||++||++|+ ++.++++||||...
T Consensus 229 ~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 229 GLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 99999999997 99999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=382.21 Aligned_cols=251 Identities=29% Similarity=0.517 Sum_probs=214.4
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||.||+|+++. +|+.||||++++.........+.+..|+.++..+.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 469999999999999876 78999999997654322334456778888888765799999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC-CCCc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRL 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~-~~~~ 289 (461)
+.||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 78 LNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEeCccCCCeecccCCCce
Confidence 9999999887654 6789999999999999999999999999999999999994 567799999999875322 2234
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 368 (461)
...+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+....+..+....+.++. .++.++++||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~ 229 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEK 229 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHH
Confidence 5578999999999986 46999999999999999999999999988888888777665544432 378999999999
Q ss_pred hcccCcCCCCCH-HHHhcCCCcCCC
Q 012518 369 LLNKDHRKRMTA-AQALTHPWLHDE 392 (461)
Q Consensus 369 ~L~~dP~~R~s~-~e~L~hp~~~~~ 392 (461)
||+.||.+|+++ +++++||||...
T Consensus 230 ~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 230 LFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HccCCHHHcCCChHHHHcCCCcCCC
Confidence 999999999998 588899999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=383.21 Aligned_cols=261 Identities=31% Similarity=0.544 Sum_probs=220.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+++++. +++.||||++.+.........+.+.+|+.+++.+. |+||++++++|.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNL 76 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeE
Confidence 479999999999999999999876 78999999997644444445567889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD---KNGHIRLADFGSCLRLL 153 (331)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC---CCCCEEEEECCceeecC
Confidence 999999999999998876667899999999999999999999999999999999999994 56779999999987654
Q ss_pred CCCCc--cccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC-CCC
Q 012518 285 PDQRL--NDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD-SPW 355 (461)
Q Consensus 285 ~~~~~--~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 355 (461)
..... ...+||+.|+|||++. +.++.++|||||||++|+|++|+.||.+....+.+..+......+.. ..+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCcc
Confidence 43322 2357999999999985 24788999999999999999999999988877777777654433221 223
Q ss_pred CCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCcCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDE 392 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~ 392 (461)
..+++++++||++||..++.+ |+++.++++||||...
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 458999999999999765544 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=381.37 Aligned_cols=251 Identities=31% Similarity=0.547 Sum_probs=214.4
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||+||+|+++. +++.||||++++.........+.+..|..++..+.+||||+++++++...+.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 469999999999999876 78899999998654433444556677888887765799999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCC-CCc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRL 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~-~~~ 289 (461)
+.||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...... ...
T Consensus 78 ~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 78 LNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC---CCCCEEEccCcCCeECCCCCCcc
Confidence 9999998887554 5799999999999999999999999999999999999994 5677999999999764322 233
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 368 (461)
...+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+++..+....+.++ ..++.++.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~ 229 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSK 229 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 4568999999999986 4589999999999999999999999999888888887776554443 2478999999999
Q ss_pred hcccCcCCCCCH-HHHhcCCCcCCC
Q 012518 369 LLNKDHRKRMTA-AQALTHPWLHDE 392 (461)
Q Consensus 369 ~L~~dP~~R~s~-~e~L~hp~~~~~ 392 (461)
||+.||.+|+++ .++++||||...
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 230 LFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HccCCHHHcCCChHHHHcCcccCCC
Confidence 999999999986 488899999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=382.64 Aligned_cols=254 Identities=29% Similarity=0.559 Sum_probs=217.3
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-SALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVM 208 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~ 208 (461)
++.||+|+||.||+|+...+..+|+.||||++++.... .......+.+|+.+|+.++ ||||++++++|.+++.+|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEE
Confidence 36799999999999987655557899999999764332 2233456778999999996 999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCC-C
Q 012518 209 EFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-Q 287 (461)
Q Consensus 209 e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~-~ 287 (461)
||+.||+|.+++... +.+.+..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...... .
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 80 EYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred eCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEeeCcCCeecccCCC
Confidence 999999999887554 6788999999999999999999999999999999999994 5678999999998754332 2
Q ss_pred CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 012518 288 RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFV 366 (461)
Q Consensus 288 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 366 (461)
.....+||+.|+|||++. ..++.++|||||||++|||++|+.||........+..+......++ +.+++++.+||
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li 231 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 334567999999999986 4588999999999999999999999998888888888776654433 35799999999
Q ss_pred HHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 367 RRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 367 ~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
.+||++||++|+ ++.++++||||...
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=394.69 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=203.4
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC-----CCCCeeEEEEEE
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS-----GHKHMIKFHDAF 198 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----~hpniv~l~~~~ 198 (461)
.++|+++++||+|+||+||+|.+.. +++.||||+++... .....+..|+++++.++ +|.+|++++++|
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcC---CCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 4689999999999999999999876 78899999996431 12344567888887774 245689999998
Q ss_pred EeC-CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecCCC--------
Q 012518 199 EDA-NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREE-------- 268 (461)
Q Consensus 199 ~~~-~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~~~-------- 268 (461)
... +.+|+|||++ |++|.+++... +.+++..++.|+.||+.||.|||+ .|||||||||+|||+...+.
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 764 5789999998 77898888654 679999999999999999999998 59999999999999964321
Q ss_pred -----CCCeeEeecccccccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHH
Q 012518 269 -----DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 342 (461)
Q Consensus 269 -----~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~ 342 (461)
...+||+|||++.... ......+||+.|+|||++.+ .|+.++|||||||+||||++|+.||.+....+.+..
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred ccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 1259999999876432 23356789999999999864 699999999999999999999999988776555444
Q ss_pred HHhcCCCCCCC------------------------------------CCC--CCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 012518 343 VLRADPNFHDS------------------------------------PWP--SVSPEAKDFVRRLLNKDHRKRMTAAQAL 384 (461)
Q Consensus 343 i~~~~~~~~~~------------------------------------~~~--~~s~~~~~li~~~L~~dP~~R~s~~e~L 384 (461)
+......++.. .+. ..++.+.|||.+||++||.+|+|++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 43221111100 000 0145678999999999999999999999
Q ss_pred cCCCcCCC
Q 012518 385 THPWLHDE 392 (461)
Q Consensus 385 ~hp~~~~~ 392 (461)
+||||...
T Consensus 437 ~Hp~~~~~ 444 (467)
T PTZ00284 437 THPYVLKY 444 (467)
T ss_pred cCcccccc
Confidence 99999864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=375.10 Aligned_cols=256 Identities=27% Similarity=0.480 Sum_probs=210.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||+||+|+++. +++.||||++...... ....+.+.+|+.+++.++ |+||++++++|.+++.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC---CCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCC-CccccchhhhEecCCEE
Confidence 379999999999999999999876 7889999999765332 233467789999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.++.+ +.+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 76 ~lv~e~~~~~~l-~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 76 YLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS---HNDVLKLCDFGFARNLS 151 (287)
T ss_pred EEEEecCCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccCccccc
Confidence 999999998655 44545556799999999999999999999999999999999999995 56779999999998764
Q ss_pred CCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC--------------
Q 012518 285 PDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD-------------- 347 (461)
Q Consensus 285 ~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------- 347 (461)
... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred ccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 322 234467999999999986 468999999999999999999999998776554443332211
Q ss_pred CCCCCC--------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 348 PNFHDS--------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 348 ~~~~~~--------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
+.+... .+..+|.++.+||.+||++||++|+|++|+|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 111000 012378899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=388.90 Aligned_cols=261 Identities=28% Similarity=0.476 Sum_probs=222.7
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||.||+|+++. +++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~ 116 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDR 116 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECC---CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCC
Confidence 34689999999999999999999876 78999999997644444444566788999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+|||||.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~---~~~~ikL~DfG~a~~ 191 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC---CCCCEEEEeCCceeE
Confidence 99999999999999988754 3589999999999999999999999999999999999995 567899999999987
Q ss_pred cCCCC--CccccccCCCcCchhhhhc-----cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 283 VRPDQ--RLNDIVGSAYYVAPEVLHR-----SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 283 ~~~~~--~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
..... .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+....+..+......+.....
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 271 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCc
Confidence 65332 2245689999999999863 2789999999999999999999999998888888888776544444444
Q ss_pred CCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCcCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDE 392 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~ 392 (461)
..++.++++||.+||..++.+ |++++|+++|+||++.
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 578999999999999854443 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=380.74 Aligned_cols=251 Identities=29% Similarity=0.535 Sum_probs=217.5
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||+||+|+++. +++.||||++++.........+.+.+|+.++..+.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 469999999999999876 78899999998765444445567788999999886799999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC-CCCc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRL 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~-~~~~ 289 (461)
+.||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 78 VNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC---CCCcEEecccCCCeecCcCCCcc
Confidence 9999998877544 5799999999999999999999999999999999999995 567799999999875322 2233
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 368 (461)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+......++ ..+++++.+||.+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~ 229 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKS 229 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHH
Confidence 4567999999999986 4689999999999999999999999998888888877776655443 2479999999999
Q ss_pred hcccCcCCCCCH-----HHHhcCCCcCCC
Q 012518 369 LLNKDHRKRMTA-----AQALTHPWLHDE 392 (461)
Q Consensus 369 ~L~~dP~~R~s~-----~e~L~hp~~~~~ 392 (461)
||..||.+|+++ .++++||||+..
T Consensus 230 ~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 230 FLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999 999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=373.43 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=217.4
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
.|++.+.||+|+||+||++.+.. +|+.||||++.............+.+|+.+++.++ |+||+++++++.+.+.+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 76 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEE
Confidence 38889999999999999999865 78999999997654444444456778999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 206 IVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
+||||+.+|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++ +++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---DYGHIRISDLGLAVEIP 153 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC---CCCCEEEeeCCCceecC
Confidence 9999999999988876543 4689999999999999999999999999999999999994 56779999999998765
Q ss_pred CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
........+|+..|+|||++. ..++.++||||+||++|+|++|+.||.+.........+..............+++.+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05605 154 EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233 (285)
T ss_pred CCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence 544445568999999999986 5689999999999999999999999987665443333322211112222345899999
Q ss_pred HHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 364 DFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 364 ~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
+||.+||..||.+|+ +++++++||||...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=379.65 Aligned_cols=256 Identities=27% Similarity=0.494 Sum_probs=221.3
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||+|+||+||+|+++. +|+.||||++.+.........+.+..|+.++..+.+|++|+++++++.+.+.+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLY 77 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEE
Confidence 47888999999999999999876 789999999986544444455677889999998876789999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 78 lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~---~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD---SEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeccccccccCC
Confidence 999999999998887543 6799999999999999999999999999999999999995 567799999999875432
Q ss_pred C-CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 286 D-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 286 ~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
. ......+||+.|+|||++. +.++.++|||||||++|+|++|+.||.+.........+......++ ..++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 229 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAV 229 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Confidence 2 2234567999999999986 4689999999999999999999999999888888888877655443 34789999
Q ss_pred HHHHHhcccCcCCCCC-----HHHHhcCCCcCCC
Q 012518 364 DFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 392 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 392 (461)
+|+.+||++||.+|++ ..++++||||...
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 9999999999999997 5799999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-48 Score=372.67 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=210.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC--CCCCeeEEEEEEE---
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS--GHKHMIKFHDAFE--- 199 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpniv~l~~~~~--- 199 (461)
.+|++.+.||+|+||+||+|++... +|+.||||+++....... ....+.+|+.+++.+. +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC--CCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 3799999999999999999987541 468899999875432221 2234567888887764 4999999999985
Q ss_pred --eCCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 200 --DANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 200 --~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~---~~~~~kl~D 153 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLAD 153 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc---CCCCEEEcc
Confidence 3456899999996 58988886542 4588999999999999999999999999999999999995 567799999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCC--
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS-- 353 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-- 353 (461)
||++.............||+.|+|||++. ..++.++|||||||++|||++|..||.+.+..+.+..+..........
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99998765554455678999999999985 568999999999999999999999999988877777776432211111
Q ss_pred ---------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 354 ---------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 354 ---------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
..+.+++.+++||.+||+.||++|||+.|+|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 113578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=394.24 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=208.9
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
....+|++++.||+|+||.||+|.+.. +|+.||||++.... ....+|+.+|+.++ |+||++++++|...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~ 131 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICID---TSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTE 131 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeec
Confidence 344689999999999999999999876 78999999885432 12347999999996 99999999887432
Q ss_pred --------CeEEEEEeccCCCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCC
Q 012518 202 --------NSVYIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 270 (461)
Q Consensus 202 --------~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~ 270 (461)
..+++||||+.+ +|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++. .+.
T Consensus 132 ~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--~~~ 208 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--NTH 208 (440)
T ss_pred ccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC--CCC
Confidence 247799999975 67666543 3467899999999999999999999999999999999999952 344
Q ss_pred CeeEeecccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC
Q 012518 271 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP 348 (461)
Q Consensus 271 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~ 348 (461)
.+||+|||+++...........+||+.|+|||++.+ .|+.++|||||||+||||++|.+||.+.+..+.+..+.....
T Consensus 209 ~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 209 TLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred ceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 699999999987765555566789999999998753 589999999999999999999999998877666655543211
Q ss_pred ------------CCCCCCC-------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 349 ------------NFHDSPW-------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 349 ------------~~~~~~~-------------~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.+....+ ...++++++||.+||++||.+|+|+.|+|+||||...
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 1111000 1367899999999999999999999999999999764
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=380.29 Aligned_cols=251 Identities=25% Similarity=0.511 Sum_probs=210.8
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||+||+|+++. +++.||+|++++...........+.+|+.++.++.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 469999999999999876 78999999998765555555677889999998886799999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC-CCCc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRL 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~-~~~~ 289 (461)
+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~---~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 78 VNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCCEEEeeCCccccccCCCCcc
Confidence 999999887754 46799999999999999999999999999999999999994 567899999999875432 2334
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCC---------ChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWAR---------TESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
...+||..|+|||++. ..++.++|||||||++|+|++|..||... ........+......++ ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~ 229 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCC
Confidence 5578999999999986 46899999999999999999999999521 11223444444443333 3588
Q ss_pred HHHHHHHHHhcccCcCCCCC------HHHHhcCCCcCCC
Q 012518 360 PEAKDFVRRLLNKDHRKRMT------AAQALTHPWLHDE 392 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s------~~e~L~hp~~~~~ 392 (461)
.++.+||.+||+.||.+|++ ++++++||||...
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999999999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=383.21 Aligned_cols=255 Identities=31% Similarity=0.526 Sum_probs=230.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe-
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS- 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~- 203 (461)
++|+.++++|+|+||.+++++++. .++.|++|.|.....+... .+...+|+.++++++ |||||.+++.|++++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~---~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKS---DDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhcc---CCceEEEEEEeccccCchh-hHHHHHHHHHHHhcc-CCCeeeeccchhcCCce
Confidence 589999999999999999999876 7789999999887766554 347788999999996 9999999999999888
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
++|||+||+||++.+.|..+. ..++|+.+..|+.||+.|+.|||+++|+|||||+.||+++ .+..|||+|||+|+.
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKI 155 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhh
Confidence 999999999999999998776 5789999999999999999999999999999999999997 455689999999999
Q ss_pred cCCCC-CccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 283 VRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 283 ~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
+.... ...+.+||++||.||++.+ .|+.++|||||||++|||++-+.+|.+.+...+...|.+....... ..++.
T Consensus 156 l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~ 232 (426)
T KOG0589|consen 156 LNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSS 232 (426)
T ss_pred cCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccH
Confidence 98776 5677899999999999974 7999999999999999999999999999999999999887632222 35899
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
+++.+|..||.++|..||++.++|.+|.+.
T Consensus 233 el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 233 ELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 999999999999999999999999998875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=370.17 Aligned_cols=249 Identities=27% Similarity=0.479 Sum_probs=207.9
Q ss_pred eccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012518 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCE 212 (461)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~~ 212 (461)
||+|+||+||++.++. +|+.||||.+.+.........+.+..|+++++.++ |+||++++++|...+.+|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEcc---CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCC
Confidence 7999999999999876 78999999997655444444567788999999995 9999999999999999999999999
Q ss_pred CCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCC-C
Q 012518 213 GGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-R 288 (461)
Q Consensus 213 gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~-~ 288 (461)
||+|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....... .
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCccceecCCCCcc
Confidence 9999877643 335689999999999999999999999999999999999994 56779999999987654432 2
Q ss_pred ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh----hHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 289 LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES----GIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 289 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
.....||+.|+|||++. +.++.++|||||||++|+|++|+.||...... .....+..... .....+++++.
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 229 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV----TYPDKFSPASK 229 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC----CCcccCCHHHH
Confidence 34467999999999986 56899999999999999999999999765432 22222222211 22245899999
Q ss_pred HHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 364 DFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 364 ~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
+|+.+||+.||++|+ +++++++||||+..
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 999999999999999 88999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=377.17 Aligned_cols=251 Identities=28% Similarity=0.499 Sum_probs=213.6
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||+||+|+++. +++.||||+++...............|..++..+.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 469999999999999876 78899999997654322333456677888888765699999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC-CCCc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRL 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~-~~~~ 289 (461)
+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 78 LNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEccCCcceECCCCCCce
Confidence 9999999887643 5789999999999999999999999999999999999995 567799999999875322 2233
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 368 (461)
...+||..|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+....+.++. .++.++++||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~ 229 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR----WLTREAKDILVK 229 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHH
Confidence 4567999999999986 46899999999999999999999999988887777777655444332 378999999999
Q ss_pred hcccCcCCCCCHH-HHhcCCCcCCC
Q 012518 369 LLNKDHRKRMTAA-QALTHPWLHDE 392 (461)
Q Consensus 369 ~L~~dP~~R~s~~-e~L~hp~~~~~ 392 (461)
||++||.+|+++. ++++||||...
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 230 LFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred HhccCHhhcCCChHHHHcCcccCCC
Confidence 9999999999996 89999999774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=379.46 Aligned_cols=261 Identities=30% Similarity=0.511 Sum_probs=220.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||+||+++.+. +++.||+|++.+...........+.+|+.++..+. |+||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNL 76 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEE
Confidence 379999999999999999999876 78899999997644333444556888999999985 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~---~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLM 153 (332)
T ss_pred EEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEeecchheecc
Confidence 999999999999999877667899999999999999999999999999999999999994 56779999999987654
Q ss_pred CCCC--ccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC-CCC
Q 012518 285 PDQR--LNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD-SPW 355 (461)
Q Consensus 285 ~~~~--~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 355 (461)
.... ....+||+.|+|||++. +.++.++|||||||++|||++|+.||......+.+..+......+.. ..+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcc
Confidence 3322 23457999999999985 34889999999999999999999999988888888877765433321 123
Q ss_pred CCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCcCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDE 392 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~ 392 (461)
..+++++++||++||..++.+ |++++|+++||||...
T Consensus 234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 468999999999999765554 6899999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=379.73 Aligned_cols=261 Identities=30% Similarity=0.512 Sum_probs=220.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||+||+++++. +++.||||++.+...........+.+|+.++..+. |+||+++++++.+.+.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~ 76 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH---TERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYL 76 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEE
Confidence 479999999999999999999876 78899999997644333444566788999999985 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~---~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD---MNGHIRLADFGSCLKMN 153 (331)
T ss_pred EEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc---CCCCEEEEeccceeecc
Confidence 999999999999999877667899999999999999999999999999999999999995 56779999999997665
Q ss_pred CCCCc--cccccCCCcCchhhhhc------cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC-CCCC
Q 012518 285 PDQRL--NDIVGSAYYVAPEVLHR------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH-DSPW 355 (461)
Q Consensus 285 ~~~~~--~~~~gt~~y~aPE~l~~------~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~ 355 (461)
..... ...+||+.|+|||++.+ .++.++|||||||+||+|++|+.||......+.+..+......+. ...+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcc
Confidence 43322 23579999999999863 478899999999999999999999998887777777766543332 1223
Q ss_pred CCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCcCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDE 392 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~ 392 (461)
..+++++++||.+||..++++ |++++++++|+||...
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 457999999999999976655 5799999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=378.30 Aligned_cols=258 Identities=28% Similarity=0.485 Sum_probs=208.0
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC----
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA---- 201 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~---- 201 (461)
+|++.+.||+|+||.||+|+++. +|+.||||++..... .......+.+|+++++.++ ||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---CCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCC
Confidence 58999999999999999999876 789999999864322 2223456789999999996 99999999988543
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 202 -NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 202 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
..+|+|||||. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 76 ~~~~~lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kL~Dfg~~ 150 (338)
T cd07859 76 FKDIYVVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLA 150 (338)
T ss_pred CceEEEEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEccCccc
Confidence 35899999995 688887754 45799999999999999999999999999999999999994 5778999999999
Q ss_pred cccCCCC----CccccccCCCcCchhhhh---ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc-------
Q 012518 281 DFVRPDQ----RLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA------- 346 (461)
Q Consensus 281 ~~~~~~~----~~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------- 346 (461)
+...... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 7543221 124467999999999985 35899999999999999999999999776644333222110
Q ss_pred --------------------CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 347 --------------------DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 347 --------------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.+......++.+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 01111112356789999999999999999999999999999997754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=381.20 Aligned_cols=256 Identities=36% Similarity=0.627 Sum_probs=231.9
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEe
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVME 209 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e 209 (461)
.+.||.|-||+||-+++++ +|+.||||+|++.++..... ..+++|+.||+++. ||.||.+.-.|+..+.+++|||
T Consensus 569 devLGSGQFG~VYgg~hRk---tGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~-HPGiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRK---TGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLH-HPGIVNLECMFETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecc---cCceeeeeeeecccCCCchH-HHHHHHHHHHHhcC-CCCeeEEEEeecCCceEEEEeh
Confidence 4689999999999999987 99999999999887765443 78999999999996 9999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCc
Q 012518 210 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL 289 (461)
Q Consensus 210 ~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~ 289 (461)
-+.|.-|.-.|.+..+++++...+.++.||+.||.|||-++|+|+||||+|||+.+.+.--.+||||||+|+++....-.
T Consensus 644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 99765554444455689999999999999999999999999999999999999987766667999999999999877777
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 368 (461)
.+.+||+.|.|||++. +.|+..-|+||+|||+|.-+.|..||. .+.++-+.|.+....|+..+|..+++++.|||..
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 8899999999999996 679999999999999999999999994 3456778888889999999999999999999999
Q ss_pred hcccCcCCCCCHHHHhcCCCcCCC
Q 012518 369 LLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 369 ~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+|+..-++|.|.+..|.|||+++.
T Consensus 802 LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHhcchHhhccchhhhcc
Confidence 999999999999999999999875
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=381.75 Aligned_cols=250 Identities=29% Similarity=0.564 Sum_probs=213.3
Q ss_pred eccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC--CCCCeeEEEEEEEeCCeEEEEEec
Q 012518 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS--GHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
||+|+||+||+|+++. +|+.||||++.+..............|..++..+. +||||++++++|.+.+.+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 7999999999999876 78999999997654433344455667777877664 699999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCC-CCc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRL 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~-~~~ 289 (461)
+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...... ...
T Consensus 78 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 78 MSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD---ATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred CCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEecCCcCcCCCCCCCCc
Confidence 999999988754 46799999999999999999999999999999999999995 5677999999998764332 334
Q ss_pred cccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012518 290 NDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 367 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 367 (461)
...+||..|+|||++.+ .++.++|||||||++|+|++|..||......+.+..+......++. ..+++++++||.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~ 230 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVK 230 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHH
Confidence 45789999999999863 4899999999999999999999999998888888877766554443 247899999999
Q ss_pred HhcccCcCCCC----CHHHHhcCCCcCCC
Q 012518 368 RLLNKDHRKRM----TAAQALTHPWLHDE 392 (461)
Q Consensus 368 ~~L~~dP~~R~----s~~e~L~hp~~~~~ 392 (461)
+||+.||.+|+ ++.++++||||.+.
T Consensus 231 ~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 231 GLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 99999999998 79999999999764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=377.87 Aligned_cols=250 Identities=29% Similarity=0.554 Sum_probs=212.1
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHH-HHhcCCCCCeeEEEEEEEeCCeEEEEEe
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI-LKALSGHKHMIKFHDAFEDANSVYIVME 209 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~~hpniv~l~~~~~~~~~~~lv~e 209 (461)
+.||+|+||+||+|+++. +|+.||||++.+...........+.+|..+ ++.++ ||||+++++++.+.+.+|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEc
Confidence 469999999999999876 789999999976544333344555566554 56675 9999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC-CCC
Q 012518 210 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQR 288 (461)
Q Consensus 210 ~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~-~~~ 288 (461)
|+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ...
T Consensus 77 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~---~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 77 YVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred CCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeccCCCcccccCCCc
Confidence 9999999887754 46789999999999999999999999999999999999994 567899999999875432 233
Q ss_pred ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012518 289 LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 367 (461)
Q Consensus 289 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 367 (461)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+.+..+......+. +.+++++.+||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 228 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLE 228 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 34567999999999986 4689999999999999999999999999888888888776544332 457999999999
Q ss_pred HhcccCcCCCCCH----HHHhcCCCcCCC
Q 012518 368 RLLNKDHRKRMTA----AQALTHPWLHDE 392 (461)
Q Consensus 368 ~~L~~dP~~R~s~----~e~L~hp~~~~~ 392 (461)
+||++||.+|+++ .++++||||...
T Consensus 229 ~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 229 GLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred HHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999987 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=376.06 Aligned_cols=251 Identities=25% Similarity=0.507 Sum_probs=211.1
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||+||+|+++. +++.||||++++.........+.+.+|+.++.++.+|+||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 469999999999999876 78999999998765555556677889999999997799999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC-CCCCc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQRL 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~-~~~~~ 289 (461)
++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 78 VNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD---ADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe---CCCCEEEeccccceeccCCCCce
Confidence 9999998877543 5799999999999999999999999999999999999995 56779999999987532 23334
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC-------hhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART-------ESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
...+||+.|+|||++. ..++.++|||||||+||+|++|..||.... .......+......++ ..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~ 229 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVK 229 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHH
Confidence 5578999999999986 568999999999999999999999995321 2233444443332222 347899
Q ss_pred HHHHHHHhcccCcCCCCC------HHHHhcCCCcCCC
Q 012518 362 AKDFVRRLLNKDHRKRMT------AAQALTHPWLHDE 392 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s------~~e~L~hp~~~~~ 392 (461)
+.++|.+||.+||.+|++ ..++++||||...
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 999999999999999998 5799999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=411.72 Aligned_cols=261 Identities=31% Similarity=0.508 Sum_probs=230.9
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
-.++|+++++||+|+||.|.+++.+. ++++||+|++.+-.+........|+.|-.||..- +.+-|++++.+|+|++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~---t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKS---TEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDER 148 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeec---cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCcc
Confidence 45689999999999999999999987 8999999999885555455567788899999876 4889999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
++||||||+.||+|..++.+.+ ++++..++.|+..|+.||.-||+.|+|||||||+|||| |..|++||+|||.+-.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLK 224 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHh
Confidence 9999999999999999876554 89999999999999999999999999999999999999 6789999999999888
Q ss_pred cCCCCC--ccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCC
Q 012518 283 VRPDQR--LNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 283 ~~~~~~--~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 354 (461)
+..+.. ....+|||.|.+||+|. +.|+..+|+||+||++|||+.|..||+..+-.+.+.+|.+.+..+..+.
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~ 304 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD 304 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence 775543 35579999999999984 3599999999999999999999999999999999999998854444443
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCcCCC
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMT---AAQALTHPWLHDE 392 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s---~~e~L~hp~~~~~ 392 (461)
-..+|+++++||+++|. +|..|.. ++++..||||.+.
T Consensus 305 ~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 305 ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 45699999999999996 6788888 9999999999864
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-48 Score=378.50 Aligned_cols=252 Identities=29% Similarity=0.553 Sum_probs=217.0
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||.||++++..+..+|+.||+|++.+.... ......+.+|+++|++++ ||||+++++++.+++.+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence 6799999999999987655558899999999765432 223345678999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCC-CCc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRL 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~-~~~ 289 (461)
+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...... ...
T Consensus 80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 80 LRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC---CCCcEEEeeccCCcccCCCCCce
Confidence 999999998854 35789999999999999999999999999999999999995 5677999999998865443 233
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 368 (461)
....||+.|+|||++. ..++.++|||||||++|+|++|+.||...+....+..+......++ ..+++++.+||++
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~ 231 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRA 231 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 4568999999999986 4589999999999999999999999998888888887776654443 3479999999999
Q ss_pred hcccCcCCCCC-----HHHHhcCCCcCCC
Q 012518 369 LLNKDHRKRMT-----AAQALTHPWLHDE 392 (461)
Q Consensus 369 ~L~~dP~~R~s-----~~e~L~hp~~~~~ 392 (461)
||+.||.+|++ +.+++.||||...
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999999999 7889999999764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=388.66 Aligned_cols=262 Identities=29% Similarity=0.508 Sum_probs=227.9
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..+.|+|+..||.|+||.||+|..+. ++-..|.|+|.. .+...++++.-||+||..+. ||+||+|++.|..++
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nke---t~~lAAaKvIet---kseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKE---TKLLAAAKVIET---KSEEELEDYLVEIEILAECD-HPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhccc---chhhhhhhhhcc---cchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccC
Confidence 34679999999999999999999886 777888999864 35667889999999999995 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+||+.|||.||-....+..-+..+++.++..+++|++.||.|||+++|||||||..|||++ .+|.|+|+|||.+..
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAK 179 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeeccccccc
Confidence 99999999999999888888888899999999999999999999999999999999999997 456699999998754
Q ss_pred cC-CCCCccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 283 VR-PDQRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 283 ~~-~~~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
.. .-.+..+++|||+|||||++. ..|++++||||||++|.||..+.+|-..-+...++-.|.+..+..-..+
T Consensus 180 n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP- 258 (1187)
T KOG0579|consen 180 NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP- 258 (1187)
T ss_pred chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc-
Confidence 33 234557799999999999874 3699999999999999999999999888777777777766654433222
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~ 395 (461)
..++..+.||+.+||.+||..||+++++|+||||++....
T Consensus 259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred chhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 4578999999999999999999999999999999876443
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=372.13 Aligned_cols=259 Identities=26% Similarity=0.454 Sum_probs=214.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|+++. +++.||+|.++...... ....+.+|+.++++++ |+||+++++++..++.+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEEG--APCTAIREVSLLKDLK-HANIVTLHDIVHTDKSL 79 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecC---CCCeEEEEEeeccccCC--cchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeE
Confidence 579999999999999999998876 78899999987543221 2345678999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKS 155 (309)
T ss_pred EEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECccccceecC
Confidence 999999975 88888876666789999999999999999999999999999999999995 56779999999987654
Q ss_pred CCC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC------------
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN------------ 349 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~------------ 349 (461)
... ......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 322 2344578999999998853 5899999999999999999999999887766655544432111
Q ss_pred -------CCC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 350 -------FHD-------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 350 -------~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
++. ...+.+++++++||.+||+.||.+|+|+.|+|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000 01235789999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=372.65 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=213.5
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||+|+||.||+++++. +|..||+|++.... .....+.+.+|+++|++++ ||||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP---SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC---CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCE
Confidence 4689999999999999999999876 78999999987542 3344577899999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN---SRGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc---CCCcEEEccCccccc
Confidence 99999999999999887544 5689999999999999999999986 699999999999995 567799999999876
Q ss_pred cCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC--------------
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD-------------- 347 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------- 347 (461)
.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||......++...+....
T Consensus 154 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 154 LIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred cccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence 5432 334567999999999986 458999999999999999999999997655443322211000
Q ss_pred ------------------------------CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 348 ------------------------------PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 348 ------------------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..........+++++++||.+||++||++|||+.|+|+||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000011112478899999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=341.30 Aligned_cols=257 Identities=25% Similarity=0.459 Sum_probs=222.1
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+.+++..||.|+.|+||+++.+. +|..+|||.+.+.. .....++++..+.++.+.++.|+||+.+|+|..+..++
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs---~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRS---TGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcc---cceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 56677889999999999999987 89999999998763 44556788899999988878999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 206 IVMEFCEGGELLDRILS-RGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+.||.|. ...+.|+. -.+.++|..+-.+..-++.||.||.++ ||+|||+||+|||+ |+.+++||||||++..+
T Consensus 168 IcMelMs--~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 168 ICMELMS--TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHHH--HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeeccccccee
Confidence 9999984 33444443 356788988999999999999999976 89999999999999 67888999999999998
Q ss_pred CCCCCccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCC-CChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWA-RTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
.+....+...|.+.|||||.+. ..|+.++||||||++|+||.||+.||.+ .++.+.+..|++..+..-.. -.++
T Consensus 243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~-~~gF 321 (391)
T KOG0983|consen 243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG-HMGF 321 (391)
T ss_pred ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc-ccCc
Confidence 8777777788999999999985 2499999999999999999999999987 56788999999866532222 2359
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
|+.+.+|+..||.+|+.+||...++|+|||+....
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 99999999999999999999999999999997653
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=380.73 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=204.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
...|.+.+.||+|+||.||+|.+.. +++.||||.... ..+.+|+++|++|+ |+|||++++++...+.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---~~~~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD---YPQRVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVVGGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC---CCCEEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCE
Confidence 4579999999999999999999876 688999996432 23458999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
.++|||++. ++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 235 ~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~---~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 235 TCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN---GPEDICLGDFGAACFA 310 (461)
T ss_pred EEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC---CCCCEEEcccCCceec
Confidence 999999995 689888877666799999999999999999999999999999999999995 5667999999999865
Q ss_pred CCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC--------hhhHHHHHHhcCCC--
Q 012518 284 RPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART--------ESGIFRSVLRADPN-- 349 (461)
Q Consensus 284 ~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~--------~~~~~~~i~~~~~~-- 349 (461)
..... ....+||+.|+|||++. ..++.++|||||||+||||++|..++.... ...+.+.+......
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 43321 23467999999999986 459999999999999999999887654321 22233333221110
Q ss_pred -------------------------CCCCCCC---CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 350 -------------------------FHDSPWP---SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 350 -------------------------~~~~~~~---~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
+....|. .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 1111232 45679999999999999999999999999999964
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=376.50 Aligned_cols=250 Identities=29% Similarity=0.541 Sum_probs=211.9
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHH-HHhcCCCCCeeEEEEEEEeCCeEEEEEe
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI-LKALSGHKHMIKFHDAFEDANSVYIVME 209 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~~hpniv~l~~~~~~~~~~~lv~e 209 (461)
+.||+|+||+||+|+++. +|+.||||++.+...........+.+|..+ ++.+. ||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEc
Confidence 469999999999999876 789999999976544333444556666654 56674 9999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC-CCC
Q 012518 210 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQR 288 (461)
Q Consensus 210 ~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~-~~~ 288 (461)
|+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ...
T Consensus 77 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~---~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 77 FVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD---SQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEeecCCcccCCCCCCC
Confidence 9999999887754 46799999999999999999999999999999999999994 567899999999875432 233
Q ss_pred ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012518 289 LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 367 (461)
Q Consensus 289 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 367 (461)
....+||+.|+|||++. +.++.++|||||||++|+|++|..||...+..++++.+......+. +.++.++.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~ 228 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILE 228 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHH
Confidence 45568999999999986 4689999999999999999999999999888888888776544332 358999999999
Q ss_pred HhcccCcCCCCCH----HHHhcCCCcCCC
Q 012518 368 RLLNKDHRKRMTA----AQALTHPWLHDE 392 (461)
Q Consensus 368 ~~L~~dP~~R~s~----~e~L~hp~~~~~ 392 (461)
+||++||.+|+++ .++++||||...
T Consensus 229 ~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 229 ELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred HHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 9999999999976 599999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=365.80 Aligned_cols=256 Identities=28% Similarity=0.437 Sum_probs=208.2
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC--CCCCeeEEEEEEEe---
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS--GHKHMIKFHDAFED--- 200 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpniv~l~~~~~~--- 200 (461)
+|++.+.||+|+||+||+|+++. +|+.||+|.++...... .....+.+|+.+++.+. +||||+++++++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 58999999999999999999876 78999999987543221 11234557888777663 49999999998864
Q ss_pred --CCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 201 --ANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 201 --~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
...+++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 77 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~kl~df 152 (288)
T cd07863 77 DRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGQVKLADF 152 (288)
T ss_pred CCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECcc
Confidence 3458999999975 8888776543 3589999999999999999999999999999999999995 5677999999
Q ss_pred ccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC-------
Q 012518 278 GLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN------- 349 (461)
Q Consensus 278 G~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~------- 349 (461)
|++.............||..|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......
T Consensus 153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 153 GLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred CccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 9998765544445677899999999886 56899999999999999999999999887776666555432110
Q ss_pred ---------CC-------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 350 ---------FH-------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 350 ---------~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
+. ...++.++.++.+||.+||++||++|||+.|+|.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 01124578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=365.25 Aligned_cols=256 Identities=26% Similarity=0.487 Sum_probs=214.1
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
.|++.+.||+|+||+||++.++. +++.||||.+.............+.+|+.+++.++ |+||+.+++.+.+.+.+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC---CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEE
Confidence 37788999999999999999886 78999999987655444444556778999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 206 IVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
+||||+.|++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.++|+|||++....
T Consensus 77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~---~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD---DHGHIRISDLGLAVHVP 153 (285)
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeccceeecC
Confidence 9999999999988875443 3588999999999999999999999999999999999995 56779999999998765
Q ss_pred CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhh---HHHHHHhcCCCCCCCCCCCCCH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG---IFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
.........||..|+|||++. ..++.++|||||||++|+|++|+.||....... ....+... ........+++
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (285)
T cd05630 154 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---VQEEYSEKFSP 230 (285)
T ss_pred CCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---hhhhcCccCCH
Confidence 444445568999999999986 568999999999999999999999997654322 22222111 11122345889
Q ss_pred HHHHHHHHhcccCcCCCCC-----HHHHhcCCCcCC
Q 012518 361 EAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHD 391 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~ 391 (461)
++++||.+||+.||.+|+| +.|+++||||+.
T Consensus 231 ~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 231 DARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999999999 999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=377.64 Aligned_cols=256 Identities=27% Similarity=0.468 Sum_probs=223.8
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
...|.-++.||.|+||-||.|++.. +.+.||||.+....-.+.....++..|+..|++|+ |||++.+.|+|-.+..
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~---n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHT 100 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccC---ccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccch
Confidence 3467888999999999999999987 88999999998766556666788999999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
.|||||||-| +-.|.+.-....+-+.++..|+.+.+.||.|||+++.||||||..|||++ +.+.|||+|||.|..+
T Consensus 101 aWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 101 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhc
Confidence 9999999965 77777766667799999999999999999999999999999999999996 6788999999999876
Q ss_pred CCCCCccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC-CCCCCCCCCCC
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD-PNFHDSPWPSV 358 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~ 358 (461)
. ...+++|||+|||||||. |.|+-++||||||++..||.-.++|+...+....+..|.+.+ +.+.. +.+
T Consensus 177 ~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs---~eW 250 (948)
T KOG0577|consen 177 A---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS---NEW 250 (948)
T ss_pred C---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC---chh
Confidence 5 346789999999999873 679999999999999999999999988877666666665544 44443 357
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
|..++.||..||++-|.+|||.+++|.|+|+....
T Consensus 251 S~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 251 SDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 89999999999999999999999999999987643
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=373.12 Aligned_cols=250 Identities=29% Similarity=0.551 Sum_probs=209.8
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHH-HHHhcCCCCCeeEEEEEEEeCCeEEEEEe
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK-ILKALSGHKHMIKFHDAFEDANSVYIVME 209 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~~hpniv~l~~~~~~~~~~~lv~e 209 (461)
+.||+|+||+||+|+++. +++.||+|++.+...........+.+|.. +++.+. |+||+++++++.+.+.+|+|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEe
Confidence 469999999999999876 78899999997654333333344555554 456674 9999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC-CCC
Q 012518 210 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQR 288 (461)
Q Consensus 210 ~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~-~~~ 288 (461)
|+.||+|.+++.. .+.+.+..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ...
T Consensus 77 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~---~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 77 YINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEEccCCCCcccccCCCC
Confidence 9999999988754 45788999999999999999999999999999999999995 567799999999875432 233
Q ss_pred ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012518 289 LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 367 (461)
Q Consensus 289 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 367 (461)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+......+ .+.+++.+.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~ 228 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLE 228 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHH
Confidence 45568999999999986 458999999999999999999999999988888888777654332 2468999999999
Q ss_pred HhcccCcCCCCCHH----HHhcCCCcCCC
Q 012518 368 RLLNKDHRKRMTAA----QALTHPWLHDE 392 (461)
Q Consensus 368 ~~L~~dP~~R~s~~----e~L~hp~~~~~ 392 (461)
+||++||.+|+++. ++++|+||...
T Consensus 229 ~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 229 GLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred HHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 99999999999876 89999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=379.08 Aligned_cols=252 Identities=19% Similarity=0.313 Sum_probs=204.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|++++.||+|+||.||+|.+.. +++.||||.... ..+.+|+++|++|+ ||||++++++|......
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~---~~~~vaiK~~~~---------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNK---TCEHVVIKAGQR---------GGTATEAHILRAIN-HPSIIQLKGTFTYNKFT 158 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECC---CCCEEEEechhh---------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCee
Confidence 579999999999999999999876 789999997532 34568999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++|||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 159 ~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~---~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc---CCCCEEEEeCCcccccc
Confidence 99999995 6888877554 5689999999999999999999999999999999999995 56779999999997543
Q ss_pred CC--CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC-------hhhHHHHHHhcCCC-----
Q 012518 285 PD--QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART-------ESGIFRSVLRADPN----- 349 (461)
Q Consensus 285 ~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~-------~~~~~~~i~~~~~~----- 349 (461)
.. ......+||+.|+|||++. ..|+.++|||||||++|||++|..||.... ....+..+......
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 22 2334568999999999986 469999999999999999999998875432 11122222111000
Q ss_pred -----------------------CCCCCC---CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 350 -----------------------FHDSPW---PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 350 -----------------------~~~~~~---~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
.....| ..++.++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 000111 135678999999999999999999999999999987543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=372.27 Aligned_cols=250 Identities=29% Similarity=0.539 Sum_probs=210.4
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHH-HHHhcCCCCCeeEEEEEEEeCCeEEEEEe
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK-ILKALSGHKHMIKFHDAFEDANSVYIVME 209 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~~hpniv~l~~~~~~~~~~~lv~e 209 (461)
+.||+|+||+||+|+++. +|+.||+|++.+...........+.+|+. +++.++ ||||+++++++.+.+.+|+|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEc
Confidence 469999999999999876 78999999997654433334455666665 567775 9999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC-CCC
Q 012518 210 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQR 288 (461)
Q Consensus 210 ~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~-~~~ 288 (461)
||+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ...
T Consensus 77 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 77 YVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEccCCCCccCCCCCCc
Confidence 9999999887754 46789999999999999999999999999999999999994 567799999999875322 223
Q ss_pred ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012518 289 LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 367 (461)
Q Consensus 289 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 367 (461)
....+||+.|+|||++. ..++.++|||||||++|||++|..||...+....+..+......++ +..+.++.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 228 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLV 228 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHH
Confidence 34567999999999986 4689999999999999999999999999887777777776543333 357899999999
Q ss_pred HhcccCcCCCCCH----HHHhcCCCcCCC
Q 012518 368 RLLNKDHRKRMTA----AQALTHPWLHDE 392 (461)
Q Consensus 368 ~~L~~dP~~R~s~----~e~L~hp~~~~~ 392 (461)
+||++||.+|+++ .++++|+||...
T Consensus 229 ~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 229 GLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred HHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 9999999999876 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=361.70 Aligned_cols=260 Identities=28% Similarity=0.468 Sum_probs=218.4
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
.|+..+.||+|+||+||++.+.. +|+.||+|.+.............+.+|+++|+.++ |+||+.+++++.+++..|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC---CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEE
Confidence 37788999999999999999876 78999999997655444444556788999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 206 IVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
+||||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~---~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC---CCCCEEEecCCcceecC
Confidence 9999999999988776543 4689999999999999999999999999999999999995 56679999999987665
Q ss_pred CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
.........|+..|+|||++. ..++.++|||||||++|+|++|..||...........+..............++.++.
T Consensus 154 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05632 154 EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAK 233 (285)
T ss_pred CCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHH
Confidence 444445567999999999986 5689999999999999999999999987765544444333222222233356899999
Q ss_pred HHHHHhcccCcCCCCC-----HHHHhcCCCcCCC
Q 012518 364 DFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 392 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 392 (461)
+|+.+||+.||.+|++ +.+++.|+||...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999999 8999999999775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=360.81 Aligned_cols=250 Identities=25% Similarity=0.444 Sum_probs=207.2
Q ss_pred eccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012518 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCE 212 (461)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~~ 212 (461)
||+|+||+||+++.+. +|+.||+|.+.............+..|++++++++ ||||+++++++.++..+|+||||+.
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEcc---CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCC
Confidence 7999999999999876 78999999997654433333445667999999995 9999999999999999999999999
Q ss_pred CCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCccc
Q 012518 213 GGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND 291 (461)
Q Consensus 213 gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~ 291 (461)
|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...........
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD---DQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc---CCCCEEEeeceeeeecCCCceeec
Confidence 999988875543 3578888999999999999999999999999999999995 567799999999987655444455
Q ss_pred cccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh----hhHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 012518 292 IVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIFRSVLRADPNFHDSPWPSVSPEAKDFV 366 (461)
Q Consensus 292 ~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 366 (461)
..||..|+|||++. ..++.++|||||||++|+|++|..||..... ..+...+......+. ...+++++++||
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li 230 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDIC 230 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHH
Confidence 67999999999986 4599999999999999999999999976433 233333333322221 235899999999
Q ss_pred HHhcccCcCCCCCH----HHHhcCCCcCCC
Q 012518 367 RRLLNKDHRKRMTA----AQALTHPWLHDE 392 (461)
Q Consensus 367 ~~~L~~dP~~R~s~----~e~L~hp~~~~~ 392 (461)
.+||++||.+|+++ .+++.|+||+..
T Consensus 231 ~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 231 RLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred HHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 99999999999999 678899999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=368.81 Aligned_cols=259 Identities=26% Similarity=0.454 Sum_probs=209.9
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
-+..|+++++||.||.+.||+|... +.+.||+|.+.... .+...+.-+.+||..|.+|++|.+||+||+|-..++
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s----~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS----DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC----CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 3568999999999999999999864 34678888765433 456678889999999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+||||||-+ .+|-.+|.++........++.|..|+|.|+.++|++||||.||||.|+|+. .|.+||+|||+|..
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANA 508 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcc
Confidence 9999999864 488888777666666678999999999999999999999999999999995 67899999999998
Q ss_pred cCCCCC---ccccccCCCcCchhhhhc------------cCCCchhHHHHHHHHHHHhhCCCCCCCCC-hhhHHHHHHhc
Q 012518 283 VRPDQR---LNDIVGSAYYVAPEVLHR------------SYNVEGDMWSIGVITYILLCGSRPFWART-ESGIFRSVLRA 346 (461)
Q Consensus 283 ~~~~~~---~~~~~gt~~y~aPE~l~~------------~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~ 346 (461)
+..+.. ..+.+||+.||+||.+.. ..+.++||||||||||+|+.|+.||..-. ...-+..|..-
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P 588 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP 588 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence 876543 245799999999998741 15678999999999999999999995432 22333334333
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 347 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 347 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+..+..+..+. ..++.++++.||..||++||++.++|+|||++-.
T Consensus 589 ~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 589 NHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred CccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 22222221111 2349999999999999999999999999999763
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=375.43 Aligned_cols=257 Identities=29% Similarity=0.492 Sum_probs=208.1
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||.||++.++. +|+.||||++..... .......+.+|+.+++.++ ||||++++++|...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 93 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV---LGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQK 93 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC---CCceeEEEEeccccc-chhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCC
Confidence 45689999999999999999998876 789999999975432 3334567789999999996 999999999986543
Q ss_pred ------eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 203 ------SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 203 ------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
.+|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~---~~~~~kl~D 166 (359)
T cd07876 94 SLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 166 (359)
T ss_pred CccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEec
Confidence 57999999975 6666553 3488899999999999999999999999999999999995 567899999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHh----------
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR---------- 345 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~---------- 345 (461)
||++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 167 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 167 FGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 99998765444455678999999999986 4699999999999999999999999987665443332221
Q ss_pred ------------cCCCCCCCC-------C---------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 346 ------------ADPNFHDSP-------W---------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 346 ------------~~~~~~~~~-------~---------~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
..+.+.... | ...++++++||.+||+.||++|||+.|+|+||||..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 111111100 0 124678999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=363.02 Aligned_cols=259 Identities=26% Similarity=0.455 Sum_probs=214.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||.|+||.||+|+++. +++.||+|.+....... ....+.+|+.+++.++ |+||+++++++.+.+.+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKL---TDNLVALKEIRLEHEEG--APCTAIREVSLLKDLK-HANIVTLHDIIHTEKSL 79 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcC---CCcEEEEEEEecccccC--chhHHHHHHHHHHhcC-CCCcceEEEEEecCCeE
Confidence 579999999999999999998875 78899999987543222 2345678999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKS 155 (301)
T ss_pred EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC---CCCcEEECcCcchhccC
Confidence 99999997 589888877666789999999999999999999999999999999999995 56779999999987654
Q ss_pred CCC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC---------
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD--------- 352 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 352 (461)
... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+....+.........
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 322 2334567899999998853 4788999999999999999999999887766555544332111100
Q ss_pred -----------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 353 -----------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 353 -----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
...+.+++++++||.+||+.||.+|||++|+|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 01135788999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-49 Score=356.40 Aligned_cols=266 Identities=24% Similarity=0.490 Sum_probs=227.5
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.+-|.++.+||+|+||.||+|.++. +|..+|||.+..+ ..++++..||.||+++. .+++|++||.|.....
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~E---sG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRE---SGHVLAIKKVPVD-----TDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhc---cCcEEEEEecCcc-----chHHHHHHHHHHHHHcC-CchhhhhhhhhccCCc
Confidence 3468899999999999999999887 8999999998654 24678889999999995 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+|||||..|+..|.+..++..++|.++..+++..+.||+|||...-||||||..|||++ .+++.||+|||.|..+
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN---T~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN---TDGIAKLADFGVAGQL 179 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc---ccchhhhhhccccchh
Confidence 9999999999999999998999999999999999999999999999999999999999995 5778999999999877
Q ss_pred CCCC-CccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc----CCCCCCCCCCC
Q 012518 284 RPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA----DPNFHDSPWPS 357 (461)
Q Consensus 284 ~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~ 357 (461)
.+.. +.++.+||+.|||||++.. .|+.++||||||++..||..|++||.+-.. ++.|+-. .+.|..+ ..
T Consensus 180 TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~PPPTF~KP--E~ 254 (502)
T KOG0574|consen 180 TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTKPPPTFKKP--EE 254 (502)
T ss_pred hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEeccCCCCCCCCCh--Hh
Confidence 6543 4567899999999999975 699999999999999999999999966543 2233221 2223222 34
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCCchHHHHHHH
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLV 406 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~~~~~~~~ 406 (461)
+|.++.|||++||.++|++|.|+-++++|||+++.....-+...+.+.+
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~~A~ 303 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLMIQDAQ 303 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHHHHHHH
Confidence 7899999999999999999999999999999998766555554444443
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=367.58 Aligned_cols=252 Identities=28% Similarity=0.452 Sum_probs=195.9
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--CCeEEEE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED--ANSVYIV 207 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~--~~~~~lv 207 (461)
+++||+|+||+||+|+++.+ .+++.||+|.+..... ...+.+|+.+|++++ ||||++++++|.+ +..+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~-~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG-KDDRDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccC-CCCceEEEEEECCCCC-----cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEE
Confidence 46899999999999987643 2678899999875432 234678999999996 9999999999854 4668999
Q ss_pred EeccCCCchHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC-CCCCCeeEeecc
Q 012518 208 MEFCEGGELLDRILSR--------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR-EEDAPLKVIDFG 278 (461)
Q Consensus 208 ~e~~~gg~L~~~l~~~--------~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~-~~~~~~kl~DFG 278 (461)
|||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+... +.++.+||+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 99996 4887776432 1258889999999999999999999999999999999999643 345679999999
Q ss_pred cccccCCCC----CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCh---------hhHHHHH
Q 012518 279 LSDFVRPDQ----RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTE---------SGIFRSV 343 (461)
Q Consensus 279 ~a~~~~~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~---------~~~~~~i 343 (461)
++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ...+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 998764322 2345688999999998864 489999999999999999999999965432 1222222
Q ss_pred HhcCCCCCC----------------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 344 LRADPNFHD----------------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 344 ~~~~~~~~~----------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
+........ ......+.++.+||.+||+.||.+|+|++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 221100000 0011235679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=376.72 Aligned_cols=255 Identities=33% Similarity=0.591 Sum_probs=232.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.-|.+.+.||+|.|++|.++++.. +|..||||+|++..... ..+..+.+|+++|+.|. |||||+++.+.+....+
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~---t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHIL---TGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLN-HPNIVKLFSVIETEATL 130 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecC---CCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcC-Ccceeeeeeeeeeccee
Confidence 369999999999999999999876 89999999998876543 34455889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+|++++++.+. +++.+..++.++.|++.|++|||+++|||||||++|||| +.+.++||+|||++.++.
T Consensus 131 ylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeec
Confidence 9999999999999999765 678889999999999999999999999999999999999 567789999999999999
Q ss_pred CCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.+....+.||++.|.|||++.+ .-++.+|+||+|++||.|+.|.+||++.+-.++...++..+..++.. ++.++
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~----ms~dc 282 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY----MSCDC 282 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce----eechh
Confidence 8888999999999999999975 35789999999999999999999999999988888888777666543 78999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+++|+++|..+|.+|+++++++.|.|....
T Consensus 283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred HHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 999999999999999999999999998654
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=372.30 Aligned_cols=250 Identities=21% Similarity=0.337 Sum_probs=202.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
..|++++.||+|+||.||+|++.. +++.||+|+.... ....|+.++++++ |+||+++++++.+.+..
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPG---QPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAIT 132 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECC---CCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCee
Confidence 469999999999999999999876 6789999985433 1246999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++||||+. ++|.+++......+++..+..|+.||+.||.|||++||+||||||+|||+. .++.+||+|||++....
T Consensus 133 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN---DVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEecCccccccc
Confidence 99999995 589998877777899999999999999999999999999999999999994 56779999999998654
Q ss_pred CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh----------hHHHHHHhcC----CC
Q 012518 285 PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES----------GIFRSVLRAD----PN 349 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----------~~~~~i~~~~----~~ 349 (461)
.........||..|+|||++. ..++.++|||||||++|||+++..++...... ..+..+.... ..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 209 VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 444445678999999999986 46999999999999999999865554332111 1111111110 00
Q ss_pred CC------------------C--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 350 FH------------------D--------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 350 ~~------------------~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
+. . .....++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 11 0 001246778899999999999999999999999999975
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=381.94 Aligned_cols=258 Identities=28% Similarity=0.479 Sum_probs=219.1
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
...+|++.+.||+|+||+||+|++.. +|+.||||++..... .......+.+|+.++..+. |+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVS---DGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKD 104 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcC---CCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceeccc
Confidence 34699999999999999999998876 789999999976544 3445567889999999996 999999998775432
Q ss_pred --------eEEEEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCC
Q 012518 203 --------SVYIVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP 271 (461)
Q Consensus 203 --------~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~ 271 (461)
.+++||||+.+|+|.+++..+ ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~---~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC---SNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe---CCCC
Confidence 378999999999999988653 34688999999999999999999999999999999999995 5677
Q ss_pred eeEeecccccccCCC---CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC
Q 012518 272 LKVIDFGLSDFVRPD---QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 347 (461)
Q Consensus 272 ~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 347 (461)
+||+|||+++..... ......+||+.|+|||++. ..|+.++|||||||+||||++|+.||.+.+..+++..+....
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~ 261 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 999999999765432 2234568999999999986 469999999999999999999999999888877777776654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 348 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 348 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
... ..+.+++++.+||.+||..||.+||++.++|+|||++.
T Consensus 262 ~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 262 YDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 322 12468999999999999999999999999999999865
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=366.81 Aligned_cols=259 Identities=29% Similarity=0.516 Sum_probs=228.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.+.|..-++||+||||.||-++.+. +|+.||+|.+.+............++|-.||++++ .+.||.+-.+|+..+.
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvra---TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRA---TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDA 259 (591)
T ss_pred ccceeeeEEEecccccceeEEEEec---chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCc
Confidence 3568888999999999999998887 99999999998776665555667789999999996 8999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
+||||..|+||+|.-+|.+.+ ..+++..++.++.+|+.||++||+.+||+|||||+|||+ |+.++++|+|+|+|..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEe
Confidence 999999999999987776553 369999999999999999999999999999999999999 6789999999999999
Q ss_pred cCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh----hHHHHHHhcCCCCCCCCCCC
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES----GIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~ 357 (461)
+..+......+||.+|||||+++ +.|+...|+|||||+||||+.|+.||....+. ++-+.++.....+. .+
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~----~k 412 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS----DK 412 (591)
T ss_pred cCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----cc
Confidence 98888888889999999999997 56999999999999999999999999765443 44455555544444 46
Q ss_pred CCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcCCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~~ 393 (461)
+|++++++.+.+|++||.+|. +++++.+||||++.+
T Consensus 413 FS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 413 FSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred cCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 999999999999999999998 467999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=369.49 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=212.4
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
.+...++..++..||+|.||+||+|++.. .||||++.....+ ....+.|++|+.++++-+ |.||+-+.|||.
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------dVAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~ 458 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG------DVAVKLLNVDDPT-PEQLQAFKNEVAVLKKTR-HENILLFMGACM 458 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc------ceEEEEEecCCCC-HHHHHHHHHHHHHHhhcc-hhhheeeehhhc
Confidence 34444567889999999999999998854 3999999877654 447899999999999997 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
.... .||+.+|+|-+|+.+++-...+|.....+.|++||+.|+.|||.++|||||||..||++ .++++|||+|||+
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGL 534 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccc
Confidence 8876 99999999999999998777788889999999999999999999999999999999999 4668899999999
Q ss_pred cccc---CCCCCccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC
Q 012518 280 SDFV---RPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD 352 (461)
Q Consensus 280 a~~~---~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 352 (461)
+... ..+.....--|...|||||++. ..|+..+|||||||++|||+||..||.......++..+-++......
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence 8643 2334445556788899999985 35999999999999999999999999876666665554444211111
Q ss_pred -CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 353 -SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 353 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
....++++++++|+..||.+++++||.+.+||.
T Consensus 615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 122456789999999999999999999999886
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=365.85 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=210.8
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.++||+|+||.||++.++. +|..+|+|++.... .....+.+.+|+++++.++ |+||++++++|.+++.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP---SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC---CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCE
Confidence 4689999999999999999999876 78899999987542 3334567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
+|+||||+.+|+|.+++... +.+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc---CCCCEEEeeCCcchh
Confidence 99999999999999988543 5688999999999999999999985 799999999999995 566799999999876
Q ss_pred cCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHH------------------
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV------------------ 343 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i------------------ 343 (461)
.... ......||..|+|||++.+ .++.++|||||||++|+|++|+.||...........+
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 154 LIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred hhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 5322 2244679999999999864 5899999999999999999999999765443322111
Q ss_pred --------------------------HhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 344 --------------------------LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 344 --------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.... .+......++.++++||.+||++||++|||+.|++.||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEP--PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCC--CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000 0000011367899999999999999999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=396.28 Aligned_cols=268 Identities=31% Similarity=0.544 Sum_probs=221.4
Q ss_pred cCCCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEE
Q 012518 117 FGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHD 196 (461)
Q Consensus 117 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~ 196 (461)
+..++...++|++++.||+|+||+||+|+++. +++.||+|++...... ......+.+|+.+|+.|. |||||++++
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~-HPNIVrl~d 79 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKR---TQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELK-HKNIVRYID 79 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECC---CCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcC-CCCcCeEEE
Confidence 34466677899999999999999999999876 7889999999765433 334567889999999996 999999999
Q ss_pred EEEe--CCeEEEEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc-------CccccCCCCCcEEEe
Q 012518 197 AFED--ANSVYIVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQ-------GVVHRDLKPENFLFT 264 (461)
Q Consensus 197 ~~~~--~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH~~-------givHrDlkp~NILl~ 264 (461)
+|.+ ...+|||||||.+|+|.++|... .+.+++..++.|+.||+.||.|||+. +||||||||+||||+
T Consensus 80 ~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 9854 45699999999999999988643 35689999999999999999999995 499999999999996
Q ss_pred cC--------------CCCCCeeEeecccccccCCCCCccccccCCCcCchhhhh---ccCCCchhHHHHHHHHHHHhhC
Q 012518 265 TR--------------EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCG 327 (461)
Q Consensus 265 ~~--------------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlGvil~elltg 327 (461)
.. +....+||+|||++............+||+.|+|||++. ..++.++||||||||||+|++|
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 42 123458999999998765544445668999999999985 3489999999999999999999
Q ss_pred CCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 328 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 328 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..||........+...+...+.+ +....+.++.+||.+||..+|.+||++.|+|.|+|++..
T Consensus 240 k~PF~~~~~~~qli~~lk~~p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 240 KTPFHKANNFSQLISELKRGPDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCCCcCCcHHHHHHHHhcCCCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 99997765544444444433322 234578999999999999999999999999999999754
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=373.47 Aligned_cols=257 Identities=29% Similarity=0.463 Sum_probs=211.3
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC---
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN--- 202 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~--- 202 (461)
+|++.+.||+|+||+||+|.+.. +|+.||||++.... ........+.+|+.+++.++ |+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---DGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---CCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccc
Confidence 47889999999999999999865 78999999986532 23334567889999999996 999999999998776
Q ss_pred --eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 203 --SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 203 --~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+|+||||+. ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~a 150 (372)
T cd07853 76 FEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN---SNCVLKICDFGLA 150 (372)
T ss_pred cceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC---CCCCEEeccccce
Confidence 7999999996 578777644 46799999999999999999999999999999999999995 5678999999999
Q ss_pred cccCCCC--CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC--------
Q 012518 281 DFVRPDQ--RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP-------- 348 (461)
Q Consensus 281 ~~~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-------- 348 (461)
....... ......+|+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+....+..+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 8654332 2344578999999999864 489999999999999999999999988776665555433110
Q ss_pred ---------------CCCC-----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 349 ---------------NFHD-----SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 349 ---------------~~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.... ......++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 0000 1113468899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=370.43 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=210.1
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... .......+.+|+.+++.+. |+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~ 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC---CCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcC-CCCccccceeecccc
Confidence 34689999999999999999999876 788999999875432 2333466788999999996 99999999988543
Q ss_pred -----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 202 -----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 202 -----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
..+|+||||+.+ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 97 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~D 169 (364)
T cd07875 97 SLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 169 (364)
T ss_pred cccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC---CCCcEEEEe
Confidence 357999999965 67776642 478899999999999999999999999999999999995 567799999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC-------
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP------- 348 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------- 348 (461)
||+++............||..|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..++....
T Consensus 170 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99998765544455678999999999986 4689999999999999999999999988777666555543211
Q ss_pred ---------------CCCCC----------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 349 ---------------NFHDS----------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 349 ---------------~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
.+... .....+.++++||.+||+.||.+|||+.|+|+||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 11000 01123568999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=368.19 Aligned_cols=244 Identities=27% Similarity=0.446 Sum_probs=209.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
..+++++.||+|-||.||+++... ...||+|.++...+. .+.+.+|++||++|+ |+|||++++++..++.+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~----~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG----STKVAVKTIKEGSMS----PEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC----CCcccceEEeccccC----hhHHHHHHHHHHhCc-ccCeEEEEEEEecCCce
Confidence 457788999999999999999853 347999999875443 256779999999997 99999999999998899
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILS-RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
|||||||..|+|.++|.. .+..+...+...++.||++|++||+++++|||||..+|||| +++..+||+|||+|+..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEccccccccc
Confidence 999999999999999987 45678889999999999999999999999999999999999 56788999999999965
Q ss_pred CCCCCcccccc---CCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 284 RPDQRLNDIVG---SAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 284 ~~~~~~~~~~g---t~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
.++.. +...| ...|.|||.+. +.|+.++|||||||+||||+| |+.||.+.+..+.++.+-++.... .+ ..+
T Consensus 354 ~d~~Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp-~P--~~C 429 (468)
T KOG0197|consen 354 GDDEY-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP-RP--EGC 429 (468)
T ss_pred CCCce-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC-CC--CCC
Confidence 54432 22222 34699999987 679999999999999999998 999999999999999887764332 22 469
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHh
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQAL 384 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L 384 (461)
++++.+++..||..+|++|||++.+.
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 99999999999999999999998543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=382.41 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=217.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
..|.+.+.||+|+||.||+|....+ .++.||+|.+... .......+.+|+.+|+.+. ||||++++++|...+.+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~--~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSD--PKEKVVAKFVMLN---DERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKL 140 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCC--CCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEE
Confidence 3599999999999999999987651 2678999977543 3334456788999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 205 YIVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
||||||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~~kL~DFgla~ 217 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC---CCCcEEEEeCcCce
Confidence 9999999999999877542 34688999999999999999999999999999999999995 56779999999998
Q ss_pred ccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 282 FVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 282 ~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
....... ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+++..+........ ...
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~ 294 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCP 294 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---Ccc
Confidence 7654322 34567999999999986 4599999999999999999999999998888888887776543211 135
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
+++++++||.+||..||++||++.++|.|+|++.
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 8899999999999999999999999999999864
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=369.26 Aligned_cols=257 Identities=27% Similarity=0.455 Sum_probs=208.2
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... .......+.+|+.+++.++ |+||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC---CCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccc
Confidence 45689999999999999999998765 788999999875432 3334567788999999996 99999999998643
Q ss_pred -----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 202 -----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 202 -----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
..+|+||||+.+ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~---~~~~~kl~D 162 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 162 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC---CCCCEEEee
Confidence 357999999975 67666642 488899999999999999999999999999999999994 567899999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc---------
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA--------- 346 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--------- 346 (461)
||+++............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+...
T Consensus 163 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred CcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999987655545556789999999999864 5899999999999999999999999877654443332221
Q ss_pred -------------CCCCCC----------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 347 -------------DPNFHD----------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 347 -------------~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
.+.+.. ......+.++++||.+||..||++|||+.|+|+||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 111100 001124678899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=319.90 Aligned_cols=258 Identities=28% Similarity=0.512 Sum_probs=224.1
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|.-.++||+|+||+||+++++. +++.||+|.++.+.-.+ ..-....+||-+|+.|+ |.|||++++....++.+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~---t~eivalkrvrldddde-gvpssalreicllkelk-hknivrl~dvlhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE---THEIVALKRVRLDDDDE-GVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC---ccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeE
Confidence 56778899999999999999887 89999999997654322 22245678999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+|+|||.. +|..+..+-++.+..+.++.++.|++.||.|||++++.||||||+|.||+ .++.+||+|||+++.++.
T Consensus 78 lvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin---~ngelkladfglarafgi 153 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN---RNGELKLADFGLARAFGI 153 (292)
T ss_pred EeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec---cCCcEEecccchhhhcCC
Confidence 99999965 88888888889999999999999999999999999999999999999995 677799999999998765
Q ss_pred CC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC----
Q 012518 286 DQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS---- 357 (461)
Q Consensus 286 ~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~---- 357 (461)
.. -....+-|.+|++|.++.+ -|++..|+||.|||+.|+.. |++.|.+.+-.+++..|+..-....+..|+.
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 43 2345678999999999865 49999999999999999986 8888999999999999988766666555543
Q ss_pred ---------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 358 ---------------------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 358 ---------------------~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
++...+||+.++|.-+|.+|++++++|+||||.+.
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 34667899999999999999999999999999775
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=365.37 Aligned_cols=255 Identities=23% Similarity=0.384 Sum_probs=202.5
Q ss_pred ccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|++.+.||+|+||.||+|.+.. ...+++.||||+++... .......+.+|+.+|..+.+||||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4689999999999999999997532 12356789999987542 2334567889999999995699999999988754
Q ss_pred -CeEEEEEeccCCCchHHHHHhcC--------------------------------------------------------
Q 012518 202 -NSVYIVMEFCEGGELLDRILSRG-------------------------------------------------------- 224 (461)
Q Consensus 202 -~~~~lv~e~~~gg~L~~~l~~~~-------------------------------------------------------- 224 (461)
+.+|+||||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 46899999999999999886431
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCC---ccccccCC
Q 012518 225 -----GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSA 296 (461)
Q Consensus 225 -----~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~ 296 (461)
..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....... .....++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~---~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc---CCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 2367788899999999999999999999999999999995 567799999999986543221 12345678
Q ss_pred CcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 012518 297 YYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDH 374 (461)
Q Consensus 297 ~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 374 (461)
.|+|||++. ..++.++|||||||+||||++ |..||.+......+...+....... ....+++++.+||.+||..||
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR--APENATPEIYRIMLACWQGDP 318 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHccCCh
Confidence 899999886 569999999999999999997 9999987654443333333222211 123578999999999999999
Q ss_pred CCCCCHHHHhc
Q 012518 375 RKRMTAAQALT 385 (461)
Q Consensus 375 ~~R~s~~e~L~ 385 (461)
.+|||+.|+++
T Consensus 319 ~~RPs~~el~~ 329 (338)
T cd05102 319 KERPTFSALVE 329 (338)
T ss_pred hhCcCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=367.35 Aligned_cols=256 Identities=24% Similarity=0.389 Sum_probs=206.6
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
....+|++++.||+|+||.||++..+. ...++.||||.+.... ...+|+++|++|+ |+||++++++|...
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~-~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~-h~~iv~~~~~~~~~ 158 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHG-DEQRKKVIVKAVTGGK--------TPGREIDILKTIS-HRAIINLIHAYRWK 158 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcC-CccceeEEEEeccccc--------cHHHHHHHHHhcC-CCCccceeeeEeeC
Confidence 345689999999999999999997643 2367889999886532 3457999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+.+|+|||++. ++|.+++ .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 159 ~~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~---~~~~~~l~DfG~a~ 233 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLGDFGAAC 233 (392)
T ss_pred CEEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEccCcccc
Confidence 99999999995 5888887 4456799999999999999999999999999999999999995 56779999999997
Q ss_pred ccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh---hhHHHHHHhcC----CCC
Q 012518 282 FVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE---SGIFRSVLRAD----PNF 350 (461)
Q Consensus 282 ~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~----~~~ 350 (461)
...... ......||+.|+|||++. ..|+.++|||||||++|||++|+.||.+... ...+..+.+.. ..+
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 654332 223467999999999987 4699999999999999999999999976532 22222222210 000
Q ss_pred CC------------------C--CC------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 351 HD------------------S--PW------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 351 ~~------------------~--~~------~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.. . .+ ..++.++.+||.+||..||++|||+.|+|.||||...
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00 0 00 1356789999999999999999999999999999764
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=367.73 Aligned_cols=258 Identities=28% Similarity=0.521 Sum_probs=209.6
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
+.++|++++.||+|+||+||+|.+.. +++.||||++..... .......+.+|+++|+.++ |+||++++++|...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 87 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTR---LRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMK-HENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECC---CCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccc
Confidence 44689999999999999999999876 788999999875422 2233456778999999996 99999999988543
Q ss_pred -----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 202 -----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 202 -----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
..+|++||++ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~---~~~~~kl~D 161 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILD 161 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC---CCCCEEEcC
Confidence 4579999998 678877663 35699999999999999999999999999999999999995 567799999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC------
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP------ 348 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------ 348 (461)
||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.....
T Consensus 162 fg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 162 FGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred CccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999986543 3345689999999999864 589999999999999999999999987665554444332111
Q ss_pred -----------------CCCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 349 -----------------NFHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 349 -----------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
..... .+...++.+.+||.+||..||.+|||+.|+|+||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 01110 1234677899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=353.29 Aligned_cols=254 Identities=33% Similarity=0.638 Sum_probs=221.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||++.+.. +++.||+|++...........+.+.+|+++++++. ||||+++++++.+.+.+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNL 76 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeE
Confidence 368999999999999999999876 78999999997665544555677889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+|+||+|+|||++ .++.+||+|||++....
T Consensus 77 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD---SDGYIKITDFGFAKRVK 152 (290)
T ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEeeCCCccccC
Confidence 9999999999999988655 6799999999999999999999999999999999999995 56779999999988765
Q ss_pred CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
.. .....|++.|+|||.+. ..++.++||||||+++|+|++|..||...........+......++ ..++..++
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~ 226 (290)
T cd05580 153 GR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAK 226 (290)
T ss_pred CC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHH
Confidence 43 34457899999999875 4588899999999999999999999988777666777665544433 24689999
Q ss_pred HHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 364 DFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 364 ~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
++|.+||..||.+|+ +++|+++||||...
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 227 DLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 999999999999999 99999999999663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=353.82 Aligned_cols=254 Identities=39% Similarity=0.695 Sum_probs=209.9
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
|++++.||+|+||+||++++.. +++.||+|++........ ......+|+.+++.++ |+||+++++++.+....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---NGQKVAVKIIDKSEIEEE-EREENIREIKILRRLR-HPNIVQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---TTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC---CCeEEEEEEecccccccc-ccchhhhhhhcccccc-ccccccccccccccccccc
Confidence 7899999999999999999987 788999999987643322 2233456999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc-CC
Q 012518 207 VMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV-RP 285 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~-~~ 285 (461)
||||+.+++|.+++. ....+++..+..++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++... ..
T Consensus 76 v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~---~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD---ENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES---TTSEEEESSGTTTEESTST
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence 999999999998886 346789999999999999999999999999999999999995 5677999999998763 23
Q ss_pred CCCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCC---hhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 286 DQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWART---ESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 286 ~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
........+|..|+|||++. ..++.++||||||+++|+|++|..||.... ...................+...+.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE 231 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence 34455678999999999987 568999999999999999999999998773 2333333332211111111112348
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
++.++|.+||+.||++||++.++++||||
T Consensus 232 ~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 232 ELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=351.75 Aligned_cols=255 Identities=28% Similarity=0.436 Sum_probs=208.2
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||+|+||.||+|+++. +|+.||||+++..... ....+.+.+|+.+++.+. |+||+++++++.+++.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---CCcEEEEEEecccccc-CCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEE
Confidence 58899999999999999999875 7889999998654322 223356788999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 206 IVMEFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAF 151 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc---CCCcEEECcccceeec
Confidence 9999997 58888775432 5689999999999999999999999999999999999995 5677999999998765
Q ss_pred CCCC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC----------
Q 012518 284 RPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF---------- 350 (461)
Q Consensus 284 ~~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~---------- 350 (461)
.... ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||.+.........+.......
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 152 GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred CCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 4332 2233467899999998853 47899999999999999999999998776544433332211100
Q ss_pred ---------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 351 ---------------HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 351 ---------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
....+..+++++++||.+||+.||.+|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 011124578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=354.84 Aligned_cols=255 Identities=28% Similarity=0.497 Sum_probs=207.8
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||+|+||.||+|+++. +|+.||+|+++..... ......+.+|+.+++.++ |+||+++++++.+.+.+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDD-EGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---CCcEEEEEEeeccccc-ccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceE
Confidence 58899999999999999999876 7899999998754322 222355778999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+|+||+. ++|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++.....
T Consensus 76 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGI 151 (284)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc---CCCcEEECccchhhccCC
Confidence 9999997 488888876667899999999999999999999999999999999999995 567799999999886543
Q ss_pred CC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCC-CChhhHHHHHHhcCC-------------
Q 012518 286 DQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWA-RTESGIFRSVLRADP------------- 348 (461)
Q Consensus 286 ~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~------------- 348 (461)
.. ......++..|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+.++.+.....
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 32 2344567899999998864 378999999999999999999988644 343344443322110
Q ss_pred -CC------C-----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 349 -NF------H-----DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 349 -~~------~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.+ . ....+.+++++++||.+||+.||.+|||++++|.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 0 01123578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-47 Score=356.13 Aligned_cols=258 Identities=26% Similarity=0.498 Sum_probs=230.8
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
..+|.++.+||+|+||.|-+|..+. +.+.||||+++++.......++--..|-++|.....-|.+++++.+|+.-+.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkg---tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ecccceEEEeccCccceeeeecccC---cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 3589999999999999999998765 7789999999988776666666667788888776667899999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+.||+|.-+|.+ -+++.|..+..++.+|+-||-|||++|||+||||.+|||+ +.++++||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeeccccccc
Confidence 9999999999999887754 4789999999999999999999999999999999999999 57888999999998743
Q ss_pred -CCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 -RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 -~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
..+....++|||+.|+|||++. +.|+..+|+||+||+||||+.|++||.+.++.++++.|......++. .+|.+
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkE 576 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKE 576 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHH
Confidence 3345667899999999999875 78999999999999999999999999999999999999998888775 48999
Q ss_pred HHHHHHHhcccCcCCCCCH-----HHHhcCCCcCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTA-----AQALTHPWLHDE 392 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~-----~e~L~hp~~~~~ 392 (461)
+.+++..+|.+.|.+|..+ .++-.||||...
T Consensus 577 Av~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 577 AVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 9999999999999999864 689999999764
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=355.66 Aligned_cols=260 Identities=33% Similarity=0.583 Sum_probs=222.1
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|.+.. +|+.||||.+...........+.+.+|+++++.+. |+||+++++.+.+.+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 76 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYL 76 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEE
Confidence 379999999999999999998876 78999999998765554445677899999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
|+||||+.|++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc---CCCCEEEeecchhhcc
Confidence 9999999999999988654 35689999999999999999999999999999999999995 5677999999998754
Q ss_pred CCCC------------------------------CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCC
Q 012518 284 RPDQ------------------------------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFW 332 (461)
Q Consensus 284 ~~~~------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~ 332 (461)
.... .....+||..|+|||++. ..++.++|||||||++|+|++|..||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 3211 112347899999999986 458899999999999999999999998
Q ss_pred CCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC----HHHHhcCCCcCCCC
Q 012518 333 ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT----AAQALTHPWLHDEN 393 (461)
Q Consensus 333 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~e~L~hp~~~~~~ 393 (461)
+......+..+......+... ..++++++++|.+||..||++||+ ++|+|+||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 234 GSNRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred CCchHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 888777777776554444332 237999999999999999999999 99999999998753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=350.78 Aligned_cols=258 Identities=31% Similarity=0.525 Sum_probs=218.6
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||.|+||.||++.+.. +++.||+|++... .....+.+.+|+++++++. |+||+++++++.+.+.
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE---TGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC---CCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCe
Confidence 3579999999999999999998865 7889999998643 3445567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+.+++|.+++......+++..++.++.|++.||.|||++||+|+||||+||+++ .++.+||+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~---~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT---LDGDVKLADFGVSAKN 153 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC---CCCCEEEccCccchhh
Confidence 9999999999999998877666799999999999999999999999999999999999994 5677999999998765
Q ss_pred CCCC-CccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 284 RPDQ-RLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 284 ~~~~-~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
.... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||........+..+......... ...
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 232 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD-QPS 232 (280)
T ss_pred cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC-Ccc
Confidence 4322 233457899999999874 23678999999999999999999999887766666555544322111 123
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.++.++.+||.+||+.||.+||++.++|+||||.+.
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 233 KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 578999999999999999999999999999999775
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=347.74 Aligned_cols=255 Identities=29% Similarity=0.526 Sum_probs=210.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
..+.|++.+.||+|+||.||+|.++. +++.||+|++..... ....+.+|+.+++++.+|+||++++++|...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC---CCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 34579999999999999999998876 788999999865421 2356788999999996699999999998753
Q ss_pred -----CeEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 202 -----NSVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 202 -----~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
..+|+||||+.+|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++ +++.+||+
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~---~~~~~~l~ 153 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLV 153 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC---CCCCEEEc
Confidence 4689999999999999988764 34688999999999999999999999999999999999995 56679999
Q ss_pred ecccccccCCC-CCccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC
Q 012518 276 DFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP 348 (461)
Q Consensus 276 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~ 348 (461)
|||++...... .......|+..|+|||++. ..++.++|||||||++|+|++|..||...........+....
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~- 232 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP- 232 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC-
Confidence 99998765432 2334567899999999884 248889999999999999999999997665544443333221
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 349 NFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 349 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
........++.++.+||.+||..||.+|||+.+++.||||
T Consensus 233 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 -APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 1222224578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=349.77 Aligned_cols=261 Identities=30% Similarity=0.492 Sum_probs=217.9
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..+.|+++++||+|+||.||+|++.. +|+.||+|++... .....+.+.+|+.+++.+. |+||+++++.+..++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 82 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKE---TGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDG 82 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECC---CCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCC
Confidence 34679999999999999999998876 7899999998653 3445677889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+||||+.+++|...+.+....+++..+..++.||+.+|.|||++||+||||||+||+++ .++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~ 159 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT---LDGDIKLADFGVSAK 159 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc---CCCCEEEccCcccee
Confidence 99999999999999888776666789999999999999999999999999999999999995 466799999999875
Q ss_pred cCCC-CCccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 283 VRPD-QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 283 ~~~~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
.... .......++..|+|||++. ..++.++|||||||++|+|++|..||...+....+..+........ ...
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 238 (292)
T cd06644 160 NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-SQP 238 (292)
T ss_pred ccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccC-CCC
Confidence 4322 2234457889999999873 2378899999999999999999999987766555555543322111 112
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
..++.++.+||.+||..||++||++.++++||||.....
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 357889999999999999999999999999999976543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=355.74 Aligned_cols=252 Identities=28% Similarity=0.466 Sum_probs=194.3
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--eCCeEEEE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE--DANSVYIV 207 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~--~~~~~~lv 207 (461)
+.+||+|+||+||+|+.+.+. ++..||+|.+..... ...+.+|+.+++.++ ||||+++++++. .+..+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~-~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGTGI-----SMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCC-ccceEEEEEecCCCC-----cHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEE
Confidence 468999999999999875432 668899999875432 235678999999996 999999999985 45678999
Q ss_pred EeccCCCchHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC-CCCCCeeEeecc
Q 012518 208 MEFCEGGELLDRILSR--------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR-EEDAPLKVIDFG 278 (461)
Q Consensus 208 ~e~~~gg~L~~~l~~~--------~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~-~~~~~~kl~DFG 278 (461)
|||+.+ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+... +.++.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 999965 787776422 1247889999999999999999999999999999999999643 345689999999
Q ss_pred cccccCCCC----CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChh---------hHHHHH
Q 012518 279 LSDFVRPDQ----RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES---------GIFRSV 343 (461)
Q Consensus 279 ~a~~~~~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---------~~~~~i 343 (461)
+++...... ......||+.|+|||++.+ .++.++|||||||++|||+||+.||...... ..+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 998764332 2344678999999999864 4899999999999999999999999654321 111111
Q ss_pred HhcCC--------------CCC--------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 344 LRADP--------------NFH--------------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 344 ~~~~~--------------~~~--------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
..... .+. .......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 11100 000 00001245678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=379.54 Aligned_cols=250 Identities=28% Similarity=0.464 Sum_probs=209.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-EE---e
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDA-FE---D 200 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~-~~---~ 200 (461)
.++++.+.|.+|||+.||+|++.. .|..||+|++-.. ++..++.+.+||++|++|++|+|||.|++. .. .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~---~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVK---GGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecC---CCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 378999999999999999999875 4589999998543 677889999999999999999999999993 22 1
Q ss_pred C---CeEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCcEEEecCCCCCCeeE
Q 012518 201 A---NSVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 201 ~---~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~g--ivHrDlkp~NILl~~~~~~~~~kl 274 (461)
+ -.++|.||||.||.|.|++..+ ..+|+|.++++|+.|+++|+.+||... |||||||-|||||+ .++++||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KL 187 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKL 187 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEe
Confidence 1 3578999999999999999765 346999999999999999999999998 99999999999995 5677999
Q ss_pred eecccccccCCCCC-c---------cccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHH
Q 012518 275 IDFGLSDFVRPDQR-L---------NDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 340 (461)
Q Consensus 275 ~DFG~a~~~~~~~~-~---------~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~ 340 (461)
||||.|.-...... . -....|+.|+|||++. ...+.|+|||||||+||-|+....||.+....
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--- 264 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--- 264 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence 99999864332211 0 1135799999999985 25899999999999999999999999876543
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 341 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 341 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.|+++.+.|+. .+.++..+++||+.||+.||.+||++.|++.+-+.
T Consensus 265 -aIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 265 -AILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred -eEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 35555555554 47899999999999999999999999999876554
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=343.52 Aligned_cols=255 Identities=25% Similarity=0.467 Sum_probs=212.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC--CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT--SALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+.|++.+.||+|+||.||++.+.. +|+.||+|.+...... .......+.+|+++++++. ||||+++++++.+.+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCC
Confidence 368899999999999999998765 7899999998754322 1223467889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+||||+.+++|.+++... +.+++..+..++.|++.||.|||+.||+||||+|+||+++ .++.+||+|||++..
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~---~~~~~~l~dfg~~~~ 153 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKR 153 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeccccee
Confidence 999999999999999887654 5688999999999999999999999999999999999995 567799999999876
Q ss_pred cCCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 283 VRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 283 ~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
...... .....|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+....... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 231 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP--QLPSH 231 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC--CCCcc
Confidence 543211 13356888999999986 458899999999999999999999997766555544444332221 12235
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
++.++.+||.+||..||.+|||+.|+|+|+||
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 232 VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 88999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=345.62 Aligned_cols=258 Identities=29% Similarity=0.527 Sum_probs=217.9
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||.|+||.||+|++.. +|+.||+|++.... .......+.+|+++++.++ |+||+++++++.++..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC---CCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeE
Confidence 378999999999999999999876 78999999987543 2234467889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+|+||+.+++|.+++... .+++..++.++.||+.||.|||+++|+||||+|+||+++ .++.++|+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLT 149 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEcccccceeec
Confidence 9999999999999988643 789999999999999999999999999999999999995 56779999999998765
Q ss_pred CC-CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.. .......|+..|+|||++. ..++.++|||||||++|+|++|..||...........+...... ......++.++
T Consensus 150 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 227 (274)
T cd06609 150 STMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP--SLEGNKFSKPF 227 (274)
T ss_pred ccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCC--CCcccccCHHH
Confidence 43 2334567899999999886 45899999999999999999999999776655555444433221 11112378999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~ 395 (461)
.++|.+||..||++|||++++++||||....+.
T Consensus 228 ~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 228 KDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 999999999999999999999999999886544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=343.04 Aligned_cols=256 Identities=27% Similarity=0.490 Sum_probs=216.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||.|+||+||+|.... ++..+|+|++....... ....+.+|+.+++.+. |+||+++++.+...+.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---CCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEE
Confidence 479999999999999999998765 78899999987654332 5678899999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 205 YIVMEFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++ +++.+||+|||++..
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~---~~~~~~l~df~~~~~ 151 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSAS 151 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccchHHH
Confidence 99999999999999886542 4689999999999999999999999999999999999995 466799999999876
Q ss_pred cCCCCCc-----cccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCC--
Q 012518 283 VRPDQRL-----NDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS-- 353 (461)
Q Consensus 283 ~~~~~~~-----~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-- 353 (461)
....... ....|+..|+|||++.. .++.++|||||||++|+|++|+.||........+..+..........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGA 231 (267)
T ss_pred hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcc
Confidence 6543221 33568999999999863 58999999999999999999999998777666666555543222111
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 354 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.+..+++++.++|.+||..||++||++.++++||||
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 124688999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=351.88 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=210.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||++.+.. +|..+|+|.+.... ......++.+|++++++++ ||||++++++|.+++.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP---SGLIMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC---CCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEE
Confidence 368999999999999999998876 78899999986532 3344567889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
|+||||++|++|.+++... +.+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||++...
T Consensus 75 ~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQL 150 (308)
T ss_pred EEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe---cCCcEEEccCCCcccc
Confidence 9999999999999988654 678999999999999999999998 5999999999999995 5667999999998765
Q ss_pred CCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC------------
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF------------ 350 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~------------ 350 (461)
... .....+|+..|+|||++.+ .++.++|||||||++|+|++|+.||...+.......+.......
T Consensus 151 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 151 IDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ccc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 332 2345678999999999864 58899999999999999999999997655333222221110000
Q ss_pred ----------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 351 ----------------------HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 351 ----------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+..+...++.++++||.+||..||++||++.++++||||...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 001112368899999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=339.16 Aligned_cols=253 Identities=28% Similarity=0.480 Sum_probs=217.0
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||+|+||.||+|.++. +|+.|++|.+...... ......+.+|+++++.++ |+||+++++++.+.+..|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---CCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEE
Confidence 47889999999999999999876 7899999998765433 345677889999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 206 IVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
+||||+.|++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceecc
Confidence 999999999999988765 45788999999999999999999999999999999999995 46779999999988665
Q ss_pred CCCC-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.... .....|+..|+|||++. +.++.++|||||||++|+|++|+.||...+.......+....... .. ..++.++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~ 229 (256)
T cd08529 153 DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP--VS-QMYSQQL 229 (256)
T ss_pred CccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--Cc-cccCHHH
Confidence 4332 23457889999999986 558899999999999999999999998888777666666543221 11 1578999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.++|.+||+.+|++||++.+++.|||+
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 230 AQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.61 Aligned_cols=256 Identities=31% Similarity=0.526 Sum_probs=214.7
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||.|+||.||+|.++. +|+.||||++...... ......+.+|+.+++.+. |+||+++++++.+.+.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLE-GGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---CCceEEEEEEEccccc-chhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeE
Confidence 58999999999999999999876 6899999998765432 233467889999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+||||+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++.....
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~---~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSE 151 (286)
T ss_pred EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---CCCcEEEeeeeecccccC
Confidence 999999 9999998877667799999999999999999999999999999999999995 467799999999887654
Q ss_pred CC--CccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC-----------
Q 012518 286 DQ--RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF----------- 350 (461)
Q Consensus 286 ~~--~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----------- 350 (461)
.. ......|+..|+|||++. ..++.++|||||||++|+|++|..+|.+......+..+.......
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 33 234567899999999875 347899999999999999999988887777666555544321110
Q ss_pred --------CC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 351 --------HD-------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 351 --------~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
.. ..++..+.++.+||.+||..||.+||+++++|+||||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 01235679999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=344.39 Aligned_cols=253 Identities=26% Similarity=0.473 Sum_probs=208.9
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|++.. +++.||+|+++... ......+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVN---TGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcC---CCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEE
Confidence 589999999999999999998876 78899999987542 223456778999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+++|.+++... +.+++..++.++.|++.||.|||++||+|+||||+||++. .++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQIT 157 (267)
T ss_pred EEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECcceeeeEcc
Confidence 9999999999999987544 5799999999999999999999999999999999999995 56679999999987654
Q ss_pred CCC-CccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC-CCCCCC
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD-SPWPSV 358 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~ 358 (461)
... ......|+..|+|||++. +.++.++|||||||++|+|++|..||..................... .....+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06645 158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237 (267)
T ss_pred CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence 322 224467999999999873 35889999999999999999999999765544333333222211111 111247
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 388 (461)
+..+.+||.+||..||++||+++++++|||
T Consensus 238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=345.60 Aligned_cols=256 Identities=30% Similarity=0.533 Sum_probs=215.6
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
.|++.+.||+|+||.||++.+.. ++..+|+|.+... .....+.+.+|+++++.+. |+||++++++|...+..|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~ 78 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLW 78 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECC---CCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEE
Confidence 47889999999999999998876 7889999998653 2344567889999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+||||+.+++|...+......+++..+..++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++.....
T Consensus 79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTR 155 (282)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---cCCCEEEccccccccccc
Confidence 99999999999887766566789999999999999999999999999999999999995 566799999999876533
Q ss_pred C-CCccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 286 D-QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 286 ~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
. .......|+..|+|||++. ..++.++|||||||++|+|++|+.||...+..+....+........ .....+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 234 (282)
T cd06643 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRW 234 (282)
T ss_pred cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-CCcccc
Confidence 2 2234467899999999873 2377899999999999999999999988776666655554432211 112357
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+.++++||.+||..||.+||++.++++||||...
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 8999999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=354.93 Aligned_cols=256 Identities=21% Similarity=0.324 Sum_probs=203.8
Q ss_pred eceeeccC--CceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 129 LGKEVGRG--HFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 129 ~~~~lG~G--~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
++++||+| +||+||++..+. +|+.||||+++.... .....+.+.+|+.+++.++ ||||++++++|..++.+|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---TGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecc---cCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEE
Confidence 56889999 788999999876 899999999976543 2334567888999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 207 VMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.++++|||.+.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe---cCCcEEEcccchhhcccc
Confidence 99999999999988654 34589999999999999999999999999999999999995 466799999986543221
Q ss_pred CC--------CccccccCCCcCchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC-CC--
Q 012518 286 DQ--------RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN-FH-- 351 (461)
Q Consensus 286 ~~--------~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~-- 351 (461)
.. ......++..|+|||++.+ .|+.++|||||||++|||++|+.||.................. ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence 11 0112356778999999863 4899999999999999999999999765544333332221100 00
Q ss_pred ---------------------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 352 ---------------------------------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 352 ---------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
......+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00012357899999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=345.69 Aligned_cols=253 Identities=27% Similarity=0.452 Sum_probs=208.9
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--CeE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA--NSV 204 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~--~~~ 204 (461)
|++.+.||+|+||.||+|.++. +++.||+|+++..... ... ....+|+.++.++.+|+||+++++++.+. +.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~-~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---TGKYYAIKCMKKHFKS-LEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcC---CCcEEEEEEehhccCC-chh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 6788999999999999999875 7889999998754322 112 23457999999997799999999999987 899
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++||||+. |+|.+.+......+++..+..++.||+.||.|||++||+||||||+||+++ . +.+||+|||++....
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 76 ALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIY 150 (282)
T ss_pred EEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccc
Confidence 99999997 588888876666789999999999999999999999999999999999995 3 789999999998775
Q ss_pred CCCCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC-------------
Q 012518 285 PDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN------------- 349 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~------------- 349 (461)
.........++..|+|||++. +.++.++|||||||++|||++|..||.+.+..+.+..+......
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred cCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 554445567899999999764 34789999999999999999999999887765555444321110
Q ss_pred -----CCCC-------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 350 -----FHDS-------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 350 -----~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
++.. ..+.++.++.+||.+||.+||++||++.++|+||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1100 013568999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=348.26 Aligned_cols=258 Identities=28% Similarity=0.473 Sum_probs=218.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||++.++. +++.||+|.+...........+.+.+|+++++.+. |+||+++++.+..++.+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE---TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHL 76 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC---CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEE
Confidence 368999999999999999999876 78899999987664444445667889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||++|++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||+++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~---~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKIGL 152 (305)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC---CCCCEEEeeCCCccccC
Confidence 9999999999999888554 5789999999999999999999999999999999999995 56779999999886421
Q ss_pred CCC----------------CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC
Q 012518 285 PDQ----------------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 347 (461)
Q Consensus 285 ~~~----------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 347 (461)
... ......|+..|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 100 011246788999999875 568999999999999999999999999888777777776655
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCcCC
Q 012518 348 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT---AAQALTHPWLHD 391 (461)
Q Consensus 348 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~L~hp~~~~ 391 (461)
...+.... .++.++.++|.+||..||++||+ +.++|+||||..
T Consensus 233 ~~~~~~~~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 233 IEWPEGDE-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred cCCCCccc-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 44443322 57899999999999999999998 799999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=337.41 Aligned_cols=253 Identities=24% Similarity=0.502 Sum_probs=212.6
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-CCeE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED-ANSV 204 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~-~~~~ 204 (461)
.|++.+.||+|+||.||+++++. +++.||+|.+..... .....+.+.+|++++++++ |+||+++++.+.. +..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---DGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---CCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEE
Confidence 48999999999999999999876 678999999875433 2334566889999999996 9999999998864 4568
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
|+||||+.+++|.+++... ...+++.+++.++.|++.||.|||++||+||||||+||+++ .++.++|+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~---~~~~~~l~df~~~~~~ 152 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVL 152 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe---cCCcEEEecccceEEe
Confidence 9999999999999988764 34589999999999999999999999999999999999995 5677999999998866
Q ss_pred CCCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 RPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
.... ......|++.|+|||++. ..++.++|||||||++|+|++|+.||...+.......+...... .....++++
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 229 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP---PMPKDYSPE 229 (257)
T ss_pred cccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCccccCHH
Confidence 4332 234457899999999886 45889999999999999999999999877766665555544321 112358899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
+.+||.+||+.||.+||++.++++||||
T Consensus 230 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 230 LGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=344.24 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=208.0
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||+|+||.||+|.+.. +++.||+|++.... .......+.+|+++++++. ||||++++++|...+..+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 75 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLL---TRRILAVKVIPLDI--TVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRIS 75 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcC---CCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEE
Confidence 68889999999999999998876 78999999987542 2334467889999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+||||+++++|..+ ..+++..+..++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++.....
T Consensus 76 lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~---~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 76 ICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN---TRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred EEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC---CCCCEEEeeCCcceeccc
Confidence 99999999988543 3578899999999999999999999999999999999995 567799999999876543
Q ss_pred CCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh-------hhHHHHHHhcCCCCCCCCCCC
Q 012518 286 DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE-------SGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 286 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~ 357 (461)
. .....+||..|+|||++. ..++.++|||||||++|+|++|..||..... ......+.... ........
T Consensus 148 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 224 (279)
T cd06619 148 S-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQ 224 (279)
T ss_pred c-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCc
Confidence 2 234568999999999886 4689999999999999999999999965321 12222222221 11112345
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
+++++++||.+||+.||.+||+++|+++||||...+.
T Consensus 225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 225 FSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred CCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence 7899999999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=347.60 Aligned_cols=259 Identities=28% Similarity=0.452 Sum_probs=209.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe-
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS- 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~- 203 (461)
++|++.+.||+|+||.||+|.+.. +|+.||||++...... ......+.+|+.+++.+.+|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 76 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN---TGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKN 76 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC---CCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCC
Confidence 369999999999999999999876 7899999998654322 22335677899999999768999999999987665
Q ss_pred ----EEEEEeccCCCchHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 204 ----VYIVMEFCEGGELLDRILSRG----GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 204 ----~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++. .++.+||+
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~--~~~~~kl~ 153 (295)
T cd07837 77 GKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK--QKGLLKIA 153 (295)
T ss_pred CCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec--CCCeEEEe
Confidence 8999999986 8888876542 35799999999999999999999999999999999999963 26779999
Q ss_pred ecccccccCCC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC
Q 012518 276 DFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD 352 (461)
Q Consensus 276 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 352 (461)
|||++...... .......+++.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+.........
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (295)
T cd07837 154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233 (295)
T ss_pred ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99998765322 22233467889999998753 4789999999999999999999999887766555544432111000
Q ss_pred ------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 353 ------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 353 ------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
...+.+++++.+||.+||..||.+||++.|+|.||||+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 01145789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=338.22 Aligned_cols=267 Identities=29% Similarity=0.460 Sum_probs=215.2
Q ss_pred cceeeceeeccCCceEEEEEEeccCCc-cCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-CC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTL-KGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED-AN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~-~~ 202 (461)
..|++...||+|+||.||+|..+.+.. ..+.+|||.++..+-..... ....|||.+++.|+ |+||+.+..+|.. +.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELK-HPNVISLVKVFLSHDK 101 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhc-CCcchhHHHHHhccCc
Confidence 379999999999999999996554321 13479999987653222222 34568999999997 9999999999876 88
Q ss_pred eEEEEEeccCCCchHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC-CCCCCeeEeec
Q 012518 203 SVYIVMEFCEGGELLDRILSR----GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR-EEDAPLKVIDF 277 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~-~~~~~~kl~DF 277 (461)
.+||++||.+. +|+..|.-. ...++...++.|+.||+.|+.|||++-|+||||||.|||+..+ .+.+.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999976 898887543 2457888999999999999999999999999999999999854 24588999999
Q ss_pred ccccccCCC----CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCC---------hhhHHHH
Q 012518 278 GLSDFVRPD----QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWART---------ESGIFRS 342 (461)
Q Consensus 278 G~a~~~~~~----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~---------~~~~~~~ 342 (461)
|+++.+... ......+-|.+|+|||.+.+ .|+.++||||+|||+.||+|-++.|.+.. ..+++..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999987543 13345788999999998864 69999999999999999999999996542 2346667
Q ss_pred HHhcCCCCCCCCCCC---------------------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 343 VLRADPNFHDSPWPS---------------------------------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 343 i~~~~~~~~~~~~~~---------------------------------~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
|+..-.......|+. -++.+.+|+.+||++||.+|+|+.++|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 776655555555542 24668899999999999999999999999999
Q ss_pred CCCCC
Q 012518 390 HDENR 394 (461)
Q Consensus 390 ~~~~~ 394 (461)
.....
T Consensus 341 ~~d~l 345 (438)
T KOG0666|consen 341 TEDPL 345 (438)
T ss_pred ccCCC
Confidence 87643
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=344.64 Aligned_cols=256 Identities=26% Similarity=0.506 Sum_probs=209.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|+++. +|+.||+|++...... ....+.+.+|+.+++++. |+||+++++++.+...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE---TGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC---CCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEE
Confidence 479999999999999999999876 7899999998654322 122345778999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++||||++++.|..++ .....+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++....
T Consensus 76 ~~v~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 76 HLVFEYCDHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILT 151 (286)
T ss_pred EEEEeccCccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc---CCCcEEECccccceecC
Confidence 9999999987776544 4445789999999999999999999999999999999999995 56679999999998765
Q ss_pred CCC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC------------
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN------------ 349 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~------------ 349 (461)
... ......++..|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 433 3344568899999999853 4889999999999999999999999877655444333221000
Q ss_pred -------CCC--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 350 -------FHD--------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 350 -------~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.+. ..++.++..+.+||.+||+.||++||++.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0124578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=350.82 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=213.7
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA-- 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~-- 201 (461)
.++|++.+.||+|+||.||+|.++. +|+.||+|+++....... ....+.+|+.++++++ |+||+++++++.+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT---SGEIVALKKVRMDNERDG-IPISSLREITLLLNLR-HPNIVELKEVVVGKHL 80 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC---CCcEEEEEEEEeccCCCC-CcchhhHHHHHHHhCC-CCCCcceEEEEecCCC
Confidence 3589999999999999999999876 789999999875432221 1234567999999996 99999999999755
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+.+|+||||+.+ +|.+.+......+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++.
T Consensus 81 ~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~kL~dfg~~~ 156 (309)
T cd07845 81 DSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLAR 156 (309)
T ss_pred CeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccceee
Confidence 568999999965 88887766556789999999999999999999999999999999999995 56779999999998
Q ss_pred ccCCCC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC------
Q 012518 282 FVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD------ 352 (461)
Q Consensus 282 ~~~~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~------ 352 (461)
...... ......++..|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 765432 2333456888999998853 5889999999999999999999999988887777766543211110
Q ss_pred -------------CC-------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 353 -------------SP-------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 353 -------------~~-------~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.. ...+++++.+||.+||+.||++|||+.|+|.||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 00 123589999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=345.10 Aligned_cols=241 Identities=18% Similarity=0.233 Sum_probs=205.7
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe----CCeEEE
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED----ANSVYI 206 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~----~~~~~l 206 (461)
..||+|++|.||+|+. +|+.||||+++..........+.+.+|+.+|++++ ||||+++++++.+ ...+++
T Consensus 26 ~~i~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~l 99 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSL 99 (283)
T ss_pred eEEeeCCceEEEEEEE-----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEE
Confidence 5799999999999976 67899999998765545455678889999999996 9999999999977 457899
Q ss_pred EEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 207 VMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
||||+.||+|.+++.+. ..+++.....++.|++.||.|||+. +++||||||+|||++ .++.+||+|||++.....
T Consensus 100 v~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~---~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 100 ILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT---ENYKLKIICHGLEKILSS 175 (283)
T ss_pred EEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC---CCCcEEEcccchHhhhcc
Confidence 99999999999988654 5788999999999999999999985 999999999999995 567899999999886543
Q ss_pred CCCccccccCCCcCchhhhh---ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 286 DQRLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 286 ~~~~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
. ....+||..|+|||++. +.++.++|||||||++|||++|+.||.+.+..+++..+......+... ..+++++
T Consensus 176 ~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l 251 (283)
T PHA02988 176 P--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEI 251 (283)
T ss_pred c--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHH
Confidence 2 23456889999999986 368999999999999999999999999888888887776554443322 2578999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhc
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++||.+||+.||++|||+.|+++
T Consensus 252 ~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 252 KCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHhcCCcccCcCHHHHHH
Confidence 99999999999999999999874
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=340.54 Aligned_cols=252 Identities=31% Similarity=0.512 Sum_probs=211.2
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||.|+||.||+|.+.. +|+.||||++.+...........+..|..++....+|+||+++++++..++.+|+||||
T Consensus 2 ~~l~~g~~~~v~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecC---CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 579999999999998876 78899999997654333333344556666665554699999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCcc
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN 290 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~ 290 (461)
+.|++|.+++... +.+++..+..++.||+.||.|||++||+||||+|+||+++ .++.+||+|||++..... ..
T Consensus 79 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~---~~ 151 (260)
T cd05611 79 LNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRNGLE---NK 151 (260)
T ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEeecccceeccc---cc
Confidence 9999998877543 5689999999999999999999999999999999999995 567799999999876432 23
Q ss_pred ccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 012518 291 DIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 369 (461)
Q Consensus 291 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 369 (461)
...|+..|+|||.+.+ .++.++||||||+++|+|++|..||...+....+..+......+.......+++++.++|.+|
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 4568899999999864 479999999999999999999999988887777777766555555444456899999999999
Q ss_pred cccCcCCCC---CHHHHhcCCCcCCC
Q 012518 370 LNKDHRKRM---TAAQALTHPWLHDE 392 (461)
Q Consensus 370 L~~dP~~R~---s~~e~L~hp~~~~~ 392 (461)
|..||++|| +++|+|.||||.+.
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcC
Confidence 999999999 45799999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=348.65 Aligned_cols=263 Identities=30% Similarity=0.480 Sum_probs=215.3
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC--CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT--SALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
+|++.+.||+|+||.||+|.+.. +|+.||||.++..... .......+..|+++++.++ |+||+++++++.+.+.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCE
Confidence 48889999999999999999876 6889999999765433 1223345678999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
.|+||||+ +|+|.+++......+++..+..++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++...
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSF 152 (298)
T ss_pred EEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc---CCCCEEEccceeeeec
Confidence 99999999 8899998865544789999999999999999999999999999999999995 5677999999999876
Q ss_pred CCCC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC--------
Q 012518 284 RPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD-------- 352 (461)
Q Consensus 284 ~~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 352 (461)
.... ......++..|+|||++.+ .++.++|||||||++|+|++|..+|.+....+.+..+.........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 153 GSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred cCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 5432 3334567889999998853 5789999999999999999998888877765555555432111000
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCC
Q 012518 353 ----------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 396 (461)
Q Consensus 353 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~ 396 (461)
..+..++.++.+||.+||..||++|||+.|+|.|+||.+...+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 01234678999999999999999999999999999998865443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=344.58 Aligned_cols=253 Identities=30% Similarity=0.490 Sum_probs=208.2
Q ss_pred eccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012518 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCE 212 (461)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~~ 212 (461)
||+|+||+||+|.+.. +|+.||+|++.+...........+.+|+++++.++ ||||+++++++...+.+|+||||++
T Consensus 1 lg~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKA---TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcC---CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCC
Confidence 6999999999998776 78999999997654433334556678999999996 9999999999999999999999999
Q ss_pred CCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCccc
Q 012518 213 GGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND 291 (461)
Q Consensus 213 gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~ 291 (461)
+++|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||+++ +++.+||+|||++...........
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD---DHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEccCcchhhhccCCcccc
Confidence 999998886654 3689999999999999999999999999999999999994 567799999999887654444445
Q ss_pred cccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhc
Q 012518 292 IVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 370 (461)
Q Consensus 292 ~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 370 (461)
..++..|+|||++. +.++.++|||||||++|+|++|+.||...........+..............+++++.++|.+||
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHc
Confidence 67888999999986 45889999999999999999999999765442222222221111122222457999999999999
Q ss_pred ccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 371 NKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 371 ~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
+.||.+|| ++.+++.||||...
T Consensus 234 ~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 234 QKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred cCChhHccCCCcccHHHHHhChhhhcC
Confidence 99999999 89999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=337.66 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=217.3
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||+|+||.||+|.+.. +++.+|||.+....... .....+.+|+++++.++ |+||+++++.+..++.++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---DQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---CCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEE
Confidence 58899999999999999999876 78999999997654433 34577889999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 206 IVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
+||||+.+++|.+++.... ..+++..+..++.|++.+|.|||++||+|+||||+||+++. ++..+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK--HKMVVKIGDFGISKILS 153 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEccCCCceecC
Confidence 9999999999999987653 35889999999999999999999999999999999999962 34568999999998776
Q ss_pred CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
.........|+..|+|||++. ..++.++|||||||++|+|++|+.||...+.......+...... .....++++++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~ 230 (256)
T cd08220 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---PISDRYSPDLR 230 (256)
T ss_pred CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC---CCCCCcCHHHH
Confidence 554445567899999999986 45889999999999999999999999887766666665543221 11235789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 364 DFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
++|.+||..||.+|||+.|+++||||
T Consensus 231 ~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 231 QLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=346.25 Aligned_cols=259 Identities=27% Similarity=0.421 Sum_probs=212.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||.||+|++.. +|+.||+|.+... ........+.+|+++++++. |+||+++++.+...+.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP---TGVTMAMKEIRLE--LDESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC---CCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeE
Confidence 378999999999999999999876 7899999998653 23334567889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 205 YIVMEFCEGGELLDRILSR--GGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
|+||||++|++|..++... ...+++..+..++.||+.||.|||+ .||+||||||+||+++ .++.+||+|||++.
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~ 151 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSG 151 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCcc
Confidence 9999999999998777543 2368999999999999999999997 5999999999999995 46779999999987
Q ss_pred ccCCCCCccccccCCCcCchhhhhc-------cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCC
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLHR-------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 354 (461)
..... ......|+..|+|||++.+ .++.++|||||||++|+|++|..||...........+...........
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd06622 152 NLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230 (286)
T ss_pred cccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCC
Confidence 65422 2334568889999998742 257899999999999999999999976555444433222111111222
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.+.+++++.+||.+||..+|++||++.+++.||||....
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 345899999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=336.00 Aligned_cols=253 Identities=28% Similarity=0.506 Sum_probs=218.4
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||.|+||.||.++... +|+.+++|.+...... .....++.+|++++++++ |+||+++++++.+.+.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---DDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---CCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEE
Confidence 58999999999999999999876 7899999998765433 344567889999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 206 IVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
+||||+.+++|.+++... ...+++..+..++.|++.||.|||+.||+|+||+|+||+++ +++.+||+|||++....
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILG 152 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEEcc
Confidence 999999999999988765 45689999999999999999999999999999999999995 56679999999988664
Q ss_pred CCC-CccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
... ......|++.|+|||++.+ .++.++|||||||++|+|++|..||......+....+......... ..++.++
T Consensus 153 ~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (256)
T cd08221 153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSEL 229 (256)
T ss_pred cccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHH
Confidence 433 2345678999999998864 5888999999999999999999999888877777777655433221 4578999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.++|.+||..||.+||++.++|+|+|+
T Consensus 230 ~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 230 ISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=339.33 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=209.5
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEeccccc---CCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM---TSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+|++.+.||+|+||+||+|... +|+.+|||.+..... ........+.+|+++++.++ |+||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCC
Confidence 4788999999999999999753 688999999865422 12233466889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+||||+.|++|.+++.+. ..+++..+..++.||+.||.|||+.||+|+||+|+||++. .++.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~ 151 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFGCARR 151 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC---CCCeEEeccchhhHh
Confidence 999999999999999888654 5688999999999999999999999999999999999994 567799999999875
Q ss_pred cCCC-------CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCC
Q 012518 283 VRPD-------QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 283 ~~~~-------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 354 (461)
.... .......|+..|+|||++. ..++.++|||||||++|+|++|..||...........+......... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 230 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR-L 230 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC-C
Confidence 4211 1123456899999999986 45889999999999999999999999776554444443333222222 2
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
...++.++.+||.+||..||.+||++.|+|+||||
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 24588999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=337.77 Aligned_cols=252 Identities=28% Similarity=0.523 Sum_probs=213.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||.|+||.||++..+. +++.||+|.+.... ..+.+.+|++++++++ |+||+++++++.+...+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---TGQVVAIKVVPVEE-----DLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---CCcEEEEEEeecHH-----HHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcE
Confidence 589999999999999999999875 67899999986542 1578889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+++||+.+++|.+++......+++..++.++.||+.||.|||+.||+||||+|+||+++ .++.+||+|||++....
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~---~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---EEGQAKLADFGVSGQLT 150 (256)
T ss_pred EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC---CCCcEEEcccccchhcc
Confidence 999999999999998876667789999999999999999999999999999999999995 56679999999988765
Q ss_pred CCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+....... ......++.++
T Consensus 151 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (256)
T cd06612 151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEF 229 (256)
T ss_pred cCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCC-CCchhhcCHHH
Confidence 433 233456889999999986 458899999999999999999999997765544443333221111 11113478899
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.++|.+||+.||++|||+.|+|.||||
T Consensus 230 ~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 230 NDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=363.15 Aligned_cols=254 Identities=24% Similarity=0.439 Sum_probs=219.0
Q ss_pred eeceeeccCCceEEEEEEeccCCccCcEEEEEEeccccc-CCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe--E
Q 012518 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM-TSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS--V 204 (461)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~--~ 204 (461)
++..+||+|+|-+||+|.+.. +|..||.-.++..++ .+...++++..|+.+|+.|+ |+||+++|++|.+... +
T Consensus 43 k~~evLGrGafKtVYka~De~---~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE---EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ehhhhcccccceeeeeccccc---cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCcee
Confidence 456789999999999999865 888999877665443 35566789999999999997 9999999999987655 8
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~g--ivHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+|++..|+|..++.+. ++++...++.|++||+.||.|||++. |||||||.+||+|+ +..+.|||+|+|||+.
T Consensus 119 n~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHH
Confidence 8999999999999988654 78999999999999999999999995 99999999999998 6788999999999998
Q ss_pred cCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCC-CChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWA-RTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
.+... ....+|||.|||||++...|+..+||||||++|+||+|+..||.. .+...+++++..+...-.... --.++
T Consensus 196 ~r~s~-aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dPe 272 (632)
T KOG0584|consen 196 LRKSH-AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK--VKDPE 272 (632)
T ss_pred hhccc-cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCHH
Confidence 87544 345899999999999999999999999999999999999999965 567778888877643211111 12689
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+++||.+||.. .+.|+|+.|+|+||||...
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 99999999999 8999999999999999875
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=342.40 Aligned_cols=252 Identities=31% Similarity=0.569 Sum_probs=215.8
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
.|++.+.||.|+||.||+|++.. +|+.||+|++.+.........+.+.+|++++++++ ||||+++++.+.+.+.+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEE
Confidence 48899999999999999999875 78999999998765555556778999999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++ +++.++|+|||++.....
T Consensus 77 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~---~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD---EQGHVHITDFNIATKVTP 152 (258)
T ss_pred EEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc---CCCCEEEeecccccccCC
Confidence 999999999999888655 5789999999999999999999999999999999999995 567799999999887655
Q ss_pred CCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh---hhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 286 DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE---SGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 286 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
........|+..|+|||++. ..++.++|+||||+++|+|++|..||..... ............. ....++.+
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 228 (258)
T cd05578 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL----YPATWSTE 228 (258)
T ss_pred CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccccc----CcccCcHH
Confidence 44445567889999999986 4589999999999999999999999987663 2222222212222 22357899
Q ss_pred HHHHHHHhcccCcCCCCCH--HHHhcCCCc
Q 012518 362 AKDFVRRLLNKDHRKRMTA--AQALTHPWL 389 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~--~e~L~hp~~ 389 (461)
+.++|.+||..||.+|+++ .|+++||||
T Consensus 229 ~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 229 AIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 9999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=334.21 Aligned_cols=264 Identities=30% Similarity=0.501 Sum_probs=224.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE---
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE--- 199 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~--- 199 (461)
....|+-+.+||+|.||.||+|+.+. +|+.||+|++-.+....... ....+|+.+|..|+ |+|++.+++.|.
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n---~~kkvalkkvlmeneKeGfp-italreikiL~~lk-Henv~nliEic~tk~ 89 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKN---TGKKVALKKVLMENEKEGFP-ITALREIKILQLLK-HENVVNLIEICRTKA 89 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcC---ccchhHHHHHHHhccccCCc-HHHHHHHHHHHHhc-chhHHHHHHHHhhcc
Confidence 44578889999999999999999887 78889999764432222112 34458999999997 999999998774
Q ss_pred -----eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeE
Q 012518 200 -----DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 200 -----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
+...+||||.+|+. +|...+.....+++..+++.++++++.||.|+|++.|+|||+|++|+||+ .++.+||
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt---~dgilkl 165 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT---KDGILKL 165 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc---CCceEEe
Confidence 23459999999976 89888876667899999999999999999999999999999999999995 6788999
Q ss_pred eecccccccCCC-----CCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC
Q 012518 275 IDFGLSDFVRPD-----QRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 347 (461)
Q Consensus 275 ~DFG~a~~~~~~-----~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 347 (461)
+|||+++.+... ...+..+.|.+|++||.+. +.|+++.|||+.||||.||+||.+-|.++++...+..|....
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 999999765432 2356678899999999875 569999999999999999999999999999999999998888
Q ss_pred CCCCCCCCCCC-------------------------------CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCC
Q 012518 348 PNFHDSPWPSV-------------------------------SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395 (461)
Q Consensus 348 ~~~~~~~~~~~-------------------------------s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~ 395 (461)
..+....||++ .+++.||+.+||..||.+|+.++++|+|.||.....+
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 88887777753 3588999999999999999999999999999876544
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=345.12 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=215.6
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
....|++.+.||+|+||+||+|.+.. +|+.||+|++.............+.+|+++++.++ ||||++++++|.+.+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~ 88 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREH 88 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCC
Confidence 44579999999999999999999875 78899999987654444555667889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
..|+||||+. |+|.+.+......+++..+..++.||+.||.|||++||+||||+|+||+++ .++.+||+|||++..
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~---~~~~~kL~dfg~~~~ 164 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASL 164 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC---CCCCEEEeecCccee
Confidence 9999999997 577777765556799999999999999999999999999999999999994 567799999999876
Q ss_pred cCCCCCccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC-CCCCCCCCCC
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD-PNFHDSPWPS 357 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 357 (461)
.... ....|+..|+|||++. +.++.++|||||||++|+|++|..||...........+.... +... ...
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 238 (307)
T cd06607 165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLS---SND 238 (307)
T ss_pred cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC---chh
Confidence 5432 3456888999999873 458899999999999999999999998776655544443322 1111 124
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
++.+++++|.+||..||.+||++.+++.||||....
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 239 WSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 688999999999999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=341.05 Aligned_cols=254 Identities=26% Similarity=0.443 Sum_probs=207.4
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
..+|++.+.||+|+||.||+|+++. +|+.||+|++..... .....+.+|+.+++++. |+||+++++++...+.
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~ 80 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH---TGELAAVKIIKLEPG---DDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREK 80 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC---CCeEEEEEEEecCcc---chHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCE
Confidence 3589999999999999999999876 788999999865422 22356788999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+.+++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKI 156 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEECcCccceee
Confidence 99999999999999887544 5789999999999999999999999999999999999994 5667999999999866
Q ss_pred CCCC-CccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCC-CCCC
Q 012518 284 RPDQ-RLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS-PWPS 357 (461)
Q Consensus 284 ~~~~-~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~ 357 (461)
.... ......|+..|+|||.+. ..++.++|||||||++|||++|..||...........+.......... ....
T Consensus 157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06646 157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236 (267)
T ss_pred cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccc
Confidence 4322 223457899999999873 347889999999999999999999996554333222222211111111 1124
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 388 (461)
++..+.+||++||..||.+||+++++|+|+|
T Consensus 237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 237 WSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 7899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=339.50 Aligned_cols=252 Identities=17% Similarity=0.314 Sum_probs=210.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|++.+.||+|+||.||+|..+.....+..||+|.++... .......+.+|+.++++++ ||||+++++++...+..
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCCc
Confidence 47999999999999999999876544467899999987642 2334567889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~---~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc---CCCcEEECCCccccccc
Confidence 999999999999988876666789999999999999999999999999999999999995 56789999999876543
Q ss_pred CCCCcc--ccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 285 PDQRLN--DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 285 ~~~~~~--~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
...... ...++..|+|||++. +.++.++|||||||++||+++ |..||......+....+..... . .....++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~ 235 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-L--PAPRNCPN 235 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-C--CCCCCCCH
Confidence 222111 234567899999876 568999999999999999775 9999998888777776654422 1 22346889
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+.+++.+||..+|.+||++.++++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=342.44 Aligned_cols=255 Identities=24% Similarity=0.464 Sum_probs=213.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|++.+.||+|+||.||++.++. +|+.||+|.+...... ..+.+.+|+.+++.+. |+||+++++.|.+....
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGDEL 92 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECC---CCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCEE
Confidence 589999999999999999998765 7889999998765432 2366889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.|++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 93 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~---~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQIT 167 (296)
T ss_pred EEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEECccccchhcc
Confidence 999999999999998743 4588999999999999999999999999999999999994 56779999999987654
Q ss_pred CCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
... ......|++.|+|||.+. ..++.++|||||||++|+|++|+.||...........+.... .........++..+
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 246 (296)
T cd06654 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIF 246 (296)
T ss_pred ccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCCCCccccCHHH
Confidence 332 223457899999999886 458899999999999999999999998776544433333221 11111224588999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.+||.+||..||.+||++.++++||||...
T Consensus 247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=337.55 Aligned_cols=255 Identities=28% Similarity=0.495 Sum_probs=214.0
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||.|+||.||+|.+.. +++.+|+|++..... ...+.+.+|++++++++ ||||+++++++.+.+.
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIA---TGELVAIKVIKLEPG---DDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecC---CCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCE
Confidence 3589999999999999999999876 678899999975432 24577889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|++|||+.+++|.+++......+++..+..++.|++.||.|||++||+|+||||+||+++ .++.+||+|||++...
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQL 151 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC---CCCCEEECccccchhh
Confidence 9999999999999988876657899999999999999999999999999999999999995 5677999999998765
Q ss_pred CCCC-CccccccCCCcCchhhhh-c---cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC-CCCCCC
Q 012518 284 RPDQ-RLNDIVGSAYYVAPEVLH-R---SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH-DSPWPS 357 (461)
Q Consensus 284 ~~~~-~~~~~~gt~~y~aPE~l~-~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~ 357 (461)
.... ......++..|+|||++. . .++.++|||||||++|+|++|..||.+.........+........ ......
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd06613 152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231 (262)
T ss_pred hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence 4332 334567899999999875 3 588899999999999999999999987765554444433311111 111234
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 388 (461)
++.++.+||.+||..||.+|||+.+++.|+|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 6789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=338.06 Aligned_cols=253 Identities=29% Similarity=0.533 Sum_probs=210.3
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCC------HHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS------ALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
+|.+.+.||+|+||.||+|.+.. +++.||+|.+....... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSL 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Confidence 47788999999999999998765 68899999986543322 223467889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
+.+..++||||+.+++|.+++... +.+++..+..++.|++.||.|||++||+||||+|+||+++ .++.+||+|||+
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~---~~~~~~l~dfg~ 152 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGI 152 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc---CCCCEEecccCC
Confidence 999999999999999998888554 5688999999999999999999999999999999999994 567799999999
Q ss_pred ccccCCCC-------CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC
Q 012518 280 SDFVRPDQ-------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH 351 (461)
Q Consensus 280 a~~~~~~~-------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 351 (461)
+....... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||........+..+.... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~ 229 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---S 229 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---C
Confidence 87664221 112346889999999886 468899999999999999999999998766554444443321 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 352 DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 352 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
......++.++.++|.+||+.||.+||++.|+++||||
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 11123578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=342.87 Aligned_cols=253 Identities=29% Similarity=0.513 Sum_probs=208.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe----
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED---- 200 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~---- 200 (461)
..|++.+.||.|+||.||+|+++. +++.||+|++.... .....+..|+.+++++.+|+||++++++|..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcC---CCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 589999999999999999999876 78899999986532 2345678899999999779999999999853
Q ss_pred --CCeEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 201 --ANSVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 201 --~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
.+.+|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++ +++.+||+||
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~---~~~~~~l~df 165 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDF 165 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeC
Confidence 46789999999999999888653 34588888999999999999999999999999999999995 5677999999
Q ss_pred ccccccCCC-CCccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC
Q 012518 278 GLSDFVRPD-QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 278 G~a~~~~~~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
|++...... .......|+..|+|||++. ..++.++|||||||++|+|++|..||...........+.... .
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~ 243 (282)
T cd06636 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--P 243 (282)
T ss_pred cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--C
Confidence 998765422 2234467899999999874 247889999999999999999999997765544443333221 1
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.......++.++.+||.+||..||.+||++.|+|+||||
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 111223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=366.50 Aligned_cols=250 Identities=27% Similarity=0.452 Sum_probs=211.8
Q ss_pred eeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEecc
Q 012518 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFC 211 (461)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~ 211 (461)
+||+|+||+||.|+++. +...+|||.|.... ....+-+..||.+.++|+ |.|||+++|.+.+++.+-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~---tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---TQVRIAIKEIPEKD---SREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeecccc---ceeEEEeeeccccc---chhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecC
Confidence 69999999999999987 66789999986542 234566889999999997 999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCC-C
Q 012518 212 EGGELLDRILSRGGRY--LEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-R 288 (461)
Q Consensus 212 ~gg~L~~~l~~~~~~~--~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~-~ 288 (461)
+||+|.+.+..+-+.+ .|..+..+.+||++||.|||++.|||||||-+|||++ .-.+.+||+|||-++....-. -
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCcc
Confidence 9999999998877777 7889999999999999999999999999999999997 467889999999988765443 3
Q ss_pred ccccccCCCcCchhhhh---ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh--hhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 289 LNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 289 ~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
..++.||..|||||++. +.|+.++|||||||++.||.||++||..-.. ..+++ + +...........+|.+++
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-V--GmyKvHP~iPeelsaeak 809 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-V--GMYKVHPPIPEELSAEAK 809 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-h--cceecCCCCcHHHHHHHH
Confidence 45688999999999996 3599999999999999999999999975432 22222 1 111222222235899999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 364 DFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.||.+|+..||.+||+|.++|.+||++..+
T Consensus 810 ~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 810 NFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 999999999999999999999999998763
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=343.96 Aligned_cols=255 Identities=27% Similarity=0.486 Sum_probs=205.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||.|+||.||++.++. +|+.||||.+....... ....+.+|+++++.++ |+||+++++++.+.+..
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKL---TGQLVALKEIRLEHEEG--APFTAIREASLLKDLK-HANIVTLHDIIHTKKTL 78 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcC---CCcEEEEEEEecccccC--CchhHHHHHHHHhhCC-CcceeeEEEEEecCCeE
Confidence 589999999999999999999875 78899999987543221 2234668999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKLADFGLARAKS 154 (291)
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc---CCCCEEECccccccccC
Confidence 999999975 99988876666789999999999999999999999999999999999995 56679999999987543
Q ss_pred CCC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCC-hhhHHHHHHhcCCCC----------
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWART-ESGIFRSVLRADPNF---------- 350 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~~~~~---------- 350 (461)
... ......++..|+|||++.+ .++.++||||+||++|+|++|+.||.... ..+.+..+.+.....
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 221 2233457889999998753 48899999999999999999999997655 223322222110000
Q ss_pred ----C------------CCCCCCCC--HHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 351 ----H------------DSPWPSVS--PEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 351 ----~------------~~~~~~~s--~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
. ...++.++ .++.++|.+||+.||.+|||+.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 00112344 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=340.82 Aligned_cols=269 Identities=26% Similarity=0.471 Sum_probs=220.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
..|+..+.||.|+||.||+|.++. ++..||||++.... .......+.+|+.+++.+. |+||+++++++.+++.+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc---CCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEE
Confidence 368888999999999999998876 68899999987542 2334577889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.||+|.+++.. +.+++..+..++.|++.||.|||+++++|+||+|+||+++ .++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---CCCCEEEcccccceecc
Confidence 999999999999998753 4689999999999999999999999999999999999995 56679999999987654
Q ss_pred CCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
... ......++..|+|||++. ..++.++|||||||++|+|++|..||...........+..... ......++..+
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 229 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPF 229 (277)
T ss_pred CCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHH
Confidence 332 223356888999999986 4588999999999999999999999987766555544432221 12223478899
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCCchHHHHHHHH
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVK 407 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~~~~~~~~~ 407 (461)
.++|.+||+.||++||++.++++|+||.........-..+.+.++
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~ 274 (277)
T cd06640 230 KEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELIDRFK 274 (277)
T ss_pred HHHHHHHcccCcccCcCHHHHHhChHhhhcchhhhHHHHHHHHHH
Confidence 999999999999999999999999999876554333333333333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=341.95 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=199.6
Q ss_pred eeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhc--CCCCCeeEEEEEEEeCCeEEEEEe
Q 012518 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL--SGHKHMIKFHDAFEDANSVYIVME 209 (461)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l--~~hpniv~l~~~~~~~~~~~lv~e 209 (461)
.||+|+||.||++.+.. +|+.||||.+.+.............+|..+++.+ .+|+||+.+++++...+..|+|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECC---CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 48999999999999875 7899999999765443332223344555444433 259999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCc
Q 012518 210 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL 289 (461)
Q Consensus 210 ~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~ 289 (461)
|+.||+|.+++..+ +.+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++...... ..
T Consensus 78 ~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~---~~~~~~l~dfg~~~~~~~~-~~ 152 (279)
T cd05633 78 LMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK-KP 152 (279)
T ss_pred cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC---CCCCEEEccCCcceecccc-Cc
Confidence 99999998877544 5799999999999999999999999999999999999994 5677999999998755432 22
Q ss_pred cccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012518 290 NDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 367 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 367 (461)
....||..|+|||++. ..++.++|||||||++|+|++|..||......... .+..............++++++++|.
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~ 231 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPDSFSPELKSLLE 231 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCcCCccccCHHHHHHHH
Confidence 3457899999999885 34889999999999999999999999754322211 11111111122223458999999999
Q ss_pred HhcccCcCCCC-----CHHHHhcCCCcCCCC
Q 012518 368 RLLNKDHRKRM-----TAAQALTHPWLHDEN 393 (461)
Q Consensus 368 ~~L~~dP~~R~-----s~~e~L~hp~~~~~~ 393 (461)
+||..||.+|+ ++.|+++||||++.+
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 99999999999 699999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=358.38 Aligned_cols=254 Identities=23% Similarity=0.372 Sum_probs=204.8
Q ss_pred cceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
++|++++.||+|+||.||+|++.. ...++..||||+++... .....+.+.+|+++++.+.+|+||++++++|...+
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 479999999999999999998643 12245689999997643 22345678899999999955999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC----------------------------------------------------------
Q 012518 203 SVYIVMEFCEGGELLDRILSRG---------------------------------------------------------- 224 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~---------------------------------------------------------- 224 (461)
.+|+|||||.+|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999885421
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCc---c
Q 012518 225 -----------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL---N 290 (461)
Q Consensus 225 -----------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~---~ 290 (461)
..+++..++.++.||+.||.|||++||+||||||+|||++ ++..+||+|||++......... .
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~---~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---CCCeEEEeeceeeeeccCCcceeecc
Confidence 2367788999999999999999999999999999999995 5677999999999765433211 1
Q ss_pred ccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012518 291 DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368 (461)
Q Consensus 291 ~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 368 (461)
...++..|||||++. ..++.++|||||||++|+|++ |+.||........+..+.......... ..++++++++|.+
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~ 350 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMKM 350 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC--CCCCHHHHHHHHH
Confidence 233566799999875 569999999999999999997 999998766544444444433222222 2468999999999
Q ss_pred hcccCcCCCCCHHHHhc
Q 012518 369 LLNKDHRKRMTAAQALT 385 (461)
Q Consensus 369 ~L~~dP~~R~s~~e~L~ 385 (461)
||+.||.+||++.++++
T Consensus 351 cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 351 CWNLEPTERPTFSQISQ 367 (374)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=343.91 Aligned_cols=255 Identities=20% Similarity=0.296 Sum_probs=203.0
Q ss_pred ccceeeceeeccCCceEEEEEEeccC-------------CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKG-------------TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~-------------~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn 190 (461)
.++|++.++||+|+||.||+|.+..+ ..++..||||++.... .......+.+|+++|.+++ |||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence 35899999999999999999986431 1244579999987542 3445567899999999996 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 012518 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG------------------GRYLEEDAKTIVEKILNIVAFCHLQGVV 252 (461)
Q Consensus 191 iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~------------------~~~~~~~~~~i~~qil~al~yLH~~giv 252 (461)
|+++++++.+.+..++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999885432 1356678899999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh--
Q 012518 253 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-- 326 (461)
Q Consensus 253 HrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-- 326 (461)
||||||+|||++ .++.+||+|||++........ .....++..|+|||++. +.++.++|||||||++|||++
T Consensus 161 H~dlkp~Nill~---~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLVG---ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEEc---CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999995 567799999999986543321 12345678899999875 569999999999999999986
Q ss_pred CCCCCCCCChhhHHHHHHhc---C-CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 012518 327 GSRPFWARTESGIFRSVLRA---D-PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384 (461)
Q Consensus 327 g~~Pf~~~~~~~~~~~i~~~---~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L 384 (461)
+..||...+....+..+... . ........+.++..+.+||.+||..||.+|||+.|+.
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 67888776665555443221 1 1111111245789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=341.82 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=206.2
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|.++. +|+.||||+++...... ....+..|+.++.+..+|+||+++++++..++.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---TGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---CCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcE
Confidence 378999999999999999999876 79999999987653222 2345556777654544699999999999999999
Q ss_pred EEEEeccCCCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 205 YIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
|+||||++ |+|.+.+.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~---~~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN---RNGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeecccc
Confidence 99999997 577766644 234689999999999999999999998 999999999999994 5678999999998
Q ss_pred cccCCCCCccccccCCCcCchhhhhc-----cCCCchhHHHHHHHHHHHhhCCCCCCCCC-hhhHHHHHHhc-CCCCCCC
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLHR-----SYNVEGDMWSIGVITYILLCGSRPFWART-ESGIFRSVLRA-DPNFHDS 353 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~-~~~~~~~ 353 (461)
.............|+..|+|||++.+ .++.++|||||||++|+|++|+.||.... ..+.+..+... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 229 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP-- 229 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC--
Confidence 87644333344578999999998742 47889999999999999999999996532 22333333322 11221
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 354 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
...++.++.+||.+||..||.+||++.++++||||....
T Consensus 230 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 230 -AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred -ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 234789999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=346.48 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=210.9
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--C
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA--N 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~--~ 202 (461)
++|++.+.||.|+||.||+|.++. +++.+|+|.++..... ......+.+|+.++++++ ||||+++++++... +
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK---TGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC---CCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCC
Confidence 479999999999999999999876 7889999999765433 222345678999999996 99999999999877 8
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
..|+||||+.+ +|.+.+......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++..
T Consensus 80 ~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~~l~d~g~~~~ 155 (293)
T cd07843 80 KIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN---NRGILKICDFGLARE 155 (293)
T ss_pred cEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCcEEEeecCceee
Confidence 99999999975 89888876656789999999999999999999999999999999999995 567799999999887
Q ss_pred cCCC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC--------
Q 012518 283 VRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH-------- 351 (461)
Q Consensus 283 ~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-------- 351 (461)
.... .......++..|+|||++.+ .++.++|||||||++|+|++|..||........+..+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 6543 23344568899999998864 368999999999999999999999988776655554433211000
Q ss_pred ------------------CCCCCC--CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 352 ------------------DSPWPS--VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 352 ------------------~~~~~~--~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
...++. +++.+.+||.+||+.||++|||+.|+|.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 011122 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=342.30 Aligned_cols=257 Identities=30% Similarity=0.512 Sum_probs=207.6
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE-- 199 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~-- 199 (461)
...++|++.+.||+|+||.||+|.++. +|+.+|+|++..... ....+.+|+.+++.+.+|+||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECC---CCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 345689999999999999999999876 788999998764321 23567789999999966999999999884
Q ss_pred ---eCCeEEEEEeccCCCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCee
Q 012518 200 ---DANSVYIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 273 (461)
Q Consensus 200 ---~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~k 273 (461)
.++.+++||||++|++|.+.+.. ....+++..++.++.|++.||.|||+++|+||||||+||+++ .++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCEE
Confidence 45679999999999999887643 335688899999999999999999999999999999999995 456699
Q ss_pred EeecccccccCCCC-CccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc
Q 012518 274 VIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA 346 (461)
Q Consensus 274 l~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~ 346 (461)
|+|||++....... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||........+..+...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 99999987654322 234457999999999874 24788999999999999999999999776554443333222
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 347 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 347 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
... .......++.++.+||.+||+.||++|||+.|+++|+||
T Consensus 245 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 PPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 111 111112367899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=342.95 Aligned_cols=257 Identities=25% Similarity=0.461 Sum_probs=213.2
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
..+|++.+.||+|+||.||++.+.. +|+.||+|.+...... ..+.+.+|+.+++.+. |+||++++++|...+.
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIA---TGQEVAIKQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGDE 90 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECC---CCCEEEEEEEecCccc---hHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCE
Confidence 3689999999999999999999765 7899999998754332 2356788999999995 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
.|+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++ .++.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~---~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQI 165 (297)
T ss_pred EEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEECcCccceEc
Confidence 9999999999999998754 4588899999999999999999999999999999999994 5677999999998765
Q ss_pred CCCCC-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 RPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
..... .....|++.|+|||.+. ..++.++|||||||++|+|++|..||...+.......+.... .........++..
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (297)
T cd06656 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAV 244 (297)
T ss_pred cCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCHH
Confidence 44332 23457899999999886 458899999999999999999999997765433322222211 1111112357899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
+++||.+||..||.+||++.++++||||+...
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 99999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=337.15 Aligned_cols=251 Identities=29% Similarity=0.569 Sum_probs=213.1
Q ss_pred eccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012518 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCE 212 (461)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~~ 212 (461)
||.|+||.||+|++.. +++.||+|++.+.........+.+.+|+.+++.+. |+||+++++++.+++.+|+||||++
T Consensus 1 lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKS---KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCC
Confidence 7999999999999876 78999999998765544455678999999999995 9999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCcccc
Q 012518 213 GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI 292 (461)
Q Consensus 213 gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~~ 292 (461)
+++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++ .++.+||+|||++............
T Consensus 77 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~---~~~~~~l~df~~~~~~~~~~~~~~~ 152 (262)
T cd05572 77 GGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKLKSGQKTWTF 152 (262)
T ss_pred CCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc---CCCCEEEeeCCcccccCcccccccc
Confidence 99999988654 5689999999999999999999999999999999999995 5677999999999877554334456
Q ss_pred ccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC--hhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 012518 293 VGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART--ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 369 (461)
Q Consensus 293 ~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 369 (461)
.|+..|++||++. ..++.++|+||||+++|+|++|..||.... ....+..+.........+ ...++++.++|.+|
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~ 230 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQL 230 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHH
Confidence 7899999999876 458999999999999999999999998776 555566655322221111 23589999999999
Q ss_pred cccCcCCCCC-----HHHHhcCCCcCCCC
Q 012518 370 LNKDHRKRMT-----AAQALTHPWLHDEN 393 (461)
Q Consensus 370 L~~dP~~R~s-----~~e~L~hp~~~~~~ 393 (461)
|..||++|++ ++|+++||||++..
T Consensus 231 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 231 LRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred ccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 9999999999 99999999998653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=339.11 Aligned_cols=255 Identities=32% Similarity=0.538 Sum_probs=210.2
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN- 202 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~- 202 (461)
.++|++.+.||.|+||.||+|.++. +++.+++|++..... ..+.+.+|+.+++++.+|+||+++++++.+..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECC---CCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 4689999999999999999999875 688999999875432 34678899999999966999999999997644
Q ss_pred -----eEEEEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeE
Q 012518 203 -----SVYIVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 203 -----~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
.+|+||||+.+++|.+++... +..+++..++.++.|++.||.|||++||+|+||+|+||+++ .++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~---~~~~~~l 154 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKL 154 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc---cCCeEEE
Confidence 489999999999998877542 36789999999999999999999999999999999999995 5677999
Q ss_pred eecccccccCCCC-CccccccCCCcCchhhhhc------cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC
Q 012518 275 IDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 347 (461)
Q Consensus 275 ~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 347 (461)
+|||++....... ......|+..|+|||++.. .++.++|||||||+||+|++|..||...........+....
T Consensus 155 ~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 234 (275)
T cd06608 155 VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234 (275)
T ss_pred CCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC
Confidence 9999987654322 2344678999999998742 37789999999999999999999997765555554444332
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 348 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 348 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
... ......++.++++||.+||..||++|||+.|+++|||+
T Consensus 235 ~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 235 PPT-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCC-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 211 11112378899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=341.30 Aligned_cols=257 Identities=28% Similarity=0.477 Sum_probs=210.5
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
..++|++.+.||+|+||.||+|..+. +|+.+|+|++.... .....+.+|+.+++++.+|+||++++++|...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~---~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 35689999999999999999999876 78999999986532 12356778999999996699999999998753
Q ss_pred ----CeEEEEEeccCCCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeE
Q 012518 202 ----NSVYIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 202 ----~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
+.+|+||||+.||+|.+++.. ....+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~---~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT---TEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEE
Confidence 468999999999999887753 345789999999999999999999999999999999999995 5667999
Q ss_pred eecccccccCCCC-CccccccCCCcCchhhhhc------cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC
Q 012518 275 IDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 347 (461)
Q Consensus 275 ~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 347 (461)
+|||++....... ......|+..|+|||++.. .++.++|||||||++|+|++|+.||........+..+....
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 9999988654332 2234578899999998752 26889999999999999999999998776655555544332
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 348 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 348 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
... ......++.++.+||.+||+.||++||++.|+++||||+
T Consensus 250 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 250 PPT-LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCC-CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 211 111134678999999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=343.57 Aligned_cols=256 Identities=28% Similarity=0.501 Sum_probs=215.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|++.+.||.|+||.||++.+.. +|+.||||.+...... ..+.+.+|+.+++.++ |+||+++++++.+.+.+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA---TGQEVAIKQINLQKQP---KKELIINEILVMKELK-NPNIVNFLDSFLVGDEL 91 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC---CCcEEEEEEEecccCc---hHHHHHHHHHHHHhcC-CCceeeeeeeEecCceE
Confidence 579999999999999999998766 7899999998754322 2466789999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++....
T Consensus 92 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~---~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG---MDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccchhcc
Confidence 999999999999887753 3589999999999999999999999999999999999994 56779999999987654
Q ss_pred CCCC-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.... .....|+..|+|||.+. +.++.++|||||||++|+|++|..||...........+...... .......+++.+
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 245 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSPIF 245 (296)
T ss_pred cccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-ccCCcccCCHHH
Confidence 4332 23457889999999886 45889999999999999999999999887765554444332211 112234688999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.+||.+||..||.+||++.+++.||||+...
T Consensus 246 ~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=359.18 Aligned_cols=259 Identities=29% Similarity=0.510 Sum_probs=223.9
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.-|..++.||-|+||+|.+|+... +...||+|.+++.++...+.+..++.|-.||..- +.+-||+||..|+|.+.+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvD---T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVD---TRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred cceEEEeeecccccceeEEEeecc---hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCce
Confidence 357888999999999999998765 6789999999998887777888899999999987 589999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||++||++..+|.+. +.|.|+.++.++.++.+|+++.|..|+|||||||+|||| |.+++|||+||||++-+.
T Consensus 705 YFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccce
Confidence 9999999999999988765 689999999999999999999999999999999999999 689999999999985321
Q ss_pred C---------CC----------------------------------CccccccCCCcCchhhhh-ccCCCchhHHHHHHH
Q 012518 285 P---------DQ----------------------------------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVI 320 (461)
Q Consensus 285 ~---------~~----------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvi 320 (461)
. +. .....+||+.|+|||+|. ..|+..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 0 00 011358999999999986 569999999999999
Q ss_pred HHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCcCCC
Q 012518 321 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM---TAAQALTHPWLHDE 392 (461)
Q Consensus 321 l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~L~hp~~~~~ 392 (461)
||||+.|+.||.+.+..+....|++....+....-.++|+++.+||.++.+ +++.|. .++|+..||||+..
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence 999999999999998888777777665555555556799999999999764 677886 46789999999875
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=342.35 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=211.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||+||+|.++. +|+.||||.+...... ....+.+.+|+++++.+. |+||+++++++.+.+.+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV---TNETIALKKIRLEQED-EGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC---CCcEEEEEehhhcccc-ccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeE
Confidence 479999999999999999999876 7899999998664322 223456788999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
|+||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||+|+||+++. .+..+||+|||++...
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAF 153 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEccccccccc
Confidence 99999996 588887755433 3678889999999999999999999999999999999963 3456999999999765
Q ss_pred CCCC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCC-------
Q 012518 284 RPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS------- 353 (461)
Q Consensus 284 ~~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------- 353 (461)
.... ......+++.|+|||++.+ .++.++|||||||++|+|++|..||......+.+..++.........
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 4322 2344567899999998854 47899999999999999999999998877666555544321111000
Q ss_pred ------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 354 ------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 354 ------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..+.+++++.++|.+||+.||.+||++.++++||||.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 124578999999999999999999999999999999764
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=339.19 Aligned_cols=249 Identities=25% Similarity=0.439 Sum_probs=199.7
Q ss_pred cceeeceee--ccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 125 AKFELGKEV--GRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 125 ~~y~~~~~l--G~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+.|++.+.+ |.|+||.||++..+. +|+.+|+|++....... .|+.+...+.+|+||++++++|...+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKP---TQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcC---CCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 466676666 999999999999876 78999999987543221 13333333446999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCC-CeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA-PLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~-~~kl~DFG~a~ 281 (461)
.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||++.. ++ .++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~---~~~~~~l~dfg~~~ 158 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR---AKDRIYLCDYGLCK 158 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC---CCCeEEEecCccce
Confidence 999999999999999988654 47999999999999999999999999999999999999963 33 79999999987
Q ss_pred ccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
..... ....|+..|+|||++. ..++.++|||||||++|+|++|..||............+..........+..+++
T Consensus 159 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T PHA03390 159 IIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSK 235 (267)
T ss_pred ecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCH
Confidence 65432 2346889999999986 4689999999999999999999999976544332111111111222233346899
Q ss_pred HHHHHHHHhcccCcCCCCC-HHHHhcCCCcCC
Q 012518 361 EAKDFVRRLLNKDHRKRMT-AAQALTHPWLHD 391 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s-~~e~L~hp~~~~ 391 (461)
.+.+||.+||+.||.+|++ ++|+|+||||++
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 9999999999999999996 599999999963
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=334.19 Aligned_cols=253 Identities=26% Similarity=0.541 Sum_probs=215.9
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||+|+||.||++++.. +|+.||+|.+...... ......+.+|+.++++++ |+||+++++++.+.+..|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMS-PKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---CCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEE
Confidence 58999999999999999999876 7889999998754332 334567889999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 206 IVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
+||||+.+++|.+.+.... ..+++..+..++.|++.||.|||++|++|+||+|+|||++ .++.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~---~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLN 152 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEEeeccceeecC
Confidence 9999999999999886643 3578999999999999999999999999999999999995 46679999999987654
Q ss_pred CCCC-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.... .....|+..|+|||++. +.++.++|||||||++|+|++|..||......+....+........ ...++.++
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 229 (256)
T cd08218 153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDL 229 (256)
T ss_pred cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHH
Confidence 3322 23356889999999986 4588899999999999999999999988877777777665432211 13578999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.++|.+||+.+|.+||++.++++||||
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=356.57 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=203.8
Q ss_pred cceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
++|++++.||+|+||+||+|.... ...++..||||+++.... ....+.+.+|+.+|..+.+||||++++++|.+.+
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 479999999999999999997532 122567899999875432 2334678899999999956999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC----------------------------------------------------------
Q 012518 203 SVYIVMEFCEGGELLDRILSRG---------------------------------------------------------- 224 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~---------------------------------------------------------- 224 (461)
..++|||||+||+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999886432
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCC
Q 012518 225 ----------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 288 (461)
Q Consensus 225 ----------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~ 288 (461)
..+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccCccc
Confidence 1367788899999999999999999999999999999995 466799999999986643322
Q ss_pred c---cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 289 L---NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 289 ~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
. ....++..|+|||++. ..++.++|||||||++|||++ |..||........+...+........ ....+.+++
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~ 347 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS--PECAPSEMY 347 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCC--CCCCCHHHH
Confidence 1 1233566799999986 569999999999999999998 89999776544433333333222211 234678999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcC
Q 012518 364 DFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+||.+||+.||++||++.|+++.
T Consensus 348 ~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 348 DIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=344.77 Aligned_cols=256 Identities=29% Similarity=0.459 Sum_probs=204.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC--
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN-- 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~-- 202 (461)
++|++.+.||+|+||.||+|.++. +|+.||||.+....... .....+.+|++++++++ ||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKATP 86 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECC---CCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCC-CCCccceEEEEeccccc
Confidence 479999999999999999999876 78999999986543222 12234568999999996 999999999987554
Q ss_pred ------eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 203 ------SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 203 ------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
..|+||||+. ++|.+.+......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~d 162 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLAD 162 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC---CCCcEEECc
Confidence 4599999996 488888876666789999999999999999999999999999999999994 567799999
Q ss_pred cccccccCCCC-----CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC
Q 012518 277 FGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN 349 (461)
Q Consensus 277 FG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~ 349 (461)
||++....... ......++..|+|||++.+ .++.++|||||||++|+|++|..||...+.......+......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99987654322 1234567889999998754 3788999999999999999999999877655444333322111
Q ss_pred CCCCCC----------------------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 350 FHDSPW----------------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 350 ~~~~~~----------------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
++...+ ...+..+.+||.+||..||.+|||++|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 111100 0135788899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=343.34 Aligned_cols=256 Identities=26% Similarity=0.476 Sum_probs=210.2
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|.++. +|+.||+|++.+..... ...+.+.+|+++++.+. |+||+++++++.+.+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---CCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeE
Confidence 368999999999999999999875 68999999986643322 33456788999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.++.|.++. .....+++..+..++.||+.||.|||+.||+|+||+|+||+++ .++.+||+|||++....
T Consensus 76 ~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~---~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 76 YLVFEFVDHTVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLA 151 (286)
T ss_pred EEEEecCCccHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCcEEEEeeeeeeecc
Confidence 9999999988776654 3445689999999999999999999999999999999999994 56779999999988654
Q ss_pred CCC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC----------
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH---------- 351 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---------- 351 (461)
... ......++..|+|||++.+ .++.++|||||||++|+|++|+.||......+....+......+.
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 332 2344678899999998863 478899999999999999999999977665444444332111110
Q ss_pred ---------C--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 352 ---------D--------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 352 ---------~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
. ..++.++..+.+||.+||..||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 1134678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=342.50 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=208.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|+..+.||+|+||.||++.+.. +|+.||||.+...... .....+.+|+.++.++.+|+||+++++++...+..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKP---SGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECC---CCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence 367778899999999999999876 7899999998764322 34567889999999997799999999999999999
Q ss_pred EEEEeccCCCchHHH---HHh-cCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 205 YIVMEFCEGGELLDR---ILS-RGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~---l~~-~~~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
++||||+.+ ++.+. +.. ....+++..+..++.|++.||+|||+. ||+||||||+|||++ .++.+||+|||+
T Consensus 79 ~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~ 154 (288)
T cd06616 79 WICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGI 154 (288)
T ss_pred EEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc---cCCcEEEeecch
Confidence 999999864 54432 222 236789999999999999999999985 999999999999995 466799999999
Q ss_pred ccccCCCCCccccccCCCcCchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCCh-hhHHHHHHhc-CCCCCCC
Q 012518 280 SDFVRPDQRLNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLRA-DPNFHDS 353 (461)
Q Consensus 280 a~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~-~~~~~~~ 353 (461)
+.............|+..|+|||++.+ .++.++|||||||++|+|++|+.||..... .+.+..+... .+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd06616 155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNS 234 (288)
T ss_pred hHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCc
Confidence 986654443445578999999999863 489999999999999999999999965442 1222222222 1222222
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 354 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.+..++.++.+||.+||.+||++|||++++++||||+..
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 334589999999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=334.89 Aligned_cols=255 Identities=24% Similarity=0.449 Sum_probs=207.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC--CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT--SALAIEDVRREVKILKALSGHKHMIKFHDAFED-- 200 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~-- 200 (461)
..|++.+.||+|+||.||+|.+.. +|+.||+|.+...... .......+.+|+.+++.++ |+||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 77 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD---TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRA 77 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC---CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCC
Confidence 368899999999999999998876 7889999998654322 2234567889999999996 9999999999875
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+.++++|||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~---~~~~~~l~dfg~~ 153 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGAS 153 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEccCCCc
Confidence 46789999999999999888654 4689999999999999999999999999999999999994 5667999999998
Q ss_pred cccCCC----CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 281 DFVRPD----QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 281 ~~~~~~----~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
...... .......++..|+|||++. ..++.++|||||||++|+|++|+.||...........+....... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~ 231 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP--QLP 231 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCC--CCc
Confidence 755321 1223356889999999986 458899999999999999999999998765554444433222111 111
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
..+++.+++|| +||..||++||+++|+++||||+
T Consensus 232 ~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 232 SHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 24688999999 67778999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=339.81 Aligned_cols=254 Identities=28% Similarity=0.523 Sum_probs=209.4
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||.|++|.||+|+++. +|+.||||+++..... ...+.+.+|+.++++++ |+||+++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---TGEIVALKEIHLDAEE--GTPSTAIREISLMKELK-HENIVRLHDVIHTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---CCeEEEEEEecccccc--cchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEE
Confidence 48899999999999999999876 7899999998765322 22356778999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 206 IVMEFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+||||+.+ +|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 75 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~---~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAF 150 (284)
T ss_pred EEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCcEEEeecchhhhh
Confidence 99999985 8888876544 4689999999999999999999999999999999999995 5677999999998765
Q ss_pred CCCC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC--------
Q 012518 284 RPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD-------- 352 (461)
Q Consensus 284 ~~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 352 (461)
.... ......++..|++||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+.........
T Consensus 151 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 151 GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred cCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 4322 2234567899999998854 4788999999999999999999999887766655554432110000
Q ss_pred -----------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 353 -----------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 353 -----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
...+.++++++++|.+||+.||.+||++.|+++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0012467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=337.30 Aligned_cols=258 Identities=24% Similarity=0.440 Sum_probs=209.2
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC---CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT---SALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+|+..+.||+|+||.||++.+.. +|+.||+|++...... .....+.+.+|+.+++.++ |+||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCC
Confidence 47788999999999999998865 7899999998754321 1224577899999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+++||||+.|++|.+++... +.+++..+..++.||+.||.|||++||+|+||||+||+++. .+..+||+|||++..
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--~~~~~~l~dfg~~~~ 153 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--TGQRLRIADFGAAAR 153 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEcccccccc
Confidence 999999999999998887543 57899999999999999999999999999999999999953 234599999999876
Q ss_pred cCCCCC-----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC-CCCCCCC
Q 012518 283 VRPDQR-----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP-NFHDSPW 355 (461)
Q Consensus 283 ~~~~~~-----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~ 355 (461)
...... .....|+..|+|||++. ..++.++|||||||++|+|++|..||...........+..... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCc
Confidence 643211 12346889999999886 4688999999999999999999999975543333333322111 1111112
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
..+++++.++|.+||..||.+||++.++++||||+
T Consensus 234 ~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 234 EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred hhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 35789999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=366.80 Aligned_cols=267 Identities=21% Similarity=0.314 Sum_probs=198.8
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEE--------------EecccccCCHHHHHHHHHHHHHHHhc
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVK--------------IISKAKMTSALAIEDVRREVKILKAL 185 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK--------------~i~~~~~~~~~~~~~~~~Ei~il~~l 185 (461)
+..+.++|++++.||+|+||+||++..+.. .+..+++| ++.+...........+.+|+.+|+++
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l 220 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRAS--TEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL 220 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEecc--chhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC
Confidence 445667999999999999999999876531 22222222 11111112223456688999999999
Q ss_pred CCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcE
Q 012518 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG----GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 261 (461)
Q Consensus 186 ~~hpniv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NI 261 (461)
. |+||+++++++.+.+..|+|||++. ++|++++.... .......++.|+.||+.||.|||++|||||||||+||
T Consensus 221 ~-HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NI 298 (501)
T PHA03210 221 N-HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI 298 (501)
T ss_pred C-CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 6 9999999999999999999999995 57877775432 2334567889999999999999999999999999999
Q ss_pred EEecCCCCCCeeEeecccccccCCCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC---
Q 012518 262 LFTTREEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART--- 335 (461)
Q Consensus 262 Ll~~~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~--- 335 (461)
|++ .++.+||+|||++..+..... ....+||..|+|||++. ..|+.++|||||||+||||++|..++....
T Consensus 299 Ll~---~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 299 FLN---CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred EEC---CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 995 567799999999987654322 23468999999999986 469999999999999999999886554322
Q ss_pred hhhHHHHHHhcC----CCCCC----------------C--------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 012518 336 ESGIFRSVLRAD----PNFHD----------------S--------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387 (461)
Q Consensus 336 ~~~~~~~i~~~~----~~~~~----------------~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 387 (461)
....+..++... ..++. . ....++.++.++|.+||+.||.+|||+.|+|.||
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 122222222110 00100 0 0013567888999999999999999999999999
Q ss_pred CcCCCC
Q 012518 388 WLHDEN 393 (461)
Q Consensus 388 ~~~~~~ 393 (461)
||....
T Consensus 456 ~f~~~~ 461 (501)
T PHA03210 456 LFSAEE 461 (501)
T ss_pred hhhcCC
Confidence 997653
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=342.04 Aligned_cols=255 Identities=29% Similarity=0.463 Sum_probs=208.1
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
.|++.+.||.|+||.||+|+++. +|+.||||.+...... ......+.+|++++++++ ||||+++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTET-EGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---CCCEEEEEEccccccc-cccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEE
Confidence 38899999999999999999876 7889999998754322 223356788999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 206 IVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||+|+||+++ .++.+||+|||++....
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~---~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEeeccchhhcc
Confidence 9999996 5888877553 35689999999999999999999999999999999999995 56779999999987654
Q ss_pred CCC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC-----------
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF----------- 350 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----------- 350 (461)
... ......++..|+|||++.+ .++.++|||||||++|+|+||+.||...........+.......
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 332 2334567889999998753 36889999999999999999999998776655444433221110
Q ss_pred -------CC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 351 -------HD-------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 351 -------~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.. ...+.++++++++|.+||+.||.+|||++++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00 0123478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=336.05 Aligned_cols=256 Identities=27% Similarity=0.485 Sum_probs=210.7
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-------CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-------SALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-------~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
+|.+.+.||.|+||.||+|.... +|+.||||.++..... .....+.+.+|+.+++.+. |+||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFE 77 (272)
T ss_pred ceeecceecccCceEEEEEeecC---CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEe
Confidence 58889999999999999998765 7899999988642211 1123456788999999996 99999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 199 EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 199 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
...+.+++||||+.+++|.+++... +.+++..+..++.||+.||.|||++|++||||+|+||+++ .++.+||+|||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~---~~~~~~l~d~~ 153 (272)
T cd06629 78 TTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD---ADGICKISDFG 153 (272)
T ss_pred ccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc---CCCeEEEeecc
Confidence 9999999999999999999988655 5789999999999999999999999999999999999995 56779999999
Q ss_pred cccccCCCC---CccccccCCCcCchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc--CCCC
Q 012518 279 LSDFVRPDQ---RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA--DPNF 350 (461)
Q Consensus 279 ~a~~~~~~~---~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~ 350 (461)
++....... ......|+..|+|||++.. .++.++||||||+++|+|++|..||........+..+... ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI 233 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence 987643221 1234568899999998853 3789999999999999999999999765554444333322 2223
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
....+..++.++.+||.+||..||.+||+++++|+||||
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 333345679999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=333.27 Aligned_cols=255 Identities=25% Similarity=0.467 Sum_probs=208.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccc--cCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAK--MTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
.+|++.+.||+|+||.||++.++. +|+.||||.+.... .......+.+.+|+.+++++. |+||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD---TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC---CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCC
Confidence 478999999999999999999876 78999999986432 122345678889999999996 99999999998763
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 202 -NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 202 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
..+++||||++|++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+|||++ .++.+||+|||++
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~Dfg~~ 153 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGAS 153 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec---CCCCEEECcCccc
Confidence 5688999999999999987654 5688999999999999999999999999999999999995 5677999999998
Q ss_pred cccCCC----CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 281 DFVRPD----QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 281 ~~~~~~----~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
...... .......|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+.... .... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~-~~ 231 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-TNPV-LP 231 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCC-CCCC-Cc
Confidence 765321 1223456899999999885 458899999999999999999999998765555444443221 1111 12
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
..++..+.++|.+||. +|++||+++|+++|||+.
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 3578899999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=353.84 Aligned_cols=236 Identities=26% Similarity=0.400 Sum_probs=203.5
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEe
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVME 209 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e 209 (461)
++-||.|+.|-||+++. .++.||||.++.-+ ..+|+-|++|+ |+||+.|.|+|.....+|||||
T Consensus 129 LeWlGSGaQGAVF~Grl-----~netVAVKKV~elk----------ETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-----HNETVAVKKVRELK----------ETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeeec-----cCceehhHHHhhhh----------hhhHHHHHhcc-CcceeeEeeeecCCceeEEeee
Confidence 56699999999999986 46789999875322 25888999996 9999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCc
Q 012518 210 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL 289 (461)
Q Consensus 210 ~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~ 289 (461)
||..|.|...|.. +..++......|.++|+.|+.|||.+.|||||||.-||||+. +..|||+|||-++...+....
T Consensus 193 fCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~---~d~VKIsDFGTS~e~~~~STk 268 (904)
T KOG4721|consen 193 FCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY---DDVVKISDFGTSKELSDKSTK 268 (904)
T ss_pred ccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec---cceEEeccccchHhhhhhhhh
Confidence 9999999997754 467888999999999999999999999999999999999975 445999999999887766666
Q ss_pred cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012518 290 NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368 (461)
Q Consensus 290 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 368 (461)
..++||..|||||+|. ...+.|+|||||||+|||||||..||.+-....++..+-.....++ ....+++.++-||+.
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp--vPstcP~GfklL~Kq 346 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP--VPSTCPDGFKLLLKQ 346 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccccc--CcccCchHHHHHHHH
Confidence 7899999999999997 5689999999999999999999999988777666554433332222 224588999999999
Q ss_pred hcccCcCCCCCHHHHhcCC
Q 012518 369 LLNKDHRKRMTAAQALTHP 387 (461)
Q Consensus 369 ~L~~dP~~R~s~~e~L~hp 387 (461)
||...|..||++.++|.|-
T Consensus 347 cw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 347 CWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHhcCCCCCccHHHHHHHH
Confidence 9999999999999999984
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=332.49 Aligned_cols=255 Identities=29% Similarity=0.504 Sum_probs=211.6
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||+|+||.||++.+.. +++.||+|+++..... ....+.+.+|+.+++.++ |+||+++++++.+.+.++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---TGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---CCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEE
Confidence 58899999999999999998765 6889999999765433 446788999999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+|+||+.+++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++ .++.+||+|||++.....
T Consensus 76 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 76 IFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred EEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEcccccccccCC
Confidence 999999999999987653 5688999999999999999999999999999999999995 567799999999887654
Q ss_pred CCC-----ccccccCCCcCchhhhhc-c---CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 286 DQR-----LNDIVGSAYYVAPEVLHR-S---YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 286 ~~~-----~~~~~gt~~y~aPE~l~~-~---~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
... .....++..|+|||++.+ . ++.++||||||+++|+|++|+.||.....................+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSL 231 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCccc
Confidence 322 123567889999999863 3 7899999999999999999999997653322222222222222223334
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.+++.+.+||.+||+.||.+||++.|++.|||+
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 232 QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 568999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=342.15 Aligned_cols=266 Identities=28% Similarity=0.463 Sum_probs=216.4
Q ss_pred cCCCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC-C----Ce
Q 012518 117 FGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH-K----HM 191 (461)
Q Consensus 117 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-p----ni 191 (461)
+..|+.+..+|++++.+|+|+||.|..+.+.. ++..||||+++.-. ...+..+-||++|+++..+ | -+
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---TKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecC---CCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 44578889999999999999999999999877 58999999997432 2345566799999999422 2 38
Q ss_pred eEEEEEEEeCCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC---
Q 012518 192 IKFHDAFEDANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE--- 267 (461)
Q Consensus 192 v~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~--- 267 (461)
|++.+||.-.++.|||+|.+ |-+++++|..++ ..++...++.+..||+.++.|||+++++|-||||||||+.+.+
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence 88999999999999999998 669999997653 4688899999999999999999999999999999999997531
Q ss_pred --------------CCCCeeEeecccccccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCC
Q 012518 268 --------------EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFW 332 (461)
Q Consensus 268 --------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~ 332 (461)
.+..|||+|||.|++.... ..+.+.|..|+|||++.+ .++..+||||+||||+|++||...|.
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 2456999999999976543 367899999999999875 79999999999999999999999998
Q ss_pred CCChhh---HHHHHHhcCCCC-------------CCCCCCC--------------------------CCHHHHHHHHHhc
Q 012518 333 ARTESG---IFRSVLRADPNF-------------HDSPWPS--------------------------VSPEAKDFVRRLL 370 (461)
Q Consensus 333 ~~~~~~---~~~~i~~~~~~~-------------~~~~~~~--------------------------~s~~~~~li~~~L 370 (461)
.....+ +++.|+...+.. ....|++ -..++.|||++||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 877655 444444321110 0112221 1245779999999
Q ss_pred ccCcCCCCCHHHHhcCCCcCCC
Q 012518 371 NKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 371 ~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..||.+|+|+.|+|.||||...
T Consensus 391 ~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 391 EFDPARRITLREALSHPFFARL 412 (415)
T ss_pred ccCccccccHHHHhcCHHhhcC
Confidence 9999999999999999999753
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=336.26 Aligned_cols=261 Identities=28% Similarity=0.475 Sum_probs=216.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
+-|++.+.||+|+||.||++.+.. +++.||||++..... ......+.+|+.+++.+. |+||+++++++.+++.+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~---~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 77 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKL 77 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECC---CCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeE
Confidence 357888999999999999998765 788999999865432 234567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++ .++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~---~~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC---CCCCEEEeecccceecc
Confidence 999999999999987743 4689999999999999999999999999999999999995 56779999999987654
Q ss_pred CCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
... ......|+..|+|||++. ..++.++|||||||++|+|++|..||...........+...... .....++.++
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 229 (277)
T cd06641 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPL 229 (277)
T ss_pred cchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC---CCCcccCHHH
Confidence 322 223456889999999886 45788999999999999999999999876665555554333211 1113478999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCCch
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLD 399 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~ 399 (461)
.++|.+||..||.+||++.++++||||..........
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~~~~~ 266 (277)
T cd06641 230 KEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYL 266 (277)
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhhhhhccchH
Confidence 9999999999999999999999999998764444433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=343.44 Aligned_cols=260 Identities=30% Similarity=0.517 Sum_probs=215.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
+.|.....||+|+||.||++.+.. +++.||||.+.... ....+.+.+|+.+++.++ |+||+++++.+...+..
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKH---TGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDEL 94 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECC---CCCEEEEEEEecch---HHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeE
Confidence 456667789999999999998765 78899999986532 234567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++ +++.+||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVS 169 (292)
T ss_pred EEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEccCcchhhcc
Confidence 999999999999887633 4689999999999999999999999999999999999994 56779999999987553
Q ss_pred CCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
... ......|+..|+|||++. ..++.++|||||||++|||++|..||........+..+........ .....++..+
T Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 248 (292)
T cd06658 170 KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-KDSHKVSSVL 248 (292)
T ss_pred cccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-ccccccCHHH
Confidence 322 224467899999999986 4689999999999999999999999988776665555443321111 1123578999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~ 397 (461)
.+||.+||..||.+|||++|+++||||.....+..
T Consensus 249 ~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 249 RGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred HHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 99999999999999999999999999987765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=332.34 Aligned_cols=253 Identities=31% Similarity=0.529 Sum_probs=214.5
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--CCe
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED--ANS 203 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~--~~~ 203 (461)
+|++.+.||.|+||.||+|.+.. +|+.||+|++..... .....+.+.+|+++++.++ |+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---CCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCE
Confidence 58899999999999999998876 788999999876543 3444577889999999996 9999999998864 456
Q ss_pred EEEEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----HcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 204 VYIVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCH-----LQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH-----~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
+|++|||+.+++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||+++ .++.+||+
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~kl~ 152 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD---ANNNVKLG 152 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe---cCCCEEEe
Confidence 89999999999999888654 467899999999999999999999 89999999999999995 56779999
Q ss_pred ecccccccCCCCC-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCC
Q 012518 276 DFGLSDFVRPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 353 (461)
Q Consensus 276 DFG~a~~~~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 353 (461)
|||++........ .....|+..|+|||++. ..++.++||||||+++|+|++|..||.........+.+.......
T Consensus 153 d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 229 (265)
T cd08217 153 DFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR--- 229 (265)
T ss_pred cccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---
Confidence 9999987654443 34567899999999986 458899999999999999999999998877666666655443211
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 354 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
....++.++.+++.+||..+|++||++.++++|||+
T Consensus 230 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 230 IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 113578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=339.52 Aligned_cols=255 Identities=26% Similarity=0.443 Sum_probs=203.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|.++. +|+.||||++...... .....+.+|+.+++.+. |+||+++++++.+++..
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRI---NGQLVALKVISMKTEE--GVPFTAIREASLLKGLK-HANIVLLHDIIHTKETL 78 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcC---CCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeE
Confidence 589999999999999999998876 7889999998654322 12235678999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+. ++|.+.+......+.+..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS---YLGELKLADFGLARAKS 154 (291)
T ss_pred EEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc---CCCcEEEeccccccccC
Confidence 99999995 688887766556788889999999999999999999999999999999995 56779999999987643
Q ss_pred CC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChh-hHHHHHHhcC-------------
Q 012518 285 PD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES-GIFRSVLRAD------------- 347 (461)
Q Consensus 285 ~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~------------- 347 (461)
.. .......++..|+|||++.+ .++.++|||||||++|+|++|..||.+.... +.+..+....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 22 22344567899999998854 4788999999999999999999999765432 2222221100
Q ss_pred -CCCCC------------CCCC--CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 348 -PNFHD------------SPWP--SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 348 -~~~~~------------~~~~--~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
+.+.. ..|. ..+.++.++|.+||..||.+|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 0011 136789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=335.36 Aligned_cols=256 Identities=26% Similarity=0.517 Sum_probs=212.8
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC--CCCCeeEEEEEEEeCCe
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS--GHKHMIKFHDAFEDANS 203 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpniv~l~~~~~~~~~ 203 (461)
.|++.+.||+|+||.||+|.+.. +|+.||+|+++... .....+.+.+|+.+++.+. +|+||+++++++.++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---TGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---CCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 57888999999999999999865 78999999987542 2334567889999999995 49999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
.|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||+.||+|+||+|+||+++ .++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeec
Confidence 9999999999999987743 4689999999999999999999999999999999999995 4677999999998876
Q ss_pred CCCC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 284 RPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 284 ~~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
.... ......|+..|+|||++.+ .++.++|||||||++|+|++|..||...........+... .........++.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 229 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSK 229 (277)
T ss_pred CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCH
Confidence 5433 2344578999999998863 4789999999999999999999999776554443332222 111222224788
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
++.++|.+||+.||++||++.|++.|+||+...
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 999999999999999999999999999997754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=332.18 Aligned_cols=246 Identities=25% Similarity=0.420 Sum_probs=207.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||++..+ .+..+|+|.+...... .+++.+|+++++.++ ||||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~----~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR----AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec----cCceEEEEecccCCcc----HHHHHHHHHHHHHCC-CCCceeEEEEEccCCCE
Confidence 46899999999999999999875 3457999988654322 356788999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++||||+++|+|.+++....+.+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++....
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc---CCCeEEECCCCCccccC
Confidence 999999999999998876556789999999999999999999999999999999999995 56779999999987654
Q ss_pred CCCCc--cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 285 PDQRL--NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 285 ~~~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
..... ....++..|+|||++. ..++.++|||||||++|+|++ |+.||...+..+.+..+......... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~ 228 (256)
T cd05114 152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASM 228 (256)
T ss_pred CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCH
Confidence 32221 2234566899999986 568999999999999999999 99999888887777777665432221 23678
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++.++|.+||..||.+||+++++++
T Consensus 229 ~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 229 TVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=336.70 Aligned_cols=256 Identities=28% Similarity=0.462 Sum_probs=212.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||.|+||.||+|.++. +++.||+|.+..... ......+.+|+++++.+. |+||+++++++...+.+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP---TGKIMAVKTIRLEIN--EAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC---CCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEE
Confidence 368889999999999999999876 789999999876532 244567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
++||||+.+++|.+++......+++..+..++.||+.||.|||+ .||+|+||||+||+++ +++.+||+|||++...
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQL 151 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccchhh
Confidence 99999999999999886655678999999999999999999999 9999999999999995 5677999999998765
Q ss_pred CCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC-----hhhHHHHHHhcCCCCCCCCCCC
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART-----ESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
..... ....++..|+|||++. ..++.++|||||||++|+|++|..||.... .....+.+..... .......
T Consensus 152 ~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 228 (265)
T cd06605 152 VNSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--PRLPSGK 228 (265)
T ss_pred HHHHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC--CCCChhh
Confidence 43222 2267889999999986 458999999999999999999999996542 2233333333221 1111112
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
++.+++++|.+||..||.+|||+.+++.||||+..
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 78999999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=330.85 Aligned_cols=249 Identities=29% Similarity=0.517 Sum_probs=211.5
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||+|+||.||++.++. +++.||+|.++... .....+.+.+|+.+++.++ |+||+++++.+.+.+.+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---SDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---CCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEE
Confidence 58899999999999999999876 78999999986543 2334577889999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 206 IVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
+||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++....
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLT 151 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC---CCCcEEEcccCcceeec
Confidence 999999999999988653 34588999999999999999999999999999999999994 56779999999987664
Q ss_pred CCCC-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.... .....|+..|+|||++. ..++.++||||||+++|+|++|..||...+.......+........ ...++..+
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 228 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL---PSHYSYEL 228 (255)
T ss_pred ccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---CcccCHHH
Confidence 3322 23467899999999986 4589999999999999999999999988777666666654433211 13578999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
.+||.+||+.||++||++.+++.-
T Consensus 229 ~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 229 RSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=336.98 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=199.4
Q ss_pred eeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHH---HHhcCCCCCeeEEEEEEEeCCeEEEEE
Q 012518 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI---LKALSGHKHMIKFHDAFEDANSVYIVM 208 (461)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~i---l~~l~~hpniv~l~~~~~~~~~~~lv~ 208 (461)
.||+|+||.||+|++.. +|+.||+|.+.+...........+..|..+ ++.. +|+||+++++++.+.+.+|+||
T Consensus 1 ~ig~g~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEec---CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEE
Confidence 48999999999998865 789999999876543322222223344443 3334 5999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCC
Q 012518 209 EFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 288 (461)
Q Consensus 209 e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~ 288 (461)
||+.||+|.+++.. .+.+++..++.++.|++.||.|||+++|+||||||+||+++ .++.+||+|||++...... .
T Consensus 77 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~---~~~~~kl~dfg~~~~~~~~-~ 151 (278)
T cd05606 77 DLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK-K 151 (278)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC---CCCCEEEccCcCccccCcc-C
Confidence 99999999887754 46799999999999999999999999999999999999995 5677999999998755432 2
Q ss_pred ccccccCCCcCchhhhh-c-cCCCchhHHHHHHHHHHHhhCCCCCCCCCh---hhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 289 LNDIVGSAYYVAPEVLH-R-SYNVEGDMWSIGVITYILLCGSRPFWARTE---SGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 289 ~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
.....|+..|+|||++. + .++.++||||+||++|+|++|+.||.+... ......+......+ +..++.++.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~ 227 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL----PDSFSPELR 227 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCC----CCcCCHHHH
Confidence 23457999999999986 3 489999999999999999999999976632 22222222222222 234789999
Q ss_pred HHHHHhcccCcCCCC-----CHHHHhcCCCcCCCC
Q 012518 364 DFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393 (461)
Q Consensus 364 ~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~~ 393 (461)
++|.+||..||.+|+ ++.++++||||++..
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 228 SLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 999999999999999 999999999997753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=339.57 Aligned_cols=260 Identities=31% Similarity=0.573 Sum_probs=214.0
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-SALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.|++.+.||+|+||.||+|++..+..+|+.||+|++...... .....+.+.+|+++++++.+|+||+.++++|..++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999998755557899999998754322 1223456788999999997799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC---CCCCEEEeeCccceecc
Confidence 9999999999999988654 5688999999999999999999999999999999999995 56789999999988654
Q ss_pred CCC--CccccccCCCcCchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCh----hhHHHHHHhcCCCCCCCCC
Q 012518 285 PDQ--RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 285 ~~~--~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~ 355 (461)
... ......|+..|+|||++.+ .++.++|||||||++|+|++|..||..... ..+...+......++
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 232 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---- 232 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC----
Confidence 332 2234678999999998753 478899999999999999999999964332 233333333332222
Q ss_pred CCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcCCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~~ 393 (461)
..+++.+.+||.+||..||++|+ ++.+++.||||+..+
T Consensus 233 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 34789999999999999999997 899999999997754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=350.21 Aligned_cols=257 Identities=27% Similarity=0.470 Sum_probs=207.7
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
+.++|++.+.||+|+||.||+|.++. +|+.||||++.+... .......+.+|+.+++++. |+||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 88 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV---TGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQK 88 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC---CCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCC
Confidence 45789999999999999999999876 789999999865422 2334456778999999996 99999999998644
Q ss_pred -----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 202 -----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 202 -----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
...|+||||+.+ +|.+.+... +++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~---~~~~~kL~D 161 (353)
T cd07850 89 SLEEFQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 161 (353)
T ss_pred CccccCcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEcc
Confidence 357999999964 888776432 88999999999999999999999999999999999995 567799999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC--------
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD-------- 347 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------- 347 (461)
||++.............|+..|+|||++. ..++.++|||||||++|+|++|+.||...+....+..+....
T Consensus 162 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 162 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred CccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99998765544445567899999999886 469999999999999999999999998766544444332211
Q ss_pred --------------CCCC---------CCC--------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 348 --------------PNFH---------DSP--------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 348 --------------~~~~---------~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
+... ... ....++++++||.+||+.||++|||+.|+|.||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0000 000 1124667899999999999999999999999998863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=337.22 Aligned_cols=253 Identities=18% Similarity=0.308 Sum_probs=210.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCC--ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
.+|++.+.||+|+||.||+|...... ..+..||+|.+.... .......+.+|+.++..++ ||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence 47899999999999999999875421 234689999986542 3344567889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC
Q 012518 203 SVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 267 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~ 267 (461)
..|++|||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~--- 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG--- 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc---
Confidence 9999999999999999886542 3577888999999999999999999999999999999995
Q ss_pred CCCCeeEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHH
Q 012518 268 EDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRS 342 (461)
Q Consensus 268 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 342 (461)
+++.+||+|||++....... ......+++.|+|||++. +.++.++|||||||++|||++ |..||.+....++...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 56779999999987654322 123345688899999875 569999999999999999998 9999998888777777
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 343 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+........ ...+++++.+|+.+||+.||.+||++.|++++
T Consensus 239 i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 665432221 24689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=340.93 Aligned_cols=259 Identities=30% Similarity=0.565 Sum_probs=215.1
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
.|+....||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.+++.+. ||||++++++|..++..|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~ 94 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKH---SGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELW 94 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcC---CCCEEEEEEEEecccc---hHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEE
Confidence 45566789999999999998865 7889999998654322 2456789999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+||||+++++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 95 iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~---~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISK 169 (297)
T ss_pred EEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc---cCCcEEEeechhHhhccc
Confidence 99999999999886643 4689999999999999999999999999999999999994 567899999999875543
Q ss_pred CC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 286 DQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 286 ~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
.. ......|+..|+|||++. ..++.++|||||||++|||++|+.||......+.+..+..... .....+..++.++.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 248 (297)
T cd06659 170 DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNAHKISPVLR 248 (297)
T ss_pred ccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-CCccccCCCCHHHH
Confidence 32 234467899999999986 4689999999999999999999999987776666555443322 22223456889999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCC
Q 012518 364 DFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~ 397 (461)
++|.+||+.||.+||++.++++||||.+...+..
T Consensus 249 ~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~ 282 (297)
T cd06659 249 DFLERMLTREPQERATAQELLDHPFLLQTGLPEC 282 (297)
T ss_pred HHHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence 9999999999999999999999999987654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=341.05 Aligned_cols=255 Identities=28% Similarity=0.494 Sum_probs=211.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
+.|+..+.||+|+||.||+|.+.. +|+.||+|.+.... .....+.+.+|+++++.+. |+||+++++++..++.+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR---TKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC---CCeEEEEEEecccc--chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCce
Confidence 468888999999999999998865 68899999987543 2234567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+|+||+|+||+++ .++.+||+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEcccccccccc
Confidence 999999999999887743 4689999999999999999999999999999999999995 56779999999987664
Q ss_pred CCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
... ......|+..|+|||++. ..++.++|||||||++|||++|..||...........+...... .....++.++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 229 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPF 229 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHH
Confidence 332 223356889999999986 45889999999999999999999999766554444433322211 1112478899
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.++|.+||..+|.+||++.++++||||....
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 230 KEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 9999999999999999999999999986543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=332.43 Aligned_cols=252 Identities=27% Similarity=0.482 Sum_probs=208.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|+.+. +|+.||||.+.............+.+|+++++.++ ||||+++++++.+.+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL---DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC---CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeE
Confidence 479999999999999999999876 78999999987655455556677889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 205 YIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
++||||+.+|+|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+|||++ .++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~---~~~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc---CCCCEEECccccce
Confidence 999999999999887743 234578899999999999999999999999999999999995 56679999999988
Q ss_pred ccCCCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh--hhHHHHHHhcCCCCCCCCCCC
Q 012518 282 FVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 282 ~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 357 (461)
...... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||..... ......+... .+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--DYPPLPTEH 232 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--CCCCCChhh
Confidence 764332 223457889999999886 4588999999999999999999999965432 2333333222 222222235
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++..+.++|.+||..+|++||++.++++
T Consensus 233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 233 YSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred cCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 7889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=329.53 Aligned_cols=254 Identities=28% Similarity=0.477 Sum_probs=212.4
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEeccccc--CCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM--TSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
+|+..+.||+|+||+||+|..+. +++.||+|.+..... ......+.+.+|+.+++.++ |+||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCe
Confidence 47788999999999999998875 688999999865432 22344567889999999995 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++ .++.+||+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~---~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD---TNGVVKLADFGMAKQV 152 (258)
T ss_pred EEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccceec
Confidence 99999999999998887544 5688999999999999999999999999999999999995 5678999999998876
Q ss_pred CCCCCccccccCCCcCchhhhh-cc-CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLH-RS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~-~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
..........|+..|+|||.+. .. ++.++|+|||||++|+|++|+.||...........+.... .. ......++++
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~ 230 (258)
T cd06632 153 VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-EL-PPIPDHLSDE 230 (258)
T ss_pred cccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cC-CCcCCCcCHH
Confidence 5444345567899999999875 34 8999999999999999999999997766544444433311 11 1122457899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
+.+||.+||..||.+||++.+++.|||+
T Consensus 231 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 231 AKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=355.59 Aligned_cols=258 Identities=26% Similarity=0.497 Sum_probs=233.9
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+++.+..||-|+||.|=+++.+. ....+|+|++++....+....+.+..|-+||..++ .|.||++|..|.+.+++|
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~---~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNS---QKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred hhhhhhhcccCccceEEEEEecc---cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhh
Confidence 56677889999999999998765 33359999999988888888889999999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
|+||-|-||+|+..+..+ +.|.+..++.++..+++|++|||++|||+|||||+|.++ +.++.+||.|||+|+.+..
T Consensus 497 mLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhcc
Confidence 999999999999877554 789999999999999999999999999999999999999 5788899999999999999
Q ss_pred CCCccccccCCCcCchhhh-hccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 012518 286 DQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364 (461)
Q Consensus 286 ~~~~~~~~gt~~y~aPE~l-~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 364 (461)
+.+..++|||+.|.|||++ ++.++.++|.||||+++|||++|.+||.+.+....+..|+++-..+..+ ..++..+.+
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~ 650 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATD 650 (732)
T ss_pred CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHH
Confidence 9999999999999999975 6789999999999999999999999999999999999999875443322 358999999
Q ss_pred HHHHhcccCcCCCCC-----HHHHhcCCCcCCCC
Q 012518 365 FVRRLLNKDHRKRMT-----AAQALTHPWLHDEN 393 (461)
Q Consensus 365 li~~~L~~dP~~R~s-----~~e~L~hp~~~~~~ 393 (461)
||+++...+|.+|.. +.||-+|-||.+.+
T Consensus 651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred HHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 999999999999986 88999999998764
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=335.98 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=211.0
Q ss_pred cceeeceeeccCCceEEEEEEeccC--CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKG--TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
++|.+.+.||+|+||.||+|.+... ..+++.||||+++... .....+.+.+|+++|+.+. |+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQ-HENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcC-CCCchheeeEEecCC
Confidence 4789999999999999999987543 2356889999987542 2334578899999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCC
Q 012518 203 SVYIVMEFCEGGELLDRILSRG-------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 269 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~-------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~ 269 (461)
..|+||||+.+++|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++ .+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc---CC
Confidence 9999999999999999986542 3467888999999999999999999999999999999995 56
Q ss_pred CCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHH
Q 012518 270 APLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVL 344 (461)
Q Consensus 270 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~ 344 (461)
+.+||+|||++........ .....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 7899999999876533221 12345678899999986 568999999999999999998 999998888877777776
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 345 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 345 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
....... ...++..++++|.+||..||++||++.|+++
T Consensus 239 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 239 QGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5433222 2358899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=347.49 Aligned_cols=258 Identities=30% Similarity=0.508 Sum_probs=206.5
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
++++|++.+.||+|+||.||+|.++. +|+.||||++.... .......+.+|+.++++++ |+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 76 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKP---TGVKVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPS 76 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcC---CCCeEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeeccc
Confidence 45789999999999999999999876 78999999986432 2233456778999999996 99999999887544
Q ss_pred ----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 202 ----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 202 ----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
...|+||||+.+ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 77 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~---~~~~~kl~df 150 (336)
T cd07849 77 FESFNDVYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TNCDLKICDF 150 (336)
T ss_pred ccccceEEEEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEECcc
Confidence 358999999964 8877663 34699999999999999999999999999999999999994 5677999999
Q ss_pred ccccccCCCC----CccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC---
Q 012518 278 GLSDFVRPDQ----RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP--- 348 (461)
Q Consensus 278 G~a~~~~~~~----~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--- 348 (461)
|++....... ......||..|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9987654322 123457899999999864 3589999999999999999999999977654433322221100
Q ss_pred --------------------CCCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 349 --------------------NFHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 349 --------------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..... ..+.+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00000 123568899999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=336.33 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=217.9
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.....|+..+.||+|+||.||++++.. +|..||+|++.............+.+|+++++.+. |+|++++++++.+.
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 97 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLRE 97 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcC---CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeC
Confidence 344568899999999999999999876 78899999997654445555677889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+..|+||||+.| +|.+.+......+++..+..++.||+.||.|||++||+||||+|+||+++ .++.+||+|||++.
T Consensus 98 ~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~---~~~~~kl~dfg~~~ 173 (317)
T cd06635 98 HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSAS 173 (317)
T ss_pred CeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC---CCCCEEEecCCCcc
Confidence 999999999975 88887766667789999999999999999999999999999999999994 56779999999987
Q ss_pred ccCCCCCccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
.... .....|+..|+|||++. +.++.++|||||||++|+|++|..||...........+....... .....
T Consensus 174 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 248 (317)
T cd06635 174 IASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNE 248 (317)
T ss_pred ccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--CCCcc
Confidence 5432 23456889999999873 458899999999999999999999998877666666555443221 11235
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
+++.+++||.+||+.+|.+||++.++++|+|+....
T Consensus 249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 788999999999999999999999999999996653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=356.64 Aligned_cols=246 Identities=35% Similarity=0.574 Sum_probs=210.5
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+.+.|++...+|.|+|+.|-.+.+.. +++..+||++.+.. .+..+|+.++....+|+||+++++.+.+..
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~---t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~ 389 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSP---TDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGK 389 (612)
T ss_pred cchhhccccccCCCCccceeeeeccc---cccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCc
Confidence 55789999999999999999888776 88999999998762 123368888888888999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
+.|+|||++.|+.|++.+.... .....+..|+++|+.|+.|||++|||||||||+|||+. +..++++|+|||.++.
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSE 465 (612)
T ss_pred eeeeeehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhh
Confidence 9999999999999999886542 33377888999999999999999999999999999995 4677899999999987
Q ss_pred cCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh-hHHHHHHhcCCCCCCCCCCCCCH
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES-GIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
.... ..+.+-|..|.|||++. ..|+.++||||||++||+||+|+.||...... ++...+... .+. ..+|+
T Consensus 466 ~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~--~~s----~~vS~ 537 (612)
T KOG0603|consen 466 LERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP--KFS----ECVSD 537 (612)
T ss_pred Cchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC--ccc----cccCH
Confidence 7654 44556788999999997 56999999999999999999999999876665 444444332 222 35999
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
+++|||.+||+.||.+|+++.+++.||||-
T Consensus 538 ~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 538 EAKDLLQQLLQVDPALRLGADEIGAHPWFL 567 (612)
T ss_pred HHHHHHHHhccCChhhCcChhhhccCcchh
Confidence 999999999999999999999999999993
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=340.40 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=203.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCc--EEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGK--VVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
++|++.+.||+|+||.||+|.++. +|. .+|+|.++.. ........+.+|+.++.++.+|+||+++++++.+++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~---~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEcc---CCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 478999999999999999999865 454 4577766532 234455678899999999966999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC
Q 012518 203 SVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 267 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~ 267 (461)
.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~--- 158 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG--- 158 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec---
Confidence 9999999999999999886432 2578899999999999999999999999999999999995
Q ss_pred CCCCeeEeecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHh
Q 012518 268 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLR 345 (461)
Q Consensus 268 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~ 345 (461)
.++.+||+|||++.............++..|+|||++. ..++.++|||||||++|+|+| |..||...+..+....+..
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 56779999999986432211111223456799999886 458899999999999999998 9999987777666665533
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 346 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 346 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
. +....+..+++++.+||.+||+.||++||+++++|.+
T Consensus 239 ~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 G---YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred C---CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 1111223478999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=336.42 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=216.2
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
...+.|...+.||+|+||+||+|++.. +|+.||+|++.............+.+|+++++.++ |+||+++++++.+.
T Consensus 18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 93 (313)
T cd06633 18 DPEEIFVGLHEIGHGSFGAVYFATNSH---TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKE 93 (313)
T ss_pred CHHHHhhcceeeccCCCeEEEEEEECC---CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeC
Confidence 344567888899999999999998765 78999999997655445555667889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+..|+||||+. |+|.+.+......+++..+..++.||+.||.|||++||+|+||+|+||+++ .++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~---~~~~~kL~dfg~~~ 169 (313)
T cd06633 94 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSAS 169 (313)
T ss_pred CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC---CCCCEEEeecCCCc
Confidence 99999999996 588888876667789999999999999999999999999999999999995 56679999999986
Q ss_pred ccCCCCCccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
... ......|+..|+|||++. +.++.++|||||||++|+|++|..||...........+..... +......
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 244 (313)
T cd06633 170 KSS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNE 244 (313)
T ss_pred ccC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccc
Confidence 532 223567899999999873 4588899999999999999999999988766555555543322 1122235
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
++..+++||.+||+++|.+||++.+++.||||...
T Consensus 245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 245 WTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 77899999999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=337.64 Aligned_cols=256 Identities=30% Similarity=0.553 Sum_probs=209.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|.++. +++.||||+++.... .....+.+.+|+++++++. |+||+++++++.+.+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA---TGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC---CCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEE
Confidence 379999999999999999999876 688999999865432 2234467889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++||||+.++.+. .+..+...+++..+..++.||+.||.|||++||+||||+|+||+++ +++.+||+|||++....
T Consensus 76 ~iv~e~~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~---~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 76 YLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALR 151 (288)
T ss_pred EEEEecCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEEeeecccccC
Confidence 9999999876554 4445556689999999999999999999999999999999999995 57789999999988765
Q ss_pred CCC--CccccccCCCcCchhhhh-c-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC------------
Q 012518 285 PDQ--RLNDIVGSAYYVAPEVLH-R-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP------------ 348 (461)
Q Consensus 285 ~~~--~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------ 348 (461)
... ......++..|+|||++. . .++.++||||||+++|+|++|+.||.+....+.+..+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 443 334567899999999985 4 588999999999999999999999987665444433322110
Q ss_pred --CCCC-----C--------CCC-CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 349 --NFHD-----S--------PWP-SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 349 --~~~~-----~--------~~~-~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.+.. . .++ .++.++++||++||..||++||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 0 011 248899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=331.36 Aligned_cols=248 Identities=27% Similarity=0.428 Sum_probs=202.3
Q ss_pred eceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEE
Q 012518 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVM 208 (461)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~ 208 (461)
....||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.+++.++ |+||+++++++..++..++||
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~---~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLS---TQVRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ceEEEecCCceEEEEeEecC---CCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEE
Confidence 34579999999999998765 67899999886542 334567889999999996 999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 012518 209 EFCEGGELLDRILSRGGRY--LEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 286 (461)
Q Consensus 209 e~~~gg~L~~~l~~~~~~~--~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~ 286 (461)
||+.+++|.+++......+ ++..+..++.||+.||.|||++||+||||||+||+++. .++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~--~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCeEEEecchhheecccC
Confidence 9999999999887654455 78889999999999999999999999999999999952 3557999999998765432
Q ss_pred C-CccccccCCCcCchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhH-HHHH--HhcCCCCCCCCCCCCC
Q 012518 287 Q-RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTESGI-FRSV--LRADPNFHDSPWPSVS 359 (461)
Q Consensus 287 ~-~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-~~~i--~~~~~~~~~~~~~~~s 359 (461)
. ......|+..|+|||++.+ .++.++|||||||++|+|++|+.||........ ...+ ....+. ....++
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 238 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE----IPESLS 238 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCC----CCcccC
Confidence 2 2234568899999999853 388999999999999999999999965433221 1111 111111 123578
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
+++++||.+||..+|.+|||+.|++.||||
T Consensus 239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 239 AEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=327.82 Aligned_cols=257 Identities=25% Similarity=0.524 Sum_probs=229.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|.++++||+|+|.+|.+++.++ +.+.||+|++++.-+.+...++.+..|-.+..+-++||.+|.++.+|+.+..+
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~---t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKK---TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred ccceeeeeecCcchhhhhheehcc---cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 589999999999999999999987 88999999999988888888889999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc-c
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF-V 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~-~ 283 (461)
++|.||++||+|.-++..+ .+++|+.++.+...|+.||.|||++|||+||||.+|+|+ +..+++||+|+|+++. +
T Consensus 327 ffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l 402 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCC
Confidence 9999999999998777544 679999999999999999999999999999999999999 5678899999999875 4
Q ss_pred CCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCC--------CCChhhHHHHHHhcCCCCCCCC
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFW--------ARTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~--------~~~~~~~~~~i~~~~~~~~~~~ 354 (461)
.++....++|||+.|.|||++.+ .|+..+|+|+|||+|+||+.|+.||. .+++.-+++.|+.....++.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr-- 480 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR-- 480 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--
Confidence 45566788999999999999986 59999999999999999999999994 34455667777776666654
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCC------CHHHHhcCCCcCCC
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRM------TAAQALTHPWLHDE 392 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~------s~~e~L~hp~~~~~ 392 (461)
.+|-.+..+++..|++||.+|. ...++..|+||...
T Consensus 481 --slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 481 --SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred --eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 3788899999999999999996 46899999999753
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=332.98 Aligned_cols=260 Identities=29% Similarity=0.501 Sum_probs=209.2
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--CC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED--AN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~--~~ 202 (461)
++|+..+.||.|++|.||++.++. +++.||+|.+..... ......+.+|+++++.++ |+||++++++|.+ .+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN---TGMIFALKTITTDPN--PDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSS 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC---CCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCC
Confidence 368999999999999999999876 789999999875432 234567889999999996 9999999999865 34
Q ss_pred eEEEEEeccCCCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 203 SVYIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
.+|+||||++|++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++ .++.+||+|||+
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~ 151 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT---RKGQVKLCDFGV 151 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---cCCeEEEeeccc
Confidence 78999999999999877643 345688999999999999999999999999999999999995 466799999999
Q ss_pred ccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC-----hhhHHHHHHhcCC-CCCC
Q 012518 280 SDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART-----ESGIFRSVLRADP-NFHD 352 (461)
Q Consensus 280 a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~-----~~~~~~~i~~~~~-~~~~ 352 (461)
+....... .....++..|+|||.+. ..++.++|||||||++|+|++|..||.... ..+....+..... ....
T Consensus 152 ~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd06621 152 SGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230 (287)
T ss_pred cccccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhcc
Confidence 87654322 23456788999999886 568999999999999999999999997652 2333333333211 1111
Q ss_pred CCC--CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 353 SPW--PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 353 ~~~--~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
... ..+++++.+||.+||..||.+|||+.|++.||||+...+
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 110 135689999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.77 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=211.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||+||++.+.. +|+.||+|++.... .....+.+.+|+++++.++ |+||+++++++.+.+.+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIP---TGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcC---CCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEE
Confidence 579999999999999999999876 78999999986542 2334577889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
|+||||+++++|.+++.. .+.+++..+..++.|++.||.|||+ .||+||||||+||+++ +++.++|+|||++...
T Consensus 79 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN---SRGQIKLCDFGVSGEL 154 (284)
T ss_pred EEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC---CCCcEEEccCCcccch
Confidence 999999999999887754 4578999999999999999999997 5999999999999994 5677999999998754
Q ss_pred CCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh-----------hHHHHHHhcCCCCC
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES-----------GIFRSVLRADPNFH 351 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-----------~~~~~i~~~~~~~~ 351 (461)
... ......|+..|+|||++. +.++.++|||||||++|+|++|..||...... +.+..+..... .
T Consensus 155 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 231 (284)
T cd06620 155 INS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--P 231 (284)
T ss_pred hhh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--C
Confidence 322 223457899999999875 56889999999999999999999999765432 22333332211 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 352 DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 352 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
......++.++.+||.+||+.||.+|||+.|+++|+||....
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 111223788999999999999999999999999999996643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=330.57 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=211.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||+||+|.++....+...||||+++... .......+.+|+.+++.++ |+||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence 47999999999999999999987543345689999986542 3344567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++||||+.+++|.+++....+.+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCCEEECccchhhccc
Confidence 999999999999999877667899999999999999999999999999999999999995 56779999999998775
Q ss_pred CCC-Ccc--ccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 285 PDQ-RLN--DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 285 ~~~-~~~--~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
... ... ...++..|+|||.+. ..++.++|||||||++|+|++ |..||...........+...... + ....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~ 234 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-P--PPMDCP 234 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-C--CCCCCC
Confidence 221 111 233467899999886 568999999999999999998 99999887777776666543211 1 123578
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+.+.+|+.+||+.||++||++.|++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=329.92 Aligned_cols=254 Identities=26% Similarity=0.508 Sum_probs=213.0
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||+|+||.||++..+. +|..||+|.+....... ...+.+.+|+++++.++ |+||+++++.+.+.+..|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---CCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEE
Confidence 58899999999999999999876 78899999987653322 23457789999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 206 IVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
+|+||+.+++|.+++.... ..+++..+..++.||+.||.|||+++|+|+||||+||+++. ++..+||+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC--CCCeEEecccccchhcc
Confidence 9999999999999886543 35789999999999999999999999999999999999963 23457999999987665
Q ss_pred CCCC-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.... .....|+..|+|||++. ..++.++|||||||++|+|++|..||...+.......+...... ...+.++.++
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRDL 230 (257)
T ss_pred CCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCHHH
Confidence 4322 23346899999999886 46889999999999999999999999877766665555443221 1124578999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
+++|.+||..+|++|||+.|+++||||
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=333.53 Aligned_cols=257 Identities=31% Similarity=0.555 Sum_probs=214.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
..|...+.||+|++|.||++.+.. +++.+|+|++.... ....+.+.+|+.+++.+. |+||+++++++...+..
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKS---TGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECC---CCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeE
Confidence 356667899999999999998765 68899999986432 223456789999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++|+||+.|++|.+++.. .++++..+..++.||+.||.|||++||+||||+|+||+++ .++.+||+|||++....
T Consensus 92 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGFCAQVS 166 (285)
T ss_pred EEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc---CCCcEEEcccccchhhc
Confidence 999999999999988755 5689999999999999999999999999999999999995 56779999999887554
Q ss_pred CCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
... ......|+..|+|||++. ..++.++|||||||++|+|++|..||...+.......+......... ....++..+
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l 245 (285)
T cd06648 167 KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRL 245 (285)
T ss_pred cCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHH
Confidence 322 223456899999999986 45899999999999999999999999887766666665544222211 123478999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
.+||.+||..||++||++.++++||||.....
T Consensus 246 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 246 RSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.53 Aligned_cols=254 Identities=30% Similarity=0.510 Sum_probs=211.0
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--CeE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA--NSV 204 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~--~~~ 204 (461)
|++.+.||.|+||.||+|.+.. +|+.+|+|++.... ........+.+|+++++.+. |+||+++++++.+. +..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---TGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---CCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcE
Confidence 6788999999999999999876 68899999997653 22233456788999999996 99999999999988 899
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++||||+.+ +|.+.+......+++..++.++.||+.||.|||++|++|+||||+|||++ +++.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~---~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 76 YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPYT 151 (287)
T ss_pred EEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc---CCCCEEEccccceeecc
Confidence 999999975 89888866656799999999999999999999999999999999999995 57789999999998765
Q ss_pred CCC--CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC-----
Q 012518 285 PDQ--RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW----- 355 (461)
Q Consensus 285 ~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----- 355 (461)
... ......++..|+|||.+.+ .++.++|||||||++|+|++|+.||...+....+..+...........|
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 443 2344567889999997653 4789999999999999999999999887776666655543211111111
Q ss_pred ---------------------CC-CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 356 ---------------------PS-VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 356 ---------------------~~-~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.. +++++.++|++||..||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 12 28899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=335.90 Aligned_cols=254 Identities=34% Similarity=0.651 Sum_probs=218.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|.++. +|+.||+|++.+...........+.+|+.+++++.+|+||+++++++.+.+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceE
Confidence 379999999999999999999876 78999999998755555555677889999999996699999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++||||+.+++|.+++.+. +.+++..++.++.|++.||.|||++|++|+||+|+||+++ .++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~---~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLD 153 (280)
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEecCCccccccC
Confidence 9999999999999988654 5799999999999999999999999999999999999995 56779999999987654
Q ss_pred CCC---------------------CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHH
Q 012518 285 PDQ---------------------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 342 (461)
Q Consensus 285 ~~~---------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~ 342 (461)
... ......|+..|+|||++. ..++.++||||||++++++++|+.||........+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 322 112346789999999876 4588899999999999999999999988877666666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCH----HHHhcCCCc
Q 012518 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA----AQALTHPWL 389 (461)
Q Consensus 343 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~----~e~L~hp~~ 389 (461)
+......+. ..+++.+.+||.+||+.||.+||++ .++|+||||
T Consensus 234 ~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 664443333 3478999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=341.11 Aligned_cols=261 Identities=31% Similarity=0.498 Sum_probs=204.2
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--Ce
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA--NS 203 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~--~~ 203 (461)
+|++.+.||+|+||.||+|.++.+ .+|+.||||.+...........+.+.+|+.+++.+. ||||+++++++.+. +.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCce
Confidence 488999999999999999998652 257899999998743222233456778999999996 99999999999988 88
Q ss_pred EEEEEeccCCCchHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEec-CCCCCCeeEeecc
Q 012518 204 VYIVMEFCEGGELLDRILSR----GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT-REEDAPLKVIDFG 278 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~-~~~~~~~kl~DFG 278 (461)
+|+||||+.+ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++. .+.++.+||+|||
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999999975 677766432 136889999999999999999999999999999999999964 1226789999999
Q ss_pred cccccCCCCC----ccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhh---------HHHHH
Q 012518 279 LSDFVRPDQR----LNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESG---------IFRSV 343 (461)
Q Consensus 279 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---------~~~~i 343 (461)
++........ .....+|..|+|||++.+ .++.++|||||||++|+|++|+.||.+..... .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9886543322 234578899999998753 48899999999999999999999997654322 11111
Q ss_pred HhcC--------------C-------CCCCCCCC------------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 344 LRAD--------------P-------NFHDSPWP------------SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 344 ~~~~--------------~-------~~~~~~~~------------~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
+... + ......++ ..+.++.++|.+||+.||++|||+.|+++||||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 1100 0 00001111 467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=345.05 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=204.0
Q ss_pred ccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED- 200 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~- 200 (461)
.++|++.+.||+|+||.||+|.... +..+++.||+|+++... .....+.+.+|+.+++++.+|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 4689999999999999999997532 22356899999986532 233446678899999999669999999998864
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC--------------------------------------------------------
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRG-------------------------------------------------------- 224 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~-------------------------------------------------------- 224 (461)
+..++++|||+.+|+|.+++....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 467899999999999998885431
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCC---ccccccCCC
Q 012518 225 ----GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAY 297 (461)
Q Consensus 225 ----~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~ 297 (461)
..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+..... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 2578888999999999999999999999999999999995 467799999999987643221 223456778
Q ss_pred cCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcC
Q 012518 298 YVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHR 375 (461)
Q Consensus 298 y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 375 (461)
|+|||++. ..++.++|||||||+||||++ |..||.+....+.+...+........ ...+++++.+++.+||+.+|+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCHHHHHHHHHHccCChh
Confidence 99999875 569999999999999999998 99999875544444333333222111 135789999999999999999
Q ss_pred CCCCHHHHhcC
Q 012518 376 KRMTAAQALTH 386 (461)
Q Consensus 376 ~R~s~~e~L~h 386 (461)
+||++.|+++|
T Consensus 319 ~RPs~~ell~~ 329 (337)
T cd05054 319 DRPTFSELVEI 329 (337)
T ss_pred hCcCHHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=328.96 Aligned_cols=256 Identities=29% Similarity=0.491 Sum_probs=215.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|++|.||+|.++. +|+.||||++...... .....+.+|+.++..++ |+||+++++++...+.+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeE
Confidence 368999999999999999999876 7899999998765322 34577889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
++||||+.+++|.+++... ..+++..+..++.||+.||.|||+ +|++||||+|+||+++ .++.++|+|||++...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~---~~~~~~l~df~~~~~~ 150 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVL 150 (264)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC---CCCCEEEccCccceec
Confidence 9999999999999988654 678999999999999999999999 9999999999999995 5677999999998876
Q ss_pred CCCCCc-cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC---hhhHHHHHHhcCCCCCCCCCCCC
Q 012518 284 RPDQRL-NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART---ESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 284 ~~~~~~-~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
...... ....++..|+|||.+. ..++.++||||||+++|+|++|..||.... ..+....+..... .......+
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 228 (264)
T cd06623 151 ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP--PSLPAEEF 228 (264)
T ss_pred ccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC--CCCCcccC
Confidence 543332 2567889999999886 458899999999999999999999997763 3444444443221 11111127
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+..+.++|.+||..+|++||++.++++||||+..
T Consensus 229 ~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 229 SPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 8999999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=328.85 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=207.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|++.+.||+|+||+||+++... +..+|||.+..... ..+.+.+|+.+++++. ||||+++++++.+.+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPI 74 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCc
Confidence 479999999999999999997653 44699999875432 2356889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+|+|.+++......+++..+..++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD---DQGCVKVSDFGLSRYVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCCEEECCCccceecC
Confidence 999999999999998876555789999999999999999999999999999999999995 56779999999987654
Q ss_pred CCCCc--cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 285 PDQRL--NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 285 ~~~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
..... ....++..|+|||++. ..++.++|||||||++|+|++ |..||...........+......... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 228 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASE 228 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCH
Confidence 33211 1233567899999986 568999999999999999998 99999887777777777655433222 23689
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
.+++++.+||..||.+||++.+++.+
T Consensus 229 ~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 229 KVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=349.34 Aligned_cols=255 Identities=21% Similarity=0.347 Sum_probs=203.9
Q ss_pred ccceeeceeeccCCceEEEEEEeccC--CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKG--TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|.+++.||+|+||.||+|.+... ...+..||||++.... .....+.+.+|+++|+++..||||++++++|.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 45899999999999999999986431 1234579999996542 2334567899999999996699999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---------------------------------------------------------
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG--------------------------------------------------------- 224 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~--------------------------------------------------------- 224 (461)
+.+|||||||++|+|.+++....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999998876431
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC
Q 012518 225 --------------------------------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 266 (461)
Q Consensus 225 --------------------------------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~ 266 (461)
..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~-- 271 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA-- 271 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe--
Confidence 2367778889999999999999999999999999999995
Q ss_pred CCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHH
Q 012518 267 EEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 341 (461)
Q Consensus 267 ~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~ 341 (461)
.++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|||++ |..||........+.
T Consensus 272 -~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 272 -QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred -CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 466799999999986543322 22345678899999886 568999999999999999997 999997755443333
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 342 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 342 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.......... ....++.++.++|.+||..||++||++.++.+
T Consensus 351 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3333322221 12457899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=369.05 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=205.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.++||+|+||.||+|.+.. +|+.||||++...........+++.+|+++++.+. ||||+++++++.+.+..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~l 77 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---CSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPV 77 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEE
Confidence 489999999999999999999876 78999999997654444555677899999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeE
Q 012518 205 YIVMEFCEGGELLDRILSR----------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
|+||||++||+|.+++... ...++...+..++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd---~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG---LFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc---CCCCEEE
Confidence 9999999999999887542 12345567788999999999999999999999999999994 5677999
Q ss_pred eecccccccCCCC-------------------CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCC
Q 012518 275 IDFGLSDFVRPDQ-------------------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWAR 334 (461)
Q Consensus 275 ~DFG~a~~~~~~~-------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~ 334 (461)
+|||++....... .....+||+.|||||++. ..++.++|||||||++|||+||..||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999997652110 112357999999999986 46899999999999999999999999775
Q ss_pred ChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 335 TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 335 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
.............+ .....+..+++.+.+++.+||..||++|++..+.+.+
T Consensus 235 ~~~ki~~~~~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYRDVILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhhhhccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 54433322111111 1112335688999999999999999999987776644
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=339.87 Aligned_cols=252 Identities=21% Similarity=0.289 Sum_probs=205.3
Q ss_pred cceeeceeeccCCceEEEEEEeccC-CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKG-TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.+|++.+.||+|+||+||+|++..+ ...+..||||+++.. ......+++.+|+.+++.+. |+||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-C
Confidence 4799999999999999999987541 112345999998643 23344567889999999996 99999999998765 5
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
.++|+||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~---~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK---TPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec---CCCcEEEccccccccc
Confidence 7899999999999999987666788999999999999999999999999999999999995 5677999999999876
Q ss_pred CCCCCc---cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 284 RPDQRL---NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 284 ~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
...... ....++..|+|||++. ..++.++|||||||++|||++ |..||.+....++.. +.......... +.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~--~~~ 236 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQP--PIC 236 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCCCCC--CCC
Confidence 543322 2233467899999886 568999999999999999997 999998776655443 33333222222 357
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+.++.++|.+||..||.+||++.+++.+
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=337.49 Aligned_cols=261 Identities=27% Similarity=0.480 Sum_probs=211.5
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
|+...++|++.+.||+|+||.||+|.++. +|+.||||+++..... ......+.+|+++++.++ ||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~ 76 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKD---TGELVALKKVRLDNEK-EGFPITAIREIKILRQLN-HRNIVNLKEIVT 76 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECC---CCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCC-CCCeeeeeheec
Confidence 34455789999999999999999999876 7889999998754322 122346678999999996 999999999987
Q ss_pred eCC----------eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCC
Q 012518 200 DAN----------SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 269 (461)
Q Consensus 200 ~~~----------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~ 269 (461)
+.. .+|+||||+.+ +|.+.+......+++..++.++.||+.||.|||++||+||||||+||+++ ++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~ 152 (302)
T cd07864 77 DKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NK 152 (302)
T ss_pred CcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CC
Confidence 654 79999999976 77777766556789999999999999999999999999999999999995 56
Q ss_pred CCeeEeecccccccCCCC--CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHh
Q 012518 270 APLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 345 (461)
Q Consensus 270 ~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~ 345 (461)
+.+||+|||++....... ......++..|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+..
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 153 GQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred CcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 779999999998664332 2233456788999998753 478999999999999999999999987766555544443
Q ss_pred cCCCCC--------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 346 ADPNFH--------------------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 346 ~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
...... ...+..++..+.++|.+||..||.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 211100 01133578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=344.70 Aligned_cols=260 Identities=30% Similarity=0.492 Sum_probs=209.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
+.++|++.+.||+|+||+||+|++.. +|+.||||.+..... .......+.+|+.+++.+. |+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~ 77 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSE---TNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPH 77 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecC---CCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCccchHHheeccc
Confidence 34689999999999999999999875 789999999875422 2223456778999999995 99999999988644
Q ss_pred ----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 202 ----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 202 ----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
..+|+||||+. ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+||
T Consensus 78 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~---~~~~~kL~Df 152 (337)
T cd07858 78 REAFNDVYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICDF 152 (337)
T ss_pred ccccCcEEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECcC
Confidence 35899999996 688887754 46799999999999999999999999999999999999995 5677999999
Q ss_pred ccccccCCC-CCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC-------
Q 012518 278 GLSDFVRPD-QRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD------- 347 (461)
Q Consensus 278 G~a~~~~~~-~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------- 347 (461)
|++...... .......++..|+|||++. ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 999866443 2234457899999999875 358999999999999999999999997765433332222110
Q ss_pred ----------------CCCC----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 348 ----------------PNFH----DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 348 ----------------~~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.... ...++.+++++.+||++||+.||.+|||+.|+|+||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000 01134689999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=330.45 Aligned_cols=250 Identities=32% Similarity=0.567 Sum_probs=213.5
Q ss_pred eccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012518 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCE 212 (461)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~~ 212 (461)
||.|+||.||++++.. +|+.||+|++...........+.+.+|+++++++. |+||+++++.+...+..|+||||+.
T Consensus 1 lg~g~~~~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCC
Confidence 6899999999999875 68999999997765544456678899999999996 9999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCC-----
Q 012518 213 GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ----- 287 (461)
Q Consensus 213 gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~----- 287 (461)
+++|.+++... +.+++..+..++.||+.||.|||++||+|+||+|+||+++ .++.+||+|||++.......
T Consensus 77 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 77 GGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc---CCCCEEEEecccchhcccCcccccc
Confidence 99998887654 4789999999999999999999999999999999999995 56779999999987654321
Q ss_pred ----CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 288 ----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 288 ----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
......++..|+|||++. ..++.++||||||+++|+|++|..||......+....+......+... ..++.++
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 230 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEA 230 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHH
Confidence 223456888999999875 458899999999999999999999998888877777776544333221 2258999
Q ss_pred HHHHHHhcccCcCCCCCH---HHHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRMTA---AQALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~---~e~L~hp~~~~~ 392 (461)
.+||.+||+.+|.+|||+ .++|+||||++.
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 999999999999999999 999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=334.38 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=215.2
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
....|...+.||+|+||.||+|+++. +++.||+|.+............++.+|+++++.++ |+|++++++++.+.+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 88 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH 88 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcC---CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCC
Confidence 44578889999999999999999876 78899999987544444445567889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
..|+||||+. |+|.+.+......+++..+..++.|++.||.|||++|++||||||+|||++ .++.+||+|||++..
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~ 164 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASI 164 (308)
T ss_pred eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC---CCCcEEECCccccee
Confidence 9999999996 588887766666789999999999999999999999999999999999995 467799999999876
Q ss_pred cCCCCCccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
.... ....|+..|+|||++. +.++.++|||||||++|+|++|..||...........+..... .......+
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~ 239 (308)
T cd06634 165 MAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHW 239 (308)
T ss_pred ecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--CCcCcccc
Confidence 5432 3456889999999874 3578899999999999999999999977665554444443321 11112357
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
+..+.+||.+||..+|.+||++.++++|+|+....
T Consensus 240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred cHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 88999999999999999999999999999997753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=330.83 Aligned_cols=257 Identities=18% Similarity=0.266 Sum_probs=209.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccC--CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKG--TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+.|.+.+.||+|+||.||+|.+... ...+..||+|.+.... .......+.+|+.+++.+. |+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence 35799999999999999999988641 1246789999876432 3334467889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
+..++||||+.|++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+..+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999886543 257889999999999999999999999999999999999765555679999
Q ss_pred ecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCC
Q 012518 276 DFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 276 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
|||++........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~- 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL- 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence 9999986632211 11223356799999986 569999999999999999997 99999887777766655443211
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
. ....++..+.+++.+||+.||++||++.++++|
T Consensus 241 ~--~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 D--PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 123578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.06 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=207.8
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
|++.+.||.|++|.||+|.++. +|+.||||++...... ....+.+.+|+++++.++ |+||+++++++.+.+..|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---TGEIVALKKIRLETED-EGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---CCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEE
Confidence 6788999999999999999876 7899999998765322 222356778999999996 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 207 VMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
||||+. ++|.+++.... ..+++..+..++.||+.||.|||+++++||||+|+||+++ .++.+||+|||++.....
T Consensus 76 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCC
Confidence 999995 68988876543 3689999999999999999999999999999999999995 467799999999876543
Q ss_pred CC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC-------------
Q 012518 286 DQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN------------- 349 (461)
Q Consensus 286 ~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~------------- 349 (461)
.. ......++..|+|||++.+ .++.++|||||||++|+|++|..||........+..+.+....
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 22 2233467889999998753 4788999999999999999999999877665544444332110
Q ss_pred -----CC-------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 350 -----FH-------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 350 -----~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
+. ....+.++.++.++|.+||+.||.+|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00 01124578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=330.81 Aligned_cols=252 Identities=27% Similarity=0.492 Sum_probs=208.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||.|+||.||++.++. +|+.||||.+.............+.+|+.+++.+. |+||++++++|.+++..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~ 77 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNEL 77 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC---CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeE
Confidence 468899999999999999999876 78999999987655445555678889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 205 YIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~ 154 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEECcchhhh
Confidence 999999999999887753 234689999999999999999999999999999999999995 56679999999987
Q ss_pred ccCCCCC-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh--hHHHHHHhcCCCCCCCCCCC
Q 012518 282 FVRPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES--GIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 282 ~~~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 357 (461)
....... .....|+..|+|||++. ..++.++||||||+++|+|++|..||.+.... .....+... .+....+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDH 232 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCccc
Confidence 6643322 23457899999999986 45889999999999999999999999765432 223333222 222223345
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+++++++||.+||..||.+|||+.++++
T Consensus 233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 233 YSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 8899999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=326.33 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=200.3
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||.||+|.++. +|+.||+|.+... ........+.+|+++++.+. |+||+++++++.+.+.+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---DNTPVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEec---CCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEee
Confidence 469999999999999876 7889999988643 23444567889999999995 99999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCc-
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL- 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~- 289 (461)
+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++.........
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~~ 151 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYAS 151 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc---CCCcEEECccccCcccccccccc
Confidence 999999998876666789999999999999999999999999999999999995 5667999999998764422111
Q ss_pred --cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 012518 290 --NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 365 (461)
Q Consensus 290 --~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 365 (461)
....++..|+|||.+. +.++.++|||||||++|+|++ |..||...........+...... .....++..+.+|
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 228 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPELCPDAVYRL 228 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCcccCCHHHHHH
Confidence 1112345699999886 568999999999999999997 99999777666555555443211 1223578999999
Q ss_pred HHHhcccCcCCCCCHHHHhc
Q 012518 366 VRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 366 i~~~L~~dP~~R~s~~e~L~ 385 (461)
|.+||+.||++|||+.++++
T Consensus 229 i~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 229 MERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=343.53 Aligned_cols=258 Identities=32% Similarity=0.508 Sum_probs=208.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
++.+|++.+.||.|+||.||+|.++. +|+.||+|.+..... ...+.+.+|+++++.++ |+||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~---~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~ 75 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSD---CDKRVAVKKIVLTDP---QSVKHALREIKIIRRLD-HDNIVKVYEVLGPSG 75 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECC---CCcEEEEEEEecCCC---chHHHHHHHHHHHHhcC-CCcchhhHhhhcccc
Confidence 45799999999999999999999876 789999999866533 33466889999999995 99999999876543
Q ss_pred -------------CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC
Q 012518 202 -------------NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 268 (461)
Q Consensus 202 -------------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~ 268 (461)
...|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++. .
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--~ 150 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--E 150 (342)
T ss_pred cccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--C
Confidence 35899999997 588877643 46899999999999999999999999999999999999963 4
Q ss_pred CCCeeEeecccccccCCCCC----ccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHH
Q 012518 269 DAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 342 (461)
Q Consensus 269 ~~~~kl~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~ 342 (461)
+..+||+|||++........ .....|+..|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 230 (342)
T cd07854 151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230 (342)
T ss_pred CceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 55689999999876533211 12346788999999875 3588999999999999999999999987776555554
Q ss_pred HHhcCCCC----------------------CC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 343 VLRADPNF----------------------HD----SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 343 i~~~~~~~----------------------~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
++...+.. .. ...+.++.++.+||.+||+.||.+|||+.|+|.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 43321110 00 0123578999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=330.67 Aligned_cols=260 Identities=20% Similarity=0.321 Sum_probs=209.6
Q ss_pred ccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|++.+.||+|+||.||+|..+. ....+..||+|.+.... .......+.+|+.+++.+. |+||+++++++.+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVVSKG 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC
Confidence 4689999999999999999997652 11245689999986542 2233456788999999995 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCe
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG---------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 272 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~ 272 (461)
+..|+||||+.+|+|.+++.... ...+...+..++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~---~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc---CCCcE
Confidence 99999999999999999986532 2245677889999999999999999999999999999995 56779
Q ss_pred eEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcC
Q 012518 273 KVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRAD 347 (461)
Q Consensus 273 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~ 347 (461)
||+|||+++....... .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+....+....+....
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876533221 12234567899999886 568999999999999999998 789998877777666655432
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc------CCCcCCC
Q 012518 348 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT------HPWLHDE 392 (461)
Q Consensus 348 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~------hp~~~~~ 392 (461)
.... ...+++.++++|.+||+.||++|||+.++++ ||||.+.
T Consensus 239 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 239 YLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 2111 1246789999999999999999999999987 8998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=329.82 Aligned_cols=255 Identities=18% Similarity=0.290 Sum_probs=206.5
Q ss_pred cccceeeceeeccCCceEEEEEEeccC--CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKG--TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..++|++.+.||+|+||.||+|.++.. ...+..||||++.... .......+.+|+.+++.++ |+||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence 356899999999999999999986531 1246789999986532 2234456889999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCC
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGG---------RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP 271 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~ 271 (461)
.+..++||||+.+|+|.+++..... .++...+..++.|++.||.|||++|++||||||+|||++ .++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~---~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc---CCCC
Confidence 9999999999999999998865321 246678889999999999999999999999999999995 5677
Q ss_pred eeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhc
Q 012518 272 LKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRA 346 (461)
Q Consensus 272 ~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~ 346 (461)
+||+|||++........ .....++..|+|||++. +.++.++|||||||++|||++ |..||.+.........+...
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999875533221 11234577899999986 568999999999999999999 78999887777766665544
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 347 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 347 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
..... ...++..+.++|.+||+.||++|||+.|++++
T Consensus 238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 238 GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32111 13578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=334.32 Aligned_cols=253 Identities=22% Similarity=0.317 Sum_probs=204.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|..+.+. ....+++|.++.. ......+.+.+|+.++.++.+||||+++++++.+.+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-LKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-CcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 57999999999999999999886521 1235788887632 23344567889999999996699999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCC
Q 012518 205 YIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 269 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~ 269 (461)
|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---EN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC---CC
Confidence 99999999999999886532 2478889999999999999999999999999999999995 56
Q ss_pred CCeeEeecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcC
Q 012518 270 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRAD 347 (461)
Q Consensus 270 ~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~ 347 (461)
+.+||+|||++..............+..|+|||++. ..++.++|||||||++|||++ |..||...........+....
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 779999999986432221111222355799999876 468999999999999999997 999998888777777665432
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 348 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 348 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
. ......++.++.+||.+||..||.+||+++++++.
T Consensus 236 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 R---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 11123588999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=340.51 Aligned_cols=263 Identities=25% Similarity=0.422 Sum_probs=211.7
Q ss_pred cccceee-ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHH-----------HHHHHHHHHHHHHhcCCCCC
Q 012518 123 FGAKFEL-GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSAL-----------AIEDVRREVKILKALSGHKH 190 (461)
Q Consensus 123 ~~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~~hpn 190 (461)
+.++|.. .+.||.|+||+||+|.++. +|+.||||++......... ....+.+|+++++.++ |+|
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ 81 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTL---TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HEN 81 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECC---CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccc
Confidence 4567765 5679999999999999875 7899999998654322210 0124678999999996 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCC
Q 012518 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 270 (461)
Q Consensus 191 iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~ 270 (461)
|+++++++...+..|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++
T Consensus 82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~---~~~ 156 (335)
T PTZ00024 82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---SKG 156 (335)
T ss_pred eeeeeEEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC---CCC
Confidence 9999999999999999999997 589887754 45789999999999999999999999999999999999995 567
Q ss_pred CeeEeecccccccCC---------------CCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCC
Q 012518 271 PLKVIDFGLSDFVRP---------------DQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWA 333 (461)
Q Consensus 271 ~~kl~DFG~a~~~~~---------------~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~ 333 (461)
.+||+|||++..... ........++..|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 799999999876541 111223457889999998864 478999999999999999999999988
Q ss_pred CChhhHHHHHHhcCCCCCCC------------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 334 RTESGIFRSVLRADPNFHDS------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 334 ~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.+..+.+..+.......... .....+.++.+||.+||+.||++||+++|+|.||||
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 87776666554322111111 013458899999999999999999999999999999
Q ss_pred CCCCC
Q 012518 390 HDENR 394 (461)
Q Consensus 390 ~~~~~ 394 (461)
+....
T Consensus 317 ~~~~~ 321 (335)
T PTZ00024 317 KSDPL 321 (335)
T ss_pred CCCCC
Confidence 87644
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=331.32 Aligned_cols=255 Identities=29% Similarity=0.469 Sum_probs=209.2
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC--CCCCeeEEEEEEEeCCe-
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS--GHKHMIKFHDAFEDANS- 203 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpniv~l~~~~~~~~~- 203 (461)
|++.+.||+|+||.||+|+++. +|+.||+|+++...... .....+.+|+.+++++. +|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---CCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 6788999999999999999875 68999999997543322 22345667888887774 49999999999988776
Q ss_pred ----EEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 204 ----VYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 204 ----~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
++++|||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+|+||+|+||+++ .++.+||+|||
T Consensus 77 ~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~---~~~~~~l~dfg 152 (287)
T cd07838 77 RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFG 152 (287)
T ss_pred CCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc---cCCCEEEeccC
Confidence 9999999975 8888776543 3589999999999999999999999999999999999995 55789999999
Q ss_pred cccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC--------
Q 012518 279 LSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN-------- 349 (461)
Q Consensus 279 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-------- 349 (461)
++.............++..|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 153 LARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred cceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 998775554445566889999999886 45889999999999999999999999888877766666542110
Q ss_pred --------CC-------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 350 --------FH-------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 350 --------~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
+. ....+.+++.+.+||.+||+.||.+||++.|++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00 00012456888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=333.36 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=210.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|.++. +|+.||||.+++.... .....+.+|+.++.++.+|+||+++++++.+...+
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECC---CCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 579999999999999999999875 6899999999764322 23455677888887877799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
|+||||+. ++|.+.+......+++..+..++.||+.||.|||+ .||+||||+|+||+++ +++.+||+|||++...
T Consensus 90 ~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~---~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 90 FICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD---ASGNVKLCDFGISGRL 165 (296)
T ss_pred EEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc---CCCCEEECccccchhc
Confidence 99999985 47777665555678999999999999999999997 5999999999999994 5678999999998876
Q ss_pred CCCCCccccccCCCcCchhhhhc-----cCCCchhHHHHHHHHHHHhhCCCCCCCCC-hhhHHHHHHhcCCCCCCCCCCC
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLHR-----SYNVEGDMWSIGVITYILLCGSRPFWART-ESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
..........++..|+|||++.+ .++.++|||||||++|+|++|+.||.... ..+.+..+........ .....
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 244 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEG 244 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCC
Confidence 54444444568889999999853 37889999999999999999999996532 2344444444322111 11124
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
++.++.+||.+||..||.+||++.+++.|+||....
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 789999999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=367.62 Aligned_cols=149 Identities=31% Similarity=0.551 Sum_probs=135.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|.++++||+|+||+||+|.+.. +|+.||||+++............+.+|+.++..++ |+||+++++++...+.+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~ 79 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNV 79 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEE
Confidence 589999999999999999999876 78999999998766666666778899999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
||||||+.|++|.+++... +.+.+..++.|+.||+.||.|||++|||||||||+|||++ .++.+||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~---~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc---CCCCEEEEeCCCCc
Confidence 9999999999999887543 5689999999999999999999999999999999999995 56789999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=331.11 Aligned_cols=251 Identities=24% Similarity=0.399 Sum_probs=208.4
Q ss_pred cceeeceeeccCCceEEEEEEeccC--CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKG--TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..|.+.+.||+|+||+||++.+... ..++..+|+|.+... .......+.+|+.+++++. |+||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Confidence 4799999999999999999986431 224567999988653 2344567889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCC
Q 012518 203 SVYIVMEFCEGGELLDRILSRG------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 270 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~ 270 (461)
.+|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~---~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---cCC
Confidence 9999999999999999886542 2488999999999999999999999999999999999995 567
Q ss_pred CeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHh
Q 012518 271 PLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLR 345 (461)
Q Consensus 271 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~ 345 (461)
.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||......+....+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 799999999886543221 12334577899999886 568999999999999999998 9999988887777777766
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 346 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 346 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...... ...++.++.+|+.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 GRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 542211 1247899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=336.99 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=207.7
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
..++|++.+.||.|+||.||+|.++. +|+.||||++......+. ....+.+|+++++.++ |+||+++++++.+.
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHNEKDG-FPITALREIKILKKLK-HPNVVPLIDMAVERP 80 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcC-CCCccchhhheeccc
Confidence 35799999999999999999999876 788999999865432221 2235678999999996 99999999987543
Q ss_pred -------CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeE
Q 012518 202 -------NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 202 -------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
..+|+||||+.+ +|...+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~---~~~~~~l 156 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID---NQGILKI 156 (311)
T ss_pred ccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEE
Confidence 357999999965 77777766566899999999999999999999999999999999999994 5677999
Q ss_pred eecccccccCCCC------------CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHH
Q 012518 275 IDFGLSDFVRPDQ------------RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 340 (461)
Q Consensus 275 ~DFG~a~~~~~~~------------~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~ 340 (461)
+|||++....... ......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~ 236 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999987654321 1223467889999998753 4889999999999999999999999887776666
Q ss_pred HHHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 341 RSVLRADPNFHD--------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 341 ~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
..+......... ..+..+++++.+||.+||..||.+|||+.|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 555432111100 0123456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=344.28 Aligned_cols=260 Identities=32% Similarity=0.543 Sum_probs=209.5
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE----
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE---- 199 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~---- 199 (461)
+++|++.+.||+|+||.||+|.++. +|+.||+|++..... .......+.+|+.+|+.++ |+||++++++|.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGA 78 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC---CCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCC
Confidence 4689999999999999999999876 789999999875432 2233466778999999996 999999999885
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
....+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~ 153 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIGDFGM 153 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEeccccc
Confidence 3457899999995 5888877543 5699999999999999999999999999999999999995 577799999999
Q ss_pred ccccCCCC-----CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc------
Q 012518 280 SDFVRPDQ-----RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA------ 346 (461)
Q Consensus 280 a~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------ 346 (461)
+....... ......|+..|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 87654322 1134578999999998753 5899999999999999999999999776544433322221
Q ss_pred -----------------CCCCCCCC----CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 347 -----------------DPNFHDSP----WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 347 -----------------~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
........ ++.+++++.++|.+||+.||.+||++.+++.||||....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 11111111 245789999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=360.28 Aligned_cols=251 Identities=21% Similarity=0.395 Sum_probs=214.2
Q ss_pred ccceeeceeeccCCceEEEEEEeccCC--ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
..+.++.+.||+|.||+||+|+.-... .....||||.++.. .+.....+|+||+++|..|+ |||||+|+|+|.++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQ-HPNIVRLLGVCREG 561 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccC
Confidence 345677899999999999999864322 23467999999765 35557889999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCC-------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGG-------------RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 268 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~-------------~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~ 268 (461)
+.+|||+|||..|||.++|..+.. .++..+...|+.||+.|+.||-++.+|||||..+|+|| ++
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---cc
Confidence 999999999999999999965421 26778899999999999999999999999999999999 57
Q ss_pred CCCeeEeecccccccCCCCCcc---ccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHH
Q 012518 269 DAPLKVIDFGLSDFVRPDQRLN---DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSV 343 (461)
Q Consensus 269 ~~~~kl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i 343 (461)
+..|||+|||+++.+...+-.. ...-..+||+||.|. +.|++++||||+||+|||+++ |..||++.+..+.++.|
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 8889999999998765433221 222346899999765 889999999999999999998 99999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHH
Q 012518 344 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQA 383 (461)
Q Consensus 344 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 383 (461)
..+.. ...+ ..++.++.+|+..||+.+|.+||++.||
T Consensus 719 ~~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 719 RAGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HcCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 88765 3333 4699999999999999999999999886
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=334.69 Aligned_cols=258 Identities=25% Similarity=0.467 Sum_probs=213.0
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||+|+||.||++.+.. +++.||+|.+..... ...+.+.+|+.+++.++ ||||+++++.|...+.
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA---TGQEVAIKQMNLQQQ---PKKELIINEILVMRENK-HPNIVNYLDSYLVGDE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC---CCCEEEEEEeccccc---hHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCc
Confidence 3689999999999999999998765 678899999864322 23466889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
.|+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~---~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQI 165 (293)
T ss_pred EEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc---CCCCEEEccCcceecc
Confidence 9999999999999988754 3578899999999999999999999999999999999995 5677999999988765
Q ss_pred CCCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 RPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
.... ......|++.|+|||++. +.++.++|||||||++|+|++|..||...+.......+.... ......+..++..
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAI 244 (293)
T ss_pred cccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHH
Confidence 4332 223457889999999875 568899999999999999999999997765544333322211 1111123457889
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
++++|.+||..+|.+||++.+++.|+||+....
T Consensus 245 l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 999999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=320.51 Aligned_cols=251 Identities=33% Similarity=0.580 Sum_probs=212.3
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||+|++|.||++.+.. +|+.+++|++..... .....+.+|+++++.+. |+||+++++++...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---CCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEE
Confidence 47888999999999999999876 788999999876532 34577889999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+++||+.+++|.+++......+++..+..++.|++.||.|||++|++||||+|+||+++ .++.+||+|||++.....
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeeccccccccc
Confidence 99999999999998876656789999999999999999999999999999999999995 467799999999987765
Q ss_pred CCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC-CCCCHHHH
Q 012518 286 DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW-PSVSPEAK 363 (461)
Q Consensus 286 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~s~~~~ 363 (461)
........|+..|+|||++. ..++.++||||||+++|+|++|+.||...+.......+.... ...... ..++..+.
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 228 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG--PPGLRNPEKWSDEFK 228 (253)
T ss_pred cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC--CCCcCcccccCHHHH
Confidence 43334567889999999986 457899999999999999999999998765444444333321 111111 22489999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCC
Q 012518 364 DFVRRLLNKDHRKRMTAAQALTHPW 388 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s~~e~L~hp~ 388 (461)
++|.+||+.||++|||+.|+|+|||
T Consensus 229 ~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 229 DFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHccCChhhCCCHHHHhcCCC
Confidence 9999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=340.27 Aligned_cols=257 Identities=30% Similarity=0.541 Sum_probs=211.0
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+.++|++.+.||+|+||.||++.+.. +|+.||||++.... ........+.+|+.+|+.+. |+||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 87 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDL 87 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECC---CCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCc
Confidence 45689999999999999999998876 78999999986532 23334466889999999996 999999999997654
Q ss_pred ------eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 203 ------SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 203 ------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
.+++||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~d 161 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILD 161 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEee
Confidence 468999999 7788776643 4689999999999999999999999999999999999995 566799999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC-----
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN----- 349 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~----- 349 (461)
||++..... ......+++.|+|||++.+ .++.++|||||||++|+|++|..||........+..+......
T Consensus 162 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 162 FGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999886543 2344578899999998864 4889999999999999999999999877665555444332111
Q ss_pred ------------------CC----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 350 ------------------FH----DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 350 ------------------~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+. ...++.+++++.++|.+||+.||.+|||+.+++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00 01124678899999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=329.06 Aligned_cols=253 Identities=17% Similarity=0.320 Sum_probs=207.5
Q ss_pred cceeeceeeccCCceEEEEEEecc-CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKK-GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
++|++.+.||+|+||+||+|.... +...++.||+|.+... ........+.+|+.+++.++ |+||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence 478999999999999999998532 2235688999998753 23344567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC
Q 012518 204 VYIVMEFCEGGELLDRILSRG----------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 267 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~----------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~ 267 (461)
.|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~--- 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG--- 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc---
Confidence 999999999999999885331 2467888999999999999999999999999999999995
Q ss_pred CCCCeeEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHH
Q 012518 268 EDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRS 342 (461)
Q Consensus 268 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 342 (461)
.+..+||+|||++....... ......++..|+|||++. +.++.++|||||||++|||++ |..||.+.....+...
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 56779999999998654332 123345677899999886 568999999999999999998 9999988776666665
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 343 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+..... . .....+++.+.++|.+||+.||.+||++.+++++
T Consensus 239 ~~~~~~-~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQL-L--PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCc-C--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 554322 1 1224578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=325.73 Aligned_cols=247 Identities=23% Similarity=0.425 Sum_probs=207.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.++||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++.++ |+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN----NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec----CCceEEEEEccCCch----hHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCC
Confidence 358999999999999999999865 456799999865322 2467889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 204 VYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.|+||||+.+|+|.+++... ...++...+..++.||+.||.|||++|++||||||+||+++ .++.+||+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~ 152 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARV 152 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec---CCCcEEECCCcccee
Confidence 99999999999999988654 35688889999999999999999999999999999999995 567799999999987
Q ss_pred cCCCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 283 VRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 283 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
...... .....++..|+|||++. +.++.++|||||||++|+|++ |..||...........+.... .......+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~ 229 (261)
T cd05072 153 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY---RMPRMENC 229 (261)
T ss_pred cCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC---CCCCCCCC
Confidence 643321 12234567899999886 568899999999999999998 999998877777766665442 12223468
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+.++.++|.+||..||++||+++++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=347.38 Aligned_cols=255 Identities=22% Similarity=0.349 Sum_probs=214.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcE-EEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~-vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
++-.+.++||+|+||.||+|+.+........ ||||..+.........+.++.+|.++|++++ |||||++||+..+...
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCc
Confidence 3455678999999999999998763221123 8999988655556777889999999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+|||+|.||+|.++|.+..+.++..+...++.+.+.||+|||++++|||||-.+|+|++ .+..+||+|||+++..
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCccccccCC
Confidence 9999999999999999988777799999999999999999999999999999999999995 4555899999998865
Q ss_pred CCCCCcc-ccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 284 RPDQRLN-DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 284 ~~~~~~~-~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
....... ...-...|+|||.+. +-|+.++|||||||++||+++ |..||.+....++...|.........+ ...+.
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p~ 390 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTPK 390 (474)
T ss_pred cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCHH
Confidence 4221111 112346799999997 679999999999999999998 899999999999999996655444333 35788
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++..++.+|+..||++|+++.++.+
T Consensus 391 ~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 391 ELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHhccCChhhccCHHHHHH
Confidence 9999999999999999999988754
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=325.73 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=205.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|++.+.||+|+||.||+++++ .+..+|+|++...... .+.+.+|+++++.+. |+||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR----GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPI 74 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec----CCccEEEEEeccCCCC----HHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCce
Confidence 36889999999999999999875 3567999998654332 246778999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||++|++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVL 151 (256)
T ss_pred EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC---CCCcEEECCcccceecc
Confidence 999999999999999877666789999999999999999999999999999999999995 56779999999987654
Q ss_pred CCCCcc--ccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 285 PDQRLN--DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 285 ~~~~~~--~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
...... ...++..|+|||++. ..++.++|||||||++|+|++ |..||......+....+..... .. ....++.
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 228 (256)
T cd05059 152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-LY--RPKLAPT 228 (256)
T ss_pred cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-CC--CCCCCCH
Confidence 322111 122345799999886 568999999999999999999 8999988777776666654321 11 1234799
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
++.+++.+||..+|++|||+.|+++.
T Consensus 229 ~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 229 EVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=326.17 Aligned_cols=252 Identities=22% Similarity=0.396 Sum_probs=209.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|++.+.||+|+||.||+|.++.....+..+|+|.++... .....+.+.+|+.+++++. ||||+++++++.+++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence 47999999999999999999876533344579999986542 2334567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+++++|.+++....+.+++.++..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN---SNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC---CCCeEEeCCCCcccccc
Confidence 999999999999999877667789999999999999999999999999999999999995 56779999999998764
Q ss_pred CCCCc----cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 285 PDQRL----NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 285 ~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
..... ....++..|+|||++. +.++.++|||||||++|++++ |..||......+....+.... ..+ ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~ 234 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RLP--APMDC 234 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cCC--CCCCC
Confidence 33211 1122356799999986 568999999999999999886 999998877766666665432 222 22457
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++.+.+++.+||+++|.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=323.67 Aligned_cols=254 Identities=24% Similarity=0.470 Sum_probs=209.1
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccc--cCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAK--MTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
.+|++.+.||+|+||.||+|.++. +|+.||+|.+.... .........+.+|++++++++ |+||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCC
Confidence 479999999999999999999875 78999999875432 123345578889999999996 99999999998764
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 202 -NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 202 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
+.+++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~ 153 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGAS 153 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECccccc
Confidence 5689999999999999888654 4588999999999999999999999999999999999995 5667999999999
Q ss_pred cccCCC----CCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 281 DFVRPD----QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 281 ~~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
...... .......|+..|+|||++.+ .++.++|||||||++|+|++|+.||...........+...... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~p 231 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK--PMLP 231 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC--CCCC
Confidence 765321 12234568999999999864 5889999999999999999999999876655555544432211 1223
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
..+++++.++|.+||. ++.+||++.+++.|||.
T Consensus 232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred cccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 4689999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=321.93 Aligned_cols=253 Identities=32% Similarity=0.574 Sum_probs=216.9
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||.|+||.||++.+.. +++.||+|++..... .......+.+|+++++.++ |+|++++++.+...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---CCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEE
Confidence 58899999999999999999876 788999999876543 2345567889999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 206 IVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
+||||+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++ .++.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~---~~~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT---SNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc---CCCcEEECCccceee
Confidence 999999999999988765 36789999999999999999999999999999999999995 467799999999887
Q ss_pred cCCCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 283 VRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 283 ~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
..... ......|++.|+|||.+. ..++.++||||+|+++|+|++|..||...........+........ ...++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 229 (258)
T cd08215 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI---PSQYSS 229 (258)
T ss_pred cccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC---CCCCCH
Confidence 65433 223457899999999875 4588999999999999999999999988776666666654432211 125789
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
++.++|.+||..+|++||++.++|+||||
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.40 Aligned_cols=252 Identities=28% Similarity=0.506 Sum_probs=208.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|.+.. +|+.||+|.++..........+.+.+|+++++++. |+||+++++++.+.+..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeE
Confidence 479999999999999999999875 78999999987655455555678899999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 205 YIVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
++||||+.+|+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+||+++ .++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~---~~~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT---ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC---CCCcEEEeccceee
Confidence 9999999999999887542 34578999999999999999999999999999999999995 56779999999987
Q ss_pred ccCCCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh--hhHHHHHHhcCCCCCCCCCCC
Q 012518 282 FVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 282 ~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 357 (461)
...... ......|+..|+|||++. ..++.++|||||||++|+|++|..||..... ......+... .+...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADH 232 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC--CCCCCChhh
Confidence 654332 223457889999999886 4589999999999999999999999965432 2233333222 122222335
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++.++.++|.+||..+|++||++.++++
T Consensus 233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 233 YSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=339.88 Aligned_cols=254 Identities=20% Similarity=0.327 Sum_probs=200.9
Q ss_pred eeeccC--CceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEE
Q 012518 131 KEVGRG--HFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVM 208 (461)
Q Consensus 131 ~~lG~G--~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~ 208 (461)
..||+| +||+||+|++.. +|+.||||++...... ....+.+.+|+.+++.++ ||||++++++|...+.+|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP---TGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcC---CCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEE
Confidence 457776 999999999876 7899999998765433 344578899999999996 999999999999999999999
Q ss_pred eccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 012518 209 EFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ 287 (461)
Q Consensus 209 e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~ 287 (461)
||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+. .++.+|++|||.+.......
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccC
Confidence 9999999998876542 3588999999999999999999999999999999999995 46679999998654322111
Q ss_pred C-c-------cccccCCCcCchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC-----
Q 012518 288 R-L-------NDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH----- 351 (461)
Q Consensus 288 ~-~-------~~~~gt~~y~aPE~l~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----- 351 (461)
. . ....++..|+|||++.+ .++.++|||||||++|+|++|..||...........++......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence 0 0 11234567999999864 378999999999999999999999977665444433332211000
Q ss_pred --------------------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 352 --------------------------------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 352 --------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
......+++.+.+||++||+.||++|||+.|+|+||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00112357889999999999999999999999999999653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=331.16 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=208.9
Q ss_pred ccceeeceeeccCCceEEEEEEeccCC--ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|++.+.||+|+||.||++..+... .....+|+|.+.... .......+.+|+++++++.+|+||+++++++..+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 358999999999999999999876422 244789999987542 2334567889999999995599999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC
Q 012518 202 NSVYIVMEFCEGGELLDRILSR---------------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 266 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~ 266 (461)
+.+|+||||+.+|+|.+++..+ ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~-- 166 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT-- 166 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc--
Confidence 9999999999999999988642 34678899999999999999999999999999999999995
Q ss_pred CCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHH
Q 012518 267 EEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 341 (461)
Q Consensus 267 ~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~ 341 (461)
+++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|||++ |..||.+....+...
T Consensus 167 -~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 167 -EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred -CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 567899999999986643321 12233567799999875 568999999999999999997 999998877766666
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 342 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 342 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
.+.... ... ....++.++.+|+.+||..||++|||+.|++++
T Consensus 246 ~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGY-RME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCC-cCC--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 554432 111 123578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=332.27 Aligned_cols=259 Identities=31% Similarity=0.581 Sum_probs=211.0
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-SALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
+|++.+.||+|+||.||+++...+..+++.||||++++.... .....+.+.+|+.+++++.+|+||+++++.+..++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999987655557889999998754322 2223456789999999997799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+|+|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++ .++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD---SEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEEECccccccc
Confidence 9999999999999888654 5688999999999999999999999999999999999995 56779999999987654
Q ss_pred CCCC--ccccccCCCcCchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCh----hhHHHHHHhcCCCCCCCCC
Q 012518 285 PDQR--LNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 285 ~~~~--~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~ 355 (461)
.... .....|+..|+|||++.+ .++.++||||||+++|+|++|..||..... .++.+.+....... .
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~ 232 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF----P 232 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC----C
Confidence 3322 223568999999998853 268899999999999999999999954322 23333333332222 2
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCcCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMT---AAQALTHPWLHDE 392 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s---~~e~L~hp~~~~~ 392 (461)
..++.++.++|.+||+.||++||| +.++|+||||+..
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 347899999999999999999998 5678999999765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=323.01 Aligned_cols=247 Identities=24% Similarity=0.383 Sum_probs=209.5
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||.||+|.+......+..||+|++....... ..+.+.+|+++++.++ |+||+++++++.+...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence 46999999999999987532347889999997653322 4678899999999997 99999999999999999999999
Q ss_pred cCCCchHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 211 CEGGELLDRILSR--------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 211 ~~gg~L~~~l~~~--------~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC---CCCcEEEcccccccc
Confidence 9999999998765 46789999999999999999999999999999999999995 567799999999987
Q ss_pred cCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 283 VRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 283 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
..... ......++..|+|||.+. ..++.++|||||||++|+|++ |..||...........+..... .. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR-LP--KPEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CC--CCcc
Confidence 65432 233456788999999886 468999999999999999999 6999988877777777665321 11 1235
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
++.++.++|.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 78999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.39 Aligned_cols=247 Identities=21% Similarity=0.359 Sum_probs=206.9
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|.+.+.||+|+||.||+|.++. +++.||+|++.... .....+.+|+++++.+. |+||+++++++..++.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPF 77 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---CCceEEEEEecCCc----hHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCc
Confidence 468999999999999999999876 78899999986532 23467889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++ +++.+||+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~df~~~~~~ 154 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM 154 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCcEEeCCCcccccc
Confidence 99999999999999886543 4588899999999999999999999999999999999995 5677999999998876
Q ss_pred CCCCCc--cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 284 RPDQRL--NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 284 ~~~~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
...... ....++..|+|||++. ..++.++|||||||++|||++ |..||.+....+....+.... .......++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (263)
T cd05052 155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---RMERPEGCP 231 (263)
T ss_pred ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---CCCCCCCCC
Confidence 433211 1223456799999886 568999999999999999998 999998877766666665432 111224588
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.++.++|.+||..||++||++.++++
T Consensus 232 ~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 232 PKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=329.99 Aligned_cols=252 Identities=17% Similarity=0.287 Sum_probs=208.8
Q ss_pred cceeeceeeccCCceEEEEEEeccC--CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKG--TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
.+|++.+.||+|+||.||+|.+..+ ...++.||||+++... .....+.+.+|+.++..+. |+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCC
Confidence 3688999999999999999987532 1246789999987542 3334567889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC
Q 012518 203 SVYIVMEFCEGGELLDRILSR---------------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 267 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~ 267 (461)
..++++||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||+.
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~--- 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF--- 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec---
Confidence 999999999999999888532 13477788999999999999999999999999999999995
Q ss_pred CCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHH
Q 012518 268 EDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRS 342 (461)
Q Consensus 268 ~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 342 (461)
+++.+||+|||+++....... .....+++.|+|||++. +.++.++|||||||++|||++ |..||.+....+.+..
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 566799999999876543321 23345678899999875 668999999999999999998 8899988888777777
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 343 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+........ ...++.++.+|+.+||+.||.+||++++++.
T Consensus 239 i~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 239 IRNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 766543321 1358899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=326.65 Aligned_cols=252 Identities=19% Similarity=0.255 Sum_probs=203.8
Q ss_pred ccceeeceeeccCCceEEEEEEeccC-CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKG-TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
.++|++.+.||+|+||+||+|++... ......||+|++.... .......+.+|+.+++.+. |+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLT-S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-C
Confidence 35899999999999999999987641 1112358999986542 3344567889999999996 9999999999875 4
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
..+++|||+++|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++ +++.+||+|||++..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFGLARL 158 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCCceee
Confidence 57899999999999999877667799999999999999999999999999999999999995 466799999999987
Q ss_pred cCCCCCc---cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 283 VRPDQRL---NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 283 ~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
....... ....++..|+|||++. ..++.++|||||||++|||++ |..||...........+..... . .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~ 235 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-L--PQPPI 235 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-C--CCCcc
Confidence 6533221 1233467899999885 568999999999999999998 9999977666555554443221 1 12245
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++.++.++|.+||..||++||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=325.40 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=205.3
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe---
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS--- 203 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~--- 203 (461)
|++++.||+|+||.||+|....+...+..||||+++.... .....+.+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence 5678999999999999998865443568899999875432 3445677889999999995 9999999998866554
Q ss_pred ---EEEEEeccCCCchHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 204 ---VYIVMEFCEGGELLDRILSR-----GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 204 ---~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
.++||||+.+|+|..++... ...+++..+..++.|++.||.|||++||+||||||+||+++ +++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR---EDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC---CCCeEEEC
Confidence 79999999999998887543 13578899999999999999999999999999999999994 56779999
Q ss_pred ecccccccCCCCCc---cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCC
Q 012518 276 DFGLSDFVRPDQRL---NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 276 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
|||+++........ ....++..|+|||++. ..++.++|||||||++|||++ |..||.+....+.+..+......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 234 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL- 234 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence 99999866433211 1223467899999886 568999999999999999999 99999887777777666544321
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
.. ...++.++.++|.+||+.||++||++.|++++
T Consensus 235 ~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 KQ--PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CC--CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 13578999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=324.75 Aligned_cols=252 Identities=22% Similarity=0.410 Sum_probs=208.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|++.+.||+|+||.||+|..+.+...+..||||++... ........+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCce
Confidence 4689999999999999999998763333457999998654 23445678999999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++||||+.+|+|.+++....+.+++..++.++.|++.||.|||++|++||||||+|||++ .+..+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~---~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc---CCCcEEECCCccccccc
Confidence 999999999999998876667789999999999999999999999999999999999994 56779999999987654
Q ss_pred CCCCc---cccc---cCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 285 PDQRL---NDIV---GSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 285 ~~~~~---~~~~---gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
..... .... ++..|+|||++. +.++.++|||||||++|||++ |..||......+....+... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~ 234 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD---YRLPPPM 234 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC---CcCCCcc
Confidence 32211 1111 235799999986 568999999999999999886 99999888777776666432 1222234
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.++..+.+++.+||..+|.+||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=331.48 Aligned_cols=254 Identities=23% Similarity=0.379 Sum_probs=206.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccC----CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKG----TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
.++|.+++.||+|+||.||+|++... ..++..+|+|.++... .......+.+|+.+++.+.+|+||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 35899999999999999999986431 1234679999987542 23345678889999999966999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEe
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 264 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~ 264 (461)
+.+.+|+||||+.+|+|.+++..+. ..++...+..++.||+.||.|||++||+||||||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 9999999999999999999986542 2477888999999999999999999999999999999995
Q ss_pred cCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhH
Q 012518 265 TREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 339 (461)
Q Consensus 265 ~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~ 339 (461)
.++.+||+|||++........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||......+.
T Consensus 175 ---~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 175 ---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred ---CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 567799999999876543221 11223456899999886 458999999999999999998 8999987776666
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 340 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 340 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...+..... . .....++.++.+||.+||..+|.+||++.++++
T Consensus 252 ~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 252 FKLLKEGHR-M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHcCCC-C--CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 665544321 1 112357899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=314.63 Aligned_cols=251 Identities=22% Similarity=0.353 Sum_probs=204.0
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA-- 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~-- 201 (461)
..+|++.+.||+|||+-||+++... ++..||+|.+.... ....+..++|++..+++. |||+++++++...+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s---~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLS---TGHLYALKKILCHS---QEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEK 92 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccC---cccchhhheeeccc---hHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhc
Confidence 4589999999999999999998654 88999999997643 456788899999999996 99999999877443
Q ss_pred ---CeEEEEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCcEEEecCCCCCCee
Q 012518 202 ---NSVYIVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENFLFTTREEDAPLK 273 (461)
Q Consensus 202 ---~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH~~g--ivHrDlkp~NILl~~~~~~~~~k 273 (461)
...||++.|...|+|.+.+... +..++|.++..|+.+|++||++||+.. ++||||||.|||++ +++.++
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~v 169 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPV 169 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceE
Confidence 3499999999999999988653 346899999999999999999999998 99999999999996 467799
Q ss_pred EeecccccccCCCC----------CccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh--
Q 012518 274 VIDFGLSDFVRPDQ----------RLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTES-- 337 (461)
Q Consensus 274 l~DFG~a~~~~~~~----------~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-- 337 (461)
|+|||.++...-.. .......|..|+|||.+. ...+.++|||||||+||+|+.|..||......
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 99999987653211 112345789999999986 23789999999999999999999999542221
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 338 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 338 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
.+.-.+.+....++.. ..+|..+.+||+.||+.||.+||++.+++.+
T Consensus 250 SlaLAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eEEEeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1112233334444444 3489999999999999999999999999864
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=329.83 Aligned_cols=254 Identities=33% Similarity=0.540 Sum_probs=211.6
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
|++.+.||.|++|.||++.+.. +|+.+|+|.+...... ......+.+|+++++.+. |+||+++++++.+.+.+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---TGEIVAIKKIKLRFES-EGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---CCcEEEEEEecccccc-chhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEE
Confidence 6678899999999999999865 7899999998765332 234467888999999996 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 012518 207 VMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 286 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~ 286 (461)
||||+.+ +|.+.+......+++..+..++.||+.||.|||++||+|+||||+||+++ .++.+||+|||.+......
T Consensus 76 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN---TEGVLKLADFGLARSFGSP 151 (283)
T ss_pred EEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC---CCCcEEEeeeeeeEecCCC
Confidence 9999975 88888877667899999999999999999999999999999999999995 5677999999998776544
Q ss_pred C-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC------------
Q 012518 287 Q-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH------------ 351 (461)
Q Consensus 287 ~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~------------ 351 (461)
. ......++..|+|||.+.+ .++.++|||||||++|+|++|+.||...+..+.+..+........
T Consensus 152 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 152 VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 3 2334568889999998753 588999999999999999999999987776555544433211100
Q ss_pred --------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 352 --------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 352 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
...++.++.++++||.+||..||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 01123478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=330.02 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=207.4
Q ss_pred cccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..++|++.+.||+|+||.||++.+.. ....+..||||.++... .....+.+.+|+.+++++.+|+||+++++++..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 34589999999999999999997632 12246689999987543 233456788999999999559999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
.+.+|+||||+.+|+|.+++..... .+++..+..++.||+.||.|||++||+|+||||+|||++ .+..+||+|||+
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc---CCCeEEECCCcc
Confidence 9999999999999999998865433 378999999999999999999999999999999999995 566799999999
Q ss_pred ccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCC
Q 012518 280 SDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 280 a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 354 (461)
+........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||......+.+........... .
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 265 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--Q 265 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--C
Confidence 886543321 12234577899999876 568999999999999999998 9999987665554444443322221 1
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
....++++.+|+.+||..+|++||++.|+++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=341.88 Aligned_cols=259 Identities=31% Similarity=0.556 Sum_probs=212.8
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+.++|++.+.||+|+||.||+|++.. +++.||||++.... ......+.+.+|+.+++++. |+||+++++++...+
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 87 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPAS 87 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECC---CCcEEEEEeccccc-chhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhccc
Confidence 45689999999999999999999876 78899999986542 22233466778999999995 999999999887655
Q ss_pred e------EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 203 S------VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 203 ~------~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
. +|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~---~~~~~kL~d 161 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILD 161 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEcc
Confidence 4 89999999 6699887753 4699999999999999999999999999999999999995 567799999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC---
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH--- 351 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--- 351 (461)
||++...... .....++..|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+........
T Consensus 162 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 162 FGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 9998865432 345678899999998853 578999999999999999999999987776666555543221100
Q ss_pred --------------------C----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 352 --------------------D----SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 352 --------------------~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
. ..+..+++++.+||.+||..||.+|||+.++++||||.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 0 011346899999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=328.51 Aligned_cols=255 Identities=20% Similarity=0.276 Sum_probs=206.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCC-------------ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGT-------------LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHM 191 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~-------------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpni 191 (461)
.+|++++.||+|+||.||+|.+.... ..+..||+|.+.... .....+.+.+|++++++++ |+||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i 81 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLS-DPNI 81 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcC-CCCE
Confidence 58999999999999999999875421 123568999987653 2345678889999999996 9999
Q ss_pred eEEEEEEEeCCeEEEEEeccCCCchHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcE
Q 012518 192 IKFHDAFEDANSVYIVMEFCEGGELLDRILSRG----------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 261 (461)
Q Consensus 192 v~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NI 261 (461)
+++++++..++..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999886543 2688999999999999999999999999999999999
Q ss_pred EEecCCCCCCeeEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh--CCCCCCCCC
Q 012518 262 LFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC--GSRPFWART 335 (461)
Q Consensus 262 Ll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt--g~~Pf~~~~ 335 (461)
+++ .++.+||+|||++....... ......++..|+|||++. +.++.++|||||||++|||++ |..||....
T Consensus 162 li~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 162 LVG---KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eec---CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 995 55779999999987654332 122345678899999876 479999999999999999998 788987776
Q ss_pred hhhHHHHHHhc----CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 336 ESGIFRSVLRA----DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 336 ~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
....+..+... ...........++.++.++|.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 66666655432 111111112346799999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=324.80 Aligned_cols=253 Identities=20% Similarity=0.333 Sum_probs=208.3
Q ss_pred ccceeeceeeccCCceEEEEEEeccCC--ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|++.+.||+|+||.||++..+... .++..||+|.+.... .......+.+|+.+++.+. |+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcCC
Confidence 468999999999999999999876422 345789999986542 2234467889999999995 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCe
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG---------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 272 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~ 272 (461)
...|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~---~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc---CCCCE
Confidence 99999999999999999886432 2367788999999999999999999999999999999995 56779
Q ss_pred eEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcC
Q 012518 273 KVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRAD 347 (461)
Q Consensus 273 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~ 347 (461)
||+|||+++...... ......++..|+|||++. +.++.++|||||||++|||++ |..||.+.+.......+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 999999987654332 123345678899999886 568999999999999999998 999998887777776665332
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 348 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 348 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.... ...++.++.++|.+||+.+|++|||+.++++
T Consensus 239 -~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 -HLDL--PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred -CCCC--CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111 1346899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=327.20 Aligned_cols=259 Identities=28% Similarity=0.488 Sum_probs=217.0
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
...+.|++.+.||+|+||.||++.+.. +++.||+|++..... ..+.+.+|+++++.+. |+||+++++++...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 87 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVG 87 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEcc---CCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEEC
Confidence 355679999999999999999999875 688999999975432 3567889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+..|+|+||+.|++|.+++......+++..+..++.|++.||.|||++||+|+||+|+||+++ .++.+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~---~~~~~~l~d~~~~~ 164 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS---KDGSVKLADFGFAA 164 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc---CCCCEEECccchhh
Confidence 999999999999999998876644799999999999999999999999999999999999995 56679999999887
Q ss_pred ccCCCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 282 FVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 282 ~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
...... ......++..|+|||++. ..++.++|||||||++|+|++|..||...........+...... .......++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 243 (286)
T cd06614 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWS 243 (286)
T ss_pred hhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCC
Confidence 654322 223456788999999876 45899999999999999999999999876665555444433221 112223478
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.++++||.+||+.+|.+||++.++|.|+||...
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 999999999999999999999999999999774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=340.27 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=199.2
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..+.|.-...||+|+||.||+|... +|+.||||++....... ..+|.+|+.++.+++ |+|+|+|+|||.+.+
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~----~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~ 144 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLS----DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HPNLVKLLGYCLEGG 144 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEEC----CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-CcCcccEEEEEecCC
Confidence 3457777889999999999999876 45889999886653321 345999999999997 999999999999998
Q ss_pred -eEEEEEeccCCCchHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC---ccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 203 -SVYIVMEFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQG---VVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 203 -~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~i~~qil~al~yLH~~g---ivHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
..+||+||+.+|+|.++|..... .+++....+|+.+++.||.|||+.. |||||||++|||+ |++++.||+||
T Consensus 145 ~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDF 221 (361)
T KOG1187|consen 145 EHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDF 221 (361)
T ss_pred ceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCc
Confidence 59999999999999999987766 8899999999999999999999964 9999999999999 57899999999
Q ss_pred ccccccCC-CCCcccc-ccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC---hhhHHH---HHHhcC-
Q 012518 278 GLSDFVRP-DQRLNDI-VGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART---ESGIFR---SVLRAD- 347 (461)
Q Consensus 278 G~a~~~~~-~~~~~~~-~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~---~i~~~~- 347 (461)
|+|+.... .....+. .||.+|+|||++. +..+.++|||||||+|+||+||+.+..... ...+.. ..+...
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~ 301 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK 301 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence 99976554 3333333 8999999999986 789999999999999999999998876432 111222 111111
Q ss_pred -CCCCCCCC--CCCC-----HHHHHHHHHhcccCcCCCCCHHHHh
Q 012518 348 -PNFHDSPW--PSVS-----PEAKDFVRRLLNKDHRKRMTAAQAL 384 (461)
Q Consensus 348 -~~~~~~~~--~~~s-----~~~~~li~~~L~~dP~~R~s~~e~L 384 (461)
..+.++.. .... ..+..+..+|++.+|.+||++.|++
T Consensus 302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 11111111 1222 2355778899999999999998864
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=322.64 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=208.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|+..+.||+|+||.||+|+.+.+......+|||.++... .....+.+.+|+++++++. |+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCc
Confidence 47888999999999999999987533234579999986542 2334567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+++|.+++....+.+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN---SNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc---CCCcEEECCCccceecc
Confidence 999999999999998877667899999999999999999999999999999999999995 56779999999987654
Q ss_pred CCCCc--c--ccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 285 PDQRL--N--DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 285 ~~~~~--~--~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
..... . ....+..|+|||++. +.++.++|||||||++|||++ |..||...+..+....+..... ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~ 235 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR---LPAPMDC 235 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC---CCCCCCC
Confidence 32211 1 122345799999886 568999999999999999997 9999988887777777754321 1122357
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+.++.+++.+||..||++||++.++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=318.18 Aligned_cols=253 Identities=30% Similarity=0.519 Sum_probs=212.2
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--Ce
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA--NS 203 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~--~~ 203 (461)
+|.+.+.||+|++|.||+|.+.. +|+.|++|++...... ....+.+.+|+.+++++. |+||+++++.+.+. +.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---TGELMAVKSVELSGDS-EEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---CCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCe
Confidence 47888999999999999999876 7889999998765432 345678899999999996 99999999999988 89
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+++||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++ .++.+||+|||.+...
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEec
Confidence 999999999999999886553 899999999999999999999999999999999999995 4677999999999877
Q ss_pred CCCCC---ccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC-hhhHHHHHHhcCCCCCCCCCCCC
Q 012518 284 RPDQR---LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART-ESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 284 ~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
..... .....++..|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+... ... ......+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~ 229 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS-GEP-PEIPEHL 229 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc-CCC-cCCCccc
Confidence 65543 345678899999999864 48999999999999999999999997765 22222222211 111 1112346
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
+.++.+||.+||..||++||++.|++.||||
T Consensus 230 ~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=329.85 Aligned_cols=254 Identities=32% Similarity=0.526 Sum_probs=209.1
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
|++.+.||+|+||+||+|.... +++.||||.+...... .......+|+..++++.+|+||+++++++.+++..|+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---TGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---CCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence 6788999999999999999875 6889999998654322 1223345799999999669999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 207 VMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
||||+ +|+|.+.+.... ..+++..+..++.|++.+|.|||++||+|+||+|+||+++ .++.++|+|||++.....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~---~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS---GPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCCEEEeecccceeccC
Confidence 99999 789998887654 4689999999999999999999999999999999999995 567799999999987765
Q ss_pred CCCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC-----------
Q 012518 286 DQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD----------- 352 (461)
Q Consensus 286 ~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 352 (461)
........++..|+|||++. ..++.++||||||+++|+|++|+.||......+.+..+.........
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 54555667899999999874 34789999999999999999999999877665555444321111100
Q ss_pred ---------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 353 ---------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 353 ---------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
...+..+.++.+||++||..||++||++.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0012346889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=338.23 Aligned_cols=256 Identities=24% Similarity=0.406 Sum_probs=201.3
Q ss_pred ccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED- 200 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~- 200 (461)
.++|++.+.||+|+||+||+|.+.. ...+++.||||+++... .......+.+|+.+|.++.+|+||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3589999999999999999998542 22367899999997543 223356788999999999769999999998865
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC--------------------------------------------------------
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRG-------------------------------------------------------- 224 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~-------------------------------------------------------- 224 (461)
+..+++|||||.+|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 456899999999999999886532
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCC---ccc
Q 012518 225 ----------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LND 291 (461)
Q Consensus 225 ----------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~---~~~ 291 (461)
..++...+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++........ ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc---CCCcEEEEecccccccccCcchhhcCC
Confidence 1356677888999999999999999999999999999995 567899999999876533221 122
Q ss_pred cccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 012518 292 IVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 369 (461)
Q Consensus 292 ~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 369 (461)
..++..|+|||++. ..++.++|||||||++|+|++ |..||........+............. ..+++++.+++.+|
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~c 318 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC--CCCCHHHHHHHHHH
Confidence 34567899999875 568999999999999999997 999997654333333333222222222 23678999999999
Q ss_pred cccCcCCCCCHHHHhcC
Q 012518 370 LNKDHRKRMTAAQALTH 386 (461)
Q Consensus 370 L~~dP~~R~s~~e~L~h 386 (461)
|+.||.+||++.|+++|
T Consensus 319 l~~~p~~Rps~~eil~~ 335 (343)
T cd05103 319 WHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=334.91 Aligned_cols=260 Identities=30% Similarity=0.498 Sum_probs=206.2
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe----C
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED----A 201 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~----~ 201 (461)
+|++.+.||+|+||.||++++.... .+..||||++.... ........+.+|+.+++++.+|+||+++++.+.. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~-~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC-cCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 4889999999999999999987521 27899999986432 2222345677899999999779999999987542 2
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
..+|++|||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~---~~~~~kl~Dfg~a~ 153 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN---ADCELKICDFGLAR 153 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc---CCCCEEeCcCCCce
Confidence 56889999986 588887754 46789999999999999999999999999999999999995 56779999999997
Q ss_pred ccCCCC-----CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC-----
Q 012518 282 FVRPDQ-----RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN----- 349 (461)
Q Consensus 282 ~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~----- 349 (461)
...... ......||..|+|||++.+ .++.++|||||||++|+|++|..||........+..++.....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 654321 1234578999999998753 5899999999999999999999999876654444433321100
Q ss_pred ------------------CC----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 350 ------------------FH----DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 350 ------------------~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.. ...++.++..+.+||.+||+.||.+|||+.|++.||||..-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 00 11234578899999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=317.68 Aligned_cols=252 Identities=33% Similarity=0.594 Sum_probs=213.9
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||+|++|.||++.++. +|+.||+|.+...... ....+.+.+|+++++++. |+|++++++++.+.+.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---TGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---CCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEE
Confidence 58899999999999999998875 7889999999776432 345678999999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+||||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 76 IILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLND 151 (254)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCC
Confidence 999999999999887654 6789999999999999999999999999999999999995 467799999999987654
Q ss_pred CCC-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 286 DQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 286 ~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
... .....++..|+|||.+. ..++.++||||||+++|+|++|..||...........+.... . ......++..+.
T Consensus 152 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~ 228 (254)
T cd06627 152 VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--H-PPLPEGISPELK 228 (254)
T ss_pred CcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC--C-CCCCCCCCHHHH
Confidence 332 23456889999999886 347899999999999999999999998766544444433221 1 112245789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 364 DFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
++|.+||..+|++||++.+++.||||
T Consensus 229 ~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=325.00 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=202.6
Q ss_pred eeceeeccCCceEEEEEEec-cCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 128 ELGKEVGRGHFGHTCCAKGK-KGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~-~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
++.+.||.|.||.||+|..+ .....+..|+||+++.. ......+.+.+|++++++++ ||||+++++++...+.+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccc-ccccccccccccccccccc
Confidence 46789999999999999988 44446788999999542 34445788999999999995 9999999999998888999
Q ss_pred EEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 207 VMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
|||||.+|+|.+++... ...+++..+..|+.||+.||.|||+++|+|+||+++|||++ .++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~---~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD---SNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE---TTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccc
Confidence 99999999999999877 56789999999999999999999999999999999999996 466799999999987632
Q ss_pred CCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 286 DQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 286 ~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
... .....+...|+|||++. ..++.++||||||+++|||++ |+.||.+....++...+...... .. ...++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL-PI--PDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET-TS--BTTSBH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ee--ccchhH
Confidence 221 12345677899999986 458999999999999999999 78999888887777777544321 11 235799
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+.++|.+||..||++||++.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=337.55 Aligned_cols=259 Identities=31% Similarity=0.532 Sum_probs=208.1
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
+.++|.+.+.||+|+||.||++.+.. +|+.||||++..... .....+.+.+|+.++++++ |+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~ 89 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 89 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcC---CCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecc
Confidence 45789999999999999999998865 789999999875422 2233456788999999996 99999999988643
Q ss_pred -----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 202 -----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 202 -----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
...|++++++ |++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~d 163 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILD 163 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc---CCCCEEEec
Confidence 3478899887 7788776643 4689999999999999999999999999999999999995 567799999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC------
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP------ 348 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------ 348 (461)
||++..... ......|+..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+.....
T Consensus 164 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T cd07877 164 FGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241 (345)
T ss_pred ccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999876532 3345678999999998754 588999999999999999999999977665444443322111
Q ss_pred -----------------CCCC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 349 -----------------NFHD----SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 349 -----------------~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
..+. ..+...++++.+||.+||+.||.+|+++.++|.||||+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0111 011246889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=327.18 Aligned_cols=251 Identities=24% Similarity=0.398 Sum_probs=206.7
Q ss_pred cceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
.+|.+.+.||+|+||.||+|+... ...++..+++|.+... .....+.+.+|++++++++ |+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence 468999999999999999998643 1225567999988643 2334467889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC
Q 012518 203 SVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 267 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~ 267 (461)
..++||||+.+++|.+++.... +.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~--- 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG--- 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---
Confidence 9999999999999999886532 3478899999999999999999999999999999999995
Q ss_pred CCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHH
Q 012518 268 EDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRS 342 (461)
Q Consensus 268 ~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 342 (461)
.++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||......+....
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 567899999999976543221 23345678899999876 568999999999999999998 9999988777776666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 343 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+....... ....++..+.++|.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 55433221 12347889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=362.87 Aligned_cols=257 Identities=32% Similarity=0.523 Sum_probs=202.3
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+..+|+.++.||+||||.||+|+++- +|+.||||.|.... +......+.+|+.+|.+|+ |||||+||..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKl---DGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs 549 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKL---DGREYAIKKIPLKA--SDKLYSKILREVKLLARLN-HPNVVRYYSAWVES 549 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecc---cchhhhhhhccCch--HHHHHHHHHHHHHHHhhcC-Ccceeeeehhhhcc
Confidence 466789999999999999999999986 89999999997654 4555678899999999996 99999998752100
Q ss_pred --------------------------------------------------------------------------------
Q 012518 202 -------------------------------------------------------------------------------- 201 (461)
Q Consensus 202 -------------------------------------------------------------------------------- 201 (461)
T Consensus 550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~ 629 (1351)
T KOG1035|consen 550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN 629 (1351)
T ss_pred CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence
Q ss_pred ---------------------------------------CeEEEEEeccCCCchHHHHHhcCCCC-CHHHHHHHHHHHHH
Q 012518 202 ---------------------------------------NSVYIVMEFCEGGELLDRILSRGGRY-LEEDAKTIVEKILN 241 (461)
Q Consensus 202 ---------------------------------------~~~~lv~e~~~gg~L~~~l~~~~~~~-~~~~~~~i~~qil~ 241 (461)
-.+||-||||+...|.+ +..++... ....++++++||++
T Consensus 630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~-iI~~N~~~~~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRD-IIRRNHFNSQRDEAWRLFREILE 708 (1351)
T ss_pred cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHH-HHHhcccchhhHHHHHHHHHHHH
Confidence 13789999998755544 54444333 46789999999999
Q ss_pred HHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC-------------------CCCCccccccCCCcCchh
Q 012518 242 IVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-------------------PDQRLNDIVGSAYYVAPE 302 (461)
Q Consensus 242 al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~-------------------~~~~~~~~~gt~~y~aPE 302 (461)
||.|+|+.|||||||||.||+++ .+..|||+|||+|+... .....+..+||--|+|||
T Consensus 709 GLaYIH~~giIHRDLKP~NIFLd---~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 709 GLAYIHDQGIIHRDLKPRNIFLD---SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHHhCceeeccCCcceeEEc---CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 99999999999999999999995 56679999999998621 112346689999999999
Q ss_pred hhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCChhh-HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 012518 303 VLHR----SYNVEGDMWSIGVITYILLCGSRPFWARTESG-IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKR 377 (461)
Q Consensus 303 ~l~~----~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 377 (461)
++.+ .|+.|+|||||||||+||+ .||....+.. ++..+......++...|..--+....+|++||+.||.+|
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccC
Confidence 9862 4999999999999999999 4675555443 334443333222222233344667789999999999999
Q ss_pred CCHHHHhcCCCcCC
Q 012518 378 MTAAQALTHPWLHD 391 (461)
Q Consensus 378 ~s~~e~L~hp~~~~ 391 (461)
|||.|+|++.||.-
T Consensus 863 PtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 863 PTATELLNSELLPP 876 (1351)
T ss_pred CCHHHHhhccCCCc
Confidence 99999999999963
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=329.91 Aligned_cols=254 Identities=22% Similarity=0.375 Sum_probs=206.5
Q ss_pred ccceeeceeeccCCceEEEEEEecc----CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK----GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
.++|.+++.||+|+||.||+|++.. ....+..||+|.++... .......+.+|+++++.+.+|+||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 3589999999999999999998632 11245679999987542 23445678899999999966999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEe
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 264 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~ 264 (461)
+.+.+|+||||+.+|+|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 9999999999999999999886532 3478888999999999999999999999999999999995
Q ss_pred cCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhH
Q 012518 265 TREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 339 (461)
Q Consensus 265 ~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~ 339 (461)
.++.+||+|||+++....... .....++..|+|||++. +.++.++|||||||++|+|++ |..||.+....+.
T Consensus 169 ---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 169 ---EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred ---CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 566799999999986543221 11223456799999886 568999999999999999999 8999988777777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 340 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 340 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+..+...... .....++.++++||.+||..||++||++.|+++
T Consensus 246 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7666543211 112357889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=338.86 Aligned_cols=258 Identities=34% Similarity=0.548 Sum_probs=214.2
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC---
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN--- 202 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~--- 202 (461)
+|++.+.||.|+||.||+|++.. +|+.||||++.... ......+.+.+|+.+++.++ |+||+++++++.+.+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---CCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCccc
Confidence 58999999999999999999865 68999999987542 12334467889999999996 999999999998775
Q ss_pred --eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 203 --SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 203 --~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.++|+|||++
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~---~~~~~~L~dfg~~ 150 (330)
T cd07834 76 FNDVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN---SNCDLKICDFGLA 150 (330)
T ss_pred ccceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccCce
Confidence 7899999997 4888877543 4799999999999999999999999999999999999995 5678999999999
Q ss_pred cccCCCC----CccccccCCCcCchhhhh-c-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCC-
Q 012518 281 DFVRPDQ----RLNDIVGSAYYVAPEVLH-R-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS- 353 (461)
Q Consensus 281 ~~~~~~~----~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~- 353 (461)
....... ......++..|+|||++. . .++.++|||||||++|+|++|..||.+.+..+.+..+..........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 8765443 234567899999999886 3 58899999999999999999999998887766666655432211110
Q ss_pred --------------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 354 --------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 354 --------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
..+.++.++.+||.+||++||.+||++.+++.||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0134788999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=329.55 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=208.2
Q ss_pred ccceeeceeeccCCceEEEEEEecc----CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK----GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
.++|.+.+.||+|+||.||+|+... ....+..||+|.+.... .......+.+|+.+++.+.+|+||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4589999999999999999997531 22245689999986542 23445678899999999966999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEe
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 264 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~ 264 (461)
..+..|+||||+.+|+|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 9999999999999999999886542 2467788899999999999999999999999999999995
Q ss_pred cCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhH
Q 012518 265 TREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 339 (461)
Q Consensus 265 ~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~ 339 (461)
.++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+.+..++
T Consensus 172 ---~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 172 ---ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred ---CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 567799999999986643221 22234567899999886 458999999999999999998 8899988877777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 340 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 340 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...+....... ....++.++.+||.+||..+|.+||++.|+++
T Consensus 249 ~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 249 FKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 77665443221 12357899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=338.40 Aligned_cols=262 Identities=29% Similarity=0.476 Sum_probs=210.1
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..+.++|++.+.||+|+||.||+|.+.. +|+.+|||.+.+... .......+.+|+.+++++.+|+||++++++|..
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~ 78 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKA 78 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcC---CCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence 3456789999999999999999999875 688999998865322 222345677899999999449999999999864
Q ss_pred C--CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 201 A--NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 201 ~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
. ..+|+||||+. ++|.+++... .+.+..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~---~~~~~kl~d~g 152 (337)
T cd07852 79 ENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFG 152 (337)
T ss_pred CCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeecc
Confidence 3 46899999997 4898877543 688889999999999999999999999999999999994 67789999999
Q ss_pred cccccCCCC------CccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC-
Q 012518 279 LSDFVRPDQ------RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN- 349 (461)
Q Consensus 279 ~a~~~~~~~------~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~- 349 (461)
++....... ......||..|+|||++. ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 987654322 223457899999999874 35789999999999999999999999876655444333222110
Q ss_pred --------------------------CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 350 --------------------------FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 350 --------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
......+.++.++.+||.+||+.||++|||+.++++||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0011224578999999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=378.76 Aligned_cols=258 Identities=29% Similarity=0.518 Sum_probs=216.5
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
+..-+|.-+..||.|.||.||.|.+.. +|+..|||-|+..... ......+.+|+.+|..+. |||+|++||+-.+.
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~---tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLD---TGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHR 1306 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCC---ccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceeecH
Confidence 344577788899999999999998876 8999999998765433 445677889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+.++|.||||+||+|.+.+ ..++...|...+.+..|++.|+.|||++|||||||||+|||++ .++.+|++|||.|.
T Consensus 1307 ekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld---~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD---FNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee---cCCcEEeeccccee
Confidence 9999999999999998865 5555677777888999999999999999999999999999995 56789999999998
Q ss_pred ccCCCC-----CccccccCCCcCchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCC-hhhHHHHHHhc-CCCC
Q 012518 282 FVRPDQ-----RLNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVITYILLCGSRPFWART-ESGIFRSVLRA-DPNF 350 (461)
Q Consensus 282 ~~~~~~-----~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~-~~~~ 350 (461)
.+.... .+...+||+.|||||++.+ ...-+.|||||||++.||+||+.||...+ +-.++..+-.+ .+.+
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC
Confidence 765432 3456899999999999964 36778999999999999999999996533 33444444332 3333
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+. .+|.+.+|||.+||+.||++|+++.|+|+|-|-+..
T Consensus 1463 P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1463 PE----RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred ch----hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 33 499999999999999999999999999999987543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=321.46 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=205.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||+|+||.||+|.+. .++.||||.++.... ..+.+.+|+.++++++ |+||+++++++...+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN----NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec----CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCC
Confidence 457999999999999999999864 356799999875432 2356889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.|+||||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~ 152 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARV 152 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc---CCCCEEECCcceEEE
Confidence 999999999999999886543 4688999999999999999999999999999999999995 567799999999987
Q ss_pred cCCCCCc--cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 283 VRPDQRL--NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 283 ~~~~~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
....... .....+..|+|||++. ..++.++|||||||++|+|++ |+.||.+.+....+..+..... . .....+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~ 229 (261)
T cd05068 153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-M--PCPPGC 229 (261)
T ss_pred ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--CCCCcC
Confidence 6532211 1122345799999876 468999999999999999999 9999988777766666654321 1 112357
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+..+.+++.+||+.||.+||++.++++
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=324.66 Aligned_cols=251 Identities=23% Similarity=0.399 Sum_probs=207.0
Q ss_pred cceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
.+|.+.++||+|+||.||+|.... ...++..+|+|.+... .....+.+.+|+++++.+. |+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQ-HQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecCC
Confidence 478889999999999999997532 2235678999988653 3345578899999999995 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC
Q 012518 203 SVYIVMEFCEGGELLDRILSRG--------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 268 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~--------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~ 268 (461)
..++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~---~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---Q 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc---C
Confidence 9999999999999999886542 2478899999999999999999999999999999999995 5
Q ss_pred CCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHH
Q 012518 269 DAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSV 343 (461)
Q Consensus 269 ~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i 343 (461)
++.+||+|||++........ .....+++.|+|||++. ..++.++|||||||++|||++ |..||......+....+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 67799999999876543221 12234577899999876 568999999999999999998 99999887777777666
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 344 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 344 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
....... ....+++.+.+||.+||+.||.+||++.|+++
T Consensus 238 ~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5543221 11358899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=319.85 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=199.1
Q ss_pred eeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEecc
Q 012518 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFC 211 (461)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~ 211 (461)
+||+|+||.||+|.++.. .+++.+|+|+++... ......+.+.+|+.+++.+. |+||+++++++. .+..++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~-~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK-KSEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecC-CCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEecC
Confidence 689999999999976432 267889999986543 33445677899999999995 999999999886 45679999999
Q ss_pred CCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCC---
Q 012518 212 EGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR--- 288 (461)
Q Consensus 212 ~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~--- 288 (461)
.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||.|||++ .+..+||+|||++........
T Consensus 78 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~---~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 78 ELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc---CCCeEEECCCccccccCCCCCeee
Confidence 999999887544 5789999999999999999999999999999999999995 567799999999987644322
Q ss_pred -ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 012518 289 -LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 365 (461)
Q Consensus 289 -~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 365 (461)
.....++..|+|||++. ..++.++|||||||++|||++ |..||......+....+..... .. ....+++++.+|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~l 230 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-ME--CPQRCPPEMYDL 230 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CC--CCCCCCHHHHHH
Confidence 12233457899999886 468899999999999999998 9999988777777766654432 11 123589999999
Q ss_pred HHHhcccCcCCCCCHHHHhc
Q 012518 366 VRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 366 i~~~L~~dP~~R~s~~e~L~ 385 (461)
|.+||+.||++||+++++..
T Consensus 231 i~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 231 MKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHhccCchhCcCHHHHHH
Confidence 99999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=327.10 Aligned_cols=256 Identities=31% Similarity=0.541 Sum_probs=212.0
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
.|+...+||+|+||.||++..+. +|+.||||.+.... ......+.+|+.+++.+. |+||++++++|...+..|
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 93 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKS---SGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW 93 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcC---CCeEEEEEEecccc---hhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEE
Confidence 34455789999999999998876 78999999985432 234567889999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+||||+.+++|.+++. ...+++..+..++.|++.||.|||++||+|+||+|+||+++ .++.++|+|||++.....
T Consensus 94 lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~---~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 94 VVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred EEEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEcccccceeccc
Confidence 9999999999988663 24689999999999999999999999999999999999995 567799999999876543
Q ss_pred CC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 286 DQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 286 ~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
.. ......|+..|+|||++. ..++.++||||+||++|+|++|..||...........+....+... .....+++.+.
T Consensus 169 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 247 (292)
T cd06657 169 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL-KNLHKVSPSLK 247 (292)
T ss_pred ccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc-CCcccCCHHHH
Confidence 32 223457899999999875 4588999999999999999999999987766555555443322211 12245789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 364 DFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
++|.+||+.||.+||++.++|.||||.....
T Consensus 248 ~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 248 GFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 9999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=319.94 Aligned_cols=243 Identities=21% Similarity=0.324 Sum_probs=198.9
Q ss_pred eeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEecc
Q 012518 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFC 211 (461)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~ 211 (461)
.||+|+||.||+|..+... .+..||+|++.... .....+.+.+|+.++++++ |+||+++++++. ....++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~-~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-~~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCC-CceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-CCCeEEEEEeC
Confidence 4899999999999875321 45679999986542 3444567889999999995 999999999886 45789999999
Q ss_pred CCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCc--
Q 012518 212 EGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL-- 289 (461)
Q Consensus 212 ~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~-- 289 (461)
.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+|||++.........
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc---CCCcEEeccCCccccccCCcccee
Confidence 99999998876666799999999999999999999999999999999999995 5677999999998765433221
Q ss_pred --cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 012518 290 --NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 365 (461)
Q Consensus 290 --~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 365 (461)
....++..|+|||++. +.++.++|||||||++|+|++ |..||.+....+....+....... .....++++.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l 230 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD---CPAECPPEMYAL 230 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHHHHHH
Confidence 1122357899999886 568999999999999999996 999998887777766665543221 113578999999
Q ss_pred HHHhcccCcCCCCCHHHHhc
Q 012518 366 VRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 366 i~~~L~~dP~~R~s~~e~L~ 385 (461)
|.+||..||++||++.++++
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=320.13 Aligned_cols=246 Identities=23% Similarity=0.377 Sum_probs=205.3
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||.||+|.+.........||||.+...... ...+.+.+|++++++++ |+||+++++++.+ ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence 4689999999999998653323447999999876543 55678899999999996 9999999999988 889999999
Q ss_pred cCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCC-
Q 012518 211 CEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR- 288 (461)
Q Consensus 211 ~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~- 288 (461)
+++|+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe---cCCEEEeccccccccccccccc
Confidence 99999999987765 4688999999999999999999999999999999999995 457799999999987644221
Q ss_pred ---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 289 ---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 289 ---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
.....++..|+|||++. ..++.++|||||||++|+|++ |..||...+..+....+.......... ..++..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERP--EACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCC--ccCCHHHH
Confidence 12245678899999986 468999999999999999998 999998877777777666433222211 34789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhc
Q 012518 364 DFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+++.+||..+|++||++.++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=324.01 Aligned_cols=248 Identities=18% Similarity=0.303 Sum_probs=201.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCc----EEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGK----VVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
.+|++.+.||+|+||+||+|.+.. +|+ .+++|.+... .......++..|+.++.++. ||||+++++++.
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~---~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~- 79 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIP---EGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP- 79 (279)
T ss_pred hhceeccccCccCCcceEEEEEcC---CCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC-
Confidence 478999999999999999998764 344 4777776432 22334467788898999995 999999999875
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
....++|+||+.+|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++ +++.+||+|||++
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~---~~~~~kl~Dfg~~ 156 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK---SDSIVQIADFGVA 156 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEEcCCccc
Confidence 4567899999999999999977667789999999999999999999999999999999999994 5678999999999
Q ss_pred cccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 281 DFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 281 ~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
+....... .....++..|+|||++. +.++.++|||||||++|||++ |..||.+.........+.... .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~ 233 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE-RLAQ--P 233 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCCC--C
Confidence 86543321 23345778899999886 569999999999999999998 999998776655444443322 2221 1
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
..++.++.+++.+||..||.+|||+.|+++
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 234 QICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 236788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=319.84 Aligned_cols=245 Identities=35% Similarity=0.675 Sum_probs=211.9
Q ss_pred eccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012518 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCE 212 (461)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~~ 212 (461)
||.|+||.||++.+.. +|+.||+|++.+.........+.+.+|+.+++++. |+||+++++.+.+++..|+||||+.
T Consensus 1 lg~G~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCC
Confidence 7999999999998865 68899999998776555556678899999999996 9999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCC-CCccc
Q 012518 213 GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLND 291 (461)
Q Consensus 213 gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~-~~~~~ 291 (461)
+++|.+++... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++ .++.++|+|||++...... .....
T Consensus 77 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (250)
T cd05123 77 GGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNT 152 (250)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CCCcEEEeecCcceecccCCCcccC
Confidence 99999988654 4689999999999999999999999999999999999995 5667999999998876543 23445
Q ss_pred cccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhc
Q 012518 292 IVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 370 (461)
Q Consensus 292 ~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 370 (461)
..++..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+......++ ..++..+.++|.+||
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l 228 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLL 228 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHh
Confidence 678899999998864 578899999999999999999999987776666666665433332 246899999999999
Q ss_pred ccCcCCCCCH---HHHhcCCCc
Q 012518 371 NKDHRKRMTA---AQALTHPWL 389 (461)
Q Consensus 371 ~~dP~~R~s~---~e~L~hp~~ 389 (461)
..||++||++ .++++||||
T Consensus 229 ~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 229 QKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred cCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=323.21 Aligned_cols=247 Identities=25% Similarity=0.390 Sum_probs=208.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|++.++||.|+||.||+|.++. ++.+|+|++..... .....+.+|+.+++.++ |+||+++++++.+.+.+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~----~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN----RVRVAIKILKSDDL---LKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPV 77 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC----CCcEEEEeccccch---hhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCe
Confidence 479999999999999999998863 67899999876432 23457889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
++||||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ +++.+||+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~---~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLI 154 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc---CCceEEEccccchhhc
Confidence 9999999999999988654 34688999999999999999999999999999999999995 5677999999999766
Q ss_pred CCCCC-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 284 RPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 284 ~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
..... .....++..|+|||++. +.++.++|||||||++|+|++ |+.||......+.+..+.... .......+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 231 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY---RMPCPAKCPQ 231 (261)
T ss_pred CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC---cCCCCCCCCH
Confidence 43321 12334567899999886 568999999999999999998 899998877777777666432 1222246889
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++.++|.+||+.||.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 232 EIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=337.31 Aligned_cols=256 Identities=32% Similarity=0.589 Sum_probs=206.9
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA-- 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~-- 201 (461)
.++|.+.+.||+|+||.||+|.++. +|+.||||++.+... .......+.+|+.+++.+. |+||++++++|...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 88 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVS 88 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCC---CCcEEEEEEecCccc-cccchhHHHHHHHHHHhcC-CCCccchhheeccccc
Confidence 4689999999999999999999865 789999999875432 2223456789999999996 99999999998754
Q ss_pred ----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 202 ----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 202 ----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
..+|+||||+.. +|...+ +..+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~---~~~~~kL~df 161 (342)
T cd07879 89 GDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDF 161 (342)
T ss_pred CCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeC
Confidence 346999999964 665543 24689999999999999999999999999999999999995 5677999999
Q ss_pred ccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC--------
Q 012518 278 GLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD-------- 347 (461)
Q Consensus 278 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------- 347 (461)
|++..... ......++..|+|||++.+ .++.++|||||||++|||++|+.||.+......+..+....
T Consensus 162 g~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 162 GLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99876532 2345678899999998853 48899999999999999999999998876555444433311
Q ss_pred ---------------CCCCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 348 ---------------PNFHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 348 ---------------~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
+.+... .++.+++++.+||.+||+.||.+||++.++|.||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 011111 1245788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=340.07 Aligned_cols=256 Identities=22% Similarity=0.364 Sum_probs=205.2
Q ss_pred ccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|.+++.||+|+||.||+|+++. ....++.||||+++... .....+.+.+|+.+|.++..|+||+++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 3578899999999999999998653 12256789999997543 2233456889999999996699999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---------------------------------------------------------
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG--------------------------------------------------------- 224 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~--------------------------------------------------------- 224 (461)
+.+++|||||.+|+|.+++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999886432
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEe
Q 012518 225 ----------------------------------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 264 (461)
Q Consensus 225 ----------------------------------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~ 264 (461)
..++...++.++.||+.||.|||++||+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 1245567788999999999999999999999999999995
Q ss_pred cCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhH
Q 012518 265 TREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 339 (461)
Q Consensus 265 ~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~ 339 (461)
.+..+||+|||+++....... .....++..|+|||++. ..++.++|||||||++|||++ |..||......+.
T Consensus 274 ---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 274 ---EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred ---CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 466799999999986533221 22345788899999886 458999999999999999998 8999977665555
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 340 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 340 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
....+....... ....++.++.+||.+||..||.+||++.|+++.
T Consensus 351 ~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 351 FYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 444443322222 223578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=349.79 Aligned_cols=278 Identities=29% Similarity=0.497 Sum_probs=227.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE----
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE---- 199 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~---- 199 (461)
.+.|++.+.||.|.+|.||+++.++ +|+..|+|++....- ..+++..|.+||+.+.+|||++.+|++|.
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~---~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVK---TGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeee---cCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 4579999999999999999999987 889999999875432 23567789999999999999999999985
Q ss_pred -eCCeEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 200 -DANSVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 200 -~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
.++.+|||||||.||+..|++... +.++.|+.+..|++.++.||.+||.+.++|||||-.|||++ .++.|||+||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvDF 167 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVDF 167 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEeee
Confidence 356899999999999999988654 56899999999999999999999999999999999999997 4566999999
Q ss_pred ccccccCCC-CCccccccCCCcCchhhhh--c----cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC
Q 012518 278 GLSDFVRPD-QRLNDIVGSAYYVAPEVLH--R----SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 278 G~a~~~~~~-~~~~~~~gt~~y~aPE~l~--~----~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
|++..+... .+..+.+||++|||||++. . .|+..+|+||||++..||.-|.+|+.+......+..|-+. +..
T Consensus 168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPP 246 (953)
T KOG0587|consen 168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPP 246 (953)
T ss_pred eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCc
Confidence 998876543 3456789999999999984 2 3888999999999999999999999877665444444332 222
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCCchHHHHHHHHHHhhcCHHH
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLK 416 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (461)
....|.+++.++.+||..||.+|-.+||+..++|+|||+.... ....+...++.....+...
T Consensus 247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~----~e~qir~~ik~~~~~~r~~ 308 (953)
T KOG0587|consen 247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP----NERQVRIQIKDHIDRSRKK 308 (953)
T ss_pred cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc----cHHHHHHHHHHHHhhccch
Confidence 2233567899999999999999999999999999999998332 3334444444444444333
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=321.06 Aligned_cols=246 Identities=23% Similarity=0.367 Sum_probs=202.3
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
..+|++.++||+|+||.||+|++.. +..||+|+++.... ..+.+.+|+++++.+. |+||+++++.+.+ +.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----~~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----CceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEECC-CC
Confidence 3579999999999999999998753 34599999875432 2356789999999996 9999999998754 56
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 204 VYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.|+||||+.+|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++ +++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~---~~~~~~L~dfg~~~~ 151 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARL 151 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc---CCCcEEeccCCceee
Confidence 89999999999999988654 34578899999999999999999999999999999999995 567799999999976
Q ss_pred cCCCCCc--cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 283 VRPDQRL--NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 283 ~~~~~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
....... ....++..|+|||++. +.++.++|||||||++|+|++ |..||.+....+....+...... . ....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~ 228 (262)
T cd05071 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-P--CPPEC 228 (262)
T ss_pred ccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-C--Ccccc
Confidence 6433221 2334667899999875 568999999999999999999 89999887777776666543211 1 12357
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+..+.++|.+||++||++||++.++++
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=326.94 Aligned_cols=254 Identities=30% Similarity=0.536 Sum_probs=210.5
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
|++.+.||+|+||.||+|+... +|+.||+|++.... ......+.+.+|+.+++.+. |+||+++++++.+.+.+++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecC---CCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEE
Confidence 6778899999999999999876 78999999997653 22223456778999999996 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 012518 207 VMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 286 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~ 286 (461)
||||+. ++|.+++......+++..+..++.|++.||.|||++||+||||+|+||+++ +++.+||+|||++......
T Consensus 76 v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~---~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFGIP 151 (282)
T ss_pred EecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc---CCCCEEEecCCcccccCCC
Confidence 999997 589998876656799999999999999999999999999999999999995 5677999999998866543
Q ss_pred C-CccccccCCCcCchhhhh-c-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC---------------
Q 012518 287 Q-RLNDIVGSAYYVAPEVLH-R-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP--------------- 348 (461)
Q Consensus 287 ~-~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--------------- 348 (461)
. ......++..|+|||++. . .++.++|||||||++|||++|..||...+..+.+..+.....
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 152 LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 2 233455678899999875 3 688999999999999999999999988776655554433111
Q ss_pred ---CCC-------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 349 ---NFH-------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 349 ---~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.+. ...++.++.++.++|.+||..||++||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 000 01223468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=322.11 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=197.3
Q ss_pred eeeccCCceEEEEEEeccCCccCc--EEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEE
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGK--VVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVM 208 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~ 208 (461)
+.||+|+||.||+|+.+. +|. .+|+|.++.. ......+.+.+|++++.++.+||||+++++++...+.+|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~---~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcC---CCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEE
Confidence 368999999999999875 443 5788887643 233445678899999999966999999999999999999999
Q ss_pred eccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCee
Q 012518 209 EFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 273 (461)
Q Consensus 209 e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~k 273 (461)
||+.+|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++ .++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~---~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc---CCCeEE
Confidence 9999999999886532 2478899999999999999999999999999999999995 567799
Q ss_pred EeecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCC
Q 012518 274 VIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFH 351 (461)
Q Consensus 274 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 351 (461)
|+|||++..............+..|+|||++. ..++.++|||||||++|||++ |..||.+.+..+....+.... ..
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~- 230 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RL- 230 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-CC-
Confidence 99999986432111111223456799999885 568999999999999999997 999998877766666654431 11
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 352 DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 352 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.....++.++.+|+.+||..||.+|||+.+++.
T Consensus 231 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 -EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 112347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=319.67 Aligned_cols=247 Identities=22% Similarity=0.359 Sum_probs=203.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.++||+|+||.||+|... .+..||+|.+...... .+.+.+|+.++++++ |+||+++++++. .+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~----~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~ 73 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN----GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLR-HDKLVQLYAVVS-EE 73 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec----CCceeEEEEecCCCCC----HHHHHHHHHHHHhcC-CCceEEEEeEEC-CC
Confidence 3468999999999999999999765 4567999998764432 256889999999996 999999999885 45
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
..|+||||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++ +++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~ 150 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeee
Confidence 689999999999999988654 34588999999999999999999999999999999999995 56679999999998
Q ss_pred ccCCCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 282 FVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 282 ~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
....... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+.+..+....+..... . .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~ 227 (260)
T cd05070 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-M--PCPQD 227 (260)
T ss_pred eccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--CCCCc
Confidence 6543321 12234566799999875 568999999999999999999 9999988777777776654321 1 11235
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+..+.+||.+||.+||++|||++++++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 7899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=317.79 Aligned_cols=247 Identities=24% Similarity=0.421 Sum_probs=206.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|++.+.||+|+||.||++.+. .+..+|+|.+...... ...+.+|+++++++. |+||+++++++......
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~----~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL----EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPI 74 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe----CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCC-CCCeeeEEEEEccCCce
Confidence 47899999999999999999875 3668999998754332 246788999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+++|.+++....+.++++.++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc---CCCeEEECCCcceeecc
Confidence 999999999999998876666789999999999999999999999999999999999995 56679999999987654
Q ss_pred CCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 285 PDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 285 ~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
.... .....++..|+|||++. +.++.++|||||||++|||++ |..||...........+......+.. ...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 228 (256)
T cd05112 152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQ 228 (256)
T ss_pred cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCH
Confidence 3221 12233567899999886 568999999999999999998 99999888777777766543222211 23689
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
++.+|+.+||..+|++||++.+++++
T Consensus 229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 229 SVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHh
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=317.93 Aligned_cols=252 Identities=29% Similarity=0.498 Sum_probs=213.6
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|++.+.||+|+||.||+++++. +|+.+|+|.+...... ......+.+|+++++.++ |+||+++++++.+....|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---DNQFYALKEVDLGSMS-QKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---CCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEE
Confidence 58899999999999999998876 7889999998765433 334567788999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 206 IVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
+||||+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++ .++.+||+|||++..
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhh
Confidence 999999999999887552 34688999999999999999999999999999999999996 466799999999987
Q ss_pred cCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
.... ......|+..|++||.+. ..++.++|+||||+++|+|++|+.||...+.......+.... +.... ..++.+
T Consensus 153 ~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~ 228 (256)
T cd08530 153 LKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--YPPIP-PIYSQD 228 (256)
T ss_pred hccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCc-hhhCHH
Confidence 6544 333456889999999986 458889999999999999999999998877666655554432 22221 257899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
++++|.+||..+|++||++.++++||++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=319.54 Aligned_cols=247 Identities=21% Similarity=0.373 Sum_probs=204.4
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|+++++||+|+||.||+|..+ +++.||+|.+...... .+++.+|+.++++++ |+||+++++++. .+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~----~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~ 73 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN----GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQ-HPRLVRLYAVVT-QE 73 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC----CCceEEEEEecCCCCc----HHHHHHHHHHHHhcC-CcCeeeEEEEEc-cC
Confidence 4568999999999999999999865 5678999998765432 357889999999996 999999999875 45
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
..|+||||+.+++|.+++... +..+++..+..++.|++.||.|||++||+||||||+||+++ .++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~ 150 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc---CCCCEEEccCccee
Confidence 689999999999999988654 34688899999999999999999999999999999999995 56779999999987
Q ss_pred ccCCCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 282 FVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 282 ~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
....... .....++..|+|||++. ..++.++|||||||++|+|++ |+.||.+.+..+....+..... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 227 (260)
T cd05067 151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR---MPRPDN 227 (260)
T ss_pred ecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---CCCCCC
Confidence 6642221 12334567899999986 568899999999999999999 9999988777666665543321 122245
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++.++.++|.+||..||++||++++++.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 228 CPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 7889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=326.35 Aligned_cols=255 Identities=19% Similarity=0.289 Sum_probs=202.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCC-----------ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGT-----------LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIK 193 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~-----------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~ 193 (461)
++|++.+.||+|+||.||++++.... .....||||.++... .....+.+.+|+++++++. |+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence 58999999999999999999865311 123459999987542 3445567899999999996 999999
Q ss_pred EEEEEEeCCeEEEEEeccCCCchHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEE
Q 012518 194 FHDAFEDANSVYIVMEFCEGGELLDRILSRG-----------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 262 (461)
Q Consensus 194 l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NIL 262 (461)
+++++...+..|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999885432 13577888999999999999999999999999999999
Q ss_pred EecCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh--CCCCCCCCCh
Q 012518 263 FTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC--GSRPFWARTE 336 (461)
Q Consensus 263 l~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt--g~~Pf~~~~~ 336 (461)
++ .++.+||+|||++........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||...+.
T Consensus 162 l~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 162 VG---NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred Ec---CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 95 466799999999876543321 12234567899999875 568999999999999999988 7789987776
Q ss_pred hhHHHHHHhcC----CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 337 SGIFRSVLRAD----PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 337 ~~~~~~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
......+.... ........+.+++.+.+||.+||..||.+||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66555443211 10111122357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=317.65 Aligned_cols=244 Identities=20% Similarity=0.310 Sum_probs=199.7
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
++||+|+||.||+|+......++..||+|.+...... ...+.+.+|+++++.+. |+||+++++++. .+.+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEe
Confidence 4699999999999987653334578999998765433 34567889999999995 999999999876 4568999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCc-
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL- 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~- 289 (461)
+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++.........
T Consensus 77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~---~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 77 APLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc---CCCcEEeccccccceeecCCccc
Confidence 9999999988654 4789999999999999999999999999999999999995 5677999999999866443321
Q ss_pred ---cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 012518 290 ---NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364 (461)
Q Consensus 290 ---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 364 (461)
....++..|+|||.+. ..++.++|||||||++|+|++ |..||...+..+....+...... .....++..+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 229 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYS 229 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHH
Confidence 1122346799999886 568999999999999999998 99999877776666665544321 122457899999
Q ss_pred HHHHhcccCcCCCCCHHHHhc
Q 012518 365 FVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 365 li~~~L~~dP~~R~s~~e~L~ 385 (461)
+|.+||..||++||++.++++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=320.91 Aligned_cols=251 Identities=20% Similarity=0.289 Sum_probs=200.6
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-----
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA----- 201 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~----- 201 (461)
|.+++.||+|+||.||+|.+.... ....||||.++... ......+.+.+|+.+++.++ |+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~-~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD-SILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCC-CeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccC
Confidence 346789999999999999876521 12369999987543 23445678889999999996 99999999987432
Q ss_pred -CeEEEEEeccCCCchHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 202 -NSVYIVMEFCEGGELLDRILSR-----GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 202 -~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
...++||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~ 154 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVA 154 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc---CCCCEEEC
Confidence 2478999999999998877432 23478899999999999999999999999999999999994 56779999
Q ss_pred ecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCC
Q 012518 276 DFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 276 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
|||++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |+.||.......+...+......
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 233 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL- 233 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence 9999987643321 12234567899999986 568999999999999999999 89999887777766666554321
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
. ..+.++..+.++|.+||+.||++|||+.+++++
T Consensus 234 ~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 K--QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred C--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 123578999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=322.18 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=195.8
Q ss_pred cce-eeceeeccCCceEEEEEEecc-CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 125 AKF-ELGKEVGRGHFGHTCCAKGKK-GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 125 ~~y-~~~~~lG~G~fg~V~~~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
++| ++.+.||+|+||+||++..+. ...++..||+|+++... .......+.+|+++++++. ||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 455 899999999999999876432 22367899999987542 2234467889999999995 99999999988653
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 202 -NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 202 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
..+|+||||+.+|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~ 154 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD---NDRLVKIGDFGLA 154 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc---CCCcEEEeecccc
Confidence 468999999999999998854 3599999999999999999999999999999999999995 5677999999998
Q ss_pred cccCCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh--hH------------HH
Q 012518 281 DFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES--GI------------FR 341 (461)
Q Consensus 281 ~~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~------------~~ 341 (461)
........ .....++..|+|||++. +.++.++|||||||++|+|++|..||...... +. +.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 86643322 12234567799999886 56899999999999999999999998543221 00 00
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 342 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 342 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
......... .....++.++.+++.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELLERGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 011111111 111347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=323.39 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=203.1
Q ss_pred ceeeceeeccCCceEEEEEEeccC--CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKG--TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
+|++.+.||+|+||.||+|..... ......+|+|.+.... ......++.+|+.+++.+. ||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence 478889999999999999987431 1234679999886543 2334567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCc
Q 012518 204 VYIVMEFCEGGELLDRILSRG-----------------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 260 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~-----------------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~N 260 (461)
.++||||+.+|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 999999999999998875421 246788899999999999999999999999999999
Q ss_pred EEEecCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCC
Q 012518 261 FLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWART 335 (461)
Q Consensus 261 ILl~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~ 335 (461)
||++ +++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+..
T Consensus 158 ill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVA---EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEc---CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9995 567799999999876533221 12234567899999875 458999999999999999998 999998877
Q ss_pred hhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 336 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 336 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...+...+.... .. .....++.++.+||.+||+.||.+||+++++++
T Consensus 235 ~~~~~~~~~~~~-~~--~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGY-RM--ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCC-CC--CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 666665544321 11 122457899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=330.87 Aligned_cols=259 Identities=32% Similarity=0.540 Sum_probs=207.5
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-C
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED-A 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~-~ 201 (461)
+.++|++.+.||.|+||.||+|.++. +|+.||||++.+... .....+.+.+|+.+++.+. ||||++++++|.. .
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 82 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQL---TGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLR-HENIISLSDIFISPL 82 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECC---CCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCC
Confidence 56789999999999999999999876 789999999865432 2223466778999999996 9999999999875 5
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+..|+||||+ +++|.+.+.. ..+++..+..++.||+.||.|||++||+||||+|.|||++ .++.+||+|||++.
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~---~~~~~~l~dfg~~~ 156 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN---ENCDLKICDFGLAR 156 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC---CCCCEEeCcccccc
Confidence 6789999999 5688776642 4588889999999999999999999999999999999994 56779999999987
Q ss_pred ccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC------------
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD------------ 347 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------ 347 (461)
.... ......++..|+|||++.+ .++.++|||||||++|+|++|+.||...........+.+..
T Consensus 157 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 157 IQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5432 2344578899999998753 58999999999999999999999997665432222111100
Q ss_pred -----------C---CCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 348 -----------P---NFH-DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 348 -----------~---~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
. ..+ ....+.+++++.++|.+||+.+|++||++.+++.||||.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 0 000 0112457899999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=330.98 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=206.7
Q ss_pred ccceeeceeeccCCceEEEEEEeccC----CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKG----TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
..+|++++.||+|+||.||+|++... ...+..||+|+++.. ......+.+.+|+++++++.+|+||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 35799999999999999999986421 112347999988643 233445778899999999966999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEe
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 264 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~ 264 (461)
+.+.+|+||||+.+|+|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 9999999999999999999886532 2366788889999999999999999999999999999995
Q ss_pred cCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhH
Q 012518 265 TREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 339 (461)
Q Consensus 265 ~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~ 339 (461)
.++.+||+|||+++....... .....++..|+|||++. ..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 169 ---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 169 ---EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred ---CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 567799999999876543221 12233456799999886 568999999999999999998 8999988877777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 340 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 340 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
...+...... . ....++.++.+||.+||+.+|.+||++.|++++
T Consensus 246 ~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 246 FKLLKEGHRM-D--KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHcCCCC-C--CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7666543221 1 123578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=323.87 Aligned_cols=256 Identities=16% Similarity=0.273 Sum_probs=202.0
Q ss_pred ccceeeceeeccCCceEEEEEEecc-------------CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK-------------GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~-------------~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn 190 (461)
.++|++.+.||+|+||.||++.+.. ...++..||+|++.... .......+.+|+++++.++ |+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence 3579999999999999999986542 11134579999987542 3344567889999999996 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCc
Q 012518 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG----------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 260 (461)
Q Consensus 191 iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~N 260 (461)
|+++++++.+.+..|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999886532 236677899999999999999999999999999999
Q ss_pred EEEecCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh--CCCCCCCC
Q 012518 261 FLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC--GSRPFWAR 334 (461)
Q Consensus 261 ILl~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt--g~~Pf~~~ 334 (461)
||++ .++.+||+|||++........ .....++..|+|||+.. +.++.++|||||||++|||++ |..||...
T Consensus 161 ili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLVG---KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEEc---CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9995 567799999999886543321 12234467899999764 679999999999999999998 78999776
Q ss_pred ChhhHHHHHHh---cC-CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 335 TESGIFRSVLR---AD-PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 335 ~~~~~~~~i~~---~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+..+.+..... .. ..........+++.+.+||.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66555443321 10 00111112347799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=314.27 Aligned_cols=242 Identities=22% Similarity=0.306 Sum_probs=200.0
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||.||++... ++..||+|++.... .......+.+|+++++.+. |+||+++++++...+..++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~----~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec----CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEEC
Confidence 36999999999999753 57789999986542 2334456889999999995 99999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCc-
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL- 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~- 289 (461)
+.+++|.+++......+.+..+..++.|++.||.|||++|++||||||+||+++ .++.+||+|||++.........
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc---CCCeEEECCCccceecccccccc
Confidence 999999998876666788999999999999999999999999999999999995 5677999999998754332211
Q ss_pred -cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 012518 290 -NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFV 366 (461)
Q Consensus 290 -~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 366 (461)
....++..|+|||++. +.++.++|||||||++|+|++ |..||...........+.... .......++..+.+++
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li 227 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY---RMSCPQKCPDDVYKVM 227 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHHHHHHH
Confidence 1223456799999986 568899999999999999998 999998777666655554332 1122245889999999
Q ss_pred HHhcccCcCCCCCHHHHhc
Q 012518 367 RRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 367 ~~~L~~dP~~R~s~~e~L~ 385 (461)
.+||..+|++||++.|+++
T Consensus 228 ~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 228 QRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHcccCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=321.28 Aligned_cols=253 Identities=26% Similarity=0.488 Sum_probs=205.6
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC--CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT--SALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
+|.+.+.||+|+||.||++++.. .+..+++|+++..... .......+.+|+.+++.++ ||||+++++++.+...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK---AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC---CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCc
Confidence 58899999999999999998875 4455666665432211 1122345668999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 204 VYIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.++||||+.+++|.+.+.. ....+++..++.++.|++.||.|||++||+|+||||+||+++ ++.+||+|||++
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~ 152 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVS 152 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCce
Confidence 9999999999999887753 345689999999999999999999999999999999999995 345999999998
Q ss_pred cccCCCCC-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 281 DFVRPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 281 ~~~~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
........ .....|+..|+|||.+. ..++.++|+||||+++|+|++|..||...........+....... ....+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 229 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS---LPETY 229 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC---Ccchh
Confidence 76643322 23456889999999876 458889999999999999999999998776666555554432111 11357
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
+.++.++|.+||..||++||++.|+++||||
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred cHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 8999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=316.96 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=202.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ..+.+.+|+++++.+. |+||+++++++. .+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNG----TTKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPLYAVVS-EEP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcC----CceEEEEEcccCCc----cHHHHHHHHHHHHhCC-CCCeeeEEEEEc-CCC
Confidence 3579999999999999999998753 34699998865432 2356788999999996 999999999885 456
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++ +++.+||+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~---~~~~~~l~dfg~~~~ 151 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCeEEECCCccceE
Confidence 899999999999999886543 3478899999999999999999999999999999999994 567799999999976
Q ss_pred cCCCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 283 VRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 283 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
...... .....++..|+|||++. +.++.++|||||||++|+|++ |..||.+....+....+.... . ......+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~ 228 (260)
T cd05069 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-R--MPCPQGC 228 (260)
T ss_pred ccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C--CCCCccc
Confidence 543321 12234667899999876 568999999999999999999 999998887777776665432 1 1222457
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+..+.++|.+||.+||++||+++++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=316.15 Aligned_cols=243 Identities=25% Similarity=0.403 Sum_probs=204.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||.|+||.||+|.. .|+.||||.+..... ..+++.+|+.+++.+. |+||+++++++.+.+..
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 75 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-----RGQKVAVKCLKDDST----AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPL 75 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-----cCcEEEEEEeccchh----HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCe
Confidence 5789999999999999999976 468899999875432 4567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
|+||||+.+++|.+++..... .+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~---~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKEA 152 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe---CCCCEEEccccccccc
Confidence 999999999999998866542 689999999999999999999999999999999999995 5677999999999876
Q ss_pred CCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
.... ....++..|+|||++. +.++.++|||||||++|+|++ |..||...+.......+.... .. .....++++
T Consensus 153 ~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~ 227 (256)
T cd05039 153 SQGQ--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-RM--EAPEGCPPE 227 (256)
T ss_pred cccc--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CC--CCccCCCHH
Confidence 3322 2334566799999876 568899999999999999997 999998877766665554331 11 112357899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhc
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+.++|.+||..+|++||++.|+++
T Consensus 228 ~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 228 VYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=319.76 Aligned_cols=251 Identities=20% Similarity=0.288 Sum_probs=206.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCC-ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGT-LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.+|++.+.||+|+||+||+|.++... .....||+|.+.... .......+.+|+.+++.+. |+||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVD-HPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-Cc
Confidence 58999999999999999999876421 122369999887653 2345567889999999996 9999999999987 78
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
.++||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK---TPQHVKITDFGLAKLL 159 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc---CCCeEEECCCcccccc
Confidence 9999999999999999877666799999999999999999999999999999999999995 5667999999999876
Q ss_pred CCCCCcc---ccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 284 RPDQRLN---DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 284 ~~~~~~~---~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
....... ...++..|+|||.+. +.++.++|||||||++||+++ |..||......++...+..... .... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~ 236 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LPQP--PIC 236 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-CCCC--CCC
Confidence 5332211 122356799999876 568999999999999999998 9999988877776666654322 2211 246
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+.++.+++.+||..||.+||++.++++
T Consensus 237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 237 TIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=329.47 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=197.5
Q ss_pred eceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEE
Q 012518 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVM 208 (461)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~ 208 (461)
+++.+|.| |.||+++.+. +|+.||||++..... .....+.+.+|+++++.++ |+||++++++|.+.+..|++|
T Consensus 6 i~~~~~~~--~~v~~~~~~~---~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 78 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKP---TNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVS 78 (314)
T ss_pred hhHhhcCC--ceEEEEEecC---CCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEE
Confidence 34444444 5566666554 789999999976532 3345678999999999996 999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 012518 209 EFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ 287 (461)
Q Consensus 209 e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~ 287 (461)
||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||.+.......
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 79 PLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred eccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeecccc
Confidence 999999999988654 34688999999999999999999999999999999999995 46779999999886543221
Q ss_pred --------CccccccCCCcCchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC-------
Q 012518 288 --------RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN------- 349 (461)
Q Consensus 288 --------~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~------- 349 (461)
......++..|+|||++.. .++.++|||||||++|+|++|..||..................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCc
Confidence 1233457788999999853 4889999999999999999999999765543332221111000
Q ss_pred CC-----------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 350 FH-----------------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 350 ~~-----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.. ......++.++.+||.+||..||++|||+.++|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00 00001245789999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=316.96 Aligned_cols=242 Identities=24% Similarity=0.389 Sum_probs=201.1
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-EeCCe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF-EDANS 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~-~~~~~ 203 (461)
.+|++.+.||+|+||.||++.. .|..||+|.++... ..+.+.+|+.+++++. |+||+++++++ .+++.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGG 74 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-----cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCc
Confidence 4799999999999999999865 46789999986432 2356889999999996 99999999976 45567
Q ss_pred EEEEEeccCCCchHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.|+||||+.+++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++ +++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~ 151 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKE 151 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc---CCCcEEecCCcccee
Confidence 9999999999999998876543 478899999999999999999999999999999999995 567799999999876
Q ss_pred cCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
..... ....++..|+|||++. ..++.++|||||||++|+|++ |+.||...........+..... ....+.+++
T Consensus 152 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 226 (256)
T cd05082 152 ASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPP 226 (256)
T ss_pred ccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCH
Confidence 54322 2334567899999886 458999999999999999997 9999987777666666654321 122246889
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+.++|.+||+.||++|||+.++++
T Consensus 227 ~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 227 VVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=321.86 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=206.8
Q ss_pred ccceeeceeeccCCceEEEEEEeccC--CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKG--TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|++.+.||+|+||.||+|.+... ..++..||+|++.... .......+.+|+.+++++. |+||+++++++.++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-HPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC
Confidence 35799999999999999999987421 1256789999987542 3344567889999999995 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG---------------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 260 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~---------------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~N 260 (461)
+..|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999886432 136778889999999999999999999999999999
Q ss_pred EEEecCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCC
Q 012518 261 FLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWART 335 (461)
Q Consensus 261 ILl~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~ 335 (461)
||++ .++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+..
T Consensus 161 il~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLVG---ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEec---CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9994 567799999999876533211 12234566799999876 568999999999999999997 889998887
Q ss_pred hhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 336 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 336 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
..+....+....... . ...++.++.+||.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~-~--~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVLS-C--PDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCCC-C--CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 777777665543221 1 1357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=315.93 Aligned_cols=248 Identities=24% Similarity=0.385 Sum_probs=206.8
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||.||+|.++ .++.||||.+..... ..+++.+|+.+++++. |+||+++++++.+..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~----~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 74 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN----GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEE 74 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc----CCceEEEEEecCCcc----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCC
Confidence 3468999999999999999999865 356799999875433 2356889999999996 999999999999989
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
..++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++.
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~---~~~~~~l~d~g~~~ 151 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLAR 151 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc---CCCCEEECccccce
Confidence 9999999999999999886643 4689999999999999999999999999999999999995 56779999999987
Q ss_pred ccCCCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 282 FVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 282 ~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
....... .....++..|+|||.+. +.++.++|||||||++|+|++ |+.||.+.+....+..+..... ......
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR---MPRPPN 228 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCC
Confidence 6643211 11223456899999886 458999999999999999998 9999988877777777654321 111234
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+.++.+++.+||..||++||+++++++
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 229 CPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=322.38 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=200.2
Q ss_pred ceeeceeeccCCceEEEEEEec-cCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--C
Q 012518 126 KFELGKEVGRGHFGHTCCAKGK-KGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA--N 202 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~-~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~--~ 202 (461)
-|++++.||+|+||.||+++.. .+..+++.||+|.++... .......+.+|+++++.+. |+||+++++++.+. .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCC
Confidence 4789999999999999999753 223478899999986542 3344567899999999996 99999999999875 5
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
..++||||++|++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECCCccccc
Confidence 68999999999999998866555689999999999999999999999999999999999995 567799999999986
Q ss_pred cCCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh--------------hhHHHHH
Q 012518 283 VRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE--------------SGIFRSV 343 (461)
Q Consensus 283 ~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------------~~~~~~i 343 (461)
...... .....++..|+|||++. +.++.++|||||||++|+|+++..|+..... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 644322 12345677899999875 5689999999999999999998776532211 0001111
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 344 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 344 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
..... ....+..++..+.+||.+||+.||.+||++.+++++
T Consensus 239 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 239 LEEGK--RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHcCc--cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 11111 112235689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=316.27 Aligned_cols=246 Identities=20% Similarity=0.283 Sum_probs=196.2
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE-eCCeEEEEEe
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE-DANSVYIVME 209 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~-~~~~~~lv~e 209 (461)
+.||+|+||.||+|.+......+..||||.+... ......+.+.+|+.+++.++ ||||+++++++. .++..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence 4689999999999987643335568999987543 23344677889999999995 999999999775 4566899999
Q ss_pred ccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCC--
Q 012518 210 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-- 287 (461)
Q Consensus 210 ~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~-- 287 (461)
|+.+|+|.+++........+..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~---~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD---ESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCccccccccCCcce
Confidence 9999999998876655677888889999999999999999999999999999995 56779999999987653321
Q ss_pred ---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 288 ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 288 ---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
......++..|+|||++. ..++.++|||||||++|||++ |..||......+....+........ ...+++.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHH
Confidence 112334677899999875 568999999999999999999 4666766666555555544322111 12468899
Q ss_pred HHHHHHhcccCcCCCCCHHHHhc
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+++.+||..+|++||++.|+++
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=317.73 Aligned_cols=247 Identities=20% Similarity=0.317 Sum_probs=194.7
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
++||+|+||.||+|....+ .....+|+|.+.... .......+.+|+.+++.+. |+||+++++++.+.+.+|+||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRASA--TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecC-CCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEe
Confidence 3699999999999976543 255678999876432 3334567889999999995 99999999999999999999999
Q ss_pred cCCCchHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 012518 211 CEGGELLDRILSRGG----RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 286 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~----~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~ 286 (461)
+.+|+|.+++..... ...+..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT---ADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec---CCCcEEEeccccccccccc
Confidence 999999998865432 245778889999999999999999999999999999995 5677999999998654322
Q ss_pred CC---ccccccCCCcCchhhhhc--------cCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcC-CCCCCC
Q 012518 287 QR---LNDIVGSAYYVAPEVLHR--------SYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRAD-PNFHDS 353 (461)
Q Consensus 287 ~~---~~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~ 353 (461)
.. .....++..|+|||++.. .++.++|||||||++|||++ |..||......+.+..+.... ......
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 11 123345678999998742 36789999999999999999 788987777666655554432 222222
Q ss_pred C-CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 354 P-WPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 354 ~-~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
. ...+++.+.+++..|+ .||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 2 1357889999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=317.97 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=205.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|.+.+.||+|+||.||+|.+.........||||.+.... .....+.+.+|+.+++.+. |+||+++++++.+ +..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CCc
Confidence 46889999999999999999876432234579999886542 2345567889999999996 9999999999875 457
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+|+|.+++......+++..+..++.||+.||.|||++|++||||||+|||++ .++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeecc
Confidence 899999999999999876555689999999999999999999999999999999999995 46679999999988664
Q ss_pred CCCCc--cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 285 PDQRL--NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 285 ~~~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
..... ....++..|+|||++. ..++.++|||||||++|+|++ |..||......+....+...... .....++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~ 235 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCPP 235 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCCH
Confidence 43221 1223456799999886 568999999999999999986 99999888777666665544322 22346889
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++.++|.+||..+|.+|||+.+++.
T Consensus 236 ~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 236 TLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=321.41 Aligned_cols=244 Identities=17% Similarity=0.247 Sum_probs=193.8
Q ss_pred eeeccCCceEEEEEEeccCC----ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 131 KEVGRGHFGHTCCAKGKKGT----LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
+.||+|+||.||+|..+... .....||+|.+... .....+.+.+|+.+++.+. ||||+++++++......++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence 46999999999999875421 23445888887543 2234467888999999996 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCC-----CCeeEeeccccc
Q 012518 207 VMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED-----APLKVIDFGLSD 281 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~-----~~~kl~DFG~a~ 281 (461)
||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.. ..+|++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999887666678999999999999999999999999999999999999753221 237999999987
Q ss_pred ccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCC-CCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGS-RPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
.... .....++..|+|||++.+ .++.++|||||||++|+|++|. .||........ ..+......++. ..
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~----~~ 228 (258)
T cd05078 157 TVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPA----PK 228 (258)
T ss_pred ccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCC----CC
Confidence 5532 233568889999999864 4899999999999999999985 56554444332 223333333332 35
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+.++.+||.+||+.||++|||++++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 6889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=311.47 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=214.4
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+.+-+..||.|+||+|++..++. +|+..|||.|+.... .....+++.|.+...+-.+.||||++||+...++..|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~---sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKP---SGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCc---cCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 45557789999999999999887 899999999987643 4556788899998888778999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 206 IVMEFCEGGELLDRILS-----RGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
|+||+|+- +| |.+.+ +..+++|.-+..|..-.+.||+||-.. .||||||||+|||+ +..+.|||||||+
T Consensus 140 iCMELMd~-Sl-DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGI 214 (361)
T KOG1006|consen 140 ICMELMDI-SL-DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGI 214 (361)
T ss_pred eeHHHHhh-hH-HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccc
Confidence 99999953 54 33322 245788988889999999999999876 89999999999999 5677899999999
Q ss_pred ccccCCCCCccccccCCCcCchhhhh---ccCCCchhHHHHHHHHHHHhhCCCCCCCCC-hhhHHHHHHhcCCCCCCCCC
Q 012518 280 SDFVRPDQRLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWART-ESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 280 a~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~ 355 (461)
+..+..+-..+.-.|...|||||.+. ..|+.++||||||++|||+.||..||.+-+ -.+++..+..+++..-....
T Consensus 215 cGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~ 294 (361)
T KOG1006|consen 215 CGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDK 294 (361)
T ss_pred hHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcc
Confidence 98877665556678999999999985 349999999999999999999999997644 34555666666554333222
Q ss_pred --CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 356 --PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 356 --~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
-.++..++.||.-||.+|-+.||...+++++||+...
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 2479999999999999999999999999999999765
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=316.30 Aligned_cols=247 Identities=21% Similarity=0.310 Sum_probs=193.9
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||.||+|....+ .++..+|+|.++.... ......+.+|+.+++.++ ||||+++++++.+...+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG-YTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCC-CCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEEC
Confidence 3699999999999987542 3567899998865432 233456888999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 012518 211 CEGGELLDRILSRG----GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 286 (461)
Q Consensus 211 ~~gg~L~~~l~~~~----~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~ 286 (461)
+++|+|.+++.... ...++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEECCccccccccCc
Confidence 99999999886532 2356677889999999999999999999999999999995 5677999999998754332
Q ss_pred CC---ccccccCCCcCchhhhhc--------cCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHh-cCCCCCCC
Q 012518 287 QR---LNDIVGSAYYVAPEVLHR--------SYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLR-ADPNFHDS 353 (461)
Q Consensus 287 ~~---~~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~-~~~~~~~~ 353 (461)
.. .....|+..|+|||++.+ .++.++|||||||++|||++ |..||......+....... ....+...
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 21 123457888999998853 25789999999999999996 9999977665554433222 22222222
Q ss_pred CC-CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 354 PW-PSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 354 ~~-~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.. ...++.+.+++.+|+ .+|++|||++|++.
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 11 246789999999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=321.71 Aligned_cols=270 Identities=28% Similarity=0.503 Sum_probs=210.6
Q ss_pred ccCCCCccc-cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC------
Q 012518 116 NFGYGKNFG-AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH------ 188 (461)
Q Consensus 116 ~~~~~~~~~-~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h------ 188 (461)
....|+.|. .+|.+.++||+|.|++||++.+.. ..+.||+|+++... ...+....||++|++++.+
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq---~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~ 140 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQ---NKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPG 140 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeecc---CCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCC
Confidence 344578887 899999999999999999999987 77899999997543 3446667899999998733
Q ss_pred -CCeeEEEEEEEe----CCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcE
Q 012518 189 -KHMIKFHDAFED----ANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENF 261 (461)
Q Consensus 189 -pniv~l~~~~~~----~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NI 261 (461)
.+||+|++.|.. +.++|||+|++ |.+|+.+|...+ ..++...++.|++|||.||.|||.. ||||-||||+||
T Consensus 141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENv 219 (590)
T KOG1290|consen 141 KKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENV 219 (590)
T ss_pred CceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCccee
Confidence 369999999974 45899999999 779999887654 4588999999999999999999986 999999999999
Q ss_pred EEecCC--------------------------------------------------------------------------
Q 012518 262 LFTTRE-------------------------------------------------------------------------- 267 (461)
Q Consensus 262 Ll~~~~-------------------------------------------------------------------------- 267 (461)
|+...+
T Consensus 220 Ll~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~ 299 (590)
T KOG1290|consen 220 LLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPN 299 (590)
T ss_pred eeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccc
Confidence 995310
Q ss_pred -------------------------------------C------------------------------------------
Q 012518 268 -------------------------------------E------------------------------------------ 268 (461)
Q Consensus 268 -------------------------------------~------------------------------------------ 268 (461)
.
T Consensus 300 ~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~ 379 (590)
T KOG1290|consen 300 QESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPL 379 (590)
T ss_pred ccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccc
Confidence 0
Q ss_pred ----------CCCeeEeecccccccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC--
Q 012518 269 ----------DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART-- 335 (461)
Q Consensus 269 ----------~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~-- 335 (461)
+..|||+|||.|.++. ..++.-+.|..|+||||+-+ .|++.+||||++|++|||+||...|....
T Consensus 380 v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~ 457 (590)
T KOG1290|consen 380 VNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGE 457 (590)
T ss_pred cCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCC
Confidence 0136788888877653 34566678999999999865 69999999999999999999999995321
Q ss_pred ----hhhHHHHHHhcCCCCC-------------------------CCCCC---------CC----CHHHHHHHHHhcccC
Q 012518 336 ----ESGIFRSVLRADPNFH-------------------------DSPWP---------SV----SPEAKDFVRRLLNKD 373 (461)
Q Consensus 336 ----~~~~~~~i~~~~~~~~-------------------------~~~~~---------~~----s~~~~~li~~~L~~d 373 (461)
+.+.+..|+.....++ ..+|+ .+ ..++.+||.-||+.+
T Consensus 458 ~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~ 537 (590)
T KOG1290|consen 458 NYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFD 537 (590)
T ss_pred CCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcC
Confidence 2222333322111111 11232 12 367789999999999
Q ss_pred cCCCCCHHHHhcCCCcCCCCCC
Q 012518 374 HRKRMTAAQALTHPWLHDENRP 395 (461)
Q Consensus 374 P~~R~s~~e~L~hp~~~~~~~~ 395 (461)
|++|+||.++|+|||+.....+
T Consensus 538 PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 538 PEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred ccccccHHHHhcCccccCCCCC
Confidence 9999999999999999876543
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=317.71 Aligned_cols=254 Identities=20% Similarity=0.350 Sum_probs=208.9
Q ss_pred cceeeceeeccCCceEEEEEEeccCC--ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
++|++.+.||+|+||.||+|+.+... ...+.||+|.+.... .....+.+.+|++++++++ |+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence 57899999999999999999976422 245789999886532 2334567889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeE
Q 012518 203 SVYIVMEFCEGGELLDRILSRGG--------RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~--------~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
..|+||||+++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS---SQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---CCCcEEE
Confidence 99999999999999998865431 588999999999999999999999999999999999995 4667999
Q ss_pred eecccccccCCC--CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCC
Q 012518 275 IDFGLSDFVRPD--QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 275 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
+|||++...... .......++..|+|||.+. +.++.++|||||||++|+|++ |..||........+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 999998754322 1233446678899999875 568899999999999999998 889998777666666665443332
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
.. ...++..+.++|.+||..||.+||++.|++++
T Consensus 239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 22 23578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=301.79 Aligned_cols=254 Identities=29% Similarity=0.605 Sum_probs=210.5
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
..++|++.+++|+|.|+.||.|.+.. +++.++||+++.- ..+.+.||+.||+.|++||||+++++...+.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~---~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINIT---NNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccC---CCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 34689999999999999999998765 6788999998653 2467899999999999999999999998765
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 202 -NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 202 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
....||+||+++.+..... ..++.-.++.++.+++.||.|||++||+|||+||.|++|+. ....++|+|+|+|
T Consensus 107 SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh--~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH--ELRKLRLIDWGLA 180 (338)
T ss_pred ccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech--hhceeeeeecchH
Confidence 4578999999887765433 35888999999999999999999999999999999999974 4567999999999
Q ss_pred cccCCCCCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCC-CCChhhHHHHHHh------------
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFW-ARTESGIFRSVLR------------ 345 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~-~~~~~~~~~~i~~------------ 345 (461)
.+..++...+-.+.+.+|--||.+- +.|+..-|+|||||+|..|+..+.||. +.+..+++-.|.+
T Consensus 181 EFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 181 EFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred hhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 9999888888888999999999874 679999999999999999999999984 3444333333221
Q ss_pred -----cCCCC-------CCCCCC---------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 346 -----ADPNF-------HDSPWP---------SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 346 -----~~~~~-------~~~~~~---------~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
.++.+ ....|. -.++++.|||.++|..|-.+|+||.|++.||||..
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 11111 122232 14799999999999999999999999999999953
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=313.23 Aligned_cols=250 Identities=25% Similarity=0.400 Sum_probs=207.6
Q ss_pred eeeceeeccCCceEEEEEEeccCC-ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGT-LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+++.+.||.|+||.||++++.... ..+..||+|++.... .....+.+.+|+.+++.+ +|+||+++++++.+.+..|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeE
Confidence 356789999999999999987521 124889999986543 222457888999999999 5999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 206 IVMEFCEGGELLDRILSRGGR-YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~-~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
+||||+.+++|.+++...... +++..+..++.||+.||.|||++|++|+||||+||+++ .++.+||+|||++....
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~---~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc---cCCeEEEcccCCceecc
Confidence 999999999999988765444 89999999999999999999999999999999999995 56679999999998765
Q ss_pred CCCCcc--ccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 285 PDQRLN--DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 285 ~~~~~~--~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
...... ...++..|+|||.+. ..++.++|||||||++|+|++ |..||...+.....+.+........ ...++.
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 231 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPP 231 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCH
Confidence 442222 133678999999885 568999999999999999998 8899988777777777665433221 134789
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++.+++.+||..||++|||+.|+++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=312.71 Aligned_cols=247 Identities=24% Similarity=0.406 Sum_probs=203.5
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||.||++... .+..+|+|.+.... ...+.+.+|+++++.+. |+||+++++.+.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~----~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~ 73 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-E 73 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec----CCccEEEEecCCCh----hHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-C
Confidence 4568999999999999999999764 35569999886532 23467889999999996 9999999999987 7
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
..|+||||+.+++|.+++... ...++...+..++.||+.||.|||++|++||||||+||+++ .++.+||+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~ 150 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLAR 150 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCCccee
Confidence 789999999999999988664 34578888999999999999999999999999999999995 56789999999987
Q ss_pred ccCCCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 282 FVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 282 ~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
....... .....++..|+|||++. +.++.++|||||||++|+|++ |..||...+.......+..... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 227 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---MPRPEN 227 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---CCCccc
Confidence 6543221 12234567799999986 468899999999999999998 9999988777666665554321 122346
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++.++.+++.+||+.||++||++.++++
T Consensus 228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 228 CPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 8899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=325.26 Aligned_cols=255 Identities=20% Similarity=0.318 Sum_probs=209.4
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
+...+...+.++||+|-||.|.++... .+..||||.++... ......+|.+||++|.+|+ ||||++++++|..
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeve----g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~ 606 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVE----GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLK-HPNIVELLGVCVQ 606 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEec----CceEEEEeecCccc--chhHHHHHHHHHHHHhccC-CCCeeEEEeeeec
Confidence 344567889999999999999999764 35889999998764 3345788999999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRY-LEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~-~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
++.+++|+||+++|+|..++..+.... .......|+.||+.||.||.+.++|||||.++|+|+ +.++++||+|||+
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgm 683 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGM 683 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCccc
Confidence 999999999999999999997764333 334556799999999999999999999999999999 5788999999999
Q ss_pred ccccCCCCCc---cccccCCCcCchhhh-hccCCCchhHHHHHHHHHHHh--hCCCCCCCCChhhHHHHHHhcCCCCCC-
Q 012518 280 SDFVRPDQRL---NDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILL--CGSRPFWARTESGIFRSVLRADPNFHD- 352 (461)
Q Consensus 280 a~~~~~~~~~---~~~~gt~~y~aPE~l-~~~~~~~~DiwSlGvil~ell--tg~~Pf~~~~~~~~~~~i~~~~~~~~~- 352 (461)
++.+..+... ...+-...|||+|.+ .+.++.++|||+|||+|||++ +...||...++.+..++..........
T Consensus 684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc
Confidence 9976544332 223456789999965 689999999999999999975 589999888887777765433222111
Q ss_pred ---CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 353 ---SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 353 ---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...+-++..+.+||.+|+..|-.+||+++++-.
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 112357899999999999999999999998743
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=318.10 Aligned_cols=243 Identities=18% Similarity=0.234 Sum_probs=192.8
Q ss_pred eeccCCceEEEEEEeccC---------------------CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCC
Q 012518 132 EVGRGHFGHTCCAKGKKG---------------------TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190 (461)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~---------------------~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn 190 (461)
.||+|+||.||++..... ......||+|++.... ......+.+|+.+++.++ |+|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence 699999999999975321 1122458999886432 223456788999999996 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC---
Q 012518 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE--- 267 (461)
Q Consensus 191 iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~--- 267 (461)
|+++++++.+....|+||||+++|+|..++....+.+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888866667889999999999999999999999999999999999997422
Q ss_pred -CCCCeeEeecccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHH-hhCCCCCCCCChhhHHHHH
Q 012518 268 -EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYIL-LCGSRPFWARTESGIFRSV 343 (461)
Q Consensus 268 -~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~el-ltg~~Pf~~~~~~~~~~~i 343 (461)
....+||+|||++...... ....++..|+|||++.+ .++.++|||||||++||| ++|..||.......... +
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-F 233 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-H
Confidence 1234899999987644221 23457888999998853 589999999999999998 47999998766544433 2
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 344 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 344 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
......++. ..++++.++|.+||+.+|.+|||+.++|++
T Consensus 234 ~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 234 YEKKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHhccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 222222222 256789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=315.33 Aligned_cols=244 Identities=17% Similarity=0.213 Sum_probs=191.8
Q ss_pred eeeccCCceEEEEEEeccCC---------ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 131 KEVGRGHFGHTCCAKGKKGT---------LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~---------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
+.||+|+||+||+++..... .....||+|++.... ......+.+|+.+++.+. ||||+++++++.+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVS-HKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 46899999999999853211 123468889876532 233456788999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC----CCCeeEeec
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE----DAPLKVIDF 277 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~----~~~~kl~DF 277 (461)
...++||||+.+|+|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+|++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999998877666667899999999999999999999999999999999999964221 123899999
Q ss_pred ccccccCCCCCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHh-hCCCCCCCCChhhHHHHHHhcCCCCCCCC
Q 012518 278 GLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILL-CGSRPFWARTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 278 G~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~ell-tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 354 (461)
|++..... .....++..|+|||++. +.++.++|||||||++|||+ +|..||......+... +.......
T Consensus 157 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~---- 228 (262)
T cd05077 157 GIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCML---- 228 (262)
T ss_pred CCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccC----
Confidence 99875432 23356788999999885 45899999999999999997 5888887655433322 22222111
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
....++++.+||.+||+.||.+||++.+++++
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 12356889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=327.39 Aligned_cols=265 Identities=31% Similarity=0.496 Sum_probs=216.9
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCC----HHHHHHHHHHHHHHHhcCCCCCeeEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS----ALAIEDVRREVKILKALSGHKHMIKFH 195 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~~Ei~il~~l~~hpniv~l~ 195 (461)
-..+.++|-++..||+|||+.||+|.+.. ..+.||||+-..++-.. ++..+...+|.+|.+.| +||.||++|
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~---EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlY 533 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLT---EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLY 533 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccc---hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeee
Confidence 34566789999999999999999999875 77899999865443222 23345567899999999 599999999
Q ss_pred EEEE-eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCcEEEecCCCCCCe
Q 012518 196 DAFE-DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENFLFTTREEDAPL 272 (461)
Q Consensus 196 ~~~~-~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~g--ivHrDlkp~NILl~~~~~~~~~ 272 (461)
++|. +.+.+|-|+|||+|.+|. +.+++...++|.+++.|+.||+.||.||.+.. |||-||||.|||+.+....+.+
T Consensus 534 DyfslDtdsFCTVLEYceGNDLD-FYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLD-FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred eeeeeccccceeeeeecCCCchh-HHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccccee
Confidence 9996 667899999999998885 45566678999999999999999999999884 9999999999999887778889
Q ss_pred eEeecccccccCCCCC--------ccccccCCCcCchhhhh-c----cCCCchhHHHHHHHHHHHhhCCCCCCCC-Chhh
Q 012518 273 KVIDFGLSDFVRPDQR--------LNDIVGSAYYVAPEVLH-R----SYNVEGDMWSIGVITYILLCGSRPFWAR-TESG 338 (461)
Q Consensus 273 kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~-~----~~~~~~DiwSlGvil~elltg~~Pf~~~-~~~~ 338 (461)
||+|||+++.+.++.. .....||.||++||.+- + ..+.++||||+|||+|.++.|+.||..+ +..+
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 9999999998865432 12367999999999763 2 3789999999999999999999999554 3334
Q ss_pred HHHH--HHhc-CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 339 IFRS--VLRA-DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 339 ~~~~--i~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
+++. |++. ...|+. -|.++.++++||++||.+.-+.|....++..||||..
T Consensus 693 ILqeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 693 ILQENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred HHhhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 4432 2322 223333 3579999999999999999999999999999999964
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=310.72 Aligned_cols=242 Identities=22% Similarity=0.307 Sum_probs=200.0
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
++||+|+||.||++.+. .|+.||+|.+...... .....+.+|+++++++. |+||+++++++.+.+..|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~----~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK----GNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEe----CCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEc
Confidence 46999999999999875 3788999998765332 34567889999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCc-
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL- 289 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~- 289 (461)
+.+++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++.........
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~~~~~~~~ 150 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSREEEGGIYTV 150 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc---CCCcEEEeeccccccccCCccee
Confidence 999999999876666788999999999999999999999999999999999994 5677999999998765422111
Q ss_pred --cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 012518 290 --NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 365 (461)
Q Consensus 290 --~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 365 (461)
....++..|+|||++. +.++.++|||||||++|+|++ |..||...........+.... ... ....++.++.++
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~l 227 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMP--APQLCPEEIYRL 227 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCC--CCccCCHHHHHH
Confidence 1123356799999876 568999999999999999999 899997777665555554321 111 123578999999
Q ss_pred HHHhcccCcCCCCCHHHHhc
Q 012518 366 VRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 366 i~~~L~~dP~~R~s~~e~L~ 385 (461)
|.+||..+|++||++.|+++
T Consensus 228 i~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 228 MLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 99999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=315.68 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=197.8
Q ss_pred cceeeceeeccCCceEEEEEEecc-CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--C
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKK-GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED--A 201 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~--~ 201 (461)
.+|++.+.||+|+||.||++..+. +..+++.||||.+... .....+.+.+|+++++++. |+||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence 479999999999999999997531 2236889999998654 2344567889999999996 9999999998753 4
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
..+++||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE---SENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC---CCCeEEECCCcccc
Confidence 568999999999999999876656789999999999999999999999999999999999994 56779999999998
Q ss_pred ccCCCCCc----cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhh---------------HHH
Q 012518 282 FVRPDQRL----NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG---------------IFR 341 (461)
Q Consensus 282 ~~~~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---------------~~~ 341 (461)
........ ....++..|+|||++. ..++.++|||||||++|||++|..++....... .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 76433221 1122345699999886 468999999999999999999877754322110 011
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 342 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 342 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.++.....+. ....++.++.+||.+||..+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1122211111 12457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=313.30 Aligned_cols=254 Identities=26% Similarity=0.477 Sum_probs=208.7
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccc-------cCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAK-------MTSALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~-------~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
.|++.+.||+|+||.||++.++.+ .++.+|+|.+.... ........++.+|+.++.+..+|+||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE
Confidence 378899999999999999998652 46889999886432 123344566778999887644699999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecCCCCCCeeE
Q 012518 199 EDANSVYIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 199 ~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
.+++..++||||+.|++|.+.+.. ....+++..++.++.|++.||.|||+ .||+|+||+|+|||++ .++.+||
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~---~~~~~~l 155 (269)
T cd08528 79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTI 155 (269)
T ss_pred ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC---CCCcEEE
Confidence 999999999999999999887743 34578999999999999999999996 6899999999999995 5677999
Q ss_pred eecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCC
Q 012518 275 IDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 353 (461)
Q Consensus 275 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 353 (461)
+|||++.............|+..|+|||++. +.++.++|||||||++|+|++|..||...........+...... ..
T Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~ 233 (269)
T cd08528 156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE--PL 233 (269)
T ss_pred ecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC--cC
Confidence 9999998765554445667899999999886 45899999999999999999999999877666655555543322 11
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 354 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
....+++++.++|.+||+.||++||++.|+..+
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 223578999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=314.66 Aligned_cols=253 Identities=18% Similarity=0.240 Sum_probs=205.4
Q ss_pred ccceeeceeeccCCceEEEEEEeccCC-ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-C
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGT-LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED-A 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~-~ 201 (461)
.++|++.+.||+|+||.||+|.+.... .++..||+|++... ......+.+.+|+.+++++. |+||+++++++.. .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLS-HQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 358999999999999999999986421 13678999998643 34455677889999999995 9999999998765 5
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeE
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG-------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~-------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
...++++||+.+|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCCcEEE
Confidence 67899999999999999886532 3588999999999999999999999999999999999995 5677999
Q ss_pred eecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCC
Q 012518 275 IDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPN 349 (461)
Q Consensus 275 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~ 349 (461)
+|||+++.+..... .....++..|+|||++. ..++.++|||||||++||+++ |+.||......++...+... ..
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CC
Confidence 99999986543321 12234567899999886 458999999999999999999 99999877666655544432 22
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 350 FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 350 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.. ....+++++.+++.+||..||++|||+.++++
T Consensus 238 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 LA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22 22457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=311.52 Aligned_cols=241 Identities=23% Similarity=0.375 Sum_probs=199.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|++.+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.+++.++ |+||+++++++..+ ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----CCCceEEEeecCcc-----hHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-Cc
Confidence 4799999999999999998753 67889999986432 2356889999999996 99999999998765 47
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
++||||+.+++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||++ .++.+||+|||++...
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~---~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVG 150 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCcEEECCCccceec
Confidence 99999999999999887653 3578899999999999999999999999999999999995 5677999999998764
Q ss_pred CCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
... ......+..|+|||++. +.++.++|||||||++|+|++ |+.||......+....+.... .......++..
T Consensus 151 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 225 (254)
T cd05083 151 SMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---RMEPPEGCPAD 225 (254)
T ss_pred ccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---CCCCCCcCCHH
Confidence 322 22234456799999886 568999999999999999997 999998877766666554431 11223468899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhc
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+.++|.+||+.+|.+||++++++.
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=318.70 Aligned_cols=249 Identities=20% Similarity=0.305 Sum_probs=201.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCc----EEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGK----VVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
.+|+..+.||+|+||.||+|.+.. +|. .||+|.+.... .......+.+|+.+++.+. |+||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~ 80 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVP---EGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMD-HPHLVRLLGVCLS 80 (303)
T ss_pred hhceeccccccCCCccEEEEEEec---CCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcC
Confidence 478899999999999999998765 343 57899886542 2333456889999999995 9999999999875
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
. ..++|+||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+. .++.+||+|||++
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~---~~~~~kL~Dfg~~ 156 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK---SPNHVKITDFGLA 156 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec---CCCceEEcccccc
Confidence 4 46799999999999999877666789999999999999999999999999999999999995 4667999999999
Q ss_pred cccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 281 DFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 281 ~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
........ .....++..|+|||++. ..++.++|||||||++|||++ |..||.+.........+. ....+.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~--~ 233 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQ--P 233 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCC--C
Confidence 86643322 12234567899999886 568999999999999999997 999997766555444433 2222222 2
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+.++..+.+++.+||..||++||+++++++.
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 234 PICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4578899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=311.17 Aligned_cols=247 Identities=19% Similarity=0.274 Sum_probs=193.4
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||.||++....+. ....+++|.+.... .....+.+.+|+.+++.++ ||||+++++.+.+....|+||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDT-GVARVVVKELKANA--SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred CcCCCCcCceEEEEEEEcCC-CcceEEEEEecCCC--ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEec
Confidence 35999999999999764322 34457777765432 2334567899999999995 99999999999999999999999
Q ss_pred cCCCchHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 012518 211 CEGGELLDRILSRG---GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ 287 (461)
Q Consensus 211 ~~gg~L~~~l~~~~---~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~ 287 (461)
+.+|+|.+++.... ....+..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~---~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT---SDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc---CCccEEecccccccccCcch
Confidence 99999999886542 2356677889999999999999999999999999999994 56779999999986432211
Q ss_pred ---CccccccCCCcCchhhhhc--------cCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCC-CCCCC-
Q 012518 288 ---RLNDIVGSAYYVAPEVLHR--------SYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADP-NFHDS- 353 (461)
Q Consensus 288 ---~~~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~- 353 (461)
......|+..|+|||++.. .++.++|||||||++|||++ |..||......+.+..+..... .....
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence 1234568899999998742 35788999999999999997 5778877777777766554422 22222
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 354 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
....+++.+.+++..|| .+|++||+++++++
T Consensus 234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 12347899999999999 68999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=313.21 Aligned_cols=249 Identities=20% Similarity=0.324 Sum_probs=199.2
Q ss_pred eeeccCCceEEEEEEeccCC---ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEE
Q 012518 131 KEVGRGHFGHTCCAKGKKGT---LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIV 207 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv 207 (461)
+.||+|+||.||+++.+... ..++.+|||.+.+.. .......+.+|+++++.+. ||||+++++++.+.+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence 36999999999999876411 234689999886542 1233567889999999996 99999999999999999999
Q ss_pred EeccCCCchHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC--CCCCeeEeeccc
Q 012518 208 MEFCEGGELLDRILSR------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE--EDAPLKVIDFGL 279 (461)
Q Consensus 208 ~e~~~gg~L~~~l~~~------~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~--~~~~~kl~DFG~ 279 (461)
|||+.+++|.+++... ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++ ....+||+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999988653 23467888999999999999999999999999999999997533 223799999999
Q ss_pred ccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCC
Q 012518 280 SDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 280 a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 354 (461)
+........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||...+..+....+.... .+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~--~~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RL--QK 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-cc--CC
Confidence 876543221 12234567899999886 568999999999999999998 999998777666655554322 11 12
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...++..+.+||.+||..+|.+||+++++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2457899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=339.77 Aligned_cols=247 Identities=28% Similarity=0.496 Sum_probs=198.4
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC---
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN--- 202 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~--- 202 (461)
-|...+.||+|+||.||+++++. +|+.||||.+++.. ....++...+|+++|++|+ |+|||+++++-++..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnke---tG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKE---TGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGL 87 (732)
T ss_pred ceeehhhhcCCccceeeeecccc---cccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCc
Confidence 46677899999999999999887 99999999998754 3334677889999999997 999999998766543
Q ss_pred ---eEEEEEeccCCCchHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC-CCCCeeEee
Q 012518 203 ---SVYIVMEFCEGGELLDRILSR--GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE-EDAPLKVID 276 (461)
Q Consensus 203 ---~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~-~~~~~kl~D 276 (461)
.-.+|||||.||+|+..+.+- ...+++.+.+.++.++..||.|||++|||||||||.||++-... .....||+|
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 467999999999999988543 34589999999999999999999999999999999999996533 334579999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh----hhHHHHHHhcCCCC
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIFRSVLRADPNF 350 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~ 350 (461)
||.|+...++....+.+||+.|.+||++. +.|+..+|.|||||++|+++||..||..... .++...+...++.-
T Consensus 168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 168 FGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99999999999999999999999999987 5699999999999999999999999954322 22333333222110
Q ss_pred C----------CCCC-------CCCC----HHHHHHHHHhcccCcCCCC
Q 012518 351 H----------DSPW-------PSVS----PEAKDFVRRLLNKDHRKRM 378 (461)
Q Consensus 351 ~----------~~~~-------~~~s----~~~~~li~~~L~~dP~~R~ 378 (461)
. ...| ..++ ..+..++..+|..+|++|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0 0011 1123 3344678888999999998
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=311.78 Aligned_cols=251 Identities=21% Similarity=0.315 Sum_probs=202.8
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC----
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN---- 202 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~---- 202 (461)
|.+.+.||+|+||.||+|..+.+..+|+.||||++.... ......+++.+|+++++.+. ||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence 677889999999999999877655578899999986543 33445677889999999996 999999999886532
Q ss_pred --eEEEEEeccCCCchHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 203 --SVYIVMEFCEGGELLDRILSRG-----GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 203 --~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
..++++||+.+|+|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||++ .+..+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~---~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc---CCCCEEEC
Confidence 2478999999999988765321 2478889999999999999999999999999999999994 56779999
Q ss_pred ecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCC
Q 012518 276 DFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 276 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
|||++........ .....++..|++||.+. +.++.++|||||||++|+|++ |..||.+....+....+.......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9999886543221 12234567899999886 568899999999999999999 899998777766666655443211
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
. .+.++..+.+++.+||..+|++||++.+++.
T Consensus 236 -~--~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 236 -Q--PPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred -C--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 1347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=342.16 Aligned_cols=258 Identities=22% Similarity=0.293 Sum_probs=176.7
Q ss_pred ccceeeceeeccCCceEEEEEEeccC-CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKG-TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDA----- 197 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~----- 197 (461)
.++|++.+.||+|+||.||+|++..+ ...+..||||.+...... +....| . +.... +.+++.++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e-~-l~~~~-~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE-R-VRRAC-PNSCADFVYGFLEPV 202 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH-H-HHhhc-hhhHHHHHHhhhccc
Confidence 46899999999999999999998751 112789999987643211 111111 1 11111 2333332222
Q ss_pred -EEeCCeEEEEEeccCCCchHHHHHhcCCCC-------------------CHHHHHHHHHHHHHHHHHHHHcCccccCCC
Q 012518 198 -FEDANSVYIVMEFCEGGELLDRILSRGGRY-------------------LEEDAKTIVEKILNIVAFCHLQGVVHRDLK 257 (461)
Q Consensus 198 -~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~-------------------~~~~~~~i~~qil~al~yLH~~givHrDlk 257 (461)
......+++||||+.+++|.+++......+ .+..+..++.||+.||.|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 245667999999999999998886442111 123467899999999999999999999999
Q ss_pred CCcEEEecCCCCCCeeEeecccccccCCCC--CccccccCCCcCchhhhh-c----------------------cCCCch
Q 012518 258 PENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-R----------------------SYNVEG 312 (461)
Q Consensus 258 p~NILl~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~----------------------~~~~~~ 312 (461)
|+|||++. +++.+||+|||+|+...... .....+||+.|||||.+. . .++.++
T Consensus 283 P~NILl~~--~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 283 PQNIIFSE--GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HHHEEEeC--CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 99999962 35679999999998654332 235578999999999653 1 134567
Q ss_pred hHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc-CCC-----------CCC------CCCCCCCHHHHHHHHHhcccCc
Q 012518 313 DMWSIGVITYILLCGSRPFWARTESGIFRSVLRA-DPN-----------FHD------SPWPSVSPEAKDFVRRLLNKDH 374 (461)
Q Consensus 313 DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-~~~-----------~~~------~~~~~~s~~~~~li~~~L~~dP 374 (461)
|||||||+||||+++..++.. ....+..++.. ... ... ..+........+||.+||++||
T Consensus 361 DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999999999998766532 21122211111 100 000 0001123456699999999999
Q ss_pred CCCCCHHHHhcCCCcCCCC
Q 012518 375 RKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 375 ~~R~s~~e~L~hp~~~~~~ 393 (461)
++|||+.|+|+||||+...
T Consensus 439 ~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 439 RQRISAKAALAHPYFDREG 457 (566)
T ss_pred ccCCCHHHHhCCcCcCCCC
Confidence 9999999999999998754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=348.72 Aligned_cols=253 Identities=20% Similarity=0.341 Sum_probs=214.3
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCcc--CcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLK--GKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
...-++.+.||+|.||.||.|........ -..||||.+++. .+.....+|.+|..+|+++. |||||+++|++.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCC
Confidence 34677889999999999999987642211 234888887654 56777899999999999995 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 202 NSVYIVMEFCEGGELLDRILSR------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
...+|++|||+||||+.+|.+. ...++..+...++.||++|++||+++++|||||..+|+||+ ....|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---ERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---ccCcEEEc
Confidence 9999999999999999999876 56688899999999999999999999999999999999996 55889999
Q ss_pred ecccccccCCCCCcc--cc-ccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCC
Q 012518 276 DFGLSDFVRPDQRLN--DI-VGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 276 DFG~a~~~~~~~~~~--~~-~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
|||+|+.+...+... .. .--..|||||.+. +.|+.++|||||||+|||++| |..||.+.+..+++..++.+. ..
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence 999999543332111 11 1225799999987 789999999999999999998 999999999888888777765 33
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
..+ ..++..+.++|..||+.+|++||++..+++
T Consensus 924 ~~P--~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 DPP--SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCC--CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 333 468999999999999999999999999987
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=310.14 Aligned_cols=241 Identities=17% Similarity=0.207 Sum_probs=189.7
Q ss_pred eeeccCCceEEEEEEeccCC-------ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 131 KEVGRGHFGHTCCAKGKKGT-------LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
+.||+|+||.||+|.++... .....+++|++..... ....+.+|+.+++.+. |+||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence 46999999999999987521 0113578887654321 1467889999999996 9999999999988 77
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC----CCCCeeEeeccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE----EDAPLKVIDFGL 279 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~----~~~~~kl~DFG~ 279 (461)
.++||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 8999999999999998876655789999999999999999999999999999999999996432 112699999999
Q ss_pred ccccCCCCCccccccCCCcCchhhhhc---cCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 280 SDFVRPDQRLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 280 a~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
+..... .....++..|+|||++.+ .++.++|||||||++|+|++ |..||............. .......
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~--- 227 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPM--- 227 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCC---
Confidence 886543 223456778999999863 58999999999999999999 588886665433333222 1111111
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.....+.++|.+||..||.+|||+.++++
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 228 -PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=313.57 Aligned_cols=253 Identities=23% Similarity=0.380 Sum_probs=202.8
Q ss_pred cceeeceeeccCCceEEEEEEeccC-CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--C
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKG-TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED--A 201 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~--~ 201 (461)
.+|++.+.||+|+||.||+|..... ..+++.||||++...... ...+.+.+|+++++.+. |+||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence 4788899999999999999986431 235789999999765332 34578899999999995 9999999999887 5
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
...++||||+++++|.+++......+++..+..++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE---SEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEccccccc
Confidence 679999999999999999877666799999999999999999999999999999999999995 56789999999998
Q ss_pred ccCCCCCc----cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhh--------------HHHH
Q 012518 282 FVRPDQRL----NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG--------------IFRS 342 (461)
Q Consensus 282 ~~~~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--------------~~~~ 342 (461)
........ ....++..|+|||.+. ..++.++|||||||++|||++|..||....... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532211 1234456799999875 568899999999999999999999986532211 1122
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 343 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+........ ...++.++.+|+.+||..||.+||++.|+++
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2222222221 2356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=309.22 Aligned_cols=228 Identities=23% Similarity=0.339 Sum_probs=186.0
Q ss_pred CCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012518 136 GHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGE 215 (461)
Q Consensus 136 G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~~gg~ 215 (461)
|.||.||+|+++. +|+.||+|++.+... ..+|...+.... ||||+++++++.+.+.+|+||||+.||+
T Consensus 4 g~~~~v~~~~~~~---~~~~~~~K~i~~~~~--------~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTR---TQQTFILKGLRKSSE--------YSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEcc---CCcEEEEEeecchhh--------hhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCC
Confidence 8999999999876 889999999976431 223444444554 9999999999999999999999999999
Q ss_pred hHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCccccccC
Q 012518 216 LLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295 (461)
Q Consensus 216 L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt 295 (461)
|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.++|+|||++...... .....++
T Consensus 72 L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~df~~~~~~~~~--~~~~~~~ 145 (237)
T cd05576 72 LWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD---DRGHIQLTYFSRWSEVEDS--CDGEAVE 145 (237)
T ss_pred HHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEecccchhccccc--cccCCcC
Confidence 99988654 4689999999999999999999999999999999999995 5667999999987655432 2345567
Q ss_pred CCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 012518 296 AYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDH 374 (461)
Q Consensus 296 ~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 374 (461)
..|+|||++. +.++.++||||+||++|+|++|..||...... + .....+..+ ..+++.+++||.+||+.||
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~~~~--~~~~~~~~~li~~~l~~dp 217 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTLNIP--EWVSEEARSLLQQLLQFNP 217 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccccCCc--ccCCHHHHHHHHHHccCCH
Confidence 8899999886 45899999999999999999999887543221 0 001111111 3478999999999999999
Q ss_pred CCCCCH-----HHHhcCCCc
Q 012518 375 RKRMTA-----AQALTHPWL 389 (461)
Q Consensus 375 ~~R~s~-----~e~L~hp~~ 389 (461)
++|+++ +++++||||
T Consensus 218 ~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 218 TERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHhcCCCccchHHHHcCCCC
Confidence 999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=327.49 Aligned_cols=263 Identities=26% Similarity=0.467 Sum_probs=220.2
Q ss_pred CCCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCC-----CCCee
Q 012518 118 GYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG-----HKHMI 192 (461)
Q Consensus 118 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~-----hpniv 192 (461)
.+|+.+..+|++....|+|-|++|..|.+.. .|..||||+|..+... .+.=++|++||++|.+ --|++
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~---r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQA---RGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccC---CCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHH
Confidence 4578888999999999999999999998876 6789999999875433 3445689999999962 34899
Q ss_pred EEEEEEEeCCeEEEEEeccCCCchHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCC
Q 012518 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGG--RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 270 (461)
Q Consensus 193 ~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~ 270 (461)
+|+..|...+++|||+|-+. .+|.+.|.+.+. .+....++.|+.|++.||..|-..||+|.||||+|||++ ....
T Consensus 498 rl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~ 574 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKN 574 (752)
T ss_pred HHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcc
Confidence 99999999999999999985 489998876543 366688999999999999999999999999999999997 4567
Q ss_pred CeeEeecccccccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC
Q 012518 271 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN 349 (461)
Q Consensus 271 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~ 349 (461)
.+||||||.|.++..+ ..+.+..+..|+|||+|.| .|+...|+||+||+||||+||+..|.+.+...+++..+.....
T Consensus 575 iLKLCDfGSA~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 575 ILKLCDFGSASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eeeeccCccccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 7999999999887644 3455666788999998875 6999999999999999999999999999998888777665555
Q ss_pred CCCCCC----------C---------------------------------------CC-------CHHHHHHHHHhcccC
Q 012518 350 FHDSPW----------P---------------------------------------SV-------SPEAKDFVRRLLNKD 373 (461)
Q Consensus 350 ~~~~~~----------~---------------------------------------~~-------s~~~~~li~~~L~~d 373 (461)
|+.... . .+ -..+++|+.+||..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 442110 0 01 156889999999999
Q ss_pred cCCCCCHHHHhcCCCcCC
Q 012518 374 HRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 374 P~~R~s~~e~L~hp~~~~ 391 (461)
|.+|.|..++|+||||..
T Consensus 734 P~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 734 PEKRITVNQALKHPFITE 751 (752)
T ss_pred hhhcCCHHHHhcCCcccC
Confidence 999999999999999964
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=310.67 Aligned_cols=254 Identities=16% Similarity=0.190 Sum_probs=186.3
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHH--------HHHHHHHHHHHhcCCCCCee
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAI--------EDVRREVKILKALSGHKHMI 192 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~--------~~~~~Ei~il~~l~~hpniv 192 (461)
+....+|++.++||+|+||+||+|.+..+...+..+|+|+............ .....++..+..+ +|+||+
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~ 86 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIP 86 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCC
Confidence 3455789999999999999999999876332366788886543321110000 1112233444555 499999
Q ss_pred EEEEEEEeCC----eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC
Q 012518 193 KFHDAFEDAN----SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 268 (461)
Q Consensus 193 ~l~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~ 268 (461)
++++++.... ..+++||++.. ++.+.+. .....++..++.++.||+.||.|||+++|+||||||+|||++ .
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~---~ 161 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD---G 161 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---C
Confidence 9999775543 34788888743 5655443 334467888999999999999999999999999999999994 5
Q ss_pred CCCeeEeecccccccCCCC--------CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh-h
Q 012518 269 DAPLKVIDFGLSDFVRPDQ--------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES-G 338 (461)
Q Consensus 269 ~~~~kl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~ 338 (461)
++.+||+|||+|+...... ......||+.|+|||++. ..++.++|||||||+||||++|..||.+.... .
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 6779999999998654221 112347999999999986 45999999999999999999999999776332 2
Q ss_pred H--------HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 339 I--------FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 339 ~--------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
. +..+..... ..+..++++.+++..|+..+|++||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1 122222211 12456899999999999999999999999874
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=326.43 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=216.5
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+..+.++||+|+||+|+++.+.....+.-.||||.++...... ...+|++|+.+|.+|. |+|+++|||+..+ ..+.
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhcc-CcceeEEeeeecc-chhh
Confidence 5677889999999999999987643334569999998765443 5789999999999996 9999999999987 6788
Q ss_pred EEEeccCCCchHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 206 IVMEFCEGGELLDRILS-RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
||||++..|+|++.|.+ ....|.......|+.||+.||.||.++++|||||..+|+|+.+ ...||||||||.+.+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas---prtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS---PRTVKICDFGLMRALG 263 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc---cceeeeecccceeccC
Confidence 99999999999999987 4456888889999999999999999999999999999999974 5569999999999887
Q ss_pred CCCCcccccc----CCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 285 PDQRLNDIVG----SAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 285 ~~~~~~~~~g----t~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
.++....+.+ -..|+|||.|. +.|+.++|||++||++|||++ |+.||.+.....+++.|-.. ..++.. +.+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-erLpRP--k~c 340 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-ERLPRP--KYC 340 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-ccCCCC--CCC
Confidence 7665543322 34699999997 789999999999999999998 89999999998998888733 333333 358
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
++++.+++..||..+|.+|||+.+|.+.-++.
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 99999999999999999999999887655543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=320.63 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=207.1
Q ss_pred eeeceeeccCCceEEEEEEeccCC-ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGT-LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
..+.+.||.|-||.||.|...... ...--||||..+.+.. ....+.|+.|..+|+++ +||||++++|+|.+. .+|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnf-dHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhC-CCcchhheeeeeecc-cee
Confidence 345678999999999999875432 1223589998877543 33478899999999999 599999999999864 589
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
||||++.-|.|..++..+...++......++.||+.||.|||++.+|||||..+|||+.+ ...|||+|||+++.+.+
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS---p~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS---PQCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC---cceeeecccchhhhccc
Confidence 999999999999999888888999999999999999999999999999999999999974 45699999999999887
Q ss_pred CCCcccccc--CCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 286 DQRLNDIVG--SAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 286 ~~~~~~~~g--t~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
+.......| ..-|||||.++ +.++.++|||.|||+|||++. |..||.+-...+.+-.+-++... +. .+++++.
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl-P~--P~nCPp~ 620 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL-PC--PPNCPPA 620 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC-CC--CCCCChH
Confidence 665444444 35699999987 789999999999999999986 99999987777766655554322 22 2579999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHh
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQAL 384 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L 384 (461)
+..|+.+||.+||.+||.+.++.
T Consensus 621 LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 621 LYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHHHhccCcccCCcHHHHH
Confidence 99999999999999999987653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=330.98 Aligned_cols=252 Identities=23% Similarity=0.430 Sum_probs=220.1
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
...+.++||.|.||.||+++.+.....-..||||.++.. ..+....+|+.|..||-++. ||||++|.|+....+.+.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCceeE
Confidence 456789999999999999999875445567999999765 34566788999999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
||+|||++|+|..+|.+++++++..+..-+++.|+.|++||-+.|+|||||..+|||++ .+..+|++|||+++.+.+
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN---snLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 783 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec---cceEEEeccccceeeccc
Confidence 99999999999999999999999999999999999999999999999999999999994 678899999999998865
Q ss_pred CC-C-cccccc--CCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 286 DQ-R-LNDIVG--SAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 286 ~~-~-~~~~~g--t~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
+. . .++.-| ...|.|||.|. +.++.++||||+||+|||.++ |..|||+.+..+.+..|.++ |..++...++
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g---yRLPpPmDCP 860 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG---YRLPPPMDCP 860 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc---cCCCCCCCCc
Confidence 54 2 222222 35799999885 889999999999999999775 99999999999999988765 3333335799
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
..+.+|+..||++|-.+||.+.||+.+
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999998763
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=324.47 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=189.0
Q ss_pred ccceeeceeeccCCceEEEEEEecc-------------CCccCcEEEEEEecccccCCHH-----------HHHHHHHHH
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK-------------GTLKGKVVAVKIISKAKMTSAL-----------AIEDVRREV 179 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~-------------~~~~g~~vAvK~i~~~~~~~~~-----------~~~~~~~Ei 179 (461)
.++|++.++||+|+||+||+|.... ....++.||||.+......... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 4689999999999999999996421 1124678999998643211000 012233477
Q ss_pred HHHHhcCCCCC-----eeEEEEEEEe--------CCeEEEEEeccCCCchHHHHHhcCC---------------------
Q 012518 180 KILKALSGHKH-----MIKFHDAFED--------ANSVYIVMEFCEGGELLDRILSRGG--------------------- 225 (461)
Q Consensus 180 ~il~~l~~hpn-----iv~l~~~~~~--------~~~~~lv~e~~~gg~L~~~l~~~~~--------------------- 225 (461)
.++.+++ |.+ +++++++|.. .+..||||||+.+++|.+++....+
T Consensus 224 ~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 224 YMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 7777776 443 4677777643 3568999999999999998864321
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCccc--cccCCCcCch
Q 012518 226 --RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND--IVGSAYYVAP 301 (461)
Q Consensus 226 --~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~--~~gt~~y~aP 301 (461)
.+++..++.++.||+.+|.|||+++|+||||||+|||++ .++.+||+|||++........... ..+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC---CCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 124567888999999999999999999999999999995 567799999999976544333332 2347899999
Q ss_pred hhhhcc---------------------CC--CchhHHHHHHHHHHHhhCCC-CCCCCCh-----------hhHHHHHHhc
Q 012518 302 EVLHRS---------------------YN--VEGDMWSIGVITYILLCGSR-PFWARTE-----------SGIFRSVLRA 346 (461)
Q Consensus 302 E~l~~~---------------------~~--~~~DiwSlGvil~elltg~~-Pf~~~~~-----------~~~~~~i~~~ 346 (461)
|++... |+ .+.||||+||++|+|++|.. ||.+... ...++.+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 987421 22 24799999999999999986 6643211 1111222222
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCc---CCCCCHHHHhcCCCcCC
Q 012518 347 DPNFHDSPWPSVSPEAKDFVRRLLNKDH---RKRMTAAQALTHPWLHD 391 (461)
Q Consensus 347 ~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~R~s~~e~L~hp~~~~ 391 (461)
.. ....|...++.++|||.+||.++| .+|+|++|+|+||||..
T Consensus 460 ~~--~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KY--DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CC--CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 22 333567789999999999999876 68999999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=299.31 Aligned_cols=254 Identities=30% Similarity=0.490 Sum_probs=207.7
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA-- 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~-- 201 (461)
..+|.-++.+|.|.- .|..|.+.. .++.||+|.+... .......++..+|..++..+. |+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v---~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQV---LGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKT 89 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhh---ccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCcccc
Confidence 458888899999998 676676554 8899999987654 222333456779999999996 99999999999543
Q ss_pred ----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 202 ----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 202 ----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
..+|+||||+.. +|...++ -.++.+.+..++.|++.|++|||+.||+||||||+||++. .+..+||.||
T Consensus 90 l~~~~e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~---~~~~lKi~df 162 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN---SDCTLKILDF 162 (369)
T ss_pred HHHHHhHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec---chhheeeccc
Confidence 358999999964 8888776 3477889999999999999999999999999999999994 6778999999
Q ss_pred ccccccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC--------
Q 012518 278 GLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP-------- 348 (461)
Q Consensus 278 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-------- 348 (461)
|+|+.....-.++.++.|.+|+|||++.+ .|...+||||+||++.||++|...|.+.+.-+.+.++.....
T Consensus 163 g~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 163 GLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred hhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 99998776667788999999999998753 499999999999999999999999988877665555432211
Q ss_pred -----------------------CCCCCCCC-------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 349 -----------------------NFHDSPWP-------SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 349 -----------------------~~~~~~~~-------~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
.|++..|+ .-+..+++|+.+||..||++|.+++++|+|||++
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 12222222 1246789999999999999999999999999997
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=287.97 Aligned_cols=242 Identities=43% Similarity=0.787 Sum_probs=203.5
Q ss_pred CceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEeccCCCch
Q 012518 137 HFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGEL 216 (461)
Q Consensus 137 ~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~~gg~L 216 (461)
+||.||++.... +|+.+|+|++........ .+.+.+|++++++++ |+||+++++++......++||||+.+++|
T Consensus 1 ~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKK---TGKLVAIKVIKKEKIKKK--RERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECC---CCcEEEEEEecccccccH--HHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence 589999999875 689999999876543322 578889999999995 99999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCccccccCC
Q 012518 217 LDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA 296 (461)
Q Consensus 217 ~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~ 296 (461)
.+++.... .++...+..++.+++.+|.|||+.||+|+||+|.||+++ .++.++|+|||++.............++.
T Consensus 75 ~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGLLTTFVGTP 150 (244)
T ss_pred HHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeeccccccccccCCc
Confidence 99876543 388999999999999999999999999999999999995 45779999999998876554556677899
Q ss_pred CcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCC-CChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 012518 297 YYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWA-RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDH 374 (461)
Q Consensus 297 ~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 374 (461)
.|++||.+. ..++.++||||||+++|+|++|..||.. .........+....... ...+..++.++.+++.+||..||
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-PPPEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-ccccccCCHHHHHHHHHHccCCc
Confidence 999999886 5688999999999999999999999977 44444444444333222 22222278999999999999999
Q ss_pred CCCCCHHHHhcCCCc
Q 012518 375 RKRMTAAQALTHPWL 389 (461)
Q Consensus 375 ~~R~s~~e~L~hp~~ 389 (461)
++||++.++++||||
T Consensus 230 ~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 230 EKRLTAEEALQHPFF 244 (244)
T ss_pred hhccCHHHHhhCCCC
Confidence 999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=308.39 Aligned_cols=245 Identities=22% Similarity=0.392 Sum_probs=207.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+.....+||-|-||.||.+.+++ -.-.||||.++.+. ..+++|+.|..+|+.++ |||+|+|+|+|..+..+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKk---yslTvAVKtLKEDt----MeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeec---cceeeehhhhhhcc----hhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCe
Confidence 345566789999999999999998 45569999997653 35789999999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
|||+|||..|+|+|+|...+. .++.-...+++.||..|++||..+++|||||..+|+|+ +++..||++|||+++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhh
Confidence 999999999999999977654 34556677899999999999999999999999999999 47788999999999988
Q ss_pred CCCCCcccccc---CCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 284 RPDQRLNDIVG---SAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 284 ~~~~~~~~~~g---t~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
..+ ..+...| ..-|.|||-|. ..++.++|||+|||+|||+.| |-.||.+-+....+..+- ....+..+ .++
T Consensus 416 tgD-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-kgyRM~~P--eGC 491 (1157)
T KOG4278|consen 416 TGD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-KGYRMDGP--EGC 491 (1157)
T ss_pred cCC-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-ccccccCC--CCC
Confidence 644 3344444 35699999875 679999999999999999998 899998887776665543 33333333 579
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHh
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQAL 384 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L 384 (461)
++...+|++.||+.+|..||+++|+-
T Consensus 492 PpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 492 PPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CHHHHHHHHHHhcCCcccCccHHHHH
Confidence 99999999999999999999999873
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=325.81 Aligned_cols=252 Identities=30% Similarity=0.445 Sum_probs=198.9
Q ss_pred eeeceeeccCCceE-EEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 127 FELGKEVGRGHFGH-TCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 127 y~~~~~lG~G~fg~-V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
|.-.+.+|.|+-|+ ||++.. .|+.||||.+-... .+...+||..|+.-.+|||||++|+.-.+....|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-----e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~Y 579 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-----EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLY 579 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-----CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEE
Confidence 33446789999986 687765 67899999875432 2456799999999888999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc--CCCC-CHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC--CCCCeeEeecccc
Q 012518 206 IVMEFCEGGELLDRILSR--GGRY-LEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE--EDAPLKVIDFGLS 280 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~--~~~~-~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~--~~~~~kl~DFG~a 280 (461)
|+.|.|.. +|.|++... .... .....+.++.|++.||.+||+.+||||||||.||||+..+ ....++|+|||++
T Consensus 580 IalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 580 IALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred EEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99999964 999988663 1111 1144678999999999999999999999999999998643 3357999999999
Q ss_pred cccCCCC----CccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhC-CCCCCCCChhhHHHHHHhcCCCCCCCC
Q 012518 281 DFVRPDQ----RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCG-SRPFWARTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 281 ~~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 354 (461)
+.+..+. ...+..||-+|+|||++.. .-+.++|||||||++|+.++| .+||.+.... -.+|+.+......-.
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLE 736 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeec
Confidence 9887654 2345679999999999974 456789999999999999885 9999654432 335555544433221
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
+....+++|||.+||..||..||+|.++|.||||++..
T Consensus 737 -~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e 774 (903)
T KOG1027|consen 737 -PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE 774 (903)
T ss_pred -cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence 11112999999999999999999999999999998754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=289.42 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=205.4
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC----
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN---- 202 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~---- 202 (461)
.+-.+-||-|+||+||.+.+-+ +|+.||+|.+..- +.+-...+.+.+|+.+|..++ |.|++..+++.+-..
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPR---dgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPR---SGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFF 129 (449)
T ss_pred CCCCCcccccceeEEEeccCCC---CccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHH
Confidence 3445779999999999998776 8999999987532 233344578899999999997 999999988775433
Q ss_pred -eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 -SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 -~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
.+|+|+|++.. +|...|. ....++.+.++-++.||++||+|||+.||.||||||.|.|++ .+..+||||||+++
T Consensus 130 qEiYV~TELmQS-DLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN---SNCvLKICDFGLAR 204 (449)
T KOG0664|consen 130 QELYVLTELMQS-DLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN---SNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHHHh-hhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec---cCceEEeccccccc
Confidence 47889999964 7766554 346789999999999999999999999999999999999995 56779999999999
Q ss_pred ccCCCC--CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC------
Q 012518 282 FVRPDQ--RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH------ 351 (461)
Q Consensus 282 ~~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~------ 351 (461)
....++ .++..+-|.+|+|||++++ .|+.++||||+|||+.||+..+..|...+..+.++.|...-....
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 876554 3455678999999999975 599999999999999999999999988887776665543211110
Q ss_pred ---------------CCCC---------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 352 ---------------DSPW---------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 352 ---------------~~~~---------~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.+.. ..-.-++.+++.++|..||++|++.++++.|+++...
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 0000 1123578899999999999999999999999998653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=267.31 Aligned_cols=213 Identities=25% Similarity=0.425 Sum_probs=180.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
+...-+..||+|+||.|-+.++.. +|+..|+|.++..- ..+..+++++|+.+..+..++|.+|.+||.+.+++.+
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~---sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQ---SGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred hhhhhhhhhcCCccchhhheeecc---CCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 455667889999999999888876 89999999997542 3445577889999988888899999999999999999
Q ss_pred EEEEeccCCCchHH---HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 205 YIVMEFCEGGELLD---RILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 205 ~lv~e~~~gg~L~~---~l~~~~~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
|+.||.|+- +|.. ....+++..+|..+-+|+..++.||.|||++ .|||||+||.|||+ +.+++||+||||++
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGIS 196 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccc
Confidence 999999953 5533 2345678899999999999999999999998 89999999999999 57888999999999
Q ss_pred cccCCCCCccccccCCCcCchhhhhc-----cCCCchhHHHHHHHHHHHhhCCCCCCC-CChhhHHHHHHhc
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLHR-----SYNVEGDMWSIGVITYILLCGSRPFWA-RTESGIFRSVLRA 346 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~ 346 (461)
..+.++...+-..|...|||||.+.. .|+.++||||||+++.||.+++.||.. .+..+++.++...
T Consensus 197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 98876655555678899999998852 599999999999999999999999965 4667777777654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.14 Aligned_cols=259 Identities=25% Similarity=0.460 Sum_probs=214.6
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|+++.++|.|+||.||+++++. +|+..|||+++..-.. ...-+.+||-+++..+ |||||-|++.|-..+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~---s~elaavkvVkLep~d---d~~~iqqei~~~~dc~-h~nivay~gsylr~d 85 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKR---SGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRD 85 (829)
T ss_pred CccchhheeeecCCcccchhhhcccc---cCchhhheeeeccCCc---cccccccceeeeecCC-CcChHHHHhhhhhhc
Confidence 45689999999999999999999987 8999999999764322 2355678999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|++||||.||+|.+... -.+.++|.++..+++..+.||+|||+.|=+|||||-.|||++ +.+.+||+|||.+..
T Consensus 86 klwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaq 161 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQ 161 (829)
T ss_pred CcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhh
Confidence 9999999999999988553 347899999999999999999999999999999999999997 456699999999876
Q ss_pred cCCC-CCccccccCCCcCchhhh----hccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC-CCCCC
Q 012518 283 VRPD-QRLNDIVGSAYYVAPEVL----HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH-DSPWP 356 (461)
Q Consensus 283 ~~~~-~~~~~~~gt~~y~aPE~l----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~ 356 (461)
+... .+..+++||++|||||+. .+.|+..+|||++|++..|+---+.|..+......+...-+..+..+ ...-.
T Consensus 162 itati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~ 241 (829)
T KOG0576|consen 162 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKT 241 (829)
T ss_pred hhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCc
Confidence 6433 355778999999999985 25799999999999999999888888655444333333332222111 11123
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.+++.+-+|++.+|.++|++||+++-+|.|||....
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 578999999999999999999999999999998654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=291.73 Aligned_cols=262 Identities=26% Similarity=0.432 Sum_probs=204.8
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
...+...|.++++||+|+|++||++.+.......+.||+|.+...... .++.+|+++|..+.++.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhc
Confidence 455667899999999999999999988754335788999998765432 468899999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
.++...+||||++..+..+++. .++-.+++.+++.++.||.++|.+|||||||||.|+|++. ..+.-.|+|||+
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~--~t~rg~LvDFgL 179 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR--RTQRGVLVDFGL 179 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc--ccCCceEEechh
Confidence 9999999999999888777652 3678899999999999999999999999999999999974 456678999999
Q ss_pred ccccC-----------------C--C---------------C-----------CccccccCCCcCchhhhhc--cCCCch
Q 012518 280 SDFVR-----------------P--D---------------Q-----------RLNDIVGSAYYVAPEVLHR--SYNVEG 312 (461)
Q Consensus 280 a~~~~-----------------~--~---------------~-----------~~~~~~gt~~y~aPE~l~~--~~~~~~ 312 (461)
|.... . + . ..-...||++|+|||++.+ .-++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 86210 0 0 0 0012469999999999864 478899
Q ss_pred hHHHHHHHHHHHhhCCCCCCCCCh-hhHHHHHH--------------hcC------C-----------------------
Q 012518 313 DMWSIGVITYILLCGSRPFWARTE-SGIFRSVL--------------RAD------P----------------------- 348 (461)
Q Consensus 313 DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~--------------~~~------~----------------------- 348 (461)
||||.|||+.-+++++.||....+ .+.+..|. -+. .
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 999999999999999999954322 11110000 000 0
Q ss_pred ---CCCCCCC-CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 349 ---NFHDSPW-PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 349 ---~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+.....| ..++..+.||+.+||+.||.+|+|++++|+||||.+.
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0011112 1245589999999999999999999999999999754
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=308.55 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=205.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCc----cCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTL----KGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
+...+.+.||+|.||.|++|..+.-.. ....||||.++.... ....+.+..|+++|+.+..|+||+.+++++..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 345667799999999999998553221 145799999876532 25678899999999999889999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEec
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 265 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~ 265 (461)
.+.+++|+|||..|+|.+++.... ..++..+...+..||+.|++||++..+|||||-.+|||++
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~- 452 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT- 452 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec-
Confidence 999999999999999999997664 2388889999999999999999999999999999999995
Q ss_pred CCCCCCeeEeecccccccCCCCCcc--ccccC--CCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCC-hhh
Q 012518 266 REEDAPLKVIDFGLSDFVRPDQRLN--DIVGS--AYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWART-ESG 338 (461)
Q Consensus 266 ~~~~~~~kl~DFG~a~~~~~~~~~~--~~~gt--~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~-~~~ 338 (461)
.+..+||+|||+|+......... ...|+ ..|||||.+. ..|+.++||||+||+||||++ |..||.+-. ..+
T Consensus 453 --~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 453 --KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred --CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 56779999999999655443332 22222 3499999987 569999999999999999998 899998754 555
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 339 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 339 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+++.+..+. ....+ ..+++++.++++.||+.+|.+||++.++.+
T Consensus 531 l~~~l~~G~-r~~~P--~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 531 LLEFLKEGN-RMEQP--EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHhcCC-CCCCC--CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 655444433 22222 347999999999999999999999988754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=331.90 Aligned_cols=240 Identities=21% Similarity=0.289 Sum_probs=182.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
..|...+.||+|+||.||+|+.+. +|+.||||.+...... ...|++++++++ |||||+++++|.+.+..
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-------~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIK---NGMQFVVKEINDVNSI-------PSSEIADMGKLQ-HPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECC---CCcEEEEEEccCCccc-------cHHHHHHHhhCC-CCCcceEEEEEEcCCCC
Confidence 356677899999999999999865 7899999998654321 124688999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH---LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH---~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
|+||||+++|+|.+++. .+++..+..++.||+.||.||| +.+|+||||||+||+++ .+...++. ||...
T Consensus 759 ~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~---~~~~~~~~-~~~~~ 830 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLR-LSLPG 830 (968)
T ss_pred EEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC---CCCceEEE-ecccc
Confidence 99999999999999884 3788999999999999999999 66999999999999995 34445654 66554
Q ss_pred ccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh--hhHHHHHH---hc-------CC
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVL---RA-------DP 348 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~---~~-------~~ 348 (461)
.... .....||..|+|||++. ..|+.++|||||||++|||+||+.||..... ..+..... .. ++
T Consensus 831 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 831 LLCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred cccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 3321 12346889999999986 5699999999999999999999999854321 11111110 00 01
Q ss_pred CCCCC-C-CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 349 NFHDS-P-WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 349 ~~~~~-~-~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
..... . -.....++.+++.+||+.||++||++.|+++.
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 11000 0 00112356789999999999999999998763
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=290.74 Aligned_cols=200 Identities=30% Similarity=0.539 Sum_probs=173.5
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHH-----HHHHHHHHHHHHhcC--CCCCeeEEEEEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALA-----IEDVRREVKILKALS--GHKHMIKFHDAF 198 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~-----~~~~~~Ei~il~~l~--~hpniv~l~~~~ 198 (461)
+|..++.+|.|+||.|++|.++. +...|+||.|.+.+.--... +-.+--||+||..|+ .|+||++++++|
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~---n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKE---NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred cceeeeeccccccceEEEeeecc---cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 59999999999999999999987 67889999998765432211 223557999999995 389999999999
Q ss_pred EeCCeEEEEEecc-CCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 199 EDANSVYIVMEFC-EGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 199 ~~~~~~~lv~e~~-~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
++++++||+||-. +|-+|+++|.. ..+++|.++..|++|++.|+++||+.||||||||-+|+.+ +.++-+||+||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidf 714 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDF 714 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeec
Confidence 9999999999975 56799998854 4689999999999999999999999999999999999999 46778999999
Q ss_pred ccccccCCCCCccccccCCCcCchhhhhcc--CCCchhHHHHHHHHHHHhhCCCCCCC
Q 012518 278 GLSDFVRPDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWA 333 (461)
Q Consensus 278 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlGvil~elltg~~Pf~~ 333 (461)
|.|.... ......++||..|.|||++.+. .+..-|||+||++||.++....||+.
T Consensus 715 gsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9988765 4567789999999999999864 57889999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=275.86 Aligned_cols=239 Identities=27% Similarity=0.414 Sum_probs=182.8
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCC--
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS-GHKHMIKFHDAFEDAN-- 202 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-~hpniv~l~~~~~~~~-- 202 (461)
..++.++||+|.||.||+|+. +++.||||++... ..+.+.+|-+|.+... .|+||++++++-+...
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-----~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-----DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred chhhHHHhhcCccceeehhhc-----cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 456788999999999999876 5689999998643 3466778888776542 4999999999876544
Q ss_pred --eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CccccCCCCCcEEEecCCCCCC
Q 012518 203 --SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ---------GVVHRDLKPENFLFTTREEDAP 271 (461)
Q Consensus 203 --~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~---------givHrDlkp~NILl~~~~~~~~ 271 (461)
.++||+||.+.|+|.++|..+ ..++....+++.-+++||.|||+. .|+|||||..|||| .+|++
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlT 354 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLT 354 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCc
Confidence 799999999999999999664 588999999999999999999974 49999999999999 57889
Q ss_pred eeEeecccccccCCCC---CccccccCCCcCchhhhhccCC-------CchhHHHHHHHHHHHhhCCC------------
Q 012518 272 LKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLHRSYN-------VEGDMWSIGVITYILLCGSR------------ 329 (461)
Q Consensus 272 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~-------~~~DiwSlGvil~elltg~~------------ 329 (461)
..|+|||+|..+..+. .....+||.+|||||+|.+..+ .+.||||+|.+||||++.-.
T Consensus 355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql 434 (534)
T KOG3653|consen 355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL 434 (534)
T ss_pred EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence 9999999998876553 3344799999999999987533 24899999999999988532
Q ss_pred CCCC-----CChhhHHHHHHhc--CCCCCCCCCCC--CCHHHHHHHHHhcccCcCCCCCHH
Q 012518 330 PFWA-----RTESGIFRSVLRA--DPNFHDSPWPS--VSPEAKDFVRRLLNKDHRKRMTAA 381 (461)
Q Consensus 330 Pf~~-----~~~~~~~~~i~~~--~~~~~~~~~~~--~s~~~~~li~~~L~~dP~~R~s~~ 381 (461)
||.. .+-.++...+.+. .+.++. .|.+ --..+++.+..||+.|++-|.|+.
T Consensus 435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~-~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPD-AWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred chhHHhcCCCCHHHHHHHHHhhccCCCChh-hhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 2321 1222233333322 222222 2322 235577888888888888888874
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=292.39 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=208.4
Q ss_pred ceeeceeeccCCceEEEEEEecc-CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKK-GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
..+..++||.|+||+||++.+.- +..-.-.||||++... .......++++|+-+|.+| +|||++++++++.... +
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-H
Confidence 44557899999999999998753 2223357999998754 3444567889999999999 4999999999998665 8
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
.||++|+++|.|+|++....+.+-......|+.||++||.|||.+++|||||-.+||||. .-.++||.|||+++...
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk---sP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK---SPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec---CCCeEEEEecchhhccC
Confidence 899999999999999998888899999999999999999999999999999999999996 45569999999999887
Q ss_pred CCCCcccc---ccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 285 PDQRLNDI---VGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 285 ~~~~~~~~---~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
.+...... .-.+.|||-|.+. +.|+.++|||||||++||++| |..|+.+....++-..+..++. ...+ +.++
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqP--piCt 926 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQP--PICT 926 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCC--CCcc
Confidence 66543222 2245699999876 679999999999999999998 9999998888777766655544 4433 4589
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
-++.-++.+||..|+..||++.++-.
T Consensus 927 iDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 927 IDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHHhccCcccCccHHHHHH
Confidence 99999999999999999999987643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=271.51 Aligned_cols=189 Identities=28% Similarity=0.458 Sum_probs=156.2
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHh--cCCCCCeeEEEEEE
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKA--LSGHKHMIKFHDAF 198 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~~hpniv~l~~~~ 198 (461)
.++..+..+.+.||+|.||.||+|++ .|+.||||++.... .....||.+|.+. |+ |+||+.+++.-
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w-----rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLR-HENILgFIaaD 274 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW-----RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLR-HENILGFIAAD 274 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc-----cCCceEEEEecccc------hhhhhhHHHHHHHHHhc-cchhhhhhhcc
Confidence 45667889999999999999998876 58899999996432 1345677777765 55 99999999876
Q ss_pred EeCC----eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCcEEEecC
Q 012518 199 EDAN----SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ--------GVVHRDLKPENFLFTTR 266 (461)
Q Consensus 199 ~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~--------givHrDlkp~NILl~~~ 266 (461)
..++ .+|||++|.+.|+|+|+|.. ..++.+...+++.-++.||.+||.. .|.|||||..|||+
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV--- 349 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--- 349 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---
Confidence 4332 58999999999999999965 4688899999999999999999964 49999999999999
Q ss_pred CCCCCeeEeecccccccCCC-----CCccccccCCCcCchhhhhccCC-------CchhHHHHHHHHHHHhh
Q 012518 267 EEDAPLKVIDFGLSDFVRPD-----QRLNDIVGSAYYVAPEVLHRSYN-------VEGDMWSIGVITYILLC 326 (461)
Q Consensus 267 ~~~~~~kl~DFG~a~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~-------~~~DiwSlGvil~ellt 326 (461)
..++..-|+|+|||-..... ...+..+||..|||||+|....+ ..+||||||.++||++.
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 46788999999999765443 23356799999999999975433 34899999999999975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=244.18 Aligned_cols=212 Identities=44% Similarity=0.788 Sum_probs=183.4
Q ss_pred eccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012518 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCE 212 (461)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~~ 212 (461)
||+|++|.||++.... +|+.+++|++....... ..+.+.+|+++++.+. |++|+++++++......+++|||+.
T Consensus 1 l~~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecC---CCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCC
Confidence 6899999999998865 68899999987653221 3467889999999996 9999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCC-Cccc
Q 012518 213 GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLND 291 (461)
Q Consensus 213 gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~-~~~~ 291 (461)
|++|.+++......++...+..++.+++.+|.|||++|++|+||+|.||++.. .+..++|+|||.+....... ....
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~--~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS--DNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeC--CCCcEEEecCCceEEccCCcchhhc
Confidence 99999988655356889999999999999999999999999999999999963 15679999999988665432 1334
Q ss_pred cccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 012518 292 IVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 369 (461)
Q Consensus 292 ~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 369 (461)
..+...|++||.+.. .++.+.|+|++|+++++| ..+.+++.+|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~ 197 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKM 197 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHH
Confidence 567888999999864 788999999999999999 5789999999
Q ss_pred cccCcCCCCCHHHHhcCC
Q 012518 370 LNKDHRKRMTAAQALTHP 387 (461)
Q Consensus 370 L~~dP~~R~s~~e~L~hp 387 (461)
|..||++||+++++++|+
T Consensus 198 l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 198 LQKDPEKRPSAKEILEHL 215 (215)
T ss_pred hhCCcccCcCHHHHhhCC
Confidence 999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=254.73 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=200.2
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEE-EEEe
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHD-AFED 200 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~-~~~~ 200 (461)
.+.+.|.+.+.||+|.||.+-+++++. +.+.+++|.+.+... ...+|.+|...--.|..|.||+.-|+ .|+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~---s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQ---SKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccC---CceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 356789999999999999999999987 788999999876533 35788899987777888999999775 6788
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+.++++|||++.|+|...+.. ..+-|...+.++.|++.||.|+|++++||||||.+||||-..+ ...|||||||+.
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t 170 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLT 170 (378)
T ss_pred CceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeecccc
Confidence 8899999999999999887744 3477888899999999999999999999999999999998644 347999999998
Q ss_pred cccCCCCCccccccCCCcCchhhhh----c--cCCCchhHHHHHHHHHHHhhCCCCCCCCChh-hHH---HHHHhcCCCC
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLH----R--SYNVEGDMWSIGVITYILLCGSRPFWARTES-GIF---RSVLRADPNF 350 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~----~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~---~~i~~~~~~~ 350 (461)
+..+..- ...--+..|.+||+.. + ..++.+|||.||+++|.++||..||...... .-+ .........-
T Consensus 171 ~k~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 171 RKVGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA 248 (378)
T ss_pred cccCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence 7654321 2222345699999763 2 2577899999999999999999999643211 111 1112221111
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCC---CCHHHHhcCCCcC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKR---MTAAQALTHPWLH 390 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R---~s~~e~L~hp~~~ 390 (461)
....+..+|+.+..+.++-|..++++| .+++......|..
T Consensus 249 ~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 249 LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred CchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 122234589999999999999999999 6777777777764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=306.17 Aligned_cols=198 Identities=18% Similarity=0.249 Sum_probs=149.8
Q ss_pred CCeeEEEEEE-------EeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcE
Q 012518 189 KHMIKFHDAF-------EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 261 (461)
Q Consensus 189 pniv~l~~~~-------~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NI 261 (461)
.||++++++| ...+.++++|||+ +++|.++|......+++..++.++.||+.||.|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777788877 3335678889988 5699999866556699999999999999999999999999999999999
Q ss_pred EEec----------------CCCCCCeeEeecccccccCCCC-----------------CccccccCCCcCchhhhh-cc
Q 012518 262 LFTT----------------REEDAPLKVIDFGLSDFVRPDQ-----------------RLNDIVGSAYYVAPEVLH-RS 307 (461)
Q Consensus 262 Ll~~----------------~~~~~~~kl~DFG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~l~-~~ 307 (461)
||+. .+.+..+||+|||+++...... .....+||++|||||++. ..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 9953 1235568888888886432100 011246899999999976 56
Q ss_pred CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 012518 308 YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387 (461)
Q Consensus 308 ~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 387 (461)
|+.++|||||||+||||++|..|+.... ..+..+.... ++.. +....+...+++.+||++||.+||++.|+|+||
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQ-ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChh-hhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 9999999999999999999998875322 1222221111 1111 112345678999999999999999999999999
Q ss_pred CcCCC
Q 012518 388 WLHDE 392 (461)
Q Consensus 388 ~~~~~ 392 (461)
||...
T Consensus 267 ~~~~~ 271 (793)
T PLN00181 267 FINEP 271 (793)
T ss_pred hhhhh
Confidence 99764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-31 Score=243.83 Aligned_cols=212 Identities=42% Similarity=0.750 Sum_probs=178.8
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
|.+.+.||.|++|.||++.... +++.+|+|.+...... ...+.+.+|++.++.+. |+|++++++++......++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---TGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---CCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEE
Confidence 5678899999999999999875 6789999999765332 24578889999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 012518 207 VMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 286 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~ 286 (461)
++||+.+++|.+++......+++..+..++.+++.+|.|||+++++|+||++.||+++ .+..++|+|||++......
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---MDGLVKLADFGLARFIHRD 151 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeCceeeEecCc
Confidence 9999999999998865533388999999999999999999999999999999999995 4577999999998877544
Q ss_pred C--CccccccCCCcCchhhh-h-ccCCCchhHHHHHHHHHHHhhCCCCCCC--CChhhHHHHHHhcC
Q 012518 287 Q--RLNDIVGSAYYVAPEVL-H-RSYNVEGDMWSIGVITYILLCGSRPFWA--RTESGIFRSVLRAD 347 (461)
Q Consensus 287 ~--~~~~~~gt~~y~aPE~l-~-~~~~~~~DiwSlGvil~elltg~~Pf~~--~~~~~~~~~i~~~~ 347 (461)
. ......++..|++||.+ . ..++.++|||+||+++|+|++|+.||.. .....+.+.+....
T Consensus 152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 3 33456788899999987 3 4577899999999999999999999977 34445666665543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=241.81 Aligned_cols=255 Identities=16% Similarity=0.214 Sum_probs=203.3
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCC--ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
.....++++...+-+|.||.||.|.++... .+-+.|-+|.++.. .+...+..++.|--.+..++ |||+..+.++.
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ 356 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGAS-HPNLLSVLGVS 356 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCc-CCCccceeEEE
Confidence 344567888999999999999999765421 22355777877644 45667788899999999997 99999999987
Q ss_pred E-eCCeEEEEEeccCCCchHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCC
Q 012518 199 E-DANSVYIVMEFCEGGELLDRILSR-------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 270 (461)
Q Consensus 199 ~-~~~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~ 270 (461)
. +....++++.++.-|+|..++... ...++..+...++.|+..|++|||++||||.||..+|++| ++..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhhe
Confidence 5 455678889999899998888621 1235556778899999999999999999999999999999 5678
Q ss_pred CeeEeecccccccCCCCC--c-cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHh
Q 012518 271 PLKVIDFGLSDFVRPDQR--L-NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLR 345 (461)
Q Consensus 271 ~~kl~DFG~a~~~~~~~~--~-~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~ 345 (461)
.+||+|=.+++...+.+- + ..-.-...||++|.+. ..|+.++|||||||+||||+| |+.||..-+..++..-+..
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 899999999987654431 1 1112345699999886 679999999999999999998 9999988888877776665
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 012518 346 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384 (461)
Q Consensus 346 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L 384 (461)
+. ....+ -++++++..++.-||..+|++||+.+|+.
T Consensus 514 Gy-RlaQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 514 GY-RLAQP--FNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred cc-eecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 43 22222 46999999999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-31 Score=263.91 Aligned_cols=244 Identities=26% Similarity=0.480 Sum_probs=210.5
Q ss_pred eeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEecc
Q 012518 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFC 211 (461)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~ 211 (461)
.+|+|+||.|++++...+...|..+|+|+.++......... ....|..++..++.||.+|+++..|+.+..++++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 37999999999998877777889999999887554333222 44568888888877999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCccc
Q 012518 212 EGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND 291 (461)
Q Consensus 212 ~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~ 291 (461)
.||+|...+.+. ..+.+...+.+...++.+++++|+.||+|||+|++||++ +.+|++|+.|||+++..-.....
T Consensus 80 rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred ccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc--
Confidence 999998877443 567888899999999999999999999999999999999 57888999999999876543332
Q ss_pred cccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcc
Q 012518 292 IVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 371 (461)
Q Consensus 292 ~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 371 (461)
|||..|||||+++ .+...+|.||||++++||+||..||.. ++...|+.....++.. ++.++++++..++.
T Consensus 154 -cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~----l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRE----LSAEARSLFRQLFK 223 (612)
T ss_pred -ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchh----hhHHHHHHHHHHHh
Confidence 9999999999998 677899999999999999999999977 7788888877776654 78899999999999
Q ss_pred cCcCCCCCH-----HHHhcCCCcCCC
Q 012518 372 KDHRKRMTA-----AQALTHPWLHDE 392 (461)
Q Consensus 372 ~dP~~R~s~-----~e~L~hp~~~~~ 392 (461)
++|.+|... .|+++|+||+..
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheee
Confidence 999999754 799999999865
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-27 Score=230.43 Aligned_cols=257 Identities=33% Similarity=0.602 Sum_probs=206.7
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
|.+.+.||.|+||.||++.+. ..+|+|.+.............+.+|+.++..+.+|++|+++++.+......++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEE
Confidence 788899999999999999875 67999999876554444567889999999999733489999999988888999
Q ss_pred EEeccCCCchHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCC-CeeEeeccccccc
Q 012518 207 VMEFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA-PLKVIDFGLSDFV 283 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~--~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~-~~kl~DFG~a~~~ 283 (461)
+++|+.++++.+.+.... ..+.+..+..++.|++.++.|+|+.|++||||||+||++. ... .++++|||++...
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceec
Confidence 999999999986554433 2689999999999999999999999999999999999995 334 6999999998855
Q ss_pred CCCC-------CccccccCCCcCchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCCh----hhHHHHHHhcCC
Q 012518 284 RPDQ-------RLNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIFRSVLRADP 348 (461)
Q Consensus 284 ~~~~-------~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~ 348 (461)
.... .....+||..|+|||.+.+ .++...|+||+|++++++++|..||..... ......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 4332 2466789999999999864 688899999999999999999999877663 344444444332
Q ss_pred C-CCCCCCCCC----CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 349 N-FHDSPWPSV----SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 349 ~-~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
. ......... ...+.+++.+++..+|..|.+..+...++|....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 2 222111111 2579999999999999999999999998776543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=223.27 Aligned_cols=162 Identities=30% Similarity=0.372 Sum_probs=128.9
Q ss_pred CchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCccccc
Q 012518 214 GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIV 293 (461)
Q Consensus 214 g~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 293 (461)
|+|.+++..++..+++..++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~---~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT---WDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc---Cccceee--ccceEeecccc----CC
Confidence 6899988776677999999999999999999999998 99999994 5677888 99988764432 36
Q ss_pred cCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh-hhHHHHHHhcCCCCCC---CCCCCCCH--HHHHHH
Q 012518 294 GSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLRADPNFHD---SPWPSVSP--EAKDFV 366 (461)
Q Consensus 294 gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~~~---~~~~~~s~--~~~~li 366 (461)
||+.|||||++. +.|+.++|||||||++|||++|+.||..... ...+..+......... .....++. +++++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999986 5699999999999999999999999976543 2333333332221111 11122344 699999
Q ss_pred HHhcccCcCCCCCHHHHhcCCCcC
Q 012518 367 RRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 367 ~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
.+||..||.+||++.|+++|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-27 Score=231.41 Aligned_cols=254 Identities=23% Similarity=0.281 Sum_probs=191.1
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCC---CCCeeEEEEEE-EeC
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG---HKHMIKFHDAF-EDA 201 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~---hpniv~l~~~~-~~~ 201 (461)
+|++.++||+|+||.||+|.+.... .+.+|+|+......... ..+..|+.++..+.. -.++..+++.+ ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 8999999999999999999987532 46899998765422211 146678999998862 36899999999 578
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC--CCCeeEeecc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE--DAPLKVIDFG 278 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~--~~~~kl~DFG 278 (461)
...|+||+.+ |.+|.+...... ++++..++..++.|++.+|++||+.|++||||||+|++++..+. ...+.|.|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 8899999998 779988765554 78999999999999999999999999999999999999986432 2579999999
Q ss_pred cccccC--CCC--------C-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc
Q 012518 279 LSDFVR--PDQ--------R-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA 346 (461)
Q Consensus 279 ~a~~~~--~~~--------~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~ 346 (461)
+++... ... . .....||..|+++.+.. ...+.+.|+||++.++.+++.|..||...........+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998322 111 1 12356999999999876 46899999999999999999999999765543333333222
Q ss_pred CCCCCCC-CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 347 DPNFHDS-PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 347 ~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
....... .....+.++.++...+-..+...+|....+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 2111111 12234566777777776677777877665543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-30 Score=266.41 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=195.0
Q ss_pred eeceeeccCCceEEEEEEeccCCccCcEEEEEEecc---cccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISK---AKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~---~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.....+|.|++|.|+.+.... ..+.++.|..+. ...........+..|+.+-..|+ |+||+..+..+.+....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~---~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRS---DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEIDGI 396 (601)
T ss_pred CccceeeecccCceEEEEecC---CCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhcccc
Confidence 456789999999888877654 344455554431 11122222233667888888886 99998888777777777
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
+-+||||++ +|+..+... +++...++..+++||+.|++|||+.||.|||||++|++++ .++.+||+|||.+....
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---ENGILKIIDFGAASVFR 471 (601)
T ss_pred hhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cCCceEEeecCcceeec
Confidence 777999999 999987544 5799999999999999999999999999999999999996 56689999999987654
Q ss_pred CCC-----CccccccCCCcCchhhhh-ccCCC-chhHHHHHHHHHHHhhCCCCCCCCChhhHH--HHHHhcCCCCC---C
Q 012518 285 PDQ-----RLNDIVGSAYYVAPEVLH-RSYNV-EGDMWSIGVITYILLCGSRPFWARTESGIF--RSVLRADPNFH---D 352 (461)
Q Consensus 285 ~~~-----~~~~~~gt~~y~aPE~l~-~~~~~-~~DiwSlGvil~elltg~~Pf~~~~~~~~~--~~i~~~~~~~~---~ 352 (461)
... .....+|+..|+|||++. ..|+. .+||||.|++++.|++|+.||......+.. ........... .
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 322 235688999999999986 45664 589999999999999999999654433221 11111111111 1
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 353 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 353 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
..|..++.+.+.+|.+||+.||.+|.|+++|++.+||+...
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 22345788999999999999999999999999999998754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=214.88 Aligned_cols=248 Identities=21% Similarity=0.313 Sum_probs=196.7
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
....|+++++||.|+||.+|++.... +|+.||||+-+... .. -++..|..+...|++...|..+..++.+.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~---~ge~VAiK~Es~~a-~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISIT---SGEEVAIKLESSKA-KH----PQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred eccceEEEEeecCCchhheeeeeecc---CCceEEEEeecccC-CC----cchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 34689999999999999999999876 89999999865432 22 346689999999987789999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
+-.||||++ |.+|.+.+.-...+++..++..++-|++.-++|+|.+++|||||||+|+|.+-......+.|+|||+|+.
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 999999998 7899998876777899999999999999999999999999999999999998766677899999999987
Q ss_pred cCCCC--------CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCC---ChhhHHHHHHhcCCCC
Q 012518 283 VRPDQ--------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWAR---TESGIFRSVLRADPNF 350 (461)
Q Consensus 283 ~~~~~--------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~i~~~~~~~ 350 (461)
+.+.. .-....||..|.+-.... -.-+.+.|+-|+|.+|..+.-|..||.+- +....++.|...+...
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 65432 124467999999877654 24567899999999999999999999774 3444555665544333
Q ss_pred CC-CCCCCCCHHHHHHHHHhcccCcCCCCC
Q 012518 351 HD-SPWPSVSPEAKDFVRRLLNKDHRKRMT 379 (461)
Q Consensus 351 ~~-~~~~~~s~~~~~li~~~L~~dP~~R~s 379 (461)
+. ....+++.++.-.+.-|=..--++-|.
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 22 122457777777777775444334443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=235.64 Aligned_cols=165 Identities=22% Similarity=0.240 Sum_probs=128.6
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEeccccc--CCHHHHHHHHHHHHHHHhcCCCCCeeE-EEEEEE
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM--TSALAIEDVRREVKILKALSGHKHMIK-FHDAFE 199 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~~hpniv~-l~~~~~ 199 (461)
+.++|.+.+.||+|+||+||+|+++.. +|+.||||++..... ......+.+.+|+++|++|. |+||+. ++++
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~-- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGD--PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT-- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCC--CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc--
Confidence 456899999999999999999987641 567789998753311 12334567899999999996 999884 5442
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCC-CCCcEEEecCCCCCCeeEeecc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDL-KPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDl-kp~NILl~~~~~~~~~kl~DFG 278 (461)
+..|||||||.|++|.. + .. .. ...++.|++.+|.|||++||+|||| ||+|||++ .++.+||+|||
T Consensus 91 --~~~~LVmE~~~G~~L~~-~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~---~~~~ikLiDFG 157 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-A-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG---PDGEAAVIDFQ 157 (365)
T ss_pred --CCcEEEEEccCCCCHHH-h-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc---CCCCEEEEECc
Confidence 46899999999998862 2 11 11 1468899999999999999999999 99999994 45679999999
Q ss_pred cccccCCCC---------CccccccCCCcCchhhhh
Q 012518 279 LSDFVRPDQ---------RLNDIVGSAYYVAPEVLH 305 (461)
Q Consensus 279 ~a~~~~~~~---------~~~~~~gt~~y~aPE~l~ 305 (461)
+|+...... ...+.++++.|+|||++.
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 998664432 124567899999999985
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=210.97 Aligned_cols=212 Identities=22% Similarity=0.403 Sum_probs=176.0
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
.+-.|+++++||+|+||+.+.+++.- +++.||||.-..... .-++..|.+..+.|.+.++|..+|.+..++.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~---nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLY---NNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred ecccceeccccccCcceeeecccccc---cCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 34589999999999999999998764 899999998644321 2456789999999988999999999989888
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC--CCCCCeeEeecccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR--EEDAPLKVIDFGLS 280 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~--~~~~~~kl~DFG~a 280 (461)
+-.||||++ |-+|+|++.-.+.+|+..++..++.|++.-++|+|++.+|+|||||+|+||+.. .+...|.|+|||+|
T Consensus 98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 899999998 779988776667789999999999999999999999999999999999999743 23456999999999
Q ss_pred cccCCCCC--------ccccccCCCcCchhhh-hccCCCchhHHHHHHHHHHHhhCCCCCCCC---ChhhHHHHH
Q 012518 281 DFVRPDQR--------LNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWAR---TESGIFRSV 343 (461)
Q Consensus 281 ~~~~~~~~--------~~~~~gt~~y~aPE~l-~~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~i 343 (461)
+.+.+... ..+..||..||+-... .+.-+.+.|+-|||-+++..|-|..||.+- +..+-+++|
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 98765432 2456799999997753 356788899999999999999999999763 444445554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=236.75 Aligned_cols=222 Identities=28% Similarity=0.497 Sum_probs=172.8
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
..+|+.++.|..|+||-||+++++. +.+.+|+|+ .+.+. +.|- |+... +.|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~---trqrfa~ki-Nkq~l--------ilRn--ilt~a-~npfvv----------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKE---TRQRFAMKI-NKQNL--------ILRN--ILTFA-GNPFVV----------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccc---cccchhhcc-cccch--------hhhc--ccccc-CCccee-----------
Confidence 3579999999999999999999886 678899954 33321 1111 22222 344444
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
||-...+. ..+.++.+. +.+++|||+.||+|||+||+|.||+. -+++|+.|||+++..
T Consensus 136 ----------gDc~tllk-~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~---mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ----------GDCATLLK-NIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITS---MGHIKLTDFGLSKKG 193 (1205)
T ss_pred ----------chhhhhcc-cCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeee---cccccccchhhhhhh
Confidence 44444332 224444332 78999999999999999999999974 566999999997642
Q ss_pred CCC----------------CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc
Q 012518 284 RPD----------------QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA 346 (461)
Q Consensus 284 ~~~----------------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~ 346 (461)
... -.-...+||+.|+||||+. +.|+..+|+|++|+|+||.+.|..||.+++..+++..++..
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd 273 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 273 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence 110 0113468999999999875 67999999999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCcCCCCC
Q 012518 347 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM---TAAQALTHPWLHDENR 394 (461)
Q Consensus 347 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~L~hp~~~~~~~ 394 (461)
...+++..+ .+.++++++|.++|+.+|..|. .+.++.+|+||+....
T Consensus 274 ~i~wpE~de-a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 274 DIEWPEEDE-ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred hccccccCc-CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 888888754 4889999999999999999995 6778999999987543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-25 Score=201.95 Aligned_cols=174 Identities=16% Similarity=0.193 Sum_probs=134.0
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHH------HHHHHHHHHhcCCCCCeeEEEE
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIED------VRREVKILKALSGHKHMIKFHD 196 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~------~~~Ei~il~~l~~hpniv~l~~ 196 (461)
+..+|++.+.||.|+||.||++.. ++..+|||++.......+..... +.+|++.+.+|. |++|..+.+
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d 102 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLND 102 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceE
Confidence 567999999999999999999654 35579999997655444444444 579999999996 999999999
Q ss_pred EEEeC--------CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC
Q 012518 197 AFEDA--------NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 268 (461)
Q Consensus 197 ~~~~~--------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~ 268 (461)
++.+. +..+|||||++|.+|.+.. .+++ ....+++.+|..||+.||+||||||.||+++ .
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~---~ 170 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS---K 170 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---C
Confidence 87643 3589999999999997752 1333 3466999999999999999999999999996 3
Q ss_pred CCCeeEeecccccccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHh
Q 012518 269 DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILL 325 (461)
Q Consensus 269 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~ell 325 (461)
++ ++|+|||............. =++.+.|+.++|+|||||++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 44 99999998765432211110 023456888999999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-24 Score=192.54 Aligned_cols=189 Identities=20% Similarity=0.242 Sum_probs=141.9
Q ss_pred eeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCC-HHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS-ALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
.+...||+|+||+||++.. .+..++.+.+....... ..+...+.+|+++|++|.+|++|++++++ +..|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~l 75 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHL 75 (218)
T ss_pred ccceeecCCCcceEEEeec-----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEE
Confidence 3567899999999997754 45667777665443221 11223578999999999867999999986 34699
Q ss_pred EEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCC-CCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 207 VMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDL-KPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDl-kp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+|||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++ .++.++|+|||+|.....
T Consensus 76 vmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred EEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCC
Confidence 9999999888653311 1 2357889999999999999999999 79999995 466799999999986554
Q ss_pred CCCc----c----------ccccCCCcCchhhhh--ccCC-CchhHHHHHHHHHHHhhCCCCCCCCCh
Q 012518 286 DQRL----N----------DIVGSAYYVAPEVLH--RSYN-VEGDMWSIGVITYILLCGSRPFWARTE 336 (461)
Q Consensus 286 ~~~~----~----------~~~gt~~y~aPE~l~--~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~ 336 (461)
.... . -...++.|++|+.-. ...+ ...++++.|+-+|.++|+..+++.+++
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 3321 0 023578888888532 3333 567999999999999999999887664
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=202.09 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=174.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCC-----------------c---------------cCcEEEEEEecccccC--CHH
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGT-----------------L---------------KGKVVAVKIISKAKMT--SAL 170 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~-----------------~---------------~g~~vAvK~i~~~~~~--~~~ 170 (461)
++|++++.||+|.-..||.|+.+.+. . ..-..|||.+-.-... +..
T Consensus 157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~~ 236 (598)
T KOG4158|consen 157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDAH 236 (598)
T ss_pred hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchHH
Confidence 57999999999999999998765410 0 0113566665321111 111
Q ss_pred HHHHHHHHHH------H--------HH-------hcCCCCCeeEEEEEEEeC---------------------------C
Q 012518 171 AIEDVRREVK------I--------LK-------ALSGHKHMIKFHDAFEDA---------------------------N 202 (461)
Q Consensus 171 ~~~~~~~Ei~------i--------l~-------~l~~hpniv~l~~~~~~~---------------------------~ 202 (461)
-++.+.+|.- . .+ +|..|||||++.++|.+. .
T Consensus 237 iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~ 316 (598)
T KOG4158|consen 237 ILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPK 316 (598)
T ss_pred HHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCc
Confidence 2222333321 0 11 123699999999987542 3
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCC-CCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED-APLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~-~~~kl~DFG~a~ 281 (461)
.+|+||.-+.. +|.+++..+ ..+....+-++.|+++|+.|||.+||.|||+|.+|||+.-+++. -.+.|+|||.+-
T Consensus 317 tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 317 TLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred eEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 58999998864 899988654 47778888999999999999999999999999999999764332 347889999764
Q ss_pred ccCC-------CCCccccccCCCcCchhhhhccC-------CCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC
Q 012518 282 FVRP-------DQRLNDIVGSAYYVAPEVLHRSY-------NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 347 (461)
Q Consensus 282 ~~~~-------~~~~~~~~gt~~y~aPE~l~~~~-------~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 347 (461)
.-.. .......-|.-..||||+..... -.++|.|+.|.+.||+++...||+...+.-+-..-.+..
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~ 473 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES 473 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh
Confidence 3211 11223345788899999986321 147899999999999999999998844321111111110
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCH---HHHhcC
Q 012518 348 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA---AQALTH 386 (461)
Q Consensus 348 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~---~e~L~h 386 (461)
..+. ....+++.+++||..+|+.||++|+++ +.+|+.
T Consensus 474 -qLPa-lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 474 -QLPA-LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred -hCCC-CcccCChHHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence 1111 113588999999999999999999985 345543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=200.50 Aligned_cols=235 Identities=24% Similarity=0.373 Sum_probs=151.1
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCC---------CCCeeEEEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG---------HKHMIKFHD 196 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~---------hpniv~l~~ 196 (461)
.+..++.||.|+|+.||.|.+.. +|+.+|||+............+++.+|.-....+.+ |-.++--++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~---t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d 89 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVE---TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD 89 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred EEEEccccccCCceEEEEEEEcc---CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence 46678899999999999999876 899999999865544444557777777755544331 222222222
Q ss_pred EE---------EeC---C-----eEEEEEeccCCCchHHHHH---hcCCC-CCH-HHH-HHHHHHHHHHHHHHHHcCccc
Q 012518 197 AF---------EDA---N-----SVYIVMEFCEGGELLDRIL---SRGGR-YLE-EDA-KTIVEKILNIVAFCHLQGVVH 253 (461)
Q Consensus 197 ~~---------~~~---~-----~~~lv~e~~~gg~L~~~l~---~~~~~-~~~-~~~-~~i~~qil~al~yLH~~givH 253 (461)
.. ... . ..+++|+-+. ++|.+.+. ..... ... ..+ ..+..|++..+.+||..||||
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVH 168 (288)
T PF14531_consen 90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVH 168 (288)
T ss_dssp EEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEe
Confidence 22 111 1 2367888774 58866643 22222 111 222 456689999999999999999
Q ss_pred cCCCCCcEEEecCCCCCCeeEeecccccccCCCCCccccccCCCcCchhhhhc---------cCCCchhHHHHHHHHHHH
Q 012518 254 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR---------SYNVEGDMWSIGVITYIL 324 (461)
Q Consensus 254 rDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~---------~~~~~~DiwSlGvil~el 324 (461)
+||||+|+|++ .++.++|+||+.....+. .......+..|.+||.... .++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~---~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLD---QDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE----TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEc---CCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999994 678899999987765432 2222345578999997642 378899999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 012518 325 LCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKR 377 (461)
Q Consensus 325 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 377 (461)
+||..||........... .|... .++++..++||+.||+.||.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~------~f~~C--~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW------DFSRC--RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG------GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc------cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence 999999976544322221 22222 2588999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=192.83 Aligned_cols=142 Identities=21% Similarity=0.202 Sum_probs=108.4
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHH-----------------------HHHHHHHHHHHHHhcC
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSAL-----------------------AIEDVRREVKILKALS 186 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~ 186 (461)
...||+|+||.||+|.+. +|+.||||+++........ ......+|++++.+|.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05147 2 NGCISTGKEANVYHATTA----NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV 77 (190)
T ss_pred CCccccccceEEEEEECC----CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 467999999999999874 6899999999764321111 0123345999999996
Q ss_pred CCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHcCccccCCCCCcEEEec
Q 012518 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC-HLQGVVHRDLKPENFLFTT 265 (461)
Q Consensus 187 ~hpniv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yL-H~~givHrDlkp~NILl~~ 265 (461)
++++.....+... ..+|||||+.|+++...+.. ...+++..+..++.|++.+|.|+ |+.||+||||||+|||++
T Consensus 78 -~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 78 -TAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred -HCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 7766433322222 23899999998877654433 35789999999999999999999 799999999999999995
Q ss_pred CCCCCCeeEeeccccccc
Q 012518 266 REEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 266 ~~~~~~~kl~DFG~a~~~ 283 (461)
++.++|+|||+|...
T Consensus 153 ---~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 ---DGKLYIIDVSQSVEH 167 (190)
T ss_pred ---CCcEEEEEccccccC
Confidence 356999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-24 Score=224.73 Aligned_cols=245 Identities=21% Similarity=0.316 Sum_probs=174.3
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccc-cCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAK-MTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
+|...+.||.+.|=+|.+|++.+ |. |+||++-+.. ..+-....+..+|++ .... .|||++.+..+.+.++.-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHH
Confidence 67888999999999999998864 54 8999986543 223233344445666 3333 599999999888888889
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc-
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV- 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~- 283 (461)
|||-+|... +|+|++-.+ .-+..-+.+.|+.||+.||.-||..||+|+|||.|||||++ -+.+.|+||...+..
T Consensus 97 ylvRqyvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS---WNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS---WNWLYLTDFASFKPTY 171 (1431)
T ss_pred HHHHHHHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee---echhhhhcccccCCcc
Confidence 999999965 999998544 34566778889999999999999999999999999999984 455899999865432
Q ss_pred -CCCC--Ccc----ccccCCCcCchhhhhc-----------c-CCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHH
Q 012518 284 -RPDQ--RLN----DIVGSAYYVAPEVLHR-----------S-YNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSV 343 (461)
Q Consensus 284 -~~~~--~~~----~~~gt~~y~aPE~l~~-----------~-~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i 343 (461)
..+. .++ +..--..|.|||.+.. . .+++.||||+||+++||++ |++||.- .++-..
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aY 247 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAY 247 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhH
Confidence 1111 111 1112235999997632 1 5678999999999999998 7888831 111111
Q ss_pred HhcCCCCCCCCCCC-CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 344 LRADPNFHDSPWPS-VSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 344 ~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
..+..........+ -+..++.||..|++.||++|.+|++.|+.
T Consensus 248 r~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11110000000000 13478999999999999999999999975
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-23 Score=185.09 Aligned_cols=143 Identities=22% Similarity=0.230 Sum_probs=110.9
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCC-----------------------HHHHHHHHHHHHHHHhcC
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS-----------------------ALAIEDVRREVKILKALS 186 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~-----------------------~~~~~~~~~Ei~il~~l~ 186 (461)
.+.||+|+||+||+|.+. +|+.||||+++...... ......+.+|.+.+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05145 2 NGCISTGKEANVYHARTG----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY 77 (190)
T ss_pred CceeecCCCcEEEEEEcC----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 568999999999999864 68999999997652110 001223468999999996
Q ss_pred CCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEec
Q 012518 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTT 265 (461)
Q Consensus 187 ~hpniv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~ 265 (461)
|++|.....+.... .||||||+.|+++...... ...+++..+..++.|++.+|.++|+ +||+||||||+|||++
T Consensus 78 -~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~- 152 (190)
T cd05145 78 -EAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred -hCCCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence 88875444433332 4899999998866544333 3568888999999999999999999 9999999999999995
Q ss_pred CCCCCCeeEeecccccccC
Q 012518 266 REEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 266 ~~~~~~~kl~DFG~a~~~~ 284 (461)
++.++|+|||++....
T Consensus 153 ---~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 ---DGKPYIIDVSQAVELD 168 (190)
T ss_pred ---CCCEEEEEcccceecC
Confidence 4669999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=182.46 Aligned_cols=138 Identities=21% Similarity=0.305 Sum_probs=106.7
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC----CCCCeeEEEEEEEeCC---
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS----GHKHMIKFHDAFEDAN--- 202 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~----~hpniv~l~~~~~~~~--- 202 (461)
.+.||+|+||.||. +.. ++.. +||++...... ..+.+.+|+.+++.|. +||||++++++++++.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~---~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPE---DAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cceecCCCceEEEE--CCC---CcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 46899999999995 433 4444 69998764322 3467899999999994 3899999999998874
Q ss_pred eEE-EEEec--cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHcCccccCCCCCcEEEecCC-CCCCeeEee-
Q 012518 203 SVY-IVMEF--CEGGELLDRILSRGGRYLEEDAKTIVEKILNIV-AFCHLQGVVHRDLKPENFLFTTRE-EDAPLKVID- 276 (461)
Q Consensus 203 ~~~-lv~e~--~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al-~yLH~~givHrDlkp~NILl~~~~-~~~~~kl~D- 276 (461)
.++ +|||| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++..+ .+..++|+|
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 434 78999 557999998844 346655 36688888888 999999999999999999997533 344799999
Q ss_pred cccc
Q 012518 277 FGLS 280 (461)
Q Consensus 277 FG~a 280 (461)
||..
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 5543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=208.82 Aligned_cols=196 Identities=24% Similarity=0.362 Sum_probs=157.8
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC--CCCCeeEEEEEEEe
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS--GHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpniv~l~~~~~~ 200 (461)
-+..|.|.+.||+|+||+||+|... +|+.||+|+-+......-. -=.+++.+|+ --+.|+.+..++.-
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~----~~~~~alK~e~P~~~WEfY------I~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHS----NGKLVALKVEKPPNPWEFY------ICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecC----CCcEEEEEeecCCCceeee------ehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3457999999999999999999875 4899999997765443221 1222333332 12466677777777
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC----CCCCCeeEee
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR----EEDAPLKVID 276 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~----~~~~~~kl~D 276 (461)
.+.-+||+||.+.|+|++++. ..+.+++..+..+..|++..++.||..+|||+||||+|+||... .+..-++|+|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 778899999999999999875 56778999999999999999999999999999999999999742 2344599999
Q ss_pred ccccccc---CCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCC
Q 012518 277 FGLSDFV---RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSR 329 (461)
Q Consensus 277 FG~a~~~---~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~ 329 (461)
||-+..+ .++.++...++|-.+-.+|+.. +.+++.+|.|.|..+++-||.|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9988644 3345677788999999999987 469999999999999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-23 Score=218.22 Aligned_cols=260 Identities=26% Similarity=0.454 Sum_probs=211.6
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
.|++.+.||+|+|+.|-++..... ....+|+|.+.... ......+.+..|..+-+.+..|.|++.+++...+.+..+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~--~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRD--PESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccchhhhhhhcCC--CcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 678888899999999988776432 34567777765443 233445666778888888877999999999999999999
Q ss_pred EEEeccCCCchHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCcEEEecCCCCC-CeeEeecccccc
Q 012518 206 IVMEFCEGGELLDRI-LSRGGRYLEEDAKTIVEKILNIVAFCH-LQGVVHRDLKPENFLFTTREEDA-PLKVIDFGLSDF 282 (461)
Q Consensus 206 lv~e~~~gg~L~~~l-~~~~~~~~~~~~~~i~~qil~al~yLH-~~givHrDlkp~NILl~~~~~~~-~~kl~DFG~a~~ 282 (461)
++++|..|+++.+.+ .......+...+..++.|+..++.|+| ..++.||||||+|.+++. .+ .+|+.|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~---s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE---SGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc---CCCcccCCCchhhcc
Confidence 999999999999988 433326778889999999999999999 999999999999999963 44 799999999987
Q ss_pred cCC-CC---Ccccccc-CCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHH-HHHHhcCCCCCCCC
Q 012518 283 VRP-DQ---RLNDIVG-SAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIF-RSVLRADPNFHDSP 354 (461)
Q Consensus 283 ~~~-~~---~~~~~~g-t~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~-~~i~~~~~~~~~~~ 354 (461)
... .. .....+| ++.|+|||...+ ......|+||+|+++..+++|..|+......... .........+....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 765 22 3345688 999999998765 4678899999999999999999998665443322 22223334456778
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
|..++....+++.++|..+|..|.+..++-.++|+..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccccccccc
Confidence 8999999999999999999999999999999999987
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-22 Score=193.79 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=168.5
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEE------EEE-
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFH------DAF- 198 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~------~~~- 198 (461)
.+.+.+..+..++|.++..+...+....+.+..|..+.++ ........+++-.+.-..+|+..+..- ..+
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 4555666777777777665544322223344444433322 122333445666655555344433321 011
Q ss_pred ----EeCCeEEEEEeccCCCchHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCe
Q 012518 199 ----EDANSVYIVMEFCEGGELLDRILSR--GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 272 (461)
Q Consensus 199 ----~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~ 272 (461)
....++||.|++|.-.+|.+||..+ ....+....+.++.|+..|++| +|.+|||+||.||++. .+..+
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~ 395 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQL 395 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhh
Confidence 1134689999999999999999643 2345567788999999999999 9999999999999996 44569
Q ss_pred eEeecccccccCCCC-------CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHH
Q 012518 273 KVIDFGLSDFVRPDQ-------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSV 343 (461)
Q Consensus 273 kl~DFG~a~~~~~~~-------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i 343 (461)
||.|||+........ ..+..+||.+||+||.|. +.|+.++||||||+||+|++. -...|. ....+..+
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~ 472 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDI 472 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhh
Confidence 999999988766554 556789999999999997 569999999999999999997 222221 11122222
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 344 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 344 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
..+ .++...|.+. ++-.+|+.+||...|.+||++.+.--|.|.
T Consensus 473 r~g--~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 RDG--IIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcC--CCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 222 2222222222 456689999999999999988887777775
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=176.60 Aligned_cols=240 Identities=19% Similarity=0.237 Sum_probs=183.9
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+..+..+|.+...|..|++++ .|..+++|++.....+.. ...+|..|.-.|+-+. ||||+.+++.|.....+.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrw-----qgndivakil~vr~~t~r-isrdfneefp~lrifs-hpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRW-----QGNDIVAKILNVREVTAR-ISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLV 263 (448)
T ss_pred hhhhhhhhccCCCcccccccc-----cCcchhhhhhhhhhcchh-hcchhhhhCcceeeec-CCchhhhhhhccCCCCce
Confidence 456777899999999998876 455677888876554433 2356888888888886 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCcEEEecCCCCCCeeE--eecccc
Q 012518 206 IVMEFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENFLFTTREEDAPLKV--IDFGLS 280 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~i~~qil~al~yLH~~g--ivHrDlkp~NILl~~~~~~~~~kl--~DFG~a 280 (461)
++..||+.|+|+..++...+ ..+..++.+++.+|++|+.|||+.. |.---|....+++ |++.+.+| +|--++
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfs 340 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFS 340 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceee
Confidence 99999999999999876643 3566889999999999999999984 4455688999999 45555554 443333
Q ss_pred cccCCCCCccccccCCCcCchhhhhcc----CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLHRS----YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
.. .....-.+.||+||.+++. .-.++|+|||.++||||.|...||.+-...+.-.+|.-...... ..+
T Consensus 341 fq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~--ipp 412 (448)
T KOG0195|consen 341 FQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH--IPP 412 (448)
T ss_pred ee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc--CCC
Confidence 21 1122346789999999743 23578999999999999999999987766555444433222222 226
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHH
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQA 383 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~ 383 (461)
+++..+..|+.-|+..||.+||.++.+
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCccee
Confidence 799999999999999999999987654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-20 Score=185.65 Aligned_cols=226 Identities=25% Similarity=0.353 Sum_probs=169.7
Q ss_pred HhcCCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCc-cccCCCCCcE
Q 012518 183 KALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV-VHRDLKPENF 261 (461)
Q Consensus 183 ~~l~~hpniv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~gi-vHrDlkp~NI 261 (461)
+.+. |.|+.+++|.+.+...+++|.+||..|+|.|.+......++......++++|+.||.|||...| .|+.++..|+
T Consensus 2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4564 9999999999999999999999999999999998877788888899999999999999999866 9999999999
Q ss_pred EEecCCCCCCeeEeecccccccCCC---CCccccccCCCcCchhhhhcc--------CCCchhHHHHHHHHHHHhhCCCC
Q 012518 262 LFTTREEDAPLKVIDFGLSDFVRPD---QRLNDIVGSAYYVAPEVLHRS--------YNVEGDMWSIGVITYILLCGSRP 330 (461)
Q Consensus 262 Ll~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~--------~~~~~DiwSlGvil~elltg~~P 330 (461)
++ +..+.+||+|||+....... .......-...|.|||.+... .+.+.||||+|++++|+++.+.|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 46888999999998766421 111122234569999998642 46779999999999999999999
Q ss_pred CCCCCh----hhHHHHHHh-cCCCCCCCCC--CCCCHHHHHHHHHhcccCcCCCCCHHHHhcC-CCcCCCC-CCCCchHH
Q 012518 331 FWARTE----SGIFRSVLR-ADPNFHDSPW--PSVSPEAKDFVRRLLNKDHRKRMTAAQALTH-PWLHDEN-RPVPLDIL 401 (461)
Q Consensus 331 f~~~~~----~~~~~~i~~-~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h-p~~~~~~-~~~~~~~~ 401 (461)
|..... .+++..+.. ....+....+ ..+.+++..+++.||..+|.+||+++++-.. ..+.... .+..+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~~~~nl~D~ 237 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGSSKGNLMDS 237 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccccccchhHHH
Confidence 976322 245555554 2222222222 1456689999999999999999999987542 1111111 12244455
Q ss_pred HHHHHHHHhhc
Q 012518 402 IYKLVKSYLRA 412 (461)
Q Consensus 402 ~~~~~~~~~~~ 412 (461)
+.+++.+|...
T Consensus 238 m~~~le~Y~~n 248 (484)
T KOG1023|consen 238 LFRMLESYADN 248 (484)
T ss_pred HHHHHHHHHhh
Confidence 66777776544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=176.82 Aligned_cols=147 Identities=24% Similarity=0.199 Sum_probs=112.1
Q ss_pred cceeeceeeccCCceEEEEEE-eccCCccCcEEEEEEecccccCC-------------------H--HHHHHHHHHHHHH
Q 012518 125 AKFELGKEVGRGHFGHTCCAK-GKKGTLKGKVVAVKIISKAKMTS-------------------A--LAIEDVRREVKIL 182 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~-~~~~~~~g~~vAvK~i~~~~~~~-------------------~--~~~~~~~~Ei~il 182 (461)
.-|.+.+.||+|+||.||+|. +.. +|+.||||+++...... . .....+.+|+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDG---SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCC---CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 358899999999999999998 433 78999999987543110 0 0113467899999
Q ss_pred HhcCCC--CCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccCCCCC
Q 012518 183 KALSGH--KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG-VVHRDLKPE 259 (461)
Q Consensus 183 ~~l~~h--pniv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~g-ivHrDlkp~ 259 (461)
+++. + ..+.+++++ ...+|||||+.|++|...+.. ...+....+..++.||+.+|.+||++| |+||||||+
T Consensus 105 ~~L~-~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~ 178 (237)
T smart00090 105 QRLY-EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY 178 (237)
T ss_pred HHHH-hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence 9996 4 234444442 235899999999888665433 245666778899999999999999999 999999999
Q ss_pred cEEEecCCCCCCeeEeecccccccC
Q 012518 260 NFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 260 NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
||+++ ++.++|+|||.+....
T Consensus 179 NIli~----~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH----DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE----CCCEEEEEChhhhccC
Confidence 99995 4569999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-19 Score=165.09 Aligned_cols=137 Identities=27% Similarity=0.379 Sum_probs=111.9
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH-----HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA-----LAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+.||+|++|.||+|.. .|..++||+......... .....+.+|+.++..+. |++|.....++.+.+..+
T Consensus 2 ~~l~~G~~~~vy~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFI 75 (211)
T ss_pred cccccCceEEEEEEee-----CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCE
Confidence 5799999999999976 467799998654332221 12345788999999996 888887777777778889
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
+||||++|++|.+.+.... . ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 76 lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 9999999999988774321 2 7788999999999999999999999999999995 45699999998875
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.8e-19 Score=185.77 Aligned_cols=142 Identities=26% Similarity=0.309 Sum_probs=112.3
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-----CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-----SALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
...|...+.||+|+||+||++... +..+++|+....... .....+.+.+|+++++.++ |++|+..+.++
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~-----~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~ 405 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL-----GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYD 405 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec-----CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEE
Confidence 345567889999999999998763 334555543221111 1123456889999999996 99999888887
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 199 EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 199 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
.+....++||||++|++|.+++. ....++.|++.+|.|||+.||+||||||+|||+. ++.++|+|||
T Consensus 406 ~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFG 472 (535)
T PRK09605 406 VDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFG 472 (535)
T ss_pred EeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCc
Confidence 77778899999999999988774 3467899999999999999999999999999993 4569999999
Q ss_pred cccccC
Q 012518 279 LSDFVR 284 (461)
Q Consensus 279 ~a~~~~ 284 (461)
+++...
T Consensus 473 la~~~~ 478 (535)
T PRK09605 473 LGKYSD 478 (535)
T ss_pred ccccCC
Confidence 998653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.7e-19 Score=161.95 Aligned_cols=134 Identities=25% Similarity=0.290 Sum_probs=105.3
Q ss_pred eeccCCceEEEEEEeccCCccCcEEEEEEecccccCC-----HHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS-----ALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
.||+|+||.||++.. .|..|++|+........ .....++.+|++++..+. |+++.....++.+.+..++
T Consensus 1 ~ig~G~~~~vy~~~~-----~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTI 74 (199)
T ss_pred CCCCCceEEEEEeec-----CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEE
Confidence 489999999999973 56789999865432221 122466788999999996 7765554445556667799
Q ss_pred EEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 207 VMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
||||++|++|.+.+.... . .++.|++.+|.+||+.|++|+|++|.||++. ++.++|+|||++...
T Consensus 75 v~e~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEEECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence 999999999988764321 1 7899999999999999999999999999995 566999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=162.21 Aligned_cols=140 Identities=26% Similarity=0.331 Sum_probs=107.1
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH-------------------HHHHHHHHHHHHHHhcC
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA-------------------LAIEDVRREVKILKALS 186 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~ 186 (461)
.|.+.+.||+|+||.||++... +|+.||||++........ .......+|+.++..+.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 4788899999999999999764 689999999765321000 01123678999999995
Q ss_pred CCC--CeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEe
Q 012518 187 GHK--HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 264 (461)
Q Consensus 187 ~hp--niv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~ 264 (461)
|. .++..++ ....++||||+.|++|.+... ......++.+|+.++.++|+.||+||||||+||+++
T Consensus 92 -~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 92 -EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred -HcCCCCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 66 4455543 244689999999998865321 134567899999999999999999999999999995
Q ss_pred cCCCCCCeeEeecccccccC
Q 012518 265 TREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 265 ~~~~~~~~kl~DFG~a~~~~ 284 (461)
.++.++|+|||++....
T Consensus 160 ---~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 ---DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ---CCCcEEEEECCccccCC
Confidence 46789999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.5e-19 Score=178.06 Aligned_cols=262 Identities=20% Similarity=0.250 Sum_probs=203.4
Q ss_pred Cccccceeeceeecc--CCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 121 KNFGAKFELGKEVGR--GHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~--G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
..+...|.+.+.+|. |.+|.||.+.... ..++..+|+|.-+.. .........-.+|+...+++..|+|.++.+..+
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCc-ccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCccc
Confidence 344557788899999 9999999998721 227888999973221 111122233347888888888899999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHcCccccCCCCCcEEEecCCCCCCeeE
Q 012518 199 EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN----IVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 199 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~----al~yLH~~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
+..+..|+-+|+|. .+|..+.......+++..++.++.+... ||.++|+.+|+|-|+||+||++..+ ....++
T Consensus 188 e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~--~~s~~~ 264 (524)
T KOG0601|consen 188 EGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSD--WTSCKL 264 (524)
T ss_pred ccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccc--cceeec
Confidence 99999999999995 6888888877777889999999999999 9999999999999999999999632 267999
Q ss_pred eecccccccCCCCCc------cccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCC--ChhhHHHHHHhc
Q 012518 275 IDFGLSDFVRPDQRL------NDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWAR--TESGIFRSVLRA 346 (461)
Q Consensus 275 ~DFG~a~~~~~~~~~------~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~--~~~~~~~~i~~~ 346 (461)
+|||+...+....-. ....|...|++||++++-++...|||+||.+..+..+|..++... ..-..++...
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-- 342 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-- 342 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--
Confidence 999998877655311 222577789999999999999999999999999999987776443 2111111111
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 347 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 347 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.+.......+.++...+..|++.++..|++++.+++|+++...
T Consensus 343 ---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 343 ---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred ---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 2222223467777789999999999999999999999998743
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=155.08 Aligned_cols=141 Identities=26% Similarity=0.285 Sum_probs=100.3
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHH---------------------HHHHHHHHHHhcCCC
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIE---------------------DVRREVKILKALSGH 188 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~~h 188 (461)
.+.||+|+||+||+|.+. +|+.||||++............ ....|...+..+.++
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECC----CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 567999999999999864 5889999998764322111111 114577777776422
Q ss_pred -CCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecC
Q 012518 189 -KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTR 266 (461)
Q Consensus 189 -pniv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~ 266 (461)
-.+.+.++. ...++||||+.|+.+......... . ...++.++.+++.++.++|. .||+||||||+||+++
T Consensus 78 ~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-- 149 (187)
T cd05119 78 GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-- 149 (187)
T ss_pred CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE--
Confidence 235555543 235899999998654322221111 1 16688999999999999999 9999999999999995
Q ss_pred CCCCCeeEeecccccccC
Q 012518 267 EEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 267 ~~~~~~kl~DFG~a~~~~ 284 (461)
++.++|+|||.+....
T Consensus 150 --~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 --DGKVYIIDVPQAVEID 165 (187)
T ss_pred --CCcEEEEECccccccc
Confidence 5679999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.7e-17 Score=153.36 Aligned_cols=138 Identities=22% Similarity=0.250 Sum_probs=102.4
Q ss_pred eeec-cCCceEEEEEEeccCCccCcEEEEEEeccccc----------CCHHHHHHHHHHHHHHHhcCCCCCe--eEEEEE
Q 012518 131 KEVG-RGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM----------TSALAIEDVRREVKILKALSGHKHM--IKFHDA 197 (461)
Q Consensus 131 ~~lG-~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~----------~~~~~~~~~~~Ei~il~~l~~hpni--v~l~~~ 197 (461)
..|| .||.|+||.+.. .+..++||.+..... ........+.+|++++.+|. |++| ++.+++
T Consensus 37 ~~lg~~~g~gtv~~v~~-----~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~ 110 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-----PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAA 110 (239)
T ss_pred ceeecCCCCccEEEEEe-----CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEee
Confidence 4587 888899998875 367799998854321 11123456789999999996 7774 777776
Q ss_pred EEeC-Ce---EEEEEeccCC-CchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCe
Q 012518 198 FEDA-NS---VYIVMEFCEG-GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 272 (461)
Q Consensus 198 ~~~~-~~---~~lv~e~~~g-g~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~ 272 (461)
.... .. .++||||++| .+|.+.+.. ..+++. .+.||+.+|.+||++||+||||||+|||++ .++.+
T Consensus 111 ~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v 181 (239)
T PRK01723 111 RVVRHGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKF 181 (239)
T ss_pred eeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCE
Confidence 5432 22 2599999997 578776633 345554 367899999999999999999999999995 34579
Q ss_pred eEeeccccccc
Q 012518 273 KVIDFGLSDFV 283 (461)
Q Consensus 273 kl~DFG~a~~~ 283 (461)
+|+|||.+...
T Consensus 182 ~LIDfg~~~~~ 192 (239)
T PRK01723 182 WLIDFDRGELR 192 (239)
T ss_pred EEEECCCcccC
Confidence 99999988753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-17 Score=142.96 Aligned_cols=133 Identities=26% Similarity=0.312 Sum_probs=110.1
Q ss_pred eceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC-CCeeEEEEEEEeCCeEEEE
Q 012518 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH-KHMIKFHDAFEDANSVYIV 207 (461)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pniv~l~~~~~~~~~~~lv 207 (461)
+++.||.|.++.||++... +..+++|.+..... ...+.+|+.+++.++++ .++++++.++...+..+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v 71 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL 71 (155)
T ss_pred cceecccccccceEEEEec-----CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence 4578999999999999863 36799999865432 35678999999999744 6899999999888899999
Q ss_pred EeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 208 MEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ---GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 208 ~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~---givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
|||+.|+.+... +......++.+++.+|.+||.. +++|+||+|+|||++ ..+.++++|||.+..
T Consensus 72 ~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~ 138 (155)
T cd05120 72 MEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY 138 (155)
T ss_pred EEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence 999998777542 4556677899999999999985 799999999999996 356799999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.1e-18 Score=178.03 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=202.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
+.+.+.+-+-.|++|.++.++-.. +|-..++|+............+.+.++-.++-..+ +|.+++...-+......
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~---sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAG---SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred ccceecccccCCCCcccccCCccc---cccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCCCc
Confidence 467788889999999999887654 66667777665443333223344444544443332 67777766556667789
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
+|||+|+.|++|...+... +..+++-++.++..+..+++|||...++|||++|.|+|.. .+++.++.|||......
T Consensus 880 ~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred chhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCcccCccccccccc
Confidence 9999999999999888654 4677788888999999999999999999999999999994 67889999998432111
Q ss_pred ---------------------CC-----------CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCC
Q 012518 285 ---------------------PD-----------QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPF 331 (461)
Q Consensus 285 ---------------------~~-----------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf 331 (461)
.. .......||+.|.+||.+. ...+..+|+|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0112357899999999875 56889999999999999999999999
Q ss_pred CCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHH---HHhcCCCcCCCC
Q 012518 332 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA---QALTHPWLHDEN 393 (461)
Q Consensus 332 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~---e~L~hp~~~~~~ 393 (461)
...+...++++|.+.....+..+ ...+.++++++.++|..++.+|..+. ++-.|+||++..
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 99999999999988765554443 24789999999999999999999887 899999998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.6e-14 Score=145.58 Aligned_cols=144 Identities=21% Similarity=0.280 Sum_probs=95.9
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH---------------------------HHH----------H
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA---------------------------LAI----------E 173 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~---------------------------~~~----------~ 173 (461)
+.||.|++|+||+|+.+ +|+.||||+.+......- ... -
T Consensus 123 ~plasaSigQVh~A~l~----~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~El 198 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV----DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRREL 198 (437)
T ss_pred cceeeeehhheEEEEec----CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHH
Confidence 56999999999999875 689999999865311000 000 0
Q ss_pred HHHHHHHHHHhcC----CCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHH
Q 012518 174 DVRREVKILKALS----GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN-IVAFCHL 248 (461)
Q Consensus 174 ~~~~Ei~il~~l~----~hpniv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~-al~yLH~ 248 (461)
++.+|...+.++. ++++|.--.-+.......+|||||++|++|.+.......... ...++.+++. .+..+|.
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh
Confidence 2445555555543 344432211122223456899999999999876543211222 2345555555 4788999
Q ss_pred cCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 249 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 249 ~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
.|++|+|+||.||++. .++.++|+|||++..+.
T Consensus 276 ~g~~H~D~hPgNilv~---~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVL---KDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEEC---CCCcEEEEeCCCeeECC
Confidence 9999999999999994 56779999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.6e-14 Score=148.96 Aligned_cols=148 Identities=20% Similarity=0.328 Sum_probs=94.8
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC--------------------------C-H----HHHHH
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT--------------------------S-A----LAIED 174 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~--------------------------~-~----~~~~~ 174 (461)
.|+. +.||.|++|+||+|+.+. +|+.||||+++..-.. + . +..+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~---~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKD---NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECC---CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 4665 789999999999999875 5999999999754100 0 0 11122
Q ss_pred ------HHHHHHHHHhcC---CCCCeeEEEEEEEe-CCeEEEEEeccCCCchHHH--HHhcCC---CCCHHHHHHHHHHH
Q 012518 175 ------VRREVKILKALS---GHKHMIKFHDAFED-ANSVYIVMEFCEGGELLDR--ILSRGG---RYLEEDAKTIVEKI 239 (461)
Q Consensus 175 ------~~~Ei~il~~l~---~hpniv~l~~~~~~-~~~~~lv~e~~~gg~L~~~--l~~~~~---~~~~~~~~~i~~qi 239 (461)
+.+|+..+.+++ .+.+.+.+-.+|.+ ....+|||||+.|+.+.+. +...+. .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 334444444442 13333333333322 4456899999999999763 222211 23344455556665
Q ss_pred HHHHHHHHHcCccccCCCCCcEEEecCC-CCCCeeEeecccccccC
Q 012518 240 LNIVAFCHLQGVVHRDLKPENFLFTTRE-EDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 240 l~al~yLH~~givHrDlkp~NILl~~~~-~~~~~kl~DFG~a~~~~ 284 (461)
+ ..|++|+|+||.||+++.++ .++.++++|||++..+.
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4 58999999999999996421 12379999999987664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.6e-15 Score=147.81 Aligned_cols=252 Identities=20% Similarity=0.210 Sum_probs=184.2
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
...+|.++..||.|.|+.|+.+... ..++..|++|.+.+.-...... ..-..|+.+...+.-|.++++++..|....
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r--~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKR--PEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ecCCcceeEEccCCccccceeeeec--CCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3457889999999999999987733 2377889999886654433322 223467777777767999999998888888
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
..|+--|||+++++...+ .-...+.+...+.+..|++.++.++|++.++|+|+||+||++.+++ +..++.|||....
T Consensus 340 ~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTR 416 (524)
T ss_pred cccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccc
Confidence 889999999999886655 2224577888999999999999999999999999999999997432 7789999998764
Q ss_pred cCCCCCccccccCCCcC-chhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 283 VRPDQRLNDIVGSAYYV-APEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~-aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
+... .......-+++ ..|++.. .+..+.|++|||..+++.++|...-+.... ...|..+. ... .+...
T Consensus 417 ~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~--~p~--~~~~~ 487 (524)
T KOG0601|consen 417 LAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGD--TPN--LPGLK 487 (524)
T ss_pred ccee--cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeeccc--ccC--CCchH
Confidence 2211 11222333444 3666543 478899999999999999998765333222 11222221 111 12345
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.++..+.+.++..|+..|+.+.++..|.=|
T Consensus 488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 488 LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 788899999999999999999998887754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.5e-15 Score=138.45 Aligned_cols=193 Identities=16% Similarity=0.239 Sum_probs=136.0
Q ss_pred CCCeeEEEEEEEeCC-----eEEEEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCC
Q 012518 188 HKHMIKFHDAFEDAN-----SVYIVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLK 257 (461)
Q Consensus 188 hpniv~l~~~~~~~~-----~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH~~g--ivHrDlk 257 (461)
|.|||+++.|+.+.+ ...++.||+..|++..+|.+. ...+....+.+|+.||+.||.|||+.. |+|+++.
T Consensus 126 HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlT 205 (458)
T KOG1266|consen 126 HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLT 205 (458)
T ss_pred HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcc
Confidence 999999999986543 478999999999998888643 346778889999999999999999985 9999999
Q ss_pred CCcEEEecCCCCCCeeEeecccccccCCC------CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCC
Q 012518 258 PENFLFTTREEDAPLKVIDFGLSDFVRPD------QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRP 330 (461)
Q Consensus 258 p~NILl~~~~~~~~~kl~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~P 330 (461)
.+-|++. .++-+|+.---. ...... .......+-++|.|||.=. -..+.++|||++|....+|..+..-
T Consensus 206 c~tifiq---~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 206 CDTIFIQ---HNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred hhheeec---CCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 9999995 556566542111 111100 0011234668899999643 4567789999999999999887654
Q ss_pred CCCC-ChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 331 FWAR-TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 331 f~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
-... .....-..|.+..... -.+--+++|.+||+..|..||++.++|.||.+-+
T Consensus 282 ~tnseS~~~~ee~ia~~i~~l-------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 282 STNSESKVEVEENIANVIIGL-------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred cCCCcceeehhhhhhhheeec-------cCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 2221 1111111221111111 1223457899999999999999999999998744
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-13 Score=121.84 Aligned_cols=129 Identities=22% Similarity=0.235 Sum_probs=95.2
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEe
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVME 209 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e 209 (461)
++.|+.|.++.||++.. .|..|++|+...... ....+.+|+.+++.+.+...+.+++.+.. ...++|||
T Consensus 3 ~~~l~~G~~~~vy~~~~-----~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e 71 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-----ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITE 71 (170)
T ss_pred eeecCCcccCceEEEEE-----CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEE
Confidence 36789999999999875 367799998754321 11245689999999863333456665543 23479999
Q ss_pred ccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCc-----cccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 210 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV-----VHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 210 ~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~gi-----vHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
|++|.++.+. ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++|+|||.+..
T Consensus 72 ~i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 72 FIEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred ecCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 9999887542 01123467899999999999985 9999999999995 34599999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.8e-13 Score=120.47 Aligned_cols=145 Identities=17% Similarity=0.165 Sum_probs=102.4
Q ss_pred ceeeccCCceEEEEEEeccC---CccCcEEEEEEeccccc--C-----------------CHHHHHHH----HHHHHHHH
Q 012518 130 GKEVGRGHFGHTCCAKGKKG---TLKGKVVAVKIISKAKM--T-----------------SALAIEDV----RREVKILK 183 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~---~~~g~~vAvK~i~~~~~--~-----------------~~~~~~~~----~~Ei~il~ 183 (461)
...||.|--+.||.|....+ ...+..+|||+.+.... . .......+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 34689999999999975421 11357899998753210 0 00112233 48999999
Q ss_pred hcCCC-CCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHcCccccCCCCCcE
Q 012518 184 ALSGH-KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC-HLQGVVHRDLKPENF 261 (461)
Q Consensus 184 ~l~~h-pniv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yL-H~~givHrDlkp~NI 261 (461)
++... -++.+.+++ ..-+|||||+.++.+.....+. ..++++.+..+..+++.+|..| |+.||||+||++.||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 98633 567777764 4568999999765443222222 3455667788899999999998 899999999999999
Q ss_pred EEecCCCCCCeeEeeccccccc
Q 012518 262 LFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 262 Ll~~~~~~~~~kl~DFG~a~~~ 283 (461)
|+. ++.+.|+|||.+...
T Consensus 157 L~~----~~~v~iIDF~qav~~ 174 (197)
T cd05146 157 LWH----DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEE----CCcEEEEECCCceeC
Confidence 995 356999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.6e-12 Score=111.39 Aligned_cols=149 Identities=21% Similarity=0.246 Sum_probs=113.0
Q ss_pred eceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH-----HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA-----LAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.+..|-+|+-+.|+++.. .|+.+.||.=-......+ ....+..+|+++|.++. --.|.--.-+|.|...
T Consensus 11 ~l~likQGAEArv~~~~~-----~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~ 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYG 84 (229)
T ss_pred cceeeeccceeeEeeecc-----CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCC
Confidence 467789999999998875 688888886332222222 23456788999999985 4455444446677777
Q ss_pred EEEEEeccCC-CchHHHHHhcCCCCCHHH-HHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 204 VYIVMEFCEG-GELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 204 ~~lv~e~~~g-g~L~~~l~~~~~~~~~~~-~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
-.|+|||++| -++.+++......-.++. ...++++|-..+.-||.++|||+||..+||++..++....+.|+|||++.
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 7899999987 367777776644333433 37899999999999999999999999999999987777778999999986
Q ss_pred cc
Q 012518 282 FV 283 (461)
Q Consensus 282 ~~ 283 (461)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 53
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.4e-11 Score=107.38 Aligned_cols=136 Identities=25% Similarity=0.297 Sum_probs=98.2
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH-----HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA-----LAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
..+++|+-+.+|.+.. -|..+++|.=.......+ ...++-.+|.+++.+++ --.|.--+-++.+.+...
T Consensus 2 ~~i~~GAEa~i~~~~~-----~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-----LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGL 75 (204)
T ss_pred chhhCCcceeEEeeec-----cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCE
Confidence 4578999999998855 355577775333222222 22345678999999886 334444344555667778
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+|||++|-.|.+.+... ...+++.+-.-+.-||..||||+||.++||++. +..+.++|||++.+..
T Consensus 76 I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~s~ 142 (204)
T COG3642 76 IVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEFSD 142 (204)
T ss_pred EEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCcccccc
Confidence 999999987777777543 245777788888899999999999999999995 3349999999998543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1e-11 Score=126.63 Aligned_cols=162 Identities=21% Similarity=0.276 Sum_probs=123.0
Q ss_pred cCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHH
Q 012518 152 KGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED 231 (461)
Q Consensus 152 ~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~ 231 (461)
++..|.|.+.+.... ...+.+.+-++-|+.|+ ||||++|++.++..+.+|||+|-+. -|..++.+ +....
T Consensus 36 ~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~ 105 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEE 105 (690)
T ss_pred cCCceEEEEEeCCCc---hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHH
Confidence 788899998876532 33456778889999997 9999999999999999999999985 45555543 33777
Q ss_pred HHHHHHHHHHHHHHHH-HcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCC-ccccccCCCcCchhhhhccCC
Q 012518 232 AKTIVEKILNIVAFCH-LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLHRSYN 309 (461)
Q Consensus 232 ~~~i~~qil~al~yLH-~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~ 309 (461)
+...+.||+.||.||| +.+++|++|.-..|+|+ ..+..||++|-++........ .....--..|..|+.+... +
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn---~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s-~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN---ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS-E 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc---CCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-c
Confidence 8889999999999998 55899999999999995 677799999988765432221 1112222346666654321 1
Q ss_pred CchhHHHHHHHHHHHhhC
Q 012518 310 VEGDMWSIGVITYILLCG 327 (461)
Q Consensus 310 ~~~DiwSlGvil~elltg 327 (461)
-..|.|-|||+++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 347999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.3e-11 Score=110.82 Aligned_cols=143 Identities=25% Similarity=0.396 Sum_probs=103.0
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeC---CeEEE
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG-HKHMIKFHDAFEDA---NSVYI 206 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~-hpniv~l~~~~~~~---~~~~l 206 (461)
+.||.|.++.||++... +|+.+++|+....... .....+.+|+++++.+.+ +.++.+++.+.... +..++
T Consensus 4 ~~l~~G~~n~~~~v~~~----~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~ 77 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY 77 (223)
T ss_pred eecCCCccceEEEEEec----CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence 56899999999999764 3578999997654321 123567899999999973 23467777776654 36789
Q ss_pred EEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 012518 207 VMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-------------------------------------- 248 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-------------------------------------- 248 (461)
||||++|.++.+.+.. ..+++.....++.+++.+|.+||+
T Consensus 78 v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 78 VMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 9999999887664421 245666666677777777777763
Q ss_pred ------------------cCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 249 ------------------QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 249 ------------------~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
..++|+|+++.|||++.+ .+..+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 236999999999999632 134578999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.2e-10 Score=110.49 Aligned_cols=211 Identities=18% Similarity=0.255 Sum_probs=150.2
Q ss_pred eEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE----eCCeEEEEEeccCC-
Q 012518 139 GHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE----DANSVYIVMEFCEG- 213 (461)
Q Consensus 139 g~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~----~~~~~~lv~e~~~g- 213 (461)
.+.|++.... +|..|++|++...+.... .....-+++++++. |.|||.+.++|. .+..++||++|.++
T Consensus 290 ~Ttyk~~s~~---DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 290 ITTYKATSNV---DGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred ceeEeeeecc---CCceeeeeeeccccccCc---ccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 4678887765 899999999943322211 11224577889996 999999999986 45679999999876
Q ss_pred CchHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 214 GELLDRILS--------------RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 214 g~L~~~l~~--------------~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
++|.++... .+...+|+.+|.++.||..||.++|+.|+.-+-|.+.+||++. +.+++|.-.|+
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G---~~RIriS~C~i 439 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTG---KMRIRISGCGI 439 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeC---cceEEEecccc
Confidence 577776532 2234678899999999999999999999999999999999963 34688888887
Q ss_pred ccccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCC-h-hhHHHHHHhcCCCCCCCCCCC
Q 012518 280 SDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWART-E-SGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 280 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~-~~~~~~i~~~~~~~~~~~~~~ 357 (461)
...+..+.. |-+.+ -.+-|.=.||.+++.|.||..-=+..+ . ...++.|. ..
T Consensus 440 ~Dvl~~d~~-------------~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~ 493 (655)
T KOG3741|consen 440 MDVLQEDPT-------------EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TT 493 (655)
T ss_pred eeeecCCCC-------------cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hh
Confidence 766544330 11111 134688899999999999965422211 1 11122222 24
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+|.+++++|.-+...++++ -++.+++.|
T Consensus 494 yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 494 YSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 7889999999999988876 677777764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.3e-11 Score=123.38 Aligned_cols=150 Identities=22% Similarity=0.322 Sum_probs=110.8
Q ss_pred HHHHHHHHHHHc-CccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCcc----------ccccCCCcCchhhhhc
Q 012518 238 KILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN----------DIVGSAYYVAPEVLHR 306 (461)
Q Consensus 238 qil~al~yLH~~-givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~----------~~~gt~~y~aPE~l~~ 306 (461)
+++.||.|+|.. ++||+.|.|++|.++ ..+.+||+-|+++........+. -..-...|.|||++..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n---a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVN---ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeec---cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 344899999987 899999999999995 56679999999876554421110 0123457999999865
Q ss_pred -cCCCchhHHHHHHHHHHHh-hCCCCCCCCChhhHHHHHHh--cCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHH
Q 012518 307 -SYNVEGDMWSIGVITYILL-CGSRPFWARTESGIFRSVLR--ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQ 382 (461)
Q Consensus 307 -~~~~~~DiwSlGvil~ell-tg~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 382 (461)
..+.++|+||+||++|.+. .|+.-+........+..... ....+... .+++.++++=|.++|..|...||++.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s--~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYS--NNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccccc--ccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 4788999999999999999 56666655433222222111 11112222 468999999999999999999999999
Q ss_pred HhcCCCcCCC
Q 012518 383 ALTHPWLHDE 392 (461)
Q Consensus 383 ~L~hp~~~~~ 392 (461)
++..+||.+.
T Consensus 262 l~~~~ff~D~ 271 (700)
T KOG2137|consen 262 LLSIPFFSDP 271 (700)
T ss_pred hhcccccCCc
Confidence 9999999875
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.6e-09 Score=101.56 Aligned_cols=131 Identities=20% Similarity=0.190 Sum_probs=90.4
Q ss_pred cCcEEEEEEecccccCC---H-----HHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEe-----CCeEEEEEeccCCC-ch
Q 012518 152 KGKVVAVKIISKAKMTS---A-----LAIEDVRREVKILKALSG-HKHMIKFHDAFED-----ANSVYIVMEFCEGG-EL 216 (461)
Q Consensus 152 ~g~~vAvK~i~~~~~~~---~-----~~~~~~~~Ei~il~~l~~-hpniv~l~~~~~~-----~~~~~lv~e~~~gg-~L 216 (461)
.|+.|.||......... . .....+.+|...+.+|.. .-..+..+.+++. ...-+||||++++. +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 56788889763322100 0 011236789988888741 1223344444443 23478999999876 78
Q ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC----CCCCCeeEeecccccc
Q 012518 217 LDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR----EEDAPLKVIDFGLSDF 282 (461)
Q Consensus 217 ~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~----~~~~~~kl~DFG~a~~ 282 (461)
.+++... .....+.....++.+++..+.-||..||+|+|+++.|||+... +++..+.|+||+.+..
T Consensus 124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 7776533 2345667788999999999999999999999999999999641 2356799999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.8e-10 Score=98.92 Aligned_cols=129 Identities=30% Similarity=0.319 Sum_probs=81.6
Q ss_pred EEEEEEeccCCccCcEEEEEEeccccc-----------------------CCHHHHHHHHHHHHHHHhcCCC-CCeeEEE
Q 012518 140 HTCCAKGKKGTLKGKVVAVKIISKAKM-----------------------TSALAIEDVRREVKILKALSGH-KHMIKFH 195 (461)
Q Consensus 140 ~V~~~~~~~~~~~g~~vAvK~i~~~~~-----------------------~~~~~~~~~~~Ei~il~~l~~h-pniv~l~ 195 (461)
.||.|... +|..+|||+.+.... ..........+|.+.|.++... -++.+.+
T Consensus 1 ~Vy~~~~~----~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~ 76 (188)
T PF01163_consen 1 DVYHAIDP----DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPY 76 (188)
T ss_dssp EEEEEEEC----TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EE
T ss_pred CEEEEECC----CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEE
Confidence 48888764 577899998754210 0011234567899999999733 2577777
Q ss_pred EEEEeCCeEEEEEeccC--CCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHcCccccCCCCCcEEEecCCCCCCe
Q 012518 196 DAFEDANSVYIVMEFCE--GGELLDRILSRGGRYLEEDAKTIVEKILNIVAF-CHLQGVVHRDLKPENFLFTTREEDAPL 272 (461)
Q Consensus 196 ~~~~~~~~~~lv~e~~~--gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~y-LH~~givHrDlkp~NILl~~~~~~~~~ 272 (461)
++. .-+|||||+. |..+ ..+.... ++.+....++.+++..+.. +|..||+|+||.+.|||+.. +.+
T Consensus 77 ~~~----~~~ivME~I~~~G~~~-~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~----~~~ 145 (188)
T PF01163_consen 77 DYN----RNVIVMEYIGEDGVPL-PRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDD----GKV 145 (188)
T ss_dssp EEE----TTEEEEE--EETTEEG-GCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEET----TCE
T ss_pred EEe----CCEEEEEecCCCccch-hhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeec----ceE
Confidence 553 2369999998 5444 3343321 2245567788888886555 57999999999999999962 369
Q ss_pred eEeeccccccc
Q 012518 273 KVIDFGLSDFV 283 (461)
Q Consensus 273 kl~DFG~a~~~ 283 (461)
.|+|||.+...
T Consensus 146 ~iIDf~qav~~ 156 (188)
T PF01163_consen 146 YIIDFGQAVDS 156 (188)
T ss_dssp EE--GTTEEET
T ss_pred EEEecCcceec
Confidence 99999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.7e-09 Score=99.74 Aligned_cols=239 Identities=16% Similarity=0.181 Sum_probs=154.7
Q ss_pred eeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE------Ee-
Q 012518 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF------ED- 200 (461)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~------~~- 200 (461)
..++.||+|+-+.+|-.-.- +. .+.|++...-... .. +.+..|.+.-+||-+-.-+.|- -+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-----~d-~VAKIYh~Pppa~---~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~ 81 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-----RD-QVAKIYHAPPPAA---QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRR 81 (637)
T ss_pred CCCccccCCccceeeecchh-----hc-hhheeecCCCchH---HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCc
Confidence 45678999999999965432 22 3348775532211 11 2333444555566554422221 11
Q ss_pred CCeEEEEEeccCCCchHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeE
Q 012518 201 ANSVYIVMEFCEGGELLDRILS------RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~------~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
...+-+.|..+.|..-...+.+ ......+..+.++.+.|+.+...||+.|.+-+|++++|+|++ +++.|.|
T Consensus 82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~L 158 (637)
T COG4248 82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVL 158 (637)
T ss_pred cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEE
Confidence 2236788888877532222211 112355678899999999999999999999999999999995 5677999
Q ss_pred eecccccccCCCCCccccccCCCcCchhhhh-c-----cCCCchhHHHHHHHHHHHhhC-CCCCCCCCh----hhHHH-H
Q 012518 275 IDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-R-----SYNVEGDMWSIGVITYILLCG-SRPFWARTE----SGIFR-S 342 (461)
Q Consensus 275 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~-----~~~~~~DiwSlGvil~elltg-~~Pf~~~~~----~~~~~-~ 342 (461)
+|-..-..-..+.....-+|...|.+||.-. + .-+...|.|.|||++++++.| ++||.+-.. ..-++ .
T Consensus 159 VdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 159 VDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred EcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 9855433333333445578999999999754 2 246779999999999999986 999954211 11111 1
Q ss_pred HHhc------------CCCCCCCCCCCCCHHHHHHHHHhccc--CcCCCCCHH
Q 012518 343 VLRA------------DPNFHDSPWPSVSPEAKDFVRRLLNK--DHRKRMTAA 381 (461)
Q Consensus 343 i~~~------------~~~~~~~~~~~~s~~~~~li~~~L~~--dP~~R~s~~ 381 (461)
|..+ .+.....+|.-+++++..|..+|+.. ++.-|||++
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 2111 12222345667899999999999974 356899975
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=8.5e-09 Score=94.66 Aligned_cols=142 Identities=18% Similarity=0.186 Sum_probs=95.6
Q ss_pred EEEEEeccCCccCcEEEEEEecccccC----CHHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeC----CeEEEEEecc
Q 012518 141 TCCAKGKKGTLKGKVVAVKIISKAKMT----SALAIEDVRREVKILKALSG-HKHMIKFHDAFEDA----NSVYIVMEFC 211 (461)
Q Consensus 141 V~~~~~~~~~~~g~~vAvK~i~~~~~~----~~~~~~~~~~Ei~il~~l~~-hpniv~l~~~~~~~----~~~~lv~e~~ 211 (461)
+|.+........++.+-+|.....-.. .........+|...+..|.. .=.+.+.+.+.+.. ...+||+|++
T Consensus 20 ~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l 99 (206)
T PF06293_consen 20 GWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEAL 99 (206)
T ss_pred EEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeC
Confidence 344433322335666777754321111 11223456788888777742 22345556655542 2458999999
Q ss_pred CCC-chHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 212 EGG-ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 212 ~gg-~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|. +|.+.+.... ..+......++.++...+.-||++||+|+|+++.|||+..++....+.|+||+-++..
T Consensus 100 ~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 100 PGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred CCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 885 6777765432 3667778899999999999999999999999999999976554457999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=9.8e-09 Score=95.01 Aligned_cols=138 Identities=32% Similarity=0.354 Sum_probs=101.3
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccc-----------------cCC--HHHHHHHHHHHHHHHhcCC
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAK-----------------MTS--ALAIEDVRREVKILKALSG 187 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~-----------------~~~--~~~~~~~~~Ei~il~~l~~ 187 (461)
+.++..||-|--+.||.|.+. .|..+|||.=+... ..+ ...+....+|.++|++|..
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred HhhccccccCccceEEEEECC----CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 457789999999999999875 58899999643210 011 1223456799999999964
Q ss_pred C-CCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC
Q 012518 188 H-KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 266 (461)
Q Consensus 188 h-pniv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~ 266 (461)
+ -.+.+-++ .+.-.+||||++|-.|... ++..+....++..|+.-+.-+-..||||+|+..-|||++
T Consensus 169 ~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~-- 236 (304)
T COG0478 169 EGVKVPKPIA----WNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT-- 236 (304)
T ss_pred cCCCCCCccc----cccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe--
Confidence 3 35666554 3556899999998666431 234566667777788877777799999999999999995
Q ss_pred CCCCCeeEeeccccc
Q 012518 267 EEDAPLKVIDFGLSD 281 (461)
Q Consensus 267 ~~~~~~kl~DFG~a~ 281 (461)
+++.+.++||--+.
T Consensus 237 -~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 -EDGDIVVIDWPQAV 250 (304)
T ss_pred -cCCCEEEEeCcccc
Confidence 56679999996544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.6e-10 Score=117.16 Aligned_cols=242 Identities=17% Similarity=0.220 Sum_probs=167.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCC-eeEEEEEEEeCCe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH-MIKFHDAFEDANS 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn-iv~l~~~~~~~~~ 203 (461)
..|.....+++|+++.+++.+... +. ....+++... ....-++++|.+++ ||| .++.++-++.+..
T Consensus 242 kws~~fh~fvK~altknpKkRpta---ek-lL~h~fvs~~--------l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTA---EK-LLQHPFVSQT--------LSRRLAIELLDKVN-NPNPVVRYLEDYDGEDY 308 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCCh---hh-heeceeeccc--------hhhHHHHHHHHHcc-CCCCcccccccCCcccc
Confidence 356677889999999999876543 22 2336666432 23345889999996 999 8888888888889
Q ss_pred EEEEEeccCCC-chHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 204 VYIVMEFCEGG-ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 204 ~~lv~e~~~gg-~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+++|+++.++ +-.+.+....-.+.+-+...+++.-+++++|+|+.-=+||| |||.+ +...|+.||+....
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQ 380 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCcc
Confidence 99999999887 22221111111233344556778888899999999889999 88875 35589999999887
Q ss_pred cCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC--CCCCC-CCCCCC
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD--PNFHD-SPWPSV 358 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~-~~~~~~ 358 (461)
+....+.++..+|+.|+|||+.. +.+....|+|++|+--.+|.-|.+|-.... .....+-... +.... ..|...
T Consensus 381 L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~ 458 (829)
T KOG0576|consen 381 LTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPV 458 (829)
T ss_pred cCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCcc
Confidence 77665667789999999999876 568899999999987777777777642210 0000000000 00000 112111
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
.-.++...|+..-|..|+....++.|.+|..
T Consensus 459 --~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 459 --FHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred --cccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 1125788899999999999999999998865
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.6e-07 Score=81.49 Aligned_cols=143 Identities=17% Similarity=0.143 Sum_probs=99.3
Q ss_pred eccCCceEEEEEEeccCCccCcEEEEEEecccc---cCCHHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEE-e----CCe
Q 012518 133 VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAK---MTSALAIEDVRREVKILKALSG-HKHMIKFHDAFE-D----ANS 203 (461)
Q Consensus 133 lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~~Ei~il~~l~~-hpniv~l~~~~~-~----~~~ 203 (461)
-|+||-+.|+.... .|+.+-+|.-...- .........+.+|+..|++|.. .-.+.+.. ++. . .-.
T Consensus 26 ~~rgG~SgV~r~~~-----~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r 99 (216)
T PRK09902 26 YRRNGMSGVQCVER-----NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR 99 (216)
T ss_pred cCCCCcceEEEEEe-----CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence 46788888988764 45568888764211 1112345678899999998852 12255554 332 1 123
Q ss_pred EEEEEeccCC-CchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 204 VYIVMEFCEG-GELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 204 ~~lv~e~~~g-g~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
-+||+|-+.| -+|.+++.... .+.++.....++.++...+.-||+.|+.|+|+.+.|||+...+ ...++++||.-++
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r 178 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccc
Confidence 6799997764 47777664432 3567777789999999999999999999999999999996322 3349999998655
Q ss_pred c
Q 012518 282 F 282 (461)
Q Consensus 282 ~ 282 (461)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.6e-07 Score=83.02 Aligned_cols=141 Identities=21% Similarity=0.226 Sum_probs=89.8
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHH------HHHHHHHHHHhcC--CCCCeeEE
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIE------DVRREVKILKALS--GHKHMIKF 194 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~------~~~~Ei~il~~l~--~hpniv~l 194 (461)
...+|++.+.+-......|.+... +|+.+++|..+......+.... ...+++..+.++. +--.+..+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-----~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-----DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-----CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 345788888888777777776653 6788999987653222111111 1234444444443 12233332
Q ss_pred EEEE-----EeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCC
Q 012518 195 HDAF-----EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 269 (461)
Q Consensus 195 ~~~~-----~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~ 269 (461)
+-+. .-....+|||||++|..|.+.. .+.+ .+...|..++.-||+.|++|+|..|.|++++ +
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~-----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~ 170 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIE-----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----N 170 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccch-----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----C
Confidence 2222 2234567999999998876532 1222 2445677789999999999999999999996 3
Q ss_pred CCeeEeeccccc
Q 012518 270 APLKVIDFGLSD 281 (461)
Q Consensus 270 ~~~kl~DFG~a~ 281 (461)
+.++++||+..+
T Consensus 171 ~~i~iID~~~k~ 182 (229)
T PF06176_consen 171 NGIRIIDTQGKR 182 (229)
T ss_pred CcEEEEECcccc
Confidence 349999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.2e-07 Score=95.77 Aligned_cols=146 Identities=18% Similarity=0.264 Sum_probs=92.7
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccC---------------------C------HHHH----H------
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT---------------------S------ALAI----E------ 173 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~---------------------~------~~~~----~------ 173 (461)
+-|+.++-|+||.|+.+ +|+.||||+.+.+-.. . ...+ +
T Consensus 131 ~PiAsASIaQVH~A~L~----sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 131 EPIASASIAQVHRAVLK----SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred CchhhhhHhhheeEEec----CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 56999999999999987 5999999998653100 0 0001 1
Q ss_pred HHHHHHHHHHhcC----CCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 012518 174 DVRREVKILKALS----GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ 249 (461)
Q Consensus 174 ~~~~Ei~il~~l~----~hpniv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~ 249 (461)
++.+|..-+.+++ +.++|.--.-+++-...-.|+|||++|-.+.+...-.....+...+...+.++. +.-+-..
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~d 284 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRD 284 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhc
Confidence 2344555555543 344433333334445667899999999888776432323355333322222211 2333348
Q ss_pred CccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 250 givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
|++|.|..|.||++. .++.+-+.|||+.....+
T Consensus 285 gffHaDpHpGNi~v~---~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVR---SDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEe---cCCcEEEEcCcceecCCH
Confidence 999999999999995 567899999999876654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.58 E-value=8.7e-07 Score=79.62 Aligned_cols=129 Identities=22% Similarity=0.288 Sum_probs=92.2
Q ss_pred cceeeceeeccCCc-eEEEEEEeccCCccCcEEEEEEeccccc----------C-CH-------HHHHHHHHHHHHHHhc
Q 012518 125 AKFELGKEVGRGHF-GHTCCAKGKKGTLKGKVVAVKIISKAKM----------T-SA-------LAIEDVRREVKILKAL 185 (461)
Q Consensus 125 ~~y~~~~~lG~G~f-g~V~~~~~~~~~~~g~~vAvK~i~~~~~----------~-~~-------~~~~~~~~Ei~il~~l 185 (461)
.++++++.||.|.- |.||+++. .|+.||+|+++.-.. . .. ...+-|..|.+..-+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-----~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRL 111 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-----DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRL 111 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-----CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHH
Confidence 58999999999999 99999976 678999999432100 0 00 2234577888877777
Q ss_pred C--CCCCe--eEEEEEEEeC------------------CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 012518 186 S--GHKHM--IKFHDAFEDA------------------NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243 (461)
Q Consensus 186 ~--~hpni--v~l~~~~~~~------------------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al 243 (461)
+ ++.++ |+++||..-. -...||.||+.... .+. ..-+.+|+.-|
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl 177 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDL 177 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHH
Confidence 5 24556 9999988321 12467888876543 112 23456777888
Q ss_pred HHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 244 ~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
..+|..||+-+|+++.|..= -||+|||.+
T Consensus 178 ~~~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred HHHHHCCeeeccCccccccC--------CEEEecccC
Confidence 99999999999999999962 489999964
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.4e-06 Score=81.14 Aligned_cols=73 Identities=18% Similarity=0.216 Sum_probs=54.4
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCC-CeeEEEEEEEeCCeEEEEEe
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK-HMIKFHDAFEDANSVYIVME 209 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp-niv~l~~~~~~~~~~~lv~e 209 (461)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+.... .+.+.+++..+.+...+|||
T Consensus 7 ~~i~~G~t~~~y~~-------~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH-------KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe-------cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence 56899999999973 24457889875432 1245688999999986332 25778888888888899999
Q ss_pred ccCCCc
Q 012518 210 FCEGGE 215 (461)
Q Consensus 210 ~~~gg~ 215 (461)
+++|.+
T Consensus 75 ~i~G~~ 80 (226)
T TIGR02172 75 LIVGKR 80 (226)
T ss_pred ecCCcc
Confidence 999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=9.7e-07 Score=76.83 Aligned_cols=132 Identities=24% Similarity=0.346 Sum_probs=93.1
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
-++.+.||+|++|.||++.+ .|..+|+|+-+.+. .+..+..|.++|..+..----.++|.|-.+ ++
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~-----~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i 89 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW-----RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FI 89 (201)
T ss_pred hhhhhhhhcccccEEEEeec-----cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----hh
Confidence 34567899999999999976 46689999865442 346788999999999744444556655443 35
Q ss_pred EEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCC-C-CcEEEecCCCCCCeeEeecccccccC
Q 012518 207 VMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK-P-ENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlk-p-~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
.|||+.|-.|.+.... .. ++-+..++.+-.-|-..||-|..|. | .||++. +..+.|+||..|++..
T Consensus 90 ~me~i~G~~L~~~~~~----~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~----~~~~~iIDFd~At~k~ 157 (201)
T COG2112 90 RMEYIDGRPLGKLEIG----GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN----DRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhhcCcchhhhhhc----cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec----CCcEEEEEccchhhcc
Confidence 5999999888664321 11 2344556666667778899999987 3 455553 3359999999988544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.51 E-value=7.6e-07 Score=96.62 Aligned_cols=205 Identities=20% Similarity=0.227 Sum_probs=142.3
Q ss_pred HHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE----EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 012518 173 EDVRREVKILKALSGHKHMIKFHDAFEDANSV----YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL 248 (461)
Q Consensus 173 ~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~----~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~ 248 (461)
.....|+..+.++. |+|++.++.|....... .+..|+|..-++...+. .-+..+.+.++.+..+++.||.|+|+
T Consensus 227 ~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 34456777888886 99999999887654332 34457888888877664 44678889999999999999999999
Q ss_pred cCccccCCCCCcEEEecCCCCCCeeEe--ecccccccCCCCCccccccCCCcCchhhhhcc-C--CCchhHHHHHHHHHH
Q 012518 249 QGVVHRDLKPENFLFTTREEDAPLKVI--DFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-Y--NVEGDMWSIGVITYI 323 (461)
Q Consensus 249 ~givHrDlkp~NILl~~~~~~~~~kl~--DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~--~~~~DiwSlGvil~e 323 (461)
....|.-+...-..-...+..+.+.+. ||+.+..............+..|.++|..... + ....|+|.+|..+..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 955555444442222222344556666 88888777655555555566778888877533 3 334699999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 324 LLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 324 lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+..|..+-. .......++.. ....+..+++.+|+.-+.++|+++.+++.|+|.+..
T Consensus 385 ~~~~~~i~~---~~~~~~~~l~~----------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 385 LSQGEDISE---KSAVPVSLLDV----------LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhcCcccc---cccchhhhhcc----------ccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 988765421 11111111111 011278899999999999999999999999998754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.9e-06 Score=81.18 Aligned_cols=74 Identities=19% Similarity=0.210 Sum_probs=53.5
Q ss_pred eccCCc-eEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEecc
Q 012518 133 VGRGHF-GHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFC 211 (461)
Q Consensus 133 lG~G~f-g~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~ 211 (461)
|-.|.. ..||++.. .+..+.||+..... ...+.+|+++++.+.++--+.+++++....+..++|||++
T Consensus 6 ~~~g~~~~~v~~~~~-----~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 74 (244)
T cd05150 6 VTEGQSGATVYRLDG-----KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV 74 (244)
T ss_pred cCCCCCcCeEEEEcC-----CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence 444444 78898854 23568888865432 2346689999999976656778888887777789999999
Q ss_pred CCCchH
Q 012518 212 EGGELL 217 (461)
Q Consensus 212 ~gg~L~ 217 (461)
+|.+|.
T Consensus 75 ~G~~l~ 80 (244)
T cd05150 75 PGVPAA 80 (244)
T ss_pred CCccHh
Confidence 987664
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.2e-06 Score=78.57 Aligned_cols=79 Identities=20% Similarity=0.220 Sum_probs=56.5
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCC-CeeEEEEEEE---eCCeEE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK-HMIKFHDAFE---DANSVY 205 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp-niv~l~~~~~---~~~~~~ 205 (461)
++.|+.|..+.||++... +..+++|+.... .....+.+|..+++.|..+- .+.+++.+.. .....+
T Consensus 2 i~~l~~G~~n~~~~v~~~-----~~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD-----DGRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEET-----TSEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred CccCCCCCeeeEEEEEEC-----CcEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence 467999999999999864 247999986543 34567789999999886442 3567776443 334579
Q ss_pred EEEeccCCCchHH
Q 012518 206 IVMEFCEGGELLD 218 (461)
Q Consensus 206 lv~e~~~gg~L~~ 218 (461)
++|++++|..+..
T Consensus 72 ~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 72 LLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEESSEEHHH
T ss_pred EEEEEeccccccc
Confidence 9999999987766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.2e-05 Score=72.77 Aligned_cols=138 Identities=20% Similarity=0.291 Sum_probs=97.1
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-------------CHHHHHHHHHHHHHHHhcC-----CCCCee
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-------------SALAIEDVRREVKILKALS-----GHKHMI 192 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-------------~~~~~~~~~~Ei~il~~l~-----~hpniv 192 (461)
..||+|+.=.||.- . ......||++...... .....++..+|+.....+. .+.+|.
T Consensus 7 ~~i~~G~~R~cy~H--P----~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P----DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred cccccCCCceEEEC--C----CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence 56999999999843 2 3455889998766500 0112355667777666653 378999
Q ss_pred EEEEEEEeCCeEEEEEeccCC------CchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC
Q 012518 193 KFHDAFEDANSVYIVMEFCEG------GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 266 (461)
Q Consensus 193 ~l~~~~~~~~~~~lv~e~~~g------g~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~ 266 (461)
+++|+.+.+...-+|+|.+.. -+|.+++.. +.+++ .+...+-.-..||-+++|+.+||+|.||++...
T Consensus 81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEec
Confidence 999999999999999998633 257776632 34555 333344455678899999999999999999876
Q ss_pred CCCC-CeeEee-cccc
Q 012518 267 EEDA-PLKVID-FGLS 280 (461)
Q Consensus 267 ~~~~-~~kl~D-FG~a 280 (461)
++.. .+.|+| ||..
T Consensus 155 ~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGEK 170 (199)
T ss_pred CCCceEEEEEeCCCCc
Confidence 6555 688888 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.31 E-value=5.9e-06 Score=91.38 Aligned_cols=83 Identities=24% Similarity=0.320 Sum_probs=57.3
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCe--eEEEEEEEeC---CeE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHM--IKFHDAFEDA---NSV 204 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpni--v~l~~~~~~~---~~~ 204 (461)
++.|+.|.++.+|+.....+. ....+++|+........ ....+.+|+++|+.|..|.+| .+++.++.+. +..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~-~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG-SVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC-cceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 467899999999998764321 11357777754432111 124677999999999646654 8888887664 467
Q ss_pred EEEEeccCCCc
Q 012518 205 YIVMEFCEGGE 215 (461)
Q Consensus 205 ~lv~e~~~gg~ 215 (461)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999998854
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.30 E-value=6.8e-06 Score=75.66 Aligned_cols=139 Identities=22% Similarity=0.199 Sum_probs=90.8
Q ss_pred eeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHH-------------------H--HHHHHHHHHHHHhcCC-CC
Q 012518 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSAL-------------------A--IEDVRREVKILKALSG-HK 189 (461)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~-------------------~--~~~~~~Ei~il~~l~~-hp 189 (461)
.|+.|--+.||+|... ++..+|||+++........ . .....+|..-|+++.. +-
T Consensus 55 ~istGKEA~Vy~a~~~----~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 55 CISTGKEANVYLAETG----DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eecCCcceEEEeeccC----CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 5666777789998753 5789999998643211110 0 1123567777777641 33
Q ss_pred CeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecCCC
Q 012518 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREE 268 (461)
Q Consensus 190 niv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~~~ 268 (461)
.+.+-+.+.. -.|||||+....+-.=.+ +.-.+..+++..+..+++..+.-|-. .|+||+||..=|||+.
T Consensus 131 rvP~Pi~~~~----nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~---- 201 (268)
T COG1718 131 RVPEPIAFRN----NVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH---- 201 (268)
T ss_pred CCCCceeecC----CeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----
Confidence 4445554443 369999995431110000 11223344788889999999988877 8999999999999994
Q ss_pred CCCeeEeeccccccc
Q 012518 269 DAPLKVIDFGLSDFV 283 (461)
Q Consensus 269 ~~~~kl~DFG~a~~~ 283 (461)
++.+.|+|||-|...
T Consensus 202 ~~~p~iID~~QaV~~ 216 (268)
T COG1718 202 DGEPYIIDVSQAVTI 216 (268)
T ss_pred CCeEEEEECcccccc
Confidence 566999999977654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=9.8e-06 Score=83.45 Aligned_cols=145 Identities=19% Similarity=0.212 Sum_probs=89.3
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH-----------------------------HHHH------HH
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA-----------------------------LAIE------DV 175 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~-----------------------------~~~~------~~ 175 (461)
+.||.-+.|+|++|+.+ +|+.||||+-+..- ... +..+ +|
T Consensus 167 ~piaaASlaQVhrA~L~----~G~~VaVKVQ~P~l-~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK----NGEDVAVKVQHPGL-EKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred chhhhcchhheEEEEec----CCCEEEEEecCcCh-HHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 56999999999999987 58999999875431 100 0011 22
Q ss_pred HHHHHHHHhcC---CCCC------eeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 012518 176 RREVKILKALS---GHKH------MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246 (461)
Q Consensus 176 ~~Ei~il~~l~---~hpn------iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yL 246 (461)
.+|.+-..+++ .|-+ |.++|-.+ .....|+||||+|..+.|.-.-....++...+...+.++. ++-|
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qI 317 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQI 317 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHH
Confidence 33443333221 1444 44443322 3456899999999866543322223355554433333322 2233
Q ss_pred HHcCccccCCCCCcEEEecC-CCCCCeeEeecccccccC
Q 012518 247 HLQGVVHRDLKPENFLFTTR-EEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 247 H~~givHrDlkp~NILl~~~-~~~~~~kl~DFG~a~~~~ 284 (461)
=..|++|+|=.|.||++..+ ..+..+.+-|||+.....
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 35689999999999999843 346779999999987654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.01 E-value=7.9e-05 Score=69.65 Aligned_cols=77 Identities=26% Similarity=0.293 Sum_probs=50.0
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEe
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVME 209 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e 209 (461)
++.|..|-...||++....+ .++.|++|+...... ..-+..+|+.+++.+..+-..+++++.+. . .+|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~--~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e 72 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKED--NQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYE 72 (235)
T ss_pred EEEcCCcccceEEEEEcCCC--CCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEE
Confidence 35678888889998864311 146788997654211 11223479999999864555666665443 2 37999
Q ss_pred ccCCCch
Q 012518 210 FCEGGEL 216 (461)
Q Consensus 210 ~~~gg~L 216 (461)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9988665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=1.8e-06 Score=95.72 Aligned_cols=211 Identities=14% Similarity=0.039 Sum_probs=139.3
Q ss_pred HHHHHHHHHhcCCCCCeeEEEEEEE--eCCeEEEEEeccCCCchHHHHHhcCCCC---CHHHHHHHHHHHHHHHHHHHHc
Q 012518 175 VRREVKILKALSGHKHMIKFHDAFE--DANSVYIVMEFCEGGELLDRILSRGGRY---LEEDAKTIVEKILNIVAFCHLQ 249 (461)
Q Consensus 175 ~~~Ei~il~~l~~hpniv~l~~~~~--~~~~~~lv~e~~~gg~L~~~l~~~~~~~---~~~~~~~i~~qil~al~yLH~~ 249 (461)
...|..-++... |+++...+.-.. .....|.+++||.+|++++.|.+...+. .+.-+.....+.+.+..-+|+.
T Consensus 1276 ll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 344545555555 888888766553 3345789999999999999987654332 3334444455557777777765
Q ss_pred C-----ccccCCCCCcEEEecCCCCCCeeEeecccccccCCC-CCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHH
Q 012518 250 G-----VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITY 322 (461)
Q Consensus 250 g-----ivHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~ 322 (461)
. .+|++||+-|.+|.. +.++|++++|+.+..... ......++++.|+.+++.+. .++.++|+|..|+-+|
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVt---ny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVT---NYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred ccCCccchhhhhhhhccceec---CCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 2 799999999999964 556999999999843332 33456778899999998875 5888899999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 323 ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 323 elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+...|..+|...... .++.+......+.... -.+.++-.....+|-..-..||.-...+.-+.|-..
T Consensus 1432 ~rs~~n~~fi~flq~-~Lkgiidn~tf~sIe~--l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1432 LRSDGNAYFIFFLQP-ALKGIIDNHTFFSIEK--LKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVG 1498 (2724)
T ss_pred HHhcccHHHHHHHHH-HHcCcccccccccccc--cCCCcccHHHHHHHHHHhhhcchhhhhccccccccc
Confidence 999888877322211 1112222111111111 123344444444555555689998888888777543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00026 Score=71.07 Aligned_cols=81 Identities=22% Similarity=0.214 Sum_probs=55.3
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEeccccc--CC--HHHHHHHHHHHHHHHhcCCC--CCeeEEEEEEEeCCe
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM--TS--ALAIEDVRREVKILKALSGH--KHMIKFHDAFEDANS 203 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~--~~--~~~~~~~~~Ei~il~~l~~h--pniv~l~~~~~~~~~ 203 (461)
.+.||.|.+..||++.... .++.|+||.-..... .. ....++...|.+.|+.+..+ .++.+++.+ +.+.
T Consensus 31 ~~elggGn~N~VyrV~~~~---g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~ 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTE---GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEEL 105 (401)
T ss_pred eeEcCCCceEEEEEEEeCC---CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCC
Confidence 3679999999999998753 225799998532110 01 23456777888888886433 457788766 4455
Q ss_pred EEEEEeccCCCc
Q 012518 204 VYIVMEFCEGGE 215 (461)
Q Consensus 204 ~~lv~e~~~gg~ 215 (461)
.++||||+++..
T Consensus 106 ~~lVME~L~~~~ 117 (401)
T PRK09550 106 AVTVMEDLSDHK 117 (401)
T ss_pred CEEEEecCCCcc
Confidence 789999998744
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.89 E-value=6.2e-05 Score=70.51 Aligned_cols=73 Identities=22% Similarity=0.165 Sum_probs=46.1
Q ss_pred eeeccCCce-EEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC--CCeeEEEEEEEeC---CeE
Q 012518 131 KEVGRGHFG-HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH--KHMIKFHDAFEDA---NSV 204 (461)
Q Consensus 131 ~~lG~G~fg-~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h--pniv~l~~~~~~~---~~~ 204 (461)
+.|+.|+.. .||++. ..+++|+..... ....+.+|.++|..|..+ --+.++++..... ...
T Consensus 3 ~~~~~gG~~n~vy~~~--------~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~ 69 (235)
T cd05155 3 EPVDSGGTDNATFRLG--------DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP 69 (235)
T ss_pred eeccCCCcccceEEcC--------CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence 457777776 488651 247778754321 235788999999988643 1355555544332 235
Q ss_pred EEEEeccCCCch
Q 012518 205 YIVMEFCEGGEL 216 (461)
Q Consensus 205 ~lv~e~~~gg~L 216 (461)
|+||++++|.++
T Consensus 70 ~~l~~~i~G~~l 81 (235)
T cd05155 70 WSVYRWLEGETA 81 (235)
T ss_pred eEEEEeecCCCC
Confidence 889999998665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=2.8e-05 Score=74.14 Aligned_cols=137 Identities=23% Similarity=0.310 Sum_probs=96.4
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEeccc-----------------ccCCHHH--HHHHHHHHHHHHhcC
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA-----------------KMTSALA--IEDVRREVKILKALS 186 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~-----------------~~~~~~~--~~~~~~Ei~il~~l~ 186 (461)
-+.+++.||-|--+.||.+-+. .|+..++|+=+.. +..+... +-...+|...|+.|.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~----~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~ 168 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE----EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALY 168 (465)
T ss_pred hhhhccccccccccceEEEecC----CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHH
Confidence 4678899999999999999876 5788888853211 1111111 223467999999997
Q ss_pred CCCC-eeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEec
Q 012518 187 GHKH-MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 265 (461)
Q Consensus 187 ~hpn-iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~ 265 (461)
.|-. +.+.+ +.+..++|||++.|-.|...-. ...+..+...++.-+.-|-.+|+||+|..-=||++.
T Consensus 169 e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~- 236 (465)
T KOG2268|consen 169 ERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRH-------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK- 236 (465)
T ss_pred HcCCCCCCcc----cccceeeHHHhhcccceeeeee-------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEe-
Confidence 5543 33333 3456789999999877754211 123445667777778889999999999999999995
Q ss_pred CCCCCCeeEeecccc
Q 012518 266 REEDAPLKVIDFGLS 280 (461)
Q Consensus 266 ~~~~~~~kl~DFG~a 280 (461)
++..++++||--.
T Consensus 237 --dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 --DDDKIVVIDFPQM 249 (465)
T ss_pred --cCCCEEEeechHh
Confidence 5677999999643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.76 E-value=7.7e-05 Score=67.23 Aligned_cols=100 Identities=23% Similarity=0.249 Sum_probs=78.1
Q ss_pred HHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCc
Q 012518 177 REVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRI--LSRGGRYLEEDAKTIVEKILNIVAFCHL---QGV 251 (461)
Q Consensus 177 ~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~~gg~L~~~l--~~~~~~~~~~~~~~i~~qil~al~yLH~---~gi 251 (461)
.|.-+|+.+.+.+++++++|+|- -++|.||...+++.... ..+-...++....+|+.+++..+++|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58889999986679999999984 25688999877664210 0111235778899999999999999998 358
Q ss_pred cccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 252 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 252 vHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
.-.|++++|+.++ +++.+|++|...+...
T Consensus 84 ~lcDv~~~nfgv~---~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVN---DDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEe---CCCcEEEEechhcchh
Confidence 8899999999996 5667999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.0002 Score=68.01 Aligned_cols=135 Identities=21% Similarity=0.171 Sum_probs=75.5
Q ss_pred eeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEecc
Q 012518 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFC 211 (461)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~ 211 (461)
.+..|-.+.+|++.. +|+.+++|+...... ... -+..+|..+++.+..+.-..+++.... -++||||+
T Consensus 3 ~~~~G~tn~~y~~~~-----~~~~~vlR~~~~~~~--~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i 70 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-----PGISFVWRPQSPVCK--ALG-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWL 70 (256)
T ss_pred cCCCcCcCCeEEEEe-----CCccEEEeeCCcccc--ccc-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEec
Confidence 355677788998862 466788887543211 100 124679999999864433345554432 26899999
Q ss_pred CCCchHH----------HH-------HhcC---CCCCH-HHHHHHHHHH---------HHHHHHHHH--------cCccc
Q 012518 212 EGGELLD----------RI-------LSRG---GRYLE-EDAKTIVEKI---------LNIVAFCHL--------QGVVH 253 (461)
Q Consensus 212 ~gg~L~~----------~l-------~~~~---~~~~~-~~~~~i~~qi---------l~al~yLH~--------~givH 253 (461)
+|..+.. .+ +... ..+.. ..+..+..++ ...+..+-. ..++|
T Consensus 71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H 150 (256)
T TIGR02721 71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH 150 (256)
T ss_pred cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence 8865421 11 1111 11111 1122222122 111222222 14899
Q ss_pred cCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 254 RDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 254 rDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
+|+.+.||+++. ++ +.|+||..+..
T Consensus 151 ~Dl~~~Nil~~~---~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 151 MDVHAYNLVVTP---QG-LKLIDWEYASD 175 (256)
T ss_pred CCCCcCcEEEeC---CC-CEEEeccccCc
Confidence 999999999963 23 78999997754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00039 Score=67.94 Aligned_cols=140 Identities=20% Similarity=0.209 Sum_probs=80.1
Q ss_pred eceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC-CCeeEEEEE------EEeC
Q 012518 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH-KHMIKFHDA------FEDA 201 (461)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pniv~l~~~------~~~~ 201 (461)
..+.++.|....||++... +| .+++|+..... . .+.+..|++++..|.++ -.+.+++.. ....
T Consensus 26 ~i~~~~~G~~n~~y~v~t~----~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTD----VG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred eccccCCccccceEEEEeC----CC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 3566778877899988642 33 47789865421 1 23455678888877522 124555442 1234
Q ss_pred CeEEEEEeccCCCchH--------------HHHHhcCCCC--------CHHH-----HH----------HHHHHHHHHHH
Q 012518 202 NSVYIVMEFCEGGELL--------------DRILSRGGRY--------LEED-----AK----------TIVEKILNIVA 244 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~--------------~~l~~~~~~~--------~~~~-----~~----------~i~~qil~al~ 244 (461)
+..++||||++|..+. ..++.....+ .... .. .....+...++
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 6678999999885431 1111111111 0000 00 01122333455
Q ss_pred HHHH-------cCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 245 FCHL-------QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 245 yLH~-------~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
++.. .++||+|+.+.||+++. +..+.|+||+.+.
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~---~~~~~vIDfd~~~ 216 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDG---DSVKGVIDFYFAC 216 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEEC---CceEEEeeccccc
Confidence 5543 58999999999999963 3446899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00043 Score=67.14 Aligned_cols=138 Identities=19% Similarity=0.170 Sum_probs=81.6
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCC-CeeEEEE------EEEeCC
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK-HMIKFHD------AFEDAN 202 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp-niv~l~~------~~~~~~ 202 (461)
.+.|..|....+|++... +..+++|+.... ..+.+..|+.++..|..+- .+.+++. +....+
T Consensus 19 i~~i~~G~~n~~y~v~~~-----~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-----SGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred eecccCccccceEEEEeC-----CCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 456778888899988642 345888987541 1245667888888885321 3555544 223445
Q ss_pred eEEEEEeccCCCchHH--------------HHHhcCCCCC--------HHHHH------------HHHHHHHHHHHHHHH
Q 012518 203 SVYIVMEFCEGGELLD--------------RILSRGGRYL--------EEDAK------------TIVEKILNIVAFCHL 248 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~--------------~l~~~~~~~~--------~~~~~------------~i~~qil~al~yLH~ 248 (461)
..++|++|++|..+.. .++.....+. ..... .....+..++.++.+
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 6789999998865421 1111100000 00000 011123334455553
Q ss_pred -------cCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 249 -------QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 249 -------~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
.++||+|+.|.|||++ .+..+.|+||+.+.
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~ 204 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLFD---GDELSGVIDFYFAC 204 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEEe---CCceEEEeehhhhc
Confidence 3799999999999995 34446899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00047 Score=67.09 Aligned_cols=78 Identities=15% Similarity=0.153 Sum_probs=49.3
Q ss_pred eeeccCCceEEEEEEeccC---CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEE
Q 012518 131 KEVGRGHFGHTCCAKGKKG---TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIV 207 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~---~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv 207 (461)
+.|..|-...||++....+ ...++.+++|+...... ...+..+|..++..+..+--..++++++.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 4566677778898865321 11357899999654321 123456899999988644445566666642 358
Q ss_pred EeccCCCch
Q 012518 208 MEFCEGGEL 216 (461)
Q Consensus 208 ~e~~~gg~L 216 (461)
+||++|..+
T Consensus 76 ~e~i~G~~l 84 (302)
T cd05156 76 EEFIPSRTL 84 (302)
T ss_pred hheeCCCcC
Confidence 999988665
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00065 Score=66.07 Aligned_cols=141 Identities=19% Similarity=0.207 Sum_probs=92.1
Q ss_pred eceeeccCCceEEEEEEeccCCccCcEEEEEEeccccc----------------------CCHHH-HHHHHHHHHHHHhc
Q 012518 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM----------------------TSALA-IEDVRREVKILKAL 185 (461)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~----------------------~~~~~-~~~~~~Ei~il~~l 185 (461)
+-..|..|--+.||.|... +|..+|||+++-.-+ ..... .-....|++-|+++
T Consensus 148 inGCiSTGKEANVYHat~~----dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl 223 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE----DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL 223 (520)
T ss_pred cccccccCccceeEeeecC----CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH
Confidence 4456778888899998765 688899998753211 00111 12345788888888
Q ss_pred CCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCcEEEe
Q 012518 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH-LQGVVHRDLKPENFLFT 264 (461)
Q Consensus 186 ~~hpniv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH-~~givHrDlkp~NILl~ 264 (461)
. ...|.----+.. ..-.|||+|+.. +=+..-.-++..++...+..+-.|++.-+.-|- ..++||.||.--|+|+
T Consensus 224 ~-~aGIP~PePIlL--k~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 224 N-NAGIPCPEPILL--KNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY- 298 (520)
T ss_pred H-hcCCCCCCceee--ecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-
Confidence 5 333221111111 124699999953 322211123345777788888888888887775 4599999999999999
Q ss_pred cCCCCCCeeEeeccccc
Q 012518 265 TREEDAPLKVIDFGLSD 281 (461)
Q Consensus 265 ~~~~~~~~kl~DFG~a~ 281 (461)
.++.+.|+|-+-+.
T Consensus 299 ---hdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 299 ---HDGKLYIIDVSQSV 312 (520)
T ss_pred ---ECCEEEEEEccccc
Confidence 47789999987654
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0052 Score=60.26 Aligned_cols=75 Identities=15% Similarity=0.108 Sum_probs=45.3
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC-CCeeEEEE------EEEeCC
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH-KHMIKFHD------AFEDAN 202 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pniv~l~~------~~~~~~ 202 (461)
.+.|+.|....+|++... .| .+++|++.. .. .+.+..|+.+++.|..+ -.+.+.+. +....+
T Consensus 27 ~~~l~~G~~n~~y~v~t~----~g-~~vLK~~~~---~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g 95 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT----QG-EYVLTLFER---LT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAG 95 (319)
T ss_pred cchhccccccceEEEEeC----CC-cEEEEEecc---CC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCC
Confidence 355777888899988753 23 588898751 11 13344566666666421 12344442 223356
Q ss_pred eEEEEEeccCCCc
Q 012518 203 SVYIVMEFCEGGE 215 (461)
Q Consensus 203 ~~~lv~e~~~gg~ 215 (461)
..+++|+|++|..
T Consensus 96 ~~~~l~~~l~G~~ 108 (319)
T PRK05231 96 KPAAIVTFLEGKW 108 (319)
T ss_pred EEEEEEEecCCCC
Confidence 6899999998864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0022 Score=63.20 Aligned_cols=78 Identities=19% Similarity=0.173 Sum_probs=50.1
Q ss_pred eeccCCceEEEEEEeccCCccCcEEEEEEecc----cccCCHHHHHHHHHHHHHHHhcCCC-C-CeeEEEEEEEeCCeEE
Q 012518 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISK----AKMTSALAIEDVRREVKILKALSGH-K-HMIKFHDAFEDANSVY 205 (461)
Q Consensus 132 ~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~----~~~~~~~~~~~~~~Ei~il~~l~~h-p-niv~l~~~~~~~~~~~ 205 (461)
.||.|....||++.... .++.|+||.-.. .........++...|...|+.+... | .+.++|. .+.+...
T Consensus 2 EigdGnlN~VfrV~~~~---g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~ 76 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE---GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAV 76 (370)
T ss_pred cCCCCceEEEEEEEcCC---CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccce
Confidence 58999999999998642 235799997421 1111233456666788888876432 3 4555543 3455567
Q ss_pred EEEeccCCC
Q 012518 206 IVMEFCEGG 214 (461)
Q Consensus 206 lv~e~~~gg 214 (461)
+|||+++..
T Consensus 77 ~vMEdL~~~ 85 (370)
T TIGR01767 77 TVMEDLSHH 85 (370)
T ss_pred ehHhhCccc
Confidence 999998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00095 Score=67.51 Aligned_cols=165 Identities=18% Similarity=0.163 Sum_probs=104.5
Q ss_pred HHHHHHHHHHHhcCCCCCeeEEEEEEEe-CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 012518 173 EDVRREVKILKALSGHKHMIKFHDAFED-ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 251 (461)
Q Consensus 173 ~~~~~Ei~il~~l~~hpniv~l~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~gi 251 (461)
.++....++++.+. |+|...++++-.. .....+|||++ +.+|+|.+..+. +-... ++
T Consensus 27 ~~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s-------~~----------- 84 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDES-------LL----------- 84 (725)
T ss_pred HHHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhh-------hc-----------
Confidence 34556788899996 9999999987753 23478999999 459988775543 21111 10
Q ss_pred cccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCC
Q 012518 252 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPF 331 (461)
Q Consensus 252 vHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf 331 (461)
+|+= -+-|| ++.+| -++... ... .++++||||+|.++.++.-|...+
T Consensus 85 ~~~~-~~~~~----------~~~td-~~~t~~------~~~---------------~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 85 AHGV-LHLNI----------IYITD-HFLTKY------PSP---------------IGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred cccc-ceehh----------hhccc-cccccC------CCC---------------CCcchhhhhHHHHHHHHHHhhHHH
Confidence 2221 11122 33344 111100 111 124999999999999999998888
Q ss_pred CCCChhhHHHHHHhcCCCCCCC--------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 332 WARTESGIFRSVLRADPNFHDS--------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 332 ~~~~~~~~~~~i~~~~~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
...+..+....+..-...-... ..-.++....++..+|+-..|..||...++++++-|.+.
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 7666666655554321110000 001256677889999999999999999999999988543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0024 Score=63.34 Aligned_cols=142 Identities=17% Similarity=0.234 Sum_probs=80.9
Q ss_pred eeeccCCceEEEEEEeccC-CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEe
Q 012518 131 KEVGRGHFGHTCCAKGKKG-TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVME 209 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e 209 (461)
+.|-.|-.-.+|++....+ ...++.|++|+..... ...++ -.+|+.+++.+..+---.++++.+... .|+|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 4454588888999864321 1134679999875432 11222 257999999987554555677766432 5799
Q ss_pred ccCCCchHHH-----------------HHhcC---CC-CC-HHHHHHHHHHH-----------------HHHHHHH----
Q 012518 210 FCEGGELLDR-----------------ILSRG---GR-YL-EEDAKTIVEKI-----------------LNIVAFC---- 246 (461)
Q Consensus 210 ~~~gg~L~~~-----------------l~~~~---~~-~~-~~~~~~i~~qi-----------------l~al~yL---- 246 (461)
|++|.+|... +++.. .. .. ...+..++.++ ...+..|
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9977655211 11111 00 11 12232332221 1111122
Q ss_pred H----HcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 247 H----LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 247 H----~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
. ...++|+|+++.|||++. .+..+.|+||..+..
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~--~~~~~~lID~Eya~~ 231 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDE--ETRAITIIDYEYASY 231 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeC--CCCcEEEEeehhccc
Confidence 1 225899999999999962 235699999987753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0029 Score=62.48 Aligned_cols=78 Identities=18% Similarity=0.204 Sum_probs=46.6
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.|..|-...+|++.......++..|.+|+..... . .. -+-.+|..+++.+..+---.++++++. ++ +|.+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~-~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~f 91 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT--D-YV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSF 91 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc--C-eE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehh
Confidence 34444777788988654321123478899875431 1 11 122479999999874444456776663 32 58899
Q ss_pred cCCCch
Q 012518 211 CEGGEL 216 (461)
Q Consensus 211 ~~gg~L 216 (461)
++|..|
T Consensus 92 i~g~~l 97 (330)
T PLN02421 92 INARTL 97 (330)
T ss_pred hcCCCC
Confidence 877654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0083 Score=58.52 Aligned_cols=29 Identities=31% Similarity=0.534 Sum_probs=24.0
Q ss_pred cCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 249 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 249 ~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~----~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD----NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC----CcEEEEECcccc
Confidence 47999999999999952 458899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0047 Score=59.99 Aligned_cols=105 Identities=10% Similarity=0.009 Sum_probs=74.5
Q ss_pred eceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC--CCeeEEEEEEEe---CCe
Q 012518 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH--KHMIKFHDAFED---ANS 203 (461)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h--pniv~l~~~~~~---~~~ 203 (461)
-.+.||.|..+.||..... +| .+.+|..+.. . ....+.+|...|+.|..+ -.+.++++++.+ .+.
T Consensus 18 ~~~~i~~G~~~~vy~~~~~----~~-~~~~k~~~~~-~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 18 RVECISEQPYAALWALYDS----QG-NPMPLMARSF-S----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred eeeecCCccceeEEEEEcC----CC-CEEEEEeccc-c----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 3467999999999988643 23 4677875321 1 124677999999999754 368889988754 366
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ 249 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~ 249 (461)
.+||||+++|+++.+ . .........+..+++.+|.-||+.
T Consensus 88 ~~LVmE~i~G~~~~~-~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 88 DVLLLERLRGVSVEA-P-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred eEEEEeccCCEecCC-C-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 899999999987765 1 123444556777888888888875
|
|
| >PF00036 EF-hand_1: EF hand; InterPro: IPR018248 Many calcium-binding proteins belong to the same evolutionary family and share a type of calcium-binding domain known as the EF-hand | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.00092 Score=40.23 Aligned_cols=27 Identities=26% Similarity=0.431 Sum_probs=24.9
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
+++.|+.+|. +||.|+.+||...+++|
T Consensus 2 ~~~~F~~~D~d~dG~I~~~Ef~~~~~~L 29 (29)
T PF00036_consen 2 LKEAFREFDKDGDGKIDFEEFKEMMKKL 29 (29)
T ss_dssp HHHHHHHHSTTSSSEEEHHHHHHHHHHT
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHhC
Confidence 6789999999 99999999999999876
|
This type of domain consists of a twelve residue loop flanked on both sides by a twelve residue alpha-helical domain. In an EF-hand loop the calcium ion is coordinated in a pentagonal bipyramidal configuration. The six residues involved in the binding are in positions 1, 3, 5, 7, 9 and 12; these residues are denoted by X, Y, Z, -Y, -X and -Z. The invariant Glu or Asp at position 12 provides two oxygens for liganding Ca (bidentate ligand).; PDB: 1BJF_A 1XFW_R 1XFV_O 2K0J_A 2F3Z_A 3BYA_A 1XFU_Q 2R28_B 1ZOT_B 3G43_D .... |
| >KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0025 Score=66.52 Aligned_cols=25 Identities=4% Similarity=0.025 Sum_probs=16.1
Q ss_pred HHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 436 RAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 436 ~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
+++.-.++. .|..--.|+|.++|++
T Consensus 1027 k~alIdm~a~~de~GVmDslLeaLqs 1052 (1102)
T KOG1924|consen 1027 KKALIDMNAEGDETGVMDSLLEALQS 1052 (1102)
T ss_pred hHHHhccccccchhhhHHHHHHHHHh
Confidence 444444555 5666667889988875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.013 Score=56.29 Aligned_cols=31 Identities=26% Similarity=0.427 Sum_probs=23.9
Q ss_pred CccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 250 givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.++|+|+.+.|||++. +....-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~--~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDE--DARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeC--CCCEEEEECcHhccc
Confidence 4899999999999962 122356999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.014 Score=56.76 Aligned_cols=126 Identities=19% Similarity=0.347 Sum_probs=70.0
Q ss_pred CcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCC--eEEEEEeccCCCchH------------
Q 012518 153 GKVVAVKIISKAKMTSALAIEDVRREVKILKALSG-HKHMIKFHDAFEDAN--SVYIVMEFCEGGELL------------ 217 (461)
Q Consensus 153 g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~-hpniv~l~~~~~~~~--~~~lv~e~~~gg~L~------------ 217 (461)
++.+++. ... ............+|..+++.+.. ---+.+.++.|.++. ..|.||+|++|..+.
T Consensus 48 ~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~ 125 (321)
T COG3173 48 GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQF 125 (321)
T ss_pred CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHH
Confidence 5667777 321 11122234566789999998842 123444566666554 679999999883221
Q ss_pred ------HHHHhc------C----CC---CCHHHHHHHHHH--------------HHHHHHHHHHc--------CccccCC
Q 012518 218 ------DRILSR------G----GR---YLEEDAKTIVEK--------------ILNIVAFCHLQ--------GVVHRDL 256 (461)
Q Consensus 218 ------~~l~~~------~----~~---~~~~~~~~i~~q--------------il~al~yLH~~--------givHrDl 256 (461)
+.|..- + +. +...++..+..+ ...-..+|+.+ .++|+|+
T Consensus 126 ~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~ 205 (321)
T COG3173 126 ALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDY 205 (321)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCc
Confidence 111000 0 00 011111111111 12224556554 3899999
Q ss_pred CCCcEEEecCCCCCCeeEeeccccccc
Q 012518 257 KPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 257 kp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
.+.||++.. +.-+=|.||+++..-
T Consensus 206 ~~gNlii~~---~~~~gVlDwe~~~lG 229 (321)
T COG3173 206 RPGNLIIDP---GRPTGVLDWELATLG 229 (321)
T ss_pred ccCCEEEeC---CCeeEEEeccccccC
Confidence 999999964 333889999988754
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.025 Score=56.87 Aligned_cols=77 Identities=17% Similarity=0.119 Sum_probs=51.0
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEeccccc-CC---HHHHHHHHHHHHHHHhcCC--CCCeeEEEEEEEeCCe
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM-TS---ALAIEDVRREVKILKALSG--HKHMIKFHDAFEDANS 203 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~-~~---~~~~~~~~~Ei~il~~l~~--hpniv~l~~~~~~~~~ 203 (461)
.+.||-|....||++.+. +..|+||.-..... .. ....++...|...|+.+.. ..++.+++.++.+ .
T Consensus 37 ~~eiggGn~N~VyrV~~~-----~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--M 109 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--C
Confidence 567899999999998763 34588997542111 11 1234455567777776642 2478888887763 4
Q ss_pred EEEEEeccCC
Q 012518 204 VYIVMEFCEG 213 (461)
Q Consensus 204 ~~lv~e~~~g 213 (461)
.+++|||+++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5788999977
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.016 Score=57.86 Aligned_cols=79 Identities=22% Similarity=0.124 Sum_probs=52.5
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecc---cccCCHHHHHHHHHHHHHHHhcCCC-C-CeeEEEEEEEeCCeE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISK---AKMTSALAIEDVRREVKILKALSGH-K-HMIKFHDAFEDANSV 204 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~---~~~~~~~~~~~~~~Ei~il~~l~~h-p-niv~l~~~~~~~~~~ 204 (461)
.+.||-|.-.-||++.+.. .++.|+||.-.. .........++...|.++|+.+... | .+.++|. .+.+..
T Consensus 34 ~~eigdGnlN~VfrV~~~~---~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~ 108 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMN 108 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHh
Confidence 5679999999999998742 245699996421 1112234466777888888876432 3 4666653 345566
Q ss_pred EEEEeccCC
Q 012518 205 YIVMEFCEG 213 (461)
Q Consensus 205 ~lv~e~~~g 213 (461)
.+|||+++.
T Consensus 109 ~~vMEdL~~ 117 (409)
T PRK12396 109 CCVMEDLSD 117 (409)
T ss_pred hHHHHhCcc
Confidence 789999864
|
|
| >PF13405 EF-hand_6: EF-hand domain; PDB: 2AMI_A 3QRX_A 1W7J_B 1OE9_B 1W7I_B 1KFU_S 1KFX_S 2BL0_B 1Y1X_B 3MSE_B | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.0048 Score=37.72 Aligned_cols=27 Identities=22% Similarity=0.543 Sum_probs=23.7
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHh-hC
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSW-LL 461 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~-~~ 461 (461)
++..|..+|. ++|.|+.+||..+++ +|
T Consensus 2 l~~~F~~~D~d~dG~I~~~el~~~l~~~l 30 (31)
T PF13405_consen 2 LREAFKMFDKDGDGFIDFEELRAILRKSL 30 (31)
T ss_dssp HHHHHHHH-TTSSSEEEHHHHHHHHHHHT
T ss_pred HHHHHHHHCCCCCCcCcHHHHHHHHHHhc
Confidence 6789999999 999999999999998 55
|
... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.04 Score=54.21 Aligned_cols=72 Identities=10% Similarity=0.056 Sum_probs=43.3
Q ss_pred CCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCC-CeeEEE---E--EEEeCCeEEEEEe
Q 012518 136 GHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK-HMIKFH---D--AFEDANSVYIVME 209 (461)
Q Consensus 136 G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp-niv~l~---~--~~~~~~~~~lv~e 209 (461)
+.-..||++... +|..+++|+.+.... ....+..|++.+..|..+- .++... | ....++..+.|++
T Consensus 36 s~eN~vy~v~~~----~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~ 107 (325)
T PRK11768 36 SYENRVYQFGDE----DGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFP 107 (325)
T ss_pred cccceEEEEecC----CCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEe
Confidence 344678988653 466799998754321 2355677888888775321 122211 1 2233567788999
Q ss_pred ccCCCc
Q 012518 210 FCEGGE 215 (461)
Q Consensus 210 ~~~gg~ 215 (461)
+++|..
T Consensus 108 ~~~G~~ 113 (325)
T PRK11768 108 RRGGRA 113 (325)
T ss_pred eeCCCC
Confidence 998753
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.0089 Score=54.85 Aligned_cols=56 Identities=30% Similarity=0.250 Sum_probs=32.6
Q ss_pred CcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEeccCCCch
Q 012518 153 GKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGEL 216 (461)
Q Consensus 153 g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~~gg~L 216 (461)
++.|+|++..... . ..-+-.+|..+++.+..+-.-.++++.+.++ +|.||+.|..|
T Consensus 2 ~~~~~~Ri~g~~t-~---~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-E---NFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCG-C---SHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE-
T ss_pred CCEEEEEeCCCCc-c---cccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEeccccc
Confidence 3568888876541 1 1234457999999887555556777765432 56799866553
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.022 Score=57.18 Aligned_cols=79 Identities=25% Similarity=0.281 Sum_probs=47.2
Q ss_pred ceeeccCCceEEEEEEeccCC---ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGT---LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
.+.|..|-...+|++....+. ...+.|.+.+.... ....+ +-.+|+++++.|..+-.-.++++.+.. ++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 345555888899988653321 01122444432111 11111 224699999999866667778877753 58
Q ss_pred EEeccCCCch
Q 012518 207 VMEFCEGGEL 216 (461)
Q Consensus 207 v~e~~~gg~L 216 (461)
|.||++|..|
T Consensus 127 l~efIeGr~l 136 (383)
T PTZ00384 127 IQEWVEGNTM 136 (383)
T ss_pred EEEEeccccC
Confidence 9999988665
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.052 Score=52.32 Aligned_cols=74 Identities=23% Similarity=0.226 Sum_probs=47.3
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC--CCCCeeEEEEEEEeCCeEEEE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS--GHKHMIKFHDAFEDANSVYIV 207 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpniv~l~~~~~~~~~~~lv 207 (461)
.+.|+-|....+|++.. +++.+.||+-... ....+..|..-|+.|. .--.+.+.+++....+.-|||
T Consensus 22 ~~~v~GG~i~~a~~~~~-----~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDT-----DGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp EEEE--SSSSEEEEEET-----TS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eEecCCCChhheEEEEC-----CCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 46788899999998873 6778999987522 1245678888888884 234577899888877777999
Q ss_pred EeccCCC
Q 012518 208 MEFCEGG 214 (461)
Q Consensus 208 ~e~~~gg 214 (461)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF13202 EF-hand_5: EF hand; PDB: 3DD4_A 2Q4U_A 2BE4_A 1UHJ_B 1UHI_A 1UHH_B 1EJ3_B 1UHK_A 2ZFD_A 1UHN_A | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.008 Score=34.74 Aligned_cols=23 Identities=26% Similarity=0.583 Sum_probs=20.7
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHH
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVV 457 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~ 457 (461)
|++.|+.+|. +||.|+.+||.+.
T Consensus 1 l~~~F~~~D~d~DG~is~~E~~~~ 24 (25)
T PF13202_consen 1 LKDAFQQFDTDGDGKISFEEFQRL 24 (25)
T ss_dssp HHHHHHHHTTTSSSEEEHHHHHHH
T ss_pred CHHHHHHHcCCCCCcCCHHHHHHH
Confidence 5678999999 9999999999874
|
... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.2 Score=48.80 Aligned_cols=30 Identities=30% Similarity=0.452 Sum_probs=25.1
Q ss_pred CccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 250 givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
++||+|+.+.|||++ .++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~---~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD---ETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEc---CCCCEEEEEhhhccc
Confidence 799999999999994 455689999987653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.13 Score=49.74 Aligned_cols=78 Identities=19% Similarity=0.123 Sum_probs=46.5
Q ss_pred ccCCceEEEEEEecc-----CCccCcEEEEEEecccccCCH--HHHHHHHHHHHHHHhcC--------C----CCCeeEE
Q 012518 134 GRGHFGHTCCAKGKK-----GTLKGKVVAVKIISKAKMTSA--LAIEDVRREVKILKALS--------G----HKHMIKF 194 (461)
Q Consensus 134 G~G~fg~V~~~~~~~-----~~~~g~~vAvK~i~~~~~~~~--~~~~~~~~Ei~il~~l~--------~----hpniv~l 194 (461)
|.|-.|.+|++.... +......+.||.......... .....+.+|+.+.+.+- . ...+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 678888888887643 111234688998763221111 12355778887766552 1 1235666
Q ss_pred EEEEEeCCeEEEEEecc
Q 012518 195 HDAFEDANSVYIVMEFC 211 (461)
Q Consensus 195 ~~~~~~~~~~~lv~e~~ 211 (461)
+....+.+..+||||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 66665555688999966
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.033 Score=55.31 Aligned_cols=123 Identities=19% Similarity=0.180 Sum_probs=0.0
Q ss_pred eccCCceEEEEEEecc------------CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEE---
Q 012518 133 VGRGHFGHTCCAKGKK------------GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDA--- 197 (461)
Q Consensus 133 lG~G~fg~V~~~~~~~------------~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~--- 197 (461)
||.|+-.+||+|..+. +....+.+|||+...+ ..+.+.+...||....+-.|++.-..|
T Consensus 197 IGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~------V~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l 270 (565)
T KOG1236|consen 197 IGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPN------VEKQIRLDLGILGFGAKLINNVPDLSWLSL 270 (565)
T ss_pred cccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCcc------HHHHHHHHHHHHhhhhhhhhhcCccccccC
Q ss_pred -------------------------------------------EEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHH
Q 012518 198 -------------------------------------------FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKT 234 (461)
Q Consensus 198 -------------------------------------------~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~ 234 (461)
..-.....|+-+|..|-++..++.... .+|...+.
T Consensus 271 ~~~vkqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kk 348 (565)
T KOG1236|consen 271 PLEVKQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKS--QPEALVKK 348 (565)
T ss_pred cchHHHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhccc--ChHHHHHH
Q ss_pred HHHHHHHHHHHHHHc-CccccCCCCCcEEE
Q 012518 235 IVEKILNIVAFCHLQ-GVVHRDLKPENFLF 263 (461)
Q Consensus 235 i~~qil~al~yLH~~-givHrDlkp~NILl 263 (461)
+..-.+.||--+--. +++|.|+.|.||++
T Consensus 349 va~lg~~AllkMl~vDNFvHaDlHPGNVli 378 (565)
T KOG1236|consen 349 VAKLGVNALLKMLIVDNFVHADLHPGNVLI 378 (565)
T ss_pred HHHHHHHHHHHHHHhhcceecccCCCcEEE
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 461 | ||||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-51 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-51 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-50 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-49 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-49 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-48 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-48 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-48 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-48 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-47 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-47 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-46 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-46 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-46 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-46 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-46 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-46 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-46 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-46 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-46 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-45 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-44 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-42 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-42 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-42 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-42 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-42 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-42 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-42 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-42 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-42 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-42 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-42 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-42 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-42 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-41 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-41 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-41 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-41 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-41 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-40 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-40 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-40 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-40 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-40 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-40 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-40 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-40 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-40 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-39 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-39 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-39 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-39 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-39 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-39 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-38 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-38 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-38 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-38 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-38 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-38 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-38 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-38 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-38 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-38 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-37 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-37 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-37 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-37 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-36 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-36 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-36 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-36 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-36 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-36 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-35 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-35 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-35 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-34 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-34 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-34 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-34 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-34 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-34 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-34 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-34 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-34 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-34 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-34 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-33 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-33 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-33 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-33 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-32 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-32 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-32 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-31 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-31 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-31 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-31 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-30 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-30 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-30 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-30 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-30 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-30 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-30 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-30 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-30 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-30 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-29 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-29 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-29 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-29 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-29 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-29 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-29 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-29 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-29 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-29 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-29 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-29 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-29 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-29 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-29 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-29 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-29 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-29 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-29 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-29 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-29 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-29 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-28 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-28 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-28 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-28 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-28 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-28 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-28 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-27 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-27 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-27 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-27 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-27 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-27 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-27 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-27 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-26 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-26 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-26 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-26 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-26 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-26 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-26 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-26 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-25 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-25 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-25 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-25 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-25 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-25 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-25 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-25 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-25 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-25 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-25 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-25 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-25 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-25 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-25 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-25 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-25 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-25 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-25 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-25 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-25 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-25 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-25 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-25 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-25 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-25 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-25 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-24 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-24 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-24 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-24 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-24 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-24 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-24 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-24 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-23 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-23 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-23 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-23 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-23 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-23 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-23 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-23 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-23 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-23 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-23 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-23 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-23 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-23 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-23 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-23 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-23 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-23 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-23 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-23 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-23 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-23 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-23 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-23 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-23 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-23 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-23 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-23 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-23 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-23 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-23 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-23 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-23 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-23 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-22 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-22 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-22 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-22 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-22 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-22 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-22 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-22 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-22 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-22 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-22 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-22 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-22 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-22 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-22 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-22 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-22 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-22 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-22 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-22 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-22 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-22 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-22 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-22 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-22 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-22 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-22 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-22 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-22 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-22 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-22 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-22 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-22 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-22 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-22 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-22 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-22 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-22 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-22 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-22 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-22 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-22 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-22 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-22 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-22 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-22 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-22 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-22 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-22 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-22 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-22 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-22 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-21 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-21 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-21 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-21 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-21 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-21 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-21 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-21 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-21 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-20 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-20 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-20 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-20 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-20 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-20 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-20 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-20 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-20 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-20 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-19 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-19 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-19 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-19 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-19 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-19 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-19 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-19 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-19 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-19 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-19 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-19 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-19 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-19 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-19 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-19 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-19 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-19 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 8e-19 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-19 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-19 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-19 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 9e-19 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-19 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 9e-19 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-19 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-18 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-18 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-18 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-18 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-18 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-18 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-18 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-18 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-18 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-18 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-18 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-18 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-18 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-18 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-18 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-18 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-18 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-18 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-18 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-18 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-18 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-18 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-18 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-18 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-18 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-18 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-18 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-18 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-18 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-18 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-18 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-18 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-18 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-18 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-18 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-18 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-18 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-18 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-18 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-18 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-18 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-18 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-18 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-18 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-18 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-18 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-18 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-18 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-18 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-18 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-18 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-18 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-18 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-18 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-18 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-18 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-18 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-18 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-18 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-18 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-18 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-18 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-18 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-18 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-17 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-17 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-17 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-17 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-17 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-17 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-17 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-17 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-17 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-17 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-17 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-17 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-17 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-17 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-17 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-17 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-17 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-17 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-17 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-17 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-17 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-17 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-17 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-17 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-17 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-17 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-17 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-17 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-17 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-17 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-17 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-17 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-17 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-16 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-16 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-15 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-15 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-14 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-14 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 9e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 9e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 8e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-04 |
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 486 bits (1253), Expect = e-170
Identities = 116/354 (32%), Positives = 187/354 (52%), Gaps = 14/354 (3%)
Query: 110 ERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA 169
+N + F ++ + +G+G FG K + + AVK+I+KA +
Sbjct: 7 HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNK 63
Query: 170 LAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLE 229
+ REV++LK L H +++K + ED++S YIV E GGEL D I+ R R+ E
Sbjct: 64 -DTSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSE 120
Query: 230 EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL 289
DA I++++ + + + H +VHRDLKPEN L ++E+D +K+IDFGLS + + ++
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 290 NDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN 349
D +G+AYY+APEVL +Y+ + D+WS GVI YILL G+ PF+ + E I + V
Sbjct: 181 KDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
Query: 350 FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR------PVPLDILIY 403
F W ++S +AKD +R++L R+TA Q L HPW+ + +P
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAM 300
Query: 404 KLVKSYLRATPLKRAALKALSKALTE-EELVYLRAQFMLLEP-KDGCVSLNNFK 455
++ + L +AAL ++ LT +E L F L+ DG + +
Sbjct: 301 TNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELV 354
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 474 bits (1222), Expect = e-165
Identities = 114/382 (29%), Positives = 180/382 (47%), Gaps = 22/382 (5%)
Query: 91 MQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGT 150
G + +++G G +G K K G
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG- 60
Query: 151 LKGKVVAVKIISKAKMTSALAI----------EDVRREVKILKALSGHKHMIKFHDAFED 200
A+K+I K++ E++ E+ +LK+L H ++IK D FED
Sbjct: 61 --HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLFDVFED 117
Query: 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 260
Y+V EF EGGEL ++I++R ++ E DA I+++IL+ + + H +VHRD+KPEN
Sbjct: 118 KKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPEN 176
Query: 261 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVI 320
L + +K++DFGLS F D +L D +G+AYY+APEVL + YN + D+WS GVI
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVI 236
Query: 321 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 380
YILLCG PF + + I + V + F + W ++S EAK+ ++ +L D+ KR TA
Sbjct: 237 MYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296
Query: 381 AQALTHPWLHDENRPV-----PLDILIYKLVKSYLRATPLKRAALKALSKALTE-EELVY 434
+AL W+ + ++ + + L +AA+ + LT EE
Sbjct: 297 EEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKE 356
Query: 435 LRAQFMLLEP-KDGCVSLNNFK 455
L F L+ DG +
Sbjct: 357 LTDIFKKLDKNGDGQLDKKELI 378
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 472 bits (1216), Expect = e-164
Identities = 117/375 (31%), Positives = 198/375 (52%), Gaps = 16/375 (4%)
Query: 91 MQAPPKEGPTSGDGGVKATERQLDKNFGYGK--NFGAKFELGKEVGRGHFGHTCCAKGKK 148
M + + + F K + ++ K++G G +G + K
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 149 GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVM 208
A+KII K ++++ + + EV +LK L H +++K +D FED + Y+VM
Sbjct: 61 T---HVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLD-HPNIMKLYDFFEDKRNYYLVM 115
Query: 209 EFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 268
E +GGEL D I+ R ++ E DA I++++L+ V + H +VHRDLKPEN L ++E+
Sbjct: 116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK 174
Query: 269 DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGS 328
DA +K++DFGLS +++ + +G+AYY+APEVL + Y+ + D+WSIGVI +ILL G
Sbjct: 175 DALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGY 234
Query: 329 RPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388
PF +T+ I R V + F W +VS AKD ++++L D ++R++A QAL HPW
Sbjct: 235 PPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294
Query: 389 L------HDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKAL-TEEELVYLRAQFML 441
+ + +P + ++ + + L +AAL ++ L ++EE L F
Sbjct: 295 IKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRH 354
Query: 442 LEP-KDGCVSLNNFK 455
++ DG +
Sbjct: 355 IDKNGDGQLDRQELI 369
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 470 bits (1211), Expect = e-164
Identities = 118/342 (34%), Positives = 182/342 (53%), Gaps = 12/342 (3%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
F +++ + +G+G FG K K G+ AVK+ISK ++ E + REV+
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREVQ 78
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
+LK L H +++K ++ FED Y+V E GGEL D I+SR R+ E DA I+ ++L
Sbjct: 79 LLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVL 136
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVA 300
+ + + H +VHRDLKPEN L ++ +DA +++IDFGLS +++ D +G+AYY+A
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 301 PEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360
PEVLH +Y+ + D+WS GVI YILL G PF E I + V + F W VS
Sbjct: 197 PEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256
Query: 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR-----PVPLDILIYKLVKSYLRATPL 415
AKD +R++L R++A AL H W+ + VP ++ + L
Sbjct: 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKL 316
Query: 416 KRAALKALSKAL-TEEELVYLRAQFMLLEP-KDGCVSLNNFK 455
+AAL + L +++E L A F ++ DG +
Sbjct: 317 AQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELI 358
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 440 bits (1134), Expect = e-154
Identities = 88/326 (26%), Positives = 155/326 (47%), Gaps = 12/326 (3%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
K K+ + +++GRG FG + + K K + V++E+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCV-ETSS--KKTYMAKFVKVKGTD----QVLVKKEIS 53
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
IL H++++ H++FE + ++ EF G ++ +RI + E + + V ++
Sbjct: 54 ILNIA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVA 300
+ F H + H D++PEN ++ TR + +K+I+FG + ++P + + Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 301 PEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359
PEV H + DMWS+G + Y+LL G PF A T I +++ A+ F + + +S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAA 419
EA DFV RLL K+ + RMTA++AL HPWL + V ++ + Y L +
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT--LIKKD 289
Query: 420 LKALSKALTEEELVYLRAQFMLLEPK 445
L + A +R+Q + K
Sbjct: 290 LNMVVSAARISCGGAIRSQKGVSVAK 315
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 437 bits (1126), Expect = e-154
Identities = 107/280 (38%), Positives = 163/280 (58%), Gaps = 8/280 (2%)
Query: 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI 181
+ + L +GRG +G A K A K I K + ++ ++E++I
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGT---RIRRAAKKIPKYFVED---VDRFKQEIEI 59
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN 241
+K+L H ++I+ ++ FED +Y+VME C GGEL +R++ + + E DA I++ +L+
Sbjct: 60 MKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLS 117
Query: 242 IVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAP 301
VA+CH V HRDLKPENFLF T D+PLK+IDFGL+ +P + + VG+ YYV+P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
Query: 302 EVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361
+VL Y E D WS GV+ Y+LLCG PF A T+S + + F + W +VSP+
Sbjct: 178 QVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237
Query: 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDIL 401
A+ +RRLL K ++R+T+ QAL H W + P ++L
Sbjct: 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNLL 277
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 437 bits (1125), Expect = e-154
Identities = 103/280 (36%), Positives = 163/280 (58%), Gaps = 6/280 (2%)
Query: 115 KNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIED 174
+N + F ++ + +G+G FG K + + AVK+I+KA +
Sbjct: 12 ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNK-DTST 67
Query: 175 VRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKT 234
+ REV++LK L H +++K + ED++S YIV E GGEL D I+ R R+ E DA
Sbjct: 68 ILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAAR 125
Query: 235 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVG 294
I++++ + + + H +VHRDLKPEN L ++E+D +K+IDFGLS + + ++ D +G
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 295 SAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP 354
+AYY+APEVL +Y+ + D+WS GVI YILL G+ PF+ + E I + V F
Sbjct: 186 TAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245
Query: 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394
W ++S +AKD +R++L R+TA Q L HPW+ +
Sbjct: 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 430 bits (1108), Expect = e-151
Identities = 96/279 (34%), Positives = 157/279 (56%), Gaps = 10/279 (3%)
Query: 114 DKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIE 173
+N + F +++G G FG + + G +K I+K + + +E
Sbjct: 11 RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRS--QVPME 65
Query: 174 DVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSR---GGRYLEE 230
+ E+++LK+L H ++IK + FED +++YIVME CEGGELL+RI+S G E
Sbjct: 66 QIEAEIEVLKSLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 231 DAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN 290
++++++N +A+ H Q VVH+DLKPEN LF +P+K+IDFGL++ + D+
Sbjct: 125 YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 291 DIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 350
+ G+A Y+APEV R + D+WS GV+ Y LL G PF + + + +PN+
Sbjct: 185 NAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY 244
Query: 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
P ++P+A D ++++L KD +R +AAQ L H W
Sbjct: 245 AVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 430 bits (1107), Expect = e-150
Identities = 96/356 (26%), Positives = 157/356 (44%), Gaps = 24/356 (6%)
Query: 46 SPFQSPLPAGVAPSPSPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGG 105
+ + + R F L + A ++L + G
Sbjct: 20 RRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMG- 78
Query: 106 VKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAK 165
++ K F K++ +GRG + G AVKI+
Sbjct: 79 ----PEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA---TGHEFAVKIMEVTA 131
Query: 166 MTSAL-----AIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRI 220
+ E RRE IL+ ++GH H+I D++E ++ +++V + GEL D +
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL 191
Query: 221 LSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280
+ E++ ++I+ +L V+F H +VHRDLKPEN L +++ +++ DFG S
Sbjct: 192 TEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFS 247
Query: 281 DFVRPDQRLNDIVGSAYYVAPEVL-------HRSYNVEGDMWSIGVITYILLCGSRPFWA 333
+ P ++L ++ G+ Y+APE+L H Y E D+W+ GVI + LL GS PFW
Sbjct: 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307
Query: 334 RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
R + + R ++ F W S KD + RLL D R+TA QAL HP+
Sbjct: 308 RRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 427 bits (1101), Expect = e-148
Identities = 101/335 (30%), Positives = 170/335 (50%), Gaps = 13/335 (3%)
Query: 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREV 179
F +++L +E+G+G F K G+ A II+ K+++ + + RE
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCV-KVLA--GQEYAAMIINTKKLSAR-DHQKLEREA 61
Query: 180 KILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKI 239
+I + L H ++++ HD+ + Y++ + GGEL + I++R Y E DA +++I
Sbjct: 62 RICRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQI 119
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYY 298
L V CH GVVHR+LKPEN L ++ + A +K+ DFGL+ V Q G+ Y
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 299 VAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357
++PEVL + Y D+W+ GVI YILL G PFW + +++ + +F W +
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239
Query: 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR--PVPLDILIYKLVKSYLRATPL 415
V+PEAKD + ++L + KR+TAA+AL HPW+ + +K + L
Sbjct: 240 VTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKL 299
Query: 416 KRAALK--ALSKALTEEELVYLRAQFMLLEP-KDG 447
K A L ++ + + ++ L+E +G
Sbjct: 300 KGAILTVMLATRNFSVRKQEIIKVTEQLIEAISNG 334
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 421 bits (1085), Expect = e-146
Identities = 98/331 (29%), Positives = 158/331 (47%), Gaps = 14/331 (4%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS--ALAIEDVRRE 178
F +EL + +G+G F + T G+ AVKI+ AK TS L+ ED++RE
Sbjct: 20 VLFEDVYELCEVIGKGPFSVVRRCI-NRET--GQQFAVKIVDVAKFTSSPGLSTEDLKRE 76
Query: 179 VKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG---GRYLEEDAKTI 235
I L H H+++ + + +Y+V EF +G +L I+ R Y E A
Sbjct: 77 ASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 236 VEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVG 294
+ +IL + +CH ++HRD+KP L ++E AP+K+ FG++ VG
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195
Query: 295 SAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 353
+ +++APEV+ R Y D+W GVI +ILL G PF+ T+ +F +++ +
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPR 254
Query: 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR--PVPLDILIYKLVKSYLR 411
W +S AKD VRR+L D +R+T +AL HPWL + +R + ++ +
Sbjct: 255 QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNA 314
Query: 412 ATPLKRAALKALSKALTEEELVYLRAQFMLL 442
LK A L A+S +
Sbjct: 315 RRKLKGAVLAAVSSHKFNSFYGDPPEELPDF 345
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 414 bits (1065), Expect = e-143
Identities = 101/343 (29%), Positives = 173/343 (50%), Gaps = 13/343 (3%)
Query: 93 APPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLK 152
P T G + +E ++ + F +++ +E+G+G F K T
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNAS----TKFSDNYDVKEELGKGAFSVVRRCV-HKTT-- 53
Query: 153 GKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCE 212
G A KII+ K+++ + + RE +I + L H ++++ HD+ ++ + Y+V +
Sbjct: 54 GLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVT 111
Query: 213 GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 272
GGEL + I++R Y E DA +++IL +A+CH G+VHR+LKPEN L ++ + A +
Sbjct: 112 GGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV 170
Query: 273 KVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPF 331
K+ DFGL+ V + + G+ Y++PEVL + Y+ D+W+ GVI YILL G PF
Sbjct: 171 KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230
Query: 332 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391
W + ++ + ++ W +V+PEAK + +L + +KR+TA QAL PW+ +
Sbjct: 231 WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290
Query: 392 ENR--PVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEEL 432
R +K + LK A L + L
Sbjct: 291 RERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSNL 333
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 410 bits (1055), Expect = e-143
Identities = 91/278 (32%), Positives = 155/278 (55%), Gaps = 7/278 (2%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
F +++ +E+G+G F K T G A KII+ K+++ + + RE +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCV-HKTT--GLEFAAKIINTKKLSAR-DFQKLEREAR 57
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
I + L H ++++ HD+ ++ + Y+V + GGEL + I++R Y E DA +++IL
Sbjct: 58 ICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQIL 115
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVA 300
+A+CH G+VHR+LKPEN L ++ + A +K+ DFGL+ V + + G+ Y++
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLS 175
Query: 301 PEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359
PEVL + Y+ D+W+ GVI YILL G PFW + ++ + ++ W +V+
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397
PEAK + +L + +KR+TA QAL PW+ + R
Sbjct: 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS 273
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 403 bits (1038), Expect = e-140
Identities = 83/306 (27%), Positives = 148/306 (48%), Gaps = 10/306 (3%)
Query: 120 GKNFGAKFEL-GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRRE 178
+NF + L KE+GRG F K T G+ A K + K + ++ E
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCI-SKST--GQEYAAKFLKKRRRGQD-CRAEILHE 78
Query: 179 VKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVE 237
+ +L+ +I H+ +E+ + + +++E+ GGE+ L E D +++
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY 297
+IL V + H +VH DLKP+N L ++ +K++DFG+S + L +I+G+
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPE 198
Query: 298 YVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356
Y+APE+L+ DMW+IG+I Y+LL + PF + ++ + + ++ + +
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258
Query: 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD---ENRPVPLDILIYKLVKSYLRAT 413
SVS A DF++ LL K+ KR TA L+H WL EN P + + + +
Sbjct: 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRS 318
Query: 414 PLKRAA 419
+ +
Sbjct: 319 SEDKTS 324
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 398 bits (1024), Expect = e-138
Identities = 94/285 (32%), Positives = 139/285 (48%), Gaps = 20/285 (7%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAI------ED 174
F +E + +GRG K T K AVKII S A E
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCI-HKPT--CKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 175 VRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKT 234
+EV IL+ +SGH ++I+ D +E ++V + + GEL D + + E++ +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRK 128
Query: 235 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVG 294
I+ +L ++ H +VHRDLKPEN L ++D +K+ DFG S + P ++L ++ G
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCG 185
Query: 295 SAYYVAPEVL-------HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 347
+ Y+APE++ H Y E DMWS GVI Y LL GS PFW R + + R ++ +
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245
Query: 348 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392
F W S KD V R L +KR TA +AL HP+
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 399 bits (1026), Expect = e-138
Identities = 124/353 (35%), Positives = 171/353 (48%), Gaps = 19/353 (5%)
Query: 71 PPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELG 130
S + + S + A G S D FE+
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRD-------ALSDFFEVE 58
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
E+GRG K +KGT K A+K++ K + VR E+ +L LS H +
Sbjct: 59 SELGRGATSIVYRCK-QKGT--QKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPN 109
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+IK + FE + +V+E GGEL DRI+ +G Y E DA V++IL VA+ H G
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENG 168
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYN 309
+VHRDLKPEN L+ T DAPLK+ DFGLS V + + G+ Y APE+L +Y
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYG 228
Query: 310 VEGDMWSIGVITYILLCGSRPFWART-ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368
E DMWS+G+ITYILLCG PF+ + +FR +L + F W VS AKD VR+
Sbjct: 229 PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK 288
Query: 369 LLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALK 421
L+ D +KR+T QAL HPW+ + K ++ + LK A
Sbjct: 289 LIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNARRKLKAAVKA 341
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 404 bits (1039), Expect = e-136
Identities = 110/411 (26%), Positives = 175/411 (42%), Gaps = 23/411 (5%)
Query: 62 PGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGY-G 120
P L P K G ++ + ++ +
Sbjct: 93 PCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH 152
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
+ +++ +E+G G FG ++ T G A K + + E VR+E++
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVT-ERAT--GNNFAAKFVMTPHESD---KETVRKEIQ 206
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
+ L H ++ HDAFED N + ++ EF GGEL +++ + E++A + ++
Sbjct: 207 TMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVA 300
+ H VH DLKPEN +FTT+ + LK+IDFGL+ + P Q + G+A + A
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAA 324
Query: 301 PEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359
PEV + DMWS+GV++YILL G PF + R+V D N DS + +S
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 384
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP---VPLDILIYKLVKSYLR----- 411
+ KDF+R+LL D RMT QAL HPWL N P + Y ++ ++
Sbjct: 385 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDA 444
Query: 412 ----ATPLKR-AALKALSKALTEEELVYLRAQFMLLEPKDGCVSLNNFKVV 457
PL R + +L K +E + V +V
Sbjct: 445 WPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPYGTEVG 495
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 392 bits (1009), Expect = e-136
Identities = 98/278 (35%), Positives = 159/278 (57%), Gaps = 10/278 (3%)
Query: 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS---ALAIEDVRRE 178
+E+G+E+G G F + +KGT GK A K I K +++S ++ E++ RE
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCR-QKGT--GKEYAAKFIKKRRLSSSRRGVSREEIERE 58
Query: 179 VKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEK 238
V IL+ + H ++I HD FE+ V +++E GGEL D + + E++A +++
Sbjct: 59 VNILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQ 116
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFTTR-EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY 297
IL+ V + H + + H DLKPEN + + + +K+IDFG++ + +I G+
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE 176
Query: 298 YVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356
+VAPE+++ +E DMWSIGVITYILL G+ PF T+ ++ + +F + +
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 236
Query: 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394
+ S AKDF+RRLL KD ++RMT AQ+L H W+ R
Sbjct: 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 391 bits (1007), Expect = e-135
Identities = 107/327 (32%), Positives = 163/327 (49%), Gaps = 18/327 (5%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS---ALAIEDVRR 177
+N ++ G+E+G G F + +K T G A K I K + S ++ ED+ R
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCR-EKST--GLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 178 EVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE 237
EV ILK + H ++I H+ +E+ V +++E GGEL D + + EE+A ++
Sbjct: 64 EVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTR-EEDAPLKVIDFGLSDFVRPDQRLNDIVGSA 296
+ILN V + H + H DLKPEN + R +K+IDFGL+ + +I G+
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 297 YYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355
+VAPE+++ +E DMWSIGVITYILL G+ PF T+ +V + F D +
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPL 415
+ S AKDF+RRLL KD +KRMT +L HPW+ ++ L +
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNME-----KF 296
Query: 416 KRAALKALSKALTEEELVYLRAQFMLL 442
K+ A + S + L F
Sbjct: 297 KKFAARKKSNNGSGGG---LNDIFEAQ 320
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 392 bits (1010), Expect = e-135
Identities = 96/312 (30%), Positives = 154/312 (49%), Gaps = 11/312 (3%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
+ +++ +E+G G FG +K T G+V K I+ V+ E+
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCV-EKAT--GRVFVAKFINTPYPLD---KYTVKNEIS 100
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
I+ L H +I HDAFED + +++EF GGEL DRI + + E + + +
Sbjct: 101 IMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 159
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVA 300
+ H +VH D+KPEN + T++ + +K+IDFGL+ + PD+ + +A + A
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCETKK-ASSVKIIDFGLATKLNPDEIVKVTTATAEFAA 218
Query: 301 PEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359
PE++ R DMW+IGV+ Y+LL G PF + ++V R D F + + SVS
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 278
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWL--HDENRPVPLDILIYKLVKSYLRATPLKR 417
PEAKDF++ LL K+ RKR+T AL HPWL N + Y ++ ++
Sbjct: 279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADW 338
Query: 418 AALKALSKALTE 429
A + +
Sbjct: 339 PAPQPAIGRIAN 350
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 393 bits (1011), Expect = e-135
Identities = 108/392 (27%), Positives = 164/392 (41%), Gaps = 35/392 (8%)
Query: 57 APSPSPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKN 116
+ SP F P PPP P P + PP + P +
Sbjct: 5 SQGQSPPVPFPAPAPPPQPPTP-----------ALPHPPAQPPPPPPQQFPQFHVKSGLQ 53
Query: 117 FGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVR 176
+ +G G G K T + A+K++ R
Sbjct: 54 IKKNAIIDDYKVTSQVLGLGINGKVLQIF-NKRT--QEKFALKMLQD--------CPKAR 102
Query: 177 REVKILKALSGHKHMIKFHDAFEDA----NSVYIVMEFCEGGELLDRILSRGGR-YLEED 231
REV++ S H+++ D +E+ + IVME +GGEL RI RG + + E +
Sbjct: 103 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 162
Query: 232 AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND 291
A I++ I + + H + HRD+KPEN L+T++ +A LK+ DFG + L
Sbjct: 163 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 222
Query: 292 IVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWA----RTESGIFRSVLRA 346
+ YYVAPEVL Y+ DMWS+GVI YILLCG PF++ G+ +
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282
Query: 347 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR--PVPLDILIYK 404
F + W VS E K +R LL + +RMT + + HPW+ + PL
Sbjct: 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR-V 341
Query: 405 LVKSYLRATPLKRAALKALSKALTEEELVYLR 436
L + R +K AL+ + E + ++
Sbjct: 342 LKEDKERWEDVKEEMTSALATMRVDYEQIKIK 373
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 378 bits (973), Expect = e-130
Identities = 96/308 (31%), Positives = 162/308 (52%), Gaps = 10/308 (3%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS---ALAIEDVRR 177
+ +++G+E+G G F + +K T G A K I K + + ++ E++ R
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCR-EKST--GLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 178 EVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE 237
EV IL+ + H ++I HD +E+ V +++E GGEL D + + EE+A + ++
Sbjct: 65 EVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIK 122
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP-LKVIDFGLSDFVRPDQRLNDIVGSA 296
+IL+ V + H + + H DLKPEN + + P +K+IDFGL+ + +I G+
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182
Query: 297 YYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355
+VAPE+++ +E DMWSIGVITYILL G+ PF T+ ++ +F + +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242
Query: 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPL 415
S AKDF+R+LL K+ RKR+T +AL HPW+ + + + R +
Sbjct: 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYV 302
Query: 416 KRAALKAL 423
+R +
Sbjct: 303 RRRWKLSF 310
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 380 bits (977), Expect = e-130
Identities = 101/368 (27%), Positives = 165/368 (44%), Gaps = 13/368 (3%)
Query: 49 QSPLPAGVAPSPSPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKA 108
S + G K S + + ++ + A
Sbjct: 9 SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68
Query: 109 TERQLDKNFGYGK--NFGAKFELGK--EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA 164
D K + + + K +G G FG + + T G +A KII
Sbjct: 69 PPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCE-ETAT--GLKLAAKIIKTR 125
Query: 165 KMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG 224
M E+V+ E+ ++ L H ++I+ +DAFE N + +VME+ +GGEL DRI+
Sbjct: 126 GMKD---KEEVKNEISVMNQLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES 181
Query: 225 GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284
E D +++I + H ++H DLKPEN L R+ +K+IDFGL+ +
Sbjct: 182 YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYK 240
Query: 285 PDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 343
P ++L G+ ++APEV++ + DMWS+GVI Y+LL G PF ++ ++
Sbjct: 241 PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300
Query: 344 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIY 403
L + D + +S EAK+F+ +LL K+ R++A++AL HPWL D L
Sbjct: 301 LACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360
Query: 404 KLVKSYLR 411
K S +
Sbjct: 361 KNRGSDAQ 368
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 376 bits (968), Expect = e-129
Identities = 105/332 (31%), Positives = 163/332 (49%), Gaps = 36/332 (10%)
Query: 121 KNFGAKFELG---KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRR 177
F ++L K +G G F K + + AVKIISK + ++
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCV-HKKS--NQAFAVKIISKRME------ANTQK 54
Query: 178 EVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE 237
E+ LK GH +++K H+ F D ++VME GGEL +RI + + E +A I+
Sbjct: 55 EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK-HFSETEASYIMR 113
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSA 296
K+++ V+ H GVVHRDLKPEN LFT ++ +K+IDFG + PD Q L +
Sbjct: 114 KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTL 173
Query: 297 YYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTES-------GIFRSVLRADP 348
+Y APE+L+++ Y+ D+WS+GVI Y +L G PF + S I + + + D
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233
Query: 349 NFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE----NRPVPLDILIYK 404
+F W +VS EAKD ++ LL D KR+ + + WL D + P+ ++
Sbjct: 234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGS 293
Query: 405 ---LVKSYLRAT-----PLKRAALK--ALSKA 426
V + ++AT KR + KA
Sbjct: 294 SGAAVHTCVKATFHAFNKYKREGFCLQNVDKA 325
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-129
Identities = 90/340 (26%), Positives = 154/340 (45%), Gaps = 54/340 (15%)
Query: 107 KATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM 166
+ L G K+ L +G+G +G A + + A+KI++K K+
Sbjct: 8 SSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQT---RAIRAIKIMNKNKI 64
Query: 167 --TSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG 224
+ +E ++ EV+++K L H ++ + ++ +ED + +VME C GG LLD++
Sbjct: 65 RQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 225 GR---------------------------------------YLEEDAKTIVEKILNIVAF 245
E+ I+ +I + + +
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-----DQRLNDIVGSAYYVA 300
H QG+ HRD+KPENFLF+T + +K++DFGLS + G+ Y+VA
Sbjct: 184 LHNQGICHRDIKPENFLFSTNK-SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 301 PEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357
PEVL+ SY + D WS GV+ ++LL G+ PF ++ VL F + +
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNV 302
Query: 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397
+SP A+D + LLN++ +R A +AL HPW+ + +
Sbjct: 303 LSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIY 342
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-129
Identities = 99/338 (29%), Positives = 168/338 (49%), Gaps = 13/338 (3%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS---ALAIEDVRR 177
+ +++G+E+G G F + +K T G A K I K + + + E++ R
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCR-EKST--GLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 178 EVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE 237
EV IL+ + H ++I HD +E+ V +++E GGEL D + + EE+A + ++
Sbjct: 65 EVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIK 122
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP-LKVIDFGLSDFVRPDQRLNDIVGSA 296
+IL+ V + H + + H DLKPEN + + P +K+IDFGL+ + +I G+
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182
Query: 297 YYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355
+VAPE+++ +E DMWSIGVITYILL G+ PF T+ ++ +F + +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242
Query: 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPL 415
S AKDF+R+LL K+ RKR+T +AL HPW+ + + + + +
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYV 302
Query: 416 KR---AALKALSKALTEEELVYLRAQFMLLEPKDGCVS 450
+R + +S + + E C S
Sbjct: 303 RRRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCES 340
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 373 bits (961), Expect = e-128
Identities = 94/309 (30%), Positives = 146/309 (47%), Gaps = 37/309 (11%)
Query: 121 KNFGAKFELGKEV-GRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREV 179
F ++L ++V G G T + AVKII K V REV
Sbjct: 8 GRFEDVYQLQEDVLGEGAHARVQTCI-NLIT--SQEYAVKIIEKQPGHI---RSRVFREV 61
Query: 180 KILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKI 239
++L GH+++++ + FE+ + Y+V E GG +L I R + E +A +V+ +
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDV 120
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI------- 292
+ + F H +G+ HRDLKPEN L + +P+K+ DF L ++ + + I
Sbjct: 121 ASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 293 -VGSAYYVAPEVL------HRSYNVEGDMWSIGVITYILLCGSRPFWAR----------- 334
GSA Y+APEV+ Y+ D+WS+GVI YILL G PF R
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240
Query: 335 ----TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390
++ +F S+ F D W +S AKD + +LL +D ++R++AAQ L HPW+
Sbjct: 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300
Query: 391 DENRPVPLD 399
L
Sbjct: 301 GCAPENTLP 309
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 372 bits (957), Expect = e-128
Identities = 109/323 (33%), Positives = 158/323 (48%), Gaps = 20/323 (6%)
Query: 119 YGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALA-----IE 173
Y K ++ + K +G G G A ++ T K VA+KIISK K A
Sbjct: 4 YPKALRDEYIMSKTLGSGACGEVKLAF-ERKT--CKKVAIKIISKRKFAIGSAREADPAL 60
Query: 174 DVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAK 233
+V E++ILK L+ H +IK + F+ YIV+E EGGEL D+++ R E K
Sbjct: 61 NVETEIEILKKLN-HPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK-RLKEATCK 117
Query: 234 TIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIV 293
++L V + H G++HRDLKPEN L +++EED +K+ DFG S + + +
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 294 GSAYYVAPEVL----HRSYNVEGDMWSIGVITYILLCGSRPFWA-RTESGIFRSVLRADP 348
G+ Y+APEVL YN D WS+GVI +I L G PF RT+ + +
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 349 NFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKS 408
NF W VS +A D V++LL D + R T +AL HPWL DE + L+
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE----DMKRKFQDLLSE 293
Query: 409 YLRATPLKRAALKALSKALTEEE 431
+T L + + + E
Sbjct: 294 ENESTALPQVLAQPSTSRKRPRE 316
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 367 bits (944), Expect = e-125
Identities = 106/337 (31%), Positives = 163/337 (48%), Gaps = 28/337 (8%)
Query: 105 GVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA 164
GV + +QL +N F +E+ +++G G + K T AVKII K+
Sbjct: 5 GVHSIVQQLHRNSI---QFTDGYEVKEDIGVGSYSVCKRCI-HKAT--NMEFAVKIIDKS 58
Query: 165 KMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG 224
K D E++IL H ++I D ++D VY+V E +GGELLD+IL +
Sbjct: 59 K-------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ- 110
Query: 225 GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA-PLKVIDFGLSDFV 283
+ E +A ++ I V + H QGVVHRDLKP N L+ + +++ DFG + +
Sbjct: 111 KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 284 RPDQR-LNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWAR---TESG 338
R + L +A +VAPEVL R Y+ D+WS+GV+ Y +L G PF T
Sbjct: 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE 230
Query: 339 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR--PV 396
I + + W SVS AKD V ++L+ D +R+TAA L HPW+ ++
Sbjct: 231 ILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQY 290
Query: 397 PLDILI-YKLVKSYLRAT-----PLKRAALKALSKAL 427
L+ LVK + AT + L+ + ++
Sbjct: 291 QLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRST 327
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 366 bits (942), Expect = e-125
Identities = 103/317 (32%), Positives = 153/317 (48%), Gaps = 28/317 (8%)
Query: 122 NFGAKFELGKEV-GRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
++L K+V G G G + T G+ A+K++ + R+EV
Sbjct: 25 AVTDDYQLSKQVLGLGVNGKVLECF-HRRT--GQKCALKLLYDSP--------KARQEVD 73
Query: 181 ILKALSGHKHMIKFHDAFEDAN----SVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTI 235
SG H++ D +E+ + + I+ME EGGEL RI RG + E +A I
Sbjct: 74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI 133
Query: 236 VEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295
+ I + F H + HRD+KPEN L+T++E+DA LK+ DFG + + L +
Sbjct: 134 MRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYT 192
Query: 296 AYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTES----GIFRSVLRADPNF 350
YYVAPEVL Y+ DMWS+GVI YILLCG PF++ T G+ R + F
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252
Query: 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP--VPLDIL-IYKLVK 407
+ W VS +AK +R LL D +R+T Q + HPW++ PL + + K
Sbjct: 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDK 312
Query: 408 SYLRATPLKRAALKALS 424
+ +K AL+
Sbjct: 313 DHWDE--VKEEMTSALA 327
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-123
Identities = 88/316 (27%), Positives = 133/316 (42%), Gaps = 43/316 (13%)
Query: 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREV 179
+ +G G G K T + A+K++ RREV
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIF-NKRT--QEKFALKMLQD--------CPKARREV 61
Query: 180 KILKALSGHKHMIKFHDAFEDA----NSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKT 234
++ S H+++ D +E+ + IVME +GGEL RI RG + E +A
Sbjct: 62 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 121
Query: 235 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVG 294
I++ I + + H + HRD+KPEN L+T++ +A LK+ DFG
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------- 166
Query: 295 SAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWA----RTESGIFRSVLRADPNF 350
A E Y+ DMWS+GVI YILLCG PF++ G+ + F
Sbjct: 167 -----AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221
Query: 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR--PVPLDILIYKLVKS 408
+ W VS E K +R LL + +RMT + + HPW+ + PL L +
Sbjct: 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR-VLKED 280
Query: 409 YLRATPLKRAALKALS 424
R +K AL+
Sbjct: 281 KERWEDVKEEMTSALA 296
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 360 bits (927), Expect = e-122
Identities = 105/290 (36%), Positives = 150/290 (51%), Gaps = 16/290 (5%)
Query: 114 DKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS----- 168
D Y K ++ + K +G G G A ++ T K VA++IISK K
Sbjct: 124 DDQSVYPKALRDEYIMSKTLGSGACGEVKLAF-ERKT--CKKVAIRIISKRKFAIGSARE 180
Query: 169 ALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYL 228
A +V E++ILK L+ H +IK + F+ YIV+E EGGEL D+++ R
Sbjct: 181 ADPALNVETEIEILKKLN-HPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK-RLK 237
Query: 229 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 288
E K ++L V + H G++HRDLKPEN L +++EED +K+ DFG S +
Sbjct: 238 EATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297
Query: 289 LNDIVGSAYYVAPEVL----HRSYNVEGDMWSIGVITYILLCGSRPFWA-RTESGIFRSV 343
+ + G+ Y+APEVL YN D WS+GVI +I L G PF RT+ + +
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 357
Query: 344 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393
NF W VS +A D V++LL D + R T +AL HPWL DE+
Sbjct: 358 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 326 bits (837), Expect = e-108
Identities = 65/327 (19%), Positives = 129/327 (39%), Gaps = 25/327 (7%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
F +G G G +G + VAVK I REV++L+
Sbjct: 25 SFCPKDVLGHGAEGTIVY----RGMFDNRDVAVKRILPECF------SFADREVQLLRES 74
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H ++I++ +D YI +E C L + + + +L + T++++ + +A
Sbjct: 75 DEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVI--DFGLSDFVRPDQ----RLNDIVGSAYYV 299
H +VHRDLKP N L + +K + DFGL + + R + + G+ ++
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 300 APEVL----HRSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNF-HDS 353
APE+L + D++S G + Y ++ GS PF + +L +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--ILLGACSLDCLH 251
Query: 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRAT 413
P A++ + +++ D +KR +A L HP+ + + + ++
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDG 311
Query: 414 PLKRAALKALSKALTEEELVYLRAQFM 440
P+ + + + + +
Sbjct: 312 PIVKQLERGGRAVVKMDWRENITVPLQ 338
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-107
Identities = 82/369 (22%), Positives = 151/369 (40%), Gaps = 49/369 (13%)
Query: 119 YGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRRE 178
+ ++ K +G G G +G+ +G+ VAVK + + E
Sbjct: 9 FEQSLKNLVVSEKILGYGSSGTVV----FQGSFQGRPVAVKRMLIDFC------DIALME 58
Query: 179 VKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG------GRYLEEDA 232
+K+L H ++I+++ + +YI +E C L D + S+ E +
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 233 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE----------EDAPLKVIDFGLSDF 282
+++ +I + VA H ++HRDLKP+N L +T E+ + + DFGL
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 283 VRPDQ-----RLNDIVGSAYYVAPEVL--------HRSYNVEGDMWSIGVITYILLC-GS 328
+ Q LN+ G++ + APE+L R D++S+G + Y +L G
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 329 RPFWAR--TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386
PF + ES I R + D S+ EA D + ++++ D KR TA + L H
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDE-MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296
Query: 387 PWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPKD 446
P +++ + + + ++ R P A L + V + + K
Sbjct: 297 PLFWPKSKKLEFLLKVSDRLEIENRDPP--SALLMKFDAG---SDFVIPSGDWTVKFDKT 351
Query: 447 GCVSLNNFK 455
+L ++
Sbjct: 352 FMDNLERYR 360
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 5e-88
Identities = 72/297 (24%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKIL 182
+ + FE +G+G FG A+ + A+K I + + + EV +L
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALD---SRYYAIKKIRHTEE----KLSTILSEVMLL 56
Query: 183 KALSGHKHMIKFHDAFEDANS-------------VYIVMEFCEGGELLDRILSRGGRYLE 229
+L+ H+++++++ A+ + + ++I ME+CE G L D I S
Sbjct: 57 ASLN-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 230 EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS--------- 280
++ + +IL +++ H QG++HRDLKP N E +K+ DFGL+
Sbjct: 116 DEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDI 172
Query: 281 ------DFVRPDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFW 332
+ L +G+A YVA EVL + YN + DM+S+G+I + ++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FST 230
Query: 333 ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
I + + F + K +R L++ D KR A L WL
Sbjct: 231 GMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 9e-85
Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 28/290 (9%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
G + + K++G G +K ++ A+K ++ + + ++ R E+ L
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLNEKK----QIYAIKYVNLEEADNQ-TLDSYRNEIAYLN 81
Query: 184 ALSGH-KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI 242
L H +I+ +D +Y+VME C +L + + + K+ + +L
Sbjct: 82 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEA 139
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYV 299
V H G+VH DLKP NFL D LK+IDFG+++ ++PD + VG+ Y+
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 300 APEVLHRS------------YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 347
PE + + + D+WS+G I Y + G PF I + D
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIID 254
Query: 348 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397
PN + +D ++ L +D ++R++ + L HP++ + PV
Sbjct: 255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 2e-84
Identities = 60/304 (19%), Positives = 112/304 (36%), Gaps = 49/304 (16%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLK--GKVVAVKIISKAKMTSALAIEDVRREVKILKA 184
+ L +G+G +G K G + A+K+ + + + RE ++LK
Sbjct: 11 WLLSDILGQGATA-----NVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKK 63
Query: 185 LSGHKHMIKFHDAFEDANS--VYIVMEFCEGGELLDRILSRG--GRYLEEDAKTIVEKIL 240
L+ HK+++K E+ + ++MEFC G L + E + ++ ++
Sbjct: 64 LN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTRE-EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV 299
+ G+VHR++KP N + E + K+ DFG + + D++ + G+ Y+
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182
Query: 300 APEVL---------HRSYNVEGDMWSIGVITYILLCGSRPFWA----RTESGIFRSVLRA 346
P++ + Y D+WSIGV Y GS PF R + ++
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 347 DPN-----------------FHDSPWPSVSPEAKD----FVRRLLNKDHRKRMTAAQALT 385
P+ S+S + + +L D K Q
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 386 HPWL 389
Sbjct: 303 ETSD 306
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 2e-84
Identities = 82/265 (30%), Positives = 140/265 (52%), Gaps = 13/265 (4%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
F++G +G+G F A+ G VA+K+I K M A ++ V+ EVKI L
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H +++ ++ FED+N VY+V+E C GE+ + +R + E +A+ + +I+ + +
Sbjct: 69 K-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVL 304
H G++HRDL N L T +K+ DFGL+ + P ++ + G+ Y++PE+
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184
Query: 305 -HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363
++ +E D+WS+G + Y LL G PF T V+ AD P +S EAK
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLSIEAK 240
Query: 364 DFVRRLLNKDHRKRMTAAQALTHPW 388
D + +LL ++ R++ + L HP+
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPF 265
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 4e-84
Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 28/290 (9%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
G + + K++G G +K ++ A+K ++ + + ++ R E+ L
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLNEKK----QIYAIKYVNLEEADNQ-TLDSYRNEIAYLN 62
Query: 184 ALSGH-KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI 242
L H +I+ +D +Y+VME C +L + + + K+ + +L
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEA 120
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYV 299
V H G+VH DLKP NFL D LK+IDFG+++ ++PD + VG+ Y+
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 300 APEVLHRS------------YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 347
PE + + + D+WS+G I Y + G PF I + D
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIID 235
Query: 348 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397
PN + +D ++ L +D ++R++ + L HP++ + PV
Sbjct: 236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 285
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 3e-82
Identities = 84/264 (31%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
FE+G+ +G+G FG+ A+ K+ ++A+K++ KA++ A +RREV+I L
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H ++++ + F DA VY+++E+ G + L + ++ E+ T + ++ N +++
Sbjct: 67 R-HPNILRLYGYFHDATRVYLILEYAPLGTVYRE-LQKLSKFDEQRTATYITELANALSY 124
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL- 304
CH + V+HRD+KPEN L + E LK+ DFG S P R D+ G+ Y+ PE++
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIE 180
Query: 305 HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
R ++ + D+WS+GV+ Y L G PF A T ++ + R + F P V+ A+D
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEGARD 236
Query: 365 FVRRLLNKDHRKRMTAAQALTHPW 388
+ RLL + +R + L HPW
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPW 260
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 3e-82
Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 18/281 (6%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLK--GKVVAVKIISKAKMTSALAIEDVRREVKI 181
++ G+ +G+G F AK + + +V A KI+ K+ + E + E+ I
Sbjct: 14 RRRYVRGRFLGKGGF-----AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN 241
++L+ H+H++ FH FED + V++V+E C LL+ R E +A+ + +I+
Sbjct: 69 HRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVL 126
Query: 242 IVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVA 300
+ H V+HRDLK N E +K+ DFGL+ V +R + G+ Y+A
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIA 183
Query: 301 PEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359
PEVL + ++ E D+WSIG I Y LL G PF + + + + + P ++
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHIN 239
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDI 400
P A ++++L D R T + L + P L I
Sbjct: 240 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPI 280
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 2e-81
Identities = 73/345 (21%), Positives = 134/345 (38%), Gaps = 35/345 (10%)
Query: 69 PLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFE 128
+ + P G D + + G +
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVK-------GRIYS 59
Query: 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH 188
+ K++G G +K ++ A+K ++ + + ++ R E+ L L H
Sbjct: 60 ILKQIGSGGSSKVFQVLNEKK----QIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 114
Query: 189 -KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH 247
+I+ +D +Y+VME C +L + + + K+ + +L V H
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH 172
Query: 248 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVL 304
G+VH DLKP NFL D LK+IDFG+++ ++PD + VG+ Y+ PE +
Sbjct: 173 QHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 305 HRS------------YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD 352
+ + D+WS+G I Y + G PF I + DPN
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEI 287
Query: 353 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397
+ +D ++ L +D ++R++ + L HP++ + PV
Sbjct: 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 5e-81
Identities = 89/359 (24%), Positives = 152/359 (42%), Gaps = 35/359 (9%)
Query: 71 PPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELG 130
P P K + + P KE P ++ G
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVL----------------VDPRSRRRYVRG 46
Query: 131 KEVGRGHFGHTCCAKGKKGTLK--GKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH 188
+ +G+G F AK + + +V A KI+ K+ + E + E+ I ++L+ H
Sbjct: 47 RFLGKGGF-----AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-H 100
Query: 189 KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL 248
+H++ FH FED + V++V+E C LL+ R E +A+ + +I+ + H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHR 159
Query: 249 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVL-HR 306
V+HRDLK N E +K+ DFGL+ V +R + G+ Y+APEVL +
Sbjct: 160 NRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 216
Query: 307 SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFV 366
++ E D+WSIG I Y LL G PF + + + + + P ++P A +
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPVAASLI 272
Query: 367 RRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSY-LRATPLKRAALKALS 424
+++L D R T + L + P L I + + + + L + K L+
Sbjct: 273 QKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLT 331
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 4e-80
Identities = 80/273 (29%), Positives = 150/273 (54%), Gaps = 14/273 (5%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
F++G+ +G+G FG+ A+ K+ ++A+K++ K+++ +RRE++I L
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H ++++ ++ F D +Y+++EF GEL L + GR+ E+ + T +E++ + + +
Sbjct: 72 R-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKE-LQKHGRFDEQRSATFMEELADALHY 129
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL- 304
CH + V+HRD+KPEN L + E LK+ DFG S P R + G+ Y+ PE++
Sbjct: 130 CHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHA-PSLRRRTMCGTLDYLPPEMIE 185
Query: 305 HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
++++ + D+W GV+ Y L G PF + + + R ++ D F P P +S +KD
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF---P-PFLSDGSKD 241
Query: 365 FVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397
+ +LL +R+ + HPW+ +R V
Sbjct: 242 LISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 250 bits (639), Expect = 5e-79
Identities = 63/361 (17%), Positives = 126/361 (34%), Gaps = 54/361 (14%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLK--GKVVAVKIISKAKMTSALAIEDVRREVKILKA 184
+ L +G+G +G K G + A+K+ + + + RE ++LK
Sbjct: 11 WLLSDILGQGATA-----NVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKK 63
Query: 185 LSGHKHMIKFHDAFEDANS--VYIVMEFCEGGELLDRILSRG--GRYLEEDAKTIVEKIL 240
L+ HK+++K E+ + ++MEFC G L + E + ++ ++
Sbjct: 64 LN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTRE-EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV 299
+ G+VHR++KP N + E + K+ DFG + + D++ + G+ Y+
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182
Query: 300 APEVL---------HRSYNVEGDMWSIGVITYILLCGSRPFWA----RTESGIFRSVLRA 346
P++ + Y D+WSIGV Y GS PF R + ++
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 347 DPNFHDSPW---------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385
P+ S + + +L D K Q
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 386 HPWLHDENRPV-PLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP 444
+ + K Y+ + + + ++ + Q ++ E
Sbjct: 303 ETSDILHRMVIHVFSLQQMTAHKIYIHSYNT----ATIFHELVYKQTKIISSNQELIYEG 358
Query: 445 K 445
+
Sbjct: 359 R 359
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-76
Identities = 86/281 (30%), Positives = 154/281 (54%), Gaps = 19/281 (6%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ L K +G+G+F K K L G+ VA+KII K ++ + +++ + REV+I+K
Sbjct: 16 NYRLLKTIGKGNFA-----KVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMK 69
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
L+ H +++K + E ++Y++ME+ GGE+ D +++ G R E++A++ +I++ V
Sbjct: 70 ILN-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAV 127
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV 303
+CH + +VHRDLK EN L + D +K+ DFG S+ +L+ G+ Y APE+
Sbjct: 128 QYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL 184
Query: 304 LH-RSYN-VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361
+ Y+ E D+WS+GVI Y L+ GS PF + + VLR + + +S +
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFY--MSTD 240
Query: 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
++ ++R L + KR T Q + W++ + L +
Sbjct: 241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFV 281
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 247 bits (631), Expect = 6e-75
Identities = 72/351 (20%), Positives = 142/351 (40%), Gaps = 41/351 (11%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLK--GKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+E+ + +G G FG + + G+ VA+K + E E++I+K
Sbjct: 15 PWEMKERLGTGGFG-----YVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMK 67
Query: 184 ALSGHKHMIKFHDAFEDANSV------YIVMEFCEGGELLDRILSRG--GRYLEEDAKTI 235
L+ H +++ + + + + ME+CEGG+L + E +T+
Sbjct: 68 KLN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 236 VEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295
+ I + + + H ++HRDLKPEN + + K+ID G + + + + VG+
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186
Query: 296 AYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP 354
Y+APE+L + Y V D WS G + + + G RPF + + +R N H
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
Query: 355 W--------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394
+ ++ + + +++ +L R+R T Q +
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306
Query: 395 PVPLDIL-IYKLVKSYLRATPLKRA-ALKALSKALTEEELVYLRAQFMLLE 443
+ L +L + +V + P+ L+ L L ++ + Q +L
Sbjct: 307 ILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQA 357
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 9e-75
Identities = 94/268 (35%), Positives = 134/268 (50%), Gaps = 18/268 (6%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ LG +G G FG K K G L G VAVKI+++ K+ S + ++RE++ LK
Sbjct: 12 HYVLGDTLGVGTFG-----KVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
H H+IK + ++VME+ GGEL D I G R E +A+ + ++IL+ V
Sbjct: 67 LFR-HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAV 124
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV 303
+CH VVHRDLKPEN L + K+ DFGLS+ + + L GS Y APEV
Sbjct: 125 DYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181
Query: 304 L-HRSYN-VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361
+ R Y E D+WS GVI Y LLCG+ PF +F+ + F+ + ++
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FYIPEY--LNRS 237
Query: 362 AKDFVRRLLNKDHRKRMTAAQALTHPWL 389
+ +L D KR T H W
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 7e-73
Identities = 43/302 (14%), Positives = 83/302 (27%), Gaps = 46/302 (15%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
K +L + + G + + A+K+ + S +E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVR-DVER--LEDFALKVFTMGAENSRSELERLHEATFAAARL 119
Query: 186 -----------------------SGHKHMIKFHDAFED--ANSVYIVMEFCEG-----GE 215
+ +D + ++M
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFS 179
Query: 216 LLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275
LD + G + +++ + A +G+VH P+N D L +
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLG 236
Query: 276 DFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS---YNVEGDMWSIGVITYILLCGSRPFW 332
D + R Y E L+ S + + W +G+ Y + C PF
Sbjct: 237 DVSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
Query: 333 ARTESGIFRSVLRAD-----PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387
T + + + K + R LN D R+R+ +A+ P
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354
Query: 388 WL 389
Sbjct: 355 EF 356
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 7e-73
Identities = 74/271 (27%), Positives = 134/271 (49%), Gaps = 22/271 (8%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
++L + +G G +G + + + + VAVKI+ + E++++E+ I K
Sbjct: 8 DWDLVQTLGEGAYG-----EVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 60
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
L+ H++++KF+ + N Y+ +E+C GGEL DRI E DA+ +++ V
Sbjct: 61 MLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 118
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP---DQRLNDIVGSAYYVA 300
+ H G+ HRD+KPEN L +E LK+ DFGL+ R ++ LN + G+ YVA
Sbjct: 119 VYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 301 PEVL-HRSYN-VEGDMWSIGVITYILLCGSRPFWARTES-GIFRSVLRADPNFHDSPWPS 357
PE+L R ++ D+WS G++ +L G P+ ++S + + +PW
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKK 233
Query: 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388
+ + ++L ++ R+T W
Sbjct: 234 IDSAPLALLHKILVENPSARITIPDIKKDRW 264
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 1e-72
Identities = 58/305 (19%), Positives = 125/305 (40%), Gaps = 51/305 (16%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA--------------KMTSALA 171
+ + + + +G F + K A+K K+ K++
Sbjct: 32 DYRIIRTLNQGKFNKIILCEKD-----NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86
Query: 172 IEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG------- 224
+D + E++I+ + +++ + + + VYI+ E+ E +L
Sbjct: 87 YDDFKNELQIITDIK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 225 GRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283
+ K I++ +LN ++ H + + HRD+KP N L +++ +K+ DFG S+++
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYM 202
Query: 284 RPDQRLNDIVGSAYYVAPEVLHRS---YNVEGDMWSIGVITYILLCGSRPFWA-RTESGI 339
D+++ G+ ++ PE + D+WS+G+ Y++ PF + +
Sbjct: 203 -VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 340 FRSVLRADPNF---------------HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384
F ++ + + +S E DF++ L K+ +R+T+ AL
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL 321
Query: 385 THPWL 389
H WL
Sbjct: 322 KHEWL 326
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 235 bits (600), Expect = 3e-72
Identities = 95/268 (35%), Positives = 139/268 (51%), Gaps = 18/268 (6%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ LG +G G FG K K G L G VAVKI+++ K+ S + +RRE++ LK
Sbjct: 17 HYILGDTLGVGTFG-----KVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK 71
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
H H+IK + + +++VME+ GGEL D I G R E++++ + ++IL+ V
Sbjct: 72 LFR-HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGV 129
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV 303
+CH VVHRDLKPEN L + K+ DFGLS+ + + L GS Y APEV
Sbjct: 130 DYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186
Query: 304 L-HRSYN-VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361
+ R Y E D+WS GVI Y LLCG+ PF +F+ + F+ + ++P
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQY--LNPS 242
Query: 362 AKDFVRRLLNKDHRKRMTAAQALTHPWL 389
++ +L D KR T H W
Sbjct: 243 VISLLKHMLQVDPMKRATIKDIREHEWF 270
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 4e-72
Identities = 75/282 (26%), Positives = 133/282 (47%), Gaps = 25/282 (8%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+E+ +G G +G + K GK++ K + MT A + + EV +L+ L
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEA-EKQMLVSEVNLLREL 62
Query: 186 SGHKHMIKFHDAFED--ANSVYIVMEFCEGGELLDRI--LSRGGRYLEED-AKTIVEKIL 240
H ++++++D D ++YIVME+CEGG+L I ++ +YL+E+ ++ ++
Sbjct: 63 K-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 241 NIVAFCH-----LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVG 294
+ CH V+HRDLKP N +K+ DFGL+ + D VG
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 295 SAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 353
+ YY++PE + SYN + D+WS+G + Y L PF A ++ + +
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----R 234
Query: 354 PWPSV-SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394
P S E + + R+LN R + + L +P + + +
Sbjct: 235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 6e-72
Identities = 83/268 (30%), Positives = 136/268 (50%), Gaps = 19/268 (7%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ + + +G G FG K K T + VA+K IS+ + + V RE+ LK
Sbjct: 10 PYIIRETLGEGSFG-----KVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK 64
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
L H H+IK +D + +V+E+ GGEL D I+ + R E++ + ++I+ +
Sbjct: 65 LLR-HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAI 121
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV 303
+CH +VHRDLKPEN L +++ +K+ DFGLS+ + L GS Y APEV
Sbjct: 122 EYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178
Query: 304 L-HRSYN-VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361
+ + Y E D+WS G++ Y++L G PF +F+ V + + +SP
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV--YVMPDF--LSPG 234
Query: 362 AKDFVRRLLNKDHRKRMTAAQALTHPWL 389
A+ +RR++ D +R+T + PW
Sbjct: 235 AQSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 9e-72
Identities = 68/268 (25%), Positives = 135/268 (50%), Gaps = 16/268 (5%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
K+ +++G G FG K + G+ +K I+ ++M+S E+ RREV +L +
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTED---GRQYVIKEINISRMSSK-EREESRREVAVLANM 80
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVA 244
H +++++ ++FE+ S+YIVM++CEGG+L RI ++ G +ED +I +
Sbjct: 81 K-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEV 303
H + ++HRD+K +N T +D +++ DFG++ + +G+ YY++PE+
Sbjct: 140 HVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196
Query: 304 L-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS-VSPE 361
++ YN + D+W++G + Y L F A + + ++ P S +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----PPVSLHYSYD 252
Query: 362 AKDFVRRLLNKDHRKRMTAAQALTHPWL 389
+ V +L ++ R R + L ++
Sbjct: 253 LRSLVSQLFKRNPRDRPSVNSILEKGFI 280
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-71
Identities = 74/271 (27%), Positives = 134/271 (49%), Gaps = 22/271 (8%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
++L + +G G +G + + + + VAVKI+ + E++++E+ I K
Sbjct: 8 DWDLVQTLGEGAYG-----EVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 60
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
L+ H++++KF+ + N Y+ +E+C GGEL DRI E DA+ +++ V
Sbjct: 61 MLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 118
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP---DQRLNDIVGSAYYVA 300
+ H G+ HRD+KPEN L +E LK+ DFGL+ R ++ LN + G+ YVA
Sbjct: 119 VYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 301 PEVL-HRSYN-VEGDMWSIGVITYILLCGSRPFWARTES-GIFRSVLRADPNFHDSPWPS 357
PE+L R ++ D+WS G++ +L G P+ ++S + + +PW
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKK 233
Query: 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388
+ + ++L ++ R+T W
Sbjct: 234 IDSAPLALLHKILVENPSARITIPDIKKDRW 264
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-71
Identities = 85/328 (25%), Positives = 138/328 (42%), Gaps = 31/328 (9%)
Query: 80 MSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFG 139
M + P+ + + AT+ K + +++++G +G G FG
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKE---KEPLESQYQVGPLLGSGGFG 57
Query: 140 HTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIED---VRREVKILKALS-GHKHMIK 193
G VA+K + K +++ + + V EV +LK +S G +I+
Sbjct: 58 -----SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 194 FHDAFEDANSVYIVMEFCEG-GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 252
D FE +S +++E E +L D I RG EE A++ ++L V CH GV+
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVL 171
Query: 253 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYN-V 310
HRD+K EN L + LK+IDFG + D D G+ Y PE + + Y+
Sbjct: 172 HRDIKDENILIDLNRGE--LKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGR 228
Query: 311 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 370
+WS+G++ Y ++CG PF + I R + VS E + +R L
Sbjct: 229 SAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVF-FRQR-------VSSECQHLIRWCL 278
Query: 371 NKDHRKRMTAAQALTHPWLHDENRPVPL 398
R T + HPW+ D P
Sbjct: 279 ALRPSDRPTFEEIQNHPWMQDVLLPQET 306
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-71
Identities = 83/272 (30%), Positives = 138/272 (50%), Gaps = 24/272 (8%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+++ K++G G+FG + L ++VAVK I + E+V+RE+ +
Sbjct: 21 RYDFVKDIGSGNFG-----VARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHR 71
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
+L H ++++F + + I+ME+ GGEL +RI + G R+ E++A+ +++L+ V
Sbjct: 72 SLR-HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGV 129
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAP-LKVIDFGLSDFVRPDQRLNDIVGSAYYVAPE 302
++CH + HRDLK EN L AP LK+ DFG S + VG+ Y+APE
Sbjct: 130 SYCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 187
Query: 303 VL-HRSYN-VEGDMWSIGVITYILLCGSRPFWARTESGIFR----SVLRADPNFHDSPWP 356
VL + Y+ D+WS GV Y++L G+ PF E +R +L + D
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR- 246
Query: 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388
+SPE + R+ D R++ + TH W
Sbjct: 247 -ISPECCHLISRIFVADPATRISIPEIKTHSW 277
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 3e-71
Identities = 74/296 (25%), Positives = 133/296 (44%), Gaps = 45/296 (15%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKM----------------- 166
++ L E+G+G +G K A+K++SK K+
Sbjct: 14 QYTLKDEIGKGSYG-----VVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRP 68
Query: 167 ------TSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN--SVYIVMEFCEGGELLD 218
IE V +E+ ILK L H +++K + +D N +Y+V E G +++
Sbjct: 69 APGGCIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME 127
Query: 219 RILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278
E+ A+ + ++ + + H Q ++HRD+KP N L ED +K+ DFG
Sbjct: 128 VP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFG 182
Query: 279 LS-DFVRPDQRLNDIVGSAYYVAPEVL---HRSYN-VEGDMWSIGVITYILLCGSRPFWA 333
+S +F D L++ VG+ ++APE L + ++ D+W++GV Y + G PF
Sbjct: 183 VSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 334 RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
+ + F D P ++ + KD + R+L+K+ R+ + HPW+
Sbjct: 243 ERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 1e-70
Identities = 82/284 (28%), Positives = 117/284 (41%), Gaps = 30/284 (10%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIED-----VRRE 178
K+ +G G FG K K V VK I K K+ IED V E
Sbjct: 25 KYSTMSPLGSGAFG-----FVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 179 VKILKALSGHKHMIKFHDAFEDANSVYIVMEF-CEGGELLDRILSRGGRYLEEDAKTIVE 237
+ IL + H ++IK D FE+ +VME G +L I R E A I
Sbjct: 80 IAILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFR 137
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY 297
++++ V + L+ ++HRD+K EN + ED +K+IDFG + ++ + G+
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIE 194
Query: 298 YVAPEVLH-RSYN-VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355
Y APEVL Y E +MWS+GV Y L+ PF + A H
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAA--IHPPYL 246
Query: 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLD 399
VS E V LL +R T + +T PW+
Sbjct: 247 --VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYT 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 1e-70
Identities = 67/317 (21%), Positives = 107/317 (33%), Gaps = 16/317 (5%)
Query: 74 SPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEV 133
+ + S Q P+ G+ D + F F+ +
Sbjct: 7 HSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRP-ESFFQQSFQRLSRL 65
Query: 134 GRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIK 193
G G +G K + G++ AVK EV + + H ++
Sbjct: 66 GHGSYGE--VFKVRS-KEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVR 121
Query: 194 FHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 253
A+E+ +Y+ E C G L + G E + L +A H QG+VH
Sbjct: 122 LEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVH 180
Query: 254 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGD 313
D+KP N K+ DFGL + G Y+APE+L SY D
Sbjct: 181 LDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAAD 237
Query: 314 MWSIGVITYILLCG-SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK 372
++S+G+ + C P + + L +S E + + +L
Sbjct: 238 VFSLGLTILEVACNMELPHGGEGWQQLRQGYL------PPEFTAGLSSELRSVLVMMLEP 291
Query: 373 DHRKRMTAAQALTHPWL 389
D + R TA L P L
Sbjct: 292 DPKLRATAEALLALPVL 308
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-70
Identities = 85/320 (26%), Positives = 137/320 (42%), Gaps = 35/320 (10%)
Query: 91 MQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGT 150
M P +GP + G D+ + F A++ LG +G+G FG G
Sbjct: 2 MLTKPLQGPPAPPGTPTPPPGGKDR-----EAFEAEYRLGPLLGKGGFG-----TVFAGH 51
Query: 151 --LKGKVVAVKIISKAKMTSALAIED---VRREVKILKALS---GHKHMIKFHDAFEDAN 202
VA+K+I + ++ + D EV +L + GH +I+ D FE
Sbjct: 52 RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE 111
Query: 203 SVYIVMEF-CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 261
+V+E +L D I +G E ++ +++ + CH +GVVHRD+K EN
Sbjct: 112 GFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENI 170
Query: 262 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYN-VEGDMWSIGV 319
L R K+IDFG + D+ D G+ Y PE + Y+ + +WS+G+
Sbjct: 171 LIDLRRGC--AKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGI 227
Query: 320 ITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT 379
+ Y ++CG PF + +L A+ H VSP+ +RR L R +
Sbjct: 228 LLYDMVCGDIPFERD------QEILEAE--LHFPAH--VSPDCCALIRRCLAPKPSSRPS 277
Query: 380 AAQALTHPWLHDENRPVPLD 399
+ L PW+ VPL+
Sbjct: 278 LEEILLDPWMQTPAEDVPLN 297
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 2e-69
Identities = 56/376 (14%), Positives = 112/376 (29%), Gaps = 64/376 (17%)
Query: 75 PAKPIMSAIKRRLGSGMQAPPKEG-PTSGDGGVKATERQLDKNFGYGKNFGAK---FELG 130
P ++ + R+ E ++ D V + + F G + G
Sbjct: 19 PGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG 78
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL----- 185
+G+ A + T G+ V + + + AI+ ++ EV L+ L
Sbjct: 79 TVLGQEDPYAYLEAT-DQET--GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 186 -------------------SGHKHMIKFHDAFEDAN--SVYIVMEFCEG-----GELLDR 219
K MI+ D S + + + GE+L
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 220 ILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279
S + + +++ ++A H G+VH L+P + + + + + F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFEH 252
Query: 280 SDFVRPDQRLNDIVGSAYYVAPEVLHRS------------YNVEGDMWSIGVITYILLCG 327
D S + PE+ R D W++G++ Y + C
Sbjct: 253 L---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 328 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387
P G + R+ N + + + L R+ QA+ P
Sbjct: 310 DLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQAMETP 361
Query: 388 WLHDENRPVPLDILIY 403
+ + +Y
Sbjct: 362 EYEQLRTELSAALPLY 377
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 9e-69
Identities = 67/287 (23%), Positives = 120/287 (41%), Gaps = 40/287 (13%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
K FG F+ + +G G FG AK + GK +K + E REVK
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN-------EKAEREVK 56
Query: 181 ILKALSGHKHMIKFHDAFED----------------ANSVYIVMEFCEGGELLDRILSRG 224
L L H +++ ++ ++ ++I MEFC+ G L I R
Sbjct: 57 ALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 115
Query: 225 GRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283
G L++ A + E+I V + H + +++RDLKP N + +K+ DFGL +
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSL 172
Query: 284 RPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 342
+ D + G+ Y++PE + + Y E D++++G+I LL + ++ F
Sbjct: 173 KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--FFTD 230
Query: 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
+ + K +++LL+K R ++ L +
Sbjct: 231 LRDG------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-67
Identities = 70/277 (25%), Positives = 123/277 (44%), Gaps = 28/277 (10%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIED-VRREVKIL 182
K+ +G +G G +G K K+ AVKI+ K K+ E V++E+++L
Sbjct: 6 KYLMGDLLGEGSYG-----KVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 183 KALSGHKHMIKFHDAFEDANS--VYIVMEFCEGG--ELLDRILSRGGRYLEEDAKTIVEK 238
+ L HK++I+ D + +Y+VME+C G E+LD + R+ A +
Sbjct: 61 RRLR-HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQ 117
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS---DFVRPDQRLNDIVGS 295
+++ + + H QG+VH+D+KP N L T LK+ G++ D GS
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 296 AYYVAPEVL--HRSYN-VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD 352
+ PE+ +++ + D+WS GV Y + G PF +F ++ + +
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--YAI 232
Query: 353 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
P D ++ +L + KR + Q H W
Sbjct: 233 PGD--CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 4e-63
Identities = 71/273 (26%), Positives = 121/273 (44%), Gaps = 20/273 (7%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
F + K++GRG F A G VA+K + + A A D +E+ +LK L
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLD---GVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRI--LSRGGRYLEEDA-KTIVEKILNI 242
+ H ++IK++ +F + N + IV+E + G+L I + R + E ++ +
Sbjct: 90 N-HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYYVAP 301
+ H + V+HRD+KP N T +K+ D GL F + +VG+ YY++P
Sbjct: 149 LEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 302 EVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTES--GIFRSVLRADPNFHDSPWPS- 357
E + YN + D+WS+G + Y + PF+ + + + + + D P PS
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY----PPLPSD 261
Query: 358 -VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
S E + V +N D KR
Sbjct: 262 HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-62
Identities = 79/298 (26%), Positives = 123/298 (41%), Gaps = 42/298 (14%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
FE + +GRG FG + K + A+K I A E V REVK L L
Sbjct: 6 DFEPIQCLGRGGFG--VVFEAKN-KVDDCNYAIKRIRLPNRELA--REKVMREVKALAKL 60
Query: 186 SGHKHMIKFHDAFEDANS------------VYIVMEFCEGGELLDRILSRGGRYL--EED 231
H ++++ +A+ + N+ +YI M+ C L D + R
Sbjct: 61 E-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 232 AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS----------- 280
I +I V F H +G++HRDLKP N FT D +KV DFGL
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 281 --DFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES 337
+ R VG+ Y++PE +H SY+ + D++S+G+I + LL PF + E
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER 233
Query: 338 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395
+ +R + F P V+ +L+ +R A + + D + P
Sbjct: 234 VRTLTDVR-NLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-60
Identities = 51/286 (17%), Positives = 99/286 (34%), Gaps = 32/286 (11%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ +++G G F + +G G A+K I + E+ +RE + +
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHD---GHFYALKRILCHEQQD---REEAQREADMHR 81
Query: 184 ALSGHKHMIKFHDAFEDANS----VYIVMEFCEGGELLDRI---LSRGGRYLEEDAKTIV 236
H ++++ ++++ F + G L + I +G E+ ++
Sbjct: 82 LF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 237 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD---------- 286
I + H +G HRDLKP N L ++ ++D G +
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 287 QRLNDIVGSAYYVAPEVL----HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 342
Q + Y APE+ H + D+WS+G + Y ++ G P+ + G
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV- 256
Query: 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388
L P S + ++ D +R L+
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 5e-58
Identities = 53/338 (15%), Positives = 106/338 (31%), Gaps = 37/338 (10%)
Query: 71 PPPSPAKPIMSAIKRRLGSGMQAPPK--EGPTSGDGGVKATERQLDKNFGYGKNFGAKFE 128
P P + +L SG+ P + A + + + G
Sbjct: 14 PNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLG-----SKLVY 68
Query: 129 LGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+ +G G F + + +K+ A + ++ LK
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLKPSM 125
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG----GRYLEEDAKTIVEKILNI 242
+KF+ A N +V E G LL+ I + + ++L +
Sbjct: 126 -QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAP--------LKVIDFGLSDFVR---PDQRLND 291
+ H ++H D+KP+NF+ + L +ID G S ++
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 292 IVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 350
++ + E+L ++ +N + D + + Y +L G+ + E G +
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV-KNEGGECKPEGLFRRLP 303
Query: 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388
H W +F +LN + + L
Sbjct: 304 HLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-57
Identities = 58/290 (20%), Positives = 114/290 (39%), Gaps = 36/290 (12%)
Query: 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI 181
+ +F +++G G FG + L G + A+K K S ++ REV
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKR---LDGCIYAIKRSKKPLAGSV-DEQNALREVYA 63
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG--GRYLEEDA-KTIVEK 238
L H H++++ A+ + + + I E+C GG L D I Y +E K ++ +
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFT----------------TREEDAPLKVIDFGLSDF 282
+ + + H +VH D+KP N + K+ D G
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH--- 180
Query: 283 VRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 340
V G + ++A EVL ++ + D++++ +T + G+ P + +
Sbjct: 181 VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGDQ--W 237
Query: 341 RSVLRADPNFHDSPWPSV-SPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
+ + P V S E + ++ +++ D +R +A + H L
Sbjct: 238 HEIRQGRL----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 4e-56
Identities = 80/272 (29%), Positives = 134/272 (49%), Gaps = 22/272 (8%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F+ GK +G G F A+ + T + A+KI+ K + + V RE ++ L
Sbjct: 32 FKFGKILGEGSFSTVVLAR-ELAT--SREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H +K + F+D +Y + + + GELL + + + G + E + +I++ + +
Sbjct: 89 -HPFFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS---DFVRPDQRLNDIVGSAYYVAPEV 303
H +G++HRDLKPEN L ED +++ DFG + R N VG+A YV+PE+
Sbjct: 147 HGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 304 LHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362
L D+W++G I Y L+ G PF A E IF+ +++ + +F P P+A
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---P-EKFFPKA 259
Query: 363 KDFVRRLLNKDHRKRMTAAQA------LTHPW 388
+D V +LL D KR+ + HP+
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-54
Identities = 63/346 (18%), Positives = 122/346 (35%), Gaps = 52/346 (15%)
Query: 91 MQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGT 150
M P G SG + ++ + + + + G F A+
Sbjct: 1 MAGPGSLGGASGRDQSDFVGQTVELG-------ELRLRVRRVLAEGGFAFVYEAQDVGS- 52
Query: 151 LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS------- 203
G+ A+K + + + +EV +K LSGH ++++F A
Sbjct: 53 --GREYALKRLLSNEEEK---NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107
Query: 204 -VYIVMEFCEGGELLDRILSR--GGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKP 258
++ E C+G L++ + G + I + V H Q ++HRDLK
Sbjct: 108 EFLLLTELCKGQ-LVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKV 166
Query: 259 ENFLFTTREEDAPLKVIDFGLSDFVRPD-------------QRLNDIVGSAYYVAPEVL- 304
EN L + +K+ DFG + + + + Y PE++
Sbjct: 167 ENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223
Query: 305 ---HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361
+ + D+W++G I Y+L PF E G ++ + P +
Sbjct: 224 LYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKLRIVNG--KYSIPPHDTQYTV 277
Query: 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVK 407
+R +L + +R++ A+ + R V I +L++
Sbjct: 278 FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLE 323
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-53
Identities = 56/384 (14%), Positives = 112/384 (29%), Gaps = 61/384 (15%)
Query: 59 SPSPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEG-PTSGDGGVKATERQLDKNF 117
S + P ++ + R+ E ++ D V + + F
Sbjct: 8 SSGRENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPF 67
Query: 118 GYGKNFGAK---FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIED 174
G + G +G+ A + T G+ V + + + AI+
Sbjct: 68 RVESELGERPRTLVRGTVLGQEDPYAYLEAT-DQET--GESFEVHVPYFTERPPSNAIKQ 124
Query: 175 VRREVKILKALSGHKH---------------------MIKFHDAFEDANSVYIVMEF--- 210
++ EV L+ L G K+ K D ++++ F
Sbjct: 125 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 184
Query: 211 -------CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 263
GE+L S + + +++ ++A H G+VH L+P + +
Sbjct: 185 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL 244
Query: 264 TTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY----YVAPEVLHRS------YNVEGD 313
+ + + F VR +G + A +L D
Sbjct: 245 D---QRGGVFLTGFEHL--VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFD 299
Query: 314 MWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKD 373
W++G+ Y + C P G + R+ N + + + L
Sbjct: 300 TWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYP 351
Query: 374 HRKRMTAAQALTHPWLHDENRPVP 397
R+ QA+ P +
Sbjct: 352 KEDRLLPLQAMETPEYEQLRTELS 375
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 7e-53
Identities = 67/273 (24%), Positives = 136/273 (49%), Gaps = 20/273 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FE+ + +G+G FG C + K T K+ A+K ++K K + +V +E++I++ L
Sbjct: 17 FEILRAIGKGSFGKVCIVQ-KNDT--KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H ++ +F+D +++V++ GG+L L + + EE K + +++ + +
Sbjct: 74 -HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYH-LQQNVHFKEETVKLFICELVMALDYL 131
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR 306
Q ++HRD+KP+N L +E + + DF ++ + + ++ + G+ Y+APE+
Sbjct: 132 QNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 307 S----YNVEGDMWSIGVITYILLCGSRPFWARTESG---IFRSVLRADPNFHDSPWPSVS 359
Y+ D WS+GV Y LL G RP+ R+ + I + + P + S
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY---P-SAWS 244
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQAL-THPWLHD 391
E +++LL + +R + + P+++D
Sbjct: 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 9e-51
Identities = 71/325 (21%), Positives = 126/325 (38%), Gaps = 28/325 (8%)
Query: 74 SPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEV 133
A + S K + T + GV TE+ ++ Y + V
Sbjct: 8 GQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEV-HWMTHQPRV 66
Query: 134 GRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVR-REVKILKALSGHKHMI 192
GRG FG K K+ G AVK + +E R E+ LS ++
Sbjct: 67 GRGSFGEVHRMKDKQ---TGFQCAVKKVR---------LEVFRVEELVACAGLS-SPRIV 113
Query: 193 KFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 252
+ A + V I ME EGG L ++ + G E+ A + + L + + H + ++
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172
Query: 253 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ------RLNDIVGSAYYVAPEVLHR 306
H D+K +N L + + + + DFG + ++PD + I G+ ++APEV+
Sbjct: 173 HGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 307 S-YNVEGDMWSIGVITYI-LLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
+ + D+WS + +L G P+ + + P + P PS +P
Sbjct: 231 KPCDAKVDIWSSC-CMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-PSCAPLTAQ 288
Query: 365 FVRRLLNKDHRKRMTAAQALTHPWL 389
++ L K+ R +A +
Sbjct: 289 AIQEGLRKEPVHRASAMELRRKVGK 313
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-50
Identities = 81/271 (29%), Positives = 129/271 (47%), Gaps = 20/271 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F+ K +G G FG K K + G A+KI+ K K+ IE E +IL+A++
Sbjct: 43 FDRIKTLGTGSFGRVMLVK-HKES--GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
++K +F+D +++Y+VME+ GGE+ L R GR+ E A+ +I+ +
Sbjct: 100 -FPFLVKLEFSFKDNSNLYMVMEYVAGGEMF-SHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR 306
H +++RDLKPEN L + ++V DFG + V R + G+ +APE++
Sbjct: 158 HSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILS 212
Query: 307 S-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 365
YN D W++GV+ Y + G PF+A I+ ++ F P S + KD
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDL 268
Query: 366 VRRLLNKDHRKRMTAAQA-----LTHPWLHD 391
+R LL D KR + H W
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-50
Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 20/277 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+E+ K +GRG FG + K T KV A+K++SK +M E I+ A +
Sbjct: 71 YEVVKVIGRGAFGEVQLVR-HKST--RKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFA 126
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
+++ AF+D +Y+VME+ GG+L+ ++S E+ A+ +++ +
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNY-DVPEKWARFYTAEVVLALDAI 184
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD--QRLNDIVGSAYYVAPEVL 304
H G +HRD+KP+N L ++ LK+ DFG + + R + VG+ Y++PEVL
Sbjct: 185 HSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 305 -----HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359
Y E D WS+GV Y +L G PF+A + G + ++ + +S
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQAL---THPWLHDEN 393
EAK+ + L D R+ H + ++
Sbjct: 302 KEAKNLICAFL-TDREVRLGRNGVEEIKRHLFFKNDQ 337
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 67/278 (24%), Positives = 114/278 (41%), Gaps = 22/278 (7%)
Query: 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK 189
+G+G +G + +A+K I + + + E+ + K L HK
Sbjct: 27 RVVLGKGTYGIVYAGRDLS---NQVRIAIKEIPERDSRY---SQPLHEEIALHKHLK-HK 79
Query: 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGR--YLEEDAKTIVEKILNIVAFCH 247
+++++ +F + + I ME GG L + S+ G E+ ++IL + + H
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 248 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH- 305
+VHRD+K +N L T LK+ DFG S + G+ Y+APE++
Sbjct: 140 DNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 306 --RSYNVEGDMWSIGVITYI-LLCGSRPFWARTESGIFRSVLRADPNFHDSPW--PSVSP 360
R Y D+WS+G T I + G P + + + F P S+S
Sbjct: 198 GPRGYGKAADIWSLG-CTIIEMATGKPP-FYELGEPQ--AAMFKVGMFKVHPEIPESMSA 253
Query: 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPL 398
EAK F+ + D KR A L +L ++
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKT 291
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 76/268 (28%), Positives = 127/268 (47%), Gaps = 14/268 (5%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F L K +G+G FG A+ K T + A+K + K + +E E ++L
Sbjct: 19 FILHKMLGKGSFGKVFLAE-FKKT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H + F+ +++ VME+ GG+L+ I ++ A +I+ + F
Sbjct: 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFL 134
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH 305
H +G+V+RDLK +N L D +K+ DFG+ + + D + N G+ Y+APE+L
Sbjct: 135 HSKGIVYRDLKLDNILLDK---DGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 191
Query: 306 R-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
YN D WS GV+ Y +L G PF + E +F S+ +P + P + EAKD
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---P-RWLEKEAKD 247
Query: 365 FVRRLLNKDHRKRMTAAQAL-THPWLHD 391
+ +L ++ KR+ + HP +
Sbjct: 248 LLVKLFVREPEKRLGVRGDIRQHPLFRE 275
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-49
Identities = 72/271 (26%), Positives = 131/271 (48%), Gaps = 20/271 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F++ + +G G FG + + G+ A+K++ K + +E E +L ++
Sbjct: 8 FQILRTLGTGSFGRVHLIR-SRHN--GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H +I+ F+DA ++++M++ EGGEL L + R+ AK ++ + +
Sbjct: 65 -HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR 306
H + +++RDLKPEN L ++ +K+ DFG + +V + G+ Y+APEV+
Sbjct: 123 HSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVST 177
Query: 307 S-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 365
YN D WS G++ Y +L G PF+ + +L A+ F P P + + KD
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNEDVKDL 233
Query: 366 VRRLLNKDHRKRM-----TAAQALTHPWLHD 391
+ RL+ +D +R+ HPW +
Sbjct: 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 6e-49
Identities = 85/281 (30%), Positives = 133/281 (47%), Gaps = 22/281 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FE+ K +GRG F K K T G+V A+KI++K M + R E +L
Sbjct: 63 FEILKVIGRGAFSEVAVVK-MKQT--GQVYAMKIMNKWDMLKRGEVSCFREERDVL-VNG 118
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
+ + + H AF+D N +Y+VME+ GG+LL + G R E A+ + +I+ +
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVL 304
H G VHRD+KP+N L +++ DFG +R D R VG+ Y++PE+L
Sbjct: 179 HRLGYVHRDIKPDNILLD---RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 305 HR--------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356
SY E D W++GV Y + G PF+A + + + ++ +
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295
Query: 357 S-VSPEAKDFVRRLLNKDHRKRMTAAQAL---THPWLHDEN 393
V EA+DF++RLL R+ A THP+ +
Sbjct: 296 EGVPEEARDFIQRLLCPP-ETRLGRGGAGDFRTHPFFFGLD 335
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-48
Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 20/279 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FE+ K +GRG FG K K KV A+KI++K +M R E +L
Sbjct: 76 FEILKVIGRGAFGEVAVVK-LKNA--DKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
K + H AF+D N++Y+VM++ GG+LL + R EE A+ + +++ +
Sbjct: 133 -SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVL 304
H VHRD+KP+N L + + +++ DFG + D + + VG+ Y++PE+L
Sbjct: 192 HQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 305 ------HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS- 357
Y E D WS+GV Y +L G PF+A + + ++ F +
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308
Query: 358 VSPEAKDFVRRLLNKDHRKRMTAAQAL---THPWLHDEN 393
VS AKD +RRL+ R+ HP+ +
Sbjct: 309 VSENAKDLIRRLICSR-EHRLGQNGIEDFKKHPFFSGID 346
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-48
Identities = 80/315 (25%), Positives = 133/315 (42%), Gaps = 59/315 (18%)
Query: 119 YGKNFG--AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVR 176
+ +G ++L +++GRG + A + V VKI+ K
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKKKKIK------ 78
Query: 177 REVKILKALSGHKHMIKFHDAFEDANS--VYIVMEFCEGGEL--LDRILSRGGRYLEEDA 232
RE+KIL+ L G ++I D +D S +V E + L + L+ + D
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT------DYDI 132
Query: 233 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI 292
+ + +IL + +CH G++HRD+KP N + E L++ID+GL++F P Q N
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVR 190
Query: 293 VGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPF------------------- 331
V S Y+ PE+L ++ Y+ DMWS+G + ++ PF
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250
Query: 332 ------WARTESGIFRSVLRADPNFHDSPW---------PSVSPEAKDFVRRLLNKDHRK 376
+ + W VSPEA DF+ +LL DH+
Sbjct: 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 310
Query: 377 RMTAAQALTHPWLHD 391
R+TA +A+ HP+ +
Sbjct: 311 RLTAREAMEHPYFYT 325
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-47
Identities = 59/272 (21%), Positives = 115/272 (42%), Gaps = 20/272 (7%)
Query: 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH 188
E+GRG F T VA + K+T + + + E ++LK L H
Sbjct: 30 FDIEIGRGSFKTVYKGLD---TETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQ-H 84
Query: 189 KHMIKFHDAFEDA----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA 244
++++F+D++E + +V E G L L R + ++ +IL +
Sbjct: 85 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 245 FCHLQG--VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPE 302
F H + ++HRDLK +N T +K+ D GL+ R ++G+ ++APE
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKRASFA-KAVIGTPEFMAPE 200
Query: 303 VLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESG--IFRSVLRADPNFHDSPWPSVSP 360
+ Y+ D+++ G + + + S ++ ++ I+R V S P
Sbjct: 201 MYEEKYDESVDVYAFG-MCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIP 257
Query: 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392
E K+ + + ++ +R + L H + +E
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-47
Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 19/273 (6%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FE + +G+G FG A+ K T G + AVK++ K + +E E +IL
Sbjct: 25 FEFIRVLGKGSFGKVMLAR-VKET--GDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H + + F+ + ++ VMEF GG+L+ + + R+ E A+ +I++ + F
Sbjct: 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFH-IQKSRRFDEARARFYAAEIISALMFL 140
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH 305
H +G+++RDLK +N L + K+ DFG+ + + G+ Y+APE+L
Sbjct: 141 HDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ 197
Query: 306 R-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
Y D W++GV+ Y +LCG PF A E +F ++L + + P + +A
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY---P-TWLHEDATG 253
Query: 365 FVRRLLNKDHRKRM-----TAAQAL-THPWLHD 391
++ + K+ R+ A+ HP+ +
Sbjct: 254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-47
Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 18/272 (6%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F +G+G FG ++ +KGT ++ AVKI+ K + +E E ++L
Sbjct: 22 FNFLMVLGKGSFGKVMLSE-RKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
+ + H F+ + +Y VME+ GG+L+ I + GR+ E A +I + F
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH 305
+G+++RDLK +N + + + +K+ DFG+ + + G+ Y+APE++
Sbjct: 138 QSKGIIYRDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194
Query: 306 R-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
Y D W+ GV+ Y +L G PF E +F+S++ + + P S+S EA
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVA 250
Query: 365 FVRRLLNKDHRKRMTAAQA-----LTHPWLHD 391
+ L+ K KR+ H +
Sbjct: 251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-47
Identities = 84/306 (27%), Positives = 148/306 (48%), Gaps = 40/306 (13%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FEL + VG G +G + K G++ A+K++ +T E++++E+ +LK S
Sbjct: 26 FELVELVGNGTYGQVYKGRHVK---TGQLAAIKVM---DVTGDE-EEEIKQEINMLKKYS 78
Query: 187 GHKHMIKFHDAF------EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDA-KTIVEKI 239
H+++ ++ AF + +++VMEFC G + D I + G L+E+ I +I
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYY 298
L ++ H V+HRD+K +N L T E+A +K++DFG+S R R N +G+ Y+
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 195
Query: 299 VAPEVLHR------SYNVEGDMWSIGVITYILL-------CGSRPFWARTESGIFRSVLR 345
+APEV+ +Y+ + D+WS+G IT I + C P A +F
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLCDMHPMRA-----LFLIPRN 249
Query: 346 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKL 405
P W S + + F+ L K+H +R Q + HP++ D+ + I +
Sbjct: 250 PAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDH 306
Query: 406 VKSYLR 411
+ +
Sbjct: 307 IDRTKK 312
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 1e-46
Identities = 82/387 (21%), Positives = 147/387 (37%), Gaps = 21/387 (5%)
Query: 12 DSITPIDHPKQPTSQPHPASTPRHPPPDSSSFTCSPFQSPLPAGVAPSPSPGRKFRWPLP 71
+ T R+ S SF S Q G S + +P
Sbjct: 231 QLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVP 290
Query: 72 PPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGK 131
P ++++ + P + F
Sbjct: 291 VPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLT---DFNFLM 347
Query: 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHM 191
+G+G FG ++ +KGT ++ AVKI+ K + +E E ++L +
Sbjct: 348 VLGKGSFGKVMLSE-RKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 192 IKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 251
+ H F+ + +Y VME+ GG+L+ I + GR+ E A +I + F +G+
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463
Query: 252 VHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR-SYN 309
++RDLK +N + + + +K+ DFG+ + + G+ Y+APE++ Y
Sbjct: 464 IYRDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG 520
Query: 310 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 369
D W+ GV+ Y +L G PF E +F+S++ + + P S+S EA + L
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICKGL 576
Query: 370 LNKDHRKRMTAAQA-----LTHPWLHD 391
+ K KR+ H +
Sbjct: 577 MTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 3e-46
Identities = 78/272 (28%), Positives = 137/272 (50%), Gaps = 17/272 (6%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FEL K +G+G FG K G+ ++ A+K++ KA + + + E IL ++
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 84
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H ++K H AF+ +Y++++F GG+L R LS+ + EED K + ++ +
Sbjct: 85 -HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHL 142
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH 305
H G+++RDLKPEN L E+ +K+ DFGLS + + +++ G+ Y+APEV++
Sbjct: 143 HSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 306 RS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
R + D WS GV+ + +L G+ PF + +L+A P +SPEA+
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEAQS 255
Query: 365 FVRRLLNKDHRKRM-----TAAQALTHPWLHD 391
+R L ++ R+ + H +
Sbjct: 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-46
Identities = 78/272 (28%), Positives = 133/272 (48%), Gaps = 19/272 (6%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F+ K +G+G FG + +K T G+ A+KI+ K + + + E ++L+
Sbjct: 7 FDYLKLLGKGTFGKVILVR-EKAT--GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H + AF+ + + VME+ GGEL LSR + EE A+ +I++ + +
Sbjct: 64 -HPFLTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYL 121
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH 305
H + VV+RD+K EN + D +K+ DFGL + + + G+ Y+APEVL
Sbjct: 122 HSRDVVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 306 R-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
Y D W +GV+ Y ++CG PF+ + +F +L + F P ++SPEAK
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---P-RTLSPEAKS 234
Query: 365 FVRRLLNKDHRKRMTAAQA-----LTHPWLHD 391
+ LL KD ++R+ + + H +
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 5e-46
Identities = 77/273 (28%), Positives = 136/273 (49%), Gaps = 17/273 (6%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAK-MTSALAIEDVRREVKILKAL 185
FEL + +G+G +G + G GK+ A+K++ KA + +A + E IL+ +
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H ++ AF+ +Y+++E+ GGEL + L R G ++E+ A + +I +
Sbjct: 79 K-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ-LEREGIFMEDTACFYLAEISMALGH 136
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL 304
H +G+++RDLKPEN + +K+ DFGL + + + G+ Y+APE+L
Sbjct: 137 LHQKGIIYRDLKPENIMLN---HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEIL 193
Query: 305 HRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363
RS +N D WS+G + Y +L G+ PF +L+ N P P ++ EA+
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEAR 249
Query: 364 DFVRRLLNKDHRKRMTAAQA-----LTHPWLHD 391
D +++LL ++ R+ A HP+
Sbjct: 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 9e-46
Identities = 79/308 (25%), Positives = 136/308 (44%), Gaps = 20/308 (6%)
Query: 93 APPKEGPTSGDGGVKATERQLDKNFGYGKNFGAK---FELGKEVGRGHFGHTCCAKGKKG 149
+ P+E N G N AK F K +G+G FG A+ K
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLAR-HKA 61
Query: 150 TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVME 209
AVK++ K + + + E +L H ++ H +F+ A+ +Y V++
Sbjct: 62 E--EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119
Query: 210 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 269
+ GGEL L R +LE A+ +I + + + H +V+RDLKPEN L
Sbjct: 120 YINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQ 175
Query: 270 APLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCG 327
+ + DFGL + + + + G+ Y+APEVLH+ Y+ D W +G + Y +L G
Sbjct: 176 GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235
Query: 328 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM----TAAQA 383
PF++R + ++ ++L P+++ A+ + LL KD KR+ +
Sbjct: 236 LPPFYSRNTAEMYDNILNKPLQL---K-PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291
Query: 384 LTHPWLHD 391
+H +
Sbjct: 292 KSHVFFSL 299
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-45
Identities = 79/335 (23%), Positives = 138/335 (41%), Gaps = 30/335 (8%)
Query: 71 PPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELG 130
PP +P + I + L ++ S + ++ N N F +
Sbjct: 141 VPPDLFQPYIEEICQNL---RGDVFQKFIESDKFTRFCQWKNVELNIHLTMN---DFSVH 194
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
+ +GRG FG + K T GK+ A+K + K ++ E +L +S
Sbjct: 195 RIIGRGGFGEVYGCR-KADT--GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 191 --MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL 248
++ AF + + +++ GG+L LS+ G + E D + +I+ + H
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 249 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-- 306
+ VV+RDLKP N L E +++ D GL+ ++ + VG+ Y+APEVL +
Sbjct: 311 RFVVYRDLKPANILLD---EHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGV 366
Query: 307 SYNVEGDMWSIGVITYILLCGSRPFWARTESG---IFRSVLRADPNFHDSPWPSVSPEAK 363
+Y+ D +S+G + + LL G PF I R L S SPE +
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELR 422
Query: 364 DFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393
+ LL +D +R+ A + P+ +
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-45
Identities = 85/324 (26%), Positives = 150/324 (46%), Gaps = 28/324 (8%)
Query: 88 GSGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAK-----FELGKEVGRGHFGHTC 142
G GDGG + + + K FEL K +G G +G
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF 71
Query: 143 CAKGKKGTLKGKVVAVKIISKAKMTSAL-AIEDVRREVKILKALSGHKHMIKFHDAFEDA 201
+ G GK+ A+K++ KA + E R E ++L+ + ++ H AF+
Sbjct: 72 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131
Query: 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 261
+++++++ GGEL LS+ R+ E + + V +I+ + H G+++RD+K EN
Sbjct: 132 TKLHLILDYINGGELFTH-LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 190
Query: 262 LFTTREEDAPLKVIDFGLS--DFVRPDQRLNDIVGSAYYVAPEVLHRS---YNVEGDMWS 316
L + + + DFGLS +R D G+ Y+AP+++ ++ D WS
Sbjct: 191 LLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWS 247
Query: 317 IGVITYILLCGSRPFWA----RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK 372
+GV+ Y LL G+ PF +++ I R +L+++P + P +S AKD ++RLL K
Sbjct: 248 LGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---P-QEMSALAKDLIQRLLMK 303
Query: 373 DHRKRM-----TAAQALTHPWLHD 391
D +KR+ A + H +
Sbjct: 304 DPKKRLGCGPRDADEIKEHLFFQK 327
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-45
Identities = 70/282 (24%), Positives = 136/282 (48%), Gaps = 28/282 (9%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F+L + +GRG + + K T ++ A+K++ K + I+ V+ E + + S
Sbjct: 11 FDLLRVIGRGSYAKVLLVR-LKKT--DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H ++ H F+ + ++ V+E+ GG+L+ + R + EE A+ +I + +
Sbjct: 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYL 126
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH 305
H +G+++RDLK +N L + +K+ D+G+ + +RP + G+ Y+APE+L
Sbjct: 127 HERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 183
Query: 306 R-SYNVEGDMWSIGVITYILLCGSRPFW---------ARTESGIFRSVLRADPNFHDSPW 355
Y D W++GV+ + ++ G PF TE +F+ +L P
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P- 239
Query: 356 PSVSPEAKDFVRRLLNKDHRKRM-----TAAQAL-THPWLHD 391
S+S +A ++ LNKD ++R+ T + HP+ +
Sbjct: 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 54/250 (21%), Positives = 100/250 (40%), Gaps = 25/250 (10%)
Query: 158 VKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELL 217
+ ++S ++ +++ + S K+ + +YI M+ C L
Sbjct: 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQLQPSSPKVYLYIQMQLCRKENLK 149
Query: 218 DRILSRGGRYLEED--AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275
D + R E I +I V F H +G++HRDLKP N FT + +KV
Sbjct: 150 DWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVG 206
Query: 276 DFGLS-------------DFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVIT 321
DFGL + VG+ Y++PE +H +Y+ + D++S+G+I
Sbjct: 207 DFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLIL 266
Query: 322 YILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 381
+ LL F + E + +R + F + P+ V+ +L+ +R A
Sbjct: 267 FELLY---SFSTQMERVRIITDVR-NLKF-PLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321
Query: 382 QALTHPWLHD 391
+ + +
Sbjct: 322 DIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 25/89 (28%), Positives = 37/89 (41%), Gaps = 6/89 (6%)
Query: 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKIL 182
+ FE + +GRG FG AK K + A+K I A E V REVK L
Sbjct: 4 YLTDFEPIQCMGRGGFGVVFEAKNK---VDDCNYAIKRIRLPNRELAR--EKVMREVKAL 58
Query: 183 KALSGHKHMIKFHDAFEDANSVYIVMEFC 211
L H ++++ +A+ + E
Sbjct: 59 AKLE-HPGIVRYFNAWLETPPEKWQEEMD 86
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 79/273 (28%), Positives = 133/273 (48%), Gaps = 20/273 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
FE K +G+G FG K +K T G+ A+KI+ K + + + E ++L S
Sbjct: 150 FEYLKLLGKGTFGKVILVK-EKAT--GRYYAMKILKKEVIVAKDEVAHTLTENRVL-QNS 205
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H + +F+ + + VME+ GGEL LSR + E+ A+ +I++ + +
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYL 264
Query: 247 HLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL 304
H + VV+RDLK EN + D +K+ DFGL + ++ + G+ Y+APEVL
Sbjct: 265 HSEKNVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 305 HRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363
+ Y D W +GV+ Y ++CG PF+ + +F +L + F P ++ PEAK
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF---P-RTLGPEAK 377
Query: 364 DFVRRLLNKDHRKRMTAAQA-----LTHPWLHD 391
+ LL KD ++R+ + H +
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 24/287 (8%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+E+ E+G G FG AK K+ G + A K+I S +ED E++IL
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIE---TKSEEELEDYIVEIEILATC 73
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H +++K A+ ++I++EFC GG + +L E + + ++L + F
Sbjct: 74 D-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVL 304
H + ++HRDLK N L T + +++ DFG+S Q+ + +G+ Y++APEV+
Sbjct: 133 LHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 305 HR------SYNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVLRADPNFHD-SPW 355
Y+ + D+WS+G IT I + P + + P S W
Sbjct: 190 MCETMKDTPYDYKADIWSLG-ITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 248
Query: 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
S E +DF++ L+K+ R +AAQ L HP++ L L+
Sbjct: 249 ---SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELV 292
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-44
Identities = 69/282 (24%), Positives = 137/282 (48%), Gaps = 28/282 (9%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F+L + +GRG + + K T ++ A++++ K + I+ V+ E + + S
Sbjct: 54 FDLLRVIGRGSYAKVLLVR-LKKT--DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H ++ H F+ + ++ V+E+ GG+L+ + R + EE A+ +I + +
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYL 169
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH 305
H +G+++RDLK +N L + + +K+ D+G+ + +RP + G+ Y+APE+L
Sbjct: 170 HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 306 R-SYNVEGDMWSIGVITYILLCGSRPFW---------ARTESGIFRSVLRADPNFHDSPW 355
Y D W++GV+ + ++ G PF TE +F+ +L P
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P- 282
Query: 356 PSVSPEAKDFVRRLLNKDHRKRM-----TAAQAL-THPWLHD 391
S+S +A ++ LNKD ++R+ T + HP+ +
Sbjct: 283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 4e-44
Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 25/281 (8%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F + +GRG FG + K T GK+ A K ++K ++ + E KIL +
Sbjct: 187 FLDFRVLGRGGFGEVFACQ-MKAT--GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGEL---LDRILSRGGRYLEEDAKTIVEKILNIV 243
+ ++ AFE + +VM GG++ + + + E A +I++ +
Sbjct: 244 -SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPE 302
H + +++RDLKPEN L +D +++ D GL+ + + G+ ++APE
Sbjct: 303 EHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359
Query: 303 VLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESG----IFRSVLRADPNFHDSPWPS 357
+L Y+ D +++GV Y ++ PF AR E + + VL + D
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD----K 415
Query: 358 VSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393
SP +KDF LL KD KR+ + THP D +
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-44
Identities = 75/283 (26%), Positives = 128/283 (45%), Gaps = 21/283 (7%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
F +E+G G FG A+ + +VVA+K +S + S +D+ +EV+ L+ L
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H + I++ + ++ ++VME+C G D + E + + L +A+
Sbjct: 112 R-HPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH 305
H ++HRD+K N L + E +K+ DFG + + N VG+ Y++APEV+
Sbjct: 170 LHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVIL 223
Query: 306 RS----YNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVLRADPNFHDSPWPSVS 359
Y+ + D+WS+G IT I L +P S ++ P W S
Sbjct: 224 AMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---S 279
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
++FV L K + R T+ L H ++ E P + LI
Sbjct: 280 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 322
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-44
Identities = 76/282 (26%), Positives = 135/282 (47%), Gaps = 21/282 (7%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
F++ +++G G +G A K+ G++VA+K + ++++ +E+ I++
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVES-----DLQEIIKEISIMQQC 81
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H++K++ ++ ++IVME+C G + D I R E++ TI++ L + +
Sbjct: 82 D-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL 304
H +HRD+K N L + K+ DFG++ + N ++G+ +++APEV+
Sbjct: 141 LHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 305 HRS-YNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVLRADPNFHD-SPWPSVSP 360
YN D+WS+G IT I + +P +A IF P F W S
Sbjct: 198 QEIGYNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW---SD 253
Query: 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
DFV++ L K +R TA Q L HP++ L LI
Sbjct: 254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLI 295
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-44
Identities = 75/301 (24%), Positives = 126/301 (41%), Gaps = 40/301 (13%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALA-IEDVRREVKILKAL 185
+ E+GRG +G K G+++AVK I + T + + ++ ++
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPS---GQIMAVKRI---RSTVDEKEQKQLLMDLDVVMRS 77
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
S ++++F+ A +I ME D+ L+ I E+IL +
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLD---DVIPEEILGKITL 132
Query: 246 CHLQG---------VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGS 295
++ ++HRD+KP N L +K+ DFG+S V + D G
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGISGQLVDSIAKTRD-AGC 188
Query: 296 AYYVAPEVLH-----RSYNVEGDMWSIGVITYI-LLCGSRPFWARTESGIFR---SVLRA 346
Y+APE + + Y+V D+WS+G IT L G P+ + +F V++
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLG-ITLYELATGRFPY--PKWNSVFDQLTQVVKG 245
Query: 347 D-PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL-HDENRPVPLDILIYK 404
D P +S SP +FV L KD KR + L HP++ E R V + + K
Sbjct: 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCK 305
Query: 405 L 405
+
Sbjct: 306 I 306
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-43
Identities = 75/307 (24%), Positives = 133/307 (43%), Gaps = 47/307 (15%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSAL---AIEDVRREVKIL 182
K+E ++G G +G + + T G++VA+K +++ + A+ RE+++L
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRD-T--GQIVAIKKFLESEDDPVIKKIAL----REIRML 56
Query: 183 KALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI 242
K L H +++ + F +++V E+C+ +L + E K+I + L
Sbjct: 57 KQLK-HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQA 114
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAP 301
V FCH +HRD+KPEN L T +K+ DFG + P +D V + +Y +P
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
Query: 302 EVL--HRSYNVEGDMWSIGVITYILLCGSRPFW-ARTE----SGIFR----------SVL 344
E+L Y D+W+IG + LL G P W +++ I + V
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230
Query: 345 RADPNFHDSP-------------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391
+ F +P++S A ++ L+ D +R+T Q L HP+ +
Sbjct: 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290
Query: 392 ENRPVPL 398
L
Sbjct: 291 IREIEDL 297
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-43
Identities = 71/325 (21%), Positives = 129/325 (39%), Gaps = 36/325 (11%)
Query: 104 GGVKATERQLDKNFGYGKNFGAK---FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKI 160
G ++ +Q G+ + A+ E E+G G G + +K G V+AVK
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKT---GHVIAVKQ 57
Query: 161 ISKAKMTSALA-IEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDR 219
+ + + + + ++ ++ ++++ F V+I ME
Sbjct: 58 M---RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC-AEKL 113
Query: 220 ILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFG 278
G E + I+ + + + GV+HRD+KP N L R + +K+ DFG
Sbjct: 114 KKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFG 170
Query: 279 LSDFVRPDQRLNDIVGSAYYVAPEVL------HRSYNVEGDMWSIGVITYI-LLCGSRPF 331
+S + D+ + G A Y+APE + Y++ D+WS+G I+ + L G P+
Sbjct: 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG-ISLVELATGQFPY 229
Query: 332 WARTESGIFRSVLRADPNF------HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385
+ F VL + S + + FV+ L KDHRKR + L
Sbjct: 230 --KNCKTDFE-VLTKVLQEEPPLLPGHMGF---SGDFQSFVKDCLTKDHRKRPKYNKLLE 283
Query: 386 HPWL-HDENRPVPLDILIYKLVKSY 409
H ++ E V + ++
Sbjct: 284 HSFIKRYETLEVDVASWFKDVMAKT 308
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-43
Identities = 68/292 (23%), Positives = 122/292 (41%), Gaps = 32/292 (10%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALA-IEDVRREVKILKAL 185
E E+GRG +G + G+++AVK I T + + ++ I
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPS---GQIMAVKRIR---ATVNSQEQKRLLMDLDISMRT 62
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGG--ELLDRILSRGGRYLEEDAKTIVEKILNIV 243
+ F+ A V+I ME + + +++ +G E+ I I+ +
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 244 AFCHLQG-VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAP 301
H + V+HRD+KP N L + +K+ DFG+S V + + G Y+AP
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAK-DIDAGCKPYMAP 178
Query: 302 EVLH-----RSYNVEGDMWSIGVITYI-LLCGSRPFWARTESGIFRS----VLRADPNFH 351
E ++ + Y+V+ D+WS+G IT I L P+ + F+ V P
Sbjct: 179 ERINPELNQKGYSVKSDIWSLG-ITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLP 235
Query: 352 DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD-ENRPVPLDILI 402
+ S E DF + L K+ ++R T + + HP+ E++ + +
Sbjct: 236 ADKF---SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFV 284
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-43
Identities = 88/296 (29%), Positives = 140/296 (47%), Gaps = 49/296 (16%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ ++G G G C A+ K G+ VAVK++ + E + EV I++
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMM---DLRKQQRRELLFNEVVIMRDY 99
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H ++++ + ++ ++++MEF +GG L D + R EE T+ E +L +A+
Sbjct: 100 Q-HFNVVEMYKSYLVGEELWVLMEFLQGGALTD--IVSQVRLNEEQIATVCEAVLQALAY 156
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVL 304
H QGV+HRD+K ++ L T D +K+ DFG + D + +VG+ Y++APEV+
Sbjct: 157 LHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 305 HRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP--------- 354
RS Y E D+WS+G I I + P P F DSP
Sbjct: 214 SRSLYATEVDIWSLG-IMVIEMVDGEP-----------------PYFSDSPVQAMKRLRD 255
Query: 355 --------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
VSP +DF+ R+L +D ++R TA + L HP+L P L LI
Sbjct: 256 SPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLI 311
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-43
Identities = 71/278 (25%), Positives = 124/278 (44%), Gaps = 22/278 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F + +G+G FG C + + T GK+ A K + K ++ E +IL+ ++
Sbjct: 186 FRQYRVLGKGGFGEVCACQ-VRAT--GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAF 245
+ ++ A+E +++ +V+ GG+L I G E A +I +
Sbjct: 243 -SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH 305
H + +V+RDLKPEN L + +++ D GL+ V Q + VG+ Y+APEV+
Sbjct: 302 LHRERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 358
Query: 306 R-SYNVEGDMWSIGVITYILLCGSRPFWARTESG----IFRSVLRADPNFHDSPWPSVSP 360
Y D W++G + Y ++ G PF R + + R V + + SP
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE----RFSP 414
Query: 361 EAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393
+A+ +LL KD +R+ +A + HP N
Sbjct: 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-43
Identities = 68/281 (24%), Positives = 127/281 (45%), Gaps = 19/281 (6%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
K+ +++G+G G A G+ VA++ + + E + E+ +++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQM---NLQQQPKKELIINEILVMREN 74
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
+ +++ + D++ + +++VME+ GG L D + E + + L + F
Sbjct: 75 K-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD--VVTETCMDEGQIAAVCRECLQALEF 131
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVL 304
H V+HRD+K +N L D +K+ DFG + P+Q + + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 305 HRS-YNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVLRADPNFHDSPWPSVSPE 361
R Y + D+WS+G I I + P + ++ P + +S
Sbjct: 189 TRKAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN--PEKLSAI 245
Query: 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
+DF+ R L D KR +A + L H +L L LI
Sbjct: 246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-43
Identities = 79/288 (27%), Positives = 139/288 (48%), Gaps = 21/288 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F +++G+G FG + KVVA+KII + IED+++E+ +L
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCD 78
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
++ K++ ++ ++I+ME+ GG LD L G E TI+ +IL + +
Sbjct: 79 -SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYL 135
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH 305
H + +HRD+K N L + E +K+ DFG++ + N VG+ +++APEV+
Sbjct: 136 HSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 192
Query: 306 RS-YNVEGDMWSIGVITYI-LLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363
+S Y+ + D+WS+G IT I L G P + + + +P + + S K
Sbjct: 193 QSAYDSKADIWSLG-ITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKPLK 248
Query: 364 DFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLR 411
+FV LNK+ R TA + L H ++ + + +L+ Y R
Sbjct: 249 EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS---YLTELIDRYKR 293
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-42
Identities = 72/307 (23%), Positives = 127/307 (41%), Gaps = 47/307 (15%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII---SKAKMTSALAIEDVRREVKIL 182
K+E VG G +G + K G++VA+K KM +A+ RE+K+L
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESDDDKMVKKIAM----REIKLL 78
Query: 183 KALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI 242
K L H++++ + + Y+V EF + +LD + + + + +I+N
Sbjct: 79 KQLR-HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAP 301
+ FCH ++HRD+KPEN L + +K+ DFG + P + +D V + +Y AP
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193
Query: 302 EVL--HRSYNVEGDMWSIGVITYILLCGSRPFW-ARTE----SGIFR----------SVL 344
E+L Y D+W+IG + + G P + ++ I +
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252
Query: 345 RADPNFHD-------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391
+P F +P +S D ++ L+ D KR A+ L H +
Sbjct: 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312
Query: 392 ENRPVPL 398
+
Sbjct: 313 DGFAERF 319
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-41
Identities = 63/352 (17%), Positives = 115/352 (32%), Gaps = 74/352 (21%)
Query: 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALA-----IEDVR 176
+ + + + + G +G C +G VA+K + +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEG----IPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 177 ---REVKILKALSGHKHMIKFHDAF-----EDANSVYIVMEFCEGGELLDRILSRGGRYL 228
RE+++L H +++ D F + +Y+V E L +++ +
Sbjct: 75 RVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVI 131
Query: 229 EED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ 287
+ + IL + H GVVHRDL P N L ++ + + DF L+ D
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLAREDTADA 188
Query: 288 RLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCG------------------ 327
V +Y APE++ + + DMWS G + +
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248
Query: 328 -----SRPFWARTESGIFRSVLRAD-PNFHDSPW----PSVSPEAKDFVRRLLNKDHRKR 377
S R LR N W P+ P A D + ++L + ++R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308
Query: 378 MTAAQALTHPWL------HDENRPVPLDI--------------LIYKLVKSY 409
++ QAL HP+ D + + V+ +
Sbjct: 309 ISTEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKIFTAEVERF 360
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-41
Identities = 72/286 (25%), Positives = 130/286 (45%), Gaps = 34/286 (11%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+EL + +G G A K + VA+K I+ K ++ ++++ +E++ +
Sbjct: 17 YELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCH 71
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLD------RILSRGGRYLEEDA-KTIVEKI 239
H +++ ++ +F + +++VM+ GG +LD L+E TI+ ++
Sbjct: 72 -HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-------DFVRPDQRLNDI 292
L + + H G +HRD+K N L ED +++ DFG+S D R R
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVR-KTF 186
Query: 293 VGSAYYVAPEVLHRS--YNVEGDMWSIGVITYI-LLCGSRPFWARTESGIFRSVLRADPN 349
VG+ ++APEV+ + Y+ + D+WS G IT I L G+ P+ + L+ DP
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFG-ITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245
Query: 350 FHDSPWPSV------SPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
++ + + L KD KR TAA+ L H +
Sbjct: 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 6e-41
Identities = 86/312 (27%), Positives = 142/312 (45%), Gaps = 64/312 (20%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM--------TSALAIEDVRR 177
K+E +++G G +G AK ++ ++VA+K + ++ +SAL R
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRET---HEIVALK---RVRLDDDDEGVPSSAL------R 50
Query: 178 EVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEG--GELLDRILSRGGRYLEEDAKTI 235
E+ +LK L HK++++ HD + +V EFC+ + D S G E K+
Sbjct: 51 EICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSF 106
Query: 236 VEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVG 294
+ ++L + FCH + V+HRDLKP+N L E LK+ +FGL+ F P + + V
Sbjct: 107 LFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVV 163
Query: 295 SAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRP-FWARTE----SGIFR------ 341
+ +Y P+VL + Y+ DMWS G I L RP F IFR
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223
Query: 342 -------SVLRADPNFHDSP-----------WPSVSPEAKDFVRRLLNKDHRKRMTAAQA 383
+ L P++ P P ++ +D ++ LL + +R++A +A
Sbjct: 224 EEQWPSMTKL---PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
Query: 384 LTHPWLHDENRP 395
L HP+ D P
Sbjct: 281 LQHPYFSDFCPP 292
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-40
Identities = 78/287 (27%), Positives = 129/287 (44%), Gaps = 56/287 (19%)
Query: 145 KGKKGTLKGKVVAVKIISKAKM--------TSALAIEDVRREVKILKALSGHKHMIKFHD 196
K + G+ A+K K ++ ++ + RE+ ILK L H +++K +D
Sbjct: 20 KAQNNY--GETFALK---KIRLEKEDEGIPSTTI------REISILKELK-HSNIVKLYD 67
Query: 197 AFEDANSVYIVMEFCEG--GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHR 254
+ +V E + +LLD G AK+ + ++LN +A+CH + V+HR
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 255 DLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVE 311
DLKP+N L E LK+ DFGL+ F P ++ + + +Y AP+VL + Y+
Sbjct: 125 DLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 312 GDMWSIGVITYILLCGSRPFWARTE----SGIFR-------------SVLR-ADPNFHDS 353
D+WS+G I ++ G+ F +E IFR + L DPNF
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 354 P-------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393
+ D + ++L D +R+TA QAL H + + N
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-39
Identities = 76/310 (24%), Positives = 131/310 (42%), Gaps = 57/310 (18%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM-------TSALAIEDVRRE 178
+ ++G G + K K +VA+K + ++ +A+ RE
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKL---TDNLVALK---EIRLEHEEGAPCTAI------RE 50
Query: 179 VKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEG--GELLDRILSRGGRYLEEDAKTIV 236
V +LK L H +++ HD S+ +V E+ + + LD G + K +
Sbjct: 51 VSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD---DCGNIINMHNVKLFL 106
Query: 237 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGS 295
++L +A+CH Q V+HRDLKP+N L R E LK+ DFGL+ P + ++ V +
Sbjct: 107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVT 163
Query: 296 AYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIFRSV------ 343
+Y P++L Y+ + DMW +G I Y + G F T IFR +
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE 223
Query: 344 ----LRADPNFHD------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387
+ ++ F S P + + D + +LL + R R++A A+ HP
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283
Query: 388 WLHDENRPVP 397
+ +
Sbjct: 284 FFLSLGERIH 293
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 70/306 (22%), Positives = 123/306 (40%), Gaps = 55/306 (17%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALA-IEDVRREVKILKAL 185
FE E+G G+ G K G V+A K+I + A + RE+++L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPS---GLVMARKLI---HLEIKPAIRNQIIRELQVLHEC 88
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
+ +++ F+ AF + I ME +GG LD++L + GR E+ + ++ + +
Sbjct: 89 N-SPYIVGFYGAFYSDGEISICMEHMDGG-SLDQVLKKAGRIPEQILGKVSIAVIKGLTY 146
Query: 246 CHLQG-VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL 304
+ ++HRD+KP N L +R E +K+ DFG+S + N VG+ Y++PE L
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERL 202
Query: 305 HRS-YNVEGDMWSIGVITYILLCGSRPF--------------------WARTESGIFRSV 343
+ Y+V+ D+WS+G+ + G P
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 344 LRADPNFHDSPWPSV--------------------SPEAKDFVRRLLNKDHRKRMTAAQA 383
P ++ S E +DFV + L K+ +R Q
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322
Query: 384 LTHPWL 389
+ H ++
Sbjct: 323 MVHAFI 328
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-39
Identities = 82/348 (23%), Positives = 141/348 (40%), Gaps = 69/348 (19%)
Query: 89 SGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKK 148
G +GP S + +D+ + ++G G +G A
Sbjct: 9 MGTLEAQTQGPGSMSVSAAPSATSIDR-----------YRRITKLGEGTYGEVYKAIDTV 57
Query: 149 GTLKGKVVAVKIISKAKMTSAL------AIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202
+ VA+K + ++ AI REV +LK L H+++I+ +
Sbjct: 58 ---TNETVAIK---RIRLEHEEEGVPGTAI----REVSLLKELQ-HRNIIELKSVIHHNH 106
Query: 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 262
++++ E+ E L + + + K+ + +++N V FCH + +HRDLKP+N L
Sbjct: 107 RLHLIFEYAEND--LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLL 164
Query: 263 FTTRE--EDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSI 317
+ + E LK+ DFGL+ F P ++ + + +Y PE+L R Y+ D+WSI
Sbjct: 165 LSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSI 224
Query: 318 GVITYILLCGSRPFWARTE----SGIFRSVLRADPNFHDSPWPSVS-------------- 359
I +L + F +E IF VL P+ D+ WP V+
Sbjct: 225 ACIWAEMLMKTPLFPGDSEIDQLFKIFE-VLGL-PD--DTTWPGVTALPDWKQSFPKFRG 280
Query: 360 ------------PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395
E D + +L D KR++A AL HP+ +
Sbjct: 281 KTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 89/344 (25%), Positives = 143/344 (41%), Gaps = 74/344 (21%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA--KMTSALAIEDVRREVKI 181
+++ VG G +G C A K G VAVK +S+ + A RE+++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRT---YRELRL 81
Query: 182 LKALSGHKHMIKFHDAF------EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTI 235
LK + H+++I D F E+ N VY+V L+ I+ + + ++ + +
Sbjct: 82 LKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--LNNIV-KCQKLTDDHVQFL 137
Query: 236 VEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRLNDIVG 294
+ +IL + + H ++HRDLKP N ED LK++DFGL+ R + V
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLA---RHTADEMTGYVA 191
Query: 295 SAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCG-----------------------SR 329
+ +Y APE++ YN D+WS+G I LL G
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251
Query: 330 PFWARTESGIFRSVLRADPNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385
+ S R+ +++ + +P A D + ++L D KR+TAAQAL
Sbjct: 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311
Query: 386 HPWL---HDENR-PV--PLDI--------------LIYKLVKSY 409
H + HD + PV P D L Y V S+
Sbjct: 312 HAYFAQYHDPDDEPVADPYDQSLESRDLLIDEWKSLTYDEVISF 355
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-39
Identities = 84/326 (25%), Positives = 128/326 (39%), Gaps = 68/326 (20%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVR--REVKI 181
G+++ K +G G G A K VA+K I S RE+KI
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLTDPQSVK-----HALREIKI 61
Query: 182 LKALSGHKHMIKFHDAF--------------EDANSVYIVMEFCEGGELLDRILSRGGRY 227
++ L H +++K + + NSVYIV E+ E L +L G
Sbjct: 62 IRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVL-EQGPL 117
Query: 228 LEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ 287
LEE A+ + ++L + + H V+HRDLKP N T ED LK+ DFGL+ + P
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPHY 175
Query: 288 RLNDI----VGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCG-------------- 327
+ + +Y +P +L +Y DMW+ G I +L G
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235
Query: 328 ---------SRPFWARTESGIFRSVLRADPNFHDSPW----PSVSPEAKDFVRRLLNKDH 374
S +R D P P +S EA DF+ ++L
Sbjct: 236 LILESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 375 RKRMTAAQALTHPWL---HDENR-PV 396
R+TA +AL+HP++ P+
Sbjct: 295 MDRLTAEEALSHPYMSIYSFPMDEPI 320
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-39
Identities = 93/344 (27%), Positives = 146/344 (42%), Gaps = 74/344 (21%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVR--REVKI 181
+ VG G +G C A K+ G+ VA+K +S+ + A R RE+ +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPFQSEIFAK---RAYRELLL 76
Query: 182 LKALSGHKHMIKFHDAF------EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTI 235
LK + H+++I D F + Y+VM F + L +I+ ++ EE + +
Sbjct: 77 LKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL--KFSEEKIQYL 131
Query: 236 VEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295
V ++L + + H GVVHRDLKP N ED LK++DFGL+ + + V +
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILDFGLARHADAE--MTGYVVT 186
Query: 296 AYYVAPEVL--HRSYNVEGDMWSIGVITYILLCG-----------------------SRP 330
+Y APEV+ YN D+WS+G I +L G
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 331 FWARTESGIFRSVLRADPNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386
F + +S +++ P + P SP+A D + ++L D KR+TAAQALTH
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306
Query: 387 PWL---HDENR----PVPLDI--------------LIYKLVKSY 409
P+ D P D IYK + ++
Sbjct: 307 PFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNF 350
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 80/320 (25%), Positives = 134/320 (41%), Gaps = 65/320 (20%)
Query: 119 YGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM--------TSAL 170
Y + K++ ++VG G +G AK +G ++VA+K + ++ ++A+
Sbjct: 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQG----RIVALK---RIRLDAEDEGIPSTAI 67
Query: 171 AIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEG--GELLDRILSRGGRYL 228
RE+ +LK L H +++ D + +V EF E ++LD
Sbjct: 68 ------REISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLD---ENKTGLQ 117
Query: 229 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQ 287
+ K + ++L VA CH ++HRDLKP+N L + LK+ DFGL+ F P +
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVR 174
Query: 288 RLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIFR 341
V + +Y AP+VL + Y+ D+WSIG I ++ G F T+ IF
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234
Query: 342 -------------SVLRADPNFHDSP------------WPSVSPEAKDFVRRLLNKDHRK 376
L P + P E D + +L D K
Sbjct: 235 ILGTPNPREWPQVQEL---PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK 291
Query: 377 RMTAAQALTHPWLHDENRPV 396
R++A A+ HP+ D + +
Sbjct: 292 RISARDAMNHPYFKDLDPQI 311
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 79/311 (25%), Positives = 126/311 (40%), Gaps = 49/311 (15%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIED-----VRREVK 180
++E +G G F A+ K ++VA+K K K+ +D RE+K
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKN---TNQIVAIK---KIKLGHRSEAKDGINRTALREIK 64
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEG--GELLDRILSRGGRYLEEDAKTIVEK 238
+L+ LS H ++I DAF +++ +V +F E ++ K +
Sbjct: 65 LLQELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLM 120
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAY 297
L + + H ++HRDLKP N L LK+ DFGL+ F P++ V + +
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRW 177
Query: 298 YVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWA-RTE----SGIFR--------- 341
Y APE+L R Y V DMW++G I LL PF ++ + IF
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLDQLTRIFETLGTPTEEQ 236
Query: 342 ----SVLRADPNFHDSP-------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390
L F P + + + D ++ L + R+TA QAL +
Sbjct: 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
Query: 391 DENRPVPLDIL 401
+ P P L
Sbjct: 297 NRPGPTPGCQL 307
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 75/320 (23%), Positives = 133/320 (41%), Gaps = 66/320 (20%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM-------TSALAIEDVRRE 178
+F+ +++G G + K G VA+K + K+ ++A+ RE
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKT---TGVYVALK---EVKLDSEEGTPSTAI------RE 53
Query: 179 VKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEG--GELLD--RILSRGGRYLEEDAKT 234
+ ++K L H+++++ +D N + +V EF + + +D + + K
Sbjct: 54 ISLMKELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 235 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIV 293
++L +AFCH ++HRDLKP+N L R + LK+ DFGL+ F P + V
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEV 169
Query: 294 GSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIFR------ 341
+ +Y AP+VL R+Y+ D+WS G I ++ G F + IF
Sbjct: 170 VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229
Query: 342 -------SVLRADPNFHDS----------------PWPSVSPEAKDFVRRLLNKDHRKRM 378
+ L P ++ + + DF+ LL + R+
Sbjct: 230 ESLWPSVTKL---PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286
Query: 379 TAAQALTHPWLHDENRPVPL 398
+A QAL HPW + +
Sbjct: 287 SAKQALHHPWFAEYYHHASM 306
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-38
Identities = 81/313 (25%), Positives = 134/313 (42%), Gaps = 59/313 (18%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA--KMTSALAIEDVRREVKI 181
A + + VG G +G C A + G VA+K + + A RE+++
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQSELFAKRA---YRELRL 77
Query: 182 LKALSGHKHMIKFHDAF------EDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKT 234
LK + H+++I D F +D Y+VM F L +++ L ED +
Sbjct: 78 LKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD--LGKLMKH--EKLGEDRIQF 132
Query: 235 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRLNDIV 293
+V ++L + + H G++HRDLKP N ED LK++DFGL+ R D + V
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLA---RQADSEMTGYV 186
Query: 294 GSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCG-----------------------S 328
+ +Y APEV+ Y D+WS+G I ++ G
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246
Query: 329 RPFWARTESGIFRSVLRADPNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384
F R +S ++ ++ P + + SP A + + ++L D +R+TA +AL
Sbjct: 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 306
Query: 385 THPWL---HDENR 394
HP+ HD
Sbjct: 307 AHPYFESLHDTED 319
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 76/334 (22%), Positives = 135/334 (40%), Gaps = 72/334 (21%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA--KMTSALAIEDVR--REV 179
+++ K +G G G C A + VA+K +S+ T A R RE+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAK-----RAYREL 112
Query: 180 KILKALSGHKHMIKFHDAF------EDANSVYIVMEFCEGGELLDRILSRGGRYLEED-A 232
++K + HK++I + F E+ VY+VME + L +++ L+ +
Sbjct: 113 VLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME---LDHERM 166
Query: 233 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI 292
++ ++L + H G++HRDLKP N + D LK++DFGL+ +
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPY 223
Query: 293 VGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCG-----------------------S 328
V + YY APEV L Y D+WS+G I ++
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283
Query: 329 RPFWARTESGIFRSVLRADPNFHDSPWPSV----------------SPEAKDFVRRLLNK 372
F + + + R+ + P + +P + + +A+D + ++L
Sbjct: 284 PEFMKKLQPTV-RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342
Query: 373 DHRKRMTAAQALTHPWL---HDENRPVPLDILIY 403
D KR++ AL HP++ +D IY
Sbjct: 343 DPAKRISVDDALQHPYINVWYDPAEVEAPPPQIY 376
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 85/358 (23%), Positives = 140/358 (39%), Gaps = 67/358 (18%)
Query: 88 GSGMQAPPKE----GPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCC 143
P + G K T G + + K +G G FG
Sbjct: 13 SCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQ 72
Query: 144 AKGKKGTLKGKVVAVK-IISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF---- 198
AK G++VA+K ++ + + RE++I++ L H ++++ F
Sbjct: 73 AKLCD---SGELVAIKKVLQDKRFKN--------RELQIMRKLD-HCNIVRLRYFFYSSG 120
Query: 199 --EDANSVYIVMEFCEGGELLDRIL---SRGGRYLEED-AKTIVEKILNIVAFCHLQGVV 252
+D + +V+++ E + R+ SR + L K + ++ +A+ H G+
Sbjct: 121 EKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 178
Query: 253 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS--YNV 310
HRD+KP+N L + A LK+ DFG + + + + S YY APE++ + Y
Sbjct: 179 HRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 236
Query: 311 EGDMWSIGVITYILLCGSRPFWARTESG------IFRSVL----RAD------------- 347
D+WS G + LL G +P + +SG I + VL R
Sbjct: 237 SIDVWSAGCVLAELLLG-QPIF-PGDSGVDQLVEIIK-VLGTPTREQIREMNPNYTEFKF 293
Query: 348 PNFHDSPW-----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW---LHDENRPVP 397
P PW P PEA RLL R+T +A H + L D N +P
Sbjct: 294 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 351
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 2e-37
Identities = 68/363 (18%), Positives = 134/363 (36%), Gaps = 68/363 (18%)
Query: 126 KFELGKEVGRGH--FGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+EL +G+G A+ K G+ V V+ I+ ++ + ++ E+ + K
Sbjct: 26 CYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEACSNE-MVTFLQGELHVSK 81
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDA-KTIVEKILNI 242
+ H +++ + F N +++V F G D I + + E A I++ +L
Sbjct: 82 LFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLN-------DIVG 294
+ + H G VHR +K + L + D + + + + QR V
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 295 SAYYVAPEVLHRS---YNVEGDMWSIGVITYI-LLCGSRPF------------------- 331
+++PEVL ++ Y+ + D++S+G IT L G PF
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVG-ITACELANGHVPFKDMPATQMLLEKLNGTVPC 256
Query: 332 -----------------WARTESGIFRSVLRADPNFHDSPWPSV------SPEAKDFVRR 368
+ SG+ S+ + P + PS SP FV +
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316
Query: 369 LLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALT 428
L ++ R +A+ L H + + + + L +L++ T + + + S
Sbjct: 317 CLQRNPDARPSASTLLNHSFFK-QIKRRASEALP-ELLRPVTPITNFEGSQSQDHSGIFG 374
Query: 429 EEE 431
Sbjct: 375 LVT 377
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 76/334 (22%), Positives = 135/334 (40%), Gaps = 72/334 (21%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA--KMTSALAIEDVR--REV 179
+++ K +G G G C A + VA+K +S+ T A R RE+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAK-----RAYREL 75
Query: 180 KILKALSGHKHMIKFHDAF------EDANSVYIVMEFCEGGELLDRILSRGGRYLEED-A 232
++K + HK++I + F E+ VYIVME + L +++ L+ +
Sbjct: 76 VLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQME---LDHERM 129
Query: 233 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI 292
++ ++L + H G++HRDLKP N + D LK++DFGL+ +
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPY 186
Query: 293 VGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCG-----------------------S 328
V + YY APEV L Y D+WS+G I ++ G
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 329 RPFWARTESGIFRSVLRADPNFHDSPW----------------PSVSPEAKDFVRRLLNK 372
F + + + R+ + P + + + +A+D + ++L
Sbjct: 247 PEFMKKLQPTV-RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 373 DHRKRMTAAQALTHPWL---HDENRPVPLDILIY 403
D KR++ +AL HP++ +D + I
Sbjct: 306 DASKRISVDEALQHPYINVWYDPSEAEAPPPKIP 339
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 76/314 (24%), Positives = 126/314 (40%), Gaps = 59/314 (18%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM--------TSALAIEDVRR 177
++E E+G G +G A+ K G+ VA+K + ++ S + R
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNG--GRFVALK---RVRVQTGEEGMPLSTI------R 60
Query: 178 EVKILKALSG--HKHMIKFHDAF-----EDANSVYIVMEFCEG--GELLDRILSRGGRYL 228
EV +L+ L H ++++ D + + +V E + LD++
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVP 118
Query: 229 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 288
E K ++ ++L + F H VVHRDLKP+N L T+ + +K+ DFGL+
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMA 175
Query: 289 LNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIFR-- 341
L +V + +Y APEVL SY D+WS+G I + F ++ I
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 342 -----------SVLRADPNFHDSP-------WPSVSPEAKDFVRRLLNKDHRKRMTAAQA 383
L FH + KD + + L + KR++A A
Sbjct: 236 GLPGEEDWPRDVALP-RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 384 LTHPWLHDENRPVP 397
L+HP+ D R
Sbjct: 295 LSHPYFQDLERCKE 308
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ E+ + VGRG FG C K + K VA+K I + E++ L +
Sbjct: 9 EIEVEEVVGRGAFGVVC-----KAKWRAKDVAIKQIESESE-----RKAFIVELRQLSRV 58
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
+ H +++K + A + V +VME+ EGG L +L A + +
Sbjct: 59 N-HPNIVKLYGACLNP--VCLVMEYAEGGSL-YNVLHGAEPLPYYTAAHAM-SWCLQCSQ 113
Query: 246 -------CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 298
+ ++HRDLKP N L LK+ DFG + + + + GSA +
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDI--QTHMTNNKGSAAW 169
Query: 299 VAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPF 331
+APEV +Y+ + D++S G+I + ++ +PF
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 85/349 (24%), Positives = 134/349 (38%), Gaps = 79/349 (22%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISK-AKMTSALAIEDVR--REVK 180
G ++ +G G +G C A VA+K IS T R RE+K
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPFEHQTYCQ-----RTLREIK 77
Query: 181 ILKALSGHKHMIKFHDAF-----EDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKT 234
IL H+++I +D E VYIV + E L ++L ++L D
Sbjct: 78 ILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLLK--TQHLSNDHICY 132
Query: 235 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI-- 292
+ +IL + + H V+HRDLKP N L LK+ DFGL+ PD
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 293 --VGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCG--------------------- 327
V + +Y APE++ + Y D+WS+G I +L
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249
Query: 328 --SRPFWARTESGIFRSVLRADPNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTAA 381
S+ + R+ L + P+ + PW P+ +A D + ++L + KR+
Sbjct: 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309
Query: 382 QALTHPWL---HDENR----PVPLDI--------------LIYKLVKSY 409
QAL HP+L +D + P LI++ +
Sbjct: 310 QALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARF 358
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 76/355 (21%), Positives = 133/355 (37%), Gaps = 65/355 (18%)
Query: 88 GSGMQAPPKEGPT-SGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKG 146
M P G + + L + G+ + K +G G FG AK
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK- 60
Query: 147 KKGTLKGKVVAVK-IISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF------E 199
++ VA+K ++ + + RE++I++ + H +++ F +
Sbjct: 61 ---LVESDEVAIKKVLQDKRFKN--------RELQIMRIVK-HPNVVDLKAFFYSNGDKK 108
Query: 200 DANSVYIVMEFCEGGELLDRIL---SRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRD 255
D + +V+E+ E + R ++ + + K + ++L +A+ H G+ HRD
Sbjct: 109 DEVFLNLVLEYVP--ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRD 166
Query: 256 LKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS--YNVEGD 313
+KP+N L LK+IDFG + + + + S YY APE++ + Y D
Sbjct: 167 IKPQNLLLD--PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNID 224
Query: 314 MWSIGVITYILLCG-----------------------SRPFWARTESGIFRSVLRADPNF 350
+WS G + L+ G SR P
Sbjct: 225 IWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKF---PQI 281
Query: 351 HDSPW-----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW---LHDENRPVP 397
P+ P P+A D + RLL R+TA +AL HP+ L +P
Sbjct: 282 RPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMP 336
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 90/329 (27%), Positives = 134/329 (40%), Gaps = 75/329 (22%)
Query: 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVR----- 176
N + F+L +G G +G C A K G++VA+K I +
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIE--------PFDKPLFALRT 56
Query: 177 -REVKILKALSGHKHMIKFHDAF-----EDANSVYIVMEFCEGGELLDRILSRGGRYLEE 230
RE+KILK H+++I + E+ N VYI+ E + L R++S + L +
Sbjct: 57 LREIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVIS--TQMLSD 111
Query: 231 D-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL 289
D + + + L V H V+HRDLKP N L + LKV DFGL+ +
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN---SNCDLKVCDFGLARIIDESAAD 168
Query: 290 NDIVGSA-----------YYVAPEVL--HRSYNVEGDMWSIGVITYILLCG--------- 327
N +Y APEV+ Y+ D+WS G I L
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 328 ---------------SRPFWARTESGIFRSVLRADPNFHDSPW----PSVSPEAKDFVRR 368
S ES R +++ P + +P P V+P+ D ++R
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288
Query: 369 LLNKDHRKRMTAAQALTHPWL---HDENR 394
+L D KR+TA +AL HP+L HD N
Sbjct: 289 MLVFDPAKRITAKEALEHPYLQTYHDPND 317
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-35
Identities = 82/351 (23%), Positives = 123/351 (35%), Gaps = 80/351 (22%)
Query: 114 DKNFGY----GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII-SKAKMTS 168
D Y + ++E+ K +G+G FG A K + VA+K++ ++ +
Sbjct: 82 DDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNEKRFHR 138
Query: 169 ALAIEDVRREVKILKALSGH-----KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSR 223
A E ++IL+ L ++I + F N + + E L + I
Sbjct: 139 QAAEE-----IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKN 192
Query: 224 GGRYLEEDA-KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282
+ + IL + H ++H DLKPEN L + + +KVIDFG S +
Sbjct: 193 KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ-GRSGIKVIDFGSSCY 251
Query: 283 VRPDQRLNDIVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPFWARTE----- 336
QR+ + S +Y APEV L Y + DMWS+G I LL G E
Sbjct: 252 E--HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA 309
Query: 337 --------------------------SGIFRSV---------------------LRADPN 349
G R LR P
Sbjct: 310 CMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPE 369
Query: 350 FHDSPWPSVSPEAKDF---VRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397
+ + F +++ L D RMT QAL HPWL P P
Sbjct: 370 SREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR-RRLPKP 419
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-35
Identities = 77/317 (24%), Positives = 122/317 (38%), Gaps = 64/317 (20%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM-----------TSALAIED 174
++E E+G G +G A+ G VA+K ++ S +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPH---SGHFVALK---SVRVPNGGGGGGGLPISTV---- 59
Query: 175 VRREVKILKALSG--HKHMIKFHDAF-----EDANSVYIVMEFCEG--GELLDRILSRGG 225
REV +L+ L H ++++ D + V +V E + LD
Sbjct: 60 --REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLD---KAPP 114
Query: 226 RYL-EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284
L E K ++ + L + F H +VHRDLKPEN L T+ +K+ DFGL+
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYS 171
Query: 285 PDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTE----SGI 339
L +V + +Y APEVL +Y DMWS+G I + F +E I
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231
Query: 340 FRSV----------LRADPNFHDSPW---------PSVSPEAKDFVRRLLNKDHRKRMTA 380
F + + P P P + + +L + KR++A
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291
Query: 381 AQALTHPWLHDENRPVP 397
+AL H +LH + P
Sbjct: 292 FRALQHSYLHKDE-GNP 307
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ +++G G FG + G VAVKI+ + + + + REV I+K L
Sbjct: 38 DLNIKEKIGAGSFGTVH-----RAEWHGSDVAVKILMEQDFHAER-VNEFLREVAIMKRL 91
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI--- 242
H +++ F A ++ IV E+ G L +L + G + D + + ++
Sbjct: 92 R-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 243 VAFCHLQG--VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYV 299
+ + H + +VHR+LK N L + +KV DFGLS G+ ++
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWM 206
Query: 300 APEVL-HRSYNVEGDMWSIGVITYILLCGSRPF 331
APEVL N + D++S GVI + L +P+
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-SALAIEDVRREVKILKALS 186
L + +G G FG + G VAVK + IE+VR+E K+ L
Sbjct: 10 TLEEIIGIGGFGKVY-----RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---V 243
H ++I ++ +VMEF GG L + + +V + I +
Sbjct: 65 -HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGM 118
Query: 244 AFCHLQG---VVHRDLKPENFLFTTREEDAP-----LKVIDFGLSDFVRPDQRLNDIVGS 295
+ H + ++HRDLK N L + E+ LK+ DFGL+ +++ G+
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGA 177
Query: 296 AYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPF 331
++APEV+ ++ D+WS GV+ + LL G PF
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 76/331 (22%), Positives = 118/331 (35%), Gaps = 76/331 (22%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII-SKAKMTSALAIEDVRREVKILKA 184
++ L +++G GHF AK VA+KI+ T A E+K+L+
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDKVYTEA-----AEDEIKLLQR 71
Query: 185 LS----------GHKHMIKFHDAFEDANSVY----IVMEFCEGGELLDRILSRGGRYLEE 230
++ G H++K D F +V E G LL I R +
Sbjct: 72 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPL 130
Query: 231 DA-KTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTR---EEDAPLKVIDFGLSDFVRP 285
K I +++L + + H + G++H D+KPEN L E +K+ D G + +
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY-- 188
Query: 286 DQRLNDIVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPFWARTESG------ 338
D+ + + + Y +PEV L + D+WS + + L+ G F
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248
Query: 339 -------------------------IFRSVLRADPNFHDSPWP----------SVSPEAK 363
F S WP EAK
Sbjct: 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 308
Query: 364 ---DFVRRLLNKDHRKRMTAAQALTHPWLHD 391
DF+ +L D RKR A + HPWL D
Sbjct: 309 EISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 84/348 (24%), Positives = 138/348 (39%), Gaps = 92/348 (26%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA--KMTSALAIEDVR--REV 179
K+EL K++G+G +G + ++ G+VVAVK I A T A R RE+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDAFQNSTDAQ-----RTFREI 59
Query: 180 KILKALSGHKHMIKFHDAF--EDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIV 236
IL LSGH++++ + ++ VY+V ++ E L ++ LE + +V
Sbjct: 60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIR--ANILEPVHKQYVV 115
Query: 237 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA 296
+++ ++ + H G++HRD+KP N L + +KV DFGLS +R+ + + +
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLN---AECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 297 ----------------------YYVAPEVL--HRSYNVEGDMWSIGVITYILLCG----- 327
+Y APE+L Y DMWS+G I +LCG
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232
Query: 328 ------------------------------------SRPFWARTESGIFRSVLRADPNFH 351
S R + N
Sbjct: 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292
Query: 352 DS--PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL---HDENR 394
P + EA D + +LL + KR++A AL HP++ H+ N
Sbjct: 293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNE 340
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-34
Identities = 65/333 (19%), Positives = 121/333 (36%), Gaps = 44/333 (13%)
Query: 69 PLPPPSPAKPIMS----AIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGY----- 119
P P + +M+ +R P + G + + +
Sbjct: 14 RAPDIDPLEALMTNPVVPESKRFCWNCGRPVGRSDSETKGASEGWCPYCGSPYSFLPQLN 73
Query: 120 -GKNFGAKFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVR 176
G ++E+ + G G + + G+ V +K + + A A+
Sbjct: 74 PGDIVAGQYEVKGCIAHGGLGWIY----LALDRNVNGRPVVLKGLVHSGDAEAQAM--AM 127
Query: 177 REVKILKALSGHKHMIKFHDAFEDANS-----VYIVMEFCEGGELLDRILSRGGRYLEED 231
E + L + H +++ + E + YIVME+ G L G + +
Sbjct: 128 AERQFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAE 183
Query: 232 AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND 291
A + +IL +++ H G+V+ DLKPEN + T + LK+ID G V
Sbjct: 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGA---VSRINSFGY 236
Query: 292 IVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH 351
+ G+ + APE++ V D++++G L +G + L D
Sbjct: 237 LYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTR-----NGRYVDGLPEDD--- 288
Query: 352 DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384
P +RR ++ D R+R T A+ +
Sbjct: 289 --PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEM 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 79/353 (22%), Positives = 128/353 (36%), Gaps = 74/353 (20%)
Query: 104 GGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISK 163
G + + +F++ + G+G FG K K G VA+K + +
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQ 58
Query: 164 AKMTSALAIEDVRREVKILKALSGHKH--MIKFHDAF-----EDANSVY--IVMEFCEGG 214
RE++I++ L+ H +++ F D +Y +VME+
Sbjct: 59 DPRFR-------NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-- 109
Query: 215 ELLDRIL---SRGGRYLEED-AKTIVEKILNIVAFCHLQ--GVVHRDLKPENFLFTTREE 268
+ L R R K + +++ + HL V HRD+KP N L E
Sbjct: 110 DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EA 167
Query: 269 DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLC 326
D LK+ DFG + + P + + S YY APE++ ++ Y D+WS+G I ++
Sbjct: 168 DGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 327 G-----------------------SRPFWARTESGIFRSVLRADPNFHDSPW-------- 355
G SR + N PW
Sbjct: 228 GEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTD---VDLYNSKGIPWSNVFSDHS 284
Query: 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW---LHDEN------RPVPLD 399
+ EA D + LL +RM +AL HP+ LHD + +P D
Sbjct: 285 LKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPED 337
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 39/217 (17%), Positives = 78/217 (35%), Gaps = 27/217 (12%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ ++ H G KG +G + VK++ ++ D E L+
Sbjct: 11 QLNFLTKLNENHSGELW-----KGRWQGNDIVVKVLKVRDWSTRK-SRDFNEECPRLRIF 64
Query: 186 SGHKHMIKFHDAFED--ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI- 242
S H +++ A + A ++ + G L + + + D V+ L++
Sbjct: 65 S-HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV--DQSQAVKFALDMA 121
Query: 243 --VAFCHLQG--VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 298
+AF H + L + + ED ++ + + R + + +
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKFSFQSPGR----MYAPAW 174
Query: 299 VAPEVL-HRSYNVEG---DMWSIGVITYILLCGSRPF 331
VAPE L + + DMWS V+ + L+ PF
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 77/341 (22%), Positives = 126/341 (36%), Gaps = 74/341 (21%)
Query: 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII-SKAKMTSALAIEDVRRE 178
G A++E+ +G G FG K G+ VAVKI+ + + A E
Sbjct: 9 GDVLSARYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNVDRYCEAARSE----- 61
Query: 179 VKILKAL-----SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDA- 232
+++L+ L + ++ + FE + IV E G D I G D
Sbjct: 62 IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHI 120
Query: 233 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE----------------EDAPLKVID 276
+ + +I V F H + H DLKPEN LF + + +KV+D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 277 FGLSDFVRPDQRLNDIVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPFWART 335
FG + + D+ + +V + +Y APEV L ++ D+WSIG I G F
Sbjct: 181 FGSATYD--DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238
Query: 336 ES----------GIF-RSVLRADP---NFHDS--PWPSVSPEAK---------------- 363
G + +++ FH W S +
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298
Query: 364 --------DFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 396
D ++++L D KR+T +AL HP+ + +
Sbjct: 299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-33
Identities = 63/222 (28%), Positives = 106/222 (47%), Gaps = 29/222 (13%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLK--GKVVAVKII----SKAKMTSALAIEDVRREV 179
+ E K++G+G FG KG L VVA+K + S+ + ++ +REV
Sbjct: 20 EIEYEKQIGKGGFGLVH-----KGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 180 KILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKI 239
I+ L+ H +++K + N +VMEF G+L R+L + + +
Sbjct: 75 FIMSNLN-HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPI---KWSVKLRLM 128
Query: 240 LNI---VAFCHLQG--VVHRDLKPENFLFTTREEDAP--LKVIDFGLSDFVRPDQRLNDI 292
L+I + + Q +VHRDL+ N + +E+AP KV DFGLS ++ +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGL 186
Query: 293 VGSAYYVAPEVL---HRSYNVEGDMWSIGVITYILLCGSRPF 331
+G+ ++APE + SY + D +S +I Y +L G PF
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-33
Identities = 71/344 (20%), Positives = 115/344 (33%), Gaps = 78/344 (22%)
Query: 114 DKNFGY----GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII-SKAKMTS 168
DK G ++E+ +G G FG VA+KII + K
Sbjct: 4 DKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARG--KSQVALKIIRNVGKYRE 61
Query: 169 ALAIEDVRREVKILKAL-----SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSR 223
A +E + +LK + + D F + I E G + +
Sbjct: 62 AARLE-----INVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKEN 115
Query: 224 GGRYLEEDA-KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE--------------- 267
+ + + ++ + + F H + H DLKPEN LF E
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175
Query: 268 -EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILL 325
++ ++V DFG + F + IV + +Y PEV L + D+WSIG I +
Sbjct: 176 VKNTSIRVADFGSATFD--HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 326 CGSRPFWARTES----------GIF-RSVLRADP---NFHDS--PWPSVSPEAK------ 363
G F G ++ F+ W S + +
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293
Query: 364 ------------------DFVRRLLNKDHRKRMTAAQALTHPWL 389
D +RR+L D +R+T A+AL HP+
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 75/334 (22%), Positives = 125/334 (37%), Gaps = 82/334 (24%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSAL------AIEDVRREV 179
K+E ++G+G FG A+ +K G+ VA+K K M + A+ RE+
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRK---TGQKVALK---KVLMENEKEGFPITAL----REI 67
Query: 180 KILKALSGHKHMIKFHD--------AFEDANSVYIVMEFCEG--GELLDRILSRGGRYLE 229
KIL+ L H++++ + S+Y+V +FCE LL + ++
Sbjct: 68 KILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTL 123
Query: 230 EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL 289
+ K +++ +LN + + H ++HRD+K N L T LK+ DFGL+ R
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLA---RAFSLA 177
Query: 290 NDIVGSAY--------YVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRP-FWARTESG 338
+ + Y Y PE+L R Y D+W G I + P TE
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQH 236
Query: 339 ----IFR-------------SVLRADPNFHDS--------------PWPSVSPEAKDFVR 367
I + + P A D +
Sbjct: 237 QLALISQLCGSITPEVWPNVDNY---ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 293
Query: 368 RLLNKDHRKRMTAAQALTHPWLHDENRPVPLDIL 401
+LL D +R+ + AL H + + P L +
Sbjct: 294 KLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGM 327
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 71/351 (20%), Positives = 119/351 (33%), Gaps = 86/351 (24%)
Query: 114 DKNFGY----GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII-SKAKMTS 168
D+ + G F + +++G G FG + K AVK++ + K T
Sbjct: 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNIKKYTR 76
Query: 169 ALAIEDVRREVKILKALSGH----KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG 224
+ IE ILK + +++K+H F + + ++ E G L + I
Sbjct: 77 SAKIE-----ADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN 130
Query: 225 GRYLEEDA-KTIVEKILNIVAFCHLQGVVHRDLKPENFLFT------------------- 264
+ K +IL + + + H DLKPEN L
Sbjct: 131 YNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190
Query: 265 ---TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV-LHRSYNVEGDMWSIGVI 320
R + +K+IDFG + F I+ + Y APEV L+ ++V DMWS G +
Sbjct: 191 IQIYRTKSTGIKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248
Query: 321 TYILLCGSRPFWARTE---------------SGIFRSVLRADPNFHDS------PWPSVS 359
L GS F + + + + + + WP +
Sbjct: 249 LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENA 308
Query: 360 ---------------------PEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
DF+ +L D R + A+ L H +L
Sbjct: 309 SSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-32
Identities = 47/223 (21%), Positives = 93/223 (41%), Gaps = 34/223 (15%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG 187
E+G+ +G+G FG G G+V A+++I + ++ +REV +
Sbjct: 36 EIGELIGKGRFGQVY-----HGRWHGEV-AIRLIDIERDNEDQ-LKAFKREVMAYRQTR- 87
Query: 188 HKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VA 244
H++++ F A + I+ C+G L + D + I +
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVL---DVNKTRQIAQEIVKGMG 144
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS------DFVRPDQRLNDIVGSAYY 298
+ H +G++H+DLK +N + ++ + + DFGL R + +L G +
Sbjct: 145 YLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 299 VAPEVL----------HRSYNVEGDMWSIGVITYILLCGSRPF 331
+APE++ ++ D++++G I Y L PF
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 65/274 (23%), Positives = 117/274 (42%), Gaps = 22/274 (8%)
Query: 120 GKNFGAKFELGKEVGRG-----HFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIED 174
GK ++++ ++G G + T+ VA+K I ++
Sbjct: 6 GKIINERYKIVDKLGGGGMSTVYLAED--------TILNIKVAIKAIFIPPREKEETLKR 57
Query: 175 VRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKT 234
REV LS H++++ D E+ + Y+VME+ EG L + + G + A
Sbjct: 58 FEREVHNSSQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSE-YIESHGPLSVDTAIN 115
Query: 235 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDI 292
+IL+ + H +VHRD+KP+N L + LK+ DFG++ + + N +
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQTNHV 172
Query: 293 VGSAYYVAPE-VLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGI-FRSVLRADPNF 350
+G+ Y +PE + + D++SIG++ Y +L G PF T I + + + PN
Sbjct: 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNV 232
Query: 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384
+ + + R KD R Q +
Sbjct: 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ +G+ +G G FG KG G V AVK+++ T ++ + EV +L+
Sbjct: 25 QITVGQRIGSGSFGTVY-----KGKWHGDV-AVKMLNVTAPTPQQ-LQAFKNEVGVLRKT 77
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H +++ F + IV ++CEG L + + ++ + I + + +
Sbjct: 78 R-HVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS---DFVRPDQRLNDIVGSAYYVAPE 302
H + ++HRDLK N ED +K+ DFGL+ + + GS ++APE
Sbjct: 136 LHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 303 VL----HRSYNVEGDMWSIGVITYILLCGSRPF 331
V+ Y+ + D+++ G++ Y L+ G P+
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 75/329 (22%), Positives = 127/329 (38%), Gaps = 68/329 (20%)
Query: 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM-TSALAIEDVRREVKILKALSG 187
G +VGRG +GH AK K G K A+K I + SA RE+ +L+ L
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGTGISMSAC------REIALLRELK- 76
Query: 188 HKHMIKFHDAFEDA--NSVYIVMEFCEG--GELLD-----RILSRGGRYLEEDAKTIVEK 238
H ++I F V+++ ++ E ++ + + + K+++ +
Sbjct: 77 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDA-PLKVIDFGL----SDFVRPDQRLNDIV 293
IL+ + + H V+HRDLKP N L + +K+ D G + ++P L+ +V
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 294 GSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD---- 347
+ +Y APE+L R Y D+W+IG I LL F R E + D
Sbjct: 197 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256
Query: 348 -------------PNFHDSPW--------------------------PSVSPEAKDFVRR 368
+ P +A +++
Sbjct: 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316
Query: 369 LLNKDHRKRMTAAQALTHPWLHDENRPVP 397
LL D KR+T+ QA+ P+ ++ P
Sbjct: 317 LLTMDPIKRITSEQAMQDPYFLEDPLPTS 345
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 52/226 (23%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLK--GKVVAVKIISKAKMTSALAIEDVRREVKILKA 184
G+ +G+G FG K T + G+V+ +K + + +EVK+++
Sbjct: 12 LIHGEVLGKGCFGQAI-----KVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRC 63
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI-- 242
L H +++KF + + E+ +GG L I S +Y V +I
Sbjct: 64 LE-HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY---PWSQRVSFAKDIAS 119
Query: 243 -VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND---------- 291
+A+ H ++HRDL N L E+ + V DFGL+ + ++ +
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 292 -----IVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPF 331
+VG+ Y++APE++ RSY+ + D++S G++ ++
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 76/317 (23%), Positives = 128/317 (40%), Gaps = 49/317 (15%)
Query: 87 LGSGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKG 146
+GS G + + G FG + L + VGRG G A+
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMDGTAESRE----GTQFG-PYRLRRLVGRGGMGDVYEAED 55
Query: 147 KKGTLKGKVVAVKIISKAKMTSALAIEDV-----RREVKILKALSGHKHMIKFHDAFEDA 201
T++ ++VA+K+ M+ L+ + V +RE + L H++ HD E
Sbjct: 56 ---TVRERIVALKL-----MSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEID 106
Query: 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 261
+Y+ M G +L +L R G A IV +I + + H G HRD+KPEN
Sbjct: 107 GQLYVDMRLINGVDL-AAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165
Query: 262 LFTTREEDAPLKVIDFGLSDFVRPDQRL---NDIVGSAYYVAPE------VLHRSYNVEG 312
L + D ++DFG++ D++L + VG+ YY+APE +R+
Sbjct: 166 LVS---ADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHATYRA----- 216
Query: 313 DMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS-----VSPEAKDFVR 367
D++++ + Y L GS P+ S + + + P PS + +
Sbjct: 217 DIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAI-----PRPSTVRPGIPVAFDAVIA 270
Query: 368 RLLNKDHRKRMTAAQAL 384
R + K+ R L
Sbjct: 271 RGMAKNPEDRYVTCGDL 287
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 78/371 (21%), Positives = 128/371 (34%), Gaps = 110/371 (29%)
Query: 119 YGKNF--GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA--KMTSALAIED 174
KN + + +GRG +G+ A K K VA+K +++ +
Sbjct: 18 GIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRMFEDLIDCK---- 70
Query: 175 VR--REVKILKALSGHKHMIKFHDAF-----EDANSVYIVMEFCEGGELLDRILSRGGRY 227
R RE+ IL L ++I+ +D + +YIV+E + L ++ + +
Sbjct: 71 -RILREITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIADSD--LKKLF-KTPIF 125
Query: 228 LEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 286
L E+ KTI+ +L F H G++HRDLKP N L +D +KV DFGL+ + +
Sbjct: 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN---QDCSVKVCDFGLARTINSE 182
Query: 287 QRLNDIVGSA-----------------------YYVAPEVL--HRSYNVEGDMWSIGVI- 320
+ N + +Y APE++ +Y D+WS G I
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242
Query: 321 ---------TYILLCGSRPF----WARTESGIFRSVLRADPNFHD----------SPWPS 357
P S S + + D +P
Sbjct: 243 AELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTED 302
Query: 358 V-----SPEAKDFVRR----------------------LLNK----DHRKRMTAAQALTH 386
PE +++ LL + KR+T QAL H
Sbjct: 303 DLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDH 362
Query: 387 PWL---HDENR 394
P+L +
Sbjct: 363 PYLKDVRKKKL 373
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 70/283 (24%), Positives = 120/283 (42%), Gaps = 35/283 (12%)
Query: 120 GKNFGAKFELGKEVGRG-----HFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIED 174
+ ++ELG+ +G G H + VAVK++
Sbjct: 7 PSHLSDRYELGEILGFGGMSEVHLARD--------LRDHRDVAVKVLRADLARDPSFYLR 58
Query: 175 VRREVKILKALSGHKHMIKFHDAFEDANS----VYIVMEFCEGGELLDRILSRGGRYLEE 230
RRE + AL+ H ++ +D E YIVME+ +G L D I+ G +
Sbjct: 59 FRREAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPK 116
Query: 231 DAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL----SDFVRPD 286
A ++ + F H G++HRD+KP N + + +KV+DFG+ +D
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSV 173
Query: 287 QRLNDIVGSAYYVAPE-VLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV-- 343
+ ++G+A Y++PE S + D++S+G + Y +L G PF +S + SV
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG--DSPV--SVAY 229
Query: 344 --LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384
+R DP + +S + V + L K+ R A +
Sbjct: 230 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 84/422 (19%), Positives = 139/422 (32%), Gaps = 118/422 (27%)
Query: 72 PPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGK 131
+ + GS + ++ S D ++E+
Sbjct: 6 AAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP------DRYEIRH 59
Query: 132 EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA--KMTSALAIEDVRREVKILKALSGHK 189
+G G +GH C A K + +VVA+K I + + I RE+ IL L+ H
Sbjct: 60 LIGTGSYGHVCEAYDKL---EKRVVAIKKILRVFEDLIDCKRI---LREIAILNRLN-HD 112
Query: 190 HMIKFHD-----AFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIV 243
H++K D E + +Y+V+E + ++ R YL E KT++ +L V
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLF-RTPVYLTELHIKTLLYNLLVGV 169
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA------- 296
+ H G++HRDLKP N L +D +KV DFGL+ V + N + +
Sbjct: 170 KYVHSAGILHRDLKPANCLVN---QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 297 ---------------------YYVAPEVL--HRSYNVEGDMWSIGVI----------TYI 323
+Y APE++ +Y D+WSIG I
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 324 LLCGSRP-------FWARTESGIFRSVLRADPNFHD----------SP----WPSV-SPE 361
P F + D +P ++ +
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346
Query: 362 AKDFVRR----------------------LLNK----DHRKRMTAAQALTHPWL---HDE 392
AK ++R LL + + KR+T + L HP+
Sbjct: 347 AKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406
Query: 393 NR 394
Sbjct: 407 EV 408
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 72/345 (20%), Positives = 124/345 (35%), Gaps = 95/345 (27%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVK-IISKAKMTSALAIEDVRREVKILKA 184
K+ LGK +G G FG C + GK A+K ++ + + RE+ I+K
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPRYKN--------RELDIMKV 56
Query: 185 LSGHKHMIKFHDAF--------------------------------------EDANSVYI 206
L H ++IK D F + +
Sbjct: 57 LD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 207 VMEFCEGGELLDRIL---SRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFL 262
+ME+ + L ++L R GR + + + ++ V F H G+ HRD+KP+N L
Sbjct: 116 IMEYVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 263 FTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVI 320
+ +D LK+ DFG + + P + + S +Y APE++ Y D+WSIG +
Sbjct: 174 VNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 321 TYILLCG-----------------------SRPFWARTESGIFRSVLRADPNFHDSPWPS 357
L+ G ++ R P W
Sbjct: 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF---PTLKAKDWRK 288
Query: 358 V-----SPEAKDFVRRLLNKDHRKRMTAAQALTHPW---LHDENR 394
+ A D + ++L + R+ +A+ HP+ L +
Sbjct: 289 ILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYE 333
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 59/237 (24%), Positives = 109/237 (45%), Gaps = 26/237 (10%)
Query: 114 DKNFGY----GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII-SKAKMTS 168
D N+ Y G+ + ++E+ +G+G FG A + + + VA+KII +K +
Sbjct: 39 DDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNKKAFLN 95
Query: 169 ALAIEDVRREVKILKALSGH-----KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSR 223
+ EV++L+ ++ H +++ F N + +V E L D + +
Sbjct: 96 Q-----AQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNT 149
Query: 224 GGRYLEEDA-KTIVEKILNIVAFCHLQ--GVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280
R + + + +++ + F ++H DLKPEN L + + +K++DFG S
Sbjct: 150 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSS 208
Query: 281 DFVRPDQRLNDIVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPFWARTE 336
+ QR+ + S +Y +PEV L Y++ DMWS+G I + G F E
Sbjct: 209 CQL--GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 9/27 (33%), Positives = 15/27 (55%)
Query: 363 KDFVRRLLNKDHRKRMTAAQALTHPWL 389
KD + R+L+ D + R+ AL H +
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFF 376
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 37/301 (12%), Positives = 66/301 (21%), Gaps = 53/301 (17%)
Query: 86 RLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAK 145
R + P + G A R + L G A
Sbjct: 7 REPDRESSAPPDDVQLVPGARIANGR---------------YRLLIFHGGVPPLQFWQAL 51
Query: 146 GKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205
T + VA+ + + +++ L + + + D
Sbjct: 52 D---TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGGL 107
Query: 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 265
+V E+ GG L + A ++ + H GV P +
Sbjct: 108 VVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI 164
Query: 266 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILL 325
D + + P+ + D+ IG Y LL
Sbjct: 165 ---DGDVVLAYPA--------------------TMPDANPQD-----DIRGIGASLYALL 196
Query: 326 CGSRPFWARTESGIFRSVLRADPNFHDSPW---PSVSPEAKDFVRRLLNKDHRKRMTAAQ 382
P R P + + R + D R +
Sbjct: 197 VNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTL 256
Query: 383 A 383
Sbjct: 257 L 257
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 54/258 (20%), Positives = 101/258 (39%), Gaps = 56/258 (21%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG 187
L + +G+G FG +G +G+ VAVKI S + S E+ L
Sbjct: 45 VLQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWFR----EAEIYQTVMLR- 94
Query: 188 HKHMIKFHDAFEDANSV----YIVMEFCEGGELLD-------------RI---LSRGGRY 227
H++++ F A N ++V ++ E G L D ++ + G +
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAH 154
Query: 228 LEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ 287
L + K + HRDLK +N L ++ + D GL+
Sbjct: 155 LHMEIVGTQGKP----------AIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSAT 201
Query: 288 RLNDI-----VGSAYYVAPEVLHRSYNVEG-------DMWSIGVITYILLCGSRPFWART 335
DI VG+ Y+APEVL S N++ D++++G++ + +
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 336 ESGI-FRSVLRADPNFHD 352
+ + + ++ +DP+ +
Sbjct: 262 DYQLPYYDLVPSDPSVEE 279
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 69/376 (18%), Positives = 122/376 (32%), Gaps = 116/376 (30%)
Query: 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII-SKAKMTSALAIEDVRRE 178
G F ++ + +++G GHF + + K VA+K++ S T E E
Sbjct: 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVVKSAEHYT-----ETALDE 83
Query: 179 VKILKALS-------GHKHMIKFHDAFE----DANSVYIVMEFCEGGELLD-RILSRGGR 226
+++LK++ + +++ D F+ + + +V E G LL I S
Sbjct: 84 IRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQG 142
Query: 227 YLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTRE------------------ 267
K I++++L + + H + ++H D+KPEN L + E
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 268 ----------------------------EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV 299
E +K+ D G + + + + + Y
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYR 260
Query: 300 APEV-LHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV--------------- 343
+ EV + YN D+WS + + L G F + R
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPR 320
Query: 344 ------------------LRADPNFHDSPWPSVSPE-----------AKDFVRRLLNKDH 374
L+ V E DF+ +L
Sbjct: 321 KLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIP 380
Query: 375 RKRMTAAQALTHPWLH 390
KR TAA+ L HPWL+
Sbjct: 381 EKRATAAECLRHPWLN 396
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 60/268 (22%), Positives = 105/268 (39%), Gaps = 47/268 (17%)
Query: 91 MQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGT 150
++ EG + + L+ + +L + +G+G FG G
Sbjct: 168 IKPKVMEGTVAAQDEFYRSGWALNMK---------ELKLLQTIGKGEFGDVM-----LGD 213
Query: 151 LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDA-FEDANSVYIVME 209
+G VAVK I K T+ + E ++ L H ++++ E+ +YIV E
Sbjct: 214 YRGNKVAVKCI-KNDATA----QAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTE 267
Query: 210 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV---AFCHLQGVVHRDLKPENFLFTTR 266
+ G L+D + SRG L +++ L++ + VHRDL N L +
Sbjct: 268 YMAKGSLVDYLRSRGRSVL--GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-- 323
Query: 267 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-------APEVL-HRSYNVEGDMWSIG 318
ED KV DFGL+ + + APE L + ++ + D+WS G
Sbjct: 324 -EDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFG 373
Query: 319 VITY-ILLCGSRPFWARTESGIFRSVLR 345
++ + I G P+ + V +
Sbjct: 374 ILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 8e-24
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 56/234 (23%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKA 184
+ L KE+G G FG G KG+ VAVK+I + M+ ++ +E + +
Sbjct: 9 EITLLKELGSGQFGVVK-----LGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMK 59
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA 244
LS H ++KF+ +YIV E+ G LL+ YL K + L +
Sbjct: 60 LS-HPKLVKFYGVCSKEYPIYIVTEYISNGCLLN--------YLRSHGKGLEPSQL--LE 108
Query: 245 FCH----------LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVG 294
C+ +HRDL N L D +KV DFG++ R ++
Sbjct: 109 MCYDVCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMT---R------YVLD 156
Query: 295 SAYYV-----------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWART 335
Y APEV + Y+ + D+W+ G++ + + G P+ T
Sbjct: 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 56/264 (21%), Positives = 104/264 (39%), Gaps = 44/264 (16%)
Query: 100 TSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKV---- 155
++G+G +++ + + L +++G G FG +G
Sbjct: 2 SAGEGPLQSLTCLIGEK---------DLRLLEKLGDGSFGVVR-----RGEWDAPSGKTV 47
Query: 156 -VAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGG 214
VAVK + ++ A++D REV + +L H+++I+ + + +V E G
Sbjct: 48 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLY-GVVLTPPMKMVTELAPLG 105
Query: 215 ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274
LLDR+ G +L ++ + + + +HRDL N L TR+ +K+
Sbjct: 106 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKI 162
Query: 275 IDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-HRSYNVEGDMWSIGVITY 322
DFGL + + Y + APE L R+++ D W GV +
Sbjct: 163 GDFGLMRALPQND-------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 215
Query: 323 -ILLCGSRPFWARTESGIFRSVLR 345
+ G P+ S I + +
Sbjct: 216 EMFTYGQEPWIGLNGSQILHKIDK 239
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 55/259 (21%), Positives = 101/259 (38%), Gaps = 58/259 (22%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK-ALS 186
L + VG+G +G +G+ +G+ VAVKI S S RE ++ +
Sbjct: 11 TLLECVGKGRYGEVW-----RGSWQGENVAVKIFSSRDEKSWF------RETELYNTVML 59
Query: 187 GHKHMIKF----HDAFEDANSVYIVMEFCEGGELLDRI----------------LSRGGR 226
H++++ F + + ++++ + E G L D + ++ G
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLA 119
Query: 227 YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-----D 281
+L + K + HRDLK +N L ++ + D GL+
Sbjct: 120 HLHIEIFGTQGKP----------AIAHRDLKSKNILVK---KNGQCCIADLGLAVMHSQS 166
Query: 282 FVRPDQRLNDIVGSAYYVAPEVLHRSYNVEG-------DMWSIGVITYILLCGSRPFWAR 334
+ D N VG+ Y+APEVL + V+ D+W+ G++ + +
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
Query: 335 TESGI-FRSVLRADPNFHD 352
+ F V+ DP+F D
Sbjct: 227 EDYKPPFYDVVPNDPSFED 245
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 52/234 (22%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGK--VVAVKIISKAKMTSALAIEDVRREVKILK 183
LG+++GRG+FG G L+ +VAVK + +E +ILK
Sbjct: 115 DLVLGEQIGRGNFGEVF-----SGRLRADNTLVAVKSCRETLPPDL--KAKFLQEARILK 167
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTI-VEKILNI 242
S H ++++ +YIVME +GG+ L +L + + V+ +L +
Sbjct: 168 QYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLT--------FLRTEGARLRVKTLLQM 218
Query: 243 V-------AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295
V + + +HRDL N L T E LK+ DFG+S
Sbjct: 219 VGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGV-------- 267
Query: 296 AYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWART 335
Y APE L + Y+ E D+WS G++ + G+ P+ +
Sbjct: 268 -YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 54/260 (20%), Positives = 99/260 (38%), Gaps = 56/260 (21%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ ++ K++G+G +G G +G+ VAVK+ + S E+ +
Sbjct: 38 QIQMVKQIGKGRYGEVW-----MGKWRGEKVAVKVFFTTEEASWFR----ETEIYQTVLM 88
Query: 186 SGHKHMIKFHDAFEDANS----VYIVMEFCEGGELLDRI----------------LSRGG 225
H++++ F A +Y++ ++ E G L D + G
Sbjct: 89 R-HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGL 147
Query: 226 RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285
+L + + K + HRDLK +N L ++ + D GL+
Sbjct: 148 CHLHTEIFSTQGKP----------AIAHRDLKSKNILVK---KNGTCCIADLGLAVKFIS 194
Query: 286 DQRLNDI-----VGSAYYVAPEVLHRSYNVEG-------DMWSIGVITYILLCGSRPFWA 333
D DI VG+ Y+ PEVL S N DM+S G+I + +
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254
Query: 334 RTESGI-FRSVLRADPNFHD 352
E + + ++ +DP++ D
Sbjct: 255 VEEYQLPYHDLVPSDPSYED 274
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 36/224 (16%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKA 184
KE+G G FG G +G+ VA+K+I + M+ ++ E K++
Sbjct: 25 DLTFLKELGTGQFGVVK-----YGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMN 75
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA 244
LS H+ +++ + ++I+ E+ G LL+ + R+ + + + + +
Sbjct: 76 LS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV----- 299
+ + +HRDL N L + +KV DFGLS R ++ Y
Sbjct: 135 YLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLS---R------YVLDDEYTSSVGSK 182
Query: 300 ------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWART 335
PEVL + ++ + D+W+ GV+ + I G P+ T
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 59/233 (25%), Positives = 90/233 (38%), Gaps = 56/233 (24%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKAL 185
+E+G G FG G K VA+K I + M+ ED E +++ L
Sbjct: 10 LTFVQEIGSGQFGLVH-----LGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKL 60
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
S H +++ + + + +V EF E G L D YL + L +
Sbjct: 61 S-HPKLVQLYGVCLEQAPICLVTEFMEHGCLSD--------YLRTQRGLFAAETL--LGM 109
Query: 246 CH----------LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295
C V+HRDL N L E+ +KV DFG++ FV DQ
Sbjct: 110 CLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQ-------- 158
Query: 296 AYYV-----------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWART 335
Y +PEV Y+ + D+WS GV+ + + G P+ R+
Sbjct: 159 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 58/240 (24%), Positives = 96/240 (40%), Gaps = 52/240 (21%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ +L + +G+G FG G +G VAVK I K T+ + E ++ L
Sbjct: 22 ELKLLQTIGKGEFGDVM-----LGDYRGNKVAVKCI-KNDATA----QAFLAEASVMTQL 71
Query: 186 SGHKHMIKFHDA-FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA 244
H ++++ E+ +YIV E+ G L+D + SRG L ++
Sbjct: 72 R-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL---------GGDCLLK 121
Query: 245 FC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVG 294
F +L VHRDL N L + ED KV DFGL+ + +
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---K------EASS 169
Query: 295 SAYYV-------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 345
+ APE L + ++ + D+WS G++ + I G P+ + V +
Sbjct: 170 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-23
Identities = 55/237 (23%), Positives = 101/237 (42%), Gaps = 42/237 (17%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKA 184
+L + +G G FG G G VAVK + + M+ + E ++K
Sbjct: 14 TLKLVERLGAGQFGEVW-----MGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQ 64
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV- 243
L H+ +++ + A +YI+ E+ E G L+D + + G L +++ I
Sbjct: 65 LQ-HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKL--TINKLLDMAAQIAE 120
Query: 244 --AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-- 299
AF + +HRDL+ N L + + K+ DFGL+ R I + Y
Sbjct: 121 GMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA---R------LIEDNEYTARE 168
Query: 300 ---------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 345
APE + + ++ ++ D+WS G++ I+ G P+ T + +++ R
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-23
Identities = 53/237 (22%), Positives = 95/237 (40%), Gaps = 40/237 (16%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ ++G G +G KK +L VAVK + + M E+ +E ++K +
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTMEV----EEFLKEAAVMKEI 66
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV-- 243
H ++++ YI+ EF G LLD + + + A ++ I
Sbjct: 67 K-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--SAVVLLYMATQISSA 123
Query: 244 -AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV--- 299
+ + +HRDL N L E+ +KV DFGLS + D Y
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD----------TYTAHA 170
Query: 300 ---------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 345
APE L + ++++ D+W+ GV+ + I G P+ S ++ + +
Sbjct: 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 7e-23
Identities = 57/237 (24%), Positives = 94/237 (39%), Gaps = 42/237 (17%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKA 184
+L K++G G FG T VAVK + M+ E E ++K
Sbjct: 189 SLKLEKKLGAGQFGEVW-----MATYNKHTKVAVKTMKPGSMSV----EAFLAEANVMKT 239
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV- 243
L H ++K H +YI+ EF G LLD + S G +++ I
Sbjct: 240 LQ-HDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQP--LPKLIDFSAQIAE 295
Query: 244 --AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-- 299
AF + +HRDL+ N L + K+ DFGL+ + ++ Y
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE---------YTARE 343
Query: 300 ---------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 345
APE + S+ ++ D+WS G++ I+ G P+ + + R++ R
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 9e-23
Identities = 59/237 (24%), Positives = 96/237 (40%), Gaps = 42/237 (17%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKA 184
L ++G+G FG GT G VA+K + M+ E +E +++K
Sbjct: 185 SLRLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKK 235
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV- 243
L H+ +++ + + +YIV E+ G LLD + G+YL +V+ I
Sbjct: 236 LR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL--RLPQLVDMAAQIAS 291
Query: 244 --AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-- 299
A+ VHRDL+ N L E+ KV DFGL+ R I + Y
Sbjct: 292 GMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA---R------LIEDNEYTARQ 339
Query: 300 ---------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 345
APE + + ++ D+WS G++ + G P+ + V R
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 48/238 (20%), Positives = 81/238 (34%), Gaps = 51/238 (21%)
Query: 126 KFELGKEVGRGHFGHTCCAK----GKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI 181
+ +G+G F G G L V +K++ KA + E +
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAASM 65
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN 241
+ LS HKH++ + + +V EF + G L YL+++ I IL
Sbjct: 66 MSKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDT--------YLKKNKNCI--NILW 114
Query: 242 IVAFCH----------LQGVVHRDLKPENFLFTTREEDAPL-----KVIDFGLSDFVRPD 286
+ ++H ++ +N L E+ K+ D G+S V P
Sbjct: 115 KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 287 QRLNDIVGSAYY------VAPEVLH--RSYNVEGDMWSIGVITY-ILLCGSRPFWART 335
V PE + ++ N+ D WS G + I G +P A
Sbjct: 175 D---------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 52/265 (19%), Positives = 101/265 (38%), Gaps = 41/265 (15%)
Query: 94 PPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKG 153
P + PT + ++++ + ++G G +G +G K
Sbjct: 198 PKRNKPTIYGVSPNYDKWEMERT---------DITMKHKLGGGQYGEVY-----EGVWKK 243
Query: 154 KV--VAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFC 211
VAVK + + M E+ +E ++K + H ++++ YI+ EF
Sbjct: 244 YSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFM 298
Query: 212 EGGELLDRILSRGGRYLEEDAKTIVEKILNIV-------AFCHLQGVVHRDLKPENFLFT 264
G LLD + + + +L + + + +HR+L N L
Sbjct: 299 TYGNLLDYLRECNRQEVS------AVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG 352
Query: 265 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY--VAPEVL-HRSYNVEGDMWSIGVIT 321
E+ +KV DFGLS + D APE L + ++++ D+W+ GV+
Sbjct: 353 ---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 409
Query: 322 Y-ILLCGSRPFWARTESGIFRSVLR 345
+ I G P+ S ++ + +
Sbjct: 410 WEIATYGMSPYPGIDLSQVYELLEK 434
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 49/241 (20%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKAL 185
F+ K +G G FG K K+ VA+K + +A A +++ E ++ ++
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASV 74
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
+ H+ + ++V ++ + G LLD Y+ E I ++ +
Sbjct: 75 D-NPHVCRLLGICLT-STVQLITQLMPFGCLLD--------YVREHKDNI--GSQYLLNW 122
Query: 246 CH----------LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295
C + +VHRDL N L T + +K+ DFGL+ + +
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAE--------E 171
Query: 296 AYYV-----------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRS 342
Y A E + HR Y + D+WS GV + ++ GS+P+ S I
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 343 V 343
+
Sbjct: 232 L 232
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 61/258 (23%), Positives = 100/258 (38%), Gaps = 52/258 (20%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+L + RG FG K L + VAVKI S EV L +
Sbjct: 25 PLQLLEVKARGRFGCVW-----KAQLLNEYVAVKIFPIQDKQS----WQNEYEVYSLPGM 75
Query: 186 SGHKHMIKFHDAFEDANSV----YIVMEFCEGGELLD-------------RI---LSRGG 225
H+++++F A + SV +++ F E G L D I ++RG
Sbjct: 76 K-HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGL 134
Query: 226 RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285
YL ED + + H + HRD+K +N L + + + DFGL+
Sbjct: 135 AYLHEDIPGLKD--------GHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEA 183
Query: 286 DQRLNDI---VGSAYYVAPEVLHRSYNVEG------DMWSIGVITYILLCGSRPFWARTE 336
+ D VG+ Y+APEVL + N + DM+++G++ + L +
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 337 SGI--FRSVLRADPNFHD 352
+ F + P+ D
Sbjct: 244 EYMLPFEEEIGQHPSLED 261
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 58/253 (22%), Positives = 95/253 (37%), Gaps = 54/253 (21%)
Query: 128 ELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ ++G+G+FG C G +VAVK + + + D +RE++ILKAL
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDN-TGALVAVKQL---QHSGPDQQRDFQREIQILKAL 81
Query: 186 SGHKHMIKFHD--AFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
++K+ S+ +VME+ G L D +L+ + ++
Sbjct: 82 H-SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD--------FLQRHRARL--DASRLL 130
Query: 244 AFC----------HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIV 293
+ + VHRDL N L E +A +K+ DFGL+ + D
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLD------- 180
Query: 294 GSAYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGI 339
YYV APE L ++ + D+WS GV+ Y + + E
Sbjct: 181 -KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 239
Query: 340 FRSVLRADPNFHD 352
R P
Sbjct: 240 MMGCERDVPALSR 252
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 2e-21
Identities = 59/237 (24%), Positives = 96/237 (40%), Gaps = 42/237 (17%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKA 184
L ++G+G FG GT G VA+K + M+ E +E +++K
Sbjct: 268 SLRLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKK 318
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV- 243
L H+ +++ + + +YIV E+ G LLD + G+YL +V+ I
Sbjct: 319 LR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL--RLPQLVDMAAQIAS 374
Query: 244 --AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-- 299
A+ VHRDL+ N L E+ KV DFGL+ R I + Y
Sbjct: 375 GMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA---R------LIEDNEYTARQ 422
Query: 300 ---------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 345
APE + + ++ D+WS G++ + G P+ + V R
Sbjct: 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 61/270 (22%), Positives = 103/270 (38%), Gaps = 54/270 (20%)
Query: 128 ELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ +++G+G+FG C + G+VVAVK + + + D RE++ILK+L
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEE---HLRDFEREIEILKSL 99
Query: 186 SGHKHMIKFHDA--FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
H +++K+ ++ ++ME+ G L D + R +I +
Sbjct: 100 Q-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV---- 299
+ + +HRDL N L E + +K+ DFGL+ + D+ YY
Sbjct: 159 EYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK--------EYYKVKEP 207
Query: 300 --------APEVL-HRSYNVEGDMWSIGV-----ITYILLCGSRPFWARTESGIFRSVLR 345
APE L ++V D+WS GV TYI S P G
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG------- 260
Query: 346 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHR 375
+ + + LL + R
Sbjct: 261 ------NDKQGQMIVFH---LIELLKNNGR 281
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-21
Identities = 58/248 (23%), Positives = 87/248 (35%), Gaps = 59/248 (23%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKV-----VAVKIISKAKMTSALAIEDVRREVK 180
L + +G G FG +G VAVK K + E E
Sbjct: 13 DVVLNRILGEGFFGEVY-----EGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAV 65
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
I+K L H H++K + +I+ME GEL YLE + ++ K+L
Sbjct: 66 IMKNLD-HPHIVKLI-GIIEEEPTWIIMELYPYGELGH--------YLERNKNSL--KVL 113
Query: 241 NIVAFCH----------LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN 290
+V + VHRD+ N L +K+ DFGLS R
Sbjct: 114 TLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS---R------ 161
Query: 291 DIVGSAYYV-----------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTES 337
I YY +PE + R + D+W V + IL G +PF+
Sbjct: 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK 221
Query: 338 GIFRSVLR 345
+ + +
Sbjct: 222 DVIGVLEK 229
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 42/222 (18%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ GK +G G FG A G VAVK++ E + E+KI+
Sbjct: 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMS 104
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN-- 241
L H++++ A V ++ E+C G+LL+ + + + A I +
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 242 -IVAFC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN 290
++ F L + +HRD+ N L T K+ DFGL+ R
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLA---R------ 212
Query: 291 DIVGSAYYV------------APEVL-HRSYNVEGDMWSIGV 319
DI+ + Y+ APE + Y V+ D+WS G+
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 59/247 (23%), Positives = 98/247 (39%), Gaps = 47/247 (19%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ +G G+FG A+ KK L+ A+K + K + S D E+++L L
Sbjct: 26 DIKFQDVIGEGNFGQVLKARIKKDGLR-MDAAIKRM-K-EYASKDDHRDFAGELEVLCKL 82
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLD-----RILSRGGRYLEEDAKTIVEKIL 240
H ++I A E +Y+ +E+ G LLD R+L + ++
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 241 NIVAFC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN 290
++ F +L + +HRDL N L E+ K+ DFGLS R
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-------RGQ 192
Query: 291 DIVGSAYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTE 336
+ YV A E L + Y D+WS GV+ + I+ G P+ T
Sbjct: 193 E-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247
Query: 337 SGIFRSV 343
+ ++ +
Sbjct: 248 AELYEKL 254
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-21
Identities = 57/245 (23%), Positives = 102/245 (41%), Gaps = 58/245 (23%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ +++G+G+FG C + G+VVAVK + + ++ + D RE++ILK
Sbjct: 11 HLKFLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKL---QHSTEEHLRDFEREIEILK 66
Query: 184 ALSGHKHMIKFHDA--FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN 241
+L H +++K+ ++ ++ME+ G L D YL++ + I +
Sbjct: 67 SLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD--------YLQKHKERI--DHIK 115
Query: 242 IVAFC----------HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND 291
++ + + +HRDL N L E + +K+ DFGL+ + D+
Sbjct: 116 LLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK---- 168
Query: 292 IVGSAYYV------------APEVL-HRSYNVEGDMWSIGV-----ITYILLCGSRPFWA 333
++ APE L ++V D+WS GV TYI S P
Sbjct: 169 ----EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224
Query: 334 RTESG 338
G
Sbjct: 225 MRMIG 229
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 8e-21
Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 52/232 (22%)
Query: 129 LGKEVGRGHFGHTCCAKGKKGTLKGKV----VAVKIISKAKMTSALAIEDVRREVKILKA 184
KE+G G+FG KG + K VAVKI+ K + +++ E +++
Sbjct: 21 EDKELGSGNFGTVK-----KGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQ 74
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV- 243
L + ++++ +A S +VME E G L YL+++ + I+ +V
Sbjct: 75 LD-NPYIVRMI-GICEAESWMLVMEMAELGPLNK--------YLQQNRHVKDKNIIELVH 124
Query: 244 ------AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY 297
+ VHRDL N L K+ DFGLS +R D+ Y
Sbjct: 125 QVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADE--------NY 173
Query: 298 YV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWART 335
Y APE + + ++ + D+WS GV+ + G +P+
Sbjct: 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 8e-21
Identities = 53/312 (16%), Positives = 103/312 (33%), Gaps = 51/312 (16%)
Query: 58 PSPSPGRKFRWPLPPPSPAKPIMSAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNF 117
P+ + P K R + M +G + +++ +
Sbjct: 13 DIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRK- 71
Query: 118 GYGKNFGAKFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDV 175
L + +G G FG + G VAVK + + D
Sbjct: 72 --------NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDF 121
Query: 176 RREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTI 235
E I+ + H+++++ + +I++E GG+L + R + + +
Sbjct: 122 LMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 236 VEKILNIVAFC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285
++ ++ +L +HRD+ N L T K+ DFG++ R
Sbjct: 181 LD----LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R- 232
Query: 286 DQRLNDIVGSAYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPF 331
DI + YY PE + + D WS GV+ + I G P+
Sbjct: 233 -----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287
Query: 332 WARTESGIFRSV 343
+++ + V
Sbjct: 288 PSKSNQEVLEFV 299
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-21
Identities = 47/266 (17%), Positives = 97/266 (36%), Gaps = 58/266 (21%)
Query: 104 GGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIIS 162
G +K R + + K +G G FG K+ V +K+I
Sbjct: 1 GAMKVLARIFKET---------ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE 51
Query: 163 KAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILS 222
+ + + V + + +L H H+++ +S+ +V ++ G LLD
Sbjct: 52 DK--SGRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCPG-SSLQLVTQYLPLGSLLD---- 103
Query: 223 RGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLKPENFLFTTREEDAPL 272
++ + + ++L + + G+VHR+L N L + +
Sbjct: 104 ----HVRQHRGALGPQLL--LNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK---SPSQV 154
Query: 273 KVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-HRSYNVEGDMWSIGVI 320
+V DFG++D + PD + A E + Y + D+WS GV
Sbjct: 155 QVADFGVADLLPPD--------DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVT 206
Query: 321 TY-ILLCGSRPFWARTESGIFRSVLR 345
+ ++ G+ P+ + + + +
Sbjct: 207 VWELMTFGAEPYAGLRLAEVPDLLEK 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 1e-20
Identities = 54/241 (22%), Positives = 92/241 (38%), Gaps = 49/241 (20%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ ELG+ +G G FG VA+K S E +E ++
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 448
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H H++K + N V+I+ME C GEL +L+ ++ + +++ +
Sbjct: 449 D-HPHIVKLIGVITE-NPVWIIMELCTLGELRS--------FLQVRKFSL--DLASLILY 496
Query: 246 CH----------LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295
+ + VHRD+ N L + + +K+ DFGLS + S
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSR---------YMEDS 544
Query: 296 AYYV-----------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRS 342
YY APE + R + D+W GV + IL+ G +PF + +
Sbjct: 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604
Query: 343 V 343
+
Sbjct: 605 I 605
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 55/242 (22%), Positives = 85/242 (35%), Gaps = 47/242 (19%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKA 184
K +G G FG K + K +V VA+K + D E I+
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQ 102
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA 244
S H ++I+ + I+ E+ E G L +L E L V
Sbjct: 103 FS-HHNIIRLEGVISKYKPMMIITEYMENGALDK--------FLREKDGEFSVLQL--VG 151
Query: 245 FCH----------LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVG 294
VHRDL N L + KV DFGLS + D
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDP------- 201
Query: 295 SAYYV-----------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFR 341
A Y APE + +R + D+WS G++ + ++ G RP+W + + +
Sbjct: 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK 261
Query: 342 SV 343
++
Sbjct: 262 AI 263
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 54/229 (23%), Positives = 78/229 (34%), Gaps = 46/229 (20%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+ K +G G G C + + + VA+K + D E I+
Sbjct: 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFD 108
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H ++I+ IV E+ E G L +L L V
Sbjct: 109 -HPNIIRLEGVVTRGRLAMIVTEYMENGSLDT--------FLRTHDGQFTIMQL--VGML 157
Query: 247 H----------LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA 296
G VHRDL N L + KV DFGLS + D A
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDP-------DA 207
Query: 297 YYV-----------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFW 332
Y APE + R+++ D+WS GV+ + +L G RP+W
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 49/241 (20%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKAL 185
F+ K +G G FG K K+ VA+K + +A A +++ E ++ ++
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASV 74
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
+ H+ + ++V ++ + G LLD Y+ E I ++ +
Sbjct: 75 D-NPHVCRLLGICLT-STVQLITQLMPFGCLLD--------YVREHKDNI--GSQYLLNW 122
Query: 246 CH----------LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295
C + +VHRDL N L T + +K+ DFGL+ + +
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAE--------E 171
Query: 296 AYYV-----------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRS 342
Y A E + HR Y + D+WS GV + ++ GS+P+ S I
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 343 V 343
+
Sbjct: 232 L 232
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 54/234 (23%), Positives = 87/234 (37%), Gaps = 62/234 (26%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK-A 184
+L + +GRG +G KG+L + VAVK+ S A ++ E I +
Sbjct: 14 NLKLLELIGRGRYGAVY-----KGSLDERPVAVKVFSFANR------QNFINEKNIYRVP 62
Query: 185 LSGHKHMIKF-----HDAFEDANSVYIVMEFCEGGELLDRI----------------LSR 223
L H ++ +F + +VME+ G L + ++R
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTR 122
Query: 224 GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283
G YL + I HRDL N L D + DFGLS +
Sbjct: 123 GLAYLHTELPRGDHYKPAI---------SHRDLNSRNVLVK---NDGTCVISDFGLSMRL 170
Query: 284 RPDQRL---------NDIVGSAYYVAPEVLHRSYNVEG--------DMWSIGVI 320
++ + VG+ Y+APEVL + N+ DM+++G+I
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 55/241 (22%), Positives = 92/241 (38%), Gaps = 49/241 (20%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ ELG+ +G G FG VA+K S E +E ++
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 73
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H H++K N V+I+ME C GEL +L+ ++ + +++ +
Sbjct: 74 D-HPHIVKLI-GVITENPVWIIMELCTLGELRS--------FLQVRKYSL--DLASLILY 121
Query: 246 CH----------LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295
+ + VHRD+ N L + + +K+ DFGLS R + S
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS---R------YMEDS 169
Query: 296 AYYV-----------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRS 342
YY APE + R + D+W GV + IL+ G +PF + +
Sbjct: 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 229
Query: 343 V 343
+
Sbjct: 230 I 230
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 42/236 (17%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
L + +G G FG + G VAVK + + D E I+
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIIS 88
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
+ H+++++ + +I+ME GG+L + R + + +++ ++
Sbjct: 89 KFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD----LL 143
Query: 244 AFC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIV 293
+L +HRD+ N L T K+ DFG++ R DI
Sbjct: 144 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIY 194
Query: 294 GSAYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWART 335
++YY PE + + D WS GV+ + I G P+ +++
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 61/247 (24%), Positives = 100/247 (40%), Gaps = 43/247 (17%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+F LG+ +G+G FG A+ K+ VAVK++ KA + ++ IE+ RE +K
Sbjct: 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEF 82
Query: 186 SGHKHMIKF------HDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKI 239
H H+ K A +++ F + G+L + R E ++ +
Sbjct: 83 D-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL--LASRIGENPFNLPLQTL 139
Query: 240 LNI---VAF--CHL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI 292
+ +A +L + +HRDL N + ED + V DFGLS R I
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLS---R------KI 187
Query: 293 VGSAYYV------------APEVLH-RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESG 338
YY A E L Y V D+W+ GV + I+ G P+ +
Sbjct: 188 YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 339 IFRSVLR 345
I+ ++
Sbjct: 248 IYNYLIG 254
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 55/238 (23%), Positives = 93/238 (39%), Gaps = 47/238 (19%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ GK +G G FG A G + VAVK++ + E + E+K+L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLS 81
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE------ 237
L H +++ A ++ E+C G+LL+ + + ++ +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 238 -KILNIVAFC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 286
+ ++++F L + +HRDL N L T K+ DFGL+ R
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA---R-- 193
Query: 287 QRLNDIVGSAYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRP 330
DI + YV APE + + Y E D+WS G+ + + GS P
Sbjct: 194 ----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 56/241 (23%), Positives = 86/241 (35%), Gaps = 46/241 (19%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ K VG G FG C + K + K VA+K + D E I+
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 103
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H ++I+ + V IV E+ E G L +L + L V
Sbjct: 104 D-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--------FLRKHDAQFTVIQL--VGM 152
Query: 246 CH----------LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295
G VHRDL N L + KV DFGL + D
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDP-------E 202
Query: 296 AYYV-----------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRS 342
A Y +PE + +R + D+WS G++ + ++ G RP+W + + ++
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262
Query: 343 V 343
V
Sbjct: 263 V 263
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-20
Identities = 47/239 (19%), Positives = 88/239 (36%), Gaps = 46/239 (19%)
Query: 128 ELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+E+G FG + G + + VA+K + E+ R E + L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEFRHEAMLRARL 69
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLD--RILSRGGRYLEEDAKTIVEKILNIV 243
H +++ + ++ +C G+L + + S D V+ L
Sbjct: 70 Q-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 244 AFCHL-------------QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN 290
F HL VVH+DL N L + +K+ D GL R
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF---R------ 176
Query: 291 DIVGSAYYV------------APE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPFWART 335
++ + YY APE +++ ++++ D+WS GV+ + + G +P+ +
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 46/239 (19%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ +LGK +GRG FG A G T + VAVK++ + + + E+KIL
Sbjct: 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILI 85
Query: 184 ALSGHKHMIKFHDA-FEDANSVYIVMEFCEGGELLD-----RILSRGGRYLEEDAKTIVE 237
+ H +++ A + + +++EFC+ G L R + ED
Sbjct: 86 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 238 KILNIVAFC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ 287
+ +++ + L + +HRDL N L + E +K+ DFGL+ R
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA---R--- 196
Query: 288 RLNDIVGSAYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFW 332
DI YV APE + R Y ++ D+WS GV+ + I G+ P+
Sbjct: 197 ---DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 8e-20
Identities = 50/243 (20%), Positives = 91/243 (37%), Gaps = 52/243 (21%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG 187
+ +GRGHFG K AVK ++ ++T + E I+K S
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFS- 84
Query: 188 HKHMIKFHDA-FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H +++ S +V+ + + G+L + ++ + + +++ F
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--------FIRNETHNP--TVKDLIGFG 134
Query: 247 --------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA 296
+L + VHRDL N + E +KV DFGL+ R D+
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---R------DMYDKE 182
Query: 297 YYV--------------APEVLH-RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIF 340
YY A E L + + + D+WS GV+ + ++ G+ P+ I
Sbjct: 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 242
Query: 341 RSV 343
+
Sbjct: 243 VYL 245
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 56/246 (22%), Positives = 92/246 (37%), Gaps = 42/246 (17%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
LGK +G G FG K+ VAVK + K +S IE+ E +K
Sbjct: 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDF 93
Query: 186 SGHKHMIK-----FHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
S H ++I+ + + +++ F + G+L + R ++ +L
Sbjct: 94 S-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL--LYSRLETGPKHIPLQTLL 150
Query: 241 NI---VAF--CHL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIV 293
+A +L + +HRDL N + +D + V DFGLS + I
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLS---K------KIY 198
Query: 294 GSAYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGI 339
YY A E L R Y + D+W+ GV + I G P+ +
Sbjct: 199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258
Query: 340 FRSVLR 345
+ +L
Sbjct: 259 YDYLLH 264
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 50/245 (20%), Positives = 91/245 (37%), Gaps = 52/245 (21%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG 187
+ +G+GHFG + A+K +S+ T +E RE +++ L+
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN- 80
Query: 188 HKHMIKFHDA-FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H +++ ++++ + G+LL ++ + K L ++F
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ--------FIRSPQRNPTVKDL--ISFG 130
Query: 247 H----------LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA 296
Q VHRDL N + E +KV DFGL+ R DI+
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLA---R------DILDRE 178
Query: 297 YYV--------------APEVLH-RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIF 340
YY A E L + + D+WS GV+ + +L G+ P+ +
Sbjct: 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT 238
Query: 341 RSVLR 345
+ +
Sbjct: 239 HFLAQ 243
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 49/229 (21%), Positives = 99/229 (43%), Gaps = 37/229 (16%)
Query: 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKI-ISKAKMTSALAIEDVRREVKI 181
G F +GK++G G+FG K + VA+K+ K++ + E +
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKN---LYTNEYVAIKLEPMKSRAPQ------LHLEYRF 57
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIV---EK 238
K L + + + +V+E G L+ + R KT++ +
Sbjct: 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTF--SLKTVLMIAIQ 113
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLF--TTREEDAPLKVIDFGLS-DFVRPDQRL------ 289
+++ + + H + +++RD+KPENFL + + +IDF L+ +++ P+ +
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173
Query: 290 -NDIVGSAYYVAPEVLHRSYNVEG----DMWSIG-VITYILLCGSRPFW 332
+ G+A Y++ ++ E D+ ++G + Y L GS P W
Sbjct: 174 HKSLTGTARYMS---INTHLGKEQSRRDDLEALGHMFMY-FLRGSLP-W 217
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 46/226 (20%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKV--VAVKIISKAKMTSALAIEDVRREVKI 181
K LGK +G G FG A G + VAVK++ + + D+ E+++
Sbjct: 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEM 93
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLD--RILSRGGRYLEEDAKTIVEKI 239
+K + HK++I A +Y+++E+ G L + R G D + E+
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 240 L---NIVAFC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 286
+ ++V+ +L Q +HRDL N L T E+ +K+ DFGL+ R
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R-- 205
Query: 287 QRLNDIVGSAYYV------------APEVL-HRSYNVEGDMWSIGV 319
DI YY APE L R Y + D+WS GV
Sbjct: 206 ----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 53/239 (22%), Positives = 95/239 (39%), Gaps = 53/239 (22%)
Query: 127 FELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKA 184
+ +++G GHFG C + G+ VAVK + + + D+++E++IL+
Sbjct: 23 LKRIRDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHI--ADLKKEIEILRN 79
Query: 185 LSGHKHMIKFHDA--FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI 242
L H++++K+ + N + ++MEF G L + YL ++ I +
Sbjct: 80 LY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE--------YLPKNKNKI--NLKQQ 128
Query: 243 VAFC----------HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI 292
+ + + VHRDL N L E + +K+ DFGL+ + D+
Sbjct: 129 LKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDK----- 180
Query: 293 VGSAYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTES 337
YY APE L + + D+WS GV + +L
Sbjct: 181 ---EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 6e-19
Identities = 63/340 (18%), Positives = 115/340 (33%), Gaps = 67/340 (19%)
Query: 21 KQPTSQPHPASTPRHPPPDSSSFTCSPFQSPLPAGVAPSPSPGRKFRWPLPPPSPAKPIM 80
+ + S++ + P P R +P +
Sbjct: 241 LKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQR-RIDTLNSDGYTPEPARI 299
Query: 81 SAIKRRLGSGMQAPPKEGPTSGDGGVKATERQLDKNFGYGKNFGAKFELGKEVGRGHFGH 140
++ + M E P S +K + L ++ E+G G+FG
Sbjct: 300 TSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRD--------NLLIADIELGCGNFGS 351
Query: 141 TCCAKGKKGTLKGK----VVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHD 196
+G + + VA+K++ + T E++ RE +I+ L + ++++
Sbjct: 352 VR-----QGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLI- 402
Query: 197 AFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH--------- 247
A ++ +VME GG L ++ + + N+ H
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFLVGKREEI----------PVSNVAELLHQVSMGMKYL 452
Query: 248 -LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------- 299
+ VHR+L N L R K+ DFGLS + D +YY
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHY---AKISDFGLSKALGADD--------SYYTARSAGKW 501
Query: 300 -----APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFW 332
APE + R ++ D+WS GV + L G +P+
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 65/253 (25%), Positives = 104/253 (41%), Gaps = 47/253 (18%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKV--VAVKIISKAKMTSALAIEDVRREVKI 181
+ LGK +G G FG A G +V VAVK++ L D+ E+++
Sbjct: 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--SDLISEMEM 127
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLD--RILSRGGRYLEEDAKTIVEKI 239
+K + HK++I A +Y+++E+ G L + + G + E+
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 240 LN---IVAFC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 286
L+ +V+ +L + +HRDL N L T ED +K+ DFGL+ R
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA---R-- 239
Query: 287 QRLNDIVGSAYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFW 332
DI YY APE L R Y + D+WS GV+ + I G P+
Sbjct: 240 ----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295
Query: 333 ARTESGIFRSVLR 345
+F+ +
Sbjct: 296 GVPVEELFKLLKE 308
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-19
Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 58/232 (25%)
Query: 132 EVGRGHFGHTCCAKGKKGTLKGKV----VAVKIISKAKMTSALAIEDVRREVKILKALSG 187
E+G G+FG +G + + VA+K++ + T E++ RE +I+ L
Sbjct: 17 ELGCGNFGSVR-----QGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD- 68
Query: 188 HKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH 247
+ ++++ A ++ +VME GG L +L + I + N+ H
Sbjct: 69 NPYIVRLI-GVCQAEALMLVMEMAGGGPLHK--------FLVGKREEI--PVSNVAELLH 117
Query: 248 ----------LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY 297
+ VHRDL N L K+ DFGLS + D +Y
Sbjct: 118 QVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADD--------SY 166
Query: 298 YV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWART 335
Y APE + R ++ D+WS GV + L G +P+
Sbjct: 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 7e-19
Identities = 60/239 (25%), Positives = 98/239 (41%), Gaps = 47/239 (19%)
Query: 128 ELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
L +E+G G FG T +VAVK + + A +D +RE ++L L
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELLTNL 74
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLD--RILSRGGRYLEEDAKTIVEKILNIV 243
H+H++KF+ D + + +V E+ + G+L R L + + L +
Sbjct: 75 Q-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 244 AFCHL-------------QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN 290
H+ Q VHRDL N L + +K+ DFG+S R
Sbjct: 134 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS---R------ 181
Query: 291 DIVGSAYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWART 335
D+ + YY PE + +R + E D+WS GVI + I G +P++ +
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 50/236 (21%), Positives = 87/236 (36%), Gaps = 42/236 (17%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
K + +E+G+G FG + AKG VA+K +++A S + E ++K
Sbjct: 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMK 83
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
H+++ ++ME G+L + S + ++
Sbjct: 84 EF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP-SLSKMI 141
Query: 244 AFC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIV 293
+L VHRDL N + ED +K+ DFG++ R DI
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---R------DIY 189
Query: 294 GSAYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWART 335
+ YY +PE L + D+WS GV+ + I +P+ +
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 46/226 (20%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKV--VAVKIISKAKMTSALAIEDVRREVKI 181
K LGK +G G FG A G + VAVK++ + + D+ E+++
Sbjct: 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEM 139
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLD--RILSRGGRYLEEDAKTIVEKI 239
+K + HK++I A +Y+++E+ G L + R G D + E+
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 240 L---NIVAFC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 286
+ ++V+ +L Q +HRDL N L T E+ +K+ DFGL+ R
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R-- 251
Query: 287 QRLNDIVGSAYYV------------APEVL-HRSYNVEGDMWSIGV 319
DI YY APE L R Y + D+WS GV
Sbjct: 252 ----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 293
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 51/231 (22%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
E GK +G G FG A G T VAVK++ + + E + E+K++
Sbjct: 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE--KADSSEREALMSELKMMT 103
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN-- 241
L H++++ A + +Y++ E+C G+LL+ + S+ ++ E++ + +K L
Sbjct: 104 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 242 ----------IVAFC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281
++ F L + VHRDL N L T +K+ DFGL+
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLA- 219
Query: 282 FVRPDQRLNDIVGSAYYV------------APEVL-HRSYNVEGDMWSIGV 319
R DI+ + YV APE L Y ++ D+WS G+
Sbjct: 220 --R------DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 50/243 (20%), Positives = 88/243 (36%), Gaps = 52/243 (21%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG 187
+ +GRGHFG K AVK ++ ++T + E I+K S
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFS- 148
Query: 188 HKHMIKFHDA-FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H +++ S +V+ + + G+L + ++ + K L + F
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--------FIRNETHNPTVKDL--IGFG 198
Query: 247 --------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA 296
L + VHRDL N + E +KV DFGL+ R D+
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---R------DMYDKE 246
Query: 297 YYV--------------APEVLH-RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIF 340
+ A E L + + + D+WS GV+ + ++ G+ P+ I
Sbjct: 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 306
Query: 341 RSV 343
+
Sbjct: 307 VYL 309
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 60/235 (25%), Positives = 91/235 (38%), Gaps = 47/235 (20%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ +++G GHFG C G++VAVK + ++E+ IL+
Sbjct: 32 YLKKIRDLGEGHFGKVSLYCYDPTNDG-TGEMVAVKALKADAGPQHR--SGWKQEIDILR 88
Query: 184 ALSGHKHMIKFHDA--FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN 241
L H+H+IK+ A S+ +VME+ G L D YL + + + +L
Sbjct: 89 TLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD--------YLPRHSIGLAQLLLF 139
Query: 242 IV------AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295
A+ H Q +HRDL N L + D +K+ DFGL+ V
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHE------- 189
Query: 296 AYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTE 336
YY APE L + D+WS GV Y +L T+
Sbjct: 190 -YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK 243
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKIL 182
G ++ LG+++G G FG G+ VA+K+ L E KI
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTD---IAAGEEVAIKLECVKTKHPQL-----HIESKIY 58
Query: 183 KALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKT---IVEKI 239
K + G + + + +VME G L+ + + R KT + +++
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKF--SLKTVLLLADQM 114
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR--------PDQRLND 291
++ + + H + +HRD+KP+NFL ++ + +IDFGL+ R P + +
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174
Query: 292 IVGSAYYVAPEVLHRSYNVEG----DMWSIG-VITYILLCGSRPFW 332
+ G+A Y + ++ +E D+ S+G V+ Y GS P W
Sbjct: 175 LTGTARYAS---INTHLGIEQSRRDDLESLGYVLMY-FNLGSLP-W 215
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 46/238 (19%)
Query: 128 ELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
L E+G G FG +VAVK + +A + A +D +RE ++L L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTML 100
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLD--RILSRGGRYLEEDAKTIVEKI--LN 241
H+H+++F + + +V E+ G+L R + L +
Sbjct: 101 Q-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 242 IVAFC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND 291
++A +L VHRDL N L + +K+ DFG+S R D
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMS---R------D 207
Query: 292 IVGSAYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWART 335
I + YY PE + +R + E D+WS GV+ + I G +P++ +
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 61/232 (26%), Positives = 89/232 (38%), Gaps = 53/232 (22%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
LGK +G G FG A KG VAVK++ + S + D+ E +LK
Sbjct: 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE--NASPSELRDLLSEFNVLK 81
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLD----------RILSRGGRYLEEDAK 233
+ H H+IK + A + +++E+ + G L L GG
Sbjct: 82 QV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 234 TIVEKIL---NIVAFC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280
E+ L ++++F +L +VHRDL N L E +K+ DFGLS
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGLS 197
Query: 281 DFVRPDQRLNDIVGSAYYV------------APEVL-HRSYNVEGDMWSIGV 319
R D+ YV A E L Y + D+WS GV
Sbjct: 198 ---R------DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 50/227 (22%), Positives = 95/227 (41%), Gaps = 33/227 (14%)
Query: 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKIL 182
G +++G+ +G G FG + VA+K + L R E +
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLN---NQQVAIKFEPRRSDAPQL-----RDEYRTY 59
Query: 183 KALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIV---EKI 239
K L+G + + ++ +V++ G L+ +L GR KT+ +++
Sbjct: 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKF--SVKTVAMAAKQM 115
Query: 240 LNIVAFCHLQGVVHRDLKPENFLF--TTREEDAPLKVIDFGLS-DFVRPDQRL------- 289
L V H + +V+RD+KP+NFL + + V+DFG+ + P +
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 290 NDIVGSAYYVAPEVLHRSYNVEG----DMWSIGVITYILLCGSRPFW 332
++ G+A Y++ ++ E D+ ++G + L GS P W
Sbjct: 176 KNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 27/222 (12%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
G KF LG+++G G FG + VA+K+ + L E KI +
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTN---IQTNEEVAIKLENVKTKHPQL-----LYESKIYR 57
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
L G + + + +VM+ G L D + + + ++++N V
Sbjct: 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR--------PDQRLNDIVGS 295
F H + +HRD+KP+NFL + +IDFGL+ R P + ++ G+
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
Query: 296 AYYVAPEVLHRSYNVEG----DMWSIG-VITYILLCGSRPFW 332
A Y + ++ +E D+ S+G V+ Y L GS P W
Sbjct: 177 ARYAS---VNTHLGIEQSRRDDLESLGYVLMY-FLRGSLP-W 213
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 51/249 (20%), Positives = 93/249 (37%), Gaps = 54/249 (21%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
E +++G G FG A G +VAVK++ + SA D +RE ++
Sbjct: 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--EASADMQADFQREAALMA 105
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL--- 240
+ +++K + ++ E+ G+L + + S + + + +
Sbjct: 106 EFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 241 ----------NIVAFC--------HL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280
+ +L + VHRDL N L E+ +K+ DFGLS
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS 221
Query: 281 DFVRPDQRLNDIVGSAYYV------------APEVL-HRSYNVEGDMWSIGVITY-ILLC 326
R +I + YY PE + + Y E D+W+ GV+ + I
Sbjct: 222 ---R------NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 327 GSRPFWART 335
G +P++
Sbjct: 273 GLQPYYGMA 281
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 48/241 (19%), Positives = 89/241 (36%), Gaps = 46/241 (19%)
Query: 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKIL 182
G ++ LGK++G G FG A K VK+ + + L E+K
Sbjct: 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV--EYQENGPL-----FSELKFY 87
Query: 183 KALSGHKHMIKFHD------------------AFEDANSVYIVMEFCEGGELLDRILSRG 224
+ ++ + K+ + F+ + ++VME G L +I +
Sbjct: 88 QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQN 145
Query: 225 GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284
G + + + ++L+++ + H VH D+K N L + D + + D+GLS
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ-VYLADYGLSYRYC 204
Query: 285 PDQRLNDI--------VGSAYYVAPEVLHRSYNVE----GDMWSIG-VITYILLCGSRPF 331
P+ G+ + H+ V D+ +G + LCG P
Sbjct: 205 PNGNHKQYQENPRKGHNGTIEF-TSLDAHK--GVALSRRSDVEILGYCMLR-WLCGKLP- 259
Query: 332 W 332
W
Sbjct: 260 W 260
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 44/276 (15%), Positives = 86/276 (31%), Gaps = 54/276 (19%)
Query: 94 PPKEGPTSGDGGVKAT-ERQLDKNFGYGKNFGAKFELGKEVGRGHFG--HTCCAKGKKGT 150
K K Q A +++G +G+G FG + +
Sbjct: 3 RVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESV 62
Query: 151 LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFH--------------- 195
VK+ + E+K + + + + K+
Sbjct: 63 GSDAPCVVKVEPSDNGP-------LFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115
Query: 196 ---DAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKT---IVEKILNIVAFCHLQ 249
+ +++M+ G L +I + KT + +IL+I+ + H
Sbjct: 116 SGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSR--KTVLQLSLRILDILEYIHEH 171
Query: 250 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI--------VGSAYYVAP 301
VH D+K N L + D + ++D+GL+ P+ G+ + +
Sbjct: 172 EYVHGDIKASNLLLNYKNPDQ-VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTS- 229
Query: 302 EVLHRSYNVE----GDMWSIG-VITYILLCGSRPFW 332
+ V GD+ +G + L G P W
Sbjct: 230 --IDAHNGVAPSRRGDLEILGYCMIQ-WLTGHLP-W 261
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 6e-12
Identities = 49/326 (15%), Positives = 96/326 (29%), Gaps = 74/326 (22%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKII-----SKAKMTSALAIEDVRREVK 180
K + +++G G FG + VA+KII + E++ E+
Sbjct: 21 KLQRCEKIGEGVFGEVF-----QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 181 ILKALSG--------HKHMIKFHDAF------------------------------EDAN 202
I K LS + I + +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENF 261
++IV+EF GG L+++ ++ AK+I+ ++ +A HRDL N
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSS--LATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 262 LFTTRE--------EDAPLKVIDFGLS----DFVRP-DQRLNDIVGSAYYVAPEVLHRSY 308
L + GL D+ +R +V + ++
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG 253
Query: 309 NVEGDMWSI-GVITYILLCGSRP----FWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363
+ + D++ + P W + + + + + +
Sbjct: 254 DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQ 313
Query: 364 DFVRRLLNKDHRKRMTAAQALTHPWL 389
+F R +LN +A L L
Sbjct: 314 EFHRTMLNFS-----SATDLLCQHSL 334
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 33/238 (13%), Positives = 74/238 (31%), Gaps = 39/238 (16%)
Query: 124 GAKFELGKEVGRGHFG-----HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRR- 177
G +++L R + G + + ++K+ +K R
Sbjct: 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100
Query: 178 ---EVKILKALSGHKHM----IKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEE 230
+V K L + +D ++V+ G L + L E
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSL-GRSLQSALDVSPKHVLSE 158
Query: 231 DAKT---IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-- 285
++ + ++L+ + F H VH ++ EN ++ + + +G + P
Sbjct: 159 --RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ-VTLAGYGFAFRYCPSG 215
Query: 286 ------DQRLNDIVGSAYYVAPEVLHRSYNVE----GDMWSIG-VITYILLCGSRPFW 332
+ + G +++ + D+ S+G + L G P W
Sbjct: 216 KHVAYVEGSRSPHEGDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLK-WLYGFLP-W 268
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 3e-11
Identities = 51/318 (16%), Positives = 109/318 (34%), Gaps = 81/318 (25%)
Query: 172 IEDVRREVKILKALSGH--KHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLE 229
++D+ + + LS H+I DA ++ + + E++ + + L
Sbjct: 38 VQDMPKSI-----LSKEEIDHIIMSKDAVSGTLRLFWTLL-SKQEEMVQKFV---EEVLR 88
Query: 230 EDAKTIVEKI--------LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281
+ K ++ I + + + ++ D + +R + P + L +
Sbjct: 89 INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQ--PYLKLRQALLE 146
Query: 282 FVRPDQRLNDIV----GSAYYV-APEVLHRSYNVEGDMWSIGVITYILLCGSRPFWA--- 333
+RP + + ++ GS A +V SY V+ M + FW
Sbjct: 147 -LRPAKNV--LIDGVLGSGKTWVALDVC-LSYKVQCKM-DFKI-----------FWLNLK 190
Query: 334 --RTESGIFRSV----LRADPNFHDSPWPSVSP-----EAKDFVRRLL-NKDHRKRMTAA 381
+ + + + DPN+ S + + +RRLL +K +
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN----- 245
Query: 382 QALT------HPWLHDENRPVPLD----ILI---YKLVKSYLRATPLKRAALKALSKALT 428
L + + + IL+ +K V +L A +L S LT
Sbjct: 246 -CLLVLLNVQNAKAWN-----AFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 429 EEELVYLRAQFMLLEPKD 446
+E+ L +++ P+D
Sbjct: 300 PDEVKSLLLKYLDCRPQD 317
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 3e-05
Identities = 53/397 (13%), Positives = 97/397 (24%), Gaps = 152/397 (38%)
Query: 146 GKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKF------HDAFE 199
G G+ GK + +A++ V K+ + + E
Sbjct: 157 GVLGS--GK-------------TWVALD-VCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 200 DANSVY--IVMEFCEGGELLDRILSRGG-------RYLEE--------------DAKTIV 236
+ I + + I R R L+ +AK
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK-AW 259
Query: 237 E------KIL------NIVAFCHLQGVVHRDLKPENFLFTTRE-------------ED-- 269
KIL + F H L + T E +D
Sbjct: 260 NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP 319
Query: 270 ------APLKVIDFG--LSDFV-RPDQ-------RLNDIVGSAY-YVAPEVLHRSYNVEG 312
P ++ + D + D +L I+ S+ + P + +
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF---- 375
Query: 313 DMWSI---GV-ITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 368
D S+ I ILL ++ W V V
Sbjct: 376 DRLSVFPPSAHIPTILLS----------------LI----------WFDVIKS---DVMV 406
Query: 369 LLNKDHRKRMTAAQALTHPW-LHD---------ENRPVPLDILI--YKLVKSYLRATPLK 416
++NK H+ + Q + EN ++ Y + K++ +
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIP 466
Query: 417 RAA-----------LKALSKALTEEEL--VYLRAQFM 440
LK + V+L +F+
Sbjct: 467 PYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL 503
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 62/286 (21%), Positives = 99/286 (34%), Gaps = 85/286 (29%)
Query: 121 KNFGAKFELGKE--VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDV--- 175
NF + +G G FG KG + VAVK K+ + + I
Sbjct: 25 NNFDERPISVGGNKMGEGGFGVV-----YKGYVNNTTVAVK-----KLAAMVDITTEELK 74
Query: 176 ---RREVKILKALSGHKHMIKFHDAF--EDANS--VYIVMEFCEGGELLDRILSRGG--- 225
+E+K++ H+++++ F + + VY + G LLDR+ G
Sbjct: 75 QQFDQEIKVMAKCQ-HENLVELL-GFSSDGDDLCLVY---VYMPNGSLLDRLSCLDGTPP 129
Query: 226 -----RYLEEDAKTIVEKI-LNI---VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276
R KI + F H +HRD+K N L +E K+ D
Sbjct: 130 LSWHMRC----------KIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISD 176
Query: 277 FGLSDFVRPDQRLND----------IVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLC 326
FGL+ R ++ IVG+ Y+APE L + D++S GV+ ++
Sbjct: 177 FGLA-------RASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229
Query: 327 GSRPF-----------WAR---TESGIFRSVLRADPNFHDSPWPSV 358
G E D +D+ SV
Sbjct: 230 GLPAVDEHREPQLLLDIKEEIEDEEKTIEDY--IDKKMNDADSTSV 273
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 8e-09
Identities = 59/255 (23%), Positives = 103/255 (40%), Gaps = 47/255 (18%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLK-GKVVAVKIISKAKMTSALAIEDVRREV 179
NF KF +G G FG K KG L+ G VA+K + S+ IE+ E+
Sbjct: 39 NNFDHKFLIGH----GVFG-----KVYKGVLRDGAKVALK---RRTPESSQGIEEFETEI 86
Query: 180 KILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKI 239
+ L H H++ ++ N + ++ ++ E G L + + + +E
Sbjct: 87 ETLSFCR-HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 240 LNI---VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQ-----RLN 290
+ + + H + ++HRD+K N L +E+ K+ DFG+S DQ
Sbjct: 146 IGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTV-- 200
Query: 291 DIVGSAYYVAPEVLHRSY-NVEGDMWSIGVITYILLCGSRPF-------------WART- 335
+ G+ Y+ PE + + D++S GV+ + +LC WA
Sbjct: 201 -VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 336 -ESGIFRSVLRADPN 349
+G + DPN
Sbjct: 260 HNNGQLEQI--VDPN 272
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 40/188 (21%), Positives = 74/188 (39%), Gaps = 20/188 (10%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ +LGK +GRG FG A G T + VAVK++ K T + + E+KIL
Sbjct: 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHS-EHRALMSELKILI 80
Query: 184 ALSGHKHMIKFHDA-FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI 242
+ H +++ A + + +++EFC+ G L + S+ ++ K
Sbjct: 81 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP-----YKTKGARF 135
Query: 243 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR----------LNDI 292
G + DLK T+ + A ++ V ++ L +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 293 VGSAYYVA 300
+ ++ VA
Sbjct: 196 ICYSFQVA 203
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 30/96 (31%), Positives = 43/96 (44%), Gaps = 26/96 (27%)
Query: 249 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV--------- 299
+ +HRDL N L + E +K+ DFGL+ R DI YV
Sbjct: 212 RKCIHRDLAARNILLS---EKNVVKICDFGLA---R------DIYKDPDYVRKGDARLPL 259
Query: 300 ---APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRP 330
APE + R Y ++ D+WS GV+ + I G+ P
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 12/77 (15%), Positives = 32/77 (41%), Gaps = 3/77 (3%)
Query: 384 LTHPWLHDENRP--VPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFML 441
+ H H R I + + K+Y ++ A+ +++ + ++ L++ F++
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60
Query: 442 LEP-KDGCVSLNNFKVV 457
L+ G ++ K
Sbjct: 61 LDEDGKGYITKEQLKKG 77
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 4/80 (5%)
Query: 382 QALTHPWLHD---ENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQ 438
H + V L + K +K++ + LK+ AL ++K L + E+ LR
Sbjct: 3 HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNI 62
Query: 439 FMLLEP-KDGCVSLNNFKVV 457
F+ L+ G +S
Sbjct: 63 FIALDVDNSGTLSSQEILDG 82
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 50/231 (21%), Positives = 90/231 (38%), Gaps = 65/231 (28%)
Query: 133 VGRGHFGHTCCAKGKKGTLK-GKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHM 191
+GRG FG KG L G +VAVK + K + T ++ + EV+++ H+++
Sbjct: 38 LGRGGFGKV-----YKGRLADGTLVAVKRL-KEERTQGGELQ-FQTEVEMISMAV-HRNL 89
Query: 192 IKFHDAFEDANSVYIVMEFCEGGELLDRIL---------------------SRGGRYLEE 230
++ +V + G + + +RG YL +
Sbjct: 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD 149
Query: 231 DAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN 290
C + ++HRD+K N L +E+ V DFGL+ +L
Sbjct: 150 H--------------CDPK-IIHRDVKAANILL---DEEFEAVVGDFGLA-------KLM 184
Query: 291 D---------IVGSAYYVAPE-VLHRSYNVEGDMWSIGVITYILLCGSRPF 331
D + G+ ++APE + + + D++ GV+ L+ G R F
Sbjct: 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 40/154 (25%), Positives = 58/154 (37%), Gaps = 22/154 (14%)
Query: 130 GKE----VGRGHFGHTCCAKGKK-GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKA 184
GKE C K K G K V K S LAI R E + L+
Sbjct: 101 GKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA 244
L G + K + +A ++ME + EL E+ +++ IL VA
Sbjct: 161 LQGL-AVPKVYAWEGNA----VLMELIDAKELYR--------VRVENPDEVLDMILEEVA 207
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278
+ +G+VH DL N L + + +IDF
Sbjct: 208 KFYHRGIVHGDLSQYNVLVSEE----GIWIIDFP 237
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 27/83 (32%), Positives = 34/83 (40%), Gaps = 14/83 (16%)
Query: 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 259
D ++ I+M + G D I ED I KI IV H V+H DL
Sbjct: 410 DLDNKRIMMSYINGKLAKDVI---------EDNLDIAYKIGEIVGKLHKNDVIHNDLTTS 460
Query: 260 NFLFTTREEDAPLKVIDFGLSDF 282
NF+F L +IDFGL
Sbjct: 461 NFIFDKD-----LYIIDFGLGKI 478
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 31/171 (18%), Positives = 57/171 (33%), Gaps = 26/171 (15%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKI-----ISKAKMTSALAIEDV------- 175
+G + G + A G K +AVKI KM L ++
Sbjct: 50 AMGGVISTGKEANVFYADGVFDG-KPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 176 RREVKILKALSGHKHMIKFHDA------FEDANSVYIVMEFCEGGEL-LDRILSRGGRYL 228
+E + +++ + +A ++MEF EL ++ G
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 229 EEDAKTIVEKILN-IVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278
E D + I ++ + +VH DL N ++ + + ID G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK-----VYFIDMG 214
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} Length = 346 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 20/127 (15%), Positives = 40/127 (31%), Gaps = 19/127 (14%)
Query: 172 IEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED 231
V K+ + + + K + ++ F ++ + ED
Sbjct: 146 PNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPF-------SQLYLQEIDGFIED 198
Query: 232 AKTIVEKILNIVAFCHLQ------GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285
I +++L + + H+D N L E+ + VID D V
Sbjct: 199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLG---ENEQIWVIDL---DTVSF 252
Query: 286 DQRLNDI 292
D + D+
Sbjct: 253 DLPIRDL 259
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 461 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.26 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.23 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.98 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.8 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.69 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.53 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.52 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.38 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.26 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 98.18 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 98.09 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.98 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.92 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.86 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.69 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.58 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.55 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.52 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.47 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.42 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 97.38 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.22 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 97.06 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.93 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.92 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.7 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.49 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 95.97 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 95.85 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 95.68 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 95.65 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 95.42 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 95.07 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 95.03 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 94.91 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 94.83 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 94.65 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.44 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 93.84 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 93.79 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 93.76 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 92.67 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 92.53 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 91.5 | |
| 1psr_A | 100 | Psoriasin, S100A7; EF-hand protein, MAD phasing, p | 91.48 | |
| 1wy9_A | 147 | Allograft inflammatory factor 1; EF-hand, calucium | 91.44 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 91.19 | |
| 2d58_A | 107 | Allograft inflammatory factor 1; EF-hand, metal bi | 91.0 | |
| 3fia_A | 121 | Intersectin-1; EH 1 domain, NESG, structural genom | 91.0 | |
| 1yx7_A | 83 | Calsensin, LAN3-6 antigen; calcium-binding protein | 90.79 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 90.58 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 90.24 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 90.11 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 90.02 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 89.87 | |
| 1wlz_A | 105 | DJBP, CAP-binding protein complex interacting prot | 89.55 | |
| 2kax_A | 92 | Protein S100-A5; EF-hand, calcium binding protien, | 88.94 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 88.89 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 88.34 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 88.17 | |
| 1c7v_A | 81 | CAVP, calcium vector protein; EF-hand family, calc | 88.09 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 88.09 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 88.02 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 87.97 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 87.68 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 87.64 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 87.55 | |
| 1a4p_A | 96 | S100A10; S100 family, EF-hand protein, ligand of a | 87.37 | |
| 2wcb_A | 95 | Protein S100-A12; calcium signalling, HOST-parasit | 87.15 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 86.98 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 86.93 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 86.83 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 86.68 | |
| 1k2h_A | 93 | S100A1, S-100 protein, alpha chain; non-covalent h | 86.64 | |
| 1k8u_A | 90 | S100A6, calcyclin, CACY; calcium regulatory protei | 86.5 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 86.18 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 86.11 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 86.03 | |
| 2jq6_A | 139 | EH domain-containing protein 1; metal binding prot | 85.72 | |
| 1qx2_A | 76 | Vitamin D-dependent calcium-binding protein, INTE; | 85.72 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 85.64 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 85.44 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 85.44 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.37 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 84.82 | |
| 1qls_A | 99 | S100C protein, calgizzarin; metal-binding protein/ | 84.81 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 84.76 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 84.42 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 83.44 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 83.43 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 83.4 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 83.03 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 82.96 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 82.76 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 82.65 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 82.48 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 82.46 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 82.29 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 81.7 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 81.69 | |
| 1xk4_A | 93 | Calgranulin A; S100 family, heterotetramer, metal | 81.47 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 81.4 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 80.55 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 80.37 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-67 Score=508.37 Aligned_cols=257 Identities=32% Similarity=0.602 Sum_probs=232.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++.+.........+.+.+|+++|++|+ |||||+++++|++++.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEecccCeEEEEEEECC---CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEE
Confidence 479999999999999999999887 89999999998765444445678999999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|||||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+.+.
T Consensus 108 yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~---~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLS 183 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc---CCCCEEEEEcCCceecC
Confidence 9999999999999998665 6799999999999999999999999999999999999994 57789999999999875
Q ss_pred CC---CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 285 PD---QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 285 ~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
.. ....+.+||+.|||||++. ..|+.++|||||||+||||+||+.||.+.+..+++..|.+....++. .+|+
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~ 259 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFP 259 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCH
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCH
Confidence 43 2356789999999999997 46999999999999999999999999999999999999988776653 5899
Q ss_pred HHHHHHHHhcccCcCCCCCHHH------HhcCCCcCCCC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQ------ALTHPWLHDEN 393 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e------~L~hp~~~~~~ 393 (461)
++++||.+||++||.+|+|++| +++||||++.+
T Consensus 260 ~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 9999999999999999999987 68999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-66 Score=493.43 Aligned_cols=254 Identities=32% Similarity=0.598 Sum_probs=212.1
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++.+.........+.+.+|+++|++|+ |||||+++++|++.+.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT---TCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 479999999999999999999876 89999999998876666666778999999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
||||||| +|+|.+++.++ +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 89 ~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTCCEEECCSSCC----
T ss_pred EEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC---CCCCEEEeecCCCeecC
Confidence 9999999 68999988655 6899999999999999999999999999999999999994 56789999999999877
Q ss_pred CCCCccccccCCCcCchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLHR-S-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
......+.+||+.|||||++.+ . ++.++|||||||+||+|+||+.||.+.+...+++.+......++ ..+|+++
T Consensus 164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 239 (275)
T 3hyh_A 164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGA 239 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHH
T ss_pred CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHH
Confidence 6666678899999999999975 3 46899999999999999999999999999999999988776554 3589999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
++||.+||++||++|||++|+|+||||+.
T Consensus 240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 240 AGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 99999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-66 Score=518.73 Aligned_cols=260 Identities=31% Similarity=0.540 Sum_probs=230.6
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
....|+++++||+|+||+||+|+++. +|+.||||++....... .+.+.+|+.+|+.|+ |||||+++++|.+.+
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQ-HENVVEMYNSYLVGD 221 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECC---CCCEEEEEEEeccchhH---HHHHHHHHHHHHhCC-CCCCCceEEEEEECC
Confidence 34679999999999999999999987 89999999997654332 356789999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|||||||+||+|.+++.. +++++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+.
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~---~~g~vKl~DFGla~~ 296 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQ 296 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC---TTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEecCccceE
Confidence 99999999999999998754 4699999999999999999999999999999999999995 567899999999987
Q ss_pred cCCC-CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 283 VRPD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 283 ~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
+... ....+.+||+.|||||++. ..|+.++|||||||+||||++|+.||.+.+..+++..|..... .....|..+|+
T Consensus 297 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~ 375 (423)
T 4fie_A 297 VSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSP 375 (423)
T ss_dssp CCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCH
T ss_pred CCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCH
Confidence 7544 4556789999999999997 4699999999999999999999999999999888888876533 23344568999
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~ 395 (461)
++++||.+||++||++|+|++|+|+||||+....+
T Consensus 376 ~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 376 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 99999999999999999999999999999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-65 Score=504.03 Aligned_cols=259 Identities=31% Similarity=0.547 Sum_probs=229.7
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
...|+++++||+|+||+||+|+++. +|+.||||++....... .+.+.+|+++|++|+ |||||+++++|.+++.
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~ 145 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQ-HENVVEMYNSYLVGDE 145 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECC---CCCEEEEEEEecCchhH---HHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 3579999999999999999999987 89999999997654333 356789999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|||||||+||+|.+++.. +++++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+.+
T Consensus 146 ~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQV 220 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC---CCCCEEEecCcCceec
Confidence 9999999999999998754 4699999999999999999999999999999999999995 5778999999999877
Q ss_pred CCC-CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 RPD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
... ....+.+||+.|||||++. ..|+.++|||||||+||||++|+.||.+.+..+++..|..... .....|..+|++
T Consensus 221 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~ 299 (346)
T 4fih_A 221 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPS 299 (346)
T ss_dssp CSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHH
T ss_pred CCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHH
Confidence 544 3456789999999999997 4699999999999999999999999999999888888876532 223345679999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~ 395 (461)
+++||.+||++||++|||++|+|+||||+....+
T Consensus 300 ~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 300 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 9999999999999999999999999999876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-66 Score=506.08 Aligned_cols=257 Identities=25% Similarity=0.516 Sum_probs=224.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|+++++||+|+||+||+|+++. +|+.||||++.+... .....+.+.+|+++|++|+ |||||+++++|++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTE---DGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETT---TCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEE
Confidence 589999999999999999999886 899999999987654 3455788999999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
|||||||+||+|.++|..+. ..+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+..
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVL 175 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC---TTCCEEECSTTEESCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCCEEEcccccceee
Confidence 99999999999999997654 4579999999999999999999999999999999999995 5678999999999876
Q ss_pred CCCC-CccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 RPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
.... ...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+.+..+++..|...... ..+..+|++
T Consensus 176 ~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~~~~~~s~~ 252 (350)
T 4b9d_A 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---PVSLHYSYD 252 (350)
T ss_dssp CHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCCTTSCHH
T ss_pred cCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---CCCccCCHH
Confidence 5432 2356789999999999974 6999999999999999999999999999999999999887543 234578999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+++||.+||++||++|||++|+|+||||+..
T Consensus 253 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999999999999999764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-65 Score=493.15 Aligned_cols=258 Identities=29% Similarity=0.539 Sum_probs=222.9
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|++..+..+++.||||++++...... ....+.+|+++|++|+ |||||+++++|++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 589999999999999999999876556889999999976543221 2235778999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|||||||+||+|.+++.+. +.+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+...
T Consensus 102 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTSCEEEESSEEEEC--
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc---CCCCEEecccccceecc
Confidence 9999999999999988665 6799999999999999999999999999999999999994 57789999999998654
Q ss_pred CC-CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.. ....+.+||+.|||||++. +.|+.++|||||||+||||+||+.||.+.+..+++..|.+....++ ..+|+++
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 253 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEA 253 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHH
Confidence 33 3456789999999999987 5699999999999999999999999999999999999998776554 3589999
Q ss_pred HHHHHHhcccCcCCCCC-----HHHHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 392 (461)
++||.+||++||++|+| ++|+++||||++.
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 99999999999999998 5899999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-64 Score=483.11 Aligned_cols=255 Identities=22% Similarity=0.386 Sum_probs=217.3
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe----CC
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED----AN 202 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~----~~ 202 (461)
|++.++||+|+||+||+|.++. +|+.||||++..... .....+.+.+|+++|++|+ |||||+++++|++ .+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEE
T ss_pred EEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCc
Confidence 4788899999999999999876 889999999976554 3445678999999999996 9999999999975 35
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~g--ivHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+|||||||+||+|.+++.+. +.+++..++.|+.||+.||.|||++| ||||||||+||||+. .++.+||+|||+|
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~--~~g~vKl~DFGla 179 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS--TTSCEEECCTTGG
T ss_pred EEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC--CCCCEEEEeCcCC
Confidence 689999999999999988654 67999999999999999999999998 999999999999952 4578999999999
Q ss_pred cccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChh-hHHHHHHhcCCCCCCCCCCCCC
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTES-GIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s 359 (461)
+... .....+.+||+.|||||++.+.|+.++|||||||+||||+||+.||.+.... .++..+..... +......++
T Consensus 180 ~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~ 256 (290)
T 3fpq_A 180 TLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAI 256 (290)
T ss_dssp GGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred EeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCC
Confidence 8644 3445678999999999999888999999999999999999999999775544 44444444322 122234578
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+++++||.+||++||++|||++|+|+||||++.
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999763
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-63 Score=483.99 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=221.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
+.|++.++||+|+||+||+|+++. +|+.||||+++..... .+|+.+|+.|+ |||||+++++|.+.+.+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~---~g~~vAiK~i~~~~~~--------~~E~~il~~l~-HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVRLEVFR--------VEELVACAGLS-SPRIVPLYGAVREGPWV 125 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCC--------THHHHTTTTCC-CTTBCCEEEEEEETTEE
T ss_pred hheEeCcEeccCCCeEEEEEEECC---CCCEEEEEEECHHHhH--------HHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence 479999999999999999999886 8999999999875432 36999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCC-CeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA-PLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~-~~kl~DFG~a~~~ 283 (461)
|||||||+||+|.++|... +.+++..++.|+.||+.||.|||++|||||||||+||||+ .++ .+||+|||+|+..
T Consensus 126 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCL 201 (336)
T ss_dssp EEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC
T ss_pred EEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEc
Confidence 9999999999999988655 6799999999999999999999999999999999999995 344 5999999999876
Q ss_pred CCCCC------ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 284 RPDQR------LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 284 ~~~~~------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
..... ....+||+.|||||++. ..|+.++|||||||+||||+||+.||.+.+...++..|....+.+. ..++
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~ 280 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPP 280 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCT
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCc
Confidence 54321 23468999999999987 4699999999999999999999999999888888888887654432 2346
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHH-------------hcCCCcCCCCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQA-------------LTHPWLHDENRP 395 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~-------------L~hp~~~~~~~~ 395 (461)
.+++++++||.+||++||.+|||+.|+ |+|||+.+...+
T Consensus 281 ~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 799999999999999999999999997 689999876544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=486.89 Aligned_cols=261 Identities=28% Similarity=0.461 Sum_probs=223.6
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED-- 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~-- 200 (461)
++++|++++.||+|+||+||+|+++. +|+.||||++++.. ......+.+.+|+++|+.|+ |||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~---t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRL---TGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTV 126 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSS
T ss_pred CCCCeEEEEEEecccCeEEEEEEECC---CCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccc
Confidence 45789999999999999999999886 89999999997654 33445677889999999996 9999999999763
Q ss_pred ----CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 201 ----ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 201 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
.+.+|||||||. |+|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+|||++ .++.+||+|
T Consensus 127 ~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~---~~~~~Ki~D 201 (398)
T 4b99_A 127 PYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN---ENCELKIGD 201 (398)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEECC
T ss_pred ccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC---CCCCEEEee
Confidence 467999999995 689888754 46899999999999999999999999999999999999995 577899999
Q ss_pred cccccccCCC-----CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC
Q 012518 277 FGLSDFVRPD-----QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN 349 (461)
Q Consensus 277 FG~a~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~ 349 (461)
||+|+.+... ....+.+||++|||||++.+ .|+.++||||+|||+|||++|+.||.+.+..+++..|......
T Consensus 202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~ 281 (398)
T 4b99_A 202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 281 (398)
T ss_dssp CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999866432 23456899999999999864 4799999999999999999999999999999988888765433
Q ss_pred CCCC---------------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 350 FHDS---------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 350 ~~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.... .++.++++++|||.+||++||.+|+|++|+|+||||+...
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 2211 1246799999999999999999999999999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-60 Score=495.56 Aligned_cols=335 Identities=34% Similarity=0.579 Sum_probs=293.3
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH----------HHHHHHHHHHHHHHhcCCCCC
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA----------LAIEDVRREVKILKALSGHKH 190 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~~hpn 190 (461)
..+.++|++++.||+|+||+||+|+++. +|+.||||++.+...... ...+.+.+|+.+|++|+ |||
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn 107 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKN---GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPN 107 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTT
T ss_pred CCcccceEEEeEecccCCeEEEEEEECC---CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCC
Confidence 3466799999999999999999999876 789999999976543221 23567889999999996 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCC
Q 012518 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 270 (461)
Q Consensus 191 iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~ 270 (461)
|++++++|.+.+.+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++...
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999999999988765 5799999999999999999999999999999999999997655555
Q ss_pred CeeEeecccccccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC
Q 012518 271 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 271 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
.+||+|||++............+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+.+..+++..+......+
T Consensus 187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 79999999999887666677788999999999998889999999999999999999999999999999999999888777
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCC-c----hHHHHHHHHHHhhcCHHHHHHHHHHHH
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP-L----DILIYKLVKSYLRATPLKRAALKALSK 425 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (461)
....|..+++++++||.+||+.||.+|||+.|+|+||||+....... . .......++++.....++++++..++.
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~ 346 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGS 346 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHH
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhc
Confidence 77777889999999999999999999999999999999987643322 1 123456678888999999999999988
Q ss_pred hc-CHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 426 AL-TEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 426 ~l-~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.+ ++++...+++.|..+|. +||.|+.+||..++..
T Consensus 347 ~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~ 383 (504)
T 3q5i_A 347 KLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNV 383 (504)
T ss_dssp HTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred cCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHH
Confidence 77 89999999999999999 9999999999988764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-61 Score=498.27 Aligned_cols=334 Identities=35% Similarity=0.602 Sum_probs=298.7
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..+.++|++.+.||+|+||+||+|+++. +|+.||||++.+.........+.+.+|+.+|+++. ||||++++++|.+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 97 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFED 97 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECC---CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence 4566799999999999999999999876 88999999997765444445678899999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+.+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999999999999988654 67999999999999999999999999999999999999976666788999999999
Q ss_pred cccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
............+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+.+..+++..+......+....|..+++
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 177 THFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp HHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred EEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 98876666677889999999999998999999999999999999999999999999999999999888888888889999
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC-----CCCchHHHHHHHHHHhhcCHHHHHHHHHHHHhc-CHHHHHH
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR-----PVPLDILIYKLVKSYLRATPLKRAALKALSKAL-TEEELVY 434 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~e~~~ 434 (461)
++++||.+||+.||.+|||+.|+|+||||+.... ..+........++++.....++++++..++..+ ++++...
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~ 336 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKE 336 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHH
Confidence 9999999999999999999999999999975432 233334556678899999999999999998876 7889999
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
+++.|..+|. +||.|+.+||..++.
T Consensus 337 l~~~F~~~D~d~dG~I~~~El~~~l~ 362 (484)
T 3nyv_A 337 LTAIFHKMDKNGDGQLDRAELIEGYK 362 (484)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred HHHHHHHhCcCCCceEeHHHHHHHHH
Confidence 9999999999 999999999966553
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-61 Score=477.09 Aligned_cols=260 Identities=25% Similarity=0.447 Sum_probs=214.5
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+.++|++.++||+|+||+||+|+++....+++.||||++.+.. ...++.+|+++|+.+.+|||||+++++|.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 45678999999999999999999987544478899999986542 1346789999999997799999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+++|||||||+||+|.+++ +.+++.+++.++.||+.||.|||++|||||||||+|||++. +.+.+||+|||+|+
T Consensus 93 ~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~--~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR--RLKKYALVDFGLAQ 166 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCE
T ss_pred CEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC--CCCeEEECcCCCCc
Confidence 9999999999999999987 35999999999999999999999999999999999999963 34679999999997
Q ss_pred ccCCC-----------------------------CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCC
Q 012518 282 FVRPD-----------------------------QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRP 330 (461)
Q Consensus 282 ~~~~~-----------------------------~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~P 330 (461)
..... ....+.+||++|||||++.+ .|+.++||||+|||+|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 54322 12345689999999999864 489999999999999999999999
Q ss_pred CCCC-ChhhHHHHHHhcC--------------------------------------------------CCCCCCCCCCCC
Q 012518 331 FWAR-TESGIFRSVLRAD--------------------------------------------------PNFHDSPWPSVS 359 (461)
Q Consensus 331 f~~~-~~~~~~~~i~~~~--------------------------------------------------~~~~~~~~~~~s 359 (461)
|... ++.+.+..|.... .......|..+|
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 9654 4444444433210 001123467799
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
++++|||.+||++||++|+|++|+|+||||++.
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-60 Score=494.31 Aligned_cols=332 Identities=35% Similarity=0.628 Sum_probs=293.5
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+.++|++++.||+|+||+||+|+++. +|+.||||++.+..... .....+.+|+.+|++++ ||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKN-KDTSTILREVELLKKLD-HPNIMKLFEILEDS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETT---TCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECC---CCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcC
Confidence 356799999999999999999999876 78999999997543222 23467889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+.+|+|||||.||+|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999999999988765 579999999999999999999999999999999999999876677889999999998
Q ss_pred ccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
...........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+.+..+++..+......+....|..+|++
T Consensus 173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp TBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred ECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 87766666778899999999999988999999999999999999999999999999999999998888887888889999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCC------chHHHHHHHHHHhhcCHHHHHHHHHHHHhc-CHHHHHH
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP------LDILIYKLVKSYLRATPLKRAALKALSKAL-TEEELVY 434 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~e~~~ 434 (461)
+++||.+||+.||.+|||+.|+|+||||+......+ ........++++.....++++++..++..+ +++++..
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~ 332 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQ 332 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHH
Confidence 999999999999999999999999999987643321 112345668899999999999999998877 8899999
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
+++.|..+|. +||.|+.+||..++.
T Consensus 333 l~~~F~~~D~d~dG~I~~~El~~~l~ 358 (486)
T 3mwu_A 333 LTEIFRKLDTNNDGMLDRDELVRGYH 358 (486)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHhCCCCCceeeHHHHHHHHH
Confidence 9999999999 899999999977664
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=496.23 Aligned_cols=333 Identities=34% Similarity=0.606 Sum_probs=292.1
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+.++|++++.||+|+||+||+|+++. +|+.||||++.+..... .....+.+|+.+|+.+. ||||++++++|.+.
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 108 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKV---THVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDK 108 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETT---TCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECC---CCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence 455689999999999999999999876 78999999997654322 22467889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+.+|+|||||.||+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999999999988765 579999999999999999999999999999999999999866667789999999999
Q ss_pred ccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
...........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+.+..+++..+......+....|..++++
T Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 188 VFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp ECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred ECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 88766666778999999999999888999999999999999999999999999999999999999888888888899999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCcCCC------CCCCCchHHHHHHHHHHhhcCHHHHHHHHHHHHhc-CHHHHHH
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDE------NRPVPLDILIYKLVKSYLRATPLKRAALKALSKAL-TEEELVY 434 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~e~~~ 434 (461)
+++||.+||+.||.+|||+.|+|+||||+.. ....+....+.+.++++.....++++++..++..+ +++++..
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~ 347 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKE 347 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHH
Confidence 9999999999999999999999999999753 11222223456778899999999999999999877 8999999
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
+++.|..+|. +||.|+.+||..+|..
T Consensus 348 l~~~F~~~D~d~dG~I~~~El~~~l~~ 374 (494)
T 3lij_A 348 LTDIFRHIDKNGDGQLDRQELIDGYSK 374 (494)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHHTTHH
T ss_pred HHHHHHHhCcCCCCeEcHHHHHHHHHH
Confidence 9999999999 8999999999887653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-60 Score=501.50 Aligned_cols=264 Identities=36% Similarity=0.642 Sum_probs=242.7
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++++.||+|+||+||+|+++. +|+.||||++.... ....+.+.+|+++|+.|+ |||||+++++|.+.+
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~---tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN 227 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSS
T ss_pred CccccEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence 44689999999999999999999987 89999999997643 334577889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|||||||+||+|+++|....+.+++.+++.|++||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+|+.
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEE
T ss_pred EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeE
Confidence 9999999999999999997777789999999999999999999999999999999999999742 346799999999999
Q ss_pred cCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
+.........+||+.|||||++. ..|+.++|||||||+||||++|..||.+.+..+++..|......+....|..+|++
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 88777778889999999999987 46999999999999999999999999999999999999999888888888899999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
+++||.+||++||.+|||+.|+|+||||+..+.
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 999999999999999999999999999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-60 Score=457.51 Aligned_cols=254 Identities=32% Similarity=0.481 Sum_probs=199.1
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC--
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN-- 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~-- 202 (461)
++|++++.||+|+||+||+|+++. +|+.||||+++... .....+.+.+|+++|++|+ |||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV---DDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT---TCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC--
T ss_pred hhCEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCcc
Confidence 479999999999999999999876 89999999997643 4455678999999999996 999999999997544
Q ss_pred ----------eEEEEEeccCCCchHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCC
Q 012518 203 ----------SVYIVMEFCEGGELLDRILSRGG--RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 270 (461)
Q Consensus 203 ----------~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~ 270 (461)
.+|||||||.||+|.+++..+.. ...+..++.|+.||+.||.|||++|||||||||+|||++ .++
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~---~~~ 155 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDD 155 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTC
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC---CCC
Confidence 37999999999999998865432 244567889999999999999999999999999999995 567
Q ss_pred CeeEeecccccccCCCC-------------CccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCh
Q 012518 271 PLKVIDFGLSDFVRPDQ-------------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTE 336 (461)
Q Consensus 271 ~~kl~DFG~a~~~~~~~-------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~ 336 (461)
.+||+|||+|+...... ..++.+||+.|||||++.+ .|+.++|||||||+||||++ ||....+
T Consensus 156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~ 232 (299)
T 4g31_A 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME 232 (299)
T ss_dssp CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH
Confidence 89999999998765432 1234689999999999874 69999999999999999996 8865332
Q ss_pred h-hHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 337 S-GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 337 ~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
. ..+..+... .++ ..+...++.+.+||.+||++||.+|||+.|+|+||||++.+
T Consensus 233 ~~~~~~~~~~~--~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 233 RVRTLTDVRNL--KFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHHHHTT--CCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHHHHhcC--CCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 2 222233222 221 12234678889999999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=448.49 Aligned_cols=251 Identities=22% Similarity=0.386 Sum_probs=208.1
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..+++++.++||+|+||+||+|+.+ ..||||+++... .+....+.|.+|+.+|++|+ |||||++++++.+ +
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~------~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH------GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-D 104 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS------SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-S
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC------CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-C
Confidence 3468899999999999999999754 249999987544 34556788999999999996 9999999998764 5
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|||||||+||+|.++|......+++..+..|+.||+.||.|||+++||||||||+||||+ .++.+||+|||+|+.
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~---~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATV 181 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---TTEEEEECCCSSCBC
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---CCCcEEEeeccCcee
Confidence 68999999999999999987777899999999999999999999999999999999999995 567899999999987
Q ss_pred cCCC---CCccccccCCCcCchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC--CC
Q 012518 283 VRPD---QRLNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH--DS 353 (461)
Q Consensus 283 ~~~~---~~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~ 353 (461)
.... ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+.+....+..+.......+ ..
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 261 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK 261 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence 6432 23456789999999999852 489999999999999999999999988766555555544332222 22
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 354 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+..+++++.+||.+||++||++|||+.|+++
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 34678999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-58 Score=454.38 Aligned_cols=252 Identities=22% Similarity=0.385 Sum_probs=209.9
Q ss_pred ccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
..+|.+.++||+|+||+||+|+.+. ...+|+.||||+++.. +....++|.+|+++|++|+ |||||+++++|.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEG 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 3578999999999999999998753 2236889999999753 4556788999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG--------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 267 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~--------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~ 267 (461)
+.+|||||||++|+|.+++.... +.+++.++..|+.||+.||.|||+++||||||||+||||+
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~--- 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG--- 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC---
Confidence 99999999999999999986532 3588999999999999999999999999999999999995
Q ss_pred CCCCeeEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHH
Q 012518 268 EDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRS 342 (461)
Q Consensus 268 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 342 (461)
.++.+||+|||+|+...... .....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+.+..+++..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 57789999999998764432 224568999999999987 569999999999999999999 9999999998888888
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 343 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+...... .....+++++.+||.+||+.||++|||+.|+++
T Consensus 273 i~~g~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 273 ITQGREL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HHHTCCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred HHcCCCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 8775421 122468999999999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-59 Score=488.45 Aligned_cols=255 Identities=25% Similarity=0.447 Sum_probs=218.1
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHH---HHHHHhcCCCCCeeEEEEEEEeC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRRE---VKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E---i~il~~l~~hpniv~l~~~~~~~ 201 (461)
++|++++.||+|+||+||+|+++. +|+.||||++.+...........+.+| +.+++.+ +|||||+++++|++.
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~---tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTP 264 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECS
T ss_pred HHeEEEEEEecccCeEEEEEEECC---CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEEC
Confidence 689999999999999999999987 899999999976543322223334444 5555566 499999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+.+|||||||.||+|.++|.+. +.+++..++.|+.||+.||.|||++|||||||||+|||| +.++++||+|||+|+
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLAC 340 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceee
Confidence 9999999999999999988665 689999999999999999999999999999999999999 467889999999998
Q ss_pred ccCCCCCccccccCCCcCchhhhh-c-cCCCchhHHHHHHHHHHHhhCCCCCCCCC---hhhHHHHHHhcCCCCCCCCCC
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLH-R-SYNVEGDMWSIGVITYILLCGSRPFWART---ESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~ 356 (461)
..... ...+.+||+.|||||++. + .|+.++|||||||+||||++|..||.+.+ ...+...+......++ .
T Consensus 341 ~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~ 415 (689)
T 3v5w_A 341 DFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----D 415 (689)
T ss_dssp ECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----T
T ss_pred ecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----c
Confidence 76543 446689999999999995 3 59999999999999999999999997643 3345666666655443 4
Q ss_pred CCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCcCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 392 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 392 (461)
.+|+++++||.+||++||.+|++ ++|+++||||++.
T Consensus 416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 68999999999999999999998 7999999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=447.95 Aligned_cols=254 Identities=23% Similarity=0.384 Sum_probs=215.9
Q ss_pred ccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|.+.++||+|+||+||+|++.. ...+|+.||||+++.. +....+++.+|+++|++|+ |||||+++++|.+.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeC
Confidence 3589999999999999999998753 2236789999999753 4456678999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCC
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 269 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~ 269 (461)
+.+|||||||+||+|.++|.... ..+++.++..|+.||+.||.|||+++||||||||+||||+ .+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~---~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---EN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC---CC
Confidence 99999999999999999997542 4689999999999999999999999999999999999995 56
Q ss_pred CCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHH
Q 012518 270 APLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVL 344 (461)
Q Consensus 270 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~ 344 (461)
+.+||+|||+|+....... ....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+.+..+++..+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 7799999999987644332 23357999999999986 679999999999999999998 999999999989988888
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 345 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 345 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
...... ....+++++.+||.+||+.||++|||+.|++ +|+
T Consensus 245 ~~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L 284 (299)
T 4asz_A 245 QGRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLL 284 (299)
T ss_dssp HTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHH
T ss_pred cCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHH
Confidence 764321 1246899999999999999999999999984 454
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=443.31 Aligned_cols=254 Identities=17% Similarity=0.288 Sum_probs=215.3
Q ss_pred ccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
..++++.++||+|+||+||+|+... ...+++.||||+++... .....++|.+|+.+|++|+ |||||+++|+|.+.
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKD 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEEC
Confidence 3578999999999999999998642 22367899999997542 2334578999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 266 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~ 266 (461)
+.+|||||||++|+|.++|..+. ..+++..+..|+.||+.||.|||+++||||||||+||||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~-- 179 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY-- 179 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC--
Confidence 99999999999999999996532 3588999999999999999999999999999999999995
Q ss_pred CCCCCeeEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHH
Q 012518 267 EEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 341 (461)
Q Consensus 267 ~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~ 341 (461)
+++.+||+|||+|+...... .....+||+.|||||++. +.|+.++|||||||+||||+| |..||.+.+..+++.
T Consensus 180 -~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 180 -DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp -GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred -CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 56779999999998764332 234578999999999986 679999999999999999998 899999999988888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 342 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 342 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
.+...... .....+++++.+||.+||+.||++|||+.|++++
T Consensus 259 ~i~~~~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVL---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 88765422 1224689999999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-57 Score=445.85 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=213.9
Q ss_pred cccceeeceeeccCCceEEEEEEeccC--CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKG--TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..++|++++.||+|+||+||+|++... ...++.||||++.... .....+.+.+|+++|.++.+|||||+++++|.+
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 346899999999999999999987642 2355789999997643 344567899999999999867999999999966
Q ss_pred -CCeEEEEEeccCCCchHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEe
Q 012518 201 -ANSVYIVMEFCEGGELLDRILSR---------------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 264 (461)
Q Consensus 201 -~~~~~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~ 264 (461)
++.+|||||||++|+|.++|... ...+++..+..|+.||+.||.|||+++||||||||+|||++
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 45789999999999999999653 23478999999999999999999999999999999999995
Q ss_pred cCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhH
Q 012518 265 TREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 339 (461)
Q Consensus 265 ~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~ 339 (461)
.++.+||+|||+|+....+.. ....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+....+.
T Consensus 220 ---~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 220 ---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp ---GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred ---CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 567799999999987654432 34568999999999986 579999999999999999998 9999988665444
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 340 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 340 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+..++........+ ..+++++.+||.+||+.||++|||+.|+++|
T Consensus 297 ~~~~i~~g~~~~~p--~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 297 FCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCC--ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 44444333322222 4589999999999999999999999999876
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-56 Score=440.89 Aligned_cols=298 Identities=32% Similarity=0.638 Sum_probs=259.2
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
+..+.++|++.+.||+|+||.||+|.++. +|+.||||++..... .....+.+.+|+.+++.|+ ||||++++++|.
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~ 98 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQ 98 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE
Confidence 44566789999999999999999999876 789999999976543 3445678899999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
+.+..|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+||+|||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 99 EESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred eCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 999999999999999999988654 5799999999999999999999999999999999999998665667799999999
Q ss_pred ccccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 280 SDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 280 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
+............+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+...++..+......++...|..+
T Consensus 178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (362)
T 2bdw_A 178 AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 257 (362)
T ss_dssp CBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGS
T ss_pred ceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC
Confidence 988776666667899999999999874 6999999999999999999999999999999999999988888888888889
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC--CCCCchHHHHHHHHHHhhcCHHHHHHHHHH
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN--RPVPLDILIYKLVKSYLRATPLKRAALKAL 423 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (461)
++++++||.+||+.||.+|||+.|+|+||||.... ............++++.....++.+.+..+
T Consensus 258 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 324 (362)
T 2bdw_A 258 TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTM 324 (362)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999997532 111223345566777777777777766654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-56 Score=454.57 Aligned_cols=318 Identities=32% Similarity=0.601 Sum_probs=265.0
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..+.++|++++.||+|+||+||+|.++. +|+.||+|++..... .....+.+.+|+.+++.|+ ||||++++++|.+
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~---~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 81 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKL-SARDHQKLEREARICRLLK-HPNIVRLHDSISE 81 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETT---TTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEEC
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECC---CCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEE
Confidence 4566799999999999999999999876 899999999987643 2344567899999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+.+|+|||||.||+|.+.+... +.+++..+..++.||+.||.|||++||+||||||+|||++.+..++.+||+|||++
T Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 82 EGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp SSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred CCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 99999999999999999988765 57999999999999999999999999999999999999986656788999999999
Q ss_pred cccCCCC-CccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 281 DFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 281 ~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
....... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+...++..+......++...|..+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccC
Confidence 8765443 3456789999999999875 6999999999999999999999999999999999999999888888889999
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC--CCCCchHHHHHHHHHHhhcCHHHHHHHHHHH--Hhc--CHHHH
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN--RPVPLDILIYKLVKSYLRATPLKRAALKALS--KAL--TEEEL 432 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l--~~~e~ 432 (461)
++++++||.+||+.||.+|||+.|+|+||||+... ............++++.....++.+.+..+. +.+ .++|+
T Consensus 241 s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~~~~~~~~~~~~e~ 320 (444)
T 3soa_A 241 TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRKQEI 320 (444)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEECCCCSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccchHHH
Confidence 99999999999999999999999999999997531 1112234456677777777777766555442 222 23445
Q ss_pred HHHHHHhhhcCC
Q 012518 433 VYLRAQFMLLEP 444 (461)
Q Consensus 433 ~~l~~~f~~~d~ 444 (461)
..+.+.|.....
T Consensus 321 ~~~~~~~l~~i~ 332 (444)
T 3soa_A 321 IKVTEQLIEAIS 332 (444)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHhhhh
Confidence 455555544443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-55 Score=435.17 Aligned_cols=267 Identities=34% Similarity=0.645 Sum_probs=237.7
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH---HHHHHHHHHHHHHHhcCCCCCeeEEEEE
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA---LAIEDVRREVKILKALSGHKHMIKFHDA 197 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~~hpniv~l~~~ 197 (461)
..+.++|++++.||+|+||+||+|+++. +|+.||||++.+...... ...+.+.+|+.+|+.+. ||||++++++
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~ 83 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDV 83 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECC---CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEE
Confidence 4566789999999999999999999876 899999999987543221 13467889999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC-CCCeeEee
Q 012518 198 FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE-DAPLKVID 276 (461)
Q Consensus 198 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~-~~~~kl~D 276 (461)
|.+.+.+|+|||||.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+..++. ...+||+|
T Consensus 84 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 84 YENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999999998854 467999999999999999999999999999999999999964321 12799999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
||++............+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..+.+..+......+....|
T Consensus 163 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp CSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred cCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 99999877666667789999999999987 46999999999999999999999999999999999999988877777667
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..+++++++||.+||.+||.+|||+.|+|+||||+..
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 8899999999999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=428.00 Aligned_cols=293 Identities=40% Similarity=0.659 Sum_probs=233.0
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
+.+.++|++.+.||+|+||+||+|+++. +++.||||++.... ..+.+.+|+.+|++++ ||||++++++|.+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 119 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKG---TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFET 119 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEEC
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECC---CCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEec
Confidence 4456789999999999999999999876 78899999997542 2356778999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+.+|+||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred CCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 99999999999999999988544 57999999999999999999999999999999999999976555788999999999
Q ss_pred cccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhh-HHHHHHhcCCCCCCCCCCCC
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESG-IFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 358 (461)
............+||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .+..+......+....|..+
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (349)
T 2w4o_A 199 KIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred cccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC
Confidence 87765555566789999999999874 69999999999999999999999997765544 67777777766666677889
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCCchHHHHHHHHHHhhcCHHHHHHHHHH
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKAL 423 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (461)
+.++++||.+||+.||++|||+.|+|+||||..............+.++.+....+++++....+
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNARRKLKAAVKAVV 343 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCSCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchhhhcchHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998875544434455666777777777766655444
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-55 Score=440.81 Aligned_cols=260 Identities=33% Similarity=0.624 Sum_probs=217.1
Q ss_pred ccceeec-eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--
Q 012518 124 GAKFELG-KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED-- 200 (461)
Q Consensus 124 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~-- 200 (461)
.++|.+. +.||+|+||+||+|.++. +|+.||||++... ..+.+|+.++.++.+||||++++++|..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~---~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECC---CCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 3567776 789999999999999876 7899999999642 3566899998776679999999999876
Q ss_pred --CCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 201 --ANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 201 --~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
.+.+|||||||.||+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 667999999999999999987653 36999999999999999999999999999999999999976545788999999
Q ss_pred ccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh----hHHHHHHhcCCCCCC
Q 012518 278 GLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES----GIFRSVLRADPNFHD 352 (461)
Q Consensus 278 G~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~ 352 (461)
|+++...........+||+.|+|||++. +.|+.++|||||||+||+|++|..||.+.... .....+......+..
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 9998776555667789999999999986 56999999999999999999999999776543 356667777777777
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 353 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 353 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
..|..+++++++||.+||+.||.+|||+.|+|+||||.....
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 778889999999999999999999999999999999986543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=422.73 Aligned_cols=256 Identities=32% Similarity=0.622 Sum_probs=230.7
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
-++|++++.||+|+||.||+|++.. +|+.||||++.+... .....+.+.+|+++|+.++ ||||+++++++.+.+.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHIL---TGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKT 88 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCE
Confidence 3589999999999999999999876 899999999976543 4455678899999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD---ADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTCCGGG
T ss_pred EEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc---CCCCEEEeeccCceec
Confidence 99999999999999988665 5799999999999999999999999999999999999994 5678999999999887
Q ss_pred CCCCCccccccCCCcCchhhhhc-cC-CCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLHR-SY-NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
.........+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+.+..++...+......++. .++++
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 240 (328)
T 3fe3_A 165 TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTD 240 (328)
T ss_dssp SSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred CCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence 76667778899999999999874 34 57999999999999999999999999999999988887665543 47999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+.+||.+||..||.+|||++|+|+||||+..
T Consensus 241 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 9999999999999999999999999999764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-55 Score=432.30 Aligned_cols=257 Identities=28% Similarity=0.530 Sum_probs=225.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++++.........+.+.+|+.+++.+.+||||++++++|.+.+.+
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcC---CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 589999999999999999999876 78999999998754444445677889999999986799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|||||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+|||+++...
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~---~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC---CCCCEEEccccceeecc
Confidence 9999999999999988655 6799999999999999999999999999999999999994 67789999999998643
Q ss_pred C-CCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 P-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~-~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
. .......+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+++..|......++. .+++++
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~ 251 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDA 251 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHH
Confidence 2 23445678999999999986 46999999999999999999999999999999999999988766653 489999
Q ss_pred HHHHHHhcccCcCCCCCH------HHHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRMTA------AQALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~------~e~L~hp~~~~~ 392 (461)
++||.+||++||.+|+++ .|+++||||++.
T Consensus 252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 252 TGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 999999999999999999 999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=435.47 Aligned_cols=297 Identities=32% Similarity=0.604 Sum_probs=239.0
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCC--HHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS--ALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
.+.++|++.+.||+|+||+||+|.++. +|+.||||++....... ....+.+.+|+.+++.++ ||||++++++|.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 96 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYS 96 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence 456789999999999999999999876 78999999996533211 113467889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 200 DANSVYIVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
+.+.+|+|||||+||+|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEec
Confidence 999999999999999998887654 23589999999999999999999999999999999999998665666799999
Q ss_pred cccccccCCCCC-ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCC
Q 012518 277 FGLSDFVRPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 277 FG~a~~~~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 354 (461)
||++........ ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+. ....+..+......+....
T Consensus 177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~ 255 (351)
T 3c0i_A 177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQ 255 (351)
T ss_dssp CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHH
T ss_pred CcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccc
Confidence 999987765433 35578999999999986 45899999999999999999999999875 4566777777766666555
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC---CCCCchHHHHHHHHHHhhcCHHHHHHHHHHH
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN---RPVPLDILIYKLVKSYLRATPLKRAALKALS 424 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (461)
|..+++++++||.+||..||.+|||+.|+|+||||+... ....+. ...+.++.+.....++.+.+..++
T Consensus 256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~ 327 (351)
T 3c0i_A 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLP-ETVEQLRKFNARRKLKGAVLAAVS 327 (351)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCH-HHHHHHHHHHHHHC----------
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccch-HHHHHHHHHHHHHHHHHHHHHHHH
Confidence 678999999999999999999999999999999998642 111222 234556666666666666555543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=426.45 Aligned_cols=262 Identities=30% Similarity=0.593 Sum_probs=237.0
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+.++|++.+.||+|+||+||+|.++. +|+.||+|++... ......+.+|+.+|+.++ ||||++++++|.+.
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESM 73 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEET
T ss_pred chhhceEeeeEEecCCCeEEEEEEECC---CCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecC
Confidence 356799999999999999999999876 7899999998643 233467889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+.+|+|||||+||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+ .++.+||+|||++.
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQAR 152 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCe
Confidence 99999999999999999987666679999999999999999999999999999999999999642 26789999999999
Q ss_pred ccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+....|+.+++
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence 8876666677889999999999875 489999999999999999999999999999999999998888777767778999
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
++++||.+||..||.+|||+.|+|+||||++.
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 99999999999999999999999999999865
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-54 Score=423.40 Aligned_cols=256 Identities=29% Similarity=0.554 Sum_probs=227.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++++...........+.+|+.+|+.++ ||||++++++|.+.+.+
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEE
Confidence 589999999999999999999876 78999999997653323334567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 81 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC---CCCCEEEeeccchhhcc
Confidence 9999999999999888654 5799999999999999999999999999999999999994 56789999999998643
Q ss_pred -CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 -PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 -~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
........+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+...++..+......++. .+++++
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 232 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEA 232 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHH
Confidence 334556789999999999986 46999999999999999999999999999988888888887665543 589999
Q ss_pred HHHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
++||.+||++||.+|+ ++.|+++||||+..
T Consensus 233 ~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999999 99999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=429.59 Aligned_cols=257 Identities=26% Similarity=0.540 Sum_probs=222.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++++.........+.+.+|..+|.++.+||||++++++|.+.+.+
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 589999999999999999999886 78999999998776555555667889999999886699999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc-
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV- 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~- 283 (461)
|||||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 129 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCC
T ss_pred EEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC---CCCCEEEeecceeeecc
Confidence 9999999999999888654 5799999999999999999999999999999999999994 6778999999999863
Q ss_pred CCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCC---------ChhhHHHHHHhcCCCCCCC
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWAR---------TESGIFRSVLRADPNFHDS 353 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~~ 353 (461)
.........+||+.|+|||++. ..|+.++|||||||++|||++|+.||... ....+.+.+......++.
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~- 283 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR- 283 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT-
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC-
Confidence 3344566789999999999987 46999999999999999999999999632 234466667766655543
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCH------HHHhcCCCcCCC
Q 012518 354 PWPSVSPEAKDFVRRLLNKDHRKRMTA------AQALTHPWLHDE 392 (461)
Q Consensus 354 ~~~~~s~~~~~li~~~L~~dP~~R~s~------~e~L~hp~~~~~ 392 (461)
.+++++++||.+||++||.+|+++ +|+++||||++.
T Consensus 284 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 284 ---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp ---TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred ---cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 489999999999999999999985 899999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=420.07 Aligned_cols=267 Identities=37% Similarity=0.669 Sum_probs=234.9
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCC---HHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS---ALAIEDVRREVKILKALSGHKHMIKFHDA 197 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~~Ei~il~~l~~hpniv~l~~~ 197 (461)
..+.++|++.+.||+|+||+||+|+++. +|+.||||++....... ....+.+.+|+.+|+.++ ||||++++++
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~ 82 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEV 82 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECC---CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEE
Confidence 3456789999999999999999999876 78999999997654321 123567889999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC-CCCCeeEee
Q 012518 198 FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE-EDAPLKVID 276 (461)
Q Consensus 198 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~-~~~~~kl~D 276 (461)
|.+.+.+|+|||||.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 83 YENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 9999999999999999999998854 46799999999999999999999999999999999999996432 223799999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
||++............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......+....+
T Consensus 162 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 162 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp CTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence 99998876666666788999999999987 56999999999999999999999999999988888888877766665556
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 7789999999999999999999999999999999764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-53 Score=417.44 Aligned_cols=257 Identities=26% Similarity=0.534 Sum_probs=225.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+.+++++.+||||++++++|.+.+.+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 589999999999999999999876 78999999998877667777788999999999985699999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 86 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCGGGCBCSC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEEecccccccc
Confidence 9999999999999988654 5799999999999999999999999999999999999994 56789999999998643
Q ss_pred -CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCC---------CChhhHHHHHHhcCCCCCCC
Q 012518 285 -PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWA---------RTESGIFRSVLRADPNFHDS 353 (461)
Q Consensus 285 -~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~---------~~~~~~~~~i~~~~~~~~~~ 353 (461)
........+||+.|+|||++. ..|+.++|||||||++|||++|+.||.. .....+...+......++
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p-- 239 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-- 239 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC--
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC--
Confidence 334456679999999999986 4689999999999999999999999965 334455666666655544
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCH------HHHhcCCCcCCC
Q 012518 354 PWPSVSPEAKDFVRRLLNKDHRKRMTA------AQALTHPWLHDE 392 (461)
Q Consensus 354 ~~~~~s~~~~~li~~~L~~dP~~R~s~------~e~L~hp~~~~~ 392 (461)
..+++++++||.+||++||.+|+++ .|+++||||++.
T Consensus 240 --~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 240 --RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred --CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 3589999999999999999999995 899999999764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=422.41 Aligned_cols=257 Identities=30% Similarity=0.505 Sum_probs=227.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||+||+|+++. +|+.||||++++.........+.+.+|..++..+.+||||++++++|.+.+.+
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 589999999999999999999876 78999999997653322234566788999999875699999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC---CCCCEEEeEChhhhhcc
Confidence 9999999999999988654 5799999999999999999999999999999999999994 56789999999998643
Q ss_pred C-CCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 P-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~-~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
. .......+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+..+++..+......++. .+++++
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 245 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEA 245 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHHH
Confidence 2 33456688999999999986 46999999999999999999999999999999999998887665543 489999
Q ss_pred HHHHHHhcccCcCCCCCHH-HHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAA-QALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~-e~L~hp~~~~~ 392 (461)
++||.+||+.||.+|+++. |+++||||++.
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 9999999999999999998 99999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-53 Score=424.61 Aligned_cols=263 Identities=35% Similarity=0.639 Sum_probs=236.5
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+.++|++++.||+|+||+||+|.++. +|+.||+|++.... ......+.+|+.+|+.|+ ||||++++++|.+.+
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKY 121 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSS
T ss_pred cccceEEEEEEecCCCEEEEEEEECC---CCCEEEEEEecccc---hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCC
Confidence 44689999999999999999999876 78999999997542 334467889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+|||||.||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+ .++.+||+|||++..
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATK 200 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEeccccee
Confidence 9999999999999999887666679999999999999999999999999999999999999642 346799999999998
Q ss_pred cCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
..........+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+......+....+..++++
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 77665566678999999999987 45899999999999999999999999999988889988888877777777889999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
+++||.+||+.||.+|||+.|+|+||||+...
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 99999999999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=403.33 Aligned_cols=267 Identities=34% Similarity=0.698 Sum_probs=241.2
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..+.++|++.+.||+|+||.||+|.++. +|+.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 76 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQE 76 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcC---CCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEc
Confidence 3567899999999999999999999876 789999999976543 4445678889999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+..|+||||+.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 99999999999999999888765 57999999999999999999999999999999999999986656667999999999
Q ss_pred cccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+......+....+..++
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T 3kk8_A 156 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235 (284)
T ss_dssp EECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred EEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccC
Confidence 8877666666788999999999986 458999999999999999999999999999999999988888888877788899
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
+++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 9999999999999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=421.91 Aligned_cols=258 Identities=26% Similarity=0.471 Sum_probs=228.4
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++++.||+|+||+||+|+++. +|+.||||++++.........+.+.+|..+|..+.+||||++++++|.+.+.
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT---EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 3589999999999999999999876 7899999999765433333456788999999988669999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc---CCCcEEEEeCCccccc
Confidence 99999999999999988654 5799999999999999999999999999999999999994 5778999999999864
Q ss_pred C-CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 R-PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~-~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
. ........+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+++..|......++. .++++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 247 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKE 247 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence 3 233456688999999999986 56999999999999999999999999999999999999987766553 58999
Q ss_pred HHHHHHHhcccCcCCCCC-----HHHHhcCCCcCCC
Q 012518 362 AKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 392 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 392 (461)
+++||.+||.+||.+|++ ++|+++||||+..
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 999999999999999994 6999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=420.56 Aligned_cols=257 Identities=31% Similarity=0.580 Sum_probs=205.7
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++++.||+|+||+||+|+++. +|+.||||++....... +.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 90 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL---TKELVAVKYIERGAAID----ENVQREIINHRSLR-HPNIVRFKEVILTPTH 90 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT---TCCEEEEEEEESSTTSC----HHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEecCcccc----HHHHHHHHHHHhCC-CCCCCcEEEEEeeCCE
Confidence 4589999999999999999999876 78999999997654333 56779999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+ ....+||+|||+++..
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~-~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS-SSCCEEECCCCCC---
T ss_pred EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCceEEEeecCccccc
Confidence 99999999999999988654 579999999999999999999999999999999999999632 2335999999999865
Q ss_pred CCCCCccccccCCCcCchhhhhc-cCCC-chhHHHHHHHHHHHhhCCCCCCCCCh----hhHHHHHHhcCCCCCCCCCCC
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLHR-SYNV-EGDMWSIGVITYILLCGSRPFWARTE----SGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~-~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~ 357 (461)
.........+||+.|+|||++.+ .++. ++|||||||++|+|++|+.||.+... ...+..+......++ ....
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 246 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP--DDIR 246 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC--TTSC
T ss_pred cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC--CcCC
Confidence 54455566789999999999864 4554 48999999999999999999987544 344444554443333 2346
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+++++++||.+||+.||.+|||+.|+|+||||...
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 89999999999999999999999999999999643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-54 Score=433.94 Aligned_cols=262 Identities=27% Similarity=0.478 Sum_probs=226.8
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++++.||+|+||+||+|+++. +|+.||||++.+.........+.+.+|+.+++.++ ||||++++++|.+.+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDR 142 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECC---CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence 34689999999999999999999886 78999999997633222222345778999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|||||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+|||++..
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMK 217 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC---CCCCEEEeccceeEe
Confidence 99999999999999998754 4699999999999999999999999999999999999994 677899999999987
Q ss_pred cCCCC--CccccccCCCcCchhhhhc-c----CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 283 VRPDQ--RLNDIVGSAYYVAPEVLHR-S----YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 283 ~~~~~--~~~~~~gt~~y~aPE~l~~-~----~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
..... ...+.+||+.|+|||++.+ . |+.++|||||||+||||++|+.||.+.+..+.+..|......+..+.+
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence 65443 2346789999999999863 2 789999999999999999999999999999999998876433344445
Q ss_pred CCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCcCCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDEN 393 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~~ 393 (461)
..+++++++||.+||+.+|.+ |++++|+++||||++.+
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 679999999999999999988 99999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=414.35 Aligned_cols=254 Identities=28% Similarity=0.611 Sum_probs=226.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++.+.........+.+.+|+.+++.+. ||||++++++|.+.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEE
Confidence 589999999999999999999876 78999999997653322234567889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 82 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSCEECS
T ss_pred EEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc---CCCCEEEeecCcceecC
Confidence 999999999999998865 46799999999999999999999999999999999999994 57789999999998754
Q ss_pred CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
. .....+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+....+..+......++ ..++++++
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 231 (318)
T 1fot_A 158 D--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVK 231 (318)
T ss_dssp S--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred C--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHH
Confidence 3 335678999999999986 4699999999999999999999999999999899999988766554 35899999
Q ss_pred HHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 364 DFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 364 ~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
+||.+||..||.+|+ +++|+++||||++.
T Consensus 232 ~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 232 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 999999999999999 99999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=411.38 Aligned_cols=264 Identities=28% Similarity=0.447 Sum_probs=220.7
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
++.+.++|++++.||+|+||+||+|+++ +|+.||||++..... .......+.+|++++++++ ||||+++++++.
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 89 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS----QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELH-HPNIVSLIDVIH 89 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET----TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC----CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcC-CCCEeeeeeEEc
Confidence 4556789999999999999999999884 588999999975432 2334467889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
+.+.+|+|||||.+ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~ 165 (311)
T 3niz_A 90 SERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGL 165 (311)
T ss_dssp CSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTT
T ss_pred cCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC---CCCCEEEccCcC
Confidence 99999999999974 89888877777799999999999999999999999999999999999995 567799999999
Q ss_pred ccccCCC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCC--
Q 012518 280 SDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP-- 354 (461)
Q Consensus 280 a~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~-- 354 (461)
+...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+...........
T Consensus 166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 166 ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp CEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred ceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 9876533 33455689999999999864 589999999999999999999999998888777776654322111111
Q ss_pred ------------------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 355 ------------------------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 355 ------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.+.+++++.+||.+||+.||.+|||++|+|+||||++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 135789999999999999999999999999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=419.70 Aligned_cols=260 Identities=35% Similarity=0.618 Sum_probs=227.8
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..+.++|++.+.||+|+||+||+|.++. +|+.||||++.+.... ..+|++++.++.+||||++++++|.+
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~ 87 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDD 87 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence 3466789999999999999999999876 7899999999765432 34688999988669999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC-CCCCeeEeeccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE-EDAPLKVIDFGL 279 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~-~~~~~kl~DFG~ 279 (461)
.+.+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+..++ ....+||+|||+
T Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 88 GKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 99999999999999999988654 6799999999999999999999999999999999999996432 224599999999
Q ss_pred ccccCCC-CCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCC---CChhhHHHHHHhcCCCCCCCC
Q 012518 280 SDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWA---RTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 280 a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~---~~~~~~~~~i~~~~~~~~~~~ 354 (461)
+...... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+......+....
T Consensus 167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 246 (342)
T 2qr7_A 167 AKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY 246 (342)
T ss_dssp CEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT
T ss_pred cccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc
Confidence 9876543 34456789999999999874 589999999999999999999999976 456677888888888887778
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
|..+++++++||.+||..||.+|||+.|+|+||||.+
T Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 8899999999999999999999999999999999965
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=434.83 Aligned_cols=263 Identities=30% Similarity=0.505 Sum_probs=226.9
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|+++++||+|+||+||+|+++. +|+.||||++.+...........+.+|+.++..+. ||||++++++|.+.+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDN 147 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSS
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcC---CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCC
Confidence 45689999999999999999999876 78999999997643222222334788999999995 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|||||||.||+|.+++....+.+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+++.
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~---~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLK 224 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc---CCCCEEEcchhhhhh
Confidence 99999999999999999877667899999999999999999999999999999999999994 677899999999987
Q ss_pred cCCCCC--ccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC--CCCCC
Q 012518 283 VRPDQR--LNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD--PNFHD 352 (461)
Q Consensus 283 ~~~~~~--~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~ 352 (461)
...... ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+.+..+.+..|+... ..++.
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence 654433 23468999999999985 358999999999999999999999999999989888887643 22322
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCcCCCC
Q 012518 353 SPWPSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDEN 393 (461)
Q Consensus 353 ~~~~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~~ 393 (461)
.+..+++++++||++||+.+|++ |++++|+++||||++.+
T Consensus 305 -~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 305 -QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp -SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred -ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 23568999999999999998888 99999999999998653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=404.43 Aligned_cols=263 Identities=36% Similarity=0.694 Sum_probs=224.6
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+.++|++.+.||+|+||+||+|+++. +|+.||+|++...... ...+.+.+|+++++.++ ||||+++++++.+.
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDY 92 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred ChhhheeecceeccCCCeEEEEEEEcc---CCceEEEEEeeccccc--hhHHHHHHHHHHHHhCC-CchHHhHHHheecC
Confidence 355789999999999999999999876 7899999999765422 23577889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 202 NSVYIVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
+.+|+||||+.+|+|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 9999999999999999988543 4679999999999999999999999999999999999999765566789999999
Q ss_pred cccccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 279 LSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 279 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
++.............||+.|+|||++.+.++.++|||||||++|+|++|..||.+....+....+......+.... ..+
T Consensus 173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~ 251 (285)
T 3is5_A 173 LAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC-RPL 251 (285)
T ss_dssp CCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCC
T ss_pred cceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc-CcC
Confidence 9987766555667789999999999988899999999999999999999999999888887777766655544332 348
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=402.60 Aligned_cols=259 Identities=24% Similarity=0.448 Sum_probs=223.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
...+|++.+.||+|+||+||+|.+.. +|+.||||++....... .+.+.+|+.+++.++ ||||++++++|.+.+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPK---KELIINEILVMRENK-NPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTT---TCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hhhceeeeeeeccCCCeEEEEEEECC---CCcEEEEEEeecccccH---HHHHHHHHHHHhcCC-CCCCCeEeEEEEECC
Confidence 45689999999999999999999876 78999999997654333 356789999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+|||||.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQ 165 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred EEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC---CCCCEEEeeCCCcee
Confidence 999999999999999988654 599999999999999999999999999999999999995 567799999999987
Q ss_pred cCCCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 283 VRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 283 ~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
..... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.........+....... ......+++
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 244 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSA 244 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CSCGGGSCH
T ss_pred cCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-CCCccccCH
Confidence 65443 345578999999999986 469999999999999999999999998888776666655443221 112246899
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 9999999999999999999999999999986543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=428.63 Aligned_cols=262 Identities=32% Similarity=0.513 Sum_probs=225.4
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++++.||+|+||+||+|+++. +|+.||||++.+.........+.+.+|+.++..+. ||||++++++|.+.+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~---~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDEN 134 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCC
Confidence 34689999999999999999999876 89999999997643333333455789999999995 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|||||||.||+|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+|||++..
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld---~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGSCLK 211 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec---CCCCEEEeechhhee
Confidence 99999999999999999987666899999999999999999999999999999999999994 677899999999987
Q ss_pred cCCCCC--ccccccCCCcCchhhhh--------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC--CCC
Q 012518 283 VRPDQR--LNDIVGSAYYVAPEVLH--------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD--PNF 350 (461)
Q Consensus 283 ~~~~~~--~~~~~gt~~y~aPE~l~--------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~ 350 (461)
...... ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+.+..+.+..|.... ..+
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence 655433 23468999999999986 358999999999999999999999999999988888887643 222
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCC---CCHHHHhcCCCcCCCC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKR---MTAAQALTHPWLHDEN 393 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R---~s~~e~L~hp~~~~~~ 393 (461)
+. ....+++++++||++||+ +|.+| ++++|+++||||++.+
T Consensus 292 p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 292 PL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp C-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred Cc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 21 124689999999999999 99998 5999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=402.49 Aligned_cols=263 Identities=40% Similarity=0.764 Sum_probs=237.2
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+.++|++.+.||+|+||+||+|.++. ++..||+|++....... .+.+.+|++++++++ ||||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKG---TRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLD-HPNIIRLYETFEDN 78 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCC---CCcEEEEEeehhhccch---HHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 355789999999999999999999876 78899999997654332 467889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+.+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..++.++.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 9999999999999999988665 569999999999999999999999999999999999999665667889999999998
Q ss_pred ccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
............||+.|+|||++.+.++.++|||||||++|+|++|..||......+....+......++...|..++++
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 158 RFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp ECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred eccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 87766666778899999999999888999999999999999999999999999998888888888777766666679999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999999653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=416.62 Aligned_cols=255 Identities=31% Similarity=0.565 Sum_probs=227.7
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++++.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+.+|+.+. ||||++++++|.+.+.
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSN 115 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCE
Confidence 3689999999999999999999876 78999999997654333334567889999999995 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC---CCCCEEEcccccceec
Confidence 99999999999999988665 5799999999999999999999999999999999999994 5678999999999876
Q ss_pred CCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.. .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..+++..+......++ ..+++++
T Consensus 192 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~ 265 (350)
T 1rdq_E 192 KG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDL 265 (350)
T ss_dssp SS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHH
T ss_pred cC--CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHH
Confidence 43 335678999999999986 5689999999999999999999999999999999999988766554 3589999
Q ss_pred HHHHHHhcccCcCCCCC-----HHHHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 392 (461)
++||.+||+.||.+|++ ++|+++||||+..
T Consensus 266 ~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 99999999999999998 9999999999764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=401.83 Aligned_cols=259 Identities=28% Similarity=0.489 Sum_probs=219.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++..... .....+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC---CCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEE
Confidence 489999999999999999999876 789999999976543 3334567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+|||||.+ +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~---~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccceecC
Confidence 999999975 77787877778899999999999999999999999999999999999995 56779999999998765
Q ss_pred CC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCC-CCCChhhHHHHHHhcCCCCCCC-------
Q 012518 285 PD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPF-WARTESGIFRSVLRADPNFHDS------- 353 (461)
Q Consensus 285 ~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf-~~~~~~~~~~~i~~~~~~~~~~------- 353 (461)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|..|| .+.+..+.+..+..........
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 33 33455689999999999864 3899999999999999999988885 5555666666665432221111
Q ss_pred ------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 354 ------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 354 ------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..+.+++++++||.+||+.||.+|||++|+|+||||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 123578999999999999999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=411.18 Aligned_cols=247 Identities=22% Similarity=0.277 Sum_probs=188.9
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN- 202 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~- 202 (461)
..+|.+.++||+|+||+||+|++ +|+.||||+++.... .......|+.++.+|+ |||||++++++.+.+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-----~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSREE----RSWFREAEIYQTVMLR-HENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-----TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccch----hhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCC
Confidence 35799999999999999999976 578999999965421 1122335666667785 999999999998654
Q ss_pred ---eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCcEEEecCCCCCC
Q 012518 203 ---SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ--------GVVHRDLKPENFLFTTREEDAP 271 (461)
Q Consensus 203 ---~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~--------givHrDlkp~NILl~~~~~~~~ 271 (461)
.+|||||||+||+|.+++... .++++.+..++.|++.||.|||++ +||||||||+|||| +.++.
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~ 146 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT 146 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSC
T ss_pred CceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCC
Confidence 589999999999999998653 589999999999999999999987 99999999999999 46788
Q ss_pred eeEeecccccccCCCCC-----ccccccCCCcCchhhhhc-------cCCCchhHHHHHHHHHHHhhCCCCCCCCC----
Q 012518 272 LKVIDFGLSDFVRPDQR-----LNDIVGSAYYVAPEVLHR-------SYNVEGDMWSIGVITYILLCGSRPFWART---- 335 (461)
Q Consensus 272 ~kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlGvil~elltg~~Pf~~~~---- 335 (461)
+||+|||+|+....... ....+||+.|||||++.+ .|+.++|||||||+||||+||..||....
T Consensus 147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~ 226 (303)
T 3hmm_A 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence 99999999987654332 234689999999999864 36789999999999999999977653211
Q ss_pred -----------hhhHHHHHHhcCC--CCCCCC-CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 336 -----------ESGIFRSVLRADP--NFHDSP-WPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 336 -----------~~~~~~~i~~~~~--~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...+...+..... .++... ....++.+.+||.+||+.||++|||+.|+++
T Consensus 227 p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1223333332221 111110 0112357889999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=419.45 Aligned_cols=257 Identities=25% Similarity=0.540 Sum_probs=224.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++++.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+++|+.++ ||||++++++|.+.+.
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEED 89 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCE
Confidence 4689999999999999999999876 78999999997654333344577889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+|||||.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC---CCCCEEEeccceeeec
Confidence 9999999999999988754 46799999999999999999999999999999999999994 6778999999999987
Q ss_pred CCCCCccccccCCCcCchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCC---hhhHHHHHHhcCCCCCCCCCC
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVITYILLCGSRPFWART---ESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~ 356 (461)
.........+||+.|+|||++.. .|+.++|||||||++|+|++|+.||.... ...++..+......++ .
T Consensus 166 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~ 241 (384)
T 4fr4_A 166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----S 241 (384)
T ss_dssp CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----T
T ss_pred cCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----C
Confidence 76667778899999999999852 48999999999999999999999997543 3444555555444443 3
Q ss_pred CCCHHHHHHHHHhcccCcCCCCC-HHHHhcCCCcCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMT-AAQALTHPWLHDE 392 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s-~~e~L~hp~~~~~ 392 (461)
.+++++.+||.+||+.||.+|++ ++++++||||++.
T Consensus 242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 58999999999999999999998 8999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=417.65 Aligned_cols=256 Identities=28% Similarity=0.545 Sum_probs=217.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHH-HhcCCCCCeeEEEEEEEeCCe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKIL-KALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~~hpniv~l~~~~~~~~~ 203 (461)
++|++++.||+|+||+||+|+++. +|+.||||++.+...........+.+|..++ +.+ +||||++++++|.+.+.
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADK 113 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETT---TCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCE
Confidence 589999999999999999999876 7899999999887655555556677788774 556 59999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+|||+++..
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCBCGGG
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEeeCcccccc
Confidence 99999999999999988654 5799999999999999999999999999999999999994 5778999999999864
Q ss_pred C-CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 R-PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~-~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
. ........+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+..+++..|+.....++ +.++++
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~ 265 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNS 265 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHH
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHH
Confidence 3 334556789999999999986 4699999999999999999999999999999999999988765544 358999
Q ss_pred HHHHHHHhcccCcCCCCCH----HHHhcCCCcCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTA----AQALTHPWLHDE 392 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~----~e~L~hp~~~~~ 392 (461)
+++||.+||++||.+|+++ .++++||||+..
T Consensus 266 ~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 9999999999999999986 699999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=406.39 Aligned_cols=267 Identities=34% Similarity=0.597 Sum_probs=220.4
Q ss_pred CCccccceeec-eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 120 GKNFGAKFELG-KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 120 ~~~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
...+.++|++. +.||+|+||+||+|+++. +|+.||||++..... ...+.+.+|+.++.++.+||||+++++++
T Consensus 7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~ 80 (316)
T 2ac3_A 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLI---TSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFF 80 (316)
T ss_dssp CCCTTTSCEECCCCCCCCSSEEEEEEECSS---SCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcccceeEEecCceecCCceEEEEEEEEcC---CCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34567789995 789999999999999876 789999999976532 23467889999999965699999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 199 EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 199 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
.+.+.+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 81 EEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred eeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 9999999999999999999988765 579999999999999999999999999999999999999754444569999999
Q ss_pred cccccCCCC--------CccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh--------
Q 012518 279 LSDFVRPDQ--------RLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTE-------- 336 (461)
Q Consensus 279 ~a~~~~~~~--------~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-------- 336 (461)
++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 987654221 223456999999999985 3489999999999999999999999977542
Q ss_pred -------hhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 337 -------SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 337 -------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
..+...+......++...|..+++++++||.+||+.||.+|||+.|+|+||||++..
T Consensus 240 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 345666666666665555567899999999999999999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=419.66 Aligned_cols=258 Identities=34% Similarity=0.625 Sum_probs=226.8
Q ss_pred ceee--ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 126 KFEL--GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 126 ~y~~--~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.|.+ .+.||+|+||.||+|.+.. +|+.||||+++... ....+.+.+|+++|++|+ ||||+++++++.+.+.
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETA---TGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD-HANLIQLYDAFESKND 160 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETT---TCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred ceeeecceEEecCcCEEEEEEEEcC---CCcEEEEEEEcccc---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence 4444 6789999999999999876 78999999997643 234577899999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|||||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||++...
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceec
Confidence 99999999999999998776667999999999999999999999999999999999999964 24567999999999987
Q ss_pred CCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.........+||+.|+|||++. +.++.++|||||||++|||++|..||.+.+..+.+..+......+....+..+++++
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 7666666778999999999986 568999999999999999999999999999999999999887777776677899999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
++||.+||+.||.+|||+.|+|+||||++
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 99999999999999999999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=419.28 Aligned_cols=257 Identities=32% Similarity=0.578 Sum_probs=220.5
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
.-++|++.+.||+|+||+||+|.+.. +|+.||||++.+...........+.+|+.+++.++ ||||+++++++.+.+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYK---TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPT 82 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCC
Confidence 34689999999999999999999876 78999999997543222223357889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+||||+ +|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---DNLNVKIADFGLSNI 157 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC---TTCCEEECCSSCTBT
T ss_pred EEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc---CCCCEEEEEecccee
Confidence 999999999 78999988765 5799999999999999999999999999999999999994 567899999999998
Q ss_pred cCCCCCccccccCCCcCchhhhhcc--CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
..........+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.........+......++ ..+++
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 233 (336)
T 3h4j_B 158 MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSP 233 (336)
T ss_dssp TTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSCH
T ss_pred ccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCCH
Confidence 7766666778999999999998743 37899999999999999999999987665544443333222222 35899
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
++.+||.+||+.||.+|||++|+++||||+..
T Consensus 234 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 234 GAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 99999999999999999999999999999754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=403.61 Aligned_cols=266 Identities=27% Similarity=0.436 Sum_probs=217.1
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC--CHHHHHHHHHHHHHHHhcC--CCCCeeEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT--SALAIEDVRREVKILKALS--GHKHMIKFH 195 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~--~hpniv~l~ 195 (461)
|..+.++|++++.||+|+||+||+|+++. +|+.||||++...... .......+.+|+.+++.++ +||||++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~ 80 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM 80 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTT---TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence 55667899999999999999999999876 7899999998753221 1111235567887777664 499999999
Q ss_pred EEEEeCC-----eEEEEEeccCCCchHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCC
Q 012518 196 DAFEDAN-----SVYIVMEFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 269 (461)
Q Consensus 196 ~~~~~~~-----~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~ 269 (461)
+++.... .+++||||+. |+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~---~~ 156 (308)
T 3g33_A 81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SG 156 (308)
T ss_dssp EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC---TT
T ss_pred eeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CC
Confidence 9998765 5899999997 599998866532 389999999999999999999999999999999999995 56
Q ss_pred CCeeEeecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC
Q 012518 270 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP 348 (461)
Q Consensus 270 ~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~ 348 (461)
+.+||+|||++............+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 157 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 157 GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp SCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 779999999998876666667789999999999985 5699999999999999999999999999998888887765433
Q ss_pred CCCCCCC-----------------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 349 NFHDSPW-----------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 349 ~~~~~~~-----------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
......| +.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 2222222 3578999999999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=411.04 Aligned_cols=275 Identities=29% Similarity=0.543 Sum_probs=236.5
Q ss_pred ccCCCCccccceeec-eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEE
Q 012518 116 NFGYGKNFGAKFELG-KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKF 194 (461)
Q Consensus 116 ~~~~~~~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l 194 (461)
.+..++.+.++|.+. +.||+|+||+||+|+++. +|+.||||++...... ......+.+|+.+++.+.+||||+++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---TGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---CCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 344556778899998 899999999999999876 7899999999765432 23356788999999999878999999
Q ss_pred EEEEEeCCeEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCee
Q 012518 195 HDAFEDANSVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 273 (461)
Q Consensus 195 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~k 273 (461)
+++|.+.+.+|+||||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++....++.+|
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999999887543 35789999999999999999999999999999999999997544467899
Q ss_pred EeecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC
Q 012518 274 VIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD 352 (461)
Q Consensus 274 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 352 (461)
|+|||++............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......+..
T Consensus 175 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254 (327)
T ss_dssp ECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred EeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence 99999999876665566778999999999986 56899999999999999999999999999998888888888777777
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 353 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 353 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
..+..+++.+.+||.+||+.||.+|||++|+|+||||++.+.
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 777889999999999999999999999999999999987643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=406.13 Aligned_cols=260 Identities=28% Similarity=0.548 Sum_probs=217.0
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-SALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
.++|++.+.||+|+||+||+|++..+..+|+.||||++++.... .......+.+|+.+|+.++ ||||+++++++.+.+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGG 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcCC
Confidence 46899999999999999999998655558999999999865432 2233456788999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLTDFGLCKE 170 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTSCEEECCCSCC--
T ss_pred EEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC---CCCcEEEEeCCcccc
Confidence 999999999999999988654 5789999999999999999999999999999999999995 567899999999976
Q ss_pred cCCC-CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 283 VRPD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 283 ~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
.... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+....+..+......++ +.+++
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~ 246 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQ 246 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSCH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCH
Confidence 4332 2345578999999999986 5689999999999999999999999999998888888888765554 35899
Q ss_pred HHHHHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 361 EAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
++++||.+||..||.+|| ++.|+++||||++.
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 999999999999999999 89999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=401.58 Aligned_cols=258 Identities=28% Similarity=0.450 Sum_probs=214.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|++. +|+.||||++...... ....+.+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKED-EGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEcC----CCCEEEEEEEeccccc-cccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeE
Confidence 47999999999999999999873 6889999999754322 222356789999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFG 151 (288)
T ss_dssp EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHHHC
T ss_pred EEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEeECccccccC
Confidence 999999975 99998877667899999999999999999999999999999999999995 56779999999998765
Q ss_pred CC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC---------
Q 012518 285 PD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD--------- 352 (461)
Q Consensus 285 ~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 352 (461)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.........
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 33 23455689999999999863 4899999999999999999999999988887777666542111110
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 353 ----------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 353 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..+..+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0123578999999999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=411.74 Aligned_cols=261 Identities=37% Similarity=0.665 Sum_probs=208.0
Q ss_pred cccceeec---eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 123 FGAKFELG---KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 123 ~~~~y~~~---~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
+.++|++. +.||+|+||+||+|.++. +|+.||||++.+. ....+.+|+.+++.+.+||||++++++|.
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~ 76 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFH 76 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETT---TCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred chhccccccCCCccccCCCeEEEEEEECC---CCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 33567775 789999999999999876 7899999999653 23567789999999977999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
+.+..|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+||+|||+
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 77 DQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGF 155 (325)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred cCCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccc
Confidence 999999999999999999988654 6799999999999999999999999999999999999998655555799999999
Q ss_pred ccccCCC-CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC-------hhhHHHHHHhcCCCC
Q 012518 280 SDFVRPD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART-------ESGIFRSVLRADPNF 350 (461)
Q Consensus 280 a~~~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~-------~~~~~~~i~~~~~~~ 350 (461)
+...... ......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.... ..+++..+......+
T Consensus 156 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~ 235 (325)
T 3kn6_A 156 ARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235 (325)
T ss_dssp CEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred ceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence 9866543 3345678999999999986 469999999999999999999999997643 346677777777666
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
....|..+++++++||.+||+.||.+|||+.|+++||||++..
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 6666678999999999999999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=425.50 Aligned_cols=258 Identities=29% Similarity=0.540 Sum_probs=218.0
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++++.||+|+||.||+|+++. +|+.||||++.+...........+.+|+.+++.++ ||||++++++|.+.+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHD 221 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETT
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcC---CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCC
Confidence 34689999999999999999999876 89999999998654444445567789999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
.+|||||||.||+|.+++... ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++.
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~---~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCK 297 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC---SSSCEEECCCCCCC
T ss_pred EEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC---CCCCEEEccCCCce
Confidence 999999999999999888654 579999999999999999999998 9999999999999995 56789999999998
Q ss_pred ccCC-CCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 282 FVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 282 ~~~~-~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
.... .......+||+.|+|||++. ..|+.++|||||||+||||++|+.||.+.+.......+......++. .++
T Consensus 298 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~ 373 (446)
T 4ejn_A 298 EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLG 373 (446)
T ss_dssp TTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSC
T ss_pred eccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCC
Confidence 6433 33456688999999999986 56999999999999999999999999999998888888887665543 489
Q ss_pred HHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 360 PEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
+++.+||.+||++||.+|| +++|+|+||||++.
T Consensus 374 ~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 9999999999999999999 99999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=404.58 Aligned_cols=267 Identities=34% Similarity=0.646 Sum_probs=232.5
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH---HHHHHHHHHHHHHHhcCCCCCeeEEEEE
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA---LAIEDVRREVKILKALSGHKHMIKFHDA 197 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~~hpniv~l~~~ 197 (461)
..+.++|++.+.||+|+||.||+|+++. +|+.||||++........ ...+.+.+|+.+++++. ||||++++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 83 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDV 83 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECC---CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEE
Confidence 4456789999999999999999999876 789999999976543221 13567889999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC-CCCeeEee
Q 012518 198 FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE-DAPLKVID 276 (461)
Q Consensus 198 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~-~~~~kl~D 276 (461)
+.+.+.+|+||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 84 YENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999999998854 467899999999999999999999999999999999999963221 11699999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......+....+
T Consensus 163 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp CTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred CccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 99998877665666778999999999986 56899999999999999999999999999988888888877665554444
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 6789999999999999999999999999999999764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=404.52 Aligned_cols=259 Identities=26% Similarity=0.432 Sum_probs=206.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|.++. +|+.||||+++.... ....+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 78 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKT---TGVYVALKEVKLDSE--EGTPSTAIREISLMKELK-HENIVRLYDVIHTENKL 78 (317)
T ss_dssp --------------CEEEEEECSS---SCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEE
T ss_pred cceeEeeEECCCCCEEEEEEEECC---CCcEEEEEEeecccc--cccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeE
Confidence 589999999999999999999876 789999999976532 222356789999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 205 YIVMEFCEGGELLDRILSRG-----GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
|+||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCSS
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc---CCCCEEECcCcc
Confidence 99999998 59998886542 3589999999999999999999999999999999999995 567799999999
Q ss_pred ccccCCC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCC---
Q 012518 280 SDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS--- 353 (461)
Q Consensus 280 a~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--- 353 (461)
+...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+..........
T Consensus 155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 155 ARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp CEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred ceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence 9876533 33456689999999999864 58999999999999999999999999988888777775432111111
Q ss_pred ---------------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 354 ---------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 354 ---------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
....+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 1124789999999999999999999999999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=416.67 Aligned_cols=263 Identities=30% Similarity=0.511 Sum_probs=211.2
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
+..+.++|++++.||+|+||+||+|.++. +|+.||||++.+. .........+.+|+.+|+.+.+||||++++++|.
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 79 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLR 79 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETT---TCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECC---CCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEe
Confidence 34456799999999999999999999876 8899999998654 2345556778899999999977999999999997
Q ss_pred eCC--eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 200 DAN--SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 200 ~~~--~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
..+ .+|+|||||. |+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 80 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DF 153 (388)
T 3oz6_A 80 ADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN---AECHVKVADF 153 (388)
T ss_dssp CTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCC
T ss_pred cCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc---CCCCEEecCC
Confidence 544 7999999997 589887754 4699999999999999999999999999999999999994 5678999999
Q ss_pred ccccccCC----------------------CCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCC
Q 012518 278 GLSDFVRP----------------------DQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWA 333 (461)
Q Consensus 278 G~a~~~~~----------------------~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~ 333 (461)
|+++.... .......+||++|+|||++.+ .|+.++|||||||++|||++|+.||.+
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 99986532 112345689999999999864 589999999999999999999999999
Q ss_pred CChhhHHHHHHhcCCCCC--------------------------C-----------------CCCCCCCHHHHHHHHHhc
Q 012518 334 RTESGIFRSVLRADPNFH--------------------------D-----------------SPWPSVSPEAKDFVRRLL 370 (461)
Q Consensus 334 ~~~~~~~~~i~~~~~~~~--------------------------~-----------------~~~~~~s~~~~~li~~~L 370 (461)
.+..+.+..++....... . ..+..+++++.+||.+||
T Consensus 234 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 888887777654211110 0 012267899999999999
Q ss_pred ccCcCCCCCHHHHhcCCCcCCC
Q 012518 371 NKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 371 ~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+.||.+|||++|+|+||||+..
T Consensus 314 ~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp CSSGGGSCCHHHHTTSTTTTTT
T ss_pred ccCcccCCCHHHHhCCHHHHHh
Confidence 9999999999999999999754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=426.48 Aligned_cols=261 Identities=34% Similarity=0.604 Sum_probs=229.8
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
+....++|++++.||+|+||+||+|+++. +|+.||||++.+.........+.+.+|+.+|+.++ ||||+++++++.
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~ 86 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHEL---TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVIS 86 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETT---TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence 33445689999999999999999999876 89999999997654332234567889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
+.+.+|+|||||.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~---~~~~vkL~DFG~ 162 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGL 162 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC---TTCCEEECCCSS
T ss_pred ECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe---cCCCeEEEeccc
Confidence 99999999999999999998754 46799999999999999999999999999999999999994 567799999999
Q ss_pred ccccCCCCCccccccCCCcCchhhhhcc--CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 280 SDFVRPDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 280 a~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
+............+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.....++..+.......+ ..
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 238 (476)
T 2y94_A 163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QY 238 (476)
T ss_dssp CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TT
T ss_pred hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----cc
Confidence 9987766666778999999999998753 47899999999999999999999999888888888887654433 34
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 239 ~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 239 LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 89999999999999999999999999999999764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=442.67 Aligned_cols=258 Identities=26% Similarity=0.472 Sum_probs=230.5
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++++.||+|+||+||+|+++. +|+.||||++++.........+.+.+|..+|..+.+|+||++++++|.+.+.
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESS---SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred ccceEEEEEEccCCCEEEEEEEECC---CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 4589999999999999999999876 7899999999865433333456778899999998779999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+||||||+.||+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+||||+ .++++||+|||+++..
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~---~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC---SSSCEEECCCTTCEEC
T ss_pred EEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc---CCCcEEEeecceeecc
Confidence 99999999999999988765 5799999999999999999999999999999999999994 6778999999999864
Q ss_pred C-CCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 R-PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~-~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
. ........+||+.|+|||++. ..|+.++|||||||+||||++|+.||.+.+..+++..|+.....++. .++++
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 568 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKE 568 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHH
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHH
Confidence 3 334456789999999999987 56999999999999999999999999999999999999988766653 58999
Q ss_pred HHHHHHHhcccCcCCCCCH-----HHHhcCCCcCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTA-----AQALTHPWLHDE 392 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~-----~e~L~hp~~~~~ 392 (461)
+++||.+||++||.+|+++ +|+++||||+..
T Consensus 569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 569 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 9999999999999999997 999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=410.71 Aligned_cols=262 Identities=34% Similarity=0.651 Sum_probs=232.0
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-C----HHHHHHHHHHHHHHHhcCCCCCeeEEEE
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-S----ALAIEDVRREVKILKALSGHKHMIKFHD 196 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-~----~~~~~~~~~Ei~il~~l~~hpniv~l~~ 196 (461)
.+.++|++.+.||+|+||.||+|+++. +|+.||||++...... . ....+.+.+|+.+++++.+||||+++++
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRA---TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECC---CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 345689999999999999999999875 7899999998764311 1 1234567899999999966999999999
Q ss_pred EEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 197 AFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 197 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
++...+..|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~---~~~~ikl~D 243 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD---DNMQIRLSD 243 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECC
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEEe
Confidence 999999999999999999999988654 5799999999999999999999999999999999999994 567899999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhc-------cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN 349 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~ 349 (461)
||++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||........+..+......
T Consensus 244 fG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 323 (365)
T 2y7j_A 244 FGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ 323 (365)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred cCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 999988876666677899999999999853 4788999999999999999999999998888888888887776
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 350 FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 350 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
+....|..+++++.+||.+||+.||.+|||+.|+|+||||+
T Consensus 324 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 66666678999999999999999999999999999999996
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=405.12 Aligned_cols=264 Identities=25% Similarity=0.427 Sum_probs=213.2
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++++.||+|+||+||+|++.. +|+.||||++..... .....+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTV---TNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNH 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETT
T ss_pred chhhEEEEEEEEecCCeEEEEEEECC---CCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCC
Confidence 34689999999999999999999876 789999999976532 2333456779999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC--CCCCeeEeecccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE--EDAPLKVIDFGLS 280 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~--~~~~~kl~DFG~a 280 (461)
.+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9999999997 4999887654 5799999999999999999999999999999999999996432 3456999999999
Q ss_pred cccCCC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCC-
Q 012518 281 DFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP- 356 (461)
Q Consensus 281 ~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~- 356 (461)
...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+...........|+
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 876533 33455678999999999864 48999999999999999999999999988888777776543222222221
Q ss_pred -------------------------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 357 -------------------------SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 357 -------------------------~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.+++++.+||.+||+.||.+|||+.|+|+||||++.+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 1689999999999999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=396.42 Aligned_cols=264 Identities=39% Similarity=0.727 Sum_probs=231.3
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..+.++|++.+.||+|+||+||+|+++. +|+.||||++...... ..+.+.+|+.+++.++ ||||+++++++.+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 77 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRL---TGKLFALKCIKKSPAF---RDSSLENEIAVLKKIK-HENIVTLEDIYES 77 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred cchhccceeeeeccCCCCceEEEEEECC---CCCEEEEEEEeccccc---chHHHHHHHHHHHhCC-CCCeeehhhhccc
Confidence 3456789999999999999999999876 7899999999764322 2356789999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+.+|+||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 78 TTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred CCEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 99999999999999999988665 57999999999999999999999999999999999999965556788999999998
Q ss_pred cccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
..... .......||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+......+....+..++
T Consensus 157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (304)
T 2jam_A 157 KMEQN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDIS 235 (304)
T ss_dssp CCCCC-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSC
T ss_pred eecCC-CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCC
Confidence 76542 2334567999999999986 468999999999999999999999999999888888888887777777778899
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
+++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 236 ESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 9999999999999999999999999999998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=398.94 Aligned_cols=256 Identities=28% Similarity=0.551 Sum_probs=214.9
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCC-----------------------HHHHHHHHHHHH
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS-----------------------ALAIEDVRREVK 180 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~-----------------------~~~~~~~~~Ei~ 180 (461)
.++|++.+.||+|+||+||+|+++. +|+.||||++....... ....+.+.+|++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN---DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT---TTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC---CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 3589999999999999999999876 78999999997654221 112456889999
Q ss_pred HHHhcCCCCCeeEEEEEEEe--CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCC
Q 012518 181 ILKALSGHKHMIKFHDAFED--ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKP 258 (461)
Q Consensus 181 il~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp 258 (461)
+|++++ ||||+++++++.+ .+.+|+||||+++++|.+++ ....+++..++.++.||+.||.|||++||+||||||
T Consensus 89 ~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 89 ILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp HHHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 999996 9999999999987 67899999999999998754 335799999999999999999999999999999999
Q ss_pred CcEEEecCCCCCCeeEeecccccccCCCC-CccccccCCCcCchhhhhcc----CCCchhHHHHHHHHHHHhhCCCCCCC
Q 012518 259 ENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHRS----YNVEGDMWSIGVITYILLCGSRPFWA 333 (461)
Q Consensus 259 ~NILl~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~----~~~~~DiwSlGvil~elltg~~Pf~~ 333 (461)
+|||++ .++.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+
T Consensus 166 ~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 166 SNLLVG---EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGEEEC---TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEEC---CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999995 56779999999998765433 33557899999999998643 47889999999999999999999998
Q ss_pred CChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 334 RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 334 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
.........+......++. .+.+++++.+||.+||+.||.+|||+.|+|+||||+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 243 ERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SSHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred ccHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 8877777777665544433 356899999999999999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=404.67 Aligned_cols=267 Identities=27% Similarity=0.454 Sum_probs=225.9
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe---
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED--- 200 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~--- 200 (461)
.++|++++.||+|+||+||+|+++. +|+.||||++....... .....+.+|+.+++.++ ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKAS 90 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETT---TCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC--
T ss_pred ccceeEEEEEecCCCcEEEEEEECC---CCCEEEEEEEecccccc-cchHHHHHHHHHHHhcc-CCCcccHhheeecccc
Confidence 3689999999999999999999876 78999999986654322 22356778999999996 9999999999987
Q ss_pred -----CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 201 -----ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 201 -----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
.+.+|+|||||.+ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~---~~~~~kl~ 166 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLA 166 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEEC
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCCEEEc
Confidence 4578999999975 88888877767899999999999999999999999999999999999995 56789999
Q ss_pred ecccccccCCC-----CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC
Q 012518 276 DFGLSDFVRPD-----QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP 348 (461)
Q Consensus 276 DFG~a~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~ 348 (461)
|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99999876422 23355689999999998863 489999999999999999999999999998888887776555
Q ss_pred CCCCCCCCCC----------------------------CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCCch
Q 012518 349 NFHDSPWPSV----------------------------SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLD 399 (461)
Q Consensus 349 ~~~~~~~~~~----------------------------s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~ 399 (461)
.+....|+.+ ++++.+||.+||+.||.+|||++|+|+||||+....+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~ 325 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLK 325 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCSH
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccccc
Confidence 5554444432 78899999999999999999999999999998865554433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=402.83 Aligned_cols=259 Identities=23% Similarity=0.335 Sum_probs=214.8
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
++.+.++|++.++||+|+||+||+|+++. +|+.||||++..... .........+|+..+.++.+|+||++++++|.
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKE---DGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETT---TSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECC---CCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 45566799999999999999999999876 789999999865433 33344556667777777756999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
+.+.+|+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~DFG~ 203 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGL 203 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---GGGCEEECCCTT
T ss_pred eCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEcccee
Confidence 999999999999 6799999888877899999999999999999999999999999999999995 566799999999
Q ss_pred ccccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 280 SDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 280 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
+.............||+.|+|||++.+.++.++|||||||++|||++|..||..... ...+.... .....+..++
T Consensus 204 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~--~~~~~~~~~~ 278 (311)
T 3p1a_A 204 LVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGY--LPPEFTAGLS 278 (311)
T ss_dssp CEECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTC--CCHHHHTTSC
T ss_pred eeecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccC--CCcccccCCC
Confidence 987765555566789999999999988999999999999999999999877755332 22332221 1112234689
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
+++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 279 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 279 SELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=403.36 Aligned_cols=259 Identities=30% Similarity=0.530 Sum_probs=215.6
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+.++|++++.||+|+||+||+|+++. +|+.||||++...... ...+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HENVVKFYGHRREGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECC---CCcEEEEEEEEccccc--chHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 45799999999999999999999876 7899999999754322 22356789999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
..|+|||||.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATV 154 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe---CCCCEEEEEeeccce
Confidence 99999999999999987743 45699999999999999999999999999999999999995 567799999999986
Q ss_pred cCCCC---CccccccCCCcCchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 283 VRPDQ---RLNDIVGSAYYVAPEVLHR-S-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 283 ~~~~~---~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
..... .....+||+.|+|||++.+ . ++.++|||||||++|+|++|+.||................. .....|..
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYLNPWKK 233 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC-TTSTTGGG
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc-ccCCcccc
Confidence 54322 2346789999999999864 3 47889999999999999999999987665433332222222 22234567
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 234 ~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 234 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 99999999999999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=433.31 Aligned_cols=259 Identities=27% Similarity=0.483 Sum_probs=225.0
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||.||+|+++. +|+.||||++.+...........+.+|+++|+.++ ||||++++++|.+.+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKD 257 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCC
Confidence 34689999999999999999999876 89999999997654333334567889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
.+|||||||.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld---~~g~vKL~DFGla~ 334 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD---DHGHIRISDLGLAV 334 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe---CCCCeEEEecccce
Confidence 9999999999999999886543 3499999999999999999999999999999999999994 67789999999999
Q ss_pred ccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC----hhhHHHHHHhcCCCCCCCCCC
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART----ESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 356 (461)
...........+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.. ...+...+......++ .
T Consensus 335 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~ 410 (576)
T 2acx_A 335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----E 410 (576)
T ss_dssp ECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----T
T ss_pred ecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----c
Confidence 8776666667899999999999874 69999999999999999999999998754 3445555555544443 4
Q ss_pred CCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
.+++++++||.+||++||.+|+ +++|+++||||++.
T Consensus 411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 5899999999999999999999 89999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=403.71 Aligned_cols=263 Identities=26% Similarity=0.438 Sum_probs=226.8
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
+.....|++++.||+|+||+||+|++.. +|+.||||++...........+.+.+|++++++++ ||||+++++++.+
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 125 (348)
T 1u5q_A 50 DDPEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR 125 (348)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred cchhhheeeeeEEccCCCEEEEEEEEcc---CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEE
Confidence 3445679999999999999999999876 78999999997665445555678899999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+..|+||||+. |+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 126 ~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a 201 (348)
T 1u5q_A 126 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA 201 (348)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTC
T ss_pred CCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEeeccCc
Confidence 999999999997 688888877777899999999999999999999999999999999999996 5677999999999
Q ss_pred cccCCCCCccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
..... ....+||+.|+|||++. +.++.++|||||||++|||++|+.||.+.+....+..+........ ...
T Consensus 202 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 276 (348)
T 1u5q_A 202 SIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSG 276 (348)
T ss_dssp BSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCT
T ss_pred eecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCC
Confidence 86543 34568999999999884 4689999999999999999999999998887777766665532221 224
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 396 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~ 396 (461)
.+++.+++||.+||+.||.+|||+.++|+||||.....+.
T Consensus 277 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~ 316 (348)
T 1u5q_A 277 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 316 (348)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcc
Confidence 5899999999999999999999999999999998765443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=422.61 Aligned_cols=265 Identities=38% Similarity=0.643 Sum_probs=216.6
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-----CHHHHHHHHHHHHHHHhcCCCCCeeEEE
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-----SALAIEDVRREVKILKALSGHKHMIKFH 195 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~~hpniv~l~ 195 (461)
..+.++|++.+.||+|+||+||+|.++. +|+.||||++.+.... .......+.+|+.+|++++ ||||++++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~ 206 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK 206 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCC
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECC---CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEE
Confidence 4456789999999999999999999876 7899999999765432 1122335789999999996 99999999
Q ss_pred EEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 196 DAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 196 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
+++. .+.+|+|||||.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+||+
T Consensus 207 ~~~~-~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 207 NFFD-AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp EEEE-SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred EEEe-cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEe
Confidence 9986 4568999999999999987754 4679999999999999999999999999999999999999876667789999
Q ss_pred ecccccccCCCCCccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh-hhHHHHHHhcCCCC
Q 012518 276 DFGLSDFVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLRADPNF 350 (461)
Q Consensus 276 DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~ 350 (461)
|||+++...........+||+.|+|||++. ..|+.++|||||||++|+|++|..||..... ......+......+
T Consensus 285 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~ 364 (419)
T 3i6u_A 285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364 (419)
T ss_dssp CSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC
T ss_pred ecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC
Confidence 999999876665666788999999999874 4588899999999999999999999976543 34555566555555
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
....|..+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 365 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 55556779999999999999999999999999999999976
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=392.89 Aligned_cols=264 Identities=34% Similarity=0.605 Sum_probs=233.9
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC--C----HHHHHHHHHHHHHHHhcCCCCCeeEEE
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT--S----ALAIEDVRREVKILKALSGHKHMIKFH 195 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~--~----~~~~~~~~~Ei~il~~l~~hpniv~l~ 195 (461)
.+.++|++.+.||+|+||.||+|.++. +|+.||||++...... . ....+.+.+|+.+++++.+||||++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcC---cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 355799999999999999999999876 7899999999764311 1 233467889999999997799999999
Q ss_pred EEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 196 DAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 196 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
+++.+.+..|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~ 166 (298)
T 1phk_A 91 DTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLT 166 (298)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEEC
T ss_pred eeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc---CCCcEEEe
Confidence 9999999999999999999999988654 5799999999999999999999999999999999999994 56779999
Q ss_pred ecccccccCCCCCccccccCCCcCchhhhh-------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC
Q 012518 276 DFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP 348 (461)
Q Consensus 276 DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~ 348 (461)
|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||...........+.....
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 167 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 999998877666666778999999999874 2478899999999999999999999999888888888888877
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 349 NFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 349 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.+....+..+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 77766677899999999999999999999999999999999865
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=423.59 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=210.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
+.++|++++.||+|+||+||+|+++. +|+.||||++.+.. ......+.+.+|+.+|+.++ ||||++++++|...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK 134 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCC
Confidence 45789999999999999999999876 78999999997652 34455678889999999996 99999999999654
Q ss_pred -----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 202 -----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 202 -----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
..+||||||+.+ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 135 ~~~~~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~---~~~~~kl~D 207 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 207 (464)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECC
T ss_pred ccccCCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe---CCCCEEEEE
Confidence 467999999976 5666663 3489999999999999999999999999999999999995 567899999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC------
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN------ 349 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~------ 349 (461)
||+++...........+||++|+|||++. ..|+.++|||||||+||||++|+.||.+.+..+.+..|......
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 208 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp CCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred EEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99999877666667789999999999986 46999999999999999999999999998887777776543211
Q ss_pred ----------------CCCCCCC----C------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 350 ----------------FHDSPWP----S------------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 350 ----------------~~~~~~~----~------------~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
+....++ . .++++++||.+||+.||.+|||++|+|+||||+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 1111100 0 1567999999999999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=419.78 Aligned_cols=260 Identities=29% Similarity=0.497 Sum_probs=198.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED-- 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~-- 200 (461)
+.++|++++.||+|+||+||+|+++. +|+.||||++... .......+.+.+|+.+|+.|+ ||||++++++|..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKL---EKRVVAIKKILRV-FEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKD 125 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC-----CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECC---CCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCC
Confidence 45789999999999999999999876 7899999999654 334556678999999999996 9999999999943
Q ss_pred ---CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 201 ---ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 201 ---~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
.+.+|+||||+ +|+|.+++. ....+++..++.++.||+.||.|||++|||||||||+||||+ .++.+||+||
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~---~~~~~kl~DF 200 (458)
T 3rp9_A 126 VEKFDELYVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN---QDCSVKVCDF 200 (458)
T ss_dssp TTTCCCEEEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEECCC
T ss_pred cccCceEEEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC---CCCCEeeccc
Confidence 36799999998 568988775 446799999999999999999999999999999999999994 5678999999
Q ss_pred ccccccCCC----------------------------CCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhh-
Q 012518 278 GLSDFVRPD----------------------------QRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLC- 326 (461)
Q Consensus 278 G~a~~~~~~----------------------------~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~ellt- 326 (461)
|+++..... ......+||++|+|||++. ..|+.++||||||||||||++
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 999876422 1234568999999999863 459999999999999999999
Q ss_pred ----------CCCCCCCCCh--------------------hhHHHHHHhcC-----------------------CCCC--
Q 012518 327 ----------GSRPFWARTE--------------------SGIFRSVLRAD-----------------------PNFH-- 351 (461)
Q Consensus 327 ----------g~~Pf~~~~~--------------------~~~~~~i~~~~-----------------------~~~~-- 351 (461)
|+++|.+... .+.+..|+... +...
T Consensus 281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (458)
T 3rp9_A 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360 (458)
T ss_dssp STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence 6777755431 12222222110 0000
Q ss_pred --CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 352 --DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 352 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
...++.+++++.+||.+||..||.+|||++|+|+||||++.
T Consensus 361 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp CGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 11245679999999999999999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=406.12 Aligned_cols=267 Identities=25% Similarity=0.401 Sum_probs=223.9
Q ss_pred ccccCCCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC----CCC
Q 012518 114 DKNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS----GHK 189 (461)
Q Consensus 114 ~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~----~hp 189 (461)
...+..|..+.++|+++++||+|+||+||+|++.. +|+.||||++... ......+.+|+.+++.+. +||
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---CCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 44556678888999999999999999999999876 7899999999642 334566778999999996 499
Q ss_pred CeeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC--
Q 012518 190 HMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR-- 266 (461)
Q Consensus 190 niv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~-- 266 (461)
||+++++++...+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTC
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccc
Confidence 9999999999999999999999 889999887654 358999999999999999999999999999999999999631
Q ss_pred --------------------CCCCCeeEeecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHh
Q 012518 267 --------------------EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILL 325 (461)
Q Consensus 267 --------------------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ell 325 (461)
..++.+||+|||++..... .....+||+.|+|||++. ..++.++|||||||++|+|+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 1267799999999986543 335678999999999986 46999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHHhcCCCCCC---------------------CCCC---------------------CCCHHHH
Q 012518 326 CGSRPFWARTESGIFRSVLRADPNFHD---------------------SPWP---------------------SVSPEAK 363 (461)
Q Consensus 326 tg~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------~~~~---------------------~~s~~~~ 363 (461)
+|+.||......+.+..+......++. ..|+ ..++.+.
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 999999988877777666544322221 0011 1247788
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 364 DFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
+||.+||+.||.+|||+.|+|+||||+
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999999995
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=394.76 Aligned_cols=266 Identities=38% Similarity=0.732 Sum_probs=236.9
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..+.++|++++.||+|+||.||+|+++. +|+.||||++...... ....+.+.+|++++++++ ||||+++++++.+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 92 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAK-NKDTSTILREVELLKKLD-HPNIMKLFEILED 92 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcC---CCcEEEEEEecccccc-hHHHHHHHHHHHHHHhcc-CCCccEEEEEEeC
Confidence 3456799999999999999999999876 7899999999765432 234567889999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+.+|+||||+.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+||+|||++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred CCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999999999988655 57999999999999999999999999999999999999976555678999999999
Q ss_pred cccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
.............||+.|+|||++.+.++.++|||||||++|+|++|..||.+....+....+......+....|..+++
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred eeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 87766655566779999999999988899999999999999999999999999988888888888776666666678999
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999999653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=408.88 Aligned_cols=263 Identities=22% Similarity=0.342 Sum_probs=217.2
Q ss_pred ccceeeceeeccC--CceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRG--HFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G--~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|++++.||+| +||+||+|+++. +|+.||||++..... .....+.+.+|+.+++.++ ||||++++++|.+.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIAD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC---CCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEEC
Confidence 4689999999999 999999999876 789999999976543 4456678889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
+.+|+|||||.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~---~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSN 175 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCGGGC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccccc
Confidence 9999999999999999988764 35699999999999999999999999999999999999994 5678999999987
Q ss_pred cccCCC--------CCccccccCCCcCchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC
Q 012518 281 DFVRPD--------QRLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN 349 (461)
Q Consensus 281 ~~~~~~--------~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~ 349 (461)
...... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+......+..+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 654221 11233579999999999864 5899999999999999999999999887666655544332111
Q ss_pred C------------------------------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 012518 350 F------------------------------------------HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387 (461)
Q Consensus 350 ~------------------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 387 (461)
. ....+..+++++.+||.+||+.||.+|||+.|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 0 0012345789999999999999999999999999999
Q ss_pred CcCCCCC
Q 012518 388 WLHDENR 394 (461)
Q Consensus 388 ~~~~~~~ 394 (461)
||+....
T Consensus 336 ~f~~~~~ 342 (389)
T 3gni_B 336 FFKQIKR 342 (389)
T ss_dssp GGGGC--
T ss_pred HHHHHhh
Confidence 9987643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=404.36 Aligned_cols=259 Identities=27% Similarity=0.472 Sum_probs=213.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++...... .....+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL---TDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECC---CCcEEEEEEEeccccc--ccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEE
Confidence 479999999999999999999876 7899999999654321 11123457999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 76 TLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN---ERGELKLADFGLARAKS 151 (324)
T ss_dssp EEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC---TTCCEEECSSSEEECC-
T ss_pred EEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC---CCCCEEEccCccccccc
Confidence 99999997 599999887777799999999999999999999999999999999999995 56779999999998654
Q ss_pred CC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC------
Q 012518 285 PD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW------ 355 (461)
Q Consensus 285 ~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------ 355 (461)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+...........|
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 33 23445688999999999864 5899999999999999999999999999888887777654332222222
Q ss_pred --------------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 356 --------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 356 --------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
+.+++++.+||.+||+.||.+|||++|+|+||||.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 34789999999999999999999999999999998753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=402.19 Aligned_cols=265 Identities=38% Similarity=0.643 Sum_probs=220.0
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-----CHHHHHHHHHHHHHHHhcCCCCCeeEEE
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-----SALAIEDVRREVKILKALSGHKHMIKFH 195 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~~hpniv~l~ 195 (461)
..+.++|++.+.||+|+||.||+|+++. +|+.||||++...... .......+.+|+++|+++. ||||++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~ 81 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK 81 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcC---CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEe
Confidence 4456789999999999999999999876 7899999999764321 1222345789999999996 99999999
Q ss_pred EEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 196 DAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 196 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
+++...+ +|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+||+
T Consensus 82 ~~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 82 NFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EEEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred eEEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 9997665 8999999999999998754 4679999999999999999999999999999999999999765556679999
Q ss_pred ecccccccCCCCCccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh-hHHHHHHhcCCCC
Q 012518 276 DFGLSDFVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTES-GIFRSVLRADPNF 350 (461)
Q Consensus 276 DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~~ 350 (461)
|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||...... .....+......+
T Consensus 160 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (322)
T 2ycf_A 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239 (322)
T ss_dssp CCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC
T ss_pred cCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc
Confidence 999998776544445678999999999873 45899999999999999999999999765443 4445555554444
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
....|..+++++.+||.+||..||.+||++.|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 43345678999999999999999999999999999999976
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=393.75 Aligned_cols=262 Identities=26% Similarity=0.475 Sum_probs=214.1
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|++.. +|+.||||++.... ......+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCC---CCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeE
Confidence 589999999999999999999876 78999999986653 34445677889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++||||+.+++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 78 ~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EEEEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred EEEEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc---CCCCEEEeeCCCchhcc
Confidence 99999999988877654 446799999999999999999999999999999999999995 56789999999998765
Q ss_pred CC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC------------
Q 012518 285 PD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN------------ 349 (461)
Q Consensus 285 ~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~------------ 349 (461)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 154 GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred CcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 33 23455689999999999863 5899999999999999999999999988877666554432110
Q ss_pred -------CCCC--------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCC
Q 012518 350 -------FHDS--------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395 (461)
Q Consensus 350 -------~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~ 395 (461)
.+.. .++.+++++.+||.+||+.||.+|||++|+|+||||++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 1100 124689999999999999999999999999999999876433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=394.17 Aligned_cols=260 Identities=30% Similarity=0.552 Sum_probs=222.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
..|+..+.||+|+||+||+|+++. +|+.||||++...... ..+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~---~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred hhhhccEEeccCCCeEEEEEEECC---CCcEEEEEEEeccchh---HHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEE
Confidence 358888999999999999999876 7899999999765332 3466889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 118 ~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~ 192 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQIS 192 (321)
T ss_dssp EEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCcEEEeeeeeeeecc
Confidence 999999999999987743 4699999999999999999999999999999999999995 56779999999998765
Q ss_pred CCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||........+..+........ .....+++++
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 271 (321)
T 2c30_A 193 KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVL 271 (321)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHH
T ss_pred cCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHH
Confidence 432 345678999999999986 4589999999999999999999999998888777777665432211 1224589999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~ 397 (461)
.+||.+||+.||.+|||+.|+|+||||.....+..
T Consensus 272 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~ 306 (321)
T 2c30_A 272 RDFLERMLVRDPQERATAQELLDHPFLLQTGLPEC 306 (321)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGGG
T ss_pred HHHHHHHccCChhhCcCHHHHhcChhhccCCCccc
Confidence 99999999999999999999999999987654433
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=406.68 Aligned_cols=266 Identities=33% Similarity=0.619 Sum_probs=225.5
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC--CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT--SALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
+.++|++.+.||+|+||+||+|.++. +++.||||++.+.... .....+.+.+|+.++++++ ||||++++++|.+
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 99 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQ---TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYED 99 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred hhhheeecceeeecCCeEEEEEEECC---CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhcc
Confidence 45689999999999999999999876 7899999999764321 2344578899999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHH
Q 012518 201 ANSVYIVMEFCEGGELLDRILSR---------------------------------------GGRYLEEDAKTIVEKILN 241 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~qil~ 241 (461)
.+.+|+|||||+||+|.+++... ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999877311 112356778899999999
Q ss_pred HHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCC-----CccccccCCCcCchhhhh---ccCCCchh
Q 012518 242 IVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLH---RSYNVEGD 313 (461)
Q Consensus 242 al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~---~~~~~~~D 313 (461)
||.|||++||+||||||+|||++.+ ....+||+|||++....... ......||+.|+|||++. ..++.++|
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCS-SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecC-CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999999999999999999999632 23479999999998653321 234568999999999985 46899999
Q ss_pred HHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 314 MWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 314 iwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
||||||++|+|++|+.||.+....+....+......+....+..+++++.+||.+||+.||.+||++.|+|+||||++..
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999999999999999999988877777766677899999999999999999999999999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=422.64 Aligned_cols=258 Identities=28% Similarity=0.461 Sum_probs=223.8
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||+|+||+||+|+++. +|+.||||++.+.........+.+.+|+.+|++++ ||||++++++|.+.+.
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTD 259 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCE
Confidence 4689999999999999999999876 79999999997654333334567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 204 VYIVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
+|+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~---~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe---CCCCEEEeeccee
Confidence 99999999999999988654 24699999999999999999999999999999999999994 6778999999999
Q ss_pred cccCCCCC-ccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC----hhhHHHHHHhcCCCCCCCC
Q 012518 281 DFVRPDQR-LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART----ESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 281 ~~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~ 354 (461)
........ ....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.. ...+...+......++
T Consensus 337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--- 413 (543)
T 3c4z_A 337 VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--- 413 (543)
T ss_dssp EECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC---
T ss_pred eeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC---
Confidence 87765443 345689999999999874 69999999999999999999999998753 3566677776655544
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCcCCC
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 392 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 392 (461)
..+++++++||.+||++||.+||+ ++++++||||++.
T Consensus 414 -~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 414 -DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred -cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 358999999999999999999995 5899999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=401.22 Aligned_cols=262 Identities=26% Similarity=0.400 Sum_probs=216.3
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCC--HHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS--ALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|++++.||+|+||.||+|+++. +|+.||||++....... ....+.+.+|+.+++.++ ||||++++++|.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHK 84 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCT
T ss_pred hcccEEEeEEeecCCEEEEEEEECC---CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeC
Confidence 4689999999999999999999876 78999999997543221 111246779999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+.+|+||||+.+ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAK 160 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCGGGS
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc---CCCCEEEEecccce
Confidence 999999999976 89888877666799999999999999999999999999999999999995 56789999999998
Q ss_pred ccCCC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC---
Q 012518 282 FVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW--- 355 (461)
Q Consensus 282 ~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--- 355 (461)
..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..++..........|
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 76433 33456789999999999853 4899999999999999999999999999888888777654222221111
Q ss_pred ---------------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 356 ---------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 356 ---------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
..+++++++||.+||..||.+|||+.|+|+||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 35679999999999999999999999999999998753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=388.84 Aligned_cols=257 Identities=32% Similarity=0.623 Sum_probs=221.7
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++++.||+|+||+||+|+++. +++.||||++.............+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATR 83 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred cccEEEeeEEecCCCeEEEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCE
Confidence 3589999999999999999999876 78899999997654333334567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
.++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHA 159 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC---TTSCEEECSCCEESCC
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc---CCCCEEEEeccccccC
Confidence 99999999999999988655 5799999999999999999999999999999999999994 5677999999998654
Q ss_pred CCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
... ......||+.|+|||++. ..++.++|||||||++|+|++|..||......+....+......++. .+++++
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 234 (279)
T 3fdn_A 160 PSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGA 234 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHH
T ss_pred Ccc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHHH
Confidence 432 334568999999999986 45889999999999999999999999998888888888776655443 488999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 235 ~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 235 RDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 9999999999999999999999999997653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=396.41 Aligned_cols=259 Identities=29% Similarity=0.502 Sum_probs=229.2
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
...+|.+.+.||+|+||.||++++.. +++.||+|++...........+.+.+|+.+++.+. |+||+++++++.+.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDND 114 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 34689999999999999999999876 78999999998776666667788999999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLATK 190 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEE
T ss_pred eEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc---CCCCEEEeeccCcee
Confidence 999999999999999877654 5799999999999999999999999999999999999995 567799999999987
Q ss_pred cCCC-CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 283 VRPD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 283 ~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
.... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||......+.+..+......++ ..+++
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~ 266 (335)
T 2owb_A 191 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINP 266 (335)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCH
T ss_pred cccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCH
Confidence 6533 3345568999999999986 4589999999999999999999999998888887777776655443 35889
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
++.+||.+||+.||.+|||+.|+|+||||....
T Consensus 267 ~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 267 VAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999999998653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=389.29 Aligned_cols=264 Identities=36% Similarity=0.697 Sum_probs=225.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH---HHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA---LAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
+.++|++.+.||+|+||+||+|+++. +|+.||||++........ ...+.+.+|+.++++++ ||||+++++++.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 78 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFE 78 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcC---CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheec
Confidence 34689999999999999999999876 789999999976543221 23577889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC-CCCCeeEeecc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE-EDAPLKVIDFG 278 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~-~~~~~kl~DFG 278 (461)
+.+..|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999999988654 5799999999999999999999999999999999999996432 12379999999
Q ss_pred cccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 279 LSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 279 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
++.............||+.|+|||++. +.++.++||||||+++|+|++|..||.+....+.+..+......+....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 998776655556678999999999986 5689999999999999999999999999888888888877665555444567
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
+++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 8999999999999999999999999999999965
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=389.20 Aligned_cols=258 Identities=31% Similarity=0.580 Sum_probs=198.1
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|++.. +|+.||||++...........+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYV 86 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEE
T ss_pred ccceeeeeecCCCceEEEEEEEcc---CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeE
Confidence 479999999999999999999875 78999999997543322233567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC---TTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEEeecceeecc
Confidence 999999999999998877667899999999999999999999999999999999999995 56779999999998765
Q ss_pred CC-CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 PD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
.. .......||+.|+|||++. ..++.++|||||||++|+|++|+.||........+..+.......+ ..++.++
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 239 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP----SFLSIEA 239 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC----TTSCHHH
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc----cccCHHH
Confidence 32 2334567999999999886 4589999999999999999999999987766655555443332222 3589999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.+||.+||+.||.+|||+.++|+||||....
T Consensus 240 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9999999999999999999999999997643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=402.16 Aligned_cols=258 Identities=29% Similarity=0.520 Sum_probs=214.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+.++|++++.||+|+||+||+|.++. +|+.||||++.... ......+.+.+|+++|+.++ ||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE 97 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred ecceEEEeEEeeecCCeEEEEEEECC---CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCC
Confidence 45689999999999999999999876 89999999986543 34555678899999999996 999999999997653
Q ss_pred ------eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 203 ------SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 203 ------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~D 171 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILD 171 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECC
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc---CCCCEEEEe
Confidence 469999999 7899887754 4699999999999999999999999999999999999995 567899999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC-----
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN----- 349 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~----- 349 (461)
||+++.... .....+||++|+|||++.+ .|+.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 172 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 172 FGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999987543 3456789999999998864 6999999999999999999999999998887777766542211
Q ss_pred ------------------CCC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 350 ------------------FHD----SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 350 ------------------~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
... ..++.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 111 12356799999999999999999999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=399.52 Aligned_cols=264 Identities=25% Similarity=0.430 Sum_probs=221.9
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
...+.++|++.+.||+|+||+||+|++.. +|+.||||++.............+.+|+.++++++ ||||+++++++.
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 82 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLR---DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGE 82 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECC---CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeee
Confidence 34567899999999999999999999876 78999999998776666667778999999999996 999999999987
Q ss_pred eCC----eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 200 DAN----SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 200 ~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
... ..|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~ 158 (311)
T 3ork_A 83 AETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVM 158 (311)
T ss_dssp EEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEEC
T ss_pred ccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEe
Confidence 654 349999999999999988655 5799999999999999999999999999999999999996 46679999
Q ss_pred ecccccccCCCC----CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC
Q 012518 276 DFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 276 DFG~a~~~~~~~----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
|||++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+.......
T Consensus 159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238 (311)
T ss_dssp CCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred eccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC
Confidence 999998664332 223467999999999986 468999999999999999999999999988888777777665554
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
....+..+++++.+||.+||+.||.+||++.++|.|+|++.
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 44445678999999999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=403.19 Aligned_cols=257 Identities=25% Similarity=0.470 Sum_probs=214.4
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG-HKHMIKFHDAFEDAN 202 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~-hpniv~l~~~~~~~~ 202 (461)
..+|++++.||+|+||+||+|.+. +|+.||||++..... .....+.+.+|+.+|++|.+ |+||+++++++...+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEccCCCeEEEEEEcC----CCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 357999999999999999999875 478999999976543 45566789999999999974 699999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+||||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQ 203 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCC
T ss_pred EEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCcccc
Confidence 9999999 5688999988654 5789999999999999999999999999999999999994 46799999999987
Q ss_pred cCCCC---CccccccCCCcCchhhhhc------------cCCCchhHHHHHHHHHHHhhCCCCCCCCCh-hhHHHHHHhc
Q 012518 283 VRPDQ---RLNDIVGSAYYVAPEVLHR------------SYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLRA 346 (461)
Q Consensus 283 ~~~~~---~~~~~~gt~~y~aPE~l~~------------~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~ 346 (461)
..... .....+||+.|+|||++.+ .|+.++|||||||+||||++|+.||..... ...+..++..
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 65432 2345689999999999864 589999999999999999999999987543 3455555554
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 347 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 347 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
...+... ...+.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 284 ~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 284 NHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp TSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cccCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 4333322 23588999999999999999999999999999998654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=391.25 Aligned_cols=256 Identities=29% Similarity=0.542 Sum_probs=213.0
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED-- 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~-- 200 (461)
..++|++++.||+|+||+||+|++.. +|+.||||++.... .+.+.+|+.+++.+++||||+++++++.+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECC---CCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 34689999999999999999999876 78999999987432 35688999999999779999999999988
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
....++||||+.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++. ++..+||+|||++
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLA 178 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCCTTC
T ss_pred CCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC--CCCEEEEEeCCCc
Confidence 678999999999999988662 4899999999999999999999999999999999999963 3347999999999
Q ss_pred cccCCCCCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCC-hhhHHHHHH-------------
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWART-ESGIFRSVL------------- 344 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~------------- 344 (461)
.............||..|+|||++. ..++.++|||||||++|+|++|..||.... ..+.+..+.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 179 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred eEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 8877666667778999999999986 458999999999999999999999995443 222222211
Q ss_pred hcCCCCC--------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 345 RADPNFH--------------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 345 ~~~~~~~--------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.....+. ......+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 1111110 011123799999999999999999999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=406.67 Aligned_cols=262 Identities=29% Similarity=0.477 Sum_probs=208.9
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+.++|++++.||+|+||+||+|+++. +|+.||||++... .......+.+.+|+.+|+.++ |+||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRM-FEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPD 97 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecC
Confidence 355799999999999999999999876 7899999999754 234555678899999999996 99999999999766
Q ss_pred -----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 202 -----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 202 -----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
+.+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~---~~~~~kL~D 172 (432)
T 3n9x_A 98 DLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN---QDCSVKVCD 172 (432)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECC
T ss_pred CCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC---CCCCEEEcc
Confidence 57999999996 599887754 46799999999999999999999999999999999999994 567899999
Q ss_pred cccccccCCCC-----------------------CccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCC--
Q 012518 277 FGLSDFVRPDQ-----------------------RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSR-- 329 (461)
Q Consensus 277 FG~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~-- 329 (461)
||+++...... .....+||++|+|||++. ..|+.++|||||||+||||++|..
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 99998765332 236678999999999863 459999999999999999998543
Q ss_pred ---------CCCCCC-----------------hhhHHHHHHhc-----------------------CCCCCCC----CCC
Q 012518 330 ---------PFWART-----------------ESGIFRSVLRA-----------------------DPNFHDS----PWP 356 (461)
Q Consensus 330 ---------Pf~~~~-----------------~~~~~~~i~~~-----------------------~~~~~~~----~~~ 356 (461)
+|.+.+ ..+.+..|+.. .+..... .++
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence 343332 11222222211 1111110 135
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 6899999999999999999999999999999998764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=406.70 Aligned_cols=256 Identities=26% Similarity=0.444 Sum_probs=211.7
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
...+|++++.||+|+||+||+|+++. +|+.||||++..... ...+|+++|+.|+ |+||++++++|...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECC---CCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccC
Confidence 34589999999999999999999876 789999999865432 1237999999996 99999999998532
Q ss_pred -----CeEEEEEeccCCCchHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCee
Q 012518 202 -----NSVYIVMEFCEGGELLDRIL---SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 273 (461)
Q Consensus 202 -----~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~k 273 (461)
..+++||||+.+ +|.+.+. .....+++..++.++.||+.||.|||++||+||||||+||||+. +.+.+|
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~~k 197 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLK 197 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET--TTTEEE
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC--CCCeEE
Confidence 237799999975 6665553 33567999999999999999999999999999999999999963 345689
Q ss_pred EeecccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc-----
Q 012518 274 VIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA----- 346 (461)
Q Consensus 274 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~----- 346 (461)
|+|||+++...........+||+.|+|||++.+ .|+.++|||||||+||||++|+.||.+.+..+.+..++..
T Consensus 198 l~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 198 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277 (420)
T ss_dssp ECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred eccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999999998766655667889999999999853 5999999999999999999999999998877766666542
Q ss_pred -------CCCCCCC--------CC-----CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 347 -------DPNFHDS--------PW-----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 347 -------~~~~~~~--------~~-----~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.+.+... .| +.+++++++||.+||++||.+|||+.|+|+||||+..
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 1111111 11 3468999999999999999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=386.65 Aligned_cols=257 Identities=29% Similarity=0.613 Sum_probs=224.4
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||+|+||.||+|++.. +++.||||++...........+.+.+|+++++.++ ||||+++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKR 88 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred hhhceeeheecCCCCeEEEEEEEcC---CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCE
Confidence 3589999999999999999999876 78899999997543322223467889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSVHA 164 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc---CCCCEEEecccccccC
Confidence 99999999999999988665 5799999999999999999999999999999999999995 5677999999998765
Q ss_pred CCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
... ......||+.|+|||++. ..++.++|||||||++|+|++|..||......+....+......++ ..+++++
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 239 (284)
T 2vgo_A 165 PSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGS 239 (284)
T ss_dssp SSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHH
T ss_pred ccc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHH
Confidence 432 334568999999999987 4589999999999999999999999998888888888877655443 3589999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
++||.+||..||.+||++.|+++||||+...
T Consensus 240 ~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 9999999999999999999999999997643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=384.55 Aligned_cols=261 Identities=34% Similarity=0.599 Sum_probs=216.8
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
|....++|++++.||+|+||.||+|.++. +|+.||||++...........+.+.+|+.+++.++ ||||+++++++.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 81 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQL---TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVIS 81 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECC---CCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEe
Confidence 34455789999999999999999999876 78999999997643322334567889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
+.+.+|+||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~ 157 (276)
T 2h6d_A 82 TPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGL 157 (276)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC---TTSCEEECCCCG
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC---CCCCEEEeeccc
Confidence 999999999999999999988655 5789999999999999999999999999999999999995 567799999999
Q ss_pred ccccCCCCCccccccCCCcCchhhhhcc-C-CCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 280 SDFVRPDQRLNDIVGSAYYVAPEVLHRS-Y-NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 280 a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
+.............||+.|+|||++.+. + +.++||||||+++|+|++|..||...........+......++ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~ 233 (276)
T 2h6d_A 158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EY 233 (276)
T ss_dssp GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TT
T ss_pred ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hh
Confidence 9877655555567899999999998753 3 6899999999999999999999998888888777776554433 34
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
++.++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 234 ~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 234 LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 78999999999999999999999999999999764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=384.07 Aligned_cols=259 Identities=29% Similarity=0.502 Sum_probs=228.5
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||+||+|+++. +|+.||+|++...........+.+.+|+.+++.+. |+||+++++++.+.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDND 88 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred cccceEEEEEEeecCCEEEEEEEECC---CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCC
Confidence 44689999999999999999999876 78999999998776666667788999999999995 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEE
T ss_pred EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc---CCCCEEEEeccCcee
Confidence 999999999999999877554 5799999999999999999999999999999999999995 567799999999987
Q ss_pred cCCC-CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 283 VRPD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 283 ~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
.... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||......+.+..+......++ ..+++
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 240 (294)
T 2rku_A 165 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINP 240 (294)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCH
T ss_pred cccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCH
Confidence 6533 2344567999999999986 4589999999999999999999999999888887777776554433 35889
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
++.+||.+||+.||.+|||+.|+++||||....
T Consensus 241 ~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 999999999999999999999999999998653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=406.78 Aligned_cols=265 Identities=28% Similarity=0.476 Sum_probs=201.3
Q ss_pred Cccccceee-ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 121 KNFGAKFEL-GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 121 ~~~~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
+.+.+.|++ +++||+|+||+||+|+++.+ .+++.||||++...... ..+.+|+.+|+.|+ ||||++++++|.
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~-hpniv~~~~~~~ 88 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDG-KDDKDYALKQIEGTGIS-----MSACREIALLRELK-HPNVISLQKVFL 88 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSS-SCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCC-CTTBCCCCEEEE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccC-CCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcC-CCCeeeEeeEEe
Confidence 345567887 55899999999999997642 26889999999765332 45778999999996 999999999995
Q ss_pred e--CCeEEEEEeccCCCchHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC-CC
Q 012518 200 D--ANSVYIVMEFCEGGELLDRILSR--------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR-EE 268 (461)
Q Consensus 200 ~--~~~~~lv~e~~~gg~L~~~l~~~--------~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~-~~ 268 (461)
+ ...+|+||||+. |+|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+... +.
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 89 SHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp ETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTT
T ss_pred cCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCC
Confidence 4 778999999996 5888877532 1248999999999999999999999999999999999999643 35
Q ss_pred CCCeeEeecccccccCCC----CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCh------
Q 012518 269 DAPLKVIDFGLSDFVRPD----QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTE------ 336 (461)
Q Consensus 269 ~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~------ 336 (461)
++.+||+|||++...... ......+||+.|+|||++.+ .|+.++|||||||+||+|++|+.||.+...
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 247 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence 678999999999876532 23355789999999999864 489999999999999999999999976554
Q ss_pred ---hhHHHHHHhcCCCCCCCCCCC----------------------------------CCHHHHHHHHHhcccCcCCCCC
Q 012518 337 ---SGIFRSVLRADPNFHDSPWPS----------------------------------VSPEAKDFVRRLLNKDHRKRMT 379 (461)
Q Consensus 337 ---~~~~~~i~~~~~~~~~~~~~~----------------------------------~s~~~~~li~~~L~~dP~~R~s 379 (461)
.+.+..++..........|.. .++++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t 327 (405)
T 3rgf_A 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327 (405)
T ss_dssp CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence 244555544333223222322 2788999999999999999999
Q ss_pred HHHHhcCCCcCCCC
Q 012518 380 AAQALTHPWLHDEN 393 (461)
Q Consensus 380 ~~e~L~hp~~~~~~ 393 (461)
++|+|+||||.+..
T Consensus 328 a~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 328 SEQAMQDPYFLEDP 341 (405)
T ss_dssp HHHHHTSGGGTSSS
T ss_pred HHHHhcChhhccCC
Confidence 99999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=381.54 Aligned_cols=258 Identities=21% Similarity=0.380 Sum_probs=216.3
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe---
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED--- 200 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~--- 200 (461)
+..|++.+.||+|+||+||+|.+.. ++..||+|++..... .....+.+.+|+.+++.++ ||||++++++|..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVK 99 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESS
T ss_pred ceeEEeeeeccCCCCeEEEEeEecC---CceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccC
Confidence 4579999999999999999999876 788999999976543 4455678899999999996 9999999999875
Q ss_pred -CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 201 -ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 201 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~g--ivHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ +.++.+||+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Df 176 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDL 176 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCT
T ss_pred CCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeC
Confidence 45689999999999999988654 57999999999999999999999999 99999999999995 25667999999
Q ss_pred ccccccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhH-HHHHHhcCCCCCCCCCC
Q 012518 278 GLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGI-FRSVLRADPNFHDSPWP 356 (461)
Q Consensus 278 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 356 (461)
|++..... .......||+.|+|||++.+.++.++|||||||++|+|++|+.||........ ...+..... ......
T Consensus 177 g~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~ 253 (290)
T 1t4h_A 177 GLATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDK 253 (290)
T ss_dssp TGGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGG
T ss_pred CCcccccc-cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--ccccCC
Confidence 99976543 33455679999999999988899999999999999999999999987554443 333333221 111123
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 467999999999999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=402.85 Aligned_cols=260 Identities=30% Similarity=0.562 Sum_probs=217.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-SALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
++|++++.||+|+||+||+|++..+..+|+.||||++++.... .....+.+.+|+++|+.+.+||||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6899999999999999999998655558999999998754321 111234566899999999669999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCcEEEeeCCCCeec
Confidence 99999999999999988765 5799999999999999999999999999999999999994 5678999999999865
Q ss_pred CCCC--CccccccCCCcCchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCC----hhhHHHHHHhcCCCCCCCC
Q 012518 284 RPDQ--RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWART----ESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 284 ~~~~--~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~ 354 (461)
.... .....+||+.|+|||++.+ .++.++|||||||+||+|++|+.||.... ...+...+....+.++
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 286 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--- 286 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC---
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC---
Confidence 4322 2345689999999999863 37899999999999999999999997543 3344555555444333
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
..++..+.+||.+||..||.+|| +++|+++||||+..
T Consensus 287 -~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 287 -QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred -cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 45899999999999999999999 99999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=384.30 Aligned_cols=264 Identities=27% Similarity=0.479 Sum_probs=219.6
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
....++|++++.||+|+||.||+|+++. +|+.||+|++..... ...+.+.+|+.+++.+. ||||+++++++.+
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIETKSE---EELEDYIVEIEILATCD-HPYIVKLLGAYYH 87 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETT---TCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred cCCccceeecceeccCCCeEEEEEEEcC---CCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCC-CCCEeeeeeeeee
Confidence 3456799999999999999999999876 789999999875432 23567889999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+.+|+||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVS 164 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTSCEEECCCHHH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC---CCCCEEEEECCCC
Confidence 9999999999999999998877677899999999999999999999999999999999999995 5677999999987
Q ss_pred cccCCC-CCccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCC
Q 012518 281 DFVRPD-QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 353 (461)
Q Consensus 281 ~~~~~~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 353 (461)
...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+........ .
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 243 (302)
T 2j7t_A 165 AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-L 243 (302)
T ss_dssp HHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-S
T ss_pred ccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-C
Confidence 543211 1224467999999999873 3588999999999999999999999998887777776666543221 1
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCC
Q 012518 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395 (461)
Q Consensus 354 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~ 395 (461)
....++.++.+||.+||..||.+|||+.|+++||||+.....
T Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred CccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 124578999999999999999999999999999999876544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=397.11 Aligned_cols=254 Identities=32% Similarity=0.489 Sum_probs=215.2
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH-----HHHHHHHHHHHHHHhcCCCCCeeEEEE
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA-----LAIEDVRREVKILKALSGHKHMIKFHD 196 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~~hpniv~l~~ 196 (461)
.+.++|++.+.||+|+||+||+|+++. +|+.||||++........ ...+.+.+|+.+|++++ ||||+++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~ 96 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKE---KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLD 96 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETT---TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECC---CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence 356799999999999999999999876 789999999987543221 12345678999999996 999999999
Q ss_pred EEEeCCeEEEEEeccCCC-chHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 197 AFEDANSVYIVMEFCEGG-ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 197 ~~~~~~~~~lv~e~~~gg-~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
+|.+.+.+++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~ 172 (335)
T 3dls_A 97 IFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLI 172 (335)
T ss_dssp EEECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEEC
T ss_pred EEeeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc---CCCcEEEe
Confidence 999999999999999777 88887754 46799999999999999999999999999999999999995 56789999
Q ss_pred ecccccccCCCCCccccccCCCcCchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCC
Q 012518 276 DFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-S-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 353 (461)
Q Consensus 276 DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 353 (461)
|||++............+||+.|+|||++.+ . ++.++|||||||++|+|++|..||..... ...... .
T Consensus 173 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~----~ 242 (335)
T 3dls_A 173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAI----H 242 (335)
T ss_dssp CCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCC----C
T ss_pred ecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhcc----C
Confidence 9999998776666667889999999999864 3 48899999999999999999999965322 111111 1
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 354 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
....+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 243 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 1234899999999999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=384.77 Aligned_cols=264 Identities=25% Similarity=0.415 Sum_probs=220.3
Q ss_pred CCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 119 YGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 119 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
.|+.+.++|++++.||+|+||+||+|++.. +|+.||||++...........+.+.+|+.++++++ ||||+++++++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~ 80 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTI---LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVD 80 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETT---TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEE
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECC---CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEee
Confidence 467788899999999999999999999876 78999999997766666677788999999999996 99999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 199 EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 199 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
.+.+.+|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg 156 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFG 156 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCS
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEEeCC
Confidence 9999999999999999999988655 5799999999999999999999999999999999999995 56779999999
Q ss_pred cccccCCCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC-CCCCCC
Q 012518 279 LSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP-NFHDSP 354 (461)
Q Consensus 279 ~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~ 354 (461)
++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+............. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T 4eqm_A 157 IAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDV 236 (294)
T ss_dssp SSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHS
T ss_pred CccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhc
Confidence 998765432 234467999999999986 4589999999999999999999999998887666555554322 221223
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
.+.+++.+.++|.+||++||.+||+..+.+.+.|..
T Consensus 237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 456899999999999999999999777777776654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=404.26 Aligned_cols=262 Identities=28% Similarity=0.419 Sum_probs=216.5
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC-----CCCCeeEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS-----GHKHMIKF 194 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----~hpniv~l 194 (461)
++.+..+|++++.||+|+||+||+|.+.. +|+.||||++... ......+.+|+.+++.++ +|+||+++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~---~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETT---TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECC---CCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 45567799999999999999999999876 7899999999753 334567788999998874 47899999
Q ss_pred EEEEEeCCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCee
Q 012518 195 HDAFEDANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 273 (461)
Q Consensus 195 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~k 273 (461)
++++...+.+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+|
T Consensus 165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~-~~~vk 242 (429)
T 3kvw_A 165 LENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-RSGIK 242 (429)
T ss_dssp EEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT-SCCEE
T ss_pred EeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC-CcceE
Confidence 999999999999999996 58999887654 3589999999999999999999999999999999999996321 12399
Q ss_pred EeecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC
Q 012518 274 VIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD 352 (461)
Q Consensus 274 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 352 (461)
|+|||++.... ......+||+.|+|||++. ..|+.++|||||||+||||++|..||.+.+..+.+..+.........
T Consensus 243 L~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 243 VIDFGSSCYEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp ECCCTTCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred EeecccceecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 99999997653 3345678999999999986 46999999999999999999999999998887777666532110000
Q ss_pred --------------------------------------------------CC-----CCCCCHHHHHHHHHhcccCcCCC
Q 012518 353 --------------------------------------------------SP-----WPSVSPEAKDFVRRLLNKDHRKR 377 (461)
Q Consensus 353 --------------------------------------------------~~-----~~~~s~~~~~li~~~L~~dP~~R 377 (461)
.. ....++++.+||.+||+.||.+|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 00 01237889999999999999999
Q ss_pred CCHHHHhcCCCcCCC
Q 012518 378 MTAAQALTHPWLHDE 392 (461)
Q Consensus 378 ~s~~e~L~hp~~~~~ 392 (461)
||++|+|+||||+..
T Consensus 401 pta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 401 MTPGQALRHPWLRRR 415 (429)
T ss_dssp CCHHHHHTSTTTC--
T ss_pred CCHHHHhCChhhccC
Confidence 999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=399.74 Aligned_cols=255 Identities=27% Similarity=0.465 Sum_probs=212.9
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED-- 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~-- 200 (461)
..++|++++.||+|+||+||+|++.. +|+.||||++...... ..+|+++|+.++ ||||++++++|..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~~~~-------~~~E~~il~~l~-hpnIv~l~~~~~~~~ 73 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPRY-------KNRELDIMKVLD-HVNIIKLVDYFYTTG 73 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETT---TCCEEEEEEEECCTTS-------CCHHHHHHTTCC-CTTBCCEEEEEEEC-
T ss_pred ccceEEEEEEEEeccCEEEEEEEECC---CCCEEEEEEEecCcch-------HHHHHHHHHHcC-CCCccchhheeeecC
Confidence 45689999999999999999999876 8899999998654322 237999999996 9999999999843
Q ss_pred ------------------------------------CCeEEEEEeccCCCchHHHHH---hcCCCCCHHHHHHHHHHHHH
Q 012518 201 ------------------------------------ANSVYIVMEFCEGGELLDRIL---SRGGRYLEEDAKTIVEKILN 241 (461)
Q Consensus 201 ------------------------------------~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~i~~qil~ 241 (461)
...+++||||+. |+|.+.+. ..+..+++..++.++.||+.
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp ------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 345899999997 48776664 34567999999999999999
Q ss_pred HHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHH
Q 012518 242 IVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGV 319 (461)
Q Consensus 242 al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGv 319 (461)
||.|||++||+||||||+|||++. .++.+||+|||++.............||+.|+|||++.+ .|+.++|||||||
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEET--TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHHHHCcCccCccCHHHEEEcC--CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 999999999999999999999962 466799999999998776666677889999999998864 4899999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHHHHhcC------------CCCCC--------CC-----CCCCCHHHHHHHHHhcccCc
Q 012518 320 ITYILLCGSRPFWARTESGIFRSVLRAD------------PNFHD--------SP-----WPSVSPEAKDFVRRLLNKDH 374 (461)
Q Consensus 320 il~elltg~~Pf~~~~~~~~~~~i~~~~------------~~~~~--------~~-----~~~~s~~~~~li~~~L~~dP 374 (461)
++|+|++|+.||.+.+..+.+..+.... +.+.. .. ...+++++.+||.+||+.||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999999988887777665421 11111 11 12478999999999999999
Q ss_pred CCCCCHHHHhcCCCcCC
Q 012518 375 RKRMTAAQALTHPWLHD 391 (461)
Q Consensus 375 ~~R~s~~e~L~hp~~~~ 391 (461)
.+|||+.|+|+||||++
T Consensus 311 ~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDH 327 (383)
T ss_dssp GGSCCHHHHHTSGGGHH
T ss_pred hhCCCHHHHhcCHHHHH
Confidence 99999999999999965
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=379.69 Aligned_cols=261 Identities=19% Similarity=0.318 Sum_probs=213.7
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
...+.++|++.+.||+|+||+||+|.++. +|+.||||++....... .....+.+|+.++..+.+||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~ 81 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRL---DGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWA 81 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEE
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcC---CCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 34466799999999999999999999876 78999999998654333 345678899999999955999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC---------
Q 012518 200 DANSVYIVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE--------- 267 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~--------- 267 (461)
+.+.+|+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence 999999999999999999988654 25689999999999999999999999999999999999997433
Q ss_pred -------CCCCeeEeecccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhh
Q 012518 268 -------EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESG 338 (461)
Q Consensus 268 -------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~ 338 (461)
....+||+|||++...... ....||+.|+|||++.+ .++.++|||||||++|+|++|..++....
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--- 235 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--- 235 (289)
T ss_dssp --------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred ccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence 4557999999999876533 23469999999999875 45679999999999999999998875443
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 339 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 339 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
....+...... .....+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 236 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 236 QWHEIRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHHHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHHHHHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 23334333221 11246899999999999999999999999999999998653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=393.39 Aligned_cols=255 Identities=30% Similarity=0.451 Sum_probs=205.7
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+.++|++++.||+|+||+||+|+++. +|+.||||++.... .....+.+.+|+.+|++|+ ||||++++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKV---DDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETT---TCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECC
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcC---CCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEec
Confidence 45689999999999999999999876 78999999997653 2334577899999999996 999999999986543
Q ss_pred ---------------------------------------------------------eEEEEEeccCCCchHHHHHhcCC
Q 012518 203 ---------------------------------------------------------SVYIVMEFCEGGELLDRILSRGG 225 (461)
Q Consensus 203 ---------------------------------------------------------~~~lv~e~~~gg~L~~~l~~~~~ 225 (461)
.+|+|||||+||+|.+++.....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 38999999999999998865432
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCC-------------Ccc
Q 012518 226 --RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-------------RLN 290 (461)
Q Consensus 226 --~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~-------------~~~ 290 (461)
...+..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....... ...
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEECSCC--------------CCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe---CCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 345567899999999999999999999999999999995 56789999999998765432 224
Q ss_pred ccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 012518 291 DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 369 (461)
Q Consensus 291 ~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 369 (461)
..+||+.|+|||++. ..++.++|||||||++|+|++|..|+.. .......+... .++ ..+...++++.+||.+|
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~--~~~-~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL--KFP-LLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT--CCC-HHHHHHCHHHHHHHHHH
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc--CCC-cccccCChhHHHHHHHH
Confidence 467999999999987 4699999999999999999998776522 12222222222 111 11234678899999999
Q ss_pred cccCcCCCCCHHHHhcCCCcCC
Q 012518 370 LNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 370 L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
|+.||.+|||+.|+|+||||++
T Consensus 310 l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 310 LSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HCSSGGGSCCHHHHHHSTTCCC
T ss_pred ccCCCCcCCCHHHHhhchhhhc
Confidence 9999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=398.52 Aligned_cols=257 Identities=27% Similarity=0.452 Sum_probs=205.4
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++++.||+|+||+||+|.++. +|+.||||++.... ......+.+.+|+.+++.++ ||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK 97 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECC---CCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeecccc
Confidence 45689999999999999999999876 78999999997643 34455677889999999996 999999999997665
Q ss_pred ------eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 203 ------SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 203 ------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
.+|+|||||.+ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~D 170 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 170 (371)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECC
T ss_pred ccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEEE
Confidence 78999999975 7888774 3589999999999999999999999999999999999995 567799999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC-----
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF----- 350 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----- 350 (461)
||++............+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 171 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 171 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp CCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred eecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99998776555556678999999999986 469999999999999999999999999988877777766532211
Q ss_pred -----------------CCCC---------CC-------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 351 -----------------HDSP---------WP-------SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 351 -----------------~~~~---------~~-------~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
.... ++ ..++++++||.+||+.||.+|||++|+|+||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 1000 00 01568999999999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=390.14 Aligned_cols=258 Identities=24% Similarity=0.454 Sum_probs=210.4
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC-CCeeEEEEEEEeC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH-KHMIKFHDAFEDA 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pniv~l~~~~~~~ 201 (461)
.+++|++++.||+|+||+||+|.+. +++.||||++.... ......+.+.+|+.+|+.+.+| +||+++++++.+.
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT----TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC----CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 3568999999999999999999874 58899999997654 3455567889999999999733 9999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+.+|+|||+ .+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.
T Consensus 82 ~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 82 QYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIAN 155 (343)
T ss_dssp SEEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSC
T ss_pred CEEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeeccccc
Confidence 999999995 578999988654 6799999999999999999999999999999999999995 4569999999998
Q ss_pred ccCCCCC---ccccccCCCcCchhhhh------------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh-hhHHHHHHh
Q 012518 282 FVRPDQR---LNDIVGSAYYVAPEVLH------------RSYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLR 345 (461)
Q Consensus 282 ~~~~~~~---~~~~~gt~~y~aPE~l~------------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~ 345 (461)
....... ....+||+.|+|||++. +.++.++|||||||++|+|++|+.||..... ...+..+..
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 7654332 24568999999999985 4588999999999999999999999976543 233444443
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 346 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 346 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
....... ....++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 236 ~~~~~~~--~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 236 PNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp TTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCcccCC--cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 3222221 234678999999999999999999999999999998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=384.97 Aligned_cols=261 Identities=28% Similarity=0.519 Sum_probs=214.5
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
....++|++++.||+|+||.||+|++.. +|+.||||++..... ..+.+.+|+.+++++.+||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECC---CCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 3455789999999999999999999876 789999999975432 235788999999999669999999999987
Q ss_pred ------CCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCee
Q 012518 201 ------ANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 273 (461)
Q Consensus 201 ------~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~k 273 (461)
.+.+|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~---~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc---CCCCEE
Confidence 568999999999999999887642 5689999999999999999999999999999999999995 567799
Q ss_pred EeecccccccCCCC-CccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc
Q 012518 274 VIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA 346 (461)
Q Consensus 274 l~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~ 346 (461)
|+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+...
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 99999988664332 234567999999999984 35899999999999999999999999888776666655544
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 347 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 347 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
... ......+++.+.+||.+||..||.+||++.++|+||||++..
T Consensus 250 ~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 250 PAP--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp CCC--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred ccc--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 322 122346899999999999999999999999999999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=400.57 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=213.0
Q ss_pred CCCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Q 012518 118 GYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDA 197 (461)
Q Consensus 118 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~ 197 (461)
..++....+|++.+.||+|+||+||+|++.. ++ .||+|++...... ..+|+++|+.++ ||||++++++
T Consensus 33 ~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~---~~-~~aikk~~~~~~~-------~~~E~~il~~l~-h~niv~l~~~ 100 (394)
T 4e7w_A 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVE---SD-EVAIKKVLQDKRF-------KNRELQIMRIVK-HPNVVDLKAF 100 (394)
T ss_dssp SSCCEEEEEEEEEEEEEEETTEEEEEEEETT---TE-EEEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEE
T ss_pred CCCCcccceEEEeEEEeeCCCeEEEEEEECC---CC-eEEEEEEecCcch-------HHHHHHHHHhCC-CCCcceEEEE
Confidence 3456667799999999999999999999864 33 4888887554322 126999999996 9999999999
Q ss_pred EEeCC------eEEEEEeccCCCchHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC
Q 012518 198 FEDAN------SVYIVMEFCEGGELLDRIL---SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 268 (461)
Q Consensus 198 ~~~~~------~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~ 268 (461)
|...+ .+|+|||||.++ +.+.+. .....+++..++.++.||+.||.|||++||+||||||+|||++ ..
T Consensus 101 ~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~ 177 (394)
T 4e7w_A 101 FYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PP 177 (394)
T ss_dssp EEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TT
T ss_pred EEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CC
Confidence 96543 388999999864 444333 2356799999999999999999999999999999999999996 24
Q ss_pred CCCeeEeecccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc
Q 012518 269 DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA 346 (461)
Q Consensus 269 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~ 346 (461)
++.+||+|||+++...........+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 178 ~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~ 257 (394)
T 4e7w_A 178 SGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257 (394)
T ss_dssp TTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 67799999999998766666667889999999999854 5999999999999999999999999998887777666542
Q ss_pred CC-----------------CCCC---C-----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 347 DP-----------------NFHD---S-----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 347 ~~-----------------~~~~---~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.. .++. . ..+.+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 11 1111 0 123488999999999999999999999999999999865
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=390.40 Aligned_cols=261 Identities=22% Similarity=0.392 Sum_probs=215.7
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
....++|++.+.||+|+||+||+|+++. +|+.||||++....... ..+.+.+|++++++++ ||||+++++++.+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 78 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLN-HKNIVKLFAIEEE 78 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECC---CCcEEEEEEeccccccc--hHHHHHHHHHHHHhcC-CCCcceEEEEeec
Confidence 3456799999999999999999999876 78999999997644322 3466789999999996 9999999999987
Q ss_pred CC--eEEEEEeccCCCchHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC-CCCCCeeEe
Q 012518 201 AN--SVYIVMEFCEGGELLDRILSRGG--RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR-EEDAPLKVI 275 (461)
Q Consensus 201 ~~--~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~-~~~~~~kl~ 275 (461)
.+ .+|+||||+.+|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+... +.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence 65 78999999999999998865432 38999999999999999999999999999999999998432 345669999
Q ss_pred ecccccccCCCCCccccccCCCcCchhhhh---------ccCCCchhHHHHHHHHHHHhhCCCCCCCCC----hhhHHHH
Q 012518 276 DFGLSDFVRPDQRLNDIVGSAYYVAPEVLH---------RSYNVEGDMWSIGVITYILLCGSRPFWART----ESGIFRS 342 (461)
Q Consensus 276 DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~ 342 (461)
|||++.............||+.|+|||++. ..++.++|||||||++|||++|+.||.... ..+.+..
T Consensus 159 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred cCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 999999887666667788999999999885 458899999999999999999999996432 3445555
Q ss_pred HHhcCCCC-------------------CC--CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 012518 343 VLRADPNF-------------------HD--SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387 (461)
Q Consensus 343 i~~~~~~~-------------------~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 387 (461)
+....+.- +. .....+++.+.+||.+||+.||++|||++|+|+||
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 55544311 10 00112456889999999999999999999999998
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=394.32 Aligned_cols=260 Identities=25% Similarity=0.442 Sum_probs=214.3
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++++.||+|+||.||+|+++. +|+.||||++.... ......+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETT---TCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECC---CCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCE
Confidence 4689999999999999999999876 78999999986653 34445567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+.+++|.+++ .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 99 ~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTL 174 (331)
T ss_dssp EEEEEECCSEEHHHHHH-HSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCTTC---
T ss_pred EEEEEecCCcchHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc---CCCcEEEEeCCCceee
Confidence 99999999988776654 4456799999999999999999999999999999999999995 5678999999999865
Q ss_pred CCC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC----------
Q 012518 284 RPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF---------- 350 (461)
Q Consensus 284 ~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~---------- 350 (461)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.......
T Consensus 175 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 443 23455689999999999864 58999999999999999999999999888776665554321110
Q ss_pred ----CC-------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 351 ----HD-------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 351 ----~~-------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.. ..++.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 00 0124679999999999999999999999999999999753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=398.47 Aligned_cols=257 Identities=31% Similarity=0.532 Sum_probs=201.2
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
+.++|++++.||+|+||.||+|.+.. +|+.||||++.... ......+.+.+|+.+|+.++ ||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 101 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETT---TTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred CCCceEEeeEEeecCCeEEEEEEECC---CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCC
Confidence 45799999999999999999999876 88999999986542 34455677889999999996 99999999999754
Q ss_pred -----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 202 -----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 202 -----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kL~D 175 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILD 175 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECC
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC---CCCCEEEee
Confidence 5689999999 7899887754 5799999999999999999999999999999999999995 567899999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC-----
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN----- 349 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~----- 349 (461)
||+++.... .....+||++|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 176 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 176 FGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999987543 3456789999999999864 6899999999999999999999999998887777666542111
Q ss_pred ------------------CCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 350 ------------------FHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 350 ------------------~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.... .++.+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 1111 124578999999999999999999999999999999865
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=379.02 Aligned_cols=261 Identities=28% Similarity=0.477 Sum_probs=223.9
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..+.|++++.||+|+||+||+|.+.. +|+.||||++...... ...+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDT 93 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECC---CCcEEEEEEecccccH--HHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence 34579999999999999999998876 7899999999765432 24577899999999995 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~~ 168 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQ 168 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC---CCCCEEEeeccccee
Confidence 99999999999999998743 5799999999999999999999999999999999999995 567799999999987
Q ss_pred cCCCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 283 VRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 283 ~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+....... ....++.
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 245 (303)
T 3a7i_A 169 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSK 245 (303)
T ss_dssp CBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---CCSSCCH
T ss_pred cCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---CccccCH
Confidence 65433 334568999999999986 468999999999999999999999998887777666665543221 2246899
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~ 397 (461)
++.+||.+||..||.+|||+.|+|+||||........
T Consensus 246 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 282 (303)
T 3a7i_A 246 PLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282 (303)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCGG
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCccH
Confidence 9999999999999999999999999999976544433
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=379.02 Aligned_cols=259 Identities=25% Similarity=0.358 Sum_probs=198.1
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++++.||+|+||+||+|++.. +|+.||||++..... .....+.+.++...++.+ +||||+++++++.+.+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVP---SGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecC---CCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccC
Confidence 34689999999999999999999876 789999999975432 222233344444446666 5999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 203 SVYIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
..|+||||+.| +|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg 155 (290)
T 3fme_A 80 DVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFG 155 (290)
T ss_dssp SEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC---TTCCEEBCCC-
T ss_pred CEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeecC
Confidence 99999999974 88776643 456799999999999999999999998 999999999999995 56789999999
Q ss_pred cccccCCCCCccccccCCCcCchhhhh-----ccCCCchhHHHHHHHHHHHhhCCCCCCC-CChhhHHHHHHhcCCCCCC
Q 012518 279 LSDFVRPDQRLNDIVGSAYYVAPEVLH-----RSYNVEGDMWSIGVITYILLCGSRPFWA-RTESGIFRSVLRADPNFHD 352 (461)
Q Consensus 279 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~ 352 (461)
++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||.. ......+......... .
T Consensus 156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~ 233 (290)
T 3fme_A 156 ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP--Q 233 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC--C
T ss_pred CcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC--C
Confidence 998776555555568999999999962 3588999999999999999999999976 3333444444433221 2
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 353 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 353 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.....+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 2234689999999999999999999999999999999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=381.24 Aligned_cols=262 Identities=26% Similarity=0.480 Sum_probs=216.9
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
+...++|++.+.||+|+||.||+|.++. +|+.||||++.... ..+.+.+|+.+++.+. ||||+++++++.+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 95 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFK 95 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETT---TCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECC---CCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEe
Confidence 3455789999999999999999999876 78999999997643 2356789999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+.+|+||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~ 172 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVA 172 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTC
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC---CCCCEEEeecccc
Confidence 9999999999999999999876677899999999999999999999999999999999999995 5677999999999
Q ss_pred cccCCCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 281 DFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 281 ~~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+....... ......+
T Consensus 173 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 251 (314)
T 3com_A 173 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT-FRKPELW 251 (314)
T ss_dssp EECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGGGS
T ss_pred hhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc-cCCcccC
Confidence 8765432 334567999999999986 458999999999999999999999998877666555544432211 1112347
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~ 395 (461)
++++.+||.+||..||.+|||+.++|+||||+.....
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV 288 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence 8999999999999999999999999999999876433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=393.13 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=217.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA-- 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~-- 201 (461)
+.+|++++.||+|+||.||+|++.. +|+.||||++... ......+.+.+|+++|++++ ||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPF--EHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTI 99 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSST
T ss_pred cccEEEEEEeecCCCeEEEEEEECC---CCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCc
Confidence 4699999999999999999999876 7899999999753 34445678899999999996 99999999999754
Q ss_pred ---CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 202 ---NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 202 ---~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
..+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 100 ~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg 173 (364)
T 3qyz_A 100 EQMKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFG 173 (364)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCT
T ss_pred cccceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC---CCCCEEEEeCc
Confidence 46999999997 599888754 4699999999999999999999999999999999999994 56779999999
Q ss_pred cccccCCCC----CccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC-
Q 012518 279 LSDFVRPDQ----RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH- 351 (461)
Q Consensus 279 ~a~~~~~~~----~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~- 351 (461)
++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+........
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 998765332 134568999999999875 3489999999999999999999999999888777776653211110
Q ss_pred ----------------------CC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 352 ----------------------DS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 352 ----------------------~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.. .++.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 01 124678999999999999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=391.43 Aligned_cols=259 Identities=37% Similarity=0.660 Sum_probs=190.5
Q ss_pred ccccceeece-eeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 122 NFGAKFELGK-EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 122 ~~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
.+.++|++.+ .||+|+||+||+|+++. +|+.||||++... . ...+|+..+.++.+|+||++++++|..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~----~----~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRR---TGQKCALKLLYDS----P----KARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESS----H----HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECC---CCCEEEEEEecCc----H----HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 4567899965 69999999999999886 7899999998653 1 223344443333369999999999976
Q ss_pred ----CCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 201 ----ANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 201 ----~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
...+|+|||||.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 456899999999999999987654 369999999999999999999999999999999999999866667789999
Q ss_pred ecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhH----HHHHHhcCCCC
Q 012518 276 DFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI----FRSVLRADPNF 350 (461)
Q Consensus 276 DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~----~~~i~~~~~~~ 350 (461)
|||++..... ......+||+.|+|||++. ..++.++|||||||++|+|++|..||........ ...+......+
T Consensus 174 Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 174 DFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp CCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred ccccceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 9999986643 3345568899999999985 5688999999999999999999999977655443 33334444555
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
....|..+++++++||.+||+.||.+|||+.|+|+||||++.
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 566677899999999999999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=395.09 Aligned_cols=265 Identities=24% Similarity=0.426 Sum_probs=219.1
Q ss_pred cCCCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCC-----e
Q 012518 117 FGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH-----M 191 (461)
Q Consensus 117 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn-----i 191 (461)
...++.+.++|++.+.||+|+||+||+|+++. +|+.||||+++.. ......+.+|+.+++.+.+|++ |
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i 118 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYI 118 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGB
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcC---CCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeE
Confidence 34567788899999999999999999999876 7899999999743 3345677889999998865664 9
Q ss_pred eEEEEEEEeCCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HcCccccCCCCCcEEEecCCC
Q 012518 192 IKFHDAFEDANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCH--LQGVVHRDLKPENFLFTTREE 268 (461)
Q Consensus 192 v~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH--~~givHrDlkp~NILl~~~~~ 268 (461)
+++++++...+.+|+||||+. |+|.+++.... ..+++..++.++.||+.||.||| +.||+||||||+|||++. +.
T Consensus 119 v~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~ 196 (382)
T 2vx3_A 119 VHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PK 196 (382)
T ss_dssp CCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TT
T ss_pred EEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CC
Confidence 999999999999999999996 59999887654 46899999999999999999999 579999999999999964 23
Q ss_pred CCCeeEeecccccccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC
Q 012518 269 DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 347 (461)
Q Consensus 269 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 347 (461)
++.+||+|||++..... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 197 ~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 274 (382)
T 2vx3_A 197 RSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274 (382)
T ss_dssp SCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred CCcEEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 56799999999987643 3456789999999999864 69999999999999999999999999988887777765431
Q ss_pred CCCC------------------CCCC-----------------CC-------------------------CCHHHHHHHH
Q 012518 348 PNFH------------------DSPW-----------------PS-------------------------VSPEAKDFVR 367 (461)
Q Consensus 348 ~~~~------------------~~~~-----------------~~-------------------------~s~~~~~li~ 367 (461)
...+ ...| .. .++++++||.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 275 GIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 1110 0000 00 0147899999
Q ss_pred HhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 368 RLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 368 ~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+||+.||.+|||++|+|+||||++.
T Consensus 355 ~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HhcCCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=401.43 Aligned_cols=258 Identities=17% Similarity=0.204 Sum_probs=197.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCCCeeEEE-------E
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS-GHKHMIKFH-------D 196 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-~hpniv~l~-------~ 196 (461)
..|++.+.||+|+||+||+|+++. +|+.||||++...........+.+.+|+.+++.|+ +||||++++ +
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVE---RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred eeeeeeeeccCCCCEEEEEEEECC---CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence 469999999999999999999876 78999999998876555566778888966665553 499988866 5
Q ss_pred EEEeC-----------------CeEEEEEeccCCCchHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHHcCccc
Q 012518 197 AFEDA-----------------NSVYIVMEFCEGGELLDRILSRGGRYLEEDA------KTIVEKILNIVAFCHLQGVVH 253 (461)
Q Consensus 197 ~~~~~-----------------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~------~~i~~qil~al~yLH~~givH 253 (461)
++... ..+|||||||. |+|.+++...+..+.+... ..++.||+.||.|||++||+|
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 55433 33899999998 8999999765444554445 577799999999999999999
Q ss_pred cCCCCCcEEEecCCCCCCeeEeecccccccCCCCCccccccCCCcCchhhhhc---cCCCchhHHHHHHHHHHHhhCCCC
Q 012518 254 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRP 330 (461)
Q Consensus 254 rDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlGvil~elltg~~P 330 (461)
|||||+|||++ .++.+||+|||++..... ......||+.|+|||++.+ .|+.++|||||||+||+|++|+.|
T Consensus 218 rDikp~NIll~---~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 218 GHFTPDNLFIM---PDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TTCSGGGEEEC---TTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCHHHEEEC---CCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 99999999995 567899999999987642 2225567799999999863 599999999999999999999999
Q ss_pred CCCCChhhH--HHH---HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 331 FWARTESGI--FRS---VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 331 f~~~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
|.+...... +.. .......+....++.+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 977643211 000 1111122233334578999999999999999999999999999999964
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=375.47 Aligned_cols=259 Identities=29% Similarity=0.537 Sum_probs=217.8
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+.++|++.+.||+|+||.||+|.++. +|+.||||++...... ...+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HENVVKFYGHRREGN 78 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred eecceEEEEEeecCCCcEEEEEEECC---CCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCC
Confidence 34689999999999999999999876 7899999999765432 24567889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATV 154 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred EEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc---cCCCEEEeeCCCccc
Confidence 99999999999999987743 45799999999999999999999999999999999999995 567799999999976
Q ss_pred cCCCC---CccccccCCCcCchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCCCCCCChhh-HHHHHHhcCCCCCCCCCC
Q 012518 283 VRPDQ---RLNDIVGSAYYVAPEVLHR-S-YNVEGDMWSIGVITYILLCGSRPFWARTESG-IFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 283 ~~~~~---~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 356 (461)
..... ......||+.|+|||++.+ . ++.++|||||||++|+|++|..||....... .+..+...... ...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 232 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWK 232 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGG
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchh
Confidence 54322 2345679999999999864 3 4788999999999999999999998765543 33333332221 22345
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred hcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 7899999999999999999999999999999998753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=390.94 Aligned_cols=262 Identities=25% Similarity=0.387 Sum_probs=218.6
Q ss_pred CCCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Q 012518 118 GYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDA 197 (461)
Q Consensus 118 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~ 197 (461)
..++...++|++.+.||+|+||+||+|+++. +|+.||+|++... ......+.+.+|+.+++.++ ||||++++++
T Consensus 26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 99 (360)
T 3eqc_A 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLE--IKPAIRNQIIRELQVLHECN-SPYIVGFYGA 99 (360)
T ss_dssp TCCCCCGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCC-CTTBCCEEEE
T ss_pred cccccccccceeeeeecCCCCeEEEEEEECC---CCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCC-CCCEEEEeEE
Confidence 3456677899999999999999999999876 7899999999765 24455678899999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcEEEecCCCCCCeeEee
Q 012518 198 FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 198 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
+.+.+.+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++ ||+||||||+|||++ .++.+||+|
T Consensus 100 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~D 175 (360)
T 3eqc_A 100 FYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCD 175 (360)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECC
T ss_pred EEECCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC---CCCCEEEEE
Confidence 99999999999999999999988655 5799999999999999999999996 999999999999995 567799999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHH-------------
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS------------- 342 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~------------- 342 (461)
||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||...........
T Consensus 176 fg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3eqc_A 176 FGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254 (360)
T ss_dssp CCCCHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred CCCCcccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence 9998755322 234568999999999987 4689999999999999999999999987665443222
Q ss_pred -----------------------------HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 343 -----------------------------VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 343 -----------------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+.... ........++.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -------------------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCcccCCCcccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 11111 1111223478999999999999999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=391.21 Aligned_cols=263 Identities=17% Similarity=0.222 Sum_probs=222.5
Q ss_pred CccccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
+...++|++++.||+|+||+||+|+... ...+++.||||++... ........+.+|+.++++++ ||||+++++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~ 143 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVS 143 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence 3445789999999999999999999543 2236789999998643 34445567889999999996 99999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCe
Q 012518 199 EDANSVYIVMEFCEGGELLDRILSRG------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 272 (461)
Q Consensus 199 ~~~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~ 272 (461)
.+.+..|+|||||.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999987653 358899999999999999999999999999999999999765566679
Q ss_pred eEeecccccccCCC---CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcC
Q 012518 273 KVIDFGLSDFVRPD---QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRAD 347 (461)
Q Consensus 273 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~ 347 (461)
||+|||+++..... .......||+.|+|||++. +.++.++|||||||++|||++ |..||......+.+..+....
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999754221 2334467899999999885 569999999999999999998 999999998888888777654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 348 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 348 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
.... ...+++++.+||.+||+.||.+|||+.++++|.|+
T Consensus 304 ~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 304 RMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 3222 24589999999999999999999999999998775
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=388.59 Aligned_cols=255 Identities=23% Similarity=0.387 Sum_probs=216.2
Q ss_pred cccceeeceeeccCCceEEEEEEecc----CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKK----GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
..++|++++.||+|+||+||+|++.. ...++..||||+++.. ......+.+.+|+.+|+.+.+||||++++++|
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 34689999999999999999998742 1235678999999765 23455678999999999995599999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEE
Q 012518 199 EDANSVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 263 (461)
Q Consensus 199 ~~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl 263 (461)
.+.+.+|+||||+.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 99999999999999999999987643 347889999999999999999999999999999999999
Q ss_pred ecCCCCCCeeEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhh
Q 012518 264 TTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESG 338 (461)
Q Consensus 264 ~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~ 338 (461)
+ .++.+||+|||++....... ......||+.|+|||++. ..|+.++|||||||++|||++ |..||.+....+
T Consensus 237 ~---~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 237 T---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp C---TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred C---CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 4 56789999999998665432 223456788999999886 569999999999999999999 999999888888
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 339 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 339 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++..+...... .....+++++.+||.+||+.||.+||++.|+++
T Consensus 314 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 314 LFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp HHHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 77776655321 122468999999999999999999999999886
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=403.61 Aligned_cols=249 Identities=17% Similarity=0.233 Sum_probs=202.6
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC--CCCCeeEEE------
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS--GHKHMIKFH------ 195 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpniv~l~------ 195 (461)
.++|++.+.||+|+||+||+|+++. +|+.||||++...........+.+.+|+.+++.++ +||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CceEEEcceeecCCCEEEEEEEECC---CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 4689999999999999999999865 78999999998665555556788999996555553 499999998
Q ss_pred -EEEEeCCe-----------------EEEEEeccCCCchHHHHHhcCCCCCH-------HHHHHHHHHHHHHHHHHHHcC
Q 012518 196 -DAFEDANS-----------------VYIVMEFCEGGELLDRILSRGGRYLE-------EDAKTIVEKILNIVAFCHLQG 250 (461)
Q Consensus 196 -~~~~~~~~-----------------~~lv~e~~~gg~L~~~l~~~~~~~~~-------~~~~~i~~qil~al~yLH~~g 250 (461)
+++.+.+. .||||||+ +|+|.+++... +.+++ ..++.|+.||+.||.|||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 77776643 89999999 68999988764 23444 778889999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCccccccCCCcCchhhhh-c-----------cCCCchhHHHHH
Q 012518 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-R-----------SYNVEGDMWSIG 318 (461)
Q Consensus 251 ivHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~-----------~~~~~~DiwSlG 318 (461)
|+||||||+|||++ .++.+||+|||+++... ......+| +.|+|||++. . .|+.++||||||
T Consensus 227 ivHrDikp~NIll~---~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLD---QRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEEC---TTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEc---CCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999995 56789999999998643 34456678 9999999986 4 599999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 319 VITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 319 vil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
|+||||++|+.||.+.........+.. .+..+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHHSSCCC------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHHCCCCCcccccccchhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 999999999999977665444333332 23568999999999999999999999999999999954
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=382.51 Aligned_cols=263 Identities=32% Similarity=0.520 Sum_probs=215.1
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
|..+.++|++++.||+|+||.||+|.++. +|+.||||++... +....+.+.+|+++++.++ ||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 78 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILG 78 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETT---TTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECC---CCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEecc
Confidence 45677899999999999999999999876 7899999998654 3455678899999999996 999999999883
Q ss_pred --------------eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEec
Q 012518 200 --------------DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 265 (461)
Q Consensus 200 --------------~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~ 265 (461)
+.+.+|+||||+. |+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 79 PSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT 155 (320)
T ss_dssp TTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred ccccccccccccccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 4468999999997 59988774 357999999999999999999999999999999999999963
Q ss_pred CCCCCCeeEeecccccccCCC----CCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhH
Q 012518 266 REEDAPLKVIDFGLSDFVRPD----QRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI 339 (461)
Q Consensus 266 ~~~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~ 339 (461)
.++.+||+|||++...... .......||..|+|||++. ..++.++|||||||++|+|++|+.||.+....+.
T Consensus 156 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 233 (320)
T 2i6l_A 156 --EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233 (320)
T ss_dssp --TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred --CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4567999999999876432 2234457899999999875 4689999999999999999999999999888777
Q ss_pred HHHHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 340 FRSVLRADPNFHD--------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 340 ~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
+..+....+.... ..++.+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 7766654322110 01246899999999999999999999999999999998754
Q ss_pred C
Q 012518 394 R 394 (461)
Q Consensus 394 ~ 394 (461)
.
T Consensus 314 ~ 314 (320)
T 2i6l_A 314 F 314 (320)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=382.39 Aligned_cols=254 Identities=22% Similarity=0.365 Sum_probs=216.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||+||+|+++.....+..||||+++.. ......+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGR 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence 446899999999999999999998764445667999999754 24455678999999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+||||++||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRV 200 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCSSCEE
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC---CCCCEEECCCCcccc
Confidence 99999999999999999877767899999999999999999999999999999999999994 567899999999987
Q ss_pred cCCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 283 VRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 283 ~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
...... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+...... ....
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 277 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL---PAPM 277 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---CCCT
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC---CCCC
Confidence 654321 22345678899999987 569999999999999999999 99999999888888877665322 1224
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+++++.+||.+||..||.+|||+.|+++
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 68999999999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=397.27 Aligned_cols=265 Identities=25% Similarity=0.447 Sum_probs=212.3
Q ss_pred cCCCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCC-------CC
Q 012518 117 FGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG-------HK 189 (461)
Q Consensus 117 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~-------hp 189 (461)
...|+.+.++|++.+.||+|+||+||+|++.. +|+.||||++... ....+.+.+|+.+|+.+++ |+
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 101 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNRE 101 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGG
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecC---CCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcc
Confidence 44567778899999999999999999999876 7899999999643 3445778899999999852 78
Q ss_pred CeeEEEEEEE----eCCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcEEE
Q 012518 190 HMIKFHDAFE----DANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLF 263 (461)
Q Consensus 190 niv~l~~~~~----~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NILl 263 (461)
||++++++|. +...+|+||||+ +++|.+.+.... ..+++..++.++.||+.||.|||++ ||+||||||+|||+
T Consensus 102 ~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll 180 (397)
T 1wak_A 102 MVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL 180 (397)
T ss_dssp GBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEE
T ss_pred eeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeE
Confidence 8999999997 556899999999 667777776653 5699999999999999999999999 99999999999999
Q ss_pred ecCC----------------------------------------------CCCCeeEeecccccccCCCCCccccccCCC
Q 012518 264 TTRE----------------------------------------------EDAPLKVIDFGLSDFVRPDQRLNDIVGSAY 297 (461)
Q Consensus 264 ~~~~----------------------------------------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~ 297 (461)
+.++ ....+||+|||++..... .....+||+.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~ 258 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQ 258 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGG
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCc
Confidence 6422 113799999999987643 3455689999
Q ss_pred cCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh------hhHHHHHHhcCCCCCC------------------
Q 012518 298 YVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE------SGIFRSVLRADPNFHD------------------ 352 (461)
Q Consensus 298 y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~------~~~~~~i~~~~~~~~~------------------ 352 (461)
|+|||++. ..|+.++|||||||+||+|++|+.||...+. ...+..+.......+.
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 99999986 4599999999999999999999999976542 2223222221111000
Q ss_pred -------CC-------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 353 -------SP-------------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 353 -------~~-------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
.. ....++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00 0123467889999999999999999999999999963
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=388.13 Aligned_cols=263 Identities=22% Similarity=0.410 Sum_probs=210.6
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEeccccc--------CCHHHHHHHHHHHHHHHhcCCCCCeeE
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM--------TSALAIEDVRREVKILKALSGHKHMIK 193 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~--------~~~~~~~~~~~Ei~il~~l~~hpniv~ 193 (461)
.+.++|++++.||+|+||.||+|.+. +|+.||||++..... ......+.+.+|++++++++ ||||++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~ 93 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS----EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILG 93 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT----TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCC
T ss_pred HhccceEEeEEeccCCCEEEEEEECC----CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccc
Confidence 45679999999999999999999875 588999999865322 23334578899999999996 999999
Q ss_pred EEEEEEe-----CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC
Q 012518 194 FHDAFED-----ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 268 (461)
Q Consensus 194 l~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~ 268 (461)
+++++.. ...+|+||||+. |+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA---D 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---T
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc---C
Confidence 9999854 346899999997 689998887767899999999999999999999999999999999999995 5
Q ss_pred CCCeeEeecccccccCCCCCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc
Q 012518 269 DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA 346 (461)
Q Consensus 269 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~ 346 (461)
++.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 249 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249 (362)
T ss_dssp TCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 6779999999998766555556678999999999886 45899999999999999999999999998877777666432
Q ss_pred CCC------------------------CCCCC----CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 347 DPN------------------------FHDSP----WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 347 ~~~------------------------~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
... ..... .+.+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 111 11111 135689999999999999999999999999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=382.36 Aligned_cols=266 Identities=27% Similarity=0.393 Sum_probs=218.7
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC--CCCCeeEEEEEEE-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS--GHKHMIKFHDAFE- 199 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpniv~l~~~~~- 199 (461)
..++|++++.||+|+||+||+|++.. .+|+.||||++....... .....+.+|+.+++.+. +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecC--CCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 44689999999999999999999852 168899999987543221 11234557888777763 4999999999987
Q ss_pred ----eCCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeE
Q 012518 200 ----DANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 200 ----~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
....+++||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~---~~~~~kl 161 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKL 161 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc---CCCCEEE
Confidence 5667999999997 59999887653 3489999999999999999999999999999999999995 5677999
Q ss_pred eecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC--
Q 012518 275 IDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH-- 351 (461)
Q Consensus 275 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-- 351 (461)
+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+........
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 9999998765544556678999999999986 5689999999999999999999999999888877777664211100
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCC
Q 012518 352 ---------------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395 (461)
Q Consensus 352 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~ 395 (461)
...+..+++++++||.+||..||.+|||+.|+|+||||++....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 01234689999999999999999999999999999999886543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=385.65 Aligned_cols=266 Identities=27% Similarity=0.435 Sum_probs=218.4
Q ss_pred CCCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCC------Ce
Q 012518 118 GYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK------HM 191 (461)
Q Consensus 118 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp------ni 191 (461)
..|+.+.++|++.+.||+|+||+||+|.+.. .+|+.||||++... ....+.+.+|+.+++.+. |+ +|
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-~~~~~~~~~i 79 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLN-TTDPNSTFRC 79 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHH-HHCTTCTTCB
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecC--CCCcEEEEEEEecC----CchhHHHHHHHHHHHHhh-hcCCCCceee
Confidence 4567788899999999999999999998743 26889999999643 334567889999999885 44 59
Q ss_pred eEEEEEEEeCCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC--
Q 012518 192 IKFHDAFEDANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE-- 268 (461)
Q Consensus 192 v~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~-- 268 (461)
+++++++.+.+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 80 VQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEE
T ss_pred EeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccc
Confidence 99999999999999999999 889999887654 36889999999999999999999999999999999999964321
Q ss_pred --------------CCCeeEeecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCC
Q 012518 269 --------------DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWA 333 (461)
Q Consensus 269 --------------~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~ 333 (461)
++.+||+|||++..... .....+||+.|+|||++. ..++.++|||||||++|||++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 56799999999986543 334568999999999986 4699999999999999999999999988
Q ss_pred CChhhHHHHHHhcCCCCCC----------------CCCC------------------------CCCHHHHHHHHHhcccC
Q 012518 334 RTESGIFRSVLRADPNFHD----------------SPWP------------------------SVSPEAKDFVRRLLNKD 373 (461)
Q Consensus 334 ~~~~~~~~~i~~~~~~~~~----------------~~~~------------------------~~s~~~~~li~~~L~~d 373 (461)
.+..+....+......++. ..|. ..++++.+||.+||+.|
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 8776655544332211110 0111 13467889999999999
Q ss_pred cCCCCCHHHHhcCCCcCCCC
Q 012518 374 HRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 374 P~~R~s~~e~L~hp~~~~~~ 393 (461)
|.+|||+.|+|+||||+...
T Consensus 317 P~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 317 PAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp TTTSCCHHHHTTSGGGGGGG
T ss_pred cccccCHHHHhcCHHHHHHh
Confidence 99999999999999997643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=379.38 Aligned_cols=261 Identities=26% Similarity=0.478 Sum_probs=199.2
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||.||+|.+.. +|+.||||++..... ....+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKD 86 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC-------CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSS
T ss_pred chhhhhhhheeccccceEEEEEEECC---CCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecC
Confidence 34689999999999999999998875 788999999865432 233567889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 203 SVYIVMEFCEGGELLDRILS-------RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~-------~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
..|+||||+.|++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc---CCCCEEEE
Confidence 99999999999999998864 245689999999999999999999999999999999999995 56779999
Q ss_pred ecccccccCCCC------CccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcC
Q 012518 276 DFGLSDFVRPDQ------RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 347 (461)
Q Consensus 276 DFG~a~~~~~~~------~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 347 (461)
|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||................
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 999987654322 123467999999999986 458999999999999999999999998877766665555443
Q ss_pred CCCC------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 348 PNFH------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 348 ~~~~------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.... ...+..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 2211 12235688999999999999999999999999999999764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=390.47 Aligned_cols=256 Identities=34% Similarity=0.575 Sum_probs=213.4
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+.++|.+.+.||+|+||+||+|.++. +|+.||||++.... ......+.+.+|+.+++.++ ||||++++++|...+
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 114 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPAS 114 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred ccccEEEEeEEecCCCeEEEEEEECC---CCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccC
Confidence 45799999999999999999999876 78999999997643 34555678889999999996 999999999998776
Q ss_pred eE------EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 203 SV------YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 203 ~~------~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
.. |+||||+. ++|.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 115 ~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kL~D 187 (371)
T 4exu_A 115 SLRNFYDFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILD 187 (371)
T ss_dssp SSTTCCCCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECS
T ss_pred CcccceeEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC---CCCCEEEEe
Confidence 54 99999997 5887765 24599999999999999999999999999999999999995 567799999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC----
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF---- 350 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~---- 350 (461)
||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 188 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 188 FGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp TTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 999986543 3455789999999999864 68999999999999999999999999888777776665421111
Q ss_pred -------------------CCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 351 -------------------HDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 351 -------------------~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
... .++.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 100 124579999999999999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=382.17 Aligned_cols=262 Identities=31% Similarity=0.491 Sum_probs=216.8
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
+..+.++|++.+.||+|+||+||+|+++. +|+.||||++... ........+.+|+.+++.++ ||||+++++++.
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 79 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPF--DKPLFALRTLREIKILKHFK-HENIITIFNIQR 79 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECC
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECC---CCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeec
Confidence 44567899999999999999999999876 7899999999643 34445667889999999996 999999999886
Q ss_pred eC-----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeE
Q 012518 200 DA-----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 200 ~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
.. ...|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 80 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~---~~~~~kl 153 (353)
T 2b9h_A 80 PDSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN---SNCDLKV 153 (353)
T ss_dssp CSCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEE
T ss_pred ccccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---CCCcEEE
Confidence 54 67999999997 589888755 4699999999999999999999999999999999999995 5677999
Q ss_pred eecccccccCCCC-----------CccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHH
Q 012518 275 IDFGLSDFVRPDQ-----------RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 341 (461)
Q Consensus 275 ~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~ 341 (461)
+|||++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus 154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 233 (353)
T 2b9h_A 154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233 (353)
T ss_dssp CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9999998764321 123457899999999875 468999999999999999999999999888766655
Q ss_pred HHHhcCC------------------------CCCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 342 SVLRADP------------------------NFHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 342 ~i~~~~~------------------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.+..... .+... .++.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 5443211 11111 1246899999999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=377.00 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=206.1
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||+||+|++ +|+.||||++..... .....+.+.+|++++++++ ||||+++++++.+.+
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-----HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSTT
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-----CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence 456899999999999999999975 577899999976543 4455678899999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGG--RYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~i~~qil~al~yLH~~g--ivHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
.+++||||+.+|+|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~---~~~~~kL~Dfg 184 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFG 184 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC---TTCCEEECCCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe---CCCcEEECCCC
Confidence 99999999999999998865432 3899999999999999999999999 99999999999994 56789999999
Q ss_pred cccccCCCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 279 LSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 279 ~a~~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
++....... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+......... ..
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~ 262 (309)
T 3p86_A 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI--PR 262 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC--CT
T ss_pred CCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--Cc
Confidence 998654332 234568999999999986 45899999999999999999999999988887777766544333322 24
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+++++.+||.+||+.||.+|||+.++++
T Consensus 263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 68999999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=378.45 Aligned_cols=256 Identities=29% Similarity=0.509 Sum_probs=210.2
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED-- 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~-- 200 (461)
+.++|++++.||+|+||+||+|++.. +|+.||||++... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNAL---DSRYYAIKKIRHT----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERR 75 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECC
T ss_pred ccccchhhheeccCCcEEEEEEEEcC---CCeEEEEEEEecc----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhc
Confidence 45689999999999999999999876 7899999999642 344577889999999996 9999999999865
Q ss_pred -----------CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCC
Q 012518 201 -----------ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 269 (461)
Q Consensus 201 -----------~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~ 269 (461)
.+.+|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~---~~ 152 (303)
T 1zy4_A 76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ES 152 (303)
T ss_dssp CCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TT
T ss_pred chhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc---CC
Confidence 4568999999999999999987666788999999999999999999999999999999999994 56
Q ss_pred CCeeEeecccccccCCC---------------CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCC
Q 012518 270 APLKVIDFGLSDFVRPD---------------QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFW 332 (461)
Q Consensus 270 ~~~kl~DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~ 332 (461)
+.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++ ||.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 77999999999765422 22345679999999999863 58999999999999999998 564
Q ss_pred CC-ChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 333 AR-TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 333 ~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.. ........+......++.......++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp SHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred CchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 33 3344555555555555554445678899999999999999999999999999999753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=385.77 Aligned_cols=257 Identities=24% Similarity=0.397 Sum_probs=212.7
Q ss_pred cccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..++|++++.||+|+||.||+|++.. ...+++.||||+++.. ......+.+.+|+++++++.+||||+++++++.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 45689999999999999999998543 3347789999999754 2344567789999999999769999999999987
Q ss_pred CCe-EEEEEeccCCCchHHHHHhcCC------------------------------------------------------
Q 012518 201 ANS-VYIVMEFCEGGELLDRILSRGG------------------------------------------------------ 225 (461)
Q Consensus 201 ~~~-~~lv~e~~~gg~L~~~l~~~~~------------------------------------------------------ 225 (461)
.+. +++|||||.||+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 554 8999999999999999876432
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCC---Cccc
Q 012518 226 -----------RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLND 291 (461)
Q Consensus 226 -----------~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~---~~~~ 291 (461)
.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....... ....
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCcEEEEeccceeeecccccchhccc
Confidence 188899999999999999999999999999999999995 56679999999998664332 2344
Q ss_pred cccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 012518 292 IVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 369 (461)
Q Consensus 292 ~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 369 (461)
..||+.|+|||++. ..++.++|||||||++|+|++ |..||.+......+............. ..+++++.++|.+|
T Consensus 255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~ 332 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDC 332 (359)
T ss_dssp CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHH
T ss_pred cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHH
Confidence 67899999999886 569999999999999999998 999998877555554444443322222 35899999999999
Q ss_pred cccCcCCCCCHHHHhcC
Q 012518 370 LNKDHRKRMTAAQALTH 386 (461)
Q Consensus 370 L~~dP~~R~s~~e~L~h 386 (461)
|+.||.+|||+.|+++|
T Consensus 333 l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 333 WHGEPSQRPTFSELVEH 349 (359)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhhCCCHHHHHHH
Confidence 99999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=384.71 Aligned_cols=257 Identities=25% Similarity=0.378 Sum_probs=202.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe-
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS- 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~- 203 (461)
++|++.+.||+|+||+||+|+++. +|+.||||++....... ....+|++.+..++ ||||++++++|...+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQDPRFR----NRELQIMQDLAVLH-HPNIVQLQSYFYTLGER 94 (360)
T ss_dssp TTEEEC----------CEEEEETT---TCCEEEEEEEECCTTCC----CHHHHHHHHHHHHC-CTTBCCEEEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEecCcccc----HHHHHHHHHHHhcC-CCCcccHHHhhhccccc
Confidence 589999999999999999999876 78999999986543222 34557888888886 9999999999976443
Q ss_pred ------EEEEEeccCCCchHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH--HcCccccCCCCCcEEEecCCCCCCe
Q 012518 204 ------VYIVMEFCEGGELLDRIL---SRGGRYLEEDAKTIVEKILNIVAFCH--LQGVVHRDLKPENFLFTTREEDAPL 272 (461)
Q Consensus 204 ------~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~i~~qil~al~yLH--~~givHrDlkp~NILl~~~~~~~~~ 272 (461)
+++||||+.+ +|.+.+. .....+++..++.++.||+.||.||| ++||+||||||+|||++. .++.+
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET--TTTEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC--CCCcE
Confidence 8999999986 5554443 24567899999999999999999999 999999999999999962 36789
Q ss_pred eEeecccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC
Q 012518 273 KVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 273 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+.......
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 9999999998776666667789999999999853 48999999999999999999999999988887777765421111
Q ss_pred C--------------------CC--------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 351 H--------------------DS--------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 351 ~--------------------~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
. .. .....++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 0 00 012257899999999999999999999999999999865
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=377.71 Aligned_cols=258 Identities=25% Similarity=0.467 Sum_probs=216.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-SALAIEDVRREVKILKALSGHKHMIKFHDAFE-- 199 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~-- 199 (461)
+.++|++++.||+|+||.||+|.++. +|+.||||++...... .....+.+.+|+.+++.++ |+||+++++++.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSE---TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNE 78 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTT---TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC
T ss_pred cccceeEeeEEecCCCeEEEEEEECC---CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcC
Confidence 34689999999999999999999876 7899999999764321 1234567899999999996 999999999984
Q ss_pred eCCeEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
+.+.+|+||||+.++ |.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~---~~~~~kl~dfg 154 (305)
T 2wtk_C 79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALG 154 (305)
T ss_dssp ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCT
T ss_pred CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---CCCcEEeeccc
Confidence 456899999999876 66666543 45799999999999999999999999999999999999995 56779999999
Q ss_pred cccccCCC---CCccccccCCCcCchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC
Q 012518 279 LSDFVRPD---QRLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD 352 (461)
Q Consensus 279 ~a~~~~~~---~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 352 (461)
++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+......+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~- 233 (305)
T 2wtk_C 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP- 233 (305)
T ss_dssp TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC-
T ss_pred cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC-
Confidence 99876432 22345679999999999864 247899999999999999999999999888888888777654433
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 353 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 353 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..+++++.+||.+||..||.+|||+.|+++||||+..
T Consensus 234 ---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 234 ---GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ---SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ---CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 3589999999999999999999999999999999865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=367.77 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=215.3
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||+|+||+||+|++. +++.||||++...... .+++.+|++++++++ ||||+++++++.+.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAP 79 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET----TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred hhhceeeheecCCCccEEEEEEec----CCCeEEEEEecccccC----HHHHHHHHHHHHhCC-CCCEeeEEEEEecCCc
Confidence 358999999999999999999876 4677999999765432 356889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---GGGCEEECCTTGGGGB
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc---CCCCEEeccccccccc
Confidence 9999999999999999977777899999999999999999999999999999999999995 4567999999999866
Q ss_pred CCCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 284 RPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 284 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
.... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||......+....+........ ...++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 233 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAS 233 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSC
T ss_pred cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCC
Confidence 4332 223456788899999986 569999999999999999999 9999999888888887776533222 23579
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+++.+||.+||+.||.+|||+.|+++|
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=369.66 Aligned_cols=258 Identities=28% Similarity=0.497 Sum_probs=219.2
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--C
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED--A 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~--~ 201 (461)
.++|++++.||+|+||.||+|+++. +|+.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+ .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTN 79 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGG
T ss_pred hhheeeehhccCCCCcEEEEEEECC---CCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCC
Confidence 3589999999999999999999876 789999999976543 3455678999999999996 9999999998854 6
Q ss_pred CeEEEEEeccCCCchHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCCCCcEEEecCCCCCCee
Q 012518 202 NSVYIVMEFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQG-----VVHRDLKPENFLFTTREEDAPLK 273 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~i~~qil~al~yLH~~g-----ivHrDlkp~NILl~~~~~~~~~k 273 (461)
+.+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~---~~~~~k 156 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVK 156 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC---SSSCEE
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc---CCCCEE
Confidence 7899999999999999988653 235899999999999999999999999 99999999999995 567799
Q ss_pred EeecccccccCCCCC-ccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC
Q 012518 274 VIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH 351 (461)
Q Consensus 274 l~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 351 (461)
|+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.......+...+........
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 236 (279)
T 2w5a_A 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236 (279)
T ss_dssp ECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred EecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC
Confidence 999999987654332 234679999999999874 689999999999999999999999998888777777776543211
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 352 DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 352 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
...+++++.+||.+||+.||.+|||+.|+|+|+|+.+.
T Consensus 237 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 237 ---PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ---CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 13589999999999999999999999999999999764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=381.51 Aligned_cols=265 Identities=25% Similarity=0.414 Sum_probs=217.4
Q ss_pred cCCCCccccceeeceeeccCCceEEEEEEeccCCccC-cEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCC-----
Q 012518 117 FGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKG-KVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH----- 190 (461)
Q Consensus 117 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn----- 190 (461)
...|+.+.++|++.+.||+|+||+||+|.++. ++ +.||||+++.. ....+.+.+|+.+++.++ |++
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~~~~~~ 82 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHA---RGKSQVALKIIRNV----GKYREAARLEINVLKKIK-EKDKENKF 82 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETT---TTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHH-HHCTTSCS
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecC---CCceEEEEEEEccc----ccchhHHHHHHHHHHHHh-hcCCCCce
Confidence 34567788899999999999999999999865 44 78999999643 334567888999999986 554
Q ss_pred -eeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC--
Q 012518 191 -MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR-- 266 (461)
Q Consensus 191 -iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~-- 266 (461)
++.+++++...+.+|+||||+ +++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||+...
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~ 161 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF 161 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCE
T ss_pred eEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccc
Confidence 999999999999999999999 667878776654 469999999999999999999999999999999999999532
Q ss_pred --------------CCCCCeeEeecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCC
Q 012518 267 --------------EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPF 331 (461)
Q Consensus 267 --------------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf 331 (461)
+.++.+||+|||++..... .....+||+.|+|||++. ..++.++|||||||++|||++|..||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp EEEECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 2467799999999986543 335568999999999986 56999999999999999999999999
Q ss_pred CCCChhhHHHHHHhcCCCCCC----------------CCCC------------------------CCCHHHHHHHHHhcc
Q 012518 332 WARTESGIFRSVLRADPNFHD----------------SPWP------------------------SVSPEAKDFVRRLLN 371 (461)
Q Consensus 332 ~~~~~~~~~~~i~~~~~~~~~----------------~~~~------------------------~~s~~~~~li~~~L~ 371 (461)
......+.+..+......++. ..|+ ..+.++.+||.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 988776655544432211110 0111 124578899999999
Q ss_pred cCcCCCCCHHHHhcCCCcCCC
Q 012518 372 KDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 372 ~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.||.+|||+.|+|+||||++.
T Consensus 320 ~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp SSTTTSCCHHHHTTSGGGGGC
T ss_pred CChhhCcCHHHHhcChhhcCC
Confidence 999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=386.38 Aligned_cols=264 Identities=23% Similarity=0.451 Sum_probs=222.4
Q ss_pred CCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHH--------------HHHHHHHHHHHHHh
Q 012518 119 YGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSAL--------------AIEDVRREVKILKA 184 (461)
Q Consensus 119 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~--------------~~~~~~~Ei~il~~ 184 (461)
.+..+.++|++.+.||+|+||.||+|.+ +|+.||||++......... ..+.+.+|+.++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 99 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTT
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHh
Confidence 3455567999999999999999999987 5889999999754332211 12678899999999
Q ss_pred cCCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCC
Q 012518 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDR------ILSR-GGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDL 256 (461)
Q Consensus 185 l~~hpniv~l~~~~~~~~~~~lv~e~~~gg~L~~~------l~~~-~~~~~~~~~~~i~~qil~al~yLH~-~givHrDl 256 (461)
++ ||||+++++++.+.+.+|+||||+++|+|.++ +... ...+++..++.++.||+.||.|||+ +||+||||
T Consensus 100 l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl 178 (348)
T 2pml_X 100 IK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178 (348)
T ss_dssp CC-CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCC
T ss_pred CC-CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCC
Confidence 96 99999999999999999999999999999887 4332 4679999999999999999999999 99999999
Q ss_pred CCCcEEEecCCCCCCeeEeecccccccCCCCCccccccCCCcCchhhhhc--cCCC-chhHHHHHHHHHHHhhCCCCCCC
Q 012518 257 KPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNV-EGDMWSIGVITYILLCGSRPFWA 333 (461)
Q Consensus 257 kp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~-~~DiwSlGvil~elltg~~Pf~~ 333 (461)
||+|||++ .++.+||+|||++...... ......||..|+|||++.+ .++. ++|||||||++|+|++|..||..
T Consensus 179 ~p~Nil~~---~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 179 KPSNILMD---KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp CGGGEEEC---TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ChHhEEEc---CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999995 5678999999999876443 4456789999999999864 3555 99999999999999999999988
Q ss_pred CCh-hhHHHHHHhcCCCCCCCC---------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 334 RTE-SGIFRSVLRADPNFHDSP---------------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 334 ~~~-~~~~~~i~~~~~~~~~~~---------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
... .+....+......++... ...+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 255 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp SSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred CCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 776 677777766654444210 14689999999999999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=367.94 Aligned_cols=249 Identities=22% Similarity=0.367 Sum_probs=212.2
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++++.||+|+||+||++++. ++..||||++...... .+.+.+|++++++++ |+||+++++++.+.+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLS-HEKLVQLYGVCTKQR 92 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET----TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc----CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCC-CCCEeeEEEEEecCC
Confidence 3468999999999999999999875 4678999999765432 356889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRY 169 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTSCEEECSTTGGGG
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc---CCCCEEEcccccccc
Confidence 99999999999999999877567799999999999999999999999999999999999995 567799999999986
Q ss_pred cCCCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 283 VRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 283 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
..... ......+|+.|+|||++. ..++.++|||||||++|+|++ |+.||...........+......... ..+
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 246 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLA 246 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTC
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcC
Confidence 64332 223345778899999986 569999999999999999998 99999998888888877765433222 357
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
++.+.+||.+||+.||.+|||+.|+++|
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 8999999999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=367.72 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=205.4
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
...++|++.+.||+|+||+||+|.+..+...+..||||++... ......+.+.+|+.++++++ ||||+++++++. +
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-E 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-S
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-c
Confidence 3456999999999999999999998764445678999998654 34455678899999999996 999999999985 5
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+..|+||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSR 164 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC-----
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECcccccc
Confidence 678999999999999999977766799999999999999999999999999999999999996 45679999999998
Q ss_pred ccCCCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 282 FVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 282 ~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+...... ...+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~ 241 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPN 241 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTT
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---CCCCC
Confidence 7654332 23345778999999986 569999999999999999996 99999998888888777665322 12346
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+++++.+||.+||..||.+|||+.|+++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=364.27 Aligned_cols=249 Identities=27% Similarity=0.384 Sum_probs=215.2
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||+||+|+++ ++..||||++...... .+.+.+|++++++++ ||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 76 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK----GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLS-HPKLVKFYGVCSKEY 76 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred chhheeeeeeeccCCCceEEEEEec----CceeEEEEEeccCCCc----HHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence 3468999999999999999999875 4667999999765432 356889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRY 153 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC---TTCCEEECCTTCEEE
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC---CCCCEEEccCcccee
Confidence 99999999999999999987766799999999999999999999999999999999999994 567899999999987
Q ss_pred cCCCCC--ccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 283 VRPDQR--LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 283 ~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
...... .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||...........+......... ..+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 230 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLA 230 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTS
T ss_pred cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcC
Confidence 654432 233456778999999874 68999999999999999999 99999988888877777665433322 347
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
++++.+||.+||+.||.+|||+.|++++
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=379.56 Aligned_cols=256 Identities=34% Similarity=0.568 Sum_probs=212.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+.++|.+.+.||+|+||.||+|.++. +|+.||||++.... ......+.+.+|+.+++.++ ||||+++++++...+
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPAS 96 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred cCceEEEeeeEecCCCeEEEEEEECC---CCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccc
Confidence 45689999999999999999999876 78999999997643 34455678889999999996 999999999998765
Q ss_pred e------EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 203 S------VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 203 ~------~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
. +|+||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~D 169 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILD 169 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTCCEEECS
T ss_pred ccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC---CCCcEEEee
Confidence 4 599999997 58877652 3599999999999999999999999999999999999995 567899999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC------
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP------ 348 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------ 348 (461)
||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 170 fg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 170 FGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred cccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999986542 2345689999999999864 589999999999999999999999998887766665543210
Q ss_pred -----------------CC----CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 349 -----------------NF----HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 349 -----------------~~----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.. ....++.+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00 011235689999999999999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=368.33 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=207.1
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
+|.....||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++ ||||+++++++.+.+.++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLS---NQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETT---TCCEEEEEEEECCC---C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECC---CCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEE
Confidence 34445589999999999999876 78999999997643 233467889999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 206 IVMEFCEGGELLDRILSRGG--RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+||||+.+++|.+++....+ .+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTCCEEECCTTTCEES
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC--CCCCEEEeeccccccc
Confidence 99999999999998876533 4568899999999999999999999999999999999963 3667999999999876
Q ss_pred CCCC-CccccccCCCcCchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhH-HHHHHhcCCCCCCCCCCCC
Q 012518 284 RPDQ-RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTESGI-FRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 284 ~~~~-~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 358 (461)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........ ........ ........+
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~ 251 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIPESM 251 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC--CCCCCCTTS
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc--ccccccccC
Confidence 5432 2345679999999999863 389999999999999999999999976443221 11111111 111122468
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
++++.+||.+||+.||.+||++.|+|+||||+...
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999998653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=379.82 Aligned_cols=253 Identities=18% Similarity=0.255 Sum_probs=206.8
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
++++|++.+.||+|+||+||+|++.. +|+.||||++...... +.+.+|+.+++.|.+|+||+++++++.+.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETT---TTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred EcCCeEEEEEeeccCCceEEEEEECC---CCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 45789999999999999999999876 7899999998754322 357789999999966999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC--CCCeeEeecccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE--DAPLKVIDFGLS 280 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~--~~~~kl~DFG~a 280 (461)
..|+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999999999 89999998776678999999999999999999999999999999999999964321 122999999999
Q ss_pred cccCCCCC--------ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh---hHHHHHHhcCC
Q 012518 281 DFVRPDQR--------LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES---GIFRSVLRADP 348 (461)
Q Consensus 281 ~~~~~~~~--------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~~~~~ 348 (461)
........ ....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.... +.+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 87644322 24678999999999987 45999999999999999999999999875433 33444433222
Q ss_pred CCCCCC-CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 349 NFHDSP-WPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 349 ~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...... ...++ ++.+||.+||..||.+||+++++++
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 221111 12234 9999999999999999999988876
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=381.17 Aligned_cols=257 Identities=23% Similarity=0.372 Sum_probs=218.3
Q ss_pred ccccceeeceeeccCCceEEEEEEecc----CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKK----GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDA 197 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~ 197 (461)
...++|++++.||+|+||+||+|++.. ....+..||||++... ........+.+|+++++++.+||||++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 344689999999999999999998743 1124568999999765 3455567889999999999559999999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEE
Q 012518 198 FEDANSVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 262 (461)
Q Consensus 198 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NIL 262 (461)
+.+.+.+|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 999999999999999999999987653 35899999999999999999999999999999999999
Q ss_pred EecCCCCCCeeEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChh
Q 012518 263 FTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTES 337 (461)
Q Consensus 263 l~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~ 337 (461)
++ .++.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.+....
T Consensus 224 l~---~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 224 VT---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp EC---TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred Ec---CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 95 56789999999998765432 234456788999999986 468999999999999999999 99999988888
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 338 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 338 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
++...+....... ....+++++.+||.+||+.||.+|||+.|++++
T Consensus 301 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 301 ELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8777776553221 124689999999999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=376.09 Aligned_cols=245 Identities=23% Similarity=0.387 Sum_probs=207.2
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|.++. +|+.||+|++... .....+.+.+|++++++++ ||||+++++++.+.+..
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~---~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRE---TGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred hHeeccceecCCCCEEEEEEEECC---CCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCee
Confidence 589999999999999999999876 7899999998543 4556678999999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMV 159 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC---TTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC---CCCCEEEeecccceecc
Confidence 999999999999999987677899999999999999999999999999999999999995 56779999999998764
Q ss_pred CCCCc---------------cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhh-----HHHHH
Q 012518 285 PDQRL---------------NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG-----IFRSV 343 (461)
Q Consensus 285 ~~~~~---------------~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-----~~~~i 343 (461)
..... ...+||+.|+|||++. ..++.++|||||||++|+|++|..||....... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 239 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence 33211 1567999999999987 468999999999999999999999986532211 11111
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 344 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 344 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.... ..+.+++++.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 240 LDRY------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHT------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccc------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111 11357889999999999999999999999976
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=374.10 Aligned_cols=263 Identities=22% Similarity=0.322 Sum_probs=199.1
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
...++|++++.||+|+||+||+|+++........||||++....... ...+.+.+|++++++++ ||||+++++++.+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFD-HPHVAKLVGVSLRS 97 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCC-CCceehhhceeecc
Confidence 34568999999999999999999987632223489999997654333 34678899999999995 99999999999877
Q ss_pred CeE------EEEEeccCCCchHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCC
Q 012518 202 NSV------YIVMEFCEGGELLDRILSRG-----GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 270 (461)
Q Consensus 202 ~~~------~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~ 270 (461)
+.. ++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~---~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc---CCC
Confidence 665 99999999999999886542 2589999999999999999999999999999999999995 567
Q ss_pred CeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHh
Q 012518 271 PLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLR 345 (461)
Q Consensus 271 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~ 345 (461)
.+||+|||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 899999999987654332 22345678899999986 469999999999999999999 9999999888888887776
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC-------HHHHhcCCCcCCC
Q 012518 346 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-------AAQALTHPWLHDE 392 (461)
Q Consensus 346 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-------~~e~L~hp~~~~~ 392 (461)
...... .+.+++++.+||.+||+.||.+||| +++++.|+|+...
T Consensus 255 ~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 255 GNRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp TCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 543222 2468999999999999999999999 7889999999764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=365.97 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=209.6
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHH----HHHHHHHHHHHhcCCCCCeeEEEEE
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAI----EDVRREVKILKALSGHKHMIKFHDA 197 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~----~~~~~Ei~il~~l~~hpniv~l~~~ 197 (461)
...++|++.+.||+|+||+||+|++.. +++.||||++........... +.+.+|+.++++++ ||||++++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~ 91 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGL 91 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETT---TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred hhhccceehhccccCCceeEEEEEEcC---CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhhee
Confidence 345689999999999999999999876 789999999876543332221 67889999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCcEEEecCCC--CCCee
Q 012518 198 FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENFLFTTREE--DAPLK 273 (461)
Q Consensus 198 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~g--ivHrDlkp~NILl~~~~~--~~~~k 273 (461)
+.+.. ++||||+.+|+|.+.+......+++..++.++.||+.||.|||++| |+||||||+|||++..+. ...+|
T Consensus 92 ~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 92 MHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp ETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred ecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 97665 6999999999999999877778999999999999999999999999 999999999999964321 22399
Q ss_pred EeecccccccCCCCCccccccCCCcCchhhhh---ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhH--HHHHHhcCC
Q 012518 274 VIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI--FRSVLRADP 348 (461)
Q Consensus 274 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~~~i~~~~~ 348 (461)
|+|||++.... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||........ ...+.....
T Consensus 170 l~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 170 VADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp ECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred eCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 99999997543 2345578999999999983 3478999999999999999999999987654433 333333322
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 349 NFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 349 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.......+++++.+||.+||+.||.+|||+.|+++
T Consensus 248 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 --RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22223568999999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=369.92 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=196.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||.||+|+++. +|+.||||++..... .....+.+.++..+++.+ +||||+++++++.+.+.+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRK---TGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp GGEEEEEEC------CEEEEEETT---TCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeecCCeeEEEEEEec---CCeEEEEEEeccccc-chHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcE
Confidence 589999999999999999999876 789999999976532 122223344444566666 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
|+||||+ ++.+..........+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||++...
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGRL 175 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC---TTSCEEECCCTTC---
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC---CCCCEEEEECCCchhc
Confidence 9999999 5555555544467899999999999999999999995 999999999999995 5677999999999876
Q ss_pred CCCCCccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCC-CChhhHHHHHHhcCCCCCCCCCC
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWA-RTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
..........||+.|+|||++. ..++.++|||||||++|+|++|+.||.. ....+.+..+........ ..+.
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 254 (318)
T 2dyl_A 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-PGHM 254 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-CSSS
T ss_pred cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-CccC
Confidence 6555555678999999999983 3588999999999999999999999987 345556666665543322 2234
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.+++++.+||.+||+.||.+||+++|+|+||||+..
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 689999999999999999999999999999999753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=370.20 Aligned_cols=259 Identities=24% Similarity=0.456 Sum_probs=210.2
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEe
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG-HKHMIKFHDAFED 200 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~-hpniv~l~~~~~~ 200 (461)
...++|++++.||+|+||.||+|.+. +|+.||||++..... .....+.+.+|+.+++++.+ |+||+++++++.+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC----CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 34568999999999999999999875 588999999976543 44566788999999999974 6999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+.+|+||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~ 173 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIA 173 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSS
T ss_pred CCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeecccc
Confidence 999999999 5578999988654 5789999999999999999999999999999999999995 367999999999
Q ss_pred cccCCCCC---ccccccCCCcCchhhhhc------------cCCCchhHHHHHHHHHHHhhCCCCCCCCCh-hhHHHHHH
Q 012518 281 DFVRPDQR---LNDIVGSAYYVAPEVLHR------------SYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVL 344 (461)
Q Consensus 281 ~~~~~~~~---~~~~~gt~~y~aPE~l~~------------~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~ 344 (461)
........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+..+.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence 87654322 234679999999999853 588899999999999999999999976543 33344444
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 345 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 345 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
........ ....++++.+||.+||..||.+||++.|+|+||||+...
T Consensus 254 ~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 254 DPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CTTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred hcccccCC--cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 33322221 234688999999999999999999999999999998653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=376.23 Aligned_cols=256 Identities=30% Similarity=0.511 Sum_probs=213.1
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH---HHHHHHHHHHHHHHhcC-CCCCeeEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA---LAIEDVRREVKILKALS-GHKHMIKFH 195 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~-~hpniv~l~ 195 (461)
++.+.++|++.+.||+|+||.||+|+++. +|+.||||++........ ...+.+.+|+.+++++. +|+||++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETT---TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 45567799999999999999999999876 789999999976543221 11234567999999997 379999999
Q ss_pred EEEEeCCeEEEEEeccCC-CchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeE
Q 012518 196 DAFEDANSVYIVMEFCEG-GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 196 ~~~~~~~~~~lv~e~~~g-g~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl 274 (461)
+++.+.+.+++||||+.+ ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. +++.+||
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~~kL 191 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKL 191 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEE
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC--CCCCEEE
Confidence 999999999999999986 8999988654 57999999999999999999999999999999999999962 4567999
Q ss_pred eecccccccCCCCCccccccCCCcCchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC
Q 012518 275 IDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-S-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD 352 (461)
Q Consensus 275 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 352 (461)
+|||++..... .......||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.... .+......+.
T Consensus 192 ~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~- 263 (320)
T 3a99_A 192 IDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR- 263 (320)
T ss_dssp CCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS-
T ss_pred eeCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc-
Confidence 99999987653 33455679999999999863 3 4788999999999999999999996532 2223322222
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 353 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 353 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 264 ---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 264 ---QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp ---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ---ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 3589999999999999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=368.88 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=214.9
Q ss_pred cccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..++|++.+.||+|+||+||+|++.. ...+++.||||++.... .....+.+.+|+.+++++.+||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34689999999999999999998632 23367899999997543 334567889999999999559999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEE
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGG-----------------RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 263 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~-----------------~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl 263 (461)
.+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 9999999999999999999876543 38999999999999999999999999999999999999
Q ss_pred ecCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhh
Q 012518 264 TTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESG 338 (461)
Q Consensus 264 ~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~ 338 (461)
+ .++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+.....
T Consensus 179 ~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 179 T---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp E---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred c---CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 5 567799999999987654432 23456788999999875 569999999999999999999 999998877655
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 339 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 339 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
....+........ ....+++++.+||.+||+.||.+|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 256 KFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5555554433222 22468999999999999999999999999886
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=374.76 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=215.6
Q ss_pred cccceeeceeeccCCceEEEEEEeccCC--ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..++|++++.||+|+||.||+|++.... .+++.||||+++... .....+.+.+|+.++++++ ||||+++++++.+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAV 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcc
Confidence 4568999999999999999999986321 256899999997542 3455678999999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRG-----------------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 257 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~-----------------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlk 257 (461)
.+.+|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 999999999999999999987642 568999999999999999999999999999999
Q ss_pred CCcEEEecCCCCCCeeEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCC
Q 012518 258 PENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFW 332 (461)
Q Consensus 258 p~NILl~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~ 332 (461)
|+|||++ .++.+||+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++ |..||.
T Consensus 202 p~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 202 TRNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp GGGEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cceEEEC---CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999995 56679999999997654322 223457889999999886 569999999999999999999 999999
Q ss_pred CCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 333 ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 333 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+....+....+........ ...+++++.+||.+||+.||.+||++.++++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 9888888877776543221 2458999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=361.54 Aligned_cols=252 Identities=26% Similarity=0.365 Sum_probs=201.4
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCC-HHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS-ALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
.++|++.+.||+|+||+||+|.+ +|+.||||++....... ....+.+.+|+++++.++ ||||+++++++.+.+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-----IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEP 79 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-----TTEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC-
T ss_pred hhheeeeeeeccCCCeEEEEEEE-----cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCC
Confidence 35899999999999999999986 47789999987643222 233567889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccCCCCCcEEEecCC-----CCCCeeE
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG---VVHRDLKPENFLFTTRE-----EDAPLKV 274 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~g---ivHrDlkp~NILl~~~~-----~~~~~kl 274 (461)
.+|+||||+.|++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++... .++.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred ceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999988773 457999999999999999999999999 89999999999996422 2667999
Q ss_pred eecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCC
Q 012518 275 IDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 353 (461)
Q Consensus 275 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 353 (461)
+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+.........
T Consensus 158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 235 (271)
T 3dtc_A 158 TDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI- 235 (271)
T ss_dssp CCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC-
T ss_pred ccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC-
Confidence 9999998665433 23567999999999986 45899999999999999999999999988877777766655433332
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 354 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
...+++++.+||.+||+.||.+|||+.|+++|
T Consensus 236 -~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 236 -PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 24689999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=368.29 Aligned_cols=257 Identities=19% Similarity=0.279 Sum_probs=211.6
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
+..+.++|++.+.||+|+||+||+|.+.. +|+.||||++...... +.+.+|+.+++.+.+|+||+++++++.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 44567799999999999999999999865 7899999998654322 346789999999977999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC--CCCCeeEeec
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE--EDAPLKVIDF 277 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~--~~~~~kl~DF 277 (461)
+....|+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+||
T Consensus 77 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 77 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 999999999999 9999999977666799999999999999999999999999999999999996432 2334999999
Q ss_pred ccccccCCCCC--------ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC---hhhHHHHHHh
Q 012518 278 GLSDFVRPDQR--------LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART---ESGIFRSVLR 345 (461)
Q Consensus 278 G~a~~~~~~~~--------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~ 345 (461)
|++........ .....||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.. ....+..+..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 99987654322 34567999999999986 468999999999999999999999998743 3333443332
Q ss_pred cCCCCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 346 ADPNFH-DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 346 ~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...... ......+++++.+||.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 211111 1112358999999999999999999999998865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=382.63 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=213.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||+|+||+||+|+++. +|+.||||+++.. ......+.+.+|+++|++++ ||||+++++++.+.+.
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRA---DNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEec---CCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCC
Confidence 4689999999999999999999876 7899999998754 23444567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~---~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREE 263 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCGGGCEEC
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc---CCCcEEECcCCCceec
Confidence 9999999999999999987766799999999999999999999999999999999999994 5678999999999865
Q ss_pred CCCCCc---cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 284 RPDQRL---NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 284 ~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
...... ....++..|+|||++. +.++.++|||||||++|||++ |..||.+.........+..... .. ....+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 340 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR-LP--CPELC 340 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-CC--CCTTC
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCCC
Confidence 432211 1234577899999986 569999999999999999998 9999988887777666654422 11 12358
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++++.+||.+||+.||.+|||+.++++
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=372.44 Aligned_cols=264 Identities=17% Similarity=0.231 Sum_probs=217.9
Q ss_pred CccccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
+...++|++++.||+|+||.||+|++.. ...+++.||||++... ........+.+|+.++++++ ||||+++++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 102 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVS 102 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCC-CCCCCeEEEEE
Confidence 3455799999999999999999998542 2237889999999643 34455677889999999995 99999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCe
Q 012518 199 EDANSVYIVMEFCEGGELLDRILSRG------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 272 (461)
Q Consensus 199 ~~~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~ 272 (461)
.+.+..|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999987653 348899999999999999999999999999999999999765566779
Q ss_pred eEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcC
Q 012518 273 KVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRAD 347 (461)
Q Consensus 273 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~ 347 (461)
||+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++ |..||......+....+....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999999987654322 223457899999999885 569999999999999999998 999998888877777776553
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 348 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 348 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
... ....+++.+.+||.+||..||.+||++.++++|.|+.
T Consensus 263 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 263 RMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 221 2246899999999999999999999999999998763
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=364.55 Aligned_cols=255 Identities=27% Similarity=0.478 Sum_probs=202.5
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
...++|++.+.||+|+||.||+|.+.. +|+.||||++...........+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 104 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIED 104 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETT---TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEET
T ss_pred ccccceEEEEeecCCCCceEEEEEEcC---CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcC
Confidence 344689999999999999999999876 78999999998765566667788999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 202 NSVYIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
+.+++||||+.+|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~---~~~~~kl~Dfg 181 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLG 181 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCC-
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc---CCCCEEEEecc
Confidence 999999999999999988754 345689999999999999999999999999999999999995 56779999999
Q ss_pred cccccCCCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh--hhHHHHHHhcCCCCCCCC
Q 012518 279 LSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE--SGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 279 ~a~~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~ 354 (461)
++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+... ......+... .+....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 259 (310)
T 2wqm_A 182 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLP 259 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT--CSCCCC
T ss_pred ceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc--cCCCCc
Confidence 988665432 234567999999999986 5689999999999999999999999976532 2334444333 233333
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...+++++.+||.+||..||.+|||+.++++
T Consensus 260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 3568999999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=374.13 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=190.5
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHH-HHHhcCCCCCeeEEEEEEEeCC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK-ILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~~hpniv~l~~~~~~~~ 202 (461)
.++|++++.||+|+||.||+|.++. +|+.||||++.... .......+.+|+. +++.+ +||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP---SGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREG 94 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT---TTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSS
T ss_pred HHHhhehheeccCCCEEEEEEEEcC---CCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCC
Confidence 3689999999999999999999876 78999999997642 3334456667777 45555 5999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 203 SVYIVMEFCEGGELLDRILS----RGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
..|+||||+.+ +|.+++.. ....+++..+..++.|++.||.|||++ ||+||||||+|||++ .++.+||+||
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---~~~~~kl~Df 170 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDF 170 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE---TTTEEEECCC
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc---CCCCEEEccC
Confidence 99999999975 77776643 246789999999999999999999999 999999999999995 5677999999
Q ss_pred ccccccCCCCCccccccCCCcCchhhhh-----ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh-hhHHHHHHhcC-CCC
Q 012518 278 GLSDFVRPDQRLNDIVGSAYYVAPEVLH-----RSYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLRAD-PNF 350 (461)
Q Consensus 278 G~a~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~-~~~ 350 (461)
|++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||..... .+.+..+.... +.+
T Consensus 171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 9998776554445568999999999983 3589999999999999999999999976432 12222222221 223
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
....+..+++++.+||.+||..||.+|||+.|+++||||...
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 333345689999999999999999999999999999999754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=379.21 Aligned_cols=253 Identities=23% Similarity=0.390 Sum_probs=204.7
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
..+|++.+.||+|+||+||+|+++....++..||||+++... .....+.+.+|+.+|++++ ||||+++++++.+.+.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCc
Confidence 458999999999999999999887443467889999997542 4455678999999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVL 197 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc---CCCCEEECcCcccccc
Confidence 9999999999999999977767899999999999999999999999999999999999994 5678999999999876
Q ss_pred CCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 284 RPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 284 ~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
..... .....+|..|+|||++. +.++.++|||||||++|||++ |+.||......++...+..... ......
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~ 274 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR---LPPPMD 274 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE---CCCCTT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcc
Confidence 54321 12234577899999986 569999999999999999998 9999999888877777655421 112235
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++.++.+||.+||+.||.+||++.++++
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 8899999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=373.85 Aligned_cols=258 Identities=23% Similarity=0.364 Sum_probs=212.6
Q ss_pred cccceeeceeeccCCceEEEEEEeccC--CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKG--TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..++|++.+.||+|+||+||+|.+... ..+++.||||++.... .....+.+.+|+.+++++.+||||+++++++.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 346899999999999999999997431 2256789999997542 223446788999999999559999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCC
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGG----------------------RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKP 258 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~----------------------~~~~~~~~~i~~qil~al~yLH~~givHrDlkp 258 (461)
.+.+|+||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 9999999999999999999876543 278899999999999999999999999999999
Q ss_pred CcEEEecCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCC
Q 012518 259 ENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWA 333 (461)
Q Consensus 259 ~NILl~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~ 333 (461)
+|||++ .++.+||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|+| |..||.+
T Consensus 201 ~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 201 RNVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp GGEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhEEEc---CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999996 566799999999986644332 23456788999999886 569999999999999999998 9999988
Q ss_pred CChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 012518 334 RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387 (461)
Q Consensus 334 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 387 (461)
......+..+......... ...+++++.+||.+||..||.+|||+.|+++|-
T Consensus 278 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 7766655555554433222 245899999999999999999999999998754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=366.37 Aligned_cols=254 Identities=17% Similarity=0.223 Sum_probs=207.4
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCC----ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGT----LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDA 197 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~ 197 (461)
...++|++.+.||+|+||+||+|+++... ..+..||+|++.... ....+.+.+|+.++++++ ||||++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 80 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLS-HKHLVLNYGV 80 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSC-CTTBCCEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCC-CCCEeEEEEE
Confidence 34568999999999999999999987521 112579999986543 234577889999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCC-----CCe
Q 012518 198 FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED-----APL 272 (461)
Q Consensus 198 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~-----~~~ 272 (461)
+.+.+..|+||||+.||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.. ..+
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999999999997765569999999999999999999999999999999999999743221 129
Q ss_pred eEeecccccccCCCCCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCC
Q 012518 273 KVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 350 (461)
Q Consensus 273 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 350 (461)
||+|||++..... .....||+.|+|||++. ..++.++|||||||++|+|++|..|+...........+......+
T Consensus 161 kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (289)
T 4fvq_A 161 KLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL 237 (289)
T ss_dssp EECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred eeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCC
Confidence 9999999875532 23456899999999986 459999999999999999999665555554444444444443333
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 351 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 351 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+ ...++++.+||.+||+.||.+|||+.|+++|
T Consensus 238 ~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 238 P----APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp C----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred C----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3 2467899999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=366.20 Aligned_cols=252 Identities=24% Similarity=0.399 Sum_probs=204.9
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||.||+|++.. +|+.||||++...........+.+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTV---RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcC---CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCeE
Confidence 589999999999999999999876 78999999998766556666788999999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 110 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~---~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSCCC-----
T ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc---CCCCEEEecCccCcccc
Confidence 9999999999999988654 5799999999999999999999999999999999999995 56779999999987665
Q ss_pred CCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 285 PDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 285 ~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+........ .............+.++++
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA-HINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHH-HHHSCCCCGGGTSTTCCTH
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHH-HhccCCCCccccCCCCCHH
Confidence 432 234567999999999986 568999999999999999999999998776554333 3333333333334678999
Q ss_pred HHHHHHHhcccCcCCCC-CHHHHhc
Q 012518 362 AKDFVRRLLNKDHRKRM-TAAQALT 385 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~-s~~e~L~ 385 (461)
+.+||.+||+.||.+|| +++++++
T Consensus 265 l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 265 FDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999999999 7777664
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=380.58 Aligned_cols=259 Identities=26% Similarity=0.432 Sum_probs=207.2
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCC----------CCCeeE
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG----------HKHMIK 193 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~----------hpniv~ 193 (461)
.++|++.+.||+|+||+||+|++.. +|+.||||++... ....+.+.+|+.+++++.+ |+||++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC---CCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 4589999999999999999999876 7899999999743 3345678899999998852 789999
Q ss_pred EEEEEEeCC----eEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCcEEEecCC
Q 012518 194 FHDAFEDAN----SVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTRE 267 (461)
Q Consensus 194 l~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~-givHrDlkp~NILl~~~~ 267 (461)
+++++...+ .+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++..+
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999998654 789999999 88999988764 34599999999999999999999998 999999999999996432
Q ss_pred ---CCCCeeEeecccccccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC------hh
Q 012518 268 ---EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART------ES 337 (461)
Q Consensus 268 ---~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~------~~ 337 (461)
....+||+|||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ..
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 334699999999987643 3455689999999999864 58999999999999999999999997654 22
Q ss_pred hHHHHHHhcCCCCCC-------------------------C-------------CCCCCCHHHHHHHHHhcccCcCCCCC
Q 012518 338 GIFRSVLRADPNFHD-------------------------S-------------PWPSVSPEAKDFVRRLLNKDHRKRMT 379 (461)
Q Consensus 338 ~~~~~i~~~~~~~~~-------------------------~-------------~~~~~s~~~~~li~~~L~~dP~~R~s 379 (461)
..+..+.......+. . ....+++++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 223332221111000 0 00124578899999999999999999
Q ss_pred HHHHhcCCCcCCC
Q 012518 380 AAQALTHPWLHDE 392 (461)
Q Consensus 380 ~~e~L~hp~~~~~ 392 (461)
++|+|+||||++.
T Consensus 328 ~~ell~hp~f~~~ 340 (373)
T 1q8y_A 328 AGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHTCGGGTTC
T ss_pred HHHHhhChhhhcc
Confidence 9999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=366.60 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=215.9
Q ss_pred cccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..++|++.+.||+|+||.||+|.+.. +..+++.||||++... ......+.+.+|+++++.++ ||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQ 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEec
Confidence 35689999999999999999998742 2235689999999754 24556678899999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRG-----------------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 257 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~-----------------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlk 257 (461)
.+.+|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 999999999999999999987643 237889999999999999999999999999999
Q ss_pred CCcEEEecCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCC
Q 012518 258 PENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFW 332 (461)
Q Consensus 258 p~NILl~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~ 332 (461)
|+|||++ .++.+||+|||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.
T Consensus 178 p~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 178 ARNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp GGGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred hheEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999996 466799999999987654332 23346788999999886 568999999999999999999 999999
Q ss_pred CCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 333 ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 333 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+.........+...... .....+++++.+||.+||+.||.+||++.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88887777766654321 1224689999999999999999999999998863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=371.28 Aligned_cols=250 Identities=20% Similarity=0.285 Sum_probs=204.9
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcE----EEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKV----VAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
.++|++.+.||+|+||+||+|++.. +|+. ||+|.+.... .....+.+.+|+.++++++ ||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 87 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICL 87 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC-------CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcC---CCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEe
Confidence 3589999999999999999999765 4443 5777775432 2334577899999999996 999999999998
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
+.. .++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 88 ~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~ 163 (327)
T 3poz_A 88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGL 163 (327)
T ss_dssp SSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTH
T ss_pred cCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCcc
Confidence 765 7899999999999999988778899999999999999999999999999999999999996 456799999999
Q ss_pred ccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCC
Q 012518 280 SDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 280 a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 354 (461)
++....... .....||..|+|||++. +.++.++|||||||++|||++ |+.||.+.....+...+...... . .
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~--~ 240 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-P--Q 240 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-C--C
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC-C--C
Confidence 987654432 23345688999999886 569999999999999999999 99999988877776666554322 1 1
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
...++.++.+||.+||+.||.+||++.|++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 24588999999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=370.93 Aligned_cols=257 Identities=28% Similarity=0.544 Sum_probs=202.8
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH---HHHHHHHHHHHHHHhcC---CCCCeeEE
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA---LAIEDVRREVKILKALS---GHKHMIKF 194 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~---~hpniv~l 194 (461)
+.+.++|++.+.||+|+||.||+|+++. +|+.||||++........ .....+.+|+.+++++. +|+||+++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLT---DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTT---TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEcc---CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 4456789999999999999999998876 789999999976543221 12234567999999982 39999999
Q ss_pred EEEEEeCCeEEEEEec-cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCee
Q 012518 195 HDAFEDANSVYIVMEF-CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 273 (461)
Q Consensus 195 ~~~~~~~~~~~lv~e~-~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~k 273 (461)
++++.+.+..++|||| +.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. .++.+|
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~k 180 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAK 180 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET--TTTEEE
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC--CCCeEE
Confidence 9999999999999999 7899999988765 56999999999999999999999999999999999999962 466799
Q ss_pred EeecccccccCCCCCccccccCCCcCchhhhhc-cC-CCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC
Q 012518 274 VIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SY-NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH 351 (461)
Q Consensus 274 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 351 (461)
|+|||++...... ......||..|+|||++.+ .+ +.++|||||||++|+|++|+.||.... .+......+.
T Consensus 181 l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~ 253 (312)
T 2iwi_A 181 LIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP 253 (312)
T ss_dssp ECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC
T ss_pred EEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc
Confidence 9999999876543 3456779999999999863 33 568999999999999999999996532 2233332222
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 352 DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 352 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
..+++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 254 ----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 254 ----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp ----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred ----ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 458999999999999999999999999999999987543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=366.70 Aligned_cols=257 Identities=24% Similarity=0.387 Sum_probs=211.5
Q ss_pred cccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..++|++.+.||+|+||+||+|++.. ...+++.||||++.... .....+.+.+|+.+++++.+||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 34689999999999999999998643 23477899999997642 344556789999999999769999999999876
Q ss_pred CC-eEEEEEeccCCCchHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEe
Q 012518 201 AN-SVYIVMEFCEGGELLDRILSRGGR---------------YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 264 (461)
Q Consensus 201 ~~-~~~lv~e~~~gg~L~~~l~~~~~~---------------~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~ 264 (461)
.+ .+|+||||+.+|+|.+++...... +++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 54 599999999999999988765332 78999999999999999999999999999999999995
Q ss_pred cCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhH
Q 012518 265 TREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 339 (461)
Q Consensus 265 ~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~ 339 (461)
.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+......
T Consensus 183 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 183 ---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp ---GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ---CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 466799999999987654322 23456889999999886 569999999999999999998 9999987665444
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 340 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 340 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+............ ...+++++.++|.+||+.||.+|||+.|+++|
T Consensus 260 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCccCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4433333222222 23589999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=359.55 Aligned_cols=253 Identities=21% Similarity=0.299 Sum_probs=212.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||+|+||+||+|++.....++..||||++.... .....+.+.+|+.+++.++ ||||+++++++.+. .
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~-~ 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEEE-P 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECSS-S
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEcCC-C
Confidence 468999999999999999999976544456789999987652 3445678899999999996 99999999998754 5
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
.|+||||+.+++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRYI 163 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGGGCC
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCCccc
Confidence 6899999999999999987777799999999999999999999999999999999999996 4567999999999876
Q ss_pred CCCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 284 RPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 284 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
.... ......+|+.|+|||++. ..++.++|||||||++|+|++ |+.||...........+....... ....++
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 240 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---KPDLCP 240 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---CCTTCC
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---CCCCCC
Confidence 5432 223456788999999986 569999999999999999998 999998887777777666543221 123589
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+.+.+||.+||..||.+|||+.|++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 241 PVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 999999999999999999999999863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=361.96 Aligned_cols=255 Identities=22% Similarity=0.397 Sum_probs=200.7
Q ss_pred CCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 119 YGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 119 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
.++...++|++.+.||+|+||+||+|++. ..||||+++... ......+.+.+|+.++++++ |+||+++++++
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~------~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 89 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS 89 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS------SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc------CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec
Confidence 35666779999999999999999999753 249999997653 34556678999999999996 99999999965
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 199 EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 199 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
..+.+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 90 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg 165 (289)
T 3og7_A 90 -TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFG 165 (289)
T ss_dssp -CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC
T ss_pred -cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccce
Confidence 56678999999999999999877777899999999999999999999999999999999999996 46679999999
Q ss_pred cccccCCC---CCccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc-CCCC
Q 012518 279 LSDFVRPD---QRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA-DPNF 350 (461)
Q Consensus 279 ~a~~~~~~---~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-~~~~ 350 (461)
++...... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||........+..+... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP 245 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc
Confidence 99765432 2334567999999999984 35888999999999999999999999886655544444333 2222
Q ss_pred C-CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 351 H-DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 351 ~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
. ......+++++.+||.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1 1223468999999999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=387.05 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=199.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+|++.+.||+|+||+||.... . +|+.||||++...... .+.+|+++|+.+.+||||+++++++.+.+.+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~-~---~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGM-F---DNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEE-S---SSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EEEecCCeeecCcCEEEEEEEE-e---CCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 3799999999999999764332 2 7899999999654322 2458999999996699999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC--CCCCeeEeecccccc
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE--EDAPLKVIDFGLSDF 282 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~--~~~~~kl~DFG~a~~ 282 (461)
|||||||. |+|.+++........+..+..++.||+.||.|||++||+||||||+|||++..+ ....+||+|||++..
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99999996 599999877666677777889999999999999999999999999999996433 234578999999987
Q ss_pred cCCCC----CccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCC
Q 012518 283 VRPDQ----RLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDS 353 (461)
Q Consensus 283 ~~~~~----~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 353 (461)
..... .....+||+.|+|||++. ..++.++|||||||++|||++ |..||.......... +..........
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~~~~~~~~~~ 251 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LLGACSLDCLH 251 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HTTCCCCTTSC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-HhccCCccccC
Confidence 65432 334578999999999985 347889999999999999999 999996554433322 22211111111
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 354 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
.....+..+++||.+||+.||.+|||+.|+|+||||+.
T Consensus 252 ~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 12234667899999999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=384.86 Aligned_cols=259 Identities=22% Similarity=0.398 Sum_probs=211.9
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
....++|++.+.||+|+||+||+|+++. +|+.||||++....... ..+.+.+|++++++++ ||||+++++++.+
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 78 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLN-HKNIVKLFAIEEE 78 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECC---CCcEEEEEEeccccccc--hHHHHHHHHHHHHhcC-CCCCCeEEEeecc
Confidence 3456799999999999999999999876 78999999997643322 3466789999999996 9999999999987
Q ss_pred CC--eEEEEEeccCCCchHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC-CCCCCeeEe
Q 012518 201 AN--SVYIVMEFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR-EEDAPLKVI 275 (461)
Q Consensus 201 ~~--~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~-~~~~~~kl~ 275 (461)
.+ .+|+|||||.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+... +.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence 65 7899999999999999886542 238999999999999999999999999999999999998432 345569999
Q ss_pred ecccccccCCCCCccccccCCCcCchhhhh---------ccCCCchhHHHHHHHHHHHhhCCCCCCC----CChhhHHHH
Q 012518 276 DFGLSDFVRPDQRLNDIVGSAYYVAPEVLH---------RSYNVEGDMWSIGVITYILLCGSRPFWA----RTESGIFRS 342 (461)
Q Consensus 276 DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwSlGvil~elltg~~Pf~~----~~~~~~~~~ 342 (461)
|||++............+||+.|+|||++. ..++.++|||||||++|||++|+.||.. ....+.+..
T Consensus 159 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp CGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred cCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 999998877666666788999999999885 3578899999999999999999999964 333455666
Q ss_pred HHhcCCCCCC---------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 343 VLRADPNFHD---------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 343 i~~~~~~~~~---------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+....+.... .....+++.+.+||.+||+.||++|+++.|+++
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 6655432100 000124568889999999999999999999754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=369.53 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=209.4
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEE--EEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVV--AVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~v--AvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|++.+.||+|+||.||+|+++. +|..+ |||.+.... .....+.+.+|+.+++++.+||||+++++++.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred HHHccceeeeecCCCceEEEEEEcc---CCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 3689999999999999999999876 56644 999886532 2334567889999999995599999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 266 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~ 266 (461)
+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-- 176 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-- 176 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc--
Confidence 99999999999999999886543 4689999999999999999999999999999999999995
Q ss_pred CCCCCeeEeecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHH
Q 012518 267 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVL 344 (461)
Q Consensus 267 ~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~ 344 (461)
.++.+||+|||++.............+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 177 -~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 177 -ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp -GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred -CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 46679999999997544333334456788999999986 458999999999999999998 999999988888777766
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 345 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 345 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
..... .....+++++.+||.+||..||.+|||+.|++++
T Consensus 256 ~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 54221 1224689999999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=364.40 Aligned_cols=254 Identities=21% Similarity=0.331 Sum_probs=202.9
Q ss_pred ccccceeeceeeccCCceEEEEEEecc-CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKK-GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
...++|++++.||+|+||+||+|+... ...+|+.||||++... .....+.+.+|++++++++ ||||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYS 82 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec
Confidence 345799999999999999999998421 2237899999998753 3455678899999999996 9999999999854
Q ss_pred --CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 201 --ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 201 --~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
...+++||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg 159 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFG 159 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccCc
Confidence 4568999999999999999977666799999999999999999999999999999999999996 45679999999
Q ss_pred cccccCCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh----------------
Q 012518 279 LSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES---------------- 337 (461)
Q Consensus 279 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---------------- 337 (461)
++........ .....||..|+|||++. ..++.++|||||||++|+|++|..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 9987654321 23345778899999986 56999999999999999999999998543211
Q ss_pred hHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 338 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 338 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.....+. ..... .....+++++.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~-~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 240 HLIELLK-NNGRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHH-TTCCC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHh-ccCcC--CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111121 12122 223468999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=373.59 Aligned_cols=250 Identities=20% Similarity=0.316 Sum_probs=206.3
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcE----EEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKV----VAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
.++|++++.||+|+||+||+|++.. +|+. ||+|++..... ......+.+|+.+++.++ ||||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIP---EGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECC---TTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred HhHceeeeeeeecCCceEEEEEEcC---CCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc
Confidence 3589999999999999999999865 4544 77787754321 112245668999999996 999999999886
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
++..++||||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~ 161 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGV 161 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES---SSSCEEECSCSG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC---CCCeEEECCCCc
Confidence 4568999999999999999877666799999999999999999999999999999999999994 567799999999
Q ss_pred ccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCC
Q 012518 280 SDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 280 a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 354 (461)
++...... ......||..|+|||++. +.++.++|||||||++|+|++ |..||.+.........+.........
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 239 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP-- 239 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC--
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC--
Confidence 98765433 234467888999999986 579999999999999999999 99999988877777766654322221
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
..++.++.+||.+||..||.+|||+.|+++|
T Consensus 240 -~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 240 -QICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2478899999999999999999999999886
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=384.16 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=200.3
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
...+.+.|.+.+.||+|+||+||.+.. . +|+.||||++.... .+.+.+|+.+|+++.+||||+++++++.
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~~-~---~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 79 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQGS-F---QGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSET 79 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEEE-S---SSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEEE-E---CCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 345566788889999999999986533 2 78999999986532 3456789999998756999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecC-------
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGR------YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR------- 266 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~------~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~------- 266 (461)
+.+.+|||||||. |+|.+++...... ..+..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence 9999999999995 6999988654211 1223457899999999999999999999999999999753
Q ss_pred ---CCCCCeeEeecccccccCCCCC-----ccccccCCCcCchhhhhc--------cCCCchhHHHHHHHHHHHhh-CCC
Q 012518 267 ---EEDAPLKVIDFGLSDFVRPDQR-----LNDIVGSAYYVAPEVLHR--------SYNVEGDMWSIGVITYILLC-GSR 329 (461)
Q Consensus 267 ---~~~~~~kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlGvil~ellt-g~~ 329 (461)
+.+..+||+|||++........ ....+||+.|+|||++.+ .++.++|||||||++|||++ |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 2456799999999987654321 234689999999999853 48899999999999999999 999
Q ss_pred CCCCCChhhHHHHHHhcCCCCCCCC---CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 330 PFWARTESGIFRSVLRADPNFHDSP---WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 330 Pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
||....... ..+........... ...+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 239 Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 239 PFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 997655433 33444433332221 1235689999999999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=356.16 Aligned_cols=247 Identities=24% Similarity=0.385 Sum_probs=213.7
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+++++.++ ||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAP 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred hhheeeeeEecCCCceeEEEEEec----CCCeEEEEEccccCCC----HHHHHHHHHHHHhCC-CCCEeeEEEEEccCCC
Confidence 358999999999999999999875 4678999999765432 357889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFV 154 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---GGGCEEECCTTGGGGB
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC---CCCCEEEccccccccc
Confidence 9999999999999999987767899999999999999999999999999999999999995 4667999999999866
Q ss_pred CCCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 284 RPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 284 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
.... ......||..|+|||++. ..++.++||||||+++|+|++ |..||......+....+........ ...++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~ 231 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAS 231 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSC
T ss_pred ccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCc
Confidence 4321 223456788999999986 568999999999999999999 9999998888888877766533222 23578
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+++.+||.+||+.||.+|||+.++++
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 232 THVYQIMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999886
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=363.83 Aligned_cols=255 Identities=21% Similarity=0.331 Sum_probs=206.5
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||+|+||+||+|++......+..||||+++..........+.+.+|++++++++ ||||+++++++.+..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence 358999999999999999999865432234479999997765445556788999999999996 999999999998765
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
.++||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEccccccccc
Confidence 8999999999999999987767799999999999999999999999999999999999996 4567999999999876
Q ss_pred CCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 284 RPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 284 ~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
..... .....+|..|+|||++. ..++.++|||||||++|+|++ |+.||.+....+....+......... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 249 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED 249 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcC
Confidence 54332 23356788999999986 458999999999999999999 99999998888888887765544332 246
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+++++.++|.+||..||.+|||+.++++
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8999999999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=357.79 Aligned_cols=252 Identities=20% Similarity=0.327 Sum_probs=215.8
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
.+...++|++.+.||+|+||+||+|.++. +++.||||++.... ...+.+.+|+.+++.++ ||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 79 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCT 79 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGG---GTEEEEEEEECSCS----THHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred ccccccceeEEeecCCCCceeEEEeEecC---CCEEEEEEecCcCH----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEc
Confidence 34456789999999999999999999876 78999999997542 23567889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
+.+.+|+||||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg 156 (288)
T 3kfa_A 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFG 156 (288)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC---GGGCEEECCCC
T ss_pred cCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc---CCCCEEEccCc
Confidence 9999999999999999999987643 4589999999999999999999999999999999999995 56679999999
Q ss_pred cccccCCCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCC
Q 012518 279 LSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 279 ~a~~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 354 (461)
++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||...........+...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~ 233 (288)
T 3kfa_A 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ER 233 (288)
T ss_dssp GGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CC
T ss_pred cceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CC
Confidence 9987654332 23456788999999986 569999999999999999999 99999888877777766554221 22
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...+++++.+||.+||..||.+|||+.|+++
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 2468999999999999999999999999865
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=378.22 Aligned_cols=260 Identities=16% Similarity=0.202 Sum_probs=197.9
Q ss_pred cccceeeceeeccCCceEEEEEEeccCC--ccCcEEEEEEecccccCCHHH--------HHHHHHHHHHHHhcCCCCCee
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALA--------IEDVRREVKILKALSGHKHMI 192 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~g~~vAvK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~~hpniv 192 (461)
..++|++++.||+|+||+||+|.++.+. ..++.||||++.......... ...+.+|+..+..+. |+||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCCC
Confidence 3459999999999999999999886532 236889999987643110000 012234455555664 99999
Q ss_pred EEEEEEEeC----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCC
Q 012518 193 KFHDAFEDA----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 268 (461)
Q Consensus 193 ~l~~~~~~~----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~ 268 (461)
++++++... ...||||||| |++|.+++....+.+++..++.|+.||+.||.|||++||+||||||+|||++. +.
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-SC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-CC
Confidence 999998764 4589999999 99999998877678999999999999999999999999999999999999963 24
Q ss_pred CCCeeEeecccccccCCCCC--------ccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhH
Q 012518 269 DAPLKVIDFGLSDFVRPDQR--------LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGI 339 (461)
Q Consensus 269 ~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~ 339 (461)
++.+||+|||+++....... ....+||+.|+|||++.+ .++.++|||||||+||||++|+.||.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 67899999999976543221 134569999999999874 599999999999999999999999986433222
Q ss_pred HHHHHhcC--CCCC---C--CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 340 FRSVLRAD--PNFH---D--SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 340 ~~~i~~~~--~~~~---~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
........ .... . .....+++++.+||.+||..||.+||++.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 21111100 0000 0 001357899999999999999999999998875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=366.37 Aligned_cols=255 Identities=23% Similarity=0.374 Sum_probs=214.3
Q ss_pred cccceeeceeeccCCceEEEEEEecc----CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKK----GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
..++|++++.||+|+||+||+|++.. ...+++.||||++.... .....+.+.+|+.+++++.+||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 34689999999999999999998752 11367889999997542 4455678899999999995599999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEE
Q 012518 199 EDANSVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 263 (461)
Q Consensus 199 ~~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl 263 (461)
.+.+.+|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 99999999999999999999886543 248899999999999999999999999999999999999
Q ss_pred ecCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhh
Q 012518 264 TTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESG 338 (461)
Q Consensus 264 ~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~ 338 (461)
+ .++.+||+|||++........ .....+|+.|+|||++. +.++.++|||||||++|+|++ |..||.+....+
T Consensus 191 ~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 191 T---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp C---TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred c---CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 4 567899999999987654332 23346788999999886 568999999999999999999 999999888887
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 339 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 339 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+...+....... ....+++++.+||.+||..||.+|||+.|+++
T Consensus 268 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 268 LFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp HHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 777766553221 22468999999999999999999999999886
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=360.14 Aligned_cols=255 Identities=18% Similarity=0.297 Sum_probs=207.4
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+.++|++.+.||+|+||+||+|++.. +|+.||||++...... +.+.+|+.+++.+++|+++..+..++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcC---CCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence 356799999999999999999999875 7899999998765432 35778999999998444555665666788
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 8899999999 899999987666789999999999999999999999999999999999999644467789999999998
Q ss_pred ccCCCCC--------ccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC---hhhHHHHHHhcCCC
Q 012518 282 FVRPDQR--------LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART---ESGIFRSVLRADPN 349 (461)
Q Consensus 282 ~~~~~~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~ 349 (461)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. ....+..+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 7654332 245689999999999874 68999999999999999999999997633 22333333332211
Q ss_pred CC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 350 FH-DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 350 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.. ......+++++.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11 0112458899999999999999999999998875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=364.81 Aligned_cols=257 Identities=18% Similarity=0.296 Sum_probs=216.3
Q ss_pred CccccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
+...++|++.+.||+|+||.||+|.++. ...+++.||||++... ........+.+|+.+++.+. |+||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 97 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVV 97 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcC-CCCEeeeEEEE
Confidence 3445689999999999999999998762 1125788999998754 23445567889999999996 99999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCC
Q 012518 199 EDANSVYIVMEFCEGGELLDRILSRG---------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 269 (461)
Q Consensus 199 ~~~~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~ 269 (461)
.+.+..|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---ED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc---CC
Confidence 99999999999999999999886532 3568999999999999999999999999999999999995 56
Q ss_pred CCeeEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHH
Q 012518 270 APLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVL 344 (461)
Q Consensus 270 ~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~ 344 (461)
+.+||+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++ |..||.+.........+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 789999999998654332 123346788999999986 569999999999999999999 899999888887777776
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 345 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 345 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
...... ....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 255 ~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 EGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 653221 124689999999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=358.25 Aligned_cols=254 Identities=20% Similarity=0.321 Sum_probs=214.1
Q ss_pred ccceeece-eeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 124 GAKFELGK-EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 124 ~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
.++|.+.+ .||+|+||+||+|.++.. .+++.||||+++.. ......+.+.+|+++++.++ ||||+++++++ ..+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAE 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESS
T ss_pred HHHhhhhhccccccCceeEEEeEeccC-CCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCC
Confidence 35788877 999999999999986532 26788999999765 34456678999999999996 99999999999 456
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKA 159 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceee
Confidence 79999999999999998876667799999999999999999999999999999999999996 456799999999987
Q ss_pred cCCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 283 VRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 283 ~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
...... .....||+.|+|||++. ..++.++|||||||++|+|++ |+.||......+....+...... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~~~ 236 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPP 236 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCT
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CCCC
Confidence 654332 22345688999999986 568999999999999999998 99999988887777777664322 1124
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 388 (461)
.+++++.+||.+||..||.+||++.++++|.+
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 68999999999999999999999999998653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=364.42 Aligned_cols=240 Identities=33% Similarity=0.610 Sum_probs=194.5
Q ss_pred cccceeec-eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-
Q 012518 123 FGAKFELG-KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED- 200 (461)
Q Consensus 123 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~- 200 (461)
+.++|.+. +.||+|+||.||+|.++. +|+.||||++... ..+.+|+.++.++.+||||++++++|.+
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcC---CCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 34577777 789999999999999876 7899999999642 3566899998666569999999999987
Q ss_pred ---CCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 201 ---ANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 201 ---~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
...+|+||||+.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 778999999999999999987654 3699999999999999999999999999999999999997654478899999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHh----cCCCCCC
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR----ADPNFHD 352 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~----~~~~~~~ 352 (461)
||++..... ..++.++|||||||++|+|++|..||...........+.. ....+..
T Consensus 164 fg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 164 FGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp CTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred ccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 999875431 3467899999999999999999999977654332221111 1111222
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 353 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 353 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
..+..+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 22246899999999999999999999999999999998764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=371.57 Aligned_cols=255 Identities=20% Similarity=0.292 Sum_probs=205.6
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
...++|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR----DGAKVALKRRTPES---SQGIEEFETEIETLSFCR-HPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT----TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCT
T ss_pred HHHhccCccceeecCCCeeEEEEEEC----CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCC
Confidence 35578999999999999999999864 58899999986543 234577889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG---GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
+.+|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD---ENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC---TTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC---CCCCEEEeecc
Confidence 99999999999999998875442 2588999999999999999999999999999999999994 57789999999
Q ss_pred cccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHH---HHH--HhcCCC
Q 012518 279 LSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF---RSV--LRADPN 349 (461)
Q Consensus 279 ~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---~~i--~~~~~~ 349 (461)
++....... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||.+....+.. ... ......
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 998654322 224456999999999885 67999999999999999999999999765432211 110 001111
Q ss_pred C--------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 012518 350 F--------HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387 (461)
Q Consensus 350 ~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 387 (461)
+ .....+..+..+.++|.+||+.||.+|||+.|+++|-
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1 1111123457789999999999999999999998753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=360.12 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=205.3
Q ss_pred ccccceeeceeeccCCceEEEEEEec-cCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGK-KGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
....+|++++.||+|+||.||+|+.. .+..+|+.||||++.... .....+.+.+|+.+++.++ ||||+++++++.+
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTE 94 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEec
Confidence 33457999999999999999999842 123378999999997543 2234577889999999996 9999999999987
Q ss_pred C--CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 201 A--NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 201 ~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
. +.+++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg 171 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFG 171 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECccc
Confidence 6 679999999999999999977777899999999999999999999999999999999999996 45679999999
Q ss_pred cccccCCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCC--------------ChhhH
Q 012518 279 LSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWAR--------------TESGI 339 (461)
Q Consensus 279 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~--------------~~~~~ 339 (461)
++........ .....||..|+|||++. ..++.++|||||||++|+|++|..|+... .....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 9987654432 23456888999999886 56889999999999999999999886321 11112
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 340 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 340 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+.......... .....+++++.+||.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKEGKRL--PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCC--CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 22222222222 223468999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=361.91 Aligned_cols=263 Identities=20% Similarity=0.251 Sum_probs=209.2
Q ss_pred cccCCCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEE
Q 012518 115 KNFGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKF 194 (461)
Q Consensus 115 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l 194 (461)
..........++|++.+.||+|+||+||+|.......+++.||||++.... ......+.+.+|+.++++++ ||||+++
T Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~ 101 (313)
T 3brb_A 24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFS-HPNVIRL 101 (313)
T ss_dssp CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCC-CTTBCCC
T ss_pred hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCC-CCCeeee
Confidence 333334445679999999999999999999887655567799999987653 24455678899999999996 9999999
Q ss_pred EEEEEeCC-----eEEEEEeccCCCchHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEe
Q 012518 195 HDAFEDAN-----SVYIVMEFCEGGELLDRILS-----RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 264 (461)
Q Consensus 195 ~~~~~~~~-----~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~ 264 (461)
++++.+.+ ..|+||||+.+|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~ 181 (313)
T 3brb_A 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR 181 (313)
T ss_dssp CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC
T ss_pred eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc
Confidence 99998755 35999999999999998853 235689999999999999999999999999999999999995
Q ss_pred cCCCCCCeeEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhH
Q 012518 265 TREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 339 (461)
Q Consensus 265 ~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~ 339 (461)
.++.+||+|||++....... ......+++.|+|||++. ..++.++|||||||++|+|++ |..||........
T Consensus 182 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 182 ---DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp ---TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ---CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 56779999999998664432 123346788999999986 468999999999999999999 9999998888888
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 340 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 340 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...+...... .....+++++.+||.+||..||.+|||+.++++
T Consensus 259 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 259 YDYLLHGHRL---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp HHHHHTTCCC---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCC---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8777665322 122468999999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=366.60 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=213.0
Q ss_pred cccceeeceeeccCCceEEEEEEeccCC--ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGT--LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..++|++.+.||+|+||+||+|.+.... ..++.||||++.... .....+.+.+|+.+++.+.+||||+++++++.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3468999999999999999999986421 133589999997542 344567889999999999559999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC
Q 012518 201 ANSVYIVMEFCEGGELLDRILSR-------------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 267 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~-------------~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~ 267 (461)
.+.+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~--- 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT--- 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE---
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC---
Confidence 99999999999999999988653 34579999999999999999999999999999999999996
Q ss_pred CCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHH
Q 012518 268 EDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRS 342 (461)
Q Consensus 268 ~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 342 (461)
.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+......+..
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 456799999999986543322 23456788999999886 569999999999999999998 9999988776666655
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 343 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+......... ...+++++.+||.+||+.||.+|||+.|+++
T Consensus 279 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 279 LVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 5554433322 2357899999999999999999999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=363.52 Aligned_cols=255 Identities=20% Similarity=0.338 Sum_probs=209.6
Q ss_pred cccceeeceeeccCCceEEEEEEeccCC-ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGT-LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
...+|++.+.||+|+||+||+|.++... ..+..||||++.... .......+.+|+.+++.++ ||||+++++++.+.
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKY 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC
Confidence 3468999999999999999999876421 124569999997542 3445667899999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+.+|+||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC---CCCcEEECCCCcch
Confidence 999999999999999999987777899999999999999999999999999999999999995 56789999999998
Q ss_pred ccCCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 282 FVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 282 ~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||......++...+...... ...
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---~~~ 272 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---PTP 272 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC---CCc
Confidence 7654321 12235678899999986 569999999999999999999 99999988888877777654221 122
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
..+++++.+||.+||+.||.+||++.+++++
T Consensus 273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4689999999999999999999999998763
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=358.53 Aligned_cols=253 Identities=19% Similarity=0.277 Sum_probs=208.9
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-EeCC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF-EDAN 202 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~-~~~~ 202 (461)
..+|++.+.||+|+||+||+|.+..+...+..||+|.+... ......+.+.+|+.++++++ ||||+++++++ ..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCC
Confidence 35799999999999999999997654434557999998753 34455678899999999996 99999999986 4566
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
..|+||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARD 177 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECSCGGGCC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC---CCCCEEECccccccc
Confidence 88999999999999999977667789999999999999999999999999999999999994 567899999999986
Q ss_pred cCCCC-----CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 283 VRPDQ-----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 283 ~~~~~-----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
..... ......||+.|+|||++. ..++.++|||||||++|+|++ |.+||......+....+.........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 254 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--- 254 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---
Confidence 64332 223456788999999986 568999999999999999999 66777777777777766665433322
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
..+++++.++|.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 357899999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=383.84 Aligned_cols=249 Identities=20% Similarity=0.344 Sum_probs=213.6
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
...+|++.+.||+|+||.||+|.++. ++..||||+++.... ..+.+.+|+.+|++++ ||||+++++++.+.+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREP 289 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGG---GTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcC---CCeEEEEEEecCccc----chHHHHHHHHHHHhcC-CCCEeeEEEEEecCC
Confidence 34679999999999999999999876 688999999976432 2467889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
.+|||||||.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSR 366 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGGCEEECCTTCEE
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC---CCCcEEEeecccce
Confidence 9999999999999999987643 4589999999999999999999999999999999999995 56779999999998
Q ss_pred ccCCCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 282 FVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 282 ~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
...... ......++..|+|||++. +.++.++|||||||+||||++ |..||.+.....+...+.... .. .....
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~ 443 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-RM--ERPEG 443 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CC--CCCTT
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC--CCCCC
Confidence 765432 123345678899999986 569999999999999999999 999999888777777665432 11 22346
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+++++.+||.+||+.||.+|||+.++++
T Consensus 444 ~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 444 CPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 8999999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=352.81 Aligned_cols=246 Identities=17% Similarity=0.221 Sum_probs=209.2
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA-- 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~-- 201 (461)
.++|++.+.||+|+||+||+|++ +|+.||||++.... ......+.+.+|+.++++++ ||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-----QGNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPA 81 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTS
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-----CCeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCC
Confidence 35899999999999999999987 47789999997654 33445677999999999996 99999999999877
Q ss_pred CeEEEEEeccCCCchHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~i~~qil~al~yLH~~g--ivHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
+.+++||||+++|+|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~---~~~~~~l~~~~ 158 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISMAD 158 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC---TTSCEEEEGGG
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc---CCcceeEEecc
Confidence 789999999999999999876543 4899999999999999999999999 99999999999994 56779999988
Q ss_pred cccccCCCCCccccccCCCcCchhhhhcc----CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCC
Q 012518 279 LSDFVRPDQRLNDIVGSAYYVAPEVLHRS----YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 279 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 354 (461)
++.... .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.........+........ .
T Consensus 159 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 232 (271)
T 3kmu_A 159 VKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--I 232 (271)
T ss_dssp SCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--C
T ss_pred ceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--C
Confidence 875432 2345789999999998642 33479999999999999999999998888777777665543322 2
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...+++++.+||.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3468999999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=359.39 Aligned_cols=251 Identities=27% Similarity=0.457 Sum_probs=212.0
Q ss_pred CCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 119 YGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 119 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
.+..+..+|++++.||+|+||.||+|++.. +|+.||||++.... +.+.+|++++++++ ||||+++++++
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~ 73 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCW 73 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETT---TCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcC---CCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeE
Confidence 355677899999999999999999999876 78999999997542 24568999999996 99999999998
Q ss_pred Ee----------------CCeEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcE
Q 012518 199 ED----------------ANSVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 261 (461)
Q Consensus 199 ~~----------------~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NI 261 (461)
.. ...+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 153 (284)
T 2a19_B 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNI 153 (284)
T ss_dssp EEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred eccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHE
Confidence 64 45589999999999999998754 35789999999999999999999999999999999999
Q ss_pred EEecCCCCCCeeEeecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHH
Q 012518 262 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 340 (461)
Q Consensus 262 Ll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~ 340 (461)
|++ .++.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||... ....
T Consensus 154 l~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~ 228 (284)
T 2a19_B 154 FLV---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFF 228 (284)
T ss_dssp EEE---ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHH
T ss_pred EEc---CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHH
Confidence 996 45679999999998877665556678999999999986 45899999999999999999999987432 2233
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 341 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 341 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
..+.... + ...+++++.+||.+||..||.+|||+.|+++|.|...
T Consensus 229 ~~~~~~~--~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 229 TDLRDGI--I----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHTTC--C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHhhccc--c----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 3333221 1 1357899999999999999999999999999987643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=359.74 Aligned_cols=255 Identities=18% Similarity=0.295 Sum_probs=201.8
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+.++|++.+.||+|+||+||+|++.. +|+.||||++...... ..+.+|+.+++.+.+|++|..+..++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcC---CCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 456799999999999999999999876 7899999987654322 34678999999998455555666666888
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 8999999999 899999987666789999999999999999999999999999999999999544467789999999998
Q ss_pred ccCCCCC--------ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh---hHHHHHHhcCCC
Q 012518 282 FVRPDQR--------LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES---GIFRSVLRADPN 349 (461)
Q Consensus 282 ~~~~~~~--------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~~~~~~ 349 (461)
....... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.... ..+..+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 7654322 23568999999999986 46999999999999999999999999764322 233333222111
Q ss_pred CC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 350 FH-DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 350 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+ ......+++++.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11 1112357899999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=356.16 Aligned_cols=252 Identities=19% Similarity=0.257 Sum_probs=208.9
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
..|++.+.||+|+||+||+|.+..+..++..||+|++... ......+.+.+|+.+++.++ ||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCCC
Confidence 3688889999999999999997664445568999998753 34456678899999999996 99999999999876665
Q ss_pred -EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 -YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 -~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARDI 174 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECCTTSSCTT
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCcEEeCcCCCcccc
Confidence 999999999999999977667899999999999999999999999999999999999994 5678999999999765
Q ss_pred CCC-----CCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCC-CCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 284 RPD-----QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRP-FWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 284 ~~~-----~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
... .......+|+.|+|||++.+ .++.++|||||||++|+|++|..| |...........+...... .. ..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~--~~ 251 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-PQ--PE 251 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-CC--CT
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-CC--Cc
Confidence 432 22334578899999999874 689999999999999999995555 5555555555555544322 11 24
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+++++.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 58999999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=376.52 Aligned_cols=244 Identities=23% Similarity=0.362 Sum_probs=206.9
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||+||++.. .|+.||||+++... ..+.+.+|+.+|++++ ||||+++++++.+.+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~-----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEK 259 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTT
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe-----cCCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCC
Confidence 346899999999999999999976 46789999997643 2367889999999996 999999999987665
Q ss_pred -eEEEEEeccCCCchHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 203 -SVYIVMEFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 203 -~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+|+|||||.+|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a 336 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT 336 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTSCEEECCCTTC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC---CCCCEEEeeCCCc
Confidence 79999999999999999987654 368999999999999999999999999999999999994 5678999999999
Q ss_pred cccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
+..... .....++..|+|||++. +.++.++|||||||+||||++ |..||.+....+....+..... ......+
T Consensus 337 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~p~~~ 411 (450)
T 1k9a_A 337 KEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGC 411 (450)
T ss_dssp EECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC---CCCCTTC
T ss_pred cccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcC
Confidence 865322 23346788999999986 569999999999999999998 9999998887777777765422 1222468
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++++.+||.+||..||.+|||+.++++
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=364.84 Aligned_cols=249 Identities=21% Similarity=0.291 Sum_probs=203.4
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcE----EEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKV----VAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
.++|++++.||+|+||+||+|++.. +|+. ||+|.+.... .....+.+.+|+.++++++ ||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 87 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICL 87 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC---TTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcC---CCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEe
Confidence 3689999999999999999999865 4544 5667665432 2234577889999999996 999999999998
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
+.. .++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 88 ~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~ 163 (327)
T 3lzb_A 88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGL 163 (327)
T ss_dssp SSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC
T ss_pred cCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCcc
Confidence 765 8899999999999999988778899999999999999999999999999999999999996 456799999999
Q ss_pred ccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCC
Q 012518 280 SDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSP 354 (461)
Q Consensus 280 a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 354 (461)
+........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+.....+...+....... .
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~ 240 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---Q 240 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---C
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---C
Confidence 987644322 23345688899999886 569999999999999999999 999999888877777665543221 1
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...++.++.+||.+||..||.+||++.|+++
T Consensus 241 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 241 PPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2458999999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=379.64 Aligned_cols=248 Identities=24% Similarity=0.397 Sum_probs=210.8
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
...++|++.+.||+|+||+||+|.++ .+..||||+++.... ..+.+.+|+.+|++|+ ||||+++++++. .
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVKLHAVVT-K 254 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET----TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCC-CTTBCCEEEEEC-S
T ss_pred echHHeEEEEEcccCCceEEEEEEEC----CccEEEEEEecCCCc----cHHHHHHHHHHHhhCC-CCCEeeEEEEEe-C
Confidence 34568999999999999999999875 467899999976432 3567899999999996 999999999986 5
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
+.+|+|||||.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DFG~a 331 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLA 331 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTCCEEECSTTGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC---CCCcEEEeeCCCc
Confidence 67899999999999999986542 3688999999999999999999999999999999999995 5678999999999
Q ss_pred cccCCCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 281 DFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 281 ~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
+...... ......+|..|+|||++. +.++.++|||||||+||||++ |+.||.+.+..++...+..... .. ...
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~--~~~ 408 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-MP--RPE 408 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC-CC--CCT
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCC
Confidence 8764322 123345678899999986 679999999999999999999 9999999888888877765422 22 224
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+++++.+||.+||..||.+|||+.++++
T Consensus 409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 409 NCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 68999999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=373.76 Aligned_cols=253 Identities=20% Similarity=0.270 Sum_probs=202.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE-eCCe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE-DANS 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~-~~~~ 203 (461)
..|++.+.||+|+||+||+|+.......+..||||.++.. ......+.+.+|+.++++++ ||||+++++++. .++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCC
Confidence 4689999999999999999987653334467999998653 33445678999999999996 999999999875 4567
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
.|+||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC---CCCCEEEeeccccccc
Confidence 8999999999999999977667789999999999999999999999999999999999994 5678999999999865
Q ss_pred CCCC-----CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 284 RPDQ-----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 284 ~~~~-----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
.... ......+|+.|+|||++. +.++.++|||||||++|||++ |..||......+....+........ ..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p~ 319 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PE 319 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---CT
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence 4322 123356788999999986 569999999999999999999 7888887777777766665543222 23
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
.+++.+.++|.+||..||.+|||+.|++++
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 589999999999999999999999998863
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=365.92 Aligned_cols=246 Identities=22% Similarity=0.289 Sum_probs=196.1
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC--
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN-- 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~-- 202 (461)
++|++++.||+|+||+||+|++ .|+.||||++.... .......+|+.++++++ ||||+++++++.+..
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQL-----LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSV 93 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEE-----TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSS
T ss_pred hhchhhheecccCceEEEEEEE-----CCCEEEEEEeecCc----hHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCC
Confidence 5899999999999999999976 46889999996542 23345567999999996 999999999998744
Q ss_pred --eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc----------CccccCCCCCcEEEecCCCCC
Q 012518 203 --SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ----------GVVHRDLKPENFLFTTREEDA 270 (461)
Q Consensus 203 --~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~----------givHrDlkp~NILl~~~~~~~ 270 (461)
.+|+|||||++|+|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++ .++
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~---~~~ 168 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNL 168 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC---TTC
T ss_pred CceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC---CCC
Confidence 47999999999999998865 3599999999999999999999999 999999999999994 567
Q ss_pred CeeEeecccccccCCCCC---ccccccCCCcCchhhhhc------cCCCchhHHHHHHHHHHHhhCCCCCCCCCh-----
Q 012518 271 PLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLHR------SYNVEGDMWSIGVITYILLCGSRPFWARTE----- 336 (461)
Q Consensus 271 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlGvil~elltg~~Pf~~~~~----- 336 (461)
.+||+|||++........ ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+...
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 899999999987654332 344689999999999864 466789999999999999999999975432
Q ss_pred -----------hhHHHHHHhcCCCCCCC-CC--CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 337 -----------SGIFRSVLRADPNFHDS-PW--PSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 337 -----------~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
......+.......... .| ...++++.+||.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11222222221111100 01 112356999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=363.24 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=206.9
Q ss_pred cceeeceeeccCCceEEEEEEecc-CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--eC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKK-GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE--DA 201 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~--~~ 201 (461)
++|++++.||+|+||.||+|+... +..+|+.||||++... .....+.+.+|++++++++ |+||+++++++. +.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSS
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCC
Confidence 589999999999999999998421 2237899999999754 3445677899999999995 999999999986 55
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+.+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAK 175 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGCE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcccccce
Confidence 679999999999999999977666799999999999999999999999999999999999996 46679999999998
Q ss_pred ccCCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh--------------hHHHH
Q 012518 282 FVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES--------------GIFRS 342 (461)
Q Consensus 282 ~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------------~~~~~ 342 (461)
....... .....||..|+|||++. ..++.++|||||||++|+|++|..||...... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 7654332 23356888999999986 45899999999999999999999998543321 11111
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 343 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
....... ......+++++.+||.+||+.||.+|||+.|++++
T Consensus 256 ~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLEEGQR--LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhcccC--CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222211 12235689999999999999999999999999653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=372.51 Aligned_cols=260 Identities=18% Similarity=0.195 Sum_probs=198.3
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH--------HHHHHHHHHHHHHHhcCCCCCeeE
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA--------LAIEDVRREVKILKALSGHKHMIK 193 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~--------~~~~~~~~Ei~il~~l~~hpniv~ 193 (461)
...++|++.+.||+|+||+||+|.+..+..++..||||++........ .....+.+|+.+++.+. ||||++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~ 112 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPL 112 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcce
Confidence 345689999999999999999999876545778999999876432110 01134567888999996 999999
Q ss_pred EEEEEEe----CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCC
Q 012518 194 FHDAFED----ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 269 (461)
Q Consensus 194 l~~~~~~----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~ 269 (461)
+++++.+ ...+|+||||| |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~ 189 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-P 189 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-T
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-C
Confidence 9999988 78899999999 99999987554 4799999999999999999999999999999999999997432 2
Q ss_pred CCeeEeecccccccCCCC--------CccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC--hhh
Q 012518 270 APLKVIDFGLSDFVRPDQ--------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART--ESG 338 (461)
Q Consensus 270 ~~~kl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~ 338 (461)
+.+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.. ...
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 379999999997654321 1245689999999999875 58999999999999999999999996532 222
Q ss_pred HHHHHHhcCCCCCC-----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 339 IFRSVLRADPNFHD-----SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 339 ~~~~i~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
...........++. .....+++++.+||.+||..||.+||++.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 22111111111111 011258899999999999999999999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=364.54 Aligned_cols=249 Identities=21% Similarity=0.368 Sum_probs=187.6
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE----
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE---- 199 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~---- 199 (461)
..+|++.+.||+|+||.||+|+++. +|+.||||++... .....+.+.+|+.+++++.+||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVG---SGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred CceEEEEEEEccCCceEEEEEEECC---CCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 3589999999999999999999876 7899999998553 34455778899999999977999999999994
Q ss_pred ----eCCeEEEEEeccCCCchHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCcEEEecCCCCCC
Q 012518 200 ----DANSVYIVMEFCEGGELLDRILS--RGGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENFLFTTREEDAP 271 (461)
Q Consensus 200 ----~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~i~~qil~al~yLH~~g--ivHrDlkp~NILl~~~~~~~~ 271 (461)
....+++||||+. |+|.+++.. ..+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~---~~~~ 176 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGT 176 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC---TTSC
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC---CCCC
Confidence 3445899999996 699888865 3457999999999999999999999999 99999999999995 5677
Q ss_pred eeEeecccccccCCCCCc-------------cccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCC
Q 012518 272 LKVIDFGLSDFVRPDQRL-------------NDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWAR 334 (461)
Q Consensus 272 ~kl~DFG~a~~~~~~~~~-------------~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~ 334 (461)
+||+|||++......... ....||+.|+|||++. ..++.++|||||||++|+|++|+.||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999999999876543221 1456999999999983 35889999999999999999999999765
Q ss_pred ChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 012518 335 TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 388 (461)
Q Consensus 335 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 388 (461)
....+.... .. .......+..+.+||.+||+.||.+|||+.|+++|-+
T Consensus 257 ~~~~~~~~~----~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 257 AKLRIVNGK----YS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -------------CC--CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hHHHhhcCc----cc--CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 544333222 11 2223457889999999999999999999999998743
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=352.85 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=207.6
Q ss_pred ccceeece-eeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 124 GAKFELGK-EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 124 ~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..+|++.+ .||+|+||+||+|.+... .+++.||||++..... .....+.+.+|+++++.++ ||||+++++++ ..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAE 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECS-SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESS
T ss_pred chhhhhccCccccccCeeeEeeeecCC-CceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCC
Confidence 35899998 999999999999965432 2678999999976532 2334677899999999996 99999999999 567
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKA 166 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCccee
Confidence 789999999999999988654 5799999999999999999999999999999999999996 456799999999987
Q ss_pred cCCCCCc----cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 283 VRPDQRL----NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 283 ~~~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
....... ....+|+.|+|||++. ..++.++|||||||++|+|++ |+.||.+....+....+...... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 243 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPA 243 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCT
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 6544321 2235678899999986 468899999999999999999 99999988887777776654321 1124
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+++++.++|.+||+.||.+||++.++++
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 68999999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=381.18 Aligned_cols=255 Identities=20% Similarity=0.300 Sum_probs=210.3
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+.++|+++++||+|+||.||+|++.. +|+.||||++...... ..+.+|+++++.|.+|++|..+..++.+.
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETT---TCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECC---CCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 456799999999999999999999876 7899999998755432 24678999999998678888888888899
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+..||||||+ +++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||+..+.++.+||+|||+++
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 9999999999 899999987767789999999999999999999999999999999999999654467789999999998
Q ss_pred ccCCCCC--------ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh---hhHHHHHHhcCCC
Q 012518 282 FVRPDQR--------LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE---SGIFRSVLRADPN 349 (461)
Q Consensus 282 ~~~~~~~--------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~~~ 349 (461)
....... ....+||+.|+|||++. ..++.++|||||||+||||++|+.||.+... ...+..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 7654332 22578999999999986 4699999999999999999999999977543 2333333222111
Q ss_pred CC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 350 FH-DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 350 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.. ......+++++.+||.+||..||.+||++.++++
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 0111357899999999999999999999987765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=387.50 Aligned_cols=250 Identities=20% Similarity=0.329 Sum_probs=206.9
Q ss_pred cceeece-eeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 125 AKFELGK-EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 125 ~~y~~~~-~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
+++.+.+ .||+|+||+||+|.++... ++..||||+++... .....+.+.+|+++|++++ |||||++++++.+ +.
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EA 409 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSS-CEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-SS
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCC-CcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-CC
Confidence 4566666 8999999999999876422 56789999997653 2234578899999999996 9999999999976 56
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|||||||.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCSTTTTC
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccCcccc
Confidence 9999999999999999877667799999999999999999999999999999999999996 4567999999999876
Q ss_pred CCCCCc----cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 284 RPDQRL----NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 284 ~~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
...... ....+|+.|+|||++. +.++.++|||||||+||||++ |+.||.+.+..++...+...... .....
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~ 563 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPE 563 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC---CCCTT
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCCc
Confidence 433221 2234568999999986 679999999999999999998 99999998888888877765322 11245
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+++++.+||.+||..||.+||++.++++
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999999999999999998753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=357.92 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=204.1
Q ss_pred cccce-eeceeeccCCceEEEEEEec-cCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 123 FGAKF-ELGKEVGRGHFGHTCCAKGK-KGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y-~~~~~lG~G~fg~V~~~~~~-~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
+..+| ++++.||+|+||+||++..+ ....+|+.||||++... ......+.+.+|++++++++ ||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCED 104 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCC-CcchhhEEEEEec
Confidence 44555 99999999999999998643 33347899999999765 34455678999999999997 9999999999987
Q ss_pred --CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 201 --ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 201 --~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
...+++||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg 179 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFG 179 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCGG
T ss_pred CCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc---CCCCEEECCcc
Confidence 46799999999999999988543 499999999999999999999999999999999999994 56779999999
Q ss_pred cccccCCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhh--------------H
Q 012518 279 LSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG--------------I 339 (461)
Q Consensus 279 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--------------~ 339 (461)
++........ .....||..|+|||++. ..++.++|||||||++|+|++|..||....... .
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 9987755432 23456888999999986 468899999999999999999999996532210 1
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 340 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 340 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+......... ......+++++.+||.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 260 LTELLERGER--LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcccC--CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1112222211 1223468999999999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=350.41 Aligned_cols=247 Identities=20% Similarity=0.361 Sum_probs=208.7
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++++.||+|+||+||+|.+. +++.||||++..... ..+.+.+|+++++.++ ||||+++++++.+ +
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-E 80 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc----CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCC-CcCcceEEEEEcC-C
Confidence 4568999999999999999999875 467899999976432 2467889999999996 9999999999874 5
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
..++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLAR 157 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCE
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc---CCCCEEECCCcccc
Confidence 6899999999999999885432 2689999999999999999999999999999999999995 56779999999998
Q ss_pred ccCCCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 282 FVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 282 ~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
....... .....+|..|+|||++. +.++.++|||||||++|+|++ |..||.+....+....+...... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 234 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VRPDN 234 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTT
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC---CCccc
Confidence 7654321 23345788999999986 568999999999999999999 99999988888777777654322 12246
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+++++.+||.+||..||.+|||+.++++
T Consensus 235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 235 CPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 8999999999999999999999998875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=356.46 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=196.4
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHh--cCCCCCeeEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKA--LSGHKHMIKFHDA 197 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~~hpniv~l~~~ 197 (461)
+..+.++|++.+.||+|+||+||+|++ +|+.||||++... ....+.+|.+++.. + +||||++++++
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~ 70 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW-----QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIAS 70 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE-----CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEe
Confidence 355678999999999999999999976 5788999998653 23455677777777 6 49999999998
Q ss_pred EEe----CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCccccCCCCCcEEEec
Q 012518 198 FED----ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH--------LQGVVHRDLKPENFLFTT 265 (461)
Q Consensus 198 ~~~----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH--------~~givHrDlkp~NILl~~ 265 (461)
+.+ ...+|+||||+.+|+|.+++. ...+++..++.++.||+.||.||| ++||+||||||+|||++
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~- 147 (301)
T 3q4u_A 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK- 147 (301)
T ss_dssp EEEEETTEEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC-
T ss_pred eccccCCCceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc-
Confidence 754 356899999999999999884 357999999999999999999999 99999999999999995
Q ss_pred CCCCCCeeEeecccccccCCCCC-----ccccccCCCcCchhhhhc-------cCCCchhHHHHHHHHHHHhhC------
Q 012518 266 REEDAPLKVIDFGLSDFVRPDQR-----LNDIVGSAYYVAPEVLHR-------SYNVEGDMWSIGVITYILLCG------ 327 (461)
Q Consensus 266 ~~~~~~~kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlGvil~elltg------ 327 (461)
.++.+||+|||++........ ....+||+.|+|||++.+ .++.++|||||||++|||++|
T Consensus 148 --~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 148 --KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp --TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred --CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 567899999999976654332 233589999999999864 345789999999999999999
Q ss_pred ----CCCCCCCCh----hhHHHHHHhcCCCCCCCC----CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 328 ----SRPFWARTE----SGIFRSVLRADPNFHDSP----WPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 328 ----~~Pf~~~~~----~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
..||..... ...+.............+ ...+++++.+||.+||+.||.+|||+.|+++
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 889865322 223333332222111111 0124578999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=371.59 Aligned_cols=250 Identities=17% Similarity=0.218 Sum_probs=199.0
Q ss_pred cccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCC--CCCeeEEEEEE
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSG--HKHMIKFHDAF 198 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~--hpniv~l~~~~ 198 (461)
..++|++.+.||+|+||+||+|.+.. ...+++.||||++.... ...+.+|+++++.++. |+||+++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 34689999999999999999995322 12378999999997542 3467788888888853 89999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEec--------C
Q 012518 199 EDANSVYIVMEFCEGGELLDRILS----RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT--------R 266 (461)
Q Consensus 199 ~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~--------~ 266 (461)
...+..|||||||+||+|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+|||++. .
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999999865 3457999999999999999999999999999999999999964 1
Q ss_pred CCCCCeeEeecccccccC---CCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHH
Q 012518 267 EEDAPLKVIDFGLSDFVR---PDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 342 (461)
Q Consensus 267 ~~~~~~kl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~ 342 (461)
+.++.+||+|||+|.... ........+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 226789999999996543 2334566789999999999874 58999999999999999999999996543211
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 343 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
......+... ..++.+.+++.+||+.+|.+|++..+.|.+
T Consensus 293 -~~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 293 -CKPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp -EEECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred -eeechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 1111112111 247789999999999999999765555443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=387.19 Aligned_cols=244 Identities=22% Similarity=0.310 Sum_probs=202.8
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
+.||+|+||+||+|.+... .+++.||||+++... ......+.+.+|+++|++|+ |||||++++++.+ +.++|||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~lv~E~ 450 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEM 450 (635)
T ss_dssp EEEEECSSEEEEEEEEECS-SCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEEEEEEC
T ss_pred CEeccCCCEEEEEEEEcCC-CcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEEEEEEc
Confidence 4799999999999966432 267899999997643 33445678999999999996 9999999999964 568999999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCC--
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR-- 288 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~-- 288 (461)
|.+|+|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+++.......
T Consensus 451 ~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 451 AELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp CTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC-----
T ss_pred cCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCccccccCcccc
Confidence 999999998854 46799999999999999999999999999999999999996 456799999999987654332
Q ss_pred --ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 012518 289 --LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364 (461)
Q Consensus 289 --~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 364 (461)
.....||+.|+|||++. ..++.++|||||||+||||++ |+.||.+....++...+....... ....+++++.+
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~ 603 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMYD 603 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHH
Confidence 23345678999999987 469999999999999999998 999999998888888777654221 12468999999
Q ss_pred HHHHhcccCcCCCCCHHHHhc
Q 012518 365 FVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 365 li~~~L~~dP~~R~s~~e~L~ 385 (461)
||.+||..||.+||++.++++
T Consensus 604 li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 604 LMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=362.03 Aligned_cols=250 Identities=19% Similarity=0.325 Sum_probs=202.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE----
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE---- 199 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~---- 199 (461)
.++|++.+.||+|+||.||+|+++. +|+.||||++... .....+.+.+|+.+++.++ ||||+++++++.
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLH---DGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERG 100 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEET
T ss_pred CeEEEEEEEecCCCCeEEEEEEecC---CCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccC
Confidence 4589999999999999999999876 7899999998653 3445678899999999996 999999999987
Q ss_pred eCCeEEEEEeccCCCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 200 DANSVYIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
.....|+||||+.+|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~d 177 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMD 177 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECC
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc---CCCCEEEEe
Confidence 34478999999999999998865 356799999999999999999999999999999999999994 567799999
Q ss_pred cccccccCCCC----------CccccccCCCcCchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCC--hhhHH
Q 012518 277 FGLSDFVRPDQ----------RLNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVITYILLCGSRPFWART--ESGIF 340 (461)
Q Consensus 277 FG~a~~~~~~~----------~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~ 340 (461)
||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... .....
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 99987643211 1123467999999999853 37899999999999999999999995321 11122
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 341 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 341 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
..+. ....+ .....+++++.+||.+||+.||.+|||+.+++++
T Consensus 258 ~~~~-~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 258 LAVQ-NQLSI--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHH-CC--C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhh-ccCCC--CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 2222 22222 2235689999999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=362.16 Aligned_cols=258 Identities=18% Similarity=0.226 Sum_probs=203.6
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
...++|++.+.||+|+||+||+|+.. +|+.||||++....... ....+.+|+.+++.++ ||||+++++++.+.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAV-HRNLLRLRGFCMTP 99 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS----SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEECCS
T ss_pred HHhhccccceeEecCCCcEEEEEEec----CCCEEEEEEeccccCch--HHHHHHHHHHHHHhcc-CCCccceEEEEecC
Confidence 34568999999999999999999754 58899999987643221 1235789999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CccccCCCCCcEEEecCCCCCCeeEe
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG---GRYLEEDAKTIVEKILNIVAFCHLQ---GVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~i~~qil~al~yLH~~---givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
+..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~---~~~~~kl~ 176 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVG 176 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC---TTCCEEEC
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC---CCCCEEec
Confidence 99999999999999999886543 2489999999999999999999999 999999999999995 56789999
Q ss_pred ecccccccCCCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCC-----CChhhHHHHHHhcC
Q 012518 276 DFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWA-----RTESGIFRSVLRAD 347 (461)
Q Consensus 276 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~-----~~~~~~~~~i~~~~ 347 (461)
|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||.. .........+....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999998765332 234456999999999985 5689999999999999999999999952 11111112111110
Q ss_pred C--CCC--------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 348 P--NFH--------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 348 ~--~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
. ... .......++++.+||.+||+.||.+|||+.|+++|-+-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0 000 00111234789999999999999999999999998654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=373.23 Aligned_cols=253 Identities=22% Similarity=0.367 Sum_probs=207.7
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||+||+|.++. +..||||+++.... ..+.+.+|+.+|++|+ ||||+++++++.+ +
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E 251 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC----CceEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-C
Confidence 45689999999999999999998863 46799999976542 2367889999999996 9999999999876 6
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
.+|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLAR 328 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC---CCCCEEECCCccce
Confidence 789999999999999998653 34689999999999999999999999999999999999995 56679999999998
Q ss_pred ccCCCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 282 FVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 282 ~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
...... ......+|..|+|||++. +.++.++|||||||+||||++ |+.||.+....+.+..+..... . .....
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~--~~~~~ 405 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-M--PCPPE 405 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-C--CCCTT
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--CCCCC
Confidence 765332 123345778899999886 679999999999999999999 9999999888888877765422 1 12246
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhc--CCCcCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALT--HPWLHD 391 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~--hp~~~~ 391 (461)
+++++.+||.+||+.||.+|||++++++ +.++..
T Consensus 406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 8999999999999999999999999886 355543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=349.01 Aligned_cols=243 Identities=22% Similarity=0.361 Sum_probs=199.3
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-C
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA-N 202 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~-~ 202 (461)
.++|++.+.||+|+||+||++++ +|+.||||++.... ..+.+.+|+.++++++ ||||+++++++.+. +
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 88 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred hhhceEEeEEecCCCceEEEEEE-----cCCEEEEEEecchh-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCC
Confidence 46899999999999999999976 47889999987542 3467889999999996 99999999997554 5
Q ss_pred eEEEEEeccCCCchHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
.+|+||||+.+|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTK 165 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC--
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe---CCCcEEEeeccccc
Confidence 78999999999999998865532 378999999999999999999999999999999999995 56789999999987
Q ss_pred ccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
..... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||......+....+..... ......++
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 240 (278)
T 1byg_A 166 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCP 240 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCC
T ss_pred ccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCC
Confidence 65432 23346789999999986 569999999999999999998 9999988887777776655421 22234689
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+++.++|.+||..||.+|||+.|+++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=352.92 Aligned_cols=241 Identities=27% Similarity=0.435 Sum_probs=192.2
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||+||+|+. .++.||||++... ...+.+.+|++++++++ ||||+++++++.+ ..
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~ 74 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-----RAKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLYGACLN--PV 74 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-----TTEEEEEEECSST-----THHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TT
T ss_pred hHeeeeeEeecCCCceEEEEEE-----CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--Cc
Confidence 5899999999999999999986 4678999998643 23567889999999996 9999999998874 47
Q ss_pred EEEEeccCCCchHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---cCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 205 YIVMEFCEGGELLDRILSRGG--RYLEEDAKTIVEKILNIVAFCHL---QGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~i~~qil~al~yLH~---~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
|+||||++||+|.+++..... .+++..+..++.||+.||.|||+ +||+||||||+|||++. ++..+||+|||+
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~~kl~Dfg~ 152 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA--GGTVLKICDFGT 152 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET--TTTEEEECCCCC
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC--CCCEEEEccccc
Confidence 999999999999998865432 47889999999999999999999 89999999999999963 223489999999
Q ss_pred ccccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChh--hHHHHHHhcCCCCCCCCCC
Q 012518 280 SDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTES--GIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 280 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~ 356 (461)
+..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .....+.... ......
T Consensus 153 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 227 (307)
T 2eva_A 153 ACDIQT--HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---RPPLIK 227 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---CCCCBT
T ss_pred cccccc--ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---CCCccc
Confidence 976543 2344579999999999874 6899999999999999999999999764332 2333333221 112235
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+++.+.+||.+||+.||.+|||+.++++
T Consensus 228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 68999999999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=354.98 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=203.1
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccc-cCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAK-MTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.|..++.||+|+||+||+|.. +++.||||++.... .......+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 105 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDL 105 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES-----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSC
T ss_pred ccccCCccccCCCeEEEEEEE-----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCce
Confidence 355568999999999999975 57889999987543 223345678899999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 205 YIVMEFCEGGELLDRILSR--GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD---EAFTAKISDFGLARA 182 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc---CCCcEEEeecccccc
Confidence 9999999999999988643 34689999999999999999999999999999999999994 567899999999987
Q ss_pred cCCCCC---ccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhH----HHHHHhcCCCC-----
Q 012518 283 VRPDQR---LNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGI----FRSVLRADPNF----- 350 (461)
Q Consensus 283 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~----~~~i~~~~~~~----- 350 (461)
...... .....||+.|+|||++.+.++.++|||||||++|+|++|..||........ ...+......+
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYID 262 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSC
T ss_pred cccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcc
Confidence 654322 234679999999999988899999999999999999999999976544322 22222111110
Q ss_pred --CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 351 --HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 351 --~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
........+..+.++|.+||+.||.+|||+.++++
T Consensus 263 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 263 KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00111224577899999999999999999999885
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=380.07 Aligned_cols=252 Identities=22% Similarity=0.373 Sum_probs=211.6
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.++||+|+||+||+|.++. +..||||+++.... ..+.+.+|+++|++|+ |+||+++++++.+ +.
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT----TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC----CceEEEEEeCCCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEee-cc
Confidence 4579999999999999999998863 46799999976542 2367889999999996 9999999999876 67
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 204 VYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
+|||||||.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARL 412 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCTTSTTT
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc---CCCcEEEccccccee
Confidence 89999999999999998653 34689999999999999999999999999999999999995 566799999999987
Q ss_pred cCCCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 283 VRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 283 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
..... ......++..|+|||++. +.++.++|||||||+||||++ |+.||.+....+++..+..... . .....+
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~--~~~~~~ 489 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-M--PCPPEC 489 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-C--CCCTTC
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--CCCCCC
Confidence 64321 122345678899999886 569999999999999999999 9999999888888877765422 1 122468
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcC--CCcCC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTH--PWLHD 391 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~h--p~~~~ 391 (461)
++++.+||.+||+.||++|||+.++++. .+|..
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 9999999999999999999999998863 55543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=394.31 Aligned_cols=261 Identities=24% Similarity=0.414 Sum_probs=210.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe----
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED---- 200 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~---- 200 (461)
++|++.+.||+|+||+||+|.++. +|+.||||++... ......+.+.+|++++++++ ||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~---tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQD---TGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTT---TTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccc
Confidence 589999999999999999998875 7899999998754 34555678999999999996 9999999999765
Q ss_pred --CCeEEEEEeccCCCchHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 201 --ANSVYIVMEFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 201 --~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
.+..|+|||||.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 677899999999999999886543 2588999999999999999999999999999999999998655555699999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHH---------H---
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS---------V--- 343 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~---------i--- 343 (461)
||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||........+.. +
T Consensus 168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 99999877666666788999999999986 5699999999999999999999999976533221100 0
Q ss_pred --HhcCCCCCC------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 344 --LRADPNFHD------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 344 --~~~~~~~~~------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
......+.. .....+++++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 001111111 111236789999999999999999999999999999964
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=363.39 Aligned_cols=249 Identities=13% Similarity=0.166 Sum_probs=199.7
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCc-----cCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeE-----
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTL-----KGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIK----- 193 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~----- 193 (461)
.++|++.+.||+|+||+||+|+++.+.. .++.||||++... +.+.+|++++++++ ||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence 4689999999999999999999875211 3789999998754 34678999999996 999887
Q ss_pred ----------EEEEEEe-CCeEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcE
Q 012518 194 ----------FHDAFED-ANSVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 261 (461)
Q Consensus 194 ----------l~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NI 261 (461)
+++++.. ++.+|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6777776 78899999999 99999998764 36799999999999999999999999999999999999
Q ss_pred EEecCCCCC--CeeEeecccccccCCCC--------CccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCC
Q 012518 262 LFTTREEDA--PLKVIDFGLSDFVRPDQ--------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRP 330 (461)
Q Consensus 262 Ll~~~~~~~--~~kl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~P 330 (461)
|++ .++ .+||+|||++....... ......||+.|+|||++.+ .++.++|||||||+||+|++|+.|
T Consensus 191 l~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 191 FVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 996 344 79999999997654322 1234589999999999874 699999999999999999999999
Q ss_pred CCCCC--hhhHHHHHH---hcCCCCC--CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 331 FWART--ESGIFRSVL---RADPNFH--DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 331 f~~~~--~~~~~~~i~---~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
|.... ...+..... .....+. ...|..+++++.+||.+||..||.+|||+.++++
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 97753 222322222 1212111 1223467999999999999999999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=367.80 Aligned_cols=251 Identities=20% Similarity=0.256 Sum_probs=198.9
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-----CHHHHHHHHHHHHHHHhcC--------CCCC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-----SALAIEDVRREVKILKALS--------GHKH 190 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~--------~hpn 190 (461)
.++|++++.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+|+.|+ .|+|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccchheeeecccCceEEEEEEe-----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 35899999999999999999986 5789999999865321 2233467889999999885 4899
Q ss_pred eeEEEEEEE------------------------------eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHH
Q 012518 191 MIKFHDAFE------------------------------DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240 (461)
Q Consensus 191 iv~l~~~~~------------------------------~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil 240 (461)
|+++++.+. +.+.+|||||||.+|++++.+.. ..+++..++.++.||+
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLT 171 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHH
Confidence 999888753 26789999999999988777743 5689999999999999
Q ss_pred HHHHHHH-HcCccccCCCCCcEEEecCC-----------------CCCCeeEeecccccccCCCCCccccccCCCcCchh
Q 012518 241 NIVAFCH-LQGVVHRDLKPENFLFTTRE-----------------EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPE 302 (461)
Q Consensus 241 ~al~yLH-~~givHrDlkp~NILl~~~~-----------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE 302 (461)
.||.||| ++||+||||||+|||++.++ ....+||+|||+|+..... ..+||+.|+|||
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE 247 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSG
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChh
Confidence 9999999 99999999999999997543 1127999999999876532 458999999999
Q ss_pred hhhccCCCchhHHHHHHH-HHHHhhCCCCCCCCCh-hhHHHHHHhcC---CCCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 012518 303 VLHRSYNVEGDMWSIGVI-TYILLCGSRPFWARTE-SGIFRSVLRAD---PNFHDSPWPSVSPEAKDFVRRLLNKDHRKR 377 (461)
Q Consensus 303 ~l~~~~~~~~DiwSlGvi-l~elltg~~Pf~~~~~-~~~~~~i~~~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 377 (461)
++.+..+.++||||||++ .+++++|..||.+... ......+.... .......++.+++++++||.+||++|
T Consensus 248 ~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 248 LFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 998777999999998777 7889999999843211 12233333211 11111123357899999999999987
Q ss_pred CCHHHHh-cCCCcC
Q 012518 378 MTAAQAL-THPWLH 390 (461)
Q Consensus 378 ~s~~e~L-~hp~~~ 390 (461)
|++|+| +||||+
T Consensus 324 -sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 -SATDLLCQHSLFK 336 (336)
T ss_dssp -SHHHHHHHCGGGC
T ss_pred -CHHHHHhcCCCcC
Confidence 999999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=381.28 Aligned_cols=253 Identities=22% Similarity=0.346 Sum_probs=212.9
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||+||+|.+......+..||||++... ......+.+.+|+.++++++ ||||+++++++. ++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-EN 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe-cC
Confidence 346899999999999999999998764445678999998653 34455678999999999996 999999999985 45
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|+||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRY 540 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCCCCS
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecCCCee
Confidence 68999999999999999977766799999999999999999999999999999999999996 456799999999987
Q ss_pred cCCCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 283 VRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 283 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
...... .....||+.|+|||++. +.++.++|||||||++|||++ |..||.+....+.+..+....... ..+.+
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~ 617 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNC 617 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---CCTTC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCccc
Confidence 654332 23345778999999986 569999999999999999997 999999988888888777654221 22468
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++++.+||.+||..||.+|||+.|+++
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=352.06 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=204.5
Q ss_pred cccceeeceeeccCCceEEEEEEecc-CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKK-GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
...+|++++.||+|+||.||+|+... ...+|+.||||++... .....+.+.+|+.++++++ ||||+++++++...
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA 114 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC-
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEec
Confidence 34589999999999999999998421 2237899999999754 3345678899999999996 99999999998754
Q ss_pred C--eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 202 N--SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 202 ~--~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
+ .+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL 191 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEecCcc
Confidence 4 78999999999999999987767799999999999999999999999999999999999996 456799999999
Q ss_pred ccccCCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCh------------hh---H
Q 012518 280 SDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE------------SG---I 339 (461)
Q Consensus 280 a~~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~------------~~---~ 339 (461)
+........ .....++..|+|||++. ..++.++|||||||++|+|++|..||..... .. .
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 987654432 12345778899999986 4589999999999999999999999853211 00 1
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 340 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 340 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+...+....... ....+++++.+||.+||..||.+|||+.|+++
T Consensus 272 ~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCCCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111222222221 22468999999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=355.53 Aligned_cols=249 Identities=20% Similarity=0.350 Sum_probs=205.8
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||.||+|++.. .||+|++...... ....+.+.+|+.++++++ |+||+++++++.+.+
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG------EVAIRLIDIERDN-EDQLKAFKREVMAYRQTR-HENVVLFMGACMSPP 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS------SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSS
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC------eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCC
Confidence 34689999999999999999998642 3999998754322 122345678999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+++||||+.|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSI 178 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC-
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCccc
Confidence 99999999999999998876656799999999999999999999999999999999999994 45799999999875
Q ss_pred cCC------CCCccccccCCCcCchhhhhc----------cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhc
Q 012518 283 VRP------DQRLNDIVGSAYYVAPEVLHR----------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA 346 (461)
Q Consensus 283 ~~~------~~~~~~~~gt~~y~aPE~l~~----------~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~ 346 (461)
... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+...
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 432 122344569999999999853 3788999999999999999999999988887777776654
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 347 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 347 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.... .....++.++.+||.+||..||.+|||+.++++
T Consensus 259 ~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 259 MKPN--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCC--CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCC--CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3222 222358899999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=371.67 Aligned_cols=248 Identities=17% Similarity=0.215 Sum_probs=193.5
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC-CCe------------
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH-KHM------------ 191 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pni------------ 191 (461)
..|++.+.||+|+||+||+|.+.. +|+.||||++...........+.+.+|+.+++.+. | .|+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCC
T ss_pred eeEEEecccccCCCEEEEEEEecC---CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccc
Confidence 458899999999999999999876 78999999998554444455678999999999996 4 321
Q ss_pred ---------eEEEEEEEe-----CCeEEEEEeccCCCchHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 012518 192 ---------IKFHDAFED-----ANSVYIVMEFCEGGELLDRILS------RGGRYLEEDAKTIVEKILNIVAFCHLQGV 251 (461)
Q Consensus 192 ---------v~l~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~------~~~~~~~~~~~~i~~qil~al~yLH~~gi 251 (461)
..+..++.. ...++++|+++ +++|.+++.. ....+++..+..++.||+.||.|||++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 111122222 23467888877 5799887731 23346778888999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCccccccCCCcCchhhh----------h-ccCCCchhHHHHHHH
Q 012518 252 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL----------H-RSYNVEGDMWSIGVI 320 (461)
Q Consensus 252 vHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l----------~-~~~~~~~DiwSlGvi 320 (461)
+||||||+|||++ .++.+||+|||+++.... .....+| +.|+|||++ . ..|+.++|||||||+
T Consensus 233 iHrDiKp~NILl~---~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLD---QRGGVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEEC---TTCCEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEe---cCCeEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999995 566799999999886543 2456678 999999998 3 237889999999999
Q ss_pred HHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 321 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 321 l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
||||++|+.||...........++.. +..+++++.+||.+||+.||.+||++.|+|+||||+.
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGGGSS--------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHCCCCCCCcchhhhHHHHHhh--------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99999999999877665544444332 2468899999999999999999999999999999954
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=350.88 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=193.2
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEE
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS-GHKHMIKFHDAFE 199 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-~hpniv~l~~~~~ 199 (461)
..+.++|++.+.||+|+||.||+|++ +|+.||||++.... .....+|.+++..+. +||||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW-----RGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEE-----CCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 34567999999999999999999976 47889999986432 234445666665541 4999999999998
Q ss_pred eC----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCcEEEecCC
Q 012518 200 DA----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ--------GVVHRDLKPENFLFTTRE 267 (461)
Q Consensus 200 ~~----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~--------givHrDlkp~NILl~~~~ 267 (461)
+. ..+|+||||+++|+|.+++... .+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~--- 176 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK--- 176 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC---
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC---
Confidence 87 7899999999999999988553 699999999999999999999999 999999999999995
Q ss_pred CCCCeeEeecccccccCCCCC-----ccccccCCCcCchhhhhcc-CCCc------hhHHHHHHHHHHHhhC--------
Q 012518 268 EDAPLKVIDFGLSDFVRPDQR-----LNDIVGSAYYVAPEVLHRS-YNVE------GDMWSIGVITYILLCG-------- 327 (461)
Q Consensus 268 ~~~~~kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~-~~~~------~DiwSlGvil~elltg-------- 327 (461)
.++.+||+|||++........ ....+||+.|+|||++.+. ++.. +|||||||++|||++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 567899999999976543322 1346899999999998643 4443 8999999999999999
Q ss_pred --CCCCCCCCh----hhHHHHHHhcCCCCCCCC----CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 328 --SRPFWARTE----SGIFRSVLRADPNFHDSP----WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 328 --~~Pf~~~~~----~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
..||..... .................+ ...+++++.+||.+||+.||.+|||+.|+++|
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 777754321 222222222211111110 01356789999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=353.72 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=188.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHH--HHhcCCCCCeeEEEEEEEe--
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI--LKALSGHKHMIKFHDAFED-- 200 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~i--l~~l~~hpniv~l~~~~~~-- 200 (461)
++|++++.||+|+||+||+|+. +|+.||||++.... ...+..|.++ +..+. |+||+++++++..
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-----DERPVAVKVFSFAN------RQNFINEKNIYRVPLME-HDNIARFIVGDERVT 80 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEEC
T ss_pred HHhheeeecccCCCeEEEEEEE-----CCeEEEEEEeeccc------hhhHHHHHHHHHHHhcc-Ccchhhheecccccc
Confidence 5899999999999999999965 57899999996542 2333344444 44464 9999999986642
Q ss_pred ---CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CccccCCCCCcEEEecCCC
Q 012518 201 ---ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ---------GVVHRDLKPENFLFTTREE 268 (461)
Q Consensus 201 ---~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~---------givHrDlkp~NILl~~~~~ 268 (461)
...+|+|||||++|+|.+++... ..++..++.++.||+.||.|||++ ||+||||||+|||++ .
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~---~ 155 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK---N 155 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC---T
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc---C
Confidence 33679999999999999988554 458899999999999999999999 999999999999995 5
Q ss_pred CCCeeEeecccccccCCCC---------CccccccCCCcCchhhhhc--------cCCCchhHHHHHHHHHHHhhCCCCC
Q 012518 269 DAPLKVIDFGLSDFVRPDQ---------RLNDIVGSAYYVAPEVLHR--------SYNVEGDMWSIGVITYILLCGSRPF 331 (461)
Q Consensus 269 ~~~~kl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlGvil~elltg~~Pf 331 (461)
++.+||+|||++....... .....+||+.|+|||++.+ .++.++|||||||++|||++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 6789999999998764321 2234579999999999864 4667899999999999999998776
Q ss_pred CCCCh-----------------hhHHHHHHhcC---CCCCCC--CCCCCCHHHHHHHHHhcccCcCCCCCHHHH------
Q 012518 332 WARTE-----------------SGIFRSVLRAD---PNFHDS--PWPSVSPEAKDFVRRLLNKDHRKRMTAAQA------ 383 (461)
Q Consensus 332 ~~~~~-----------------~~~~~~i~~~~---~~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~s~~e~------ 383 (461)
..... ........... +.++.. ....+++++.+||.+||+.||.+|||+.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 43221 11111111111 111111 011245689999999999999999999999
Q ss_pred hcCCCcCCCCC
Q 012518 384 LTHPWLHDENR 394 (461)
Q Consensus 384 L~hp~~~~~~~ 394 (461)
+-++|-++..+
T Consensus 316 ll~~~~~~~~~ 326 (336)
T 3g2f_A 316 LMMIWERNKSV 326 (336)
T ss_dssp HHHCCCC----
T ss_pred HHHHHHhcccC
Confidence 45677666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=344.58 Aligned_cols=230 Identities=14% Similarity=0.098 Sum_probs=190.2
Q ss_pred CC-ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012518 120 GK-NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAF 198 (461)
Q Consensus 120 ~~-~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~ 198 (461)
|. .+.++|++.+.||+|+||.||+|++.. +|+.||||++...........+.+.+|+.++.++. ||||+++++++
T Consensus 25 g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~ 100 (286)
T 3uqc_A 25 GARIANGRYRLLIFHGGVPPLQFWQALDTA---LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVV 100 (286)
T ss_dssp TCEETTTTEEEEEEEEBSTTCEEEEEEETT---TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred CCEEecCcEEEEEEEcccCCeEEEEEEecC---CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEE
Confidence 44 566799999999999999999999875 78999999998776666667788999999999996 99999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecc
Q 012518 199 EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 278 (461)
Q Consensus 199 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG 278 (461)
.+.+..|+||||++|++|.+++.. + ....++..++.||+.||.|||++||+||||||+|||++ .++.+||+++|
T Consensus 101 ~~~~~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~ 174 (286)
T 3uqc_A 101 HTRAGGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA 174 (286)
T ss_dssp EETTEEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCC
T ss_pred EECCcEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEecc
Confidence 999999999999999999998732 2 46677889999999999999999999999999999996 46679988554
Q ss_pred cccccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHH---HHHhcCCCCCCCCC
Q 012518 279 LSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR---SVLRADPNFHDSPW 355 (461)
Q Consensus 279 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~ 355 (461)
|++| ++.++|||||||++|+|++|+.||.+.+....+. ..............
T Consensus 175 -------------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T 3uqc_A 175 -------------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID 229 (286)
T ss_dssp -------------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHC
T ss_pred -------------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcc
Confidence 3433 6889999999999999999999998766533211 11111111111123
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+.+++++.+||.+||++||.+| |+.|+++
T Consensus 230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 230 RDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp TTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred cCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 5689999999999999999999 9999876
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=351.37 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=199.8
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHh--cCCCCCeeEEEEEE
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKA--LSGHKHMIKFHDAF 198 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~~hpniv~l~~~~ 198 (461)
..+.++|++.+.||+|+||+||+|++ +|+.||||++... ....+.+|++++.. + +||||+++++++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~ni~~~~~~~ 105 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR------EERSWFREAEIYQTVML-RHENILGFIAAD 105 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECGG------GHHHHHHHHHHHHHSCC-CCTTBCCEEEEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-----cCccEEEEEeCch------hHHHHHHHHHHHHHhhc-CCCcEEEEEeee
Confidence 34557899999999999999999986 4789999998643 23567789999988 5 499999999999
Q ss_pred EeCC----eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCccccCCCCCcEEEecC
Q 012518 199 EDAN----SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH--------LQGVVHRDLKPENFLFTTR 266 (461)
Q Consensus 199 ~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH--------~~givHrDlkp~NILl~~~ 266 (461)
...+ .+|+||||+.+|+|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+|||++
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~-- 181 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-- 181 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC--
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC--
Confidence 8876 89999999999999998865 36899999999999999999999 89999999999999995
Q ss_pred CCCCCeeEeecccccccCCCC-----CccccccCCCcCchhhhhcc-------CCCchhHHHHHHHHHHHhhC-------
Q 012518 267 EEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLHRS-------YNVEGDMWSIGVITYILLCG------- 327 (461)
Q Consensus 267 ~~~~~~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~-------~~~~~DiwSlGvil~elltg------- 327 (461)
.++.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|||++|
T Consensus 182 -~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 182 -KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp -TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred -CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 56789999999998765443 23456799999999998653 33689999999999999999
Q ss_pred ---CCCCCCCC-----hhhHHHHHHhcCCCCCCC-CC--CCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 328 ---SRPFWART-----ESGIFRSVLRADPNFHDS-PW--PSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 328 ---~~Pf~~~~-----~~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
..||.... .......+.......... .| ...++.+.+||.+||+.||.+|||+.|+++|
T Consensus 261 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 88987643 223333333222111110 00 1234688999999999999999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=387.52 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=205.6
Q ss_pred cCCCCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEE
Q 012518 117 FGYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHD 196 (461)
Q Consensus 117 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~ 196 (461)
...|+.+.++|++.+.||+|+||+||+|.++. .+|+.||||++... ......+.+.+|++++++++ ||||+++++
T Consensus 72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~--~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~ 146 (681)
T 2pzi_A 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRN--VNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVV-HPSIVQIFN 146 (681)
T ss_dssp SCTTCEETTTEEEEEEEEEETTEEEEEEEEGG--GTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCC-CTTBCCEEE
T ss_pred CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcC--CCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcC-CCCcCeEee
Confidence 34567788899999999999999999999864 25789999998653 23455677889999999996 999999999
Q ss_pred EEEeCCe-----EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCC
Q 012518 197 AFEDANS-----VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP 271 (461)
Q Consensus 197 ~~~~~~~-----~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~ 271 (461)
+|.+.+. .||||||++|++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+|||++. +.
T Consensus 147 ~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~----~~ 219 (681)
T 2pzi_A 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE----EQ 219 (681)
T ss_dssp EEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS----SC
T ss_pred eEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC----Cc
Confidence 9987665 7999999999999886633 6999999999999999999999999999999999999953 37
Q ss_pred eeEeecccccccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC
Q 012518 272 LKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH 351 (461)
Q Consensus 272 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 351 (461)
+||+|||++...... ...+||+.|+|||++.+.++.++|||||||+||+|++|..||.+.....+ ..
T Consensus 220 ~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~ 286 (681)
T 2pzi_A 220 LKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PE 286 (681)
T ss_dssp EEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------CT
T ss_pred EEEEecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccccc----------cc
Confidence 999999999876543 45679999999999987789999999999999999999999865321100 00
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 352 DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 352 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
.......++.+.+||.+||++||.+||+..+++.|+|+.
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 111112468899999999999999999999999888763
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=315.87 Aligned_cols=190 Identities=21% Similarity=0.148 Sum_probs=135.8
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-------CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-------SALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-------~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
..++.|++|.+..++..- .|+.||||++.+.... .+...+++.+|+++|+++.+|+||+++++++++++.
T Consensus 240 ~~~~~~~~~~h~~~rr~~---fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~ 316 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYF---FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS 316 (569)
T ss_dssp CC-C--------CCEEEE---ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred hccccCCccccccccccc---ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence 346777777777665543 7899999999765322 233456799999999999779999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|||||||+|++|.++|.. .+.+++. .|+.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+..
T Consensus 317 ~yLVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~---~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD---ARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEEEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC---TTSCEEECCCTTEESC
T ss_pred EEEEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC---CCCCEEEeecccCeeC
Confidence 9999999999999998864 4667664 5899999999999999999999999999995 5678999999999876
Q ss_pred CCC-CCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCC
Q 012518 284 RPD-QRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRP 330 (461)
Q Consensus 284 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~P 330 (461)
... ....+.+||+.|||||++.+.+..++|+||+|+++|+|.++..+
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred CCCCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence 543 34566899999999999998888999999999999888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=271.66 Aligned_cols=184 Identities=21% Similarity=0.200 Sum_probs=143.8
Q ss_pred eeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH-----HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA-----LAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 128 ~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
...+.||+|+||+||++.. .++.+|+|.+........ ...+++.+|+++|++++ ||||+++..++.+.+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~ 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLD 412 (540)
T ss_dssp ---------CCEEEEEEEC-----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETT
T ss_pred CCCCEEeeCCCEEEEEEEE-----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCC
Confidence 3456899999999999943 578899998755433322 22456899999999996 999996555555777
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
..|||||||+|++|.+++.. +..++.||+.||.|||++||+||||||+|||++ . .+||+|||+++.
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~ 478 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKI 478 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEE
T ss_pred ccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEE
Confidence 78999999999999988743 568999999999999999999999999999995 2 799999999998
Q ss_pred cCCCCC--------ccccccCCCcCchhhhh---ccCCCchhHHHHHHHHHHHhhCCCCC
Q 012518 283 VRPDQR--------LNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPF 331 (461)
Q Consensus 283 ~~~~~~--------~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlGvil~elltg~~Pf 331 (461)
...... ....+||+.|||||++. ..|+..+|+||..+-..+.+.++.+|
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 754322 13578999999999986 35888899999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=224.20 Aligned_cols=158 Identities=27% Similarity=0.301 Sum_probs=122.1
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH---------------HHHHHHHHHHHHHHhcCCCCC
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA---------------LAIEDVRREVKILKALSGHKH 190 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~~hpn 190 (461)
.|++++.||+|+||.||+|.+ . +|+.||||+++....... .....+.+|+.+|++++ |.+
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~---~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~ 165 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-E---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLA 165 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-T---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSS
T ss_pred EEEecCEeccCCCceEEEEEe-C---CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCC
Confidence 466779999999999999998 4 789999999965322111 23567889999999997 554
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCC
Q 012518 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 270 (461)
Q Consensus 191 iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~ 270 (461)
+.. ++.. +..|+|||||+||+|.+ +. . .....++.||+.||.|||++||+||||||+|||++ ++
T Consensus 166 v~~---~~~~-~~~~lvmE~~~g~~L~~-l~-----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~ 229 (282)
T 1zar_A 166 VPK---VYAW-EGNAVLMELIDAKELYR-VR-----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EE 229 (282)
T ss_dssp SCC---EEEE-ETTEEEEECCCCEEGGG-CC-----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TT
T ss_pred cCe---EEec-cceEEEEEecCCCcHHH-cc-----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CC
Confidence 444 4433 45699999999999987 41 1 23557999999999999999999999999999995 56
Q ss_pred CeeEeecccccccCCCCCccccccCCCcCchhhhhc-----------cCCCchhHHH
Q 012518 271 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-----------SYNVEGDMWS 316 (461)
Q Consensus 271 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~DiwS 316 (461)
.+||+|||+|.. +..|+|||++.+ .|+..+|+|.
T Consensus 230 ~vkl~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 230 GIWIIDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EEEECCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred cEEEEECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 799999999863 345899998853 3566667665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-24 Score=202.38 Aligned_cols=141 Identities=20% Similarity=0.190 Sum_probs=106.9
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcE--EEEEEecccccCC---------------------HHHHHHHHHHHHHH
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKV--VAVKIISKAKMTS---------------------ALAIEDVRREVKIL 182 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~--vAvK~i~~~~~~~---------------------~~~~~~~~~Ei~il 182 (461)
-|++.+.||+|+||.||+|.+.. +|+. ||||+++...... ......+.+|+.+|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~---~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVF---DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEE---TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcC---CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 47899999999999999998854 6888 9999976532110 11224678999999
Q ss_pred HhcCCCCC--eeEEEEEEEeCCeEEEEEeccCC-C----chHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCcccc
Q 012518 183 KALSGHKH--MIKFHDAFEDANSVYIVMEFCEG-G----ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH-LQGVVHR 254 (461)
Q Consensus 183 ~~l~~hpn--iv~l~~~~~~~~~~~lv~e~~~g-g----~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH-~~givHr 254 (461)
..|. |++ +..++++ +..+|||||+.+ | +|.+.... .++..+..++.||+.||.||| ++||+||
T Consensus 125 ~~l~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHr 195 (258)
T 1zth_A 125 ERAK-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHA 195 (258)
T ss_dssp HHHH-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred HHHH-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 9996 664 4445543 246899999932 3 55554321 235567899999999999999 9999999
Q ss_pred CCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 255 DLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 255 Dlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
||||+|||++ . .++|+|||+|...
T Consensus 196 Dlkp~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEES---S--SEEECCCTTCEET
T ss_pred CCCHHHEEEc---C--cEEEEECcccccC
Confidence 9999999995 2 7999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.8e-19 Score=174.89 Aligned_cols=141 Identities=17% Similarity=0.226 Sum_probs=100.6
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC--------------C-HH----HHHHHHHHHHHHHhcC
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT--------------S-AL----AIEDVRREVKILKALS 186 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~--------------~-~~----~~~~~~~Ei~il~~l~ 186 (461)
-|++++.||.|+||.||+|.+. +|+.||||+++..... . .. ..-...+|...|.+|.
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~----~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE----KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT----TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC----CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 4899999999999999999875 6899999998643111 0 00 0112346888888884
Q ss_pred CCCCe--eEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEe
Q 012518 187 GHKHM--IKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 264 (461)
Q Consensus 187 ~hpni--v~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~ 264 (461)
+.++ ...+++ .. .+|||||+.|+.|.+.. ..+.+..++.||+.+|.|||++|||||||||.|||++
T Consensus 172 -~~gv~vp~p~~~--~~--~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 172 -EEGFPVPEPIAQ--SR--HTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR 239 (397)
T ss_dssp -HTTCSCCCEEEE--ET--TEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred -hcCCCCCeeeec--cC--ceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 4443 223322 22 37999999998885432 1234567899999999999999999999999999997
Q ss_pred cCCCC-------CCeeEeecccccc
Q 012518 265 TREED-------APLKVIDFGLSDF 282 (461)
Q Consensus 265 ~~~~~-------~~~kl~DFG~a~~ 282 (461)
.+++. ..+.|+||+-+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 54321 1378999996643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-13 Score=130.58 Aligned_cols=140 Identities=18% Similarity=0.153 Sum_probs=110.6
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
.|++...+|.|+++.||++.. .|+.+++|+........ ...+.+|+.+|+.|..+..+.++++++.+.+..|
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~-----~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC-----SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred cceeEeeccCCCCCeEEEEEC-----CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 588888999999999999864 36789999986532111 1357799999999976788999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL------------------------------------- 248 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~------------------------------------- 248 (461)
+||||++|.+|.+.+. +......++.++..+|..||+
T Consensus 87 lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999998876421 122345788999999999998
Q ss_pred ----------------------cCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 249 ----------------------QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 249 ----------------------~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
..++|+|+++.|||++ ++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence 4589999999999995 234457999997653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.33 E-value=2.5e-12 Score=120.59 Aligned_cols=135 Identities=15% Similarity=0.111 Sum_probs=97.1
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCC-eeEEEEEEEeCCeE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH-MIKFHDAFEDANSV 204 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn-iv~l~~~~~~~~~~ 204 (461)
.|.+....+.|..+.||++... +|+.+++|+..... ...+.+|+.+++.|.+|.- +.++++++.+.+..
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~----~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ----GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT----TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred CCceEecccCCCCceEEEEecC----CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 4555444456667999998653 56779999975431 1346789999999974522 67799988888889
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC----------------------------------
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG---------------------------------- 250 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~g---------------------------------- 250 (461)
|+||||++|.+| + . . ... ...++.++...|..||+..
T Consensus 91 ~~v~e~i~G~~l-~-~-~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 91 WLLLGEVPGQDL-L-S-S---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEEECCSSEET-T-T-S---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEEEEecCCccc-C-c-C---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 999999999888 3 2 1 112 1246667777777777643
Q ss_pred ------------------------ccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 251 ------------------------VVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 251 ------------------------ivHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
++|+|++|.|||++ ++..++|+|||.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence 99999999999995 334466999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.26 E-value=2.6e-11 Score=119.75 Aligned_cols=142 Identities=23% Similarity=0.372 Sum_probs=104.5
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEec--ccccCCHHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeC---Ce
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIIS--KAKMTSALAIEDVRREVKILKALSG-HKHMIKFHDAFEDA---NS 203 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~--~~~~~~~~~~~~~~~Ei~il~~l~~-hpniv~l~~~~~~~---~~ 203 (461)
++.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+++.|.. +..+.+++.++.+. +.
T Consensus 43 ~~~l~~G~sn~~y~v~~~-----~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-----GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp EEECCC-CCSCEEEEECS-----SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred EEEcCCcccceEEEEEEC-----CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 567899999999998753 4578888775 32211 123467789999999974 34588999988776 45
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL----------------------------------- 248 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~----------------------------------- 248 (461)
.|+||||++|..+.+.. ...+++.....++.+++..|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp CEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred eEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 89999999998775422 1346788888999999999999997
Q ss_pred -----------------------cCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 249 -----------------------QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 249 -----------------------~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+++|+|+++.|||++.++ ...+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-PRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-SCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-CcEEEEECcccccc
Confidence 3589999999999996321 12368999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.23 E-value=3.2e-11 Score=116.28 Aligned_cols=182 Identities=16% Similarity=0.221 Sum_probs=123.8
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCC--eeEEEEEEEeCC---eE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH--MIKFHDAFEDAN---SV 204 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpn--iv~l~~~~~~~~---~~ 204 (461)
++.++.|.+..||++. ..+++|+.... .....+.+|+.+|+.|..+.. +.+++......+ ..
T Consensus 25 i~~~~~G~~n~v~~v~--------~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~ 91 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN--------RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS 91 (304)
T ss_dssp CCEEEECSSEEEEEST--------TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred eEecCCCCcceEEEEC--------CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence 3458999999999762 34889986432 345678899999999853433 455655544333 34
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL------------------------------------ 248 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~------------------------------------ 248 (461)
|+|||+++|..|.+... ..++.++...++.++...|..||+
T Consensus 92 ~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 92 FAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred eEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 88999999988865443 247777888888888888888886
Q ss_pred ----------------------cCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCccccccCCCc---Cchhh
Q 012518 249 ----------------------QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY---VAPEV 303 (461)
Q Consensus 249 ----------------------~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y---~aPE~ 303 (461)
..++|+|+++.|||++.+ ....+.|+||+.+........+ .....+ ..++.
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl---~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDF---ISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHH---HTTCCTTTSCCHHH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHH---HHHHhhccccCHHH
Confidence 137999999999999632 1445789999988754322111 111111 23332
Q ss_pred hh---ccCC------------CchhHHHHHHHHHHHhhCCCCC
Q 012518 304 LH---RSYN------------VEGDMWSIGVITYILLCGSRPF 331 (461)
Q Consensus 304 l~---~~~~------------~~~DiwSlGvil~elltg~~Pf 331 (461)
+. ..|+ ...+.|++|+++|.+.+|..+|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 21 1222 2258999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=1.1e-07 Score=91.54 Aligned_cols=138 Identities=14% Similarity=0.247 Sum_probs=93.7
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCC--CeeEEEEEEE-eCCeEEE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK--HMIKFHDAFE-DANSVYI 206 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp--niv~l~~~~~-~~~~~~l 206 (461)
++.++.|....||++ |..+++|+-. .......+.+|..+|+.|..|- .+.+++.+.. ..+..|+
T Consensus 24 v~~l~~G~~n~v~~v--------g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE--------TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEE
T ss_pred eeecCCCcceeEEEE--------CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEE
Confidence 356788998999987 2448888843 2234567889999999997442 3567777664 4566789
Q ss_pred EEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------
Q 012518 207 VMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ------------------------------------- 249 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~------------------------------------- 249 (461)
||||++|..|.+... ..++......++.++...|..||+.
T Consensus 91 v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp EEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred EEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 999999988865322 1244444555555555555555532
Q ss_pred -----------------------CccccCCCCCcEEEecCCCCCC-eeEeeccccccc
Q 012518 250 -----------------------GVVHRDLKPENFLFTTREEDAP-LKVIDFGLSDFV 283 (461)
Q Consensus 250 -----------------------givHrDlkp~NILl~~~~~~~~-~kl~DFG~a~~~ 283 (461)
.++|+|+++.|||++.++.++. +.|+||+.+...
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999964222344 489999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=2.4e-07 Score=87.07 Aligned_cols=133 Identities=17% Similarity=0.225 Sum_probs=93.3
Q ss_pred eccCCce-EEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEecc
Q 012518 133 VGRGHFG-HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFC 211 (461)
Q Consensus 133 lG~G~fg-~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~~ 211 (461)
+..|..| .||+..... .+..+.+|+-... ....+.+|..+|+.|..+--+.+++.++.+.+..|+|||++
T Consensus 32 ~~~G~S~~~v~rl~~~~---~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKP---NAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp EECSSSSCEEEEEECCT---TCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccCCCcCCeEEEEEecC---CCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence 4445555 689887654 5667999986532 23567899999999976656888999999999999999999
Q ss_pred CCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc------------------------------------------
Q 012518 212 EGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ------------------------------------------ 249 (461)
Q Consensus 212 ~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~------------------------------------------ 249 (461)
+|.++.+..... ......+..++...|.-||+.
T Consensus 103 ~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 103 PGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp CSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred CCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 998776644221 112233445555555555521
Q ss_pred ----------------CccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 250 ----------------GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 250 ----------------givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.++|+|+.+.|||++ ++..+-|+||+.+..
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECccccc
Confidence 178999999999995 344456999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=2.7e-07 Score=92.00 Aligned_cols=81 Identities=17% Similarity=0.182 Sum_probs=51.3
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEeccccc-CC---HHHHHHHHHHHHHHHhcCCC-C-CeeEEEEEEEeCCe
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM-TS---ALAIEDVRREVKILKALSGH-K-HMIKFHDAFEDANS 203 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~-~~---~~~~~~~~~Ei~il~~l~~h-p-niv~l~~~~~~~~~ 203 (461)
.+.||.|.++.||++.... .++.++||....... .. ....+++.+|.++|+.+..+ + .+.+++.+ +.+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred EEECCCCceEEEEEEEECC---CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc
Confidence 4679999999999997643 467899998653211 00 01234567899999887533 3 34466643 3445
Q ss_pred EEEEEeccCCCc
Q 012518 204 VYIVMEFCEGGE 215 (461)
Q Consensus 204 ~~lv~e~~~gg~ 215 (461)
.++||||+.|..
T Consensus 110 ~~lvmE~l~g~~ 121 (397)
T 2olc_A 110 AVTVMEDLSHLK 121 (397)
T ss_dssp TEEEECCCTTSE
T ss_pred cEEEEEeCCCcc
Confidence 689999998743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2e-07 Score=91.49 Aligned_cols=86 Identities=9% Similarity=0.152 Sum_probs=57.3
Q ss_pred eeceee-ccCCceEEEEEEecc---CCccCcEEEEEEecccc---cCCHHHHHHHHHHHHHHHhcCCC--CCeeEEEEEE
Q 012518 128 ELGKEV-GRGHFGHTCCAKGKK---GTLKGKVVAVKIISKAK---MTSALAIEDVRREVKILKALSGH--KHMIKFHDAF 198 (461)
Q Consensus 128 ~~~~~l-G~G~fg~V~~~~~~~---~~~~g~~vAvK~i~~~~---~~~~~~~~~~~~Ei~il~~l~~h--pniv~l~~~~ 198 (461)
...+.| +.|....+|++.... +..+|..+++|+..... ... ...+.+|+.+|+.|..+ -.+.+++.++
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 345678 889899999886530 00015678999865432 101 13466899999988644 3577888887
Q ss_pred EeC---CeEEEEEeccCCCch
Q 012518 199 EDA---NSVYIVMEFCEGGEL 216 (461)
Q Consensus 199 ~~~---~~~~lv~e~~~gg~L 216 (461)
.+. +..|+||||++|..+
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCC
T ss_pred cCCCccCCceEEEEecCCCCh
Confidence 655 356899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.26 E-value=7.8e-06 Score=79.22 Aligned_cols=75 Identities=11% Similarity=0.139 Sum_probs=43.1
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC-CCeeEEEE------EEEeCC
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH-KHMIKFHD------AFEDAN 202 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pniv~l~~------~~~~~~ 202 (461)
.+.|+.|..+.||++... +| .+++|+.... . ..+..|+.+++.|..+ -.+.+++. +....+
T Consensus 37 ~~~l~gG~~n~~~~v~~~----~~-~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~ 104 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD----SG-AVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGS 104 (346)
T ss_dssp EEECC----CEEEEEEET----TE-EEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETT
T ss_pred eeeccccccCcEEEEEeC----CC-CEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECC
Confidence 345677788999998753 23 4899998642 1 2344566666655421 12333332 123567
Q ss_pred eEEEEEeccCCCch
Q 012518 203 SVYIVMEFCEGGEL 216 (461)
Q Consensus 203 ~~~lv~e~~~gg~L 216 (461)
..++||||++|..+
T Consensus 105 ~~~~l~~~i~G~~~ 118 (346)
T 2q83_A 105 FLFVVYDWIEGRPF 118 (346)
T ss_dssp EEEEEEECCCCBCC
T ss_pred EEEEEEEeecCccC
Confidence 78999999998643
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=98.18 E-value=2.5e-06 Score=76.29 Aligned_cols=76 Identities=22% Similarity=0.209 Sum_probs=62.6
Q ss_pred cCCCcCCCC-CCCCchHHHHHHHHHHhhcCHHHHHHHHHHHHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 385 THPWLHDEN-RPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 385 ~hp~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.|||.+... ...+++..+...+++|...+.+++.++..++..++++|+..|++.|..+|. ++|.|+.+||..++..
T Consensus 8 ~~~~~~~~~~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~ 85 (197)
T 3pm8_A 8 SSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKK 85 (197)
T ss_dssp ---------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred cchHhhhccCCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH
Confidence 489998764 566778888999999999999999999999999999999999999999999 9999999999999874
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=98.09 E-value=3.6e-06 Score=74.81 Aligned_cols=77 Identities=13% Similarity=0.162 Sum_probs=62.7
Q ss_pred cCCCcC-CCCCCCCchHHHHHHHHHHhhcCHHHHHHHHHHHHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 385 THPWLH-DENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 385 ~hp~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
.|||+. ......+++..+.+.+++|...+.++++++..++..++++++..+++.|..+|. ++|.|+.+||..++..+
T Consensus 3 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~ 81 (191)
T 3k21_A 3 HHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEKD 81 (191)
T ss_dssp -----------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHT
T ss_pred CCccccCCccccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHc
Confidence 355554 445566788889999999999999999999999999999999999999999999 89999999999998653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.98 E-value=3e-05 Score=77.74 Aligned_cols=77 Identities=13% Similarity=0.026 Sum_probs=44.8
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEeccccc--CCH----HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKM--TSA----LAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~--~~~----~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.+.||.|..+.||++.. .++.++||....... ... .....+..|+..+..-.....+.+++.+. .+.
T Consensus 39 i~~l~~G~~n~vyrv~~-----~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~ 111 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-----SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTM 111 (420)
T ss_dssp EEECCCSSSCEEEEEEC-----SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTT
T ss_pred EEEccCCCcEEEEEEEc-----CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCc
Confidence 46789999999999853 456799994321100 000 01222333433332211134567777665 466
Q ss_pred EEEEEecc-CC
Q 012518 204 VYIVMEFC-EG 213 (461)
Q Consensus 204 ~~lv~e~~-~g 213 (461)
.++||||+ +|
T Consensus 112 ~~lv~e~l~~g 122 (420)
T 2pyw_A 112 ALIGMRYLEPP 122 (420)
T ss_dssp TEEEECCCCTT
T ss_pred cEEEEeecCCc
Confidence 78999999 77
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.92 E-value=6.9e-05 Score=71.92 Aligned_cols=76 Identities=13% Similarity=0.098 Sum_probs=60.2
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC--CCeeEEEEEEEeCCeEEEE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH--KHMIKFHDAFEDANSVYIV 207 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h--pniv~l~~~~~~~~~~~lv 207 (461)
.+.|+.|.+..+|++.. .+..+++|+.... ....+.+|...|+.|..+ ..+.+++.+....+..|+|
T Consensus 41 ~~~l~gG~~n~~y~v~~-----~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv 109 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-----EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL 109 (312)
T ss_dssp EEEECCSSSSEEEEEES-----SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred eEEeCCccceeeeEEEE-----CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence 46789999999999864 3567889987542 245678899999988533 5688899988888899999
Q ss_pred EeccCCCch
Q 012518 208 MEFCEGGEL 216 (461)
Q Consensus 208 ~e~~~gg~L 216 (461)
|||++|..+
T Consensus 110 me~l~G~~~ 118 (312)
T 3jr1_A 110 LEALNKSKN 118 (312)
T ss_dssp EECCCCCCC
T ss_pred EEeccCCCC
Confidence 999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00013 Score=65.26 Aligned_cols=123 Identities=15% Similarity=0.088 Sum_probs=80.8
Q ss_pred CchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCCcccc
Q 012518 214 GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI 292 (461)
Q Consensus 214 g~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~~~~~ 292 (461)
-+|.+.|...+..++|+++|.++.|.+.+|.-+-. ..-..+=+-|..|+|. .+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-cccc-----------
Confidence 37899999999999999999999999999876622 1112333456888885 456665543 1110
Q ss_pred ccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccc
Q 012518 293 VGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK 372 (461)
Q Consensus 293 ~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 372 (461)
.....+.+||......+.+.=|||||+++|.-+--..| ...-..+|+.+.+||..|..-
T Consensus 98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence 11234668887654556788999999999999853332 111245999999999999865
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.69 E-value=8.3e-05 Score=70.88 Aligned_cols=72 Identities=10% Similarity=-0.030 Sum_probs=45.5
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEe
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVME 209 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e 209 (461)
.+.|+.|....+|++ ..+++|+....... ..+..+|+.+++.+..+.-..+++.++ .+.-++|+|
T Consensus 23 i~~l~gG~tN~~~~~---------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE---------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEE
T ss_pred eeEcCCcccccccee---------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEe
Confidence 577989999999988 23888987542110 012246888888876443335666543 333478999
Q ss_pred cc-CCCch
Q 012518 210 FC-EGGEL 216 (461)
Q Consensus 210 ~~-~gg~L 216 (461)
|+ +|.+|
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 66544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00045 Score=65.25 Aligned_cols=80 Identities=16% Similarity=0.045 Sum_probs=56.2
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC--CCeeEEEEEEEeCC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH--KHMIKFHDAFEDAN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h--pniv~l~~~~~~~~ 202 (461)
.+..-++.+|.|..+.||++... +|+.|.+|+-....... ...+.+|...|+.|... --+.+++.+. .
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~----DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~- 84 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA----DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D- 84 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET----TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T-
T ss_pred CCeEEEEecCCCCCeEEEEEEEC----CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C-
Confidence 35566788999999999999864 68899999865432221 23567899999998633 2355666542 2
Q ss_pred eEEEEEeccCCCc
Q 012518 203 SVYIVMEFCEGGE 215 (461)
Q Consensus 203 ~~~lv~e~~~gg~ 215 (461)
-++||||+.++.
T Consensus 85 -~~lv~e~l~~~~ 96 (288)
T 3f7w_A 85 -RTLAMEWVDERP 96 (288)
T ss_dssp -TEEEEECCCCCC
T ss_pred -ceEEEEeecccC
Confidence 378999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00019 Score=68.82 Aligned_cols=140 Identities=19% Similarity=0.168 Sum_probs=77.9
Q ss_pred eceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCC-CeeEEEEE------EEeC
Q 012518 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK-HMIKFHDA------FEDA 201 (461)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp-niv~l~~~------~~~~ 201 (461)
-.+.|+.|....||++... +| .+++|+..... ..+.+..|+.+++.|..+. .+.+++.. ....
T Consensus 26 ~~~~i~~G~~n~~~~v~~~----~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT----KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp EEEEECC---EEEEEEEES----SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred EeeccCCCcccceEEEEeC----Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 3466888888999998753 23 58899886521 1134567888888775331 13333321 2234
Q ss_pred CeEEEEEeccCCCch--------------HHHHHhcCCCC--------CHHHHHH---------------HHHHHHHHHH
Q 012518 202 NSVYIVMEFCEGGEL--------------LDRILSRGGRY--------LEEDAKT---------------IVEKILNIVA 244 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L--------------~~~l~~~~~~~--------~~~~~~~---------------i~~qil~al~ 244 (461)
+..++||+|++|..+ +..++.....+ ....... +...+...+.
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 677999999988543 11222211111 1110000 0011334455
Q ss_pred HHHH-------cCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 245 FCHL-------QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 245 yLH~-------~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+++. .+++|+|+.+.|||++. +..+.|+||+.+.
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~---~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFLG---DELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEET---TEEEEECCCTTCE
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEeC---CceEEEecchhcc
Confidence 5553 36999999999999962 3334799998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00023 Score=68.49 Aligned_cols=76 Identities=8% Similarity=0.077 Sum_probs=48.8
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCC-CeeEEEEE-----EEeCCeE
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK-HMIKFHDA-----FEDANSV 204 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp-niv~l~~~-----~~~~~~~ 204 (461)
..|+ |....||++... +|+.+++|+...... . .+.+..|..+++.|..+. .+++++.. ....+..
T Consensus 32 ~~l~-g~~n~~y~v~~~----~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~ 102 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE----DRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFY 102 (328)
T ss_dssp EEEC-CSSSEEEEECCT----TCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEE
T ss_pred Eeec-CcccceEEEEcC----CCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEE
Confidence 4466 888899987543 466799999864321 1 345667888888875321 23444432 2335667
Q ss_pred EEEEeccCCCc
Q 012518 205 YIVMEFCEGGE 215 (461)
Q Consensus 205 ~lv~e~~~gg~ 215 (461)
++||+|++|..
T Consensus 103 ~~l~~~i~G~~ 113 (328)
T 1zyl_A 103 FAVFPSVGGRQ 113 (328)
T ss_dssp EEEEECCCCEE
T ss_pred EEEEEecCCCC
Confidence 89999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00025 Score=68.50 Aligned_cols=140 Identities=16% Similarity=0.106 Sum_probs=70.8
Q ss_pred eeeccCCceE-EEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCC-CeeEEEEEEEeCCeEEEEE
Q 012518 131 KEVGRGHFGH-TCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK-HMIKFHDAFEDANSVYIVM 208 (461)
Q Consensus 131 ~~lG~G~fg~-V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp-niv~l~~~~~~~~~~~lv~ 208 (461)
+.|+.|+... +|++... +|..+++|....... +.+..|+.+++.|..+. .+.+++.+..+.+ ++||
T Consensus 24 ~~l~gg~s~~~~~r~~~~----~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~ 91 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP----TGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLI 91 (333)
T ss_dssp CC--------CCEEEECT----TCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEE
T ss_pred eECCCCCCCceEEEEEcC----CCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEE
Confidence 3465554444 6666431 255677776443210 23446888888775332 3566776643333 7899
Q ss_pred eccCCCchHHHHHhc---------------------C----CCCCHHHHH-------H-HH------------HHHHHHH
Q 012518 209 EFCEGGELLDRILSR---------------------G----GRYLEEDAK-------T-IV------------EKILNIV 243 (461)
Q Consensus 209 e~~~gg~L~~~l~~~---------------------~----~~~~~~~~~-------~-i~------------~qil~al 243 (461)
|++.+..+.+.+... . ..+...... . +. ..+...+
T Consensus 92 e~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~ 171 (333)
T 3csv_A 92 EDLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRF 171 (333)
T ss_dssp CCCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHH
T ss_pred eeCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 999765554333110 0 112221110 0 00 1111222
Q ss_pred HHHH------HcCccccCCCCCcEEEecCCC-CCCeeEeecccccc
Q 012518 244 AFCH------LQGVVHRDLKPENFLFTTREE-DAPLKVIDFGLSDF 282 (461)
Q Consensus 244 ~yLH------~~givHrDlkp~NILl~~~~~-~~~~kl~DFG~a~~ 282 (461)
..+. ...++|+|+.+.|||+..+.. ...+.|+||+.+..
T Consensus 172 ~~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 172 AQILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3331 236999999999999963210 14689999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00064 Score=66.98 Aligned_cols=145 Identities=12% Similarity=0.134 Sum_probs=83.7
Q ss_pred ceeeccCCceEEEEEEeccC----CccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 130 GKEVGRGHFGHTCCAKGKKG----TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
++.|..|-...+|++....+ ..+++.|.+|+.... .. ....+.+|..+++.|..+.-..++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 35677788889999876321 113467999985321 11 234566899999988755555777776653 2
Q ss_pred EEEeccCCCchH-----------------HHHHhcC---C-CC--CHHHHHHHHHHHHH-------------------HH
Q 012518 206 IVMEFCEGGELL-----------------DRILSRG---G-RY--LEEDAKTIVEKILN-------------------IV 243 (461)
Q Consensus 206 lv~e~~~gg~L~-----------------~~l~~~~---~-~~--~~~~~~~i~~qil~-------------------al 243 (461)
+||||++|..|. ..|+... + .. ...++..++.++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 899999885542 1111111 1 11 13455555554422 23
Q ss_pred HHHHH--------cCccccCCCCCcEEEecC-CCCCCeeEeecccccc
Q 012518 244 AFCHL--------QGVVHRDLKPENFLFTTR-EEDAPLKVIDFGLSDF 282 (461)
Q Consensus 244 ~yLH~--------~givHrDlkp~NILl~~~-~~~~~~kl~DFG~a~~ 282 (461)
..|.+ ..++|+|+.+.|||+..+ +..+.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33332 249999999999999743 1135799999987753
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00032 Score=61.16 Aligned_cols=63 Identities=16% Similarity=0.351 Sum_probs=58.0
Q ss_pred hHHHHHHHHHHhhcCHHHHHHHHHHHHhcC--HHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 399 DILIYKLVKSYLRATPLKRAALKALSKALT--EEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
+..++..++.|...+.+++..+..++..++ ++++..+++.|..+|. ++|.|+.+||..++..+
T Consensus 3 ~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~ 68 (180)
T 3mse_B 3 SPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLASV 68 (180)
T ss_dssp CHHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHc
Confidence 456788999999999999999999999997 8999999999999999 89999999999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00043 Score=69.50 Aligned_cols=78 Identities=13% Similarity=0.046 Sum_probs=51.5
Q ss_pred ceeeccCCceEEEEEEeccCC----ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGT----LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
++.|+.|....||++....+. ..++.+++|+..... . .+.+.+|..+++.|..+.-..++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 467888888999999754210 125679999874321 1 13445799999988655445677776542 2
Q ss_pred EEEeccCCCch
Q 012518 206 IVMEFCEGGEL 216 (461)
Q Consensus 206 lv~e~~~gg~L 216 (461)
+||||++|..|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999986443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00046 Score=67.71 Aligned_cols=78 Identities=18% Similarity=0.111 Sum_probs=45.6
Q ss_pred ceeeccCCceEEEEEEeccCC-----ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGT-----LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
.+.|+.|....||++....+. ..+..+++|+...... ...+..+|..+++.|..+.-+.++++.+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 456788888899998754210 0136788898654211 1112357888888886443355777654 22
Q ss_pred EEEEeccCCCc
Q 012518 205 YIVMEFCEGGE 215 (461)
Q Consensus 205 ~lv~e~~~gg~ 215 (461)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998754
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00051 Score=60.09 Aligned_cols=64 Identities=20% Similarity=0.100 Sum_probs=58.0
Q ss_pred CchHHHHHHHHHHhhcCHHHHHHHHHHHHhc-CHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 397 PLDILIYKLVKSYLRATPLKRAALKALSKAL-TEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
++...+.+.++++...+.++++.+..++..+ ++++...+++.|..+|. ++|.|+.+||..++..
T Consensus 3 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~ 68 (191)
T 3khe_A 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRK 68 (191)
T ss_dssp CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHH
Confidence 3456678889999999999999999999988 88999999999999999 9999999999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0032 Score=60.92 Aligned_cols=69 Identities=13% Similarity=0.049 Sum_probs=44.1
Q ss_pred ccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC--CCeeEEEEE------EEeCCeEE
Q 012518 134 GRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH--KHMIKFHDA------FEDANSVY 205 (461)
Q Consensus 134 G~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h--pniv~l~~~------~~~~~~~~ 205 (461)
|.|....||++... +| .+++|+...... .+|+.+++.|..+ +++++.+.. ....+..+
T Consensus 32 G~g~~N~vy~v~~~----~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~ 97 (339)
T 3i1a_A 32 GADTNAFAYQADSE----SK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKI 97 (339)
T ss_dssp TSCSSCEEEEEECS----SC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEE
T ss_pred cCccccceEEEEeC----CC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEE
Confidence 44446789998753 34 799998765431 2567777666422 324554432 23457789
Q ss_pred EEEeccCCCch
Q 012518 206 IVMEFCEGGEL 216 (461)
Q Consensus 206 lv~e~~~gg~L 216 (461)
+||+|++|..+
T Consensus 98 ~l~~~i~G~~~ 108 (339)
T 3i1a_A 98 IAYPFIHAPNG 108 (339)
T ss_dssp EEEECCCCCBT
T ss_pred EEEeccCCCcC
Confidence 99999998655
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0088 Score=60.34 Aligned_cols=76 Identities=21% Similarity=0.156 Sum_probs=48.7
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEe
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVME 209 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e 209 (461)
++.|+.|-...+|++.... .+..+++|+..... .. .. +..+|..+++.|..+.-..++++.+. +. +|||
T Consensus 113 i~~lsgG~tN~~y~v~~~~---~~~~~vLRi~g~~~-~~--~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e 181 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS---KQAKYLIRLYGPKT-DE--II-NREREKKISCILYNKNIAKKIYVFFT--NG--RIEE 181 (458)
T ss_dssp EEEECC--CEEEEEEEETT---TTEEEEEEEECC-C-CS--CS-CHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEE
T ss_pred EEEcCCCeEeEEEEEEECC---CCceEEEEECCCCh-hh--hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEE
Confidence 4578888889999987632 24678899874321 11 00 12479999999975544567887773 22 5999
Q ss_pred ccCCCch
Q 012518 210 FCEGGEL 216 (461)
Q Consensus 210 ~~~gg~L 216 (461)
|++|..|
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9987544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0066 Score=60.59 Aligned_cols=79 Identities=16% Similarity=0.156 Sum_probs=49.9
Q ss_pred ceeeccCCceEEEEEEeccCCcc----CcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLK----GKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~----g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
++.|..|-...+|++....+..+ ++.|++++..... ... -+..+|..+++.|..+.-..++++.+. + +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKF-YDSKVELDVFRYLSNINIAPNIIADFP--E--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CC-CCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chh-cCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence 45677788889999876432111 5789999864321 111 123479999988865544566776442 2 6
Q ss_pred EEEeccCCCch
Q 012518 206 IVMEFCEGGEL 216 (461)
Q Consensus 206 lv~e~~~gg~L 216 (461)
+||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998653
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=95.97 E-value=0.0013 Score=63.24 Aligned_cols=100 Identities=16% Similarity=0.142 Sum_probs=61.7
Q ss_pred CCCCHHHHHHHHHhc---ccCcCCCCCHHHHhcC------CCcCCCCCC--------------------CCc--hH---H
Q 012518 356 PSVSPEAKDFVRRLL---NKDHRKRMTAAQALTH------PWLHDENRP--------------------VPL--DI---L 401 (461)
Q Consensus 356 ~~~s~~~~~li~~~L---~~dP~~R~s~~e~L~h------p~~~~~~~~--------------------~~~--~~---~ 401 (461)
.+.+.++.+|.++++ ..+|..|...++.+.| +|+....+. ... .. .
T Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~ 94 (323)
T 1ij5_A 15 KKVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLAS 94 (323)
T ss_dssp HHHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHH
Confidence 346788999999998 8899999999999988 877543100 000 00 1
Q ss_pred HHHHHH-HHhhcCHHHHHHHHHHHHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 402 IYKLVK-SYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 402 ~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
++..++ ++...+.+++ ++..++++++..|+..|..+|. ++|.|+.+||..+|..
T Consensus 95 vl~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~ 150 (323)
T 1ij5_A 95 LLKDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAK 150 (323)
T ss_dssp HHHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHH
Confidence 111121 2223333222 3457899999999999999999 9999999999999864
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=95.85 E-value=0.0087 Score=44.77 Aligned_cols=37 Identities=14% Similarity=0.099 Sum_probs=21.8
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 424 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 424 ~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
+..+++++...++..|..+|. ++|.|+.+||..++..
T Consensus 2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~ 39 (86)
T 2opo_A 2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKT 39 (86)
T ss_dssp ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHT
T ss_pred CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHH
Confidence 345566666666666666666 6666666666666653
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.68 E-value=0.0047 Score=48.27 Aligned_cols=35 Identities=20% Similarity=0.363 Sum_probs=27.1
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 426 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 426 ~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.+++++...|++.|..+|. ++|.|+.+||+.+|+.
T Consensus 29 ~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~ 64 (100)
T 2lv7_A 29 DIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRS 64 (100)
T ss_dssp CCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHH
Confidence 4567777778888888888 7888888888887764
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=95.65 E-value=0.015 Score=43.96 Aligned_cols=38 Identities=21% Similarity=0.332 Sum_probs=29.1
Q ss_pred HHHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 423 LSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 423 ~~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
++..+++++...++..|..+|. ++|.|+.+||..++..
T Consensus 10 ~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~ 48 (90)
T 1avs_A 10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRM 48 (90)
T ss_dssp HHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred HHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 4556777777888888888887 7888888888877754
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=95.07 E-value=0.018 Score=41.82 Aligned_cols=32 Identities=25% Similarity=0.454 Sum_probs=16.8
Q ss_pred CHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 428 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 428 ~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
++++...++..|..+|. ++|.|+.+||..++.
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~ 34 (77)
T 2joj_A 2 SEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMR 34 (77)
T ss_dssp CHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 34445555555555555 555555555555543
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.03 E-value=0.014 Score=44.36 Aligned_cols=35 Identities=23% Similarity=0.343 Sum_probs=20.9
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 425 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 425 ~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
..+++++...++..|..+|. ++|.|+.+||..++.
T Consensus 19 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~ 54 (91)
T 2pmy_A 19 ADGDGEELARLRSVFAACDANRSGRLEREEFRALCT 54 (91)
T ss_dssp CHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 34455555666666666666 566666666666554
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=94.91 E-value=0.022 Score=43.54 Aligned_cols=32 Identities=25% Similarity=0.312 Sum_probs=17.3
Q ss_pred CHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 428 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 428 ~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
+.++...+++.|..+|. ++|.|+.+||..+|.
T Consensus 4 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~ 36 (92)
T 1fi6_A 4 TDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFT 36 (92)
T ss_dssp CHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHH
Confidence 44455555555555555 555555555555543
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=94.83 E-value=0.023 Score=43.72 Aligned_cols=32 Identities=19% Similarity=0.163 Sum_probs=17.6
Q ss_pred CHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 428 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 428 ~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
+.++...+++.|..+|. ++|.|+.+||+.+|.
T Consensus 5 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~ 37 (95)
T 1c07_A 5 SPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFL 37 (95)
T ss_dssp CSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 34455555555555555 555555555555554
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=94.65 E-value=0.011 Score=44.30 Aligned_cols=33 Identities=12% Similarity=0.038 Sum_probs=15.9
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 427 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 427 l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
+++++...++..|..+|. ++|.|+.+||..++.
T Consensus 8 l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~ 41 (86)
T 1j7q_A 8 LGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLT 41 (86)
T ss_dssp CSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 334444444555555554 455555555544443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.44 E-value=0.15 Score=50.18 Aligned_cols=32 Identities=31% Similarity=0.509 Sum_probs=25.7
Q ss_pred ccccCCCCCcEEEecC---CCCCCeeEeecccccc
Q 012518 251 VVHRDLKPENFLFTTR---EEDAPLKVIDFGLSDF 282 (461)
Q Consensus 251 ivHrDlkp~NILl~~~---~~~~~~kl~DFG~a~~ 282 (461)
++|+|+.+.|||+... +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999642 3456799999988764
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=93.84 E-value=0.062 Score=42.28 Aligned_cols=27 Identities=26% Similarity=0.425 Sum_probs=19.5
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.+.+++...|. +||.|+.+||..++..
T Consensus 49 el~~i~~~~D~d~dG~id~~EF~~~m~~ 76 (106)
T 1eh2_A 49 ILGRVWELSDIDHDGMLDRDEFAVAMFL 76 (106)
T ss_dssp HHHHHHHHHCSSCSSBCCHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCcCcHHHHHHHHHH
Confidence 35567777787 7888888888777653
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=93.79 E-value=0.043 Score=53.97 Aligned_cols=37 Identities=27% Similarity=0.470 Sum_probs=31.5
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 425 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 425 ~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
+.|+++|+..|++.|..+|. ++|.|+.+||..+|+.|
T Consensus 294 E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrsL 331 (440)
T 3u0k_A 294 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSL 331 (440)
T ss_dssp BCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHT
T ss_pred hhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHHc
Confidence 47788889999999999998 89999999998888754
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.76 E-value=0.065 Score=42.49 Aligned_cols=31 Identities=10% Similarity=0.110 Sum_probs=16.1
Q ss_pred CHHHHHHHHHHhhhcCC-CCCeecHHHHHHHH
Q 012518 428 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVVS 458 (461)
Q Consensus 428 ~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~ 458 (461)
++++...+++.|..+|. ++|.|+.+||+.+|
T Consensus 9 s~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l 40 (111)
T 2kgr_A 9 PQSSRLKYRQLFNSHDKTMSGHLTGPQARTIL 40 (111)
T ss_dssp CHHHHHHHHHHHHTTSCSSCCEEEHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHH
Confidence 34444455555555555 45555555555544
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=92.67 E-value=0.091 Score=39.52 Aligned_cols=25 Identities=16% Similarity=0.185 Sum_probs=14.7
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
+...|..+|. ++|.|+.+||...+.
T Consensus 47 ~~~l~~~~d~~~dg~i~~~eF~~~~~ 72 (92)
T 2kn2_A 47 VEQMIKEADLDGDGQVNYEEFVKMMM 72 (92)
T ss_dssp HHHHHHHHCSSCCSSEEHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 3445555666 666666666665543
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=92.53 E-value=0.036 Score=43.99 Aligned_cols=25 Identities=24% Similarity=0.312 Sum_probs=15.9
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
+.+++..+|. ++|.|+.+||..++.
T Consensus 58 l~~i~~~~D~d~dG~I~~~EF~~~m~ 83 (110)
T 1iq3_A 58 LSYIWELSDADCDGALTLPEFCAAFH 83 (110)
T ss_dssp HHHHHHHHCSSSCSEEEHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCcCcHHHHHHHHH
Confidence 4456666666 667777777766654
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=91.50 E-value=0.25 Score=43.96 Aligned_cols=36 Identities=11% Similarity=0.030 Sum_probs=32.5
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 425 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 425 ~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..++++++..+++.|..+|. ++|.|+.+||..++..
T Consensus 40 ~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~ 76 (219)
T 3cs1_A 40 REKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLE 76 (219)
T ss_dssp CSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 45788999999999999999 8999999999998864
|
| >1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A | Back alignment and structure |
|---|
Probab=91.48 E-value=0.18 Score=38.96 Aligned_cols=32 Identities=9% Similarity=0.084 Sum_probs=27.8
Q ss_pred HHHHHHHHHHhhhcCCCCCeecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLEPKDGCVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d~~~g~~~~~el~~~~~~ 460 (461)
++++..|++.|..+|.++|.|+.+||+.+|..
T Consensus 6 ~~~~~~l~~~F~~fD~~~g~Is~~El~~~l~~ 37 (100)
T 1psr_A 6 ERSIIGMIDMFHKYTRRDDKIDKPSLLTMMKE 37 (100)
T ss_dssp HHHHHHHHHHHHHTCCTTSCBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCeECHHHHHHHHHH
Confidence 45677899999999988899999999999863
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A | Back alignment and structure |
|---|
Probab=91.44 E-value=0.31 Score=40.44 Aligned_cols=33 Identities=15% Similarity=0.264 Sum_probs=29.7
Q ss_pred HHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 429 EEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
+++...++..|..+|. ++|.|+.+||..++..+
T Consensus 44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~ 77 (147)
T 1wy9_A 44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKL 77 (147)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHh
Confidence 5788899999999999 89999999999998753
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.19 E-value=0.17 Score=35.59 Aligned_cols=28 Identities=14% Similarity=0.253 Sum_probs=20.9
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..++..|..+|. ++|.|+.+||..++..
T Consensus 6 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~ 34 (71)
T 2b1u_A 6 EDLQVAFRAFDQDGDGHITVDELRRAMAG 34 (71)
T ss_dssp HHHHHHHTTSCCSSSSEEEHHHHHHHGGG
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 446677888887 7888888888877654
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.00 E-value=0.2 Score=38.91 Aligned_cols=32 Identities=13% Similarity=0.211 Sum_probs=22.2
Q ss_pred HHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
+++...++..|..+|. ++|.|+.+||..++..
T Consensus 28 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~ 60 (107)
T 2d58_A 28 PSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEK 60 (107)
T ss_dssp HHHHHHHHHHHTTSCCCTTSCEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 4566667777777777 6777777777776654
|
| >3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A | Back alignment and structure |
|---|
Probab=91.00 E-value=0.23 Score=39.96 Aligned_cols=28 Identities=21% Similarity=0.274 Sum_probs=23.5
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..|.+++...|. +||.|+++||..++..
T Consensus 66 ~~L~~Iw~laD~d~dG~Ld~~EF~~aM~L 94 (121)
T 3fia_A 66 PVLAQIWALADMNNDGRMDQVEFSIAMKL 94 (121)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHHHHHH
Confidence 447788888998 8999999999998764
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A | Back alignment and structure |
|---|
Probab=90.79 E-value=0.046 Score=40.26 Aligned_cols=31 Identities=23% Similarity=0.231 Sum_probs=26.4
Q ss_pred HHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 430 EELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 430 ~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
++...++..|..+|. ++|.|+.+||..++..
T Consensus 4 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~ 35 (83)
T 1yx7_A 4 KVKAELEAAFKKLDANGDGYVTALELQTFMVT 35 (83)
T ss_dssp CSCTHHHHHHHHHSSSCSSSCSHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 344568899999999 9999999999998864
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=90.58 E-value=0.023 Score=42.38 Aligned_cols=29 Identities=21% Similarity=0.352 Sum_probs=18.1
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHH
Q 012518 426 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVV 457 (461)
Q Consensus 426 ~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~ 457 (461)
.++++++ ...|..+|. ++|.|+.+||...
T Consensus 55 ~~~~~~~---~~l~~~~d~~~~g~i~~~eF~~~ 84 (87)
T 1s6j_A 55 ELMESEI---KDLMDAADIDKSGTIDYGEFIAA 84 (87)
T ss_dssp SCCHHHH---HHHHHHHCTTCSSEECHHHHTTC
T ss_pred CCCHHHH---HHHHHHhCCCCCCcCcHHHHHHH
Confidence 3455443 456666677 6777877777654
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=90.24 E-value=0.14 Score=44.69 Aligned_cols=37 Identities=24% Similarity=0.408 Sum_probs=32.4
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 425 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 425 ~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
..++.+++..|++.|..+|. ++|.|+.+||..+|..+
T Consensus 49 ~~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~l 86 (196)
T 3dtp_E 49 AMFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSL 86 (196)
T ss_dssp CSSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHTT
T ss_pred hhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHh
Confidence 35778888999999999999 89999999999998754
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=90.11 E-value=0.067 Score=47.99 Aligned_cols=45 Identities=11% Similarity=0.225 Sum_probs=34.7
Q ss_pred HHHHHHHHHHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 416 KRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 416 ~~~~~~~~~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
++.....+...++++++..+++.|..+|. ++|.|+.+||..++..
T Consensus 34 ~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~ 79 (220)
T 3sjs_A 34 RNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFP 79 (220)
T ss_dssp HTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBG
T ss_pred HHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 33333445677888899999999999998 8999999998887654
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=90.02 E-value=0.21 Score=34.62 Aligned_cols=24 Identities=33% Similarity=0.584 Sum_probs=11.9
Q ss_pred HHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 436 RAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 436 ~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
++.|..+|. ++|.|+.+||..++.
T Consensus 4 ~~~F~~~D~d~~G~i~~~el~~~l~ 28 (67)
T 1tiz_A 4 KRVFEKFDKNKDGKLSLDEFREVAL 28 (67)
T ss_dssp HHHHHHHCTTSSSCEEHHHHHHHHH
T ss_pred HHHHHHHCCCCCCcCcHHHHHHHHH
Confidence 444555555 455555555554443
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.87 E-value=0.22 Score=40.10 Aligned_cols=32 Identities=13% Similarity=0.203 Sum_probs=28.0
Q ss_pred HHHHHHHHHHhhhcCCCCCeecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLEPKDGCVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d~~~g~~~~~el~~~~~~ 460 (461)
+..+..|+..|+.+|.++|.||.+||+.+|+.
T Consensus 11 E~~ie~l~~~F~~yd~ddG~Is~~EL~~~l~~ 42 (121)
T 4drw_A 11 EHAMETMMFTFHKFAGDKGYLTKEDLRVLMEK 42 (121)
T ss_dssp HHHHHHHHHTTGGGSCTTCSCCHHHHHHHTTT
T ss_pred HHHHHHHHHHHHHHcCCCCEEcHHHHHHHHHH
Confidence 44578899999999998899999999999864
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=89.55 E-value=0.26 Score=37.95 Aligned_cols=22 Identities=9% Similarity=0.058 Sum_probs=10.3
Q ss_pred HHhhhcCC-CCCeecHHHHHHHH
Q 012518 437 AQFMLLEP-KDGCVSLNNFKVVS 458 (461)
Q Consensus 437 ~~f~~~d~-~~g~~~~~el~~~~ 458 (461)
..|..+|. ++|.|+.+||...+
T Consensus 64 ~l~~~~d~~~~g~i~~~eF~~~~ 86 (105)
T 1wlz_A 64 RLWNEMPVNAKGRLKYPDFLSRF 86 (105)
T ss_dssp HHHTTSCBCTTSCBCHHHHHHHH
T ss_pred HHHHHcCCCCCCCCcHHHHHHHH
Confidence 33444444 44555555554443
|
| >2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A | Back alignment and structure |
|---|
Probab=88.94 E-value=0.34 Score=36.64 Aligned_cols=30 Identities=13% Similarity=0.099 Sum_probs=19.9
Q ss_pred HHHHHHHHHhhhcC-C-CCC-eecHHHHHHHHh
Q 012518 430 EELVYLRAQFMLLE-P-KDG-CVSLNNFKVVSW 459 (461)
Q Consensus 430 ~e~~~l~~~f~~~d-~-~~g-~~~~~el~~~~~ 459 (461)
+++..|++.|..+| . ++| .|+.+||+.++.
T Consensus 7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~ 39 (92)
T 2kax_A 7 KALTTMVTTFHKYSGREGSKLTLSRKELKELIK 39 (92)
T ss_dssp HHHHHHHHHHHHHHTTSSCSSEEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCeeCHHHHHHHHH
Confidence 34556667777777 5 666 777777777664
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=88.89 E-value=7.8 Score=36.72 Aligned_cols=137 Identities=13% Similarity=0.111 Sum_probs=74.0
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEE---------
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDA--------- 197 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~--------- 197 (461)
++.++..-.|..|.++.+. ++..|.||-.. ....+.+-.++...-.+. -|+..-+...
T Consensus 71 v~~I~~s~~Gstgvff~~t------d~~~~VVK~s~------~l~~E~l~s~LA~~LGlp-iP~~Riv~~~~~E~~e~~~ 137 (342)
T 1cja_A 71 FKGIERSEKGTEGLFFVET------ESGVFIVKRST------NIESETFCSLLCMRLGLH-APKVRVVSSNSEEGTNMLE 137 (342)
T ss_dssp EEEEEECCSTTSCEEEEEE------SSCEEEEECCT------THHHHHHHHHHHHHHTCC-CCCEEEEESSSHHHHHHHH
T ss_pred eeEEEeccCCCCCeEEEEe------CCCEEEEeCcH------HHHHHHHHHHHHHHhCCC-CCCeeEEeeCcHHHHHHHH
Confidence 6666777777655554443 35678899431 123344444444444453 5553322211
Q ss_pred -------------EEeCCeEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHH--HHHHHHHHHcC----c-cccCC
Q 012518 198 -------------FEDANSVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKI--LNIVAFCHLQG----V-VHRDL 256 (461)
Q Consensus 198 -------------~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qi--l~al~yLH~~g----i-vHrDl 256 (461)
....+...++|||..|..|.+.-... ...+.+ ..++++ +-++.++..++ . -+.--
T Consensus 138 ~L~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~----~~~k~LG~Ii~FDi~InN~DR~Pl~W~n~G 213 (342)
T 1cja_A 138 CLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTK----STMQQLGSLMALDVIVNNSDRLPIAWTNEG 213 (342)
T ss_dssp HHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCH----HHHHHHHHHHHHHHHHTCCSSSCSSSCSCC
T ss_pred HHHHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCH----HHHHhhchhheehhhhcCCccCcccccCCC
Confidence 00123577999999976664311000 001222 233332 34567777663 2 22236
Q ss_pred CCCcEEEecCCCCCCeeEeecccccc
Q 012518 257 KPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 257 kp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.++|||+..+ +..+.++|-+++..
T Consensus 214 N~~NIL~~~~--n~~~~~IDhn~af~ 237 (342)
T 1cja_A 214 NLDNIMLSER--GATVVPIDSKIIPL 237 (342)
T ss_dssp CGGGEEEESB--TTCEEECSCCCCCC
T ss_pred ChhheEEeCC--CCeEEEEcCCcccc
Confidence 8999999853 34689999998864
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=88.34 E-value=0.53 Score=32.39 Aligned_cols=28 Identities=18% Similarity=0.274 Sum_probs=23.8
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
.+...|..+|. ++|.|+.+||...+..+
T Consensus 37 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 65 (66)
T 3li6_A 37 LLQLIFKSIDADGNGEIDQNEFAKFYGSI 65 (66)
T ss_dssp HHHHHHHHHCTTCSSSCCHHHHHHHHTCC
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 35678888999 89999999999998754
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=88.17 E-value=0.48 Score=36.08 Aligned_cols=32 Identities=13% Similarity=0.085 Sum_probs=26.4
Q ss_pred HHHHHHHHHHhhhcC-C-C-CCeecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLE-P-K-DGCVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d-~-~-~g~~~~~el~~~~~~ 460 (461)
+++...|++.|..+| . + +|.|+.+||+.+|..
T Consensus 5 ~~~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~ 39 (95)
T 1j55_A 5 ETAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEK 39 (95)
T ss_dssp HHHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHH
Confidence 346678899999999 5 4 489999999999864
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A | Back alignment and structure |
|---|
Probab=88.09 E-value=0.17 Score=36.93 Aligned_cols=25 Identities=8% Similarity=0.185 Sum_probs=15.5
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
+...|..+|. ++|.|+.+||...+.
T Consensus 47 ~~~~~~~~D~~~dg~i~~~eF~~~~~ 72 (81)
T 1c7v_A 47 VEEAMKEADEDGNGVIDIPEFMDLIK 72 (81)
T ss_dssp HHHHHHHHCSSGGGSEEHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 4455666666 666677776666554
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=88.09 E-value=0.15 Score=39.45 Aligned_cols=25 Identities=24% Similarity=0.267 Sum_probs=12.7
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
+.+++..+|. ++|.|+.+||..++.
T Consensus 47 l~~i~~~~D~d~dG~i~~~EF~~~~~ 72 (99)
T 1qjt_A 47 LGKIWDLADTDGKGVLSKQEFFVALR 72 (99)
T ss_dssp HHHHHHHHCCSSSSSCCSHHHHHHHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHH
Confidence 3444555555 455555555555443
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=88.02 E-value=0.27 Score=44.00 Aligned_cols=36 Identities=8% Similarity=0.061 Sum_probs=31.9
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 424 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 424 ~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
...++++++..|++.|..+|. ++|.|+.+||..++.
T Consensus 42 ~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~ 78 (226)
T 2lvv_A 42 PRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCY 78 (226)
T ss_dssp CSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHH
T ss_pred chhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHH
Confidence 446789999999999999999 999999999998553
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=87.97 E-value=0.17 Score=44.42 Aligned_cols=36 Identities=17% Similarity=0.155 Sum_probs=26.1
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 425 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 425 ~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..++++++..+++.|..+|. ++|.|+.+||..++..
T Consensus 28 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~ 64 (208)
T 2hpk_A 28 EDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDR 64 (208)
T ss_dssp --------CHHHHHHHHHCTTCSSEECHHHHTHHHHH
T ss_pred HHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 56778888999999999999 9999999999998864
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=87.68 E-value=0.32 Score=34.99 Aligned_cols=25 Identities=20% Similarity=0.308 Sum_probs=15.2
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
++..|..+|. ++|.|+.+||..++.
T Consensus 5 l~~~F~~~D~~~~G~i~~~el~~~l~ 30 (78)
T 1k9u_A 5 MERIFKRFDTNGDGKISLSELTDALR 30 (78)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCcCcHHHHHHHHH
Confidence 4555666666 566666666666554
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=87.64 E-value=0.34 Score=36.72 Aligned_cols=26 Identities=19% Similarity=0.311 Sum_probs=15.4
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
.+++.|..+|. ++|.|+.+||..++.
T Consensus 30 ~l~~~F~~~D~d~~G~I~~~El~~~l~ 56 (94)
T 2kz2_A 30 EIREAFRVEDKDGNGYISAAELRHVMT 56 (94)
T ss_dssp HHHHHHHHHCTTCCSCBCHHHHHHHHH
T ss_pred HHHHHHHHHCCCCcCcCCHHHHHHHHH
Confidence 34555666666 566666666666554
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=87.55 E-value=0.15 Score=35.44 Aligned_cols=26 Identities=27% Similarity=0.280 Sum_probs=22.8
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
+++.|..+|. ++|.|+.+||..++..
T Consensus 2 l~~~F~~~D~d~~G~i~~~e~~~~l~~ 28 (66)
T 3li6_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSK 28 (66)
T ss_dssp CCHHHHHHCTTCSSSCCHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHH
Confidence 4578999999 9999999999998864
|
| >1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A | Back alignment and structure |
|---|
Probab=87.37 E-value=0.3 Score=37.32 Aligned_cols=31 Identities=13% Similarity=0.232 Sum_probs=26.3
Q ss_pred HHHHHHHHHHhhhcCCCCCeecHHHHHHHHh
Q 012518 429 EEELVYLRAQFMLLEPKDGCVSLNNFKVVSW 459 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d~~~g~~~~~el~~~~~ 459 (461)
+++...|++.|..+|.++|.|+.+||+.+|.
T Consensus 5 ~~~~~~l~~~F~~fD~~dg~Is~~El~~~l~ 35 (96)
T 1a4p_A 5 EHAMETMMFTFHKFAGDKGYLTKEDLRVLME 35 (96)
T ss_dssp HHHHHHHHHHHHHHHGGGCSBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCeECHHHHHHHHH
Confidence 3466778999999997678999999999985
|
| >2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A | Back alignment and structure |
|---|
Probab=87.15 E-value=0.48 Score=36.05 Aligned_cols=32 Identities=19% Similarity=0.026 Sum_probs=26.2
Q ss_pred HHHHHHHHHHhhhcC-C-CCC-eecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLE-P-KDG-CVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d-~-~~g-~~~~~el~~~~~~ 460 (461)
+++...|++.|..+| . ++| .|+.+||+.++..
T Consensus 8 e~~~~~l~~~F~~fD~~dg~gg~I~~~El~~~l~~ 42 (95)
T 2wcb_A 8 EEHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTK 42 (95)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCccCHHHHHHHHHH
Confidence 345678899999999 5 666 9999999999863
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=86.98 E-value=0.5 Score=35.66 Aligned_cols=32 Identities=19% Similarity=0.187 Sum_probs=26.2
Q ss_pred HHHHHHHHHHhhhcCCCCC---eecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLEPKDG---CVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d~~~g---~~~~~el~~~~~~ 460 (461)
+..+..|++.|..+|.+|| .|+.+||+.+|..
T Consensus 5 e~~~~~l~~~F~~~D~~dG~~g~Is~~EL~~~l~~ 39 (92)
T 3rm1_A 5 EKAVVALIDVFHQYSGREGDKHKLKKSELKELINN 39 (92)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHccCCCCcCeECHHHHHHHHHH
Confidence 3456778899999996556 9999999999875
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=86.93 E-value=0.58 Score=38.88 Aligned_cols=32 Identities=19% Similarity=0.332 Sum_probs=26.3
Q ss_pred HHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.++...++..|..+|. ++|.|+.+||..++..
T Consensus 46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~ 78 (150)
T 2jjz_A 46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEK 78 (150)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHH
Confidence 4567778888999998 8899999999888765
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=86.83 E-value=0.33 Score=37.60 Aligned_cols=28 Identities=14% Similarity=0.253 Sum_probs=17.1
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..+...|..+|. ++|.|+.+||...+..
T Consensus 81 ~~~~~~~~~~d~~~dg~i~~~eF~~~~~~ 109 (110)
T 1pva_A 81 AETKAFLKAADKDGDGKIGIDEFETLVHE 109 (110)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHHHHh
Confidence 445566666666 5666666666665543
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=86.68 E-value=0.64 Score=36.84 Aligned_cols=32 Identities=16% Similarity=0.099 Sum_probs=26.6
Q ss_pred HHHHHHHHHHhhhcC-C-CCC-eecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLE-P-KDG-CVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d-~-~~g-~~~~~el~~~~~~ 460 (461)
+++...|++.|..+| . ++| .|+.+||+.+|..
T Consensus 18 ~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~ 52 (113)
T 2lnk_A 18 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTR 52 (113)
T ss_dssp HHHHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHH
Confidence 456678899999999 6 676 9999999999863
|
| >1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A | Back alignment and structure |
|---|
Probab=86.64 E-value=0.5 Score=35.32 Aligned_cols=32 Identities=19% Similarity=0.063 Sum_probs=27.3
Q ss_pred HHHHHHHHHHhhhcC-C-CCC-eecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLE-P-KDG-CVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d-~-~~g-~~~~~el~~~~~~ 460 (461)
+++...++..|..+| . ++| .|+.+||..++..
T Consensus 5 ~~~~~~l~~~F~~~D~~d~~G~~I~~~el~~~l~~ 39 (93)
T 1k2h_A 5 ETAMETLINVFHAHSGKEGDKYKLSKKELKDLLQT 39 (93)
T ss_dssp HHHHHHHHHHHHHHHTTSSCCSSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCcCccCHHHHHHHHHH
Confidence 346678899999999 7 899 9999999998864
|
| >1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A | Back alignment and structure |
|---|
Probab=86.50 E-value=0.6 Score=34.49 Aligned_cols=31 Identities=19% Similarity=0.117 Sum_probs=25.8
Q ss_pred HHHHHHHHHhhhcC-C-CCC-eecHHHHHHHHhh
Q 012518 430 EELVYLRAQFMLLE-P-KDG-CVSLNNFKVVSWL 460 (461)
Q Consensus 430 ~e~~~l~~~f~~~d-~-~~g-~~~~~el~~~~~~ 460 (461)
+....++..|..+| . ++| .|+.+||..++..
T Consensus 7 ~~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~ 40 (90)
T 1k8u_A 7 QAIGLLVAIFHKYSGREGDKHTLSKKELKELIQK 40 (90)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHH
Confidence 44567889999999 5 789 9999999998864
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=86.18 E-value=0.59 Score=35.91 Aligned_cols=32 Identities=19% Similarity=0.061 Sum_probs=26.1
Q ss_pred HHHHHHHHHHhhhcC-C-CCC-eecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLE-P-KDG-CVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d-~-~~g-~~~~~el~~~~~~ 460 (461)
++++..|++.|..+| . ++| .|+.+||+.+|..
T Consensus 6 ~~~~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~ 40 (99)
T 2y5i_A 6 EGAMDALITVFHNYSGSEGDKYKLSKGELKELLNA 40 (99)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHH
Confidence 345677899999997 5 666 9999999999863
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=86.11 E-value=0.56 Score=37.00 Aligned_cols=31 Identities=13% Similarity=0.161 Sum_probs=26.6
Q ss_pred HHHHHHHHHHhhhcC-C-CCC-eecHHHHHHHHh
Q 012518 429 EEELVYLRAQFMLLE-P-KDG-CVSLNNFKVVSW 459 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d-~-~~g-~~~~~el~~~~~ 459 (461)
++++..|++.|..+| . ++| .|+.+||+.+|.
T Consensus 8 ~~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~ 41 (113)
T 1xk4_C 8 ERNIETIINTFHQYSVKLGHPDTLNQGEFKELVR 41 (113)
T ss_dssp HHHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHH
Confidence 345678899999999 4 789 999999999986
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=86.03 E-value=0.77 Score=35.41 Aligned_cols=32 Identities=16% Similarity=0.189 Sum_probs=26.4
Q ss_pred HHHHHHHHHHhhhcCC-C---CCeecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLEP-K---DGCVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d~-~---~g~~~~~el~~~~~~ 460 (461)
+..+..|++.|..+|. + +|.|+.+||+.+|..
T Consensus 7 e~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~ 42 (100)
T 3nxa_A 7 EKAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQK 42 (100)
T ss_dssp HHHHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHH
Confidence 3456778999999998 3 599999999998863
|
| >2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A | Back alignment and structure |
|---|
Probab=85.72 E-value=0.53 Score=38.82 Aligned_cols=28 Identities=25% Similarity=0.373 Sum_probs=22.8
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..|.+++...|. +||.|+.+||..++..
T Consensus 84 ~el~~I~~~~D~d~dG~Ld~~EF~~am~l 112 (139)
T 2jq6_A 84 TVLGKIWKLADVDKDGLLDDEEFALANHL 112 (139)
T ss_dssp HHHHHHHHHHCSSCCSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 457788888898 8999999999888754
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A | Back alignment and structure |
|---|
Probab=85.72 E-value=0.49 Score=33.64 Aligned_cols=26 Identities=19% Similarity=0.312 Sum_probs=16.2
Q ss_pred HHHHHhhhc-CC-CC-CeecHHHHHHHHh
Q 012518 434 YLRAQFMLL-EP-KD-GCVSLNNFKVVSW 459 (461)
Q Consensus 434 ~l~~~f~~~-d~-~~-g~~~~~el~~~~~ 459 (461)
.++..|..+ |. ++ |.|+.+||..++.
T Consensus 6 ~l~~~F~~~~D~d~~~G~i~~~el~~~l~ 34 (76)
T 1qx2_A 6 EIKGAFEVFAAKEGDPNQISKEELKLVMQ 34 (76)
T ss_dssp HHHHHHHHHHTSSSCTTSEEHHHHHHHHH
T ss_pred HHHHHHHHHcccCCCcCeECHHHHHHHHH
Confidence 455666666 66 56 6666666666654
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=85.64 E-value=0.89 Score=31.19 Aligned_cols=33 Identities=15% Similarity=0.244 Sum_probs=25.8
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 426 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 426 ~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
.+++++ +...|..+|. ++|.|+.+||...+..+
T Consensus 33 ~~~~~~---~~~~~~~~D~~~dg~i~~~ef~~~~~~~ 66 (67)
T 1tiz_A 33 YFTQED---IVKFFEEIDVDGNGELNADEFTSCIEKM 66 (67)
T ss_dssp TSCHHH---HHHHHHHHCCSSSSEECHHHHHHHHHTC
T ss_pred CCCHHH---HHHHHHHHCCCCCCcCcHHHHHHHHHHH
Confidence 445555 4567888899 89999999999988753
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=85.44 E-value=0.71 Score=35.75 Aligned_cols=31 Identities=10% Similarity=0.012 Sum_probs=25.7
Q ss_pred HHHHHHHHHhhhcC-C-CC-CeecHHHHHHHHhh
Q 012518 430 EELVYLRAQFMLLE-P-KD-GCVSLNNFKVVSWL 460 (461)
Q Consensus 430 ~e~~~l~~~f~~~d-~-~~-g~~~~~el~~~~~~ 460 (461)
..+..|++.|..+| . ++ |.||.+||+.+|..
T Consensus 7 ~~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~ 40 (101)
T 3nso_A 7 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQK 40 (101)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHH
Confidence 45677899999998 5 55 99999999999863
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=85.44 E-value=0.67 Score=36.20 Aligned_cols=26 Identities=19% Similarity=0.310 Sum_probs=12.4
Q ss_pred HHHHHHhhhcC-C-CC-CeecHHHHHHHH
Q 012518 433 VYLRAQFMLLE-P-KD-GCVSLNNFKVVS 458 (461)
Q Consensus 433 ~~l~~~f~~~d-~-~~-g~~~~~el~~~~ 458 (461)
..|++.|..+| . ++ |.|+.+||+.+|
T Consensus 22 ~~l~~aF~~fD~~dg~~G~Is~~EL~~~l 50 (106)
T 2h2k_A 22 ETVVTTFFTFARQEGRKDSLSVNEFKELV 50 (106)
T ss_dssp HHHHHHHHHHHTSSSSTTEECHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCCCEECHHHHHHHH
Confidence 34445555555 3 22 455555555544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.37 E-value=0.06 Score=54.30 Aligned_cols=63 Identities=14% Similarity=0.085 Sum_probs=17.5
Q ss_pred eceeeccCCceEEEEEEeccCCccCcEEEE------EEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAV------KIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~g~~vAv------K~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
+.+.|| ||.||++.... ....||| |..+.... .......+.+|..+++.+. |+|+++.+++-.
T Consensus 146 l~~~lG---fG~v~~g~~~~---~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~-H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYK---KHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQ-IPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC------------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccc---cCCchhhhhccCccccccccc-ccccccccccccccccccc-ccccCCCcceEE
Confidence 345676 99999998754 2356888 66544332 2333456778999998885 999999988754
|
| >1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A | Back alignment and structure |
|---|
Probab=84.81 E-value=0.79 Score=34.67 Aligned_cols=30 Identities=17% Similarity=0.069 Sum_probs=26.0
Q ss_pred HHHHHHHHHhhhcC-C-CCC-eecHHHHHHHHh
Q 012518 430 EELVYLRAQFMLLE-P-KDG-CVSLNNFKVVSW 459 (461)
Q Consensus 430 ~e~~~l~~~f~~~d-~-~~g-~~~~~el~~~~~ 459 (461)
+....++..|..+| . ++| .|+.+||..++.
T Consensus 10 ~~~~~l~~~F~~~Dd~d~~G~~I~~~el~~~l~ 42 (99)
T 1qls_A 10 RCIESLIAIFQKHAGRDGNNTKISKTEFLIFMN 42 (99)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhcCCCcCeeCHHHHHHHHH
Confidence 34567899999998 7 899 999999999986
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=84.76 E-value=0.6 Score=41.61 Aligned_cols=42 Identities=17% Similarity=0.345 Sum_probs=31.1
Q ss_pred HHHHHHHH--hcCHHHHHHHHHHhhhcCC---CCCeecHHHHHHHHh
Q 012518 418 AALKALSK--ALTEEELVYLRAQFMLLEP---KDGCVSLNNFKVVSW 459 (461)
Q Consensus 418 ~~~~~~~~--~l~~~e~~~l~~~f~~~d~---~~g~~~~~el~~~~~ 459 (461)
..+..+.. .++.+++..+++.|..+|. ++|.|+.+||..+|.
T Consensus 31 ~~~~~l~~~~~ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~~l~ 77 (226)
T 2zfd_A 31 GDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALF 77 (226)
T ss_dssp -CTHHHHHHSSCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHhCCCCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHHHHh
Confidence 44445544 5688888888888888886 678888888888764
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=84.42 E-value=4.5 Score=32.72 Aligned_cols=38 Identities=18% Similarity=0.272 Sum_probs=28.9
Q ss_pred HHHhcCHHHHHHH-HHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 423 LSKALTEEELVYL-RAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 423 ~~~~l~~~e~~~l-~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
....++.+++..+ ...|..+|. ++|.|+.+||...+..
T Consensus 105 ~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~ 144 (155)
T 3ll8_B 105 VGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGG 144 (155)
T ss_dssp HGGGSCHHHHHHHHHHHHHHHCTTSSSSBCHHHHHHHHGG
T ss_pred hccCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHhc
Confidence 3456777777654 445666899 8999999999998875
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=83.44 E-value=0.61 Score=35.93 Aligned_cols=27 Identities=15% Similarity=0.273 Sum_probs=15.7
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
..++..|..+|. ++|.|+.+||..++.
T Consensus 41 ~~l~~~F~~~D~d~~G~I~~~el~~~l~ 68 (109)
T 1rwy_A 41 DDVKKVFHILDKDKSGFIEEDELGSILK 68 (109)
T ss_dssp HHHHHHHHHHSTTCSSEECHHHHHTHHH
T ss_pred HHHHHHHHHHCCCCCCeEcHHHHHHHHH
Confidence 344556666666 566666666665554
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=83.43 E-value=0.78 Score=38.26 Aligned_cols=29 Identities=17% Similarity=0.235 Sum_probs=25.1
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
..|+..|..+|. ++|.|+.+||+.+|..+
T Consensus 85 ~~l~~aF~~fD~d~~G~I~~~el~~~l~~~ 114 (153)
T 3i5g_B 85 DALRNAFSMFDEDGQGFIPEDYLKDLLENM 114 (153)
T ss_dssp HHHHHHHHTTCSSCSSCCCHHHHHHHHHSS
T ss_pred HHHHHHHhccccCCCCeEeHHHHHHHHHHc
Confidence 357889999999 89999999999998753
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=83.40 E-value=0.64 Score=39.08 Aligned_cols=25 Identities=16% Similarity=0.218 Sum_probs=11.6
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
|++.|..+|. ++|.|+.+||+.+|.
T Consensus 87 l~~aF~~fD~d~~G~I~~~el~~~l~ 112 (159)
T 3i5g_C 87 FMEAFKTFDREGQGLISSAEIRNVLK 112 (159)
T ss_dssp HHHHHHHHCTTSSSEECHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCcCcHHHHHHHHH
Confidence 3344444444 444444444444443
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=83.03 E-value=0.58 Score=36.03 Aligned_cols=28 Identities=14% Similarity=0.293 Sum_probs=18.2
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..++..|..+|. ++|.|+.+||..++..
T Consensus 41 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~ 69 (108)
T 2pvb_A 41 DDVKKAFYVIDQDKSGFIEEDELKLFLQN 69 (108)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHTGGGG
T ss_pred HHHHHHHHHHCCCCCCcCCHHHHHHHHHH
Confidence 345666777776 6777777777666543
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=82.96 E-value=0.83 Score=37.07 Aligned_cols=26 Identities=19% Similarity=0.162 Sum_probs=14.1
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
.++..|..+|. ++|.|+.+||..++.
T Consensus 41 ~l~~~F~~~D~d~~G~I~~~el~~~l~ 67 (135)
T 3h4s_E 41 ELCKGFSLLADPERHLITAESLRRNSG 67 (135)
T ss_dssp HHHHHHHHHSBTTTTBBCHHHHHHHGG
T ss_pred HHHHHHHHHCCCCCCcCCHHHHHHHHH
Confidence 34455555555 555555555555544
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=82.76 E-value=2.9 Score=35.34 Aligned_cols=28 Identities=11% Similarity=0.202 Sum_probs=24.9
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..++..|..+|. ++|.|+.+||..++..
T Consensus 98 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~ 126 (183)
T 1dgu_A 98 IKSHYAFRIFDFDDDGTLNREDLSRLVNC 126 (183)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence 468899999999 8999999999998764
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=82.65 E-value=1.2 Score=38.72 Aligned_cols=34 Identities=26% Similarity=0.406 Sum_probs=22.5
Q ss_pred hcCHHHHHHHHHHhhhcCC---CCCeecHHHHHHHHh
Q 012518 426 ALTEEELVYLRAQFMLLEP---KDGCVSLNNFKVVSW 459 (461)
Q Consensus 426 ~l~~~e~~~l~~~f~~~d~---~~g~~~~~el~~~~~ 459 (461)
.++.+++..+++.|..+|. ++|.|+.+||..++.
T Consensus 30 ~~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~ 66 (207)
T 2ehb_A 30 PFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALF 66 (207)
T ss_dssp SCCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHh
Confidence 4566666667777777765 467777777766653
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=82.48 E-value=0.7 Score=35.64 Aligned_cols=25 Identities=16% Similarity=0.230 Sum_probs=13.6
Q ss_pred HHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 436 RAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 436 ~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
...|..+|. ++|.|+.+||...+.+
T Consensus 83 ~~~~~~~D~~~dg~i~~~eF~~~~~~ 108 (109)
T 5pal_A 83 KALLAAGDSDHDGKIGADEFAKMVAQ 108 (109)
T ss_dssp HHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCcCcHHHHHHHHHh
Confidence 344555555 5566666666555543
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=82.46 E-value=0.61 Score=35.90 Aligned_cols=28 Identities=11% Similarity=0.215 Sum_probs=18.1
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..++..|..+|. ++|.|+.+||..++..
T Consensus 41 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~ 69 (108)
T 1rro_A 41 SQVKDIFRFIDNDQSGYLDGDELKYFLQK 69 (108)
T ss_dssp HHHHHHHHHHCTTCSSEECTHHHHTGGGG
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence 345566777776 6777777777666543
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=82.29 E-value=0.65 Score=35.80 Aligned_cols=27 Identities=15% Similarity=0.375 Sum_probs=16.4
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
..++..|..+|. ++|.|+.+||..++.
T Consensus 42 ~~l~~~F~~~D~d~~G~I~~~el~~~l~ 69 (109)
T 1bu3_A 42 DDIKKAFFVIDQDKSGFIEEDELKLFLQ 69 (109)
T ss_dssp HHHHHHHHHHCTTCSSSEEHHHHHTHHH
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHH
Confidence 345566666666 666666666666554
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=81.70 E-value=0.68 Score=35.71 Aligned_cols=25 Identities=16% Similarity=0.375 Sum_probs=12.7
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
++..|..+|. ++|.|+.+||..++.
T Consensus 44 l~~~F~~~D~d~~G~i~~~el~~~l~ 69 (109)
T 3fs7_A 44 IKKVFGILDQDKSGFIEEEELQLFLK 69 (109)
T ss_dssp HHHHHHHHSTTCSSSBCHHHHHTTGG
T ss_pred HHHHHHHHCCCCCCeEeHHHHHHHHH
Confidence 4445555555 455555555554443
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=81.69 E-value=1.1 Score=33.86 Aligned_cols=32 Identities=13% Similarity=0.002 Sum_probs=25.5
Q ss_pred HHHHHHHHHHhhhcCC--C-CCeecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLEP--K-DGCVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d~--~-~g~~~~~el~~~~~~ 460 (461)
+..+..|++.|..+|. + +|.|+.+||+.++..
T Consensus 6 e~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~ 40 (93)
T 4eto_A 6 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTR 40 (93)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCeECHHHHHHHHHH
Confidence 3456778999999984 3 379999999999863
|
| >1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A | Back alignment and structure |
|---|
Probab=81.47 E-value=1.2 Score=33.29 Aligned_cols=25 Identities=24% Similarity=0.396 Sum_probs=16.7
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
+...|..+|. ++|.|+.+||...+.
T Consensus 51 ~~~l~~~~D~d~dG~I~~~EF~~~~~ 76 (93)
T 1xk4_A 51 ADVWFKELDINTDGAVNFQEFLILVI 76 (93)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 4556666777 677777777776654
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=81.40 E-value=1.2 Score=44.31 Aligned_cols=22 Identities=9% Similarity=0.265 Sum_probs=10.9
Q ss_pred HHhhhcCC-CCCeecHHHHHHHH
Q 012518 437 AQFMLLEP-KDGCVSLNNFKVVS 458 (461)
Q Consensus 437 ~~f~~~d~-~~g~~~~~el~~~~ 458 (461)
.+|..+|. ++|.|+.+||...+
T Consensus 352 ~Lf~~~D~DgdG~IsfeEFl~ll 374 (450)
T 3sg6_A 352 DMINEVDADGNGTIDFPEFLTMM 374 (450)
T ss_dssp HHHHTTCTTSSSSEEHHHHHHHH
T ss_pred HHHHHhccCCCCcccHHHHHHHH
Confidence 34444455 45555555555444
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.55 E-value=1.3 Score=34.48 Aligned_cols=32 Identities=16% Similarity=0.046 Sum_probs=25.6
Q ss_pred HHHHHHHHHHhhhcCC--CC-CeecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLEP--KD-GCVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d~--~~-g~~~~~el~~~~~~ 460 (461)
+..+..|++.|..+|. ++ |.|+.+||+.+|..
T Consensus 9 e~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~ 43 (104)
T 3zwh_A 9 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTR 43 (104)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHH
Confidence 3456788999999984 43 79999999999863
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.37 E-value=0.66 Score=40.19 Aligned_cols=32 Identities=13% Similarity=0.067 Sum_probs=16.6
Q ss_pred HHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.+++..+++.|..+|. ++|.|+.+||..++..
T Consensus 33 ~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~ 65 (204)
T 3e3r_A 33 ASGIQGLARFFRQLDRDGSRSLDADEFRQGLAK 65 (204)
T ss_dssp -------CHHHHHHCTTCCSSBCHHHHHHHHHT
T ss_pred chhHHHHHHHHHHHccCCCCCcCHHHHHHHHHH
Confidence 3455566666666666 6677777776666653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 461 | ||||
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-83 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-82 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-81 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-80 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-80 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-77 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-77 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-75 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-74 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-73 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-72 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-71 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-70 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-69 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-68 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-67 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-67 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-66 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-66 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-65 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-63 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-62 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-60 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-60 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-60 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-60 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-58 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-58 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-58 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-57 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-57 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-55 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-55 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-54 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-52 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-51 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-50 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-49 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-42 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-39 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 6e-05 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 7e-04 |
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 258 bits (659), Expect = 4e-83
Identities = 93/276 (33%), Positives = 145/276 (52%), Gaps = 9/276 (3%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+++ +E+G G FG K G+V K I+ V+ E+ I+ L
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYPLDK---YTVKNEISIMNQL 83
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H +I HDAFED + +++EF GGEL DRI + + E + + + +
Sbjct: 84 H-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH 305
H +VH D+KPEN + T++ + +K+IDFGL+ + PD+ + +A + APE++
Sbjct: 143 MHEHSIVHLDIKPENIMCETKK-ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 201
Query: 306 RS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
R DMW+IGV+ Y+LL G PF + ++V R D F + + SVSPEAKD
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261
Query: 365 FVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDI 400
F++ LL K+ RKR+T AL HPWL ++ + I
Sbjct: 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 256 bits (655), Expect = 2e-82
Identities = 97/297 (32%), Positives = 145/297 (48%), Gaps = 9/297 (3%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+++ +E+G G FG + G A K + + E VR+E++ + L
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHESD---KETVRKEIQTMSVL 80
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H ++ HDAFED N + ++ EF GGEL +++ + E++A + ++ +
Sbjct: 81 R-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH 305
H VH DLKPEN +FTT + LK+IDFGL+ + P Q + G+A + APEV
Sbjct: 140 MHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198
Query: 306 -RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
+ DMWS+GV++YILL G PF + R+V D N DS + +S + KD
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258
Query: 365 FVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALK 421
F+R+LL D RMT QAL HPWL N P + + K A
Sbjct: 259 FIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWP 315
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 251 bits (642), Expect = 4e-81
Identities = 104/301 (34%), Positives = 163/301 (54%), Gaps = 9/301 (2%)
Query: 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREV 179
++ ++ +G G F A+ K+ K+VA+K I+K + + E+
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRT---QKLVAIKCIAKKALEGKE--GSMENEI 58
Query: 180 KILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKI 239
+L + H +++ D +E +Y++M+ GGEL DRI+ +G Y E DA ++ ++
Sbjct: 59 AVLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQV 116
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV 299
L+ V + H G+VHRDLKPEN L+ + +ED+ + + DFGLS P L+ G+ YV
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 176
Query: 300 APEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358
APEVL + Y+ D WSIGVI YILLCG PF+ ++ +F +L+A+ F W +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH-DENRPVPLDILIYKLVKSYLRATPLKR 417
S AKDF+R L+ KD KR T QAL HPW+ D + + + +K + K+
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQ 296
Query: 418 A 418
A
Sbjct: 297 A 297
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 248 bits (634), Expect = 2e-80
Identities = 93/280 (33%), Positives = 137/280 (48%), Gaps = 20/280 (7%)
Query: 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALA------IEDVR 176
F +E + +GRG K K AVKII S A E
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELREATL 57
Query: 177 REVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIV 236
+EV IL+ +SGH ++I+ D +E ++V + + GEL D + + E++ + I+
Sbjct: 58 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 116
Query: 237 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA 296
+L ++ H +VHRDLKPEN L +D +K+ DFG S + P ++L ++ G+
Sbjct: 117 RALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTP 173
Query: 297 YYVAPEVL-------HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN 349
Y+APE++ H Y E DMWS GVI Y LL GS PFW R + + R ++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 350 FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
F W S KD V R L +KR TA +AL HP+
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 3e-80
Identities = 86/307 (28%), Positives = 149/307 (48%), Gaps = 12/307 (3%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
K K+ + +++GRG FG K K + L V++E+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSS---KKTYMAKFVKVKGTDQVL----VKKEIS 53
Query: 181 ILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKIL 240
IL H++++ H++FE + ++ EF G ++ +RI + E + + V ++
Sbjct: 54 ILNIAR-HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 241 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVA 300
+ F H + H D++PEN ++ TR + +K+I+FG + ++P + + Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 301 PEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359
PEV H + DMWS+G + Y+LL G PF A T I +++ A+ F + + +S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAA 419
EA DFV RLL K+ + RMTA++AL HPWL + V ++ + +K L +
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI--RTLKHRRYYHTLIKKD 289
Query: 420 LKALSKA 426
L + A
Sbjct: 290 LNMVVSA 296
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (614), Expect = 1e-77
Identities = 82/265 (30%), Positives = 144/265 (54%), Gaps = 14/265 (5%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
FE+G+ +G+G FG+ A+ K+ ++A+K++ KA++ A +RREV+I L
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQS---KFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H ++++ + F DA VY+++E+ G + R L + ++ E+ T + ++ N +++
Sbjct: 64 R-HPNILRLYGYFHDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSY 121
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL- 304
CH + V+HRD+KPEN L LK+ DFG S P R + G+ Y+ PE++
Sbjct: 122 CHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIE 177
Query: 305 HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
R ++ + D+WS+GV+ Y L G PF A T ++ + R + F V+ A+D
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARD 233
Query: 365 FVRRLLNKDHRKRMTAAQALTHPWL 389
+ RLL + +R + L HPW+
Sbjct: 234 LISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (612), Expect = 6e-77
Identities = 80/279 (28%), Positives = 138/279 (49%), Gaps = 19/279 (6%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+E+ E+G G FG A+ K+ + A K+I +ED E+ IL +
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKET---SVLAAAKVIDTKSEEE---LEDYMVEIDILASCD 67
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H +++K DAF N+++I++EFC GG + +L E + + ++ L+ + +
Sbjct: 68 -HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH 305
H ++HRDLK N LFT D +K+ DFG+S R QR + +G+ Y++APEV+
Sbjct: 127 HDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 306 ------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359
R Y+ + D+WS+G+ + P + + +++P P S
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWS 242
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWL-HDENRPVP 397
KDF+++ L K+ R T +Q L HP++ D N+P+
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 281
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 2e-75
Identities = 102/283 (36%), Positives = 154/283 (54%), Gaps = 10/283 (3%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA---LAIEDVRR 177
+N ++ G+E+G G F + K G A K I K + S+ ++ ED+ R
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 178 EVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE 237
EV ILK + H ++I H+ +E+ V +++E GGEL D + + EE+A ++
Sbjct: 63 EVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLK 120
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP-LKVIDFGLSDFVRPDQRLNDIVGSA 296
+ILN V + H + H DLKPEN + R P +K+IDFGL+ + +I G+
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 180
Query: 297 YYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355
+VAPE++ + +E DMWSIGVITYILL G+ PF T+ +V + F D +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPL 398
+ S AKDF+RRLL KD +KRMT +L HPW+ ++ L
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 283
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 232 bits (594), Expect = 6e-74
Identities = 76/309 (24%), Positives = 136/309 (44%), Gaps = 20/309 (6%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
F +E+G G FG A+ + +VVA+K +S + S +D+ +EV+ L+ L
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRN---SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H + I++ + ++ ++VME+C G D + E + + L +A+
Sbjct: 73 R-HPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL- 304
H ++HRD+K N L + E +K+ DFG + + P N VG+ Y++APEV+
Sbjct: 131 LHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVIL 184
Query: 305 ---HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361
Y+ + D+WS+G+ L P + + + + S
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHWSEY 242
Query: 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALK 421
++FV L K + R T+ L H ++ E P + LI + K +R L +
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI-QRTKDAVRE--LDNLQYR 299
Query: 422 ALSKALTEE 430
+ K L +E
Sbjct: 300 KMKKILFQE 308
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 1e-73
Identities = 93/321 (28%), Positives = 148/321 (46%), Gaps = 22/321 (6%)
Query: 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH 188
+ +G G G K+ + A+K++ RREV++ S
Sbjct: 16 TSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDCPK--------ARREVELHWRASQC 64
Query: 189 KHMIKFHDAFEDA----NSVYIVMEFCEGGELLDRILSRGGRYL-EEDAKTIVEKILNIV 243
H+++ D +E+ + IVME +GGEL RI RG + E +A I++ I +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV 303
+ H + HRD+KPEN L+T++ +A LK+ DFG + L + YYVAPEV
Sbjct: 125 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 184
Query: 304 L-HRSYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIFRSVLRADPNFHDSPWPSV 358
L Y+ DMWS+GVI YILLCG PF++ G+ + F + W V
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVK-SYLRATPLKR 417
S E K +R LL + +RMT + + HPW+ + + +++K R +K
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKE 304
Query: 418 AALKALSKALTEEELVYLRAQ 438
AL+ + E + ++
Sbjct: 305 EMTSALATMRVDYEQIKIKKI 325
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 1e-72
Identities = 81/276 (29%), Positives = 135/276 (48%), Gaps = 22/276 (7%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
F+ GK +G G F A+ + A+KI+ K + + V RE ++ L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERDVMSRL 65
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H +K + F+D +Y + + + GELL I + G + E + +I++ + +
Sbjct: 66 D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEY 123
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPE 302
H +G++HRDLKPEN L ED +++ DFG + + P+ R N VG+A YV+PE
Sbjct: 124 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 303 VL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361
+L +S D+W++G I Y L+ G PF A E IF+ +++ + +F P+
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPK 236
Query: 362 AKDFVRRLLNKDHRKRMTAAQA------LTHPWLHD 391
A+D V +LL D KR+ + HP+
Sbjct: 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 3e-71
Identities = 79/277 (28%), Positives = 136/277 (49%), Gaps = 19/277 (6%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
++L + +G G +G A + + VAVKI+ + E++++E+ I K L
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVT---EEAVAVKIVDMKRAVDCP--ENIKKEICINKML 60
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
+ H++++KF+ + N Y+ +E+C GGEL DRI E DA+ +++ V +
Sbjct: 61 N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPE 302
H G+ HRD+KPEN L E LK+ DFGL+ R + R LN + G+ YVAPE
Sbjct: 119 LHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 303 VLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360
+L R + D+WS G++ +L G P+ ++S S + + + PW +
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKKIDS 234
Query: 361 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397
+ ++L ++ R+T W N+P+
Sbjct: 235 APLALLHKILVENPSARITIPDIKKDRWY---NKPLK 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 6e-70
Identities = 65/279 (23%), Positives = 130/279 (46%), Gaps = 15/279 (5%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
K+ +++G+G G A G+ VA++ ++ + E + E+ +++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPKK---ELIINEILVMREN 74
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
+ +++ + D++ + +++VME+ GG L D + E + + L + F
Sbjct: 75 K-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEF 131
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVL 304
H V+HRD+K +N L D +K+ DFG + P+Q + + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 305 -HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363
++Y + D+WS+G++ ++ G P+ + + +S +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIFR 247
Query: 364 DFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 402
DF+ R L+ D KR +A + L H +L L LI
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 4e-69
Identities = 59/275 (21%), Positives = 114/275 (41%), Gaps = 18/275 (6%)
Query: 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI 181
N G + E+GRG F + VA + K+T + + + E ++
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKS-ERQRFKEEAEM 61
Query: 182 LKALSGHKHMIKFHDAFEDA----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE 237
LK L H ++++F+D++E + +V E G L L R + ++
Sbjct: 62 LKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSG-TLKTYLKRFKVMKIKVLRSWCR 119
Query: 238 KILNIVAFCHLQG--VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS 295
+IL + F H + ++HRDLK +N T +K+ D GL+ R ++G+
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRASF-AKAVIGT 176
Query: 296 AYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFW-ARTESGIFRSVLRADPNFHDSP 354
++APE+ Y+ D+++ G+ + P+ + + I+R V S
Sbjct: 177 PEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVKPASF 234
Query: 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
PE K+ + + ++ +R + L H +
Sbjct: 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 9e-68
Identities = 76/270 (28%), Positives = 128/270 (47%), Gaps = 14/270 (5%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F L K +G+G FG A+ KK + A+K + K + +E E ++L
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H + F+ +++ VME+ GG+L+ I ++ A +I+ + F
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFL 119
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL- 304
H +G+V+RDLK +N L +D +K+ DFG+ + + D + N G+ Y+APE+L
Sbjct: 120 HSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 176
Query: 305 HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
+ YN D WS GV+ Y +L G PF + E +F S+ +P + + EAKD
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKD 232
Query: 365 FVRRLLNKDHRKRMTAAQA-LTHPWLHDEN 393
+ +L ++ KR+ HP + N
Sbjct: 233 LLVKLFVREPEKRLGVRGDIRQHPLFREIN 262
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-67
Identities = 74/276 (26%), Positives = 127/276 (46%), Gaps = 23/276 (8%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+E+ +G G +G + K GK++ K + MT A + + EV +L+ L
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEA-EKQMLVSEVNLLREL 60
Query: 186 SGHKHMIKFHDAFEDA--NSVYIVMEFCEGGELLDRI---LSRGGRYLEEDAKTIVEKIL 240
H ++++++D D ++YIVME+CEGG+L I EE ++ ++
Sbjct: 61 K-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 241 NIVAFCHLQG-----VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVG 294
+ CH + V+HRDLKP N +K+ DFGL+ + D VG
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKAFVG 176
Query: 295 SAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 353
+ YY++PE ++R SYN + D+WS+G + Y L PF A ++ + +
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--- 233
Query: 354 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
S E + + R+LN R + + L +P +
Sbjct: 234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 6e-67
Identities = 72/310 (23%), Positives = 124/310 (40%), Gaps = 53/310 (17%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
FE E+G G+ G K G V+A K+I + + RE+++L
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLEIKPAIR--NQIIRELQVLHEC 61
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
+ +++ F+ AF + I ME +GG L D++L + GR E+ + ++ + +
Sbjct: 62 N-SPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 246 CH-LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL 304
++HRD+KP N L +R E +K+ DFG+S + D N VG+ Y++PE L
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERL 175
Query: 305 H-RSYNVEGDMWSIGVITYILLCGSRPFWARTES---GIFRSVLRADPNFHDS------- 353
Y+V+ D+WS+G+ + G P +F + D
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 354 ------------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQA 383
P S E +DFV + L K+ +R Q
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 384 LTHPWLHDEN 393
+ H ++ +
Sbjct: 296 MVHAFIKRSD 305
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 213 bits (542), Expect = 1e-66
Identities = 63/279 (22%), Positives = 115/279 (41%), Gaps = 11/279 (3%)
Query: 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVK 180
+ ++ELG+ +G G A+ + + VAVK++ RRE +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 181 ILKALSGHKHMIKFHDAFEDANS----VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIV 236
AL+ H ++ +D E YIVME+ +G L D I+ G + A ++
Sbjct: 60 NAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVI 117
Query: 237 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG-LSDFVRPDQRLNDIVGS 295
+ F H G++HRD+KP N + + + ++D + ++G+
Sbjct: 118 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 296 AYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP 354
A Y++PE S + D++S+G + Y +L G PF + + +R DP +
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393
+S + V + L K+ R A + + N
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 3e-66
Identities = 78/279 (27%), Positives = 125/279 (44%), Gaps = 22/279 (7%)
Query: 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIED---VRREV 179
+++++G +G G FG VA+K + K +++ + + V EV
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSD---NLPVAIKHVEKDRISDWGELPNGTRVPMEV 58
Query: 180 KILKALS-GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEK 238
+LK +S G +I+ D FE +S +++E E + L ++ G EE A++ +
Sbjct: 59 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 298
+L V CH GV+HRD+K EN L LK+IDFG + D D G+ Y
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL-KDTVYTDFDGTRVY 175
Query: 299 VAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356
PE + HR + +WS+G++ Y ++CG PF E ++R F
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFF----RQ 225
Query: 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395
VS E + +R L R T + HPW+ D P
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 212 bits (540), Expect = 3e-65
Identities = 67/276 (24%), Positives = 119/276 (43%), Gaps = 18/276 (6%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F + + +GRG FG + GK+ A+K + K ++ E +L +S
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 187 --GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA 244
++ AF + + +++ GG+L LS+ G + E D + +I+ +
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL 304
H + VV+RDLKP N L E +++ D GL+ ++ + VG+ Y+APEVL
Sbjct: 122 HMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVL 177
Query: 305 HR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362
+ +Y+ D +S+G + + LL G PF + R S SPE
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPEL 236
Query: 363 KDFVRRLLNKDHRKRMT-----AAQALTHPWLHDEN 393
+ + LL +D +R+ A + P+ +
Sbjct: 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-63
Identities = 62/281 (22%), Positives = 114/281 (40%), Gaps = 23/281 (8%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ +G+ +G G FG KG G V AVK+++ T ++ + EV +L+
Sbjct: 9 QITVGQRIGSGSFGTVY-----KGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRKT 61
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H +++ F + A + IV ++CEG L + ++ I + + +
Sbjct: 62 R-HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD---QRLNDIVGSAYYVAPE 302
H + ++HRDLK N ED +K+ DFGL+ + + GS ++APE
Sbjct: 120 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 303 VL----HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP--WP 356
V+ Y+ + D+++ G++ Y L+ G P+ ++ D
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397
+ K + L K +R Q L + R +P
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILAS--IELLARSLP 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 203 bits (517), Expect = 2e-62
Identities = 71/273 (26%), Positives = 132/273 (48%), Gaps = 20/273 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
F++ + +G G FG + + G+ A+K++ K + +E E +L ++
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H +I+ F+DA ++++M++ EGGEL +L + R+ AK ++ + +
Sbjct: 63 -HPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-H 305
H + +++RDLKPEN L ++ +K+ DFG + +V + G+ Y+APEV+
Sbjct: 121 HSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVST 175
Query: 306 RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 365
+ YN D WS G++ Y +L G PF+ + +L A+ F P + + KD
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDL 231
Query: 366 VRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393
+ RL+ +D +R+ HPW +
Sbjct: 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-60
Identities = 77/275 (28%), Positives = 132/275 (48%), Gaps = 19/275 (6%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
F+ K +G+G FG + K G+ A+KI+ K + + + E ++L+
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H + AF+ + + VME+ GGEL + SR + EE A+ +I++ + +
Sbjct: 63 R-HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEY 120
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVL 304
H + VV+RD+K EN + +D +K+ DFGL + G+ Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 305 HRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363
+ Y D W +GV+ Y ++CG PF+ + +F +L + F ++SPEAK
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAK 233
Query: 364 DFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393
+ LL KD ++R+ A + + H + N
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 5e-60
Identities = 78/279 (27%), Positives = 133/279 (47%), Gaps = 15/279 (5%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS-ALAIEDVRREVKILKA 184
FEL K +G G +G + G GK+ A+K++ KA + A E R E ++L+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVA 244
+ ++ H AF+ +++++++ GGEL LS+ R+ E + + V +I+ +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP--DQRLNDIVGSAYYVAPE 302
H G+++RD+K EN L + + + DFGLS +R D G+ Y+AP+
Sbjct: 144 HLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 303 VL---HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359
++ ++ D WS+GV+ Y LL G+ PF E + R +S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 360 PEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393
AKD ++RLL KD +KR+ A + H + N
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 197 bits (501), Expect = 5e-60
Identities = 81/304 (26%), Positives = 135/304 (44%), Gaps = 53/304 (17%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
++L +++GRG + A + V VKI+ K + ++RE+KIL+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKK------KKIKREIKILENL 86
Query: 186 SGHKHMIKFHDAFEDANS--VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
G ++I D +D S +V E + + D + + +IL +
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKAL 142
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV 303
+CH G++HRD+KP N + E L++ID+GL++F P Q N V S Y+ PE+
Sbjct: 143 DYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200
Query: 304 L--HRSYNVEGDMWSIGVITYILLCGSRPFWA------------------RTESGIFRSV 343
L ++ Y+ DMWS+G + ++ PF+ I +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 344 LRADPNFHDS----------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387
+ DP F+D VSPEA DF+ +LL DH+ R+TA +A+ HP
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320
Query: 388 WLHD 391
+ +
Sbjct: 321 YFYT 324
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 9e-60
Identities = 71/297 (23%), Positives = 119/297 (40%), Gaps = 37/297 (12%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
++E E+G G +G A+ K G+ VA+K + + REV +L+ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNG--GRFVALKRVRVQTGEEGMP-LSTIREVAVLRHL 64
Query: 186 SG--HKHMIKFHDAFEDA-----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEK 238
H ++++ D + + +V E + E K ++ +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 298
+L + F H VVHRDLKP+N L T+ + K+ DFGL+ L +V + +Y
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQI---KLADFGLARIYSFQMALTSVVVTLWY 181
Query: 299 VAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP- 356
APEVL +S Y D+WS+G I + F ++ +L + WP
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 357 ----------------------SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391
+ KD + + L + KR++A AL+HP+ D
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 1e-58
Identities = 76/318 (23%), Positives = 131/318 (41%), Gaps = 54/318 (16%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
K+E ++G+G FG A+ +K G+ VA+K + I RE+KIL+ L
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPIT-ALREIKILQLL 66
Query: 186 SGHKHMIKFHDAFEDA--------NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE 237
H++++ + S+Y+V +FCE L + + ++ + K +++
Sbjct: 67 K-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQ 124
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-----RLNDI 292
+LN + + H ++HRD+K N L T D LK+ DFGL+ + R +
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 293 VGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 350
V + +Y PE+L R Y D+W G I + S TE + + +
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 351 HDSPWPSV----------------------------SPEAKDFVRRLLNKDHRKRMTAAQ 382
WP+V P A D + +LL D +R+ +
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 383 ALTHPWLHDENRPVPLDI 400
AL H + + P+P D+
Sbjct: 302 ALNHDFFWSD--PMPSDL 317
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-58
Identities = 74/299 (24%), Positives = 118/299 (39%), Gaps = 37/299 (12%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA--LAIEDVRREVKILKAL 185
E +G G F A+ K ++VA+K I + A RE+K+L+ L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNT---NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
S H ++I DAF +++ +V +F E + I K + L + +
Sbjct: 58 S-HPNIIGLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL 304
H ++HRDLKP N L E+ LK+ DFGL+ F P++ V + +Y APE+L
Sbjct: 116 LHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 172
Query: 305 --HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP------ 356
R Y V DMW++G I LL ++ + + WP
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 357 ------------------SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397
+ + D ++ L + R+TA QAL + + P P
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 190 bits (483), Expect = 7e-58
Identities = 74/294 (25%), Positives = 129/294 (43%), Gaps = 38/294 (12%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
K+ +++G G +G A+ G + A+K I K + RE+ ILK L
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYG----ETFALKKIRLEKEDEGI-PSTTIREISILKEL 57
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H +++K +D + +V E + +L + G AK+ + ++LN +A+
Sbjct: 58 K-HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVL 304
CH + V+HRDLKP+N L + LK+ DFGL+ P ++ + + +Y AP+VL
Sbjct: 116 CHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 305 HRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP------ 356
S Y+ D+WS+G I ++ G+ F +E+ + R + WP
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 357 -------------------SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391
+ D + ++L D +R+TA QAL H + +
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 9e-58
Identities = 59/265 (22%), Positives = 102/265 (38%), Gaps = 23/265 (8%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ +L + +G+G FG G +G VAVK I + E ++ L
Sbjct: 8 ELKLLQTIGKGEFGDVM-----LGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQL 57
Query: 186 SGHKHMIKFHDAF-EDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIV 243
H ++++ E+ +YIV E+ G L+D + SRG L D + +
Sbjct: 58 R-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV 303
+ VHRDL N L + ED KV DFGL+ Q + + APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEA 171
Query: 304 L-HRSYNVEGDMWSIGVITYILL-CGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361
L + ++ + D+WS G++ + + G P+ + V + + P
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPA 228
Query: 362 AKDFVRRLLNKDHRKRMTAAQALTH 386
+ ++ + D R + Q
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-57
Identities = 74/316 (23%), Positives = 121/316 (38%), Gaps = 48/316 (15%)
Query: 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI 181
+ G ++ +G G +G C A VA+K IS + + + RE+KI
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVN---KVRVAIKKISPFEHQTY--CQRTLREIKI 59
Query: 182 LKALSGHKHMIKFHDAFEDANSV----YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVE 237
L H+++I +D ++ G +L + + + +
Sbjct: 60 LLRFR-HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLY 116
Query: 238 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ----RLNDIV 293
+IL + + H V+HRDLKP N L LK+ DFGL+ PD L + V
Sbjct: 117 QILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYV 173
Query: 294 GSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA----- 346
+ +Y APE++ S Y D+WS+G I +L F + +L
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233
Query: 347 ------------------DPNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384
P+ + PW P+ +A D + ++L + KR+ QAL
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
Query: 385 THPWLHDENRPVPLDI 400
HP+L P I
Sbjct: 294 AHPYLEQYYDPSDEPI 309
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-57
Identities = 55/264 (20%), Positives = 100/264 (37%), Gaps = 13/264 (4%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
L +++G G FG + + K VAVK + ++ A++D REV + +L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H+++I+ + + +V E G LLDR+ G +L ++ + +
Sbjct: 70 -HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPE 302
+ +HRDL N L TR+ +K+ DFGL + + + APE
Sbjct: 128 ESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 303 VL-HRSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360
L R+++ D W GV + + G P+ S I + +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--PRPEDCPQ 242
Query: 361 EAKDFVRRLLNKDHRKRMTAAQAL 384
+ + + + R T
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 5e-57
Identities = 78/300 (26%), Positives = 129/300 (43%), Gaps = 36/300 (12%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
F+ +++G G +G A+ K G+VVA+K I T + RE+ +LK L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGV-PSTAIREISLLKEL 58
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
+ H +++K D N +Y+V EF S K+ + ++L +AF
Sbjct: 59 N-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVL 304
CH V+HRDLKP+N L + +K+ DFGL+ P + V + +Y APE+L
Sbjct: 118 CHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 305 HRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS----- 357
Y+ D+WS+G I ++ F +E + R + WP
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 358 --------------------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397
+ + + + ++L+ D KR++A AL HP+ D +PVP
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-56
Identities = 67/313 (21%), Positives = 117/313 (37%), Gaps = 48/313 (15%)
Query: 118 GYGKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRR 177
G + + K +G G FG AK G++VA+K + + K R
Sbjct: 13 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDK-------RFKNR 62
Query: 178 EVKILKALSGHKHMIKFHDAFEDANS------VYIVMEFCEGG--ELLDRILSRGGRYLE 229
E++I++ L H ++++ F + + +V+++ +
Sbjct: 63 ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 230 EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL 289
K + ++ +A+ H G+ HRD+KP+N L + A LK+ DFG + + +
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPN 179
Query: 290 NDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 347
+ S YY APE++ + Y D+WS G + LL G F + +++
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
Query: 348 --------------------PNFHDSPW-----PSVSPEAKDFVRRLLNKDHRKRMTAAQ 382
P PW P PEA RLL R+T +
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299
Query: 383 ALTHPWLHDENRP 395
A H + + P
Sbjct: 300 ACAHSFFDELRDP 312
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-55
Identities = 64/290 (22%), Positives = 115/290 (39%), Gaps = 36/290 (12%)
Query: 126 KFELGKEVGRGHFGHTCCA--KGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
E GK +G G FG A G T VAVK++ + +S E + E+K++
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER--EALMSELKMMT 95
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLE-------------- 229
L H++++ A + +Y++ E+C G+LL+ + S+ ++ E
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 230 --------EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281
ED ++ + F + VHRDL N L T +K+ DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLAR 212
Query: 282 FVRPDQRL---NDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITY-ILLCGSRPFWARTE 336
+ D + ++APE L Y ++ D+WS G++ + I G P+
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 337 SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386
F +++ + + E ++ D RKR + +
Sbjct: 273 DANFYKLIQNGFKMDQPFY--ATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-55
Identities = 55/264 (20%), Positives = 108/264 (40%), Gaps = 19/264 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
KE+G G FG K + VA+K+I + M+ ++ E K++ LS
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQ----YDVAIKMIKEGSMSE----DEFIEEAKVMMNLS 57
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H+ +++ + ++I+ E+ G LL+ + R+ + + + + + +
Sbjct: 58 -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVL 304
+ +HRDL N L + +KV DFGLS +V D+ + PEVL
Sbjct: 117 ESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 305 -HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362
+ ++ + D+W+ GV+ + I G P+ T S + + S +
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---GLRLYRPHLASEKV 230
Query: 363 KDFVRRLLNKDHRKRMTAAQALTH 386
+ ++ +R T L++
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSN 254
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (470), Expect = 3e-55
Identities = 80/274 (29%), Positives = 129/274 (47%), Gaps = 20/274 (7%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+F+ K +G G FG K K+ G A+KI+ K K+ IE E +IL+A+
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
+ ++K +F+D +++Y+VME+ GGE+ L R GR+ E A+ +I+ +
Sbjct: 99 N-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS-HLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL- 304
H +++RDLKPEN L ++V DFG + R R + G+ +APE++
Sbjct: 157 LHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIIL 211
Query: 305 HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
+ YN D W++GV+ Y + G PF+A I+ ++ F S + KD
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKD 267
Query: 365 FVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 393
+R LL D KR H W +
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 5e-55
Identities = 58/264 (21%), Positives = 104/264 (39%), Gaps = 19/264 (7%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+E+G G FG VA+K I + M+ ED E +++ LS
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREGAMSE----EDFIEEAEVMMKLS 58
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H +++ + + + +V EF E G L D + ++ G + E + + +A+
Sbjct: 59 -HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND--IVGSAYYVAPEVL 304
V+HRDL N L E+ +KV DFG++ FV DQ + + +PEV
Sbjct: 118 EEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 305 -HRSYNVEGDMWSIGVITYILLCGSRPFW-ARTESGIFRSVLRADPNFHDSPWPSVSPEA 362
Y+ + D+WS GV+ + + + + R+ S + + F S
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLASTHV 231
Query: 363 KDFVRRLLNKDHRKRMTAAQALTH 386
+ + R ++ L
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 7e-54
Identities = 70/306 (22%), Positives = 125/306 (40%), Gaps = 42/306 (13%)
Query: 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI 181
A + + VG G +G C A + G VA+K + + S L + RE+++
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQ-SELFAKRAYRELRL 70
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRI---LSRGGRYLEEDAKTIVEK 238
LK + H+++I D F ++ +F + L + + E+ + +V +
Sbjct: 71 LKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 129
Query: 239 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 298
+L + + H G++HRDLKP N ED LK++DFGL+ D + V + +Y
Sbjct: 130 MLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ--ADSEMTGYVVTRWY 184
Query: 299 VAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW- 355
APEV+ Y D+WS+G I ++ G F + +++
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 356 --------------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389
+ SP A + + ++L D +R+TA +AL HP+
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304
Query: 390 HDENRP 395
+
Sbjct: 305 ESLHDT 310
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 4e-53
Identities = 77/299 (25%), Positives = 130/299 (43%), Gaps = 38/299 (12%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
K+E +++G G +G AK ++ ++VA+K + + RE+ +LK L
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRVRLDDDDEGV-PSSALREICLLKEL 58
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
HK++++ HD + +V EFC+ G E K+ + ++L + F
Sbjct: 59 K-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD-PEIVKSFLFQLLKGLGF 116
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL 304
CH + V+HRDLKP+N L E K+ +FGL+ F P + + V + +Y P+VL
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 305 HRS--YNVEGDMWSIGVITYILLCGSRP-FWARTESGIFRSVLRADPNFHDSPWPS---- 357
+ Y+ DMWS G I L RP F + + R + WPS
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 358 ---------------------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395
++ +D ++ LL + +R++A +AL HP+ D P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 5e-53
Identities = 56/265 (21%), Positives = 101/265 (38%), Gaps = 14/265 (5%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ ELG+ +G G FG VA+K S E +E ++
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQEALTMRQF 65
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
H H++K + N V+I+ME C GEL + R ++ +A+
Sbjct: 66 D-HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEV 303
+ VHRD+ N L ++ + +K+ DFGLS ++ + + ++APE
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 304 L-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361
+ R + D+W GV + IL+ G +PF + + + + P+ P
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPNCPPT 237
Query: 362 AKDFVRRLLNKDHRKRMTAAQALTH 386
+ + D +R +
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (451), Expect = 5e-53
Identities = 57/268 (21%), Positives = 97/268 (36%), Gaps = 17/268 (6%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
++ + +G G FG C K + VA+K + D E I+
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASIMGQFD 85
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H ++I + V I+ EF E G L + G++ ++ I + +
Sbjct: 86 -HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND------IVGSAYYVA 300
VHRDL N L + KV DFGLS F+ D + A
Sbjct: 145 ADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 301 PEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358
PE + +R + D+WS G++ + ++ G RP+W T + ++ + ++ P
Sbjct: 202 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDC 258
Query: 359 SPEAKDFVRRLLNKDHRKRMTAAQALTH 386
+ KD R Q +
Sbjct: 259 PSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-52
Identities = 60/294 (20%), Positives = 108/294 (36%), Gaps = 28/294 (9%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS 186
+ +G G+FG A+ KK G + I + S D E+++L L
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRIL---------------SRGGRYLEED 231
H ++I A E +Y+ +E+ G LLD + S +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 232 AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND 291
+ + + + +HRDL N L E+ K+ DFGLS +
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTM 185
Query: 292 IVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILL-CGSRPFWARTESGIFRSVLRADPN 349
++A E L+ S Y D+WS GV+ + ++ G P+ T + ++ + +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---G 242
Query: 350 FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH--PWLHDENRPVPLDIL 401
+ + E D +R+ + +R + AQ L L + V +
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-52
Identities = 51/267 (19%), Positives = 99/267 (37%), Gaps = 20/267 (7%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
E+G G+FG + K VA+K++ + + E++ RE +I+ L + +
Sbjct: 15 IELGCGNFGSVRQGV-YRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLD-NPY 70
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+++ + ++ +VME GG L ++ + + ++ ++ + + +
Sbjct: 71 IVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 129
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND----IVGSAYYVAPEVL-H 305
VHRDL N L K+ DFGLS + D + APE +
Sbjct: 130 FVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186
Query: 306 RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
R ++ D+WS GV + L G +P+ + + + P PE
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPPECPPELYA 243
Query: 365 FVRRLLNKDHRKRMTAA---QALTHPW 388
+ R Q + +
Sbjct: 244 LMSDCWIYKWEDRPDFLTVEQRMRACY 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (446), Expect = 3e-52
Identities = 49/281 (17%), Positives = 103/281 (36%), Gaps = 25/281 (8%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
G ++ LG+++G G FG G+ VA+K+ + E KI K
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTK-----HPQLHIESKIYK 57
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
+ G + + + +VME L D ++ + + +++++ +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPS-LEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--------RLNDIVGS 295
+ H + +HRD+KP+NFL ++ + +IDFGL+ R + ++ G+
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 296 AYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP 354
A Y + + D+ S+G + GS P+ + + R +P
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 355 ----WPSVSPEAKDFVRRLLNKDHRKRMTAA---QALTHPW 388
E ++ + + + Q + +
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 5e-52
Identities = 58/267 (21%), Positives = 107/267 (40%), Gaps = 20/267 (7%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKH 190
KE+G G+FG + + K VAVKI+ AL +++ E +++ L + +
Sbjct: 13 KELGSGNFGTVKKGYYQMKKV-VKTVAVKILKNEANDPAL-KDELLAEANVMQQLD-NPY 69
Query: 191 MIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 250
+++ E S +VME E G L ++ L + +++ +V ++ + +
Sbjct: 70 IVRMIGICEA-ESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 251 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND----IVGSAYYVAPEVL-H 305
VHRDL N L K+ DFGLS +R D+ + APE + +
Sbjct: 128 FVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 306 RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364
++ + D+WS GV+ + G +P+ S + + + + E D
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGCPREMYD 241
Query: 365 FVRRLLNKDHRKRMTAAQ---ALTHPW 388
+ D R A L + +
Sbjct: 242 LMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-51
Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 25/272 (9%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLK-GKVVAVKIISKAKMTSALAIEDVRREVKILKA 184
L ++G+G FG GT VA+K + M+ E +E +++K
Sbjct: 18 SLRLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKK 68
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYL-EEDAKTIVEKILNIV 243
L H+ +++ + + +YIV E+ G LLD + G+YL + +I + +
Sbjct: 69 LR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAP 301
A+ VHRDL+ N L E+ KV DFGL+ + ++ + AP
Sbjct: 127 AYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 302 EVL-HRSYNVEGDMWSIGVITYILLCGSRPFW-ARTESGIFRSVLRADPNFHDSPWPSVS 359
E + + ++ D+WS G++ L R + + V R + P
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECP 240
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391
D + + K+ +R T +L D
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYL--QAFLED 270
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 9e-51
Identities = 57/283 (20%), Positives = 103/283 (36%), Gaps = 31/283 (10%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLK--GKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ GK +G G FG A VAVK++ + + E + E+K+L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLS 81
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYL--------------- 228
L H +++ A ++ E+C G+LL+ + + ++
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 229 --EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 286
ED + ++ +AF + +HRDL N L K+ DFGL+ ++ D
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLARDIKND 198
Query: 287 QRL---NDIVGSAYYVAPEVLHRSY-NVEGDMWSIGVITYILLCGSRP-FWARTESGIFR 341
+ ++APE + E D+WS G+ + L + F
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 342 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384
+++ F E D ++ + D KR T Q +
Sbjct: 259 KMIK--EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (435), Expect = 5e-50
Identities = 70/321 (21%), Positives = 125/321 (38%), Gaps = 57/321 (17%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+++ K +G G G C A + VA+K +S+ + RE+ ++K +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQT-HAKRAYRELVLMKCV 73
Query: 186 SGHKHMIKFHDAF------EDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKI 239
+ HK++I + F E+ VY+VME + E ++ ++
Sbjct: 74 N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQM 128
Query: 240 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV 299
L + H G++HRDLKP N + D LK++DFGL+ + V + YY
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 300 APE-VLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA------------ 346
APE +L Y D+WS+G I ++ F R + V+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 347 ----------DPNFHDSPWPS----------------VSPEAKDFVRRLLNKDHRKRMTA 380
P + +P + +A+D + ++L D KR++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 381 AQALTHPWLHDENRPVPLDIL 401
AL HP+++ P ++
Sbjct: 306 DDALQHPYINVWYDPAEVEAP 326
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 9e-50
Identities = 55/272 (20%), Positives = 109/272 (40%), Gaps = 25/272 (9%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLK-GKVVAVKIISKAKMTSALAIEDVRREVKILKA 184
+L + +G G FG G VAVK + + M+ + E ++K
Sbjct: 14 TLKLVERLGAGQFGEVW-----MGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQ 64
Query: 185 LSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEE-DAKTIVEKILNIV 243
L H+ +++ + +YI+ E+ E G L+D + + G L + +I +
Sbjct: 65 LQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 244 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAP 301
AF + +HRDL+ N L + K+ DFGL+ + ++ + AP
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 302 EVL-HRSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359
E + + ++ ++ D+WS G++ ++ G P+ T + +++ R + +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GYRMVRPDNCP 236
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391
E +R + R T + L D
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRS--VLED 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (426), Expect = 2e-49
Identities = 51/263 (19%), Positives = 101/263 (38%), Gaps = 17/263 (6%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
+ ++G G +G KK VAVK + + M +E+ +E ++K +
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKY---SLTVAVKTLKEDTM----EVEEFLKEAAVMKEI 70
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVA 244
H ++++ YI+ EF G LLD + + + + +I + +
Sbjct: 71 K-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 245 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPE 302
+ + +HRDL N L E+ +KV DFGLS + D + APE
Sbjct: 130 YLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 303 VL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361
L + ++++ D+W+ GV+ + + + + +L D +
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM--ERPEGCPEK 244
Query: 362 AKDFVRRLLNKDHRKRMTAAQAL 384
+ +R + R + A+
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIH 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 168 bits (426), Expect = 2e-49
Identities = 49/269 (18%), Positives = 99/269 (36%), Gaps = 24/269 (8%)
Query: 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
G +++G+ +G G FG + VA+K + +R E + K
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSD-----APQLRDEYRTYK 55
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 243
L+G + + ++ +V++ G L D + G ++ + +++L V
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114
Query: 244 AFCHLQGVVHRDLKPENFLFT--TREEDAPLKVIDFGLSDFVRPD--------QRLNDIV 293
H + +V+RD+KP+NFL + + V+DFG+ F R + ++
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 294 GSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESG----IFRSVLRADP 348
G+A Y++ R + D+ ++G + L GS P+ + R +
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 349 NFHDSPWPSVSPEAKDFVRRLLNKDHRKR 377
E ++ N
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 6e-49
Identities = 78/313 (24%), Positives = 131/313 (41%), Gaps = 46/313 (14%)
Query: 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI 181
+++ VG G +G C A K G VAVK +S+ S + + RE+++
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQ-SIIHAKRTYRELRL 70
Query: 182 LKALSGHKHMIKFHDAFEDANSV-----YIVMEFCEGGELLDRILSRGGRYLEEDAKTIV 236
LK + H+++I D F A S+ ++ G +L + + + + ++ + ++
Sbjct: 71 LKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLI 127
Query: 237 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA 296
+IL + + H ++HRDLKP N ED LK++DFGL+ D + V +
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARH--TDDEMTGYVATR 182
Query: 297 YYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP 354
+Y APE++ YN D+WS+G I LL G F + +LR
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 355 W---------------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 387
+P A D + ++L D KR+TAAQAL H
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302
Query: 388 WLHDENRPVPLDI 400
+ + P +
Sbjct: 303 YFAQYHDPDDEPV 315
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 9e-49
Identities = 53/266 (19%), Positives = 104/266 (39%), Gaps = 16/266 (6%)
Query: 127 FELGKEVGRGHFGHTCCAKGKK-GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
F+ K +G G FG G VA+K + +A TS A +++ E ++ ++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASV 68
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
+ H+ + ++V ++ + G LLD + + +I + +
Sbjct: 69 D-NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPE 302
+ +VHRDL N L +K+ DFGL+ + +++ ++A E
Sbjct: 127 LEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 303 VL-HRSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360
+ HR Y + D+WS GV + L+ GS+P+ S I + + P +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPICTI 240
Query: 361 EAKDFVRRLLNKDHRKRMTAAQALTH 386
+ + + D R + +
Sbjct: 241 DVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 1e-48
Identities = 49/289 (16%), Positives = 101/289 (34%), Gaps = 39/289 (13%)
Query: 126 KFELGKEVGRGHFGHTCCA--KGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
E +++G G FG A G +VAVK++ + D +RE ++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMA 71
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYL--------------- 228
+ +++K + ++ E+ G+L + + S +
Sbjct: 72 EFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 229 --------EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280
+ I ++ +A+ + VHRDL N L E+ +K+ DFGLS
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS 187
Query: 281 DFVRPDQRL---NDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSR-PFWART 335
+ + ++ PE + + Y E D+W+ GV+ + + P++
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 336 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384
+ V + + + E + +R +K R +
Sbjct: 248 HEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-48
Identities = 54/280 (19%), Positives = 105/280 (37%), Gaps = 26/280 (9%)
Query: 126 KFELGKEVGRGHFGHTCCAK----GKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKI 181
+ LGK +G G FG A+ K + VAVK++ + D+ E+++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEM 71
Query: 182 LKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYL------------- 228
+K + HK++I A +Y+++E+ G L + + +R L
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 229 --EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 286
+D + ++ + + + +HRDL N L T +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 287 QRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVL 344
++ + ++APE L R Y + D+WS GV+ + I G P+ +F+ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 345 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384
+ + E +R + +R T Q +
Sbjct: 252 E---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-45
Identities = 47/265 (17%), Positives = 95/265 (35%), Gaps = 15/265 (5%)
Query: 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH 188
+ +GRGHFG K AVK +++ + E I+K S H
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFS-H 87
Query: 189 KHMIKFHDA-FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH 247
+++ S +V+ + + G+L + I + +D ++ + F
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 248 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPE 302
+ VHRDL N + E +KV DFGL+ + + ++A E
Sbjct: 148 SKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 303 VLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361
L + + + D+WS GV+ + L+ P + + L +
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY--CPDP 262
Query: 362 AKDFVRRLLNKDHRKRMTAAQALTH 386
+ + + + R + ++ ++
Sbjct: 263 LYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-45
Identities = 54/265 (20%), Positives = 99/265 (37%), Gaps = 16/265 (6%)
Query: 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKV-VAVKIISKAKMTSALAIEDVRREVKILKAL 185
K +G G FG K + K +V VA+K + D E I+
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQF 66
Query: 186 SGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 245
S H ++I+ + I+ E+ E G L + + G + ++ I + +
Sbjct: 67 S-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 246 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAP 301
VHRDL N L + KV DFGLS + D + + AP
Sbjct: 126 LANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 302 EVL-HRSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359
E + +R + D+WS G++ + ++ G RP+W + + +++ + F
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---NDGFRLPTPMDCP 239
Query: 360 PEAKDFVRRLLNKDHRKRMTAAQAL 384
+ + ++ +R A +
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIV 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-44
Identities = 49/290 (16%), Positives = 106/290 (36%), Gaps = 31/290 (10%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
K + +E+G+G FG + AKG VA+K +++A + E ++K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMK 78
Query: 184 ALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYL---------EEDAKT 234
+ H+++ ++ME G+L + S
Sbjct: 79 EFN-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 235 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL---ND 291
+ +I + +A+ + VHRDL N + ED +K+ DFG++ +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 292 IVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSR-PFWARTESGIFRSVLRADPN 349
+ +++PE L + D+WS GV+ + + + P+ + + R V+
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL- 253
Query: 350 FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT------HPWLHDEN 393
+ + +R + + R + + ++ P + +
Sbjct: 254 --LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 2e-42
Identities = 63/284 (22%), Positives = 116/284 (40%), Gaps = 30/284 (10%)
Query: 126 KFELGKEVGRGHFG--HTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK 183
+ +LGK +GRG FG A G T + VAVK++ + S + E+KIL
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILI 71
Query: 184 ALSGHKHMIKFHDA-FEDANSVYIVMEFCEGGELLDRILSRGGRYL-------------- 228
+ H +++ A + + +++EFC+ G L + S+ ++
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 229 -EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ 287
E ++ + F + +HRDL N L + E +K+ DFGL+ + D
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDP 188
Query: 288 ---RLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSR-PFWARTESGIFRS 342
R D ++APE + R Y ++ D+WS GV+ + + P+ F
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 343 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386
L+ + +PE + + + +R T ++ + H
Sbjct: 249 RLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-42
Identities = 56/301 (18%), Positives = 107/301 (35%), Gaps = 57/301 (18%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
L + +G+G FG +G +G+ VAVKI S + S E+ L
Sbjct: 4 TIVLQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWFR----EAEIYQTVML 54
Query: 186 SGHKHMIKFHDAFEDANS----VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILN 241
H++++ F A N +++V ++ E G L D + E + +
Sbjct: 55 R-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTAS 111
Query: 242 IVAFCHLQ--------GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-----R 288
+A H++ + HRDLK +N L ++ + D GL+
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIA 168
Query: 289 LNDIVGSAYYVAPEVL-------HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGI-F 340
N VG+ Y+APEVL H D++++G++ + + + + +
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228
Query: 341 RSVLRADPNFHD-----------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQA 383
++ +DP+ + +R + R+TA +
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
Query: 384 L 384
Sbjct: 289 K 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 143 bits (360), Expect = 3e-39
Identities = 72/344 (20%), Positives = 120/344 (34%), Gaps = 68/344 (19%)
Query: 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKAL 185
++ L +++G GHF AK VA+KI+ K+ + E E+K+L+ +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVN---NTHVAMKIVRGDKVYT----EAAEDEIKLLQRV 66
Query: 186 S----------GHKHMIKFHDAFEDANS----VYIVMEFCEGGELLDRILSRGGRYLEED 231
+ G H++K D F V +V E L
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 232 AKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPL-KVIDFGLSDFVRPDQRL 289
K I +++L + + H + G++H D+KPEN L + L ++ L + D+
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 290 NDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF-------- 340
+ + + Y +PEVL + D+WS + + L+ G F
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 341 -------------------------RSVLRADPNFHDSPWPSV-----------SPEAKD 364
R +LR P V + E D
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 365 FVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKS 408
F+ +L D RKR A + HPWL D + + +L S
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGS 350
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.7 bits (206), Expect = 2e-19
Identities = 45/213 (21%), Positives = 73/213 (34%), Gaps = 41/213 (19%)
Query: 128 ELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT---------------SALAI 172
+GK +G G +K VK + S LAI
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKF----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAI 58
Query: 173 EDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDA 232
R E + L+ L + K + + ++ME + R E+
Sbjct: 59 RSARNEFRALQKLQ-GLAVPKVYAWEGN----AVLMELIDAK--------ELYRVRVENP 105
Query: 233 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLND 291
+++ IL VA + +G+VH DL N L + + + +IDF S + R +
Sbjct: 106 DEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSVEVGEEGWR--E 159
Query: 292 IVGSAYYVAPEVLHRSYNVEGDMWSIGVITYIL 324
I+ R+Y E D+ S I IL
Sbjct: 160 ILERDVRNIITYFSRTYRTEKDINS--AIDRIL 190
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 42.3 bits (98), Expect = 6e-05
Identities = 22/178 (12%), Positives = 54/178 (30%), Gaps = 8/178 (4%)
Query: 150 TLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVME 209
+ + + +K+ + DV RE ++ L G + K ++M
Sbjct: 34 VGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90
Query: 210 FCEGGELLDRIL--SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 267
+G + + +E A+ I ++ C + L ++L
Sbjct: 91 EADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL--NN 148
Query: 268 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYIL 324
+ A + ++ + + L D + + V H G ++ +
Sbjct: 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFI 206
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 39.4 bits (91), Expect = 7e-04
Identities = 24/165 (14%), Positives = 50/165 (30%), Gaps = 8/165 (4%)
Query: 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKI----ISKAKMTSALAIEDVRREVKILKALS 186
+E+G G+ + ++ + + +K + L I+ R E L
Sbjct: 32 QEIGDGNLNYVFHIYDQEH---DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQG 88
Query: 187 GHKHMIKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 246
H + + D VME ++ + L G ++ I E + + +
Sbjct: 89 EHVPHLVPRVFYSDTEMAVTVMEDLSHLKIARKGL-IEGENYPHLSQHIGEFLGKTLFYS 147
Query: 247 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND 291
+ + K FT E + + F F +
Sbjct: 148 SDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDTNDFEE 192
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 461 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.65 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.2 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.05 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.28 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 96.68 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 96.6 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 96.55 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 96.47 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 96.46 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 96.37 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.92 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 95.69 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 94.06 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 93.79 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 93.73 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 93.2 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 93.12 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 92.8 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 92.79 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 92.6 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 92.13 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 92.08 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 91.51 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 91.28 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 91.01 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 90.19 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 90.0 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 89.24 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 88.73 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 88.7 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 88.62 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 88.07 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 87.93 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 87.6 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 87.22 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 87.08 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 86.5 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 85.4 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 85.2 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 85.03 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 85.02 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 84.81 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 83.05 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 82.97 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 82.83 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 82.76 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 82.62 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 82.55 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 82.22 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 81.78 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 81.33 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 80.54 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 80.26 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-65 Score=492.37 Aligned_cols=289 Identities=35% Similarity=0.690 Sum_probs=232.8
Q ss_pred CCccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 120 GKNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
.+.+.++|++++.||+|+||+||+|+++. +|+.||||++.+..... ....+.+|+.+|++|+ |||||+++++|.
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 77 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKR---TQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIK-HPNIVALDDIYE 77 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGEEEEEETT---TCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEE
T ss_pred CCCCccceEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence 34567789999999999999999999876 78999999998754332 2356789999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccc
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 279 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~ 279 (461)
+++.+|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+...++++.+||+|||+
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred ECCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccce
Confidence 99999999999999999998865 46799999999999999999999999999999999999998766788899999999
Q ss_pred ccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 280 SDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 280 a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
|+.........+.+||+.|||||++. +.|+.++|||||||+||||++|+.||.+....++...+......+....++.+
T Consensus 157 a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (307)
T d1a06a_ 157 SKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred eEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCC
Confidence 99877666667789999999999987 46999999999999999999999999999999999999998888887778899
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC-CCCchHHHHHHHHHHhhcCHH
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR-PVPLDILIYKLVKSYLRATPL 415 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 415 (461)
|+++++||.+||++||++|||++|+|+||||++... .......+.+.+++....+.+
T Consensus 237 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (307)
T d1a06a_ 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKW 294 (307)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCCCCCHHHHHHHHHHHSCCCTT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCccccccchhHHHHHHHHHHHhhh
Confidence 999999999999999999999999999999986532 333444455555554444433
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-64 Score=473.91 Aligned_cols=254 Identities=31% Similarity=0.613 Sum_probs=228.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++.+....+....+.+.+|+++|++++ |||||++++++.+.+.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 81 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRV 81 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECC---CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEE
Confidence 579999999999999999999886 78999999997654444444677889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|||||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|....
T Consensus 82 ~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAP 157 (263)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCSCSCCC
T ss_pred EEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec---CCCCEeecccceeeecC
Confidence 9999999999999988654 5799999999999999999999999999999999999995 56779999999998765
Q ss_pred CCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
. ......+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+.+..+++..+.+....++ ..+|++++
T Consensus 158 ~-~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 232 (263)
T d2j4za1 158 S-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGAR 232 (263)
T ss_dssp C-CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHH
T ss_pred C-CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHH
Confidence 3 34456789999999999975 599999999999999999999999999999999999888766554 35899999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 364 DFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 364 ~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
+||.+||++||++|||++|+|+||||+.
T Consensus 233 ~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 233 DLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 9999999999999999999999999964
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.1e-63 Score=487.21 Aligned_cols=263 Identities=36% Similarity=0.640 Sum_probs=240.1
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+-++|++++.||+|+||+||+|+++. +|+.||||++.+.. ....+.+.+|+.+|++|+ |||||+++++|.+.+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~---~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETT
T ss_pred CccCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 34689999999999999999999876 89999999997643 344577899999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|||||||+||+|.+++....+.+++..++.|+.||+.||.|||++|||||||||+|||++.+ .++.+||+|||+|+.
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~-~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-CCCeEEEeecchhee
Confidence 9999999999999999987666789999999999999999999999999999999999999642 356799999999998
Q ss_pred cCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
..........+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+..+++..|......+....++.+|++
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 877777777899999999999874 5899999999999999999999999999999999999998888877777789999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
+++||.+||++||++|||++|+|+||||+..+
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-63 Score=472.88 Aligned_cols=259 Identities=30% Similarity=0.532 Sum_probs=219.0
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+-++|++++.||+|+||+||+|+++. +|+.||||++...... ...+.+.+|+++|++++ |||||++++++.+.+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HENVVKFYGHRREGN 76 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred CCcceEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCc
Confidence 34689999999999999999999876 7999999999765432 23457889999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|||||||+||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 77 ~~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~---~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATV 152 (271)
T ss_dssp EEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEE
T ss_pred eeEEEEeccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC---CCCCEEEccchhhee
Confidence 9999999999999999874 446799999999999999999999999999999999999995 566799999999987
Q ss_pred cCCCC---CccccccCCCcCchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 283 VRPDQ---RLNDIVGSAYYVAPEVLHR-S-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 283 ~~~~~---~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
..... .....+||+.|||||++.+ . ++.++|||||||+||||++|+.||.................. ....|..
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKK 231 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-TSTTGGG
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCcccc
Confidence 64332 3456789999999999864 3 467899999999999999999999876655444444433332 2334567
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+|+++++||.+||+.||++|||++|+|+||||+..
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 232 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 99999999999999999999999999999999754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-62 Score=484.18 Aligned_cols=261 Identities=36% Similarity=0.647 Sum_probs=239.2
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++++.||+|+||+||+|+++. +|+.||||++++.. ....+.+.+|+.+|++|+ |||||+++++|.+++.
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYE 100 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSE
T ss_pred ccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 3579999999999999999999876 79999999997643 334567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|||||||+||+|.+++......+++.+++.|+.||+.||.|||++|||||||||+||||+.. .++.+||+|||+|...
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~-~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-CCCeEEEeecccceec
Confidence 999999999999999887776789999999999999999999999999999999999999642 4578999999999998
Q ss_pred CCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 284 RPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 284 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
..........||+.|||||++.+ .|+.++|||||||+||+|+||+.||.+.+..+++..+......++...++.+|+++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 87777777899999999999874 59999999999999999999999999999999999999988888888888999999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
++||.+||++||.+|||++|+|+||||+..
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-62 Score=469.17 Aligned_cols=256 Identities=25% Similarity=0.467 Sum_probs=224.6
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++++.||+|+||+||+|+++. +|+.||||++....... .+.+.+|+.+|++++ |||||+++++|.+.+.
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPK---KELIINEILVMRENK-NPNIVNYLDSYLVGDE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTT---TCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred ccccEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEecccChH---HHHHHHHHHHHHhCC-CCCEeeEeEEEEECCE
Confidence 4589999999999999999999876 89999999997654433 467889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|||||||+||+|.+++.. +.+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+..
T Consensus 92 ~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQI 166 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC---CCCcEeeccchhheee
Confidence 9999999999999987654 4699999999999999999999999999999999999995 5678999999999877
Q ss_pred CCCC-CccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 RPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
.... .....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+....+..+...... ....+..+|++
T Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~ 245 (293)
T d1yhwa1 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAI 245 (293)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHH
T ss_pred ccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHH
Confidence 5443 4466789999999999874 5999999999999999999999999998887777776655322 12233568999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+++||.+||++||.+|||++|+|+||||+..
T Consensus 246 ~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-62 Score=474.38 Aligned_cols=268 Identities=37% Similarity=0.672 Sum_probs=238.2
Q ss_pred CccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCC---HHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Q 012518 121 KNFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS---ALAIEDVRREVKILKALSGHKHMIKFHDA 197 (461)
Q Consensus 121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~~Ei~il~~l~~hpniv~l~~~ 197 (461)
+++.++|++++.||+|+||+||+|+++. +|+.||||++++..... ....+.+.+|+.+|++|+ |||||+++++
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~ 81 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEV 81 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEE
Confidence 3466789999999999999999999876 89999999997654332 223578899999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC-CCCCeeEee
Q 012518 198 FEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE-EDAPLKVID 276 (461)
Q Consensus 198 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~-~~~~~kl~D 276 (461)
|.+.+.+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|
T Consensus 82 ~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 82 YENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecc
Confidence 99999999999999999999988665 5799999999999999999999999999999999999997533 233699999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
||+|..........+..||+.|+|||++.+ .|+.++|||||||+||||++|+.||.+.+..+.+..+......+....+
T Consensus 161 fG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (293)
T d1jksa_ 161 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240 (293)
T ss_dssp CTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred hhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 999998877767777899999999999974 6999999999999999999999999999999999999988777766666
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
+.+|+++++||.+||+.||.+|||++|+|+||||+..+
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 78999999999999999999999999999999998643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-63 Score=473.16 Aligned_cols=257 Identities=32% Similarity=0.598 Sum_probs=226.7
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++.+.........+.+.+|+++|++|+ ||||++++++|.+++.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEE
Confidence 579999999999999999999876 78999999997654444445678899999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|||||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+...
T Consensus 84 ~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~---~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLS 159 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred EEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC---CCceEEecccccceecc
Confidence 9999999999999987655 6799999999999999999999999999999999999994 56789999999998765
Q ss_pred CCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 285 PDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 285 ~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
... ...+.+||+.|||||++. ..|+.++|||||||+||||++|+.||.+.+..+++..|.+....++ ..+++
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 235 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFP 235 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCH
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCH
Confidence 332 345678999999999987 4699999999999999999999999999999999999988776654 35899
Q ss_pred HHHHHHHHhcccCcCCCCCHHH------HhcCCCcCCCC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQ------ALTHPWLHDEN 393 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e------~L~hp~~~~~~ 393 (461)
++++||.+||++||++|||++| +++||||++.+
T Consensus 236 ~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp HHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 9999999999999999999987 68999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-62 Score=471.26 Aligned_cols=257 Identities=29% Similarity=0.512 Sum_probs=226.4
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.+.|++++.||+|+||+||+|+++. +|+.||||+++... ....+.+.+|+++|++|+ |||||+++++|.+.+.
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKE---TSVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENN 83 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECC---CCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCe
Confidence 3579999999999999999999876 88999999997643 234567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|||||||+||+|.+++.+..+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|...
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~---~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKN 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC---CCCCEEEEechhhhcc
Confidence 9999999999999998877777899999999999999999999999999999999999995 5677999999999765
Q ss_pred CCC-CCccccccCCCcCchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 284 RPD-QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 284 ~~~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
... ....+.+||+.|||||++. ..|+.++|||||||+||||+||+.||.+.+..+.+..+....+.... .+.
T Consensus 161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 239 (288)
T d2jfla1 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-QPS 239 (288)
T ss_dssp HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS-SGG
T ss_pred CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-ccc
Confidence 432 2335678999999999983 34899999999999999999999999999998998888877543222 235
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
.+|+++++||.+||++||++|||++|+|+||||+.
T Consensus 240 ~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 68999999999999999999999999999999974
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-61 Score=461.74 Aligned_cols=262 Identities=35% Similarity=0.611 Sum_probs=236.8
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCC------HHHHHHHHHHHHHHHhcCCCCCeeEEEE
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTS------ALAIEDVRREVKILKALSGHKHMIKFHD 196 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~~hpniv~l~~ 196 (461)
|.++|++.+.||+|+||+||+|+++. +|+.||||++++..... ....+.+.+|+.+|++|+.||||+++++
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 77 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECC---CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence 34799999999999999999999876 79999999998754332 2234568899999999977999999999
Q ss_pred EEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 197 AFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 197 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
+|.+++.+|||||||+||+|.+++..+ +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 78 ~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~~kl~D 153 (277)
T d1phka_ 78 TYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTD 153 (277)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECC
T ss_pred ecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc---CCCCeEEcc
Confidence 999999999999999999999998765 5799999999999999999999999999999999999994 677899999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhc-------cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN 349 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~ 349 (461)
||+++...........+||+.|+|||++.+ .++.++||||+||+||+|++|+.||.+.+.......+......
T Consensus 154 FG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~ 233 (277)
T d1phka_ 154 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233 (277)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred chheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC
Confidence 999998877666677899999999998852 3688999999999999999999999999999999999988877
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 350 FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 350 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
+....++.+|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 777777789999999999999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-61 Score=459.83 Aligned_cols=253 Identities=21% Similarity=0.382 Sum_probs=216.4
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe----CC
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED----AN 202 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~----~~ 202 (461)
|++.++||+|+||+||+|+++. +|+.||||++..... .....+.+.+|+++|++|+ |||||+++++|.+ .+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~---~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred EEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCC
Confidence 4788899999999999999876 789999999977554 3445678999999999996 9999999999975 45
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~g--ivHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
.+|||||||+||+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ +.++.+||+|||+|
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred EEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcc
Confidence 689999999999999988654 57999999999999999999999998 99999999999996 34667999999999
Q ss_pred cccCCCCCccccccCCCcCchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCh-hhHHHHHHhcCCCCCCCCCCCCC
Q 012518 281 DFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 281 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
+.... ....+.+||+.|||||++.+.|+.++|||||||+||||++|+.||.+... ..+++.+..... +......++
T Consensus 163 ~~~~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~ 239 (270)
T d1t4ha_ 163 TLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAI 239 (270)
T ss_dssp GGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred eeccC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--CcccCccCC
Confidence 86543 34456789999999999998899999999999999999999999976554 444555544322 112234578
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcCCCcC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 390 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 390 (461)
+++++||.+||++||++|||++|+|+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-61 Score=474.50 Aligned_cols=256 Identities=29% Similarity=0.554 Sum_probs=230.9
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++++.........+.+.+|+.+|++++ ||||++++++|++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeecccccc
Confidence 579999999999999999999886 89999999998764443445677889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+...
T Consensus 81 ~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~---~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSC
T ss_pred ccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec---CCCCEEEeecccccccc
Confidence 9999999999999987654 6799999999999999999999999999999999999994 56789999999998764
Q ss_pred C-CCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHH
Q 012518 285 P-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 362 (461)
Q Consensus 285 ~-~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 362 (461)
. .......+||+.|||||++. ..|+.++|||||||+||||++|+.||.+.+..+++..+......++ ..+|+++
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 232 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEA 232 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHH
Confidence 4 34556789999999999987 5699999999999999999999999999999999999988876654 4589999
Q ss_pred HHHHHHhcccCcCCCCC-----HHHHhcCCCcCCC
Q 012518 363 KDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 392 (461)
Q Consensus 363 ~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 392 (461)
++||.+||++||.+|++ ++|+++||||++.
T Consensus 233 ~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 99999999999999994 9999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-61 Score=469.10 Aligned_cols=259 Identities=25% Similarity=0.413 Sum_probs=227.3
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
....|++++.||+|+||+||+|+++. +|+.||||++...........+.+.+|+++|++|+ |||||+++++|.+.+
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH 88 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETT
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECC---CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECC
Confidence 34579999999999999999999876 78999999998776666666788999999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|||||||.||+|..++ ...+.+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|..
T Consensus 89 ~~~iv~E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASI 164 (309)
T ss_dssp EEEEEEECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBS
T ss_pred EEEEEEEecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---CCCCEEEeecccccc
Confidence 999999999998886544 4457899999999999999999999999999999999999996 567799999999987
Q ss_pred cCCCCCccccccCCCcCchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
... ....+||+.|||||++. +.|+.++|||||||++|||++|..||.+.+..+.+..+........ ....+
T Consensus 165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~ 239 (309)
T d1u5ra_ 165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHW 239 (309)
T ss_dssp SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTS
T ss_pred cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCC
Confidence 543 34578999999999985 3489999999999999999999999999888888887776643322 22468
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
|+++++||.+||++||.+|||++|+|+||||.....
T Consensus 240 s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 999999999999999999999999999999976543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-61 Score=472.88 Aligned_cols=261 Identities=30% Similarity=0.591 Sum_probs=237.4
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+-++|++++.||+|+||+||+|.++. +|+.||||++++.. .....+.+|+++|+.++ |||||+++++|++.+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~---~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESME 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETT
T ss_pred CccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence 45789999999999999999999887 78999999997643 22356789999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+|||||||+||+|.+++......+++.+++.|+.||+.||.|||++||+||||||+|||++.+ ....+||+|||++..
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~-~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-CceEEEEcccchhhc
Confidence 9999999999999999987666689999999999999999999999999999999999999642 356799999999998
Q ss_pred cCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 283 VRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 283 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
..........+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..+++..|.+....++...|+.+|++
T Consensus 154 ~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred cccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence 77666667788999999999986 56999999999999999999999999999999999999998888887777889999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+++||.+||++||.+|||++|+|+||||+..
T Consensus 234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-61 Score=457.97 Aligned_cols=254 Identities=28% Similarity=0.492 Sum_probs=212.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--CC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED--AN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~--~~ 202 (461)
++|++++.||+|+||+||+|+++. +|+.||||++..... .....+.+.+|+++|++++ |||||++++++.+ ++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----
T ss_pred hhCEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCC
Confidence 589999999999999999999886 899999999987654 3455678999999999996 9999999999964 56
Q ss_pred eEEEEEeccCCCchHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCCCCcEEEecCCCCCCeeE
Q 012518 203 SVYIVMEFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQG-----VVHRDLKPENFLFTTREEDAPLKV 274 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~i~~qil~al~yLH~~g-----ivHrDlkp~NILl~~~~~~~~~kl 274 (461)
.+|||||||+||+|.+++.+ ....+++..++.++.||+.||.|||++| ||||||||+|||++ .++.+||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~---~~~~vkl 155 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKL 155 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC---TTSCEEE
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC---CCCcEEE
Confidence 68999999999999998854 3467999999999999999999999986 99999999999995 5678999
Q ss_pred eecccccccCCCC-CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC
Q 012518 275 IDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD 352 (461)
Q Consensus 275 ~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 352 (461)
+|||+|+...... .....+||+.|||||++. ..|+.++|||||||++|||+||+.||.+.+..++...+.......
T Consensus 156 ~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~-- 233 (269)
T d2java1 156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-- 233 (269)
T ss_dssp CCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--
T ss_pred eeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence 9999998876543 345678999999999996 469999999999999999999999999999888888888765432
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 353 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 353 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
....+|+++++||.+||+.||.+|||++|+|+|||+
T Consensus 234 -~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 234 -IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 224689999999999999999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.7e-61 Score=464.85 Aligned_cols=254 Identities=28% Similarity=0.611 Sum_probs=227.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++++.........+.+.+|+.+|+.++ |||||++++++.+.+.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCee
Confidence 479999999999999999999876 89999999997654433445678899999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+|||||.||+|..++. ....+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+...
T Consensus 80 ~ivmE~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~---~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVP 155 (316)
T ss_dssp EEEECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSCEECS
T ss_pred eeEeeecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc---CCCCEEEecCccceEec
Confidence 99999999999988765 446789999999999999999999999999999999999994 56789999999998765
Q ss_pred CCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
. ...+.+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+.+..+++..+......++ +.++++++
T Consensus 156 ~--~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 229 (316)
T d1fota_ 156 D--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVK 229 (316)
T ss_dssp S--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred c--ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 3 3456789999999999975 599999999999999999999999999999999999988766554 35899999
Q ss_pred HHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 364 DFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 364 ~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
++|.+||.+||.+|+ |++|+|+||||++.
T Consensus 230 ~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 999999999999996 99999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-61 Score=467.04 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=214.1
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|+++++||+|+||+||+|+++. +|+.||||+++... .....+.+.+|+.+|++++ |||||+++++|.+.+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDG 77 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETT---TTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSS
T ss_pred CccCCEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 35689999999999999999999876 89999999997653 2334577899999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
.+|||||||+||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|+
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSG 153 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCH
T ss_pred EEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC---CCCCEEEeeCCCcc
Confidence 999999999999999988655 579999999999999999999997 5999999999999995 56789999999998
Q ss_pred ccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHH------------------
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS------------------ 342 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~------------------ 342 (461)
.... ....+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+.......
T Consensus 154 ~~~~-~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 154 QLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHHH-HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred ccCC-CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 7643 23456799999999999874 699999999999999999999999977654322110
Q ss_pred ------------------------HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 343 ------------------------VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 343 ------------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
+.... .+..+...+|.+++|||.+||+.||.+|||++|+|+||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00000 0011112368999999999999999999999999999999753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-60 Score=467.29 Aligned_cols=254 Identities=31% Similarity=0.569 Sum_probs=228.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. +|+.||||++.+.........+.+.+|+++|+.++ |||||+++++|.+.+.+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeeccccccccccc
Confidence 589999999999999999999876 89999999997654444445677899999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.||+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+...
T Consensus 117 ~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~---~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECS
T ss_pred ccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC---CCCCEEeeeceeeeecc
Confidence 9999999999999988665 5799999999999999999999999999999999999994 56789999999998775
Q ss_pred CCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012518 285 PDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 363 (461)
Q Consensus 285 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 363 (461)
. ...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+.+...++..+......++ ..+++++.
T Consensus 193 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 266 (350)
T d1rdqe_ 193 G--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLK 266 (350)
T ss_dssp S--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHH
T ss_pred c--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHH
Confidence 3 3456789999999999874 599999999999999999999999999999999999988766554 45899999
Q ss_pred HHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 364 DFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 364 ~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
+||++||++||.+|+ |++|+|+||||++.
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 999999999999995 99999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-61 Score=470.27 Aligned_cols=260 Identities=33% Similarity=0.611 Sum_probs=221.9
Q ss_pred cccceeece-eeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-
Q 012518 123 FGAKFELGK-EVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED- 200 (461)
Q Consensus 123 ~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~- 200 (461)
+-++|++.. .||+|+||+||+|+++. +|+.||||++++. ..+.+|+.++.++.+|||||+++++|++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECC---CCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 346899875 59999999999999876 8899999999643 4567899998776569999999999976
Q ss_pred ---CCeEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 201 ---ANSVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 201 ---~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
+..+|||||||+||+|.+++..++ ..+++.+++.|+.||+.||.|||++||+||||||+|||++.++..+.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 467999999999999999997653 4699999999999999999999999999999999999998766678899999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHH----HhcCCCCC
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV----LRADPNFH 351 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i----~~~~~~~~ 351 (461)
||+|+...........+||+.|||||++.+ .|+.++|||||||+||+|+||+.||.+.+.......+ ......++
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~ 237 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 999998877777778899999999999874 6999999999999999999999999877655544433 33344455
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 352 DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 352 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
...|..+|+++++||++||++||++|||+.|+|+||||++..
T Consensus 238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 455567899999999999999999999999999999997654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-59 Score=457.91 Aligned_cols=256 Identities=30% Similarity=0.510 Sum_probs=225.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHH-hcCCCCCeeEEEEEEEeCCe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILK-ALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~-~l~~hpniv~l~~~~~~~~~ 203 (461)
++|++++.||+|+||+||+|+++. +|+.||||++++.........+.+.+|+.++. .+ +|||||+++++|.+++.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~~~~ 77 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQTKEN 77 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEccCCc
Confidence 579999999999999999999886 89999999997654333334566778888776 46 59999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 78 ~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~---~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKEN 153 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCC
T ss_pred eeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec---CCCceeccccchhhhc
Confidence 99999999999999988654 6799999999999999999999999999999999999995 5678999999999876
Q ss_pred CCC-CCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHH
Q 012518 284 RPD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 361 (461)
Q Consensus 284 ~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 361 (461)
... ......+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+.+..+++..+....+.++ ..+|++
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~ 229 (320)
T d1xjda_ 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKE 229 (320)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred ccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHH
Confidence 543 3345578999999999987 4699999999999999999999999999999999999988766554 358999
Q ss_pred HHHHHHHhcccCcCCCCCHH-HHhcCCCcCCC
Q 012518 362 AKDFVRRLLNKDHRKRMTAA-QALTHPWLHDE 392 (461)
Q Consensus 362 ~~~li~~~L~~dP~~R~s~~-e~L~hp~~~~~ 392 (461)
+++||.+||++||.+|||+. |+++||||++.
T Consensus 230 ~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 230 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 99999999999999999995 89999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-59 Score=462.67 Aligned_cols=258 Identities=24% Similarity=0.414 Sum_probs=215.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHH---HHHHHhcCCCCCeeEEEEEEEeC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRRE---VKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E---i~il~~l~~hpniv~l~~~~~~~ 201 (461)
++|++++.||+|+||+||+|+++. +|+.||||++.+...........+.+| +.+++.+. |||||+++++|.+.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTP 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECS
T ss_pred HhCeeeeEEecCCCeEEEEEEECC---CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEEEC
Confidence 589999999999999999999876 899999999976543322223334444 55666664 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
+.+|||||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~---~~g~iKl~DFGla~ 155 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLAC 155 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---SSSCEEECCCTTCE
T ss_pred CEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc---CCCcEEEeeeceee
Confidence 9999999999999999988655 6789999999999999999999999999999999999994 56789999999998
Q ss_pred ccCCCCCccccccCCCcCchhhhh-c-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLH-R-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
..... .....+||+.|||||++. + .|+.++|||||||+||||+||+.||.+.......... ..........+..+|
T Consensus 156 ~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~s 233 (364)
T d1omwa3 156 DFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFS 233 (364)
T ss_dssp ECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-HHSSSCCCCCCSSSC
T ss_pred ecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcccCCCCCCCCCC
Confidence 76543 445678999999999985 3 5899999999999999999999999876554433322 222222333345799
Q ss_pred HHHHHHHHHhcccCcCCCCC-----HHHHhcCCCcCCC
Q 012518 360 PEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 392 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 392 (461)
+++++||.+||++||.+||| ++|+|+||||++.
T Consensus 234 ~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 99999999999999999999 7999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-59 Score=448.06 Aligned_cols=264 Identities=29% Similarity=0.476 Sum_probs=220.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|+++++||+|+||+||+|+++. +|+.||||+++.... .....+.+.+|+++|++++ |||||+++++|.+.+.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC---CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccce
Confidence 589999999999999999999876 889999999976542 2234567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRIL-SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~-~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
|+|||||.++ +.+.+. .....+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+..
T Consensus 77 ~iv~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~---~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTHHHHH
T ss_pred eEEEeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec---ccCcceeccCCcceec
Confidence 9999999764 444443 3456799999999999999999999999999999999999994 5678999999999877
Q ss_pred CCC-CCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCC------
Q 012518 284 RPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP------ 354 (461)
Q Consensus 284 ~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~------ 354 (461)
... ......+||+.|+|||++.. .++.++|||||||++|+|++|+.||.+.+..+.+..+...........
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 544 34556789999999998753 468999999999999999999999999888777777654322222111
Q ss_pred -------------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCCCC
Q 012518 355 -------------------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 397 (461)
Q Consensus 355 -------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~ 397 (461)
++.+|+++++||.+||+.||.+|||++|+|+||||++..++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 2357899999999999999999999999999999998877654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-59 Score=451.92 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=214.3
Q ss_pred eceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCH--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEE
Q 012518 129 LGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSA--LAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYI 206 (461)
Q Consensus 129 ~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~--~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~l 206 (461)
.+++||+|+||+||+|+++. +|+.||||+++....... ...+.+.+|+.+|++++ |||||+++++|.+++.+||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~i 77 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISL 77 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEE
T ss_pred cceEeccCcCeEEEEEEECC---CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceee
Confidence 46889999999999999876 899999999976543221 12356889999999996 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 012518 207 VMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 286 (461)
Q Consensus 207 v~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~ 286 (461)
|||||.|+++. .+......+++..++.+++||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.....
T Consensus 78 vmE~~~~~~~~-~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~---~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 78 VFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp EEECCSEEHHH-HHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCGGGSTTTSC
T ss_pred hhhhhcchHHh-hhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec---CCCccccccCccccccCCC
Confidence 99999887665 4555567899999999999999999999999999999999999994 5678999999999876544
Q ss_pred C-CccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCC---------
Q 012518 287 Q-RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP--------- 354 (461)
Q Consensus 287 ~-~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 354 (461)
. .....+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+..+++..|.+.........
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 3 345678999999999985 3589999999999999999999999999999888888765322111111
Q ss_pred ---------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCC
Q 012518 355 ---------------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 394 (461)
Q Consensus 355 ---------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 394 (461)
++.+++++++||.+||+.||++|||+.|+|+||||++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 1357899999999999999999999999999999987643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-58 Score=441.18 Aligned_cols=253 Identities=30% Similarity=0.523 Sum_probs=213.0
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHH---HHHHHHHHHHHHHhcC-CCCCeeEEEEEE
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSAL---AIEDVRREVKILKALS-GHKHMIKFHDAF 198 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~---~~~~~~~Ei~il~~l~-~hpniv~l~~~~ 198 (461)
+.++|++++.||+|+||+||+|+++. +|+.||||++.+....... ...++.+|+.+|++++ .|||||+++++|
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 45689999999999999999999876 7899999999765433221 1233568999999996 489999999999
Q ss_pred EeCCeEEEEEeccCC-CchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 199 EDANSVYIVMEFCEG-GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 199 ~~~~~~~lv~e~~~g-g~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
.+.+.+|+||||+.+ +++.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. +++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--~~~~vkl~DF 155 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDF 155 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCC
T ss_pred eeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--CCCeEEECcc
Confidence 999999999999986 5666666544 67999999999999999999999999999999999999963 3467999999
Q ss_pred ccccccCCCCCccccccCCCcCchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 278 GLSDFVRPDQRLNDIVGSAYYVAPEVLHR-S-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 278 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
|+|.... .....+.+||+.|+|||++.+ . ++.++|||||||+||||++|+.||.... .+.+....+.
T Consensus 156 G~a~~~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~---- 224 (273)
T d1xwsa_ 156 GSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR---- 224 (273)
T ss_dssp TTCEECC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----
T ss_pred ccceecc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCC----
Confidence 9998654 334567889999999999863 3 5778999999999999999999996532 3444444333
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..+|+++++||.+||++||++|||++|+|+||||++.
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 4589999999999999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-58 Score=445.07 Aligned_cols=266 Identities=26% Similarity=0.375 Sum_probs=220.2
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC--CCCCeeEEEEEEEe-
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS--GHKHMIKFHDAFED- 200 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--~hpniv~l~~~~~~- 200 (461)
.++|+++++||+|+||+||+|++... +++.||||+++...... .....+.+|+.+|+.|+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC--CCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 36899999999999999999998651 46789999997643222 12234567888877763 49999999999853
Q ss_pred ----CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 201 ----ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 201 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
...+|++||||.++.+..........+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~---~~~~~kl~d 159 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLAD 159 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc---CCCCeeecc
Confidence 3568999999998877655555667799999999999999999999999999999999999995 567799999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC----
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH---- 351 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---- 351 (461)
||++............+||+.|||||++. ..|+.++|||||||++|||++|+.||.+.+..+.+..++.......
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 99998776666667789999999999986 5699999999999999999999999999998888877764311111
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCCCC
Q 012518 352 -------------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 395 (461)
Q Consensus 352 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~ 395 (461)
...+..+++++++||.+||++||++|||++|+|+||||++..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence 01234579999999999999999999999999999999886543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.1e-58 Score=436.56 Aligned_cols=260 Identities=25% Similarity=0.437 Sum_probs=220.9
Q ss_pred ccccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 122 NFGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.+.++|++.+.||+|+||+||+|+++. +|+.||||++++....+....+.+.+|+++|+.++ |||||++++++.+.
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAE 79 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEE
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeec
Confidence 456799999999999999999999876 79999999998877667777788999999999996 99999999999765
Q ss_pred C----eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 202 N----SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 202 ~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
+ .+|||||||+||+|.+++... +.+++.+++.++.||+.||.|||++|||||||||+|||++ .++.++|+||
T Consensus 80 ~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~d~ 155 (277)
T d1o6ya_ 80 TPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDF 155 (277)
T ss_dssp CSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEECCC
T ss_pred cCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceeehh
Confidence 4 389999999999999877655 6799999999999999999999999999999999999996 4667999999
Q ss_pred ccccccCCCC----CccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC
Q 012518 278 GLSDFVRPDQ----RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD 352 (461)
Q Consensus 278 G~a~~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 352 (461)
|++....... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+.+..+.+..++...+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG
T ss_pred hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc
Confidence 9987654332 3455789999999999874 5999999999999999999999999999998888888888777766
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 012518 353 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 389 (461)
Q Consensus 353 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 389 (461)
..++.+|+++.+||.+||++||.+||+..+.|.|+|+
T Consensus 236 ~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 6678899999999999999999999955555556664
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-56 Score=430.60 Aligned_cols=257 Identities=27% Similarity=0.440 Sum_probs=214.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|+++++||+|+||+||+|+++ +|+.||||+++.... .....+.+.+|+.+|++++ |||||+++++|.+.+..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC----CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCce
Confidence 58999999999999999999875 678999999976543 2333567889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+||||+.++.+ ..+....+.+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||++....
T Consensus 76 ~i~~e~~~~~~~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~---~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 76 VLVFEHLDQDLK-KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFG 151 (286)
T ss_dssp EEEEECCSEEHH-HHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHHHC
T ss_pred eEEEEeehhhhH-HHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc---CCCCEEecccccceecc
Confidence 999999977555 55556668899999999999999999999999999999999999994 56789999999998765
Q ss_pred CCC-CccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCC---------
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD--------- 352 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 352 (461)
... .....+|++.|+|||++. ..++.++|||||||++|||++|+.||.+.+..+.+..+.........
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 432 345567999999999985 35799999999999999999999999998888777776542211111
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 353 ----------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 353 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
.....++++++|||++||++||++|||+.|+|+||||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112457899999999999999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-56 Score=429.05 Aligned_cols=250 Identities=20% Similarity=0.322 Sum_probs=210.8
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
..++|++.+.||+|+||+||+|+++. +|+.||||+++.+.. ..+++.+|+++|++|+ |||||+++++|.+.+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREP 86 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGG---GTEEEEEEECCTTCS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECC---CCeEEEEEEECCccc----hHHHHHHHHHHHHhCC-CCCEecCCccEeeCC
Confidence 34689999999999999999999876 789999999976532 2467899999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
.+|||||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||+|+
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSR 163 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCCTT
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC---CCCcEEEcccccee
Confidence 999999999999999988754 45689999999999999999999999999999999999995 56779999999998
Q ss_pred ccCCCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 282 FVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 282 ~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
....... .....||+.|+|||++. +.|+.++|||||||++|||++|..||........+..++...... .....+
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~--~~~~~~ 241 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM--ERPEGC 241 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC--CCCTTC
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC--CCCccc
Confidence 7654432 23456899999999886 679999999999999999999777765544444333333333222 223568
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++++++||.+||+.||++|||++|+++
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-57 Score=428.58 Aligned_cols=251 Identities=23% Similarity=0.393 Sum_probs=207.7
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++++.||+|+||+||+|+.+ ..||||+++..... ....+.+.+|+.+|++++ |||||++++++. .+.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTR-HVNILLFMGYST-APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS------SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC------CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe-ccE
Confidence 468999999999999999999753 24999999765433 345678999999999996 999999999875 456
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|||||||+||+|.+++......+++..+..|+.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+..
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~---~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVK 154 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTSSEEECCCCCSCC-
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc---CCCCEEEccccceeec
Confidence 8999999999999999987777899999999999999999999999999999999999995 5678999999999876
Q ss_pred CCC---CCccccccCCCcCchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC--CCC
Q 012518 284 RPD---QRLNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH--DSP 354 (461)
Q Consensus 284 ~~~---~~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~ 354 (461)
... .......||+.|||||++.+ .|+.++|||||||+||||+||+.||.+.+....+..+.......+ ...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 533 23456789999999999852 489999999999999999999999988776655555444332221 123
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 355 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 355 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
...+++++.+||.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 45689999999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-56 Score=430.09 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=206.8
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++.+.||+|+||+||+|+++........||||.+... ......+.+.+|+++|++|+ |||||++++++.+.+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCE
Confidence 46899999999999999999998753223346899988654 34455678999999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+|||||+||+|.+++....+.+++.++..++.||+.||.|||++||+||||||+||||+ .++.+||+|||+|+..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC---CCCcEEECCcccceEc
Confidence 9999999999999998877777899999999999999999999999999999999999994 6778999999999876
Q ss_pred CCCCCc------cccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 284 RPDQRL------NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 284 ~~~~~~------~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
...... ....||+.|||||++. +.|+.++|||||||+||||+| |+.||.+.+..+++..+..... ....
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~---~~~~ 255 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR---LPPP 255 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CCCC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCC
Confidence 543321 2246789999999986 569999999999999999998 8999999998888887765432 1223
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
..+++++.+||.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 468999999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=422.22 Aligned_cols=247 Identities=24% Similarity=0.390 Sum_probs=204.3
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++ +++.||||+++..... .+++.+|++++++++ |||||+++++|.+.+.+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET----TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC----CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcC-CCCcccccceeccCCce
Confidence 57999999999999999999875 4678999999764432 357889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
|+|||||++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++...
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC---GGGCEEECSCC------
T ss_pred EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec---CCCCeEecccchheecc
Confidence 999999999999999887777899999999999999999999999999999999999995 56779999999998765
Q ss_pred CCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 285 PDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 285 ~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
.... .....||+.|+|||++. +.|+.++|||||||+||||+| |.+||...+..+++..+........ ...+++
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~ 229 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAST 229 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCH
T ss_pred CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCH
Confidence 4432 23467999999999987 569999999999999999999 5666777777777777766533222 235789
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
++.+||.+||+.||++|||++|+++|
T Consensus 230 ~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 230 HVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-56 Score=434.41 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=213.4
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCc--cCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTL--KGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|++++.||+|+||+||+|+++.... .+..||||++.... .......+.+|+.+|.++.+|||||+++++|.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3689999999999999999999865221 23469999986543 2234467889999999995699999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCC
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG----------------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 259 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~----------------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~ 259 (461)
+.+|||||||+||+|.++|..+. ..+++..++.|+.||+.||.|||++|||||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 99999999999999999987653 24788899999999999999999999999999999
Q ss_pred cEEEecCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCC
Q 012518 260 NFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWAR 334 (461)
Q Consensus 260 NILl~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~ 334 (461)
|||++ .++.+||+|||+|+....... ..+..||+.|||||++. +.|+.++|||||||+||||+| |+.||.+.
T Consensus 194 Nill~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 194 NVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccccc---cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99995 567899999999987654432 23567899999999886 679999999999999999998 89999887
Q ss_pred ChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 335 TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 335 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
.....+..++.....+.. ...+++++++||.+||+.||++|||++|+++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 776777777665544332 24689999999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-56 Score=423.92 Aligned_cols=254 Identities=20% Similarity=0.326 Sum_probs=215.0
Q ss_pred cceeecee-eccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 125 AKFELGKE-VGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 125 ~~y~~~~~-lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
++|.+.+. ||+|+||+||+|.++... ++..||||+++.. ......+++.+|+++|++|+ |||||++++++.+ +.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EA 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SS
T ss_pred cCeEECCcEEecccCeEEEEEEEecCC-CcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-Ce
Confidence 46888884 999999999999875422 5668999999764 34556778999999999996 9999999999875 46
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|||||||+||+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+..
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhcc
Confidence 8999999999999998877667899999999999999999999999999999999999996 4667999999999877
Q ss_pred CCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCC
Q 012518 284 RPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPS 357 (461)
Q Consensus 284 ~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 357 (461)
..... .....||+.|+|||++. +.|+.++|||||||++|||+| |+.||.+.+..+++..+..+... ...+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~ 236 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPE 236 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTT
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCc
Confidence 54432 23457899999999986 679999999999999999998 99999988888888877765322 12246
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHH---hcCCCc
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQA---LTHPWL 389 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~---L~hp~~ 389 (461)
+++++.+||.+||+.||++|||+.++ |+|+|+
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 89999999999999999999999887 556665
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-55 Score=430.48 Aligned_cols=255 Identities=30% Similarity=0.557 Sum_probs=213.1
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--C
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED--A 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~--~ 201 (461)
.++|+++++||+|+||+||+|+++. +|+.||||+++... .+++.+|+++|+++++||||++++++|.. .
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 4689999999999999999999876 89999999997542 35688999999999779999999999974 4
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 202 NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
..+|+|||||.+++|.... +.+++..++.++.||+.||.|||++|||||||||+|||++. ++..+||+|||+|.
T Consensus 105 ~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~--~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAE 178 (328)
T ss_dssp CSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCGGGCE
T ss_pred CceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC--CCCeeeecccccce
Confidence 5699999999999986642 56999999999999999999999999999999999999973 34469999999999
Q ss_pred ccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCh-hhHHHHHHhc------------
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLRA------------ 346 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~------------ 346 (461)
...........+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||..... .+....+...
T Consensus 179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred eccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 8877777778899999999998763 489999999999999999999999976543 2222222110
Q ss_pred -CCC--------------------CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 347 -DPN--------------------FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 347 -~~~--------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
... +....+..++++++|||++||++||.+|+|++|+|+||||++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 000 01112234789999999999999999999999999999998754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=435.96 Aligned_cols=254 Identities=25% Similarity=0.390 Sum_probs=212.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe----
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED---- 200 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~---- 200 (461)
.+|+.+++||+|+||+||+|+++. +|+.||||++.+.... ..+|+++|++|+ |+||++++++|..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~-h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKRF-------KNRELQIMRKLD-HCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSSS-------CCHHHHHHHHCC-CTTBCCEEEEEEEC--C
T ss_pred CCcEeeeEEeeCcCeEEEEEEECC---CCCEEEEEEECccchH-------HHHHHHHHHhcC-CCCCCcEEEEEEecCcc
Confidence 379999999999999999999986 8999999999765422 237999999996 9999999999854
Q ss_pred --CCeEEEEEeccCCCchHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEe
Q 012518 201 --ANSVYIVMEFCEGGELLDRIL---SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 275 (461)
Q Consensus 201 --~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~ 275 (461)
..++|||||||.++. .+.+. .....+++..++.++.||+.||+|||++||+||||||+|||++. +...+||+
T Consensus 89 ~~~~~~~lv~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~--~~~~~kl~ 165 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLC 165 (350)
T ss_dssp CSCCEEEEEEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TTCCEEEC
T ss_pred CCceEEEEEEeccCCcc-HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec--CCCceeEe
Confidence 335899999997653 33332 34567999999999999999999999999999999999999963 33479999
Q ss_pred ecccccccCCCCCccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC-----
Q 012518 276 DFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP----- 348 (461)
Q Consensus 276 DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----- 348 (461)
|||++..........+.+||+.|+|||++. ..|+.++|||||||++|||++|+.||...+..+.+..+++...
T Consensus 166 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 166 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp CCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 999999887777777789999999999875 3589999999999999999999999999888777776653211
Q ss_pred ------------CCC--------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 349 ------------NFH--------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 349 ------------~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.+. ....+.+++++.+||.+||++||++|||+.|+|+||||++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 111 01124579999999999999999999999999999999764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=416.39 Aligned_cols=247 Identities=22% Similarity=0.368 Sum_probs=218.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|+++++||+|+||+||+|+.+ +++.||||++++.... .+++.+|+.++++++ ||||++++++|.+.+.+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcC-CCceeeEEEEEeeCCce
Confidence 57899999999999999999975 5778999999875432 357889999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~---~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC---TTCCEEECCCSSCCBCS
T ss_pred EEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc---CCCcEEECcchhheecc
Confidence 999999999999998877777899999999999999999999999999999999999994 67789999999998765
Q ss_pred CCCC--ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCH
Q 012518 285 PDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 360 (461)
Q Consensus 285 ~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 360 (461)
.... .....||+.|+|||++. ..|+.++|||||||++|||+| |+.||.+.+..++...+....... ....+++
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~ 228 (258)
T d1k2pa_ 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASE 228 (258)
T ss_dssp SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCH
T ss_pred CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---CcccccH
Confidence 4432 23467899999999986 569999999999999999998 899999999988888887654322 2246889
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 361 EAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 361 ~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
++.+||.+||+.||++|||++++|+|
T Consensus 229 ~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 229 KVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=428.22 Aligned_cols=260 Identities=27% Similarity=0.449 Sum_probs=214.1
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe----
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED---- 200 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~---- 200 (461)
++|+++++||+|+||+||+|+++. +|+.||||++...... .....++.+|+++|++++ |+||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKASP 84 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC----
T ss_pred CCEEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccc
Confidence 589999999999999999999876 8999999998765433 234467889999999996 9999999999854
Q ss_pred ----CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 201 ----ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 201 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
.+.+|+|||||.++.+ ..+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~-~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~---~~~~~kl~d 160 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLAD 160 (318)
T ss_dssp ------CEEEEEECCCEEHH-HHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECC
T ss_pred ccccCceEEEEEeccCCCcc-chhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec---CCCcEEeee
Confidence 4568999999987654 44555567899999999999999999999999999999999999995 567799999
Q ss_pred cccccccCCCC-----CccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC
Q 012518 277 FGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN 349 (461)
Q Consensus 277 FG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~ 349 (461)
||++....... .....+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+.......+......
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99997665322 234468999999999985 35899999999999999999999999998888877777665444
Q ss_pred CCCCCCCC----------------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 350 FHDSPWPS----------------------------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 350 ~~~~~~~~----------------------------~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
+....+.. .+++++|||.+||+.||++|+|++|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 33322221 377899999999999999999999999999998653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-56 Score=434.38 Aligned_cols=264 Identities=29% Similarity=0.498 Sum_probs=220.6
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC-CHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT-SALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
++|++++.||+|+||+||+|++..+..+|+.||||++++.... +....+.+.+|+++|+++++||||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999998766668999999999764322 122345677899999999756999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+||||+.||+|.+++... +.+.+..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec---CCCCEEEeeccchhhh
Confidence 99999999999999988655 5788999999999999999999999999999999999995 5678999999999876
Q ss_pred CCC--CCccccccCCCcCchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 284 RPD--QRLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 284 ~~~--~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
... .......||+.|+|||.+.+ .++.++|||||||+||+|++|+.||.+....+....+.+............+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 433 23355789999999999853 4788999999999999999999999887665555555443322222223468
Q ss_pred CHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcCCC
Q 012518 359 SPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 392 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 392 (461)
|+++.+||.+||++||.+|+ |++|+|+||||++.
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 99999999999999999999 58999999999764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=419.47 Aligned_cols=251 Identities=20% Similarity=0.359 Sum_probs=211.0
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++++.||+|+||+||+|+.+ +++.||||+++.... ..+.+.+|+++|++++ |||||++++++.+ +.
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC----CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CC
Confidence 468999999999999999999875 467899999976432 2367899999999996 9999999998764 56
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
+|+|||||++|+|.+++.... ..+++..+..|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+|+.
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~---~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARL 158 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee---cccceeeccccceEE
Confidence 799999999999988775432 3589999999999999999999999999999999999994 677899999999998
Q ss_pred cCCCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhC-CCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 283 VRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCG-SRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 283 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
..... ......||+.|||||++. +.|+.++|||||||+||||+|| .+||...+..+++..+....... ....+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~---~p~~~ 235 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNC 235 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTC
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---CcccC
Confidence 75443 234567999999999987 5699999999999999999995 55566666777777776543222 12468
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhc--CCCcC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALT--HPWLH 390 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~--hp~~~ 390 (461)
++++.+||.+||+.||++|||++|+++ |+||.
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999999999999999999999987 67764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-55 Score=432.21 Aligned_cols=257 Identities=28% Similarity=0.519 Sum_probs=212.0
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
+.++|++++.||+|+||+||+|.++. +|+.||||++++.. ......+.+.+|+++|+.++ |||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE 90 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCc
Confidence 56799999999999999999999876 89999999997653 35556678899999999996 999999999997655
Q ss_pred ------eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEee
Q 012518 203 ------SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 276 (461)
Q Consensus 203 ------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~D 276 (461)
.+|+||||| +++|...+. . +.+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~-~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~---~~~~~kl~D 164 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMK-H-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILD 164 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHH-H-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECC
T ss_pred cccccceEEEEEecc-cccHHHHHH-h-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc---ccccccccc
Confidence 579999999 556666543 3 5799999999999999999999999999999999999994 677899999
Q ss_pred cccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC------
Q 012518 277 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP------ 348 (461)
Q Consensus 277 FG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------ 348 (461)
||+|+... ...+..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 165 fg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 165 FGLARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CTTCEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccceeccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 99998764 34566789999999999853 579999999999999999999999998887766655443211
Q ss_pred -----------------CCCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 349 -----------------NFHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 349 -----------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
..... ....+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 11111 124679999999999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-55 Score=416.95 Aligned_cols=253 Identities=22% Similarity=0.363 Sum_probs=207.6
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCe
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANS 203 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~ 203 (461)
.++|++++.||+|+||+||+|++......+..||||.++.. ......+.+.+|+++|++++ |||||++++++. ++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCe
Confidence 46899999999999999999998764445667999988643 34556678999999999996 999999999996 467
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 204 VYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 204 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
+|+|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchhheec
Confidence 8999999999999998887777899999999999999999999999999999999999996 4567999999999876
Q ss_pred CCCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 284 RPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 284 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
.... ......||+.|+|||++. +.|+.++|||||||+||||+| |..||.+.+..+++..+...... ..++.++
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~ 235 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCP 235 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence 5432 234467899999999986 579999999999999999998 89999999998988888765422 2346799
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+++.+||.+||..||++|||+.|+++|
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=419.02 Aligned_cols=248 Identities=22% Similarity=0.329 Sum_probs=205.1
Q ss_pred eeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEEEEEec
Q 012518 131 KEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVYIVMEF 210 (461)
Q Consensus 131 ~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~lv~e~ 210 (461)
++||+|+||+||+|.++... +++.||||+++... .+....+.+.+|+++|++|+ |||||+++++|.+ +.+||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~-~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS-SEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES-SSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCC-cCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCC-CCCCceEEEEecc-CCEEEEEEc
Confidence 47999999999999875422 57889999997653 23445678999999999996 9999999999865 467899999
Q ss_pred cCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCCCCC--
Q 012518 211 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR-- 288 (461)
Q Consensus 211 ~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~~~~-- 288 (461)
|++|+|.+++.. ...+++..+..|+.||+.||.|||++|||||||||+|||++ .++.+||+|||+++.......
T Consensus 89 ~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~---~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 89 AELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp CTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEE
T ss_pred CCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc---ccCcccccchhhhhhcccccccc
Confidence 999999988754 46799999999999999999999999999999999999996 467799999999987654432
Q ss_pred --ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 012518 289 --LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 364 (461)
Q Consensus 289 --~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 364 (461)
.....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.+..++...+.+.... .....+++++.+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~~~~ 241 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYD 241 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHHHH
Confidence 23357899999999986 569999999999999999998 89999998888888777765322 122468999999
Q ss_pred HHHHhcccCcCCCCCHHHH---hcCCCc
Q 012518 365 FVRRLLNKDHRKRMTAAQA---LTHPWL 389 (461)
Q Consensus 365 li~~~L~~dP~~R~s~~e~---L~hp~~ 389 (461)
||.+||+.||.+|||++++ |+|+|+
T Consensus 242 li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 242 LMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999999998 455554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=415.54 Aligned_cols=259 Identities=28% Similarity=0.475 Sum_probs=217.8
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|+++++||+|+||+||+|+++. +|+.||||+++.... ......++.+|+.+|+.++ ||||++++++|.+.+.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---CCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccce
Confidence 589999999999999999999886 889999999976543 3445678899999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++|||++.|++|..++ ...+.+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||.+....
T Consensus 77 ~iv~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~---~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECC
T ss_pred eEEeeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc---cCCceeeeecchhhccc
Confidence 9999999988876654 5567899999999999999999999999999999999999995 46679999999998776
Q ss_pred CCC-CccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCC-CCChhhHHHHHHhcCCCCCC--------
Q 012518 285 PDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFW-ARTESGIFRSVLRADPNFHD-------- 352 (461)
Q Consensus 285 ~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~-~~~~~~~~~~i~~~~~~~~~-------- 352 (461)
... ......+++.|+|||++.+ .++.++|||||||++|||++|+.||. +.+..+.+..+.........
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 543 3344568899999998863 47999999999999999999999864 45555555555432211111
Q ss_pred -----------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 353 -----------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 353 -----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
.....+++++++||++||+.||.+|||++|+|+||||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 1124578999999999999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=427.47 Aligned_cols=258 Identities=28% Similarity=0.475 Sum_probs=210.8
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
++.+|++++.||+|+||+||+|+++. +|+.||||++++.. .....+.+.+|+++|++|+ ||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNV---NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPT 79 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETT---TCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSS
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECC---CCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecc
Confidence 45789999999999999999999876 89999999997643 4455678899999999996 999999999997543
Q ss_pred -----eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 203 -----SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 203 -----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
.+||+ +|+.||+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+||
T Consensus 80 ~~~~~~~~l~-~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~---~~~~~kl~Df 153 (345)
T d1pmea_ 80 IEQMKDVYLV-THLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDF 153 (345)
T ss_dssp TTTCCCEEEE-EECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCC
T ss_pred ccccceEEEE-EeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC---CCCCEEEccc
Confidence 34554 55668999998854 3699999999999999999999999999999999999995 5678999999
Q ss_pred ccccccCCCC----CccccccCCCcCchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCC--
Q 012518 278 GLSDFVRPDQ----RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN-- 349 (461)
Q Consensus 278 G~a~~~~~~~----~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-- 349 (461)
|++....... .....+||+.|+|||++. ..|+.++||||+||++|+|++|+.||.+....+...........
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCC
Confidence 9998664332 235578999999999985 35889999999999999999999999887766555444321111
Q ss_pred ---------------------CCC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCC
Q 012518 350 ---------------------FHD----SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 350 ---------------------~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 392 (461)
... ..++.+++++++||.+||++||.+|||+.|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 111 1135688999999999999999999999999999999855
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-55 Score=414.51 Aligned_cols=254 Identities=21% Similarity=0.336 Sum_probs=208.2
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++.+.||+|+||+||+|+.......+..||||++++....+....+++.+|+.+|++++ |||||++++++.+ +.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-cch
Confidence 47999999999999999999876543344579999998776666666788999999999996 9999999999976 467
Q ss_pred EEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccC
Q 012518 205 YIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 284 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~ 284 (461)
++|||||++|+|.+++..+.+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~---~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE---TTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc---ccceeeccchhhhhcc
Confidence 8999999999999998887778999999999999999999999999999999999999964 5679999999999875
Q ss_pred CCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCC
Q 012518 285 PDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 285 ~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
.... .....|+..|+|||++. ..++.++|||||||++|||+| |+.||.+.+..+.+..+.+....++ .+..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~ 240 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDC 240 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTTC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--Ccccc
Confidence 4432 23356888999999986 569999999999999999998 8999999999999888887654443 23578
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
++++++||.+||..||++|||+.|+++
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999863
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=408.23 Aligned_cols=253 Identities=19% Similarity=0.321 Sum_probs=204.8
Q ss_pred ccceeeceeeccCCceEEEEEEeccCC-ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGT-LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
.++|++.++||+|+||+||+|..+.+. .....||||++... .......++.+|+++|++|+ |||||++++++.+.+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYK 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc--cChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCC
Confidence 357999999999999999999876521 12247999999654 23445567899999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
.+++|||||.+|++.+.+......+++..+..++.||+.||.|||+++|+||||||+||||+ .++.+||+|||+++.
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~---~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRV 159 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC---
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC---CCCeEEEcccchhhc
Confidence 99999999999999998887778899999999999999999999999999999999999994 677899999999987
Q ss_pred cCCCCC----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCC-CCCCChhhHHHHHHhcCCCCCCCCCC
Q 012518 283 VRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRP-FWARTESGIFRSVLRADPNFHDSPWP 356 (461)
Q Consensus 283 ~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~ 356 (461)
...... .....||+.|||||++. +.|+.++|||||||+||||++|..| |......+++..+.... .. ....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~~--~~~~ 236 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RL--PTPM 236 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CC--CCCT
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-CC--CCch
Confidence 654322 23356899999999986 5699999999999999999996554 55566666666665442 11 2224
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 357 SVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 357 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.+++++.+||.+||+.||++|||+.|+++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 68999999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=425.69 Aligned_cols=259 Identities=29% Similarity=0.484 Sum_probs=214.5
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA- 201 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~- 201 (461)
+.++|++++.||+|+||+||+|+++. +|+.||||++++.. .+....+.+.+|+++|++|+ |||||+++++|...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 90 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETT---TTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeecc
Confidence 35789999999999999999999876 89999999998654 34445667889999999996 99999999999633
Q ss_pred ----CeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 202 ----NSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 202 ----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
...++||+|+.||+|.+++. .+++++..++.++.||+.||.|||++||+||||||+|||++ .++.+|++||
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~---~~~~~kl~df 165 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDF 165 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCC
T ss_pred ccccCceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc---cccccccccc
Confidence 34466677788999998774 35799999999999999999999999999999999999994 5678999999
Q ss_pred ccccccCCCCCccccccCCCcCchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCCCCC----
Q 012518 278 GLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH---- 351 (461)
Q Consensus 278 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---- 351 (461)
|++.... ....+..||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 166 g~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 166 GLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp ----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred chhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 9987653 34456789999999998653 478999999999999999999999999888777776654422211
Q ss_pred -------------------CC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCCCC
Q 012518 352 -------------------DS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 393 (461)
Q Consensus 352 -------------------~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 393 (461)
.. .+..++++++|||.+||+.||.+|||+.|+|+||||++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00 1246899999999999999999999999999999998653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=412.17 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=203.1
Q ss_pred ccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|+++++||+|+||+||+|.+.. ...+++.||||+++... .....+.+.+|+.++.++.+|+||+.+++++.+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 3689999999999999999998754 23356899999987542 3445567888999999887799999999988654
Q ss_pred -CeEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEec
Q 012518 202 -NSVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 265 (461)
Q Consensus 202 -~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~ 265 (461)
+.+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+||||+
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~- 168 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 168 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC-
Confidence 56899999999999999986542 3478999999999999999999999999999999999995
Q ss_pred CCCCCCeeEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhC-CCCCCCCChhhHH
Q 012518 266 REEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCG-SRPFWARTESGIF 340 (461)
Q Consensus 266 ~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg-~~Pf~~~~~~~~~ 340 (461)
.++.+||+|||+|+...... .....+||+.|||||++. +.|+.++|||||||++|||+|| ..||.+....+.+
T Consensus 169 --~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 169 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp --GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred --CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 56779999999998654432 234568999999999986 5699999999999999999986 5678776655555
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 341 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 341 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
..++........ ...+++++++||.+||+.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 247 CRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCC--CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555444333322 24589999999999999999999999999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=408.51 Aligned_cols=252 Identities=22% Similarity=0.356 Sum_probs=206.4
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeE
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSV 204 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~ 204 (461)
++|++++.||+|+||+||+|+++. ++.||||+++..... .+.+.+|+.+|++++ |+|||++++++.+ +.+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~----~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~~ 86 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPI 86 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECC----CCEEEEEEECcccCC----HHHHHHHHHHHHhcc-cCCEeEEEEEEec-CCe
Confidence 589999999999999999999863 467999999765432 367889999999996 9999999999865 568
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccccc
Q 012518 205 YIVMEFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 283 (461)
Q Consensus 205 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~ 283 (461)
|+|||||.+|+|.+++... ...+++.+++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++..
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~---~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLI 163 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC--
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC---CCCcEEEcccchhhhc
Confidence 9999999999998887654 35699999999999999999999999999999999999995 5677999999999876
Q ss_pred CCCC--CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCC-CCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 284 RPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRP-FWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 284 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
.... ......||+.|+|||++. +.++.++|||||||+||||++|..| |......+++..+..... ......++
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~---~~~~~~~~ 240 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECP 240 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTSC
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---CCCCcccC
Confidence 5433 234467999999999986 6799999999999999999996544 555666667777665432 12335689
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhc--CCCcCCC
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALT--HPWLHDE 392 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~--hp~~~~~ 392 (461)
+++++||.+||+.||++|||++++++ |+||...
T Consensus 241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 99999999999999999999999988 8898654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=413.69 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=208.0
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCc----EEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGK----VVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
++|++++.||+|+||+||+|+++. +|+ .||||.++... +....+.+.+|+.+|++++ |||||+++++|.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~---~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLT 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC-------CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEES
T ss_pred HHCEEeeEEecCCCeEEEEEEEcC---CCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec
Confidence 479999999999999999998865 444 58888876432 3334578999999999996 9999999999986
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccc
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 280 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a 280 (461)
+ ..+++|||+.+|+|.+.+......+++..++.|+.||+.||.|||++|||||||||+|||++ .++.+||+|||+|
T Consensus 83 ~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~---~~~~~kl~DFGla 158 (317)
T d1xkka_ 83 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLA 158 (317)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCCSHH
T ss_pred C-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---CCCCeEeeccccc
Confidence 5 57788999999999999988888899999999999999999999999999999999999996 4667999999999
Q ss_pred cccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCC
Q 012518 281 DFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPW 355 (461)
Q Consensus 281 ~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 355 (461)
+....... .....||+.|||||++. +.|+.++|||||||+||||+| |..||.+.+..++...+..+... . ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~--~p 235 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-P--QP 235 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-C--CC
T ss_pred eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-C--CC
Confidence 87754432 23457899999999886 569999999999999999998 89999888888877777664322 1 12
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 356 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 356 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
+.+++++.+||.+||..||.+|||+.|+++|
T Consensus 236 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 4689999999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=421.98 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=202.4
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe---
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED--- 200 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~--- 200 (461)
.++|+++++||+|+||+||+|+++. +|+.||||++.+... +.....++.+|+.+|++++ |||||+++++|..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~---t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKT 90 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETT---TTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCcCeEEEEEEECC---CCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccc
Confidence 3689999999999999999999886 899999999976543 4555678899999999996 9999999999963
Q ss_pred ---CCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeec
Q 012518 201 ---ANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 277 (461)
Q Consensus 201 ---~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DF 277 (461)
...+|+|||||.+ ++++.+ ...+++..++.+++||+.||.|||++||+||||||+|||++ .++.+|++||
T Consensus 91 ~~~~~~~~iv~Ey~~~-~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~---~~~~~kl~df 163 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDA-NLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDF 163 (355)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC
T ss_pred cccCceeEEEEeccch-HHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc---cccceeeech
Confidence 4689999999976 455544 24689999999999999999999999999999999999995 5677999999
Q ss_pred ccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHhcCC--------
Q 012518 278 GLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP-------- 348 (461)
Q Consensus 278 G~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-------- 348 (461)
|+++...........+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+.......+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 164 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp CC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 9998877766777789999999999986 4699999999999999999999999998887766655543211
Q ss_pred --------------CCCCCCC----------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcCC
Q 012518 349 --------------NFHDSPW----------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 391 (461)
Q Consensus 349 --------------~~~~~~~----------------~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 391 (461)
......+ ..+++++++||++||..||++||||+|+|+||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 1111100 114678999999999999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=412.69 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=209.9
Q ss_pred cceeeceeeccCCceEEEEEEeccCCccCc--EEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 125 AKFELGKEVGRGHFGHTCCAKGKKGTLKGK--VVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
++|++.++||+|+||+||+|+++. +|. .||||.++... .....+.+.+|+++|+++.+|||||+++++|.+.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~---~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC---CCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 589999999999999999999876 554 46777775432 23345678999999999966999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC
Q 012518 203 SVYIVMEFCEGGELLDRILSR---------------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 267 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~ 267 (461)
.+|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~--- 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG--- 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc---
Confidence 999999999999999988643 35789999999999999999999999999999999999995
Q ss_pred CCCCeeEeecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCC-CCCCCCChhhHHHHHHh
Q 012518 268 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGS-RPFWARTESGIFRSVLR 345 (461)
Q Consensus 268 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~-~Pf~~~~~~~~~~~i~~ 345 (461)
.++.+||+|||+++............||..|+|||.+. +.|+.++|||||||++|||++|. .||.+.+..+++..+.+
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 56679999999998765544445667999999999986 56999999999999999999965 57888888888888766
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 346 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 346 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
... ...+..+++++++||.+||+.||++|||+.|+++|
T Consensus 242 ~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 421 22335689999999999999999999999999976
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=403.71 Aligned_cols=254 Identities=23% Similarity=0.392 Sum_probs=210.9
Q ss_pred ccceeeceeeccCCceEEEEEEeccCC----ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGT----LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFE 199 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~ 199 (461)
.++|++++.||+|+||.||+|+..... .++..||||++++.. .......+.+|+.++.++.+|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 469999999999999999999875421 234589999997653 44556788899999999967999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEe
Q 012518 200 DANSVYIVMEFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 264 (461)
Q Consensus 200 ~~~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~ 264 (461)
+++.+|+|||||++|+|.+++..+. ..+++.+++.++.||+.||+|||++|||||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 9999999999999999999986543 3589999999999999999999999999999999999994
Q ss_pred cCCCCCCeeEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhH
Q 012518 265 TREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 339 (461)
Q Consensus 265 ~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~ 339 (461)
.++.+||+|||+++...... ......||+.|+|||++. +.|+.++|||||||++|||++ |..||.+.+...+
T Consensus 170 ---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 170 ---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp ---TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred ---CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 66789999999998765433 234467999999999886 679999999999999999998 7999988888877
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 340 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 340 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+..+.... .+. ....+++++.+||.+||+.||.+|||+.|+++
T Consensus 247 ~~~i~~~~-~~~--~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 247 FKLLKEGH-RMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTTC-CCC--CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCC-CCC--CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 77665542 222 22468999999999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-52 Score=403.56 Aligned_cols=254 Identities=20% Similarity=0.293 Sum_probs=214.7
Q ss_pred cccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED 200 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~ 200 (461)
..++|++++.||+|+||+||+|+.+. +..+++.||||+++... .....+++.+|+++|++++ ||||++++++|.+
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~ 87 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAV 87 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceeeecc
Confidence 34689999999999999999998753 22367889999987542 4455678999999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Q 012518 201 ANSVYIVMEFCEGGELLDRILSRG-----------------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 257 (461)
Q Consensus 201 ~~~~~lv~e~~~gg~L~~~l~~~~-----------------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlk 257 (461)
.+..++||||+.+|+|.+++.... ..+++..+..|+.||+.||.|||++||||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 999999999999999999886432 237888999999999999999999999999999
Q ss_pred CCcEEEecCCCCCCeeEeecccccccCCCC---CccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCC-CCCC
Q 012518 258 PENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGS-RPFW 332 (461)
Q Consensus 258 p~NILl~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~-~Pf~ 332 (461)
|+|||++ .++.+||+|||+|+...... ...+..||+.|+|||++. ..|+.++|||||||+||||++|. .||.
T Consensus 168 p~NILld---~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 168 TRNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp GGGEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccceEEC---CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 9999995 56779999999998664332 234567899999999987 56999999999999999999985 6888
Q ss_pred CCChhhHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 333 ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 333 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+.+..+++..+...... .....+++++.+||.+||+.||++|||+.|+++
T Consensus 245 ~~~~~e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 245 GMAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88888888888765432 122468999999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=397.36 Aligned_cols=243 Identities=22% Similarity=0.363 Sum_probs=200.3
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-CC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED-AN 202 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~-~~ 202 (461)
.++|++++.||+|+||.||+|+. +|+.||||++++.. ..+.+.+|+++|++++ ||||+++++++.+ .+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 74 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-----CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCC
Confidence 35799999999999999999986 46789999997543 2367889999999996 9999999999854 56
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
.+||||||+++|+|.+++..+. ..+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec---CCCCEeecccccce
Confidence 7899999999999999986543 3589999999999999999999999999999999999994 67789999999998
Q ss_pred ccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhHHHHHHhcCCCCCCCCCCCCC
Q 012518 282 FVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 359 (461)
Q Consensus 282 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 359 (461)
.... ......+|..|+|||++. +.++.++|||||||++|||+| |+.||...+..++...+.+.... .....++
T Consensus 152 ~~~~--~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~ 226 (262)
T d1byga_ 152 EASS--TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCP 226 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCC
T ss_pred ecCC--CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccCC
Confidence 7543 234467899999999986 679999999999999999998 79999888888888887654221 1224589
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 360 PEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 360 ~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+++++||.+||+.||.+|||+.|+++
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 99999999999999999999999876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-52 Score=401.55 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=214.7
Q ss_pred ccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|+++++||+|+||.||+|+.+. ...+++.||||+++... .......+.+|+.+++++.+|||||++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 3699999999999999999998743 23467899999997653 3445667899999999997799999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEe
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG-----------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 264 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~-----------------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~ 264 (461)
+.+|||||||++|+|.+++.... ..+++..+..++.||+.||.|||++|||||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999886542 2588899999999999999999999999999999999995
Q ss_pred cCCCCCCeeEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCChhhH
Q 012518 265 TREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 339 (461)
Q Consensus 265 ~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~ 339 (461)
.++.+||+|||+++....... ....+||+.|+|||++. +.++.++|||||||++|||+| |.+||......+.
T Consensus 180 ---~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 180 ---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp ---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred ---ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 567799999999987654332 23468999999999986 679999999999999999998 6666766666666
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 340 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 340 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
+..++......... ..+++++.+||.+||+.||++|||++|+++
T Consensus 257 ~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 257 FYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66666554333222 458999999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=396.15 Aligned_cols=251 Identities=20% Similarity=0.264 Sum_probs=204.9
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-CCeEE
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFED-ANSVY 205 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~-~~~~~ 205 (461)
+++.++||+|+||+||+|+...+..+...||||++++. .+....+++.+|+++|++|+ ||||+++++++.+ ++.++
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceE
Confidence 34468899999999999998654333457999998653 45666788999999999996 9999999999865 56899
Q ss_pred EEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccccCC
Q 012518 206 IVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 285 (461)
Q Consensus 206 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~~~~ 285 (461)
+|||||++|+|.+++.......++..+..++.||+.||.|||+++|+||||||+|||++ +++.+||+|||+++....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~---~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC---CCCCEEEecccchhhccc
Confidence 99999999999998877777788899999999999999999999999999999999994 677899999999987654
Q ss_pred CCC-----ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC-hhhHHHHHHhcCCCCCCCCCCCC
Q 012518 286 DQR-----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART-ESGIFRSVLRADPNFHDSPWPSV 358 (461)
Q Consensus 286 ~~~-----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 358 (461)
... .....||+.|+|||++. +.++.++|||||||+||||+||..||.... ..++...+..+... ..+ ..+
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~-~~p--~~~ 259 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-LQP--EYC 259 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC-CCC--TTC
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CCc--ccC
Confidence 322 23357899999999986 679999999999999999999888876543 33445555554322 221 458
Q ss_pred CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 012518 359 SPEAKDFVRRLLNKDHRKRMTAAQALTH 386 (461)
Q Consensus 359 s~~~~~li~~~L~~dP~~R~s~~e~L~h 386 (461)
++++.+||.+||+.||++||++.|+++|
T Consensus 260 ~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 260 PDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 8999999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-51 Score=397.55 Aligned_cols=260 Identities=19% Similarity=0.294 Sum_probs=209.4
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
.+++|++++.||+|+||+||+|+++. +|+.||||++...... +++.+|+++++.+++|++|+.+.+++.+.+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECC---CCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 45789999999999999999999876 7899999998765322 346789999999986667777888888999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCeeEeecccccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 282 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~~ 282 (461)
..++||||| +++|.+.+......+++..+..++.||+.||+|||++|||||||||+|||++..+.+..+||+|||+|+.
T Consensus 77 ~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 999999999 5677777777778899999999999999999999999999999999999997666777899999999987
Q ss_pred cCCCC--------CccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChhhHHHHHHh---cCCCC
Q 012518 283 VRPDQ--------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR---ADPNF 350 (461)
Q Consensus 283 ~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~---~~~~~ 350 (461)
..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||...........+.. .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 65432 2245689999999999874 599999999999999999999999977654433322211 11001
Q ss_pred -CCCCCCCCCHHHHHHHHHhcccCcCCCCCHH---HHhcCCCcCC
Q 012518 351 -HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA---QALTHPWLHD 391 (461)
Q Consensus 351 -~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~---e~L~hp~~~~ 391 (461)
.......+++++.+||.+||..||.+||++. ++|+|+|.+.
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 1112346899999999999999999999987 4567776543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-51 Score=394.37 Aligned_cols=253 Identities=19% Similarity=0.292 Sum_probs=215.0
Q ss_pred ccceeeceeeccCCceEEEEEEecc--CCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKK--GTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDA 201 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~ 201 (461)
.++|++++.||+|+||+||+|.++. ...+++.||||+++.. ........+.+|+++++++. |||||++++++...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecC
Confidence 4689999999999999999998752 1124678999999754 34455677899999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCCe
Q 012518 202 NSVYIVMEFCEGGELLDRILSRG---------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 272 (461)
Q Consensus 202 ~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~~ 272 (461)
+.+++|||||.+|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceE
Confidence 99999999999999999886431 246888999999999999999999999999999999999 467789
Q ss_pred eEeecccccccCCCCC---ccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhC-CCCCCCCChhhHHHHHHhcC
Q 012518 273 KVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCG-SRPFWARTESGIFRSVLRAD 347 (461)
Q Consensus 273 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg-~~Pf~~~~~~~~~~~i~~~~ 347 (461)
||+|||+|+....... .....||+.|+|||.+. +.++.++|||||||+||||+|| ..||.+.+..+.+..+.+..
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999987654332 23457899999999986 5689999999999999999998 58888888888888877654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 348 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 348 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
... ....+++.+.+||.+||+.||++|||+.|+++
T Consensus 253 ~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 253 LLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 321 12468999999999999999999999999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.2e-50 Score=384.10 Aligned_cols=253 Identities=19% Similarity=0.279 Sum_probs=207.6
Q ss_pred cccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012518 123 FGAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN 202 (461)
Q Consensus 123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~ 202 (461)
++++|++++.||+|+||+||+|+++. +|+.||||++...... ..+.+|+++++.|.+|+||+.+++++.+..
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CCCceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 45799999999999999999999876 7899999998654322 346789999999987799999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCC--CCCCeeEeecccc
Q 012518 203 SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE--EDAPLKVIDFGLS 280 (461)
Q Consensus 203 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~--~~~~~kl~DFG~a 280 (461)
..|+||||| +++|.+.+......+++..+..++.|++.||+|||++||+||||||+|||++... .++.+||+|||+|
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 999999999 6899998877777899999999999999999999999999999999999997432 3567999999999
Q ss_pred cccCCCC--------CccccccCCCcCchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCChh---hHHHHHHhcCC
Q 012518 281 DFVRPDQ--------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTES---GIFRSVLRADP 348 (461)
Q Consensus 281 ~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~~~~~ 348 (461)
+...... .....+||+.|||||++.+ .++.++|||||||++|||++|..||.+.... ..+..+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 8764321 2345689999999999874 5999999999999999999999999764432 23333322211
Q ss_pred CC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 012518 349 NF-HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 384 (461)
Q Consensus 349 ~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L 384 (461)
.. .....+.+++++.+++..|+..+|++||+.+.+.
T Consensus 234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 11 1111245889999999999999999999876653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=378.74 Aligned_cols=247 Identities=22% Similarity=0.275 Sum_probs=187.4
Q ss_pred ccceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-
Q 012518 124 GAKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDAN- 202 (461)
Q Consensus 124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~- 202 (461)
..+|.+.+.||+|+||+||+|+. +|+.||||+++.... .......|+..+.+++ |||||++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-----~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSREE----RSWFREAEIYQTVMLR-HENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccch----hHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCC
Confidence 35799999999999999999975 578999999865421 1112234555555675 999999999997654
Q ss_pred ---eEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------cCccccCCCCCcEEEecCCCCCC
Q 012518 203 ---SVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL--------QGVVHRDLKPENFLFTTREEDAP 271 (461)
Q Consensus 203 ---~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~--------~givHrDlkp~NILl~~~~~~~~ 271 (461)
.+|||||||++|+|.+++.+. .+++..+..++.|++.||.|||+ +|||||||||+||||+ .++.
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~---~~~~ 146 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGT 146 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC---TTSC
T ss_pred cceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc---CCCC
Confidence 689999999999999998654 58999999999999999999996 5999999999999994 6778
Q ss_pred eeEeecccccccCCCC-----CccccccCCCcCchhhhhcc-------CCCchhHHHHHHHHHHHhhCCCCCCCCC----
Q 012518 272 LKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLHRS-------YNVEGDMWSIGVITYILLCGSRPFWART---- 335 (461)
Q Consensus 272 ~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~-------~~~~~DiwSlGvil~elltg~~Pf~~~~---- 335 (461)
+||+|||++....... .....+||+.|||||++.+. ++.++|||||||+||||+||..||....
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 9999999998765433 23457899999999998642 5778999999999999999988763211
Q ss_pred -----------hhhHHHHHHhcCC--CCCCCC-CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 012518 336 -----------ESGIFRSVLRADP--NFHDSP-WPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 385 (461)
Q Consensus 336 -----------~~~~~~~i~~~~~--~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 385 (461)
.......+..... .++... ......++.+|+.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1122222222111 111100 0112346889999999999999999999875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.2e-47 Score=375.41 Aligned_cols=265 Identities=27% Similarity=0.436 Sum_probs=200.5
Q ss_pred CCCccc-cceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcC----------C
Q 012518 119 YGKNFG-AKFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALS----------G 187 (461)
Q Consensus 119 ~~~~~~-~~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~----------~ 187 (461)
.|+.+. .+|+++++||+|+||+||+|+++. +|+.||||++++.. ...+.+.+|+++++.+. +
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~---~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~ 78 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMG 78 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred CCCCccCCcEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcC
Confidence 466665 479999999999999999999876 89999999997642 33466788999998874 2
Q ss_pred CCCeeEEEEEEEe--CCeEEEEEeccCCCchHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCcEE
Q 012518 188 HKHMIKFHDAFED--ANSVYIVMEFCEGGELLDRI--LSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFL 262 (461)
Q Consensus 188 hpniv~l~~~~~~--~~~~~lv~e~~~gg~L~~~l--~~~~~~~~~~~~~~i~~qil~al~yLH~-~givHrDlkp~NIL 262 (461)
|+||+++++++.. ....++||+++..+...... ......+++..++.++.||+.||.|||+ .||+||||||+|||
T Consensus 79 ~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIl 158 (362)
T d1q8ya_ 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 158 (362)
T ss_dssp HTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEE
T ss_pred cCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHee
Confidence 6889999988854 45677777777555443332 2334678999999999999999999998 89999999999999
Q ss_pred EecCCCC---CCeeEeecccccccCCCCCccccccCCCcCchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCChh-
Q 012518 263 FTTREED---APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES- 337 (461)
Q Consensus 263 l~~~~~~---~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~- 337 (461)
++..+.. ..+||+|||.+..... .....+||+.|+|||++. ..|+.++||||+||++++|++|+.||......
T Consensus 159 l~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 159 MEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred eeccCcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 9753322 2489999999876542 335678999999999876 56999999999999999999999999654321
Q ss_pred -----hHHHHHHhcCC------------------------CCCC--------------CCCCCCCHHHHHHHHHhcccCc
Q 012518 338 -----GIFRSVLRADP------------------------NFHD--------------SPWPSVSPEAKDFVRRLLNKDH 374 (461)
Q Consensus 338 -----~~~~~i~~~~~------------------------~~~~--------------~~~~~~s~~~~~li~~~L~~dP 374 (461)
+.+..+..... .... ..+...+++++|||.+||+.||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 11111110000 0000 0112246889999999999999
Q ss_pred CCCCCHHHHhcCCCcCCC
Q 012518 375 RKRMTAAQALTHPWLHDE 392 (461)
Q Consensus 375 ~~R~s~~e~L~hp~~~~~ 392 (461)
.+|||++|+|+||||++.
T Consensus 317 ~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp TTCBCHHHHHTCGGGTTC
T ss_pred hHCcCHHHHhcCcccCCC
Confidence 999999999999999865
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1.1e-27 Score=214.33 Aligned_cols=167 Identities=25% Similarity=0.239 Sum_probs=122.9
Q ss_pred eeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccC---------------CHHHHHHHHHHHHHHHhcCCCCCe
Q 012518 127 FELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMT---------------SALAIEDVRREVKILKALSGHKHM 191 (461)
Q Consensus 127 y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~~hpni 191 (461)
+.++++||+|+||+||+|++. +|+.||||+++..... .........+|+..+.++. |.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~----~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v 76 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAV 76 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSS
T ss_pred chhCCEeeeCcceEEEEEECC----CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCc
Confidence 457899999999999999874 6889999987642111 0111234567899999996 9999
Q ss_pred eEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcEEEecCCCCCC
Q 012518 192 IKFHDAFEDANSVYIVMEFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP 271 (461)
Q Consensus 192 v~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~i~~qil~al~yLH~~givHrDlkp~NILl~~~~~~~~ 271 (461)
+..+++.. .++||||+.++.+.+ +.+..+..++.||+.+|.|||++||+||||||+|||++. ..
T Consensus 77 ~~~~~~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~----~~ 140 (191)
T d1zara2 77 PKVYAWEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE----EG 140 (191)
T ss_dssp CCEEEEET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET----TE
T ss_pred ceEEEecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC----CC
Confidence 99886532 279999998865532 445567789999999999999999999999999999962 34
Q ss_pred eeEeecccccccCCCCCccccccCCCcCc------hhhhhccCCCchhHHHHHHHH
Q 012518 272 LKVIDFGLSDFVRPDQRLNDIVGSAYYVA------PEVLHRSYNVEGDMWSIGVIT 321 (461)
Q Consensus 272 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~a------PE~l~~~~~~~~DiwSlGvil 321 (461)
++|+|||+|........ ..|.. .+.+.+.|+.++|+||+.--+
T Consensus 141 ~~liDFG~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 141 IWIIDFPQSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EEECCCTTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EEEEECCCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99999999876542211 11211 133456789999999976543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.65 E-value=8.8e-08 Score=87.38 Aligned_cols=85 Identities=15% Similarity=0.096 Sum_probs=62.2
Q ss_pred ceeeceeeccCCceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 126 KFELGKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
.|+..+..+-++.+.||++.. .++.+.||+........ ...+.+|..++..|..+--+.+++.+..+++..|
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~-----~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEEC-----SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred ceEEEEcCCCCCCCcEEEEEe-----CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 566666655555678998753 45668889876543222 2346789999998876656788899889999999
Q ss_pred EEEeccCCCchHH
Q 012518 206 IVMEFCEGGELLD 218 (461)
Q Consensus 206 lv~e~~~gg~L~~ 218 (461)
+||++++|..+.+
T Consensus 87 lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 87 LLMSEADGVLCSE 99 (263)
T ss_dssp EEEECCSSEEHHH
T ss_pred EEEEecccccccc
Confidence 9999999877654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.20 E-value=1.4e-06 Score=84.29 Aligned_cols=82 Identities=18% Similarity=0.214 Sum_probs=51.5
Q ss_pred ceeeccCCceEEEEEEeccCCccCcEEEEEEeccc-cc---CCHHHHHHHHHHHHHHHhcCCC--CCeeEEEEEEEeCCe
Q 012518 130 GKEVGRGHFGHTCCAKGKKGTLKGKVVAVKIISKA-KM---TSALAIEDVRREVKILKALSGH--KHMIKFHDAFEDANS 203 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~~~g~~vAvK~i~~~-~~---~~~~~~~~~~~Ei~il~~l~~h--pniv~l~~~~~~~~~ 203 (461)
.+.||.|....||++.... .|+.|+||.-... .. ......++..+|..+|+.+..+ ..+.+++.+ +.+.
T Consensus 31 ~~eig~G~~N~vfrV~~~~---~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC-------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred EEEeCCCceEeEEEEEeCC---CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC
Confidence 4568999999999998654 5678999974321 00 0111234556788888877543 346666654 4445
Q ss_pred EEEEEeccCCCch
Q 012518 204 VYIVMEFCEGGEL 216 (461)
Q Consensus 204 ~~lv~e~~~gg~L 216 (461)
.++|||++.+..+
T Consensus 106 ~~lvmE~L~~~~~ 118 (392)
T d2pula1 106 AVTVMEDLSHLKI 118 (392)
T ss_dssp TEEEECCCTTSEE
T ss_pred CEEEEeccCCccc
Confidence 5789999987554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.05 E-value=6.5e-06 Score=74.09 Aligned_cols=75 Identities=15% Similarity=0.139 Sum_probs=52.8
Q ss_pred eeccCCc-eEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCC-CCeeEEEEEEEeCCeEEEEEe
Q 012518 132 EVGRGHF-GHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGH-KHMIKFHDAFEDANSVYIVME 209 (461)
Q Consensus 132 ~lG~G~f-g~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~h-pniv~l~~~~~~~~~~~lv~e 209 (461)
.+..|.. +.||++... .|..+.+|....... ..+.+|+..|+.|..+ -.+.+++.+..+.+..++||+
T Consensus 17 ~~~~G~s~~~v~r~~~~----~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~ 86 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ----GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 86 (255)
T ss_dssp ECSCTTSSCEEEEEECT----TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred EcCCcccCCeEEEEEeC----CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEE
Confidence 3444543 678988754 466688898654432 2356788888877543 236778888888889999999
Q ss_pred ccCCCch
Q 012518 210 FCEGGEL 216 (461)
Q Consensus 210 ~~~gg~L 216 (461)
+++|.++
T Consensus 87 ~i~G~~~ 93 (255)
T d1nd4a_ 87 EVPGQDL 93 (255)
T ss_dssp CCSSEET
T ss_pred eeecccc
Confidence 9988655
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.44 E-value=0.00017 Score=69.20 Aligned_cols=78 Identities=13% Similarity=0.052 Sum_probs=52.8
Q ss_pred ceeeccCCceEEEEEEeccCC----ccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCeEE
Q 012518 130 GKEVGRGHFGHTCCAKGKKGT----LKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHKHMIKFHDAFEDANSVY 205 (461)
Q Consensus 130 ~~~lG~G~fg~V~~~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hpniv~l~~~~~~~~~~~ 205 (461)
++.|+-|-.-.+|++....+. ...+.|.+++.-.. ... .+..+|..+++.+..+.-..++++++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 467888888899999865422 13456777776421 122 3455899999999766555688887753 5
Q ss_pred EEEeccCCCch
Q 012518 206 IVMEFCEGGEL 216 (461)
Q Consensus 206 lv~e~~~gg~L 216 (461)
+||||++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.28 E-value=0.00036 Score=64.95 Aligned_cols=69 Identities=9% Similarity=0.079 Sum_probs=45.0
Q ss_pred ceEEEEEEeccCCccCcEEEEEEecccccCCHHHHHHHHHHHHHHHhcCCCC-CeeEEE-----EEEEeCCeEEEEEecc
Q 012518 138 FGHTCCAKGKKGTLKGKVVAVKIISKAKMTSALAIEDVRREVKILKALSGHK-HMIKFH-----DAFEDANSVYIVMEFC 211 (461)
Q Consensus 138 fg~V~~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~~hp-niv~l~-----~~~~~~~~~~lv~e~~ 211 (461)
--.||++... +|+.|++|+.+.... ..+++..|+..+..|.++. -++..+ ..+...+..+.+++++
T Consensus 35 EN~vy~v~~~----dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 35 ENRVYQFQDE----DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp SSEEEEECCT----TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred cceeEEEEcC----CCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeec
Confidence 3589998764 678899999865432 2356778999888875221 111111 1234567789999999
Q ss_pred CCC
Q 012518 212 EGG 214 (461)
Q Consensus 212 ~gg 214 (461)
.|.
T Consensus 107 ~G~ 109 (325)
T d1zyla1 107 GGR 109 (325)
T ss_dssp CCE
T ss_pred CCc
Confidence 774
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=96.68 E-value=0.00056 Score=48.47 Aligned_cols=36 Identities=28% Similarity=0.478 Sum_probs=32.6
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 426 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 426 ~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
+|+++|+..+++.|..+|. ++|.|+.+||..++..+
T Consensus 1 qLs~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~ 37 (73)
T d2pq3a1 1 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSL 37 (73)
T ss_dssp CCCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHT
T ss_pred CcCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHh
Confidence 4789999999999999999 99999999999998764
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=96.60 E-value=0.00054 Score=49.10 Aligned_cols=36 Identities=25% Similarity=0.454 Sum_probs=29.3
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 425 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 425 ~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..|+++|+..+++.|..+|. ++|.|+.+||..+|..
T Consensus 2 ~~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~ 38 (77)
T d1f54a_ 2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRS 38 (77)
T ss_dssp CCCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHH
Confidence 35778888888888888888 8888888888888764
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=96.55 E-value=0.0016 Score=47.16 Aligned_cols=41 Identities=32% Similarity=0.387 Sum_probs=35.1
Q ss_pred HHHHHhcCHHHHHHHHHHhhhcCC-C-CCeecHHHHHHHHhhC
Q 012518 421 KALSKALTEEELVYLRAQFMLLEP-K-DGCVSLNNFKVVSWLL 461 (461)
Q Consensus 421 ~~~~~~l~~~e~~~l~~~f~~~d~-~-~g~~~~~el~~~~~~~ 461 (461)
+.....|+++++..+++.|..+|. + +|.|+..||+.+|+.|
T Consensus 3 k~~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~l 45 (82)
T d1wrka1 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRML 45 (82)
T ss_dssp HHHHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHT
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHc
Confidence 345678999999999999999998 4 6999999999998764
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=96.47 E-value=0.00093 Score=38.93 Aligned_cols=28 Identities=21% Similarity=0.357 Sum_probs=25.3
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
.|++.|+.+|. ++|.|+.+||+.+|.+|
T Consensus 4 el~eAF~~FDkDg~G~Is~~EL~~vm~~l 32 (33)
T d2hf5a1 4 EIREAFRVFDKDGNGYISAAELRHVMTNL 32 (33)
T ss_dssp HHHHHHHHHSSSCCSCBCHHHHHHHTTSC
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHHc
Confidence 46789999999 99999999999999875
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=96.46 E-value=0.0014 Score=47.42 Aligned_cols=34 Identities=18% Similarity=0.178 Sum_probs=29.7
Q ss_pred CHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 428 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 428 ~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
|++|+..+++.|..+|. ++|.|+.+||..+|.+|
T Consensus 1 T~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~l 35 (81)
T d2opoa1 1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKTL 35 (81)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHh
Confidence 56788889999999999 89999999999988764
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.37 E-value=0.002 Score=46.47 Aligned_cols=37 Identities=24% Similarity=0.390 Sum_probs=32.0
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 425 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 425 ~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
..|+++++..+++.|..+|. ++|.|+.+||..+|..+
T Consensus 6 ~~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~ 43 (81)
T d1avsa_ 6 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRML 43 (81)
T ss_dssp HHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHT
T ss_pred ccCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHc
Confidence 35788899999999999999 89999999999988754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.92 E-value=0.0064 Score=55.61 Aligned_cols=30 Identities=37% Similarity=0.552 Sum_probs=24.4
Q ss_pred cCccccCCCCCcEEEecCCCCCCeeEeeccccc
Q 012518 249 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 281 (461)
Q Consensus 249 ~givHrDlkp~NILl~~~~~~~~~kl~DFG~a~ 281 (461)
.|+||+|+.++||+++ .+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFL---GDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcc---cccceeEecccccc
Confidence 3799999999999995 34445799999775
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=95.69 E-value=0.0004 Score=51.15 Aligned_cols=38 Identities=21% Similarity=0.385 Sum_probs=26.4
Q ss_pred HHHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 423 LSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 423 ~~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
|+..++++++..|++.|..+|. ++|.|+.+||+.+|+.
T Consensus 13 ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~ 51 (87)
T d1s6ja_ 13 MAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR 51 (87)
T ss_dssp SSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHT
T ss_pred HHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHH
Confidence 4556666666667777777777 7777777777777664
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.06 E-value=0.02 Score=42.23 Aligned_cols=25 Identities=20% Similarity=0.255 Sum_probs=14.3
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
|.++|...|. ++|.|+.+||..++.
T Consensus 46 l~~i~~~~D~d~dG~l~~~EF~~am~ 71 (95)
T d1c07a_ 46 LAHIWSLCDTKDCGKLSKDQFALAFH 71 (95)
T ss_dssp HHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred HHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 4455555565 566666666655543
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=93.79 E-value=0.025 Score=38.40 Aligned_cols=27 Identities=22% Similarity=0.404 Sum_probs=24.2
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
|++.|+.+|. ++|.|+.+||+.++..+
T Consensus 5 l~~aF~~fD~d~~G~I~~~el~~~l~~l 32 (65)
T d1fw4a_ 5 IREAFRVFDKDGNGYISAAELRHVMTNL 32 (65)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHHHHHHT
T ss_pred HHHHHHHHcCCCCCcCCHHHHHHHHHHh
Confidence 6789999999 99999999999998764
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=93.73 E-value=0.033 Score=40.74 Aligned_cols=24 Identities=29% Similarity=0.425 Sum_probs=11.8
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHH
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVS 458 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~ 458 (461)
|+.++...|. ++|.|+.+||..++
T Consensus 45 l~~i~~~~D~d~dG~l~~~EF~~a~ 69 (92)
T d1fi6a_ 45 LSHIWELSDFDKDGALTLDEFCAAF 69 (92)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred HHHHHHHhCCCCCCeecHHHHHHHH
Confidence 4444445555 45555555554443
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=93.20 E-value=0.034 Score=37.13 Aligned_cols=28 Identities=18% Similarity=0.259 Sum_probs=24.7
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
.+++.|..+|. ++|.|+.+||+.++..+
T Consensus 2 el~~aF~~fD~~~~G~I~~~el~~~l~~~ 30 (61)
T d2fcea1 2 DFVKAFQVFDKESTGKVSVGDLRYMLTGL 30 (61)
T ss_dssp HHHHHHHHHCTTCCSCEEHHHHHHHHHHT
T ss_pred hHHHHHHHHCCCCCCeEeHHHHHHHHHHc
Confidence 46788999999 99999999999998754
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=93.12 E-value=0.045 Score=37.24 Aligned_cols=38 Identities=18% Similarity=0.247 Sum_probs=29.9
Q ss_pred HHHHHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 421 KALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 421 ~~~~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
..+...++++++ .+.|..+|. ++|.|+.+||...+.++
T Consensus 28 ~~lg~~~~~~~i---~~~~~~~D~d~dg~I~~~EF~~~m~~~ 66 (67)
T d1tiza_ 28 LAFSPYFTQEDI---VKFFEEIDVDGNGELNADEFTSCIEKM 66 (67)
T ss_dssp HHTCTTSCHHHH---HHHHHHHCCSSSSEECHHHHHHHHHTC
T ss_pred HHhccccchHHH---HHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence 334556777775 467788899 99999999999998764
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.80 E-value=0.052 Score=39.91 Aligned_cols=28 Identities=25% Similarity=0.375 Sum_probs=20.1
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..|+.++...|. ++|.|+++||..++..
T Consensus 43 ~~L~~Iw~~~D~~~dG~l~~~EF~~a~~L 71 (95)
T d2jxca1 43 DILGRVWELSDIDHDGMLDRDEFAVAMFL 71 (95)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCeEcHHHHHHHHHH
Confidence 346677777787 7888888888776543
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.79 E-value=0.039 Score=38.63 Aligned_cols=28 Identities=14% Similarity=0.292 Sum_probs=24.1
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
.|++.|..+|. ++|.|+.+||+.+|..+
T Consensus 10 el~~~F~~fD~~~~G~I~~~el~~~l~~l 38 (75)
T d1jc2a_ 10 ELANCFRIFDKNADGFIDIEELGEILRAT 38 (75)
T ss_dssp HHHHHHHHHCCSTTSSEEHHHHHHHHHHS
T ss_pred HHHHHHHHHcCCCcCeEcHHHHHHHHHhc
Confidence 46788999999 89999999999998764
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=92.60 E-value=0.038 Score=37.68 Aligned_cols=27 Identities=30% Similarity=0.514 Sum_probs=24.6
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
+++.|+.+|. ++|.|+.+||+.+++.+
T Consensus 3 ~r~~F~~~D~d~~G~I~~~El~~~l~~l 30 (67)
T d1tiza_ 3 AKRVFEKFDKNKDGKLSLDEFREVALAF 30 (67)
T ss_dssp HHHHHHHHCTTSSSCEEHHHHHHHHHHT
T ss_pred HHHHHHHHCCCCcCcCcHHHHHHHHHHh
Confidence 6789999999 99999999999998764
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=92.13 E-value=0.036 Score=38.95 Aligned_cols=28 Identities=14% Similarity=0.328 Sum_probs=20.6
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..|++.|..+|. ++|.|+.+||+.+|..
T Consensus 9 e~l~~~F~~~D~d~~G~I~~~el~~~l~~ 37 (77)
T d1oqpa_ 9 EEILKAFRLFDDDNSGTITIKDLRRVAKE 37 (77)
T ss_dssp HHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCEechHHHHHHHHH
Confidence 356777777777 7788888887777654
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=92.08 E-value=0.057 Score=38.30 Aligned_cols=28 Identities=21% Similarity=0.404 Sum_probs=24.1
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
.|++.|..+|. ++|.|+.+||..++..+
T Consensus 16 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~ 44 (81)
T d1fi5a_ 16 ELSDLFRMFDKNADGYIDLEELKIMLQAT 44 (81)
T ss_dssp HHHHHHHHHCSSCSSEECHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCCCCcccHHHHHHHHHhc
Confidence 46788999999 89999999999998754
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=91.51 E-value=0.038 Score=37.86 Aligned_cols=28 Identities=18% Similarity=0.446 Sum_probs=22.6
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
.|++.|..+|. ++|.|+.+||+.++..+
T Consensus 3 el~~~F~~~D~d~~G~I~~~el~~~l~~~ 31 (68)
T d1c7va_ 3 EILRAFKVFDANGDGVIDFDEFKFIMQKV 31 (68)
T ss_dssp HHHHHHHHHSCSGGGEECHHHHHHHSSTT
T ss_pred HHHHHHHHHcCCCcCeEcHHHHHHHHHHh
Confidence 36788888898 89999999998887653
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=91.28 E-value=0.12 Score=28.70 Aligned_cols=26 Identities=15% Similarity=0.397 Sum_probs=21.5
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
|.+.|..+|. .||.|+.+||...+.+
T Consensus 6 Lae~FRifDkNaDGyiD~eEl~~ilr~ 32 (34)
T d1ctda_ 6 LANAFRIFDKNADGYIDIEELGEILRA 32 (34)
T ss_dssp HHHHHHTTCCSSSSCBCHHHHHHHHHH
T ss_pred HHHHHHHHccCCcccccHHHHHHHHHh
Confidence 4567777799 8999999999988764
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=91.01 E-value=0.047 Score=41.16 Aligned_cols=27 Identities=15% Similarity=0.179 Sum_probs=14.8
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
..++++|+.+|. +||.|+.+||.+.++
T Consensus 79 ~~~~~l~~~~D~d~dG~I~~~EF~~~m~ 106 (107)
T d2pvba_ 79 AETKAFLADGDKDGDGMIGVDEFAAMIK 106 (107)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence 345555555555 555555555555443
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.19 E-value=0.096 Score=37.14 Aligned_cols=28 Identities=14% Similarity=0.288 Sum_probs=16.7
Q ss_pred HHHHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 432 LVYLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 432 ~~~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
...+++.|+.+|. ++|.|+.+||+.+|.
T Consensus 19 ~~~l~~~F~~~D~~~~G~i~~~ef~~~l~ 47 (83)
T d1wlza1 19 YHAITQEFENFDTMKTNTISREEFRAICN 47 (83)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCceEChhHHHHHHH
Confidence 3445566666666 666666666666554
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=90.00 E-value=0.13 Score=35.86 Aligned_cols=46 Identities=22% Similarity=0.263 Sum_probs=28.0
Q ss_pred HHHHHHHHHHHhcCHHH---HHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 415 LKRAALKALSKALTEEE---LVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 415 ~~~~~~~~~~~~l~~~e---~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
+....+..+...+...- ...+.++|..+|. ++|.|+.+||...+..
T Consensus 24 I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m~~ 73 (76)
T d1qx2a_ 24 ISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKK 73 (76)
T ss_dssp EEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred ECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHHHH
Confidence 44444544444444321 1236677788888 7888888888877654
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=89.24 E-value=0.077 Score=39.94 Aligned_cols=26 Identities=12% Similarity=0.271 Sum_probs=15.6
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
.+++.|..+|. ++|.|+.+||+.+++
T Consensus 42 ~l~~~F~~~D~d~~G~I~~~El~~~l~ 68 (108)
T d1rroa_ 42 QVKDIFRFIDNDQSGYLDGDELKYFLQ 68 (108)
T ss_dssp HHHHHHHHHCTTCSSEECTHHHHTGGG
T ss_pred HHHHHHhhhcCCCCCeEcHHHHHHHHH
Confidence 34556666666 666666666665554
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=88.73 E-value=0.09 Score=39.61 Aligned_cols=27 Identities=15% Similarity=0.255 Sum_probs=18.6
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.++..|..+|. ++|.|+.+||+.++++
T Consensus 42 ~~~~~F~~~D~d~~G~I~~~El~~~l~~ 69 (109)
T d1rwya_ 42 DVKKVFHILDKDKSGFIEEDELGSILKG 69 (109)
T ss_dssp HHHHHHHHHSTTCSSEECHHHHHTHHHH
T ss_pred HHHHHhhcccCCCCCcCcHHHHHHHHHH
Confidence 35566777777 7777777777776653
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.70 E-value=1 Score=36.13 Aligned_cols=27 Identities=22% Similarity=0.255 Sum_probs=18.4
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHHHHh
Q 012518 358 VSPEAKDFVRRLLNKDHRKRMTAAQAL 384 (461)
Q Consensus 358 ~s~~~~~li~~~L~~dP~~R~s~~e~L 384 (461)
++.+....+..++..|-..|.+..|-+
T Consensus 37 ~s~~~~~~li~~~D~~~~G~i~~~EF~ 63 (165)
T d1k94a_ 37 FSLETCRIMIAMLDRDHTGKMGFNAFK 63 (165)
T ss_dssp CCHHHHHHHHHHHCTTCSSCBCHHHHH
T ss_pred CCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 566666666666777777787777643
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=88.62 E-value=0.1 Score=39.34 Aligned_cols=27 Identities=19% Similarity=0.256 Sum_probs=21.5
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.|++.|..+|. ++|.|+.+||+.+++.
T Consensus 42 ~l~~~F~~~D~d~~G~I~~~El~~~l~~ 69 (109)
T d5pala_ 42 QVKEVFEILDKDQSGFIEEEELKGVLKG 69 (109)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHTHHHH
T ss_pred HHHHHHhhhcCCCCCeEcHHHHHHHHHH
Confidence 46778888888 8888888888877653
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=88.07 E-value=0.12 Score=37.51 Aligned_cols=31 Identities=13% Similarity=0.232 Sum_probs=26.8
Q ss_pred HHHHHHHHHHhhhcCCCCCeecHHHHHHHHh
Q 012518 429 EEELVYLRAQFMLLEPKDGCVSLNNFKVVSW 459 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d~~~g~~~~~el~~~~~ 459 (461)
++.+..|...|..+|.++|.||.+||..++.
T Consensus 5 E~~ie~l~~~F~~yd~ddG~is~~El~~~l~ 35 (92)
T d1a4pa_ 5 EHAMETMMFTFHKFAGDKGYLTKEDLRVLME 35 (92)
T ss_dssp HHHHHHHHHHHHHHHGGGCSBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCEEcHHHHHHHHH
Confidence 3456789999999998889999999999975
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=87.93 E-value=0.22 Score=34.47 Aligned_cols=39 Identities=18% Similarity=0.278 Sum_probs=30.1
Q ss_pred HHHHHHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 420 LKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 420 ~~~~~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
+..+...++.+++ .+.|..+|. ++|.|+.+||...+++|
T Consensus 35 l~~lg~~~~~~e~---~~~~~~~D~d~dg~I~~~EF~~~m~~~ 74 (75)
T d1jc2a_ 35 LRATGEHVIEEDI---EDLMKDSDKNNDGRIDFDEFLKMMEGV 74 (75)
T ss_dssp HHHSSSCCCHHHH---HHHHHHHCSSSCSEECHHHHHHHHHTC
T ss_pred HHhcCCCccHHHH---HHHHHHhCCCCCCcEeHHHHHHHHHhC
Confidence 3344556677775 466788899 89999999999998865
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=87.60 E-value=0.12 Score=39.00 Aligned_cols=27 Identities=15% Similarity=0.239 Sum_probs=20.3
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.++..|..+|. ++|.|+.+||+.++..
T Consensus 42 ~~~~~F~~~D~d~~G~I~~~El~~~l~~ 69 (109)
T d1pvaa_ 42 DVKKVFKAIDADASGFIEEEELKFVLKS 69 (109)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHTGGGG
T ss_pred HHHHHhhCccCCCcCeEcHHHHHHHHHH
Confidence 35677888888 7888888888777654
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.22 E-value=0.15 Score=37.51 Aligned_cols=26 Identities=15% Similarity=0.249 Sum_probs=23.3
Q ss_pred HHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 435 LRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 435 l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
++..|..+|. ++|.|+.+||..++..
T Consensus 18 ~r~~F~~~D~DgdG~i~~~El~~~l~~ 44 (99)
T d1snla_ 18 PKTFFILHDINSDGVLDEQELEALFTK 44 (99)
T ss_dssp HHHHHHHHCSSCCSEEEHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHH
Confidence 5789999999 9999999999998853
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.08 E-value=0.086 Score=39.84 Aligned_cols=27 Identities=26% Similarity=0.305 Sum_probs=22.2
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.|..++...|. ++|.|+++||..+|..
T Consensus 57 ~L~~Iw~l~D~d~dG~l~~~EF~~am~L 84 (110)
T d1iq3a_ 57 ELSYIWELSDADCDGALTLPEFCAAFHL 84 (110)
T ss_dssp CHHHHHHHHCSSSCSEEEHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCeECHHHHHHHHHH
Confidence 47778888888 8999999999888764
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=86.50 E-value=0.53 Score=36.63 Aligned_cols=27 Identities=11% Similarity=0.180 Sum_probs=20.8
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.++..|..+|. ++|.|+.+||+.++..
T Consensus 77 ~l~~aF~~~D~d~~G~I~~~el~~~l~~ 104 (142)
T d1wdcb_ 77 TIRNAFAMFDEQETKKLNIEYIKDLLEN 104 (142)
T ss_dssp HHHHHHHTTCTTCCSCEEHHHHHHHHHH
T ss_pred hHHHhhhhhcccCCCcccHHHHHHHHHH
Confidence 45677888888 7888888888887764
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=85.40 E-value=0.22 Score=35.01 Aligned_cols=36 Identities=14% Similarity=0.193 Sum_probs=28.1
Q ss_pred HHHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 423 LSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 423 ~~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
+...++.+++. .+|..+|. ++|.|+.+||...++.+
T Consensus 44 ~g~~~~~~ev~---~~~~~~D~d~dg~I~~~EF~~~m~~~ 80 (81)
T d1fi5a_ 44 TGETITEDDIE---ELMKDGDKNNDGRIDYDEFLEFMKGV 80 (81)
T ss_dssp SSSCCCHHHHH---HHHHHHCSSSSSSEEHHHHHHHHSCC
T ss_pred cCCCCCHHHHH---HHHHHHCCCCCCcEeHHHHHHHHHhc
Confidence 34456776654 67788899 99999999999988764
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=85.20 E-value=0.41 Score=35.09 Aligned_cols=32 Identities=9% Similarity=0.084 Sum_probs=28.0
Q ss_pred HHHHHHHHHHhhhcCCCCCeecHHHHHHHHhh
Q 012518 429 EEELVYLRAQFMLLEPKDGCVSLNNFKVVSWL 460 (461)
Q Consensus 429 ~~e~~~l~~~f~~~d~~~g~~~~~el~~~~~~ 460 (461)
++.+..+..+|..++.++|.|+.+||++.++.
T Consensus 6 E~~i~~l~~~F~~y~~~dG~i~~~El~~ll~~ 37 (100)
T d1psra_ 6 ERSIIGMIDMFHKYTRRDDKIDKPSLLTMMKE 37 (100)
T ss_dssp HHHHHHHHHHHHHTCCTTSCBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCcccHHHHHHHHHH
Confidence 55678889999999888999999999999874
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.03 E-value=0.45 Score=34.68 Aligned_cols=28 Identities=14% Similarity=0.127 Sum_probs=24.6
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..+..+|..+|. +||.||.+||..++++
T Consensus 68 ~~v~~~~~~~D~d~DG~Is~~EF~~~~~~ 96 (99)
T d1snla_ 68 RMREHVMKNVDTNQDRLVTLEEFLASTQR 96 (99)
T ss_dssp HHHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred HHHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence 346889999999 9999999999998764
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=85.02 E-value=0.51 Score=32.52 Aligned_cols=37 Identities=11% Similarity=0.213 Sum_probs=28.9
Q ss_pred HHHHHHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 420 LKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 420 ~~~~~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
+..+...++++++ .+.|..+|. ++|.|+.+||...+.
T Consensus 36 l~~~g~~~t~~e~---~~~~~~~D~~~~g~I~~~eF~~~m~ 73 (77)
T d1f54a_ 36 MRSLGLSPSEAEV---NDLMNEIDVDGNHQIEFSEFLALMS 73 (77)
T ss_dssp HHHHTCCCCHHHH---HHHHHTTCCSSCCEEEHHHHHHHHT
T ss_pred HHHhCCCCCHHHH---HHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 4445566777774 577888899 899999999998875
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=84.81 E-value=0.52 Score=32.49 Aligned_cols=37 Identities=27% Similarity=0.307 Sum_probs=28.1
Q ss_pred HHHHHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 421 KALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 421 ~~~~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..+...++.+++ .+.|..+|. ++|.|+.+||...++.
T Consensus 36 ~~~g~~~~~~e~---~~~~~~~D~d~~G~I~~~EF~~~m~k 73 (77)
T d1oqpa_ 36 KELGENLTEEEL---QEMIAEADRNDDNEIDEDEFIRIMKK 73 (77)
T ss_dssp HHHTCCCCHHHH---HHHHHHHCCSSSSEECHHHHHHHHHH
T ss_pred HHhCCCCCHHHH---HHHHHHhCCCCCCcEeHHHHHHHHHc
Confidence 334445666664 467888899 9999999999998764
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=83.05 E-value=0.47 Score=36.99 Aligned_cols=31 Identities=26% Similarity=0.349 Sum_probs=16.0
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 426 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 426 ~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.++.+|+..+. .. |. ++|.|+.+||.+.+.+
T Consensus 113 ~~~~~e~~~l~---~~-~~d~dG~I~y~eF~~~ll~ 144 (145)
T d2mysc_ 113 KMTEEEVEELM---KG-QEDSNGCINYEAFVKHIMS 144 (145)
T ss_pred CCCHHHHHHHH---hh-cCCCCCeEEHHHHHHHHhc
Confidence 44555544332 22 33 5666666666665554
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.97 E-value=1.3 Score=35.20 Aligned_cols=36 Identities=19% Similarity=0.266 Sum_probs=27.0
Q ss_pred HhcCHHHH-HHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 425 KALTEEEL-VYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 425 ~~l~~~e~-~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..+..+.. ..+...|..+|. +||.|+.+||.+.+..
T Consensus 117 ~~~~~~~~~~~~~~~~~~~D~~~dG~Is~~EF~~i~~~ 154 (165)
T d1auib_ 117 NNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGG 154 (165)
T ss_dssp TSSCHHHHHHHHHHHHHHHCTTSSSSEEHHHHHHHHGG
T ss_pred ccCchHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHHhc
Confidence 34444333 335688999999 8999999999998864
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=82.83 E-value=0.57 Score=31.91 Aligned_cols=38 Identities=18% Similarity=0.344 Sum_probs=28.6
Q ss_pred HHHHHHHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHh
Q 012518 419 ALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSW 459 (461)
Q Consensus 419 ~~~~~~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~ 459 (461)
++..+...++++++ ..++..+|. ++|.|+.+||...+.
T Consensus 33 ~l~~~g~~~s~~~~---~~~~~~~D~d~~g~I~f~eF~~~m~ 71 (73)
T d2pq3a1 33 VMRSLGQNPTEAEL---QDMINEVDADGNGTIDFPEFLTMMA 71 (73)
T ss_dssp HHHHTTCCCCHHHH---HHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred HHHHhCCCCCHHHH---HHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 34445556777765 467777899 999999999998775
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=82.76 E-value=0.55 Score=38.79 Aligned_cols=30 Identities=13% Similarity=0.130 Sum_probs=26.0
Q ss_pred HHHHHHHhhhcCC-CCCeecHHHHHHHHhhC
Q 012518 432 LVYLRAQFMLLEP-KDGCVSLNNFKVVSWLL 461 (461)
Q Consensus 432 ~~~l~~~f~~~d~-~~g~~~~~el~~~~~~~ 461 (461)
+..++..|..+|. ++|.|+.+||..+|..+
T Consensus 92 ~~~~~~~F~~~D~d~sG~i~~~El~~~l~~~ 122 (188)
T d1qxpa2 92 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAA 122 (188)
T ss_dssp HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHT
T ss_pred hHHHHHHHHHhCCCCCCEECHHHHHHHHHHh
Confidence 3457889999999 99999999999998764
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=82.62 E-value=0.57 Score=32.85 Aligned_cols=39 Identities=23% Similarity=0.312 Sum_probs=29.0
Q ss_pred HHHHHHHhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 419 ALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 419 ~~~~~~~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
++..+...++++++. +.+..+|. ++|.|+.+||...+.+
T Consensus 41 ~l~~lg~~~t~~el~---~~i~~~D~d~~G~I~f~eFl~im~~ 80 (82)
T d1wrka1 41 VMRMLGQNPTPEELQ---EMIDEVDEDGSGTVDFDEFLVMMVR 80 (82)
T ss_dssp HHHHTTCCCCHHHHH---HHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred HHHHcCCCCCHHHHH---HHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 344455566777754 66778899 8999999999987653
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=82.55 E-value=0.37 Score=42.95 Aligned_cols=36 Identities=28% Similarity=0.282 Sum_probs=32.3
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 425 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 425 ~~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..+++++...+++.|..+|. ++|.|+.+||+.+|..
T Consensus 114 ~~l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~ 150 (321)
T d1ij5a_ 114 PMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAK 150 (321)
T ss_dssp CCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHH
Confidence 35788899999999999999 8999999999998854
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=82.22 E-value=0.4 Score=34.53 Aligned_cols=35 Identities=23% Similarity=0.288 Sum_probs=31.7
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 426 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 426 ~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.++.+|...+++.|..+|. ++|.|+.+|+...|+.
T Consensus 2 ~ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~ 37 (92)
T d1fi6a_ 2 KITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTK 37 (92)
T ss_dssp CCCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHH
Confidence 3688999999999999999 9999999999998864
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=81.78 E-value=0.31 Score=35.77 Aligned_cols=32 Identities=25% Similarity=0.269 Sum_probs=26.5
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 426 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 426 ~l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.+.+++ |.++++..|. ++|.|+.+||..++..
T Consensus 41 ~L~~~~---L~~i~~~~D~d~dG~L~~~EF~~am~L 73 (99)
T d1qjta_ 41 GLPDLI---LGKIWDLADTDGKGVLSKQEFFVALRL 73 (99)
T ss_dssp SSCHHH---HHHHHHHHCCSSSSSCCSHHHHHHHHH
T ss_pred CCcHHH---HHHHHHHHcCCCCCccCHHHHHHHHHH
Confidence 455554 6688899999 9999999999999864
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=81.33 E-value=0.42 Score=34.58 Aligned_cols=27 Identities=15% Similarity=0.185 Sum_probs=23.1
Q ss_pred HHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 434 YLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 434 ~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
.++++|..+|. +||.|+.+||...+.+
T Consensus 53 ~~~~i~~~~D~n~DG~I~F~EF~~lm~~ 80 (93)
T d3c1va1 53 AFQKLMSNLDSNRDNEVDFQEYCVFLSC 80 (93)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCHHHHHHHHHH
Confidence 36788899999 9999999999987654
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.54 E-value=0.27 Score=35.79 Aligned_cols=34 Identities=18% Similarity=0.151 Sum_probs=31.0
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 427 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 427 l~~~e~~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
++.+|...++++|..+|. ++|.|+.+|+...|+.
T Consensus 4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~ 38 (95)
T d1c07a_ 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLK 38 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHh
Confidence 677888999999999999 9999999999998865
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=80.26 E-value=0.44 Score=37.19 Aligned_cols=28 Identities=25% Similarity=0.254 Sum_probs=23.8
Q ss_pred HHHHHHhhhcCC-CCCeecHHHHHHHHhh
Q 012518 433 VYLRAQFMLLEP-KDGCVSLNNFKVVSWL 460 (461)
Q Consensus 433 ~~l~~~f~~~d~-~~g~~~~~el~~~~~~ 460 (461)
..++..|..+|. ++|.|+.+||++++..
T Consensus 83 ~~~~~aF~~~D~d~~G~I~~~el~~~l~~ 111 (146)
T d1lkja_ 83 QELLEAFKVFDKNGDGLISAAELKHVLTS 111 (146)
T ss_dssp HHHHHHHHHHCSSSSCEEEHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 457788999999 8999999999988764
|